PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Francischetti, IMB; Gordon, E; Bizzarro, B; Gera, N; Andrade, BB; Oliveira, F; Ma, DY; Assumpcao, TCF; Ribeiro, JMC; Pena, M; Qi, CF; Diouf, A; Moretz, SE; Long, CA; Ackerman, HC; Pierce, SK; Sa-Nunes, A; Waisberg, M				Francischetti, Ivo M. B.; Gordon, Emile; Bizzarro, Bruna; Gera, Nidhi; Andrade, Bruno B.; Oliveira, Fabiano; Ma, Dongying; Assumpcao, Teresa C. F.; Ribeiro, Jose M. C.; Pena, Mirna; Qi, Chen-Feng; Diouf, Ababacar; Moretz, Samuel E.; Long, Carole A.; Ackerman, Hans C.; Pierce, Susan K.; Sa-Nunes, Anderson; Waisberg, Michael			Tempol, an Intracellular Antioxidant, Inhibits Tissue Factor Expression, Attenuates Dendritic Cell Function, and Is Partially Protective in a Murine Model of Cerebral Malaria	PLOS ONE			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; FACTOR-KAPPA-B; BLOOD-BRAIN-BARRIER; INNATE IMMUNE-RESPONSE; PLASMODIUM-FALCIPARUM; OXIDATIVE STRESS; ENDOTHELIAL-CELLS; PLATELET ACTIVATION; HEME OXYGENASE-1; FACTOR INDUCTION	Background: The role of intracellular radical oxygen species (ROS) in pathogenesis of cerebral malaria (CM) remains incompletely understood. Methods and Findings: We undertook testing Tempol-a superoxide dismutase (SOD) mimetic and pleiotropic intracellular antioxidant-in cells relevant to malaria pathogenesis in the context of coagulation and inflammation. Tempol was also tested in a murine model of CM induced by Plasmodium berghei Anka infection. Tempol was found to prevent transcription and functional expression of procoagulant tissue factor in endothelial cells (ECs) stimulated by lipopolysaccharide (LPS). This effect was accompanied by inhibition of IL-6, IL-8, and monocyte chemoattractant protein (MCP-1) production. Tempol also attenuated platelet aggregation and human promyelocytic leukemia HL60 cells oxidative burst. In dendritic cells, Tempol inhibited LPS-induced production of TNF-alpha, IL-6, and IL-12p70, downregulated expression of co-stimulatory molecules, and prevented antigen-dependent lymphocyte proliferation. Notably, Tempol (20 mg/kg) partially increased the survival of mice with CM. Mechanistically, treated mice had lowered plasma levels of MCP-1, suggesting that Tempol downmodulates EC function and vascular inflammation. Tempol also diminished blood brain barrier permeability associated with CM when started at day 4 post infection but not at day 1, suggesting that ROS production is tightly regulated. Other antioxidants-such as a-phenyl N-tertiary-butyl nitrone (PBN; a spin trap), MnTe-2-PyP and MnTBAP (Mn-phorphyrin), Mitoquinone (MitoQ) and Mitotempo (mitochondrial antioxidants), M30 (an iron chelator), and epigallocatechin gallate (EGCG; polyphenol from green tea) did not improve survival. By contrast, these compounds (except PBN) inhibited Plasmodium falciparum growth in culture with different IC50s. Knockout mice for SOD1 or phagocyte nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (gp91(phox-/-)) or mice treated with inhibitors of SOD (diethyldithiocarbamate) or NADPH oxidase (diphenyleneiodonium) did not show protection or exacerbation for CM. Conclusion: Results with Tempol suggest that intracellular ROS contribute, in part, to CM pathogenesis. Therapeutic targeting of intracellular ROS in CM is discussed.	[Francischetti, Ivo M. B.; Oliveira, Fabiano; Ma, Dongying; Assumpcao, Teresa C. F.; Ribeiro, Jose M. C.; Diouf, Ababacar; Moretz, Samuel E.; Long, Carole A.; Ackerman, Hans C.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Gordon, Emile; Gera, Nidhi; Pena, Mirna; Qi, Chen-Feng; Pierce, Susan K.; Waisberg, Michael] NIAID, Immunogenet Lab, NIH, Rockville, MD USA; [Bizzarro, Bruna; Sa-Nunes, Anderson] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Expt Immunol Lab, Sao Paulo, Brazil; [Andrade, Bruno B.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Waisberg, Michael] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universidade de Sao Paulo; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Virginia	Francischetti, IMB (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA.	ifrancischetti@niaid.nih.gov; waisberg@gmail.com	Sa-Nunes, Anderson/D-8667-2012; Oliveira, Fabiano/AAG-5388-2019; Sa-Nunes, Anderson/M-5654-2019; ma, dongying/D-8623-2012; Andrade, Bruno/AAI-2248-2020; Ackerman, Hans/U-9621-2019; Andrade, Bruno/J-9111-2012; Ribeiro, Jose/J-7011-2015; Bizzarro, Bruna/K-4778-2016	Sa-Nunes, Anderson/0000-0002-1859-4973; Oliveira, Fabiano/0000-0002-7924-8038; Sa-Nunes, Anderson/0000-0002-1859-4973; Ackerman, Hans/0000-0003-4940-3305; Andrade, Bruno/0000-0001-6833-3811; Bizzarro, Bruna/0000-0001-6315-0549; Ribeiro, Jose/0000-0002-9107-0818	Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Brazilian Malaria Network (MCT/CNPq/MS/SCTIE/DECIT/PRONEX) [555648/2009-5]; Research Network on Bioactive Molecules from Arthropod Vectors (NAP-MOBIARVE, University of Sao Paulo); PATH/Malaria Vaccine Initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001064, ZIAAI000810, ZIAAI001150, ZIAAI001020] Funding Source: NIH RePORTER	Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Brazilian Malaria Network (MCT/CNPq/MS/SCTIE/DECIT/PRONEX); Research Network on Bioactive Molecules from Arthropod Vectors (NAP-MOBIARVE, University of Sao Paulo); PATH/Malaria Vaccine Initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. Dr. Anderson Sa-Nunes is recipient of grants from Brazilian Malaria Network (MCT/CNPq/MS/SCTIE/DECIT/PRONEX - 555648/2009-5) and from the Research Network on Bioactive Molecules from Arthropod Vectors (NAP-MOBIARVE, University of Sao Paulo). GIA Reference Center is supported by the PATH/Malaria Vaccine Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade BB, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000650; Anidi IU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071010; Assumpcao TCF, 2013, J BIOL CHEM, V288, P14341, DOI 10.1074/jbc.M113.466995; Avery JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031090; Banfi C, 2011, J THROMB HAEMOST, V9, P1608, DOI 10.1111/j.1538-7836.2011.04366.x; Banfi C, 2009, J THROMB HAEMOST, V7, P206, DOI 10.1111/j.1538-7836.2008.03204.x; Batinic-Haberle I, 2010, ANTIOXID REDOX SIGN, V13, P877, DOI 10.1089/ars.2009.2876; Batinic-Haberle I, 2009, FREE RADICAL BIO MED, V46, P192, DOI 10.1016/j.freeradbiomed.2008.09.042; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; BIERHAUS A, 1995, THROMB HAEMOSTASIS, V73, P39; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Charunwatthana P, 2009, CRIT CARE MED, V37, P516, DOI 10.1097/CCM.0b013e3181958dfd; Chatterjee PK, 2000, KIDNEY INT, V58, P658, DOI 10.1046/j.1523-1755.2000.00212.x; Clark IA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-85; COCCO D, 1981, J BIOL CHEM, V256, P8983; CONRAD ME, 1969, ANN INTERN MED, V70, P134, DOI 10.7326/0003-4819-70-1-134; COOPER JM, 1988, J NEUROL SCI, V83, P335, DOI 10.1016/0022-510X(88)90079-2; COOPER JM, 1988, BIOCHEM PHARMACOL, V37, P687, DOI 10.1016/0006-2952(88)90143-8; Crompton PD, 2010, INFECT IMMUN, V78, P737, DOI 10.1128/IAI.00960-09; Cuzzocrea S, 2004, FREE RADICAL RES, V38, P813, DOI 10.1080/10715760410001710829; DAS BS, 1993, AM J TROP MED HYG, V49, P720, DOI 10.4269/ajtmh.1993.49.720; Dasari P, 2012, BLOOD, V119, P4301, DOI 10.1182/blood-2011-11-392134; de Mast Q, 2010, BRIT J HAEMATOL, V151, P495, DOI 10.1111/j.1365-2141.2010.08399.x; de Mast Q, 2009, AM J TROP MED HYG, V80, P492, DOI 10.4269/ajtmh.2009.80.492; Debierre-Grockiego F, 2010, GLYCOBIOLOGY, V20, P801, DOI 10.1093/glycob/cwq038; DENNIS LH, 1967, BLOOD-J HEMATOL, V29, P713; Dey S, 2012, J BIOL CHEM, V287, P26630, DOI 10.1074/jbc.M112.341255; Esmon CT, 2011, ANNU REV PHYSIOL, V73, P503, DOI 10.1146/annurev-physiol-012110-142300; Faille D, 2009, THROMB HAEMOSTASIS, V102, P1093, DOI 10.1160/TH09-05-0337; Fairhurst RM, 2012, MICROBES INFECT, V14, P851, DOI 10.1016/j.micinf.2012.05.006; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Finney CAM, 2011, MOL MED, V17, P717, DOI 10.2119/molmed.2010.00214; Francischetti IMB, 2007, J THROMB HAEMOST, V5, P155, DOI 10.1111/j.1538-7836.2006.02232.x; Francischetti IMB, 2008, TRENDS PARASITOL, V24, P258, DOI 10.1016/j.pt.2008.03.009; Francischetti IMB, 2008, MICROCIRCULATION, V15, P81, DOI 10.1080/10739680701451516; Francischetti IMB, 2012, ARTERIOSCL THROM VAS, V32, P786, DOI 10.1161/ATVBAHA.111.240291; Fraser PA, 2011, FREE RADICAL BIO MED, V51, P967, DOI 10.1016/j.freeradbiomed.2011.06.003; Gal S, 2006, J NEURAL TRANSM-SUPP, P447; GATLEY SJ, 1979, XENOBIOTICA, V9, P539, DOI 10.3109/00498257909042319; Ghosh A, 2010, FREE RADICAL BIO MED, V49, P1674, DOI 10.1016/j.freeradbiomed.2010.08.028; Golenser J, 1998, FREE RADICAL BIO MED, V24, P1504, DOI 10.1016/S0891-5849(98)00026-4; Goyal M, 2012, CURR MED CHEM, V19, P1475, DOI 10.2174/092986712799828328; Gozzelino R, 2012, CELL HOST MICROBE, V12, P693, DOI 10.1016/j.chom.2012.10.011; Greve B, 1999, J INFECT DIS, V179, P1584, DOI 10.1086/314780; Griffin JH, 2012, INT J HEMATOL, V95, P333, DOI 10.1007/s12185-012-1059-0; Griffith JW, 2009, J IMMUNOL, V183, P5208, DOI 10.4049/jimmunol.0713552; Griffiths MJ, 2001, BRIT J HAEMATOL, V113, P486, DOI 10.1046/j.1365-2141.2001.02758.x; Guha M, 2006, FASEB J, V20, P1224, DOI 10.1096/fj.05-5338fje; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hawkes M, 2013, VIRULENCE, V4, P543, DOI 10.4161/viru.25949; HEMMER CJ, 1991, AM J MED, V91, P37, DOI 10.1016/0002-9343(91)90071-5; Higgins SJ, 2011, EXPERT REV ANTI-INFE, V9, P803, DOI [10.1586/eri.11.96, 10.1586/ERI.11.96]; HIGUCHI DA, 1992, BLOOD, V79, P1712; Jiang F, 2011, PHARMACOL REV, V63, P218, DOI 10.1124/pr.110.002980; Kanegasaki S, 2003, J IMMUNOL METHODS, V282, P1, DOI 10.1016/j.jim.2003.07.008; Karlsson M, 2013, INT J BIOCHEM CELL B, V45, P151, DOI 10.1016/j.biocel.2012.08.008; Kim YS, 2007, J CARDIOVASC PHARM, V49, P376, DOI 10.1097/FJC.0b013e31804a5e34; Kluge MA, 2013, CIRC RES, V112, P1171, DOI 10.1161/CIRCRESAHA.111.300233; Kono H, 2001, AM J PHYSIOL-GASTR L, V280, pG1005, DOI 10.1152/ajpgi.2001.280.5.G1005; Kremsner PG, 2000, LANCET, V355, P40, DOI 10.1016/S0140-6736(99)04761-3; Krishna MC, 1996, J BIOL CHEM, V271, P26026, DOI 10.1074/jbc.271.42.26026; Krotz F, 2004, ARTERIOSCL THROM VAS, V24, P1988, DOI 10.1161/01.ATV.0000145574.90840.7d; Langhorne J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-23; Larkin D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000349; Leonarduzzi G, 2011, CURR PHARM DESIGN, V17, P3994, DOI 10.2174/138161211798764906; Li XH, 2008, J IMMUNOL, V181, P1215, DOI 10.4049/jimmunol.181.2.1215; Linares M, 2013, BBA-MOL BASIS DIS, V1832, P2009, DOI 10.1016/j.bbadis.2013.07.010; Liu ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034280; Lochhead JJ, 2010, J CEREBR BLOOD F MET, V30, P1625, DOI 10.1038/jcbfm.2010.29; Lucchi NW, 2011, PLACENTA, V32, P579, DOI 10.1016/j.placenta.2011.05.003; Luyendyk JP, 2007, ARTERIOSCL THROM VAS, V27, P1857, DOI 10.1161/ATVBAHA.107.143552; Mackman N, 1997, THROMB HAEMOSTASIS, V78, P747; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; MANWELL RD, 1976, J PARASITOL, V62, P110, DOI 10.2307/3279052; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; Matsue H, 2003, J IMMUNOL, V171, P3010, DOI 10.4049/jimmunol.171.6.3010; Metz JM, 2004, CLIN CANCER RES, V10, P6411, DOI 10.1158/1078-0432.CCR-04-0658; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; Milner DA, 2010, CURR OPIN INFECT DIS, V23, P456, DOI 10.1097/QCO.0b013e32833c3dbe; Moore JM, 2012, ARTERIOSCL THROM VAS, V32, P541, DOI 10.1161/ATVBAHA.111.242776; Moreno A, 2013, INFECT IMMUN, V81, P1889, DOI 10.1128/IAI.00027-13; Mukhopadhyay P, 2012, FREE RADICAL BIO MED, V52, P497, DOI 10.1016/j.freeradbiomed.2011.11.001; Nacer A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002982; Narsaria N, 2012, J TROP PEDIATRICS, V58, P147, DOI 10.1093/tropej/fmr043; Ndonwi M, 2011, BLOOD, V117, P6347, DOI 10.1182/blood-2010-12-326876; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; Oberley-Deegan RE, 2009, AM J RESP CELL MOL, V41, P170, DOI 10.1165/rcmb.2008-0138OC; OLEARY DS, 1972, AM J TROP MED HYG, V21, P282, DOI 10.4269/ajtmh.1972.21.282; Oliveira F, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000226; Opal SM, 2003, CRIT CARE, V7, P23, DOI 10.1186/cc1854; Owens AP, 2012, J CLIN INVEST, V122, P558, DOI 10.1172/JCI58969; Pabon A, 2003, CLIN BIOCHEM, V36, P71, DOI 10.1016/S0009-9120(02)00423-X; Paiva CN, 2013, ANTIOXID REDOX SIGN; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; PECANHA LMT, 1988, ANN TROP MED PARASIT, V82, P429, DOI 10.1080/00034983.1988.11812272; Pendurthi UR, 1999, ARTERIOSCL THROM VAS, V19, P419, DOI 10.1161/01.ATV.19.2.419; Percario S, 2012, INT J MOL SCI, V13, P16346, DOI 10.3390/ijms131216346; Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514; Pino P, 2005, THROMB HAEMOSTASIS, V94, P336, DOI 10.1160/TH05-05-0354; Pino P, 2003, ANN NY ACAD SCI, V1010, P582, DOI 10.1196/annals.1299.109; Pino P, 2003, J INFECT DIS, V187, P1283, DOI 10.1086/373992; Postma NS, 1996, PHARM WORLD SCI, V18, P121, DOI 10.1007/BF00717727; Prommano Oranan, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1359; Punsawad C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-260; Punsawad C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-191; REINER G, 1991, ACTA TROP, V50, P59, DOI 10.1016/0001-706X(91)90073-S; Reis PA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003099; Reis PA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000963; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Ruf W, 2004, CRIT CARE MED, V32, pS287, DOI 10.1097/01.CCM.0000126364.46191.12; Ruf W, 2009, J THROMB HAEMOST, V7, P118, DOI 10.1111/j.1538-7836.2009.03374.x; Sa-Nunes A, 2007, J IMMUNOL, V179, P1497, DOI 10.4049/jimmunol.179.3.1497; Sa-Nunes A, 2009, J IMMUNOL, V182, P7422, DOI 10.4049/jimmunol.0900075; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; Sanni LA, 1999, J INFECT DIS, V179, P217, DOI 10.1086/314552; Schober A, 2008, ARTERIOSCL THROM VAS, V28, P1950, DOI 10.1161/ATVBAHA.107.161224; Schwartz E, 1999, INFLAMMATION, V23, P361; Seixas E, 2009, EUR J IMMUNOL, V39, P1850, DOI 10.1002/eji.200838403; Seydel KB, 2006, J INFECT DIS, V194, P208, DOI 10.1086/505078; Silver KL, 2010, CELL MICROBIOL, V12, P1036, DOI 10.1111/j.1462-5822.2010.01492.x; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Smith RAJ, 2012, TRENDS PHARMACOL SCI, V33, P341, DOI 10.1016/j.tips.2012.03.010; Snow BJ, 2010, MOVEMENT DISORD, V25, P1670, DOI 10.1002/mds.23148; Steiner S, 2005, CIRCULATION, V111, P1841, DOI 10.1161/01.CIR.0000158665.27783.0C; Taoufiq Z, 2006, MOL BIOCHEM PARASIT, V150, P166, DOI 10.1016/j.molbiopara.2006.07.008; Tardif JC, 2008, LANCET, V371, P1761, DOI 10.1016/S0140-6736(08)60763-1; Thuma PE, 1998, T ROY SOC TROP MED H, V92, P214, DOI 10.1016/S0035-9203(98)90753-2; THUMWOOD CM, 1989, BRIT J EXP PATHOL, V70, P293; Tripathi AK, 2006, INFECT IMMUN, V74, P3262, DOI 10.1128/IAI.01625-05; Trnka J, 2008, FREE RADICAL BIO MED, V44, P1406, DOI 10.1016/j.freeradbiomed.2007.12.036; Trnka J, 2009, FREE RADICAL RES, V43, P4, DOI 10.1080/10715760802582183; Tsuhako MH, 2010, FREE RADICAL BIO MED, V48, P704, DOI 10.1016/j.freeradbiomed.2009.12.013; van der Poll T, 2011, CURR OPIN INFECT DIS, V24, P273, DOI 10.1097/QCO.0b013e328344c078; Villegas-Mendez A, 2012, J IMMUNOL, V189, P968, DOI 10.4049/jimmunol.1200688; von Montfort C, 2012, J HEPATOL, V57, P852, DOI 10.1016/j.jhep.2012.05.024; Waisberg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062820; Waisberg M, 2011, P NATL ACAD SCI USA, V108, P1122, DOI 10.1073/pnas.1017996108; Watson SP, 2009, CURR PHARM DESIGN, V15, P1358, DOI 10.2174/138161209787846702; Weinberg JM, 2008, CUTIS, V81, P21; Widlansky ME, 2011, ANTIOXID REDOX SIGN, V15, P1517, DOI 10.1089/ars.2010.3642; Wilcox CS, 2010, PHARMACOL THERAPEUT, V126, P119, DOI 10.1016/j.pharmthera.2010.01.003; Zhu JH, 2011, BIOCHEM BIOPH RES CO, V404, P559, DOI 10.1016/j.bbrc.2010.12.025	142	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e87140	10.1371/journal.pone.0087140	http://dx.doi.org/10.1371/journal.pone.0087140			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586264	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200011
J	Trachtenberg, S; Schuck, P; Phillips, TM; Andrews, SB; Leapman, RD				Trachtenberg, Shlomo; Schuck, Peter; Phillips, Terry M.; Andrews, S. Brian; Leapman, Richard D.			A Structural Framework for a Near-Minimal Form of Life: Mass and Compositional Analysis of the Helical Mollicute Spiroplasma melliferum BC3	PLOS ONE			English	Article							BACTERIAL LINEAR MOTOR; CRYOELECTRON TOMOGRAPHY; SYNTHETIC BIOLOGY; MYCOPLASMA-PNEUMONIAE; PHYLOGENETIC ANALYSIS; GENOME; CITRI; CELLS; ORGANIZATION; TRANSMISSION	Spiroplasma melliferum is a wall-less bacterium with dynamic helical geometry. This organism is geometrically well defined and internally well ordered, and has an exceedingly small genome. Individual cells are chemotactic, polar, and swim actively. Their dynamic helicity can be traced at the molecular level to a highly ordered linear motor (composed essentially of the proteins fib and MreB) that is positioned on a defined helical line along the internal face of the cell's membrane. Using an array of complementary, informationally overlapping approaches, we have taken advantage of this uniquely simple, near-minimal life-form and its helical geometry to analyze the copy numbers of Spiroplasma's essential parts, as well as to elucidate how these components are spatially organized to subserve the whole living cell. Scanning transmission electron microscopy (STEM) was used to measure the mass-per-length and mass-per-area of whole cells, membrane fractions, intact cytoskeletons and cytoskeletal components. These local data were fit into whole-cell geometric parameters determined by a variety of light microscopy modalities. Hydrodynamic data obtained by analytical ultracentrifugation allowed computation of the hydration state of whole living cells, for which the relative amounts of protein, lipid, carbohydrate, DNA, and RNA were also estimated analytically. Finally, ribosome and RNA content, genome size and gene expression were also estimated (using stereology, spectroscopy and 2D-gel analysis, respectively). Taken together, the results provide a general framework for a minimal inventory and arrangement of the major cellular components needed to support life.	[Trachtenberg, Shlomo] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Microbiol & Mol Genet, IL-91010 Jerusalem, Israel; [Andrews, S. Brian] NINDS, Neurobiol Lab, NIH, Bethesda, MD 20892 USA; [Schuck, Peter; Phillips, Terry M.; Leapman, Richard D.] Natl Inst Biomed Imaging & Bioengn, Lab Cellular Imaging & Macromol Biophys, NIH, Bethesda, MD USA	Hebrew University of Jerusalem; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Trachtenberg, S (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Microbiol & Mol Genet, IL-91010 Jerusalem, Israel.	shlomot@ekmd.huji.ac.il	Schuck, Peter/AAA-6888-2020	Schuck, Peter/0000-0002-8859-6966; Leapman, Richard/0000-0002-8575-4084	Israel Science Foundation (ISF); US-Israel Science Foundation (BSF); Intramural Research Program of the National Institute of Biomedical Imaging and Bioengineering (NIBIB); National Institute of Neurological Disorders and Stroke (NINDS); National Institutes of Health (NIH), USA; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000017, ZIAEB000006, ZIAEB000008] Funding Source: NIH RePORTER	Israel Science Foundation (ISF)(Israel Science Foundation); US-Israel Science Foundation (BSF); Intramural Research Program of the National Institute of Biomedical Imaging and Bioengineering (NIBIB); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health (NIH), USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was supported by funds from the Israel Science Foundation (ISF) and US-Israel Science Foundation (BSF) and in part by the Intramural Research Program of the National Institute of Biomedical Imaging and Bioengineering (NIBIB), and the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeev D, 2012, J PROTEOME RES, V11, P224, DOI 10.1021/pr2008626; BASTIAN FO, 1979, ARCH PATHOL LAB MED, V103, P665; Bastian FO, 2007, J MED MICROBIOL, V56, P1235, DOI 10.1099/jmm.0.47159-0; Bastian FO, 2011, VET OPHTHALMOL, V14, P10, DOI 10.1111/j.1463-5224.2010.00833.x; Benders GA, 2010, NUCLEIC ACIDS RES, V38, P2558, DOI 10.1093/nar/gkq119; Bove JM, 2003, ANNU REV PHYTOPATHOL, V41, P483, DOI 10.1146/annurev.phyto.41.052102.104034; CARLE P, 1995, INT J SYST BACTERIOL, V45, P178, DOI 10.1099/00207713-45-1-178; Carle P, 2010, APPL ENVIRON MICROB, V76, P3420, DOI 10.1128/AEM.02954-09; Carpane P, 2013, PHYTOPATHOLOGY, V103, P129, DOI 10.1094/PHYTO-07-12-0158-R; Cohen-Krausz S, 2011, J MOL BIOL, V410, P194, DOI 10.1016/j.jmb.2011.04.067; DANIELS MJ, 1984, CURR MICROBIOL, V10, P191, DOI 10.1007/BF01627253; DANIELS MJ, 1980, J GEN MICROBIOL, V118, P429; Das S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-186; DAVIS PJ, 1985, J BACTERIOL, V161, P118, DOI 10.1128/JB.161.1.118-122.1985; DAVIS RE, 1973, PHYTOPATHOLOGY, V63, P403, DOI 10.1094/Phyto-63-403; DAVIS RE, 1972, SCIENCE, V176, P521, DOI 10.1126/science.176.4034.521; DURCHSCHLAG H, 1986, THERMODYNAMIC DATA B, P45; Duret S, 2003, APPL ENVIRON MICROB, V69, P6225, DOI 10.1128/AEM.69.10.6225-6234.2003; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Gasparich GE, 2002, FRONT BIOSCI, V7, pD619, DOI 10.2741/gaspari; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gilad R, 2003, MOL MICROBIOL, V47, P657, DOI 10.1046/j.1365-2958.2003.03200.x; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Guell O, 2012, SCI REP-UK, V2, DOI 10.1038/srep00621; HOLMES A., 1927, PETROGRAPHIC METHODS; Killiny N, 2005, PHYTOPATHOLOGY, V95, P541, DOI 10.1094/PHYTO-95-0541; Ku CA, 2013, GENOME BIOL EVOL, V5, P1151, DOI 10.1093/gbe/evt084; Kurner J, 2005, SCIENCE, V307, P436, DOI 10.1126/science.1104031; Lartigue C, 2007, SCIENCE, V317, P632, DOI 10.1126/science.1144622; LIVESEY AK, 1986, J CHEM PHYS, V84, P5102, DOI 10.1063/1.450663; Lluch-Senar M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003191; Lowe J, 2004, ANNU REV BIOPH BIOM, V33, P177, DOI 10.1146/annurev.biophys.33.110502.132647; Luisi PL, 2011, NAT CHEM, V3, P755, DOI 10.1038/nchem.1156; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; Mayer F, 2006, J MOL MICROB BIOTECH, V11, P228, DOI 10.1159/000094057; Merkle D, 2008, CHEMBIOCHEM, V9, P2673, DOI 10.1002/cbic.200800340; Miyata M, 2010, ANNU REV MICROBIOL, V64, P519, DOI 10.1146/annurev.micro.112408.134116; Moya A, 2009, FEMS MICROBIOL REV, V33, P225, DOI 10.1111/j.1574-6976.2008.00151.x; Murtas G, 2007, BIOCHEM BIOPH RES CO, V363, P12, DOI 10.1016/j.bbrc.2007.07.201; Ortiz JO, 2006, J STRUCT BIOL, V156, P334, DOI 10.1016/j.jsb.2006.04.014; Oshima K, 2007, J MOL EVOL, V65, P249, DOI 10.1007/s00239-007-9010-3; Phillips TM, 2000, AFFINITY IMMUNOAFFIN, P317; Purcell O, 2013, CHAOS, V23, DOI 10.1063/1.4811182; Regassa LB, 2006, FRONT BIOSCI-LANDMRK, V11, P2983, DOI 10.2741/2027; Russ J.C., 1999, PRACTICAL STEREOLOGY; Saillard C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-195; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuck P, 1999, BIOPHYS J, V76, P2288, DOI 10.1016/S0006-3495(99)77384-4; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Schwille P, 2011, SCIENCE, V333, P1252, DOI 10.1126/science.1211701; Serrano L, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100202; Shaevitz JW, 2005, CELL, V122, P941, DOI 10.1016/j.cell.2005.07.004; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Sousa AA, 2012, ULTRAMICROSCOPY, V123, P38, DOI 10.1016/j.ultramic.2012.04.005; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Stano P, 2011, BIOTECHNOL J, V6, P850, DOI 10.1002/biot.201100079; Svedberg T, 1940, THE ULTRACENTRIFUGE; TOWNSEND R, 1980, J BACTERIOL, V142, P694, DOI 10.1128/JB.142.2.694-700.1980; Trachtenberg S, 1998, J STRUCT BIOL, V123, P45, DOI 10.1006/jsbi.1998.4015; Trachtenberg S, 2005, CURR BIOL, V15, pR483, DOI 10.1016/j.cub.2005.06.049; TRACHTENBERG S, 1993, MICROSC RES TECHNIQ, V24, P173, DOI 10.1002/jemt.1070240209; Trachtenberg S, 2000, J STRUCT BIOL, V130, P10, DOI 10.1006/jsbi.2000.4215; Trachtenberg S, 2004, J MOL MICROB BIOTECH, V7, P78, DOI 10.1159/000077872; Trachtenberg S, 2003, J BACTERIOL, V185, P1987, DOI 10.1128/JB.185.6.1987-1994.2003; Trachtenberg S, 2003, MOL MICROBIOL, V47, P671, DOI 10.1046/j.1365-2958.2003.t01-1-03200.x; Trachtenberg S, 2001, MOL MICROBIOL, V41, P827, DOI 10.1046/j.1365-2958.2001.02527.x; TRACHTENBERG S, 1992, ULTRAMICROSCOPY, V45, P307, DOI 10.1016/0304-3991(92)90142-7; Trachtenberg S, 2008, J MOL BIOL, V378, P778, DOI 10.1016/j.jmb.2008.02.020; Trachtenberg S, 2006, J MOL MICROB BIOTECH, V11, P265, DOI 10.1159/000094060; WALL JS, 1986, ANNU REV BIOPHYS BIO, V15, P355; Wang X, 1996, J BACTERIOL, V178, P2314, DOI 10.1128/jb.178.8.2314-2319.1996; WEISBURG WG, 1989, J BACTERIOL, V171, P6455, DOI 10.1128/jb.171.12.6455-6467.1989; Wieslander A, 2002, MOL BIOL PATHOGENICI, P131; WILLIAMSON DL, 1991, J BACTERIOL, V173, P4353, DOI 10.1128/JB.173.14.4353-4362.1991; Wodke JAH, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.6; WOESE CR, 1980, P NATL ACAD SCI-BIOL, V77, P494, DOI 10.1073/pnas.77.1.494; Zhao Y, 2004, DNA CELL BIOL, V23, P127, DOI 10.1089/104454904322759948	79	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e87921	10.1371/journal.pone.0087921	http://dx.doi.org/10.1371/journal.pone.0087921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586297	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900015
J	Rutledge, CE; Lau, HT; Mangan, H; Hardy, LL; Sunnotel, O; Guo, F; MacNicol, AM; Walsh, CP; Lees-Murdock, DJ				Rutledge, Charlotte E.; Lau, Ho-Tak; Mangan, Hazel; Hardy, Linda L.; Sunnotel, Olaf; Guo, Fan; MacNicol, Angus M.; Walsh, Colum P.; Lees-Murdock, Diane J.			Efficient Translation of Dnmt1 Requires Cytoplasmic Polyadenylation and Musashi Binding Elements	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; XENOPUS OOCYTE MATURATION; CELL-CYCLE PROGRESSION; DNA METHYLTRANSFERASE; CYTOSINE METHYLATION; POSTMITOTIC NEURONS; MEIOTIC PROGRESSION; TEMPORAL CONTROL; STEM-CELLS; GERM-CELLS	Regulation of DNMT1 is critical for epigenetic control of many genes and for genome stability. Using phylogenetic analysis we characterized a block of 27 nucleotides in the 3'UTR of Dnmt1 mRNA identical between humans and Xenopus and investigated the role of the individual elements contained within it. This region contains a cytoplasmic polyadenylation element (CPE) and a Musashi binding element (MBE), with CPE binding protein 1 (CPEB1) known to bind to the former in mouse oocytes. The presence of these elements usually indicates translational control by elongation and shortening of the poly(A) tail in the cytoplasm of the oocyte and in some somatic cell types. We demonstrate for the first time cytoplasmic polyadenylation of Dnmt1 during periods of oocyte growth in mouse and during oocyte activation in Xenopus. Furthermore we show by RNA immunoprecipitation that Musashi1 (MSI1) binds to the MBE and that this element is required for polyadenylation in oocytes. As well as a role in oocytes, site-directed mutagenesis and reporter assays confirm that mutation of either the MBE or CPE reduce DNMT1 translation in somatic cells, but likely act in the same pathway: deletion of the whole conserved region has more severe effects on translation in both ES and differentiated cells. In adult cells lacking MSI1 there is a greater dependency on the CPE, with depletion of CPEB1 or CPEB4 by RNAi resulting in substantially reduced levels of endogenous DNMT1 protein and concurrent upregulation of the well characterised CPEB target mRNA cyclin B1. Our findings demonstrate that CPE-and MBE-mediated translation regulate DNMT1 expression, representing a novel mechanism of post-transcriptional control for this gene.	[Rutledge, Charlotte E.; Lau, Ho-Tak; Mangan, Hazel; Sunnotel, Olaf; Walsh, Colum P.; Lees-Murdock, Diane J.] Univ Ulster, Transcript Regulat & Epigenet Res Grp, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland; [Hardy, Linda L.; MacNicol, Angus M.] Univ Arkansas Med Sci, Dept Neurobiol & Dev Sci, Little Rock, AR 72205 USA; [Guo, Fan] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai, Peoples R China	Ulster University; University of Arkansas System; University of Arkansas Medical Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Lees-Murdock, DJ (corresponding author), Univ Ulster, Transcript Regulat & Epigenet Res Grp, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland.	dj.lees@ulster.ac.uk	Guo, Fan/AAX-4952-2021; Walsh, Colum/ABD-7013-2020; Guo, Fan/J-1857-2019	Walsh, Colum/0000-0001-9921-7506; Guo, Fan/0000-0002-0165-073X; Lees-Murdock, Diane/0000-0002-1309-1605	Wellcome Trust [082595]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035688] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a grant from The Wellcome Trust (www.wellcome.ac.uk grant number 082595) to DLM and CPW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov IM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002457; Arumugam K, 2012, MOL REPROD DEV, V79, P553, DOI 10.1002/mrd.22060; Arumugam K, 2010, EMBO J, V29, P387, DOI 10.1038/emboj.2009.337; Ballantyne S, 1997, MOL BIOL CELL, V8, P1633, DOI 10.1091/mbc.8.8.1633; Bartolomei MS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002592; Belloc E, 2008, BIOCHEM SOC T, V36, P665, DOI 10.1042/BST0360665; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808; Charlesworth A, 2004, J BIOL CHEM, V279, P17650, DOI 10.1074/jbc.M313837200; Charlesworth A, 2002, EMBO J, V21, P2798, DOI 10.1093/emboj/21.11.2798; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; Chen TP, 2007, NAT GENET, V39, P391, DOI 10.1038/ng1982; de Moor CH, 1999, EMBO J, V18, P2294, DOI 10.1093/emboj/18.8.2294; Ding F, 2002, P NATL ACAD SCI USA, V99, P14861, DOI 10.1073/pnas.232565599; Dunican DS, 2008, DEVELOPMENT, V135, P1295, DOI 10.1242/dev.016402; Endres M, 2001, NEUROREPORT, V12, P3763, DOI 10.1097/00001756-200112040-00032; FOX CA, 1989, GENE DEV, V3, P2151, DOI 10.1101/gad.3.12b.2151; GARDNER RL, 1982, J EMBRYOL EXP MORPH, V68, P175; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Gaudet F, 1998, J BIOL CHEM, V273, P32725, DOI 10.1074/jbc.273.49.32725; GEBAUER F, 1994, EMBO J, V13, P5712, DOI 10.1002/j.1460-2075.1994.tb06909.x; Groisman I, 2006, GENE DEV, V20, P2701, DOI 10.1101/gad.1438906; Groppo R, 2011, MOL CELL BIOL, V31, P2707, DOI 10.1128/MCB.05133-11; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; HUARTE J, 1992, CELL, V69, P1021, DOI 10.1016/0092-8674(92)90620-R; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Inano K, 2000, J BIOCHEM-TOKYO, V128, P315, DOI 10.1093/oxfordjournals.jbchem.a022755; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Kim KC, 2011, J NEUROSCI, V21, P1621; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; KOI M, 1994, CANCER RES, V54, P4308; Lees-Murdock DJ, 2005, DEV DYNAM, V232, P992, DOI 10.1002/dvdy.20288; Lees-Murdock DJ, 2004, GENOMICS, V84, P193, DOI 10.1016/j.ygeno.2004.02.004; Lees-Murdock DJ, 2003, GENOMICS, V82, P230, DOI 10.1016/S0888-7543(03)00105-8; Liu LO, 2000, MOL BRAIN RES, V82, P150, DOI 10.1016/S0169-328X(00)00203-5; Loughery JEP, 2011, HUM MOL GENET, V20, P3241, DOI 10.1093/hmg/ddr236; MacNicol MC, 2011, CELL CYCLE, V10, P39, DOI 10.4161/cc.10.1.14388; Macnicol MC, 2010, MOL REPROD DEV, V77, P662, DOI 10.1002/mrd.21191; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Mendez R, 2002, EMBO J, V21, P1833, DOI 10.1093/emboj/21.7.1833; Mertineit C, 1998, DEVELOPMENT, V125, P889; Novoa I, 2010, NAT CELL BIOL, V12, P447, DOI 10.1038/ncb2046; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; PARIS J, 1990, MOL CELL BIOL, V10, P5634, DOI 10.1128/MCB.10.11.5634; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Prasad CK, 2008, MOL REPROD DEV, V75, P1258, DOI 10.1002/mrd.20877; Racki WJ, 2006, DEVELOPMENT, V133, P4527, DOI 10.1242/dev.02651; Rassa JC, 2000, VIROLOGY, V274, P438, DOI 10.1006/viro.2000.0494; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; SALLES FJ, 1992, GENE DEV, V6, P1202, DOI 10.1101/gad.6.7.1202; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Stancheva I, 2000, GENE DEV, V14, P313; Tay J, 2003, GENE DEV, V17, P1457, DOI 10.1101/gad.1071403; Tay J, 2001, DEV CELL, V1, P201, DOI 10.1016/S1534-5807(01)00025-9; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Torrisani J, 2007, MOL CELL BIOL, V27, P395, DOI 10.1128/MCB.01236-06; VASSALLI JD, 1989, GENE DEV, V3, P2163, DOI 10.1101/gad.3.12b.2163; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	61	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88385	10.1371/journal.pone.0088385	http://dx.doi.org/10.1371/journal.pone.0088385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586322	Green Published, gold, Green Submitted			2022-12-27	WOS:000331714700017
J	Li, LL; Jiang, ZG				Li, Linlin; Jiang, Zhigang			International Trade of CITES Listed Bird Species in China	PLOS ONE			English	Article							AMAZON PARROTS; SOUTH-AMERICA; WILDLIFE; CONSERVATION; ISLAND; BIODIVERSITY; POPULATION; ABUNDANCE; INDONESIA; IMPACTS	Commercial trade of wild birds may devastate wild bird populations. Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) controls the trade of wild species listed in its appendices to avoid these species being threatened by international trade. China used to be one of the major trading countries with significant bird trade with foreign countries; on the other hand, China is a country with unique avian fauna, many Important Bird Areas and critically endangered bird species. What is the role of the country in world wild bird trade? What kind of insights can we extract from trade records for improving future management of wild bird trade in the country? We retrieved and analyzed international trade records of the CITES listed bird species of China from 1981 to 2010 from the CITES Trade Database maintained by United Nations Environment Program and World Conservation Monitoring Centre (UNEP-WCMC). We found that: (1) International trade of live birds in China peaked during the late 1990s, then decreased to the level before the surge of trade in a few years, the trade dynamics of wild birds may be affected by governmental policy and the outbreak of avian influenza during the period. (2) Most frequently traded CITES Appendix listed birds in China were parrots, most of which were exotic species to the country. (3) Birds were mainly traded for commercial purpose. Exotic birds in trade were mainly captive-bred while the most Chinese birds traded internationally were captured from the wild. Since many bird species in international trade are threatened to extinction, China should take stricter measures on importing of wild-captured birds and should collaborate with the countries of original in the international bird trade to avoid unsustainable harvesting of wild birds. It is urgent for China to carry out population surveys on those domestic bird species once in significant international trade and to make better conservation decisions based on population status of those birds. In addition, more scientific researchers should be encouraged to participate in the wildlife trade management to avoid misreporting trade data or biased analyses of the trade records.	[Li, Linlin; Jiang, Zhigang] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Li, Linlin; Jiang, Zhigang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Jiang, Zhigang] Endangered Species Sci Commiss Peoples Republ Chi, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Jiang, ZG (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	jiangzg@ioz.ac.cn	Jiang, Zhigang/E-4598-2014	Jiang, Zhigang/0000-0003-2154-8588	Key Program of Knowledge Innovation Program of Chinese Academy of Sciences [KSCX2-EW-Z-4]	Key Program of Knowledge Innovation Program of Chinese Academy of Sciences	This study was supported by the Key Program of Knowledge Innovation Program of Chinese Academy of Sciences (KSCX2-EW-Z-4, http://www.bio.cas.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott B, 2011, ECOL ECON, V70, P721, DOI 10.1016/j.ecolecon.2010.11.006; An R, 2006, CHINESE WILDLIFE, V27, P25; Bi J, 2005, J INNER MONGOLIA NOR, V34, P93; BirdLife International, 2012, IUCN 2012 IUCN RED L; BirdLife International, 2008, CRIT END BIRDS GLOB; BirdLife International, 2012, IUCN 2012 RED LIST T; Birdlife International, 2008, STAT WORLDS BIRDS IN; Blundell AG, 2005, CONSERV BIOL, V19, P2020, DOI 10.1111/j.1523-1739.2005.00253.x; Brooks EGE, 2010, BIOL CONSERV, V143, P2808, DOI 10.1016/j.biocon.2010.07.030; Brooks-Moizer F, 2009, ECOL SOC, V14; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Butchart SHM, 2008, BIRD CONSERV INT, V18, pS245, DOI 10.1017/S095927090800035X; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cahill AJ, 2006, ORYX, V40, P161, DOI 10.1017/S0030605306000366; Monterrubio-Rico TC, 2010, ORYX, V44, P602, DOI 10.1017/S0030605310000980; Chomel BB, 2007, EMERG INFECT DIS, V13, P6, DOI 10.3201/eid1301.060480; CITES, 1979, CONV INT TRAD END SP; Collar N. J., 2000, International Zoo Yearbook, V37, P21, DOI 10.1111/j.1748-1090.2000.tb00704.x; Cooney R, 2006, ORYX, V40, P18, DOI 10.1017/S0030605306000056; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Alves RRD, 2010, HUM ECOL, V38, P147, DOI 10.1007/s10745-009-9295-5; Dallimer M, 2008, AFR J ECOL, V46, P258, DOI 10.1111/j.1365-2028.2007.00891.x; Damania R, 2007, ECOL ECON, V62, P461, DOI 10.1016/j.ecolecon.2006.07.007; Raso TD, 2006, VET MICROBIOL, V117, P235, DOI 10.1016/j.vetmic.2006.06.025; De Labra MA, 2010, ORNITOL NEOTROP, V21, P599; Deem SL, 2005, J ZOO WILDLIFE MED, V36, P598, DOI 10.1638/04094.1; Downs CT, 2005, AFR ZOOL, V40, P15; Dutton AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021243; Gastanaga M, 2011, BIRD CONSERV INT, V21, P76, DOI 10.1017/S0959270910000249; Ginsberg J, 2002, CONSERV BIOL, V16, P1184, DOI 10.1046/j.1523-1739.2002.16504.x; Gonzalez JA, 2003, BIOL CONSERV, V114, P437, DOI 10.1016/S0006-3207(03)00071-5; Herrera M, 2007, BIRD CONSERV INT, V17, P295, DOI 10.1017/S0959270907000858; Huo Ya-peng, 2009, Shenyang Shifan Daxue Xuebao Ziran Kexue Ban, V27, P245; Jarry Guy, 2004, Bulletin de la Societe Zoologique de France, V129, P103; Jepson P, 2005, ORYX, V39, P442, DOI 10.1017/S0030605305001110; Jiang ZG, 2013, ORYX, V47, P532, DOI 10.1017/S0030605313000057; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Li S, 2004, CHINA POULTRY, V26, P51; LI Y, 2010, CHINESE J WILDLIFE, V31, P280; Ngenyi A., 2003, Journal of the Cameroon Academy of Sciences, V3, P11; Nijman V, 2010, BIODIVERS CONSERV, V19, P1101, DOI 10.1007/s10531-009-9758-4; Nogueira SSC, 2011, BIODIVERS CONSERV, V20, P1385, DOI 10.1007/s10531-011-0047-7; Persulessy Yan E., 2009, ZGAP Mitteilungen, V25, P17; Phelps J, 2011, SCIENCE, V331, P400; Rivera L, 2010, ORYX, V44, P110, DOI 10.1017/S0030605309990950; Rodriguez-Ferraro A, 2007, WILSON J ORNITHOL, V119, P602, DOI 10.1676/06-028.1; Rosen GE, 2010, ECOHEALTH, V7, P24, DOI 10.1007/s10393-010-0317-y; Rosser AM, 2002, CONSERV BIOL, V16, P584, DOI 10.1046/j.1523-1739.2002.01635.x; Sanz V, 1998, CONSERV BIOL, V12, P430, DOI 10.1046/j.1523-1739.1998.96261.x; Senne DA, 2007, AVIAN DIS, V51, P167, DOI 10.1637/7621-042606R1.1; Shepherd C.R., 2007, Traffic Bulletin, V21, P85; Shepherd CR, 2008, BIODIVERS CONSERV, V17, P35, DOI 10.1007/s10531-007-9228-9; Shitaye JE, 2010, VET MED-CZECH, V55, P339, DOI 10.17221/2927-VETMED; State Forestry Administration, 1999, URG ANN STRENGTH MAN; State Forestry Administration, 2003, PROCL STAT FOR ADM C; Strandby U, 2008, BIOL CONSERV, V141, P2959, DOI 10.1016/j.biocon.2008.08.023; UNEP-WCMC, 2010, GUID US CITES TRADE; Wang J, 2001, ANIMAL SCI VET MED, V18, P67; Wang J., 2001, MOD ANIM HUSB, V4, P38; Wilson-Wilde L, 2010, FORENSIC SCI MED PAT, V6, P221, DOI 10.1007/s12024-010-9167-8; Xu Jiliang, 2002, Journal of Beijing Normal University (Natural Science), V38, P535; Zheng G, 1998, RED DATA BOOK BIRDS; Zhou ZH, 2004, CONSERV BIOL, V18, P1386, DOI 10.1111/j.1523-1739.2004.00251.x; Zhou Zhihua, 2004, Scientia Silvae Sinicae, V40, P151	64	43	45	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e85012	10.1371/journal.pone.0085012	http://dx.doi.org/10.1371/journal.pone.0085012			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586234	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900004
J	Chou, WC; Chung, YT; Chen, HY; Wang, CJ; Ying, TH; Chuang, CY; Tseng, YC; Wang, SL				Chou, Wei-Chun; Chung, Yu-The; Chen, Hsiao-Yen; Wang, Chien-Jen; Ying, Tsung-Ho; Chuang, Chun-Yu; Tseng, Ying-Chih; Wang, Shu-Li			Maternal Arsenic Exposure and DNA Damage Biomarkers, and the Associations with Birth Outcomes in a General Population from Taiwan	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; DIMETHYLARSINIC ACID; METHYLATION; METABOLITES; PREGNANCY; PROMOTES; WEIGHT; URINE; EXPRESSION; PROTEIN	Inorganic arsenic (iAs) is an established transplacental agent known to affect fetal development in animal studies. However, iAs has not been adequately studied in the general population with respect to iAs exposure during pregnancy and its impact on the health status of newborns. The aims of this study were to 1) elucidate the association between arsenic exposure and oxidative/methylated DNA damage in pregnant women, and 2) determine the association with birth outcomes. A birth cohort study of 299 pregnant mother-newborn pairs was recruited during 2001-2002 in Taiwan. We collected maternal urine samples during the 3rd trimester for measuring iAs and its metabolites. We used high-performance liquid chromatography/inductively coupled plasma mass spectrometry (HPLC-ICP-MS) for quantifications of the arsenic species. Liquid chromatography/tandem mass spectrometer (LC-MS/MS) was used to measure the 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG) and N-7-methylguanosine (N-7-MeG) DNA damage biomarkers. Birth outcomes were collected to assess the associations with maternal arsenic exposure and the DNA damage biomarkers. Multiple regression analyses showed that maternal urinary iAs had positive associations with the methylated N-7-MeG (beta = 0.35, p<0.001) and oxidative 8-oxodG (beta = 0.24, p<0.001) DNA damage biomarkers, and a decreased one-minute (1-min) Apgar score (beta = -0.23, p = 0.041). Maternal N-7-MeG was also associated with a decreased 1-min Apgar score (beta = -0.25, p = 0.042). Mutual adjustment for iAs and N-7-MeG showed an independent and significant prediction for a decreased 1-min Apgar score of iAs (beta = -0.28, p = 0.036). Maternal iAs exposure was associated with both maternal DNA damage and adverse newborn health. Maternal N-7-MeG levels might be a novel biomarker for monitoring fetal health related to iAs.	[Chou, Wei-Chun; Chuang, Chun-Yu] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Chou, Wei-Chun; Chung, Yu-The; Chen, Hsiao-Yen; Wang, Chien-Jen; Wang, Shu-Li] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan, Miaoli County, Taiwan; [Ying, Tsung-Ho] Chung Shan Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan; [Tseng, Ying-Chih] Hsinchu Cathay Gen Hosp, Dept Obstet & Gynecol, Hsinchu, Taiwan; [Wang, Shu-Li] NIEHS, Epidemiol Branch, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA	National Tsing Hua University; National Health Research Institutes - Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital; Cathay General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Chuang, CY (corresponding author), Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.	slwang@nhri.org.tw	Wang, Shu-Li/C-1367-2010; Chou, Wei-Chun/AAO-6532-2020	Chou, Wei-Chun/0000-0003-3355-6921; Wang, Shu-Li/0000-0002-0686-4729	National Science Council, Taiwan [NSC98-2314-B-400-001-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	Financial support received from the National Science Council, Taiwan, is gratefully acknowledged (grants no.: NSC98-2314-B-400-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2011, ENVIRON HEALTH PERSP, V119, P258, DOI 10.1289/ehp.1002086; Baskett TF, 2000, RESUSCITATION, V47, P215, DOI 10.1016/S0300-9572(00)00340-3; Bjerg A, 2011, PEDIATRICS, V127, pE905, DOI 10.1542/peds.2010-2850; Casey BM, 2001, NEW ENGL J MED, V344, P467, DOI 10.1056/NEJM200102153440701; Chan CTY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001247; Chao MR, 2008, CANCER EPIDEM BIOMAR, V17, P3381, DOI 10.1158/1055-9965.EPI-08-0721; Chen CC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000561; Chiang SY, 2005, RAPID COMMUN MASS SP, V19, P1915, DOI 10.1002/rcm.2003; Chou WC, 2012, ARSEN ENVIR, P157; Christian WJ, 2006, ENVIRON RES, V100, P115, DOI 10.1016/j.envres.2005.03.009; Concha G, 1998, TOXICOL SCI, V44, P185, DOI 10.1006/toxs.1998.2486; Davey JC, 2008, ENVIRON HEALTH PERSP, V116, P165, DOI 10.1289/ehp.10131; Doctor BA, 2001, AM J OBSTET GYNECOL, V185, P652, DOI 10.1067/mob.2001.116749; Engstrom KS, 2010, FREE RADICAL BIO MED, V48, P1211, DOI 10.1016/j.freeradbiomed.2010.02.004; Gardner RM, 2011, REPROD TOXICOL, V31, P210, DOI 10.1016/j.reprotox.2010.11.002; Hall M, 2007, ENVIRON HEALTH PERSP, V115, P1503, DOI 10.1289/ehp.9906; He WJ, 2007, TOXICOL SCI, V99, P244, DOI 10.1093/toxsci/kfm162; Hill DS, 2008, BIRTH DEFECTS RES B, V83, P40, DOI 10.1002/bdrb.20142; Huyck KL, 2007, J OCCUP ENVIRON MED, V49, P1097, DOI 10.1097/JOM.0b013e3181566ba0; Kajantie E, 2005, INT J EPIDEMIOL, V34, P655, DOI 10.1093/ije/dyi048; LEE MMS, 1992, INT J EPIDEMIOL, V21, P922, DOI 10.1093/ije/21.5.922; Lin IH, 2009, TOXICOLOGY, V260, P1, DOI 10.1016/j.tox.2009.02.015; MANDEL LR, 1966, NATURE, V209, P586, DOI 10.1038/209586a0; Myers SL, 2010, J EPIDEMIOL COMMUN H, V64, P325, DOI 10.1136/jech.2008.084392; Navas-Acien A, 2011, ENVIRON RES, V111, P110, DOI 10.1016/j.envres.2010.10.009; Odd DE, 2008, ARCH DIS CHILD-FETAL, V93, pF115, DOI 10.1136/adc.2007.123745; Piao FY, 2005, J OCCUP HEALTH, V47, P445, DOI 10.1539/joh.47.445; Qin XJ, 2012, TOXICOL SCI, V127, P120, DOI 10.1093/toxsci/kfs099; Rahman A, 2009, AM J EPIDEMIOL, V169, P304, DOI 10.1093/aje/kwn332; Ritsema R, 1998, APPL ORGANOMET CHEM, V12, P591, DOI 10.1002/(SICI)1099-0739(199808/09)12:8/9<591::AID-AOC767>3.0.CO;2-E; RYDBERG B, 1982, EMBO J, V1, P211, DOI 10.1002/j.1460-2075.1982.tb01149.x; Saenger P, 2007, ENDOCR REV, V28, P219, DOI 10.1210/er.2006-0039; SHUKER DEG, 1992, CHEM RES TOXICOL, V5, P450, DOI 10.1021/tx00028a001; STILLWELL WG, 1989, CHEM RES TOXICOL, V2, P94, DOI 10.1021/tx00008a004; Tuorto F, 2012, NAT STRUCT MOL BIOL, V19, P900, DOI 10.1038/nsmb.2357; Vahter M, 2009, ANNU REV NUTR, V29, P381, DOI 10.1146/annurev-nutr-080508-141102; VALDEZ R, 1994, DIABETOLOGIA, V37, P624, DOI 10.1007/s001250050157; Vijayaraghavan M, 2001, CANCER LETT, V165, P11, DOI 10.1016/S0304-3835(00)00711-4; Walter I, 2007, DNA REPAIR, V6, P61, DOI 10.1016/j.dnarep.2006.08.008; Wang SL, 2004, CHEMOSPHERE, V54, P1459, DOI 10.1016/j.chemosphere.2003.08.012; Xie YX, 2007, TOXICOLOGY, V236, P7, DOI 10.1016/j.tox.2007.03.021; Yamanaka K, 2001, BIOL PHARM BULL, V24, P510, DOI 10.1248/bpb.24.510; Yang CY, 2003, EPIDEMIOLOGY, V14, pS127, DOI 10.1097/00001648-200309001-00311	43	30	30	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e86398	10.1371/journal.pone.0086398	http://dx.doi.org/10.1371/journal.pone.0086398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558361	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700007
J	Gerard, FCA; Yang, RF; Romani, B; Poisson, A; Belzile, JP; Rougeau, N; Cohen, EA				Gerard, Francine C. A.; Yang, Ruifeng; Romani, Bizhan; Poisson, Alexis; Belzile, Jean-Philippe; Rougeau, Nicole; Cohen, Eric A.			Defining the Interactions and Role of DCAF1/VPRBP in the DDB1-Cullin4A E3 Ubiquitin Ligase Complex Engaged by HIV-1 Vpr to Induce a G(2) Cell Cycle Arrest	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 VPR; PROTEASOMAL DEGRADATION; PROTEIN VPR; IN-VIVO; DDB1; ACTIVATION; BINDING; ATR; LOCALIZATION	HIV viral protein R (Vpr) induces a cell cycle arrest at the G(2)/M phase by activating the ATR DNA damage/replication stress signalling pathway through engagement of the DDB1-CUL4A-DCAF1 E3 ubiquitin ligase via a direct binding to the substrate specificity receptor DCAF1. Since no high resolution structures of the DDB1-DCAF1-Vpr substrate recognition module currently exist, we used a mutagenesis approach to better define motifs in DCAF1 that are crucial for Vpr and DDB1 binding. Herein, we show that the minimal domain of DCAF1 that retained the ability to bind Vpr and DDB1 was mapped to residues 1041 to 1393 (DCAF1 WD). Mutagenic analyses identified an alpha-helical H-box motif and F/YxxF/Y motifs located in the N-terminal domain of DCAF1 WD that are involved in exclusive binding to DDB1. While we could not identify elements specifically involved in Vpr binding, overall, the mutagenesis data suggest that the predicted beta-propeller conformation of DCAF1 is likely to be critical for Vpr association. Importantly, we provide evidence that binding of Vpr to DCAF1 appears to modulate the formation of a DDB1/DCAF1 complex. Lastly, we show that expression of DCAF1 WD in the absence of endogenous DCAF1 was not sufficient to enable Vpr-mediated G(2) arrest activity. Overall, our results reveal that Vpr and DDB1 binding on DCAF1 can be genetically separated and further suggest that DCAF1 contains determinants in addition to the Vpr and DDB1 minimal binding domain, which are required for Vpr to enable the induction of a G(2) arrest.	[Gerard, Francine C. A.; Yang, Ruifeng; Romani, Bizhan; Poisson, Alexis; Belzile, Jean-Philippe; Rougeau, Nicole; Cohen, Eric A.] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Cohen, Eric A.] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal	Cohen, EA (corresponding author), Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada.	eric.cohen@ircm.qc.ca			Canadian Institutes of Health Research (CIHR) [MOP 12381]; CIHR	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by grant MOP 12381 from the Canadian Institutes of Health Research (CIHR) to EAC. FCAG is supported by a post-doctoral fellowship from CIHR. EAC holds the Canada Research Chair in Human Retrovirology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2011, BIOCHEMISTRY-US, V50, P1359, DOI 10.1021/bi101749s; Ahn J, 2010, J BIOL CHEM, V285, P37333, DOI 10.1074/jbc.M110.133181; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19754, DOI 10.1073/pnas.1010005107; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Belzile JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001080; Belzile JP, 2010, J VIROL, V84, P3320, DOI 10.1128/JVI.02590-09; Bergamaschi A, 2009, J VIROL, V83, P4854, DOI 10.1128/JVI.00187-09; BouHamdan M, 1998, J BIOL CHEM, V273, P8009, DOI 10.1074/jbc.273.14.8009; DeHart JL, 2008, J VIROL, V82, P1066, DOI 10.1128/JVI.01628-07; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; Dube M, 2009, J VIROL, V83, P4574, DOI 10.1128/JVI.01800-08; Harris RS, 2012, J BIOL CHEM, V287, P40875, DOI 10.1074/jbc.R112.416925; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Huang J, 2008, ONCOGENE, V27, P4056, DOI 10.1038/onc.2008.44; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Kaur M, 2012, NUCLEIC ACIDS RES, V40, P7332, DOI 10.1093/nar/gks366; Kulkosky J, 1999, VIROLOGY, V255, P77, DOI 10.1006/viro.1998.9544; Lai MY, 2005, J VIROL, V79, P15443, DOI 10.1128/JVI.79.24.15443-15451.2005; Le Rouzic E, 2008, J BIOL CHEM, V283, P21686, DOI 10.1074/jbc.M710298200; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Leupin O, 2003, J VIROL, V77, P6274, DOI 10.1128/JVI.77.11.6274-6283.2003; Li T, 2010, NAT STRUCT MOL BIOL, V17, P105, DOI 10.1038/nsmb.1719; Li W, 2010, CELL, V140, P477, DOI 10.1016/j.cell.2010.01.029; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Okui N, 2000, HUM GENE THER, V11, P537, DOI 10.1089/10430340050015725; Roshal M, 2003, J BIOL CHEM, V278, P25879, DOI 10.1074/jbc.M303948200; Salsman J, 2012, J VIROL, V86, P806, DOI 10.1128/JVI.05442-11; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Tan L, 2007, J VIROL, V81, P10822, DOI 10.1128/JVI.01380-07; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Wen XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030939; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229; Yao XJ, 1998, J VIROL, V72, P4686, DOI 10.1128/JVI.72.6.4686-4693.1998; Zhang SG, 2001, GENE, V263, P131, DOI 10.1016/S0378-1119(00)00583-7; Zimmerman ES, 2006, J VIROL, V80, P10407, DOI 10.1128/JVI.01212-06	41	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89195	10.1371/journal.pone.0089195	http://dx.doi.org/10.1371/journal.pone.0089195			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558487	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700133
J	Gladine, C; Newman, JW; Durand, T; Pedersen, TL; Galano, JM; Demougeot, C; Berdeaux, O; Pujos-Guillot, E; Mazur, A; Comte, B				Gladine, Cecile; Newman, John W.; Durand, Thierry; Pedersen, Theresa L.; Galano, Jean-Marie; Demougeot, Celine; Berdeaux, Olivier; Pujos-Guillot, Estelle; Mazur, Andrzej; Comte, Blandine			Lipid Profiling following Intake of the Omega 3 Fatty Acid DHA Identifies the Peroxidized Metabolites F-4-Neuroprostanes as the Best Predictors of Atherosclerosis Prevention	PLOS ONE			English	Article							N-3 FATTY-ACIDS; EICOSAPENTAENOIC ACID; DOCOSAHEXAENOIC ACID; IN-VIVO; FISH INTAKE; NEUROPROSTANES; QUANTIFICATION; PEROXIDATION; MEDIATORS; HUMANS	The anti-atherogenic effects of omega 3 fatty acids, namely eicosapentaenoic (EPA) and docosahexaenoic acids (DHA) are well recognized but the impact of dietary intake on bioactive lipid mediator profiles remains unclear. Such a profiling effort may offer novel targets for future studies into the mechanism of action of omega 3 fatty acids. The present study aimed to determine the impact of DHA supplementation on the profiles of polyunsaturated fatty acids (PUFA) oxygenated metabolites and to investigate their contribution to atherosclerosis prevention. A special emphasis was given to the nonenzymatic metabolites knowing the high susceptibility of DHA to free radical-mediated peroxidation and the increased oxidative stress associated with plaque formation. Atherosclerosis prone mice (LDLR-/-) received increasing doses of DHA (0, 0.1, 1 or 2% of energy) during 20 weeks leading to a dose-dependent reduction of atherosclerosis (R-2 = 0.97, p = 0.02), triglyceridemia (R-2 = 0.97, p = 0.01) and cholesterolemia (R-2 = 0.96, p, 0.01). Targeted lipidomic analyses revealed that both the profiles of EPA and DHA and their corresponding oxygenated metabolites were substantially modulated in plasma and liver. Notably, the hepatic level of F-4-neuroprostanes, a specific class of DHA peroxidized metabolites, was strongly correlated with the hepatic DHA level. Moreover, unbiased statistical analysis including correlation analyses, hierarchical cluster and projection to latent structure discriminate analysis revealed that the hepatic level of F4-neuroprostanes was the variable most negatively correlated with the plaque extent (p<0.001) and along with plasma EPA-derived diols was an important mathematical positive predictor of atherosclerosis prevention. Thus, oxygenated n-3 PUFAs, and F-4-neuroprostanes in particular, are potential biomarkers of DHA-associated atherosclerosis prevention. While these may contribute to the anti-atherogenic effects of DHA, further in vitro investigations are needed to confirm such a contention and to decipher the molecular mechanisms of action.	[Gladine, Cecile; Pujos-Guillot, Estelle; Mazur, Andrzej; Comte, Blandine] Univ Auvergne, Clermont Univ, CRNH Auvergne, UMR1019,INRA,UNH, Clermont Ferrand, France; [Newman, John W.; Pedersen, Theresa L.] ARS, Obes & Metab Res Unit, USDA, Western Human Nutr Res Ctr, Davis, CA USA; [Newman, John W.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Durand, Thierry; Galano, Jean-Marie] Univ Montpellier I, IBMM, CNRS, UMR 5247, Montpellier, France; [Durand, Thierry; Galano, Jean-Marie] Univ Montpellier 2, IBMM, CNRS, UMR 5247, Montpellier, France; [Demougeot, Celine] Univ Franche Comte, EA Fonct & Dysfonct Epitheliales 4267, F-25030 Besancon, France; [Berdeaux, Olivier] CNRS, Ctr Sci Gout & Alimentat, UMR6265, Dijon, France; [Berdeaux, Olivier] INRA, Ctr Sci Gout & Alimentat, UMR1324, F-21034 Dijon, France; [Berdeaux, Olivier] Univ Bourgogne, Ctr Sci Gout & Alimentat, UMR, Dijon, France; [Pujos-Guillot, Estelle] INRA, Plateforme Explorat Metab, UMR 1019, Clermont Ferrand, France	INRAE; Universite Clermont Auvergne (UCA); United States Department of Agriculture (USDA); University of California System; University of California Davis; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; Universite de Franche-Comte; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; INRAE	Comte, B (corresponding author), Univ Auvergne, Clermont Univ, CRNH Auvergne, UMR1019,INRA,UNH, Clermont Ferrand, France.	blandine.comte@clermont.inra.fr	Mazur, Andre/AAG-9751-2020; Gladine, Cecile/W-9843-2018	Mazur, Andre/0000-0002-1067-5066; Gladine, Cecile/0000-0001-7693-6241; PUJOS-GUILLOT, Estelle/0000-0002-4693-5712; Comte, Blandine/0000-0002-4662-6581; Newman, John/0000-0001-9632-6571; Demougeot, Celine/0000-0003-0639-9756	intramural French National Institute for Agricultural Research (INRA); United States Department of Agriculture-Agricultural Research Service (USDA-ARS) [5306-51530-019-00D]	intramural French National Institute for Agricultural Research (INRA); United States Department of Agriculture-Agricultural Research Service (USDA-ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The project was partially supported by intramural French National Institute for Agricultural Research (INRA, http://www.alimh.inra.fr/) and United States Department of Agriculture-Agricultural Research Service (USDA-ARS, http://www.ars.usda.gov/main/main.htm), Project 5306-51530-019-00D (JWN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adan Y, 1999, BIOSCI BIOTECH BIOCH, V63, P111, DOI 10.1271/bbb.63.111; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brooks JD, 2008, J BIOL CHEM, V283, P12043, DOI 10.1074/jbc.M800122200; Brooks JD, 2011, J NEUROCHEM, V119, P604, DOI 10.1111/j.1471-4159.2011.07422.x; Brossard N, 1996, AM J CLIN NUTR, V64, P577, DOI 10.1093/ajcn/64.4.577; Brown AL, 2012, ARTERIOSCL THROM VAS, V32, P2122, DOI 10.1161/ATVBAHA.112.253435; Calder PC, 2012, MOL NUTR FOOD RES, V56, P1073, DOI 10.1002/mnfr.201100710; COSGROVE JP, 1987, LIPIDS, V22, P299, DOI 10.1007/BF02533996; De Caterina R, 2001, LIPIDS, V36, pS69, DOI 10.1007/s11745-001-0685-9; Erkkila AT, 2004, AM J CLIN NUTR, V80, P626; Gertow K, 2011, ATHEROSCLEROSIS, V215, P411, DOI 10.1016/j.atherosclerosis.2011.01.015; Gladine C., 2011, BR J NUTR, P1; Grapov D, 2012, BIOINFORMATICS; Jahn U, 2008, ANGEW CHEM INT EDIT, V47, P5894, DOI 10.1002/anie.200705122; Jude S, 2003, BRIT J PHARMACOL, V139, P816, DOI 10.1038/sj.bjp.0705308; Keenan AH, 2012, J LIPID RES, V53, P1662, DOI 10.1194/jlr.P025577; Matsumoto M, 2008, ATHEROSCLEROSIS, V197, P524, DOI 10.1016/j.atherosclerosis.2007.07.023; MAZUR A, 1990, J NUTR, V120, P1037, DOI 10.1093/jn/120.9.1037; Miles EA, 2012, BRIT J NUTR, V107, pS171, DOI 10.1017/S0007114512001560; Milne GL, 2011, CHEM REV, V111, P5973, DOI 10.1021/cr200160h; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Musiek ES, 2008, J BIOL CHEM, V283, P19927, DOI 10.1074/jbc.M803625200; Musiek ES, 2004, J CHROMATOGR B, V799, P95, DOI 10.1016/j.jchromb.2003.10.036; Nakajima K, 2011, ARTERIOSCL THROM VAS, V31, P1963, DOI 10.1161/ATVBAHA.111.229443; Newman JW, 2007, J LIPID RES, V48, P1792, DOI 10.1194/jlr.M700146-JLR200; Newman JW, 2002, J LIPID RES, V43, P1563, DOI 10.1194/jlr.D200018-JLR200; Nicoletti A, 1998, J CLIN INVEST, V102, P910, DOI 10.1172/JCI119892; Oger C, 2008, ORG LETT, V10, P5087, DOI 10.1021/ol802104z; Oger C, 2010, CHEM-EUR J, V16, P13976, DOI 10.1002/chem.201002304; PERERA SK, 1979, J AM CHEM SOC, V101, P7390, DOI 10.1021/ja00518a043; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Qu L, 2009, IEEE T INTELL TRANSP, V10, P512, DOI 10.1109/TITS.2009.2026312; Roberts LJ, 1998, J BIOL CHEM, V273, P13605, DOI 10.1074/jbc.273.22.13605; Saito M, 1998, J AGR FOOD CHEM, V46, P184, DOI 10.1021/jf970385d; Saraswathi V, 2007, J NUTR, V137, P1776, DOI 10.1093/jn/137.7.1776; Schuchardt JP, 2013, PROSTAG LEUKOTR ESS, V89, P19, DOI 10.1016/j.plefa.2013.04.001; Serhan CN, 2011, CURR TOP MED CHEM, V11, P629; Sethi S, 2002, BLOOD, V100, P1340, DOI 10.1182/blood-2002-01-0316; Sethi S, 1996, J LAB CLIN MED, V128, P27, DOI 10.1016/S0022-2143(96)90111-0; Shearer GC, 2010, J LIPID RES, V51, P2074, DOI 10.1194/M900193-JLR200; Shearer GC, 2008, PROSTAG LEUKOTR ESS, V79, P215, DOI 10.1016/j.plefa.2008.09.023; Simopoulos AP, 2000, PROSTAG LEUKOTR ESS, V63, P119, DOI 10.1054/plef.2000.0176; Smedes F, 1999, ANALYST, V124, P1711, DOI 10.1039/a905904k; Stephensen CB, 2011, J LIPID RES, V52, P991, DOI 10.1194/jlr.P012864; Stocker R, 2005, J THROMB HAEMOST, V3, P1825, DOI 10.1111/j.1538-7836.2005.01370.x; Ulu A, 2008, J CARDIOVASC PHARM, V52, P314, DOI 10.1097/FJC.0b013e318185fa3c; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Vila L, 2004, MED RES REV, V24, P399, DOI 10.1002/med.10065; Chong W, 2006, IEEE T NEURAL NETWOR, V17, P789, DOI 10.1109/TNN.2006.871718; Wang S, 2009, ATHEROSCLEROSIS, V204, P147, DOI 10.1016/j.atherosclerosis.2008.08.024; Zampolli A, 2006, ATHEROSCLEROSIS, V184, P78, DOI 10.1016/j.atherosclerosis.2005.04.018; Zhao Z, 2001, CLIN CHEM, V47, P1306	52	60	60	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89393	10.1371/journal.pone.0089393	http://dx.doi.org/10.1371/journal.pone.0089393			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558496	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700142
J	Xu, F; Li, X; Chang, CK; Guo, J; Wu, LY; He, Q; Zhang, Z; Zhu, Y; Gu, SC; Shi, WH; Song, LX; Su, JY; Zhou, LY; Zhang, X; Wu, D				Xu, Feng; Li, Xiao; Chang, Chun-Kang; Guo, Juan; Wu, Ling-Yun; He, Qi; Zhang, Zheng; Zhu, Yang; Gu, Shu-Chen; Shi, Wen-Hui; Song, Lu-Xi; Su, Ji-Ying; Zhou, Li-Yu; Zhang, Xi; Wu, Dong			Establishment and Validation of an Updated Diagnostic FCM Scoring System Based on Pooled Immunophenotyping in CD34+Blasts and Its Clinical Significance for Myelodysplastic Syndromes	PLOS ONE			English	Article							FLOW-CYTOMETRIC ANALYSIS; EUROPEAN LEUKEMIANET; WORKING CONFERENCE; MARROW; CELLS; TRANSPLANTATION; ABNORMALITIES; EXPRESSION; UTILITY; TIME	Abnormal immunophenotypes of hematopoietic cells can be detected by flow cytometry (FCM) to assist the diagnosis of myelodysplastic syndromes (MDS). We previously established a FCM scoring system for the diagnosis of low-grade MDS. In this study, additional valuable antigens were involved in an updated FCM scoring system (u-FCMSS) for all MDS subtypes. The u-FCMSS showed better sensitivity and specificity (89.4% and 96.5%) in distinguishing MDS from non-clonal cytopenia diseases. Validation analysis of u-FCMSS exhibited comparable sensitivity and specificity (86.7% and 93.3%) and high agreement rate (88.9%) of FCM diagnosis with morphological diagnosis at optimal cut-off (score 3). The distribution of FCM scores in different disease stages was also analyzed. The results suggested that early scoring from abnormal expression of mature myeloid/lymphoid antigens and advanced scoring from abnormal expression of stem/progenitor antigens expression constituted the majority of FCM scores of low-grade and high-grade MDS, respectively. High early scoring was generally accompanied by low IPSS-R score and superior survival, whereas high advanced scoring was accompanied by high IPSS-R score and inferior survival. In addition, the low-risk MDS patients with high early scoring and low advanced scoring were revealed as candidates for immunosuppressive therapy, whereas those with high advanced scoring and low early scoring may be more suitable for decitabine treatment. In conclusion, the u-FCMSS is a useful tool for diagnosis, prognosis and treatment selection in MDS. Differences in classes of antigens expressed and in distribution of FCM scores may reflect distinctive stage characteristics of MDS during disease progression.	[Xu, Feng; Li, Xiao; Chang, Chun-Kang; Guo, Juan; Wu, Ling-Yun; He, Qi; Zhang, Zheng; Zhu, Yang; Gu, Shu-Chen; Shi, Wen-Hui; Song, Lu-Xi; Su, Ji-Ying; Zhou, Li-Yu; Zhang, Xi; Wu, Dong] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Hematol, Shanghai 200030, Peoples R China; [Xu, Feng; Li, Xiao; Chang, Chun-Kang] Shanghai Jiao Tong Univ, Sch Med, Dept Internal Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Li, X (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Hematol, Shanghai 200030, Peoples R China.	lixiao3326@163.com	Wu, Ling/GZN-2235-2022; SHI, wen/GPW-9531-2022; GUO, JUAN/HIK-2220-2022		National High Technology Research and Development Program of China ("863'' program) [2012AA02A505]; National Natural Science Foundation of China [81270584, 81300389]	National High Technology Research and Development Program of China ("863'' program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was funded by the National High Technology Research and Development Program of China ("863'' program, Item No. 2012AA02A505) and the National Natural Science Foundation of China (Grant No. 81270584 and 81300389). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chu SC, 2011, LEUKEMIA RES, V35, P868, DOI 10.1016/j.leukres.2011.02.016; Della Porta MG, 2012, HAEMATOL-HEMATOL J, V97, P1209, DOI 10.3324/haematol.2011.048421; Della Porta MG, 2006, LEUKEMIA, V20, P549, DOI 10.1038/sj.leu.2404142; Font P, 2006, LEUKEMIA RES, V30, P957, DOI 10.1016/j.leukres.2005.11.026; Goardon N, 2009, HAEMATOL-HEMATOL J, V94, P1160, DOI 10.3324/haematol.2008.004085; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Greenberg PL, 2011, J NATL COMPR CANC NE, V9, P30, DOI 10.6004/jnccn.2011.0005; Itzykson R, 2012, CURR OPIN HEMATOL, V19, P65, DOI 10.1097/MOH.0b013e32834ff58a; Li X, 2004, INT J HEMATOL, V80, P140, DOI 10.1532/IJH97.NA0402; LOKEN MR, 1987, BLOOD, V70, P1316; Lorand-Metze I, 2007, LEUKEMIA RES, V31, P147, DOI 10.1016/j.leukres.2006.04.010; Malcovati L, 2007, J CLIN ONCOL, V25, P3503, DOI 10.1200/JCO.2006.08.5696; Ogata K, 2002, BLOOD, V100, P3887, DOI 10.1182/blood-2002-01-0222; Ogata K, 2006, BLOOD, V108, P1037, DOI 10.1182/blood-2005-12-4916; Sperling C, 1997, HAEMATOLOGICA, V82, P617; Stachurski D, 2008, LEUKEMIA RES, V32, P215, DOI 10.1016/j.leukres.2007.06.012; Stetler-Stevenson M, 2001, BLOOD, V98, P979, DOI 10.1182/blood.V98.4.979; Tien HF, 1998, LEUKEMIA LYMPHOMA, V31, P93, DOI 10.3109/10428199809057588; Valent P, 2007, LEUKEMIA RES, V31, P727, DOI 10.1016/j.leukres.2006.11.009; van de Loosdrecht AA, 2008, BLOOD, V111, P1067, DOI 10.1182/blood-2007-07-098764; van de Loosdrecht AA, 2009, HAEMATOL-HEMATOL J, V94, P1124, DOI 10.3324/haematol.2009.005801; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; Weinberg OK, 2010, LEUKEMIA, V24, P1844, DOI 10.1038/leu.2010.202; Wells DA, 2003, BLOOD, V102, P394, DOI 10.1182/blood-2002-09-2768; Xiao M, 2000, LEUKEMIA LYMPHOMA, V38, P489, DOI 10.3109/10428190009059267; Xu F, 2010, BRIT J HAEMATOL, V149, P587, DOI 10.1111/j.1365-2141.2010.08146.x; Zhang HB, 2010, J HEART LUNG TRANSPL, V29, P133, DOI 10.1016/j.healun.2009.08.013; Zhang Z, 2011, EUR J HAEMATOL, V86, P47, DOI 10.1111/j.1600-0609.2010.01535.x; Zhang Z, 2010, EXP HEMATOL, V38, P677, DOI 10.1016/j.exphem.2010.04.002	29	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88706	10.1371/journal.pone.0088706	http://dx.doi.org/10.1371/journal.pone.0088706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558415	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700061
J	Gao, QH; Yu, JG; Wu, CS; Wang, ZS; Wang, YK; Zhu, DL; Wang, M				Gao, Qing-Han; Yu, Jin-Gang; Wu, Chun-Sen; Wang, Zhi-Sheng; Wang, You-Ke; Zhu, De-Lan; Wang, Min			Comparison of Drip, Pipe and Surge Spring Root Irrigation for Jujube (Ziziphus jujuba Mill.) Fruit Quality in the Loess Plateau of China	PLOS ONE			English	Article							REGULATED DEFICIT IRRIGATION; PHENOLIC PROFILES; ANTIOXIDANT CAPACITY; WATER; TOMATO; YIELD; NECTARINES; COMPONENTS; CULTIVARS; RESPONSES	Loess Plateau is a typical rain-fed farming region, facing the threat of drought. Irrigation method is among the most important factors affecting jujube quality. This study investigated the response of Ziziphus jujuba Mill. cv. Lizao quality to three different irrigation methods (drip-, pipe-and surge spring root irrigation) combining two water levels (20 m(3)/hm(2) and 120 m(3)/hm(2)). The effects of the trials were evaluated by taking into account the physical-chemical characteristics of jujubes and the antioxidant activity. Concomitant to this, the concentration of some taste-related (viz. glucose, fructose, TSS and malic acid) and health-related compounds/parameters (viz. catechin and epicatechin) were generally much greater in jujube fruit treated with drip irrigation (120 m(3)/hm(2)). Different irrigation treatments had no significant effects on antioxidant capacity, total phenolics and proanthocyanidins (except for pipe irrigation 20 m(3)/hm(2)). The best compromise between quality and irrigation of jujube fruit was achieved with drip irrigation (120 m(3)/hm(2)).	[Gao, Qing-Han; Yu, Jin-Gang; Wu, Chun-Sen; Wang, Min] Northwest A& F Univ, Coll Food Sci & Engn, YangLing, Shaanxi, Peoples R China; [Gao, Qing-Han] Ningxia Med Univ, Sch Publ Hlth, Ningxia, Peoples R China; [Wang, Zhi-Sheng] Ningxia Med Univ, Lab Anim Ctr, Ningxia, Peoples R China; [Wang, You-Ke] Northwest A& F Univ, Coll Resources & Environm, YangLing, Shaanxi, Peoples R China; [Zhu, De-Lan] Northwest A& F Univ, Coll Water Resources & Architectural Engn, YangLing, Shaanxi, Peoples R China	Northwest A&F University - China; Ningxia Medical University; Ningxia Medical University; Northwest A&F University - China; Northwest A&F University - China	Wang, M (corresponding author), Northwest A& F Univ, Coll Food Sci & Engn, YangLing, Shaanxi, Peoples R China.	wangmin20050606@yahoo.com.cn			National Technology Support Project [2007BAD88B05, 2011BAD29B00]; People's Republic of China	National Technology Support Project; People's Republic of China	This work received financial support from the National Technology Support Project with a federal grant (numbers 2007BAD88B05 and 2011BAD29B00), People's Republic of China (http://www.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer KH, 2011, AGR WATER MANAGE, V98, P1197, DOI 10.1016/j.agwat.2011.03.003; AOAC, 1996, OFFICIAL METHODS ANA, V16th; Bandurska H, 2012, ACTA PHYSIOL PLANT, V34, P161, DOI 10.1007/s11738-011-0814-9; Buendia B, 2008, J AGR FOOD CHEM, V56, P3601, DOI 10.1021/jf800190f; Caldwell CR, 2005, J AGR FOOD CHEM, V53, P1125, DOI 10.1021/jf0355351; Castellarin SD, 2007, PLANTA, V227, P101, DOI 10.1007/s00425-007-0598-8; De Souza CR, 2005, VITIS, V44, P103; Favati F, 2009, SCI HORTIC-AMSTERDAM, V122, P562, DOI 10.1016/j.scienta.2009.06.026; Froehlicher T, 2009, FOOD CHEM, V115, P897, DOI 10.1016/j.foodchem.2009.01.004; Gao QH, 2013, J AGR FOOD CHEM, V61, P3351, DOI 10.1021/jf4007032; Gao QH, 2012, J FOOD SCI, V77, pC1218, DOI 10.1111/j.1750-3841.2012.02946.x; Gao QH, 2011, SCI HORTIC-AMSTERDAM, V130, P67, DOI 10.1016/j.scienta.2011.06.005; Gao XD, 2011, AGR WATER MANAGE, V102, P66, DOI 10.1016/j.agwat.2011.10.007; Gelly M, 2004, J SCI FOOD AGR, V84, P561, DOI 10.1002/jsfa.1686; Girona J, 2005, AGR WATER MANAGE, V72, P97, DOI 10.1016/j.agwat.2004.09.011; He L, 2011, FOOD RES INT, V44, P1161, DOI 10.1016/j.foodres.2010.05.023; Hutton RJ, 2011, AGR WATER MANAGE, V98, P1485, DOI 10.1016/j.agwat.2011.04.010; Ikram EHK, 2009, J FOOD COMPOS ANAL, V22, P388, DOI 10.1016/j.jfca.2009.04.001; Iqbal S, 2005, FOOD CHEM, V93, P265, DOI 10.1016/j.foodchem.2004.09.024; Jordan MJ, 2009, IND CROP PROD, V29, P145, DOI 10.1016/j.indcrop.2008.04.021; Kong KW, 2011, FOOD RES INT, V44, P2332, DOI 10.1016/j.foodres.2010.10.039; KUBOTA N, 1992, J JPN SOC HORTIC SCI, V61, P31, DOI 10.2503/jjshs.61.31; Kumar MSY, 2011, FOOD CHEM, V127, P1309, DOI 10.1016/j.foodchem.2011.01.088; Li JW, 2005, PROCESS BIOCHEM, V40, P3607, DOI 10.1016/j.procbio.2005.03.005; Liu K, 2011, AGRON J, V103, P1339, DOI 10.2134/agronj2011.0111; Mahajan G, 2006, AGR WATER MANAGE, V84, P202, DOI 10.1016/j.agwat.2006.03.003; Malash N, 2005, AGR WATER MANAGE, V78, P25, DOI 10.1016/j.agwat.2005.04.016; MITCHELL JP, 1991, PHYSIOL PLANTARUM, V83, P177, DOI [10.1034/j.1399-3054.1991.830127.x, 10.1111/j.1399-3054.1991.tb01299.x]; Navarro JM, 2010, FOOD CHEM, V119, P1591, DOI 10.1016/j.foodchem.2009.09.048; Perez-Pastor A, 2007, J SCI FOOD AGR, V87, P2409, DOI 10.1002/jsfa.2905; Pernice R, 2010, SCI HORTIC-AMSTERDAM, V126, P156, DOI 10.1016/j.scienta.2010.06.021; Plastina P, 2012, J ETHNOPHARMACOL, V140, P325, DOI 10.1016/j.jep.2012.01.022; Pliakoni ED, 2010, J AGR FOOD CHEM, V58, P11783, DOI 10.1021/jf102387m; Sanchez-Bel P, 2008, J AGR FOOD CHEM, V56, P10056, DOI 10.1021/jf8012212; Sanchez-Rodriguez E, 2012, FOOD CHEM, V134, P775, DOI 10.1016/j.foodchem.2012.02.180; Santesteban LG, 2011, AGR WATER MANAGE, V98, P1171, DOI 10.1016/j.agwat.2011.02.011; Thakur A, 2012, SCI HORTIC-AMSTERDAM, V135, P112, DOI 10.1016/j.scienta.2011.12.013; Tomas-Barberan F, 2001, J SCI FOOD AGR, V81, P853, DOI 10.1002/jsfa.885; Tovar MJ, 2002, J SCI FOOD AGR, V82, P892, DOI 10.1002/jsfa.1122; Wang F, 2011, AGR WATER MANAGE, V98, P1228, DOI 10.1016/j.agwat.2011.03.004; Zhang H, 2010, FOOD CHEM TOXICOL, V48, P1461, DOI 10.1016/j.fct.2010.03.011; ZHU XA, 1983, GEODERMA, V29, P237, DOI 10.1016/0016-7061(83)90090-3; Zong L, 2011, TURK J AGRIC FOR, V35, P297, DOI 10.3906/tar-0908-5	43	9	9	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88912	10.1371/journal.pone.0088912	http://dx.doi.org/10.1371/journal.pone.0088912			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551188	Green Submitted, Green Published, gold			2022-12-27	WOS:000331271500080
J	Jefferson, M; Whelband, M; Mohorianu, I; Powell, PP				Jefferson, Matthew; Whelband, Matthew; Mohorianu, Irina; Powell, Penny P.			The Pestivirus N Terminal Protease N-pro Redistributes to Mitochondria and Peroxisomes Suggesting New Sites for Regulation of IRF3 by N-pro	PLOS ONE			English	Article							SWINE-FEVER VIRUS; KAPPA-B; ANTIVIRAL RESPONSE; VIRAL EVASION; INTERFERON; MAVS; APOPTOSIS; DEGRADATION; BAX; IDENTIFICATION	The N-terminal protease of pestiviruses, N-pro is a unique viral protein, both because it is a distinct autoprotease that cleaves itself from the following polyprotein chain, and also because it binds and inactivates IRF3, a central regulator of interferon production. An important question remains the role of N-pro in the inhibition of apoptosis. In this study, apoptotic signals induced by staurosporine, interferon, double stranded RNA, sodium arsenate and hydrogen peroxide were inhibited by expression of wild type N-pro, but not by mutant protein N-pro C112R, which we show is less efficient at promoting degradation of IRF3, and led to the conclusion that N-pro inhibits the stress-induced intrinsic mitochondrial pathway through inhibition of IRF3-dependent Bax activation. Both expression of N-pro and infection with Bovine Viral Diarrhea Virus (BVDV) prevented Bax redistribution and mitochondrial fragmentation. Given the role played by signaling platforms during IRF3 activation, we have studied the subcellular distribution of N-pro and we show that, in common with many other viral proteins, N-pro targets mitochondria to inhibit apoptosis in response to cell stress. N-pro itself not only relocated to mitochondria but in addition, both N-pro and IRF3 associated with peroxisomes, with over 85% of N-pro puncta co-distributing with PMP70, a marker for peroxisomes. In addition, peroxisomes containing N-pro and IRF3 associated with ubiquitin. IRF3 was degraded, whereas N-pro accumulated in response to cell stress. These results implicate mitochondria and peroxisomes as new sites for IRF3 regulation by N-pro, and highlight the role of these organelles in the anti-viral pathway.	[Jefferson, Matthew; Whelband, Matthew; Mohorianu, Irina; Powell, Penny P.] Univ E Anglia, Norwich Med Sch & Biol Sci, Biomed Res Ctr, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Powell, PP (corresponding author), Univ E Anglia, Norwich Med Sch & Biol Sci, Biomed Res Ctr, Norwich NR4 7TJ, Norfolk, England.	P.Powell@uea.ac.uk	Mohorianu, Irina/J-2549-2019	Powell, Penny/0000-0002-5347-0490; Mohorianu, Irina/0000-0003-4863-761X	Biotechnology and Biological Sciences Research Council [BBS/B/00686]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding came from a Biotechnology and Biological Sciences Research Council grant BBS/B/00686 to PPP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achmuller C, 2007, NAT METHODS, V4, P1037, DOI 10.1038/nmeth1116; Bauhofer O, 2007, J VIROL, V81, P3087, DOI 10.1128/JVI.02032-06; Belgnaoui SM, 2011, CURR OPIN IMMUNOL, V23, P564, DOI 10.1016/j.coi.2011.08.001; Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; Castanier C, 2010, BIOCHIM BIOPHYS ACTA, V1813, P575; Chattopadhyay S, 2010, EMBO J, V29, P1762, DOI 10.1038/emboj.2010.50; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Doceul V, 2008, J GEN VIROL, V89, P1881, DOI 10.1099/vir.0.83643-0; Ettema TJG, 2003, TRENDS BIOCHEM SCI, V28, P170, DOI 10.1016/S0968-0004(03)00037-9; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Killip MJ, 2013, J VIROL, V87, P4798, DOI 10.1128/JVI.03383-12; La Rocca SA, 2005, J VIROL, V79, P7239, DOI 10.1128/JVI.79.11.7239-7247.2005; Lazarow PB, 2011, CURR OPIN MICROBIOL, V14, P458, DOI 10.1016/j.mib.2011.07.009; Li Y, 2012, P NATL ACAD SCI USA, V109, P11770, DOI 10.1073/pnas.1203405109; Lloyd RE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002741; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; MOENNIG V, 1992, ADV VIRUS RES, V41, P53, DOI 10.1016/S0065-3527(08)60035-4; Mohan KVK, 2002, J VIROL, V76, P2543, DOI 10.1128/JVI.76.5.2543-2547.2002; Paz S, 2009, MOL CELL BIOL, V29, P3401, DOI 10.1128/MCB.00880-08; Peterhans E, 2010, VET MICROBIOL, V142, P18, DOI 10.1016/j.vetmic.2009.09.038; Platta HW, 2007, TRENDS CELL BIOL, V17, P474, DOI 10.1016/j.tcb.2007.06.009; Renault TT, 2011, BIOCHIMIE, V93, P1379, DOI 10.1016/j.biochi.2011.05.013; Ruggli N, 2009, J VIROL, V83, P817, DOI 10.1128/JVI.01509-08; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2010, CELL, V141, P570, DOI 10.1016/j.cell.2010.04.043; Szymanski MR, 2009, J MOL BIOL, V391, P438, DOI 10.1016/j.jmb.2009.06.040; Tait SWG, 2007, J CELL BIOL, V179, P1453, DOI 10.1083/jcb.200707063; Taylor KE, 2013, IMMUNOLOGY, V138, P190, DOI 10.1111/imm.12038; Vince JE, 2010, EMBO J, V29, P1627, DOI 10.1038/emboj.2010.79; Wolff T, 1996, J VIROL, V70, P5363, DOI 10.1128/JVI.70.8.5363-5372.1996; Zemirli N, 2012, INT J BIOCHEM CELL B, V44, P1473, DOI 10.1016/j.biocel.2012.05.018	33	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88838	10.1371/journal.pone.0088838	http://dx.doi.org/10.1371/journal.pone.0088838			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551175	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000331271500075
J	Phelps, NBD; Mor, SK; Armien, AG; Batts, W; Goodwin, AE; Hopper, L; McCann, R; Ng, TFF; Puzach, C; Waltzek, TB; Delwart, E; Winton, J; Goyal, SM				Phelps, Nicholas B. D.; Mor, Sunil K.; Armien, Anibal G.; Batts, William; Goodwin, Andrew E.; Hopper, Lacey; McCann, Rebekah; Ng, Terry Fei Fan; Puzach, Corey; Waltzek, Thomas B.; Delwart, Eric; Winton, James; Goyal, Sagar M.			Isolation and Molecular Characterization of a Novel Picornavirus from Baitfish in the USA	PLOS ONE			English	Article							VIRUS; PROTEIN; RNA; ECOLOGY; FAMILY; MEMBER; WILD	During both regulatory and routine surveillance sampling of baitfish from the states of Illinois, Minnesota, Montana, and Wisconsin, USA, isolates (n = 20) of a previously unknown picornavirus were obtained from kidney/spleen or entire viscera of fathead minnows (Pimephales promelas) and brassy minnows (Hybognathus hankinsoni). Following the appearance of a diffuse cytopathic effect, examination of cell culture supernatant by negative contrast electron microscopy revealed the presence of small, round virus particles (similar to 30-32 nm), with picornavirus-like morphology. Amplification and sequence analysis of viral RNA identified the agent as a novel member of the Picornaviridae family, tentatively named fathead minnow picornavirus (FHMPV). The full FHMPV genome consisted of 7834 nucleotides. Phylogenetic analysis based on 491 amino acid residues of the 3D gene showed 98.6% to 100% identity among the 20 isolates of FHMPV compared in this study while only 49.5% identity with its nearest neighbor, the bluegill picornavirus (BGPV) isolated from bluegill (Lepomis macrochirus). Based on complete polyprotein analysis, the FHMPV shared 58% (P1), 33% (P2) and 43% (P3) amino acid identities with BGPV and shared less than 40% amino acid identity with all other picornaviruses. Hence, we propose the creation of a new genus (Piscevirus) within the Picornaviridae family. The impact of FHMPV on the health of fish populations is unknown at present.	[Phelps, Nicholas B. D.; Mor, Sunil K.; Armien, Anibal G.; Goyal, Sagar M.] Minnesota Vet Diagnost Lab, St Paul, MN 55108 USA; [Phelps, Nicholas B. D.; Armien, Anibal G.; Goyal, Sagar M.] Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA; [Batts, William; Winton, James] US Geol Survey, Western Fisheries Res Ctr, Seattle, WA USA; [Goodwin, Andrew E.] US Fish & Wildlife Serv, Portland, OR USA; [Hopper, Lacey] US Fish & Wildlife Serv, Bozeman Fish Hlth Ctr, Bozeman, MT USA; [McCann, Rebekah; Puzach, Corey] US Fish & Wildlife Serv, La Crosse Fish Hlth Ctr, Onalaska, WI USA; [Ng, Terry Fei Fan; Delwart, Eric] Blood Syst Res Inst, San Francisco, CA USA; [Ng, Terry Fei Fan; Delwart, Eric] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Waltzek, Thomas B.] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL USA	University of Minnesota System; University of Minnesota Twin Cities; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; State University System of Florida; University of Florida	Phelps, NBD (corresponding author), Minnesota Vet Diagnost Lab, St Paul, MN 55108 USA.	phelp083@umn.edu	Waltzek, Thomas/AHD-3209-2022; Ng, Terry Fei Fan/H-5305-2019; Mor, Sunil Kumar/M-6325-2018	Ng, Terry Fei Fan/0000-0002-4815-8697; Mor, Sunil Kumar/0000-0002-1112-088X; Delwart, Eric/0000-0002-6296-4484; Waltzek, Thomas/0000-0001-6383-5978; Phelps, Nicholas/0000-0003-3116-860X				Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adams MJ, 2013, ARCH VIROL, V158, P2023, DOI 10.1007/s00705-013-1688-5; AMBROS V, 1978, J BIOL CHEM, V253, P5263; Barbknecht M, 2009, THESIS U WISCONSIN C; Batts W, 2011, VIRUS RES, V158, P116, DOI 10.1016/j.virusres.2011.03.019; Batts WN, 2012, J GEN VIROL, V93, P1247, DOI 10.1099/vir.0.041210-0; BLOCH B, 1991, DIS AQUAT ORGAN, V10, P65, DOI 10.3354/dao010065; Blom N, 1996, PROTEIN SCI, V5, P2203, DOI 10.1002/pro.5560051107; Drummond A., 2011, GENEIOUS V5 5; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fichtner D, 2013, J VIROL, V87, P10895, DOI 10.1128/JVI.01094-13; Gaughan DJ, 2001, REV FISH BIOL FISHER, V11, P113, DOI 10.1023/A:1015255900836; Goodwin AE, 2004, FISHERIES, V29, P19, DOI 10.1577/1548-8446(2004)29[19:TOEFV]2.0.CO;2; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Gunderson JL, 2000, WHITE PAPER STATUS; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; HEDRICK RP, 1991, CAN J FISH AQUAT SCI, V48, P99, DOI 10.1139/f91-014; Hedrick RP, 1996, REV SCI TECH OIE, V15, P523, DOI 10.20506/rst.15.2.938; Hughes PJ, 2000, J GEN VIROL, V81, P201, DOI 10.1099/0022-1317-81-1-201; Iwanowicz LR, 2000, J FISH DIS, V23, P349, DOI 10.1046/j.1365-2761.2000.00245.x; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kapoor A, 2008, J VIROL, V82, P311, DOI 10.1128/JVI.01240-07; Kim R, 2011, J ADV RES, V2, P9, DOI 10.1016/j.jare.2010.05.007; Knowles NJ, 2012, VIRUS TAXONOMY CLASS, P855, DOI DOI 10.1016/B978-0-12-384684-6.00074-4; LITVAK MK, 1993, FISHERIES, V18, P6, DOI 10.1577/1548-8446(1993)018<0006:EOFBUI>2.0.CO;2; McCann R, 2012, THESIS U WISCONSIN L; McEntire ME, 2003, J AQUAT ANIM HEALTH, V15, P257, DOI 10.1577/H03-046.1; MORI KI, 1992, VIROLOGY, V187, P368, DOI 10.1016/0042-6822(92)90329-N; Muhire B, 2013, ARCH VIROL, V158, P1411, DOI 10.1007/s00705-012-1601-7; Nanda S, 2008, J VIROL METHODS, V152, P18, DOI 10.1016/j.jviromet.2008.06.007; OIE (World Organization for Animal Health), 2011, MAN DIAGN AQ AN; Racaniello VR, 2007, FIELDS VIROLOGY, P795; Sanchez R, 2011, NUCLEIC ACIDS RES, V39, P1, DOI DOI 10.1093/NAR/G5R408; Sauvage V, 2012, J VIROL, V86, P10036, DOI 10.1128/JVI.00046-12; STANWAY G, 1994, J VIROL, V68, P8232, DOI 10.1128/JVI.68.12.8232-8238.1994; Stone N, 2001, USDA PUBLICATION, V120; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Terry FFN, 2012, J VIROL, V86, P12161, DOI 10.1128/JVI.00869-12; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tseng CH, 2007, VIRUS RES, V123, P190, DOI 10.1016/j.virusres.2006.09.007; USDA (United States Department of Agriculture), 2008, FED ORD PREV SPREAD; USDA (United States Department of Agriculture), 2006, AC02SP2 USDA; USFWS and AFS-FHS (U.S. Fish and Wildlife Service and American Fisheries Society-Fish Health Section), 2010, AFS FHS FHS BLUE BOO; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08	44	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e87593	10.1371/journal.pone.0087593	http://dx.doi.org/10.1371/journal.pone.0087593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586283	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900012
J	Venkataramani, S; Van Wyk, M; Buldyrev, I; Sivyer, B; Vaney, DI; Taylor, WR				Venkataramani, Sowmya; Van Wyk, Michiel; Buldyrev, Ilya; Sivyer, Benjamin; Vaney, David I.; Taylor, W. Rowland			Distinct Roles for Inhibition in Spatial and Temporal Tuning of Local Edge Detectors in the Rabbit Retina	PLOS ONE			English	Article							CONE BIPOLAR CELLS; GANGLION-CELLS; MAMMALIAN RETINA; AMACRINE CELLS; CAT RETINA; RECEPTIVE-FIELDS; MOUSE RETINA; SYNAPTIC PATHWAYS; PRIMATE RETINA; COMBINED GOLGI	This paper examines the role of inhibition in generating the receptive-field properties of local edge detector (LED) ganglion cells in the rabbit retina. We confirm that the feed-forward inhibition is largely glycinergic but, contrary to a recent report, our data demonstrate that the glycinergic inhibition contributes to temporal tuning for the OFF and ON inputs to the LEDs by delaying the onset of spiking; this delay was more pronounced for the ON inputs (similar to 340 ms) than the OFF inputs (similar to 12 ms). Blocking glycinergic transmission reduced the delay to spike onset and increased the responses to flickering stimuli at high frequencies. Analysis of the synaptic conductances indicates that glycinergic amacrine cells affect temporal tuning through both postsynaptic inhibition of the LEDs and presynaptic modulation of the bipolar cells that drive the LEDs. The results also confirm that presynaptic GABAergic transmission contributes significantly to the concentric surround antagonism in LEDs; however, unlike presumed LEDs in the mouse retina, the surround is only partly generated by spiking amacrine cells.	[Venkataramani, Sowmya; Buldyrev, Ilya; Taylor, W. Rowland] Oregon Hlth & Sci Univ, Dept Ophthalmol, Portland, OR 97201 USA; [Van Wyk, Michiel] Univ Bern, Inst Anim Pathol, Bern, Switzerland; [Sivyer, Benjamin; Vaney, David I.] Univ Queensland, Queensland Brain Inst, Australian Res Council Ctr Excellence Vis Sci, Brisbane, Qld, Australia	Oregon Health & Science University; University of Bern; University of Queensland	Taylor, WR (corresponding author), Oregon Hlth & Sci Univ, Dept Ophthalmol, Portland, OR 97201 USA.	taylorw@ohsu.edu		van Wyk, Michiel/0000-0003-3055-9721; Taylor, William/0000-0002-6806-3249	NHMRC (Australia) [351538]; NSH; NIH [EY014888]; RPB; NATIONAL EYE INSTITUTE [P30EY010572, R01EY014888] Funding Source: NIH RePORTER	NHMRC (Australia)(National Health and Medical Research Council (NHMRC) of Australia); NSH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RPB; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by NHMRC (Australia) grant 351538 to DIV and NSH, and by NIH grant EY014888 to WRT and an unrestricted grant to the Department of Ophthalmology from RPB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asari H, 2012, NAT NEUROSCI, V15, P1581, DOI 10.1038/nn.3241; Berntson A, 2004, VISUAL NEUROSCI, V21, P693, DOI 10.1017/S0952523804215048; Berson DM, 1998, J COMP NEUROL, V399, P269, DOI 10.1002/(SICI)1096-9861(19980921)399:2<269::AID-CNE9>3.0.CO;2-Z; Borg-Graham LJ, 2001, NAT NEUROSCI, V4, P176, DOI 10.1038/84007; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; Bowery NG, 2006, BRIT J PHARMACOL, V147, pS109, DOI 10.1038/sj.bjp.0706443; Buldyrev I, 2013, J PHYSIOL-LONDON, V591, P303, DOI 10.1113/jphysiol.2012.243113; Buldyrev I, 2012, J NEUROPHYSIOL, V107, P1795, DOI 10.1152/jn.00924.2011; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P277, DOI 10.1113/jphysiol.1978.sp012233; CLELAND BG, 1974, J PHYSIOL-LONDON, V240, P457, DOI 10.1113/jphysiol.1974.sp010618; Cook PB, 1998, J NEUROSCI, V18, P2301; Cui JJ, 2008, VISUAL NEUROSCI, V25, P635, DOI 10.1017/S0952523808080851; Demb JB, 1999, J NEUROSCI, V19, P9756; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; DOWLING JE, 1966, PROC R SOC SER B-BIO, V166, P80, DOI 10.1098/rspb.1966.0086; Eggers ED, 2006, J PHYSIOL-LONDON, V572, P215, DOI 10.1113/jphysiol.2005.103648; Eggers ED, 2010, J NEUROPHYSIOL, V103, P25, DOI 10.1152/jn.00458.2009; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; Flores-Herr N, 2001, J NEUROSCI, V21, P4852, DOI 10.1523/JNEUROSCI.21-13-04852.2001; Heads JA, 2008, J NEUROCHEM, V105, P1418, DOI 10.1111/j.1471-4159.2008.05244.x; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Kittila CA, 1997, J NEUROPHYSIOL, V77, P675, DOI 10.1152/jn.1997.77.2.675; LEVICK WR, 1967, J PHYSIOL-LONDON, V188, P285, DOI 10.1113/jphysiol.1967.sp008140; Macneil MA, 1999, J COMP NEUROL, V413, P305; Manookin MB, 2008, J NEUROSCI, V28, P4136, DOI 10.1523/JNEUROSCI.4274-07.2008; MULLER F, 1988, J NEUROPHYSIOL, V59, P1657, DOI 10.1152/jn.1988.59.6.1657; Nobles RD, 2012, J NEUROSCI, V32, P3321, DOI 10.1523/JNEUROSCI.5341-11.2012; Pan ZH, 2000, J NEUROPHYSIOL, V84, P2564, DOI 10.1152/jn.2000.84.5.2564; POURCHO RG, 1983, J COMP NEUROL, V219, P25, DOI 10.1002/cne.902190104; POURCHO RG, 1985, J COMP NEUROL, V233, P473, DOI 10.1002/cne.902330406; Puthussery T, 2013, J NEUROSCI, V33, P16045, DOI 10.1523/JNEUROSCI.1249-13.2013; Renna JM, 2007, VISUAL NEUROSCI, V24, P503, DOI 10.1017/S0952523807070241; RODIECK RW, 1993, J COMP NEUROL, V338, P289, DOI 10.1002/cne.903380211; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Roska B, 2006, J NEUROPHYSIOL, V95, P3810, DOI 10.1152/jn.00113.2006; Russell TL, 2010, J NEUROPHYSIOL, V103, P2757, DOI 10.1152/jn.00987.2009; Sampath AP, 2004, NEURON, V41, P431, DOI 10.1016/S0896-6273(04)00005-4; Saszik S, 2012, J NEUROSCI, V32, P297, DOI 10.1523/JNEUROSCI.2739-08.2012; Shields CR, 2003, J NEUROPHYSIOL, V89, P2449, DOI 10.1152/jn.00916.2002; STONE C, 1992, J PHYSIOL-LONDON, V456, P125, DOI 10.1113/jphysiol.1992.sp019330; Taylor WR, 1999, VISUAL NEUROSCI, V16, P285, DOI 10.1017/S0952523899162096; Taylor WR, 2002, J NEUROSCI, V22, P7712; Van Wyk M, 2009, VISUAL NEUROSCI, V26, P297, DOI 10.1017/S0952523809990137; van Wyk M, 2006, J NEUROSCI, V26, P13250, DOI 10.1523/JNEUROSCI.1991-06.2006; VAUGHN JE, 1981, J COMP NEUROL, V197, P113, DOI 10.1002/cne.901970109; Venkataramani S, 2010, J NEUROSCI, V30, P15664, DOI 10.1523/JNEUROSCI.2081-10.2010; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wilson M, 2003, VISUAL NEUROSCIENCES; WYATT HJ, 1976, SCIENCE, V191, P204, DOI 10.1126/science.1857; Xu Y, 2005, J NEUROPHYSIOL, V93, P2388, DOI 10.1152/jn.01088.2004; Zeck GM, 2005, EUR J NEUROSCI, V22, P2016, DOI 10.1111/j.1460-9568.2005.04390.x; Zhang C, 2012, VISUAL NEUROSCI, V29, P11, DOI 10.1017/S0952523812000028; Zhang JA, 1997, VISUAL NEUROSCI, V14, P553, DOI 10.1017/S0952523800012219; Zhang YF, 2012, P NATL ACAD SCI USA, V109, pE2391, DOI 10.1073/pnas.1211547109	54	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e88560	10.1371/journal.pone.0088560	http://dx.doi.org/10.1371/journal.pone.0088560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586343	gold, Green Published, Green Submitted			2022-12-27	WOS:000331717900019
J	Moussaoui, N; Braniste, V; Ait-Belgnaoui, A; Gabanou, M; Sekkal, S; Olier, M; Theodorou, V; Martin, PGP; Houdeau, E				Moussaoui, Nabila; Braniste, Viorica; Ait-Belgnaoui, Afifa; Gabanou, Melissa; Sekkal, Soraya; Olier, Maiwenn; Theodorou, Vassilia; Martin, Pascal G. P.; Houdeau, Eric			Changes in Intestinal Glucocorticoid Sensitivity in Early Life Shape the Risk of Epithelial Barrier Defect in Maternal-Deprived Rats	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; LONG-TERM ALTERATIONS; NECROTIZING ENTEROCOLITIS; BACTERIAL TRANSLOCATION; COLONIC PERMEABILITY; MUCOSAL BARRIER; IMMUNE-SYSTEM; STRESS; MATURATION; CELLS	Glucocorticoids (GC) contribute to human intestine ontogeny and accelerate gut barrier development in preparation to birth. Rat gut is immature at birth, and high intestinal GC sensitivity during the first two weeks of life resembles that of premature infants. This makes suckling rats a model to investigate postpartum impact of maternal separation (MS)-associated GC release in preterm babies, and whether GC sensitivity may shape MS effects in immature gut. A 4 hours-MS applied once at postnatal day (PND) 10 enhanced plasma corticosterone in male and female pups, increased by two times the total in vivo intestinal permeability (IP) to oral FITC-Dextran 4 kDa (FD4) immediately after the end of MS, and induced bacterial translocation (BT) to liver and spleen. Ussing chamber experiments demonstrated a 2-fold increase of permeability to FD4 in the colon immediately after the end of MS, but not in the ileum. Colonic permeability was not only increased for FD4 but also to intact horseradish peroxidase 44 kDa in MS pups. In vivo, the glucocorticoid receptor (GR) antagonist RU486 or ML7 blockade of myosin light chain kinase controlling epithelial cytoskeleton contraction prevented MS-induced IP increase to oral FD4 and BT. In addition, the GR agonist dexamethasone dose-dependently mimicked MS-increase of IP to oral FD4. In contrast, MS effects on IP to oral FD4 and BT were absent at PND20, a model for full-term infant, characterized by a marked drop of IP to FD4 in response to dexamethasone, and decreased GR expression in the colon only compared to PND10 pups. These results show that high intestinal GC responsiveness in a rat model of prematurity defines a vulnerable window for a post-delivery MS, evoking immediate disruption of epithelial integrity in the large intestine, and increasing susceptibility to macromolecule passage and bacteremia.	[Moussaoui, Nabila; Braniste, Viorica; Gabanou, Melissa; Houdeau, Eric] INRA, Res Ctr Food Toxicol Toxalim, F-31931 Toulouse, France; [Moussaoui, Nabila; Ait-Belgnaoui, Afifa; Sekkal, Soraya; Olier, Maiwenn; Theodorou, Vassilia; Martin, Pascal G. P.] INRA, Toxalim, F-31931 Toulouse, France; [Martin, Pascal G. P.] INRA, Toxalim, GeT TRiX Facil, F-31931 Toulouse, France	INRAE; INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Houdeau, E (corresponding author), INRA, Toxalim UMR1331, 180 Chemin Tournefeuille,BP 93173, F-31027 Toulouse 3, France.	eric.houdeau@toulouse.inra.fr	Olier, Maïwenn/N-3383-2019; Martin, Pascal/K-8184-2019; Olier, Maïwenn/C-4971-2015	Olier, Maïwenn/0000-0001-7214-1134; Martin, Pascal/0000-0002-4271-658X; Olier, Maïwenn/0000-0001-7214-1134; Braniste, Viorica/0000-0003-1992-3609	Institut National de la Recherche Agronomique (INRA); Region Midi-Pyrenees	Institut National de la Recherche Agronomique (INRA); Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie)	This work was supported by the Institut National de la Recherche Agronomique (INRA) and Grant from the Region Midi-Pyrenees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Belgnaoui A, 2005, PAIN, V113, P141, DOI 10.1016/j.pain.2004.10.002; Anand RJ, 2007, SHOCK, V27, P124, DOI 10.1097/01.shk.0000239774.02904.65; ARTURSSON P, 1990, J PHARM SCI, V79, P595, DOI 10.1002/jps.2600790710; Barreau F, 2008, GUT, V57, P582, DOI 10.1136/gut.2007.126680; Barreau F, 2004, GUT, V53, P501, DOI 10.1136/gut.2003.024174; Barreau F, 2007, PEDIATR RES, V62, P240, DOI 10.1203/PDR.0b013e3180db2949; Braniste V, 2009, J PHYSIOL-LONDON, V587, P3317, DOI 10.1113/jphysiol.2009.169300; Bystrova K, 2009, BIRTH-ISS PERINAT C, V36, P97, DOI 10.1111/j.1523-536X.2009.00307.x; CATASSI C, 1995, J PEDIATR GASTR NUTR, V21, P383, DOI 10.1097/00005176-199511000-00003; Chen M, 2011, WORLD J GASTROENTERO, V17, P2933, DOI 10.3748/wjg.v17.i24.2933; Colome G, 2007, ACTA PAEDIATR, V96, P69, DOI 10.1111/j.1651-2227.2007.00030.x; Corthesy B, 2007, J NUTR, V137, p781S, DOI 10.1093/jn/137.3.781S; Costalos C, 2003, EARLY HUM DEV, V74, P83, DOI 10.1016/S0378-3782(03)00087-2; Dageville C, 2011, ARCH PEDIATRIE, V18, P994, DOI 10.1016/j.arcped.2011.06.007; Dong P, 2010, EARLY HUM DEV, V86, P51, DOI 10.1016/j.earlhumdev.2010.01.002; Flacking R, 2012, ACTA PAEDIATR, V101, P1032, DOI 10.1111/j.1651-2227.2012.02787.x; Gareau MG, 2008, CURR MOL MED, V8, P274, DOI 10.2174/156652408784533760; Gordon P V, 2001, J Perinatol, V21, P156, DOI 10.1038/sj.jp.7200520; HENNING SJ, 1975, J BIOL CHEM, V250, P2073; HENNING SJ, 1978, AM J PHYSIOL, V235, pE451, DOI 10.1152/ajpendo.1978.235.5.E451; Holmes JL, 2006, GENE EXPR PATTERNS, V6, P581, DOI 10.1016/j.modgep.2005.12.001; Maayan-Metzger Ayala, 2004, J Perinatol, V24, P494, DOI 10.1038/sj.jp.7211135; MAEHLY AC, 1954, METHOD BIOCHEM ANAL, V1, P357; Maheshwari A, 2006, HEMATOL MEET REP, V2, P18; McCracken VJ, 2001, CELL MICROBIOL, V3, P1, DOI 10.1046/j.1462-5822.2001.00090.x; Moore ER, 2012, COCHRANE DB SYST REV, V16; Morgan BE, 2011, BIOL PSYCHIAT, V70, P817, DOI 10.1016/j.biopsych.2011.06.018; Moriez R, 2007, SHOCK, V28, P118, DOI 10.1097/SHK.0b013e3180315ba9; Nanthakumar NN, 2005, AM J PHYSIOL-GASTR L, V288, pG85, DOI 10.1152/ajpgi.00169.2004; Nanthakumar NN, 2003, AM J PHYSIOL-REG I, V285, pR162, DOI 10.1152/ajpregu.00721.2001; Neu J, 2007, AM J CLIN NUTR, V85, p629S, DOI 10.1093/ajcn/85.2.629S; O'Mahony SM, 2011, PSYCHOPHARMACOLOGY, V214, P71, DOI 10.1007/s00213-010-2010-9; Oines E, 2012, PHYSIOL BEHAV, V105, P1058, DOI 10.1016/j.physbeh.2011.11.024; Pacha J, 2003, PEDIATR RES, V53, P808, DOI 10.1203/01.PDR.0000058923.08017.6F; Patel RM, 2012, AM J PATHOL, V180, P626, DOI 10.1016/j.ajpath.2011.10.025; Perez PF, 2007, PEDIATRICS, V119, pE724, DOI 10.1542/peds.2006-1649; Perez-Cano FJ, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/537310; Petrosyan M, 2009, PEDIATR SURG INT, V25, P309, DOI 10.1007/s00383-009-2344-8; Puiman P, 2008, CURR OPIN CLIN NUTR, V11, P601, DOI 10.1097/MCO.0b013e32830b5b15; Quaroni A, 1999, AM J PHYSIOL-GASTR L, V277, pG1027, DOI 10.1152/ajpgi.1999.277.5.G1027; Schmidt M, 2004, J NEUROENDOCRINOL, V16, P52, DOI 10.1111/j.1365-2826.2004.01123.x; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; UDALL JN, 1981, PEDIATR RES, V15, P241, DOI 10.1203/00006450-198103000-00008; Urao M, 1996, J PEDIATR SURG, V31, P1482, DOI 10.1016/S0022-3468(96)90160-8; VANELBURG RM, 1992, SCAND J GASTROENTERO, V27, P19, DOI 10.3109/00365529209096021; Vazquez DM, 1998, PSYCHONEUROENDOCRINO, V23, P663; Wagner CL, 2008, CLIN REV ALLERG IMMU, V34, P191, DOI 10.1007/s12016-007-8032-3; WEAVER LT, 1984, ARCH DIS CHILD, V59, P236, DOI 10.1136/adc.59.3.236; Yajima M, 2001, J PEDIATR GASTR NUTR, V33, P592, DOI 10.1097/00005176-200111000-00015; Zeuthen LH, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-2; Zheng G, 2013, NEUROGASTROENT MOTIL, V25, pE127, DOI 10.1111/nmo.12066	51	56	57	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88382	10.1371/journal.pone.0088382	http://dx.doi.org/10.1371/journal.pone.0088382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586321	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700016
J	Pearce, B; Crichton, S; Mackiewicz, M; Finlayson, GD; Hurlbert, A				Pearce, Bradley; Crichton, Stuart; Mackiewicz, Michal; Finlayson, Graham D.; Hurlbert, Anya			Chromatic Illumination Discrimination Ability Reveals that Human Colour Constancy Is Optimised for Blue Daylight Illuminations	PLOS ONE			English	Article							NATURAL IMAGES; CONE-EXCITATION; STATISTICS; ARTICULATION; ADAPTATION; VISION; MECHANISMS; FOLIAGE; SCENES	The phenomenon of colour constancy in human visual perception keeps surface colours constant, despite changes in their reflected light due to changing illumination. Although colour constancy has evolved under a constrained subset of illuminations, it is unknown whether its underlying mechanisms, thought to involve multiple components from retina to cortex, are optimised for particular environmental variations. Here we demonstrate a new method for investigating colour constancy using illumination matching in real scenes which, unlike previous methods using surface matching and simulated scenes, allows testing of multiple, real illuminations. We use real scenes consisting of solid familiar or unfamiliar objects against uniform or variegated backgrounds and compare discrimination performance for typical illuminations from the daylight chromaticity locus (approximately blue-yellow) and atypical spectra from an orthogonal locus (approximately red-green, at correlated colour temperature 6700 K), all produced in real time by a 10-channel LED illuminator. We find that discrimination of illumination changes is poorer along the daylight locus than the atypical locus, and is poorest particularly for bluer illumination changes, demonstrating conversely that surface colour constancy is best for blue daylight illuminations. Illumination discrimination is also enhanced, and therefore colour constancy diminished, for uniform backgrounds, irrespective of the object type. These results are not explained by statistical properties of the scene signal changes at the retinal level. We conclude that high-level mechanisms of colour constancy are biased for the blue daylight illuminations and variegated backgrounds to which the human visual system has typically been exposed.	[Pearce, Bradley; Crichton, Stuart; Hurlbert, Anya] Newcastle Univ, Fac Med Sci, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Mackiewicz, Michal; Finlayson, Graham D.] Univ E Anglia, Sch Comp Sci, Norwich NR4 7TJ, Norfolk, England	Newcastle University - UK; University of East Anglia	Pearce, B (corresponding author), Newcastle Univ, Fac Med Sci, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	b.m.pearce@ncl.ac.uk		Mackiewicz, Michal/0000-0002-8777-8880; Hurlbert, Anya/0000-0002-9879-5758	Engineering and Physical Sciences Research Council (EPSRC) [EP/H022236/1]; EPSRC [EP/H022236/1, EP/H022325/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H022325/1, 980601, EP/H022236/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This project was part of a larger project funded by the Engineering and Physical Sciences Research Council (EPSRC), grant number: EP/H022236/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AREND L, 1986, J OPT SOC AM A, V3, P1743, DOI 10.1364/JOSAA.3.001743; Brainard DH, 2004, J VISION, V4, pII, DOI 10.1167/4.9.i; Brainard DH, 1998, J OPT SOC AM A, V15, P307, DOI 10.1364/JOSAA.15.000307; Cecchi GA, 2010, J VISION, V10, DOI 10.1167/10.11.21; CRAVEN BJ, 1992, VISION RES, V32, P1359, DOI 10.1016/0042-6989(92)90228-B; Danilova MV, 2010, J VISION, V10, DOI 10.1167/10.1.4; de Almeida VMN, 2010, PERCEPTION, V39, P770, DOI 10.1068/p6485; FEDERER CA, 1966, ECOLOGY, V47, P555, DOI 10.2307/1933932; Finlayson GD, 2005, J OPT SOC AM A, V22, P810, DOI 10.1364/JOSAA.22.000810; Foster DH, 2011, VISION RES, V51, P674, DOI 10.1016/j.visres.2010.09.006; FOSTER DH, 1994, P ROY SOC B-BIOL SCI, V257, P115, DOI 10.1098/rspb.1994.0103; Gegenfurtner KR, 2003, NAT REV NEUROSCI, V4, P563, DOI 10.1038/nrn1138; Giesel M, 2009, J VISION, V9, DOI 10.1167/9.9.11; Granzier JJM, 2012, I-PERCEPTION, V3, P190, DOI 10.1068/i0461; Hernandez-Andres J, 2001, J OPT SOC AM A, V18, P1325, DOI 10.1364/JOSAA.18.001325; Hunt RWG, 1957, REPROD COLOUR; Hurlbert A., PERCEPTUAL CONSTANCY, V1998, P283; Hurlbert A, 2007, CURR BIOL, V17, pR906, DOI 10.1016/j.cub.2007.08.022; Kanematsu E, 2013, COLOR RES APPL, P1; Kinnear PR, 2002, BRIT J OPHTHALMOL, V86, P1408, DOI 10.1136/bjo.86.12.1408; Kraft JM, 1999, P NATL ACAD SCI USA, V96, P307, DOI 10.1073/pnas.96.1.307; KRAUSKOPF J, 1992, VISION RES, V32, P2165, DOI 10.1016/0042-6989(92)90077-V; LAND EH, 1959, P NATL ACAD SCI USA, V45, P115, DOI 10.1073/pnas.45.1.115; Linnell KJ, 2002, PERCEPTION, V31, P151, DOI 10.1068/p03sp; MacAdam DL, 1942, J OPT SOC AM, V32, P247, DOI 10.1364/JOSA.32.000247; Mackiewicz M, 2012, P 6 COL GRAPH IM VIS; MACLEOD DIA, 1979, J OPT SOC AM, V69, P1183, DOI 10.1364/JOSA.69.001183; Maloney LT, 2002, PERCEPTION, V31, P135, DOI 10.1068/p12sp; McDermott KC, 2012, J OPT SOC AM A, V29, pA182, DOI 10.1364/JOSAA.29.00A182; Olkkonen M, 2008, J VISION, V8, DOI [10.1167/8.5.13, 10.1167/8.8.8]; Olkkonen M, 2009, J VISION, V9, DOI 10.1167/9.12.6; Parraga CA, 2000, CURR BIOL, V10, P35, DOI 10.1016/S0960-9822(99)00262-6; Parraga CA, 2005, VISION RES, V45, P3145, DOI 10.1016/j.visres.2005.08.006; Regan BC, 2001, PHILOS T R SOC B, V356, P229, DOI 10.1098/rstb.2000.0773; Schirillo JA, 1999, J OPT SOC AM A, V16, P793, DOI 10.1364/JOSAA.16.000793; Smithson HE, 2005, PHILOS T R SOC B, V360, P1329, DOI 10.1098/rstb.2005.1633; Sumner P, 2000, J EXP BIOL, V203, P1963; van Bommel W. J. M., 2004, Lighting Research & Technology, V36, P255, DOI 10.1191/1365782804li122oa; Webster MA, 1997, VISION RES, V37, P3283, DOI 10.1016/S0042-6989(97)00125-9; Webster MA, 2007, NETWORK-COMP NEURAL, V18, P213, DOI 10.1080/09548980701654405; Werner A, 2000, VISION RES, V40, P1101, DOI 10.1016/S0042-6989(00)00012-2; WORTHEY JA, 1985, J OPT SOC AM A, V2, P1014, DOI 10.1364/JOSAA.2.001014; Wyszecki Gn, 1982, COLOR SCI CONCEPTS M, Vxv; Yang JN, 2001, VISION RES, V41, P2581, DOI 10.1016/S0042-6989(01)00143-2	44	63	63	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e87989	10.1371/journal.pone.0087989	http://dx.doi.org/10.1371/journal.pone.0087989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586299	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000331711900021
J	Jiang, JL; Wang, XR; Shan, ZJ; Yang, LY; Zhou, JY; Bu, YQ				Jiang, Jinlin; Wang, Xiaorong; Shan, Zhengjun; Yang, Liuyan; Zhou, Junying; Bu, Yuanqin			Proteomic Analysis of Hepatic Tissue of Cyprinus carpio L. Exposed to Cyanobacterial Blooms in Lake Taihu, China	PLOS ONE			English	Article							FRESH-WATER FISH; MICROCYSTIN-LR; OXIDATIVE STRESS; CARASSIUS-AURATUS; AQUATIC ORGANISMS; RAT HEPATOCYTES; SILVER CARP; BIOACCUMULATION; PEROXIREDOXIN; CELLS	With the rapid development of industry and agriculture and associated pollution, the cyanobacterial blooms in Lake Taihu have become a major threat to aquatic wildlife and human health. In this study, the ecotoxicological effects of cyanobacterial blooms on cage-cultured carp (Cyprinus carpio L.) in Meiliang Bay of Lake Taihu were investigated. Microcystins (MCs), major cyanobacterial toxins, have been detected in carp cultured at different experimental sites of Meiliang Bay. We observed that the accumulation of MCs in carp was closely associated with several environmental factors, including temperature, pH value, and density of cyanobacterial blooms. The proteomic profile of carp liver exposed to cyanobacterial blooms was analyzed using two-dimensional difference in-gel electrophoresis (2D-DIGE) and mass spectrometry. The toxic effects of cyanobacterial blooms on carp liver were similar to changes caused by MCs. MCs were transported into liver cells and induced the excessive production of reactive oxygen species (ROS). MCs and ROS inhibited protein phosphatase and aldehyde dehydrogenase (ALDH), directly or indirectly resulting in oxidative stress and disruption of the cytoskeleton. These effects further interfered with metabolic pathways in the liver through the regulation of series of related proteins. The results of this study indicated that cyanobacterial blooms pose a major threat to aquatic wildlife in Meiliang Bay in Lake Taihu. These results provided evidence of the molecular mechanisms underlying liver damage in carp exposed to cyanobacterial blooms.	[Jiang, Jinlin; Shan, Zhengjun; Zhou, Junying; Bu, Yuanqin] Nanjing Inst Environm Sci, Minist Environm Protect, Key Lab Pesticide Environm Assessment & Pollut Co, Nanjing, Jiangsu, Peoples R China; [Wang, Xiaorong; Yang, Liuyan] Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Sch Environm, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Jiang, JL (corresponding author), Nanjing Inst Environm Sci, Minist Environm Protect, Key Lab Pesticide Environm Assessment & Pollut Co, Nanjing, Jiangsu, Peoples R China.	jjl@nies.org; ekxr@nju.edu.cn	wang, xiao/HGB-7081-2022; yang, liu/GVU-8760-2022; Jiang, Jinlin/GQB-2974-2022; liu, yang/HHY-8583-2022	wang, xiao/0000-0002-4088-3341; 	Special Funds of the National Natural Science Foundation of China [31340017]; National Basic Research Program of China [2008CB418102]	Special Funds of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This research was financially supported by the Special Funds of the National Natural Science Foundation of China (Grant number 31340017) and the National Basic Research Program of China (Grant number 2008CB418102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APHA, 1995, STANDARD METHODS EXA; Aranda-Rodriguez R, 2005, ENVIRON TOXICOL, V20, P390, DOI 10.1002/tox.20116; Behnisch PA, 2001, ENVIRON INT, V27, P441, DOI 10.1016/S0160-4120(01)00114-3; Blaha L, 2004, ACTA VET BRNO, V73, P477, DOI 10.2754/avb200473040477; Chen YM, 2006, TOXICON, V47, P742, DOI 10.1016/j.toxicon.2006.01.026; Codd GA, 2005, TOXICOL APPL PHARM, V203, P264, DOI 10.1016/j.taap.2004.02.016; Cossu C, 2000, ECOTOX ENVIRON SAFE, V45, P106, DOI 10.1006/eesa.1999.1842; de Magalhaes VF, 2001, TOXICON, V39, P1077; Dietrich D, 2005, TOXICOL APPL PHARM, V203, P273, DOI 10.1016/j.taap.2004.09.005; Ding WX, 2000, HEPATOLOGY, V32, P547, DOI 10.1053/jhep.2000.16183; Ding WX, 2003, FEMS MICROBIOL LETT, V220, P1, DOI 10.1016/S0378-1097(03)00100-9; Harford J. B., 1997, POSTTRANSCRIPTIONAL; Jiang JL, 2012, COMP BIOCHEM PHYS C, V155, P483, DOI 10.1016/j.cbpc.2011.12.008; Jiang JL, 2011, ECOTOXICOLOGY, V20, P1000, DOI 10.1007/s10646-011-0646-9; Jiang JL, 2011, J HAZARD MATER, V190, P188, DOI 10.1016/j.jhazmat.2011.03.023; KACZMAREK MJ, 1977, CLIN CHIM ACTA, V79, P69, DOI 10.1016/0009-8981(77)90462-4; Kang SW, 2005, TRENDS MOL MED, V11, P571, DOI 10.1016/j.molmed.2005.10.006; Kopp R, 2009, AQUAC RES, V40, P1683, DOI 10.1111/j.1365-2109.2009.02285.x; Li L, 2008, THESCIENTIFICWORLDJO, V8, P121, DOI 10.1100/tsw.2008.32; Li XY, 2005, COMP BIOCHEM PHYS C, V141, P292, DOI 10.1016/j.cca.2005.07.004; Li XY, 2003, TOXICON, V42, P85, DOI 10.1016/S0041-0101(03)00104-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livingstone DR, 2001, MAR POLLUT BULL, V42, P656, DOI 10.1016/S0025-326X(01)00060-1; Luo Y, 2005, ENVIRON TOXICOL CHEM, V24, P2145, DOI 10.1897/04-640R.1; Magalhaes VF, 2003, TOXICON, V42, P289, DOI 10.1016/S0041-0101(03)00144-2; Malbrouck C, 2003, COMP BIOCHEM PHYS C, V135, P39, DOI 10.1016/S1532-0456(03)00047-4; Malecot M, 2009, AQUAT TOXICOL, V94, P153, DOI 10.1016/j.aquatox.2009.06.012; Mezhoud K, 2008, TOXICON, V51, P1431, DOI 10.1016/j.toxicon.2008.03.017; Ministry of Environmental Protection of the People's Republic of China, 2002, STANDARD METHODS EXA; Park SH, 2000, CLIN CANCER RES, V6, P4915; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qin BQ, 2007, HYDROBIOLOGIA, V581, P3, DOI 10.1007/s10750-006-0521-5; Rhee NJ, 2000, EUR J BIOCHEM, V267, P3220, DOI 10.1046/j.1432-1327.2000.01345.x; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Runnegar M, 1997, HEPATOLOGY, V26, P176; Snape JR, 2004, AQUAT TOXICOL, V67, P143, DOI 10.1016/j.aquatox.2003.11.011; Song LR, 2007, WATER RES, V41, P2853, DOI 10.1016/j.watres.2007.02.013; Wang H, 2013, RES VET SCI, V95, P1125, DOI 10.1016/j.rvsc.2013.07.022; Wang MH, 2010, TOXICOL SCI, V113, P60, DOI 10.1093/toxsci/kfp248; [王晓蓉 WANG Xiaorong], 2006, [环境化学, Environmental Chemistry], V25, P320; WINSTON GW, 1991, AQUAT TOXICOL, V19, P137, DOI 10.1016/0166-445X(91)90033-6; [吴庆龙 WU Qinglong], 2008, [地球科学进展, Advance in Earth Sciences], V23, P1115; Xie LQ, 2007, TOXICON, V49, P646, DOI 10.1016/j.toxicon.2006.11.004; Xie LQ, 2005, ENVIRON TOXICOL, V20, P293, DOI 10.1002/tox.20120; Xie LQ, 2004, ENVIRON POLLUT, V127, P431, DOI 10.1016/j.envpol.2003.08.011; Zeng J, 2009, WORLD J MICROB BIOT, V25, P225, DOI 10.1007/s11274-008-9883-3	46	14	15	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88211	10.1371/journal.pone.0088211	http://dx.doi.org/10.1371/journal.pone.0088211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558380	gold, Green Submitted, Green Published			2022-12-27	WOS:000331706700026
J	Mir, M; Bergamaschi, A; Katzenellenbogen, BS; Popescu, G				Mir, Mustafa; Bergamaschi, Anna; Katzenellenbogen, Benita S.; Popescu, Gabriel			Highly Sensitive Quantitative Imaging for Monitoring Single Cancer Cell Growth Kinetics and Drug Response	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; CYCLE PROGRESSION; GENE-EXPRESSION; C-MYC; PROLIFERATION; ANTIESTROGEN; ACTIVATION; MCF-7; ASSAY; LINE	The detection and treatment of cancer has advanced significantly in the past several decades, with important improvements in our understanding of the fundamental molecular and genetic basis of the disease. Despite these advancements, drug-screening methodologies have remained essentially unchanged since the introduction of the in vitro human cell line screen in 1990. Although the existing methods provide information on the overall effects of compounds on cell viability, they are restricted by bulk measurements, large sample sizes, and lack capability to measure proliferation kinetics at the individual cell level. To truly understand the nature of cancer cell proliferation and to develop personalized adjuvant therapies, there is a need for new methodologies that provide quantitative information to monitor the effect of drugs on cell growth as well as morphological and phenotypic changes at the single cell level. Here we show that a quantitative phase imaging modality known as spatial light interference microscopy (SLIM) addresses these needs and provides additional advantages over existing proliferation assays. We demonstrate these capabilities through measurements on the effects of the hormone estradiol and the antiestrogen ICI182,780 (Faslodex) on the growth of MCF-7 breast cancer cells. Along with providing information on changes in the overall growth, SLIM provides additional biologically relevant information. For example, we find that exposure to estradiol results in rapidly growing cells with lower dry mass than the control population. Subsequently blocking the estrogen receptor with ICI results in slower growing cells, with lower dry masses than the control. This ability to measure changes in growth kinetics in response to environmental conditions provides new insight on growth regulation mechanisms. Our results establish the capabilities of SLIM as an advanced drug screening technology that provides information on changes in proliferation kinetics at the cellular level with greater sensitivity than any existing method.	[Mir, Mustafa; Popescu, Gabriel] Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Elect & Comp Engn, Quantitat Light Imaging Lab, Urbana, IL 61801 USA; [Bergamaschi, Anna; Katzenellenbogen, Benita S.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Popescu, G (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Elect & Comp Engn, Quantitat Light Imaging Lab, Urbana, IL 61801 USA.	gpopescu@illinois.edu		Mir, Mustafa/0000-0001-8280-2821	National Science Foundation (NSF) Grants: Science and Technology Center on Emergent Behaviors of Integrated Cellular Systems CBET [0939511]; NSF [08-46660]; Breast Cancer Research Foundation; National Institutes of Health (NIH) [P50 AT006268]; Department of Defense [W81XWH-09-1-0398];  [CBET-1040461 MRI]; National Center for Complementary & Integrative Health [P50AT006268] Funding Source: NIH RePORTER	National Science Foundation (NSF) Grants: Science and Technology Center on Emergent Behaviors of Integrated Cellular Systems CBET; NSF(National Science Foundation (NSF)); Breast Cancer Research Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); ; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Science Foundation (NSF) Grants: Science and Technology Center on Emergent Behaviors of Integrated Cellular Systems CBET 0939511 (to G. P.), NSF CAREER 08-46660 (to G. P.), CBET-1040461 MRI (to G. P.), Breast Cancer Research Foundation (to B. S. K.), National Institutes of Health (NIH) P50 AT006268 (to B. S. K.), and a Postdoctoral Fellowship from the Department of Defense, W81XWH-09-1-0398 (to A. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEY MC, 1988, CANCER RES, V48, P589; BARER R, 1952, NATURE, V169, P366, DOI 10.1038/169366b0; BOYD MR, 1995, DRUG DEVELOP RES, V34, P91, DOI 10.1002/ddr.430340203; BROOKS SC, 1973, J BIOL CHEM, V248, P6251; Collins P, 1999, NAT MED, V5, P1130, DOI 10.1038/13453; Dalvai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011011; DeVita VT, 2008, CANCER RES, V68, P8643, DOI 10.1158/0008-5472.CAN-07-6611; Doisneau-Sixou SF, 2003, ENDOCR-RELAT CANCER, V10, P179, DOI 10.1677/erc.0.0100179; DRISCOLL JS, 1984, CANCER TREAT REP, V68, P63; DUBIK D, 1992, ONCOGENE, V7, P1587; Dunn GA, 1998, CELL BIOL LAB HDB; Frasor J, 2004, CANCER RES, V64, P1522, DOI 10.1158/0008-5472.CAN-03-3326; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Godin M, 2010, NAT METHODS, V7, P387, DOI [10.1038/nmeth.1452, 10.1038/NMETH.1452]; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Lloyd AC, 2013, CELL, V154, P1194, DOI 10.1016/j.cell.2013.08.053; Manual, 2013, WST 1 CELL PROL ASS; McGowan EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020623; Mir M, 2011, P NATL ACAD SCI USA, V108, P13124, DOI 10.1073/pnas.1100506108; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Obiorah I, 2011, MATURITAS, V70, P315, DOI 10.1016/j.maturitas.2011.09.006; Park K, 2010, P NAT ACAD SCI; PAULL KD, 1988, J HETEROCYCLIC CHEM, V25, P911, DOI 10.1002/jhet.5570250340; Popescu G., 2011, QUANTITATIVE PHASE I; Popescu G, 2008, AM J PHYSIOL-CELL PH, V295, pC538, DOI 10.1152/ajpcell.00121.2008; Prall OWJ, 1998, MOL CELL BIOL, V18, P4499, DOI 10.1128/MCB.18.8.4499; Prall OWJ, 1998, J STEROID BIOCHEM, V65, P169, DOI 10.1016/S0960-0760(98)00021-1; RUBINSTEIN LV, 1990, J NATL CANCER I, V82, P1113, DOI 10.1093/jnci/82.13.1113; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Society AC, 2012, CANC FACTS FIG 2012; Son S, 2012, NAT METHODS, V9, P910, DOI 10.1038/nmeth.2133; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Soulez M, 2001, J MOL ENDOCRINOL, V27, P259, DOI 10.1677/jme.0.0270259; Sridharan S, 2011, BIOMED OPT EXPRESS, V2, P2815, DOI 10.1364/BOE.2.002815; SUTHERLAND RL, 1983, CANCER RES, V43, P3998; Teicher BA, 2004, BRIT J CANCER, V91, P1977, DOI 10.1038/sj.bjc.6602286; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; WAKELING AE, 1991, CANCER RES, V51, P3867; Wang Z, 2011, OPT EXPRESS, V19, P1016, DOI 10.1364/OE.19.001016; Wang Z, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3304787	40	47	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89000	10.1371/journal.pone.0089000	http://dx.doi.org/10.1371/journal.pone.0089000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558461	Green Submitted, Green Published, gold			2022-12-27	WOS:000331706700107
J	Virk, J; Obel, C; Li, J; Olsen, J				Virk, Jasveer; Obel, Carsten; Li, Jiong; Olsen, Jorn			In-Utero Exposure to Bereavement and Offspring IQ: A Danish National Cohort Study	PLOS ONE			English	Article							MATERNAL ANTENATAL ANXIETY; CIVIL REGISTRATION SYSTEM; PRENATAL STRESS; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; BEHAVIOURAL/EMOTIONAL PROBLEMS; COGNITIVE-ABILITY; GESTATIONAL-AGE; BIRTH-WEIGHT; INTELLIGENCE; CHILDREN	Background: Intelligence is a life-long trait that has strong influences on lifestyle, adult morbidity and life expectancy. Hence, lower cognitive abilities are therefore of public health interest. Our primary aim was to examine if prenatal bereavement measured as exposure to death of a close family member is associated with the intelligence quotient (IQ) scores at 18-years of age of adult Danish males completing a military cognitive screening examination. Methods: We extracted records for the Danish military screening test and found kinship links with biological parents, siblings, and maternal grandparents using the Danish Civil Registration System (N = 167,900). The prenatal exposure period was defined as 12 months before conception until birth of the child. We categorized children as exposed in utero to severe stress (bereavement) during prenatal life if their mothers lost an elder child, husband, parent or sibling during the prenatal period; the remaining children were included in the unexposed cohort. Mean score estimates were adjusted for maternal and paternal age at birth, residence, income, maternal education, gestational age at birth and birth weight. Results: When exposure was due to death of a father the offsprings' mean IQ scores were lower among men completing the military recruitment exam compared to their unexposed counterparts, adjusted difference of 6.5 standard IQ points (p-value = 0.01). We did not observe a clinically significant association between exposure to prenatal maternal bereavement caused by death of a sibling, maternal uncle/aunt or maternal grandparent even after stratifying deaths only due to traumatic events. Conclusion: We found maternal bereavement to be adversely associated with IQ in male offspring, which could be related to prenatal stress exposure though more likely is due to changes in family conditions after death of the father. This finding supports other literature on maternal adversity during fetal life and cognitive development in the offspring.	[Virk, Jasveer] Univ Calif Los Angeles, Dept Epidemiol, UCLA Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA; [Obel, Carsten] Aarhus Univ, Dept Publ Hlth, Sect Gen Practice, Aarhus, Denmark; [Li, Jiong; Olsen, Jorn] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark	University of California System; University of California Los Angeles; Aarhus University; Aarhus University	Virk, J (corresponding author), Univ Calif Los Angeles, Dept Epidemiol, UCLA Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA.	jasvirk@ucla.edu	li, jiong/L-6534-2014; Olsen, Jørn/F-8801-2015; Obel, Carsten/H-9605-2016	li, jiong/0000-0002-1716-8067; Olsen, Jørn/0000-0001-7462-5140; li, jiong/0000-0003-1125-026X; Obel, Carsten/0000-0001-5004-1933	Danish Medical Research Council [271-05-0616, 271-07-0437]; NordForsk [070331]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NordForsk	The study was supported by Danish Medical Research Council (projects no. 271-05-0616 and 271-07-0437), and NordForsk (070331). The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PERS SOC PSYCHOL B, V38, P1157; Baibazarova E, 2013, PSYCHONEUROENDOCRINO, V38, P907, DOI 10.1016/j.psyneuen.2012.09.015; Barbazanges A, 1996, J NEUROSCI, V16, P3943; Bergman K, 2007, J AM ACAD CHILD PSY, V46, P1454, DOI 10.1097/chi.0b013e31814a62f6; BROWN RW, 1993, ENDOCRINOLOGY, V132, P2614, DOI 10.1210/en.132.6.2614; Davis EP, 2010, CHILD DEV, V81, P131, DOI 10.1111/j.1467-8624.2009.01385.x; Der G, 2006, BMJ-BRIT MED J, V333, P945, DOI 10.1136/bmj.38978.699583.55; Eriksen W, 2010, AM J EPIDEMIOL, V172, P530, DOI 10.1093/aje/kwq199; Gutteling BM, 2005, EUR CHILD ADOLES PSY, V14, P41, DOI 10.1007/s00787-005-0435-1; HENRY C, 1994, J NEUROENDOCRINOL, V6, P341, DOI 10.1111/j.1365-2826.1994.tb00591.x; Huizink AC, 2004, PSYCHOL BULL, V130, P115, DOI 10.1037/0033-2909.130.1.115; Kaltman S, 2003, J ANXIETY DISORD, V17, P131, DOI 10.1016/S0887-6185(02)00184-6; Kapoor A, 2005, J PHYSIOL-LONDON, V566, P967, DOI 10.1113/jphysiol.2005.090191; Khashan AS, 2008, ARCH GEN PSYCHIAT, V65, P146, DOI 10.1001/archgenpsychiatry.2007.20; Kilgour AHM, 2010, MATURITAS, V65, P98, DOI 10.1016/j.maturitas.2009.09.021; Kirkegaard I, 2006, PEDIATRICS, V118, P1600, DOI 10.1542/peds.2005-2700; Kristensen P BT, SCIENCE, V316, P1717; Kristensen P, 2012, PSYCHIATRY, V75, P76, DOI 10.1521/psyc.2012.75.1.76; Krozowski Z, 1999, MOL CELL ENDOCRINOL, V151, P121, DOI 10.1016/S0303-7207(98)00256-1; Laplante DP, 2008, J AM ACAD CHILD PSY, V47, P1063, DOI 10.1097/CHI.0b013e31817eec80; Li J, 2008, EPILEPSY RES, V81, P52, DOI 10.1016/j.eplepsyres.2008.04.014; Li JO, 2010, EUR CHILD ADOLES PSY, V19, P747, DOI 10.1007/s00787-010-0113-9; Li J, 2009, PSYCHOSOM MED, V71, P615, DOI 10.1097/PSY.0b013e3181a56ca1; Li J, 2009, J AUTISM DEV DISORD, V39, P1047, DOI 10.1007/s10803-009-0717-4; Lohaugen GCC, 2013, J PEDIAT NULL, DOI DOI 10.1016/J.JPEDS.2013.01.060.ACCESSED; MORTENSEN EL, 1989, SCAND J PSYCHOL, V30, P315, DOI 10.1111/j.1467-9450.1989.tb01094.x; O'Connor TG, 2003, J CHILD PSYCHOL PSYC, V44, P1025, DOI 10.1111/1469-7610.00187; O'Connor TG, 2002, BRIT J PSYCHIAT, V180, P502, DOI 10.1192/bjp.180.6.502; O'Donnell K, 2009, DEV NEUROSCI-BASEL, V31, P285, DOI 10.1159/000216539; Pedersen CB, 2006, DAN MED BULL, V53, P441; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Salaria S, 2006, NEUROBIOL DIS, V23, P630, DOI 10.1016/j.nbd.2006.05.003; Schneider ML, 1999, CHILD DEV, V70, P263, DOI 10.1111/1467-8624.00020; Seckl JR, 2000, KIDNEY INT, V57, P1412, DOI 10.1046/j.1523-1755.2000.00984.x; Sjostrom K, 1997, EUR J OBSTET GYN R B, V74, P149, DOI 10.1016/S0301-2115(97)00100-0; Staud F, 2006, PLACENTA, V27, P171, DOI 10.1016/j.placenta.2005.01.001; Teasdale TW, 2011, SCAND J PSYCHOL, V52, P126, DOI 10.1111/j.1467-9450.2010.00862.x; Teasdale TW, 2009, SCAND J PSYCHOL, V50, P633, DOI 10.1111/j.1467-9450.2009.00789.x; Wyrwoll CS, 2009, ENDOCRINOLOGY, V150, P1287, DOI 10.1210/en.2008-1100	39	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88477	10.1371/journal.pone.0088477	http://dx.doi.org/10.1371/journal.pone.0088477			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3RA	24558394	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700040
J	Lu, W; Zhong, M; Chai, Q; Wang, ZS; Yu, LL; Wei, YA				Lu, Wei; Zhong, Meng; Chai, Qian; Wang, Zhaoshuai; Yu, Linliang; Wei, Yinan			Functional Relevance of AcrB Trimerization in Pump Assembly and Substrate Binding	PLOS ONE			English	Article							MULTIDRUG EFFLUX PUMP; ESCHERICHIA-COLI; TRANSPORTER ACRB; CRYSTAL-STRUCTURE; PERIPLASMIC DOMAIN; EXPORTER ACRB; RESISTANCE; SITE; REVEALS; COMPLEX	AcrB is a multidrug transporter in the inner membrane of Escherichia coli. It is an obligate homotrimer and forms a tripartite efflux complex with AcrA and TolC. AcrB is the engine of the efflux machinery and determines substrate specificity. Active efflux depends on several functional features including proton translocation across the inner membrane through a proton relay pathway in the transmembrane domain of AcrB; substrate binding and migration through the substrate translocation pathway; the interaction of AcrB with AcrA and TolC; and the formation of AcrB homotrimer. Here we investigated two aspects of the inter-correlation between these functional features, the dependence of AcrA-AcrB interaction on AcrB trimerization, and the reliance of substrate binding and penetration on protein-protein interaction. Interaction between AcrA and AcrB was investigated through chemical crosslinking, and a previously established in vivo fluorescent labeling method was used to probe substrate binding. Our data suggested that dissociation of the AcrB trimer drastically decreased its interaction with AcrA. In addition, while substrate binding with AcrB seemed to be irrelevant to the presence or absence of AcrA and TolC, the capability of trimerization and conduction of proton influx did affect substrate binding at selected sites along the substrate translocation pathway in AcrB.	[Lu, Wei; Zhong, Meng; Chai, Qian; Wang, Zhaoshuai; Yu, Linliang; Wei, Yinan] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA	University of Kentucky	Wei, YA (corresponding author), Univ Kentucky, Dept Chem, Lexington, KY 40506 USA.	yinan.wei@uky.edu	Zhong, Meng/O-5070-2016	Wang, Zhaoshuai/0000-0002-5593-368X	National Science Foundation [MCB-1158036]; National Institute of Health [1R21AI103717-01]; Kentucky NASA EPSCoR program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI103717] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky NASA EPSCoR program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Science Foundation (MCB-1158036, YW), National Institute of Health (1R21AI103717-01, YW), and Kentucky NASA EPSCoR program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bohnert JA, 2008, J BACTERIOL, V190, P8225, DOI 10.1128/JB.00912-08; Das D, 2007, J STRUCT BIOL, V158, P494, DOI 10.1016/j.jsb.2006.12.004; Eicher T, 2012, P NATL ACAD SCI USA, V109, P5687, DOI 10.1073/pnas.1114944109; Feng ZW, 2012, MOL BIOSYST, V8, P2699, DOI 10.1039/c2mb25184a; Hearn EM, 2006, J BACTERIOL, V188, P115, DOI 10.1128/JB.188.1.115-123.2006; Husain F, 2011, J BACTERIOL, V193, P5847, DOI 10.1128/JB.05759-11; Husain F, 2010, MOL MICROBIOL, V78, P320, DOI 10.1111/j.1365-2958.2010.07330.x; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Lu W, 2012, J MOL BIOL, V423, P123, DOI 10.1016/j.jmb.2012.06.036; Lu W, 2011, PROTEIN PEPTIDE LETT, V18, P863, DOI 10.2174/092986611796011446; Lu W, 2011, J MOL BIOL, V411, P264, DOI 10.1016/j.jmb.2011.05.042; Mao WM, 2002, MOL MICROBIOL, V46, P889, DOI 10.1046/j.1365-2958.2002.03223.x; Middlemiss JK, 2004, J BACTERIOL, V186, P1258, DOI 10.1128/JB.186.5.1258-1269.2004; Monroe N, 2011, J STRUCT BIOL, V174, P269, DOI 10.1016/j.jsb.2011.01.014; Murakami S, 2004, J BIOL CHEM, V279, P3743, DOI 10.1074/jbc.M308893200; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nakashima R, 2011, NATURE, V480, P565, DOI 10.1038/nature10641; Nikaido H, 1998, CURR OPIN MICROBIOL, V1, P516, DOI 10.1016/S1369-5274(98)80083-0; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Schulz R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000806; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sennhauser G, 2007, PLOS BIOL, V5, P106, DOI 10.1371/journal.pbio.0050007; Su CC, 2006, J BACTERIOL, V188, P7290, DOI 10.1128/JB.00684-06; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Takatsuka Y, 2007, J BACTERIOL, V189, P8677, DOI 10.1128/JB.01127-07; Takatsuka Y, 2006, J BACTERIOL, V188, P7284, DOI 10.1128/JB.00683-06; Takatsuka Y, 2010, P NATL ACAD SCI USA, V107, P6559, DOI 10.1073/pnas.1001460107; Takatsuka Y, 2009, J BACTERIOL, V191, P1729, DOI 10.1128/JB.01441-08; Tamura N, 2005, BIOCHEMISTRY-US, V44, P11115, DOI 10.1021/bi050452u; Tikhonova EB, 2004, J BIOL CHEM, V279, P32116, DOI 10.1074/jbc.M402230200; Vargiu AV, 2012, P NATL ACAD SCI USA, V109, P20637, DOI 10.1073/pnas.1218348109; Veesler D, 2008, ACTA CRYSTALLOGR F, V64, P880, DOI 10.1107/S1744309108028248; Weeks JW, 2010, MOL MICROBIOL, V75, P1468, DOI 10.1111/j.1365-2958.2010.07068.x; Yu LL, 2013, BIOCHEMISTRY-US, V52, P6790, DOI 10.1021/bi400452v; Zgurskaya HI, 2000, J BACTERIOL, V182, P4264, DOI 10.1128/JB.182.15.4264-4267.2000	42	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89143	10.1371/journal.pone.0089143	http://dx.doi.org/10.1371/journal.pone.0089143			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551234	Green Published, Green Submitted, gold			2022-12-27	WOS:000331271500100
J	Ziemlinska, E; Kugler, S; Schachner, M; Wewior, I; Czarkowska-Bauch, J; Skup, M				Ziemlinska, Ewelina; Kuegler, Sebastian; Schachner, Melitta; Wewior, Iwona; Czarkowska-Bauch, Julita; Skup, Malgorzata			Overexpression of BDNF Increases Excitability of the Lumbar Spinal Network and Leads to Robust Early Locomotor Recovery in Completely Spinalized Rats	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; VESICULAR GLUTAMATE TRANSPORTERS; KCL COTRANSPORTER KCC2; NEUROTROPHIC FACTOR; CORD TRANSECTION; AMINO-ACIDS; DOWN-REGULATION; SYNAPTIC PLASTICITY; TRANSMITTER SYSTEMS; GENE-EXPRESSION	Strategies to induce recovery from lesions of the spinal cord have not fully resulted in clinical applications. This is a consequence of a number of impediments that axons encounter when trying to regrow beyond the lesion site, and that intraspinal rearrangements are subjected to. In the present study we evaluated (1) the possibility to improve locomotor recovery after complete transection of the spinal cord by means of an adeno-associated (AAV) viral vector expressing the neurotrophin brain-derived neurotrophic factor (BDNF) in lumbar spinal neurons caudal to the lesion site and (2) how the spinal cord transection and BDNF treatment affected neurotransmission in the segments caudal to the lesion site. BDNF overexpression resulted in clear increases in expression levels of molecules involved in glutamatergic (VGluT2) and GABAergic (GABA, GAD65, GAD67) neurotransmission in parallel with a reduction of the potassium-chloride co-transporter (KCC2) which contributes to an inhibitory neurotransmission. BDNF treated animals showed significant improvements in assisted locomotor performance, and performed locomotor movements with body weight support and plantar foot placement on a moving treadmill. These positive effects of BDNF local overexpression were detectable as early as two weeks after spinal cord transection and viral vector application and lasted for at least 7 weeks. Gradually increasing frequencies of clonic movements at the end of the experiment attenuated the quality of treadmill walking. These data indicate that BDNF has the potential to enhance the functionality of isolated lumbar circuits, but also that BDNF levels have to be tightly controlled to prevent hyperexcitability.	[Ziemlinska, Ewelina; Wewior, Iwona; Czarkowska-Bauch, Julita; Skup, Malgorzata] Nencki Inst Expt Biol, Warsaw, Poland; [Kuegler, Sebastian] Univ Gottingen, Ctr Mol Physiol Brain, D-37073 Gottingen, Germany; [Schachner, Melitta] Shantou Univ, Coll Med, Ctr Neurosci, Shantou, Peoples R China	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Gottingen; Shantou University	Schachner, M (corresponding author), Shantou Univ, Coll Med, Ctr Neurosci, Shantou, Peoples R China.	mskup@nencki.gov.pl; schachner@stu.edu.ch	Czarkowska-Bauch, Julita/AAB-6872-2020	Ziemlinska, Ewelina/0000-0002-7602-3239; Skup, Malgorzata/0000-0002-2605-0124	Polish-German cooperation [S007/P-N/2007/01]; EMBO Short-Term Fellowship [ASTF 211.00.2007]; Bio-Imagine grant [264173]; Nencki Institute	Polish-German cooperation; EMBO Short-Term Fellowship(European Molecular Biology Organization (EMBO)); Bio-Imagine grant; Nencki Institute	This work was supported by a Polish-German cooperation grant (S007/P-N/2007/01), an EMBO Short-Term Fellowship to E. Ziemlinska (ASTF 211.00.2007), GA No 264173 Bio-Imagine grant and statutory funds for the Nencki Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez FJ, 2004, J COMP NEUROL, V472, P257, DOI 10.1002/cne.20012; Antri M, 2002, EUR J NEUROSCI, V16, P467, DOI 10.1046/j.1460-9568.2002.02088.x; Antri M, 2003, EUR J NEUROSCI, V18, P1963, DOI 10.1046/j.1460-9568.2003.02916.x; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Bardoni R, 2007, DEV NEUROBIOL, V67, P960, DOI 10.1002/dneu.20401; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beaumont E, 2008, NEUROSCI RES, V62, P147, DOI 10.1016/j.neures.2008.07.003; Bennett DJ, 2001, J NEUROPHYSIOL, V86, P1972, DOI 10.1152/jn.2001.86.4.1972; Betley JN, 2009, CELL, V139, P161, DOI 10.1016/j.cell.2009.08.027; Blum R, 2002, NATURE, V419, P687, DOI 10.1038/nature01085; Bos R, 2013, P NATL ACAD SCI USA, V110, P348, DOI 10.1073/pnas.1213680110; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Boyce VS, 2012, EUR J NEUROSCI, V35, P221, DOI 10.1111/j.1460-9568.2011.07950.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caesar K, 2008, J CEREBR BLOOD F MET, V28, P906, DOI 10.1038/sj.jcbfm.9600581; Cantoria MJ, 2011, J NEUROSCI, V31, P18598, DOI 10.1523/JNEUROSCI.3499-11.2011; Cheung G, 2009, J PHYSIOL-LONDON, V587, P753, DOI 10.1113/jphysiol.2008.163923; Cote MP, 2011, J NEUROTRAUM, V28, P299, DOI 10.1089/neu.2010.1594; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; de Leon RD, 1999, J NEUROPHYSIOL, V82, P359, DOI 10.1152/jn.1999.82.1.359; DEMEDIUK P, 1989, J NEUROCHEM, V52, P1529, DOI 10.1111/j.1471-4159.1989.tb09204.x; Di Luca M, 2001, NEUROREPORT, V12, P1301, DOI 10.1097/00001756-200105080-00049; Diaz-Ruiz A, 2007, NEUROCHEM RES, V32, P57, DOI 10.1007/s11064-006-9225-5; Drinkut A, 2012, MOL THER, V20, P534, DOI 10.1038/mt.2011.249; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Farooque M, 1996, J NEUROTRAUM, V13, P537, DOI 10.1089/neu.1996.13.537; Frank L, 1997, EXP NEUROL, V145, P62, DOI 10.1006/exnr.1997.6440; Gajewska-Wozniak O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065937; Gazula VR, 2004, J COMP NEUROL, V476, P130, DOI 10.1002/cne.20204; Gomez-Pinilla F, 2002, J NEUROPHYSIOL, V88, P2187, DOI 10.1152/jn.00152.2002; Gomez-Pinilla F, 2004, J NEUROPHYSIOL, V92, P3423, DOI 10.1152/jn.00432.2004; Guidotti G, 2012, NEUROPSYCHOPHARMACOL, V37, P746, DOI 10.1038/npp.2011.252; Haapasalo A, 2002, J BIOL CHEM, V277, P43160, DOI 10.1074/jbc.M205202200; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Ichiyama RM, 2008, J NEUROSCI, V28, P7370, DOI 10.1523/JNEUROSCI.1881-08.2008; Ichiyama RM, 2006, J COMP NEUROL, V499, P306, DOI 10.1002/cne.21110; Ichiyama RM, 2011, J NEUROSCI, V31, P26, DOI 10.1523/JNEUROSCI.6433-09.2011; Jakeman LB, 1998, EXP NEUROL, V154, P170, DOI 10.1006/exnr.1998.6924; Joseph MS, 2012, NEUROSCIENCE, V224, P135, DOI 10.1016/j.neuroscience.2012.08.024; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; KAILA K, 1994, PROG NEUROBIOL, V42, P489, DOI 10.1016/0301-0082(94)90049-3; Keeler BE, 2012, BRAIN RES, V1438, P8, DOI 10.1016/j.brainres.2011.12.015; Kerr BJ, 1999, J NEUROSCI, V19, P5138; Khristy W, 2009, BRAIN RES, V1273, P9, DOI 10.1016/j.brainres.2009.03.060; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kiehn O, 2010, BIOCHEM BIOPH RES CO, V396, P11, DOI 10.1016/j.bbrc.2010.02.107; Kishino A, 1997, EXP NEUROL, V144, P273, DOI 10.1006/exnr.1996.6367; Kitzman P, 2006, EXP NEUROL, V197, P407, DOI 10.1016/j.expneurol.2005.10.005; KOERBER HR, 1994, J NEUROSCI, V14, P3655; Kong XY, 2011, NEUROSCIENCE, V177, P114, DOI 10.1016/j.neuroscience.2010.12.062; Koshimizu H, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-27; Krauss Gregory L., 2003, Epilepsy Curr, V3, P19, DOI 10.1046/j.1535-7597.2003.03107.x; Kugler S, 2001, MOL CELL NEUROSCI, V17, P78, DOI 10.1006/mcne.2000.0929; Kuhn SA, 2004, MOL CELL NEUROSCI, V25, P312, DOI 10.1016/j.mcn.2003.10.023; Li Y, 2004, J NEUROPHYSIOL, V92, P2694, DOI 10.1152/jn.00164.2004; Li YR, 2004, J NEUROPHYSIOL, V91, P767, DOI 10.1152/jn.00788.2003; Llewellyn-Smith IJ, 2007, J COMP NEUROL, V503, P741, DOI 10.1002/cne.21414; Lu B, 1997, REV NEUROSCIENCE, V8, P1; Lu VB, 2012, J NEUROPHYSIOL; Lubick K, 2007, J LEUKOCYTE BIOL, V82, P1062, DOI 10.1189/jlb.0407255; Macias M, 2007, EUR J NEUROSCI, V25, P2425, DOI 10.1111/j.1460-9568.2007.05498.x; Macias M, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-144; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; MCBRIDE WJ, 1984, J NEUROCHEM, V42, P1625, DOI 10.1111/j.1471-4159.1984.tb12752.x; MCBRIDE WJ, 1988, J NEUROCHEM, V50, P603, DOI 10.1111/j.1471-4159.1988.tb02953.x; Norreel JC, 2003, J NEUROSCI, V23, P1924; Novikov LN, 2000, NEUROSCIENCE, V100, P171, DOI 10.1016/S0306-4522(00)00256-6; Oliveira ALR, 2003, SYNAPSE, V50, P117, DOI 10.1002/syn.10249; Ornung G, 1996, J COMP NEUROL, V365, P413; PANTER SS, 1990, ANN NEUROL, V27, P96, DOI 10.1002/ana.410270115; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Petruska JC, 2007, J NEUROSCI, V27, P4460, DOI 10.1523/JNEUROSCI.2302-06.2007; Reed WR, 2006, NEUROSCIENCE, V142, P1195, DOI 10.1016/j.neuroscience.2006.07.017; Ren LQ, 2013, NEUROSCIENCE, V236, P31, DOI 10.1016/j.neuroscience.2012.12.063; Rivera C, 2005, J PHYSIOL-LONDON, V562, P27, DOI 10.1113/jphysiol.2004.077495; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Roach JD, 2008, NEUROIMMUNOMODULAT, V15, P117, DOI 10.1159/000148194; ROBINSON GA, 1986, EXP BRAIN RES, V62, P387, DOI 10.1007/BF00238858; Rossignol S, 2004, CAN J PHYSIOL PHARM, V82, P617, DOI 10.1139/Y04-068; Rossignol S, 2011, ANNU REV NEUROSCI, V34, P413, DOI 10.1146/annurev-neuro-061010-113746; Seidel J, 2007, STEM CELLS DEV, V16, P827, DOI 10.1089/scd.2007.0004; Shapiro S, 1997, NEUROSURGERY, V40, P168, DOI 10.1097/00006123-199701000-00037; Shevtsova Z, 2010, AM J PATHOL, V177, P271, DOI 10.2353/ajpath.2010.091267; Skup M, 2007, SPINAL CORD, V45, P140, DOI 10.1038/sj.sc.3101945; Skup M, 2002, EXP NEUROL, V176, P289, DOI 10.1006/exnr.2002.7943; Skup M, 2012, EUR J NEUROSCI; Skup M, 2011, ISN ESN 23 BIENN M A; Skup M, 2012, EUR J NEUROSCI, V36, P2679, DOI 10.1111/j.1460-9568.2012.08182.x; Slack SE, 2004, EUR J NEUROSCI, V20, P1769, DOI 10.1111/j.1460-9568.2004.03656.x; Stil A, 2011, EUR J NEUROSCI, V33, P1212, DOI 10.1111/j.1460-9568.2010.07592.x; TAAL W, 1994, NEUROREPORT, V5, P2225, DOI 10.1097/00001756-199411000-00005; Tan AM, 2012, J NEUROSCI, V32, P12896, DOI 10.1523/JNEUROSCI.6451-11.2012; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P512, DOI 10.1152/jn.1989.61.3.512; Tillakaratne NJK, 2000, J NEUROSCI RES, V60, P219, DOI 10.1002/(SICI)1097-4547(20000415)60:2<219::AID-JNR11>3.3.CO;2-6; Tillakaratne NJK, 2002, J NEUROSCI, V22, P3130, DOI 10.1523/JNEUROSCI.22-08-03130.2002; Tobias CA, 2005, J NEUROTRAUM, V22, P138, DOI 10.1089/neu.2005.22.138; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; Todd AJ, 1996, J NEUROSCI, V16, P974; Toyoda H, 2003, J NEUROPHYSIOL, V89, P1353, DOI 10.1152/jn.00721.2002; Vanderhorst VGJM, 1997, J COMP NEUROL, V382, P46; Wardle RA, 2003, J NEUROSCI, V23, P8722; WEBER ED, 1977, BRAIN RES, V125, P241, DOI 10.1016/0006-8993(77)90618-7; Wienecke J, 2010, J NEUROPHYSIOL, V103, P761, DOI 10.1152/jn.00609.2009; Wienecke J RL, 2012, NEUR M PLANN PROGR; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Ying Z, 2008, NEUROSCIENCE, V155, P1070, DOI 10.1016/j.neuroscience.2008.06.057; Ying Z, 2005, EXP NEUROL, V193, P411, DOI 10.1016/j.expneurol.2005.01.015; Ying Z, 2003, BRAIN RES, V987, P93, DOI 10.1016/S0006-8993(03)03258-X; Ziemlinska E, 2008, 6 FOR EUR NEUR GEN S, V4; Ziemlinska E, 2010, NEUR M PLANN SAN DIE; Ziemlinska E, 2010, 7 FOR EUR NEUR AMST, V5	113	39	43	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88833	10.1371/journal.pone.0088833	http://dx.doi.org/10.1371/journal.pone.0088833			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551172	Green Published, Green Submitted, gold			2022-12-27	WOS:000331271500072
J	Li, WJ; Zhao, JM; Zou, ZS; Liu, Y; Li, BS; Sun, Y; Li, XD; Liu, SH; Cai, SP; Yao, WM; Xin, SJ; Lu, FM; Xu, DP				Li, Weijie; Zhao, Jingmin; Zou, Zhengsheng; Liu, Yan; Li, Baosen; Sun, Ying; Li, Xiaodong; Liu, Shuhong; Cai, Shaoping; Yao, Weimin; Xin, Shaojie; Lu, Fengmin; Xu, Dongping			Analysis of Hepatitis B Virus Intrahepatic Covalently Closed Circular DNA and Serum Viral Markers in Treatment-Naive Patients with Acute and Chronic HBV Infection	PLOS ONE			English	Article							SURFACE-ANTIGEN; NATURAL-HISTORY; REPLICATIVE ACTIVITY; LIVER-TISSUE; CCCDNA; QUANTITATION; PERSISTENCE; REDUCTION; DECLINE	Background: This study aimed to investigate the relationships of intrahepatic cccDNA with serum HBsAg and with HBV DNA in treatment-naive patients throughout acute and chronic HBV infection. Methods: A total of 120 patients who had a liver biopsy were enrolled, including 19 with acute hepatitis B (AHB), and 101 patients with chronic HBV infection (CHB) of whom were 10 in immune-tolerant (IT) phase, 59 in immune-clearance (IC) phase, 8 in low-replicative (LR) phase, and 24 in HBeAg-negative hepatitis (ENH) phase. Intrahepatic cccDNA, serum HBsAg and serum HBV DNA levels were comparatively analyzed. Results: The median intrahepatic cccDNA levels were 0.18 4.80, 3.81, 0.22 and 0.97 copies/cell for patients with AHB, CHB-IT, CHB-IC, CHB-LR, and CHB-ENH, respectively. In AHB patients, intrahepatic cccDNA was positively correlated with serum HBsAg (r = 0.665, P = 0.003), as well as serum HBV DNA (r = 0.536, P = 0.022). In CHB patients, intrahepatic cccDNA was positively correlated with serum HBsAg in the IC phase (r = 0.392, P = 0.005), and with serum HBV DNA in the IC phase (r = 0.301, P = 0.036) and ENH phase (r = 0.588, P = 0.013). HBV replicative efficiency, defined as the ratio of serum HBV DNA to intrahepatic cccDNA, was obviously lower in AHB and CHB-LR patients than in CHB-IT, CHB-IC and CHB-ENH patients (0.70 and 0.53 vs. 1.12, 1.09 and 0.99, P<0.001, values were logarithmic transformed for analysis). In CHB-IC patients, HBV replicative efficiency was positively correlated with histological activity index of liver inflammation (r = 0.308, P = 0.009). Conclusion: Serum HBsAg and HBV DNA levels may reflect the amount of active intrahepatic cccDNA in treatment-naive AHB and CHB-IC patients. Reduced intrahepatic cccDNA and HBV replicative efficiency may imply effective immune control of HBV infection.	[Li, Weijie; Lu, Fengmin; Xu, Dongping] Peking Univ, Hlth Sci Ctr, Dept Microbiol, Beijing 100871, Peoples R China; [Li, Weijie; Zou, Zhengsheng; Liu, Yan; Li, Baosen; Sun, Ying; Li, Xiaodong; Cai, Shaoping; Yao, Weimin; Xin, Shaojie; Xu, Dongping] Beijing 302 Hosp, Inst Infect Dis, Beijing, Peoples R China; [Li, Weijie; Zou, Zhengsheng; Liu, Yan; Li, Baosen; Sun, Ying; Li, Xiaodong; Cai, Shaoping; Yao, Weimin; Xin, Shaojie; Xu, Dongping] Beijing 302 Hosp, Med Ctr Liver Failure, Beijing, Peoples R China; [Zhao, Jingmin; Liu, Shuhong] Beijing 302 Hosp, Dept Pathol, Beijing, Peoples R China	Peking University; Fifth Medical Center of Chinese PLA General Hospital; Fifth Medical Center of Chinese PLA General Hospital; Fifth Medical Center of Chinese PLA General Hospital	Lu, FM (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Microbiol, Beijing 100871, Peoples R China.	lu.fengmin@hsc.pku.edu.cn; xudongping302@sina.com			National Natural Science Foundation of China [81171617]; 12th Five-Year High-Tech Grand [2010gxjs009]; 12th Five-Year Special Grand project for Infectious Diseases [2012ZX10004503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 12th Five-Year High-Tech Grand; 12th Five-Year Special Grand project for Infectious Diseases	This work was supported by the National Natural Science Foundation of China (81171617), and 12th Five-Year High-Tech Grand (2010gxjs009), and 12th Five-Year Special Grand project for Infectious Diseases (2012ZX10004503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourne EJ, 2007, J VIRAL HEPATITIS, V14, P55, DOI 10.1111/j.1365-2893.2006.00775.x; Chan HLY, 2007, CLIN GASTROENTEROL H, V5, P1462, DOI 10.1016/j.cgh.2007.09.005; Chan HLY, 2010, HEPATOLOGY, V52, P1232, DOI 10.1002/hep.23803; Chinese Association of Infectious Diseases and Parasitology Hepatology, 2000, CHINESE J HEPATOLOGY, V6, P324; Chinese Society of Hepatology and Chinese Society of Infectious Diseases Chinese Medical Association, 2011, Zhonghua Gan Zang Bing Za Zhi, V19, P13, DOI 10.3760/cma.j.issn.1007-3418.2011.01.007; Guner R, 2011, EUR J GASTROEN HEPAT, V23, P1185, DOI 10.1097/MEG.0b013e32834ba13a; Jaroszewicz J, 2010, J HEPATOL, V52, P514, DOI 10.1016/j.jhep.2010.01.014; Kim JW, 2011, INTERVIROLOGY, V54, P316, DOI 10.1159/000321450; Laras A, 2006, HEPATOLOGY, V44, P694, DOI 10.1002/hep.21299; LARSSON SB, 2013, LIVER INT, DOI DOI 10.1111/LIV.12345.[; Lenci I, 2010, DIGEST LIVER DIS, V42, P578, DOI 10.1016/j.dld.2009.12.003; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Li XD, 2010, J CLIN MICROBIOL, V48, P4363, DOI 10.1128/JCM.01518-10; Lin LY, 2010, J MED VIROL, V82, P1494, DOI 10.1002/jmv.21863; Liu Y, 2010, J CLIN VIROL, V47, P243, DOI 10.1016/j.jcv.2009.12.013; Lu L, 2009, J VIRAL HEPATITIS, V16, P104, DOI 10.1111/j.1365-2893.2008.01054.x; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Popotheodoridis GV, 2008, LANCET INFECT DIS, V8, P167, DOI 10.1016/S1473-3099(07)70264-5; Seto WK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043087; Sung JJY, 2005, GASTROENTEROLOGY, V128, P1890, DOI 10.1053/j.gastro.2005.03.009; Takkenberg B, 2011, J GASTROEN HEPATOL, V26, P1527, DOI 10.1111/j.1440-1746.2011.06766.x; Takkenberg RB, 2010, EUR J GASTROEN HEPAT, V22, P952, DOI 10.1097/MEG.0b013e3283376a63; Wang MR, 2013, J MED VIROL, V85, P219, DOI 10.1002/jmv.23461; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Wong DKH, 2013, CLIN GASTROENTEROL H, V11, P1004, DOI 10.1016/j.cgh.2013.01.026; Wong DKH, 2004, HEPATOLOGY, V40, P727, DOI 10.1002/hep.20353; Wursthorn K, 2006, HEPATOLOGY, V44, P675, DOI 10.1002/hep.21282; Xu ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072799; Zhang Xiaoyong, 2013, Frontiers in Genetics, V4, P202, DOI 10.3389/fgene.2013.00202; Zhong YW, 2011, CLIN CHIM ACTA, V412, P1905, DOI 10.1016/j.cca.2011.06.031; Zoulim F, 2005, J HEPATOL, V42, P302, DOI 10.1016/j.jhep.2004.12.015	31	27	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89046	10.1371/journal.pone.0089046	http://dx.doi.org/10.1371/journal.pone.0089046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551214	gold, Green Submitted, Green Published			2022-12-27	WOS:000331266000094
J	Schile, LM; Callaway, JC; Morris, JT; Stralberg, D; Parker, VT; Kelly, M				Schile, Lisa M.; Callaway, John C.; Morris, James T.; Stralberg, Diana; Parker, V. Thomas; Kelly, Maggi			Modeling Tidal Marsh Distribution with Sea-Level Rise: Evaluating the Role of Vegetation, Sediment, and Upland Habitat in Marsh Resiliency	PLOS ONE			English	Article							COASTAL MARSHES; SOIL FORMATION; CLIMATE-CHANGE; SALT MARSHES; ACCRETION; RIVER; BAY; RATES; PRODUCTIVITY; INUNDATION	Tidal marshes maintain elevation relative to sea level through accumulation of mineral and organic matter, yet this dynamic accumulation feedback mechanism has not been modeled widely in the context of accelerated sea-level rise. Uncertainties exist about tidal marsh resiliency to accelerated sea-level rise, reduced sediment supply, reduced plant productivity under increased inundation, and limited upland habitat for marsh migration. We examined marsh resiliency under these uncertainties using the Marsh Equilibrium Model, a mechanistic, elevation-based soil cohort model, using a rich data set of plant productivity and physical properties from sites across the estuarine salinity gradient. Four tidal marshes were chosen along this gradient: two islands and two with adjacent uplands. Varying century sea-level rise (52, 100, 165, 180 cm) and suspended sediment concentrations (100%, 50%, and 25% of current concentrations), we simulated marsh accretion across vegetated elevations for 100 years, applying the results to high spatial resolution digital elevation models to quantify potential changes in marsh distributions. At low rates of sea-level rise and mid-high sediment concentrations, all marshes maintained vegetated elevations indicative of mid/high marsh habitat. With century sea-level rise at 100 and 165 cm, marshes shifted to low marsh elevations; mid/high marsh elevations were found only in former uplands. At the highest century sea-level rise and lowest sediment concentrations, the island marshes became dominated by mudflat elevations. Under the same sediment concentrations, low salinity brackish marshes containing highly productive vegetation had slower elevation loss compared to more saline sites with lower productivity. A similar trend was documented when comparing against a marsh accretion model that did not model vegetation feedbacks. Elevation predictions using the Marsh Equilibrium Model highlight the importance of including vegetation responses to sea-level rise. These results also emphasize the importance of adjacent uplands for long-term marsh survival and incorporating such areas in conservation planning efforts.	[Schile, Lisa M.] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA; [Schile, Lisa M.; Kelly, Maggi] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Callaway, John C.] Univ San Francisco, Dept Environm Sci, San Francisco, CA 94117 USA; [Morris, James T.] Univ S Carolina, Belle W Baruch Inst Marine Biol & Coastal Res, Columbia, SC 29208 USA; [Stralberg, Diana] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Parker, V. Thomas] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA	Smithsonian Institution; Smithsonian Environmental Research Center; University of California System; University of California Berkeley; University of San Francisco; Clemson University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Alberta; California State University System; San Francisco State University	Schile, LM (corresponding author), Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA.	lschile@berkeley.edu	morris, james/AAQ-5605-2020; Stralberg, Diana/W-9267-2019; morris, james/ABC-8111-2020	morris, james/0000-0002-0511-642X; Stralberg, Diana/0000-0003-4900-024X; 	California Bay-Delta Authority for research under California Bay-Delta Authority [U-04-SC-005]; CALFED Science Program [1037]	California Bay-Delta Authority for research under California Bay-Delta Authority; CALFED Science Program	This paper was prepared in cooperation with the California Bay-Delta Authority for research funded under California Bay-Delta Authority Agreement No. U-04-SC-005 and under CALFED Science Program Grant #1037. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cahoon DR, 2006, ECOL STUD-ANAL SYNTH, V190, P271; Cahoon DR, 2003, J ECOL, V91, P1093, DOI 10.1046/j.1365-2745.2003.00841.x; Callaway J.C., 1996, CURRENT TOPICS WETLA, V2, P2; Callaway JC, 2012, ESTUAR COAST, V35, P1163, DOI 10.1007/s12237-012-9508-9; Chen ZY, 2001, GEOMORPHOLOGY, V41, P77, DOI 10.1016/S0169-555X(01)00106-4; Cloern JE, 2012, REV GEOPHYS, V50, DOI 10.1029/2012RG000397; Cloern JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024465; Craft C, 2009, FRONT ECOL ENVIRON, V7, P73, DOI 10.1890/070219; DAY JW, 1995, ESTUARIES, V18, P636, DOI 10.2307/1352382; Department of Commerce National Oceanic and Atmospheric Administration National Ocean Service Coastal Services Center, 2012, 2009 2011 CAL COAST; Deverel SJ, 2010, SAN FRANCISCO ESTUAR, V8; Donnelly JP, 2001, P NATL ACAD SCI USA, V98, P14218, DOI 10.1073/pnas.251209298; Drexler JZ, 2009, ESTUAR COAST, V32, P871, DOI 10.1007/s12237-009-9202-8; Elsey-Quirk T, 2011, WETLANDS, V31; Fagherazzi S, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000359; Gedan KB, 2009, ANNU REV MAR SCI, V1, P117, DOI 10.1146/annurev.marine.010908.163930; Grinsted A, 2010, CLIM DYNAM, V34, P461, DOI 10.1007/s00382-008-0507-2; Hladik C, 2012, REMOTE SENS ENVIRON, V121, P224, DOI 10.1016/j.rse.2012.01.018; Ibanez C, 1996, REGUL RIVER, V12, P51, DOI 10.1002/(SICI)1099-1646(199601)12:1&lt;51::AID-RRR376&gt;3.0.CO;2-I; Intergovernmental Panel on Climate Change, 2007, SUMM POL; Kirwan ML, 2007, P NATL ACAD SCI USA, V104, P6118, DOI 10.1073/pnas.0700958104; Kirwan ML, 2012, NATURE, V489, P550, DOI 10.1038/nature11440; Kirwan ML, 2012, J ECOL, V100, P764, DOI 10.1111/j.1365-2745.2012.01957.x; Kirwan ML, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045489; Kirwan ML, 2009, GLOBAL CHANGE BIOL, V15, P1982, DOI 10.1111/j.1365-2486.2008.01834.x; Krone R.B., 1987, COASTAL SEDIMENTS 87, P316; Marion C, 2009, ESTUAR COAST SHELF S, V83, P475, DOI 10.1016/j.ecss.2009.03.039; Mariotti G, 2013, P NATL ACAD SCI USA, V110, P5353, DOI 10.1073/pnas.1219600110; Mckee KL, 2007, GLOBAL ECOL BIOGEOGR, V16, P545, DOI 10.1111/j.1466-8238.2007.00317.x; Morecroft MD, 2012, J APPL ECOL, V49, P547, DOI [10.1111/j.1365-2664.2012.02136.x, 10.1111/j.1365-2664.2012.02147.x]; Morris JT, 2013, WETLANDS, V33, P975, DOI 10.1007/s13157-013-0480-3; Morris J.T., 2012, RECARBONIZATION BIOS, P517; MORRIS JT, 1990, ECOLOGY, V71, P2209, DOI 10.2307/1938633; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; MORRIS JT, 1986, SOIL SCI SOC AM J, V50, P96, DOI 10.2136/sssaj1986.03615995005000010019x; Morris JT, 2007, ESTIMATING NET PRIMA; Mudd SM, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001566; Mudd SM, 2009, ESTUAR COAST SHELF S, V82, P377, DOI 10.1016/j.ecss.2009.01.028; National Research Council, 2012, SEA LEVEL RISE COAST; National Research Council, 1987, RESP CHANG SEA LEV E; Neubauer SC, 2002, ESTUAR COAST SHELF S, V54, P713, DOI 10.1006/ecss.2001.0854; Nur N, 2012, TECHNICAL REPORT; NYMAN JA, 1990, ESTUAR COAST SHELF S, V31, P57, DOI 10.1016/0272-7714(90)90028-P; NYMAN JA, 1993, MAR ECOL PROG SER, V96, P269, DOI 10.3354/meps096269; Nyman JA, 2006, ESTUAR COAST SHELF S, V69, P370, DOI 10.1016/j.ecss.2006.05.041; Orr M., 2003, SAN FRANC ESTUARY WA, V1, DOI [10.15447/sfews.2003v1iss1art5, DOI 10.15447/SFEWS.2003V1ISS1ART5]; Parker VT, 2012, ECOLOGY, CONSERVATION, AND RESTORATION OF TIDAL MARSHES: THE SAN FRANCISCO ESTUARY, P97; Prahalad VN, 2011, AUST J BOT, V59, P741, DOI 10.1071/BT11206; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; REED DJ, 1995, EARTH SURF PROC LAND, V20, P39, DOI 10.1002/esp.3290200105; Rogers K, 2012, ECOL MODEL, V244, P148, DOI 10.1016/j.ecolmodel.2012.06.014; Rybczyk J.M., 2009, COASTAL WETLANDS INT, P835; Rybczyk JM, 1998, ECOL MODEL, V112, P23, DOI 10.1016/S0304-3800(98)00125-2; Sanderson EW, 2000, PLANT ECOL, V146, P29, DOI 10.1023/A:1009882110988; Schile LM, 2011, WETLANDS, V31, P1165, DOI 10.1007/s13157-011-0227-y; Schoellhamer D.H., 2004, SAN FRANCISCO ESTUAR, V2; Schoellhamer DH, 2011, ESTUAR COAST, V34, P885, DOI 10.1007/s12237-011-9382-x; Schwimmer RA, 2001, J COASTAL RES, V17, P672; Stralberg D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027388; Syvitski JPM, 2009, NAT GEOSCI, V2, P681, DOI 10.1038/NGEO629; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; THOM RM, 1992, WETLANDS, V12, P147, DOI 10.1007/BF03160603; Tornqvist TE, 2008, NAT GEOSCI, V1, P173, DOI 10.1038/ngeo129; Turner RE, 2004, ECOL RES, V19, P29, DOI 10.1111/j.1440-1703.2003.00610.x; Turner RE, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P583; Tuxen K, 2011, WETL ECOL MANAG, V19, P141, DOI 10.1007/s11273-010-9207-x; Tweel AW, 2012, LIMNOL OCEANOGR, V57, P18, DOI 10.4319/lo.2012.57.1.0018; van der Wal D, 2004, GEOMORPHOLOGY, V61, P373, DOI 10.1016/j.geomorph.2004.02.005; Vasey MC, 2012, SAN FRANC ESTUARY WA, V10, P1; Veloz SD, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00341.1; Vermeer M, 2009, P NATL ACAD SCI USA, V106, P21527, DOI 10.1073/pnas.0907765106; Voss CM, 2012, MARINE BIOL; WARREN RS, 1993, ECOLOGY, V74, P96, DOI 10.2307/1939504; Williams PB, 2002, RESTOR ECOL, V10, P527, DOI 10.1046/j.1526-100X.2002.02031.x; Zedler JB, 1999, ECOSYSTEMS, V2, P19, DOI 10.1007/s100219900055	75	119	119	1	141	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88760	10.1371/journal.pone.0088760	http://dx.doi.org/10.1371/journal.pone.0088760			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551156	Green Published, gold			2022-12-27	WOS:000331266000064
J	Kayama, T; Yamashita, H; Fukao, A; Kubota, I; Kato, T; Kitanaka, C; Sato, S; Ueno, Y; Kubota, I; Sato, S; Konta, T; Shibata, Y; Watanabe, T; Abe, S; Miyamoto, T; Inoue, S; Miyashita, T; Ichikawa, K; Shishido, T; Arimoto, T; Takahashi, H; Nishiyama, S; Ikeda, A; Kato, T; Daimon, M; Kawanami, T; Wada, M; Arawaka, S; Oizumi, H; Kuro-Kawa, K; Susa, S; Katou, Y; Kameda, W; Koyama, S; Karasawa, S; Iseki, C; Takahashi, Y; Kitanaka, C; Ueno, Y; Ueno, Y; Kawata, S; Saito, T; Makino, N; Okumoto, K; Haga, H; Sato, T; Sato, C; Watanabe, H; Nishise, Y; Ishii, R; Matsuda, A; Tozawa, T; Yamashita, H; Honma, K; Fukao, A; Narimatsu, H; Shibata, K; Miura, A; Inoue, R; Numazawa, A; Kudo, K; Aita, Y; Umezawa, N; Saito, Y; Takahashi, Y; Suzuki, Y; Otani, K; Hozawa, A; Shao, L; Orui, M; Kobayashi, A; Kanoya, Y; Hosoya, T; Suzuki, I; Otake, M; Morikagi, Y; Sekimata, A; Hiraka, M; Matsuda, Y; Sato, C; Takeda, Y; Matsunami, Y; Horie, T; Sato, S; Inoue, M; Baba, K; Tamiya, G; Ueki, M; Nakamura, T; Tamiya, G; Jambaldorj, J; Araki, S; Nakajima, O; Takahashi, K; Goto, K; Ishizaka, K				Kayama, Takamasa; Yamashita, Hidetoshi; Fukao, Akira; Kubota, Isao; Kato, Takeo; Kitanaka, Chifumi; Sato, Shinya; Ueno, Yoshiyuki; Kubota, Isao; Sato, Shinya; Konta, Tsuneo; Shibata, Yoko; Watanabe, Tetsu; Abe, Shuichi; Miyamoto, Takuya; Inoue, Sumito; Miyashita, Takehiko; Ichikawa, Kazunobu; Shishido, Tetsuro; Arimoto, Takanori; Takahashi, Hiroki; Nishiyama, Satoshi; Ikeda, Ami; Kato, Takeo; Daimon, Makoto; Kawanami, Toru; Wada, Manabu; Arawaka, Shigeki; Oizumi, Hidetoshi; Kuro-Kawa, Katsuro; Susa, Shingi; Katou, Yuichi; Kameda, Wataru; Koyama, Shingo; Karasawa, Shigeru; Iseki, Chifumi; Takahashi, Yoshimi; Kitanaka, Chifumi; Ueno, Yoshiyuki; Ueno, Yoshiyuki; Kawata, Sumio; Saito, Takafumi; Makino, Naohiko; Okumoto, Kazuo; Haga, Hiroaki; Sato, Takeshi; Sato, Chikako; Watanabe, Hisayoshi; Nishise, Yuko; Ishii, Rika; Matsuda, Akiko; Tozawa, Tomohiro; Yamashita, Hidetoshi; Honma, Kei; Fukao, Akira; Narimatsu, Hiroto; Shibata, Kyoko; Miura, Akiko; Inoue, Rina; Numazawa, Ai; Kudo, Kahori; Aita, Yoko; Umezawa, Noriko; Saito, Yuko; Takahashi, Yumi; Suzuki, Yuka; Otani, Katsumi; Hozawa, Atsushi; Shao, Li; Orui, Masatsugu; Kobayashi, Atsuko; Kanoya, Yuka; Hosoya, Takiko; Suzuki, Ikuko; Otake, Mariko; Morikagi, Yuko; Sekimata, Akiko; Hiraka, Manami; Matsuda, Yumi; Sato, Chika; Takeda, Yoko; Matsunami, Yoko; Horie, Tatsuya; Sato, Shiho; Inoue, Mizue; Baba, Kaoru; Tamiya, Gen; Ueki, Masao; Nakamura, Tomohiro; Tamiya, Gen; Jambaldorj, Jamiyansuren; Araki, Satoko; Nakajima, Osamu; Takahashi, Kazuei; Goto, Kazuo; Ishizaka, Kimishige		YUGCC	Pleiotropic Effect of Common Variants at ABO Glycosyltranferase Locus in 9q32 on Plasma Levels of Pancreatic Lipase and Angiotensin Converting Enzyme	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; JAPANESE POPULATION; DISEASES; SUSCEPTIBILITY; CANCER; STEATOSIS; GENETICS; TRAITS; RISK	For forty-three clinical test values presumably associated to common complex human diseases, we carried out a genome-wide association study using 600K SNPs in a general Japanese population of 1,639 individuals (1,252 after quality control procedures) drawn from a regional cohort, followed by a replication study for statistically significant SNPs (p = 1.95x10(-9)-8.34x10(-39)) using an independent population of 1,671 from another cohort. In this single two-stage study, we newly found strong and robust associations of common variants at the ABO histo-blood glycosyltransferase locus in 9q32 with the plasma levels of pancreatic lipase (P-LIP), in addition to successful confirmation of the known ABO association of angiotensin converting enzyme (ACE) independent of the ACE1 gene in 17q23.2 with the ACE level. Our results are compatible with the previously reported association between the ABO gene and pancreatic cancer, and show that the effect of these common variants at the ABO locus on the P-LIP and ACE levels is largely opposing and pleiotropic.	[Kayama, Takamasa; Sato, Shinya] Yamagata Univ, Grad Sch Med, Dept Neurosurg, Yamagata 990, Japan; [Makino, Naohiko; Matsuda, Akiko; Tozawa, Tomohiro] Yamagata Univ Hosp, Div Endoscopy, Yamagata, Japan; [Orui, Masatsugu] Yamagata Prefectural Tsuruoka Hosp, Yamagata, Japan	Yamagata University; Yamagata University	Kawata, S (corresponding author), Hyogo Prefectural Nishinomiya Hosp, Hyogo, Japan.	shibata@med.id.yamagata-u.ac.jp; namakino@med.id.yamagata-u.ac.jp; gtamiya@genetix-h.com	Daimon, Makoto/AAY-1289-2020; Narimatsu, Hiroto/ABC-9150-2021; ISEKI, CHIFUMI/AIE-8333-2022; Konta, Tsuneo/AAO-9286-2021; Jamiyansuren, Jambaldorj/X-6016-2019; Ueno, Yoshiyuki/R-9242-2019	Daimon, Makoto/0000-0002-3775-1719; Narimatsu, Hiroto/0000-0002-5302-5872; Jamiyansuren, Jambaldorj/0000-0001-6240-5108; Ueno, Yoshiyuki/0000-0001-5623-4250; Tamiya, Gen/0000-0002-0597-415X	Global Center of Excellence program of the Japan Society for the Promotion of Science, "Formation of an International Network for Education and Research of Molecular Epidemiology"; Grants-in-Aid for Scientific Research [25870074] Funding Source: KAKEN	Global Center of Excellence program of the Japan Society for the Promotion of Science, "Formation of an International Network for Education and Research of Molecular Epidemiology"; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This project study was fully supported by a Grant-in-aid from the Global Center of Excellence program of the Japan Society for the Promotion of Science, "Formation of an International Network for Education and Research of Molecular Epidemiology" (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036926; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BOERWINKLE E, 1988, AM J HUM GENET, V42, P104; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Boulanger LM, 2004, NAT REV NEUROSCI, V5, P521, DOI 10.1038/nrn1428; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chung CM, 2010, PHARMACOGENOMICS J, V10, P537, DOI 10.1038/tpj.2009.70; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Falconer D. S., 1996, INTRO QUANTITATIVE G; Ferlay J, 2004, GLOBOCAN 2002 CANC I; Gregersen PK, 2006, NAT REV GENET, V7, P917, DOI 10.1038/nrg1944; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Jacob S, 2002, NAT GENET, V30, P175, DOI 10.1038/ng830; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; King R.C., 2006, DICT GENETICS; Konta T, 2006, KIDNEY INT, V70, P751, DOI 10.1038/sj.ki.5001504; Malka D, 2002, GUT, V51, P849, DOI 10.1136/gut.51.6.849; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; MARCUS DM, 1969, NEW ENGL J MED, V280, P994, DOI 10.1056/NEJM196905012801806; Mathur A, 2009, J AM COLL SURGEONS, V208, P989, DOI 10.1016/j.jamcollsurg.2008.12.026; Pare G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001374; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rahman P, 2003, AM J HUM GENET, V73, P677, DOI 10.1086/378076; Raimondi S, 2010, BEST PRACT RES CL GA, V24, P349, DOI 10.1016/j.bpg.2010.02.007; Shintani-Ishida K, 2008, INT J LEGAL MED, V122, P7, DOI 10.1007/s00414-006-0148-0; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Tanikawa C, 2012, NAT GENET, V44, P430, DOI 10.1038/ng.1109; van Raalte DH, 2010, CURR OPIN CLIN NUTR, V13, P478, DOI 10.1097/MCO.0b013e32833aa1ef; Venables WN., 2002, MODERN APPL STAT S 4; Vogel F, 1982, HUMAN GENETICS PROBL, V2nd; Wray NR, 2007, GENES AND COMMON DISEASES: GENETICS IN MODERN MEDICINE, P59; Yang J, 2010, GENET EPIDEMIOL, V34, P254, DOI 10.1002/gepi.20456; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012	37	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e55903	10.1371/journal.pone.0055903	http://dx.doi.org/10.1371/journal.pone.0055903			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586218	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200001
J	Clemente, MI; Alvarez, S; Serramia, MJ; Martinez-Bonet, M; Munoz-Fernandez, MA				Isabel Clemente, Maria; Alvarez, Susana; Jesus Serramia, Maria; Martinez-Bonet, Marta; Angeles Munoz-Fernandez, Maria			Prostaglandin E-2 Reduces the Release and Infectivity of New Cell-Free Virions and Cell-To-Cell HIV-1 Transfer	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEIN-KINASE-A; VIROLOGICAL SYNAPSE FORMATION; ELEMENT-BINDING PROTEIN; GENE-EXPRESSION; CYCLIC-AMP; CYTOKINE SECRETION; OXIDATIVE STRESS; EXCHANGE FACTOR; EPAC PROTEINS	Background: The course of human immunodeficiency virus type-1 (HIV-1) infection is influenced by a complex interplay between viral and host factors. HIV infection stimulates several proinflammatory genes, such as cyclooxigense-2 (COX-2), which leads to an increase in prostaglandin (PG) levels in the plasma of HIV-1-infected patients. These genes play an indeterminate role in HIV replication and pathogenesis. The effect of prostaglandin E-2 (PGE(2)) on HIV infection is quite controversial and even contradictory, so we sought to determine the role of PGE(2) and the signal transduction pathways involved in HIV infection to elucidate possible new targets for antiretrovirals. Results: Our results suggest that PGE(2) post-infection treatment acts in the late stages of the viral cycle to reduce HIV replication. Interestingly, viral protein synthesis was not affected, but a loss of progeny virus production was observed. No modulation of CD4 CXCR4 and CCR5 receptor expression, cell proliferation, or activation after PGE(2) treatment was detected. Moreover, PGE(2) induced an increase in intracellular cAMP (cyclic AMP) levels through the EP2/EP4 receptors. PGE(2) effects were mimicked by dbcAMP and by a specific Epac (exchange protein directly activated by cyclic AMP) agonist, 8-Cpt-cAMP. Treatment with PGE(2) increased Rap1 activity, decreased RhoA activity and subsequently reduced the polymerization of actin by approximately 30% compared with untreated cells. In connection with this finding, polarized viral assembly platforms enriched in Gag were disrupted, altering HIV cell-to-cell transfer and the infectivity of new virions. Conclusions: Our results demonstrate that PGE(2), through Epac and Rap activation, alters the transport of newly synthesized HIV-1 components to the assembly site, reducing the release and infectivity of new cell-free virions and cell-to-cell HIV-1 transfer.	[Isabel Clemente, Maria; Alvarez, Susana; Jesus Serramia, Maria; Martinez-Bonet, Marta; Angeles Munoz-Fernandez, Maria] Hosp Gen Univ Gregorio Maranon, Lab InmunoBiol Mol, Madrid, Spain; [Isabel Clemente, Maria; Alvarez, Susana; Jesus Serramia, Maria; Martinez-Bonet, Marta; Angeles Munoz-Fernandez, Maria] Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain; [Isabel Clemente, Maria; Alvarez, Susana; Jesus Serramia, Maria; Martinez-Bonet, Marta; Angeles Munoz-Fernandez, Maria] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Zaragoza, Spain	General University Gregorio Maranon Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Munoz-Fernandez, MA (corresponding author), Hosp Gen Univ Gregorio Maranon, Lab InmunoBiol Mol, Madrid, Spain.	mmunoz.hgugm@gmail.com	sourisseau, marion/M-7542-2014	Martinez Bonet, Marta/0000-0003-0715-403X; Munoz-Fernandez/0000-0002-0813-4500	Fondo de Investigacion Sanitaria en Espana (FIS) [INTRASALUD PS09/02029, RD09/0076/00103]; Fundacion Eugenio Rodriguez Pascual; Red Espanola de Investigacion en SIDA (RIS) [RETIC RD06/0006/0035, RD12-0017-0037]; "Fundacion para la Investigacion y la Prevencion del Sida en Espana'' (FIPSE); Comunidad de Madrid [INDISNET S-2010/BMD-2332]; Fondo de Investigacion Sanitaria [CA10/01274]	Fondo de Investigacion Sanitaria en Espana (FIS); Fundacion Eugenio Rodriguez Pascual; Red Espanola de Investigacion en SIDA (RIS); "Fundacion para la Investigacion y la Prevencion del Sida en Espana'' (FIPSE); Comunidad de Madrid(Comunidad de Madrid); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III)	This work was supported by grants provided by Fondo de Investigacion Sanitaria en Espana (FIS) [grant numbers INTRASALUD PS09/02029, RD09/0076/00103]; the Fundacion Eugenio Rodriguez Pascual; Red Espanola de Investigacion en SIDA (RIS) [grant numbers RETIC RD06/0006/0035, RD12-0017-0037]; "Fundacion para la Investigacion y la Prevencion del Sida en Espana'' (FIPSE); and Comunidad de Madrid [INDISNET S-2010/BMD-2332]. MIC is supported by Fondo de Investigacion Sanitaria (CA10/01274). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronoff DM, 2006, CLIN PHARMACOL THER, V79, P9, DOI 10.1016/j.clpt.2005.09.009; Aronoff DM, 2005, J IMMUNOL, V174, P595, DOI 10.4049/jimmunol.174.2.595; BETZ M, 1991, J IMMUNOL, V146, P108; Bivona TG, 2004, J CELL BIOL, V164, P461, DOI 10.1083/jcb.200311093; Blanco J, 2004, J BIOL CHEM, V279, P51305, DOI 10.1074/jbc.M408547200; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Breen EC, 2000, CLIN DIAGN LAB IMMUN, V7, P769, DOI 10.1128/CDLI.7.5.769-773.2000; Bukrinsky M, 2004, MOL MED, V10, P1; Cooper J, 2011, J BIOL CHEM, V286, P28498, DOI 10.1074/jbc.M111.239053; Cui Qi, 2004, Anatomical Science International, V79, P209, DOI 10.1111/j.1447-073x.2004.00089.x; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dumais N, 2002, J IMMUNOL, V168, P274, DOI 10.4049/jimmunol.168.1.274; Dumais N, 1998, J BIOL CHEM, V273, P27306, DOI 10.1074/jbc.273.42.27306; Dustin ML, 2004, NAT IMMUNOL, V5, P363, DOI 10.1038/ni1057; Elbim C, 2001, J CLIN VIROL, V20, P99, DOI 10.1016/S1386-6532(00)00133-5; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Garcia-Merino I, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-27; GENDELMAN HE, 1987, VIROLOGY, V160, P323, DOI 10.1016/0042-6822(87)90002-X; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Gladnikoff M, 2009, BIOPHYS J, V97, P2419, DOI 10.1016/j.bpj.2009.08.016; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Goetzl EJ, 1995, J IMMUNOL; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Grandoch M, 2010, BRIT J PHARMACOL, V159, P265, DOI 10.1111/j.1476-5381.2009.00458.x; Graziano F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023674; Graziosi C, 1996, P NATL ACAD SCI USA, V93, P4386, DOI 10.1073/pnas.93.9.4386; Greene WC, 2002, NAT MED, V8, P673, DOI 10.1038/nm0702-673; Haraguchi H, 2010, MICROBIOL IMMUNOL, V54, P734, DOI 10.1111/j.1348-0421.2010.00276.x; HASLER F, 1983, J IMMUNOL, V131, P768; Hayes MM, 2002, CELL IMMUNOL, V215, P61, DOI 10.1016/S0008-8749(02)00017-5; HILKENS CMU, 1995, EUR J IMMUNOL, V25, P59, DOI 10.1002/eji.1830250112; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; Huang S, 2007, AM J PHYSIOL-LUNG C, V292, pL405, DOI 10.1152/ajplung.00232.2006; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Janelle ME, 2002, J BIOL CHEM, V277, P30665, DOI 10.1074/jbc.M203041200; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Jolly C, 2007, J VIROL, V81, P13916, DOI 10.1128/JVI.01585-07; Jolly C, 2007, J VIROL, V81, P7873, DOI 10.1128/JVI.01845-06; Jolly C, 2007, J VIROL, V81, P5547, DOI 10.1128/JVI.01469-06; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; KRAAN TCTMV, 1995, MOL MED TODAY, V1, P61; LAURENCE J, 1990, BLOOD, V75, P696; Lehmann M, 2011, VIRUSES-BASEL, V3, P1757, DOI 10.3390/v3091757; Lorenowicz MJ, 2006, J LEUKOCYTE BIOL, V80, P1542, DOI 10.1189/jlb.0506357; Lu YB, 2005, J IMMUNOL, V175, P5423, DOI 10.4049/jimmunol.175.8.5423; Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200; Mothes W, 2010, J VIROL, V84, P8360, DOI 10.1128/JVI.00443-10; Naghavi MH, 2007, CURR OPIN IMMUNOL, V19, P402, DOI 10.1016/j.coi.2007.07.003; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Nijholt IM, 2008, CELL SIGNAL, V20, P1715, DOI 10.1016/j.cellsig.2008.05.001; Nisole Sebastien, 2004, Retrovirology, V1, P9, DOI 10.1186/1742-4690-1-9; Noda S, 2010, EUR J CANCER, V46, P995, DOI 10.1016/j.ejca.2010.01.007; Pereira CF, 2000, J LEUKOCYTE BIOL, V68, P423; Ploubidou A, 2001, CURR OPIN CELL BIOL, V13, P97, DOI 10.1016/S0955-0674(00)00180-0; Pyeon D, 2000, J VIROL, V74, P5740, DOI 10.1128/JVI.74.12.5740-5745.2000; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Roper R L, 1994, Adv Prostaglandin Thromboxane Leukot Res, V22, P101; Roscioni SS, 2008, N-S ARCH PHARMACOL, V377, P345, DOI 10.1007/s00210-007-0246-7; Rossen JWA, 2004, J VIROL, V78, P9721, DOI 10.1128/JVI.78.18.9721-9730.2004; Rudnicka D, 2009, J VIROL, V83, P6234, DOI 10.1128/JVI.00282-09; SASAKI H, 1995, P NATL ACAD SCI USA, V92, P2026, DOI 10.1073/pnas.92.6.2026; Sasaki H, 2004, BIOCHEM BIOPH RES CO, V316, P588, DOI 10.1016/j.bbrc.2004.02.088; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; SNIJDEWINT FGM, 1993, J IMMUNOL, V150, P5321; Sol-Foulon N, 2007, EMBO J, V26, P516, DOI 10.1038/sj.emboj.7601509; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Steer SA, 2003, VIRAL IMMUNOL, V16, P447, DOI 10.1089/088282403771926283; Symensma TL, 2003, J VIROL, V77, P12753, DOI 10.1128/JVI.77.23.12753-12763.2003; Thivierge M, 1998, BLOOD, V92, P40, DOI 10.1182/blood.V92.1.40.413k43_40_45; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; van Oirschot BA, 2001, J BIOL CHEM, V276, P33854, DOI 10.1074/jbc.M104395200; Vasiliver-Shamis G, 2009, J VIROL, V83, P11341, DOI 10.1128/JVI.01440-09; Watzer B, 2009, J MATER SCI-MATER M, V20, P1357, DOI 10.1007/s10856-008-3678-9	74	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e85230	10.1371/journal.pone.0085230	http://dx.doi.org/10.1371/journal.pone.0085230			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586238	gold, Green Published, Green Submitted			2022-12-27	WOS:000332385900003
J	Yang, F; Zhang, L; Wu, H; Zou, HB; Du, YJ				Yang, Fan; Zhang, Li; Wu, Hao; Zou, Hongbin; Du, Yujun			Clinical Analysis of Cause, Treatment and Prognosis in Acute Kidney Injury Patients	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; INTENSIVE-CARE-UNIT; EPIDEMIOLOGY; OUTCOMES; DEATH; RISK; DIALYSIS; MANNITOL; CRITERIA	Acute kidney injury (AKI) is characterized by an abrupt decline in renal function, resulting in an inability to secrete waste products and maintain electrolyte and water balance, and is associated with high risks of morbidity and mortality. This study retrospectively analyzed clinical data, treatment, and prognosis of 271 hospitalized patients (172 males and 99 females) diagnosed with AKI from December, 2008 to December, 2011. In addition, this study explored the association between the cause of AKI and prognosis, severity and treatment of AKI. The severity of AKI was classified according to the Acute Kidney Injury Network (AKIN) criteria. Renal recovery was defined as a decrease in a serum creatinine level to the normal value. Prerenal, renal, and postrenal causes accounted for 36.5% (99 patients), 46.5% (126 patients) and 17.0% (46 patients), respectively, of the incidence of AKI. Conservative, surgical, and renal replacement treatments were given to 180 (66.4%), 30 (11.1%) and 61 patients (22.5%), respectively. The overall recovery rate was 21.0%, and the mortality rate was 19.6%. Levels of Cl-, Na+ and carbon dioxide combining power decreased with increasing severity of AKI. Cause and treatment were significantly associated with AKI prognosis. Likewise, the severity of AKI was significantly associated with cause, treatment and prognosis. Multivariate logistic regression analysis found that respiratory injury and multiple organ dysfunction syndrome (MODS) were associated with AKI patient death. Cause, treatment and AKIN stage are associated with the prognosis of AKI. Respiratory injury and MODS are prognostic factors for death of AKI patients.	[Yang, Fan; Zhang, Li; Wu, Hao; Zou, Hongbin; Du, Yujun] Jilin Univ, Dept Nephrol, Bethune Hosp 1, Changchun, Jilin, Peoples R China	Jilin University	Du, YJ (corresponding author), Jilin Univ, Dept Nephrol, Bethune Hosp 1, Changchun, Jilin, Peoples R China.	kjkduyujun@126.com						Akcay A, 2010, INT J NEPHROL RENOV, V3, P129, DOI 10.2147/IJNRD.S8641; Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Barretti P, 1997, RENAL FAILURE, V19, P253, DOI 10.3109/08860229709026285; Bernieh B, 2004, TRANSPL P, V36, P1784, DOI 10.1016/j.transproceed.2004.07.016; BRADY HR, 1995, LANCET, V346, P1533, DOI 10.1016/S0140-6736(95)92057-9; Chen YC, 2001, RENAL FAILURE, V23, P207, DOI 10.1081/JDI-100103492; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Fang L, 2010, RENAL FAILURE, V32, P673, DOI 10.3109/0886022X.2010.486492; Hilton R, 2006, BMJ-BRIT MED J, V333, P786, DOI 10.1136/bmj.38975.657639.AE; Hoste EAJ, 2008, CRIT CARE MED, V36, pS146, DOI 10.1097/CCM.0b013e318168c590; Hoste EAJ, 2006, CURR OPIN CRIT CARE, V12, P531, DOI 10.1097/MCC.0b013e3280102af7; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Lafrance JP, 2010, J AM SOC NEPHROL, V21, P345, DOI 10.1681/ASN.2009060636; Lameire Norbert H, 2003, Curr Opin Crit Care, V9, P481, DOI 10.1097/00075198-200312000-00004; Mataloun SE, 2006, BRAZ J MED BIOL RES, V39, P1339, DOI 10.1590/S0100-879X2006001000010; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; MORAN M, 1987, NEW ENGL J MED, V317, P150, DOI 10.1056/NEJM198707163170306; Pannu N, 2008, JAMA-J AM MED ASSOC, V299, P793, DOI 10.1001/jama.299.7.793; Pereira MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047746; Ricci Z, 2011, NAT REV NEPHROL, V7, P201, DOI 10.1038/nrneph.2011.14; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Visweswaran P, 1997, J AM SOC NEPHROL, V8, P1028; Waikar SS, 2008, CLIN J AM SOC NEPHRO, V3, P844, DOI 10.2215/CJN.05191107; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1143, DOI 10.1681/ASN.2005091017; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; WOODROW G, 1992, NEPHROL DIAL TRANSPL, V7, P230, DOI 10.1093/oxfordjournals.ndt.a092111	26	20	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e85214	10.1371/journal.pone.0085214	http://dx.doi.org/10.1371/journal.pone.0085214			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586237	Green Submitted, Green Published, gold			2022-12-27	WOS:000331717900003
J	Cantin, NE; Lough, JM				Cantin, Neal E.; Lough, Janice M.			Surviving Coral Bleaching Events: Porites Growth Anomalies on the Great Barrier Reef	PLOS ONE			English	Article							TEMPERATURE-VARIATION; MONTASTREA-ANNULARIS; THERMAL TOLERANCE; LUMINESCENT LINES; MASSIVE PORITES; BAND FORMATION; CLIMATE-CHANGE; CALCIFICATION; RECORDS; DENSITY	Mass coral bleaching affected large parts of the Great Barrier Reef (GBR) in 1998 and 2002. In this study, we assessed if signatures of these major thermal stress events were recorded in the growth characteristics of massive Porites colonies. In 2005 a suite of short (<50 cm) cores were collected from apparently healthy, surviving Porites colonies, from reefs in the central GBR (18-19 degrees S) that have documented observations of widespread bleaching. Sites included inshore (Nelly Bay, Pandora Reef), annually affected by freshwater flood events, midshelf (Rib Reef), only occasionally affected by freshwater floods and offshore (Myrmidon Reef) locations primarily exposed to open ocean conditions. Annual growth characteristics (extension, density and calcification) were measured in 144 cores from 79 coral colonies and analysed over the common 24-year period, 1980-2003. Visual examination of the annual density bands revealed growth hiatuses associated with the bleaching years in the form of abrupt decreases in annual linear extension rates, high density stress bands and partial mortality. The 1998 mass-bleaching event reduced Porites calcification by 13 and 18% on the two inshore locations for 4 years, followed by recovery to baseline calcification rates in 2002. Evidence of partial mortality was apparent in 10% of the offshore colonies in 2002; however no significant effects of the bleaching events were evident in the calcification rates at the mid shelf and offshore sites. These results highlight the spatial variation of mass bleaching events and that all reef locations within the GBR were not equally stressed by the 1998 and 2002 mass bleaching events, as some models tend to suggest, which enabled recovery of calcification on the GBR within 4 years. The dynamics in annual calcification rates and recovery displayed here should be used to improve model outputs that project how coral calcification will respond to ongoing warming of the tropical oceans.	[Cantin, Neal E.; Lough, Janice M.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Australian Institute of Marine Science	Cantin, NE (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	n.cantin@aims.gov.au	Lough, Janice M/L-1682-2013	Lough, Janice M/0000-0002-3789-1009	Australian Institute of Marine Science; Super Science Fellowship from the Australian Research Council	Australian Institute of Marine Science; Super Science Fellowship from the Australian Research Council(Australian Research Council)	This work was supported by the Australian Institute of Marine Science and a Super Science Fellowship from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bak RPM, 2009, B MAR SCI, V84, P287; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; BARNES DJ, 1989, J EXP MAR BIOL ECOL, V131, P45, DOI 10.1016/0022-0981(89)90010-5; BARNES DJ, 1990, J EXP MAR BIOL ECOL, V137, P141, DOI 10.1016/0022-0981(90)90066-L; Barnes DJ, 2003, J EXP MAR BIOL ECOL, V295, P91, DOI 10.1016/S0022-0981(03)00274-0; BARNES DJ, 1992, J EXP MAR BIOL ECOL, V159, P113, DOI 10.1016/0022-0981(92)90261-8; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berkelmans R, 1999, CORAL REEFS, V18, P55, DOI 10.1007/s003380050154; Berkelmans R, 2004, CORAL REEFS, V23, P74, DOI 10.1007/s00338-003-0353-y; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Budd AF, 2012, ZOOL J LINN SOC-LOND, V166, P465, DOI 10.1111/j.1096-3642.2012.00855.x; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Carilli JE, 2010, GLOBAL CHANGE BIOL, V16, P1247, DOI 10.1111/j.1365-2486.2009.02043.x; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; CHALKER BE, 1990, CORAL REEFS, V9, P11, DOI 10.1007/BF00686717; Cooper TF, 2008, GLOBAL CHANGE BIOL, V14, P529, DOI 10.1111/j.1365-2486.2007.01520.x; Cooper TF, 2012, SCIENCE, V335, P593, DOI 10.1126/science.1214570; D'Olivo JP, 2013, CORAL REEFS, V32, P999, DOI 10.1007/s00338-013-1071-8; De'ath G, 2013, MAR GEOL, DOI [10.1016/j.margeo.2013.09.008, DOI 10.1016/J.MARGE0.2013.09.008]; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; De'ath G, 2010, ECOL APPL, V20, P840, DOI 10.1890/08-2023.1; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Eakin C. M., 2009, V205, P41; GOREAU TJ, 1990, CORAL REEFS, V8, P211, DOI 10.1007/BF00265013; Guest JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033353; Hendy EJ, 2003, HOLOCENE, V13, P187, DOI 10.1191/0959683603hl606rp; Heron SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012210; HUDSON JH, 1981, B MAR SCI, V31, P444; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; KNUTSON DW, 1972, SCIENCE, V177, P270, DOI 10.1126/science.177.4045.270; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; LEDER JJ, 1991, CORAL REEFS, V10, P19, DOI 10.1007/BF00301902; Liu G., 2003, EOS, V84, P137, DOI [10.1029/2003EO150001, DOI 10.1029/2003E0150001]; Lough JM, 2011, CORAL REEFS, V30, P169, DOI 10.1007/s00338-010-0688-0; Lough JM, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001377; Lough JM, 2011, EARTH-SCI REV, V108, P170, DOI 10.1016/j.earscirev.2011.07.001; Lough JM, 2008, MAR ECOL PROG SER, V373, P257, DOI 10.3354/meps07398; Lough JM, 2000, J EXP MAR BIOL ECOL, V245, P225, DOI 10.1016/S0022-0981(99)00168-9; LOUGH JM, 1990, J EXP MAR BIOL ECOL, V135, P35, DOI 10.1016/0022-0981(90)90197-K; LOUGH JM, 1990, J EXP MAR BIOL ECOL, V143, P91, DOI 10.1016/0022-0981(90)90113-Q; Lough JM, 2002, CORAL REEFS, V21, P333, DOI 10.1007/s00338-002-0253-6; Lough JM, 2010, CLIMATE RECORDS CORA; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Macintyre IG, 1974, X RADIOGRAPHIC STUDI; Manzello DP, 2010, CORAL REEFS, V29, P749, DOI 10.1007/s00338-010-0623-4; Marshall AT, 2004, CORAL REEFS, V23, P218, DOI 10.1007/s00338-004-0369-y; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Marubini F, 2008, CORAL REEFS, V27, P491, DOI 10.1007/s00338-008-0375-6; Maynard JA, 2008, MAR BIOL, V155, P173, DOI 10.1007/s00227-008-1015-y; McClanahan TR, 2007, MAR ECOL PROG SER, V337, P1, DOI 10.3354/meps337001; McClanahan TR, 2009, GLOBAL CHANGE BIOL, V15, P1804, DOI 10.1111/j.1365-2486.2008.01799.x; McClanahan TR, 2007, ECOL MONOGR, V77, P503, DOI 10.1890/06-1182.1; McClanahan TR, 2005, MAR ECOL PROG SER, V298, P131, DOI 10.3354/meps298131; McClanahan TR, 2004, MAR POLLUT BULL, V48, P327, DOI 10.1016/j.marpolbul.2003.08.024; Mendes JM, 2002, MAR ECOL PROG SER, V235, P93, DOI 10.3354/meps235093; Michalek-Wagner K, 2001, CORAL REEFS, V19, P231, DOI 10.1007/s003380170003; Mumby PJ, 2001, MAR ECOL PROG SER, V222, P209, DOI 10.3354/meps222209; Oliver TA, 2009, MARINE ECOLOGY PROGR, V222, P209; Osborne K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017516; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Pratchett M. S., 2009, V205, P139; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Riegl B, 2003, CORAL REEFS, V22, P433, DOI 10.1007/s00338-003-0335-0; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Salm RV, 2001, P WORKSH MIT COR BLE; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Sheppard CRC, 2008, MAR ECOL PROG SER, V362, P109, DOI 10.3354/meps07436; Skirving W, 2001, OCEANOGRAPHIC PROCESSES OF CORAL REEFS : PHYSICAL AND BIOLOGICAL LINKS IN THE GREAT BARRIER REEF, P301; Smith LD, 2008, CORAL REEFS, V27, P197, DOI 10.1007/s00338-007-0311-1; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stat M, 2009, CORAL REEFS, V28, P709, DOI 10.1007/s00338-009-0509-5; Sweatman H, 2011, CORAL REEFS, V30, P521, DOI 10.1007/s00338-010-0715-1; Tanzil JTI, 2009, CORAL REEFS, V28, P519, DOI 10.1007/s00338-008-0457-5; Tanzil JT, 2013, GLOBAL CHANGE BIOL, V19, P3011, DOI 10.1111/gcb.12279; Thompson DM, 2009, P ROY SOC B-BIOL SCI, V276, P2893, DOI 10.1098/rspb.2009.0591; Thornhill DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029535; Tudhope AW, 1993, GROWTH CHARACTERISTI; ZAR JH, 1996, BIOSTATISTICAL ANAL	80	90	90	3	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88720	10.1371/journal.pone.0088720	http://dx.doi.org/10.1371/journal.pone.0088720			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586377	gold, Green Published, Green Submitted			2022-12-27	WOS:000331711900042
J	Haug, U; Engel, S; Verheyen, F; Linder, R				Haug, Ulrike; Engel, Susanne; Verheyen, Frank; Linder, Roland			Estimating Colorectal Cancer Treatment Costs: A Pragmatic Approach Exemplified by Health Insurance Data from Germany	PLOS ONE			English	Article							CARE; COLONOSCOPY; DIAGNOSIS; ILLNESS	Background: The cost of colorectal cancer (CRC) treatment is a crucial parameter to inform cost-effectiveness analyses on CRC screening but it is not readily available and therefore often lacking. We aimed to elaborate and exemplify a pragmatic approach to estimate CRC treatment cost based on health insurance data from Germany. Methods: We included two groups of persons who were continuously health-insured between 2005-2010: A) Cases: Persons with a hospital discharge diagnosis of CRC (ICD C18-C20) between 2007-2010 and no such a diagnosis between 2005-2006 (to focus on incident CRC cases); B) Controls: Persons without a diagnosis of CRC during the observation period, matched to CRC cases by age and sex (matching factor: 1: 5). We considered in-patient, out-patient and drug costs and calculated incremental costs as the difference in means between cases and controls. We divided costs into three phases of care (initial, intermediate and end-of-life phase). Results: The initial, the intermediate and the end-of-life phase included 12,792, 5,280, and 3,779 CRC cases, respectively, and 63,960, 26,400, and 18,895 controls. The mean incremental costs -annualized for each phase -were (sic)26,000, (sic)2,300, and (sic)51,700, respectively. The costs of the initial phase of care were higher for rectal than for colon cancer. Annualized stagespecific cost estimates ranged from (sic)15,000 to (sic)21,300 for early stages and from (sic)29,800 to (sic)35,000 for late stages. Conclusion: This pragmatic and feasible approach provided plausible estimates of CRC treatment costs in Germany; being transferable to other settings, it may thus facilitate to weigh up potential savings in treatment costs against the resources required for CRC control programs in various countries.	[Haug, Ulrike] German Canc Res Ctr, Epidemiol Canc Registry Baden Wuerttemberg, Heidelberg, Germany; [Engel, Susanne; Verheyen, Frank; Linder, Roland] WINEG Sci Inst Techniker Krankenkasse TK Benefit, Hamburg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Haug, U (corresponding author), German Canc Res Ctr, Epidemiol Canc Registry Baden Wuerttemberg, Heidelberg, Germany.	u.haug@dkfz.de		Haug, Ulrike/0000-0002-1886-2923				BARNETT V, 1994, OUTLIERS STAT DATA; Benson VS, 2008, INT J CANCER, V122, P1357, DOI 10.1002/ijc.23273; Breckenkamp J, 2012, GESUNDHEITSWESEN, V74, pE52, DOI 10.1055/s-0031-1286274; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Brown ML, 1999, MED CARE, V37, P1249, DOI 10.1097/00005650-199912000-00008; Clerc L, 2008, EUR J HEALTH ECON, V9, P361, DOI 10.1007/s10198-007-0083-0; Delco F, 2005, ALIMENT PHARM THER, V21, P615, DOI 10.1111/j.1365-2036.2005.02362.x; Elmunzer BJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001352; Gutierrez-Ibarluzea I, 2008, INT J TECHNOL ASSESS, V24, P270, DOI 10.1017/S0266462308080367; Hewitson P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001216.pub2; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kanavos P, 2010, EUR J HEALTH ECON, V10, P115, DOI 10.1007/s10198-009-0201-2; Knudsen AB, 2010, JNCI-J NATL CANCER I, V102, P1238, DOI 10.1093/jnci/djq242; Kriza C, 2013, PHARMACOECONOMICS, V31, P577, DOI 10.1007/s40273-013-0055-4; Lansdorp-Vogelaar I, 2009, JNCI-J NATL CANCER I, V101, P1412, DOI 10.1093/jnci/djp319; Larg A, 2011, PHARMACOECONOMICS, V29, P653, DOI 10.2165/11588380-000000000-00000; Neubauer G, 2007, BKK, V06/2007, P265; Sieg A, 2007, Z GASTROENTEROL, V45, P945, DOI 10.1055/s-2007-963435; Tilson L, 2012, EUR J HEALTH ECON, V13, P511, DOI 10.1007/s10198-011-0325-z; Wilschut JA, 2011, GASTROENTEROLOGY, V141, P1648, DOI 10.1053/j.gastro.2011.07.020; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103; Yabroff KR, 2009, MED CARE, V47, pS56, DOI 10.1097/MLR.0b013e3181a4f482	22	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88407	10.1371/journal.pone.0088407	http://dx.doi.org/10.1371/journal.pone.0088407			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586324	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900028
J	Dithmer, M; Fuchs, S; Shi, Y; Schmidt, H; Richert, E; Roider, J; Klettner, A				Dithmer, Michaela; Fuchs, Sabine; Shi, Yang; Schmidt, Harald; Richert, Elisabeth; Roider, Johann; Klettner, Alexa			Fucoidan Reduces Secretion and Expression of Vascular Endothelial Growth Factor in the Retinal Pigment Epithelium and Reduces Angiogenesis In Vitro	PLOS ONE			English	Article							HUMAN PERIPHERAL-BLOOD; MACULAR DEGENERATION; CELLS; PHAGOCYTOSIS; ACTIVATION; MECHANISMS; INGESTION; APOPTOSIS; ANTITUMOR; SURVIVAL	Fucoidan is a polysaccharide isolated from brown algae which is of current interest for anti-tumor therapy. In this study, we investigated the effect of fucoidan on the retinal pigment epithelium (RPE), looking at physiology, vascular endothelial growth factor (VEGF) secretion, and angiogenesis, thus investigating a potential use of fucoidan for the treatment of exudative age-related macular degeneration. For this study, human RPE cell line ARPE-19 and primary porcine RPE cells were used, as well as RPE/choroid perfusion organ cultures. The effect of fucoidan on RPE cells was investigated with methyl thiazolyl tetrazolium - assay, trypan blue exclusion assay, phagocytosis assay and a wound healing assay. VEGF expression was evaluated in immunocytochemistry and Western blot, VEGF secretion was evaluated in ELISA. The effect of fucoidan on angiogenesis was tested in a Matrigel assay using calcein-AM vital staining, evaluated by confocal laser scanning microcopy and quantitative image analysis. Fucoidan displays no toxicity and does not diminish proliferation or phagocytosis, but reduces wound healing in RPE cells. Fucoidan decreases VEGF secretion in RPE/choroid explants and RPE cells. Furthermore, it diminishes VEGF expression in RPE cells even when co-applied with bevacizumab. Furthermore, fucoidan reduces RPE-supernatant- and VEGF-induced angiogenesis of peripheral endothelial cells. In conclusion, fucoidan is a non-toxic agent that reduces VEGF expression and angiogenesis in vitro and may be of interest for further studies as a potential therapy against exudative age-related macular degeneration.	[Dithmer, Michaela; Richert, Elisabeth; Roider, Johann; Klettner, Alexa] Univ Kiel, Dept Ophthalmol, Univ Med Ctr, Kiel, Germany; [Fuchs, Sabine; Shi, Yang] Univ Kiel, Univ Med Ctr, Kiel, Germany; [Schmidt, Harald] MetaPhysiol, Essenheim, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Klettner, A (corresponding author), Univ Kiel, Dept Ophthalmol, Univ Med Ctr, Kiel, Germany.	aklettner@auge.uni-kiel.de	Klettner, Alexa Karina/M-8344-2018	Klettner, Alexa/0000-0002-2709-1059	DFG [KL2425]; Hermann Wacker Fond	DFG(German Research Foundation (DFG)); Hermann Wacker Fond	This study has been partly supported by a DFG research grand (KL2425) and the Hermann Wacker Fond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2013, J FOOD SCI, V78, pT648, DOI 10.1111/j.1750-3841.2012.02966.x; Aisa Y, 2005, AM J HEMATOL, V78, P7, DOI 10.1002/ajh.20182; Araya N, 2011, ANTIVIR THER, V16, P89, DOI 10.3851/IMP1699; Azuma K, 2012, MAR DRUGS, V10, P2337, DOI 10.3390/md10102337; Blaauwgeers HGT, 1999, AM J PATHOL, V155, P421, DOI 10.1016/S0002-9440(10)65138-3; Cai H, 2006, MOL VIS, V12, P1; Campochiaro P A, 1999, Mol Vis, V5, P34; Caramoy A, 2012, BRIT J OPHTHALMOL, V96, P1211, DOI 10.1136/bjophthalmol-2012-301750; Cumashi A, 2007, GLYCOBIOLOGY, V17, P541, DOI 10.1093/glycob/cwm014; Fitton JH, 2011, MAR DRUGS, V9, P1731, DOI 10.3390/md9101731; Fuchs S, 2007, TISSUE ENG, V13, P2577, DOI 10.1089/ten.2007.0022; Fuchs S, 2006, BIOMATERIALS, V27, P5399, DOI 10.1016/j.biomaterials.2006.06.015; Fuchs S, 2009, BIOMATERIALS, V30, P1329, DOI 10.1016/j.biomaterials.2008.11.028; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Ho J, 2011, OPHTHALMOLOGY, V118, P687, DOI 10.1016/j.ophtha.2010.08.010; Hodge W, 2010, CAN J OPHTHALMOL, V45, P223, DOI 10.3129/i10-047; Irhimeh MR, 2007, EXP HEMATOL, V35, P989, DOI 10.1016/j.exphem.2007.02.009; Johnson JD, 2003, J LEUKOCYTE BIOL, V74, P810, DOI 10.1189/jlb.0303092; Kim EJ, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-96; Klettner A, 2008, INVEST OPHTH VIS SCI, V49, P4523, DOI 10.1167/iovs.08-2055; Klettner A, 2013, MOL VIS, V19, P281; Klettner A, 2012, OXID STRESS APPL BAS, P277, DOI 10.1007/978-1-61779-606-7_13; Klettner A, 2011, OPHTHALMIC RES, V46, P88, DOI 10.1159/000323271; Klettner A, 2010, CUTAN OCUL TOXICOL, V29, P122, DOI 10.3109/15569521003745685; Klettner AK, 2009, GRAEF ARCH CLIN EXP, V247, P1601, DOI 10.1007/s00417-009-1136-0; Koyanagi S, 2003, BIOCHEM PHARMACOL, V65, P173, DOI 10.1016/S0006-2952(02)01478-8; Li N, 2005, FOOD CHEM TOXICOL, V43, P421, DOI 10.1016/j.fct.2004.12.001; Liu RM, 2005, ANTICANCER RES, V25, P2129; LOPEZ PF, 1995, ARCH OPHTHALMOL-CHIC, V113, P1437, DOI 10.1001/archopht.1995.01100110097032; Lu Ming, 2006, Ophthalmol Clin North Am, V19, P323; Matou S, 2002, THROMB RES, V106, P213, DOI 10.1016/S0049-3848(02)00136-6; Miller DW, 2003, OPHTHALMOLOGE, V100, P92, DOI 10.1007/s00347-002-0760-4; Miller JW, 2013, OPHTHALMOLOGY, V120, P106, DOI 10.1016/j.ophtha.2012.07.038; Minuth WW, 1999, EXP NEPHROL, V7, P394; Miura Y, 2010, OPHTHAL RES, V43, P122, DOI 10.1159/000252979; Myers SP, 2010, BIOL-TARGETS THER, V4, P33; Narazaki M, 2008, BLOOD, V111, P4126, DOI 10.1182/blood-2007-09-112474; Parmeggiani F, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/546786; Peters S, 2007, AM J OPHTHALMOL, V143, P995, DOI 10.1016/j.ajo.2007.03.007; Rasband W., 2006, IMAGEJ; Riou D, 1996, ANTICANCER RES, V16, P1213; de Souza MCR, 2007, J APPL PHYCOL, V19, P153, DOI 10.1007/s10811-006-9121-z; ROIDER J, 1992, ARCH OPHTHALMOL-CHIC, V110, P1786, DOI 10.1001/archopht.1992.01080240126045; Rosenfeld Philip J, 2006, Ophthalmol Clin North Am, V19, P361; Saint-Geniez M, 2006, INVEST OPHTH VIS SCI, V47, P3135, DOI 10.1167/iovs.05-1229; Schlingemann RO, 2004, GRAEF ARCH CLIN EXP, V242, P91, DOI 10.1007/s00417-003-0828-0; Schrader WF, 2006, OPHTHALMOLOGE, V103, P742, DOI 10.1007/s00347-006-1418-4; Sparrow JR, 2012, MOL ASPECTS MED, V33, P436, DOI 10.1016/j.mam.2012.03.007; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Tissot B, 2003, BBA-PROTEINS PROTEOM, V1651, P5, DOI 10.1016/S1570-9639(03)00230-9; Wiencke AK, 2003, ACTA OPHTHALMOL SCAN, V81, P170, DOI 10.1034/j.1600-0420.2003.00030.x; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598	52	52	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89150	10.1371/journal.pone.0089150	http://dx.doi.org/10.1371/journal.pone.0089150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558482	gold, Green Submitted, Green Published			2022-12-27	WOS:000331706700128
J	Kiene, M; Rethi, B; Jansson, M; Dillon, S; Lee, E; Lantto, R; Wilson, C; Pohlmann, S; Chiodi, F				Kiene, Miriam; Rethi, Bence; Jansson, Marianne; Dillon, Stephanie; Lee, Eric; Lantto, Rebecka; Wilson, Cara; Poehlmann, Stefan; Chiodi, Francesca			Toll-Like Receptor 3 Signalling Up-Regulates Expression of the HIV Co-Receptor G-Protein Coupled Receptor 15 on Human CD4(+) T Cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DOUBLE-STRANDED-RNA; SIMIAN IMMUNODEFICIENCY; ANTIRETROVIRAL THERAPY; GASTROINTESTINAL-TRACT; CLINICAL-SIGNIFICANCE; CELLULAR SUBSETS; DENDRITIC CELLS; EARLY INFECTION; CENTRAL MEMORY	Background: Many HIV-2 and SIV isolates, as well as some HIV-1 strains, can use the orphan 7-transmembrane receptor GPR15 as co-receptor for efficient entry into host cells. GPR15 is expressed on central memory and effector memory CD4(+) T cells in healthy individuals and a subset of these cells is susceptible to HIV-1 and SIV infection. However, it has not been determined whether GPR15 expression is altered in the context of HIV-1 infection. Results: Here, we show that GPR15 expression in CD4(+) T cells is markedly up-regulated in some HIV-1 infected individuals compared to the rest of the infected patients and to healthy controls. Infection of the PM1 T cell line with primary HIV-1 isolates was found to up-regulate GPR15 expression on the infected cells, indicating that viral components can induce GPR15 expression. Up-regulation of GPR15 expression on CD4(+) T cells was induced by activation of Toll-like receptor 3 signalling via TIR-domain-containing adapter-inducing interferon-beta (TRIF) and was more prominent on gut-homing compared to lymph node-homing CD4(+) T cells. Conclusion: These results suggest that infection-induced up-regulation of GPR15 expression could increase susceptibility of CD4(+) T cells to HIV infection and target cell availability in the gut in some infected individuals.	[Kiene, Miriam] Hannover Med Sch, Inst Virol, Hannover, Germany; [Kiene, Miriam; Rethi, Bence; Lantto, Rebecka; Chiodi, Francesca] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Poehlmann, Stefan] German Primate Ctr, Infect Biol Unit, Gottingen, Germany; [Jansson, Marianne] Lund Univ, Dept Lab Med, Lund, Sweden; [Dillon, Stephanie; Lee, Eric; Wilson, Cara] Univ Colorado, Div Infect Dis, Aurora, CO USA	Hannover Medical School; Karolinska Institutet; Deutsches Primatenzentrum (DPZ); Lund University; University of Colorado System; University of Colorado Anschutz Medical Campus	Chiodi, F (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	francesca.chiodi@ki.se	Pöhlmann, Stefan/H-2395-2011; Rethi, Bence/C-5770-2013	Pöhlmann, Stefan/0000-0001-6086-9136; Dillon, Stephanie/0000-0003-0174-3263; Rethi, Bence/0000-0001-8220-5015	International Research Training Group 1273; Swedish Medical Research Council	International Research Training Group 1273; Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	This work is supported by the International Research Training Group 1273 (MK) and by the Swedish Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Bjorndal A, 1997, J VIROL, V71, P7478; Blaak H, 2005, J VIROL, V79, P1686, DOI 10.1128/JVI.79.3.1686-1700.2005; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Chung JJ, 2009, FEBS J, V276, P5547, DOI 10.1111/j.1742-4658.2009.07241.x; Cilliers T, 2005, VIROLOGY, V339, P136, DOI 10.1016/j.virol.2005.05.027; Clayton F, 2001, AM J PATHOL, V159, P1933, DOI 10.1016/S0002-9440(10)63040-4; Dasari P, 2005, CELL IMMUNOL, V236, P140, DOI 10.1016/j.cellimm.2005.08.020; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dillon SM, 2012, J IMMUNOL, V189, P885, DOI 10.4049/jimmunol.1200681; Dillon SM, 2010, J IMMUNOL, V184, P6612, DOI 10.4049/jimmunol.1000041; Dolganiuc A, 2006, WORLD J GASTROENTERO, V12, P1198, DOI 10.3748/wjg.v12.i8.1198; Edinger AL, 1997, P NATL ACAD SCI USA, V94, P4005, DOI 10.1073/pnas.94.8.4005; Elliott STC, 2012, J VIROL, V86, P898, DOI 10.1128/JVI.06415-11; Farzan M, 1997, J EXP MED, V186, P405, DOI 10.1084/jem.186.3.405; Fenyo EM, 2011, J INTERN MED, V270, P520, DOI 10.1111/j.1365-2796.2011.02455.x; Frange P, 2013, CLIN MICROBIOL INFEC, V19, pE252, DOI 10.1111/1469-0691.12127; Funami K, 2007, J IMMUNOL, V179, P6867, DOI 10.4049/jimmunol.179.10.6867; Groot F, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-52; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hammond T, 2010, CELL IMMUNOL, V264, P150, DOI 10.1016/j.cellimm.2010.06.001; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Howe R, 2009, CLIN IMMUNOL, V131, P317, DOI 10.1016/j.clim.2008.12.003; Huang W, 2009, AIDS RES HUM RETROV, V25, P795, DOI 10.1089/aid.2008.0252; Jansson M, 1996, P NATL ACAD SCI USA, V93, P15382, DOI 10.1073/pnas.93.26.15382; Jiang CL, 2011, J VIROL, V85, P10669, DOI 10.1128/JVI.05249-11; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kiene M, 2012, VIROLOGY, V433, P73, DOI 10.1016/j.virol.2012.07.012; Kim SV, 2013, SCIENCE, V340, P1456, DOI 10.1126/science.1237013; Lester RT, 2008, AIDS, V22, P685, DOI 10.1097/QAD.0b013e3282f4de35; Li QS, 2008, J INFECT DIS, V197, P420, DOI 10.1086/525046; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; LUSSO P, 1995, J VIROL, V69, P3712, DOI 10.1128/JVI.69.6.3712-3720.1995; MACKAY CR, 1990, J EXP MED, V171, P801, DOI 10.1084/jem.171.3.801; Mansson A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-36; Marshall-Clarke S, 2007, J BIOL CHEM, V282, P24759, DOI 10.1074/jbc.M700188200; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Morner A, 1999, J VIROL, V73, P2343; Murooka TT, 2012, NATURE, V490, P283, DOI 10.1038/nature11398; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Pohlmann S, 1999, J INFECT DIS, V180, P1494, DOI 10.1086/315097; Pohlmann S, 1999, J GEN VIROL, V80, P1241, DOI 10.1099/0022-1317-80-5-1241; Poveda E, 2012, AIDS REV, V14, P208; Rucker J, 1997, J VIROL, V71, P8999, DOI 10.1128/JVI.71.12.8999-9007.1997; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sanghavi SK, 2005, J IMMUNOL, V175, P5314, DOI 10.4049/jimmunol.175.8.5314; Sarkar SN, 2003, J BIOL CHEM, V278, P4393, DOI 10.1074/jbc.C200655200; Schacker T, 2001, J INFECT DIS, V183, P555, DOI 10.1086/318524; Schuitemaker H, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S5; Sharron M, 2000, BLOOD, V96, P41, DOI 10.1182/blood.V96.1.41.013k53_41_49; Simone Rita, 2009, Open Microbiol J, V3, P1, DOI 10.2174/1874285800903010001; Tilton JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/j.antiviral.2009.07.022; Tomchuck SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039592; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; WILLEY RL, 1988, P NATL ACAD SCI USA, V85, P9580, DOI 10.1073/pnas.85.24.9580; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Xu W, 2008, J IMMUNOL, V181, P276, DOI 10.4049/jimmunol.181.1.276; Yang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049526; Zhang LQ, 1998, J VIROL, V72, P9307, DOI 10.1128/JVI.72.11.9307-9312.1998; Zhang YJ, 2001, AIDS RES HUM RETROV, V17, P217, DOI 10.1089/088922201750063133	65	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88195	10.1371/journal.pone.0088195	http://dx.doi.org/10.1371/journal.pone.0088195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558379	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700025
J	Santruckova, E; Dolezal, V; El-Fakahany, EE; Jakubik, J				Santruckova, Eva; Dolezal, Vladimir; El-Fakahany, Esam E.; Jakubik, Jan			Long-Term Activation upon Brief Exposure to Xanomleline Is Unique to M-1 and M-4 Subtypes of Muscarinic Acetylcholine Receptors	PLOS ONE			English	Article							ANTIPSYCHOTIC-LIKE ACTIVITY; AGONIST XANOMELINE; DIFFERENTIAL REGULATION; PERSISTENT ACTIVATION; BINDING; SELECTIVITY; PROTEIN; IDENTIFICATION	Xanomeline is an agonist endowed with functional preference for M-1/M-4 muscarinic acetylcholine receptors. It also exhibits both reversible and wash-resistant binding to and activation of these receptors. So far the mechanisms of xanomeline selectivity remain unknown. To address this question we employed microfluorometric measurements of intracellular calcium levels and radioligand binding to investigate differences in the short-and long-term effects of xanomeline among muscarinic receptors expressed individually in Chinese hamster ovary cells. 1/One-min exposure of cells to xanomeline markedly increased intracellular calcium at hM(1) and hM(4), and to a lesser extent at hM(2) and hM(3) muscarinic receptors for more than 1 hour. 2/Unlike the classic agonists carbachol, oxotremorine, and pilocarpine 10-min exposure to xanomeline did not cause internalization of any receptor subtype. 3/Wash-resistant xanomeline selectively prevented further increase in intracellular calcium by carbachol at hM(1) and hM(4) receptors. 4/After transient activation xanomeline behaved as a long-term antagonist at hM(5) receptors. 5/The antagonist N-methylscopolamine (NMS) reversibly blocked activation of hM(1) through hM(4) receptors by xanomeline. 6/NMS prevented formation of xanomeline wash-resistant binding and activation at hM(2) and hM(4) receptors and slowed them at hM(1), hM(3) and hM(5) receptors. Our results show commonalities of xanomeline reversible and wash-resistant binding and short-time activation among the five muscarinic receptor subtypes. However long-term receptor activation takes place in full only at hM(1) and hM(4) receptors. Moreover xanomeline displays higher efficacy at hM(1) and hM(4) receptors in primary phasic intracellular calcium release. These findings suggest the existence of particular activation mechanisms specific to these two receptors.	[Dolezal, Vladimir; Jakubik, Jan] Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic; [Santruckova, Eva; El-Fakahany, Esam E.] Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; University of Minnesota System; University of Minnesota Twin Cities	Jakubik, J (corresponding author), Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic.	jakubik@biomed.cas.cz	Jakubik, Jan/B-7461-2012; Dolejsi, Eva/AAM-9473-2020; Dolejsi, Eva/G-1341-2016; Dolezal, Vladimir/A-8732-2008	Jakubik, Jan/0000-0002-1737-1487; Dolejsi, Eva/0000-0002-5845-182X; Dolejsi, Eva/0000-0002-5845-182X; Dolezal, Vladimir/0000-0003-3412-256X	Academy of Sciences of the Czech Republic [AV0Z 50110509, RVO:67985823]; Grant Agency of the Czech Republic [305/09/0681, P304/12/G069]	Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This work was supported by the Academy of Sciences of the Czech Republic project [AV0Z 50110509] and support [RVO:67985823], the Grant Agency of the Czech Republic grants [305/09/0681] and [P304/12/G069]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MB, 2003, NEUROPSYCHOPHARMACOL, V28, P1168, DOI 10.1038/sj.npp.1300151; Bodick NC, 1997, ARCH NEUROL-CHICAGO, V54, P465, DOI 10.1001/archneur.1997.00550160091022; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; Bymaster FP, 2003, NEUROCHEM RES, V28, P437, DOI 10.1023/A:1022844517200; Bymaster FP, 1998, BRAIN RES, V795, P179, DOI 10.1016/S0006-8993(98)00267-4; Bymaster FP, 2002, CNS NEUROL DISORD-DR, V1, P163, DOI 10.2174/1568007024606249; CHRISTIE JE, 1981, BRIT J PSYCHIAT, V138, P46, DOI 10.1192/bjp.138.1.46; Christopoulos A, 1998, MOL PHARMACOL, V53, P1120; Christopoulos A, 1997, EUR J PHARMACOL, V334, pR3, DOI 10.1016/S0014-2999(97)01162-X; Davis Christopher N., 2009, BMC Pharmacology, V9, P14, DOI 10.1186/1471-2210-9-14; Felder CC, 2001, LIFE SCI, V68, P2605, DOI 10.1016/S0024-3205(01)01059-1; Grant MKO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015722; Grant MKO, 2005, J PHARMACOL EXP THER, V315, P313, DOI 10.1124/jpet.105.090134; Gregory KJ, 2010, J BIOL CHEM, V285, P7459, DOI 10.1074/jbc.M109.094011; Jakubik J, 2004, J PHARMACOL EXP THER, V308, P105, DOI 10.1124/jpet.103.058594; Jakubik J, 2002, J PHARMACOL EXP THER, V301, P1033, DOI 10.1124/jpet.301.3.1033; Jakubik J, 2008, PHYSIOL RES, V57, pS39, DOI 10.33549/physiolres.931449; JAKUBIK J, 1995, J PHARMACOL EXP THER, V274, P1077; Jakubik J, 2006, MOL PHARMACOL, V70, P656, DOI 10.1124/mol.106.023762; Jakubik J, 2010, PHARMACEUTICALS, V3, P2838, DOI 10.3390/ph3092838; Koenig JA, 1996, MOL PHARMACOL, V49, P351; Krudewig R, 2000, J NEUROCHEM, V74, P1721, DOI 10.1046/j.1471-4159.2000.0741721.x; Langmead CJ, 2008, PHARMACOL THERAPEUT, V117, P232, DOI 10.1016/j.pharmthera.2007.09.009; Lu ZL, 1999, J BIOL CHEM, V274, P7309, DOI 10.1074/jbc.274.11.7309; Machova E, 2007, J PHARMACOL EXP THER, V322, P316, DOI 10.1124/jpet.107.122093; Milligan G, 1996, TRENDS PHARMACOL SCI, V17, P235, DOI 10.1016/0165-6147(96)10026-2; Mirza NR, 2003, CNS DRUG REV, V9, P159; Noetzel MJ, 2009, PHARMACOLOGY, V83, P301, DOI 10.1159/000214843; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; SHANNON HE, 1994, J PHARMACOL EXP THER, V269, P271; Shannon HE, 2000, SCHIZOPHR RES, V42, P249, DOI 10.1016/S0920-9964(99)00138-3; Shekhar A, 2008, AM J PSYCHIAT, V165, P1033, DOI 10.1176/appi.ajp.2008.06091591; Shockley MS, 1999, EUR J PHARMACOL, V377, P137, DOI 10.1016/S0014-2999(99)00303-9; Stanhope KJ, 2001, J PHARMACOL EXP THER, V299, P782; Wood MD, 1999, BRIT J PHARMACOL, V126, P1620, DOI 10.1038/sj.bjp.0702463	35	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88910	10.1371/journal.pone.0088910	http://dx.doi.org/10.1371/journal.pone.0088910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558448	Green Submitted, Green Published, gold			2022-12-27	WOS:000331706700094
J	Maltha, J; Guiraud, I; Kabore, B; Lompo, P; Ley, B; Bottieau, E; Van Geet, C; Tinto, H; Jacobs, J				Maltha, Jessica; Guiraud, Issa; Kabore, Berenger; Lompo, Palpouguini; Ley, Benedikt; Bottieau, Emmanuel; Van Geet, Chris; Tinto, Halidou; Jacobs, Jan			Frequency of Severe Malaria and Invasive Bacterial Infections among Children Admitted to a Rural Hospital in Burkina Faso	PLOS ONE			English	Article							SEVERE FEBRILE ILLNESS; FALCIPARUM-MALARIA; BACTEREMIA; SALMONELLA; PREVALENCE; DIAGNOSIS	Background: Although severe malaria is an important cause of mortality among children in Burkina Faso, data on community-acquired invasive bacterial infections (IBI, bacteremia and meningitis) are lacking, as well as data on the involved pathogens and their antibiotic resistance rates. Methods: The present study was conducted in a rural hospital and health center in Burkina Faso, in a seasonal malaria transmission area. Hospitalized children (<15 years) presenting with T >= 38.0 degrees C and/or signs of severe illness were enrolled upon admission. Malaria diagnosis and blood culture were performed for all participants, lumbar puncture when clinically indicated. We assessed the frequency of severe malaria (microscopically confirmed, according to World Health Organization definitions) and IBI, and the species distribution and antibiotic resistance of the bacterial pathogens causing IBI. Results: From July 2012 to July 2013, a total of 711 patients were included. Severe malaria was diagnosed in 292 (41.1%) children, including 8 (2.7%) with IBI co-infection. IBI was demonstrated in 67 (9.7%) children (bacteremia, n = 63; meningitis, n = 6), 8 (11.8%) were co-infected with malaria. Non-Typhoid Salmonella spp. (NTS) was the predominant isolate from blood culture (32.8%), followed by Salmonella Typhi (18.8%), Streptococcus pneumoniae (18.8%) and Escherichia coli (12.5%). High antibiotic resistance rates to first line antibiotics were observed, particularly among Gram-negative pathogens. In addition, decreased ciprofloxacin susceptibility and extended-spectrum beta lactamase (ESBL) production was reported for one NTS isolate each. ESBL production was observed in 3/8 E. coli isolates. In-hospital mortality was 8.2% and case-fatality rates for IBI (23.4%) were significantly higher compared to severe malaria (6.8%, p<0.001). Conclusions: Although severe malaria was the main cause of illness, IBI were not uncommon and had higher case-fatality rates. The high frequency, antibiotic resistance rates and mortality rates of community acquired IBI require improvement in hygiene, better diagnostic methods and revision of current treatment guidelines.	[Maltha, Jessica; Ley, Benedikt; Bottieau, Emmanuel; Jacobs, Jan] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Maltha, Jessica; Van Geet, Chris] Katholieke Univ Leuven, Ctr Mol & Vasc Biol, Louvain, Belgium; [Guiraud, Issa; Kabore, Berenger; Lompo, Palpouguini; Tinto, Halidou] IRSS Clin Res Unit Nanoro CRUN, Nanoro, Burkina Faso; [Van Geet, Chris] Katholieke Univ Leuven, Louvain, Belgium	Institute of Tropical Medicine (ITM); KU Leuven; KU Leuven	Maltha, J (corresponding author), Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.	jessicamaltha@gmail.com	Jacobs, Jan/GRX-7316-2022; Issa, GUIRAUD/AGU-8073-2022; Kaboré, Bérenger/J-2773-2017	Kaboré, Bérenger/0000-0002-3719-7033; Tinto, Halidou/0000-0002-0472-3586; Ley, Benedikt/0000-0002-5734-0845	Steunfonds Margeurite-Marie Delacroix; Scientific Research-Flanders (F.W.O.-Vlaanderen, Belgium); Junior Mobility program of KU Leuven; McKinsey Company	Steunfonds Margeurite-Marie Delacroix; Scientific Research-Flanders (F.W.O.-Vlaanderen, Belgium)(FWO); Junior Mobility program of KU Leuven; McKinsey Company	The work of JM was funded by "Steunfonds Margeurite-Marie Delacroix''. For this study, JM received additional grants from the Fund for Scientific Research-Flanders (F.W.O.-Vlaanderen, Belgium), the Junior Mobility program of KU Leuven and McKinsey & Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Heart Association, 2006, PED ADV LIF SUPP; Bahwere P, 2001, Int J Infect Dis, V5, P180, DOI 10.1016/S1201-9712(01)90067-0; Bassat Q, 2009, TROP MED INT HEALTH, V14, P1011, DOI 10.1111/j.1365-3156.2009.02326.x; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Berkley JA, 2009, CLIN INFECT DIS, V49, P336, DOI 10.1086/600299; Bhutta ZA, 2006, BMJ-BRIT MED J, V333, P78, DOI 10.1136/bmj.333.7558.78; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; Breiman RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029119; Brent AJ, 2006, LANCET, V367, P482, DOI 10.1016/S0140-6736(06)68180-4; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; CLSI, 2013, PERFORMANCE STANDARD; Crawley J, 2010, LANCET, V375, P1468, DOI 10.1016/S0140-6736(10)60447-3; Cunnington AJ, 2012, NAT MED, V18, P120, DOI 10.1038/nm.2601; Enwere G, 2006, PEDIATR INFECT DIS J, V25, P700, DOI 10.1097/01.inf.0000226839.30925.a5; European Committee on Antimicrobial Susceptibility Testing, 2013, BREAKP TABL INT MICS; Evans JA, 2004, QJM-INT J MED, V97, P591, DOI 10.1093/qjmed/hch093; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Geiger C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-27; Grimont F, 2007, J MED MICROBIOL, V56, P749, DOI 10.1099/jmm.0.46818-0; Gwer S, 2007, AM J TROP MED HYG, V77, P6, DOI 10.4269/ajtmh.2007.77.6; Hendriksen ICE, 2013, J INFECT DIS, V207, P351, DOI 10.1093/infdis/jis675; Institut National de la Statistique et de la Demographie (INSD) et ICF International, 2012, ENQ DEM SANT IND MUL; Lunguya Octavie, 2012, PLoS Negl Trop Dis, V6, pe1921, DOI 10.1371/journal.pntd.0001921; MABEY DCW, 1987, J INFECT DIS, V155, P1319, DOI 10.1093/infdis/155.6.1319; Mallewa M, 2013, LANCET GLOBAL HLTH, V1; Manyando C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056916; Marks F, 2010, EMERG INFECT DIS, V16, P1796, DOI 10.3201/eid1611.100388; Ministere de la Sante, 2012, PLANT ACT 2013 DISTR; Mtove G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009244; Nadjm B, 2012, T ROY SOC TROP MED H, V106, P688, DOI 10.1016/j.trstmh.2012.08.006; Nielsen MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044063; Ouedraogo Abdoul-Salam, 2011, Sante, V21, P221, DOI 10.1684/san.2011.0273; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Scott JAG, 2011, LANCET, V378, P1316, DOI 10.1016/S0140-6736(11)60888-X; Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d; Sjolund-Karlsson M, 2011, ANTIMICROB AGENTS CH, V55, P3985, DOI 10.1128/AAC.00590-11; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 1991, BAS MAL MICR 1	39	52	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89103	10.1371/journal.pone.0089103	http://dx.doi.org/10.1371/journal.pone.0089103			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551225	Green Submitted, gold, Green Published			2022-12-27	WOS:000331271500097
J	Raknes, G; Hunskaar, S				Raknes, Guttorm; Hunskaar, Steinar			Method Paper - Distance and Travel Time to Casualty Clinics in Norway Based on Crowdsourced Postcode Coordinates: A Comparison with Other Methods	PLOS ONE			English	Article								We describe a method that uses crowdsourced postcode coordinates and Google maps to estimate average distance and travel time for inhabitants of a municipality to a casualty clinic in Norway. The new method was compared with methods based on population centroids, median distance and town hall location, and we used it to examine how distance affects the utilisation of out-of-hours primary care services. At short distances our method showed good correlation with mean travel time and distance. The utilisation of out-of-hours services correlated with postcode based distances similar to previous research. The results show that our method is a reliable and useful tool for estimating average travel distances and travel times.	[Raknes, Guttorm; Hunskaar, Steinar] Uni Res, Natl Ctr Emergency Primary Hlth Care, Uni Hlth, Bergen, Norway; [Hunskaar, Steinar] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway	University of Bergen	Raknes, G (corresponding author), Uni Res, Natl Ctr Emergency Primary Hlth Care, Uni Hlth, Bergen, Norway.	guttorm.raknes@uni.no	Raknes, Guttorm/I-2145-2019	Raknes, Guttorm/0000-0002-3376-6761				[Anonymous], 2013, CREAT COMM ATTR 3 0; Berke EM, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-23; Bolstad E, 2013, NORSKE POSTNUMMER ME; Bolstad E, 2013, DUGNAD PA YR NO; Boulos MNK, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-67; Brabham D.C., 2008, CONVERGENCE-US, V14, P75, DOI DOI 10.1177/1354856507084420; Foskett M, 2008, CONVERT UK POSTCODES; Hansen EH, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-62; Kittur A, 2008, CSCW: 2008 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK, CONFERENCE PROCEEDINGS, P37; Morken T, 2012, 62012 NAT CTR EM PRI, P9; Mutton P, 2010, UK POSTCODES FINDING; Raknes G, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-222	12	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89287	10.1371/journal.pone.0089287	http://dx.doi.org/10.1371/journal.pone.0089287			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551243	Green Published, gold, Green Submitted			2022-12-27	WOS:000331271500108
J	Teo, JDW; MacAry, PA; Tan, KSW				Teo, Joshua D. W.; MacAry, Paul A.; Tan, Kevin S. W.			Pleiotropic Effects of Blastocystis spp. Subtypes 4 and 7 on Ligand-Specific Toll-Like Receptor Signaling and NF-kappa B Activation in a Human Monocyte Cell Line	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; CYSTEINE PROTEASES; GENETIC DIVERSITY; FOOD ALLERGY; INFLAMMATION; HOMINIS; RECOGNITION; EXPRESSION; RESISTANT; INFECTION	Blastocystis spp. is a common enteric stramenopile parasite that colonizes the colon of hosts of a diverse array of species, including humans. It has been shown to compromise intestinal epithelial cell barrier integrity and mediate the production of pro-inflammatory cytokines and chemokines. Mucosal epithelial surfaces, including the intestinal epithelium, are increasingly recognized to perform a vital surveillance role in the context of innate immunity, through the expression of pathogen recognition receptors, such as Toll-like receptors (TLRs). In this study, we use the human TLR reporter monocytic cell line, THP1-Blue, which expresses all human TLRs, to investigate effects of Blastocystis on TLR activation, more specifically the activation of TLR-2, -4 and -5. We have observed that live Blastocystis spp. parasites and whole cell lysate (WCL) alone do not activate TLRs in THP1-Blue. Live ST4-WR1 parasites inhibited LPS-mediated NF-kappa B activation in THP1-Blue. In contrast, ST7-B WCL and ST4-WR1 WCL induced pleiotropic modulation of ligand-specific TLR-2 and TLR-4 activation, with no significant effects on flagellin-mediated TLR-5 activation. Real time-qPCR analysis on SEAP reporter gene confirmed the augmenting effect of ST7-B on LPS-mediated NF-kappa B activation in THP1-Blue. Taken together, this is the first study to characterize interactions between Blastocystis spp. and host TLR activation using an in vitro reporter model.	[Teo, Joshua D. W.; MacAry, Paul A.; Tan, Kevin S. W.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Lab Mol & Cellular Parasitol, Singapore 117548, Singapore; [MacAry, Paul A.] Natl Univ Singapore, Program Immunol, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Tan, KSW (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Lab Mol & Cellular Parasitol, Singapore 117548, Singapore.	mictank@nus.edu.sg			National University of Singapore	National University of Singapore(National University of Singapore)	JDWT acknowledges a generous research scholarship from the National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Abreu MT, 2002, J BIOL CHEM, V277, P20431, DOI 10.1074/jbc.M110333200; Alfellani MA, 2013, PROTIST, V164, P497, DOI 10.1016/j.protis.2013.05.003; Arisue N, 2002, J EUKARYOT MICROBIOL, V49, P42, DOI 10.1111/j.1550-7408.2002.tb00339.x; Bart A, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-389; Bashir MEH, 2004, J IMMUNOL, V172, P6978, DOI 10.4049/jimmunol.172.11.6978; Bobo LD, 2013, INFECT IMMUN, V81, P713, DOI 10.1128/IAI.00186-12; Boorom KF, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-40; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Cario E, 2004, GASTROENTEROLOGY, V127, P224, DOI 10.1053/j.gastro.2004.04.015; Cario E, 2006, ANN NY ACAD SCI, V1072, P332, DOI 10.1196/annals.1326.006; Cekin AH, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-122; Chen LW, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-48; Chen XQ, 1997, LAB ANIM SCI, V47, P91; Cobo ER, 2012, INFECT IMMUN, V80, P143, DOI 10.1128/IAI.05029-11; Fukata M, 2011, INFLAMM BOWEL DIS, V17, P1464, DOI 10.1002/ibd.21527; Hausmann M, 2002, GASTROENTEROLOGY, V122, P1987, DOI 10.1053/gast.2002.33662; HO LC, 1993, PARASITOL RES, V79, P614, DOI 10.1007/BF00932249; HUANG CM, 1990, ANTIMICROB AGENTS CH, V34, P1824, DOI 10.1128/AAC.34.9.1824; Iguchi A, 2009, PARASITOL RES, V105, P135, DOI 10.1007/s00436-009-1373-5; Kida Y, 2008, CELL MICROBIOL, V10, P1491, DOI 10.1111/j.1462-5822.2008.01142.x; Kida Y, 2007, INFECT IMMUN, V75, P164, DOI 10.1128/IAI.01239-06; Long HY, 2001, PARASITOL RES, V87, P1029; Mirza H, 2012, CELL MICROBIOL, V14, P1474, DOI 10.1111/j.1462-5822.2012.01814.x; Mirza H, 2011, INFECT IMMUN, V79, P5019, DOI 10.1128/IAI.05632-11; Moe KT, 1997, PARASITOL RES, V83, P319, DOI 10.1007/s004360050256; Poirier P, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002545; Puthia MK, 2008, EUKARYOT CELL, V7, P435, DOI 10.1128/EC.00371-07; Puthia MK, 2006, INFECT IMMUN, V74, P4114, DOI 10.1128/IAI.00328-06; Puthia MK, 2005, PARASITOL RES, V97, P386, DOI 10.1007/s00436-005-1461-0; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rathinam VAK, 2013, NATURE, V501, P173, DOI 10.1038/nature12556; Renard P, 1997, BIOCHEM PHARMACOL, V53, P149, DOI 10.1016/S0006-2952(96)00645-4; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; Sato M, 2003, J IMMUNOL, V171, P417, DOI 10.4049/jimmunol.171.1.417; Scanlan PD, 2012, TRENDS PARASITOL, V28, P327, DOI 10.1016/j.pt.2012.05.001; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Stenson WF, 2001, INFECT IMMUN, V69, P3382, DOI 10.1128/IAI.69.5.3382-3388.2001; Stensvold CR, 2009, EPIDEMIOL INFECT, V137, P1655, DOI 10.1017/S0950268809002672; Stensvold CR, 2007, TRENDS PARASITOL, V23, P93, DOI 10.1016/j.pt.2007.01.004; Stensvold CR, 2012, INFECT GENET EVOL, V12, P263, DOI 10.1016/j.meegid.2011.11.002; Tan Kevin S W, 2010, Curr Infect Dis Rep, V12, P28, DOI 10.1007/s11908-009-0073-8; Uematsu S, 2010, MICROBIOL IMMUNOL, V54, P645, DOI 10.1111/j.1348-0421.2010.00267.x; Westerholm-Ormio M, 2010, J PEDIATR GASTR NUTR, V50, P367, DOI 10.1097/MPG.0b013e3181cd2636; Yamamoto-Furusho JK, 2010, DIGESTION, V82, P18, DOI 10.1159/000273871	45	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89036	10.1371/journal.pone.0089036	http://dx.doi.org/10.1371/journal.pone.0089036			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551212	gold, Green Published, Green Submitted			2022-12-27	WOS:000331271500093
J	Wang, YX; Xu, L; Li, JJ; Yang, H; Zhang, YQ; Jonas, JB				Wang, Ya Xing; Xu, Liang; Li, Jian Jun; Yang, Hua; Zhang, Ya Qin; Jonas, Jost B.			Snoring and Glaucoma	PLOS ONE			English	Article							SLEEP-APNEA SYNDROME; ISCHEMIC OPTIC NEUROPATHY; BEIJING EYE; HIGH PREVALENCE; POPULATION; PRESSURE; CHINA; ANGLE	Purpose: To examine a potential association between snoring and glaucoma in a population-based setting. Methods: The population-based Beijing Eye Study 2011 included 3468 subjects with an age of 50+ years. The participants underwent a detailed ophthalmic examination. Glaucoma was determined according to the ophthalmoscopic appearance of the optic nerve head. Snoring assessed in an interview was graded into "severe snoring'', "moderate snoring'', and "no snoring''. Results: Data on snoring and glaucoma were available for 3146 subjects. Snoring was reported for 1787 (66.8%) subjects, with moderate snoring reported for 1384 (44.0%) subjects and severe snoring for 403 (12.8%) subjects. In multivariate analysis, prevalence of severe snoring was significantly associated with male gender (P = 0.002; regression coefficient B: 0.36; Odds ratio (OR): 1.44 (95% confidence interval (CI): 1.14, 1.81)), higher body mass index (P<0.001; B: 0.12; OR: 1.13 (95% CI: 1.09, 1.16)), higher systolic blood pressure (P<0.001; B: 0.01; OR: 1.01 (95% CI: 1.005, 1.02)), younger age (P = 0.007; B: -0.018; OR: 0.98 (95% CI: 0.97, 0.995)), and higher cognitive function (P = 0.03; B: 0.04; OR: 1.04 (95% CI: 1.004, 1.08)), however it was not significantly associated with the prevalence of open-angle glaucoma (P = 0.10; B: -0.63; OR: 0.53 (95% CI: 0.25, 1.12)). Prevalence of severe snoring was neither significantly associated with the prevalence of angle-closure glaucoma (P = 0.65), retinal vein occlusions (P = 0.24), neuroretinal rim area (P = 0.19), retinal nerve fiber layer thickness (P = 0.16) nor vertical cup/disc ratio (P = 0.64). Conclusions: Severe snoring was not significantly associated with the prevalence of open-angle glaucoma, angle-closure glaucoma or retinal vein occlusions after adjustment for age, gender, body mass index, systolic blood pressure and cognitive function score. Our population-based study did not reveal that snoring was a risk factor for glaucoma and thus did not provide a reason to assess or to treat snoring in patients with glaucoma.	[Wang, Ya Xing; Xu, Liang; Li, Jian Jun; Yang, Hua; Zhang, Ya Qin; Jonas, Jost B.] Capital Univ Med Sci, Beijing Inst Ophthalmol, Beijing Tongren Hosp, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Fac Clin Med Mannheim, Dept Ophthalmol, Mannheim, Germany	Capital Medical University; Ruprecht Karls University Heidelberg	Xu, L (corresponding author), Capital Univ Med Sci, Beijing Inst Ophthalmol, Beijing Tongren Hosp, Beijing, Peoples R China.	xlbio@163.com; jost.jonas@medma.uni-heidelberg.de	wang, YA XING/K-9671-2016	wang, YA XING/0000-0003-2749-7793	National Natural Science Foundation of China [81770890]; National Key Technology R&D Program of the Ministry of Science and Technology [2012BAH05F05, 2013BAH19F04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program of the Ministry of Science and Technology(National Key Technology R&D Program)	This study was supported by National Natural Science Foundation of China (grant # 81770890); National Key Technology R&D Program of the Ministry of Science and Technology (numbers 2012BAH05F05 and 2013BAH19F04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdal H, 2006, SLEEP MED, V7, P107, DOI 10.1016/j.sleep.2005.08.010; Behbehani R, 2005, AM J OPHTHALMOL, V139, P518, DOI 10.1016/j.ajo.2004.11.004; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Duran J, 2001, AM J RESP CRIT CARE, V163, P685, DOI 10.1164/ajrccm.163.3.2005065; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Geyer O, 2003, AM J OPHTHALMOL, V136, P1093, DOI 10.1016/S0002-9394(03)00709-8; Hayreh S., 1996, OPHTHALMOL CLIN N AM, V9, P407; Karakucuk S, 2008, GRAEF ARCH CLIN EXP, V246, P129, DOI 10.1007/s00417-007-0656-8; Lee AG, 2002, OPHTHALMOLOGY, V109, P482, DOI 10.1016/S0161-6420(01)00987-3; Li YB, 2006, AM J OPHTHALMOL, V142, P788, DOI 10.1016/j.ajo.2006.06.001; Lin CC, 2013, OPHTHALMOLOGY, V120, P1559, DOI 10.1016/j.ophtha.2013.01.006; Lin PW, 2011, GRAEF ARCH CLIN EXP, V249, P585, DOI 10.1007/s00417-010-1544-1; Lin PW, 2011, J GLAUCOMA, V20, P553, DOI 10.1097/IJG.0b013e3181f3eb81; Malhotra A, 2002, LANCET, V360, P237, DOI 10.1016/S0140-6736(02)09464-3; Mojon DS, 1998, OPHTHALMOLOGY, V105, P874, DOI 10.1016/S0161-6420(98)95030-8; Mojon DS, 1999, OPHTHALMOLOGY, V106, P1009, DOI 10.1016/S0161-6420(99)00525-4; Mojon DS, 2002, ARCH OPHTHALMOL-CHIC, V120, P601, DOI 10.1001/archopht.120.5.601; Ohana EB, 2010, EUR ANN OTORHINOLARY, V127, P159, DOI 10.1016/j.anorl.2010.07.003; Onen SH, 2000, ACTA OPHTHALMOL SCAN, V78, P638, DOI 10.1034/j.1600-0420.2000.078006638.x; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; WALSH JT, 1982, THORAX, V37, P845, DOI 10.1136/thx.37.11.845; Wang YX, 2010, AM J OPHTHALMOL, V150, P917, DOI 10.1016/j.ajo.2010.06.037; Xu L, 2008, AM J OPHTHALMOL, V145, P929, DOI 10.1016/j.ajo.2008.01.004; Yip JLY, 2011, INVEST OPHTH VIS SCI, V52, P8186, DOI 10.1167/iovs.11-8267	25	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88949	10.1371/journal.pone.0088949	http://dx.doi.org/10.1371/journal.pone.0088949			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551196	Green Published, gold, Green Submitted			2022-12-27	WOS:000331266000085
J	Xu, F; Ware, RS; Tse, LA; Wang, YF; Wang, ZY; Hong, X; Chan, EYY; Dunstan, DW; Owen, N				Xu, Fei; Ware, Robert S.; Tse, Lap Ah; Wang, YouFa; Wang, ZhiYong; Hong, Xin; Chan, Emily Ying Yang; Dunstan, David W.; Owen, Neville			Joint Associations of Physical Activity and Hypertension with the Development of Type 2 Diabetes among Urban Men and Women in Mainland China	PLOS ONE			English	Article							PREVALENCE; RISK; RELIABILITY; PRESSURE; VALIDITY	Background: Physical activity (PA) and hypertension (HTN) are important influences on the development of type 2 diabetes (T2D). However, the joint impact of PA and HTN on T2D development is unknown. Methods: Two community-based prospective cohort studies, with the same protocols, instruments and questionnaires, were conducted among adults in urban areas of Nanjing, China, during 2004-2007 and 2007-2010. T2D was defined using World Health Organization criteria based on physicians' diagnosis and fasting blood glucose concentration. PA level (sufficient/insufficient) and blood pressure status (hypertensive/normotensive) were assessed at baseline and the third year of follow-up. We pooled and analyzed data from these two studies. Results: Among 4550 participants aged 35 years or older, the three-year cumulative incidence of T2D was 5.1%. After adjusting for potential confounders, participants with sufficient PA were less likely to develop T2D than those with insufficient PA (OR = 0.43, 95%CI = 0.27, 0.68) and those who were normotensive were less likely to develop T2D than those who were hypertensive (OR = 0.39, 95%CI = 0.29, 0.51). Compared to participants with insufficient PA and who were hypertensive, those with sufficient PA and hypertension were at lower risk of developing T2D (OR = 0.36, 95%CI = 0.19, 0.69), as were those with insufficient PA who were normotensive (OR = 0.37, 95%CI = 0.28, 0.50) and those with sufficient PA who were normotensive (OR = 0.19, 95%CI = 0.10, 0.37). Conclusions: Insufficient PA was found to be associated with the development of T2D among adults with and without hypertension. These findings support a role for promoting higher physical activity levels to lower T2D risk in both hypertensive and non-hypertensive individuals.	[Xu, Fei; Wang, ZhiYong; Hong, Xin] Nanjing Municipal Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Ware, Robert S.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Tse, Lap Ah; Chan, Emily Ying Yang] Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Wang, YouFa] Univ Baltimore, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21201 USA; [Dunstan, David W.; Owen, Neville] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	University of Queensland; Chinese University of Hong Kong; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University System of Maryland; University of Baltimore; Baker Heart and Diabetes Institute	Xu, F (corresponding author), Nanjing Municipal Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China.	f.xufei@gmail.com	Dunstan, David Wayne/E-8473-2010; Owen, Neville/K-5986-2012; Ware, Robert S./B-2024-2014; Chan, Emily Ying Yang/H-6849-2017	Dunstan, David Wayne/0000-0003-2629-9568; Owen, Neville/0000-0003-2784-4820; Ware, Robert S./0000-0002-6129-6736; Tse, Lap Ah/0000-0003-0355-6218; Chan, Emily Ying Yang/0000-0002-8854-5093	Young Medical Experts Project of Nanjing Medical Science and Technique Development Foundation, China [QRX11038]; Nanjing Medical Science and Technique Development Foundation, China [2003-ZKK0310, 2007-ZKX07026]; Jiangsu Provincial Science and Technology Foundation, China [2003-BS200231]; Jiangsu Provincial Government Scholarship for Overseas Studies, China [JS-2010-109]; National Health and Medical Research Council of Australia Program Grant (NHMRC) [569940]; Senior Principal Research Fellowship (NHMRC) [1003960]; Victorian Government's Operational Infrastructure Support Program; Australian Research Council Future Fellowship [FT100100918]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD070725] Funding Source: NIH RePORTER	Young Medical Experts Project of Nanjing Medical Science and Technique Development Foundation, China; Nanjing Medical Science and Technique Development Foundation, China; Jiangsu Provincial Science and Technology Foundation, China; Jiangsu Provincial Government Scholarship for Overseas Studies, China; National Health and Medical Research Council of Australia Program Grant (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Senior Principal Research Fellowship (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; Australian Research Council Future Fellowship(Australian Research Council); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by The Young Medical Experts Project of Nanjing Medical Science and Technique Development Foundation (QRX11038), Nanjing Medical Science and Technique Development Foundation (2003-ZKK0310 and 2007-ZKX07026) and Jiangsu Provincial Science and Technology Foundation (2003-BS200231) and Jiangsu Provincial Government Scholarship for Overseas Studies, China (JS-2010-109), China. NO was supported by National Health and Medical Research Council of Australia Program Grant (NHMRC # 569940), a Senior Principal Research Fellowship (NHMRC # 1003960) and by the Victorian Government's Operational Infrastructure Support Program. DWD was supported by an Australian Research Council Future Fellowship (FT100100918) and by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson JL, 2002, HYPERTENSION, V39, P197, DOI 10.1161/hy0202.104270; [Anonymous], 2011, CHIN J HYPERTENS; Cooperative Meta-analysis Group of China Obesity Task Force, 2002, CHIN J EPIDEMIOL, V23, P5; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Deng HB, 2008, MED SCI SPORT EXER, V40, P303, DOI 10.1249/mss.0b013e31815b0db5; Fernandez-Real JM, 2001, J CLIN ENDOCR METAB, V86, P1154, DOI 10.1210/jc.86.3.1154; Gavin JR, 1997, DIABETES CARE, V20, P1183; Geiss Linda S., 2012, Morbidity and Mortality Weekly Report, V61, P918; Ginter E, 2013, ADV EXP MED BIOL, V771, P35; Gress TW, 2000, NEW ENGL J MED, V342, P905, DOI 10.1056/NEJM200003303421301; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Lonati C, 2008, J HYPERTENS, V26, P1801, DOI 10.1097/HJH.0b013e328307a07f; Ong KL, 2008, ANN EPIDEMIOL, V18, P222, DOI 10.1016/j.annepidem.2007.10.007; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Sigal RJ, 2004, DIABETES CARE, V27, P2518, DOI 10.2337/diacare.27.10.2518; SocietyC, 2010, CLIN J DIABETES, V22, P865; Sowers JR, 2004, AM J PHYSIOL-HEART C, V286, pH1597, DOI 10.1152/ajpheart.00026.2004; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; Weycker D, 2009, J DIABETES COMPLICAT, V23, P330, DOI 10.1016/j.jdiacomp.2008.04.002; Writing group of 2004 Chinese guidelines for the management of hypertension, 2004, CHINESE J HYPERTENSI, V12, P483; Xu F, ASIA PAC J IN PRESS; Xu LZ, 2004, PUBLIC HEALTH NUTR, V7, P91, DOI 10.1079/PHN2003510; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yang ZJ, 2012, EUR HEART J, V33, P213, DOI 10.1093/eurheartj/ehr205	24	11	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88719	10.1371/journal.pone.0088719	http://dx.doi.org/10.1371/journal.pone.0088719			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551143	Green Published, gold			2022-12-27	WOS:000331266000058
J	Schlatterer, JC; Martin, JS; Laederach, A; Brenowitz, M				Schlatterer, Joerg C.; Martin, Joshua S.; Laederach, Alain; Brenowitz, Michael			Mapping the Kinetic Barriers of a Large RNA Molecule's Folding Landscape	PLOS ONE			English	Article							GROUP-I RIBOZYME; HYDROGEN-BONDS; TETRAHYMENA RIBOZYME; PATHWAYS; ENERGETICS; STABILITY; FORM; PROTEINS; REVEAL	The folding of linear polymers into discrete three-dimensional structures is often required for biological function. The formation of long-lived intermediates is a hallmark of the folding of large RNA molecules due to the ruggedness of their energy landscapes. The precise thermodynamic nature of the barriers (whether enthalpic or entropic) that leads to intermediate formation is still poorly characterized in large structured RNA molecules. A classic approach to analyzing kinetic barriers are temperature dependent studies analyzed with Eyring's transition state theory. We applied Eyring's theory to time-resolved hydroxyl radical (center dot OH) footprinting kinetics progress curves collected at eight temperature from 21.5 degrees C to 51 degrees C to characterize the thermodynamic nature of folding intermediate formation for the Mg2+-mediated folding of the Tetrahymena thermophila group I ribozyme. A common kinetic model configuration describes this RNA folding reaction over the entire temperature range studied consisting of primary (fast) transitions to misfolded intermediates followed by much slower secondary transitions, consistent with previous studies. Eyring analysis reveals that the primary transitions are moderate in magnitude and primarily enthalpic in nature. In contrast, the secondary transitions are daunting in magnitude and entropic in nature. The entropic character of the secondary transitions is consistent with structural rearrangement of the intermediate species to the final folded form. This segregation of kinetic control reveals distinctly different molecular mechanisms during the two stages of RNA folding and documents the importance of entropic barriers to defining rugged RNA folding landscapes.	[Schlatterer, Joerg C.; Brenowitz, Michael] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA; [Martin, Joshua S.] Natl Evolutionary Synth Ctr, Durham, NC USA; [Martin, Joshua S.; Laederach, Alain] Univ N Carolina, Dept Biol, Chapel Hill, NC USA	Yeshiva University; Albert Einstein College of Medicine; The National Evolutionary Synthesis Center; University of North Carolina; University of North Carolina Chapel Hill	Brenowitz, M (corresponding author), Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA.	michael.brenowitz@einstein.yu.edu		Schlatterer, Joerg/0000-0002-2637-978X; Laederach, Alain/0000-0002-5088-9907	National Institutes of Health [1RO1-GM085130, R01-HL111527, R01- GM101237]; National Evolutionary Synthesis Center by National Science Foundation [EF-0905606]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085130, R01GM101237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Evolutionary Synthesis Center by National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The National Institutes of Health through grants 1RO1-GM085130, R01-HL111527 and R01- GM101237 supported this study. JSM was partially supported through the National Evolutionary Synthesis Center by National Science Foundation grant #EF-0905606. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrhenius S., 1889, Z PHYS CHEM, V4U, P226, DOI [10.1515/zpch-1889-0416, DOI 10.1515/ZPCH-1889-0416]; Bachu R, 2011, JOVE-J VIS EXP, DOI 10.3791/3244; BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; BRENOWITZ M, 1986, P NATL ACAD SCI USA, V83, P8462, DOI 10.1073/pnas.83.22.8462; Eyring H, 1935, CHEM REV, V17, P65, DOI 10.1021/cr60056a006; Fleming PJ, 2005, PROTEIN SCI, V14, P1911, DOI 10.1110/ps.051454805; FREIER SM, 1986, BIOCHEMISTRY-US, V25, P3214, DOI 10.1021/bi00359a020; Guo F, 2004, MOL CELL, V16, P351, DOI 10.1016/S1097-2765(04)00592-1; Hougland JL, 2004, J AM CHEM SOC, V126, P13578, DOI 10.1021/ja0469129; IKEMURA T, 1989, METHOD ENZYMOL, V180, P14; Klostermeier D, 2002, BIOCHEMISTRY-US, V41, P14095, DOI 10.1021/bi025551b; Kwok LW, 2006, J MOL BIOL, V355, P282, DOI 10.1016/j.jmb.2005.10.070; Laederach A, 2007, P NATL ACAD SCI USA, V104, P7045, DOI 10.1073/pnas.0608765104; Laederach A, 2006, J MOL BIOL, V358, P1179, DOI 10.1016/j.jmb.2006.02.075; Martin JS, 2009, ALGORITHMS, V2, P200, DOI 10.3390/a2010200; Mitra S, 2011, RNA, V17, P1589, DOI 10.1261/rna.2694811; OLIVEBERG M, 1995, P NATL ACAD SCI USA, V92, P8926, DOI 10.1073/pnas.92.19.8926; Rook MS, 1998, J MOL BIOL, V281, P609, DOI 10.1006/jmbi.1998.1960; Russell R, 2001, J MOL BIOL, V308, P839, DOI 10.1006/jmbi.2001.4751; Russell R, 2006, J MOL BIOL, V363, P531, DOI 10.1016/j.jmb.2006.08.024; Schlatterer JC, 2008, J MOL BIOL, V379, P859, DOI 10.1016/j.jmb.2008.04.013; Sclavi B, 1998, SCIENCE, V279, P1940, DOI 10.1126/science.279.5358.1940; Shcherbakova I, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl055; Shcherbakova I, 2008, CURR OPIN CHEM BIOL, V12, P655, DOI 10.1016/j.cbpa.2008.09.017; Shi XS, 2012, J AM CHEM SOC, V134, P1910, DOI 10.1021/ja2083575; Silverman SK, 2000, BIOCHEMISTRY-US, V39, P12465, DOI 10.1021/bi000828y; Silverman SK, 1999, BIOCHEMISTRY-US, V38, P8691, DOI 10.1021/bi9906118; Suresh SJ, 2000, J CHEM PHYS, V113, P9727, DOI 10.1063/1.1320822; Thirumalai D, 2000, RNA, V6, P790, DOI 10.1017/S1355838200000522; Thirumalai D, 2001, ANNU REV PHYS CHEM, V52, P751, DOI 10.1146/annurev.physchem.52.1.751; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Tinoco I., 1995, PHYS CHEM PRINCIPLES; Treiber DK, 1998, SCIENCE, V279, P1943, DOI 10.1126/science.279.5358.1943; Treiber DK, 2001, J MOL BIOL, V305, P11, DOI 10.1006/jmbi.2000.4253; TURNER DH, 1987, J AM CHEM SOC, V109, P3783, DOI 10.1021/ja00246a047; ZAUG AJ, 1988, BIOCHEMISTRY-US, V27, P8924, DOI 10.1021/bi00425a008; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	37	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e85041	10.1371/journal.pone.0085041	http://dx.doi.org/10.1371/journal.pone.0085041			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586236	Green Submitted, Green Published, gold			2022-12-27	WOS:000332385900002
J	Canas-Duarte, SJ; Restrepo, S; Pedraza, JM				Canas-Duarte, Silvia J.; Restrepo, Silvia; Pedraza, Juan Manuel			Novel Protocol for Persister Cells Isolation	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; BACTERIAL PERSISTENCE; AFFECTS FREQUENCY; HIPA; HETEROGENEITY; INHIBITION; RESISTANCE; MECHANISM; GENE	Bacterial persistence, where a fraction of a population presents a transient resistance to bactericidal substances, has great medical importance due to its relation with the appearance of antibiotic resistances and untreatable bacterial chronic infections. The mechanisms behind this phenomenon remain largely unknown in spite of recent advances, in great part because of the difficulty in isolating the very small fraction of the population that is in this state at any given time. Current protocols for persister isolation have resulted in possible biases because of the induction of this state by the protocol itself. Here we present a novel protocol that allows rapid isolation of persister cells both from exponential and stationary phase. Moreover, it is capable of differentiating between type I and type II persister cells, which should allow the field to move beyond its current state of studying only one type. While this protocol prompts a revision of many of the current results, it should greatly facilitate further advances in the field.	[Canas-Duarte, Silvia J.; Restrepo, Silvia] Univ Los Andes, Dept Biol Sci, Bogota, Colombia; [Pedraza, Juan Manuel] Univ Los Andes, Dept Phys, Bogota, Colombia	Universidad de los Andes (Colombia); Universidad de los Andes (Colombia)	Pedraza, JM (corresponding author), Univ Los Andes, Dept Phys, Bogota, Colombia.	jmpedraza@uniandes.edu.co		Canas-Duarte, Silvia J/0000-0001-5705-0023; Restrepo, Silvia/0000-0001-9016-1040; Pedraza, Juan/0000-0002-1802-3337	University of the Andes	University of the Andes	Funded through a "new assistant professor grant'' from the University of the Andes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bigger JW, 1944, LANCET, V2, P497; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Dorr T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000760; Fux CA, 2004, J BACTERIOL, V186, P4486, DOI 10.1128/JB.186.14.4486-4491.2004; Gefen O, 2009, FEMS MICROBIOL REV, V33, P704, DOI 10.1111/j.1574-6976.2008.00156.x; Gradelski E, 2002, J ANTIMICROB CHEMOTH, V49, P185, DOI 10.1093/jac/49.1.185; Herbert D, 1996, ANTIMICROB AGENTS CH, V40, P2296, DOI 10.1128/AAC.40.10.2296; Hong SH, 2012, MICROB BIOTECHNOL, V5, P509, DOI 10.1111/j.1751-7915.2011.00327.x; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Keren I, 2011, MBIO, V2, DOI 10.1128/mBio.00100-11; Kint CI, 2012, TRENDS MICROBIOL, V20, P577, DOI 10.1016/j.tim.2012.08.009; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Korch SB, 2006, J BACTERIOL, V188, P3826, DOI 10.1128/JB.01740-05; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; MAISONNEUVE E, 2011, PROC, DOI DOI 10.1073/PNAS.1100186108; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Michel JB, 2008, P NATL ACAD SCI USA, V105, P14918, DOI 10.1073/pnas.0800944105; MOYED HS, 1986, J BACTERIOL, V166, P399, DOI 10.1128/jb.166.2.399-403.1986; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001; WOLFSON JS, 1990, ANTIMICROB AGENTS CH, V34, P1938, DOI 10.1128/AAC.34.10.1938	26	34	37	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e88660	10.1371/journal.pone.0088660	http://dx.doi.org/10.1371/journal.pone.0088660			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586365	Green Submitted, Green Published, gold			2022-12-27	WOS:000331717900023
J	Tanaka, N; Delemotte, L; Klein, ML; Komaromy, AM; Tanaka, JC				Tanaka, Naoto; Delemotte, Lucie; Klein, Michael L.; Komaromy, Andras M.; Tanaka, Jacqueline C.			A Cyclic Nucleotide-Gated Channel Mutation Associated with Canine Daylight Blindness Provides Insight into a Role for the S2 Segment Tri-Asp motif in Channel Biogenesis	PLOS ONE			English	Article							SHAKER K+ CHANNEL; VOLTAGE-SENSOR DOMAIN; CONE CNG CHANNEL; ION CHANNELS; ELECTROSTATIC INTERACTIONS; MOLECULAR-DYNAMICS; CHARGED RESIDUES; TRANSMEMBRANE SEGMENTS; SUBUNIT STOICHIOMETRY; TOTAL COLOURBLINDNESS	Cone cyclic nucleotide-gated channels are tetramers formed by CNGA3 and CNGB3 subunits; CNGA3 subunits function as homotetrameric channels but CNGB3 exhibits channel function only when co-expressed with CNGA3. An aspartatic acid (Asp) to asparagine (Asn) missense mutation at position 262 in the canine CNGB3 (D262N) subunit results in loss of cone function (daylight blindness), suggesting an important role for this aspartic acid residue in channel biogenesis and/or function. Asp 262 is located in a conserved region of the second transmembrane segment containing three Asp residues designated the Tri-Asp motif. This motif is conserved in all CNG channels. Here we examine mutations in canine CNGA3 homomeric channels using a combination of experimental and computational approaches. Mutations of these conserved Asp residues result in the absence of nucleotide-activated currents in heterologous expression. A fluorescent tag on CNGA3 shows mislocalization of mutant channels. Co-expressing CNGB3 Tri-Asp mutants with wild type CNGA3 results in some functional channels, however, their electrophysiological characterization matches the properties of homomeric CNGA3 channels. This failure to record heteromeric currents suggests that Asp/Asn mutations affect heteromeric subunit assembly. A homology model of S1-S6 of the CNGA3 channel was generated and relaxed in a membrane using molecular dynamics simulations. The model predicts that the Tri-Asp motif is involved in non-specific salt bridge pairings with positive residues of S3/S4. We propose that the D262N mutation in dogs with CNGB3-day blindness results in the loss of these inter-helical interactions altering the electrostatic equilibrium within in the S1-S4 bundle. Because residues analogous to Tri-Asp in the voltage-gated Shaker potassium channel family were implicated in monomer folding, we hypothesize that destabilizing these electrostatic interactions impairs the monomer folding state in D262N mutant CNG channels during biogenesis.	[Tanaka, Naoto; Tanaka, Jacqueline C.] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA; [Delemotte, Lucie; Klein, Michael L.] Temple Univ, Inst Computat & Mol Sci, Philadelphia, PA 19122 USA; [Komaromy, Andras M.] Michigan State Univ, Coll Vet Med, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA; [Komaromy, Andras M.] Univ Penn, Sch Vet Med, Dept Clin Studies, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Michigan State University; University of Pennsylvania	Komaromy, AM (corresponding author), Michigan State Univ, Coll Vet Med, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA.	komaromy@cvm.msu.edu; jtanaka@temple.edu		Tanaka, Naoto/0000-0001-7312-0239; Delemotte, Lucie/0000-0002-0828-3899	National Institutes of Health-National Eye Institute [EY-019304, EY-06855]; National Science Foundation [CNS-09-58854]; European Union [PIOF-GA-2012-329534]; NATIONAL EYE INSTITUTE [R01EY006855] Funding Source: NIH RePORTER	National Institutes of Health-National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Science Foundation(National Science Foundation (NSF)); European Union(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health-National Eye Institute EY-019304 and EY-06855, and by the National Science Foundation through major research instrumentation grant number CNS-09-58854. LD receives funding from the European Union Framework Program (PIOF-GA-2012-329534) "Voltsens.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707; Behnen P, 2010, BIOL CHEM, V391, P631, DOI 10.1515/BC.2010.063; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeCaen PG, 2009, P NATL ACAD SCI USA, V106, P22498, DOI 10.1073/pnas.0912307106; Ding XQ, 2010, ADV EXP MED BIOL, V664, P245, DOI 10.1007/978-1-4419-1399-9_28; Fox DA, 1999, ANN NY ACAD SCI, V893, P282, DOI 10.1111/j.1749-6632.1999.tb07837.x; FURMAN RE, 1989, BIOCHEMISTRY-US, V28, P2785, DOI 10.1021/bi00433a007; Garcia MM, 2010, AM J VET RES, V71, P97, DOI 10.2460/ajvr.71.1.97; Gosselin-Badaroudine P, 2012, P NATL ACAD SCI USA, V109, P19250, DOI 10.1073/pnas.1217990109; Grunwald ME, 1998, J BIOL CHEM, V273, P9148, DOI 10.1074/jbc.273.15.9148; HAYNES L, 1985, NATURE, V317, P61, DOI 10.1038/317061a0; HAYNES LW, 1995, J GEN PHYSIOL, V106, P507, DOI 10.1085/jgp.106.3.507; Izaguirre JA, 1999, J CHEM PHYS, V110, P9853, DOI 10.1063/1.478995; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Koeppen K, 2008, EUR J NEUROSCI, V27, P2391, DOI 10.1111/j.1460-9568.2008.06195.x; Koeppen K, 2010, HUM MUTAT, V31, P830, DOI 10.1002/humu.21283; Kohl S, 1998, NAT GENET, V19, P257, DOI 10.1038/935; Komaromy AM, 2013, MOL THER, V21, P1131, DOI 10.1038/mt.2013.50; Komaromy AM, 2010, HUM MOL GENET, V19, P2581, DOI 10.1093/hmg/ddq136; KORENBROT JI, 1995, CELL CALCIUM, V18, P285, DOI 10.1016/0143-4160(95)90025-X; Korenbrot JI, 2012, PROG RETIN EYE RES, V31, P442, DOI 10.1016/j.preteyeres.2012.05.002; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEWIS CA, 1979, J PHYSIOL-LONDON, V286, P417, DOI 10.1113/jphysiol.1979.sp012629; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Matveev AV, 2010, BIOCHEMISTRY-US, V49, P1628, DOI 10.1021/bi901960u; Okada A, 2004, INVEST OPHTH VIS SCI, V45, P2324, DOI 10.1167/iovs.03-1094; Paillart C, 2006, VISUAL NEUROSCI, V23, P99, DOI 10.1017/S0952523806231092; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; Patel KA, 2005, INVEST OPHTH VIS SCI, V46, P2282, DOI 10.1167/iovs.05-0179; Peng CH, 2004, NEURON, V42, P401, DOI 10.1016/S0896-6273(04)00225-9; Peng CH, 2003, J BIOL CHEM, V278, P34533, DOI 10.1074/jbc.M305102200; Peng CH, 2003, J BIOL CHEM, V278, P24617, DOI 10.1074/jbc.M301699200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PLANELLSCASES R, 1995, P NATL ACAD SCI USA, V92, P9422, DOI 10.1073/pnas.92.20.9422; Pless SA, 2011, NAT CHEM BIOL, V7, P617, DOI [10.1038/nchembio.622, 10.1038/NCHEMBIO.622]; Reuter P, 2008, HUM MUTAT, V29, P1228, DOI 10.1002/humu.20790; Saliba RS, 2002, J CELL SCI, V115, P2907; Sato Y, 2003, J BIOL CHEM, V278, P13227, DOI 10.1074/jbc.M300431200; Sato Y, 2002, P NATL ACAD SCI USA, V99, P60, DOI 10.1073/pnas.012399799; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Shuart NG, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1466; Sidjanin DJ, 2002, HUM MOL GENET, V11, P1823, DOI 10.1093/hmg/11.16.1823; Silverman WR, 2003, P NATL ACAD SCI USA, V100, P2935, DOI 10.1073/pnas.0636603100; Sundin OH, 2000, NAT GENET, V25, P289, DOI 10.1038/77162; Tanaka N, 2011, BIOPHYS J, V100, P104; Thiadens AAHJ, 2009, OPHTHALMOLOGY, V116, P1984, DOI 10.1016/j.ophtha.2009.03.053; Trudeau MC, 2003, J BIOL CHEM, V278, P18705, DOI 10.1074/jbc.R300001200; Trudeau MC, 2002, P NATL ACAD SCI USA, V99, P8424, DOI 10.1073/pnas.122015999; Trudeau MC, 2002, NEURON, V34, P197, DOI 10.1016/S0896-6273(02)00647-5; Tu LW, 2010, J MOL BIOL, V396, P1346, DOI 10.1016/j.jmb.2009.12.059; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Weitz D, 2002, NEURON, V36, P881, DOI 10.1016/S0896-6273(02)01098-X; Wells GB, 1997, BIOPHYS J, V72, P127, DOI 10.1016/S0006-3495(97)78652-1; Wu D, 2010, J GEN PHYSIOL, V135, P595, DOI 10.1085/jgp.201010408; YAU KW, 1987, NEUROSCI RES, pS45, DOI 10.1016/0921-8696(87)90006-5; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; Zhang LY, 2007, P NATL ACAD SCI USA, V104, P8263, DOI 10.1073/pnas.0611007104; Zhang M, 2005, J MEMBRANE BIOL, V207, P169, DOI 10.1007/s00232-005-0812-1; Zheng J, 2004, NEURON, V42, P411, DOI 10.1016/S0896-6273(04)00253-3; Zheng J, 2002, NEURON, V36, P891, DOI 10.1016/S0896-6273(02)01099-1; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201; Zhong HN, 2003, P NATL ACAD SCI USA, V100, P5509, DOI 10.1073/pnas.0931279100; Zong XG, 1998, EMBO J, V17, P353, DOI 10.1093/emboj/17.2.353	67	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e88768	10.1371/journal.pone.0088768	http://dx.doi.org/10.1371/journal.pone.0088768			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586388	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900027
J	Lu, WP; Lu, MS; Li, ZH; Zhang, CX				Lu, Wei-Ping; Lu, Min-Shan; Li, Zong-Hua; Zhang, Cai-Xia			Effects of Multimicronutrient Supplementation during Pregnancy on Postnatal Growth of Children under 5 Years of Age: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							MULTIPLE MICRONUTRIENT SUPPLEMENTATION; VITAMIN-A SUPPLEMENTATION; ZINC SUPPLEMENTATION; DOUBLE-BLIND; FOLLOW-UP; CALCIUM SUPPLEMENTATION; IRON SUPPLEMENTATION; MENTAL-DEVELOPMENT; COST-EFFECTIVENESS; BLOOD-PRESSURE	Background: The beneficial effect of antenatal multiple micronutrients supplementation on infant birth outcomes has been proposed by previous meta-analyses. However, their benefits on postnatal health of children have not been summarized. A meta-analysis of randomized controlled trials was conducted to evaluate the effect of maternal multimicronutrient supplementation on postnatal growth of children under 5 years of age. Methods: We searched both published and ongoing trials through the PubMed, EMBASE, CENTRAL (OVID platform), Web of Science, BIOSIS Previews, Chinese Science Citation Database, Scopus, ProQuest, ClinicalTrials. gov, Chinese Biomedical Database, and WANFANG database for randomized controlled trials. Reference lists of included studies and relevant reviews were also reviewed for eligible studies. Standard mean difference (SMD) was employed as the index for continuous variables by using fixed effects models. Trend analysis by visual inspection was applied to evaluate the change of mean difference of weight and height between the groups over time. Results: Nine trials (12 titles) from nine different countries were retrieved for analysis. Pooled results showed that antenatal multimicronutrient supplementation increased child head circumference (SMD = 0.08, 95% CI: 0.00-0.15) compared with supplementation with two micronutrient or less. No evidence was found for the benefits of antenatal multimicronutrient supplementation on weight (P = 0.11), height (P = 0.66), weight-for-age z scores (WAZ) (P = 0.34), height-for-age z scores (HAZ) (P = 0.81) and weight-for-height z scores (WHZ) (P = 0.22). A positive effect was found on chest circumference based on two included studies. Conclusions: Antenatal multimicronutrient supplementation has a significant positive effect on head circumference of children under 5 years. No impact of the supplementation was found on weight, height, WAZ, HAZ and WHZ.	[Lu, Wei-Ping; Lu, Min-Shan; Li, Zong-Hua; Zhang, Cai-Xia] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhang, CX (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China.	zhangcx3@mail.sysu.edu.cn	Mireku, Michael/D-5262-2016; Lu, Wei/AAE-2921-2022	Lu, Wei/0000-0002-4150-8674	Chinese Nutrition Society (CNS) Nutrition Research Foundation-DSM Research Fund	Chinese Nutrition Society (CNS) Nutrition Research Foundation-DSM Research Fund	This study was supported by 2012 Chinese Nutrition Society (CNS) Nutrition Research Foundation-DSM Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aleem H, 2009, J MATERN-FETAL NEO M, V22, P94, DOI 10.1080/14767050802464569; Abu-Saad K, 2010, EPIDEMIOL REV, V32, P5, DOI 10.1093/epirev/mxq001; Allen LH, 2000, AM J CLIN NUTR, V71, p1280S, DOI 10.1093/ajcn/71.5.1280s; [Anonymous], 2000, EFFECT CALCIUM IRON; [Anonymous], DAV EFF LIP BAS NUTR; Bd Benoist., 2008, WORLDWIDE PREVALENCE; Belizan JM, 1997, BMJ-BRIT MED J, V315, P281, DOI 10.1136/bmj.315.7103.281; Checkley W, 2010, NEW ENGL J MED, V362, P1784, DOI 10.1056/NEJMoa0907441; Cummings P, 2011, ARCH PEDIAT ADOL MED, V165, P592, DOI 10.1001/archpediatrics.2011.97; CZEIZEL AE, 1994, ARCH DIS CHILD, V70, P229, DOI 10.1136/adc.70.3.229; Daud NA, 2012, FASEB J, V26; Dijkhuizen MA, 2004, AM J CLIN NUTR, V80, P1299, DOI 10.1093/ajcn/80.5.1299; Dobo M, 1998, EUR J PEDIATR, V157, P719, DOI 10.1007/s004310050922; Dong H, 2004, STUDIES CORRELATION; Edejer TTT, 2005, BMJ-BRIT MED J, V331, P1177, DOI 10.1136/bmj.38652.550278.7C; Haider BA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004905.pub3; Hamadani JD, 2002, LANCET, V360, P290, DOI 10.1016/S0140-6736(02)09551-X; Hawkesworth S, 2010, AM J CLIN NUTR, V92, P741, DOI 10.3945/ajcn.2010.29475; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hong J, 2008, PUBLIC HEALTH NUTR, V11, P998, DOI 10.1017/S1368980007001322; Hou X, 2007, EFFECT NUTR STATUS P; Hovdenak N, 2012, EUROPEAN J OBSTET GY; Huang J, 2001, OCCUPATION HLTH, V17, P108; HUNT IF, 1985, AM J CLIN NUTR, V42, P815, DOI 10.1093/ajcn/42.5.815; Iannotti L, 2007, MATERNAL ZINC SUPPLE; Iannotti LL, 2008, AM J CLIN NUTR, V88, P154, DOI 10.1093/ajcn/88.1.154; Iannotti LL, 2010, J PEDIATR-US, V156, P960, DOI 10.1016/j.jpeds.2009.12.023; Jarjou LM, 2006, AM J CLIN NUTR, V83, P657, DOI 10.1093/ajcn.83.3.657; Khan AI, 2012, MATERNAL CHILD NUTR; Khan AI, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-134; MATSUI T, 1995, PEPTIDES, V16, P1063, DOI 10.1016/0196-9781(95)00067-T; MOHER D, 1994, JAMA-J AM MED ASSOC, V272, P122, DOI 10.1001/jama.272.2.122; Neufeld LM, 2002, FASEB J, V16, pA1028; Neville TL, 2010, J ANIM SCI, V88, P3645, DOI 10.2527/jas.2009-2666; Perez EM, 2005, J NUTR, V135, P850, DOI 10.1093/jn/135.4.850; Peters JL, 2008, J EVAL CLIN PRACT, V14, P941, DOI 10.1111/j.1365-2753.2008.01010.x; Polimeni M, 1996, MECH DEVELOP, V54, P107, DOI 10.1016/0925-4773(95)00465-3; Prawirohartono EP, 2011, PUBLIC HEALTH NUTR, V14, P2197, DOI 10.1017/S1368980011001078; Preziosi P, 1997, AM J CLIN NUTR, V66, P1178, DOI 10.1093/ajcn/66.5.1178; Qiaozhen H, 2008, EFFECT MULTIPLE MICR; Ramakrishnan U, 2012, PAEDIATR PERINAT EP, V26, P153, DOI 10.1111/j.1365-3016.2012.01276.x; Roberfroid D, 2008, AM J CLIN NUTR, V88, P1330, DOI 10.3945/ajcn.2008.26296; Roberfroid D, 2012, AM J CLIN NUTR, V95, P916, DOI 10.3945/ajcn.111.029033; Roberts G, 2013, PEDIATRICS, V131, pE439, DOI 10.1542/peds.2012-1135; Rouse DJ, 2003, J NUTR, V133, p1640S, DOI 10.1093/jn/133.5.1640S; Schmidt MK, 2002, EUR J CLIN NUTR, V56, P338, DOI 10.1038/sj.ejcn.1601318; Schmidt MK, 2001, BRIT J NUTR, V86, P607, DOI 10.1079/BJN2001444; Stewart CP, 2009, AM J CLIN NUTR, V90, P132, DOI 10.3945/ajcn.2008.27368; Tampere Uo, 2012, SUPPL MAT INF DIET H; Tamura T, 2003, AM J CLIN NUTR, V77, P1512, DOI 10.1093/ajcn/77.6.1512; Vaidya A, 2008, LANCET, V371, P492, DOI 10.1016/S0140-6736(08)60172-5; Vandevijvere S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043868; Villamor E, 2005, AM J CLIN NUTR, V81, P880, DOI 10.1093/ajcn/81.4.880; von Beckerath AK, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.014; Wang W, 2012, EUR J CLIN NUTR, V66, P261, DOI 10.1038/ejcn.2011.190; World Health Organization, 2009, GLOB PREV VIT A DEF; Yuan Wei, 2004, Fudan Xuebao (Yixuekexueban), V31, P496; Yuzhong S, 2000, SHANDONG MED J, V40, P22; Zekavat OR, 2012, TRACE ELEM ELECTROLY, V29, P239, DOI 10.5414/TE0X1248; Zhou Ming, 2004, FOREIGN MED SCI SECT, V25, P19; Zhou SJ, 2006, AM J CLIN NUTR, V83, P1112, DOI 10.1093/ajcn/83.5.1112	62	31	36	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88496	10.1371/journal.pone.0088496	http://dx.doi.org/10.1371/journal.pone.0088496			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586335	Green Published, gold, Green Submitted			2022-12-27	WOS:000331714700018
J	Ohiorhenuan, IE; Mechler, F; Purpura, KP; Schmid, AM; Hu, Q; Victor, JD				Ohiorhenuan, Ifije E.; Mechler, Ferenc; Purpura, Keith P.; Schmid, Anita M.; Hu, Qin; Victor, Jonathan D.			Cannabinoid Neuromodulation in the Adult Early Visual Cortex	PLOS ONE			English	Article							GABAERGIC TRANSMISSION; SOMATOSENSORY CORTEX; CORTICAL-NEURONS; CRITICAL PERIOD; SYNAPTIC INPUT; IN-VIVO; STATE; MODULATION; ATTENTION; SYNCHRONIZATION	Sensory processing is an active process involving the interaction of ongoing cortical activity with incoming stimulus information. However, the modulators and circuits involved in this interaction are incompletely understood. One potential candidate is the cannabinoid-signaling system, which is known to modulate the dynamics of cortical networks. Here, we show that in the primate primary and secondary visual cortices, the cannabinoid CP55940 modulates not only population dynamics but also influences the dynamics of the stimulus-response relationship of individual neurons. At the population level, CP55940 decreases EEG power, LFP power, and LFP coherence. At the single-neuron level, intrinsic spike train dynamics appear relatively unchanged, but visual receptive fields are altered: CP55940 induced an overall delay and broadening of the temporal component of V1 and V2 spatiotemporal receptive fields. Our findings provide neurophysiologic evidence for a link between cannabinoid-signaling, network dynamics and the function of a canonical cortical circuit.	[Ohiorhenuan, Ifije E.; Mechler, Ferenc; Purpura, Keith P.; Schmid, Anita M.; Hu, Qin; Victor, Jonathan D.] Weill Cornell Med Coll, Brain & Mind Res Inst, Div Syst Neurol & Neurosci, New York, NY 10021 USA	Cornell University	Ohiorhenuan, IE (corresponding author), Weill Cornell Med Coll, Brain & Mind Res Inst, Div Syst Neurol & Neurosci, New York, NY 10021 USA.	ifije.ohiorhenuan@usc.edu			NIH [F31-EY019454, GM7739, R01-EY9314]; NATIONAL EYE INSTITUTE [R01EY009314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH F31-EY019454 and NIH GM7739 (IEO) and NIH R01-EY9314 (JDV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Brusberg M, 2009, J NEUROSCI, V29, P1554, DOI 10.1523/JNEUROSCI.5166-08.2009; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Destexhe A, 2006, SCIENCE, V314, P85, DOI 10.1126/science.1127241; Eggan SM, 2007, CEREB CORTEX, V17, P175, DOI 10.1093/cercor/bhj136; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Haider B, 2007, J NEUROPHYSIOL, V97, P4186, DOI 10.1152/jn.01114.2006; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hasenstaub A, 2007, J NEUROSCI, V27, P9607, DOI 10.1523/JNEUROSCI.2184-07.2007; Holderith N, 2011, J PHYSIOL-LONDON, V589, P4921, DOI 10.1113/jphysiol.2011.216259; Jiang B, 2010, J NEUROSCI, V30, P14261, DOI 10.1523/JNEUROSCI.2979-10.2010; Jiang B, 2010, NEURON, V66, P248, DOI 10.1016/j.neuron.2010.03.021; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Koethe D, 2006, SCHIZOPHR RES, V88, P142, DOI 10.1016/j.schres.2006.07.023; Li L, 2009, NEURON, V64, P537, DOI 10.1016/j.neuron.2009.10.005; Linden H, 2011, NEURON, V72, P859, DOI 10.1016/j.neuron.2011.11.006; Liu CH, 2008, NEURON, V58, P340, DOI 10.1016/j.neuron.2008.02.020; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Murakami M, 2005, NEURON, V46, P285, DOI 10.1016/j.neuron.2005.02.025; Muthukumaraswamy SD, 2013, J NEUROSCI, V33, P15171, DOI 10.1523/JNEUROSCI.2063-13.2013; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Robbe D, 2006, NAT NEUROSCI, V9, P1526, DOI 10.1038/nn1801; Sachdev RNS, 2004, J NEUROPHYSIOL, V92, P3511, DOI 10.1152/jn.00347.2004; Schmid AM, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.015.2009; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Sippy T, 2013, J NEUROSCI, V33, P9813, DOI 10.1523/JNEUROSCI.4579-12.2013; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Worgotter F, 1998, NATURE, V396, P165, DOI 10.1038/24157; Yazulla S, 2008, PROG RETIN EYE RES, V27, P501, DOI 10.1016/j.preteyeres.2008.07.002	33	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e87362	10.1371/journal.pone.0087362	http://dx.doi.org/10.1371/journal.pone.0087362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586271	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900012
J	Chiou, WF; Huang, YL; Liu, YW				Chiou, Wen-Fei; Huang, Yu-Ling; Liu, Yen-Wenn			(+)-Vitisin A Inhibits Osteoclast Differentiation by Preventing TRAF6 Ubiquitination and TRAF6-TAK1 Formation to Suppress NFATc1 Activation	PLOS ONE			English	Article							NF-KAPPA-B; HISTONE DEACETYLASE INHIBITORS; RECEPTOR ACTIVATOR; BONE-RESORPTION; C-FOS; NUCLEAR-FACTOR; MEDIATED OSTEOCLASTOGENESIS; VITIS-THUNBERGII; SODIUM-BUTYRATE; TERMINAL KINASE	We recently reported that oral administration of a (+)-vitisin A-enriched product prepared from Vitis thunbergii obviously ameliorated bone loss in ovariectomized mice and (+)-vitisin A was able to inhibit receptor activator of NF-kappa B ligand (RANKL)-induced osteoclast differentiation in RAW264.7 cells. Here we further clarified the mechanism(s) by which (+)-vitisin A targets osteoclastic differentiation and activity. Osteoclast-characteristic enzyme activity was determined using gel zymography or spectroflurometric-based assay. Expression of signal molecules was analyzed via Western blot or immunoprecipitation. Results showed that (+)-vitisin A suppressed RANKL-induced multinuclear cells (MNCs) formation and bone resorption which was accompanied with reduction in beta 3 integrin, osteoclast stimulatory transmembrane protein (OC-STAMP), matrix metalloproteinase-9 (MMP-9) and cathepsin K proteins expression. (+)-Vitisin A also down-regulated the proteolytic activities of MMP-9 and cathepsin K via targeting at the late stage function. (+)-Vitisin A prominently abrogated RANKL-triggered nuclear translocations of NF-kappa B, AP-1 (c-Fos/c-Jun dimer) and associated induction and nuclear accumulation of nuclear factor of activated T cells c1 (NFATc1). The upstream I kappa B degradation as well as ERK and JNK phosphorylation were also substantially repressed. Transfection with siRNA targeting tumor necrosis factor receptor associated factor 6 (TRAF6) clearly restrained RANKL-induced MNCs formation and NFATc1 induction. Interesting, RANKL triggered poly-ubiquitination of TRAF6 and associated TRAF6-TAK1 (transforming growth factor beta-activated kinase 1) complex formation was prominently attenuated by (+)-vitisin A. Furthermore, the interaction between c-src tyrosine kinase (c-Src) and beta 3 was markedly induced by RANKL stimulation. (+)-Vitisin A significantly attenuated this interaction when concomitant treated with RANKL in RAW264.7 cells, but failed to affect c-Src/beta 3 complex formation when post-cultured with MNCs. Taken together, (+)-vitisin A suppressed bone resorption possibly via interruption of RANKL-induced TRAF6 ubiquitination and associated downstream signaling pathways. Furthermore, action through negative regulation of the proteolytic activity of MMP-9 and cathepsin K might also contribute to the anti-resorption effect of (+)-vitisin A.	[Chiou, Wen-Fei; Huang, Yu-Ling; Liu, Yen-Wenn] Minist Hlth & Welf, Natl Res Inst Chinese Med, Taipei, Taiwan; [Chiou, Wen-Fei] Hungkuang Univ, Dept Biotechnol, Taichung, Taiwan; [Huang, Yu-Ling] Chang Gung Univ Sci & Technol, Dept Cosmet Sci, Tao Yuan, Taiwan	National Research Institute of Chinese Medicine; Hungkuang University; Chang Gung University of Science & Technology	Chiou, WF (corresponding author), Minist Hlth & Welf, Natl Res Inst Chinese Med, Taipei, Taiwan.	wfchiou@nricm.edu.tw			National Science Council Foundation [NSC 101-2320-B-077-009-MY3]; National Research Institute of Chinese Medicine Foundation [NRICM101-DBCM-02, NRICM100-DMC-05]	National Science Council Foundation(Ministry of Science and Technology, Taiwan); National Research Institute of Chinese Medicine Foundation	This work was supported by National Science Council Foundation grant (NSC 101-2320-B-077-009-MY3 to W.F.C.) and National Research Institute of Chinese Medicine Foundation grants (NRICM101-DBCM-02 to W.F.C. and NRICM100-DMC-05 to Y.L.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Boyce BF, 2005, J BONE MINER METAB, V23, P11, DOI 10.1007/BF03026317; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chiou WF, 2010, BRIT J PHARMACOL, V161, P321, DOI 10.1111/j.1476-5381.2010.00823.x; Chiou WF, 2011, BIOCHEM PHARMACOL, V81, P752, DOI 10.1016/j.bcp.2010.12.022; Chiou WF, 2009, PLANTA MED, V75, P856, DOI 10.1055/s-0029-1185404; Chiu N.Y., 1995, ILLUSTRATED MED PLAN; Collin-Osdoby P, 2012, METHODS MOL BIOL, V816, P187, DOI 10.1007/978-1-61779-415-5_13; Darnay BG, 1998, J BIOL CHEM, V273, P20551, DOI 10.1074/jbc.273.32.20551; Delaisse JM, 2000, CLIN CHIM ACTA, V291, P223, DOI 10.1016/S0009-8981(99)00230-2; Dossetter AG, 2012, J MED CHEM, V55, P6363, DOI 10.1021/jm3007257; Duong L, 2000, MATRIX BIOL, V19, P97, DOI 10.1016/S0945-053X(00)00051-2; Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879; Feng X, 2005, IUBMB LIFE, V57, P389, DOI 10.1080/15216540500137669; Franco GCN, 2011, EXP CELL RES, V317, P1454, DOI 10.1016/j.yexcr.2011.03.014; Fretz JA, 2008, MOL ENDOCRINOL, V22, P737, DOI 10.1210/me.2007-0333; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Huang YL, 2005, J NAT PROD, V68, P217, DOI 10.1021/np049686p; Huang YL, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/409421; Hwang YS, 2013, J BONE MINER METAB; Insogna KL, 1997, J CLIN INVEST, V100, P2476, DOI 10.1172/JCI119790; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; IWAMI K, 1993, INT J BIOCHEM, V25, P1631, DOI 10.1016/0020-711X(93)90522-G; Izawa T, 2012, MOL CELL BIOL, V32, P2943, DOI 10.1128/MCB.00077-12; Jensen AB, 2010, CLIN BREAST CANCER, V10, P452, DOI 10.3816/CBC.2010.n.059; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Kim HH, 1999, FEBS LETT, V443, P297, DOI 10.1016/S0014-5793(98)01731-1; Kim K, 2005, J BIOL CHEM, V280, P35209, DOI 10.1074/jbc.M505815200; Lamothe B, 2007, BIOCHEM BIOPH RES CO, V359, P1044, DOI 10.1016/j.bbrc.2007.06.017; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Landstrom M, 2010, INT J BIOCHEM CELL B, V42, P585, DOI 10.1016/j.biocel.2009.12.023; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Milner JM, 2003, ARTHRITIS RHEUM-US, V48, P1057, DOI 10.1002/art.10873; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Miyamoto Takeshi, 2003, Keio J Med, V52, P1; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; Nakamura I, 1999, J CELL SCI, V112, P3985; Nakamura T, 2005, J IMMUNOL, V175, P5809, DOI 10.4049/jimmunol.175.9.5809; NESBITT S, 1993, J BIOL CHEM, V268, P16737; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Ortega N, 2003, ANN NY ACAD SCI, V995, P109, DOI 10.1111/j.1749-6632.2003.tb03214.x; Rahman MM, 2003, BLOOD, V101, P3451, DOI 10.1182/blood-2002-08-2622; Schroeder TM, 2005, J BONE MINER RES, V20, P2254, DOI 10.1359/JBMR.050813; Seo SW, 2010, BONE, V46, P695, DOI 10.1016/j.bone.2009.10.032; Szewczyk KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060285; Takada Y, 2006, J BIOL CHEM, V281, P5612, DOI 10.1074/jbc.M507213200; Takatsuna H, 2005, J BONE MINER RES, V20, P653, DOI 10.1359/JBMR.041213; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Touaitahuata H, 2013, EUR J CELL BIOL, V92, P139, DOI 10.1016/j.ejcb.2013.03.001; Votta BJ, 1997, J BONE MINER RES, V12, P1396, DOI 10.1359/jbmr.1997.12.9.1396; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; Yang M, 2008, J CELL PHYSIOL, V215, P497, DOI 10.1002/jcp.21331; Yi T, 2007, EXP MOL MED, V39, P213, DOI 10.1038/emm.2007.24; Zou W, 2007, J CELL BIOL, V176, P877, DOI 10.1083/jcb.200611083; Zou W, 2010, ANN NY ACAD SCI, V1192, P27, DOI 10.1111/j.1749-6632.2009.05245.x	64	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89159	10.1371/journal.pone.0089159	http://dx.doi.org/10.1371/journal.pone.0089159			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558484	Green Submitted, Green Published, gold			2022-12-27	WOS:000331706700130
J	Dunning, JL; Pant, S; Bass, A; Coburn, Z; Prather, JF				Dunning, Jeffery L.; Pant, Santosh; Bass, Aaron; Coburn, Zachary; Prather, Jonathan F.			Mate Choice in Adult Female Bengalese Finches: Females Express Consistent Preferences for Individual Males and Prefer Female-Directed Song Performances	PLOS ONE			English	Article							ZEBRA FINCH; SPECIES RECOGNITION; EARLY EXPERIENCE; BEAK COLOR; CANARIES; DISCRIMINATION; RESPONSES; EXPOSURE; VARIABILITY; COMPLEXITY	In the process of mate selection by female songbirds, male suitors advertise their quality through reproductive displays in which song plays an important role. Females evaluate the quality of each signal and the associated male, and the results of that evaluation guide expression of selective courtship displays. Some studies reveal broad agreement among females in their preferences for specific signal characteristics, indicating that those features are especially salient in female mate choice. Other studies reveal that females differ in their preference for specific characteristics, indicating that in those cases female evaluation of signal quality is influenced by factors other than simply the physical properties of the signal. Thus, both the physical properties of male signals and specific traits of female signal evaluation can impact female mate choice. Here, we characterized the mate preferences of female Bengalese finches. We found that calls and copulation solicitation displays are equally reliable indicators of female preference. In response to songs from an array of males, each female expressed an individual-specific song preference, and those preferences were consistent across tests spanning many months. Across a population of females, songs of some males were more commonly preferred than others, and females preferred female-directed songs more than undirected songs, suggesting that some song features are broadly attractive. Preferences were indistinguishable for females that did or did not have social experience with the singers, indicating that female preference is strongly directed by song features rather than experiences associated with the singer. Analysis of song properties revealed several candidate parameters that may influence female evaluation. In an initial investigation of those parameters, females could be very selective for one song feature yet not selective for another. Therefore, multiple song parameters are evaluated independently. Together these findings reveal the nature of signal evaluation and mate choice in this species.	[Dunning, Jeffery L.; Pant, Santosh; Bass, Aaron; Coburn, Zachary; Prather, Jonathan F.] Univ Wyoming, Dept Zool & Physiol, Program Neurosci, Laramie, WY 82071 USA	University of Wyoming	Prather, JF (corresponding author), Univ Wyoming, Dept Zool & Physiol, Program Neurosci, Laramie, WY 82071 USA.	Jonathan.Prather@uwyo.edu		Dunning, Jeffery/0000-0003-0397-4006	National Institute of General Medical Sciences of the National Institutes of Health [P 30 GM 103398]; University of Wyoming INBRE Program of the National Institutes of Health; University of Wyoming EPSCoR Program of the National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103398] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Wyoming INBRE Program of the National Institutes of Health; University of Wyoming EPSCoR Program of the National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by startup funds provided by an Institutional Development Award from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P 30 GM 103398. This research was also supported by the University of Wyoming INBRE Program of the National Institutes of Health (JFP) and by an Undergraduate Research Fellowship (ZC) from the University of Wyoming EPSCoR Program of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RC, 2009, BEHAV ECOL SOCIOBIOL, V64, P215, DOI 10.1007/s00265-009-0838-y; BAKER MC, 1981, SCIENCE, V214, P819, DOI 10.1126/science.214.4522.819; Ballentine B, 2004, BEHAV ECOL, V15, P163, DOI 10.1093/beheco/arg090; Banerjee SB, 2011, HORM BEHAV, V60, P233, DOI 10.1016/j.yhbeh.2011.05.011; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; CLAYTON N, 1989, ANIM BEHAV, V38, P352, DOI 10.1016/S0003-3472(89)80096-X; Coleman SW, 2004, NATURE, V428, P742, DOI 10.1038/nature02419; Collins SA, 1996, ANIM BEHAV, V52, P105, DOI 10.1006/anbe.1996.0156; COLLINS SA, 1995, ANIM BEHAV, V49, P479, DOI 10.1006/anbe.1995.0062; COLLINS SA, 1994, BEHAV ECOL SOCIOBIOL, V35, P21, DOI 10.1007/s002650050065; Draganoiu TI, 2002, P ROY SOC B-BIOL SCI, V269, P2525, DOI 10.1098/rspb.2002.2192; Dugatkin L, 1992, AM NATURALIST, V139; Eda-Fujiwara H, 2003, EUR J NEUROSCI, V17, P149, DOI 10.1046/j.1460-9568.2003.02414.x; Forstmeier W, 2004, ANIM BEHAV, V68, P1017, DOI 10.1016/j.anbehav.2004.02.007; Gentner TQ, 2000, ANIM BEHAV, V59, P443, DOI 10.1006/anbe.1999.1313; Gentner TQ, 2001, J NEUROBIOL, V46, P48, DOI 10.1002/1097-4695(200101)46:1<48::AID-NEU5>3.0.CO;2-3; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Kato Y, 2010, J ETHOL, V28, P447, DOI 10.1007/s10164-010-0203-7; KROODSMA DE, 1976, SCIENCE, V192, P574, DOI 10.1126/science.192.4239.574; Lauay C, 2004, ANIM BEHAV, V68, P1249, DOI 10.1016/j.anbehav.2003.12.025; Leitao A, 2006, ANIM BEHAV, V71, P1289, DOI 10.1016/j.anbehav.2005.08.008; MacDougall-Shackleton S, 1998, NEUROREPORT, V9, P3047; Menardy F, 2012, EUR J NEUROSCI, V35, P1322, DOI 10.1111/j.1460-9568.2012.08047.x; Morisaka Tadamichi, 2008, Ornithological Science, V7, P75, DOI 10.2326/1347-0558(2008)7[75:VIPFCS]2.0.CO;2; Nagle L, 1997, BEHAVIOUR, V134, P89, DOI 10.1163/156853997X00296; Nagle L, 1997, CAN J ZOOL, V75, P1346, DOI 10.1139/z97-759; Nagle L, 2002, ETHOLOGY, V108, P463, DOI 10.1046/j.1439-0310.2002.00790.x; NAGLE L, 1993, EXPERIENTIA, V49, P1022, DOI 10.1007/BF02125652; Neubauer RL, 1999, EVOL ECOL, V13, P365, DOI 10.1023/A:1006708826432; O'Loghlen A. B., 1996, ANIM BEHAV, V53, P835; Okanoya K, 2004, ANN NY ACAD SCI, V1016, P724, DOI 10.1196/annals.1298.026; Okanoya K., 1997, T TECH COMM PSYCHOL, V27, P1; Okanoya K., 1998, T TECH COMM PSYCHOL, V28, P1; Prather JF, 2013, HEARING RES, V305, P144, DOI 10.1016/j.heares.2013.06.007; Remage-Healey L, 2010, P NATL ACAD SCI USA, V107, P3852, DOI 10.1073/pnas.0906572107; Riebel K, 1998, ANIM BEHAV, V56, P1443, DOI 10.1006/anbe.1998.0933; Riebel K, 2000, P ROY SOC B-BIOL SCI, V267, P2553, DOI 10.1098/rspb.2000.1320; Ritschard M, 2010, ANIM BEHAV, V79, P877, DOI 10.1016/j.anbehav.2009.12.038; Sakata JT, 2008, J NEUROPHYSIOL, V99, P1700, DOI 10.1152/jn.01296.2007; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Searcy WA, 1997, CONDOR, V99, P826, DOI 10.2307/1370497; SEARCY WA, 1992, NATO ADV SCI I A-LIF, V228, P175; SEARCY WA, 1981, ANIM BEHAV, V29, P997, DOI 10.1016/S0003-3472(81)80053-X; SEARCY WA, 1992, AM ZOOL, V32, P71; SEARCY WA, 1986, ANNU REV ECOL SYST, V17, P507, DOI 10.1146/annurev.es.17.110186.002451; SEARCY WA, 1990, ANIM BEHAV, V40, P1119, DOI 10.1016/S0003-3472(05)80178-2; SEARCY WA, 1988, NATURE, V332, P152, DOI 10.1038/332152a0; Seki Y, 2008, J COMP PSYCHOL, V122, P26, DOI 10.1037/0735-7036.122.1.26; SOSSINKA R, 1980, Z TIERPSYCHOL, V53, P123; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Vallet E, 1998, ANIM BEHAV, V55, P291, DOI 10.1006/anbe.1997.0631; VALLET E, 1995, ANIM BEHAV, V49, P1603, DOI 10.1016/0003-3472(95)90082-9; Vignal C, 2008, BEHAV PROCESS, V77, P191, DOI 10.1016/j.beproc.2007.09.003; Vyas A, 2009, HORM BEHAV, V55, P50, DOI 10.1016/j.yhbeh.2008.08.005; WEST MJ, 1981, ANIM BEHAV, V29, P490, DOI 10.1016/S0003-3472(81)80110-8; WEST MJ, 1988, DEV PSYCHOBIOL, V21, P543, DOI 10.1002/dev.420210605; Woolley SC, 2008, PLOS BIOL, V6, P525, DOI 10.1371/journal.pbio.0060062; YONEDA T, 1991, J ETHOL, V9, P41, DOI 10.1007/BF02350206	59	30	32	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89438	10.1371/journal.pone.0089438	http://dx.doi.org/10.1371/journal.pone.0089438			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558501	gold, Green Published, Green Submitted			2022-12-27	WOS:000331706700147
J	Tang, LY; Peng, H; Xu, T; Wang, AL; Wang, GY; Tong, WJ; Zhang, YH				Tang, Lingyan; Peng, Hao; Xu, Tian; Wang, Aili; Wang, Guiyan; Tong, Weijun; Zhang, Yonghong			Association of Biomarkers of Inflammation with Dyslipidemia and Its Components among Mongolians in China	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INTERCELLULAR-ADHESION MOLECULE-1; DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR RISK-FACTORS; CORONARY-HEART-DISEASE; E-SELECTIN; INSULIN-RESISTANCE; NITRIC-OXIDE; P-SELECTIN; HYPERTENSION	Objective: This study aims to examine the association between inflammatory biomarkers and dyslipidemia and its components among Mongolians in China. Methods: Data were obtained from 2544 Mongolians via standard questionnaires and blood samples in Inner Mongolia, China. High sensitivity C-reactive protein (hsCRP), soluble intercellular adhesion molecule-1 (sICAM-1) and soluble E-selectin (sE-selectin) as well as blood lipids were examined. Results: Individuals with dyslipidemia had higher levels of hsCRP, sICAM-1 and sE-selectin than those without dyslipidemia (all P values<0.001). Compared to the lowest quartile of inflammatory biomarkers, individuals with the highest quartile were more likely to have dyslipidemia (odds ratio, 95% confidence interval: 3.215, 2.551-4.116 for hsCRP; 1.575, 1.253-1.980 for sICAM-1; 1.495, 1.193-1.873 for sE-selectin). Moreover, hsCRP was associated with all the components of dyslipidemia, whereas, sICAM-1 was not related to high density lipoprotein cholesterol (HDL-c) or triglycerides (TAG). Additionally, sE-selectin was just associated with TAG. Conclusion: Our study indicated that elevated plasma levels of hsCRP, sICAM-1 and sE-selectin were positively and significantly associated with increased risk of dyslipidemia among Mongolians. However, the associations were not identical for different inflammatory biomarkers with the components of dyslipidemia.	[Tang, Lingyan; Peng, Hao; Xu, Tian; Wang, Aili; Wang, Guiyan; Tong, Weijun; Zhang, Yonghong] Soochow Univ, Coll Med, Sch Publ Hlth, Dept Epidemiol, Suzhou, Jiangsu, Peoples R China; [Wang, Guiyan] Xiamen Maternal & Child Care Hosp, Dept Hlth Care, Xiamen, Fujian, Peoples R China	Soochow University - China	Zhang, YH (corresponding author), Soochow Univ, Coll Med, Sch Publ Hlth, Dept Epidemiol, Suzhou, Jiangsu, Peoples R China.	yhzhang@suda.edu.cn	Peng, Hao/I-1134-2014; Peng, Hao/AAB-4759-2022	Peng, Hao/0000-0001-6277-662X; 	National Natural Science Foundation of China [30972531]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This study was supported by National Natural Science Foundation of China (Grant No. 30972531) and a Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 1998, ARTERIOSCL THROM VAS, V18, P723, DOI 10.1161/01.ATV.18.5.723; Alvarez-Sala LA, 2008, CLIN THER, V30, P84, DOI 10.1016/j.linthera.2008.01.013; Anderson KM, 1998, JAMA-J AM MED ASSOC, V257, P2176; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; Cannon RO, 1998, CLIN CHEM, V44, P1809; Cesari M, 2009, J NUTR HEALTH AGING, V13, P587, DOI 10.1007/s12603-009-0168-9; Cucuzzella M, 2004, J FAM PRACTICE, V53, P142; De Caterina R, 2001, AM J HYPERTENS, V14, P259, DOI 10.1016/S0895-7061(00)01276-0; Demerath E, 2001, ANN HUM BIOL, V28, P664, DOI 10.1080/03014460110048530; Duarte MMMF, 2009, CLIN BIOCHEM, V42, P666, DOI 10.1016/j.clinbiochem.2009.01.010; Ferroni P, 1999, HAEMOSTASIS, V29, P277; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Glowinska B, 2005, METABOLISM, V54, P1020, DOI 10.1016/j.metabol.2005.03.004; Goswami B, 2010, CARDIOVASC J AFR, V21, P41; Hackman A, 1996, CIRCULATION, V93, P1334, DOI 10.1161/01.CIR.93.7.1334; HALLER H, 1995, HYPERTENSION, V25, P511, DOI 10.1161/01.HYP.25.4.511; Hsu LA, 2009, METABOLISM, V58, P983, DOI 10.1016/j.metabol.2009.02.021; Hwang SJ, 1997, CIRCULATION, V96, P4219; Keles T, 2008, ANATOL J CARDIOL, V8, P407; Li HM, 2008, CIRC J, V72, P1666, DOI 10.1253/circj.CJ-08-0138; Malik I, 2001, LANCET, V358, P971, DOI 10.1016/S0140-6736(01)06104-9; Martinez-Hervas S, 2010, NUTR METAB CARDIOVAS, V20, P734, DOI 10.1016/j.numecd.2009.06.003; Mineo C, 2006, CIRC RES, V98, P1352, DOI 10.1161/01.RES.0000225982.01988.93; Moriarty PM, 2003, ATHEROSCLEROSIS, V166, P201, DOI 10.1016/S0021-9150(02)00319-2; OHARA Y, 1994, ARTERIOSCLER THROMB, V14, P1007, DOI 10.1161/01.ATV.14.6.1007; Pasceri V, 2000, CIRCULATION, V102, P2165; Rohde LEP, 1999, ARTERIOSCL THROM VAS, V19, P1595, DOI 10.1161/01.ATV.19.7.1595; Rost NS, 2001, STROKE, V32, P2575, DOI 10.1161/hs1101.098151; Stanojevic NB, 2005, INT HEART J, V46, P593, DOI 10.1536/ihj.46.593; Sun ZQ, 2008, INT J CARDIOL, V128, P250, DOI 10.1016/j.ijcard.2007.08.127; Szmitko PE, 2003, CIRCULATION, V108, P1917, DOI 10.1161/01.CIR.0000089190.95415.9F; Vidal F, 1998, EUR J BIOCHEM, V252, P378, DOI 10.1046/j.1432-1327.1998.2520378.x; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972; Zhao WH, 2007, BIOMED ENVIRON SCI, V20, P329	35	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89023	10.1371/journal.pone.0089023	http://dx.doi.org/10.1371/journal.pone.0089023			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558466	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700112
J	Lohelaid, H; Teder, T; Toldsepp, K; Ekins, M; Samel, N				Lohelaid, Helike; Teder, Tarvi; Toldsepp, Kadri; Ekins, Merrick; Samel, Nigulas			Up-Regulated Expression of AOS-LOXa and Increased Eicosanoid Synthesis in Response to Coral Wounding	PLOS ONE			English	Article							ALLENE OXIDE SYNTHASE; LIPOXYGENASE FUSION PROTEIN; CARIBBEAN GORGONIAN CORALS; GENE-EXPRESSION; PROSTAGLANDIN SYNTHESIS; HYDROPEROXIDE LYASE; CLAVULARIA-VIRIDIS; GERSEMIA-FRUTICOSA; MOLECULAR-CLONING; ARACHIDONIC-ACID	In octocorals, a catalase-like allene oxide synthase (AOS) and an 8R-lipoxygenase (LOX) gene are fused together encoding for a single AOS-LOX fusion protein. Although the AOS-LOX pathway is central to the arachidonate metabolism in corals, its biological function in coral homeostasis is unclear. Using an acute incision wound model in the soft coral Capnella imbricata, we here test whether LOX pathway, similar to its role in plants, can contribute to the coral damage response and regeneration. Analysis of metabolites formed from exogenous arachidonate before and after fixed time intervals following wounding indicated a significant increase in AOS-LOX activity in response to mechanical injury. Two AOS-LOX isoforms, AOS-LOXa and AOS-LOXb, were cloned and expressed in bacterial expression system as active fusion proteins. Transcription levels of corresponding genes were measured in normal and stressed coral by qPCR. After wounding, AOS-LOXa was markedly up-regulated in both, the tissue adjacent to the incision and distal parts of a coral colony (with the maximum reached at 1 h and 6 h post wounding, respectively), while AOS-LOXb was stable. According to mRNA expression analysis, combined with detection of eicosanoid product formation for the first time, the AOS-LOX was identified as an early stress response gene which is induced by mechanical injury in coral.	[Lohelaid, Helike; Teder, Tarvi; Toldsepp, Kadri; Samel, Nigulas] Tallinn Univ Technol, Dept Chem, EE-19086 Tallinn, Estonia; [Ekins, Merrick] Queensland Museum, Brisbane, Qld 4101, Australia	Tallinn University of Technology; Queensland Museum	Samel, N (corresponding author), Tallinn Univ Technol, Dept Chem, EE-19086 Tallinn, Estonia.	nigulas.samel@ttu.ee	Lõhelaid, Helike/G-5425-2013; Teder, Tarvi/M-6893-2018; Samel, Nigulas/A-1420-2019; Ekins, Merrick G/B-8256-2015	Lõhelaid, Helike/0000-0002-6885-8666; Teder, Tarvi/0000-0002-8489-3955; Ekins, Merrick G/0000-0002-4825-462X	Estonian Science Foundation [9410]; Estonian Ministry of Education and Research [0140010s08]	Estonian Science Foundation; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia)	This work was supported by the Estonian Science Foundation Grant 9410 and the Estonian Ministry of Education and Research Grant 0140010s08 (both to NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreou A, 2009, PROG LIPID RES, V48, P148, DOI 10.1016/j.plipres.2009.02.002; Ariel A, 2013, J PATHOL, V229, P250, DOI 10.1002/path.4108; Bate NJ, 1998, PLANT PHYSIOL, V117, P1393, DOI 10.1104/pp.117.4.1393; BELL E, 1995, P NATL ACAD SCI USA, V92, P8675, DOI 10.1073/pnas.92.19.8675; Boutaud O, 1999, J BIOL CHEM, V274, P33764, DOI 10.1074/jbc.274.47.33764; BRASH AR, 1987, J BIOL CHEM, V262, P15829; BUNDY GL, 1986, J BIOL CHEM, V261, P747; Coffa G, 2005, BIOCHEM BIOPH RES CO, V338, P87, DOI 10.1016/j.bbrc.2005.07.185; Cordeiro JV, 2013, NAT REV MOL CELL BIO, V14, P249, DOI 10.1038/nrm3541; COREY EJ, 1985, TETRAHEDRON LETT, V26, P4171, DOI 10.1016/S0040-4039(00)98982-2; COREY EJ, 1987, J AM CHEM SOC, V109, P289, DOI 10.1021/ja00235a053; COREY EJ, 1973, J AM CHEM SOC, V95, P2054, DOI 10.1021/ja00787a079; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; Fang LS, 1997, CORAL REEFS, V16, P127, DOI 10.1007/s003380050066; GERHART DJ, 1991, AM J PHYSIOL, V260, pR839, DOI 10.1152/ajpregu.1991.260.5.R839; Gfeller A, 2011, PLANT PHYSIOL, V156, P1797, DOI 10.1104/pp.111.181008; Glauser G, 2009, J BIOL CHEM, V284, P34506, DOI 10.1074/jbc.M109.061432; Grechkin AN, 2004, BBA-MOL CELL BIOL L, V1636, P47, DOI 10.1016/j.bbalip.2003.12.003; Halitschke R, 2004, PLANT J, V40, P35, DOI 10.1111/j.1365-313X.2004.02185.x; Hashimoto N, 2003, LIPIDS, V38, P991, DOI 10.1007/s11745-003-1153-2; Howe GA, 2000, PLANT PHYSIOL, V123, P711, DOI 10.1104/pp.123.2.711; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Kalish BT, 2013, PROSTAG OTH LIPID M, V104, P130, DOI 10.1016/j.prostaglandins.2013.05.002; Koljak R, 1997, SCIENCE, V277, P1994, DOI 10.1126/science.277.5334.1994; Koljak R, 2001, J BIOL CHEM, V276, P7033, DOI 10.1074/jbc.M009803200; Kombrink E, 2012, PLANTA, V236, P1351, DOI 10.1007/s00425-012-1705-z; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Laudert D, 1996, PLANT MOL BIOL, V31, P323, DOI 10.1007/BF00021793; Lee DS, 2008, NATURE, V455, P363, DOI 10.1038/nature07307; Leon J, 2001, J EXP BOT, V52, P1, DOI 10.1093/jexbot/52.354.1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohelaid H, 2008, BBA-GEN SUBJECTS, V1780, P315, DOI 10.1016/j.bbagen.2007.10.010; Maffei ME, 2007, TRENDS PLANT SCI, V12, P310, DOI 10.1016/j.tplants.2007.06.001; Mauch F, 1997, PLANT PHYSIOL, V114, P1561, DOI 10.1104/pp.114.4.1561; Meszaros A, 1999, J INVERTEBR PATHOL, V73, P321, DOI 10.1006/jipa.1999.4851; Mortimer M, 2006, ARCH BIOCHEM BIOPHYS, V445, P147, DOI 10.1016/j.abb.2005.10.023; Mydlarz LD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001811; Mydlarz LD, 2007, COMP BIOCHEM PHYS A, V146, P54, DOI 10.1016/j.cbpa.2006.09.005; O'Neal W, 2002, MAR ECOL PROG SER, V240, P117, DOI 10.3354/meps240117; Palmer CV, 2008, P ROY SOC B-BIOL SCI, V275, P2687, DOI 10.1098/rspb.2008.0335; Palmer CV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023992; PAWLIK JR, 1987, J EXP MAR BIOL ECOL, V108, P55, DOI 10.1016/0022-0981(87)90130-4; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Reitzel AM, 2008, BIOL BULL-US, V214, P233, DOI 10.2307/25470666; Rodriguez PG, 2008, DERMATOL SURG, V34, P1159, DOI 10.1111/j.1524-4725.2008.34254.x; Rodriguez-Lanetty M, 2008, J BIOCHEM BIOPH METH, V70, P985, DOI 10.1016/j.jbbm.2007.08.005; Rotjan RD, 2008, MAR ECOL PROG SER, V367, P73, DOI 10.3354/meps07531; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Seneca FO, 2010, MAR BIOTECHNOL, V12, P594, DOI 10.1007/s10126-009-9247-5; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Sivasankar S, 2000, PLANT PHYSIOL, V122, P1335, DOI 10.1104/pp.122.4.1335; SONG WC, 1993, P NATL ACAD SCI USA, V90, P8519, DOI 10.1073/pnas.90.18.8519; Souter P, 2011, MOL ECOL RESOUR, V11, P328, DOI 10.1111/j.1755-0998.2010.02923.x; SU X, 1988, ANAL BIOCHEM, V174, P650, DOI 10.1016/0003-2697(88)90068-1; Valmsen K, 2004, EUR J BIOCHEM, V271, P3533, DOI 10.1111/j.0014-2956.2004.04289.x; VARVAS K, 1994, TETRAHEDRON LETT, V35, P8267, DOI 10.1016/0040-4039(94)88299-1; VARVAS K, 1993, TETRAHEDRON LETT, V34, P3643, DOI 10.1016/S0040-4039(00)73658-6; Varvas K, 1999, J BIOL CHEM, V274, P9923, DOI 10.1074/jbc.274.15.9923; VICK BA, 1987, PLANT PHYSIOL, V85, P1073, DOI 10.1104/pp.85.4.1073; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Wenemoser D, 2012, GENE DEV, V26, P988, DOI 10.1101/gad.187377.112; Whalen Kristen E., 2010, BMC Ecology, V10, P24, DOI 10.1186/1472-6785-10-24; Woo S, 2010, MOL CELL TOXICOL, V6, P387, DOI 10.1007/s13273-010-0051-0; Work TM, 2010, J INVERTEBR PATHOL, V105, P116, DOI 10.1016/j.jip.2010.05.009	68	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89215	10.1371/journal.pone.0089215	http://dx.doi.org/10.1371/journal.pone.0089215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551239	Green Submitted, Green Published, gold			2022-12-27	WOS:000331271500104
J	Xia, WL; Gooden, D; Liu, LH; Zhao, SM; Soderblom, EJ; Toone, EJ; Beyer, WF; Walder, H; Spector, NL				Xia, Wenle; Gooden, David; Liu, Leihua; Zhao, Sumin; Soderblom, Erik J.; Toone, Eric J.; Beyer, Wayne F., Jr.; Walder, Harold; Spector, Neil L.			Photo-Activated Psoralen Binds the ErbB2 Catalytic Kinase Domain, Blocking ErbB2 Signaling and Triggering Tumor Cell Apoptosis	PLOS ONE			English	Article							BREAST-CANCER; EXTRACORPOREAL PHOTOCHEMOTHERAPY; INHIBITOR; RESISTANCE; HER-2	Photo-activation of psoralen with UVA irradiation, referred to as PUVA, is used in the treatment of proliferative skin disorders. The anti-proliferative effects of PUVA have been largely attributed to psoralen intercalation of DNA, which upon UV treatment, triggers the formation of interstrand DNA crosslinks (ICL) that inhibit transcription and DNA replication. Here, we show that PUVA exerts antitumor effects in models of human breast cancer that overexpress the ErbB2 receptor tyrosine kinase oncogene, through a new mechanism. Independent of ICL formation, the antitumor effects of PUVA in ErbB2+ breast cancer models can instead be mediated through inhibition of ErbB2 activation and signaling. Using a mass spectroscopy-based approach, we show for the first time that photo-activated 8MOP (8-methoxypsoralen) interacts with the ErbB2 catalytic autokinase domain. Furthermore, PUVA can reverse therapeutic resistance to lapatinib and other ErbB2 targeted therapies, including resistance mediated via expression of a phosphorylated, truncated form of ErbB2 (p85(ErbB2)) that is preferentially expressed in tumor cell nuclei. Current ErbB2 targeted therapies, small molecule kinase inhibitors or antibodies, do not block the phosphorylated, activated state of p85(ErbB2). Here we show that PUVA reduced p85(ErbB2) phosphorylation leading to tumor cell apoptosis. Thus, in addition to its effects on DNA and the formation of ICL, PUVA represents a novel ErbB2 targeted therapy for the treatment of ErbB2+ breast cancers, including those that have developed resistance to other ErbB2 targeted therapies.	[Xia, Wenle; Spector, Neil L.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Xia, Wenle; Liu, Leihua; Zhao, Sumin; Spector, Neil L.] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC USA; [Gooden, David; Soderblom, Erik J.; Toone, Eric J.] Duke Univ, Dept Chem, Durham, NC 27706 USA; [Beyer, Wayne F., Jr.] QNS Grp LLC, Bahama, NC USA; [Walder, Harold] Immunolight LLC, Detroit, MI USA	Duke University; Duke University; Duke University	Xia, WL (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	wenle.xia@duke.edu; Neil.Spector@duke.edu			Immunolight LLC; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER	Immunolight LLC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the funding from Immunolight LLC. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aertgeerts K, 2011, J BIOL CHEM, V286, P18756, DOI 10.1074/jbc.M110.206193; Anido J, 2006, EMBO J, V25, P3234, DOI 10.1038/sj.emboj.7601191; BERGER CL, 1985, ANN NY ACAD SCI, V453, P80, DOI 10.1111/j.1749-6632.1985.tb11800.x; Canton M, 2002, FEBS LETT, V522, P168, DOI 10.1016/S0014-5793(02)02926-5; CIMINO GD, 1985, ANNU REV BIOCHEM, V54, P1151, DOI 10.1146/annurev.bi.54.070185.005443; Di Cosimo S, 2010, NAT REV CLIN ONCOL, V7, P139, DOI 10.1038/nrclinonc.2009.234; EDELSON R, 1987, NEW ENGL J MED, V316, P297, DOI 10.1056/NEJM198702053160603; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Greinix HT, 1998, BLOOD, V92, P3098, DOI 10.1182/blood.V92.9.3098.421k32_3098_3104; HEARST JE, 1984, Q REV BIOPHYS, V17, P1, DOI 10.1017/S0033583500005242; Johnston S, 2008, J CLIN ONCOL, V26, P1066, DOI 10.1200/JCO.2007.13.9949; LASKIN JD, 1985, P NATL ACAD SCI USA, V82, P6158, DOI 10.1073/pnas.82.18.6158; Liang K, 2003, MOL CANCER THER, V2, P1113; MERMELSTEIN FH, 1989, MOL PHARMACOL, V36, P848; Nahta R, 2006, NAT CLIN PRACT ONCOL, V3, P269, DOI 10.1038/ncponc0509; PARRISH JA, 1974, NEW ENGL J MED, V291, P1207, DOI 10.1056/NEJM197412052912301; Polier S, 2013, NAT CHEM BIOL, V9, P307, DOI [10.1038/NCHEMBIO.1212, 10.1038/nchembio.1212]; Rabindran SK, 2004, CANCER RES, V64, P3958, DOI 10.1158/0008-5472.CAN-03-2868; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Toyooka T, 2009, CANCER RES, V69, P3492, DOI 10.1158/0008-5472.CAN-08-2546; Xia W, 2006, P NATL ACAD SCI USA, V103, P7795, DOI 10.1073/pnas.0602468103; Xia WL, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3480; Xia WL, 2011, MOL CANCER THER, V10, P1367, DOI 10.1158/1535-7163.MCT-10-0991; Xia WL, 2005, ONCOGENE, V24, P6213, DOI 10.1038/sj.onc.1208774	25	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88983	10.1371/journal.pone.0088983	http://dx.doi.org/10.1371/journal.pone.0088983			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551203	Green Published, Green Submitted, gold			2022-12-27	WOS:000331271500089
J	Shim, HJ; Lee, EM; Nguyen, LD; Shim, J; Song, YH				Shim, Hee Jin; Lee, Eun-Mi; Long Duy Nguyen; Shim, Jaekyung; Song, Young-Han			High-Dose Irradiation Induces Cell Cycle Arrest, Apoptosis, and Developmental Defects during Drosophila Oogenesis	PLOS ONE			English	Article							DNA-DAMAGE CHECKPOINT; IONIZING-RADIATION; MEIOTIC CHECKPOINT; MELANOGASTER; ACTIVATION; REPAIR; ATM; TRANSLATION; GURKEN; STRESS	Ionizing radiation (IR) treatment induces a DNA damage response, including cell cycle arrest, DNA repair, and apoptosis in metazoan somatic cells. Because little has been reported in germline cells, we performed a temporal analysis of the DNA damage response utilizing Drosophila oogenesis as a model system. Oogenesis in the adult Drosophila female begins with the generation of 16-cell cyst by four mitotic divisions of a cystoblast derived from the germline stem cells. We found that high-dose irradiation induced S and G2 arrests in these mitotically dividing germline cells in a grp/Chk1- and mnk/Chk2-dependent manner. However, the upstream kinase mei-41, Drosophila ATR ortholog, was required for the S-phase checkpoint but not for the G2 arrest. As in somatic cells, mnk/Chk2 and dp53 were required for the major cell death observed in early oogenesis when oocyte selection and meiotic recombination occurs. Similar to the unscheduled DNA double-strand breaks (DSBs) generated from defective repair during meiotic recombination, IR-induced DSBs produced developmental defects affecting the spherical morphology of meiotic chromosomes and dorsal-ventral patterning. Moreover, various morphological abnormalities in the ovary were detected after irradiation. Most of the IR-induced defects observed in oogenesis were reversible and were restored between 24 and 96 h after irradiation. These defects in oogenesis severely reduced daily egg production and the hatch rate of the embryos of irradiated female. In summary, irradiated germline cells induced DSBs, cell cycle arrest, apoptosis, and developmental defects resulting in reduction of egg production and defective embryogenesis.	[Shim, Hee Jin; Lee, Eun-Mi; Long Duy Nguyen; Song, Young-Han] Hallym Univ, Ilsong Inst Life Sci, Anyang, Gyeonggi Do, South Korea; [Shim, Jaekyung] Sejong Univ, Dept Mol Biol, Seoul, South Korea	Hallym University; Sejong University	Song, YH (corresponding author), Hallym Univ, Ilsong Inst Life Sci, Anyang, Gyeonggi Do, South Korea.	ysong@hallym.ac.kr		Song, Young-Han/0000-0002-0758-3654	Mid-career Researcher Program through the NRF; MEST Korea [NRF-2007-0054123]	Mid-career Researcher Program through the NRF(National Research Foundation of Korea); MEST Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Mid-career Researcher Program through the NRF grant funded by the MEST (NRF-2007-0054123) Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdu U, 2002, CURR BIOL, V12, P1645, DOI 10.1016/S0960-9822(02)01165-X; Ashburner M, 2005, DROSOPHILA LAB HDB; Bi XL, 2005, GENETICS, V171, P845, DOI 10.1534/genetics.105.047720; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brodsky MH, 2004, MOL CELL BIOL, V24, P1219, DOI 10.1128/MCB.24.3.1219-1231.2004; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Ghabrial A, 1999, NAT CELL BIOL, V1, P354, DOI 10.1038/14046; Hong A, 2007, EMBO J, V26, P2071, DOI 10.1038/sj.emboj.7601648; Jaklevic BR, 2004, CURR BIOL, V14, P23, DOI 10.1016/j.cub.2003.12.032; Joyce EF, 2011, J CELL BIOL, V195, P359, DOI 10.1083/jcb.201104121; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Kondo S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001350; Lancaster OM, 2007, J CELL BIOL, V179, P817, DOI 10.1083/jcb.200706067; Lancaster OM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001179; LaRocque JR, 2007, GENETICS, V175, P1023, DOI 10.1534/genetics.106.067330; Lee EM, 2012, DNA REPAIR, V11, P741, DOI 10.1016/j.dnarep.2012.06.007; Mathe E, 2004, METH MOL B, V247, P89; Mehrotra S, 2006, PLOS GENET, V2, P1883, DOI 10.1371/journal.pgen.0020200; Mehrotra S, 2008, GENE DEV, V22, P3158, DOI 10.1101/gad.1710208; Sibon OCM, 1999, CURR BIOL, V9, P302, DOI 10.1016/S0960-9822(99)80138-9; Song YH, 2005, MOL CELLS, V19, P167; Song YH, 2004, CURR BIOL, V14, P1354, DOI 10.1016/j.cub.2004.06.064; Takada S, 2003, CELL, V113, P87, DOI 10.1016/S0092-8674(03)00202-2; TOUCHBERRY RW, 1964, GENETICS, V49, P387; Vermezovic J, 2012, CELL DEATH DIFFER, V19, P1847, DOI 10.1038/cdd.2012.69; Wichmann A, 2006, P NATL ACAD SCI USA, V103, P9952, DOI 10.1073/pnas.0510528103; WIESCHAUS E, 1979, DEV BIOL, V68, P29, DOI 10.1016/0012-1606(79)90241-0	27	18	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89009	10.1371/journal.pone.0089009	http://dx.doi.org/10.1371/journal.pone.0089009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551207	Green Published, Green Submitted, gold			2022-12-27	WOS:000331266000088
J	Sierra, E; Fernandez, A; de los Monteros, AE; Arbelo, M; Diaz-Delgado, J; Andrada, M; Herraez, P				Sierra, Eva; Fernandez, Antonio; Espinosa de los Monteros, Antonio; Arbelo, Manuel; Diaz-Delgado, Josue; Andrada, Marisa; Herraez, Pedro			Histopathological Muscle Findings May Be Essential for a Definitive Diagnosis of Suspected Sharp Trauma Associated with Ship Strikes in Stranded Cetaceans	PLOS ONE			English	Article							SKELETAL-MUSCLE; CAPTURE MYOPATHY; WHALES; STRESS; INJURY; DEATH; RHABDOMYOLYSIS; PATHOGENESIS; ADAPTATION; COLLISIONS	Ship strikes are a major issue for the conservation of may cetacean species. Certain gross and microscopic criteria have been previously reported for establishing a diagnosis of death due to ship strikes in these animals. However, some ship-strike injuries may be masked by advanced carcass decomposition and may be undetectable due to restricted access to the animals. In this report we describe histopathological muscular findings in 13 cetaceans with sharp trauma from ship strikes as the cause of death. Skeletal muscle samples were taken from the incision site and from the main locomotor muscle, the longissimus dorsi, in areas not directly affected by the sharp injury. The microscopic findings in tissues from both sites mainly consisted of haemorrhages; oedema; flocculent, granular or/ and hyalinised segmentary degeneration; contraction band necrosis; and discoid degeneration or fragmentation of myofibres. We propose that skeletal muscle histopathology provides evidence of ante-mortem injuries even if the sample was taken elsewhere in the carcass and not only within or adjacent to the sharp trauma site and despite the advanced decomposition of some of the carcasses. This method helps to establish the diagnosis of ship strike as the cause of death.	[Sierra, Eva; Fernandez, Antonio; Espinosa de los Monteros, Antonio; Arbelo, Manuel; Diaz-Delgado, Josue; Andrada, Marisa; Herraez, Pedro] Univ Las Palmas Gran Canaria, Sch Vet, Inst Anim Hlth, Unit Histol & Vet Pathol, Arucas Las Palmas, Canary Islands, Spain	Universidad de Las Palmas de Gran Canaria	Sierra, E (corresponding author), Univ Las Palmas Gran Canaria, Sch Vet, Inst Anim Hlth, Unit Histol & Vet Pathol, Arucas Las Palmas, Canary Islands, Spain.	esierra@becarios.ulpgc.es	Borzollino, Marisa Ana Andrada/M-3870-2014; Fernandez, Antonio/G-3448-2015; Arbelo, Manuel/D-6789-2013; Sierra, Eva/H-9352-2015	Fernandez, Antonio/0000-0001-5281-0521; Arbelo, Manuel/0000-0002-1623-5010; Sierra, Eva/0000-0003-3749-8845; Herraez, Pedro/0000-0001-9316-2882	Ministerio de Ciencia, Investigacion e Innovacion [CGL2009-13052]; Ministerio de Economia e Innovacion [CGL2012-39681]; Direccion General de Innovacion, Spain [C200801000288]	Ministerio de Ciencia, Investigacion e Innovacion; Ministerio de Economia e Innovacion(Spanish Government); Direccion General de Innovacion, Spain	This study was supported by the following projects: CGL2009-13052, from the Ministerio de Ciencia, Investigacion e Innovacion; CGL2012-39681, from the Ministerio de Economia e Innovacion; and the C200801000288, from the Direccion General de Innovacion, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegboyega PA, 1996, CARDIOVASC PATHOL, V5, P315, DOI 10.1016/S1054-8807(96)00041-5; Allen C., 1992, ARMED FORCES I PATHO, P53; Arbelo M, 2013, DIS AQUAT ORGAN, V103, P87, DOI 10.3354/dao02558; Arnicia E., 1992, AFIP LAB METHODS HIS, V1st, P98; Campbell-Malone R, 2008, J ZOO WILDLIFE MED, V39, P37, DOI 10.1638/2006-0057.1; Carrillo Manuel, 2010, Journal of Cetacean Research and Management, V11, P131; Chapman CR, 2008, J PAIN, V9, P122, DOI 10.1016/j.jpain.2007.09.006; Cowan DF, 2008, J COMP PATHOL, V139, P24, DOI 10.1016/j.jcpa.2007.11.009; Cowan DF, 2002, LJ0224C NAT MAR FISH; De Kloet ER, 2004, ANN NY ACAD SCI, V1032, P14, DOI 10.1196/annals.1314.003; Dhalla N, 1992, CARDIOTOXICITY CATEC; FECHNER G, 1991, INT J LEGAL MED, V104, P215, DOI 10.1007/BF01369810; Fieguth A, 2003, FORENSIC SCI INT, V135, P218, DOI 10.1016/S0379-0738(03)00210-X; Gaffney E, 1992, AM REGISTRY PATHOLOG, P149; Geraci JR, 2005, MARINE MAMMALS ASHOR, P182; GONCHAR' M G, 1990, Arkhiv Anatomii Gistologii i Embriologii, V98, P13; Herraez P, 2007, J WILDLIFE DIS, V43, P770, DOI 10.7589/0090-3558-43.4.770; Herraez P, 2013, VET J, V196, P181, DOI 10.1016/j.tvjl.2012.09.021; HOWELL A. BRAZIER, 1928, PROC U S NATION MUS, V73, P1; Hulland TJ, 1993, PATHOLOGY DOMESTIC A, V1, P220; Johnson FB, 1992, AFIP LAB METHODS HIS, P197; Kuiken T, 1993, NEWSLETTER, V17; Laist DW, 2001, MAR MAMMAL SCI, V17, P35, DOI 10.1111/j.1748-7692.2001.tb00980.x; Martin V, 2009, P 18 C BIOL MAR MAMM; MCEWEN SA, 1986, VET PATHOL, V23, P400, DOI 10.1177/030098588602300409; MOORE DH, 1956, J BIOPHYS BIOCHEM CY, V2, P755, DOI 10.1083/jcb.2.6.755; Moore MJ, 2013, DIS AQUAT ORGAN, V103, P229, DOI 10.3354/dao02566; Noren SR, 2000, COMP BIOCHEM PHYS A, V126, P181, DOI 10.1016/S1095-6433(00)00182-3; Pabst DA, 1993, J ZOOLOGY LONDON, V230, P1; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Panigada S, 2006, MAR POLLUT BULL, V52, P1287, DOI 10.1016/j.marpolbul.2006.03.014; Pugliares K, 2007, 200706 WOODS HOL OC, P117; SEKAMOVA S M, 1976, Arkhiv Patologii, V38, P25; SEKAMOVA SM, 1986, ARK PATOL, V48, P39; Selye H, 1936, NATURE, V138, P32, DOI 10.1038/138032a0; SELYE H, 1946, J CLIN ENDOCR METAB, V6, P117, DOI 10.1210/jcem-6-2-117; Shkrum M.J., 2007, FORENSIC PATHOLOGY T; Sierra E, 2012, VET J, V193, P152, DOI 10.1016/j.tvjl.2011.09.021; Sierra E, 2013, J WILDLIFE DIS, V49, P679, DOI 10.7589/2012-04-103; Sierra E, 2013, SCI REP-UK, V3, DOI 10.1038/srep01795; Stekelenburg A, 2006, J APPL PHYSIOL, V100, P1946, DOI 10.1152/japplphysiol.00889.2005; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; TULSI RS, 1975, J ANAT, V119, P39; Turnbull BS, 1998, J COMP PATHOL, V118, P317, DOI 10.1016/S0021-9975(07)80007-7; Valentine BA, 2007, VET REC, V161, P786; Valentine BA, 2007, PATHOLOGIC BASES VET, V63149, P989; Van der Hoop JM, 2013, CONSERV BIOL, V27, P121, DOI 10.1111/j.1523-1739.2012.01934.x; Van Waerebeek K, 2007, SC59BC12 INT WHAL CO; Van Waerebeek K, 2008, SC60BC5 INT WHAL COM; YOUNG JG, 1956, AM J PHYSIOL, V186, P67, DOI 10.1152/ajplegacy.1956.186.1.67; [No title captured]; [No title captured]	52	17	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88780	10.1371/journal.pone.0088780	http://dx.doi.org/10.1371/journal.pone.0088780			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551162	Green Published, gold, Green Submitted			2022-12-27	WOS:000331266000068
J	Li, H; Glusman, G; Huff, C; Caballero, J; Roach, JC				Li, Hong; Glusman, Gustavo; Huff, Chad; Caballero, Juan; Roach, Jared C.			Accurate and Robust Prediction of Genetic Relationship from Whole-Genome Sequences	PLOS ONE			English	Article							ASSOCIATION; PEDIGREE; GENOTYPE; FORMAT; LOCI	Computing the genetic relationship between two humans is important to studies in genetics, genomics, genealogy, and forensics. Relationship algorithms may be sensitive to noise, such as that arising from sequencing errors or imperfect reference genomes. We developed an algorithm for estimation of genetic relationship by averaged blocks (GRAB) that is designed for whole-genome sequencing (WGS) data. GRAB segments the genome into blocks, calculates the fraction of blocks sharing identity, and then uses a classification tree to infer 1st- to 5th-degree relationships and unrelated individuals. We evaluated GRAB on simulated and real sequenced families, and compared it with other software. GRAB achieves similar performance, and does not require knowledge of population background or phasing. GRAB can be used in workflows for identifying unreported relationships, validating reported relationships in family-based studies, and detection of sample-tracking errors or duplicate inclusion. The software is available at familygenomics.systemsbiology.net/grab.	[Li, Hong; Glusman, Gustavo; Caballero, Juan; Roach, Jared C.] Inst Syst Biol, Seattle, WA USA; [Huff, Chad] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	Institute for Systems Biology (ISB); University of Texas System; UTMD Anderson Cancer Center	Roach, JC (corresponding author), Inst Syst Biol, Seattle, WA USA.	jroach@systemsbiology.org		Glusman, Gustavo/0000-0001-8060-5955; Caballero Perez, Juan/0000-0002-6160-3644	National Institutes of Health [GM076547]; University of Luxembourg - ISB Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Luxembourg - ISB Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health [grant GM076547] and the University of Luxembourg - ISB Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brush G, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S41; Cherny SS, 2001, GENET EPIDEMIOL, V21, pS117, DOI 10.1002/gepi.2001.21.s1.s117; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Huff CD, 2011, GENOME RES, V21, P768, DOI 10.1101/gr.115972.110; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reese MG, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r88; Roach JC, 2011, AM J HUM GENET, V89, P382, DOI 10.1016/j.ajhg.2011.07.023; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Roberson EDO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006711; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Staples J, 2013, GENET EPIDEMIOL, V37, P136, DOI 10.1002/gepi.21684; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weir BS, 2006, NAT REV GENET, V7, P771, DOI 10.1038/nrg1960	15	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e85437	10.1371/journal.pone.0085437	http://dx.doi.org/10.1371/journal.pone.0085437			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586241	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200007
J	Yap, L; Carruthers, S; Thompson, S; Cheng, W; Jones, J; Simpson, P; Richards, A; Thein, HH; Haber, P; Lloyd, A; Butler, T				Yap, Lorraine; Carruthers, Susan; Thompson, Sandra; Cheng, Wendy; Jones, Jocelyn; Simpson, Paul; Richards, Alun; Thein, Hla-Hla; Haber, Paul; Lloyd, Andrew; Butler, Tony			A Descriptive Model of Patient Readiness, Motivators, and Hepatitis C Treatment Uptake among Australian Prisoners	PLOS ONE			English	Article							INJECTION-DRUG USERS; VIRUS HCV INFECTION; COINFECTION; BARRIERS; ACCESS; CARE; FEASIBILITY; CLIENTS; PEOPLE; SYSTEM	Background: Hepatitis C virus infection (HCV) has a significant global health burden with an estimated 2%-3% of the world's population infected, and more than 350,000 dying annually from HCV-related conditions including liver failure and liver cancer. Prisons potentially offer a relatively stable environment in which to commence treatment as they usually provide good access to health care providers, and are organised around routine and structure. Uptake of treatment of HCV, however, remains low in the community and in prisons. In this study, we explored factors affecting treatment uptake inside prisons and hypothesised that prisoners have unique issues influencing HCV treatment uptake as a consequence of their incarceration which are not experienced in other populations. Method and Findings: We undertook a qualitative study exploring prisoners' accounts of why they refused, deferred, delayed or discontinued HCV treatment in prison. Between 2010 and 2013, 116 Australian inmates were interviewed from prisons in New South Wales, Queensland, and Western Australia. Prisoners experienced many factors similar to those which influence treatment uptake of those living with HCV infection in the community. Incarceration, however, provides different circumstances of how these factors are experienced which need to be better understood if the number of prisoners receiving treatment is to be increased. We developed a descriptive model of patient readiness and motivators for HCV treatment inside prisons and discussed how we can improve treatment uptake among prisoners. Conclusion: This study identified a broad and unique range of challenges to treatment of HCV in prison. Some of these are likely to be diminished by improving treatment options and improved models of health care delivery. Other barriers relate to inmate understanding of their illness and stigmatisation by other inmates and custodial staff and generally appear less amenable to change although there is potential for peer-based education to address lack of knowledge and stigma.	[Yap, Lorraine; Simpson, Paul; Thein, Hla-Hla; Butler, Tony] Univ New S Wales, Kirby Inst, Justice Hlth Res Program, Sydney, NSW, Australia; [Carruthers, Susan; Jones, Jocelyn] Curtin Univ, Natl Drug Res Inst, Perth, WA 6845, Australia; [Thompson, Sandra] Combined Univ Rural Hlth, Geraldton, WA, Australia; [Cheng, Wendy] Royal Perth Hosp, Perth, WA 6001, Australia; [Richards, Alun] Queensland Hlth, Offender Hlth Serv, Brisbane, Qld, Australia; [Thein, Hla-Hla] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Haber, Paul] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Lloyd, Andrew] Univ New S Wales, Inflammat & Infect Res Ctr, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute; Curtin University; Royal Perth Hospital; University of Western Australia; Queensland Health; University of Toronto; University of Sydney; University of New South Wales Sydney	Yap, L (corresponding author), Univ New S Wales, Kirby Inst, Justice Hlth Res Program, Sydney, NSW, Australia.	l.yap@unsw.edu.au	Lloyd, Andrew/AFJ-8960-2022; Lloyd, Andrew/E-7334-2017; Lloyd, Andrew/AAF-6071-2022	Lloyd, Andrew/0000-0001-6277-8887; Lloyd, Andrew/0000-0001-6277-8887; Jones, Jocelyn/0000-0001-6260-0472; Butler, Tony/0000-0002-2679-2769; Thein, Hla-Hla/0000-0003-4950-187X	National Health and Medical Research Council (NHMRC) [594444]; Australian Research Council (ARC) [FT0991864]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council)	This study was supported by a National Health and Medical Research Council (NHMRC) grant (No. 594444). Tony Butler is supported by an Australian Research Council (ARC) Future Fellowship (No. FT0991864). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Material in this paper cannot be considered as either endorsed by or an expression of the policies or views of the departments of corrective services.	Allen SA, 2003, ANN INTERN MED, V138, P187, DOI 10.7326/0003-4819-138-3-200302040-00010; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Averhoff FM, 2012, CLIN INFECT DIS, V55, pS10, DOI 10.1093/cid/cis361; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Boonwaat L, 2010, MED J AUSTRALIA, V192, P496, DOI 10.5694/j.1326-5377.2010.tb03605.x; Butler T, 2001, 2001 INMATE HLTH SUR; Butler T., 2017, NATL PRISON ENTRANTS; Butler T, 2007, AUST NZ J PUBL HEAL, V31, P44, DOI 10.1111/j.1753-6405.2007.00009.x; Coupland H, 2009, HEALTH PROMOT J AUST, V20, P234, DOI 10.1071/HE09234; Crofts, 1997, Health Hum Rights, V2, P86, DOI 10.2307/4065273; Dai CY, 2010, DIGEST DIS SCI, V55, P3300, DOI 10.1007/s10620-010-1452-6; DOHA, 2012, COMM DIS INT AUSTR N; Dore GJ, 2012, MED J AUSTRALIA, V196, P629, DOI 10.5694/mja11.11531; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Gidding HF, 2009, J GASTROEN HEPATOL, V24, P1648, DOI 10.1111/j.1440-1746.2009.05910.x; Glaser B.G., 1968, DISCOV GROUNDED THEO; Grebely J, 2008, DRUG ALCOHOL DEPEN, V93, P141, DOI 10.1016/j.drugalcdep.2007.09.008; Grebely J, 2013, J INFECT DIS, V207, pS19, DOI 10.1093/infdis/jis928; Grebely J, 2011, CURR OPIN HIV AIDS, V6, P501, DOI 10.1097/COH.0b013e32834bcb36; Holt DT, 2007, RES ORGAN CHAN DEV, V16, P289, DOI 10.1016/S0897-3016(06)16009-7; Khaw FM, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-98; Lloyd AR, 2013, CLIN INFECT DIS, V56, P1078, DOI 10.1093/cid/cis1202; Maru DSR, 2008, CLIN INFECT DIS, V47, P952, DOI 10.1086/591707; McLaren M, 2008, CAN J GASTROENTEROL, V22, P133, DOI 10.1155/2008/949582; McNally S, 2009, RECOGNISING RESPONDI; Mehta SH, 2005, AIDS, V19, pS179, DOI 10.1097/01.aids.0000192088.72055.90; Norman J, 2008, HARM REDUCT J, V5, DOI 10.1186/1477-7517-5-8; Osilla KC, 2009, AIDS PATIENT CARE ST, V23, P993, DOI 10.1089/apc.2009.0153; Post JJ, 2013, CLIN INFECT DIS, V57, pS70, DOI 10.1093/cid/cit265; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Scheft H, 2005, CLIN INFECT DIS, V40, pS292, DOI 10.1086/427443; Strathdee SA, 2005, CLIN INFECT DIS, V40, pS304, DOI 10.1086/427445; The Kirby Institute, 2012, HIV VIR HEP SEX TRAN; Treloar C, 2010, J VIRAL HEPATITIS, V17, P839, DOI 10.1111/j.1365-2893.2009.01250.x; Treloar C, 2008, AUST HEALTH REV, V32, P570, DOI 10.1071/AH080570; Vickerman P, 2011, DRUG ALCOHOL DEPEN, V113, P83, DOI 10.1016/j.drugalcdep.2010.08.001; Wagner GJ, 2005, AIDS, V19, pS190, DOI 10.1097/01.aids.0000192089.54130.b6; Walsh N, 2008, J GASTROEN HEPATOL, V23, P1891, DOI 10.1111/j.1440-1746.2008.05508.x; Ward JW, 2012, GASTROENTEROLOGY, V143, P887, DOI 10.1053/j.gastro.2012.08.027; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	40	34	34	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e87564	10.1371/journal.pone.0087564	http://dx.doi.org/10.1371/journal.pone.0087564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586281	Green Published, gold			2022-12-27	WOS:000332390800004
J	Brown, VL; Drake, JM; Barton, HD; Stallknecht, DE; Brown, JD; Rohani, P				Brown, Vicki L.; Drake, John M.; Barton, Heather D.; Stallknecht, David E.; Brown, Justin D.; Rohani, Pejman			Neutrality, Cross-Immunity and Subtype Dominance in Avian Influenza Viruses	PLOS ONE			English	Article							ENVIRONMENTAL TRANSMISSION; A VIRUSES; DYNAMICS; PATTERNS; H5N1; DETERMINANTS; COEXISTENCE; PERSISTENCE; DUCKS	Avian influenza viruses (AIVs) are considered a threat for their potential to seed human influenza pandemics. Despite their acknowledged importance, there are significant unknowns regarding AIV transmission dynamics in their natural hosts, wild birds. Of particular interest is the difference in subtype dynamics between human and bird populations-in human populations, typically only two or three subtypes cocirculate, while avian populations are capable of simultaneously hosting a multitude of subtypes. One species in particular-ruddy turnstones (Arenaria interpres)-has been found to harbour a very wide range of AIV subtypes, which could make them a key player in the spread of new subtypes in wild bird populations. Very little is known about the mechanisms that drive subtype dynamics in this species, and here we address this gap in our knowledge. Taking advantage of two independent sources of data collected from ruddy turnstones in Delaware Bay, USA, we examine patterns of subtype diversity and dominance at this site. We compare these patterns to those produced by a stochastic, multi-strain transmission model to investigate possible mechanisms that are parsimonious with the observed subtype dynamics. We find, in agreement with earlier experimental work, that subtype differences are unnecessary to replicate the observed dynamics, and that neutrality alone is sufficient. We also evaluate the role of subtype cross-immunity and find that it is not necessary to generate patterns consistent with observations. This work offers new insights into the mechanisms behind subtype diversity and dominance in a species that has the potential to be a key player in AIV dynamics in wild bird populations.	[Brown, Vicki L.; Rohani, Pejman] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Brown, Vicki L.; Rohani, Pejman] Univ Michigan, Ctr Study Complex Syst, Ann Arbor, MI 48109 USA; [Drake, John M.; Barton, Heather D.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Stallknecht, David E.; Brown, Justin D.] Univ Georgia, Southeastern Cooperat Wildlife Dis Study, Athens, GA 30602 USA; [Rohani, Pejman] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Rohani, P (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	rohani@umich.edu		Drake, John/0000-0003-4646-1235; rohani, pejman/0000-0002-7221-3801; Brown, Victoria/0000-0002-9751-0984	James S. McDonnell Foundation; National Science Foundation [DEB-0917853]; RAPIDD program of the Science & Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services [HHSN266200700007C]	James S. McDonnell Foundation; National Science Foundation(National Science Foundation (NSF)); RAPIDD program of the Science & Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the James S. McDonnell Foundation and the National Science Foundation (DEB-0917853). PR was also supported by the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. DES and JDB were also supported by the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services, under Contract HHSN266200700007C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 1975, TEMPORAL GEOGRAPHIC, V125; Belshe RB, 2005, NEW ENGL J MED, V353, P2209, DOI 10.1056/NEJMp058281; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; Brown VL, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0804; Brown VL, 2012, BIOL LETTERS, V8, P1036, DOI 10.1098/rsbl.2012.0635; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Delaware Department of Natural Resources and Environmental Control, 2011, 2011 2012 DEL MIGR G; Drilling N., 2002, MALLARD ANAS PLATYRH; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gilbert M, 2008, P NATL ACAD SCI USA, V105, P4769, DOI 10.1073/pnas.0710581105; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799; Gomes MGM, 2002, P ROY SOC B-BIOL SCI, V269, P227, DOI 10.1098/rspb.2001.1869; HALVORSON DA, 1985, APPL ENVIRON MICROB, V49, P914, DOI 10.1128/AEM.49.4.914-919.1985; Keeling, 2008, MODELLING INFECT DIS; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Krauss S, 2010, P ROY SOC B-BIOL SCI, V277, P3373, DOI 10.1098/rspb.2010.1090; Lebarbenchon C, 2012, P R SOC B; Lipsitch M, 2009, EPIDEMICS-NETH, V1, P2, DOI 10.1016/j.epidem.2008.07.001; Longcore JR, 2000, BIRDS N AM, DOI [10.2173/bna.481, DOI 10.2173/BNA.481]; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Maxted AM, 2012, J WILDLIFE DIS, V48, P322, DOI 10.7589/0090-3558-48.2.322; Nettleship D. N., 2000, BIRDS N AM, DOI [10. 2173/bna. 537, DOI 10.2173/BNA.537]; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Roche B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-87; Roche B, 2010, EPIDEMICS-NETH, V2, P92, DOI 10.1016/j.epidem.2010.03.002; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; Sharp GB, 1997, J VIROL, V71, P6128, DOI 10.1128/JVI.71.8.6128-6135.1997; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; To KKW, 2013, LANCET INFECT DIS, V13, P809, DOI 10.1016/S1473-3099(13)70167-1; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250; Wood SN, 2010, NATURE, V466, P1102, DOI 10.1038/nature09319	37	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e88817	10.1371/journal.pone.0088817	http://dx.doi.org/10.1371/journal.pone.0088817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586401	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900013
J	Sowa, K; Watanabe, T; Kan, H; Yamano, H				Sowa, Kohki; Watanabe, Tsuyoshi; Kan, Hironobu; Yamano, Hiroya			Influence of Land Development on Holocene Porites Coral Calcification at Nagura Bay, Ishigaki Island, Japan	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; GREAT-BARRIER-REEF; OKINAWA TROUGH; EQUATORIAL PACIFIC; SKELETAL EXTENSION; LAST DEGLACIATION; GROWTH-RATES; TEMPORAL VARIABILITY; KUROSHIO CURRENT; MASSIVE PORITES	To evaluate the relationships between coral calcification, thermal stress, and sedimentation and eutrophication linked to human impact (hereafter referred to as "land development") by river discharge, we analyzed growth characteristics in the context of a paleoenvironment that was reconstructed from geochemical signals in modern and fossil (1.2 cal kyr BP and 3.5 cal kyr BP, respectively) massive Porites corals from Nagura Bay ("Nagura") and from modern Porites corals from the estuary of the Todoroki River, Shiraho Reef ("Todoroki"). Both sites are on Ishigaki Island, Japan, and Nagura is located approximately 12 km west of Todoroki. At Nagura, the individual corals provide time windows of 13 (modern), 10 (1.2 cal kyr BP), and 38 yr in length (3.5 cal kyr BP). Here, we present the coral annual calcification for Nagura and Todoroki, and (bi) monthly resolved records of Sr/Ca (a proxy of sea surface temperature (SST)) and Ba/Ca (a proxy of sedimentation and nutrients related to land development) for Nagura. At Nagura, the winter SST was cooler by 2.8 degrees C in the 1.2 cal kyr BP, and the annual and winter SSTs in the 3.5 cal kyr BP were cooler by 2.6 degrees C and 4.6 degrees C, respectively. The annual periodicity of Ba/Ca in modern coral is linked to river discharge and is associated with land development including sugar cane cultivation. Modern coral calcification also has declined with SST warming and increasing Ba/Ca peaks in winter. However, calcification of fossil corals does not appear to have been influenced by variations in Sr/Ca and Ba/Ca. Modern coral growth characteristics at Nagura and Todoroki indicate that coral growth is both spatially and temporally influenced by river discharge and land development. At Nagura, our findings suggest that land development induces negative thermal sensitivity for calcification in winter due to sugar cane harvest, which is a specifically modern phenomenon.	[Sowa, Kohki; Watanabe, Tsuyoshi] Hokkaido Univ, Dept Nat Hist Sci, Sapporo, Hokkaido, Japan; [Kan, Hironobu] Okayama Univ, Grad Sch Nat Sci, Grad Sch Educ, Okayama 7008530, Japan; [Yamano, Hiroya] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan	Hokkaido University; Okayama University; National Institute for Environmental Studies - Japan	Sowa, K (corresponding author), Hokkaido Univ, Dept Nat Hist Sci, Sapporo, Hokkaido, Japan.	sowa@frontier.hokudai.ac.jp	Sowa, Kohki/T-7332-2019	Kan, Hironobu/0000-0003-2693-9596; Sowa, Kohki/0000-0001-6382-4865; Yamano, Hiroya/0000-0002-1549-2429	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [20121004]	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas "Coral reef science for symbiosis and coexistence of human and ecosystem under combined stresses" (No. 20121004) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram NJ, 2001, CORAL REEFS, V20, P221; Alibert C, 2003, GEOCHIM COSMOCHIM AC, V67, P231, DOI 10.1016/S0016-7037(02)01055-4; Anderegg D., 1997, P1725; Asami R, 2009, EARTH PLANET SC LETT, V288, P96, DOI 10.1016/j.epsl.2009.09.011; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; BECK JW, 1992, SCIENCE, V257, P644, DOI 10.1126/science.257.5070.644; Beck JW, 1997, NATURE, V385, P705, DOI 10.1038/385705a0; BROWN B, 1986, MAR BIOL, V93, P83, DOI 10.1007/BF00428657; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Carilli J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034418; Carilli JE, 2010, GLOBAL CHANGE BIOL, V16, P1247, DOI 10.1111/j.1365-2486.2009.02043.x; Carilli JE, 2009, MAR POLLUT BULL, V58, P1835, DOI 10.1016/j.marpolbul.2009.07.024; Carlton R, 1996, PRINCIPLES RADIOGRAP; Carr J., 2013, CORAL REEFS, V41, P1, DOI [10.1007/s00338-013-1028-y, DOI 10.1007/S00338-013-1028-Y:1-9]; Carricart-Ganivet JP, 2007, MAR BIOL, V153, P1, DOI 10.1007/s00227-007-0780-3; Carricart-Ganivet JP, 2004, J EXP MAR BIOL ECOL, V302, P249, DOI 10.1016/j.jembe.2003.10.015; Carricart-Ganivet JP, 2007, J EXP MAR BIOL ECOL, V344; Carricart-Ganivet JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032859; Castillo KD, 2012, NAT CLIM CHANGE, V2, P756, DOI [10.1038/nclimate1577, 10.1038/NCLIMATE1577]; Castillo KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014615; CHALKER BE, 1990, CORAL REEFS, V9, P11, DOI 10.1007/BF00686717; Cooper TF, 2008, GLOBAL CHANGE BIOL, V14, P529, DOI 10.1111/j.1365-2486.2007.01520.x; Cooper TF, 2012, SCIENCE, V335, P593, DOI 10.1126/science.1214570; Correge T, 2006, PALAEOGEOGR PALAEOCL, V232, P408, DOI 10.1016/j.palaeo.2005.10.014; Correge T, 2004, NATURE, V428, P927, DOI 10.1038/nature02506; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; DeLong KL, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002758; DEVILLIERS S, 1995, SCIENCE, V269, P1247, DOI 10.1126/science.269.5228.1247; Dietzel M, 2004, CHEM GEOL, V203, P139, DOI 10.1016/j.chemgeo.2003.09.008; DODGE RE, 1984, B MAR SCI, V34, P288; Dunn JG, 2012, J EXP MAR BIOL ECOL, V411, P34, DOI 10.1016/j.jembe.2011.10.013; Dykoski CA, 2005, EARTH PLANET SC LETT, V233, P71, DOI 10.1016/j.epsl.2005.01.036; Edinger EN, 2000, MAR POLLUT BULL, V40, P404, DOI 10.1016/S0025-326X(99)00237-4; Fallon SJ, 1999, EARTH PLANET SC LETT, V172, P221, DOI 10.1016/S0012-821X(99)00200-9; Gagan MK, 1998, SCIENCE, V279, P1014, DOI 10.1126/science.279.5353.1014; Ge QS, 2004, PROG NAT SCI-MATER, V14, P730, DOI 10.1080/10020070412331344241; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; GOREAU TJ, 1992, AM ZOOL, V32, P683; GOREAU TJ, 1994, AMBIO, V23, P176; Guzman HM, 2008, AMBIO, V37, P342, DOI 10.1579/07-A-372.1; Guzman HM, 1998, MAR ECOL PROG SER, V166, P109, DOI 10.3354/meps166109; Halley Robert B., 2007, V192, P161; Hart SR, 1996, GEOCHIM COSMOCHIM AC, V60, P3075, DOI 10.1016/0016-7037(96)00154-8; Hasegawa H., 2011, J REMOTE SENS SOC JA, V31, P73, DOI [DOI 10.11440/RSSJ.31.73, 10.11440/rssj.31.73]; Hayashi E, 2013, EARTH PLANET SC LETT, V362, P198, DOI 10.1016/j.epsl.2012.11.046; Helmle KP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1222; Hideshima S, 2001, RADIOCARBON, V43, P473; Ikeda S, 2009, P JPN ACAD B-PHYS, V85, P374, DOI 10.2183/pjab.85.374; Isdale PJ, 1998, HOLOCENE, V8, P1, DOI 10.1191/095968398670905088; Jian ZM, 2000, EARTH PLANET SC LETT, V184, P305, DOI 10.1016/S0012-821X(00)00321-6; KNUTSON DW, 1972, SCIENCE, V177, P270, DOI 10.1126/science.177.4045.270; Koop K, 2001, MAR POLLUT BULL, V42, P91, DOI 10.1016/S0025-326X(00)00181-8; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; LaVigne M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031926; LEA DW, 1989, NATURE, V340, P373, DOI 10.1038/340373a0; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Lewis SE, 2007, PALAEOGEOGR PALAEOCL, V246, P471, DOI 10.1016/j.palaeo.2006.10.021; Li TG, 2001, PALAEOGEOGR PALAEOCL, V176, P133, DOI 10.1016/S0031-0182(01)00332-7; Lin YS, 2006, MAR MICROPALEONTOL, V59, P153, DOI 10.1016/j.marmicro.2006.02.003; Linsley BK, 2010, NAT GEOSCI, V3, P578, DOI [10.1038/NGEO920, 10.1038/ngeo920]; Liu G., 2003, EOS T AM GEOPHYS UN, V84, P137, DOI [10.1029/2003EO150001, DOI 10.1029/2003E0150001, DOI 10.1029/2003EO150001]; Lough JM, 2000, GEOPHYS RES LETT, V27, P3901, DOI 10.1029/2000GL011715; Lough JM, 2000, J EXP MAR BIOL ECOL, V245, P225, DOI 10.1016/S0022-0981(99)00168-9; Lough JM, 1997, J EXP MAR BIOL ECOL, V211, P29, DOI 10.1016/S0022-0981(96)02710-4; Marion GS, 2005, MAR POLLUT BULL, V50, P931, DOI 10.1016/j.marpolbul.2005.04.001; Marshall AT, 2004, CORAL REEFS, V23, P218, DOI 10.1007/s00338-004-0369-y; McCulloch M, 1996, EARTH PLANET SC LETT, V138, P169, DOI 10.1016/0012-821X(95)00230-A; McCulloch M, 2003, NATURE, V421, P727, DOI 10.1038/nature01361; McCulloch M, 2012, NAT CLIM CHANGE, V2, P623, DOI 10.1038/NCLIMATE1473; Montaggioni LF, 2006, PALAEOGEOGR PALAEOCL, V237, P436, DOI 10.1016/j.palaeo.2005.12.018; Moy CM, 2002, NATURE, V420, P162, DOI 10.1038/nature01194; Moyer RP, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2011PA002249; Nagtegaal R, 2012, CHEM GEOL, V318, P6, DOI 10.1016/j.chemgeo.2012.05.006; Nojima S, 2008, NIPPON SUISAN GAKK, V74, P884, DOI 10.2331/suisan.74.884; Nurhati IS, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040270; OHGAKI S-C, 1992, Japanese Journal of Ecology (Tokyo), V42, P9; Okai T, 2002, GEOSTANDARD NEWSLETT, V26, P95, DOI 10.1111/j.1751-908X.2002.tb00627.x; Omata Tamano, 2002, Report of Japan Marine Science and Technology Center, V45, P17; Osawa K, 2008, JSCE, V52, P577; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Petris G, 2009, USE R, P1, DOI 10.1007/b135794_1; Prouty NG, 2010, MAR POLLUT BULL, V60, P1822, DOI 10.1016/j.marpolbul.2010.05.024; R Development Core Team, 2011, R LANG ENV STAT COMP; REYNOLDS RW, 1994, J CLIMATE, V7, P929, DOI 10.1175/1520-0442(1994)007<0929:IGSSTA>2.0.CO;2; RISK MJ, 1991, MAR ECOL PROG SER, V69, P195, DOI 10.3354/meps069195; Rosenthal Y, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016612; Seki A, 2012, GEOCHEM J, V46, pE27, DOI 10.2343/geochemj.2.0207; Shen G, 1990, TRACE ELEMENT INDICA; Shen GT, 1992, PALEOCEANOGRAPHY, V7, P563, DOI 10.1029/92PA01825; Sheppard CRC, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198566359.001.0001; Sinclair DJ, 2005, EARTH PLANET SC LETT, V237, P354, DOI 10.1016/j.epsl.2005.06.039; Sinclair DJ, 2004, PALAEOGEOGR PALAEOCL, V214, P155, DOI 10.1016/j.palaeo.2004.07.028; Smith BJ, 2005, BAYESIAN OUTPUT ANAL; Sowa K., 2013, JAMSTEC REPORT RES D, V16, P31; Stott L, 2004, NATURE, V431, P56, DOI 10.1038/nature02903; Strong A.E., 1997, P 8 INT COR REEF S, V2, P1495; Stuiver M, 1995, QUATERNARY RES, V44, P341, DOI 10.1006/qres.1995.1079; Sun YB, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001061; Suzuki A, 2003, CORAL REEFS, V22, P357, DOI 10.1007/s00338-003-0323-4; Tanzil JTI, 2009, CORAL REEFS, V28, P519, DOI 10.1007/s00338-008-0457-5; Tudhope AW, 1996, PALAIOS, V11, P347, DOI 10.2307/3515245; Ujiie H, 1999, MAR MICROPALEONTOL, V37, P23, DOI 10.1016/S0377-8398(99)00010-9; Ujiie Y, 2003, MAR MICROPALEONTOL, V49, P335, DOI 10.1016/S0377-8398(03)00062-8; Umezawa Y, 2002, LIMNOL OCEANOGR, V47, P1405, DOI 10.4319/lo.2002.47.5.1405; Wang YJ, 2005, SCIENCE, V308, P854, DOI 10.1126/science.1106296; Watanabe T, 2011, NATURE, V471, P209, DOI 10.1038/nature09777; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Wooldridge SA, 2009, MAR POLLUT BULL, V58, P745, DOI 10.1016/j.marpolbul.2008.12.013; Worum FP, 2007, LIMNOL OCEANOGR, V52, P2317, DOI 10.4319/lo.2007.52.5.2317; Wu WC, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052749; Xiang R, 2007, PALAEOGEOGR PALAEOCL, V243, P378, DOI 10.1016/j.palaeo.2006.08.016; Xu JA, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2010PA001934; Yamada Hideaki, 2009, Bulletin of the Japanese Society of Fisheries Oceanography, V73, P8	113	27	27	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e88790	10.1371/journal.pone.0088790	http://dx.doi.org/10.1371/journal.pone.0088790			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586393	Green Published, Green Submitted, gold			2022-12-27	WOS:000331880700009
J	Bao, S; Wu, DB; Wang, QG; Su, T				Bao, Song; Wu, Dongbei; Wang, Qigang; Su, Teng			Functional Elastic Hydrogel as Recyclable Membrane for the Adsorption and Degradation of Methylene Blue	PLOS ONE			English	Article							AQUEOUS-SOLUTION; DYE REMOVAL; NANOCOMPOSITE; WATER; CLAY; MODEL	Developing the application of high-strength hydrogels has gained much attention in the fields of medical, pharmacy, and pollutant removal due to their versatility and stimulus-responsive properties. In this presentation, a high-strength freestanding elastic hydrogel membrane was constructed by clay nanosheets, N, N-dimethylacrylamide and 2-acrylamide-2-methylpropanesulfonic acid for adsorption of methylene blue and heavy metal ions. The maximum values of elongation and Young's modulus for 0.5% AMPSNa hydrogel were 1901% and 949.4 kPa, respectively, much higher than those of traditional hydrogels. The adsorptions were confirmed to follow pseudo-second kinetic equation and Langmuir isotherm model fits the data well. The maximum adsorption capacity of hydrogel towards methylene blue was 434.8 mg g(-1). The hydrogel also exhibited higher separation selectivity to Pb2+ than Cu2+. The methylene blue adsorbed onto the hydrogel membrane can be photocatalytically degraded by Fenton agent and the hydrogel membrane could be recycled at least five times without obvious loss in mechanical properties. In conclusion, this presentation demonstrates a convenient strategy to prepare tough and elastic clay nanocomposite hydrogel, which can not only be applied as recyclable membrane for the photocatalytic degradation of organic dye, but also for the recovery of valuables.	[Bao, Song; Wu, Dongbei; Wang, Qigang; Su, Teng] Tongji Univ, Dept Chem, Shanghai 200092, Peoples R China; [Wang, Qigang; Su, Teng] Tongji Univ, Adv Res Inst, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Wu, DB (corresponding author), Tongji Univ, Dept Chem, Shanghai 200092, Peoples R China.	wudongbei@tongji.edu.cn; wangqg66@tongji.edu.cn	Su, Teng/G-2709-2012; Wang, Qigang/G-1124-2010	Su, Teng/0000-0001-7888-0763; Wang, Qigang/0000-0002-4026-3337	National Natural Science Foundation of China [21274111]; Program for New Century Excellent Talents in University of Ministry of Education of China [NECT-11-0386]; Pujiang talents program [11PJ1409500]; Recruitment Program of Global Experts; Fundamental Research Funds for Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); Pujiang talents program; Recruitment Program of Global Experts; Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (No. 21274111), the Program for New Century Excellent Talents in University of Ministry of Education of China (NECT-11-0386), the Fundamental Research Funds for Central Universities, the Pujiang talents program (No. 11PJ1409500), and the Recruitment Program of Global Experts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acarregui A, 2013, BIOMACROMOLECULES, V14, P322, DOI 10.1021/bm301690a; Ariga K, 2012, CHEM MATER, V24, P728, DOI 10.1021/cm202281m; Chatterjee S, 2011, ENVIRON TECHNOL, V32, P1503, DOI 10.1080/09593330.2010.543157; Chen DH, 2012, ADV FUNCT MATER, V22, P1966, DOI 10.1002/adfm.201102878; Chen YQ, 2013, J MATER CHEM A, V1, P1992, DOI 10.1039/c2ta00406b; Coskun R, 2012, POLYM BULL, V68, P1889, DOI 10.1007/s00289-011-0664-z; Do D.D., 1998, ADSORPTION ANAL EQUI; Dou XQ, 2012, SOFT MATTER, V8, P3231, DOI 10.1039/c2sm06927j; Feng YF, 2012, BIORESOURCE TECHNOL, V125, P138, DOI 10.1016/j.biortech.2012.08.128; Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385; Geng ZG, 2012, J MATER CHEM, V22, P3527, DOI 10.1039/c2jm15544c; Gupta VK, 2012, J HAZARD MATER, V243, P179, DOI 10.1016/j.jhazmat.2012.10.018; Haraguchi K, 2002, ADV MATER, V14, P1120, DOI 10.1002/1521-4095(20020816)14:16<1120::AID-ADMA1120>3.0.CO;2-9; Haraguchi K, 2012, MACROMOLECULES, V45, P385, DOI 10.1021/ma202114z; Haraguchi K, 2011, POLYM J, V43, P223, DOI 10.1038/pj.2010.141; Kasgoz H, 2008, POLYM ADVAN TECHNOL, V19, P838, DOI 10.1002/pat.1045; Kredatusova J, 2012, APPL CLAY SCI, V62-63, P94, DOI 10.1016/j.clay.2012.04.009; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Liu F, 2012, ACS APPL MATER INTER, V4, P922, DOI 10.1021/am201590z; Mahmoud GA, 2013, MONATSH CHEM, V144, P1097, DOI 10.1007/s00706-013-0957-z; MARGULIES L, 1988, CLAY CLAY MINER, V36, P270, DOI 10.1346/CCMN.1988.0360309; Ozay O, 2009, WATER RES, V43, P4403, DOI 10.1016/j.watres.2009.06.058; Parasuraman D, 2011, ACS APPL MATER INTER, V3, P4714, DOI 10.1021/am201132x; Ramirez E, 2011, J HAZARD MATER, V192, P432, DOI 10.1016/j.jhazmat.2011.04.109; Ren HY, 2011, MACROMOLECULES, V44, P8516, DOI 10.1021/ma201272j; Rytwo G, 2002, APPL CLAY SCI, V20, P273, DOI 10.1016/S0169-1317(01)00068-0; Shi YR, 2013, POLYM BULL, V70, P1163, DOI 10.1007/s00289-012-0898-4; Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409; Luan VH, 2013, J MATER CHEM A, V1, P208, DOI 10.1039/c2ta00444e; Wang Q, 2010, NATURE, V463, P339, DOI 10.1038/nature08693; Yan L, 2013, J AM CHEM SOC, V135, P3748, DOI 10.1021/ja3114714; Yang XL, 2013, J MATER CHEM A, V1, P473, DOI 10.1039/c2ta00594h; Yi JZ, 2008, BIORESOURCE TECHNOL, V99, P2182, DOI 10.1016/j.biortech.2007.05.028; Zhang D, 2013, SCI REP-UK, V3, DOI 10.1038/srep01399	34	15	15	2	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88802	10.1371/journal.pone.0088802	http://dx.doi.org/10.1371/journal.pone.0088802			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586396	Green Published, gold, Green Submitted			2022-12-27	WOS:000331714700031
J	Han, C; Feng, H; Han, YQ; Liu, WW; Zhang, ZS; Yang, WZ; Duan, L				Han, Cong; Feng, Hui; Han, Yi-Qin; Liu, Wei-Wei; Zhang, Zheng-Shan; Yang, Wei-Zhong; Duan, Lian			Prospective Screening of Family Members with Moyamoya Disease Patients	PLOS ONE			English	Article							TRANSCRANIAL DOPPLER SONOGRAPHY; FEATURES; MULTICENTER; ANGIOGRAPHY	Background: Genetic factors play an important role in the pathogenesis of moyamoya disease (MMD). Previous studies concentrated on familial MMD patients. In this study, we focused on family members of sporadic MMD patients, and aimed to gain a clearer understanding of the role that genetic factors play in MMD. Methods: The immediate family members of MMD patients were initially screened by transcranial Doppler sonography (TCD) and positive cases were verified by magnetic resonance angiography (MRA). Results: From July 2011 to March 2013, there were 527 MMD patients managed in our hospital, including 38 familial MMD cases. In this study, 285 immediate family members of 245 sporadic MMD patients were screened. Another 41 cases of familial MMD cases were identified, which included 21 family members and 20 corresponding sporadic MMD patients who had family members confirmed positive with MMD. As a result, the proportion of familial MMD patients increased from 7% (38/527) to 15% (79/527) in this period. For the main segments of the circle of Willis, Kappa values between TCD and MRA for the anterior cerebral arteries, middle cerebral arteries and posterior cerebral arteries were 0.91, 0.72, and 0.47, respectively. Familial cases confirmed by our screening showed a significantly higher percentage of asymptomatic patients (57%) compared with 9% from the control group who had a clear family history before. Conclusions: Familial MMD patients may account for a higher percentage among all cases than previously thought. Some family members of MMD patients may also have MMD, but not have any obvious symptoms. Routine screening should be implemented for all family members of MMD patients to improve the detection rate for this part of the patient base. TCD has a high diagnostic agreement with MRA for MMD. TCD may be the preferred choice for screening because it is inexpensive and safe.	[Han, Cong; Han, Yi-Qin; Zhang, Zheng-Shan; Yang, Wei-Zhong; Duan, Lian] PLA, Dept Neurosurg, Hosp 307, Beijing, Peoples R China; [Feng, Hui] PLA, Dept Ultrasound, Hosp 302, Beijing, Peoples R China; [Liu, Wei-Wei] PLA, Acad Mil Med Sci, Consulting Ctr Biomed Stat, Beijing, Peoples R China	Fifth Medical Center of Chinese PLA General Hospital; Academy of Military Medical Sciences - China	Duan, L (corresponding author), PLA, Dept Neurosurg, Hosp 307, Beijing, Peoples R China.	duanlian307@sina.com	Yang, Wei/HIA-0360-2022		National Natural Science Foundation of China [81171083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grant from National Natural Science Foundation of China (81171083, www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov AV, 2007, J NEUROIMAGING, V17, P1811; Baba T, 2008, J NEUROL NEUROSUR PS, V79, P900, DOI 10.1136/jnnp.2007.130666; Houkin K, 2005, CEREBROVASC DIS, V20, P347, DOI 10.1159/000087935; Im Sang Hyuk, 2012, J Cerebrovasc Endovasc Neurosurg, V14, P75, DOI 10.7461/jcen.2012.14.2.75; Kuriyama S, 2008, STROKE, V39, P42, DOI 10.1161/STROKEAHA.107.490714; Kuroda S, 2007, STROKE, V38, P1430, DOI 10.1161/STROKEAHA.106.478297; Lee YS, 2004, J NEUROIMAGING, V14, P319, DOI 10.1177/1051228404264958; Li ZW, 2013, CEREBROVASC DIS, V35, P455, DOI 10.1159/000350197; Liu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022542; Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis, 2012, Neurol Med Chir (Tokyo), V52, P245; Scott RM, 2009, NEW ENGL J MED, V360, P1226, DOI 10.1056/NEJMra0804622; Suwanwela NC, 2002, AM J NEURORADIOL, V23, P1352; Yamada M, 2005, NEUROL SURG TOKYO, V33, P337; Zhao LM, 2011, STROKE, V42, P3429, DOI 10.1161/STROKEAHA.111.621235	14	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88765	10.1371/journal.pone.0088765	http://dx.doi.org/10.1371/journal.pone.0088765			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586386	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900045
J	Gregg, RD; Rouse, EJ; Hargrove, LJ; Sensinger, JW				Gregg, Robert D.; Rouse, Elliott J.; Hargrove, Levi J.; Sensinger, Jonathon W.			Evidence for a Time-Invariant Phase Variable in Human Ankle Control	PLOS ONE			English	Article							STANCE PHASE; HUMAN LOCOMOTION; SWING PHASE; WALKING; LOAD; ROLLOVER; GAIT; ADAPTATION; CONTRIBUTE; PROSTHESES	Human locomotion is a rhythmic task in which patterns of muscle activity are modulated by state-dependent feedback to accommodate perturbations. Two popular theories have been proposed for the underlying embodiment of phase in the human pattern generator: a time-dependent internal representation or a time-invariant feedback representation (i.e., reflex mechanisms). In either case the neuromuscular system must update or represent the phase of locomotor patterns based on the system state, which can include measurements of hundreds of variables. However, a much simpler representation of phase has emerged in recent designs for legged robots, which control joint patterns as functions of a single monotonic mechanical variable, termed a phase variable. We propose that human joint patterns may similarly depend on a physical phase variable, specifically the heel-to-toe movement of the Center of Pressure under the foot. We found that when the ankle is unexpectedly rotated to a position it would have encountered later in the step, the Center of Pressure also shifts forward to the corresponding later position, and the remaining portion of the gait pattern ensues. This phase shift suggests that the progression of the stance ankle is controlled by a biomechanical phase variable, motivating future investigations of phase variables in human locomotor control.	[Gregg, Robert D.] Univ Texas Dallas, Dept Mech Engn, Richardson, TX 75083 USA; [Gregg, Robert D.] Univ Texas Dallas, Dept Bioengn, Richardson, TX 75083 USA; [Rouse, Elliott J.] MIT, Dept Media Arts & Sci, Cambridge, MA 02139 USA; [Hargrove, Levi J.] Rehabil Inst Chicago, Ctr Bion Med, Chicago, IL 60611 USA; [Hargrove, Levi J.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Sensinger, Jonathon W.] Univ New Brunswick, Inst Biomed Engn, Fredericton, NB, Canada; [Sensinger, Jonathon W.] Univ New Brunswick, Dept Elect & Comp Engn, Fredericton, NB, Canada	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas; Massachusetts Institute of Technology (MIT); Shirley Ryan AbilityLab; Northwestern University; University of New Brunswick; University of New Brunswick	Gregg, RD (corresponding author), Univ Texas Dallas, Dept Mech Engn, Richardson, TX 75083 USA.	rgregg@ieee.org	Rouse, Elliott/AAP-1756-2021	Rouse, Elliott/0000-0003-3880-1527; Gregg, Robert/0000-0002-0729-2857	USAMRAA [W81XWH-09-2-0020]; National Institutes of Health from the National Institute of Neurological Disorders and Stroke [F31NS074687]; Burroughs Wellcome Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP2HD080349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS074687] Funding Source: NIH RePORTER	USAMRAA; National Institutes of Health from the National Institute of Neurological Disorders and Stroke; Burroughs Wellcome Fund(Burroughs Wellcome Fund); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by USAMRAA grant W81XWH-09-2-0020 (www.usamraa.army.mil) and National Institutes of Health award number F31NS074687 from the National Institute of Neurological Disorders and Stroke (www.nih.gov). Robert D. Gregg, IV, Ph.D., holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund (www.bwfund.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett-Cowan M, 2009, EXP BRAIN RES, V198, P221, DOI 10.1007/s00221-009-1779-4; BUEHLER M, 1994, INT J ROBOT RES, V13, P101, DOI 10.1177/027836499401300201; Chevallereau C, 2003, IEEE CONTR SYST MAG, V23, P57, DOI 10.1109/MCS.2003.1234651; Conditt MA, 1999, P NATL ACAD SCI USA, V96, P11625, DOI 10.1073/pnas.96.20.11625; DiBerardino LA, 2012, J APPL BIOMECH, V28, P210, DOI 10.1123/jab.28.2.210; Dietz V, 2000, GAIT POSTURE, V11, P102, DOI 10.1016/S0966-6362(99)00052-1; DIETZ V, 1992, EXP BRAIN RES, V89, P229; Donelan JM, 2004, CAN J PHYSIOL PHARM, V82, P589, DOI 10.1139/Y04-043; Drew T, 2004, PROG BRAIN RES, V143, P251, DOI 10.1016/S0079-6123(03)43025-2; Earhart GM, 2000, J NEUROPHYSIOL, V84, P605, DOI 10.1152/jn.2000.84.2.605; Eilenberg MF, 2010, IEEE T NEUR SYS REH, V18, P164, DOI 10.1109/TNSRE.2009.2039620; Geyer H, 2010, IEEE T NEUR SYS REH, V18, P263, DOI 10.1109/TNSRE.2010.2047592; Gordon KE, 2010, J NEUROPHYSIOL, V104, P1325, DOI 10.1152/jn.00604.2009; Gordon KE, 2009, J NEUROPHYSIOL, V101, P2062, DOI 10.1152/jn.90949.2008; Gregg RD, 2013, INT C REHAB ROBOT; Gregg RD, 2014, IEEE T CONTR SYST T, V22, P246, DOI 10.1109/TCST.2012.2236840; Gregg RD, 2013, P AMER CONTR CONF, P5702; Grey MJ, 2004, CAN J PHYSIOL PHARM, V82, P610, DOI 10.1139/y04-077; GRILLNER S, 1978, BRAIN RES, V146, P269, DOI 10.1016/0006-8993(78)90973-3; Grizzle JW, 2001, IEEE T AUTOMAT CONTR, V46, P51, DOI 10.1109/9.898695; Gruben KG, 2012, HUM MOVEMENT SCI, V31, P649, DOI 10.1016/j.humov.2011.07.006; Hansen AH, 2004, HUM MOVEMENT SCI, V23, P807, DOI 10.1016/j.humov.2004.08.023; Hansen AH, 2010, DISABIL REHABIL, V32, P2201, DOI 10.3109/09638288.2010.502586; Hiebert GW, 1996, J NEUROPHYSIOL, V75, P1126, DOI 10.1152/jn.1996.75.3.1126; HOGAN N, 1985, J DYN SYST-T ASME, V107, P8, DOI 10.1115/1.3140713; Holgate MA, 2009, IEEE INT CONF ROBOT, P2435; Ivanenko YP, 2002, J NEUROPHYSIOL, V87, P3070, DOI 10.1152/jn.2002.87.6.3070; Kavounoudias A, 2001, J PHYSIOL-LONDON, V532, P869, DOI 10.1111/j.1469-7793.2001.0869e.x; KAWAMURA K, 1991, ACTA MED OKAYAMA, V45, P179; KODITSCHEK DE, 1991, INT J ROBOT RES, V10, P587, DOI 10.1177/027836499101000601; Lay AN, 2006, J BIOMECH, V39, P1621, DOI 10.1016/j.jbiomech.2005.05.005; Leroux A, 2002, GAIT POSTURE, V15, P64, DOI 10.1016/S0966-6362(01)00181-3; Leroux A, 1999, EXP BRAIN RES, V126, P359, DOI 10.1007/s002210050743; Ljung L., 1999, SYSTEM IDENTIFICATIO; MCGEER T, 1990, INT J ROBOT RES, V9, P62, DOI 10.1177/027836499000900206; Pang MYC, 2000, J PHYSIOL-LONDON, V528, P389, DOI 10.1111/j.1469-7793.2000.00389.x; Pearson KG, 1995, CURR OPIN NEUROBIOL, V5, P786, DOI 10.1016/0959-4388(95)80107-3; Poppele RE, 2002, J NEUROPHYSIOL, V87, P409, DOI 10.1152/jn.00022.2001; Prochazka A, 2007, PROG BRAIN RES, V165, P255, DOI 10.1016/S0079-6123(06)65016-4; Ramezani A, 2014, J DYN SYST-T ASME, V136, DOI 10.1115/1.4025693; REDFERN MS, 1994, J BIOMECH, V27, P1339, DOI 10.1016/0021-9290(94)90043-4; Redfern MS, 1997, GAIT POSTURE, V6, P119; Revzen S, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051907; Revzen S, 2009, ADV EXP MED BIOL, V629, P25, DOI [10.1007/978-0-357-77064-2_3, 10.1007/978-0-387-77064-2_3]; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Rouse EJ, 2013, ASME T BIOMECH ENG, V135; Rouse EJ, 2011, IEEE ENG MED BIO, P8179, DOI 10.1109/IEMBS.2011.6092017; Sacco ICN, 2009, CLIN BIOMECH, V24, P687, DOI 10.1016/j.clinbiomech.2009.05.003; Sejdic E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043104; Solomon JH, 2010, ADAPT BEHAV, V18, P492, DOI 10.1177/1059712310389624; Spong M.W., 2006, ROBOT MODELING CONTR, VVolume 3; Sreenath K, 2011, INT J ROBOT RES, V30, P1170, DOI 10.1177/0278364910379882; STEIN JL, 1987, J BIOMECH, V20, P19, DOI 10.1016/0021-9290(87)90263-6; Sup F, 2011, IEEE T NEUR SYS REH, V19, P71, DOI 10.1109/TNSRE.2010.2087360; Tilton AK, 2012, P AMER CONTR CONF, P3433; Valero-Cuevas FJ, 2009, J NEUROPHYSIOL, V102, P59, DOI 10.1152/jn.90324.2008; Vogelstein RJ, 2006, IEEE T NEUR SYS REH, V14, P257, DOI 10.1109/TNSRE.2006.881586; Westervelt E R, 2007, FEEDBACK CONTROL DYN; Winter D.A., 2009, BIOMECHANICS MOTOR C, V370; Yang T, 2009, AUTON ROBOT, V27, P277, DOI 10.1007/s10514-009-9126-y	60	34	34	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89163	10.1371/journal.pone.0089163	http://dx.doi.org/10.1371/journal.pone.0089163			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558485	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700131
J	Santana, SS; Gennari-Cardoso, ML; Carvalho, FC; Roque-Barreira, MC; Santiago, AD; Alvim, FC; Pirovani, CP				Santana, Sanzio Silva; Gennari-Cardoso, Margareth Leitao; Carvalho, Fernanda Caroline; Roque-Barreira, Maria Cristina; Santiago, Andre da Silva; Alvim, Fatima Cerqueira; Pirovani, Carlos Priminho			Eutirucallin, a RIP-2 Type Lectin from the Latex of Euphorbia tirucalli L. Presents Proinflammatory Properties	PLOS ONE			English	Article							GALACTOSE-BINDING LECTIN; SHIGA TOXIN; PROTEINS; PLANTS; TREE; PURIFICATION; RECOGNITION; QUANTITIES; ACTIVATION; PRINCIPLES	Lectins are carbohydrate-binding proteins that recognize and modulate physiological activities and have been used as a toll for detection and identification of biomolecules, and therapy of diseases. In this study we have isolated a lectin present in the latex of Euphorbia tirucalli, and named it Eutirucallin. The latex protein extract was subjected to ion exchange chromatography and showed two peaks with haemagglutinating activity. Polypeptides of 32 kDa protein extract strongly interacted with immobilized galactose (alpha-lactose > D-N-acetylgalactosamine). The Eutirucallin was obtained with a yield of 5.6% using the a-lactose column. The lectin domain has 32 kDa subunits and at least two of which are joined by disulfide bridges. The agglutinating capacity for human erythrocytes A(+), B+ and O+ is inhibited by D-galactose. The haemagglutinating activity of Eutirucallin was independent of Ca2+ and maintained until the temperature of 55 degrees C. Eutirucallin presented biological activities such as neutrophils recruitment and cytokine prodution by macrophages. The analysis of the trypsin-digested Eutirucallin by ms/ms in ESI-Q-TOFF resulted in nine peptides similar to type 2 ribosome-inactivating protein (type-2 RIP). It's partial sequence showed a similarity of 67.4 - 83.1% for the lectin domain of type-2 RIP [Ricin and Abrin (83.1%), Viscumin, Ebulin, Pulchellin, Cinnamomin, Volkensin and type-2 RIP Iris hollandica]. Our data suggest that Eutirucallin is a new member of type 2 ribosome-inactivating protein and presents biotechnological potential.	[Santana, Sanzio Silva; Gennari-Cardoso, Margareth Leitao; Santiago, Andre da Silva; Alvim, Fatima Cerqueira; Pirovani, Carlos Priminho] Univ Estadual Santa Cruz, Ctr Biotecnol & Genet, Ilheus, BA, Brazil; [Carvalho, Fernanda Caroline; Roque-Barreira, Maria Cristina] Univ Sao Paulo, Med Sch Ribeirao Preto, Sao Paulo, Brazil	Universidade Estadual de Santa Cruz; Universidade de Sao Paulo	Pirovani, CP (corresponding author), Univ Estadual Santa Cruz, Ctr Biotecnol & Genet, Ilheus, BA, Brazil.	pirovani@uesc.br	Pirovani, Carlos P/J-3426-2017; Pirovani, Carlos Priminho/N-1153-2019; Ibrahim, Essam Hassan/G-1960-2018; Roque-Barreira, Maria-Cristina/A-4552-2008	Pirovani, Carlos P/0000-0002-6176-4069; Pirovani, Carlos Priminho/0000-0002-6176-4069; Ibrahim, Essam Hassan/0000-0003-0130-2257; Roque-Barreira, Maria-Cristina/0000-0001-7425-0908	Fundacao de Amparo Pesquisa of Bahia (FAPESB - PRONEM) [PNE0005/2011]	Fundacao de Amparo Pesquisa of Bahia (FAPESB - PRONEM)	Funding from Fundacao de Amparo Pesquisa of Bahia (FAPESB - PRONEM, TO No. no PNE0005/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosi M, 2005, ORG BIOMOL CHEM, V3, P1593, DOI 10.1039/b414350g; BARBIERI L, 1983, BIOCHEM J, V215, P433, DOI 10.1042/bj2150433; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brasileiro Beatriz Gonçalves, 2006, Rev. Bras. Cienc. Farm., V42, P195, DOI 10.1590/S1516-93322006000200004; Coelho LCBB, 2000, PHYTOCHEM ANALYSIS, V11, P295, DOI 10.1002/1099-1565(200009/10)11:5&lt;295::AID-PCA517&gt;3.0.CO;2-S; Elifio-Esposito S, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-10; EMMERICH C, 1994, ACTA CRYSTALLOGR D, V50, P749, DOI 10.1107/S0907444994002143; FURSTENBERGER G, 1985, Z NATURFORSCH C, V40, P631; Goldstein J, 1989, Transfus Med Rev, V3, P206, DOI 10.1016/S0887-7963(89)70080-8; Hartley MR, 2004, BBA-PROTEINS PROTEOM, V1701, P1, DOI 10.1016/j.bbapap.2004.06.004; Konozy EHE, 2003, ARCH BIOCHEM BIOPHYS, V410, P222, DOI 10.1016/S0003-9861(02)00695-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lis H, 1998, CHEM REV, V98, P637, DOI 10.1021/cr940413g; Loris R, 2002, BBA-GEN SUBJECTS, V1572, P198, DOI 10.1016/S0304-4165(02)00309-4; Loyola W, 2012, INT IMMUNOPHARMACOL, V12, P378, DOI 10.1016/j.intimp.2011.12.010; Machuka JS, 1999, PHYTOCHEMISTRY, V51, P721, DOI 10.1016/S0031-9422(99)00136-3; MacNeil A, 2003, BRIT J CANCER, V88, P1566, DOI 10.1038/sj.bjc.6600929; OLSNES S, 1974, J BIOL CHEM, V249, P803; Pajic I, 2002, COMP BIOCHEM PHYS C, V132, P213, DOI 10.1016/S1532-0456(02)00068-6; Panunto-Castelo A, 2001, GLYCOBIOLOGY, V11, P1035, DOI 10.1093/glycob/11.12.1035; Rahuman AA, 2008, PARASITOL RES, V102, P867, DOI 10.1007/s00436-007-0839-6; Sandvig K, 1996, PHYSIOL REV, V76, P949, DOI 10.1152/physrev.1996.76.4.949; Sharon N, 2002, J AGR FOOD CHEM, V50, P6586, DOI 10.1021/jf020190s; Sharon N, 2001, ADV EXP MED BIOL, V491, P1; Souza MA, 2005, BRAZ ARCH BIOL TECHN, V48, P705, DOI 10.1590/S1516-89132005000600005; STIRPE F, 1983, BIOCHEM J, V216, P617, DOI 10.1042/bj2160617; Tiwari S, 2005, ENVIRON RES, V99, P378, DOI 10.1016/j.envres.2004.12.008; Turton K, 2004, GLYCOBIOLOGY, V14, P923, DOI 10.1093/glycob/cwh114; Valadares MC, 2006, INT IMMUNOPHARMACOL, V6, P294, DOI 10.1016/j.intimp.2005.07.013; Wititsuwannakul R, 1998, PHYTOCHEMISTRY, V47, P183, DOI 10.1016/S0031-9422(97)00329-4; Xu H, 2004, ACTA BIOCH BIOPH SIN, V36, P169, DOI 10.1093/abbs/36.3.169; Yamamoto Y, 1981, Plant Cell Rep, V1, P29, DOI 10.1007/BF00267653; Yamasaki C, 2004, BBA-GEN SUBJECTS, V1671, P44, DOI 10.1016/j.bbagen.2004.01.002	33	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88422	10.1371/journal.pone.0088422	http://dx.doi.org/10.1371/journal.pone.0088422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558388	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700034
J	Suh, JH; Kanathezhath, B; Shenvi, S; Guo, H; Zhou, A; Tiwana, A; Kuypers, F; Ames, BN; Walters, MC				Suh, Jung H.; Kanathezhath, Bindu; Shenvi, Swapna; Guo, Hua; Zhou, Alicia; Tiwana, Anureet; Kuypers, Frans; Ames, Bruce N.; Walters, Mark C.			Thiol/Redox Metabolomic Profiling Implicates GSH Dysregulation in Early Experimental Graft versus Host Disease (GVHD)	PLOS ONE			English	Article							NF-KAPPA-B; STEM-CELL TRANSPLANTATION; NITRIC-OXIDE; GLUTATHIONE DISULFIDE; OXIDATIVE STRESS; REDOX REGULATION; MOLECULAR-BASIS; IN-VIVO; EFFLUX; LIVER	Graft-versus-host disease (GVHD) is a common complication of allogeneic bone marrow transplantation (BMT). Upregulation of inflammatory cytokines precedes the clinical presentation of GVHD and predicts its severity. In this report, thiol/redox metabolomics was used to identify metabolic perturbations associated with early preclinical (Day+4) and clinical (Day+10) stages of GVHD by comparing effects in Syngeneic (Syn; major histocompatibility complex-identical) and allogeneic transplant recipients (Allo BMT) in experimental models. While most metabolic changes were similar in both groups, plasma glutathione (GSH) was significantly decreased, and GSH disulfide (GSSG) was increased after allogeneic compared to syngeneic recipient and non-transplant controls. The early oxidation of the plasma GSH/GSSG redox couple was also observed irrespective of radiation conditioning treatment and was accompanied by significant rise in hepatic protein oxidative damage and ROS generation. Despite a significant rise in oxidative stress, compensatory increase in hepatic GSH synthesis was absent following Allo BMT. Early shifts in hepatic oxidative stress and plasma GSH loss preceded a statistically significant rise in TNF-alpha. To identify metabolomic biomarkers of hepatic GVHD injury, plasma metabolite concentrations analyzed at Day+10 were correlated with hepatic organ injury. GSSG (oxidized GSH) and beta-alanine, were positively correlated, and plasma GSH cysteinylglycine, and branched chain amino acids were inversely correlated with hepatic injury. Although changes in plasma concentrations of cysteine, cystathionine (GSH precursors) and cysteinylglycine (a GSH catabolite) were not significant by univariate analysis, principal component analysis (PCA) indicated that accumulation of these metabolites after Allo BMT contributed significantly to early GVHD in contrast to Syn BMT. In conclusion, thiol/redox metabolomic profiling implicates that early dysregulation of host hepatic GSH metabolism and oxidative stress in subclinical GVHD before elevated TNF-alpha levels is associated with GVHD pathogenesis. Future studies will probe the mechanisms for these changes and examine the potential of antioxidant intervention strategies to modulate GVHD.	[Suh, Jung H.; Shenvi, Swapna; Zhou, Alicia; Tiwana, Anureet; Kuypers, Frans; Ames, Bruce N.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Kanathezhath, Bindu; Guo, Hua; Walters, Mark C.] Childrens Hosp & Res Ctr Oakland, Oakland, CA USA; [Kanathezhath, Bindu; Walters, Mark C.] Childrens Hosp & Res Ctr Oakland, Div Blood & Marrow Transplantat, Oakland, CA USA; [Guo, Hua] Childrens Hosp & Res Ctr Oakland, Dept Pathol, Oakland, CA USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Suh, JH (corresponding author), Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA.	jsuh@chori.org; mwalters@mail.cho.org			CHORI-Ames Supporting Foundation; Bechtel SD Jr. Foundation; CIRM [T10007]; CHORI; Jordan Foundation Endowment Award	CHORI-Ames Supporting Foundation; Bechtel SD Jr. Foundation; CIRM(California Institute for Regenerative Medicine); CHORI; Jordan Foundation Endowment Award	This study was funded by The CHORI-Ames Supporting Foundation, Bechtel SD Jr. Foundation http://www.sdbjrfoundation.org/grant to JHS, CIRM T10007 http://www.cirm.ca.gov/grants award to BK, CHORI Clinical Research Award to JHS and BK and the Jordan Foundation Endowment Award to MCW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABHYANKAR S, 1993, TRANSPLANTATION, V56, P1518, DOI 10.1097/00007890-199312000-00045; ADAMS JD, 1983, J PHARMACOL EXP THER, V227, P749; Amer J, 2007, ANN HEMATOL, V86, P753, DOI 10.1007/s00277-007-0321-7; ANDERSON MT, 1994, P NATL ACAD SCI USA, V91, P11527, DOI 10.1073/pnas.91.24.11527; Barkholt L, 2008, BONE MARROW TRANSPL, V41, P785, DOI 10.1038/sj.bmt.1705969; Beilhack A, 2005, BLOOD, V106, P1113, DOI 10.1182/blood-2005-02-0509; Blackwell TS, 2000, ANTIOXID REDOX SIGN, V2, P93, DOI 10.1089/ars.2000.2.1-93; Blazar BR, 2012, NAT REV IMMUNOL, V12, P443, DOI 10.1038/nri3212; Brechbuhl HM, 2010, J BIOL CHEM, V285, P16582, DOI 10.1074/jbc.M109.090506; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Carta S, 2009, J LEUKOCYTE BIOL, V86, P549, DOI 10.1189/jlb.1008598; Dalle-Donne I, 2008, ANTIOXID REDOX SIGN, V10, P445, DOI 10.1089/ars.2007.1716; DENEKE SM, 1989, AM J PHYSIOL, V257, pL163, DOI 10.1152/ajplung.1989.257.4.L163; Ellison CA, 2003, IMMUNOLOGY, V109, P440, DOI 10.1046/j.1365-2567.2003.01663.x; Evens AM, 2004, BONE MARROW TRANSPL, V34, P561, DOI 10.1038/sj.bmt.1704591; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Flohe L, 1997, FREE RADICAL BIO MED, V22, P1115, DOI 10.1016/S0891-5849(96)00501-1; Franco R, 2012, ANTIOXID REDOX SIGN, V17, P1694, DOI 10.1089/ars.2012.4553; Gatza E, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001975; Go YM, 2011, FREE RADICAL BIO MED, V50, P495, DOI 10.1016/j.freeradbiomed.2010.11.029; Grimble RF, 2006, J NUTR, V136, p1660S, DOI 10.1093/jn/136.6.1660S; Hill GR, 1997, BLOOD, V90, P3204, DOI 10.1182/blood.V90.8.3204; Hoppe G, 2006, EXP CELL RES, V312, P3526, DOI 10.1016/j.yexcr.2006.07.020; Iyer SS, 2009, AM J RESP CELL MOL, V40, P90, DOI 10.1165/rcmb.2007-0447OC; Iyer SS, 2010, STEM CELLS INT, V2010, P1, DOI [10.1182/blood-2008-09-176198, DOI 10.1182/BL00D-2008-09-176198]; Jonas CR, 2000, AM J CLIN NUTR, V72, P181; Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865; Jung YY, 2008, J BIOL CHEM, V283, P23863, DOI 10.1074/jbc.M803072200; Kanathezhath B, 2011, EXP BIOL MED, V236, P492, DOI 10.1258/ebm.2011.010216; Karlsson H, 2011, EUR J IMMUNOL, V41, P1143, DOI 10.1002/eji.201040589; Kuypers FA, 2005, ANN NY ACAD SCI, V1054, P214, DOI 10.1196/annals.1345.026; Liu SY, 2008, EUR J IMMUNOL, V38, P410, DOI 10.1002/eji.200737556; Maccarrone M, 2009, CELL DEATH DIFFER, V16, P1184, DOI 10.1038/cdd.2009.65; Maeda Y, 2005, BLOOD, V105, P2023, DOI 10.1182/blood-2004-08-3036; Morgan B, 2013, NAT CHEM BIOL, V9, P119, DOI [10.1038/nchembio.1142, 10.1038/NCHEMBIO.1142]; Moriarty-Craige SE, 2004, ANNU REV NUTR, V24, P481, DOI 10.1146/annurev.nutr.24.012003.132208; Mukherjee TK, 2007, J IMMUNOL, V178, P1835, DOI 10.4049/jimmunol.178.3.1835; OOKHTENS M, 1985, J CLIN INVEST, V75, P258, DOI 10.1172/JCI111682; Paczesny S, 2009, BLOOD, V113, P273, DOI 10.1182/blood-2008-07-167098; Pullarkat V, 2008, BONE MARROW TRANSPL, V42, P799, DOI 10.1038/bmt.2008.262; Ratajczak P, 2012, BIOL BLOOD MARROW TR, V18, P150, DOI 10.1016/j.bbmt.2011.08.002; Sari I, 2008, ANN CLIN LAB SCI, V38, P120; SCHLEGEL PG, 1995, J IMMUNOL, V155, P3856; Shelton MD, 2008, MOL CELLS, V25, P332; Shin HJ, 2011, BLOOD, V118, P2342, DOI 10.1182/blood-2010-10-313684; SIES H, 1984, METHOD ENZYMOL, V105, P445; Sprangers B, 2011, BONE MARROW TRANSPL, V46, P586, DOI 10.1038/bmt.2010.162; Suh JH, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-37; Suh JH, 2009, J CHROMATOGR B, V877, P3418, DOI 10.1016/j.jchromb.2009.06.041; Szymanska E, 2012, METABOLOMICS, V8, pS3, DOI 10.1007/s11306-011-0330-3; Tephly LA, 2007, AM J RESP CELL MOL, V37, P366, DOI 10.1165/rcmb.2006-0268OC; Themeli M, 2010, LEUKEMIA, V24, P536, DOI 10.1038/leu.2009.284; Tschetter JR, 2000, J IMMUNOL, V165, P5987, DOI 10.4049/jimmunol.165.10.5987; Ullala AJ, 2009, EPIGENETICS AUTOIMMU, P165; Vodanovic-Jankovic S, 2006, BLOOD, V107, P827, DOI 10.1182/blood-2005-05-1820; Vora A, 1997, BONE MARROW TRANSPL, V20, P385, DOI 10.1038/sj.bmt.1700898; Weiss G, 1995, TRANSPLANTATION, V60, P1239; Xia J, 2011, CURR PROTOC BIOINFOR, DOI [10.1002/0471250953.bi1410s34, DOI 10.1002/0471250953.BI1410S34]; Yan ZH, 2009, NAT CHEM BIOL, V5, P721, DOI 10.1038/nchembio.212; Yang SX, 2001, AM J PHYSIOL-LUNG C, V281, pL922, DOI 10.1152/ajplung.2001.281.4.L922; Ziegler TR, 2001, TRANSPLANTATION, V72, P1354, DOI 10.1097/00007890-200110270-00004	62	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88868	10.1371/journal.pone.0088868	http://dx.doi.org/10.1371/journal.pone.0088868			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558439	gold, Green Submitted, Green Published			2022-12-27	WOS:000331706700085
J	Osborne, JE; Dudman, JT				Osborne, Jason E.; Dudman, Joshua T.			RIVETS: A Mechanical System for In Vivo and In Vitro Electrophysiology and Imaging	PLOS ONE			English	Article							MOTOR CORTEX; VISUAL-CORTEX; AWAKE; MICE; NEURONS; RATS; MICROELECTRODE; MOVEMENTS; CIRCUITS; BEHAVIOR	A number of recent studies have provided compelling demonstrations that both mice and rats can be trained to perform a variety of behavioral tasks while restrained by mechanical elements mounted to the skull. The independent development of this technique by a number of laboratories has led to diverse solutions. We found that these solutions often used expensive materials and impeded future development and modification in the absence of engineering support. In order to address these issues, here we report on the development of a flexible single hardware design for electrophysiology and imaging both in brain tissue in vitro. Our hardware facilitates the rapid conversion of a single preparation between physiology and imaging system and the conversion of a given system between preparations. In addition, our use of rapid prototyping machines ("3D printers") allows for the deployment of new designs within a day. Here, we present specifications for design and manufacturing as well as some data from our lab demonstrating the suitability of the design for physiology in behaving animals and imaging in vitro and in vivo.	[Osborne, Jason E.; Dudman, Joshua T.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Dudman, JT (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	dudmanj@janelia.hhmi.org		Dudman, Joshua/0000-0002-4436-1057	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by the Howard Hughes Medical Institute (hhmi.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andermann ML, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00003; Bermejo R, 2004, SOMATOSENS MOT RES, V21, P183, DOI 10.1080/08990220400012430; Carey RM, 2009, J NEUROPHYSIOL, V101, P1073, DOI 10.1152/jn.90902.2008; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; EVARTS EV, 1962, SCIENCE, V135, P727, DOI 10.1126/science.135.3505.726; Greenberg DS, 2009, J NEUROSCI METH, V176, P1, DOI 10.1016/j.jneumeth.2008.08.020; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Haiss F, 2010, J NEUROSCI METH, V187, P67, DOI 10.1016/j.jneumeth.2009.12.015; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hill DN, 2011, NEURON, V72, P344, DOI 10.1016/j.neuron.2011.09.020; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; HUBEL DH, 1959, J PHYSIOL-LONDON, V147, P226, DOI 10.1113/jphysiol.1959.sp006238; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Isomura Y, 2009, NAT NEUROSCI, V12, P1586, DOI 10.1038/nn.2431; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; LI CL, 1956, J NEUROPHYSIOL, V19, P111, DOI 10.1152/jn.1956.19.2.111; Mahon S, 2006, J NEUROSCI, V26, P12587, DOI 10.1523/JNEUROSCI.3987-06.2006; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Olsen SR, 2012, NATURE, V483, P47, DOI 10.1038/nature10835; Pan WX, 2013, NAT NEUROSCI, V16, P71, DOI 10.1038/nn.3283; Stern EA, 1998, NATURE, V394, P475, DOI 10.1038/28848; WURTZ RH, 1968, SCIENCE, V162, P1148, DOI 10.1126/science.162.3858.1148	23	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89007	10.1371/journal.pone.0089007	http://dx.doi.org/10.1371/journal.pone.0089007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551206	Green Published, Green Submitted, gold			2022-12-27	WOS:000331271500092
J	Shao, C; Liao, CP; Hu, PZ; Chu, CY; Zhang, L; Bui, MHT; Ng, CS; Josephson, DY; Knudsen, B; Tighiouart, M; Kim, HL; Zhau, HYE; Chung, LWK; Wang, RX; Posadas, EM				Shao, Chen; Liao, Chun-Peng; Hu, Peizhen; Chu, Chia-Yi; Zhang, Lei; Bui, Matthew H. T.; Ng, Christopher S.; Josephson, David Y.; Knudsen, Beatrice; Tighiouart, Mourad; Kim, Hyung L.; Zhau, Haiyen E.; Chung, Leland W. K.; Wang, Ruoxiang; Posadas, Edwin M.			Detection of Live Circulating Tumor Cells by a Class of Near-Infrared Heptamethine Carbocyanine Dyes in Patients with Localized and Metastatic Prostate Cancer	PLOS ONE			English	Article							BREAST-CANCER; PERIPHERAL-BLOOD; EXPRESSION; APOPTOSIS; HETEROGENEITY; TRANSPORTERS; ENUMERATION; CARCINOMAS; KIDNEY; GUIDE	Tumor cells are inherently heterogeneous and often exhibit diminished adhesion, resulting in the shedding of tumor cells into the circulation to form circulating tumor cells (CTCs). A fraction of these are live CTCs with potential of metastatic colonization whereas others are at various stages of apoptosis making them likely to be less relevant to understanding the disease. Isolation and characterization of live CTCs may augment information yielded by standard enumeration to help physicians to more accurately establish diagnosis, choose therapy, monitor response, and provide prognosis. We previously reported on a group of near-infrared (NIR) heptamethine carbocyanine dyes that are specifically and actively transported into live cancer cells. In this study, this viable tumor cell-specific behavior was utilized to detect live CTCs in prostate cancer patients. Peripheral blood mononuclear cells (PBMCs) from 40 patients with localized prostate cancer together with 5 patients with metastatic disease were stained with IR-783, the prototype heptamethine cyanine dye. Stained cells were subjected to flow cytometric analysis to identify live (NIR+) CTCs from the pool of total CTCs, which were identified by EpCAM staining. In patients with localized tumor, live CTC counts corresponded with total CTC numbers. Higher live CTC counts were seen in patients with larger tumors and those with more aggressive pathologic features including positive margins and/or lymph node invasion. Even higher CTC numbers (live and total) were detected in patients with metastatic disease. Live CTC counts declined when patients were receiving effective treatments, and conversely the counts tended to rise at the time of disease progression. Our study demonstrates the feasibility of applying of this staining technique to identify live CTCs, creating an opportunity for further molecular interrogation of a more biologically relevant CTC population.	[Shao, Chen; Liao, Chun-Peng; Hu, Peizhen; Chu, Chia-Yi; Knudsen, Beatrice; Kim, Hyung L.; Zhau, Haiyen E.; Chung, Leland W. K.; Wang, Ruoxiang; Posadas, Edwin M.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Urooncol Res Labs, Los Angeles, CA 90048 USA; [Shao, Chen; Liao, Chun-Peng; Hu, Peizhen; Chu, Chia-Yi; Knudsen, Beatrice; Kim, Hyung L.; Zhau, Haiyen E.; Chung, Leland W. K.; Wang, Ruoxiang; Posadas, Edwin M.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Urol Oncol Program, Los Angeles, CA 90048 USA; [Chung, Leland W. K.; Wang, Ruoxiang; Posadas, Edwin M.] Cedars Sinai Med Ctr, Dept Med, Div Hematol Oncol, Los Angeles, CA 90048 USA; [Bui, Matthew H. T.; Ng, Christopher S.; Josephson, David Y.; Kim, Hyung L.] Cedars Sinai Med Ctr, Dept Surg, Div Urol, Los Angeles, CA 90048 USA; [Knudsen, Beatrice] Cedars Sinai Med Ctr, Translat Pathol & Biobank, Los Angeles, CA 90048 USA; [Tighiouart, Mourad] Cedars Sinai Med Ctr, Biostat & Bioinformat Res Ctr, Los Angeles, CA 90048 USA; [Shao, Chen] Fourth Mil Med Univ, Xijing Hosp, Dept Urol, Xian 710032, Shaanxi, Peoples R China; [Zhang, Lei] Fourth Mil Med Univ, Xijing Hosp, Dept Epidemiol, Xian 710032, Shaanxi, Peoples R China	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Air Force Military Medical University; Air Force Military Medical University	Chung, LWK (corresponding author), Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Urooncol Res Labs, Los Angeles, CA 90048 USA.	Leland.chung@cshs.org; Ruoxiang.wang@cshs.org; Edwin.Posadas@scmc.edu	Kim, Hyung/F-5129-2017	Kim, Hyung/0000-0003-2085-6140	Prostate Cancer Foundation; National Institutes of Health/National Cancer Institute [2PO1CA098912, 1RO1CA122602]; Board of Governors Cancer Research Chair (LWKC); Program of International Science and Technology Cooperation of China [2011DFA33110]; NATIONAL CANCER INSTITUTE [R01CA122602, P01CA098912] Funding Source: NIH RePORTER	Prostate Cancer Foundation; National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Board of Governors Cancer Research Chair (LWKC); Program of International Science and Technology Cooperation of China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by research grants from the Prostate Cancer Foundation, National Institutes of Health/National Cancer Institute (2PO1CA098912 and 1RO1CA122602) and the Board of Governors Cancer Research Chair (LWKC), and by the Program of International Science and Technology Cooperation of China (No. 2011DFA33110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix-Panabieres C, 2014, LAB CHIP, V14, P57, DOI 10.1039/c3lc50644d; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Becker TM, 2014, INT J CANCER, V134, P2523, DOI 10.1002/ijc.28516; Coumans FAW, 2012, CLIN CANCER RES, V18, P5711, DOI 10.1158/1078-0432.CCR-12-1585; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Diaz-Cano SJ, 2012, INT J MOL SCI, V13, P1951, DOI 10.3390/ijms13021951; Farace F, 2011, BRIT J CANCER, V105, P847, DOI 10.1038/bjc.2011.294; Harb W, 2013, TRANSL ONCOL, V6, P528, DOI 10.1593/tlo.13367; Harouaka R, 2013, PHARMACOL THERAPEUT, DOI [10.1016/j.pharmthera.2013.10.004, DOI 10.1016/J.PHARMTHERA.2013.10.004.[]; Hogan BV, 2008, MOL MED REP, V1, P775, DOI 10.3892/mmr_00000027; Hu Brian, 2013, Cancers (Basel), V5, P1676, DOI 10.3390/cancers5041676; Hu PZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028670; Ito A, 2003, INVEST OPHTH VIS SCI, V44, P4877, DOI 10.1167/iovs.02-1108; Kallergi G, 2013, MOL CANCER THER, V12, P1886, DOI 10.1158/1535-7163.MCT-12-1167; Kalliokoski A, 2009, BRIT J PHARMACOL, V158, P693, DOI 10.1111/j.1476-5381.2009.00430.x; Karlsson M, 2008, J IMMUNOL METHODS, V334, P122, DOI 10.1016/j.jim.2008.02.008; Larson CJ, 2004, CYTOM PART A, V62A, P46, DOI 10.1002/cyto.a.20073; Lu YT, 2013, METHODS, V64, P144, DOI 10.1016/j.ymeth.2013.06.019; Morgan TM, 2009, CLIN CANCER RES, V15, P677, DOI 10.1158/1078-0432.CCR-08-1754; Pantel K, 2012, CANCER DISCOV, V2, P974, DOI 10.1158/2159-8290.CD-12-0432; POSADAS EM, 2005, PRINCIPLES PRACTICE, P73; POSTE G, 1982, P NATL ACAD SCI-BIOL, V79, P6574, DOI 10.1073/pnas.79.21.6574; Rao CG, 2005, INT J ONCOL, V27, P49; Riethdorf S, 2007, CLIN CANCER RES, V13, P920, DOI 10.1158/1078-0432.CCR-06-1695; Robinson VL, 2004, BIOL SKELETAL METAST; Rossi E, 2010, CLIN CANCER RES, V16, P5233, DOI 10.1158/1078-0432.CCR-10-1449; Schilling D, 2012, NAT REV UROL, DOI [10.1038/nrurol.2012.1136, DOI 10.1038/NRUR0L.2012.1136.[]; Shi GX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058017; Smerage JB, 2013, MOL ONCOL, V7, P680, DOI 10.1016/j.molonc.2013.02.013; Svoboda M, 2011, CURR DRUG METAB, V12, P139, DOI 10.2174/138920011795016863; Thalgott M, 2013, J CANCER RES CLIN, V139, P755, DOI 10.1007/s00432-013-1377-5; Watanabe M, 2013, CYTOM PART A, DOI [10.1002/cyto.a.22422, DOI 10.1002/CYT0.A.22422.[]; Williams Anthony, 2012, Recent Results Cancer Res, V195, P87, DOI 10.1007/978-3-642-28160-0_8; Yang XJ, 2013, J UROLOGY, V189, P702, DOI 10.1016/j.juro.2012.09.056; Yang XJ, 2010, CLIN CANCER RES, V16, P2833, DOI 10.1158/1078-0432.CCR-10-0059; Zair ZM, 2008, PHARMACOGENOMICS, V9, P597, DOI 10.2217/14622416.9.5.597; Zhao L, 2013, ADV MATER, DOI [10.1002/adma.201205237, DOI 10.1002/ADMA.201205237.[]	37	39	43	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88967	10.1371/journal.pone.0088967	http://dx.doi.org/10.1371/journal.pone.0088967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551200	Green Published, gold, Green Submitted			2022-12-27	WOS:000331271500087
J	Wolfe, F; Walitt, BT; Katz, RS; Hauser, W				Wolfe, Frederick; Walitt, Brian T.; Katz, Robert S.; Haeuser, Winfried			Symptoms, the Nature of Fibromyalgia, and Diagnostic and Statistical Manual 5 (DSM-5) Defined Mental Illness in Patients with Rheumatoid Arthritis and Fibromyalgia	PLOS ONE			English	Article							FUNCTIONAL SOMATIC SYNDROMES; HEALTH SURVEY SF-36; SOMATOFORM DISORDERS; PRIMARY-CARE; UNITED-STATES; FIELD TRIALS; SOMATIZATION; CRITERIA; CLASSIFICATION; RELIABILITY	Purpose: To describe and evaluate somatic symptoms in patients with rheumatoid arthritis (RA) and fibromyalgia, determine the relation between somatization syndromes and fibromyalgia, and evaluate symptom data in light of the Diagnostic and Statistical Manual-5 (DSM-5) criteria for somatic symptom disorder. Methods: We administered the Patient Health Questionnaire-15 (PHQ-15), a measure of somatic symptom severity to 6,233 persons with fibromyalgia, RA, and osteoarthritis. PHQ-15 scores of 5, 10, and 15 represent low, medium, and high somatic symptom severity cut-points. A likely somatization syndrome was diagnosed when PHQ-15 score was >= 10. The intensity of fibromyalgia diagnostic symptoms was measured by the polysymptomatic distress (PSD) scale. Results: 26.4% of RA patients and 88.9% with fibromyalgia had PHQ-15 scores >= 10 compared with 9.3% in the general population. With each step-wise increase in PHQ-15 category, more abnormal mental and physical health status scores were observed. RA patients satisfying fibromyalgia criteria increased from 1.2% in the PHQ-15 low category to 88.9% in the high category. The sensitivity and specificity of PHQ-15 >= 10 for fibromyalgia diagnosis was 80.9% and 80.0% (correctly classified = 80.3%) compared with 84.3% and 93.7% (correctly classified = 91.7%) for the PSD scale. 51.4% of fibromyalgia patients and 14.8% with RA had fatigue, sleep or cognitive problems that were severe, continuous, and life-disturbing; and almost all fibromyalgia patients had severe impairments of function and quality of life. Conclusions: All patients with fibromyalgia will satisfy the DSM-5 "A'' criterion for distressing somatic symptoms, and most would seem to satisfy DSM-5 "B'' criterion because symptom impact is life-disturbing or associated with substantial impairment of function and quality of life. But the "B'' designation requires special knowledge that symptoms are "disproportionate'' or "excessive,'' something that is uncertain and controversial. The reliability and validity of DSM-5 criteria in this population is likely to be low.	[Wolfe, Frederick] Natl Data Bank Rheumat Dis, Wichita, KS 67214 USA; [Wolfe, Frederick] Univ Kansas, Sch Med, Wichita, KS 67214 USA; [Walitt, Brian T.] Washington Hosp Ctr, Washington, DC 20010 USA; [Katz, Robert S.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Haeuser, Winfried] Tech Univ Munich, Dept Psychosomat Med & Psychotherapy, D-80290 Munich, Germany; [Haeuser, Winfried] Klinikum Saarbrucken, Dept Internal Med 1, Saarbrucken, Germany	National Data Bank for Rheumatic Diseases; University of Kansas; University of Kansas Medical Center; MedStar Washington Hospital Center; Rush University; Technical University of Munich	Wolfe, F (corresponding author), Natl Data Bank Rheumat Dis, Wichita, KS 67214 USA.	fwolfe@arthritis-research.org	Häuser, Winfried/AAX-6231-2021; Häuser, Winfried/AAH-6633-2021	Wolfe, Frederick/0000-0002-2801-6413; Hauser, Winfried/0000-0002-3742-729X				American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Association AP, 1980, DIAGN STAT MAN MENT; Barker KK, 2011, SOCIAL SCI MED; Barker Kristin, 2009, FIBROMYALGIA STORY M; Barsky AJ, 1999, ANN INTERN MED, V130, P910, DOI 10.7326/0003-4819-130-11-199906010-00016; Clarke DE, 2013, AM J PSYCHIAT, V170, P43, DOI 10.1176/appi.ajp.2012.12070998; Creed FH, 2012, J PSYCHOSOMATIC RES; Crombez G, 2009, PAIN, V145, P31, DOI 10.1016/j.pain.2009.04.006; Dimsdale JE, 2013, J PSYCHOSOMATIC RES; Fink P, 2005, PSYCHOSOMATICS, V46, P540, DOI 10.1176/appi.psy.46.6.540; Fink P, 1999, PSYCHOSOMATICS, V40, P330, DOI 10.1016/S0033-3182(99)71228-4; Fink P, 2010, J PSYCHOSOM RES, V68, P415, DOI 10.1016/j.jpsychores.2010.02.004; Frances A, 2013, AUST NZ J PSYCHIAT, V47, P483, DOI 10.1177/0004867413484525; Frances A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1580; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Gervais RO, 2001, J RHEUMATOL, V28, P1892; Grabe HJ, 2003, PSYCHOSOMATICS, V44, P304, DOI 10.1176/appi.psy.44.4.304; Gross M, 2013, CURR BIOL, V23, pR295, DOI 10.1016/j.cub.2013.04.009; HIDDING A, 1994, J RHEUMATOL, V21, P818; Houtveen JH, 2003, J PSYCHOSOM RES, V55, P481, DOI 10.1016/S0022-3999(03)00011-4; Kocalevent RD, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-91; Korber S, 2011, J PSYCHOSOM RES, V71, P142, DOI 10.1016/j.jpsychores.2011.01.006; Kroenke K, 2006, J PSYCHOSOM RES, V60, P335, DOI 10.1016/j.jpsychores.2006.01.022; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2007, PSYCHIAT CLIN N AM, V30, P593, DOI 10.1016/j.psc.2007.08.002; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leeb BF, 2004, RHEUMATOLOGY, V43, P1504, DOI 10.1093/rheumatology/keh322; LIPOWSKI ZJ, 1988, AM J PSYCHIAT, V145, P1358; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Obradovic M, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-110; Regier DA, 2013, AM J PSYCHIAT, V170, P59, DOI 10.1176/appi.ajp.2012.12070999; Sharpe M, 2001, ANN INTERN MED, V134, P926, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00018; Speckens AEM, 1996, J PSYCHOSOM RES, V40, P95, DOI 10.1016/0022-3999(95)00561-7; van Ravesteijn H, 2009, ANN FAM MED, V7, P232, DOI 10.1370/afm.985; VANDERHEIJDE DMFM, 1990, ANN RHEUM DIS, V49, P916, DOI 10.1136/ard.49.11.916; Walitt B, 2011, J RHEUMATOLOGY; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; WARE JE, 1994, INT J MENT HEALTH, V23, P49, DOI 10.1080/00207411.1994.11449283; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2; Wessely S, 2004, BRIT J PSYCHIAT, V185, P95, DOI 10.1192/bjp.185.2.95; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2013, NATURE REV RHEUMATOL; Wolfe F, 2013, ARTHRIT CARE RES, V65, P777, DOI 10.1002/acr.21931; Wolfe F, 2011, J RHEUMATOL, V38, P1113, DOI 10.3899/jrheum.100594; Wolfe F, 2011, RHEUMATOLOGY, V50, P16, DOI 10.1093/rheumatology/keq155; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Wolfe F, 2010, ARTHRIT CARE RES, V62, P583, DOI 10.1002/acr.20156; YUNUS M, 1981, SEMIN ARTHRITIS RHEU, V11, P151, DOI 10.1016/0049-0172(81)90096-2	52	55	56	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88740	10.1371/journal.pone.0088740	http://dx.doi.org/10.1371/journal.pone.0088740			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7IR	24551146	Green Published, gold			2022-12-27	WOS:000331271500061
J	Bello-Morales, R; Crespillo, AJ; Garcia, B; Dorado, LA; Martin, B; Tabares, E; Krummenacher, C; de Castro, F; Lopez-Guerrero, JA				Bello-Morales, Raquel; Jesus Crespillo, Antonio; Garcia, Beatriz; Dorado, Luis Angel; Martin, Beatriz; Tabares, Enrique; Krummenacher, Claude; de Castro, Fernando; Antonio Lopez-Guerrero, Jose			The Effect of Cellular Differentiation on HSV-1 Infection of Oligodendrocytic Cells	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; MYELIN-ASSOCIATED GLYCOPROTEIN; MULTIPLE-SCLEROSIS; HEPARAN-SULFATE; ENTRY MEDIATOR; SENSORY NEURONS; ENDOCYTIC ENTRY; BINDING-SITE; IN-VITRO; LOW-PH	Herpes simplex type 1 (HSV-1) is a neurotropic virus that infects many types of cells. Previous studies have demonstrated that oligodendrocytic cells are highly susceptible to HSV-1 infection. Here we analysed HSV-1 infection of a human oligodendrocytic cell line, HOG, and oligodendrocyte precursor cells (OPCs) cultured under growth or differentiation conditions. In addition to cell susceptibility, the role of the major cell receptors for viral entry was assessed. Our results revealed that OPCs and HOG cells cultured under differentiation conditions became more susceptible to HSV-1. On the other hand, viral infection induced morphological changes corresponding to differentiated cells, suggesting that HSV-1 might be inducing cell differentiation. We also observed colocalization of HVEM and nectin-1 with viral particles, suggesting that these two major HSV-1 receptors are functional in HOG cells. Finally, electron microscopy assays indicated that HSV-1 may be also entering OLs by macropinocytosis depending on their differentiation stage. In addition, vesicles containing intracellular enveloped virions observed in differentiated cells point to an endocytic mechanism of virus entry. All these data are indicative of diverse entry pathways dependent on the maturation stage of OLs.	[Bello-Morales, Raquel; Dorado, Luis Angel] Univ Autonoma Madrid, Dept Biol Mol, Madrid, Spain; [Jesus Crespillo, Antonio; Garcia, Beatriz; Antonio Lopez-Guerrero, Jose] CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Martin, Beatriz; Tabares, Enrique] Univ Autonoma Madrid, Fac Med, Madrid, Spain; [Krummenacher, Claude] Univ Penn, Dept Pathobiol, Sch Vet Med, Philadelphia, PA USA; [de Castro, Fernando] Hosp Nacl Paraplj, Grp Neurobiol Desarrollo GNDe, Toledo, OH, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; University of Pennsylvania; Hospital Nacional de Paraplejicos	Lopez-Guerrero, JA (corresponding author), Univ Autonoma Madrid, Dept Biol Mol, Edificio Biol Darwin 2, Madrid, Spain.	rbellomorales@cbm.uam.es	Guerrero, Jose Antonio Lopez/Z-2413-2019; de Castro, Fernando/Q-8624-2018; Tabares, Enrique/AAA-4492-2019; LÓPEZ-GUERRERO, JOSÉ ANTONIO/L-5667-2017; Bello-Morales, Raquel/AHD-5028-2022	Guerrero, Jose Antonio Lopez/0000-0002-7369-8388; de Castro, Fernando/0000-0002-7018-8032; LÓPEZ-GUERRERO, JOSÉ ANTONIO/0000-0003-2817-5956; Krummenacher, Claude/0000-0002-3492-4987; Bello-Morales, Raquel/0000-0002-4415-6483; Bello-Morales, Raquel/0000-0002-8526-6590	Ministerio de Economia y Competitividad-MINECO [SAF2012-40023, RD12-0032-12]; FEDER-European Union/Una manera de hacer Europa; National Institute of Allergy and Infectious Diseases [AI-097171]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI097171] Funding Source: NIH RePORTER	Ministerio de Economia y Competitividad-MINECO; FEDER-European Union/Una manera de hacer Europa; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was partially supported by the Ministerio de Economia y Competitividad-MINECO (SAF2012-40023 and RD12-0032-12 -partially funded by FEDER-European Union/Una manera de hacer Europa). FdeC is hired by Gobierno de Castilla-La Mancha-SESCAM. CK is supported by Public Health Service grant AI-097171 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar J, 2008, INVEST OPHTH VIS SCI, V49, P4026, DOI 10.1167/iovs.08-1807; Alvarez-Lafuente R, 2008, MULT SCLER J, V14, P595, DOI 10.1177/1352458507086425; Arii J, 2010, NATURE, V467, P859, DOI 10.1038/nature09420; BANSAL R, 1994, DEV BIOL, V162, P511, DOI 10.1006/dbio.1994.1105; Bauer NG, 2009, GLIA, V57, P1691, DOI 10.1002/glia.20885; Bello-Morales R, 2005, J NEUROVIROL, V11, P190, DOI 10.1080/13550280590924179; Bello-Morales R, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-265; Bello-Morales R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019388; Bello-Morales R, 2009, EXP CELL RES, V315, P3453, DOI 10.1016/j.yexcr.2009.08.003; Bertke AS, 2013, J VIROL, V87, P6512, DOI 10.1128/JVI.00383-13; Bribian A, 2008, DEV NEUROBIOL, V68, P1503, DOI 10.1002/dneu.20678; Buntinx M, 2003, J NEUROCYTOL, V32, P25, DOI 10.1023/A:1027324230923; Cheshenko N, 2013, FASEB J, V27, P2584, DOI 10.1096/fj.12-220285; Choudhary S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/264350; Christensen T, 2005, REV MED VIROL, V15, P179, DOI 10.1002/rmv.465; Clement C, 2006, J CELL BIOL, V174, P1009, DOI 10.1083/jcb.200509155; Ortega MC, 2012, GLIA, V60, P851, DOI 10.1002/glia.22316; de Castro F, 2013, CELL MOL LIFE SCI, V70, P4355, DOI 10.1007/s00018-013-1365-6; DELUCA NA, 1985, J VIROL, V56, P558, DOI 10.1128/JVI.56.2.558-570.1985; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; DUBOISDALCQ M, 1986, J CELL BIOL, V102, P384, DOI 10.1083/jcb.102.2.384; Eisenberg RJ, 2012, VIRUSES-BASEL, V4, P800, DOI 10.3390/v4050800; Ferrante P, 2000, J NEUROVIROL, V6, pS109; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; Gianni T, 2012, J VIROL, V86, P2850, DOI 10.1128/JVI.06689-11; Giraudon P, 2009, REV NEUROL-FRANCE, V165, P789, DOI 10.1016/j.neurol.2009.07.004; Hayashi T, 2004, P NATL ACAD SCI USA, V101, P14949, DOI 10.1073/pnas.0402890101; Heldwein EE, 2008, CELL MOL LIFE SCI, V65, P1653, DOI 10.1007/s00018-008-7570-z; Ji QY, 2010, NAT IMMUNOL, V11, P628, DOI 10.1038/ni.1888; Kakalacheva K, 2011, BBA-MOL BASIS DIS, V1812, P132, DOI 10.1016/j.bbadis.2010.06.012; Karasneh GA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-481; Krummenacher C, 2005, EMBO J, V24, P4144, DOI 10.1038/sj.emboj.7600875; Krummenacher C, 2004, VIROLOGY, V322, P286, DOI 10.1016/j.virol.2004.02.005; Krummenacher C, 2000, J VIROL, V74, P10863, DOI 10.1128/JVI.74.23.10863-10872.2000; Lara-Pezzi E, 2001, HEPATOLOGY, V33, P1270, DOI 10.1053/jhep.2001.1270; LEVY DN, 1993, CELL, V72, P541, DOI 10.1016/0092-8674(93)90073-Y; MacLeod IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009560; Medina-Rodriguez EM, 2013, CELL MOL LIFE SCI, V70, P3449, DOI 10.1007/s00018-013-1340-2; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Milne RSB, 2005, J VIROL, V79, P6655, DOI 10.1128/JVI.79.11.6655-6663.2005; Mitchell BM, 2003, J NEUROVIROL, V9, P194, DOI 10.1080/13550280390194000; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Nicola AV, 2004, J VIROL, V78, P7508, DOI 10.1128/JVI.78.14.7508-7517.2004; Nicola AV, 2003, J VIROL, V77, P5324, DOI 10.1128/JVI.77.9.5324-5332.2003; O'Donnell CD, 2010, VIROLOGY, V397, P389, DOI 10.1016/j.virol.2009.11.011; Pietropaolo V, 2005, NEW MICROBIOL, V28, P199; POST GR, 1992, MOL CHEM NEUROPATHOL, V16, P303, DOI 10.1007/BF03159976; Properzi F, 2008, EUR J NEUROSCI, V27, P593, DOI 10.1111/j.1460-9568.2008.06042.x; QUARLES RH, 1989, CRIT REV NEUROBIOL, V5, P1; Reske A, 2007, REV MED VIROL, V17, P205, DOI 10.1002/rmv.531; Richart SM, 2003, J VIROL, V77, P3307, DOI 10.1128/JVI.77.5.3307-3311.2003; Rikitake Y, 2012, J CELL SCI, V125, P3713, DOI 10.1242/jcs.099572; Rizzo R, 2012, J NEUROIMMUNOL, V251, P55, DOI 10.1016/j.jneuroim.2012.07.004; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Ruprecht K, 2006, J NEUROVIROL, V12, P65, DOI 10.1080/13550280600614973; Sanders VJ, 1996, ARCH NEUROL-CHICAGO, V53, P125, DOI 10.1001/archneur.1996.00550020029012; Sanderson C M, 1999, Expert Rev Mol Med, V1999, P1, DOI 10.1017/S1462399499000629; Satoh T, 2008, CELL, V132, P935, DOI 10.1016/j.cell.2008.01.043; Schnaar RL, 2009, J NEUROSCI RES, V87, P3267, DOI 10.1002/jnr.21992; Schretlen DJ, 2010, SCHIZOPHR RES, V118, P224, DOI 10.1016/j.schres.2010.01.008; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Silva MA, 2012, J CROHNS COLITIS, V6, P454, DOI 10.1016/j.crohns.2011.09.015; Simmons A, 2001, Herpes, V8, P60; Simpson SA, 2005, J NEUROVIROL, V11, P208, DOI 10.1080/13550280590924214; Sotelo J, 2007, J NEUROL SCI, V262, P113, DOI 10.1016/j.jns.2007.07.001; Stiles KM, 2008, VIROLOGY, V373, P98, DOI 10.1016/j.virol.2007.11.012; Stiles KM, 2010, VIROLOGY, V399, P109, DOI 10.1016/j.virol.2009.12.034; Suenaga T, 2010, P NATL ACAD SCI USA, V107, P866, DOI 10.1073/pnas.0913351107; Swanborg RH, 2003, J NEUROIMMUNOL, V136, P1, DOI 10.1016/S0165-5728(02)00465-4; Tang S, 1997, J CELL BIOL, V138, P1355, DOI 10.1083/jcb.138.6.1355; Terry-Allison T, 1998, J VIROL, V72, P5802, DOI 10.1128/JVI.72.7.5802-5810.1998; Tiwari V, 2008, FEBS J, V275, P5272, DOI 10.1111/j.1742-4658.2008.06655.x; Warner MS, 1998, VIROLOGY, V246, P179, DOI 10.1006/viro.1998.9218; Whitley RJ, 2006, ANTIVIR RES, V71, P141, DOI 10.1016/j.antiviral.2006.04.002; YANKASKAS JR, 1993, AM J PHYSIOL, V264, pC1219, DOI 10.1152/ajpcell.1993.264.5.C1219; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006	77	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89141	10.1371/journal.pone.0089141	http://dx.doi.org/10.1371/journal.pone.0089141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551233	Green Published, Green Submitted, gold			2022-12-27	WOS:000331266000107
J	Bodewes, R; van de Bildt, MWG; van Elk, CE; Bunskoek, PE; van de Vijver, DAMC; Smits, SL; Osterhaus, ADME; Kuiken, T				Bodewes, Rogier; van de Bildt, Marco W. G.; van Elk, Cornelis E.; Bunskoek, Paulien E.; van de Vijver, David A. M. C.; Smits, Saskia L.; Osterhaus, Albert D. M. E.; Kuiken, Thijs			No Serological Evidence that Harbour Porpoises Are Additional Hosts of Influenza B Viruses	PLOS ONE			English	Article							MARINE MAMMALS; SEALS; ANTIBODIES	Influenza A and B viruses circulate among humans causing epidemics almost annually. While various hosts for influenza A viruses exist, influenza B viruses have been detected only in humans and seals. However, recurrent infections of seals in Dutch coastal waters with influenza B viruses that are antigenetically distinct from influenza B viruses circulating among humans suggest that influenza B viruses have been introduced into this seal population by another, non-human, host. Harbour porpoises (Phocoena phocoena) are sympatric with seals in these waters and are also occasionally in close contact with humans after stranding and subsequent rehabilitation. In addition, virus attachment studies demonstrated that influenza B viruses can bind to cells of the respiratory tract of these animals. Therefore, we hypothesized that harbour porpoises might be a reservoir of influenza B viruses. In the present study, an unique set of serum samples from 79 harbour porpoises, stranded alive on the Dutch coast between 2003 and 2013, was tested for the presence of antibodies against influenza B viruses by use of the hemagglutination inhibition test and for antibodies against influenza A viruses by use of a competitive influenza A nucleoprotein ELISA. No antibodies were detected against either virus, suggesting that influenza A and B virus infections of harbour porpoises in Dutch coastal waters are not common, which was supported by statistical analysis of the dataset.	[Bodewes, Rogier; van de Bildt, Marco W. G.; van Elk, Cornelis E.; van de Vijver, David A. M. C.; Smits, Saskia L.; Osterhaus, Albert D. M. E.; Kuiken, Thijs] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [van Elk, Cornelis E.; Bunskoek, Paulien E.] SOS Dolphin Fdn, Harderwijk, Netherlands; [van Elk, Cornelis E.; Bunskoek, Paulien E.] Dolfinarium Harderwijk, Harderwijk, Netherlands; [Smits, Saskia L.; Osterhaus, Albert D. M. E.] Viroclin Biosci BV, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Bodewes, R (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.	r.bodewes@erasmusmc.nl		van de Vijver, David/0000-0001-5877-8526; Kuiken, Thijs/0000-0001-5501-9049; Bodewes, Rogier/0000-0002-0689-7889	European Community [223498]; VIRGO Consortium	European Community(European Commission); VIRGO Consortium	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under the project "European Management Platform for Emerging and Re-emerging Infectious disease Entities'' (EMPERIE) EC grant agreement number 223498 and the VIRGO Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMITAGE P, 2002, STAT METHODS MED RES, P1; Blanc A, 2009, J WILDLIFE DIS, V45, P519, DOI 10.7589/0090-3558-45.2.519; Bland M., 2000, INTRO MED STAT, V3rd; Bodewes R, 2011, CLIN VACCINE IMMUNOL, V18, P469, DOI 10.1128/CVI.00396-10; Bodewes R, 2013, EMERG INFECT DIS, V19, P511, DOI 10.3201/eid1903.120965; De Jong JC., 2011, NED TIJDSCHR MED MIC, V19, P21; DEBOER GF, 1990, ARCH VIROL, V115, P47, DOI 10.1007/BF01310622; Geelhoed Steve C. V., 2013, Lutra, V56, P45; Hammond PS, 2002, J APPL ECOL, V39, P361, DOI 10.1046/j.1365-2664.2002.00713.x; Harkonen T, 2006, DIS AQUAT ORGAN, V68, P115, DOI 10.3354/dao068115; Lebarbenchon C, 2012, J VET DIAGN INVEST, V24, P161, DOI 10.1177/1040638711416626; Nielsen O, 2001, J WILDLIFE DIS, V37, P820, DOI 10.7589/0090-3558-37.4.820; Ohishi K, 2002, MICROBIOL IMMUNOL, V46, P639, DOI 10.1111/j.1348-0421.2002.tb02746.x; Osterhaus ADME, 2000, SCIENCE, V288, P1051, DOI 10.1126/science.288.5468.1051; Palmer DF, 1975, ADV LAB TECHNIQUES I, P25; Ramis AJ, 2012, EMERG INFECT DIS, V18, P817, DOI 10.3201/eid1805.111828; Read AJ, 1998, HDB MARINE MAMMALS, P336; Reperant LA, 2009, REV SCI TECH OIE, V28, P137, DOI 10.20506/rst.28.1.1876; Runstadler J, 2013, INFECT GENET EVOL, V17, P162, DOI 10.1016/j.meegid.2013.02.020; SCANS-II, 2008, SMALL CET EUR ATL N; Scheidat M, 2012, J SEA RES, V69, P1, DOI 10.1016/j.seares.2011.12.004	21	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89058	10.1371/journal.pone.0089058	http://dx.doi.org/10.1371/journal.pone.0089058			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551217	Green Published, gold			2022-12-27	WOS:000331266000096
J	Jain, M; Lim, Y; Arce-Nazario, JA; Uriarte, M				Jain, Meha; Lim, Yili; Arce-Nazario, Javier A.; Uriarte, Maria			Perceptional and Socio-Demographic Factors Associated with Household Drinking Water Management Strategies in Rural Puerto Rico	PLOS ONE			English	Article							POINT-OF-USE; QUALITY; REGRESSION; MODELS	Identifying which factors influence household water management can help policy makers target interventions to improve drinking water quality for communities that may not receive adequate water quality at the tap. We assessed which perceptional and socio-demographic factors are associated with household drinking water management strategies in rural Puerto Rico. Specifically, we examined which factors were associated with household decisions to boil or filter tap water before drinking, or to obtain drinking water from multiple sources. We find that households differ in their management strategies depending on the institution that distributes water (i.e. government PRASA vs community-managed non-PRASA), perceptions of institutional efficacy, and perceptions of water quality. Specifically, households in PRASA communities are more likely to boil and filter their tap water due to perceptions of low water quality. Households in non-PRASA communities are more likely to procure water from multiple sources due to perceptions of institutional inefficacy. Based on informal discussions with community members, we suggest that water quality may be improved if PRASA systems improve the taste and odor of tap water, possibly by allowing for dechlorination prior to distribution, and if non-PRASA systems reduce the turbidity of water at the tap, possibly by increasing the degree of chlorination and filtering prior to distribution. Future studies should examine objective water quality standards to identify whether current management strategies are effective at improving water quality prior to consumption.	[Jain, Meha; Lim, Yili; Uriarte, Maria] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Arce-Nazario, Javier A.] Univ Puerto Rico Cayey, Dept Biol, Cayey, PR USA	Columbia University; University of Puerto Rico; University of Puerto Rico at Cayey	Jain, M (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA.	mj2415@columbia.edu			National Science Foundation [DEB 0620910]; Crosscutting Initiatives program, Earth Institute, Columbia University; National Center on Minority Health and Health Disparities [P20MD006144]; National Science Foundation Graduate Research Fellowship [11-44155]; National Institute on Minority Health and Health Disparities [P20MD006144] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Crosscutting Initiatives program, Earth Institute, Columbia University; National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Funding was provided by awards to MU from National Science Foundation DEB 0620910 and the Crosscutting Initiatives program, Earth Institute, Columbia University. This study was partially supported by Award Number P20MD006144 from the National Center on Minority Health and Health Disparities. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center on Minority Health and Health Disparities or the National Institutes of Health. This work was also supported by the National Science Foundation Graduate Research Fellowship under Grant No. 11-44155 awarded to MJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold BF, 2007, AM J TROP MED HYG, V76, P354, DOI 10.4269/ajtmh.2007.76.354; Autoridad de Acueductos y Alcantarillados, 2001, WAT QUAL REP; Below TB, 2012, GLOBAL ENVIRON CHANG, V22, P223, DOI 10.1016/j.gloenvcha.2011.11.012; Berkes F, 2006, ECOL SOC, V11; BIERNACKI P, 1981, SOCIOL METHOD RES, V10, P141, DOI 10.1177/004912418101000205; Boose ER, 2004, ECOL MONOGR, V74, P335, DOI 10.1890/02-4057; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cash DW, 2006, ECOL SOC, V11; Chowdhury S, 2009, SCI TOTAL ENVIRON, V407, P4189, DOI 10.1016/j.scitotenv.2009.04.006; Clasen TF, 2004, TROP MED INT HEALTH, V9, P187, DOI 10.1046/j.1365-3156.2003.01191.x; de Cardenas SC, 2011, DOES PRIVATE MANAGEM; Environmental Protection Agency, 2010, PUERT RIC AQ SEW AUT; Fielding KS, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR012398; Gartin M, 2010, ECOL SOC, V15; Gelman A., 2007, DATA ANAL USING REGR, DOI 10.1017/CBO9780511790942; Gueprero-Preston R, 2008, P R HEALTH SCI J, V27, P229; Hellard ME, 2001, ENVIRON HEALTH PERSP, V109, P773, DOI 10.2307/3454818; Hu ZH, 2011, INT J ENV RES PUB HE, V8, P565, DOI 10.3390/ijerph8020565; Hunter PR, 2010, BMC PUBLIC HLTH, V10; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Jehu-Appiah C, 2012, HEALTH POLICY PLANN, V27, P222, DOI 10.1093/heapol/czr032; Jorgensen B, 2009, J ENVIRON MANAGE, V91, P227, DOI 10.1016/j.jenvman.2009.08.009; Katuwal H, 2011, J WATER HEALTH, V9, P143, DOI 10.2166/wh.2010.151; Larson AM, 2008, ANNU REV ENV RESOUR, V33, P213, DOI 10.1146/annurev.environ.33.020607.095522; Lebel L, 2005, ECOLOGY SOC, V10; LECESSIE S, 1991, BIOMETRICS, V47, P1267, DOI 10.2307/2532385; Makutsa P, 2001, AM J PUBLIC HEALTH, V91, P1571, DOI 10.2105/AJPH.91.10.1571; Mintz E, 2001, AM J PUBLIC HEALTH, V91, P1565, DOI 10.2105/AJPH.91.10.1565; Molina-Rivera W, 1998, ESTIMATED WATER USE; NORTH DC, 1991, J ECON PERSPECT, V5, P97, DOI 10.1257/jep.5.1.97; Olsson P, 2004, ENVIRON MANAGE, V34, P75, DOI 10.1007/s00267-003-0101-7; Palanski ME, 2011, J BUS ETHICS, V99, P201, DOI 10.1007/s10551-010-0650-7; PAYMENT P, 1985, APPL ENVIRON MICROB, V49, P1418, DOI 10.1128/AEM.49.6.1418-1428.1985; Peters RG, 1997, RISK ANAL, V17, P43, DOI 10.1111/j.1539-6924.1997.tb00842.x; Pruss A, 2002, ENVIRON HEALTH PERSP, V110, P537, DOI 10.1289/ehp.02110537; Puerto Rico Department of Public Health, 1996, WAT QUAL REP; Quinones F, 2005, PRASA HAS AMPLE WATE; Sabau G, 2008, WATER ENVIRON J, V22, P168, DOI 10.1111/j.1747-6593.2007.00096.x; Sangodoyin AY, 1993, ENV MANAGEMENT HLTH; Saravanan VS, 2008, ECOL COMPLEX, V5, P202, DOI 10.1016/j.ecocom.2008.04.003; Sarker A, 2008, ECOL ECON, V68, P461, DOI 10.1016/j.ecolecon.2008.05.001; Sobsey M. D., 2002, MANAGING WATER HOME; Teunis P, 1997, WATER RES; Toro GR, 2004, REGULATION FINANCING; Trevett AF, 2004, INT J ENVIRON HEAL R, V14, P273, DOI 10.1080/09603120410001725612; US Bureau of the Census, 2000, CENS POP SOC EC CHAR; Worley JL, 2000, EVALUATION DECHLORIN; Young WF, 1996, WATER RES, V30, P331, DOI 10.1016/0043-1354(95)00173-5; Zerah, 2000, WATER UNRELIABLE SUP	49	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e88059	10.1371/journal.pone.0088059	http://dx.doi.org/10.1371/journal.pone.0088059			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3DW	24586302	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200015
J	Steen, JA; Bohlke, N; Vickers, CE; Nielsen, LK				Steen, Jennifer A.; Bohlke, Nina; Vickers, Claudia E.; Nielsen, Lars K.			The Trehalose Phosphotransferase System (PTS) in E. coli W Can Transport Low Levels of Sucrose that Are Sufficient to Facilitate Induction of the csc Sucrose Catabolism Operon	PLOS ONE			English	Article							ESCHERICHIA-COLI; MALTOSE REGULON; METABOLISM; PERMEASE; GENES; PHOSPHOENOLPYRUVATE; DERIVATIVES; REPRESSION; CLONING; STRAIN	Plasticity in substrate acceptance is a well-characterised phenomenon for disaccharide transporters. Sucrose, a non-reducing disaccharide, is usually metabolised via either the permease-mediated chromosomally-encoded sucrose catabolism (csc) regulon or the sucrose phosphotransferase system (PTS). E. coli W is a fast-growing strain which efficiently utilises sucrose at concentrations above 1% via the csc regulon. To examine if sucrose could be metabolised via other routes, a library of transposon mutants was generated and screened on 0.2% sucrose. One mutant identified from this library had an insertion in the repressor for the regulon controlling catabolism of the disaccharide trehalose (treR). A series of mutants was constructed to elucidate the mechanism of sucrose utilization in the treR insertion strain. Analysis of these mutants provided evidence that deletion of TreR enables uptake of sucrose via TreB, an enzyme II protein required for PTS-mediated uptake of trehalose. Once inside the cell, this sucrose is not processed by the TreC hydrolase, nor is it sufficient for growth of the strain. QRT-PCR analysis showed that levels of cscA (invertase) transcript increased in the W Delta treR mutant relative to the wild-type strain when grown under low sucrose conditions. This result suggests that the intracellular sucrose provided by TreB can facilitate de-repression of the csc regulon, leading to increased gene expression, sucrose uptake and sucrose utilization in the treR mutant.	[Steen, Jennifer A.; Bohlke, Nina; Vickers, Claudia E.; Nielsen, Lars K.] Univ Queensland, AIBN, Brisbane, Qld, Australia	University of Queensland	Vickers, CE (corresponding author), Univ Queensland, AIBN, Brisbane, Qld, Australia.	c.vickers@uq.edu.au	Vickers, Claudia E/A-1288-2009; Nielsen, Lars K/A-5519-2011	Vickers, Claudia E/0000-0002-0792-050X; Nielsen, Lars K/0000-0001-8191-3511; Steen, Jennifer/0000-0002-4760-9492	Queensland State Government National and International Research Alliance Program; Cooperative Research Centre for Sugar Industry Innovation through Biotechnology (CRC SIIB); Queensland State Government Smart Futures fellowship	Queensland State Government National and International Research Alliance Program; Cooperative Research Centre for Sugar Industry Innovation through Biotechnology (CRC SIIB)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Queensland State Government Smart Futures fellowship	This work was supported by the Queensland State Government National and International Research Alliance Program and the Cooperative Research Centre for Sugar Industry Innovation through Biotechnology (CRC SIIB). CEV was supported by a Queensland State Government Smart Futures fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGBONLAHOR DE, 1982, T ROY SOC TROP MED H, V76, P265, DOI 10.1016/0035-9203(82)90293-0; Archer CT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-9; Arifin Y, 2011, J BIOTECHNOL, V156, P275, DOI 10.1016/j.jbiotec.2011.07.003; BOCKMANN J, 1992, MOL GEN GENET, V235, P22, DOI 10.1007/BF00286177; BOOS W, 1990, J BACTERIOL, V172, P3450, DOI 10.1128/jb.172.6.3450-3461.1990; Bruschi M, 2012, BIOTECHNOL ADV, V30, P1001, DOI 10.1016/j.biotechadv.2011.08.019; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Decker K, 1999, MOL MICROBIOL, V32, P777, DOI 10.1046/j.1365-2958.1999.01395.x; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; Edwards P. R., 1972, IDENTIFICATION ENTER; FRILLINGOS S, 1995, BIOCHEMISTRY-US, V34, P9368, DOI 10.1021/bi00029a012; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; HARDESTY C, 1991, J BACTERIOL, V173, P449, DOI 10.1128/jb.173.2.449-456.1991; Horlacher R, 1997, J BIOL CHEM, V272, P13026, DOI 10.1074/jbc.272.20.13026; HUBER RE, 1975, CAN J BIOCHEM CELL B, V53, P1035, DOI 10.1139/o75-142; Jahreis K, 2002, J BACTERIOL, V184, P5307, DOI 10.1128/JB.184.19.5307-5316.2002; Jensen JB, 2002, J BACTERIOL, V184, P2978, DOI 10.1128/JB.184.11.2978-2986.2002; KLEIN W, 1995, J BACTERIOL, V177, P4043, DOI 10.1128/jb.177.14.4043-4052.1995; Lee JW, 2010, APPL MICROBIOL BIOT, V88, P905, DOI 10.1007/s00253-010-2825-7; LEE SY, 1993, BIOTECHNOL LETT, V15, P971, DOI 10.1007/BF00131766; LIN ECC, 1976, ANNU REV MICROBIOL, V30, P535, DOI 10.1146/annurev.mi.30.100176.002535; MARECHAL LR, 1984, ARCH MICROBIOL, V137, P70, DOI 10.1007/BF00425810; Moritz RL, 2006, J CLIN MICROBIOL, V44, P4038, DOI 10.1128/JCM.01172-06; Murray GL, 2008, MICROBES INFECT, V10, P791, DOI 10.1016/j.micinf.2008.04.010; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Peng Y, 2009, J MEMBRANE BIOL, V228, P79, DOI 10.1007/s00232-009-9161-9; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; POY F, 1990, INFECT IMMUN, V58, P1479, DOI 10.1128/IAI.58.5.1479-1480.1990; RAIBAUD O, 1987, J BACTERIOL, V169, P3059, DOI 10.1128/jb.169.7.3059-3061.1987; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; RIMMELE M, 1994, J BACTERIOL, V176, P5654, DOI 10.1128/JB.176.18.5654-5664.1994; Sabri S, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-60; Sabri S, 2013, APPL ENVIRON MICROB, V79, P478, DOI 10.1128/AEM.02544-12; Sahin-Toth M, 1999, CAN J MICROBIOL, V45, P418, DOI 10.1139/cjm-45-5-418; SAHINTOTH M, 1995, BIOCHEM BIOPH RES CO, V208, P1116, DOI 10.1006/bbrc.1995.1449; Sambrook J., 2001, MOL CLONING LAB MANU; SCHMID K, 1988, MOL MICROBIOL, V2, P1, DOI 10.1111/j.1365-2958.1988.tb00001.x; SCHMID K, 1982, J BACTERIOL, V151, P68, DOI 10.1128/JB.151.1.68-76.1982; Schuerman PL, 1997, APPL MICROBIOL BIOT, V47, P560, DOI 10.1007/s002530050973; Silva Z, 2005, J BACTERIOL, V187, P1210, DOI 10.1128/JB.187.4.1210-1218.2005; SPRENGER GA, 1988, J GEN MICROBIOL, V134, P1635; TAO L, 1993, J DENT RES, V72, P1386, DOI 10.1177/00220345930720100701; TSUNEKAWA H, 1992, APPL ENVIRON MICROB, V58, P2081, DOI 10.1128/AEM.58.6.2081-2088.1992; Vickers CE, 2012, BIOTECHNOL LETT, V34, P585, DOI 10.1007/s10529-011-0821-3; Wang YF, 1997, J MOL BIOL, V272, P56, DOI 10.1006/jmbi.1997.1224; Zhou ZM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008700	49	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e88688	10.1371/journal.pone.0088688	http://dx.doi.org/10.1371/journal.pone.0088688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586369	gold, Green Published, Green Submitted			2022-12-27	WOS:000332396200026
J	Volakis, LI; Li, R; Ackerman, WE; Mihai, C; Bechel, M; Summerfield, TL; Ahn, CS; Powell, HM; Zielinski, R; Rosol, TJ; Ghadiali, SN; Kniss, DA				Volakis, Leonithas I.; Li, Ruth; Ackerman, William E.; Mihai, Cosmin; Bechel, Meagan; Summerfield, Taryn L.; Ahn, Christopher S.; Powell, Heather M.; Zielinski, Rachel; Rosol, Thomas J.; Ghadiali, Samir N.; Kniss, Douglas A.			Loss of Myoferlin Redirects Breast Cancer Cell Motility towards Collective Migration	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MEMBRANE TENSION; EXPRESSION; STABILITY; SIGNATURE; FILOPODIA; DYNAMICS; PROGRAMS; FUSION	Cell migration plays a central role in the invasion and metastasis of tumors. As cells leave the primary tumor, they undergo an epithelial to mesenchymal transition (EMT) and migrate as single cells. Epithelial tumor cells may also migrate in a highly directional manner as a collective group in some settings. We previously discovered that myoferlin (MYOF) is overexpressed in breast cancer cells and depletion of MYOF results in a mesenchymal to epithelial transition (MET) and reduced invasion through extracellular matrix (ECM). However, the biomechanical mechanisms governing cell motility during MYOF depletion are poorly understood. We first demonstrated that lentivirus-driven shRNA-induced MYOF loss in MDA-MB-231 breast cancer cells (MDA-231 MYOF-KD) leads to an epithelial morphology compared to the mesenchymal morphology observed in control (MDA-231 LTVC) and wild-type cells. Knockdown of MYOF led to significant reductions in cell migration velocity and MDA-231 MYOF-KD cells migrated directionally and collectively, while MDA-231 LTVC cells exhibited single cell migration. Decreased migration velocity and collective migration were accompanied by significant changes in cell mechanics. MDA-231 MYOF-KD cells exhibited a 2-fold decrease in cell stiffness, a 2-fold increase in cell-substrate adhesion and a 1.5-fold decrease in traction force generation. In vivo studies demonstrated that when immunocompromised mice were implanted with MDA-231 MYOF-KD cells, tumors were smaller and demonstrated lower tumor burden. Moreover, MDA-231 MYOF-KD tumors were highly circularized and did not invade locally into the adventia in contrast to MDA-231(LTVC)-injected animals. Thus MYOF loss is associated with a change in tumor formation in xenografts and leads to smaller, less invasive tumors. These data indicate that MYOF, a previously unrecognized protein in cancer, is involved in MDA-MB-231 cell migration and contributes to biomechanical alterations. Our results indicate that changes in biomechanical properties following loss of this protein may be an effective way to alter the invasive capacity of cancer cells.	[Volakis, Leonithas I.; Mihai, Cosmin; Ahn, Christopher S.; Powell, Heather M.; Zielinski, Rachel; Ghadiali, Samir N.; Kniss, Douglas A.] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Li, Ruth; Ackerman, William E.; Bechel, Meagan; Summerfield, Taryn L.; Kniss, Douglas A.] Ohio State Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, Columbus, OH 43210 USA; [Li, Ruth; Ackerman, William E.; Bechel, Meagan; Summerfield, Taryn L.; Kniss, Douglas A.] Ohio State Univ, Lab Perinatal Res, Columbus, OH 43210 USA; [Powell, Heather M.] Ohio State Univ, Dept Mat Sci Engn, Columbus, OH 43210 USA; [Rosol, Thomas J.] Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH 43210 USA; [Ghadiali, Samir N.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kniss, DA (corresponding author), Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA.	kniss.1@osu.edu	Ghadiali, Samir/AAN-7772-2020; Ghadiali, Samir N./C-5463-2012; Ackerman, William Edward/GRS-5804-2022; Rosol, Thomas/G-9585-2011	Ghadiali, Samir/0000-0002-6845-774X; Ghadiali, Samir N./0000-0002-6845-774X; Ackerman, William Edward/0000-0001-7366-3903; Rosol, Thomas/0000-0003-3737-1190; Powell, Heather/0000-0002-6845-8101; Ahn, Christopher/0000-0003-4036-5656	NSF CBET [1134201]; NSF EEC [042562]; Ohio State University Wexner Medical Center's Perinatal Research and Development Fund	NSF CBET(National Science Foundation (NSF)); NSF EEC(National Science Foundation (NSF)); Ohio State University Wexner Medical Center's Perinatal Research and Development Fund	The authors acknowledge grant support from NSF CBET#1134201, NSF EEC#042562 (http://NSF.gov), and The Ohio State University Wexner Medical Center's Perinatal Research and Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz J, 2003, BIOPHYS J, V84, P2071, DOI 10.1016/S0006-3495(03)75014-0; Nieto MA, 2012, SEMIN CANCER BIOL, V22, P361, DOI 10.1016/j.semcancer.2012.05.003; ARGON Y, 1980, GENETICS, V96, P413; Arjonen A, 2011, CELL ADHES MIGR, V5, P421, DOI 10.4161/cam.5.5.17723; Batchelder EL, 2011, P NATL ACAD SCI USA, V108, P11429, DOI 10.1073/pnas.1010481108; Bernatchez PN, 2007, J BIOL CHEM, V282, P30745, DOI 10.1074/jbc.M704798200; Bernatchez PN, 2009, AM J PHYSIOL-CELL PH, V297, pC484, DOI 10.1152/ajpcell.00498.2008; BILODEAU GG, 1992, J APPL MECH-T ASME, V59, P519, DOI 10.1115/1.2893754; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Burridge K, 2013, J CELL BIOL, V200, P9, DOI 10.1083/jcb.201210090; Demonbreun AR, 2010, FASEB J, V24, P1284, DOI 10.1096/fj.09-136309; Diz-Munoz A, 2013, TRENDS CELL BIOL, V23, P47, DOI 10.1016/j.tcb.2012.09.006; Doherty KR, 2005, DEVELOPMENT, V132, P5565, DOI 10.1242/dev.02155; Dusheck J, 2012, NATURE, V491, pS50, DOI 10.1038/491S50a; Eisenberg MC, 2011, P NATL ACAD SCI USA, V108, P20078, DOI 10.1073/pnas.1116327108; Eyckmans J, 2011, DEV CELL, V21, P35, DOI 10.1016/j.devcel.2011.06.015; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gauthier NC, 2012, TRENDS CELL BIOL, V22, P527, DOI 10.1016/j.tcb.2012.07.005; Guck J, 2010, INTEGR BIOL-UK, V2, P575, DOI 10.1039/c0ib00050g; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Keren K, 2011, EUR BIOPHYS J BIOPHY, V40, P1013, DOI 10.1007/s00249-011-0741-0; Kraning-Rush CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032572; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lek A, 2012, TRAFFIC, V13, P185, DOI 10.1111/j.1600-0854.2011.01267.x; Leung C, 2013, AM J PATHOL, V182, P1900, DOI 10.1016/j.ajpath.2013.01.041; Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078; Li R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039766; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Mihai C, 2012, AM J PHYSIOL-LUNG C, V302, pL287, DOI 10.1152/ajplung.00037.2011; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Plodinec M, 2012, NAT NANOTECHNOL, V7, P757, DOI [10.1038/nnano.2012.167, 10.1038/NNANO.2012.167]; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Rorth P, 2012, EMBO REP, V13, P984, DOI 10.1038/embor.2012.149; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Rotsch C, 1999, P NATL ACAD SCI USA, V96, P921, DOI 10.1073/pnas.96.3.921; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Swaminathan V, 2011, CANCER RES, V71, P5075, DOI 10.1158/0008-5472.CAN-11-0247; Tambe DT, 2011, NAT MATER, V10, P469, DOI [10.1038/NMAT3025, 10.1038/nmat3025]; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; Vedel S, 2013, P NATL ACAD SCI USA, V110, P129, DOI 10.1073/pnas.1204291110; Weiger MC, 2010, BIOPHYS J, V98, P67, DOI 10.1016/j.bpj.2009.09.051; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Xu WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046609; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yu C, 2011, VASC PHARMACOL, V55, P26, DOI 10.1016/j.vph.2011.04.001; Zielinski R, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024467	55	44	45	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e86110	10.1371/journal.pone.0086110	http://dx.doi.org/10.1371/journal.pone.0086110			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586247	gold, Green Submitted, Green Published			2022-12-27	WOS:000332389000004
J	Qian, J; Zhou, H; Chen, JW; Ding, Q; Cao, Q; Qin, C; Shao, PF; Li, P; Cai, HZ; Meng, XX; Ju, XB; Wang, ML; Zhang, ZD; Li, J; Hua, LX; Yin, CJ				Qian, Jian; Zhou, Hai; Chen, Jiawei; Ding, Qi; Cao, Qiang; Qin, Chao; Shao, Pengfei; Li, Pu; Cai, Hongzhou; Meng, Xiaoxin; Ju, Xiaobing; Wang, Meilin; Zhang, Zhengdong; Li, Jie; Hua, Lixin; Yin, Changjun			Genetic Polymorphisms in IGF-I and IGFBP-3 Are Associated with Prostate Cancer in the Chinese Population	PLOS ONE			English	Article							GROWTH-FACTOR-I; FACTOR-BINDING-PROTEINS; COLORECTAL-CANCER; BREAST-CANCER; PLASMA-LEVELS; RISK-FACTORS; LUNG-CANCER; SURVIVAL; MORTALITY; COHORT	Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3) are members of the insulin-like growth factor (IGF) family that play important roles in carcinogenesis. We hypothesized that the functional polymorphisms in IGF-I and IGFBP-3 may be associated with the risk of prostate cancer (PCa) in the Chinese population. This hospital-based case-control study included 664 PCa patients and 702 cancer-free controls. Nine SNPs in IGF-I and IGFBP-3 were genotyped using the TaqMan assay. The genetic associations between the pathogenesis and progression of PCa were assessed by logistic regression. We found that the genotype and allele frequency distribution of rs6218, rs35767 and rs5742612 were significantly different when comparing PCa cases to controls (P = 0.005, 0.005 and 0.020, respectively). In the combined analysis, individuals with 2-6 risk alleles had an elevated risk of PCa compared to those with 0-1 risk alleles. We also found that the association between the combined risk alleles and the risk of PCa appeared stronger in the following subgroups: individuals older than 71 years of age (OR = 1.41, 95% CI = 1.05-1.91, P = 0.020), nonsmokers (OR = 1.68, 95% CI = 1.21-2.32, P = 0.002), nondrinkers (OR = 1.32, 95% CI = 1.02-1.61, P = 0.002), and those with a negative family history of PCa (OR = 1.28, 95% CI = 1.02-1.71, P = 0.022). Our results indicate that the three SNPs (rs6218, rs35767 and rs5742612) and the joint genotypes with 2-6 risk alleles, may contribute to the susceptibility to PCa, but not the progression, in the Chinese population.	[Qian, Jian; Zhou, Hai; Cao, Qiang; Qin, Chao; Shao, Pengfei; Li, Pu; Cai, Hongzhou; Meng, Xiaoxin; Ju, Xiaobing; Li, Jie; Hua, Lixin; Yin, Changjun] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Chen, Jiawei] Shandong Univ, Qiluhospital, Dept Pediat Surg, Jinan 250100, Peoples R China; [Ding, Qi] Suzhou Univ, Changshu Hosp, Dept Urol, Changshu, Peoples R China; [Wang, Meilin; Zhang, Zhengdong] Nanjing Med Univ, Sch Publ Hlth, Dept Mol & Genet Toxicol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Shandong University; Nanjing Medical University	Hua, LX (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	hlx5858@163.com; drcjyin@gmail.com	Cao, Qiang/K-2349-2019; zhang, zheng/HCH-9684-2022	Cai, Hongzhou/0000-0001-6915-564X	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Provincial Special Program of Medical Science [BL2012027]; Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University; National Natural Science Foundation of China [81171963, 81201998, 81201571]	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Provincial Special Program of Medical Science; Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), by the Jiangsu Provincial Special Program of Medical Science (BL2012027), by the Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University, by the National Natural Science Foundation of China [grant number 81171963, 81201998, 81201571]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bostwick DG, 2004, CANCER-AM CANCER SOC, V101, P2371, DOI 10.1002/cncr.20408; Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; Chen WS, 2009, EUR J HUM GENET, V17, P1668, DOI 10.1038/ejhg.2009.86; Cheng I, 2006, JNCI-J NATL CANCER I, V98, P123, DOI 10.1093/jnci/djj013; Darago A, 2011, CLIN CHEM LAB MED, V49, P1699, DOI 10.1515/CCLM.2011.651; Deming SL, 2007, BREAST CANCER RES TR, V104, P309, DOI 10.1007/s10549-006-9420-8; Dianat SS, 2009, BJU INT, V104, P1560, DOI 10.1111/j.1464-410X.2009.08973.x; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Harrela M, 1996, J CLIN INVEST, V98, P2612, DOI 10.1172/JCI119081; Johansson M, 2009, PROSTATE, V69, P1281, DOI 10.1002/pros.20972; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Khandwala HM, 2000, ENDOCR REV, V21, P215, DOI 10.1210/er.21.3.215; Lin J-K, 2010, INT J BIOL MARKERS; Ma J, 1999, J NATL CANCER I, V91, P620, DOI 10.1093/jnci/91.7.620; Maroni Paul D, 2004, Cell Commun Signal, V2, P5, DOI 10.1186/1478-811X-2-5; Maslov AY, 2009, BBA-GEN SUBJECTS, V1790, P963, DOI 10.1016/j.bbagen.2009.03.020; McCracken M, 2007, CA-CANCER J CLIN, V57, P190, DOI 10.3322/canjclin.57.4.190; McGrath M, 2011, GYNECOL ONCOL, V120, P174, DOI 10.1016/j.ygyno.2010.10.012; McIntosh J, 2010, J BIOL CHEM, V285, P38788, DOI 10.1074/jbc.M110.177311; Morimoto LM, 2005, CANCER EPIDEM BIOMAR, V14, P1394, DOI 10.1158/1055-9965.EPI-04-0694; Peehl DM, 1996, J ANDROL, V17, P2; Peng Liming, 2002, Journal of West China University of Medical Sciences, V33, P137; Pollak M, 2000, GROWTH HORM IGF RES, V10, pS6, DOI 10.1016/S1096-6374(00)90002-9; Qian BY, 2011, BREAST CANCER RES TR, V130, P217, DOI 10.1007/s10549-011-1552-9; Qu BH, 1999, J BIOL CHEM, V274, P31179, DOI 10.1074/jbc.274.44.31179; Quinn M, 2002, BJU INT, V90, P162, DOI 10.1046/j.1464-410X.2002.2822.x; Rosen CJ, 1999, CLIN CHEM, V45, P1384; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Schumacher FR, 2010, HUM MOL GENET, V19, P3089, DOI 10.1093/hmg/ddq210; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stattin P, 2004, J CLIN ONCOL, V22, P3104, DOI 10.1200/JCO.2004.10.105; Terry KL, 2009, CARCINOGENESIS, V30, P2042, DOI 10.1093/carcin/bgp257; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472; Yu H, 1999, JNCI-J NATL CANCER I, V91, P151, DOI 10.1093/jnci/91.2.151; Zecevic M, 2006, JNCI-J NATL CANCER I, V98, P139, DOI 10.1093/jnci/djj016; Zhang MF, 2010, CLIN CANCER RES, V16, P1236, DOI 10.1158/1078-0432.CCR-09-2719	38	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e85609	10.1371/journal.pone.0085609	http://dx.doi.org/10.1371/journal.pone.0085609			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586243	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900005
J	Henriques, R; Potts, WM; Santos, CV; Sauer, WHH; Shaw, PW				Henriques, Romina; Potts, Warren M.; Santos, Carmen V.; Sauer, Warwick H. H.; Shaw, Paul W.			Population Connectivity and Phylogeography of a Coastal Fish, Atractoscion aequidens (Sciaenidae), across the Benguela Current Region: Evidence of an Ancient Vicariant Event	PLOS ONE			English	Article							MICROSATELLITE NULL ALLELES; MITOCHONDRIAL-DNA VARIATION; GENETIC DIVERSITY; LIFE-HISTORY; PATAGONIAN TOOTHFISH; UPWELLING SYSTEM; ATLANTIC; SOUTHERN; MARINE; SPECIATION	Contemporary patterns of genetic diversity and population connectivity within species can be influenced by both historical and contemporary barriers to gene flow. In the marine environment, present day oceanographic features such as currents, fronts and upwelling systems can influence dispersal of eggs/larvae and/juveniles/adults, shaping population substructuring. The Benguela Current system in the southeastern Atlantic is one of the oldest upwelling systems in the world, and provides a unique opportunity to investigate the relative influence of contemporary and historical mechanisms shaping the evolutionary history of warm-temperate fish species. Using the genetic variation in the mitochondrial DNA Control Region and eight nuclear microsatellite DNA loci, we identified the presence of two highly divergent populations in a vagile and warm-temperate fish species, Atractoscion aequidens, across the Benguela region. The geographical distributions of the two populations, on either side of the perennial upwelling cell, suggest a strong correlation between the oceanographic features of the system and the breakdown of gene flow within this species. Genetic divergence (mtDNA phi(ST) = 0.902, microsatellite F-ST = 0.055: probability of genetic homogeneity for either marker = p < 0.001), absence of migrants (less than 1% per generation) between populations and coalescent estimates of time since most recent common ancestor suggest that the establishment of the main oceanographic features of the system (2 million years ago), particularly the strengthening and position of the perennial upwelling cell, is the most likely mechanism behind the observed isolation. Concordance between mitochondrial and nuclear genetic markers indicates that isolation and divergence of the northern and southern Benguela populations of A. aequidens occurred deep in the past and has continued to the present day. These findings suggest that the Benguela Current system may constitute an ancient and impermeable barrier to gene flow for warm-temperate fish species.	[Henriques, Romina] Royal Holloway Univ London, Sch Biol Sci, Ctr Ecol Evolut & Behav, Egham, Surrey, England; [Henriques, Romina; Potts, Warren M.; Sauer, Warwick H. H.] Rhodes Univ, Dept Ichthyol & Fisheries Sci, ZA-6140 Grahamstown, South Africa; [Santos, Carmen V.] Univ Agostinho Neto, Fac Ciencias, Luanda, Angola; [Shaw, Paul W.] Aberystwyth Univ, Inst Biol Environm & Rural Sci IBERS, Aberystwyth, Dyfed, Wales	University of London; Royal Holloway University London; Rhodes University; University Agostinho Neto; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Henriques, R (corresponding author), Royal Holloway Univ London, Sch Biol Sci, Ctr Ecol Evolut & Behav, Egham, Surrey, England.	rhenriques@sun.ac.za	Santos, Carmen Van-Dúnem/O-1778-2014; Sauer, Warwick/GJI-2267-2022	Santos, Carmen Van-Dúnem/0000-0003-0643-5462; Sauer, Warwick/0000-0002-9756-1757; Henriques, Romina/0000-0002-6544-5532; Shaw, Paul/0000-0003-2637-6332	Fundacao da Ciencia e Tecnologia (FCT) [SFRH/BD/36176/2007]	Fundacao da Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and Technology)	The molecular work and R. Henriques were supported by a Fundacao da Ciencia e Tecnologia (FCT) grant (ref. SFRH/BD/36176/2007). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2014, TRACER V1 6; [Anonymous], [No title captured]; Appleyard SA, 2002, ANTARCT SCI, V14, P364, DOI 10.1017/S0954102002000238; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beerli Peter, 2009, V17, P42; Bernardi G, 2005, MOL ECOL, V14, P4085, DOI 10.1111/j.1365-294X.2005.02729.x; Bester-van der Merwe AE, 2011, CONSERV GENET, V12, P543, DOI 10.1007/s10592-010-0162-0; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Diaz-Jaimes P, 2010, MOL PHYLOGENET EVOL, V57, P1209, DOI 10.1016/j.ympev.2010.10.005; Diester-Haass L, 2002, MAR GEOL, V180, P87, DOI 10.1016/S0025-3227(01)00207-9; Diester-Haass L, 1990, PALEOCEANOGRAPHY, V5, P685, DOI 10.1029/PA005i005p00685; Domingues VS, 2007, J EXP MAR BIOL ECOL, V346, P102, DOI 10.1016/j.jembe.2007.03.002; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Eytan RI, 2012, MOL PHYLOGENET EVOL, V62, P159, DOI 10.1016/j.ympev.2011.09.028; Faria R, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-194; Fennel W, 1999, J PHYS OCEANOGR, V29, P177, DOI 10.1175/1520-0485(1999)029<0177:TOTBUS>2.0.CO;2; Francisco SM, 2011, J EXP MAR BIOL ECOL, V403, P14, DOI 10.1016/j.jembe.2011.03.020; Fu YX, 1997, GENETICS, V147, P915; Galarza JA, 2009, P NATL ACAD SCI USA, V106, P1473, DOI 10.1073/pnas.0806804106; Gopal K, 2006, MAR ECOL PROG SER, V319, P191, DOI 10.3354/meps319191; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Grant WS, 2006, BIOL J LINN SOC, V88, P673, DOI 10.1111/j.1095-8312.2006.00651.x; Griffiths MH, 1995, J FISH BIOL, V47, P962, DOI 10.1111/j.1095-8649.1995.tb06022.x; Heemstra P.C., 2004, COASTAL FISHES SO AF; Hemmer-Hansen J, 2007, MOL ECOL, V16, P3104, DOI 10.1111/j.1365-294X.2007.03367.x; Henriques R, 2012, AFR J MAR SCI, V34, P585, DOI 10.2989/1814232X.2012.749809; Henriques R, 2011, CONSERV GENET, V4, P85; Ho SYW, 2011, MOL ECOL RESOUR, V11, P423, DOI 10.1111/j.1755-0998.2011.02988.x; Hutchings L, 2002, MAR FRESHWATER RES, V53, P307, DOI 10.1071/MF01147; Hutchings L, 2009, PROG OCEANOGR, V83, P15, DOI 10.1016/j.pocean.2009.07.046; Jahn B, 2003, PALAEOGEOGR PALAEOCL, V193, P515, DOI 10.1016/S0031-0182(03)00264-5; Janko K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-220; Kirst GJ, 1999, QUATERNARY RES, V52, P92, DOI 10.1006/qres.1999.2040; Krammer R, 2006, PALAEOGEOGR PALAEOCL, V230, P319, DOI 10.1016/j.palaeo.2005.07.022; Lass HU, 2000, J PHYS OCEANOGR, V30, P2589, DOI 10.1175/1520-0485(2000)030<2589:HACMIT>2.0.CO;2; Lecomte F, 2004, MOL ECOL, V13, P2169, DOI 10.1111/j.1365-294X.2004.02229.x; Lett C, 2007, MAR ECOL PROG SER, V347, P247, DOI 10.3354/meps06982; Marlow JR, 2000, SCIENCE, V290, P2288; Martinez P, 2006, MOL PHYLOGENET EVOL, V39, P404, DOI 10.1016/j.ympev.2005.07.022; Matthee CA, 2007, MAR FRESHWATER RES, V58, P1130, DOI 10.1071/MF07138; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Ravago-Gotanco RG, 2007, MAR ECOL PROG SER, V336, P161, DOI 10.3354/meps336161; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rock J, 2009, GENE, V437, P60, DOI 10.1016/j.gene.2009.02.008; ROFF DA, 1988, ENVIRON BIOL FISH, V22, P133, DOI 10.1007/BF00001543; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; Sachs JP, 2001, SCIENCE, V293, P2077, DOI 10.1126/science.1063584; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SHANNON LV, 1985, OCEANOGR MAR BIOL, V23, P105; Shaw PW, 2004, MOL ECOL, V13, P3293, DOI 10.1111/j.1365-294X.2004.02327.x; Shen KN, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-83; SIESSER WG, 1981, J GEOL, V89, P523, DOI 10.1086/628618; TAJIMA F, 1989, GENETICS, V123, P585; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Oosterhout C, 2006, MOL ECOL NOTES, V6, P255, DOI 10.1111/j.1471-8286.2005.01082.x; von der Heyden S, 2007, MOL PHYLOGENET EVOL, V42, P517, DOI 10.1016/j.ympev.2006.08.004; von der Heyden S, 2010, MOL PHYLOGENET EVOL, V55, P1183, DOI 10.1016/j.ympev.2009.09.018; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; WARD RD, 1994, J FISH BIOL, V44, P213, DOI 10.1111/j.1095-8649.1994.tb01200.x; Waters JM, 2004, MOL ECOL, V13, P2797, DOI 10.1111/j.1365-294X.2004.02282.x; Weir BS, 1996, GENETC DATA ANAL; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; Wilson GA, 2003, GENETICS, V163, P1177	71	51	53	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e87907	10.1371/journal.pone.0087907	http://dx.doi.org/10.1371/journal.pone.0087907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586296	Green Submitted, gold, Green Published			2022-12-27	WOS:000331714700008
J	Okuno, A; Hirano, K; Asano, K; Takase, W; Masuda, R; Morinaka, Y; Ueguchi-Tanaka, M; Kitano, H; Matsuoka, M				Okuno, Ayako; Hirano, Ko; Asano, Kenji; Takase, Wakana; Masuda, Reiko; Morinaka, Yoichi; Ueguchi-Tanaka, Miyako; Kitano, Hidemi; Matsuoka, Makoto			New Approach to Increasing Rice Lodging Resistance and Biomass Yield Through the Use of High Gibberellin Producing Varieties	PLOS ONE			English	Article							GREEN-REVOLUTION; CYTOCHROME-P450 MONOOXYGENASE; GENE; BIOSYNTHESIS; ENCODES; CULM; DIFFERENCE; LIGNIN; IMPACT; LOCUS	Traditional breeding for high-yielding rice has been dependent on the widespread use of fertilizers and the cultivation of gibberellin (GA)-deficient semi-dwarf varieties. The use of semi-dwarf plants facilitates high grain yield since these varieties possess high levels of lodging resistance, and thus could support the high grain weight. Although this approach has been successful in increasing grain yield, it is desirable to further improve grain production and also to breed for high biomass. In this study, we re-examined the effect of GA on rice lodging resistance and biomass yield using several GA-deficient mutants (e.g. having defects in the biosynthesis or perception of GA), and high-GA producing line or mutant. GA-deficient mutants displayed improved bending-type lodging resistance due to their short stature; however they showed reduced breaking-ype lodging resistance and reduced total biomass. In plants producing high amounts of GA, the bending-type lodging resistance was inferior to the original cultivars. The breaking-type lodging resistance was improved due to increased lignin accumulation and/or larger culm diameters. Further, these lines had an increase in total biomass weight. These results show that the use of rice cultivars producing high levels of GA would be a novel approach to create higher lodging resistance and biomass.	[Okuno, Ayako; Hirano, Ko; Asano, Kenji; Takase, Wakana; Masuda, Reiko; Morinaka, Yoichi; Ueguchi-Tanaka, Miyako; Kitano, Hidemi; Matsuoka, Makoto] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan	Nagoya University	Hirano, K (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan.	khirano@agr.nagoya-u.ac.jp			Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation) [IPG-0003]; NC-CARP project; Ministry of Education, Science, Sports and Culture of Japan; Japan Society for the Promotion of Science (JSPS) through the "Funding Program for Next Generation World-Leading Researchers (MU-T)''	Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation)(Ministry of Agriculture Forestry & Fisheries - Japan); NC-CARP project; Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS) through the "Funding Program for Next Generation World-Leading Researchers (MU-T)''(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation, IPG-0003 for MM,), partly by Grants-in-Aid from the NC-CARP project, the Ministry of Education, Science, Sports and Culture of Japan, to HK and KH, and partly by Japan Society for the Promotion of Science (JSPS) through the "Funding Program for Next Generation World-Leading Researchers (MU-T)'', Grant-in-Aid for Scientific Research on Innovative Areas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2009, CURR BIOL, V19, P1188, DOI 10.1016/j.cub.2009.05.059; Asano K, 2009, MOL GENET GENOMICS, V281, P223, DOI 10.1007/s00438-008-0406-6; Asano K, 2011, P NATL ACAD SCI USA, V108, P11034, DOI 10.1073/pnas.1019490108; Asano Kenji, 2007, Tanpakushitsu Kakusan Koso, V52, P1931; Biemelt S, 2004, PLANT PHYSIOL, V135, P254, DOI 10.1104/pp.103.036988; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Dalrymple DG, 1986, Development and spread of high -yielding wheat varieties in developing countries, V7th; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; GRAFIUS JE, 1954, AGRON J, V46, P414, DOI 10.2134/agronj1954.00021962004600090006x; Gui JS, 2011, PLANT PHYSIOL, V157, P574, DOI 10.1104/pp.111.178301; HARGROVE TR, 1979, BIOSCIENCE, V29, P731, DOI 10.2307/1307667; Hirano K, 2013, PLANT CELL PHYSIOL, V54, P1803, DOI 10.1093/pcp/pct121; Hirano K, 2012, PLANT CELL REP, V31, P91, DOI 10.1007/s00299-011-1142-7; Irie Kenji, 2008, Journal of Agricultural Science Tokyo Nogyo Daigaku, V53, P69; Itoh H, 2004, PLANT MOL BIOL, V54, P533, DOI 10.1023/B:PLAN.0000038261.21060.47; Kaneko M, 2003, PLANT J, V35, P104, DOI 10.1046/j.1365-313X.2003.01780.x; Kashiwagi T., 2007, Japanese Journal of Crop Science, V76, P1, DOI 10.1626/jcs.76.1; Khush GS, 1999, GENOME, V42, P646, DOI 10.1139/gen-42-4-646; Kono M, 1995, SCI RICE PLANT PHYSL, V2, P971; Lin SY, 1998, THEOR APPL GENET, V96, P997, DOI 10.1007/s001220050831; Lo SF, 2008, PLANT CELL, V20, P2603, DOI 10.1105/tpc.108.060913; Luo AD, 2006, PLANT CELL PHYSIOL, V47, P181, DOI 10.1093/pcp/pci233; OGI Y, 1993, JPN J BREED, V43, P267; OOKAWA T, 1992, JPN J CROP SCI, V61, P419, DOI 10.1626/jcs.61.419; OOKAWA T, 1993, JPN J CROP SCI, V62, P378, DOI 10.1626/jcs.62.378; Ookawa T, 2010, PLANT PROD SCI, V13, P58, DOI 10.1626/pps.13.58; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Suzuki S, 2009, PLANT BIOTECHNOL-NAR, V26, P337, DOI 10.5511/plantbiotechnology.26.337; Ueguchi-Tanaka M, 2007, PLANT CELL, V19, P2140, DOI 10.1105/tpc.106.043729; XIA BS, 1991, JPN J CROP SCI, V60, P36, DOI 10.1626/jcs.60.36; Zhang KW, 2006, PLANT PHYSIOL, V140, P972, DOI 10.1104/pp.105.073007; Zhu YY, 2006, PLANT CELL, V18, P442, DOI 10.1105/tpc.105.038455	33	86	92	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e86870	10.1371/journal.pone.0086870	http://dx.doi.org/10.1371/journal.pone.0086870			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586255	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900006
J	Eijkelkamp, BA; Morey, JR; Ween, MP; Ong, CIY; McEwan, AG; Paton, JC; McDevitt, CA				Eijkelkamp, Bart A.; Morey, Jacqueline R.; Ween, Miranda P.; Ong, Cheryl-Iynn Y.; McEwan, Alastair G.; Paton, James C.; McDevitt, Christopher A.			Extracellular Zinc Competitively Inhibits Manganese Uptake and Compromises Oxidative Stress Management in Streptococcus pneumoniae	PLOS ONE			English	Article							CAPSULAR POLYSACCHARIDE BIOSYNTHESIS; SUPEROXIDE-DISMUTASE; STAPHYLOCOCCUS-AUREUS; NASOPHARYNGEAL CARRIAGE; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; GENOME SEQUENCE; YOUNG-CHILDREN; PSAA MUTANTS; NADH OXIDASE	Streptococcus pneumoniae requires manganese for colonization of the human host, but the underlying molecular basis for this requirement has not been elucidated. Recently, it was shown that zinc could compromise manganese uptake and that zinc levels increased during infection by S. pneumoniae in all the niches that it colonized. Here we show, by quantitative means, that extracellular zinc acts in a dose dependent manner to competitively inhibit manganese uptake by S. pneumoniae, with an EC50 of 30.2 mu M for zinc in cation-defined media. By exploiting the ability to directly manipulate S. pneumoniae accumulation of manganese, we analyzed the connection between manganese and superoxide dismutase (SodA), a primary source of protection for S. pneumoniae against oxidative stress. We show that manganese starvation led to a decrease in sodA transcription indicating that expression of sodA was regulated through an unknown manganese responsive pathway. Intriguingly, examination of recombinant SodA revealed that the enzyme was potentially a cambialistic superoxide dismutase with an iron/manganese cofactor. SodA was also shown to provide the majority of protection against oxidative stress as a S. pneumoniae Delta sodA mutant strain was found to be hypersensitive to oxidative stress, despite having wild-type manganese levels, indicating that the metal ion alone was not sufficiently protective. Collectively, these results provide a quantitative assessment of the competitive effect of zinc upon manganese uptake and provide a molecular basis for how extracellular zinc exerts a 'toxic' effect on bacterial pathogens, such as S. pneumoniae.	[Eijkelkamp, Bart A.; Morey, Jacqueline R.; Ween, Miranda P.; Paton, James C.; McDevitt, Christopher A.] Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA 5005, Australia; [Ong, Cheryl-Iynn Y.; McEwan, Alastair G.] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; [Ong, Cheryl-Iynn Y.; McEwan, Alastair G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	University of Adelaide; University of Queensland; University of Queensland	McDevitt, CA (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA 5005, Australia.	christopher.mcdevitt@adelaide.edu.au	Eijkelkamp, Bart/G-7109-2015; McDevitt, Christopher A./A-4940-2009; Ong, Cheryl-lynn Y/C-5238-2014	Eijkelkamp, Bart/0000-0003-0179-8977; McDevitt, Christopher A./0000-0003-1596-4841; Ong, Cheryl-lynn Y/0000-0001-6036-6889; ween, miranda/0000-0002-0600-4585; McEwan, Alastair/0000-0002-2419-1003	Australian Research Council (ARC) [DP0986578, DP120103957]; National Health & Medical Research Council (NHMRC) [1022240, 565526]	Australian Research Council (ARC)(Australian Research Council); National Health & Medical Research Council (NHMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Research Council (ARC) grants DP0986578 to A.G.M. and DP120103957 to C.A.M., and the National Health & Medical Research Council (NHMRC) Project grant 1022240 to C.A.M. and Program grant 565526 to J.C.P. and A.G.M. J.C.P. is a NHMRC Senior Principal Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre JD, 2012, J BIOL CHEM, V287, P13541, DOI 10.1074/jbc.R111.312181; Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; [Anonymous], 2003, Weekly Epidemiological Record, V78, P110; ARCHIBALD FS, 1981, J BACTERIOL, V145, P442, DOI 10.1128/JB.145.1.442-451.1981; Auzat I, 1999, MOL MICROBIOL, V34, P1018, DOI 10.1046/j.1365-2958.1999.01663.x; Brooks WA, 2004, LANCET, V363, P1683, DOI 10.1016/S0140-6736(04)16252-1; Broome C, 1996, PROGR VACCINE RES DE, P28; BULLEN JJ, 1981, REV INFECT DIS, V3, P1127; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Counago RM, 2014, NAT CHEM BIOL, V10, P35, DOI [10.1038/NCHEMBIO.1382, 10.1038/nchembio.1382]; Counago RM, 2012, CURR DRUG TARGETS, V13, P1400; Damo SM, 2013, P NATL ACAD SCI US; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; De Vendittis A, 2010, MOL BIOSYST, V6, P1973, DOI 10.1039/c003557b; Dintilhac A, 1997, MOL MICROBIOL, V25, P727, DOI 10.1046/j.1365-2958.1997.5111879.x; Gat O, 2005, MOL MICROBIOL, V58, P533, DOI 10.1111/j.1365-2958.2005.04848.x; Goldblatt D, 2005, J INFECT DIS, V192, P387, DOI 10.1086/431524; Gribenko A, 2013, J MOL BIOL, V425, P3429, DOI 10.1016/j.jmb.2013.06.033; Hardie J. M., 1986, BERGEYS MANUAL SYSTE, V2, P1043; Hendriksen WT, 2009, MICROBIOL-SGM, V155, P1569, DOI 10.1099/mic.0.025072-0; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Horsburgh MJ, 2002, MOL MICROBIOL, V44, P1269, DOI 10.1046/j.1365-2958.2002.02944.x; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012; IRVING H, 1953, J CHEM SOC, P3192, DOI 10.1039/jr9530003192; IRVING H, 1948, NATURE, V162, P746, DOI 10.1038/162746a0; Ispahani P, 2004, ARCH DIS CHILD, V89, P757, DOI 10.1136/adc.2003.036921; Jacobsen FE, 2011, METALLOMICS, V3, P38, DOI 10.1039/c0mt00050g; Jakubovics NS, 2002, MICROBIOL-SGM, V148, P3255, DOI 10.1099/00221287-148-10-3255; Janulczyk R, 2003, INFECT IMMUN, V71, P2656, DOI 10.1128/IAI.71.5.2656-2664.2003; KEELE BB, 1970, J BIOL CHEM, V245, P6176; Kehl-Fie TE, 2013, INFECT IMMUN, V81, P3395, DOI 10.1128/IAI.00420-13; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Lawrence MC, 1998, STRUCTURE, V6, P1553, DOI 10.1016/S0969-2126(98)00153-1; Lewis VG, 2012, PROTOPLASMA, V249, P919, DOI 10.1007/s00709-011-0360-8; Mahalanabis D, 2004, AM J CLIN NUTR, V79, P430; McAllister LJ, 2004, MOL MICROBIOL, V53, P889, DOI 10.1111/j.1365-2958.2004.04164.x; McDevitt CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002357; Morona JK, 2004, J INFECT DIS, V189, P1905, DOI 10.1086/383352; Morona JK, 2000, MOL MICROBIOL, V35, P1431, DOI 10.1046/j.1365-2958.2000.01808.x; Niven DF, 1999, CAN J MICROBIOL, V45, P1027, DOI 10.1139/cjm-45-12-1027; Ogunniyi AD, 2010, J BACTERIOL, V192, P4489, DOI 10.1128/JB.00064-10; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Pericone CD, 2003, J BACTERIOL, V185, P6815, DOI 10.1128/JB.185.23.6815-6825.2003; Plumptre CD, 2014, MOL MICROBIOL, V91, P834, DOI 10.1111/mmi.12504; Saha SK, 2009, CLIN INFECT DIS, V48, pS75, DOI 10.1086/596544; Sobota JM, 2011, P NATL ACAD SCI USA, V108, P5402, DOI 10.1073/pnas.1100410108; Strand TA, 2003, INFECT IMMUN, V71, P2009, DOI 10.1128/IAI.71.4.2009-2013.2003; Strand TA, 2001, BRIT J NUTR, V86, P301, DOI 10.1079/BJN2001399; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tseng HJ, 2002, INFECT IMMUN, V70, P1635, DOI 10.1128/IAI.70.3.1635-1639.2002; Tseng HJ, 2001, MOL MICROBIOL, V40, P1175, DOI 10.1046/j.1365-2958.2001.02460.x; Varon E, 2010, CLIN MICROBIOL INFEC, V16, P401, DOI 10.1111/j.1469-0691.2010.03190.x; WEINBERG ED, 1974, SCIENCE, V184, P952, DOI 10.1126/science.184.4140.952; Weinberg ED, 2009, BBA-GEN SUBJECTS, V1790, P600, DOI 10.1016/j.bbagen.2008.07.002; Wu HJ, 2010, J PROTEOMICS, V73, P899, DOI 10.1016/j.jprot.2009.12.001; Xu FF, 2012, APPL ENVIRON MICROB, V78, P3614, DOI 10.1128/AEM.07368-11; Yesilkaya H, 2000, INFECT IMMUN, V68, P2819, DOI 10.1128/IAI.68.5.2819-2826.2000; Yu J, 2001, MICROBIOL-UK, V147, P431, DOI 10.1099/00221287-147-2-431; Zaidi AKM, 2009, PEDIATR INFECT DIS J, V28, pS10, DOI 10.1097/INF.0b013e3181958769	61	82	83	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89427	10.1371/journal.pone.0089427	http://dx.doi.org/10.1371/journal.pone.0089427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558498	Green Published, gold			2022-12-27	WOS:000331706700144
J	Kirui, DK; Mai, JH; Palange, AL; Qin, GT; van de Ven, AL; Liu, XW; Shen, HF; Ferrari, M				Kirui, Dickson K.; Mai, Juahua; Palange, Anna-Lisa; Qin, Guoting; van de Ven, Anne L.; Liu, Xuewu; Shen, Haifa; Ferrari, Mauro			Transient Mild Hyperthermia Induces E-selectin Mediated Localization of Mesoporous Silicon Vectors in Solid Tumors	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; NANOPARTICLE EXTRAVASATION; MULTISTAGE NANOVECTORS; IN-VIVO; DELIVERY; ACCUMULATION; PENETRATION; DOXORUBICIN; RECEPTORS; LIPOSOMES	Background: Hyperthermia treatment has been explored as a strategy to overcome biological barriers that hinder effective drug delivery in solid tumors. Most studies have used mild hyperthermia treatment (MHT) to target the delivery of thermo-sensitive liposomes carriers. Others have studied its application to permeabilize tumor vessels and improve tumor interstitial transport. However, the role of MHT in altering tumor vessel interfacial and adhesion properties and its relationship to improved delivery has not been established. In the present study, we evaluated effects of MHT treatment on tumor vessel flow dynamics and expression of adhesion molecules and assessed enhancement in particle localization using mesoporous silicon vectors (MSVs). We also determined the optimal time window at which maximal accumulation occur. Results: In this study, using intravital microscopy analyses, we showed that temporal mild hyperthermia (similar to 1 W/cm(2)) amplified delivery and accumulation of MSVs in orthotopic breast cancer tumors. The number of discoidal MSVs (1000x400 nm) adhering to tumor vasculature increased 6-fold for SUM159 tumors and 3-fold for MCF-7 breast cancer tumors. By flow chamber experiments and Western blotting, we established that a temporal increase in E-selectin expression correlated with enhanced particle accumulation. Furthermore, MHT treatment was shown to increase tumor perfusion in a time-dependent fashion. Conclusions: Our findings reveal that well-timed mild hyperthermia treatment can transiently elevate tumor transport and alter vascular adhesion properties and thereby provides a means to enhance tumor localization of non-thermally sensitive particles such as MSVs. Such enhancement in accumulation could be leveraged to increase therapeutic efficacy and reduce drug dosing in cancer therapy.	[Kirui, Dickson K.; Mai, Juahua; Palange, Anna-Lisa; Qin, Guoting; van de Ven, Anne L.; Liu, Xuewu; Shen, Haifa; Ferrari, Mauro] Houston Methodist Res Inst, Dept NanoMed, Houston, TX 77030 USA; [Shen, Haifa] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA; [Ferrari, Mauro] Weill Cornell Med Coll, Dept Internal Med, New York, NY USA	The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University; Cornell University	Ferrari, M (corresponding author), Houston Methodist Res Inst, Dept NanoMed, Houston, TX 77030 USA.	mferrari@houstonmethodist.org	Qin, Guoting/A-7847-2010	Palange, Anna Lisa/0000-0002-2584-7297; van de Ven, Anne/0000-0002-0347-4004; Qin, Guoting/0000-0001-8916-6311; Mai, Junhua/0000-0001-8374-4352	Methodist Hospital Research Institute; Ernest Cockrell Jr. Distinguished Endowed Chair; National Institute of Health (NIH)'s Physical Sciences Oncology Center (PS-OC) [U54CA143837]; Department of Defense [W81XWH-09-1-0212]; NIH [U54CA151668]; NATIONAL CANCER INSTITUTE [U54CA143837, U54CA151668] Funding Source: NIH RePORTER	Methodist Hospital Research Institute; Ernest Cockrell Jr. Distinguished Endowed Chair; National Institute of Health (NIH)'s Physical Sciences Oncology Center (PS-OC); Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors gratefully acknowledge funding provided by the Methodist Hospital Research Institute, including the Ernest Cockrell Jr. Distinguished Endowed Chair and National Institute of Health (NIH)'s Physical Sciences Oncology Center (PS-OC) U54CA143837. Authors also acknowledge partial supports from the following funding sources: Department of Defense (W81XWH-09-1-0212) and NIH (U54CA151668). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriani G, 2012, BIOMATERIALS, V33, P5504, DOI 10.1016/j.biomaterials.2012.04.027; Agarwal A, 2011, ACS NANO, V5, P4919, DOI 10.1021/nn201010q; Atkinson RL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001447; BICHER HI, 1980, RADIOLOGY, V137, P523, DOI 10.1148/radiology.137.2.7433686; Blanco E, 2013, CANCER LETT, V334, P245, DOI 10.1016/j.canlet.2012.07.027; Choi R, 2010, LANGMUIR, V26, P17520, DOI 10.1021/la1029728; Dreher MR, 2007, CANCER RES, V67, P4418, DOI 10.1158/0008-5472.CAN-06-4444; Dreher MR, 2006, JNCI-J NATL CANCER I, V98, P335, DOI 10.1093/jnci/djj070; Godin B, 2011, ACCOUNTS CHEM RES, V44, P979, DOI 10.1021/ar200077p; Grull H, 2012, J CONTROL RELEASE, V161, P317, DOI 10.1016/j.jconrel.2012.04.041; Hildebrandt B, 2002, CRIT REV ONCOL HEMAT, V43, P33, DOI 10.1016/S1040-8428(01)00179-2; Hu M, 2006, CHEM SOC REV, V35, P1084, DOI 10.1039/b517615h; Huang XH, 2006, J AM CHEM SOC, V128, P2115, DOI 10.1021/ja057254a; Jain PK, 2006, J PHYS CHEM B, V110, P7238, DOI 10.1021/jp057170o; Jain RK, 2013, J CLIN ONCOL, V31, P2205, DOI 10.1200/JCO.2012.46.3653; JANSEN W, 1990, PATHOL RES PRACT, V186, P247, DOI 10.1016/S0344-0338(11)80542-X; Joshi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032067; Kapp D. S., 2000, PRINCIPLES HYPERTHER; Kaufmann JE, 2000, J CLIN INVEST, V106, P107, DOI 10.1172/JCI9516; Kim P, 2013, PROTOCOL EXCHANGE; Kirui D, 2013, NANOMED-NANOTECHNOL, DOI [10.1016/j.nano.2013.11.001, DOI 10.1016/J.NAN0.2013.11.001]; Kong G, 2001, CANCER RES, V61, P3027; Kong G, 2000, CANCER RES, V60, P4440; Kruskal JB, 2001, J VASC INTERV RADIOL, V12, P1193, DOI 10.1016/S1051-0443(07)61679-0; LEEUWENBERG JFM, 1992, IMMUNOLOGY, V77, P543; Li L, 2013, J CONTROL RELEASE, V167, P130, DOI 10.1016/j.jconrel.2013.01.026; Liu M, 2012, PLOS ONE, V7; Mann AP, 2011, ADV MATER, V23, pH278, DOI 10.1002/adma.201101541; Martinez JO, 2013, BIOMATERIALS, V34, P8469, DOI 10.1016/j.biomaterials.2013.07.049; Melancon MP, 2011, J CONTROL RELEASE, V156, P265, DOI 10.1016/j.jconrel.2011.06.030; Mitsunaga M, 2011, NAT MED, V17, P1685, DOI 10.1038/nm.2554; OVERGAARD J, 1995, LANCET, V345, P540, DOI 10.1016/S0140-6736(95)90463-8; Parodi A, 2013, NAT NANOTECHNOL, V8, P61, DOI 10.1038/nnano.2012.212; Pasut G, 2012, J CONTROL RELEASE, V161, P461, DOI 10.1016/j.jconrel.2011.10.037; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; ROVAINEN CM, 1993, J CEREBR BLOOD F MET, V13, P359, DOI 10.1038/jcbfm.1993.49; Shen HF, 2013, CLIN CANCER RES, V19, P1806, DOI 10.1158/1078-0432.CCR-12-2764; SONG CW, 1984, CANCER RES, V44, P4721; Tanaka T, 2010, CANCER RES, V70, P3687, DOI 10.1158/0008-5472.CAN-09-3931; Tasciotti E, 2008, NAT NANOTECHNOL, V3, P151, DOI 10.1038/nnano.2008.34; van de Ven AL, 2012, AIP ADV, V2, DOI 10.1063/1.3699060; van de Ven AL, 2012, J CONTROL RELEASE, V158, P148, DOI 10.1016/j.jconrel.2011.10.021; van der Zee J, 2002, ANN ONCOL, V13, P1173, DOI 10.1093/annonc/mdf280; Vertrees RA, 2005, CANCER BIOL THER, V4, P1144, DOI 10.4161/cbt.4.10.2074; Visaria RK, 2006, MOL CANCER THER, V5, P1014, DOI 10.1158/1535-7163.MCT-05-0381; von Maltzahn G, 2011, NAT MATER, V10, P545, DOI [10.1038/nmat3049, 10.1038/NMAT3049]; Xiaojing Z, 2009, NANOTECHNOLOGY; Xu R, 2013, SMALL, V9, P1799, DOI 10.1002/smll.201201510; Yokoi K, 2013, CANCER LETT, V334, P319, DOI 10.1016/j.canlet.2012.09.001; You J, 2012, CANCER RES, V72, P4777, DOI 10.1158/0008-5472.CAN-12-1003; Yudina A, 2012, J CONTROL RELEASE, V161, P90, DOI 10.1016/j.jconrel.2012.04.018; Zhu L, 2013, INTEGR BIOL-UK, V5, P96, DOI 10.1039/c2ib20135f	52	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e86489	10.1371/journal.pone.0086489	http://dx.doi.org/10.1371/journal.pone.0086489			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558362	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700008
J	Lin, L; Tian, SL; Kaeppler, S; Liu, ZR; An, YQ				Lin, Li; Tian, Shulan; Kaeppler, Shawn; Liu, Zongrang; An, Yong-Qiang (Charles)			Conserved Transcriptional Regulatory Programs Underlying Rice and Barley Germination	PLOS ONE			English	Article							SEED-GERMINATION; ARABIDOPSIS-THALIANA; ACTIN SUBCLASS; ALPHA-AMYLASE; ABSCISIC-ACID; BETA-AMYLASE; EXPRESSION; GENES; GIBBERELLIN; ENDOSPERM	Germination is a biological process important to plant development and agricultural production. Barley and rice diverged 50 million years ago, but share a similar germination process. To gain insight into the conservation of their underlying gene regulatory programs, we compared transcriptomes of barley and rice at start, middle and end points of germination, and revealed that germination regulated barley and rice genes (BRs) diverged significantly in expression patterns and/or protein sequences. However, BRs with higher protein sequence similarity tended to have more conserved expression patterns. We identified and characterized 316 sets of conserved barley and rice genes (cBRs) with high similarity in both protein sequences and expression patterns, and provided a comprehensive depiction of the transcriptional regulatory program conserved in barley and rice germination at gene, pathway and systems levels. The cBRs encoded proteins involved in a variety of biological pathways and had a wide range of expression patterns. The cBRs encoding key regulatory components in signaling pathways often had diverse expression patterns. Early germination up-regulation of cell wall metabolic pathway and peroxidases, and late germination up-regulation of chromatin structure and remodeling pathways were conserved in both barley and rice. Protein sequence and expression pattern of a gene change quickly if it is not subjected to a functional constraint. Preserving germination-regulated expression patterns and protein sequences of those cBRs for 50 million years strongly suggests that the cBRs are functionally significant and equivalent in germination, and contribute to the ancient characteristics of germination preserved in barley and rice. The functional significance and equivalence of the cBR genes predicted here can serve as a foundation to further characterize their biological functions and facilitate bridging rice and barley germination research with greater confidence.	[Lin, Li; Tian, Shulan; An, Yong-Qiang (Charles)] ARS, USDA, Plant Genet Res Unit, Donald Danforth Plant Sci Ctr, St Louis, MO USA; [Tian, Shulan] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Lin, Li; Kaeppler, Shawn] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA; [Liu, Zongrang] ARS, USDA, Appalachian Fruit Res Stn, Kearneysville, WV USA	Donald Danforth Plant Science Center; United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA)	An, YQ (corresponding author), ARS, USDA, Plant Genet Res Unit, Donald Danforth Plant Sci Ctr, St Louis, MO USA.	yong-qiang.an@ars.usda.gov		Kaeppler, Shawn/0000-0002-5964-1668	USDA-ARS; American Malting and Barley Association, Inc.	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); American Malting and Barley Association, Inc.	The research is supported by funds from USDA-ARS and American Malting and Barley Association, Inc. to Yong-Qiang An. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An YQ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-105; An YQC, 2010, PLANT MOL BIOL REP, V28, P481, DOI 10.1007/s11105-009-0171-7; An YQ, 1996, PLANT CELL, V8, P15, DOI 10.1105/tpc.8.1.15; An YQ, 1996, PLANT J, V10, P107, DOI 10.1046/j.1365-313X.1996.10010107.x; Barrero JM, 2009, PLANT PHYSIOL, V150, P1006, DOI 10.1104/pp.109.137901; Bewley J. D., 2013, SEEDS, DOI [10.1017/S0960258513000287, DOI 10.1007/978-1-4614-4693-4_1]; Bewley J.D, 1985, SEEDS PHYSL DEV GERM; Chen F, 2000, PLANT PHYSIOL, V124, P1265, DOI 10.1104/pp.124.3.1265; Chen KG, 2010, ACTA PHYSIOL PLANT, V32, P789, DOI 10.1007/s11738-010-0464-3; Chen KG, 2006, J INTEGR PLANT BIOL, V48, P591, DOI 10.1111/j.1744-7909.2006.00270.x; CHRISPEE.MJ, 1967, PLANT PHYSIOL, V42, P398, DOI 10.1104/pp.42.3.398; Dubcovsky J, 2001, PLANT PHYSIOL, V125, P1342, DOI 10.1104/pp.125.3.1342; FINCHER GB, 1989, ANNU REV PLANT PHYS, V40, P305, DOI 10.1146/annurev.pp.40.060189.001513; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Gu ZL, 2004, NAT GENET, V36, P577, DOI 10.1038/ng1355; Gu ZL, 2002, TRENDS GENET, V18, P609, DOI 10.1016/S0168-9525(02)02837-8; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; KREIS M, 1987, EUR J BIOCHEM, V169, P517, DOI 10.1111/j.1432-1033.1987.tb13640.x; Kucera B, 2005, SEED SCI RES, V15, P281, DOI 10.1079/SSR2005218; LAURIERE C, 1986, PHYSIOL PLANTARUM, V67, P383, DOI 10.1111/j.1399-3054.1986.tb05752.x; Li W. H, 1997, MOL EVOLUTION; Li Y, 2002, PLANT PHYSIOL, V128, P854, DOI 10.1104/pp.010658; Liu YX, 2007, PLANT CELL, V19, P433, DOI 10.1105/tpc.106.049221; MacGregor A.W., 1993, CARBOHYDRATES BARLEY; MAYER AM, 1974, ANNU REV PLANT PHYS, V25, P167, DOI 10.1146/annurev.pp.25.060174.001123; MCQUEENMASON SJ, 1995, PLANT PHYSIOL, V107, P87, DOI 10.1104/pp.107.1.87; Meagher RB, 1999, TRENDS GENET, V15, P278, DOI 10.1016/S0168-9525(99)01759-X; Morohashi Y, 2002, J EXP BOT, V53, P1643, DOI 10.1093/jxb/erf012; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; Parrish Rudolph S, 2004, J Biopharm Stat, V14, P575, DOI 10.1081/BIP-200025650; Peng JR, 2002, CURR OPIN PLANT BIOL, V5, P376, DOI 10.1016/S1369-5266(02)00279-0; Potokina E, 2002, FUNCT INTEGR GENOMIC, V2, P28, DOI 10.1007/s10142-002-0050-x; SHUTOV AD, 1987, PHYTOCHEMISTRY, V26, P1557, DOI 10.1016/S0031-9422(00)82245-1; SKADSEN RW, 1993, PLANT PHYSIOL, V102, P195, DOI 10.1104/pp.102.1.195; Sreenivasulu N, 2008, PLANT PHYSIOL, V146, P1738, DOI 10.1104/pp.107.111781; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; Tai HH, 2005, PLANT MOL BIOL, V59, P909, DOI 10.1007/s11103-005-2081-x; Tanaka M, 2008, PLANT PHYSIOL, V146, P149, DOI 10.1104/pp.107.111674; Ullah H, 2003, PLANT CELL, V15, P393, DOI 10.1105/tpc.006148; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; Usadel B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-535; van Noort V, 2003, TRENDS GENET, V19, P238, DOI 10.1016/S0168-9525(03)00056-8; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Watson Loraine, 2005, Functional & Integrative Genomics, V5, P155, DOI 10.1007/s10142-005-0133-6; White J, 2006, PLANT BIOTECHNOL J, V4, P289, DOI 10.1111/j.1467-7652.2006.00181.x; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	49	5	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e87261	10.1371/journal.pone.0087261	http://dx.doi.org/10.1371/journal.pone.0087261			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558366	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700012
J	Wakai, M; Abe, S; Kazuki, Y; Oshimura, M; Ishikawa, F				Wakai, Michihito; Abe, Satoshi; Kazuki, Yasuhiro; Oshimura, Mitsuo; Ishikawa, Fuyuki			A Human Artificial Chromosome Recapitulates the Metabolism of Native Telomeres in Mammalian Cells	PLOS ONE			English	Article							REPEAT-CONTAINING RNA; POLYMERASE-II; REPLICATION; TERRA; DNA; PROTECTION; BINDING; TRANSCRIPTION; RECRUITMENT; EFFICIENT	Telomeric and subtelomeric regions of human chromosomes largely consist of highly repetitive and redundant DNA sequences, resulting in a paucity of unique DNA sequences specific to individual telomeres. Accordingly, it is difficult to analyze telomere metabolism on a single-telomere basis. To circumvent this problem, we have exploited a human artificial chromosome (HAC#21) derived from human chromosome 21 (hChr21). HAC#21 was generated through truncation of the long arm of native hChr21 by the targeted telomere seeding technique. The newly established telomere of HAC#21 lacks canonical subtelomere structures but possesses unique sequences derived from the target vector backbone and the internal region of hChr21 used for telomere targeting, which enabled us to molecularly characterize the single HAC telomere. We established HeLa and NIH-3T3 sub-lines containing a single copy of HAC#21, where it was robustly maintained. The seeded telomere is associated with telomeric proteins over a length similar to that reported in native telomeres, and is faithfully replicated in mid-S phase in HeLa cells. We found that the seeded telomere on HAC#21 is transcribed from the newly juxtaposed site. The transcript, HAC-telRNA, shares several features with TERRA (telomeric repeat-containing RNA): it is a short-lived RNA polymerase II transcript, rarely contains a poly(A) tail, and associates with chromatin. Interestingly, HAC-telRNA undergoes splicing. These results suggest that transcription into TERRA is locally influenced by the subtelomeric context. Taken together, we have established human and mouse cell lines that will be useful for analyzing the behavior of a uniquely identifiable, functional telomere.	[Wakai, Michihito; Ishikawa, Fuyuki] Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Sakyo Ku, Kyoto, Japan; [Abe, Satoshi; Kazuki, Yasuhiro; Oshimura, Mitsuo] Tottori Univ, Dept Biomed Sci, Inst Regenerat Med & Biofunct, Grad Sch Med Sci, Yonago, Tottori, Japan; [Kazuki, Yasuhiro; Oshimura, Mitsuo] Tottori Univ, Chromosome Engn Res Ctr, Tottori 680, Japan	Kyoto University; Tottori University; Tottori University	Ishikawa, F (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Japan.	fishikaw@lif.kyoto-u.ac.jp	Ishikawa, Fuyuki/AAU-4056-2021	Ishikawa, Fuyuki/0000-0002-5580-2305	Ministry of Education, Culture, Sports, Science and Technology, Japan [22220012]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (22220012). URL: http://kaken.nii.ac.jp/d/p/22220012.en.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnoult N, 2012, NAT STRUCT MOL BIOL, V19, P948, DOI 10.1038/nsmb.2364; Arnoult N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000920; Azzalin CM, 2008, CELL CYCLE, V7, P1161, DOI 10.4161/cc.7.9.5836; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; BARNETT MA, 1993, NUCLEIC ACIDS RES, V21, P27, DOI 10.1093/nar/21.1.27; BROWN WRA, 1990, CELL, V63, P119, DOI 10.1016/0092-8674(90)90293-N; Caslini C, 2009, MOL CELL BIOL, V29, P4519, DOI 10.1128/MCB.00195-09; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Cusanelli E, 2013, MOL CELL, V51, P780, DOI 10.1016/j.molcel.2013.08.029; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Deng Z, 2012, EMBO J, V31, P4165, DOI 10.1038/emboj.2012.266; Deng Z, 2009, MOL CELL, V35, P403, DOI 10.1016/j.molcel.2009.06.025; Drosopoulos WC, 2012, J CELL BIOL, V197, P253, DOI 10.1083/jcb.201112083; Egloff S, 2012, TRENDS GENET, V28, P333, DOI 10.1016/j.tig.2012.03.007; FARR C, 1991, P NATL ACAD SCI USA, V88, P7006, DOI 10.1073/pnas.88.16.7006; Flynn RL, 2011, NATURE, V471, P532, DOI 10.1038/nature09772; Giannone RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012407; Golfier G, 2003, GENE, V312, P51, DOI 10.1016/S0378-1119(03)00673-5; GOTTSCHLING DE, 1986, CELL, V47, P195, DOI 10.1016/0092-8674(86)90442-3; GUIALIS A, 1977, CELL, V10, P53, DOI 10.1016/0092-8674(77)90139-8; HERRICK DJ, 1994, MOL CELL BIOL, V14, P2119, DOI 10.1128/MCB.14.3.2119; Hirai Y, 2012, GENES CELLS, V17, P186, DOI 10.1111/j.1365-2443.2012.01581.x; Hiratani I, 2009, EPIGENETICS-US, V4, P93, DOI 10.4161/epi.4.2.7772; IKENO M, 1994, HUM MOL GENET, V3, P1245, DOI 10.1093/hmg/3.8.1245; ITZHAKI JE, 1992, NAT GENET, V2, P283, DOI 10.1038/ng1292-283; Kanoh J, 2005, CURR BIOL, V15, P1808, DOI 10.1016/j.cub.2005.09.041; Karnani N, 2007, GENOME RES, V17, P865, DOI 10.1101/gr.5427007; Katoh M, 2004, BIOCHEM BIOPH RES CO, V321, P280, DOI 10.1016/j.bbrc.2004.06.145; Linardopoulou EV, 2007, PLOS GENET, V3, P2477, DOI 10.1371/journal.pgen.0030237; de Silanes IL, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1032; Nakamura M, 2005, MOL CELL BIOL, V25, P11073, DOI 10.1128/MCB.25.24.11073-11088.2005; Nandakumar J, 2012, NATURE, V492, P285, DOI 10.1038/nature11648; Nergadze SG, 2009, RNA, V15, P2186, DOI 10.1261/rna.1748309; Nittis T, 2010, MOL CELL PROTEOMICS, V9, P1144, DOI 10.1074/mcp.M900490-MCP200; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Porro A, 2010, MOL CELL BIOL, V30, P4808, DOI 10.1128/MCB.00460-10; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Silahtaroglu A, 2004, CYTOGENET GENOME RES, V107, P32, DOI 10.1159/000079569; Takai KK, 2010, J BIOL CHEM, V285, P1457, DOI 10.1074/jbc.M109.038026; TENHAGEN KG, 1990, MOL CELL BIOL, V10, P6348, DOI 10.1128/MCB.10.12.6348; Weuts A, 2012, NUCLEIC ACIDS RES, V40, P11477, DOI 10.1093/nar/gks926; Wright WE, 1999, EXP CELL RES, V251, P492, DOI 10.1006/excr.1999.4602; Xie SQ, 2006, MOL BIOL CELL, V17, P1723, DOI 10.1091/mbc.E05-08-0726; Yehezkel S, 2011, EPIGENETICS-US, V6, P63, DOI 10.4161/epi.6.1.13390; Zhong FL, 2012, CELL, V150, P481, DOI 10.1016/j.cell.2012.07.012; Zou Y, 2004, P NATL ACAD SCI USA, V101, P12928, DOI 10.1073/pnas.0404106101	49	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88530	10.1371/journal.pone.0088530	http://dx.doi.org/10.1371/journal.pone.0088530			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558398	Green Published, gold			2022-12-27	WOS:000331706700044
J	Wang, GS; Mayes, MA; Gu, LH; Schadt, CW				Wang, Gangsheng; Mayes, Melanie A.; Gu, Lianhong; Schadt, Christopher W.			Representation of Dormant and Active Microbial Dynamics for Ecosystem Modeling	PLOS ONE			English	Article							MAINTENANCE CARBON REQUIREMENTS; NITROGEN TURNOVER; THEORETICAL-MODEL; FUNCTIONAL-GROUPS; SOIL; BIOMASS; GROWTH; DECOMPOSITION; RESPIRATION; BACTERIA	Dormancy is an essential strategy for microorganisms to cope with environmental stress. However, global ecosystem models typically ignore microbial dormancy, resulting in notable model uncertainties. To facilitate the consideration of dormancy in these large-scale models, we propose a new microbial physiology component that works for a wide range of substrate availabilities. This new model is based on microbial physiological states and the major parameters are the maximum specific growth and maintenance rates of active microbes and the ratio of dormant to active maintenance rates. A major improvement of our model over extant models is that it can explain the low active microbial fractions commonly observed in undisturbed soils. Our new model shows that the exponentially-increasing respiration from substrate-induced respiration experiments can only be used to determine the maximum specific growth rate and initial active microbial biomass, while the respiration data representing both exponentially-increasing and non-exponentially-increasing phases can robustly determine a range of key parameters including the initial total live biomass, initial active fraction, the maximum specific growth and maintenance rates, and the half-saturation constant. Our new model can be incorporated into existing ecosystem models to account for dormancy in microbially-driven processes and to provide improved estimates of microbial activities.	[Wang, Gangsheng; Mayes, Melanie A.; Gu, Lianhong; Schadt, Christopher W.] Oak Ridge Natl Lab, Climate Change Sci Inst, Oak Ridge, TN 37831 USA; [Wang, Gangsheng; Mayes, Melanie A.; Gu, Lianhong] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Schadt, Christopher W.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory	Wang, GS (corresponding author), Oak Ridge Natl Lab, Climate Change Sci Inst, Oak Ridge, TN 37831 USA.	wangg@ornl.gov	Gu, Lianhong/H-8241-2014; Schadt, Christopher W./B-7143-2008; Schadt, Christopher/M-8746-2019; Wang, Gangsheng/F-8940-2012	Gu, Lianhong/0000-0001-5756-8738; Schadt, Christopher W./0000-0001-8759-2448; Schadt, Christopher/0000-0001-8759-2448; Wang, Gangsheng/0000-0002-8117-5034	Laboratory Directed Research and Development (LDRD) Program of the Oak Ridge National Laboratory (ORNL); U.S. Department of Energy Biological and Environmental Research (BER) program; U.S. Department of Energy [DE-AC05-00OR22725]	Laboratory Directed Research and Development (LDRD) Program of the Oak Ridge National Laboratory (ORNL); U.S. Department of Energy Biological and Environmental Research (BER) program(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	This research was funded by the Laboratory Directed Research and Development (LDRD) Program of the Oak Ridge National Laboratory (ORNL) and by the U.S. Department of Energy Biological and Environmental Research (BER) program. ORNL is managed by UT-Battelle, LLC, for the U.S. Department of Energy under contract DE-AC05-00OR22725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam G, 2001, SOIL BIOL BIOCHEM, V33, P943, DOI 10.1016/S0038-0717(00)00244-3; Alvarez CR, 1998, SOIL BIOL BIOCHEM, V30, P767, DOI 10.1016/S0038-0717(97)00168-5; ANDERSON JPE, 1978, SOIL BIOL BIOCHEM, V10, P215, DOI 10.1016/0038-0717(78)90099-8; ANDERSON TH, 1985, SOIL BIOL BIOCHEM, V17, P197, DOI 10.1016/0038-0717(85)90115-4; ANDERSON TH, 1985, BIOL FERT SOILS, V1, P81, DOI 10.1007/BF00255134; Ayati BP, 2012, J THEOR BIOL, V293, P34, DOI 10.1016/j.jtbi.2011.10.003; Bar M, 2002, P ROY SOC B-BIOL SCI, V269, P937, DOI 10.1098/rspb.2002.1958; BEEFTINK HH, 1990, FEMS MICROBIOL ECOL, V73, P203, DOI 10.1016/0378-1097(90)90731-5; Blagodatsky SA, 2000, BIOL FERT SOILS, V32, P73, DOI 10.1007/s003740000219; Blagodatsky SA, 1998, SOIL BIOL BIOCHEM, V30, P1743, DOI 10.1016/S0038-0717(98)00028-5; Blagodatsky SA, 1998, SOIL BIOL BIOCHEM, V30, P1757, DOI 10.1016/S0038-0717(98)00029-7; Boulos L, 1999, J MICROBIOL METH, V37, P77, DOI 10.1016/S0167-7012(99)00048-2; Buerger S, 2012, APPL ENVIRON MICROB, V78, P3221, DOI 10.1128/AEM.07307-11; Colores GM, 1996, SOIL BIOL BIOCHEM, V28, P1569, DOI 10.1016/S0038-0717(96)00253-2; DUAN QY, 1992, WATER RESOUR RES, V28, P1015, DOI 10.1029/91WR02985; Gignoux J, 2001, GLOBAL ECOL BIOGEOGR, V10, P639, DOI 10.1046/j.1466-822X.2001.00250.x; Hoehler TM, 2013, NAT REV MICROBIOL, V11, P83, DOI 10.1038/nrmicro2939; HUNT HW, 1977, ECOLOGY, V58, P469, DOI 10.2307/1938998; JENKINSON DS, 1976, SOIL BIOL BIOCHEM, V8, P209, DOI 10.1016/0038-0717(76)90005-5; JONES KH, 1985, J HISTOCHEM CYTOCHEM, V33, P77, DOI 10.1177/33.1.2578146; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Khomutova TE, 2004, MICROBIOLOGY+, V73, P196, DOI 10.1023/B:MICI.0000023989.04745.7b; Konopka A, 1999, MICROBIAL ECOL, V38, P321, DOI 10.1007/s002489900178; Lawrence CR, 2009, SOIL BIOL BIOCHEM, V41, P1923, DOI 10.1016/j.soilbio.2009.06.016; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Locey KJ, 2010, J BIOGEOGR, V37, P1835, DOI 10.1111/j.1365-2699.2010.02357.x; Lodge D.J., 1993, BMS S SERIES, V19, P37; MASON CA, 1986, FEMS MICROBIOL LETT, V39, P373; Moorhead DL, 2012, SOIL BIOL BIOCHEM, V53, P133, DOI 10.1016/j.soilbio.2012.05.011; Orwin KH, 2006, OIKOS, V112, P196, DOI 10.1111/j.0030-1299.2006.13813.x; Panikov NS, 1996, MATH COMPUT SIMULAT, V42, P179, DOI 10.1016/0378-4754(95)00127-1; Panikov NS, 1996, J MICROBIOL METH, V24, P219, DOI 10.1016/0167-7012(95)00074-7; Panikov NS, 1995, MICROBIAL GROWTH KIN; PIRT SJ, 1965, PROC R SOC SER B-BIO, V163, P224, DOI 10.1098/rspb.1965.0069; Price PB, 2004, P NATL ACAD SCI USA, V101, P4631, DOI 10.1073/pnas.0400522101; Schimel JP, 2003, SOIL BIOL BIOCHEM, V35, P549, DOI 10.1016/S0038-0717(03)00015-4; Schulz S, 2010, J MICROBIOL METH, V80, P295, DOI 10.1016/j.mimet.2010.01.005; Sinsabaugh RL, 2013, ECOL LETT, V16, P930, DOI 10.1111/ele.12113; Stenstrom J, 2001, FEMS MICROBIOL ECOL, V36, P93, DOI 10.1016/S0168-6496(01)00122-2; Stocks SM, 2004, CYTOM PART A, V61A, P189, DOI 10.1002/cyto.a.20069; Stolpovsky K, 2011, ECOL MODEL, V222, P3092, DOI 10.1016/j.ecolmodel.2011.07.006; Todd-Brown KEO, 2012, BIOGEOCHEMISTRY, V109, P19, DOI 10.1007/s10533-011-9635-6; Treseder KK, 2012, BIOGEOCHEMISTRY, V109, P7, DOI 10.1007/s10533-011-9636-5; VANDEWERF H, 1987, SOIL BIOL BIOCHEM, V19, P261, DOI 10.1016/0038-0717(87)90007-1; Wang G., 2009, WATER RESOUR RES, V45; Wang GS, 2013, SOIL BIOL BIOCHEM, V57, P946, DOI 10.1016/j.soilbio.2012.08.028; Wang GS, 2013, ECOL APPL, V23, P255, DOI 10.1890/12-0681.1; Wang GS, 2012, FEMS MICROBIOL ECOL, V81, P610, DOI 10.1111/j.1574-6941.2012.01389.x; Wang GS, 2012, SOIL BIOL BIOCHEM, V48, P28, DOI 10.1016/j.soilbio.2012.01.011; Wieder WR, 2013, NAT CLIM CHANGE, V3, P909, DOI [10.1038/nclimate1951, 10.1038/NCLIMATE1951]; Wirtz KW, 2003, FEMS MICROBIOL ECOL, V46, P295, DOI 10.1016/S0168-6496(03)00196-X; Yarwood S, 2013, APPL ENVIRON MICROB, V79, P1385, DOI 10.1128/AEM.03181-12	52	61	61	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89252	10.1371/journal.pone.0089252	http://dx.doi.org/10.1371/journal.pone.0089252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558490	gold, Green Submitted, Green Published			2022-12-27	WOS:000331706700136
J	Wolf, M; Baumer, P; Pedro, M; Dombert, T; Staub, F; Heiland, S; Bendszus, M; Pham, M				Wolf, Marcel; Baeumer, Philipp; Pedro, Maria; Dombert, Thomas; Staub, Frank; Heiland, Sabine; Bendszus, Martin; Pham, Mirko			Sciatic Nerve Injury Related to Hip Replacement Surgery: Imaging Detection by MR Neurography Despite Susceptibility Artifacts	PLOS ONE			English	Article							MAGNETIC-RESONANCE NEUROGRAPHY; ARTHROPLASTY; LESIONS; PALSY; EXPERIENCE; MANAGEMENT; NEUROPATHY; PROGNOSIS; DIAGNOSIS; OUTCOMES	Sciatic nerve palsy related to hip replacement surgery (HRS) is among the most common causes of sciatic neuropathies. The sciatic nerve may be injured by various different periprocedural mechanisms. The precise localization and extension of the nerve lesion, the determination of nerve continuity, lesion severity, and fascicular lesion distribution are essential for assessing the potential of spontaneous recovery and thereby avoiding delayed or inappropriate therapy. Adequate therapy is in many cases limited to conservative management, but in certain cases early surgical exploration and release of the nerve is indicated. Nerve-conduction-studies and electromyography are essential in the diagnosis of nerve injuries. In postsurgical nerve injuries, additional diagnostic imaging is important as well, in particular to detect or rule out direct mechanical compromise. Especially in the presence of metallic implants, commonly applied diagnostic imaging tests generally fail to adequately visualize nervous tissue. MRI has been deemed problematic due to implant-related artifacts after HRS. In this study, we describe for the first time the spectrum of imaging findings of Magnetic Resonance neurography (MRN) employing pulse sequences relatively insensitive to susceptibility artifacts (susceptibility insensitive MRN, siMRN) in a series of 9 patients with HRS procedure related sciatic nerve palsy. We were able to determine the localization and fascicular distribution of the sciatic nerve lesion in all 9 patients, which clearly showed on imaging predominant involvement of the peroneal more than the tibial division of the sciatic nerve. In 2 patients siMRN revealed direct mechanical compromise of the nerve by surgical material, and in one of these cases indication for surgical release of the sciatic nerve was based on siMRN. Thus, in selected cases of HRS related neuropathies, especially when surgical exploration of the nerve is considered, siMRN, with its potential to largely overcome implant related artifacts, is a useful diagnostic addition to nerve-conduction-studies and electromyography.	[Wolf, Marcel; Baeumer, Philipp; Bendszus, Martin; Pham, Mirko] Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany; [Pedro, Maria] Univ Ulm, Dept Neurosurg, Gunzburg, Germany; [Dombert, Thomas; Staub, Frank] Ctr Peripheral Nerve Surg, Dossenheim Heidelberg, Germany; [Heiland, Sabine] Heidelberg Univ, Sect Expt Radiol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ulm University; Ruprecht Karls University Heidelberg	Wolf, M (corresponding author), Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany.	marcel.wolf@med.uni-heidelberg.de	Pham, Mirko/AAI-8713-2020		Medical Faculty of the University of Heidelberg; German Osteoarthritis Foundation (Deutsche Arthrose Hilfe e.V.) [P215-A482]	Medical Faculty of the University of Heidelberg; German Osteoarthritis Foundation (Deutsche Arthrose Hilfe e.V.)	This study was supported by a Postdoctoral-Fellowship granted to MP from the Medical Faculty of the University of Heidelberg and a project grant from the German Osteoarthritis Foundation (Deutsche Arthrose Hilfe e.V.), Grant number P215-A482. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumer P, 2011, RADIOLOGY, V260, P199, DOI 10.1148/radiol.11102357; Cahir JG, 2007, CLIN RADIOL, V62, P1163, DOI 10.1016/j.crad.2007.04.018; Duffy Patrick, 2006, Instr Course Lect, V55, P223; EDWARDS BN, 1987, CLIN ORTHOP RELAT R, P136; Farrell CM, 2005, J BONE JOINT SURG AM, V87A, P2619, DOI 10.2106/JBJS.C.01564; Farrelly C, 2010, AM J ROENTGENOL, V194, pW60, DOI 10.2214/AJR.08.1740; Filler A, 2009, NEUROSURGERY, V65, pA29, DOI 10.1227/01.NEU.0000351279.78110.00; Filler Aaron G, 2009, Neurosurg Focus, V26, pE9, DOI 10.3171/FOC.2009.26.2.E9; Filler AG, 2005, J NEUROSURG-SPINE, V2, P99, DOI 10.3171/spi.2005.2.2.0099; Filler AG, 2004, NEUROL CLIN, V22, P643, DOI 10.1016/j.ncl.2004.03.005; Hargreaves BA, 2011, AM J ROENTGENOL, V197, P547, DOI 10.2214/AJR.11.7364; Kim DH, 1996, NEUROSURGERY, V39, P312, DOI 10.1097/00006123-199608000-00014; KIM DH, 1995, J NEUROSURG, V83, P783, DOI 10.3171/jns.1995.83.5.0783; Kim DH, 2004, J NEUROSURG, V101, P8, DOI 10.3171/jns.2004.101.1.0008; Koltzenburg M, 2004, CURR OPIN NEUROL, V17, P621, DOI 10.1097/00019052-200410000-00013; Kuntz C, 1996, NEUROSURGERY, V39, P750, DOI 10.1097/00006123-199610000-00021; Lee MJ, 2007, RADIOGRAPHICS, V27, P791, DOI 10.1148/rg.273065087; Miller TT, 2012, EUR J RADIOL, V81, P3802, DOI 10.1016/j.ejrad.2011.03.103; Nercessian O A, 1994, J Arthroplasty, V9, P645; Oldenburg M, 1997, INT ORTHOP, V21, P1, DOI 10.1007/s002640050107; Pham M, 2010, FERTIL STERIL, V94, DOI 10.1016/j.fertnstert.2009.12.046; Pham M, 2011, J NEUROL, V258, P1120, DOI 10.1007/s00415-010-5895-7; Plewnia C, 1999, J TRAUMA, V47, P986, DOI 10.1097/00005373-199911000-00036; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; SCHMALZRIED TP, 1991, J BONE JOINT SURG AM, V73A, P1074, DOI 10.2106/00004623-199173070-00018; Simon J P, 1993, Acta Orthop Belg, V59, P156; Stoll G, 2009, J NEUROL, V256, P1043, DOI 10.1007/s00415-009-5064-z; Toms AP, 2010, CLIN RADIOL, V65, P447, DOI 10.1016/j.crad.2009.12.014; Unwin A, 1999, INT ORTHOP, V23, P133, DOI 10.1007/s002640050329; WEBER ER, 1976, J BONE JOINT SURG AM, V58, P66, DOI 10.2106/00004623-197658010-00011; Wessig C, 2004, EXP NEUROL, V185, P254, DOI 10.1016/j.expneurol.2003.10.012; Yeremeyeva E, 2009, NEUROSURGERY, V65, pA63, DOI 10.1227/01.NEU.0000346265.17661.1E; Zhan CL, 2007, J BONE JOINT SURG AM, V89A, P526, DOI 10.2106/JBJS.F.00952	33	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89154	10.1371/journal.pone.0089154	http://dx.doi.org/10.1371/journal.pone.0089154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558483	Green Submitted, gold, Green Published			2022-12-27	WOS:000331706700129
J	Wong, TM; Boyapalle, S; Sampayo, V; Nguyen, HD; Bedi, R; Kamath, SG; Moore, ML; Mohapatra, S; Mohapatra, SS				Wong, Terianne M.; Boyapalle, Sandhya; Sampayo, Viviana; Nguyen, Huy D.; Bedi, Raminder; Kamath, Siddharth G.; Moore, Martin L.; Mohapatra, Subhra; Mohapatra, Shyam S.			Respiratory Syncytial Virus (RSV) Infection in Elderly Mice Results in Altered Antiviral Gene Expression and Enhanced Pathology	PLOS ONE			English	Article							DENDRITIC CELLS; FUSION PROTEIN; VIRAL-INFECTION; BALB/C MICE; IN-VITRO; T-CELLS; OSTEOPONTIN; INFLUENZA; LUNG; DISEASE	Elderly persons are more susceptible to RSV-induced pneumonia than young people, but the molecular mechanism underlying this susceptibility is not well understood. In this study, we used an aged mouse model of RSV-induced pneumonia to examine how aging alters the lung pathology, modulates antiviral gene expressions, and the production of inflammatory cytokines in response to RSV infection. Young (2-3 months) and aged (19-21 months) mice were intranasally infected with mucogenic or non-mucogenic RSV strains, lung histology was examined, and gene expression was analyzed. Upon infection with mucogenic strains of RSV, leukocyte infiltration in the airways was elevated and prolonged in aged mice compared to young mice. Minitab factorial analysis identified several antiviral genes that are influenced by age, infection, and a combination of both factors. The expression of five antiviral genes, including pro-inflammatory cytokines IL-1b and osteopontin (OPN), was altered by both age and infection, while age was associated with the expression of 15 antiviral genes. Both kinetics and magnitude of antiviral gene expression were diminished as a result of older age. In addition to delays in cytokine signaling and pattern recognition receptor induction, we found TLR7/8 signaling to be impaired in alveolar macrophages in aged mice. In vivo, induction of IL-1b and OPN were delayed but prolonged in aged mice upon RSV infection compared to young. In conclusion, this study demonstrates inherent differences in response to RSV infection in young vs. aged mice, accompanied by delayed antiviral gene induction and cytokine signaling.	[Wong, Terianne M.; Boyapalle, Sandhya; Mohapatra, Subhra; Mohapatra, Shyam S.] James A Haley Vet Affairs Hosp, Dept Internal Med, Tampa, FL 33612 USA; [Wong, Terianne M.; Boyapalle, Sandhya; Sampayo, Viviana; Nguyen, Huy D.; Bedi, Raminder; Kamath, Siddharth G.; Mohapatra, Shyam S.] Univ S Florida, Dept Internal Med, Div Translat Med, Morsani Coll Med, Tampa, FL 33612 USA; [Wong, Terianne M.; Boyapalle, Sandhya; Sampayo, Viviana; Nguyen, Huy D.; Bedi, Raminder; Kamath, Siddharth G.; Mohapatra, Shyam S.] Univ S Florida, Dept Internal Med, Nanomed Res Ctr, Morsani Coll Med, Tampa, FL 33612 USA; [Moore, Martin L.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Moore, Martin L.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Mohapatra, Subhra] Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Emory University; Children's Healthcare of Atlanta (CHOA); State University System of Florida; University of South Florida	Mohapatra, SS (corresponding author), James A Haley Vet Affairs Hosp, Dept Internal Med, Tampa, FL 33612 USA.	smohapat@health.usf.edu	Mohapatra, Shyam/C-2500-2012		Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development; Research Career Scientist and Veterans Affairs Merit Review Award; University of South Florida; NIH [1R01AI087798, 1U19AI095227]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087798, U19AI095227] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development(US Department of Veterans Affairs); Research Career Scientist and Veterans Affairs Merit Review Award; University of South Florida; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This material is based upon work supported in part by Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development. The contents of this report do not represent the views of the Department of Veterans Affairs or the United States Government. Work in this study was financially supported with Research Career Scientist and Veterans Affairs Merit Review Award to Dr. Shyam Mohapatra and University of South Florida Signature Research Fellowship to Mrs. Terianne Wong. Martin L. Moore was supported by NIH 1R01AI087798 and NIH 1U19AI095227. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel B, 2005, J IMMUNOL, V175, P6006, DOI 10.4049/jimmunol.175.9.6006; Aeffner F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046660; Alvarez-Rodriguez L, 2012, CELL IMMUNOL, V273, P124, DOI 10.1016/j.cellimm.2012.01.001; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Bartlett DB, 2012, AGING CELL, V11, P912, DOI 10.1111/j.1474-9726.2012.00849.x; Bendelja K, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-143; Boehmer ED, 2005, MECH AGEING DEV, V126, P1305, DOI 10.1016/j.mad.2005.07.009; Boukhvalova MS, 2007, J INFECT DIS, V195, P511, DOI 10.1086/510628; Boyapalle S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029386; Bruunsgaard H, 2001, CURR OPIN HEMATOL, V8, P131, DOI 10.1097/00062752-200105000-00001; Busse PJ, 2010, J ALLERGY CLIN IMMUN, V126, P690, DOI 10.1016/j.jaci.2010.08.011; Cabalka AK, 2004, PEDIATR INFECT DIS J, V23, pS41, DOI 10.1097/01.inf.0000108220.94201.1a; Camous X, 2012, J BIOMED BIOTECHNOL, V2012, P8; Cherukuri A, 2013, CLIN VACCINE IMMUNOL, V20, P239, DOI 10.1128/CVI.00580-12; Cherukuri A, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-21; Chiba S, 2000, MICROBIOL IMMUNOL, V44, P319, DOI 10.1111/j.1348-0421.2000.tb02501.x; Curtis SJ, 2002, EXP BIOL MED, V227, P799, DOI 10.1177/153537020222700912; Cyr SL, 2007, VACCINE, V25, P3228, DOI 10.1016/j.vaccine.2007.01.037; Ehre C, 2012, P NATL ACAD SCI USA, V109, P16528, DOI 10.1073/pnas.1206552109; Eigenbrod T, 2012, J IMMUNOL, V189, P328, DOI 10.4049/jimmunol.1103258; Eisenhut M, 2006, CRIT CARE, V10, DOI 10.1186/cc4984; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Fulton Ross B, 2009, Aging health, V5, P775, DOI 10.2217/ahe.09.69; Gern JE, 2009, CURR OPIN ALLERGY CL, V9, P73, DOI 10.1097/ACI.0b013e32831f8f1b; Giles BM, 2011, VACCINE, V29, P3043, DOI 10.1016/j.vaccine.2011.01.100; Gonzalez PA, 2008, P NATL ACAD SCI USA, V105, P14999, DOI 10.1073/pnas.0802555105; Harker JA, 2010, J VIROL, V84, P4073, DOI 10.1128/JVI.02014-09; Inoue M, 2012, P NATL ACAD SCI USA, V109, P10480, DOI 10.1073/pnas.1201836109; Johnstone J, 2008, CHEST, V134, P1141, DOI 10.1378/chest.08-0888; Kohan M, 2009, AM J RESP CELL MOL, V41, P290, DOI 10.1165/rcmb.2008-0307OC; Konno S, 2011, CLIN EXP ALLERGY, V41, P1360, DOI 10.1111/j.1365-2222.2011.03775.x; Kovacs EJ, 2009, TRENDS IMMUNOL, V30, P319, DOI 10.1016/j.it.2009.03.012; Liang S, 2009, MECH AGEING DEV, V130, P538, DOI 10.1016/j.mad.2009.06.006; Lindell DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021823; Lowery EM, 2013, CLIN INTERV AGING, V8, P1489, DOI 10.2147/CIA.S51152; Lukacs NW, 2010, J IMMUNOL, V185, P2231, DOI 10.4049/jimmunol.1000733; Matsui Y, 2009, ARTHRITIS RHEUM-US, V60, P2362, DOI 10.1002/art.24705; Mohapatra SS, 2008, CLIN MICROBIOL REV, V21, P495, DOI 10.1128/CMR.00054-07; Moore ML, 2009, J VIROL, V83, P4185, DOI 10.1128/JVI.01853-08; Morimoto J, 2011, J IMMUNOL, V187, P5671, DOI 10.4049/jimmunol.1101825; Mukherjee S, 2011, AM J PATHOL, V179, P248, DOI 10.1016/j.ajpath.2011.03.003; O'Regan A, 2003, CYTOKINE GROWTH F R, V14, P479, DOI 10.1016/S1359-6101(03)00055-8; Paliwal P, 2012, AGING-US, V4, P553, DOI 10.18632/aging.100477; Panda A, 2010, J IMMUNOL, V184, P2518, DOI 10.4049/jimmunol.0901022; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Prasse A, 2009, AM J PATHOL, V174, P1683, DOI 10.2353/ajpath.2009.080689; Qian F, 2011, J INFECT DIS, V203, P1415, DOI 10.1093/infdis/jir048; Ramirez A, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-27; Renshaw M, 2002, J IMMUNOL, V169, P4697, DOI 10.4049/jimmunol.169.9.4697; Sato K, 2012, BIOCHEM BIOPH RES CO, V417, P274, DOI 10.1016/j.bbrc.2011.11.100; Schlafer S, 2012, J NAT PROD, V75, P2108, DOI 10.1021/np300514z; Schlender J, 2000, J VIROL, V74, P8234, DOI 10.1128/JVI.74.18.8234-8242.2000; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Solana R, 2006, IMMUNITY, V24, P491, DOI 10.1016/j.immuni.2006.05.003; Stokes KL, 2011, J VIROL, V85, P5782, DOI 10.1128/JVI.01693-10; Stout-Delgado HW, 2012, J IMMUNOL, V188, P2815, DOI 10.4049/jimmunol.1103051; Takahashi F, 2001, AM J RESP CELL MOL, V24, P264, DOI 10.1165/ajrcmb.24.3.4293; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tran KC, 2004, J VIROL, V78, P692, DOI 10.1128/JVI.78.2.692-699.2004; van der Windt GJW, 2010, EUR RESPIR J, V36, P1337, DOI 10.1183/09031936.00002710; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Xanthou G, 2007, NAT MED, V13, P570, DOI 10.1038/nm1580; XUAN JW, 1995, J CELL BIOCHEM, V57, P680, DOI 10.1002/jcb.240570413; Zhang Y, 2002, EXP BIOL MED; Zhao W, 2010, J BIOL CHEM, V285, P20452, DOI 10.1074/jbc.M110.110312; Zhou W, 2006, MICROBES INFECT, V8, P2880, DOI 10.1016/j.micinf.2006.09.007	66	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88764	10.1371/journal.pone.0088764	http://dx.doi.org/10.1371/journal.pone.0088764			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558422	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700068
J	Yang, B; Wagner, J; Damaschke, N; Yao, TY; Wuerzberger-Davis, SM; Lee, MH; Svaren, J; Miyamoto, S; Jarrard, DF				Yang, Bing; Wagner, Jennifer; Damaschke, Nathan; Yao, Tianyu; Wuerzberger-Davis, Shelly M.; Lee, Moon-Hee; Svaren, John; Miyamoto, Shigeki; Jarrard, David F.			A Novel Pathway Links Oxidative Stress to Loss of Insulin Growth Factor-2 (IGF2) Imprinting through NF-kappa B Activation	PLOS ONE			English	Article							CTCF BINDING-SITES; PROSTATE-CANCER; DNA METHYLATION; EXPRESSION; INDUCTION; MOUSE; TRANSCRIPTION; CELLS	Genomic imprinting is the allele-specific expression of a gene based on parental origin. Loss of imprinting(LOI) of Insulin-like Growth Factor 2 (IGF2) during aging is important in tumorigenesis, yet the regulatory mechanisms driving this event are largely unknown. In this study oxidative stress, measured by increased NF-kappa B activity, induces LOI in both cancerous and noncancerous human prostate cells. Decreased expression of the enhancer-blocking element CCCTC-binding factor(CTCF) results in reduced binding of CTCF to the H19-ICR (imprint control region), a major factor in the allelic silencing of IGF2. This ICR then develops increased DNA methylation. Assays identify a recruitment of the canonical pathway proteins NF-kappa B p65 and p50 to the CTCF promoter associated with the co-repressor HDAC1 explaining gene repression. An I kappa B alpha super-repressor blocks oxidative stress-induced activation of NF-kappa B and IGF2 imprinting is maintained. In vivo experiments using I kappa B alpha mutant mice with continuous NF-kappa B activation demonstrate increased IGF2 LOI further confirming a central role for canonical NF-kappa B signaling. We conclude CTCF plays a central role in mediating the effects of NF-kappa B activation that result in altered imprinting both in vitro and in vivo. This novel finding connects inflammation found in aging prostate tissues with the altered epigenetic landscape.	[Yang, Bing; Wagner, Jennifer; Damaschke, Nathan; Yao, Tianyu; Jarrard, David F.] Univ Wisconsin, Dept Urol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Wuerzberger-Davis, Shelly M.; Lee, Moon-Hee; Miyamoto, Shigeki] Univ Wisconsin, McArdle Lab Canc Res, Dept Oncol, Madison, WI 53706 USA; [Svaren, John; Jarrard, David F.] Univ Wisconsin, Madison, WI USA; [Miyamoto, Shigeki; Jarrard, David F.] Univ Wisconsin, Carbone Comprehens Canc Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Jarrard, DF (corresponding author), Univ Wisconsin, Dept Urol, Sch Med & Publ Hlth, Madison, WI 53706 USA.	jarrard@urology.wisc.edu	Svaren, John/A-1605-2010	Svaren, John/0000-0003-2963-7921; Damaschke, Nathan/0000-0002-0216-1516	National Institutes of Health [2R01CA097131]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009135, P30CA014520, R01CA097131] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health, No. 2R01CA097131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AS, 2008, CELL CYCLE, V7, P556, DOI 10.4161/cc.7.5.5490; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bennett-Baker PE, 2003, GENETICS, V165, P2055; Bhusari SS, 2010, EPIGENETICS-US, V5, P402, DOI 10.4161/epi.5.5.11853; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Chen CL, 2000, J IMMUNOL, V165, P5418, DOI 10.4049/jimmunol.165.10.5418; Engel N, 2006, HUM MOL GENET, V15, P2945, DOI 10.1093/hmg/ddl237; Fu VX, 2008, CANCER RES, V68, P6797, DOI 10.1158/0008-5472.CAN-08-1714; Gao ZG, 2005, J BIOL CHEM, V280, P21091, DOI 10.1074/jbc.M500754200; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; INOUE J, 1991, P NATL ACAD SCI USA, V88, P3715, DOI 10.1073/pnas.88.9.3715; Jarrard DF, 1999, CANCER RES, V59, P2957; Jin R, 2013, CANC RES IN PRESS; Jin RJ, 2008, CANCER RES, V68, P6762, DOI 10.1158/0008-5472.CAN-08-0107; Khosla S, 2001, BIOL REPROD, V64, P918, DOI 10.1095/biolreprod64.3.918; Kim HJ, 2002, FREE RADICAL BIO MED, V32, P991, DOI 10.1016/S0891-5849(02)00798-0; Koul HK, 2010, DRUG TODAY, V46, P929, DOI 10.1358/dot.2010.46.12.1537942; Lee MH, 2011, MOL CELL, V43, P180, DOI 10.1016/j.molcel.2011.06.017; Li Q, 2001, ANTIOXID REDOX SIGN, V3, P415, DOI 10.1089/15230860152409068; Li Q, 2006, J BIOL CHEM, V281, P37566, DOI 10.1074/jbc.M603643200; Li T, 2007, EXP CELL RES, V313, P3057, DOI 10.1016/j.yexcr.2007.05.018; Lu L, 2010, J BIOL CHEM, V285, P9373, DOI 10.1074/jbc.M109.094425; Malins DC, 2001, CANCER RES, V61, P6025; MEYER M, 1993, EMBO J, V12, P2005, DOI 10.1002/j.1460-2075.1993.tb05850.x; Miyamoto S, 2004, MOL CELL, V13, P763, DOI 10.1016/S1097-2765(04)00158-3; Murrell A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001849; O'Conner JL, 1997, MOL CELL ENDOCRINOL, V136, P67, DOI 10.1016/S0303-7207(97)00216-5; Paradowska A, 2009, INT J ONCOL, V35, P87, DOI 10.3892/ijo_00000316; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Plummer SM, 1999, ONCOGENE, V18, P6013, DOI 10.1038/sj.onc.1202980; Risques RA, 2008, GASTROENTEROLOGY, V135, P410, DOI 10.1053/j.gastro.2008.04.008; Shen T, 2010, BIOL PHARM BULL, V33, P1159, DOI 10.1248/bpb.33.1159; Siddiqui IA, 2008, PHARM RES-DORDR, V25, P2135, DOI 10.1007/s11095-008-9553-z; Szabo PE, 2004, MOL CELL BIOL, V24, P4791, DOI 10.1128/MCB.24.11.4791-4800.2004; TURK PW, 1995, CARCINOGENESIS, V16, P1253, DOI 10.1093/carcin/16.5.1253; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Wu ZH, 2008, EMBO J, V27, P1963, DOI 10.1038/emboj.2008.127; Yang B, 2013, NEOPLASIA, V15, P399, DOI 10.1593/neo.13280; Yang YW, 2003, J CELL BIOCHEM, V90, P1038, DOI 10.1002/jcb.10684	43	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88052	10.1371/journal.pone.0088052	http://dx.doi.org/10.1371/journal.pone.0088052			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558376	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700022
J	Yang, OO; Ibarrondo, FJ; Price, C; Hultin, LE; Elliott, J; Hultin, PM; Shih, R; Hausner, MA; Ng, HL; Hoffman, J; Jamieson, BD; Anton, PA				Yang, Otto O.; Ibarrondo, F. Javier; Price, Charles; Hultin, Lance E.; Elliott, Julie; Hultin, Patricia M.; Shih, Roger; Hausner, Mary Ann; Ng, Hwee L.; Hoffman, Jennifer; Jamieson, Beth D.; Anton, Peter A.			Differential Blood and Mucosal Immune Responses against an HIV-1 Vaccine Administered Via Inguinal or Deltoid Injection	PLOS ONE			English	Article							T-CELL RESPONSES; IMMUNODEFICIENCY-VIRUS TYPE-1; INFECTION; IMMUNIZATION; REPLICATION; PROTECTION; DEPLETION; MACAQUES; ALVAC; SITE	Mucosal immunity is central to sexual transmission and overall pathogenesis of HIV-1 infection, but the ability of vaccines to induce immune responses in mucosal tissue compartments is poorly defined. Because macaque vaccine studies suggest that inguinal (versus limb) vaccination may better target sexually-exposed mucosa, we performed a randomized, double-blinded, placebo-controlled Phase I trial in HIV-1-uninfected volunteers, using the recombinant Canarypox (CP) vaccine vCP205 delivered by different routes. 12 persons received vaccine and 6 received placebo, divided evenly between deltoid-intramuscular (deltoid-IM) or inguinal-subcutaneous (inguinal-SC) injection routes. The most significant safety events were injection site reactions (Grade 3) in one inguinal vaccinee. CP-specific antibodies were detected in the blood of all 12 vaccinees by Day 24, while HIV-1-specific antibodies were observed in the blood and gut mucosa of 1/9 and 4/9 evaluated vaccinees respectively, with gut antibodies appearing earlier in inguinal vaccinees (24-180 versus 180-365 days). HIV-1-specific CD8+ T lymphocytes (CTLs) were observed in 7/12 vaccinees, and blood and gut targeting were distinct. Within blood, both deltoid and inguinal responders had detectable CTL responses by 17-24 days; inguinal responders had early responses (within 10 days) while deltoid responders had later responses (24-180 days) in gut mucosa. Our results demonstrate relative safety of inguinal vaccination and qualitative or quantitative compartmentalization of immune responses between blood and gut mucosa, and highlight the importance of not only evaluating early blood responses to HIV-1 vaccines but also mucosal responses over time.	[Yang, Otto O.; Ibarrondo, F. Javier; Price, Charles; Hultin, Lance E.; Elliott, Julie; Hultin, Patricia M.; Shih, Roger; Hausner, Mary Ann; Ng, Hwee L.; Hoffman, Jennifer; Jamieson, Beth D.; Anton, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Yang, Otto O.; Ibarrondo, F. Javier; Price, Charles; Hultin, Lance E.; Elliott, Julie; Hultin, Patricia M.; Shih, Roger; Hausner, Mary Ann; Ng, Hwee L.; Hoffman, Jennifer; Jamieson, Beth D.; Anton, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, AIDS Inst, Los Angeles, CA 90095 USA; [Yang, Otto O.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Yang, Otto O.] AIDS Healthcare Fdn, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Yang, OO (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	OYang@mednet.ucla.edu			R01 grant under the Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health [AI060614]; University of California, Los Angeles Center for AIDS Research [5P30 AI28697]; Cores of Mucosal Immunology, Flow Cytometry and Biostatistics; University of California Los Angeles Centers for AIDS Research [AI060614]; American Foundation for AIDS Research [02620]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI060614, P30AI028697] Funding Source: NIH RePORTER	R01 grant under the Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health; University of California, Los Angeles Center for AIDS Research; Cores of Mucosal Immunology, Flow Cytometry and Biostatistics; University of California Los Angeles Centers for AIDS Research; American Foundation for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded by an R01 grant under the Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health (AI060614). Additional support was provided by the University of California, Los Angeles Center for AIDS Research (5P30 AI28697) Cores of Mucosal Immunology, Flow Cytometry and Biostatistics with data derived from pilot funding from the University of California Los Angeles Centers for AIDS Research seed grants (AI060614) and American Foundation for AIDS Research support (#02620). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackers ML, 2003, J INFECT DIS, V187, P879, DOI 10.1086/368169; Anton PA, 2000, AIDS, V14, P1761, DOI 10.1097/00002030-200008180-00011; Anton PA, 2001, J VIROL METHODS, V95, P65, DOI 10.1016/S0166-0934(01)00295-6; Anton PA, 2008, VACCINE, V26, P4617, DOI 10.1016/j.vaccine.2008.05.084; Belyakov IM, 2007, J IMMUNOL, V178, P7211, DOI 10.4049/jimmunol.178.11.7211; Belyakov IM, 2009, J IMMUNOL, V183, P6883, DOI 10.4049/jimmunol.0901466; Bolton DL, 2012, MUCOSAL IMMUNOL, V5, P41, DOI 10.1038/mi.2011.45; Clements-Mann ML, 1998, J INFECT DIS, V177, P1230, DOI 10.1086/515288; Ellenberger D, 2006, VIROLOGY, V352, P216, DOI 10.1016/j.virol.2006.04.005; Ferre AL, 2010, J VIROL, V84, P10354, DOI 10.1128/JVI.00803-10; Hird TR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002599; Ibarrondo FJ, 2005, J VIROL, V79, P4289, DOI 10.1128/JVI.79.7.4289-4297.2005; Jamieson BD, 2006, VACCINE, V24, P3426, DOI 10.1016/j.vaccine.2006.02.023; Jones N, 2003, J IMMUNOL METHODS, V274, P139, DOI 10.1016/S0022-1759(02)00510-0; Kaul R, 2001, J CLIN INVEST, V107, P1303, DOI 10.1172/JCI12433; Kozlowski PA, 2000, J ACQ IMMUN DEF SYND, V24, P297; Lehner T, 2003, VACCINE, V21, pS68, DOI 10.1016/S0264-410X(03)00204-4; Lin SW, 2007, VACCINE, V25, P2187, DOI 10.1016/j.vaccine.2006.11.044; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; Pal R, 2006, J VIROL, V80, P3732, DOI 10.1128/JVI.80.8.3732-3742.2006; Papagno L, 2011, AIDS, V25, P27, DOI 10.1097/QAD.0b013e328340fe55; Perreau M, 2011, J VIROL, V85, P9854, DOI 10.1128/JVI.00788-11; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Russell ND, 2007, JAIDS-J ACQ IMM DEF, V44, P203, DOI 10.1097/01.qai.0000248356.48501.ff; Shacklett Barbara L, 2010, Curr Infect Dis Rep, V12, P19, DOI 10.1007/s11908-009-0072-9; Shacklett BL, 2003, J IMMUNOL METHODS, V279, P17, DOI 10.1016/S0022-1759(03)00255-2; Tartaglia J, 1998, AIDS RES HUM RETROV, V14, pS291; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Yang OO, 1997, J VIROL, V71, P3120, DOI 10.1128/JVI.71.4.3120-3128.1997	29	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88621	10.1371/journal.pone.0088621	http://dx.doi.org/10.1371/journal.pone.0088621			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558403	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700049
J	Yurube, T; Sumi, M; Nishida, K; Miyamoto, H; Kohyama, K; Matsubara, T; Miura, Y; Hirata, H; Sugiyama, D; Doita, M				Yurube, Takashi; Sumi, Masatoshi; Nishida, Kotaro; Miyamoto, Hiroshi; Kohyama, Kozo; Matsubara, Tsukasa; Miura, Yasushi; Hirata, Hiroaki; Sugiyama, Daisuke; Doita, Minoru			Accelerated Development of Cervical Spine Instabilities in Rheumatoid Arthritis: A Prospective Minimum 5-Year Cohort Study	PLOS ONE			English	Article							ATLANTO-AXIAL SUBLUXATION; RADIOLOGICAL CHANGES; FOLLOW-UP; VERTICAL TRANSLOCATION; NATURAL-HISTORY; LESIONS; PROGRESSION; RECOMMENDATIONS; DISLOCATION; PREDICTORS	Objective: To clarify the incidence and predictive risk factors of cervical spine instabilities which may induce compression myelopathy in patients with rheumatoid arthritis (RA). Methods: Three types of cervical spine instability were radiographically categorized into "moderate" and "severe" based on atlantoaxial subluxation (AAS: atlantodental interval >3 mm versus >= 10 mm), vertical subluxation (VS: Ranawat value < 13 mm versus <= 10 mm), and subaxial subluxation (SAS: irreducible translation >= 2 mm versus >= 4 mm or at multiple). 228 "definite" or "classical" RA patients (140 without instability and 88 with "moderate" instability) were prospectively followed for >5 years. The endpoint incidence of "severe" instabilities and predictors for "severe" instability were determined. Results: Patients with baseline "moderate" instability, including all sub-groups (AAS(+) [VS- SAS(-)], VS+ [SAS(-) AAS(-)], and SAS(+) [AAS(-) VS-]), developed "severe" instabilities more frequently (33.3% with AAS(+), 75.0% with VS+, and 42.9% with SAS(+)) than those initially without instability (12.9%; p<0.003, p<0.003, and p = 0.061, respectively). The incidence of cervical canal stenosis and/or basilar invagination was also higher in patients with initial instability (17.5% with AAS(+), 37.5% with VS+, and 14.3% with SAS(+)) than in those without instability (7.1%; p = 0.028, p<0.003, and p = 0.427, respectively). Multivariable logistic regression analysis identified corticosteroid administration, Steinbrocker stage III or IV at baseline, mutilating changes at baseline, and the development of mutilans during the follow-up period correlated with the progression to "severe" instability (p<0.05). Conclusions: This prospective cohort study demonstrates accelerated development of cervical spine involvement in RA patients with pre-existing instability-especially VS. Advanced peripheral erosiveness and concomitant corticosteroid treatment are indicators for poor prognosis of the cervical spine in RA.	[Yurube, Takashi; Nishida, Kotaro; Miura, Yasushi; Hirata, Hiroaki] Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, Kobe, Hyogo 657, Japan; [Sumi, Masatoshi] Kobe Rosai Hosp, Dept Orthopaed Surg, Chuo Ku, Kobe, Hyogo, Japan; [Miyamoto, Hiroshi] Kobe Med Ctr, Dept Orthopaed Surg, Suma Ku, Kobe, Hyogo, Japan; [Kohyama, Kozo] Kohnan Kakogawa Hosp, Dept Orthopaed Surg, Kakogawa, Hyogo, Japan; [Matsubara, Tsukasa] Matsubara Mayflower Hosp, Dept Orthopaed Surg, Fujita, Kato, Japan; [Sugiyama, Daisuke] Kobe Univ, Grad Sch Med, Dept Evidence Based Lab Med, Chuo Ku, Kobe, Hyogo 657, Japan	Kobe University; Kobe City Medical Center General Hospital; Kobe University	Sumi, M (corresponding author), Kobe Rosai Hosp, Dept Orthopaed Surg, Chuo Ku, Kobe, Hyogo, Japan.	sumim@kobeh.rofuku.go.jp	Sugiyama, Daisuke/L-4347-2013; Sokabe, Masahiro/I-1565-2012	Sugiyama, Daisuke/0000-0002-6487-8934; 				Alamanos Y, 2005, AUTOIMMUN REV, V4, P130, DOI 10.1016/j.autrev.2004.09.002; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; BALL J, 1971, ANN RHEUM DIS, V30, P213, DOI 10.1136/ard.30.3.213; Belt EA, 1999, ANN RHEUM DIS, V58, P250, DOI 10.1136/ard.58.4.250; BODEN SD, 1993, J BONE JOINT SURG AM, V75A, P1282, DOI 10.2106/00004623-199309000-00004; Casey ATH, 1996, LANCET, V347, P1004, DOI 10.1016/S0140-6736(96)90146-4; Casey ATH, 1997, J NEUROSURG, V87, P863, DOI 10.3171/jns.1997.87.6.0863; Casey ATH, 1997, J NEUROSURG, V87, P856, DOI 10.3171/jns.1997.87.6.0856; CLARK CR, 1989, J BONE JOINT SURG AM, V71A, P381, DOI 10.2106/00004623-198971030-00012; COLLINS DN, 1991, CLIN ORTHOP RELAT R, P127; CONLON PW, 1966, ANN RHEUM DIS, V25, P120, DOI 10.1136/ard.25.2.120; Farkas B, 2010, CLIN ORTHOP RELAT R, V468, P3112, DOI 10.1007/s11999-010-1443-0; Fujiwara K, 1998, SPINE, V23, P2052, DOI 10.1097/00007632-199810010-00003; Fujiwara K, 2000, J SPINAL DISORD, V13, P519, DOI 10.1097/00002517-200012000-00010; Grauer JN, 2004, J BONE JOINT SURG AM, V86A, P1420, DOI 10.2106/00004623-200407000-00009; Grossman JM, 2010, ARTHRIT CARE RES, V62, P1515, DOI 10.1002/acr.20295; HALLA JT, 1990, ARTHRITIS RHEUM, V33, P325, DOI 10.1002/art.1780330304; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; ISDALE IC, 1971, ANN RHEUM DIS, V30, P387, DOI 10.1136/ard.30.4.387; Kaito T, 2012, SPINE, V37, P1742, DOI 10.1097/BRS.0b013e318256b584; Kataoka O, 1977, J W PACIFIC ORTHOP A, V14, P1; KAUPPI M, 1990, J RHEUMATOL, V17, P167; Laiho K, 2001, RHEUMATOL INT, V20, P225, DOI 10.1007/s002960100114; LARSEN A, 1977, ACTA RADIOL DIAGN, V18, P481, DOI 10.1177/028418517701800415; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; LOURIE H, 1961, NEW ENGL J MED, V265, P677, DOI 10.1056/NEJM196110052651405; MARTEL W, 1961, AMER J ROENTGENOL RA, V86, P223; MATHEWS JA, 1974, ANN RHEUM DIS, V33, P526, DOI 10.1136/ard.33.6.526; MATHEWS JA, 1969, ANN RHEUM DIS, V28, P260, DOI 10.1136/ard.28.3.260; MCRAE DL, 1953, AM J ROENTGENOL, V70, P23; Neva MH, 2003, ARTHRITIS RHEUM-US, V48, P1808, DOI 10.1002/art.11086; Neva MH, 2000, J RHEUMATOL, V27, P90; Olsen MA, 2008, J BONE JOINT SURG AM, V90A, P62, DOI 10.2106/JBJS.F.01515; Paimela L, 1997, J RHEUMATOL, V24, P1280; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; PELLICCI PM, 1981, J BONE JOINT SURG AM, V63, P342, DOI 10.2106/00004623-198163030-00003; RANA NA, 1989, SPINE, V14, P1054, DOI 10.1097/00007632-198910000-00005; RANAWAT CS, 1979, J BONE JOINT SURG AM, V61, P1003, DOI 10.2106/00004623-197961070-00006; RASKER JJ, 1978, ANN RHEUM DIS, V37, P529, DOI 10.1136/ard.37.6.529; REDLUNDJOHNELL I, 1984, ACTA RADIOL DIAGN, V25, P23, DOI 10.1177/028418518402500105; ROPES M W, 1958, Bull Rheum Dis, V9, P175; RUDGE SR, 1981, RHEUMATOL REHABIL, V20, P102, DOI 10.1093/rheumatology/20.2.102; Seki E, 2009, CLIN RHEUMATOL, V28, P453, DOI 10.1007/s10067-008-1076-9; SHARP J, 1961, ANN RHEUM DIS, V20, P47, DOI 10.1136/ard.20.1.47; SMITH PH, 1972, ANN RHEUM DIS, V31, P431, DOI 10.1136/ard.31.6.431; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; STEINBROCKER O, 1949, JAMA-J AM MED ASSOC, V140, P659, DOI 10.1001/jama.1949.02900430001001; WEISSMAN BNW, 1982, RADIOLOGY, V144, P745, DOI 10.1148/radiology.144.4.7111719; WINFIELD J, 1981, ANN RHEUM DIS, V40, P109, DOI 10.1136/ard.40.2.109; WINFIELD J, 1983, ANN RHEUM DIS, V42, P613, DOI 10.1136/ard.42.6.613; YONEZAWA T, 1995, SPINE, V20, P208, DOI 10.1097/00007632-199501150-00015; Yurube T, 2012, SPINE, V37, P2136, DOI 10.1097/BRS.0b013e31826def1c; Yurube T, 2011, SPINE, V36, P647, DOI 10.1097/BRS.0b013e3181da21c5	53	17	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88970	10.1371/journal.pone.0088970	http://dx.doi.org/10.1371/journal.pone.0088970			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558457	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700103
J	He, YDD; Karbowski, CM; Werner, J; Everds, N; Di Palma, C; Chen, Y; Higgins-Garn, M; Tran, S; Afshari, CA; Hamadeh, HK				He, Yudong D.; Karbowski, Christine M.; Werner, Jon; Everds, Nancy; Di Palma, Chris; Chen, Yuan; Higgins-Garn, Marnie; Tran, Sandra; Afshari, Cynthia A.; Hamadeh, Hisham K.			Common Handling Procedures Conducted in Preclinical Safety Studies Result in Minimal Hepatic Gene Expression Changes in Sprague-Dawley Rats	PLOS ONE			English	Article							CHRONIC STRESS; ANTIBODY-RESPONSE; IMMUNE-RESPONSE; VACCINATION; ACTIVATION; SIZE	Gene expression profiling is a tool to gain mechanistic understanding of adverse effects in response to compound exposure. However, little is known about how the common handling procedures of experimental animals during a preclinical study alter baseline gene expression. We report gene expression changes in the livers of female Sprague-Dawley rats following common handling procedures. Baseline gene expression changes identified in this study provide insight on how these changes may affect interpretation of gene expression profiles following compound exposure. Rats were divided into three groups. One group was not subjected to handling procedures and served as controls for both handled groups. Animals in the other two groups were weighed, subjected to restraint in Broome restrainers, and administered water via oral gavage daily for 1 or 4 days with tail vein blood collections at 1, 2, 4, and 8 hours postdose on days 1 and 4. Significantly altered genes were identified in livers of animals following 1 or 4 days of handling when compared to the unhandled animals. Gene changes in animals handled for 4 days were similar to those handled for 1 day, suggesting a lack of habituation. The altered genes were primarily immune function related genes. These findings, along with a correlating increase in corticosterone levels suggest that common handling procedures may cause a minor immune system perturbance.	[He, Yudong D.; Everds, Nancy; Di Palma, Chris] Amgen Inc, Comparat Biol & Safety Sci, Seattle, WA USA; [Karbowski, Christine M.; Werner, Jon; Chen, Yuan; Higgins-Garn, Marnie; Tran, Sandra; Afshari, Cynthia A.; Hamadeh, Hisham K.] Amgen Inc, Comparat Biol & Safety Sci, Thousand Oaks, CA 91320 USA	Amgen; Amgen	Hamadeh, HK (corresponding author), Amgen Inc, Comparat Biol & Safety Sci, Thousand Oaks, CA 91320 USA.	hhamadeh@amgen.com						Afshari CA, 2011, TOXICOL SCI, V120, pS225, DOI 10.1093/toxsci/kfq373; Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; Burns VE, 2003, VACCINE, V21, P2523, DOI 10.1016/S0264-410X(03)00041-0; Burns VE, 2002, PSYCHOSOM MED, V64, P963, DOI 10.1097/01.PSY.0000038936.67401.28; Burns VE, 2008, PSYCHOSOM MED, V70, P387, DOI 10.1097/PSY.0b013e31816ded22; Dhabhar FS, 2009, NEUROIMMUNOMODULAT, V16, P300, DOI 10.1159/000216188; Dhabhar FS, 2000, ANN NY ACAD SCI, V917, P876, DOI 10.1111/j.1749-6632.2000.tb05454.x; Dragos Dorin, 2010, J Med Life, V3, P10; Fielden MR, 2005, AM J PHARMACOGENOMIC, V5, P161, DOI 10.2165/00129785-200505030-00003; Fleshner M, 2001, J IMMUNOL, V166, P3813, DOI 10.4049/jimmunol.166.6.3813; Fleshner M, 1998, AM J PHYSIOL-REG I, V275, pR870, DOI 10.1152/ajpregu.1998.275.3.R870; Freudenberg JM, 2011, BIOINFORMATICS, V27, P70, DOI 10.1093/bioinformatics/btq593; Glaser R, 2000, PSYCHOSOM MED, V62, P804, DOI 10.1097/00006842-200011000-00010; Gouin JP, 2008, NEUROIMMUNOMODULAT, V15, P251, DOI 10.1159/000156468; IoLAR, 1996, GUIDE CARE USE LAB A; Mongan MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015595; Pressman SD, 2005, HEALTH PSYCHOL, V24, P297, DOI 10.1037/0278-6133.24.3.297; Sharp J, 2003, CONTEMP TOP LAB ANIM, V42, P8; Sharp JL, 2002, CONTEMP TOP LAB ANIM, V41, P8; Silberman DM, 2003, J NEUROIMMUNOL, V144, P53, DOI 10.1016/j.jneuroim.2003.08.031; Singh SS, 2006, CURR DRUG METAB, V7, P165, DOI 10.2174/138920006775541552; Tournier JN, 2001, IMMUNOLOGY, V102, P87, DOI 10.1046/j.1365-2567.2001.01152.x; VANDERLINDEN PWG, 1990, LANCET, V336, P904, DOI 10.1016/0140-6736(90)92272-J	23	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88750	10.1371/journal.pone.0088750	http://dx.doi.org/10.1371/journal.pone.0088750			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551150	Green Submitted, Green Published, gold			2022-12-27	WOS:000331271500063
J	Krushelnycky, PD				Krushelnycky, Paul D.			Evaluating the Interacting Influences of Pollination, Seed Predation, Invasive Species and Isolation on Reproductive Success in a Threatened Alpine Plant	PLOS ONE			English	Article							HABITAT FRAGMENTATION; ARGENTINE ANT; FLORAL VISITORS; FRASERA-SPECIOSA; POPULATION-SIZE; PATCH SIZE; HONEY-BEES; DENSITY; PATTERNS; VISITATION	Reproduction in rare plants may be influenced and limited by a complex combination of factors. External threats such as invasive species and landscape characteristics such as isolation may impinge on both pollination and seed predation dynamics, which in turn can strongly affect reproduction. I assessed how patterns in floral visitation, seed predation, invasive ant presence, and plant isolation influenced one another and ultimately affected viable seed production in Haleakala silverswords (Argyroxiphium sandwicense subsp. macrocephalum) of Hawai'i. Floral visitation was dominated by endemic Hylaeus bees, and patterns of visitation were influenced by floral display size and number of plants clustered together, but not by floral herbivory or nearest flowering neighbor distance. There was also some indication that Argentine ant presence impacted floral visitation, but contradictory evidence and limitations of the study design make this result uncertain. Degree of seed predation was associated only with plant isolation, with the two main herbivores partitioning resources such that one preferentially attacked isolated plants while the other attacked clumped plants; total seed predation was greater in more isolated plants. Net viable seed production was highly variable among individuals (0-55% seed set), and was affected mainly by nearest neighbor distance, apparently owing to low cross-pollination among plants separated by even short distances (> 10-20 m). This isolation effect dominated net seed set, with no apparent influence from floral visitation rates, percent seed predation, or invasive ant presence. The measured steep decline in seed set with isolation distance may not be typical of the entire silversword range, and may indicate that pollinators in addition to Hylaeus bees could be important for greater gene flow. Management aimed at maintaining or maximizing silversword reproduction should focus on the spatial context of field populations and outplanting efforts, as well as on conserving the widest possible range of pollinator taxa.	Univ Hawaii Manoa, Dept Plant & Environm Protect Sci, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Krushelnycky, PD (corresponding author), Univ Hawaii Manoa, Dept Plant & Environm Protect Sci, Honolulu, HI 96822 USA.	pauldk@hawaii.edu			U.S. Geological Survey; National Park Service through University of Hawai'i	U.S. Geological Survey(United States Geological Survey); National Park Service through University of Hawai'i	Funding came from the U.S. Geological Survey through the Park Oriented Biological Support program, and from the National Park Service through a cooperative agreement with the University of Hawai'i, administered by the Hawai'i Pacific Islands Cooperative Ecosystems Studies Unit and the College of Tropical Agriculture and Human Resources of the University of Hawai'i. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Abe T, 2008, BIODIVERS CONSERV, V17, P1465, DOI 10.1007/s10531-008-9355-y; Abe T, 2011, BIOL INVASIONS, V13, P957, DOI 10.1007/s10530-010-9882-9; Agren J, 1996, ECOLOGY, V77, P1779, DOI 10.2307/2265783; Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; AIZEN MA, 1994, ECOL APPL, V4, P378, DOI 10.2307/1941941; AIZEN MA, 1994, ECOLOGY, V75, P330, DOI 10.2307/1939538; BEATTIE AJ, 1973, ECOLOGY, V54, P81, DOI 10.2307/1934376; Blancafort X, 2005, ACTA OECOL, V28, P49, DOI 10.1016/j.actao.2005.02.004; Bleil R, 2011, PAC SCI, V65, P291, DOI 10.2984/65.3.291; Burgman MA, 2007, BIOL CONSERV, V134, P73, DOI 10.1016/j.biocon.2006.08.005; CAPPUCCINO N, 1992, ECOL ENTOMOL, V17, P109, DOI 10.1111/j.1365-2311.1992.tb01166.x; Caraballo-Ortiz MA, 2011, J TROP ECOL, V27, P521, DOI 10.1017/S0266467411000289; CARR GD, 1986, EVOLUTION, V40, P430, DOI 10.1111/j.1558-5646.1986.tb00485.x; COLE FR, 1992, ECOLOGY, V73, P1313, DOI 10.2307/1940678; COURTNEY SP, 1982, ECOL ENTOMOL, V7, P131, DOI 10.1111/j.1365-2311.1982.tb00651.x; Daly HV, 2003, INSECTS HAWAII, V17; Degener O, 1930, FERNS FLOWERING PLAN; Dukas R, 2005, ECOLOGY, V86, P1401, DOI 10.1890/04-1663; Elzinga JA, 2005, OECOLOGIA, V144, P416, DOI 10.1007/s00442-005-0096-2; FEINSINGER P, 1991, ECOLOGY, V72, P1953, DOI 10.2307/1941550; Fenner M, 2002, OECOLOGIA, V130, P72, DOI 10.1007/s004420100773; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Fishbein M, 1996, ECOLOGY, V77, P1061, DOI 10.2307/2265576; Forsyth SA, 2003, OECOLOGIA, V136, P551, DOI 10.1007/s00442-003-1295-3; Forsyth SA, 2002, THESIS U ARIZONA TUS; Ghazoul J, 1998, J ECOL, V86, P462, DOI 10.1046/j.1365-2745.1998.00270.x; Ghazoul J, 2005, BIOL REV, V80, P413, DOI 10.1017/S1464793105006731; Gonzalez-Varo JP, 2009, BIOL CONSERV, V142, P1058, DOI 10.1016/j.biocon.2009.01.017; Groom MJ, 1998, AM NAT, V151, P487, DOI 10.1086/286135; Hartley S, 2010, ECOGRAPHY, V33, P83, DOI 10.1111/j.1600-0587.2009.06037.x; HERRERA CM, 1987, OIKOS, V50, P79, DOI 10.2307/3565403; Hopper D. R, 2002, THESIS U HAWAII MANO; INOUYE DW, 1979, ECOLOGY, V60, P1, DOI 10.2307/1936460; Ivey CT, 2003, AM J BOT, V90, P214, DOI 10.3732/ajb.90.2.214; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; JENNERSTEN O, 1988, CONSERV BIOL, V2, P359, DOI 10.1111/j.1523-1739.1988.tb00200.x; Johnson SD, 2000, TRENDS ECOL EVOL, V15, P140, DOI 10.1016/S0169-5347(99)01811-X; Kearns C. A., 1993, TECHNIQUES POLLINATI; Kelly D, 2002, ANNU REV ECOL SYST, V33, P427, DOI 10.1146/annurev.ecolsys.33.020602.095433; Knight TM, 2005, NATURE, V437, P880, DOI 10.1038/nature03962; KOBAYASHI H, 1974, P HAWAII ENTOMOL SOC, V21, P397; Kobayashi S, 1965, RES POPUL ECOL, V7, P109; Koch JB, 2013, PAC SCI, V67, P253, DOI 10.2984/67.2.8; KRUESS A, 1994, SCIENCE, V264, P1581, DOI 10.1126/science.264.5165.1581; Krushelnycky PD, 2008, ECOL APPL, V18, P1547, DOI 10.1890/07-1293.1; Krushelnycky PD, 2013, GLOBAL CHANGE BIOL, V19, P911, DOI 10.1111/gcb.12111; Krushelnycky PD, 2010, BIODIVERS CONSERV, V19, P1971, DOI 10.1007/s10531-010-9819-8; Krushelnycky PD, 2005, DIVERS DISTRIB, V11, P319, DOI 10.1111/j.1366-9516.2005.00151.x; KUNIN WE, 1992, OECOLOGIA, V91, P129, DOI 10.1007/BF00317251; Kunin WE, 1999, OIKOS, V84, P515, DOI 10.2307/3546430; Lach L, 2008, ECOL ENTOMOL, V33, P155, DOI 10.1111/j.1365-2311.2007.00969.x; LINDSEY AH, 1984, AM J BOT, V71, P375, DOI 10.2307/2443496; Loope LL, 1986, CNPRSU58 U HAW; LOOPE LL, 1994, TROPICAL ALPINE ENV, P337; Magnacca KN, 2007, PAC SCI, V61, P173, DOI 10.2984/1534-6188(2007)61[173:CSOTEB]2.0.CO;2; Ollerton J, 1996, J ECOL, V84, P767, DOI 10.2307/2261338; PLATT WJ, 1974, OECOLOGIA, V17, P55, DOI 10.1007/BF00345095; Powell EA, 1992, THESIS U HAWAII MANO; Rhainds M, 2003, ECOL ENTOMOL, V28, P348, DOI 10.1046/j.1365-2311.2003.00508.x; RODRIGUEZROBLES JA, 1992, AM J BOT, V79, P1009, DOI 10.2307/2444910; Sahli HF, 2007, AM J BOT, V94, P203, DOI 10.3732/ajb.94.2.203; Sahli HF, 2006, OECOLOGIA, V148, P365, DOI 10.1007/s00442-006-0396-1; Sakai AK, 2002, SYST BIOL, V51, P276, DOI 10.1080/10635150252899770; SCHEMSKE DW, 1984, SCIENCE, V225, P519, DOI 10.1126/science.225.4661.519; Selling OH, 1946, STUDIES HAWAIIAN POL; SIH A, 1987, ECOLOGY, V68, P1679, DOI 10.2307/1939860; SILANDER JA, 1978, BIOTROPICA, V10, P292, DOI 10.2307/2387681; Steffan-Dewenter I, 1999, OECOLOGIA, V121, P432, DOI 10.1007/s004420050949; SUGDEN EA, 1986, AM J BOT, V73, P919, DOI 10.2307/2444305; Swezey OH, 1928, P HAWAIIAN ENTOMOL S, V7, P183; Swezey OH, 1954, BP BISHOP MUSEUM SPE, V44; TAYLOR OR, 1985, ECOLOGY, V66, P521, DOI 10.2307/1940400; US Fish & Wildlife Service, 1997, REC PLAN MAUI PLANT; Valido A, 2002, ACTA OECOL, V23, P413, DOI 10.1016/S1146-609X(02)01167-0; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; Wagenius S, 2006, ECOLOGY, V87, P931, DOI 10.1890/0012-9658(2006)87[931:SDORFI]2.0.CO;2; Wagner WL, 1999, MANUAL FLOWERING PLA, V1; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Wilson EE, 2010, ECOLOGY, V91, P3294, DOI 10.1890/09-1187.1; Wilson EE, 2010, MOL ECOL, V19, P4823, DOI 10.1111/j.1365-294X.2010.04849.x; WILSON P, 1991, ECOLOGY, V72, P1503, DOI 10.2307/1941124	82	17	17	0	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88948	10.1371/journal.pone.0088948	http://dx.doi.org/10.1371/journal.pone.0088948			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551195	Green Published, gold, Green Submitted			2022-12-27	WOS:000331271500084
J	Oberst, S; Evans, TA; Lai, JCS				Oberst, Sebastian; Evans, Theodore A.; Lai, Joseph C. S.			Novel Method for Pairing Wood Samples in Choice Tests	PLOS ONE			English	Article							SUBTERRANEAN TERMITES ISOPTERA; COPTOTERMES-FORMOSANUS SHIRAKI; RHINOTERMITIDAE; PREFERENCE; RESISTANCE; TOXICITY	Choice tests are a standard method to determine preferences in bio-assays, e. g. for food types and food additives such as bait attractants and toxicants. Choice between food additives can be determined only when the food substrate is sufficiently homogeneous. This is difficult to achieve for wood eating organisms as wood is a highly variable biological material, even within a tree species due to the age of the tree (e.g. sapwood vs. heartwood), and components therein (sugar, starch, cellulose and lignin). The current practice to minimise variation is to use wood from the same tree, yet the variation can still be large and the quantity of wood from one tree may be insufficient. We used wood samples of identical volume from multiple sources, measured three physical properties (dry weight, moisture absorption and reflected light intensity), then ranked and clustered the samples using fuzzy c-means clustering. A reverse analysis of the clustered samples found a high correlation between their physical properties and their source of origin. This suggested approach allows a quantifiable, consistent, repeatable, simple and quick method to maximize control over similarity of wood used in choice tests.	[Oberst, Sebastian; Lai, Joseph C. S.] Univ New S Wales, Sch Engn & Informat Technol, Acoust & Vibrat Unit, Canberra, ACT, Australia; [Evans, Theodore A.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	University of New South Wales Sydney; National University of Singapore	Oberst, S (corresponding author), Univ New S Wales, Sch Engn & Informat Technol, Acoust & Vibrat Unit, Canberra, ACT, Australia.	s.oberst@adfa.edu.au	Oberst, Sebastian/AAQ-2854-2020; Evans, Theodore A/A-6020-2008	Oberst, Sebastian/0000-0002-1388-2749; Evans, Theodore A/0000-0002-0558-3036; Lai, Joseph/0000-0002-8946-9993	Australian Research Council's Discovery Projects [DP110102564]	Australian Research Council's Discovery Projects(Australian Research Council)	This research was supported under Australian Research Council's Discovery Projects funding scheme (project number DP110102564). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; Bluthgen N, 2004, ECOLOGY, V85, P1479, DOI 10.1890/03-0430; Bowyer J. L, 2007, FOREST PRODUCTS WOOD; Bucur V., 2006, ACOUSTICS WOOD, V2nd ed., P403; CARTWRIGHT K. St. G., 1941, FORESTRY, V15, P65, DOI 10.1093/forestry/15.1.65; Chen J, 1996, J CHEM ECOL, V22, P2359, DOI 10.1007/BF02029552; DELAPLANE KS, 1989, J ECON ENTOMOL, V82, P95, DOI 10.1093/jee/82.1.95; DELAPLANE KS, 1989, J ECON ENTOMOL, V82, P1363, DOI 10.1093/jee/82.5.1363; Evans TA, 2005, P NATL ACAD SCI USA, V102, P3732, DOI 10.1073/pnas.0408649102; Evans TA, 2009, P ROY SOC B-BIOL SCI, V276, P4035, DOI 10.1098/rspb.2009.1147; FARRAR RR, 1994, J ECON ENTOMOL, V87, P44, DOI 10.1093/jee/87.1.44; Gautam BK, 2011, ENVIRON ENTOMOL, V40, P1232, DOI 10.1603/EN11062; Gominho J, 2001, IND CROP PROD, V13, P1, DOI 10.1016/S0926-6690(00)00044-3; Gore JC, 2004, J MED ENTOMOL, V41, P953, DOI 10.1603/0022-2585-41.5.953; Ilic J, 1990, HARDWOOD IDENTIFICAT; Inta R, 2007, J R SOC INTERFACE, V4, P735, DOI 10.1098/rsif.2007.0223; Kay S., 2012, INTUITIVE PROBABILIT, V4th; Kenney J.F., 1962, MATH STAT, V3rd ed., P101; LENZ M, 1985, B ENTOMOL RES, V75, P13, DOI 10.1017/S0007485300014139; Lenz Michael, 1994, P159; Lukmandaru G, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2008047; PAL NR, 1995, IEEE T FUZZY SYST, V3, P370, DOI 10.1109/91.413225; Peters BC, 1997, MATER ORGANISMEN, V31, P293; RUDMAN P, 1967, HOLZFORSCHUNG, V21, P21, DOI 10.1515/hfsg.1967.21.1.21; Rudman P, 1963, HOLZFORSCHUNG, V17, P2125; Rust MK, 2004, J ECON ENTOMOL, V97, P1017, DOI 10.1603/0022-0493(2004)097[1017:DTAACF]2.0.CO;2; Sornnuwat Yupaporn, 1995, Wood Research, V82, P8; STRONG CA, 1993, J ECON ENTOMOL, V86, P1458, DOI 10.1093/jee/86.5.1458; Taylor G, 2002, ANN BOT-LONDON, V90, P681, DOI 10.1093/aob/mcf255; WALLER DA, 1987, B ENTOMOL RES, V77, P417, DOI 10.1017/S0007485300011883; Zobel B.J., 1989, WOOD VARIATION ITS C	31	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88835	10.1371/journal.pone.0088835	http://dx.doi.org/10.1371/journal.pone.0088835			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551173	Green Published, gold, Green Submitted			2022-12-27	WOS:000331271500073
J	Saeki, T; Hosokawa, M; Lim, T; Harada, M; Matsunaga, T; Tanaka, T				Saeki, Tatsuya; Hosokawa, Masahito; Lim, Tae-kyu; Harada, Manabu; Matsunaga, Tadashi; Tanaka, Tsuyoshi			Digital Cell Counting Device Integrated with a Single-Cell Array	PLOS ONE			English	Article							MICROCAVITY ARRAY; CHIP; SENSOR	In this paper, we present a novel cell counting method accomplished using a single-cell array fabricated on an image sensor, complementary metal oxide semiconductor sensor. The single-cell array was constructed using a microcavity array, which can trap up to 7,500 single cells on microcavities periodically arranged on a plane metallic substrate via the application of a negative pressure. The proposed method for cell counting is based on shadow imaging, which uses a light diffraction pattern generated by the microcavity array and trapped cells. Under illumination, the cell-occupied microcavities are visualized as shadow patterns in an image recorded by the complementary metal oxide semiconductor sensor due to light attenuation. The cell count is determined by enumerating the uniform shadow patterns created from one-on-one relationships with single cells trapped on the microcavities in digital format. In the experiment, all cell counting processes including entrapment of non-labeled HeLa cells from suspensions on the array and image acquisition of a wide-field-of-view of 30 mm(2) in 1/60 seconds were implemented in a single integrated device. As a result, the results from the digital cell counting had a linear relationship with those obtained from microscopic observation (r(2) = 0.99). This platform could be used at extremely low cell concentrations, i. e., 25-15,000 cells/mL. Our proposed system provides a simple and rapid miniaturized cell counting device for routine laboratory use.	[Saeki, Tatsuya; Hosokawa, Masahito; Matsunaga, Tadashi; Tanaka, Tsuyoshi] Tokyo Univ Agr & Technol, Inst Engn, Div Biotechnol & Life Sci, Tokyo, Japan; [Lim, Tae-kyu; Harada, Manabu] Malcom Co Ltd, Tokyo, Japan	Tokyo University of Agriculture & Technology	Tanaka, T (corresponding author), Tokyo Univ Agr & Technol, Inst Engn, Div Biotechnol & Life Sci, Tokyo, Japan.	tsuyo@cc.tuat.ac.jp	Tanaka, Tsuyoshi/B-9949-2013; Matsunaga, Tadashi/A-6293-2015	Tanaka, Tsuyoshi/0000-0003-2601-2256; Matsunaga, Tadashi/0000-0002-6216-3687; Hosokawa, Masahito/0000-0002-7070-4690	The New Energy and Industrial Technology Development Organization [P03040]; Japan Society for the Promotion of Science [12J03043]; Grants-in-Aid for Scientific Research [23360363] Funding Source: KAKEN	The New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded in part by a support program for technology development based on academic findings from The New Energy and Industrial Technology Development Organization (P03040). TS is supported in part by the Japan Society for the Promotion of Science (12J03043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkes CA, 2012, J MICROBIOL METH, V91, P468, DOI 10.1016/j.mimet.2012.09.008; D'Anto V, 2012, OPEN DENT J, V6, P177, DOI 10.2174/1874210601206010177; Hosokawa M, 2013, BIOSENS BIOELECTRON, V40, P110, DOI 10.1016/j.bios.2012.06.043; Hosokawa M, 2012, BIOTECHNOL BIOENG, V109, P2017, DOI 10.1002/bit.24471; Hosokawa M, 2010, ANAL CHEM, V82, P6629, DOI 10.1021/ac101222x; Hosokawa M, 2009, ANAL CHEM, V81, P5308, DOI 10.1021/ac900535h; Hosseini Y, 2010, SENSOR ACTUAT A-PHYS, V157, P1, DOI 10.1016/j.sna.2009.10.018; Huang LC, 2010, BIOLOGICALS, V38, P393, DOI 10.1016/j.biologicals.2010.01.009; Kang-Ho L, 2012, SOL STAT CIRC C ISSC, p[19, 304]; Kim SB, 2011, LAB CHIP, V11, P1801, DOI [10.1039/c1lc20098d, 10.1039/c11c20098d]; Lindstrom S, 2010, LAB CHIP, V10, P3363, DOI [10.1039/c0lc00150c, 10.1039/c01c00150c]; Matsunaga T, 2008, ANAL CHEM, V80, P5139, DOI 10.1021/ac800352j; Moon S, 2009, BIOSENS BIOELECTRON, V24, P3208, DOI 10.1016/j.bios.2009.03.037; Peng L, 2007, INT J LAB HEMATOL, V29, P361, DOI 10.1111/j.1751-553X.2007.00868.x; Seo S, 2010, ANAL CHEM, V82, P4621, DOI 10.1021/ac1007915; Seo S, 2009, LAB CHIP, V9, P777, DOI 10.1039/b813943a; Su TW, 2010, ANAL CHEM, V82, P8307, DOI 10.1021/ac101845q; Su TW, 2009, BIOTECHNOL BIOENG, V102, P856, DOI 10.1002/bit.22116; Tanaka T, 2010, LAB CHIP, V10, P3348, DOI [10.1039/c0lc00039f, 10.1039/c01c00039f]; Tanaka T, 2010, BIOSENS BIOELECTRON, V26, P1460, DOI 10.1016/j.bios.2010.07.081; Wu YF, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3462327; Zhao YX, 2009, ANAL CHEM, V81, P1285, DOI 10.1021/ac802250d	22	15	17	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89011	10.1371/journal.pone.0089011	http://dx.doi.org/10.1371/journal.pone.0089011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551208	Green Published, Green Submitted, gold			2022-12-27	WOS:000331266000089
J	Vetrovsky, T; Steffen, KT; Baldrian, P				Vetrovsky, Tomas; Steffen, Kari Timo; Baldrian, Petr			Potential of Cometabolic Transformation of Polysaccharides and Lignin in Lignocellulose by Soil Actinobacteria	PLOS ONE			English	Article							BETA-GLUCOSIDASE; CELLULOSE UTILIZATION; C-14-LABELED LIGNIN; SELECTIVE ISOLATION; GLYCOSYL HYDROLASE; GINSENOSIDE RB1; STREPTOMYCES SP; LEAF-LITTER; PURIFICATION; DEGRADATION	While it is known that several Actinobacteria produce enzymes that decompose polysaccharides or phenolic compounds in dead plant biomass, the occurrence of these traits in the environment remains largely unclear. The aim of this work was to screen isolated actinobacterial strains to explore their ability to produce extracellular enzymes that participate in the degradation of polysaccharides and their ability to cometabolically transform phenolic compounds of various complexities. Actinobacterial strains were isolated from meadow and forest soils and screened for their ability to grow on lignocellulose. The potential to transform C-14-labelled phenolic substrates (dehydrogenation polymer (DHP), lignin and catechol) and to produce a range of extracellular, hydrolytic enzymes was investigated in three strains of Streptomyces spp. that possessed high lignocellulose degrading activity. Isolated strains showed high variation in their ability to produce cellulose- and hemicellulose-degrading enzymes and were able to mineralise up to 1.1% and to solubilise up to 4% of poplar lignin and to mineralise up to 11.4% and to solubilise up to 64% of catechol, while only minimal mineralisation of DHP was observed. The results confirm the potential importance of Actinobacteria in lignocellulose degradation, although it is likely that the decomposition of biopolymers is limited to strains that represent only a minor portion of the entire community, while the range of simple, carbon-containing compounds that serve as sources for actinobacterial growth is relatively wide.	[Vetrovsky, Tomas; Baldrian, Petr] Inst Microbiol ASCR, Vvi, Lab Environm Microbiol, Prague, Czech Republic; [Steffen, Kari Timo] Univ Helsinki, Dept Appl Chem & Microbiol, Helsinki, Finland	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of Helsinki	Baldrian, P (corresponding author), Inst Microbiol ASCR, Vvi, Lab Environm Microbiol, Prague, Czech Republic.	baldrian@biomed.cas.cz	Baldrian, Petr/A-9170-2009; Steffen, Kari T./A-5353-2008; Vetrovsky, Tomas/R-5817-2017	Baldrian, Petr/0000-0002-8983-2721; 	Academy of Sciences of the Czech Republic [IAA603020901]; Institute of Microbiology of the ASCR, v.v.i. [RVO61388971]	Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Institute of Microbiology of the ASCR, v.v.i.(Czech Academy of Sciences)	This work was supported by the Academy of Sciences of the Czech Republic (IAA603020901) and by the research concept of the Institute of Microbiology of the ASCR, v.v.i. (RVO61388971). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An DS, 2010, APPL ENVIRON MICROB, V76, P5827, DOI 10.1128/AEM.00106-10; Anderson I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039331; Baldrian P, 2009, PLANT SOIL ENVIRON, V55, P370, DOI 10.17221/134/2009-PSE; Baldrian P, 2008, BR MYCOL SY, V28, P19; Baldrian P, 2011, SOIL BIOL, V22, P167, DOI 10.1007/978-3-642-14225-3_9; Baldrian P, 2011, PLANT SOIL, V338, P111, DOI 10.1007/s11104-010-0324-3; Berlemont R, 2013, APPL ENVIRON MICROB, V79, P1545, DOI 10.1128/AEM.03305-12; Brunow G, 1998, PHYTOCHEMISTRY, V47, P1495, DOI 10.1016/S0031-9422(98)80013-7; Caliz J, 2013, J SOIL SEDIMENT, V13, P413, DOI 10.1007/s11368-012-0609-7; CARTWRIGHT NJ, 1973, MICROBIOS, V8, P7; Chater KF, 2010, FEMS MICROBIOL REV, V34, P171, DOI 10.1111/j.1574-6976.2009.00206.x; CRAWFORD DL, 1982, ARCH MICROBIOL, V131, P140, DOI 10.1007/BF01053996; CRAWFORD DL, 1978, APPL ENVIRON MICROB, V35, P1041, DOI 10.1128/AEM.35.6.1041-1045.1978; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; Eastwood DC, 2011, SCIENCE, V333, P762, DOI 10.1126/science.1205411; El Azhari N, 2010, J HAZARD MATER, V177, P593, DOI 10.1016/j.jhazmat.2009.12.074; Enkhbaatar B, 2012, APPL ENVIRON MICROB, V78, P607, DOI 10.1128/AEM.06482-11; Fan HX, 2011, ENZYME MICROB TECH, V49, P94, DOI 10.1016/j.enzmictec.2011.03.001; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Harichova J, 2012, BIOLOGIA, V67, P1038, DOI 10.2478/s11756-012-0123-9; Hayakawa M, 1996, J APPL BACTERIOL, V80, P375, DOI 10.1111/j.1365-2672.1996.tb03232.x; HAYAKAWA M, 1987, J FERMENT BIOENG, V65, P501, DOI 10.1016/0385-6380(87)90108-7; KERR TJ, 1983, APPL ENVIRON MICROB, V46, P1201, DOI 10.1128/AEM.46.5.1201-1206.1983; KHANNA S, 1993, ENZYME MICROB TECH, V15, P990, DOI 10.1016/0141-0229(93)90177-4; Krastanov A, 2013, ENG LIFE SCI, V13, P76, DOI 10.1002/elsc.201100227; Li CJ, 2009, J MICROBIOL BIOTECHN, V19, P873, DOI 10.4014/jmb.0812.689; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Martinez AT, 2005, INT MICROBIOL, V8, P195; MCCARTHY AJ, 1987, FEMS MICROBIOL LETT, V46, P145, DOI 10.1111/j.1574-6968.1987.tb02456.x; Muhlbachova G, 2011, ECOL ENG, V37, P1064, DOI 10.1016/j.ecoleng.2010.08.004; Nakano H, 1998, J FERMENT BIOENG, V85, P162, DOI 10.1016/S0922-338X(97)86761-X; Nunoura N, 1996, BIOSCI BIOTECH BIOCH, V60, P188, DOI 10.1271/bbb.60.188; ODIER E, 1981, APPL ENVIRON MICROB, V41, P337, DOI 10.1128/AEM.41.2.337-341.1981; Oh HW, 2008, ANTON LEEUW INT J G, V93, P437, DOI 10.1007/s10482-007-9210-2; Osono T, 2005, ECOL RES, V20, P41, DOI 10.1007/s11284-004-0002-0; Pasti MB, APPL ENV MICROBIOL, V56, P2213; Petrosyan P, 2002, BIOTECHNOL LETT, V24, P1473, DOI 10.1023/A:1019879200497; Post DA, 2005, APPL MICROBIOL BIOT, V67, P91, DOI 10.1007/s00253-004-1764-6; Quan LH, 2012, J AGR FOOD CHEM, V60, P3776, DOI 10.1021/jf300186a; ROBINSON LE, 1978, FEMS MICROBIOL LETT, V4, P301; Sagova-Mareckova M, 2008, APPL ENVIRON MICROB, V74, P2902, DOI 10.1128/AEM.02161-07; She YL, 2012, ADV MATER RES-SWITZ, V365, P332, DOI 10.4028/www.scientific.net/AMR.365.332; Shi PJ, 2011, ENZYME MICROB TECH, V49, P277, DOI 10.1016/j.enzmictec.2011.06.003; Sjostrom E., 1993, WOOD CHEM, V2nd, P1, DOI [DOI 10.1016/B978-0-08-092589-9.50005-X, 10.1016/B978-0-08-092589-9.50005-X]; Snajdr J, 2011, FEMS MICROBIOL ECOL, V75, P291, DOI 10.1111/j.1574-6941.2010.00999.x; Snajdr J, 2010, SOIL BIOL BIOCHEM, V42, P1541, DOI 10.1016/j.soilbio.2010.05.023; Song JM, 2010, BIOMASS BIOENERG, V34, P1930, DOI 10.1016/j.biombioe.2010.08.010; Stursova M, 2012, FEMS MICROBIOL ECOL, V80, P735, DOI 10.1111/j.1574-6941.2012.01343.x; Sun Y, 2007, BIORESOURCE TECHNOL, V98, P2866, DOI 10.1016/j.biortech.2006.09.055; SUTHERLAND JB, 1979, CURR MICROBIOL, V2, P123, DOI 10.1007/BF02603069; TAJANA E, 1992, APPL ENVIRON MICROB, V58, P1447, DOI 10.1128/AEM.58.5.1447-1450.1992; Theuerl S, 2010, BIOL FERT SOILS, V46, P215, DOI 10.1007/s00374-010-0440-5; TROJANOWSKI J, 1977, ARCH MICROBIOL, V114, P149, DOI 10.1007/BF00410776; Tuomela M, 2002, SOIL BIOL BIOCHEM, V34, P1613, DOI 10.1016/S0038-0717(02)00145-1; Valaskova V, 2007, SOIL BIOL BIOCHEM, V39, P2651, DOI 10.1016/j.soilbio.2007.05.023; VICUNA R, 1988, ENZYME MICROB TECH, V10, P646, DOI 10.1016/0141-0229(88)90055-5; Wang GZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043480; Warren RAJ, 1996, ANNU REV MICROBIOL, V50, P183, DOI 10.1146/annurev.micro.50.1.183; Yin LJ, 2010, J AGR FOOD CHEM, V58, P9833, DOI 10.1021/jf1019104; Yoon MH, 2007, J MICROBIOL BIOTECHN, V17, P1291; Zhang F, 2012, PROCESS BIOCHEM, V47, P225, DOI 10.1016/j.procbio.2011.10.032; ZIMMERMANN W, 1990, J BIOTECHNOL, V13, P119, DOI 10.1016/0168-1656(90)90098-V	62	105	109	7	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89108	10.1371/journal.pone.0089108	http://dx.doi.org/10.1371/journal.pone.0089108			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551229	Green Published, Green Submitted, gold			2022-12-27	WOS:000331266000103
J	Pompilio, A; Ciavardelli, D; Crocetta, V; Consalvo, A; Zappacosta, R; Di Ilio, C; Di Bonaventura, G				Pompilio, Arianna; Ciavardelli, Domenico; Crocetta, Valentina; Consalvo, Ada; Zappacosta, Roberta; Di Ilio, Carmine; Di Bonaventura, Giovanni			Stenotrophomonas maltophilia Virulence and Specific Variations in Trace Elements during Acute Lung Infection: Implications in Cystic Fibrosis	PLOS ONE			English	Article							BIOFILM FORMATION; RESPIRATORY-TRACT; IRON; ZINC; HOMEOSTASIS; SUPPLEMENTATION; MAGNESIUM; SELENIUM; PROTEIN; CELL	Metal ions are necessary for the proper functioning of the immune system, and, therefore, they might have a significant influence on the interaction between bacteria and host. Ionic dyshomeostasis has been recently observed also in cystic fibrosis (CF) patients, whose respiratory tract is frequently colonized by Stenotrophomonas maltophilia. For the first time, here we used an inductively mass spectrometry method to perform a spatial and temporal analysis of the pattern of changes in a broad range of major trace elements in response to pulmonary infection by S. maltophilia. To this, DBA/2 mouse lungs were comparatively infected by a CF strain and by an environmental one. Our results showed that pulmonary ionomic profile was significantly affected during infection. Infected mice showed increased lung levels of Mg, P, S, K, Zn, Se, and Rb. To the contrary, Mn, Fe, Co, and Cu levels resulted significantly decreased. Changes of element concentrations were correlated with pulmonary bacterial load and markers of inflammation, and occurred mostly on day 3 post-exposure, when severity of infection culminated. Interestingly, CF strain - significantly more virulent than the environmental one in our murine model - provoked a more significant impact in perturbing pulmonary metal homeostasis. Particularly, exposure to CF strain exclusively increased P and K levels, while decreased Fe and Mn ones. Overall, our data clearly indicate that S. maltophilia modulates pulmonary metal balance in a concerted and virulence-dependent manner highlighting the potential role of the element dyshomeostasis during the progression of S. maltophilia infection, probably exacerbating the harmful effects of the loss of CF transmembrane conductance regulator function. Further investigations are required to understand the biological significance of these alterations and to confirm they are specifically caused by S. maltophilia.	[Pompilio, Arianna; Ciavardelli, Domenico; Crocetta, Valentina; Consalvo, Ada; Di Ilio, Carmine; Di Bonaventura, Giovanni] Univ G dAnnunzio, Ctr Excellence Aging, Clin Microbiol Unit, Chieti, Italy; [Pompilio, Arianna; Crocetta, Valentina; Zappacosta, Roberta; Di Ilio, Carmine; Di Bonaventura, Giovanni] Univ G DAnnunzio, Dept Expt & Clin Sci, Sch Med, Chieti, Italy; [Ciavardelli, Domenico] Kore Univ, Sch Engn Architecture & Motor Sci, Enna, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Universita Kore di ENNA	Di Bonaventura, G (corresponding author), Univ G dAnnunzio, Ctr Excellence Aging, Clin Microbiol Unit, Chieti, Italy.	gdibonaventura@unich.it	Pompilio, Arianna/AAL-8050-2021; Di Bonaventura, Giovanni/AAK-5850-2020	Di Bonaventura, Giovanni/0000-0001-5850-2810; CONSALVO, ADA/0000-0003-3860-9404	University of Chieti-Pescara; Fondazione per la Ricerca sulla Fibrosi Cistica - Onlus, Verona (Italy)	University of Chieti-Pescara; Fondazione per la Ricerca sulla Fibrosi Cistica - Onlus, Verona (Italy)	The present work was supported by a grant from University of Chieti-Pescara ("ex-60%"), and by a grant from Fondazione per la Ricerca sulla Fibrosi Cistica - Onlus, Verona (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulhamid I, 2008, PEDIATR PULM, V43, P281, DOI 10.1002/ppul.20771; Abrantes MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026519; Amini M, 2009, BRAZ J INFECT DIS, V13, P83, DOI 10.1590/S1413-86702009000200002; ARELLA M, 1979, CAN J MICROBIOL, V25, P321, DOI 10.1139/m79-051; Beisel WR, 2004, TB PEDIAT INFECT DIS, V1, P62; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Ciavardelli D, 2013, MOL BIOSYST, V9, P1117, DOI 10.1039/c3mb25594h; Ciavardelli D, 2012, METALLOMICS, V4, P1321, DOI 10.1039/c2mt20162c; Ciavardelli D, 2011, MOL BIOSYST, V7, P608, DOI 10.1039/c0mb00140f; Ciofu O, 2013, CURR OPIN PULM MED, V19, P251, DOI 10.1097/MCP.0b013e32835f1afc; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Culha G, 2007, BIOL TRACE ELEM RES, V118, P21, DOI 10.1007/s12011-007-0017-9; CUTHBERT AW, 1991, THORAX, V46, P124, DOI 10.1136/thx.46.2.124; Davies JC, 2007, SEMIN RESP CRIT CARE, V28, P312, DOI 10.1055/s-2007-981652; Di Bonaventura G, 2007, INT J IMMUNOPATH PH, V20, P529, DOI 10.1177/039463200702000311; Di Bonaventura G, 2007, FOLIA MICROBIOL, V52, P86, DOI 10.1007/BF02932144; Di Bonaventura G, 2004, ANTIMICROB AGENTS CH, V48, P151, DOI 10.1128/AAC.48.1.151-160.2004; Di Bonaventura G, 2010, INFECT IMMUN, V78, P2466, DOI 10.1128/IAI.01391-09; Dubin PJ, 2007, AM J PHYSIOL-LUNG C, V292, pL519, DOI 10.1152/ajplung.00312.2006; Edvinsson M, 2008, BIOMETALS, V21, P229, DOI 10.1007/s10534-007-9114-7; FELEGIE TP, 1979, ANTIMICROB AGENTS CH, V16, P833, DOI 10.1128/AAC.16.6.833; Figueiredo PMS, 2006, LETT APPL MICROBIOL, V43, P443, DOI 10.1111/j.1472-765X.2006.01965.x; Foster SL, 2001, J NUTR, V131, P1452, DOI 10.1093/jn/131.5.1452; Gode-Potratz CJ, 2010, J BACTERIOL, V192, P6025, DOI 10.1128/JB.00654-10; Goss CH, 2002, AM J RESP CRIT CARE, V166, P356, DOI 10.1164/rccm.2109078; Gray RD, 2010, CHEST, V137, P635, DOI 10.1378/chest.09-1047; Griese Matthias, 2003, J Cyst Fibros, V2, P136, DOI 10.1016/S1569-1993(03)00062-6; Gupta A, 2007, J CYST FIBROS, V6, P360, DOI 10.1016/j.jcf.2007.01.004; Ilback NG, 2004, TOXICOLOGY, V199, P241, DOI 10.1016/j.tox.2003.12.019; Jakubovics NS, 2001, MICROBIOL-SGM, V147, P1709, DOI 10.1099/00221287-147-7-1709; JOHANSEN HK, 1993, APMIS, V101, P207, DOI 10.1111/j.1699-0463.1993.tb00103.x; KARPATI F, 1994, INFECTION, V22, P258, DOI 10.1007/BF01739911; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Li MS, 2012, BRIT J PHARMACOL, V167, P1062, DOI 10.1111/j.1476-5381.2012.02041.x; Lusitani D, 2003, INFECT IMMUN, V71, P4711, DOI 10.1128/IAI.71.8.4711-4716.2003; MacGregor G, 2008, J CYST FIBROS, V7, P352, DOI 10.1016/j.jcf.2007.12.005; McKenzie RC, 1998, IMMUNOL TODAY, V19, P342, DOI 10.1016/S0167-5699(98)01294-8; MILANINO R, 1993, AGENTS ACTIONS, V39, P195, DOI 10.1007/BF01998974; MILNE DB, 1985, CLIN CHEM, V31, P65; Nielubowicz GR, 2010, INFECT IMMUN, V78, P2823, DOI 10.1128/IAI.01220-09; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Pfeiffer J, 2002, INFECT IMMUN, V70, P3930, DOI 10.1128/IAI.70.7.3930-3934.2002; Pizzichini E, 1996, AM J RESP CRIT CARE, V154, P308, DOI 10.1164/ajrccm.154.2.8756799; Pompilio A, 2008, FEMS MICROBIOL LETT, V287, P41, DOI 10.1111/j.1574-6968.2008.01292.x; Pompilio A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-159; Pompilio A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-102; Rahmanto AS, 2012, IUBMB LIFE, V64, P863, DOI 10.1002/iub.1084; Reid DW, 2002, CHEST, V121, P48, DOI 10.1378/chest.121.1.48; Rink L, 2007, TRENDS IMMUNOL, V28, P1, DOI 10.1016/j.it.2006.11.005; Rosenecker J, 2009, EUR J MED RES, V14, P304, DOI 10.1186/2047-783X-14-7-304; Samonis G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037375; Shankar AH, 1998, AM J CLIN NUTR, V68, p447S, DOI 10.1093/ajcn/68.2.447S; Stites SW, 1999, AM J RESP CRIT CARE, V160, P796, DOI 10.1164/ajrccm.160.3.9811018; Su YC, 2010, ACTA CRYSTALLOGR F, V66, P636, DOI 10.1107/S1744309110013941; Tam M, 2003, EUR J CLIN NUTR, V57, P1193, DOI 10.1038/sj.ejcn.1601689; Thurnham DI, 2005, P NUTR SOC, V64, P502, DOI 10.1079/PNS2005468; Toth L A, 2000, ILAR J, V41, P72; Wang LJ, 2009, J INNATE IMMUN, V1, P455, DOI 10.1159/000210016; Wobbrock JO, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P143, DOI 10.1145/1978942.1978963; WOLPE SD, 1989, P NATL ACAD SCI USA, V86, P612, DOI 10.1073/pnas.86.2.612; Wood LG, 2003, AM J CLIN NUTR, V77, P150, DOI 10.1093/ajcn/77.1.150; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319	62	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e88769	10.1371/journal.pone.0088769	http://dx.doi.org/10.1371/journal.pone.0088769			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586389	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200027
J	Ghassemi, R; Narayanan, S; Banwell, B; Sled, JG; Shroff, M; Arnold, DL				Ghassemi, Rezwan; Narayanan, Sridar; Banwell, Brenda; Sled, John G.; Shroff, Manohar; Arnold, Douglas L.		Canadian Pediatric Demyelinating D	Quantitative Determination of Regional Lesion Volume and Distribution in Children and Adults with Relapsing-Remitting Multiple Sclerosis	PLOS ONE			English	Article							MAGNETIC-RESONANCE; WHITE-MATTER; DIAGNOSTIC-CRITERIA; BRAIN; MRI; ONSET; REGISTRATION; DISABILITY; INSIGHTS; BURDEN	Introduction: Onset of MS occurs during childhood in about 5% of cases. It is unclear whether very young age at MS onset, when the nervous system is still myelinating, affects MS lesion accrual or regional distribution. Objective: To compare the frequency, volume and distribution of T2 and T1 lesions in children and adults with relapsing-remitting multiple sclerosis (RRMS). Methods: Lesions were segmented on T2- and T1-weighted MRI images from 29 children and 29 adults with RRMS, matched for disease duration. Results: All subjects exhibited T2-weighted brain lesions. Children had higher whole-brain T2-weighted-lesion-volume (T2LV) compared to adults (mean (SD) in cm 3 : 12.76(2.7) vs. 10.03(3.4), p<0.0013). The supratentorial-T2LV was similar in children and adults (8.45(1.7) vs. 7.94(1.7), mean (SD), p = 0.2582), but adults were more likely to have supratentorial lesions (96.5% vs. 68.9%, p<0.012). Children were more likely to have infratentorial-T2-weighted lesions (75.9% vs. 43.4%, p<0.03), specifically in the brainstem (62.1% vs. 26.7%, p<0.019) and the pons (48.3% vs. 17.24%, p<0.024), had higher infratentorial-T2-weighted-lesion counts (4.1(5.6) vs. 1.45(2.3), p<0.021), a greater infratentorial-T2LV (4.31(2.7) vs. 2.08(2.4), p<0.0013), and a greater infratentorial-T1-weighted-lesion-volume (T1LV) (3.7(2.5) vs. 1.08(1.9), p<0.0007). Whole-brain-T1LV was higher in children (9.3(2.5) vs. 6.43(2.1), p>0.001). Adult MS patients had higher supratentorial-T1LV (5.5(0.92) vs. 6.41(2.1), mean (SD), p<0.034), whereas children were more likely to have infratentorial-T1-weighted lesions (58.6% vs. 23.3%, p<0.015). Discussion: Onset of MS during childhood is associated with a higher volume of brain lesions in the first few years of disease relative to adults. Children with MS are more likely than adults to have T2 and T1 lesions in the infratentorial white matter, raising the possibility of preferential immune targeting of more mature myelin. Children with MS have a lower supratentorial T1 lesion burden, possibly reflecting more effective remyelination and repair in brain regions that are still engaged in active primary myelination.	[Ghassemi, Rezwan; Narayanan, Sridar; Arnold, Douglas L.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Banwell, Brenda; Sled, John G.; Shroff, Manohar] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Banwell, Brenda] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Arnold, DL (corresponding author), McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.	douglas.arnold@mcgill.ca	Shroff, Manohar/AAM-2418-2020; Sled, John G/D-8268-2012	Sled, John G/0000-0002-4461-283X; Arnold, Douglas/0000-0003-4266-0106	Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; Canadian Multiple Sclerosis Scientific Research Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Multiple Sclerosis Society of Canada; Canadian Multiple Sclerosis Scientific Research Foundation	This study was funded by the Canadian Institutes of Health Research, the Multiple Sclerosis Society of Canada, and the Canadian Multiple Sclerosis Scientific Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afifi AA, 2007, ANNU REV PUBL HEALTH, V28, P95, DOI 10.1146/annurev.publhealth.28.082206.094100; Banwell B, 2011, NAT REV NEUROL, V7, P109, DOI 10.1038/nrneurol.2010.198; Bar-Or A, 2008, ANN NEUROL, V63, P395, DOI 10.1002/ana.21363; Barkhof F, 2007, ARCH NEUROL-CHICAGO, V64, P1292, DOI 10.1001/archneur.64.9.1292; Callen DJA, 2009, NEUROLOGY, V72, P961, DOI 10.1212/01.wnl.0000338629.01627.54; Caramanos Z, 2012, ARCH NEUROL-CHICAGO, V69, P89, DOI 10.1001/archneurol.2011.765; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Collins DL, 1997, INT J PATTERN RECOGN, V11, P1271, DOI 10.1142/S0218001497000597; Comi G, 2001, ANN NEUROL, V49, P290, DOI 10.1002/ana.64; Francis SJ., 2004, THESIS MCGILL U MONT; Gallucci M, 2001, CHILD NERV SYST, V17, P202, DOI 10.1007/s003810000331; Gedamu EL, 2008, J MAGN RESON IMAGING, V28, P308, DOI 10.1002/jmri.21434; Ghassemi R, 2008, ANN NEUROL, V63, P401, DOI 10.1002/ana.21322; Ketelslegers IA, 2010, NEUROLOGY, V74, P1412, DOI 10.1212/WNL.0b013e3181dc138b; Krupp LB, 2007, NEUROLOGY, V68, pS7, DOI 10.1212/01.wnl.0000259422.44235.a8; Laribiere A, 2005, EUR J CLIN PHARMACOL, V61, P907, DOI 10.1007/s00228-005-0053-3; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Narayanan S, 1997, ANN NEUROL, V41, P385, DOI 10.1002/ana.410410314; Nyul LG, 1999, MAGNET RESON MED, V42, P1072, DOI 10.1002/(SICI)1522-2594(199912)42:6<1072::AID-MRM11>3.0.CO;2-M; O'Connor P, 2009, NEUROLOGY, V72, P73, DOI 10.1212/01.wnl.0000338569.32367.3d; Paus T, 2001, BRAIN RES BULL, V54, P255, DOI 10.1016/S0361-9230(00)00434-2; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Rose JW, 2004, ANN NEUROL, V56, P864, DOI 10.1002/ana.20287; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Steen RG, 1997, AM J NEURORADIOL, V18, P819; Till C, 2011, NEUROPSYCHOLOGY, V25, P319, DOI 10.1037/a0022051; van Waesberghe JHTM, 1999, ANN NEUROL, V46, P747; Verhey LH, 2011, LANCET NEUROL, V10, P1065, DOI 10.1016/S1474-4422(11)70250-2; Waubant E, 2009, ARCH NEUROL-CHICAGO, V66, P967, DOI 10.1001/archneurol.2009.135; Yeh EA, 2009, BRAIN, V132, P3392, DOI 10.1093/brain/awp278	32	50	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e85741	10.1371/journal.pone.0085741	http://dx.doi.org/10.1371/journal.pone.0085741			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586244	Green Published, gold, Green Submitted			2022-12-27	WOS:000332389000002
J	Jamornthanyawat, N; Awab, GR; Tanomsing, N; Pukrittayakamee, S; Yamin, F; Dondorp, AM; Day, NPJ; White, NJ; Woodrow, CJ; Imwong, M				Jamornthanyawat, Natsuda; Awab, Ghulam R.; Tanomsing, Naowarat; Pukrittayakamee, Sasithon; Yamin, Fazel; Dondorp, Arjen M.; Day, Nicholas P. J.; White, Nicholas J.; Woodrow, Charles J.; Imwong, Mallika			A Population Survey of the Glucose-6-Phosphate Dehydrogenase (G6PD) 563C. T (Mediterranean) Mutation in Afghanistan	PLOS ONE			English	Article							SICKLE-CELL TRAIT; MOLECULAR CHARACTERIZATION; DEFICIENCY; POLYMORPHISM; MALARIA; VARIANT; GENE; PREVALENCE; PAKISTAN; ORIGIN	Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common inherited enzyme defect and an important problem in areas with Plasmodium vivax infection because of the risk of haemolysis following administration of primaquine to treat the liver forms of the parasite. We undertook a genotypic survey of 713 male individuals across nine provinces of Afghanistan in which malaria is found, four in the north and five in the east. RFLP typing at nucleotide position 563 detected 40 individuals with the Mediterranean mutation 563C. T, an overall prevalence of 5.6%. This varied according to self-reported ethnicity, with prevalence in the Pashtun/Pashai group of 33/369 (8.9%) compared to 7/344 individuals in the rest of the population (2.0%; p, 0.001, Chi-squared test). Multivariate analysis of ethnicity and geographical location indicated an adjusted odds ratio of 3.50 (95% CI 1.36-9.02) for the Pashtun/Pashai group, while location showed only a trend towards higher prevalence in eastern provinces (adjusted odds ratio = 1.73, 0.73-4.13). Testing of known polymorphic markers (1311C. T in exon 11, and C93T in intron XI) in a subset of 82 individuals wild-type at C563 revealed a mixture of 3 haplotypes in the background population and was consistent with data from the 1000 Genomes Project and published studies. By comparison individuals with G6PD deficiency showed a highly skewed haplotype distribution, with 95% showing the CT haplotype, a finding consistent with relatively recent appearance and positive selection of the Mediterranean variant in Afghanistan. Overall, the data confirm that the Mediterranean variant of G6PD is common in many ethnic groups in Afghanistan, indicating that screening for G6PD deficiency is required in all individuals before radical treatment of P. vivax with primaquine.	[Jamornthanyawat, Natsuda; Pukrittayakamee, Sasithon] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand; [Awab, Ghulam R.; Dondorp, Arjen M.; Day, Nicholas P. J.; White, Nicholas J.; Woodrow, Charles J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit MORU, Bangkok, Thailand; [Tanomsing, Naowarat; Woodrow, Charles J.; Imwong, Mallika] Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand; [Awab, Ghulam R.; Yamin, Fazel] Minist Publ Hlth, Kabul, Afghanistan; [Dondorp, Arjen M.; Day, Nicholas P. J.; White, Nicholas J.; Woodrow, Charles J.] Univ Oxford, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford, England	Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Mahidol University; University of Oxford	Imwong, M (corresponding author), Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand.	noi@tropmedres.ac	Imwong, Mallika/ABE-6493-2020; White, Nick/AAC-6527-2019	White, Nick/0000-0002-1897-1978; Yamin, Fazal/0000-0001-5422-0293; Woodrow, Charles/0000-0002-5134-7165	Mahidol-Oxford Research Unit; Thailand International Development and Cooperation Agency; Mahidol University; Wellcome Trust Mahidol University-Oxford Tropical Medicine Research Programme; Wellcome Trust of Great Britain	Mahidol-Oxford Research Unit; Thailand International Development and Cooperation Agency; Mahidol University; Wellcome Trust Mahidol University-Oxford Tropical Medicine Research Programme(Wellcome Trust); Wellcome Trust of Great Britain(Wellcome Trust)	GRA was supported by the Mahidol-Oxford Research Unit as a continuation of an MSc scholarship granted by the Thailand International Development and Cooperation Agency. The study was supported by Mahidol University and The Dean's Research Fund, Faculty of Tropical Medicine, and was part of the Wellcome Trust Mahidol University-Oxford Tropical Medicine Research Programme supported by the Wellcome Trust of Great Britain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainoon O, 2003, Hum Mutat, V21, P101, DOI 10.1002/humu.9103; Al-Allawi Nasir, 2010, BMC Blood Disord, V10, P6, DOI 10.1186/1471-2326-10-6; Al-Musawi Bassam Ms, 2012, BMC Blood Disord, V12, P4, DOI 10.1186/1471-2326-12-4; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], 1989, B WORLD HEALTH ORGAN, V67, P601; Bakhramov S M, 2011, Lik Sprava, P73; BEUTLER E, 1962, P NATL ACAD SCI USA, V48, P9, DOI 10.1073/pnas.48.1.9; BEUTLER E, 1990, AM J HUM GENET, V47, P1008; BOUMA MJ, 1995, T ROY SOC TROP MED H, V89, P62, DOI 10.1016/0035-9203(95)90661-4; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; Chalvam R, 2011, ANN HUM BIOL, V38, P106, DOI 10.3109/03014460.2010.488251; Clark TG, 2009, EUR J HUM GENET, V17, P1080, DOI 10.1038/ejhg.2009.8; Cocco P, 1998, BLOOD, V91, P706, DOI 10.1182/blood.V91.2.706.706_706_709; Haber M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034288; HELLER P, 1979, NEW ENGL J MED, V300, P1001, DOI 10.1056/NEJM197905033001801; HOIBERG A, 1981, ARCH INTERN MED, V141, P1485, DOI 10.1001/archinte.141.11.1485; KURDIHAIDAR B, 1990, AM J HUM GENET, V47, P1013; Leslie T, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-230; Leslie T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000283; Liu WL, 2013, INT J LAB HEMATOL, V35, pE1, DOI 10.1111/ijlh.12046; Louicharoen C, 2009, SCIENCE, V326, P1546, DOI 10.1126/science.1178849; Moiz B, 2011, INT J LAB HEMATOL, V33, P570, DOI 10.1111/j.1751-553X.2011.01325.x; Moiz B, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-41; Rahimi Z, 2006, BLOOD CELL MOL DIS, V37, P91, DOI 10.1016/j.bcmd.2006.07.004; Rebholz CE, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-51; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; SAHA N, 1994, HUM HERED, V44, P85, DOI 10.1159/000154196; SAHA S, 1994, AM J HEMATOL, V47, P273, DOI 10.1002/ajh.2830470405; Samilchuk E, 1999, HUM HERED, V49, P41, DOI 10.1159/000022838; Sarkar S, 2010, INFECT GENET EVOL, V10, P1228, DOI 10.1016/j.meegid.2010.08.003; Sirdah M, 2012, BLOOD CELL MOL DIS, V48, P203, DOI 10.1016/j.bcmd.2012.01.007; Sukumar S, 2004, BLOOD CELL MOL DIS, V33, P141, DOI 10.1016/j.bcmd.2004.06.003; TANG TK, 1992, BLOOD, V79, P2135, DOI 10.1182/blood.V79.8.2135.bloodjournal7982135; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; VULLIAMY TJ, 1991, P NATL ACAD SCI USA, V88, P8568, DOI 10.1073/pnas.88.19.8568; WHO, 2010, GUID TREATM MAL, V2nd; WHO-EMRO, 2012, WORLD MALARIA REPORT	38	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e88605	10.1371/journal.pone.0088605	http://dx.doi.org/10.1371/journal.pone.0088605			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586352	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900021
J	Hennus, PML; de Kort, LMO; Bosch, JLH; de Jong, TPVM; van der Heijden, GJMG				Hennus, Pauline M. L.; de Kort, Laetitia M. O.; Bosch, J. L. H.; de Jong, Tom P. V. M.; van der Heijden, Geert J. M. G.			A Systematic Review on the Accuracy of Diagnostic Procedures for Infravesical Obstruction in Boys	PLOS ONE			English	Review							POSTERIOR URETHRAL VALVES; VOIDING CYSTOURETHROGRAPHY; ULTRASOUND; LESIONS; US	Background: Infravesical obstruction leads to kidney and bladder dysfunction in a significant proportion of boys. The aim of this review is to determine the value of diagnostic tests for ascertainment of infravesical obstruction in boys. Methodology: We searched PubMed and EMBASE databases until January 1, 2013, to identify papers that described original diagnostic accuracy research for infravesical obstruction in boys. We extracted information on (1) patient characteristics and clinical presentation of PUV and (2) diagnostic pathway, (3) diagnostic accuracy measures and (4) assessed risk of bias. Principal Findings: We retrieved 15 studies describing various diagnostic pathways in 1,189 boys suspected for infravesical obstruction. The included studies reflect a broad clinical spectrum of patients, but all failed to present a standardised approach to confirm the presence and severity of obstruction. The risk of bias of included studies is rather high due to workup bias and missing data. Conclusions: As a consequence of low quality of methods of the available studies we put little confidence in the reported estimates for the diagnostic accuracy of US, VCUG and new additional tests for ruling in or ruling out infravesical obstruction. To date, firm evidence to support common diagnostic pathways is lacking. Hence, we are unable to draw conclusions on diagnostic accuracy of tests for infravesical obstruction. In order to be able to standardise the diagnostic pathway for infravesical obstruction, adequate design and transparent reporting is mandatory.	[Hennus, Pauline M. L.; de Kort, Laetitia M. O.; Bosch, J. L. H.; de Jong, Tom P. V. M.] Univ Med Ctr Utrecht, Dept Urol, Utrecht, Netherlands; [de Jong, Tom P. V. M.] Wilhelmina Childrens Hosp, Pediat Renal Ctr, Utrecht, Netherlands; [de Jong, Tom P. V. M.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [van der Heijden, Geert J. M. G.] Univ Med Ctr Utrecht, Div Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands; [van der Heijden, Geert J. M. G.] Univ Amsterdam, Dept Social Dent, Acad Ctr Dent Amsterdam ACTA, Amsterdam, Netherlands; [van der Heijden, Geert J. M. G.] Vrije Univ Amsterdam, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Hennus, PML (corresponding author), Univ Med Ctr Utrecht, Dept Urol, Utrecht, Netherlands.	P.M.L.Hennus@umcutrecht.nl	de Jong, Tom/AAG-5659-2020	de Jong, Tom P.V.M./0000-0002-9091-1099	Astellas Pharma B.V.	Astellas Pharma B.V.(Astellas Pharmaceuticals)	Astellas Pharma B.V. www.astellas.nl (No specific grant number). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh A, 2007, PAK J MED SCI, V23, P88; Berrocal T, 2005, RADIOLOGY, V234, P235, DOI 10.1148/radiol.2341031503; Bosio M, 2002, J UROLOGY, V168, P1711, DOI 10.1016/S0022-5347(05)64395-9; Bosio Maurizio, 2002, Rays, V27, P135; Bossuyt PM, 2006, BRIT MED J, V332, P1089, DOI 10.1136/bmj.332.7549.1089; Chaumoitre K, 2004, J UROLOGY, V171, P1280, DOI 10.1097/01.ju.0000109871.22016.6d; COHEN HL, 1994, RADIOLOGY, V192, P261, DOI 10.1148/radiology.192.1.8208949; de Groot JAH, 2012, AM J EPIDEMIOL, V175, P847, DOI 10.1093/aje/kwr383; de Jong TPVM, 2008, UROLOGY, V72, P1022, DOI 10.1016/j.urology.2008.04.037; De Kort LMO, 2004, UROLOGY, V63, P967, DOI 10.1016/j.urology.2003.11.047; de Kort LMO, 2003, UROLOGY, V62, P127, DOI 10.1016/S0090-4295(03)00384-4; Duran C, 2009, PEDIATR RADIOL, V39, P124, DOI 10.1007/s00247-008-1050-3; ELLENBOGEN PH, 1978, AM J ROENTGENOL, V130, P731, DOI 10.2214/ajr.130.4.731; Goldman M, 2000, PEDIATRICS, V105, P1232, DOI 10.1542/peds.105.6.1232; HENDREN WH, 1971, J UROLOGY, V106, P298, DOI 10.1016/S0022-5347(17)61278-3; Hennus PML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044663; Kaefer M, 1997, J UROLOGY, V158, P1026, DOI 10.1016/S0022-5347(01)64380-5; Kaefer M, 1997, J UROLOGY, V157, P989, DOI 10.1016/S0022-5347(01)65127-9; Kihara T, 2008, INT J UROL, V15, P235, DOI 10.1111/j.1442-2042.2007.01968.x; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Mate A, 2003, EUR RADIOL, V13, P1534, DOI 10.1007/s00330-002-1790-7; Nakamura S, 2011, BJU INT, V107, P1304, DOI 10.1111/j.1464-410X.2010.09578.x; Oliveira EA, 2000, FETAL DIAGN THER, V15, P180, DOI 10.1159/000021002; Payabvash S, 2008, PEDIATR SURG INT, V24, P979, DOI 10.1007/s00383-008-2196-7; PIERETTI RV, 1993, J PEDIATR SURG, V28, P701, DOI 10.1016/0022-3468(93)90036-K; Rutjes Anne W S, 2006, CMAJ, V174, P469, DOI 10.1503/cmaj.050090; Schober JM, 2004, BJU INT, V94, P616, DOI 10.1111/j.1464-410X.2004.05011.x; WHITAKER RH, 1979, UROL CLIN N AM, V6, P529; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009	29	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e85474	10.1371/journal.pone.0085474	http://dx.doi.org/10.1371/journal.pone.0085474			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586242	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700003
J	Thierry, A; Giraud, S; Robin, A; Barra, A; Bridoux, F; Ameteau, V; Hauet, T; Girard, JP; Touchard, G; Gombert, JM; Herbelin, A				Thierry, Antoine; Giraud, Sebastien; Robin, Aurelie; Barra, Anne; Bridoux, Franck; Ameteau, Virginie; Hauet, Thierry; Girard, Jean-Philippe; Touchard, Guy; Gombert, Jean-Marc; Herbelin, Andre			The Alarmin Concept Applied to Human Renal Transplantation: Evidence for a Differential Implication of HMGB1 and IL-33	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; IFN-GAMMA PRODUCTION; ACUTE KIDNEY INJURY; ALLOGRAFT SURVIVAL; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; DANGER SIGNALS; CYTOKINE IL-33; IMMUNE-SYSTEM; NK CELLS	The endogenous molecules high mobility group box 1 (HMGB1) and interleukin-33 (IL-33) have been identified as alarmins, capable of mediating danger signals during tissue damage. Here, we address their possible role as innate-immune mediators in ischemia-reperfusion injury (IRI) following human kidney transplantation. We analysed serum and urinary HMGB1 and IL-33 levels, all determined by enzyme-linked immunosorbent assay, in a cohort of 26 deceased renal transplant recipients. Urinary HMGB1 and IL-33 levels were significantly increased as soon as 30 min after reperfusion, as compared to those before treatment. Moreover, both serum and urinary IL-33 (but not HMGB1) increase was positively correlated with cold ischemia time, from 30 min to 3 days post-transplantation. In vitro, human umbilical vein endothelial cells subjected to hypoxia conditions released both HMGB-1 and IL-33, while only the latter was further increased upon subsequent reoxygenation. Finally, we postulate that leukocytes from renal recipient patients are targeted by both HMGB1 and IL-33, as suggested by increased transcription of their respective receptors (TLR2/4 and ST2L) shortly after transplantation. Consistent with this view, we found that iNKT cells, an innate-like T cell subset involved in IRI and targeted by IL-33 but not by HMGB1 was activated 1 hour post-transplantation. Altogether, these results are in keeping with a potential role of IL-33 as an innate-immune mediator during kidney IRI in humans.	[Thierry, Antoine; Bridoux, Franck; Touchard, Guy] Ctr Hosp Univ Poitiers, Serv Nephrol Hemodialyse Transplantat Renale, Poitiers, France; [Thierry, Antoine; Giraud, Sebastien; Robin, Aurelie; Ameteau, Virginie; Hauet, Thierry; Touchard, Guy; Gombert, Jean-Marc; Herbelin, Andre] INSERM, U1082, Poitiers, France; [Giraud, Sebastien; Barra, Anne; Bridoux, Franck; Ameteau, Virginie; Hauet, Thierry; Touchard, Guy; Gombert, Jean-Marc; Herbelin, Andre] Univ Poitiers, Poitiers, France; [Barra, Anne] INSERM, U935, Poitiers, France; [Barra, Anne; Gombert, Jean-Marc] Ctr Hosp Univ Poitiers, Immunol Lab, Poitiers, France; [Hauet, Thierry] Ctr Hosp Univ Poitiers, Biochim Lab, Poitiers, France; [Girard, Jean-Philippe] Inst Pharmacol & Biol Struct, Toulouse, France; [Girard, Jean-Philippe] CNRS, Unite Mixte Rech, Toulouse, France; [Girard, Jean-Philippe] Univ Toulouse, Toulouse, France	CHU Poitiers; Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Universite de Poitiers; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse	Herbelin, A (corresponding author), INSERM, U1082, Poitiers, France.	andre.herbelin@inserm.fr	GIRARD, Jean-Philippe/F-5229-2010; GIRAUD, Sebastien/AAB-9095-2021; Hauet, Thierry/AAC-9277-2021; Herbelin, Andre/D-3096-2017; raphael, thuillier/P-5709-2016	GIRARD, Jean-Philippe/0000-0002-9154-1691; Hauet, Thierry/0000-0002-0117-071X; Herbelin, Andre/0000-0003-0193-7084; raphael, thuillier/0000-0002-7482-0031; Aurelie, Robin/0000-0003-0961-7878; giraud, sebastien/0000-0001-9015-8968; Bridoux, Frank/0000-0002-2005-8424	AREN-PC (Association pour la Recherche en Nephrologie-Poitou-Charentes); INSERM, Universite de Poitiers, Region Poitou-Charentes, Conseil general de la Vienne and CHU de Poitiers	AREN-PC (Association pour la Recherche en Nephrologie-Poitou-Charentes); INSERM, Universite de Poitiers, Region Poitou-Charentes, Conseil general de la Vienne and CHU de Poitiers(Region Nouvelle-Aquitaine)	This study was funded by AREN-PC (Association pour la Recherche en Nephrologie-Poitou-Charentes), INSERM, Universite de Poitiers, Region Poitou-Charentes, Conseil general de la Vienne and CHU de Poitiers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay A, 2011, J AM SOC NEPHROL, V22, P2057, DOI 10.1681/ASN.2010091011; Ali S, 2007, P NATL ACAD SCI USA, V104, P18660, DOI 10.1073/pnas.0705939104; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Bao YS, 2012, J CLIN IMMUNOL, V32, P587, DOI 10.1007/s10875-011-9622-7; Bon D, 2012, NAT REV NEPHROL, V8, P339, DOI 10.1038/nrneph.2012.83; Bourgeois E, 2009, EUR J IMMUNOL, V39, P1046, DOI 10.1002/eji.200838575; Bourgeois EA, 2011, EUR J IMMUNOL, V41, P299, DOI 10.1002/eji.201040647; Brunner SM, 2011, TRANSPL INT, V24, P1027, DOI 10.1111/j.1432-2277.2011.01306.x; Chen JL, 2011, KIDNEY INT, V79, P288, DOI 10.1038/ki.2010.381; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Fagundes CT, 2007, J LEUKOCYTE BIOL, V81, P492, DOI 10.1189/jlb.0606422; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Haraldsen G, 2009, TRENDS IMMUNOL, V30, P227, DOI 10.1016/j.it.2009.03.003; Kruger B, 2010, EUR J IMMUNOL, V40, P2914, DOI 10.1002/eji.201040601; Kruger B, 2009, P NATL ACAD SCI USA, V106, P3390, DOI 10.1073/pnas.0810169106; Kuhlicke J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001364; Le Goffic R, 2011, AM J RESP CELL MOL, V45, P1125, DOI 10.1165/rcmb.2010-0516OC; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Li JH, 2011, NEPHROL DIAL TRANSPL, V26, P469, DOI 10.1093/ndt/gfq466; Li L, 2007, J IMMUNOL, V178, P5899, DOI 10.4049/jimmunol.178.9.5899; Liu AD, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/436145; Matsuoka N, 2010, J CLIN INVEST, V120, P735, DOI 10.1172/JCI41360; Matsuyama Y, 2012, RHEUMATOL INT, V32, P1397, DOI 10.1007/s00296-011-1854-6; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P378, DOI 10.1111/j.1600-6143.2004.00332.x; Mirchandani AS, 2012, TRENDS IMMUNOL, V33, P389, DOI 10.1016/j.it.2012.04.005; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Muller S, 2004, J INTERN MED, V255, P332, DOI 10.1111/j.1365-2796.2003.01296.x; Mullins GE, 2004, SCAND J IMMUNOL, V60, P566, DOI 10.1111/j.0300-9475.2004.01518.x; Nankivell BJ, 2006, TRANSPLANTATION, V81, P643, DOI 10.1097/01.tp.0000190423.82154.01; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Powers KA, 2006, J EXP MED, V203, P1951, DOI 10.1084/jem.20060943; Rabadi MM, 2012, AM J PHYSIOL-RENAL, V302, pF730, DOI 10.1152/ajprenal.00520.2011; Rao DA, 2008, CRIT REV IMMUNOL, V28, P229, DOI 10.1615/CritRevImmunol.v28.i3.40; Sakai N, 2012, HEPATOLOGY, V56, P1468, DOI 10.1002/hep.25768; Salahudeen AK, 2004, KIDNEY INT, V65, P713, DOI 10.1111/j.1523-1755.2004.00416.x; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Thurman JM, 2007, CLIN IMMUNOL, V123, P7, DOI 10.1016/j.clim.2006.09.008; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Turnquist HR, 2011, J IMMUNOL, V187, P4598, DOI 10.4049/jimmunol.1100519; Wagenaar JFP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000453; Wolfs TGAM, 2002, J IMMUNOL, V168, P1286, DOI 10.4049/jimmunol.168.3.1286; Wu HL, 2010, J AM SOC NEPHROL, V21, P1878, DOI 10.1681/ASN.2009101048; Yin H, 2010, TRANSPLANTATION, V89, P1189, DOI 10.1097/TP.0b013e3181d720af	45	35	37	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88742	10.1371/journal.pone.0088742	http://dx.doi.org/10.1371/journal.pone.0088742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586382	Green Published, gold, Green Submitted			2022-12-27	WOS:000331714700027
J	Makrantoni, V; Corbishley, SJ; Rachidi, N; Morrice, NA; Robinson, DA; Stark, MJR				Makrantoni, Vasso; Corbishley, Stephen J.; Rachidi, Najma; Morrice, Nicholas A.; Robinson, David A.; Stark, Michael J. R.			Phosphorylation of Sli15 by Ipl1 Is Important for Proper CPC Localization and Chromosome Stability in Saccharomyces cerevisiae	PLOS ONE			English	Article							AURORA-B KINASE; BUDDING YEAST; SPINDLE CHECKPOINT; INNER CENTROMERE; HISTONE H3; COMPLEX; TENSION; INCENP; BIORIENTATION; ORIENTATION	The chromosomal passenger complex (CPC) is a key regulator of eukaryotic cell division, consisting of the protein kinase Aurora B/Ipl1 in association with its activator (INCENP/Sli15) and two additional proteins (Survivin/Bir1 and Borealin/Nbl1). Here we have identified multiple sites of CPC autophosphorylation on yeast Sli15 that are located within its central microtubule-binding domain and examined the functional significance of their phosphorylation by Ipl1 through mutation of these sites, either to non-phosphorylatable alanine (sli15-20A) or to acidic residues to mimic constitutive phosphorylation (sli15-20D). Both mutant sli15 alleles confer chromosome instability, but this is mediated neither by changes in the capacity of Sli15 to activate Ipl1 kinase nor by decreased efficiency of chromosome biorientation, a key process in cell division that requires CPC function. Instead, we find that mimicking constitutive phosphorylation of Sli15 on the Ipl1 phosphorylation sites causes delocalization of the CPC in metaphase, whereas blocking phosphorylation of Sli15 on the Ipl1 sites drives excessive localization of Sli15 to the mitotic spindle in pre-anaphase cells. Consistent with these results, direct interaction of Sli15 with microtubules in vitro is greatly reduced either following phosphorylation by Ipl1 or when constitutive phosphorylation at the Ipl1-dependent phosphorylation sites is mimicked by aspartate or glutamate substitutions. Furthermore, we find that mimicking Ipl1 phosphorylation of Sli15 interferes with the 'tension checkpoint' - the CPC-dependent mechanism through which cells activate the spindle assembly checkpoint to delay anaphase in the absence of tension on kinetochore-microtubule attachments. Ipl1-dependent phosphorylation of Sli15 therefore inhibits its association with microtubules both in vivo and in vitro and may negatively regulate the tension checkpoint mechanism.	[Makrantoni, Vasso; Corbishley, Stephen J.; Rachidi, Najma; Stark, Michael J. R.] Univ Dundee, Coll Life Sci, Ctr Gene Regulat & Express, Dundee DD1 4HN, Scotland; [Morrice, Nicholas A.] Univ Dundee, Coll Life Sci, MRC Prot Phosphorylat Unit, Dundee DD1 4HN, Scotland; [Robinson, David A.] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 4HN, Scotland	University of Dundee; University of Dundee; University of Dundee	Stark, MJR (corresponding author), Univ Dundee, Coll Life Sci, Ctr Gene Regulat & Express, Dundee DD1 4HN, Scotland.	m.j.r.stark@dundee.ac.uk	Stark, Michael J. R./B-2815-2014	Stark, Michael J. R./0000-0001-9086-191X; Rachidi, Najma/0000-0002-1247-7768; Makrantoni, Vasso/0000-0003-0668-6157; Robinson, David/0000-0003-1979-5918	Biotechnology and Biological Sciences Research Council [BB/G003440/1]; Wellcome Trust [083524/Z/07/Z]; BBSRC [BB/G003440/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by Project Grant BB/G003440/1 from the Biotechnology and Biological Sciences Research Council awarded to Michael Stark. We also gratefully acknowledge support from the Wellcome Trust (083524/Z/07/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberg DC., 2005, METHODS YEAST GENETI; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Bishop JD, 2002, J BIOL CHEM, V277, P27577, DOI 10.1074/jbc.C200307200; Bodenmiller B, 2008, NAT BIOTECHNOL, V26, P1339, DOI 10.1038/nbt1208-1339; Buvelot S, 2003, J CELL BIOL, V160, P329, DOI 10.1083/jcb.200209018; Campbell CS, 2013, NATURE, V497, P118, DOI 10.1038/nature12057; Campbell David G, 2002, J Biomol Tech, V13, P119; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cho US, 2012, NAT STRUCT MOL BIOL, V19, P48, DOI 10.1038/nsmb.2178; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Hummer S, 2009, CURR BIOL, V19, P607, DOI 10.1016/j.cub.2009.02.046; Indjeian VB, 2005, SCIENCE, V307, P130, DOI 10.1126/science.1101366; Kang JS, 2001, J CELL BIOL, V155, P763, DOI 10.1083/jcb.200105029; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Keating P, 2009, J CELL SCI, V122, P4375, DOI 10.1242/jcs.055566; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; King EMJ, 2007, GENE DEV, V21, P1163, DOI 10.1101/gad.431507; Koch A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001588; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Makrantoni V, 2009, MOL CELL BIOL, V29, P4552, DOI 10.1128/MCB.01911-08; Mekhail K, 2008, NATURE, V456, P667, DOI 10.1038/nature07460; Mirchenko L, 2010, CURR BIOL, V20, P1396, DOI 10.1016/j.cub.2010.06.023; Nakajima Y, 2011, J CELL BIOL, V194, P137, DOI 10.1083/jcb.201009137; Nakajima Y, 2009, MOL BIOL CELL, V20, P1772, DOI 10.1091/mbc.E08-10-1011; Panigada D, 2013, DEV CELL, V26, P483, DOI 10.1016/j.devcel.2013.07.013; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Pinsky BA, 2003, DEV CELL, V5, P735, DOI 10.1016/S1534-5807(03)00322-8; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Sadowski I, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat026; Sandall S, 2006, CELL, V127, P1179, DOI 10.1016/j.cell.2006.09.049; Santaguida S, 2011, EMBO J, V30, P1508, DOI 10.1038/emboj.2011.70; Shimogawa MM, 2009, MOL BIOL CELL, V20, P915, DOI 10.1091/mbc.E08-07-0723; SPENCER F, 1992, P NATL ACAD SCI USA, V89, P8908, DOI 10.1073/pnas.89.19.8908; Stark C, 2010, DATABASE-OXFORD, DOI 10.1093/database/bap026; Storchova Z, 2011, MOL BIOL CELL, V22, P1473, DOI 10.1091/mbc.E10-08-0673; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tanaka TU, 2005, NAT REV MOL CELL BIO, V6, P929, DOI 10.1038/nrm1764; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tien JF, 2010, J CELL BIOL, V189, P713, DOI 10.1083/jcb.200910142; Vaughan KT, 2005, J CELL BIOL, V171, P197, DOI 10.1083/jcb.200509150; Vazquez-Novelle MD, 2010, CURR BIOL, V20, P1402, DOI 10.1016/j.cub.2010.06.036; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Woodruff JB, 2010, J CELL BIOL, V191, P795, DOI 10.1083/jcb.201006028; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; Yoon HJ, 1999, P NATL ACAD SCI USA, V96, P13208, DOI 10.1073/pnas.96.23.13208; Zimniak T, 2012, CURR BIOL, V22, P787, DOI 10.1016/j.cub.2012.03.007; Zimniak T, 2009, J CELL BIOL, V186, P379, DOI 10.1083/jcb.200901036	52	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89399	10.1371/journal.pone.0089399	http://dx.doi.org/10.1371/journal.pone.0089399			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558497	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700143
J	Mentaberre, G; Romero, B; de Juan, L; Navarro-Gonzalez, N; Velarde, R; Mateos, A; Marco, I; Olive-Boix, X; Dominguez, L; Lavin, S; Serrano, E				Mentaberre, Gregorio; Romero, Beatriz; de Juan, Lucia; Navarro-Gonzalez, Nora; Velarde, Roser; Mateos, Ana; Marco, Ignasi; Olive-Boix, Xavier; Dominguez, Lucas; Lavin, Santiago; Serrano, Emmanuel			Long-Term Assessment of Wild Boar Harvesting and Cattle Removal for Bovine Tuberculosis Control in Free Ranging Populations	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; SPATIAL-DISTRIBUTION; RISK-FACTORS; RED DEER; MANAGEMENT; EPIDEMIOLOGY; ERADICATION; INFECTIONS; LESIONS; PREVALENCE	Wild boar is a recognized reservoir of bovine tuberculosis (TB) in the Mediterranean ecosystems, but information is scarce outside of hotspots in southern Spain. We describe the first high-prevalence focus of TB in a non-managed wild boar population in northern Spain and the result of eight years of TB management. Measures implemented for disease control included the control of the local wild boar population through culling and stamping out of a sympatric infected cattle herd. Post-mortem inspection for detection of tuberculosis-like lesions as well as cultures from selected head and cervical lymph nodes was done in 745 wild boar, 355 Iberian ibexes and five cattle between 2004 and 2012. The seasonal prevalence of TB reached 70% amongst adult wild boar and ten different spoligotypes and 13 MIRU-VNTR profiles were detected, although more than half of the isolates were included in the same clonal complex. Only 11% of infected boars had generalized lesions. None of the ibexes were affected, supporting their irrelevance in the epidemiology of TB. An infected cattle herd grazed the zone where 168 of the 197 infected boars were harvested. Cattle removal and wild boar culling together contributed to a decrease in TB prevalence. The need for holistic, sustained over time, intensive and adapted TB control strategies taking into account the multi-host nature of the disease is highlighted. The potential risk for tuberculosis emergence in wildlife scenarios where the risk is assumed to be low should be addressed.	[Mentaberre, Gregorio; Navarro-Gonzalez, Nora; Velarde, Roser; Marco, Ignasi; Lavin, Santiago; Serrano, Emmanuel] Univ Autonoma Barcelona, Fac Vet, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge SEFaS, E-08193 Barcelona, Spain; [Romero, Beatriz; de Juan, Lucia; Dominguez, Lucas] Univ Complutense, VISAVET Hlth Surveillance Ctr, E-28040 Madrid, Spain; [Romero, Beatriz; de Juan, Lucia; Mateos, Ana; Dominguez, Lucas] Univ Complutense, Fac Vet, Dept Sanidad Anim, E-28040 Madrid, Spain; [Serrano, Emmanuel] Univ Lleida, Dept Matemat, Lleida, Spain; [Olive-Boix, Xavier] Reserva Nacl Caca Ports Tortosa & Beseit, Tarragona, Spain	Autonomous University of Barcelona; Complutense University of Madrid; Complutense University of Madrid; Universitat de Lleida	Mentaberre, G (corresponding author), Univ Autonoma Barcelona, Fac Vet, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge SEFaS, E-08193 Barcelona, Spain.	caprapyrenaica@gmail.com	Lavín, Santiago/L-5975-2014; SERRANO-FERRON, Emmanuel/J-4489-2013; studies, IT VISAVET Account for bibliometric/C-3115-2014; Mentaberre, Gregorio A/H-4629-2015; Navarro-Gonzalez, Nora/N-9799-2017; Marco, Ignasi/E-8633-2015; de Juan, Lucía/I-6465-2016; Rodríguez, Lucas Domínguez/B-9668-2014; Velarde, Roser/M-1614-2014; Romero, Beatriz/J-5942-2015; Navarro-Gonzalez, Nora/GYD-6516-2022; Mentaberre, Gregorio/AAB-5912-2020	Lavín, Santiago/0000-0001-5655-588X; SERRANO-FERRON, Emmanuel/0000-0002-9799-9804; studies, IT VISAVET Account for bibliometric/0000-0003-3319-0050; Mentaberre, Gregorio A/0000-0001-9542-7514; Navarro-Gonzalez, Nora/0000-0002-1878-1242; Marco, Ignasi/0000-0001-7479-3419; de Juan, Lucía/0000-0002-7070-6872; Rodríguez, Lucas Domínguez/0000-0001-8843-0010; Velarde, Roser/0000-0003-3332-6405; Romero, Beatriz/0000-0001-5263-1806; Mentaberre, Gregorio/0000-0001-9542-7514	Ministry of Science and Innovation [FAU2006-00011, FAU2008-00021]	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work has been funded by the Ministry of Science and Innovation within the Programme of Interaction between wild animals and livestock (FAU2006-00011 and FAU2008-00021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Acevedo P, 2007, EPIDEMIOL INFECT, V135, P519, DOI 10.1017/S0950268806007059; Acevedo Pelayo, 2009, Galemys, V21, P13; Allepuz A, 2011, PREV VET MED, V100, P44, DOI 10.1016/j.prevetmed.2011.02.012; Bieber C, 2005, J APPL ECOL, V42, P1203, DOI 10.1111/j.1365-2664.2005.01094.x; Blanchong JA, 2008, BIOL LETTERS, V4, P130, DOI 10.1098/rsbl.2007.0523; Boadella M, 2012, PREV VET MED; Boadella M, 2011, ECOHEALTH; BOITANI L, 1992, ONGULES / UNGULATES 91, P419; Buddle BM, 2000, VET IMMUNOL IMMUNOP, V74, P1, DOI 10.1016/S0165-2427(00)00163-X; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CORNER LA, 1988, VET MICROBIOL, V18, P127, DOI 10.1016/0378-1135(88)90058-2; Corner LAL, 2006, VET MICROBIOL, V112, P303, DOI 10.1016/j.vetmic.2005.11.015; Cowled BD, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-3; Dandy N, 2012, EUR J WILDLIFE RES, V58, P695, DOI 10.1007/s10344-012-0619-1; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; Delahay RJ, 2007, VET J, V173, P287, DOI 10.1016/j.tvjl.2005.11.011; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Duarte EL, 2008, VET MICROBIOL, V130, P415, DOI 10.1016/j.vetmic.2008.02.012; FANDOS P, 1995, MAMMALIA, V59, P229, DOI 10.1515/mamm.1995.59.2.229; Focardi S, 2008, J MAMMAL, V89, P1113, DOI 10.1644/07-MAMM-A-164.1; Galindo RC, 2009, VET IMMUNOL IMMUNOP, V129, P119, DOI 10.1016/j.vetimm.2008.12.012; Gamelon M, 2012, J APPL ECOL, V49, P833, DOI 10.1111/j.1365-2664.2012.02160.x; Garcia-Jimenez WL, 2013, TRANSBOUND EMERG DIS, V60, P102, DOI 10.1111/j.1865-1682.2012.01321.x; Garcia-Jimenez WL, 2013, PREV VET MED; Gortazar C, 2005, VET RES, V36, P43, DOI 10.1051/vetres:2004051; Gortazar C, 2012, MAMMAL REV, V42, P193, DOI 10.1111/j.1365-2907.2011.00191.x; Gortazar C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002776; Jenkins HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009090; Jolles AE, 2008, ECOLOGY, V89, P2239, DOI 10.1890/07-0995.1; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Keet DF, 2000, ONDERSTEPOORT J VET, V67, P115; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Lisle G. W. de, 1994, Surveillance (Wellington), V21, P23; Lopez-Olvera JR, 2006, PARASITOL RES, V98, P582, DOI 10.1007/s00436-005-0099-2; Martin-Hernando MP, 2007, TUBERCULOSIS, V87, P360, DOI 10.1016/j.tube.2007.02.003; Mentaberre G, 2012, ZOONOSES PUBLIC HLTH; Mentaberre G, 2010, VET REC, V166, P700, DOI 10.1136/vr.c2552; Munoz PM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-46; Naranjo V, 2008, VET MICROBIOL, V127, P1, DOI 10.1016/j.vetmic.2007.10.002; Nishi JS, 2006, VET MICROBIOL, V112, P325, DOI 10.1016/j.vetmic.2005.11.013; O'Brien DJ, 2011, VET MICROBIOL, V151, P23, DOI 10.1016/j.vetmic.2011.02.022; Parra A, 2006, RES VET SCI, V80, P140, DOI 10.1016/j.rvsc.2005.05.010; Parra A, 2003, VET MICROBIOL, V97, P123, DOI 10.1016/j.vetmic.2003.08.007; R Development Core Team, LANG ENV STAT COMP; Radunz B, 2006, VET MICROBIOL, V112, P283, DOI 10.1016/j.vetmic.2005.11.017; Renwick AR, 2007, EPIDEMIOL INFECT, V135, P529, DOI 10.1017/S0950268806007205; Riordan P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028904; Rodriguez S, 2010, VET MICROBIOL, V141, P89, DOI 10.1016/j.vetmic.2009.08.007; Rodriguez-Campos S, 2012, INFECT GENET EVOL, V12, P877, DOI 10.1016/j.meegid.2011.10.008; Rodriguez-Campos S, 2011, J CLIN MICROBIOL, V49, P3361, DOI 10.1128/JCM.00301-11; Romero B, 2008, VET MICROBIOL, V132, P87, DOI 10.1016/j.vetmic.2008.04.032; Ryan TJ, 2006, VET MICROBIOL, V112, P211, DOI 10.1016/j.vetmic.2005.11.025; Santos N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012663; Van Campen H, 2010, VET CLIN N AM-FOOD A, V26, P147, DOI 10.1016/j.cvfa.2009.10.008; Vicente J, 2006, VET RES, V37, P107, DOI 10.1051/vetres:2005044; Vicente J, 2007, VET RES, V38, P451, DOI 10.1051/vetres:2007002; Wilton S, 1992, PCR Methods Appl, V1, P269; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zar J.H., 2009, BIOSTATISTICAL ANAL; Zuur Alain F., 2009, P1	60	28	28	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88824	10.1371/journal.pone.0088824	http://dx.doi.org/10.1371/journal.pone.0088824			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558435	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000331706700081
J	Pirog, KA; Irman, A; Young, S; Halai, P; Bell, PA; Boot-Handford, RP; Briggs, MD				Pirog, Katarzyna A.; Irman, Andreja; Young, Siobhan; Halai, Poonam; Bell, Peter A.; Boot-Handford, Raymond P.; Briggs, Michael D.			Abnormal Chondrocyte Apoptosis in the Cartilage Growth Plate is Influenced by Genetic Background and Deletion of CHOP in a Targeted Mouse Model of Pseudoachondroplasia	PLOS ONE			English	Article							OLIGOMERIC MATRIX PROTEIN; MULTIPLE EPIPHYSEAL DYSPLASIA; C/EBP-HOMOLOGOUS PROTEIN; CELL-DEATH; IX COLLAGEN; COMP; MUTATION; TRANSCRIPTION; MECHANISMS; ATTACHMENT	Pseudoachondroplasia (PSACH) is an autosomal dominant skeletal dysplasia caused by mutations in cartilage oligomeric matrix protein (COMP) and characterised by short limbed dwarfism and early onset osteoarthritis. Mouse models of PSACH show variable retention of mutant COMP in the ER of chondrocytes, however, in each case a different stress pathway is activated and the underlying disease mechanisms remain largely unknown. T585M COMP mutant mice are a model of moderate PSACH and demonstrate a mild ER stress response. Although mutant COMP is not retained in significant quantities within the ER of chondrocytes, both BiP and the pro-apoptotic ER stress-related transcription factor CHOP are mildly elevated, whilst bcl-2 levels are decreased, resulting in increased and spatially dysregulated chondrocyte apoptosis. To determine whether the abnormal chondrocyte apoptosis observed in the growth plate of mutant mice is CHOP-mediated, we bred T585M COMP mutant mice with CHOP-null mice to homozygosity, and analysed the resulting phenotype. Although abnormal apoptosis was alleviated in the resting zone following CHOP deletion, the mutant growth plates were generally more disorganised. Furthermore, the bone lengths of COMP mutant CHOP null mice were significantly shorter at 9 weeks of age when compared to the COMP mutant mice, including a significant difference in the skull length. Overall, these data demonstrate that CHOP-mediated apoptosis is an early event in the pathobiology of PSACH and suggest that the lack of CHOP, in conjunction with a COMP mutation, may lead to aggravation of the skeletal phenotype via a potentially synergistic effect on endochondral ossification.	[Pirog, Katarzyna A.; Bell, Peter A.; Briggs, Michael D.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Irman, Andreja; Young, Siobhan; Halai, Poonam; Boot-Handford, Raymond P.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England	Newcastle University - UK; University of Manchester	Pirog, KA (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Katarzyna.Pirog@ncl.ac.uk; Michael.Briggs@ncl.ac.uk	Pirog, Katarzyna/AAD-6682-2021	Pirog, Katarzyna/0000-0003-0736-3296; Boot-Handford, Raymond/0000-0002-6167-8419	Wellcome Trust [071161/Z/03/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust Senior Research Fellowship in Basic Biomedical Science, Grant 071161/Z/03/Z (MDB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Briggs MD, 2002, HUM MUTAT, V19, P465, DOI 10.1002/humu.10066; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; Chapman KL, 2003, PEDIATR PATHOL MOL M, V22, P53, DOI 10.1080/15227950307699; Chen FH, 2007, J BIOL CHEM, V282, P24591, DOI 10.1074/jbc.M611390200; Chen FH, 2005, J BIOL CHEM, V280, P32655, DOI 10.1074/jbc.M504778200; Chen RH, 2000, RES COMMUN MOL PATH, V108, P3; Delot E, 1999, HUM MOL GENET, V8, P123, DOI 10.1093/hmg/8.1.123; DICESARE P, 1994, FEBS LETT, V354, P237, DOI 10.1016/0014-5793(94)01134-6; Dixon J, 2004, DEV DYNAM, V229, P907, DOI 10.1002/dvdy.20004; FORNACE AJ, 1988, P NATL ACAD SCI USA, V85, P8800, DOI 10.1073/pnas.85.23.8800; Gal I, 2000, J HISTOCHEM CYTOCHEM, V48, P963, DOI 10.1177/002215540004800709; Halasz K, 2007, J BIOL CHEM, V282, P31166, DOI 10.1074/jbc.M705735200; Hecht JT, 2004, J ORTHOP RES, V22, P759, DOI 10.1016/j.orthres.2003.11.010; Hecht JT, 2001, MATRIX BIOL, V20, P251, DOI 10.1016/S0945-053X(01)00136-6; Holden P, 2001, J BIOL CHEM, V276, P6046, DOI 10.1074/jbc.M009507200; Kennedy Jason, 2005, Hum Mutat, V25, P593, DOI 10.1002/humu.9342; Mann HH, 2004, J BIOL CHEM, V279, P25294, DOI 10.1074/jbc.M403778200; Marciniak S, 2004, GENES DEV, V18; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; McKeand J, 1996, AM J MED GENET, V63, P406; McLaughlin M, 2007, NEUROCHEM RES, V32, P167, DOI 10.1007/s11064-006-9122-y; Moore K, 2012, ANNU REV GENET; Nundlall S, 2010, CELL STRESS CHAPERON, V15, P835, DOI 10.1007/s12192-010-0193-y; Pereira RC, 2006, J CELL BIOCHEM, V97, P633, DOI 10.1002/jcb.20660; Pereira RC, 2004, ENDOCRINOLOGY, V145, P1952, DOI 10.1210/en.2003-0868; Pham TV, 2010, BIOINFORMATICS, V26, P363, DOI 10.1093/bioinformatics/btp677; Pirog-Garcia KA, 2007, HUM MOL GENET, V16, P2072, DOI 10.1093/hmg/ddm155; Posey KL, 2012, AM J PATHOL, V180, P727, DOI 10.1016/j.ajpath.2011.10.035; Posey KL, 2009, AM J PATHOL, V175, P1555, DOI 10.2353/ajpath.2009.090184; Rock MJ, 2010, MOL CELL BIOCHEM, V338, P215, DOI 10.1007/s11010-009-0355-3; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Schmitz M, 2006, J BIOL CHEM, V281, P32587, DOI 10.1074/jbc.M601976200; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Spitznagel L, 2004, BIOCHEM J, V377, P479, DOI 10.1042/BJ20031179; Suleman F, 2012, HUM MUTAT, V33, P218, DOI 10.1002/humu.21631; Ubeda M, 1999, MOL CELL BIOL, V19, P7589; Unger SL, 2001, PEDIATR RADIOL, V31, P10, DOI 10.1007/s002470000362; Vranka J, 2001, MATRIX BIOL, V20, P439, DOI 10.1016/S0945-053X(01)00148-2; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	42	27	29	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e85145	10.1371/journal.pone.0085145	http://dx.doi.org/10.1371/journal.pone.0085145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558358	gold, Green Published			2022-12-27	WOS:000331706700004
J	Wang, WZ; Zhang, XY; Shen, C; Zhi, XF; Wang, BL; Xu, ZK				Wang, Weizhi; Zhang, Xiaoyu; Shen, Chen; Zhi, Xiaofei; Wang, Baolin; Xu, Zekuan			Laparoscopic versus Open Total Gastrectomy for Gastric Cancer: An Updated Meta-Analysis	PLOS ONE			English	Article							ASSISTED DISTAL GASTRECTOMY; LYMPH-NODE DISSECTION; RANDOMIZED CLINICAL-TRIAL; SURGICAL OUTCOMES; LEARNING-CURVE; COMPARING OPEN; RISK-FACTORS; BLOOD-LOSS; SURGERY; SURVIVAL	Objective: To expand the current knowledge on the feasibility and safety of laparoscopic total gastrectomy (LTG) for gastric cancer in comparison with open total gastrectomy (OTG). Background: Additional studies comparing laparoscopic versus open total gastric resection have been published, and it is necessary to update the meta-analysis of this subject. Methods: Original articles compared LTG and OTG for gastric cancer, which published in English from January 1990 to July 2013 were searched in PubMed, Embase, and Web of Knowledge by two reviewers independently. Operative time, blood loss, harvested lymph nodes, proximal resection margin, analgesic medication, first flatus day, first oral intake, postoperative hospital stay, postoperative complications, hospital mortality, 5-year overall survival (OS) and disease-free survival (DFS) were compared using STATA version 10.1. Results: 17 studies were selected in this analysis, which included a total of 2313 patients (955 in LTG and 1358 in OTG). LTG showed longer operative time, less blood loss, fewer analgesic uses, earlier passage of flatus, quicker resumption of oral intake, earlier hospital discharge, and reduced postoperative morbidity. The number of harvested lymph nodes, proximal resection margin, hospital mortality, 5-year OS and DFS were similar. Conclusion: LTG had the benefits of less blood loss, less postoperative pain, quicker bowel function recovery, shorter hospital stay and lower postoperative morbidity, at the price of longer operative time. There were no statistical differences in lymph node dissection, resection margin, hospital mortality, and long-term outcomes, which indicated the similar oncological safety with OTG. A positive trend was indicated towards LTG. So LTG can be performed as an alternative to OTG by the experienced surgeons in high-volume centers. Whereas, due to the relative small sample size of long-term outcomes and lack of randomized control trials, more studies are required.	[Wang, Weizhi; Zhang, Xiaoyu; Zhi, Xiaofei; Xu, Zekuan] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China; [Shen, Chen; Wang, Baolin] Nanjing Med Univ, Affiliated Hosp 2, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Wang, BL (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China.	1195945071@qq.com; xuzekuan@njmu.edu.cn	Zhang, xiaoyu/GXA-3206-2022		National Natural Science Foundation of China [81072031, 81272712]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81072031, 81272712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2000, ARCH SURG-CHICAGO, V135, P806, DOI 10.1001/archsurg.135.7.806; Arrington AK, 2012, AM SURGEON, V78, P1054; Bo T, 2013, J GASTROINTEST SURG, V17, P1202, DOI 10.1007/s11605-013-2218-1; Bonenkamp JJ, 1999, NEW ENGL J MED, V340, P908, DOI 10.1056/NEJM199903253401202; Csendes A, 2002, SURGERY, V131, P401, DOI 10.1067/msy.2002.121891; Cuschieri A, 1999, BRIT J CANCER, V79, P1522, DOI 10.1038/sj.bjc.6690243; Danielson H, 2007, SCAND J SURG, V96, P35, DOI 10.1177/145749690709600107; de Manzoni G, 2002, BRIT J CANCER, V87, P171, DOI 10.1038/sj.bjc.6600432; Degiuli M, 2010, BRIT J SURG, V97, P643, DOI 10.1002/bjs.6936; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Du JJ, 2010, HEPATO-GASTROENTEROL, V57, P1589; Dulucq JL, 2005, SURG ENDOSC, V19, P933, DOI 10.1007/s00464-004-2172-9; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Enzinger PC, 2007, ANN SURG, V245, P426, DOI 10.1097/01.sla.0000245469.35088.42; Eom BW, 2012, SURG ENDOSC, V26, P3273, DOI 10.1007/s00464-012-2338-9; Fujiwara M, 2005, J SURG ONCOL, V91, P26, DOI 10.1002/jso.20166; GALBRAITH RF, 1988, TECHNOMETRICS, V30, P271, DOI 10.2307/1270081; Griffin SM, 2005, BRIT J SURG, V92, P1055, DOI 10.1002/bjs.5121; Guan G, 2012, SURG ENDOSC; Hamabe A, 2012, SURG ENDOSC, V26, P1702, DOI 10.1007/s00464-011-2096-0; Hartgrink HH, 2004, EJSO-EUR J SURG ONC, V30, P643, DOI 10.1016/j.ejso.2004.04.013; Hartgrink HH, 2004, J CLIN ONCOL, V22, P2069, DOI 10.1200/JCO.2004.08.026; Haverkamp L, 2013, SURG ENDOSC, V27, P1509, DOI 10.1007/s00464-012-2661-1; Hayashi H, 2005, SURG ENDOSC, V19, P1172, DOI 10.1007/s00464-004-8207-4; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Hur H, 2008, J SURG ONCOL, V98, P515, DOI 10.1002/jso.21155; Jeong O, 2013, J AM COLL SURGEONS, V216, P184, DOI 10.1016/j.jamcollsurg.2012.10.014; Jin SH, 2007, SURG ENDOSC, V21, P28, DOI 10.1007/s00464-005-0634-3; Kawamura H, 2008, WORLD J SURG, V32, P2366, DOI 10.1007/s00268-008-9697-3; Kawamura H, 2009, WORLD J SURG, V33, P2389, DOI 10.1007/s00268-009-0208-y; Kim HS, 2013, J LAPAROENDOSC ADV S, V23, P323, DOI 10.1089/lap.2012.0389; Kim MG, 2011, J KOREAN SURG SOC, V80, P245, DOI 10.4174/jkss.2011.80.4.245; Kim MC, 2005, WORLD J GASTROENTERO, V11, P7508, DOI 10.3748/wjg.v11.i47.7508; Kim SG, 2008, J LAPAROENDOSC ADV S, V18, P572, DOI 10.1089/lap.2007.0106; Kim YW, 2008, ANN SURG, V248, P721, DOI 10.1097/SLA.0b013e318185e62e; Kitano S, 2002, SURGERY, V131, pS306, DOI 10.1067/msy.2002.120115; KITANO S, 1994, SURG LAPAROSC ENDOSC, V4, P146; Kodera Y, 2005, BRIT J SURG, V92, P1103, DOI 10.1002/bjs.4979; Kunisaki C, 2008, SURG LAPARO ENDO PER, V18, P236, DOI 10.1097/SLE.0b013e31816aa13f; Kunisaki C, 2012, SURG ENDOSC, V26, P804, DOI 10.1007/s00464-011-1956-y; Lee JH, 2005, SURG ENDOSC, V19, P168, DOI 10.1007/s00464-004-8808-y; Lee JH, 2007, ANN SURG ONCOL, V14, P1288, DOI 10.1245/s10434-006-9235-1; Lee MS, 2013, SURG ENDOSC; Lee SE, 2009, J SURG ONCOL, V100, P392, DOI 10.1002/jso.21345; Lee SE, 2009, ANN SURG ONCOL, V16, P2231, DOI 10.1245/s10434-009-0490-9; MANTEL N, 1959, J NATL CANCER I, V22, P719; MARUYAMA K, 1989, ANN SURG, V210, P596, DOI 10.1097/00000658-198911000-00005; McCulloch P, 2006, BEST PRACT RES CL GA, V20, P767, DOI 10.1016/j.bpg.2006.03.006; Memon MA, 2008, SURG ENDOSC, V22, P1781, DOI 10.1007/s00464-008-9925-9; Mochiki E, 2005, SURGERY, V137, P317, DOI 10.1016/j.surg.2004.10.012; Mochiki E, 2008, SURG ENDOSC, V22, P1997, DOI 10.1007/s00464-008-0015-9; NOGUCHI Y, 1989, CANCER, V64, P2053, DOI 10.1002/1097-0142(19891115)64:10<2053::AID-CNCR2820641014>3.0.CO;2-J; Ohtani H, 2010, J GASTROINTEST SURG, V14, P958, DOI 10.1007/s11605-010-1195-x; Ojima T, 2009, ARCH SURG-CHICAGO, V144, P351, DOI 10.1001/archsurg.2009.20; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Ryu KW, 2008, ANN SURG ONCOL, V15, P1625, DOI 10.1245/s10434-008-9845-x; Sakuramoto S, 2009, SURG ENDOSC, V23, P2416, DOI 10.1007/s00464-009-0371-0; Shinohara T, 2009, ARCH SURG-CHICAGO, V144, P1138, DOI 10.1001/archsurg.2009.223; Siani LM, 2012, MINERVA CHIR, V67, P319; Sierra A, 2003, ANN SURG ONCOL, V10, P219, DOI 10.1245/ASO.2003.07.009; Song KY, 2008, SURG ENDOSC, V22, P655, DOI 10.1007/s00464-007-9431-5; Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X; SPENCE RK, 1990, AM J SURG, V159, P320, DOI 10.1016/S0002-9610(05)81227-9; Takiguchi S, 2005, SURG TODAY, V35, P896, DOI 10.1007/s00595-005-3030-7; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Topal B, 2008, SURG ENDOSC, V22, P980, DOI 10.1007/s00464-007-9549-5; Usui S, 2005, SURG LAPARO ENDO PER, V15, P309, DOI 10.1097/01.sle.0000191589.84485.4a; Vinuela EF, 2012, ANN SURG, V255, P446, DOI 10.1097/SLA.0b013e31824682f4; Wells GA, 2003, 11 INT COCHR C BARC, VO-63, P26; Wu WC, 2010, ANN SURG, V252, P11, DOI 10.1097/SLA.0b013e3181e3e43f; Yu W, 2006, BRIT J SURG, V93, P559, DOI 10.1002/bjs.5353	71	50	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88753	10.1371/journal.pone.0088753	http://dx.doi.org/10.1371/journal.pone.0088753			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558421	gold, Green Published, Green Submitted			2022-12-27	WOS:000331706700067
J	Page, M; Quartey-Papafio, R; Robinson, M; Hassall, M; Cranage, M; Stott, J; Almond, N				Page, Mark; Quartey-Papafio, Ruby; Robinson, Mark; Hassall, Mark; Cranage, Martin; Stott, James; Almond, Neil			Complement-Mediated Virus Infectivity Neutralisation by HLA Antibodies Is Associated with Sterilising Immunity to SIV Challenge in the Macaque Model for HIV/AIDS	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; HUMAN MONOCLONAL-ANTIBODIES; HIV-1 PLASMA VIRUS; RHESUS MACAQUES; PASSIVE-IMMUNIZATION; VACCINE PROTECTION; LEUKOCYTE ANTIGEN; IN-VIVO; TYPE-1; CELLS	Sterilising immunity is a desired outcome for vaccination against human immunodeficiency virus (HIV) and has been observed in the macaque model using inactivated simian immunodeficiency virus (SIV). This protection was attributed to antibodies specific for cell proteins including human leucocyte antigens (HLA) class I and II incorporated into virions during vaccine and challenge virus preparation. We show here, using HLA bead arrays, that vaccinated macaques protected from virus challenge had higher serum antibody reactivity compared with non-protected animals. Moreover, reactivity was shown to be directed against HLA framework determinants. Previous studies failed to correlate serum antibody mediated virus neutralisation with protection and were confounded by cytotoxic effects. Using a virus entry assay based on TZM-bl cells we now report that, in the presence of complement, serum antibody titres that neutralise virus infectivity were higher in protected animals. We propose that complement-augmented virus neutralisation is a key factor in inducing sterilising immunity and may be difficult to achieve with HIV/SIV Env-based vaccines. Understanding how to overcome the apparent block of inactivated SIV vaccines to elicit anti-envelope protein antibodies that effectively engage the complement system could enable novel anti-HIV antibody vaccines that induce potent, virolytic serological response to be developed.	[Page, Mark; Quartey-Papafio, Ruby; Robinson, Mark; Hassall, Mark; Stott, James; Almond, Neil] Natl Inst Biol Stand & Controls, Div Virol, Potters Bar EN6 3QG, Herts, England; [Cranage, Martin] St Georges Univ London, Div Clin Sci, Ctr Infect & Immun, London, England	National Institute for Biological Standards & Control; St Georges University London	Page, M (corresponding author), Natl Inst Biol Stand & Controls, Div Virol, Blanche Lane S Mimms, Potters Bar EN6 3QG, Herts, England.	mark.page@nibsc.org			Medical Research Council [G9025730]; Europrise; EU FP6; Medical Research Council [G0601201] Funding Source: researchfish; MRC [G9025730, G0601201] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Europrise; EU FP6(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This report is work commissioned in part by the National Institute for Health Research. The views expressed in this publication are those of the authors and not necessarily those of the National Institute for Health Research or the Department of Health. This work was supported in part by grants from the Medical Research Council G9025730 and also EU FP6 funding from Europrise. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akari H, 1996, VIROLOGY, V218, P382, DOI 10.1006/viro.1996.0207; ARTHUR LO, 1995, J VIROL, V69, P3117, DOI 10.1128/JVI.69.5.3117-3124.1995; ARTHUR LO, 1992, SCIENCE, V258, P1935, DOI 10.1126/science.1470916; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Barnetta SW, 2008, AIDS, V22, P339, DOI 10.1097/QAD.0b013e3282f3ca57; Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Bower JF, 2006, VACCINE, V24, P5442, DOI 10.1016/j.vaccine.2006.03.063; CARLSON JR, 1990, AIDS RES HUM RETROV, V6, P1239, DOI 10.1089/aid.1990.6.1239; CHAN WL, 1995, AIDS, V9, P223, DOI 10.1097/00002030-199509030-00002; CHAN WL, 1992, J EXP MED, V176, P1203, DOI 10.1084/jem.176.4.1203; Chojnacki J, 2012, SCIENCE, V338, P524, DOI 10.1126/science.1226359; CRANAGE MP, 1992, LANCET, V339, P273, DOI 10.1016/0140-6736(92)91335-6; CRANAGE MP, 1993, AIDS RES HUM RETROV, V9, P13, DOI 10.1089/aid.1993.9.13; Cranage MP, 1990, ELSEVIER SCI, P103; DESROSIERS RC, 1989, P NATL ACAD SCI USA, V86, P6353, DOI 10.1073/pnas.86.16.6353; DORMONT D, 1995, VACCINE, V13, P295; GARDNER M, 1995, AIDS RES HUM RETROV, V11, P843, DOI 10.1089/aid.1995.11.843; HAHN B, 1983, NATURE, V303, P253, DOI 10.1038/303253a0; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; HIRSCH VM, 1994, VIRUS RES, V32, P183, DOI 10.1016/0168-1702(94)90041-8; Hofmann-Lehmann R, 2001, J VIROL, V75, P7470, DOI 10.1128/JVI.75.16.7470-7480.2001; Huber M, 2006, PLOS MED, V3, P2078, DOI 10.1371/journal.pmed.0030441; HULSKOTTE EGJ, 1995, J VIROL, V69, P6289, DOI 10.1128/JVI.69.10.6289-6296.1995; Jiang HX, 2011, IMMUNOL RES, V49, P147, DOI 10.1007/s12026-010-8178-6; Johnson RP, 1999, J VIROL, V73, P4952, DOI 10.1128/JVI.73.6.4952-4961.1999; LEGRAND R, 1992, VACCINE, V10, P873, DOI 10.1016/0264-410X(92)90052-L; Leith JG, 2003, AIDS RES HUM RETROV, V19, P957, DOI 10.1089/088922203322588305; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Montefiori D, 2007, PLOS MED, V4, P1867, DOI 10.1371/journal.pmed.0040348; Morner A, 2011, J VIROL, V85, P6442, DOI 10.1128/JVI.00129-11; Mouquet H, 2013, NATURE, V496, P441, DOI 10.1038/nature12091; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; MURPHEYCORB M, 1989, SCIENCE, V246, P1293, DOI 10.1126/science.2555923; Page M, 2007, AIDS, V21, P375, DOI 10.1097/QAD.0b013e328012b873; PUTKONEN P, 1993, J MED PRIMATOL, V22, P100; Ranjbar S, 1997, AIDS RES HUM RETROV, V13, P797, DOI 10.1089/aid.1997.13.797; ROSE J, 1995, J VIROL METHODS, V51, P229, DOI 10.1016/0166-0934(94)00109-T; Sattentau QJ, 1999, IMMUNOL LETT, V66, P143, DOI 10.1016/S0165-2478(98)00174-6; SPEAR GT, 1993, J VIROL, V67, P53, DOI 10.1128/JVI.67.1.53-59.1993; SPEAR GT, 1993, VIROLOGY, V195, P475, DOI 10.1006/viro.1993.1398; Spruth M, 1999, AIDS RES HUM RETROV, V15, P533, DOI 10.1089/088922299311051; Stoiber H, 2005, MOL IMMUNOL, V42, P153, DOI 10.1016/j.molimm.2004.06.024; STOTT EJ, 1990, LANCET, V336, P1538, DOI 10.1016/0140-6736(90)93310-L; STOTT EJ, 1984, J HYG-CAMBRIDGE, V93, P251, DOI 10.1017/S0022172400064779; STOTT EJ, 1991, NATURE, V353, P393, DOI 10.1038/353393a0; Stott EJ, 1998, J GEN VIROL, V79, P423; Stott EJ, 1993, HUITIEME COLLOQUE DE, P131; Stott J, 1994, BIOTECHNOLOGY AIDS, P151; Sullivan BL, 1996, J IMMUNOL, V157, P1791; Sullivan BL, 1998, VIROLOGY, V248, P173, DOI 10.1006/viro.1998.9289; VALIM YML, 1991, CLIN EXP IMMUNOL, V84, P1, DOI 10.1111/j.1365-2249.1991.tb08115.x; Wang YF, 1999, NAT MED, V5, P1004, DOI 10.1038/12440; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Willey S, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-16	56	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88735	10.1371/journal.pone.0088735	http://dx.doi.org/10.1371/journal.pone.0088735			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551145	Green Published, gold, Green Submitted			2022-12-27	WOS:000331271500060
J	Sharma, Y; Chilamakuri, CSR; Bakke, M; Lenhard, B				Sharma, Yogita; Chilamakuri, Chandra Sekhar Reddy; Bakke, Marit; Lenhard, Boris			Computational Characterization of Modes of Transcriptional Regulation of Nuclear Receptor Genes	PLOS ONE			English	Article							KEY DEVELOPMENTAL GENES; EMBRYONIC STEM-CELLS; COMPARATIVE GENOMICS; VERTEBRATE GENOMES; DRUG TARGETS; SUPERFAMILY; ELEMENTS; BLOCKS; EXPRESSION; ENHANCERS	Background: Nuclear receptors are a large structural class of transcription factors that act with their co-regulators and repressors to maintain a variety of biological and physiological processes such as metabolism, development and reproduction. They are activated through the binding of small ligands, which can be replaced by drug molecules, making nuclear receptors promising drug targets. Transcriptional regulation of the genes that encode them is central to gaining a deeper understanding of the diversity of their biochemical and biophysical roles and their role in disease and therapy. Even though they share evolutionary history, nuclear receptor genes have fundamentally different expression patterns, ranging from ubiquitously expressed to tissue-specific and spatiotemporally complex. However, current understanding of regulation in nuclear receptor gene family is still nascent. Methodology/Principal Findings: In this study, we investigate the relationship between long-range regulation of nuclear receptor family and their known functionality. Towards this goal, we identify the nuclear receptor genes that are potential targets based on counts of highly conserved non-coding elements. We validate our results using publicly available expression (RNA-seq) and histone modification (ChIP-seq) data from the ENCODE project. We find that nuclear receptor genes involved in developmental roles show strong evidence of long-range mechanism of transcription regulation with distinct cis-regulatory content they feature clusters of highly conserved non-coding elements distributed in regions spanning several Megabases, long and multiple CpG islands, bivalent promoter marks and statistically significant higher enrichment of enhancer mark around their gene loci. On the other hand nuclear receptor genes that are involved in tissue-specific roles lack these features, having simple transcriptional controls and a greater variety of mechanisms for producing paralogs. We further examine the combinatorial patterns of histone maps associated with dynamic functional elements in order to explore the regulatory landscape of the gene family. The results show that our proposed classification capturing long-range regulation is strongly indicative of the functional roles of the nuclear receptors compared to existing classifications. Conclusions/Significanc: We present a new classification for nuclear receptor gene family capturing whether a nuclear receptor is a possible target of long-range regulation or not. We compare our classification to existing structural (mechanism of action) and homology-based classifications. Our results show that understanding long-range regulation of nuclear receptors can provide key insight into their functional roles as well as evolutionary history; and this strongly merits further study.	[Sharma, Yogita; Bakke, Marit] Univ Bergen, Dept Biomed, Bergen, Norway; [Chilamakuri, Chandra Sekhar Reddy] Univ Bergen, Dept Clin Med, Bergen, Norway; [Lenhard, Boris] Univ London Imperial Coll Sci Technol & Med, Fac Med, Inst Clin Sci, London, England; [Lenhard, Boris] MRC Clin Sci Ctr, London, England; [Lenhard, Boris] Univ Bergen, Dept Informat, N-5008 Bergen, Norway	University of Bergen; University of Bergen; Imperial College London; University of Bergen	Lenhard, B (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Inst Clin Sci, London, England.	b.lenhard@imperial.ac.uk		Lenhard, Boris/0000-0002-1114-1509	National Program for Research in Functional Genomics in Norway (FUGE) in the Research Council of Norway; EU project NeuroXsys (FP7) [223262]; Norwegian Research Council (YFF scheme); Bergen Research Foundation; Medical Research Council (UK); MRC [MC_UP_1102/1] Funding Source: UKRI; Medical Research Council [MC_UP_1102/1] Funding Source: researchfish	National Program for Research in Functional Genomics in Norway (FUGE) in the Research Council of Norway(Research Council of Norway); EU project NeuroXsys (FP7); Norwegian Research Council (YFF scheme); Bergen Research Foundation; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	YS was supported by the National Program for Research in Functional Genomics in Norway (FUGE) in the Research Council of Norway. CSRC was supported by the EU project NeuroXsys (FP7 grant 223262). BL was supported by Norwegian Research Council (YFF scheme), Bergen Research Foundation and Medical Research Council (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hayyeh S, 2013, MOL CELL ENDOCRINOL, V368, P120, DOI 10.1016/j.mce.2012.10.027; Akalin A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r38; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Biddie SC, 2011, J NEUROENDOCRINOL, V23, P94, DOI 10.1111/j.1365-2826.2010.02079.x; Dong XJ, 2010, NUCLEIC ACIDS RES, V38, P1071, DOI 10.1093/nar/gkp1124; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Engstrom PG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r34; Engstrom PG, 2007, GENOME RES, V17, P1898, DOI 10.1101/gr.6669607; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Gao F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01588; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Hokamp Karsten, 2003, Journal of Structural and Functional Genomics, V3, P95, DOI 10.1023/A:1022661917301; Huq MDM, 2005, MOL CELL PROTEOMICS, V4, P975, DOI 10.1074/mcp.M500015-MCP200; Jetten AM, 2001, PROG NUCLEIC ACID RE, V69, P205, DOI 10.1016/S0079-6603(01)69048-2; Kikuta H, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S4; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; King DC, 2007, GENOME RES, V17, P775, DOI 10.1101/gr.5592107; Klinge CM, 2000, STEROIDS, V65, P227, DOI 10.1016/S0039-128X(99)00107-5; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Kumar R, 1999, STEROIDS, V64, P310, DOI 10.1016/S0039-128X(99)00014-8; LAUDET V, 1992, EMBO J, V11, P1003, DOI 10.1002/j.1460-2075.1992.tb05139.x; Lee SK, 2001, MOL ENDOCRINOL, V15, P241, DOI 10.1210/me.15.2.241; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; Linja MJ, 2004, CLIN CANCER RES, V10, P1032, DOI 10.1158/1078-0432.CCR-0990-3; McMorrow JP, 2011, BIOCHEM SOC T, V39, P688, DOI 10.1042/BST0390688; Navratilova Pavla, 2009, Briefings in Functional Genomics & Proteomics, V8, P333, DOI 10.1093/bfgp/elp019; Olefsky JM, 2001, J BIOL CHEM, V276, P36863, DOI 10.1074/jbc.R100047200; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Owen GI, 2000, CELL MOL LIFE SCI, V57, P809, DOI 10.1007/s000180050043; Park SP, 2013, GRAEF ARCH CLIN EXP, V251, P2299, DOI 10.1007/s00417-013-2296-5; Pascual G, 2006, TRENDS ENDOCRIN MET, V17, P321, DOI 10.1016/j.tem.2006.08.005; Pfeffer PL, 2002, DEVELOPMENT, V129, P307; Ragvin A, 2010, P NATL ACAD SCI USA, V107, P775, DOI 10.1073/pnas.0911591107; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Robinson-Rechavi M, 2003, J CELL SCI, V116, P585, DOI 10.1242/jcs.00247; Saez PJ, 2010, ELS; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Serpente P, 2005, DEVELOPMENT, V132, P503, DOI 10.1242/dev.01593; Takeda Y, 2009, J BIOCHEM, V146, P113, DOI 10.1093/jb/mvp049; Tobin JF, 2006, TRENDS ENDOCRIN MET, V17, P284, DOI 10.1016/j.tem.2006.07.004; Tomassy GS, 2010, P NATL ACAD SCI USA, V107, P3576, DOI 10.1073/pnas.0911792107; Wolf IM, 2008, J CELL BIOCHEM, V104, P1580, DOI 10.1002/jcb.21755; Xu H, 2010, BIOINFORMATICS, V26, P1199, DOI 10.1093/bioinformatics/btq128; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhang ZD, 2004, GENOME RES, V14, P580, DOI 10.1101/gr.2160004; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	48	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88880	10.1371/journal.pone.0088880	http://dx.doi.org/10.1371/journal.pone.0088880			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551185	Green Published, gold			2022-12-27	WOS:000331266000080
J	Allison, A; Pearce, CEM; Abbott, D				Allison, Andrew; Pearce, Charles E. M.; Abbott, Derek			A Variational Approach to the Analysis of Dissipative Electromechanical Systems	PLOS ONE			English	Article							FORMULATION; MECHANICS; INTEGRALS; CALCULUS	We develop a method for systematically constructing Lagrangian functions for dissipative mechanical, electrical, and electromechanical systems. We derive the equations of motion for some typical electromechanical systems using deterministic principles that are strictly variational. We do not use any ad hoc features that are added on after the analysis has been completed, such as the Rayleigh dissipation function. We generalise the concept of potential, and define generalised potentials for dissipative lumped system elements. Our innovation offers a unified approach to the analysis of electromechanical systems where there are energy and power terms in both the mechanical and electrical parts of the system. Using our novel technique, we can take advantage of the analytic approach from mechanics, and we can apply these powerful analytical methods to electrical and to electromechanical systems. We can analyse systems that include non-conservative forces. Our methodology is deterministic, and does does require any special intuition, and is thus suitable for automation via a computer-based algebra package.	[Allison, Andrew; Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia; [Pearce, Charles E. M.] Univ Adelaide, Sch Math Sci, Adelaide, SA, Australia	University of Adelaide; University of Adelaide	Allison, A (corresponding author), Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia.	aallison@eleceng.adelaide.edu.au	Allison, Andrew/AAG-8356-2019; Abbott, Derek/E-8352-2011	Allison, Andrew/0000-0003-3865-511X; Abbott, Derek/0000-0002-0945-2674				Agrawal OP, 2002, J MATH ANAL APPL, V272, P368, DOI 10.1016/S0022-247X(02)00180-4; Allison A, 2009, THESIS U ADELAIDE AD; Almeida R, 2010, J MATH PHYS, V51, DOI 10.1063/1.3319559; Almeida R, 2009, APPL MATH LETT, V22, P1816, DOI 10.1016/j.aml.2009.07.002; [Anonymous], 2000, CLASSICAL MECH; [Anonymous], 1974, MATH SCI ENG; Bauer PS, 1931, P NATL ACAD SCI USA, V17, P311, DOI 10.1073/pnas.17.5.311; Davis BR, 2001, CHAOS, V11, P747, DOI 10.1063/1.1394191; Dreisigmeyer DW, 2003, J PHYS A-MATH GEN, V36, P8297, DOI 10.1088/0305-4470/36/30/307; Dreisigmeyer DW, 2004, J PHYS A, V37; Dreisigmeyer DW, 2004, PHYSICS0402056 ARXIV; El-Nabulsi RA, 2008, J MATH PHYS, V49, DOI 10.1063/1.2929662; Feynman R. P., 1963, FEYNMAN LECT PHYS, V3; Fowles GR, 1962, ANAL MECH; Frederico GSF, 2008, NONLINEAR DYNAM, V53, P215, DOI 10.1007/s11071-007-9309-z; Frederico GSF, 2007, J MATH ANAL APPL, V334, P834, DOI 10.1016/j.jmaa.2007.01.013; Frederico GSF, 2010, APPL MATH COMPUT, V217, P1023, DOI 10.1016/j.amc.2010.01.100; Gelfand I. M., 1963, CALCULUS VARIATIONS; Gelfand I.M., 1991, CALCULUS VARIATIONS; Giesecke F, 1980, TECHNICAL DRAWING; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; ILLERT C, 1989, NUOVO CIMENTO D, V11, P761, DOI 10.1007/BF02451562; JAYNES ET, 1980, ANNU REV PHYS CHEM, V31, P579, DOI 10.1146/annurev.pc.31.100180.003051; Kane C, 1999, J MATH PHYS, V40, P3353, DOI 10.1063/1.532892; Karnopp DC., 2000, SYSTEM DYNAMICS MODE; Kirchhoff GR., 1848, ANN PHYS-NEW YORK, V75, P1891, DOI 10.1002/andp.18481511003; Lamb H, 1946, DYNAMICS; Lanczos C., 1949, VARIATIONAL PRINCIPL; Lomen D, 1988, DIFFERENTIAL EQUATIO; Malinowska, 2012, INTRO FRACTIONAL CAL; McCuskey SW, 1959, INTRO ADV DYNAMICS; Melia F, 2001, CHIC L PHYS, DOI 10.7208/chicago/9780226788449.001.0001; Middlebrook R.D., 1976, 1976 IEEE POWER ELEC, P18, DOI DOI 10.1109/PESC.1976.7072895; Musielak ZE, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/5/055205; PENFIELD P, 1966, PR INST ELECTR ELECT, V54, P1200, DOI 10.1109/PROC.1966.5079; Penrose R., 2005, ROAD REALITY; Pooseh S, 2013, ASIAN J CONTROL, V15, P698, DOI 10.1002/asjc.617; Pooseh S, 2012, COMPUT MATH APPL, V64, P3090, DOI 10.1016/j.camwa.2012.01.068; Post E., 1997, FORMAL STRUCTURE ELE; Post E. G., 1962, FORMAL STRUCTURE ELE; Rabei EM., 2004, TURK J PHYS, V28, P213; Rabenstein AL, 1972, INTRO ORDINARY DIFFE; Reif F., 1965, FUNDAMENTALS STAT TH; Reif F., 1985, FUNDAMENTALS STAT TH; Resnick R, 1960, PHYSICS; Riewe F, 1996, PHYS REV E, V53, P1890, DOI 10.1103/PhysRevE.53.1890; Riewe F, 1997, PHYS REV E, V55, P3581, DOI 10.1103/PhysRevE.55.3581; Smith D., 1974, VARIATIONAL METHODS; Smith D. R., 1998, VARIATIONAL METHODS; Tonti E., 1973, ANAL MAT PURA APPL, VXCV, P331; Wannier GH, 1987, STAT PHYS; WEBER J, 1956, PHYS REV, V101, P1620, DOI 10.1103/PhysRev.101.1620; Williams Jr JH, 1996, FUNDAMENTALS APPL DY; Wylie Jr CR, 1960, ADV ENG MATH	56	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e77190	10.1371/journal.pone.0077190	http://dx.doi.org/10.1371/journal.pone.0077190			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586221	Green Published, gold			2022-12-27	WOS:000332396200002
J	Arend, N; Hilgers, KF; Campean, V; Karpe, B; Cordasic, N; Klanke, B; Amann, K				Arend, Nicole; Hilgers, Karl F.; Campean, Valentina; Karpe, Britta; Cordasic, Nada; Klanke, Bernd; Amann, Kerstin			Darbepoetin Alpha Reduces Oxidative Stress and Chronic Inflammation in Atherosclerotic Lesions of Apo E Deficient Mice in Experimental Renal Failure	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ACUTE MYOCARDIAL-INFARCTION; ASYMMETRIC DIMETHYLARGININE; ACCELERATED ATHEROSCLEROSIS; ERYTHROPOIETIN SUPPRESSES; CARDIOVASCULAR MORTALITY; VASCULAR CALCIFICATION; ADHESION; ICAM-1; CELLS	Background: Cardiovascular morbidity and mortality is very important in patients with chronic renal failure. This occurs even in mild impairment of renal function and may be related to oxidative stress and chronic inflammation. The nephrectomized apo E knockout mouse is an accepted model for evaluating atherosclerosis in renal dysfunction. Erythropoietin derivates showed anti-oxidative and anti-inflammatory effects. Therefore, this study evaluates the effects of Darbepoetin on markers of oxidative stress and chronic inflammation in atherosclerotic lesions in apo E knockout mice with renal dysfunction. Methods: Apo E knockout mice underwent unilateral (Unx, n = 20) or subtotal (Snx, n = 26) nephrectomy or sham operation (Sham, n = 16). Mice of each group were either treated with Darbepoetin or saline solution, a part of Snx mice received a tenfold higher dose of Darbepoetin. The aortic plaques were measured and morphologically characterized. Additional immunhistochemical analyses were performed on tissue samples taken from the heart and the aorta. Results: Both Unx and Snx mice showed increased expression of markers of oxidative stress and chronic inflammation. While aortic plaque size was not different, Snx mice showed advanced plaque stages when compared to Unx mice. Darbepoetin treatment elevated hematocrit and lowered Nitrotyrosin as one marker of oxidative stress, inflammation in heart and aorta, plaque stage and in the high dose even plaque cholesterol content. In contrast, there was no influence of Darbepoetin on aortic plaque size; high dose Darbepoetin treatment resulted in elevated renal serum parameters. Conclusion: Darbepoetin showed some protective cardiovascular effects irrespective of renal function, i.e. it improved plaque structure and reduced some signs of oxidative stress and chronic inflammation without affecting plaque size. Nevertheless, the dose dependent adverse effects must be considered as high Darbepoetin treatment elevated serum urea. Elevation of hematocrit might be a favorable effect in anemic Snx animals but a thrombogenic risk in Sham animals.	[Arend, Nicole; Hilgers, Karl F.; Cordasic, Nada; Klanke, Bernd] Univ Erlangen Nurnberg, Dept Internal Med Nephrol, D-91054 Erlangen, Germany; [Campean, Valentina; Karpe, Britta; Amann, Kerstin] Univ Erlangen Nurnberg, Dept Nephropathol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Arend, N (corresponding author), Univ Munich, Dept Ophthalmol, Munich, Germany.	Nicole.arend@med.uni-muenchen.de			Interdisciplinary Centre for Clinical Research (IZKF) at the University Hospital of the University of Erlangen-Nurnberg [A11, F1]; AMGEN Co.	Interdisciplinary Centre for Clinical Research (IZKF) at the University Hospital of the University of Erlangen-Nurnberg; AMGEN Co.	The study was supported by the Interdisciplinary Centre for Clinical Research (IZKF) at the University Hospital of the University of Erlangen-Nurnberg (Projects No. A11 and F1), and by a grant from AMGEN Co. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann K, 2002, CLIN NEPHROL, V58, pS62; Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Bahlmann FH, 2004, CIRCULATION, V110, P1006, DOI 10.1161/01.CIR.0000139335.04152.F3; Bahlmann FH, 2004, BLOOD, V103, P921, DOI 10.1182/blood-2003-04-1284; Bernardi S, 2011, NEPHROL DIAL TRANSPL, V26, P832, DOI 10.1093/ndt/gfq524; Bourdillon MC, 2000, ARTERIOSCL THROM VAS, V20, P2630, DOI 10.1161/01.ATV.20.12.2630; Bro S, 2004, J AM SOC NEPHROL, V15, P1495, DOI 10.1097/01.ASN.0000128371.33195.7B; Bro S, 2003, J AM SOC NEPHROL, V14, P2466, DOI 10.1097/01.ASN.0000088024.72216.2E; Buzello M, 2003, J AM SOC NEPHROL, V14, P311, DOI 10.1097/01.ASN.0000045048.71975.FC; Cai ZQ, 2003, CIRCULATION, V108, P79, DOI 10.1161/01.CIR.0000078635.89229.8A; Campean V, 2005, KIDNEY BLOOD PRESS R, V28, P280, DOI 10.1159/000090182; Campean V, 2007, ATHEROSCLEROSIS, V190, P156, DOI 10.1016/j.atherosclerosis.2006.01.014; Cases A, 2002, NEFROLOGIA, V22, P68; Chatterjee PK, 2005, LANCET, V365, P1890, DOI 10.1016/S0140-6736(05)66622-6; Collins AJ, 2003, AM J MED SCI, V325, P163, DOI 10.1097/00000441-200304000-00002; Del Vecchio L, 2011, SEMIN DIALYSIS, V24, P56, DOI 10.1111/j.1525-139X.2010.00819.x; Dessi Mariarita, 2013, ISRN Inflamm, V2013, P191823, DOI 10.1155/2013/191823; DURSUN E, 2009, ACTA HISTOCHEM; Egrie JC, 2003, EXP HEMATOL, V31, P290, DOI 10.1016/S0301-472X(03)00006-7; FRIED W, 1995, ANNU REV NUTR, V15, P353, DOI 10.1146/annurev.nu.15.070195.002033; Frostegard J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-117; FUSTER V, 1990, CIRCULATION, V82, P47; Gocmen AY, 2008, CLIN BIOCHEM, V41, P836, DOI 10.1016/j.clinbiochem.2008.04.006; Horton DB, 2001, ANN NY ACAD SCI, V947, P329; Iseki K, 2000, AM J KIDNEY DIS, V36, P820, DOI 10.1053/ajkd.2000.17676; Ivanovski O, 2005, KIDNEY INT, V67, P2288, DOI 10.1111/j.1523-1755.2005.00332.x; Jungers P, 1997, NEPHROL DIAL TRANSPL, V12, P2597, DOI 10.1093/ndt/12.12.2597; Kahraman S, 2005, NEPHROLOGY, V10, P264, DOI 10.1111/j.1440-1797.2005.00405.x; Katavetin P, 2007, KIDNEY INT, V72, pS10, DOI 10.1038/sj.ki.5002482; Kielstein JT, 2002, J AM SOC NEPHROL, V13, P170, DOI 10.1681/ASN.V131170; Knox JB, 1997, CIRCULATION, V95, P205, DOI 10.1161/01.CIR.95.1.205; Kourea K, 2008, ATHEROSCLEROSIS, V199, P215, DOI 10.1016/j.atherosclerosis.2007.09.039; Lee JH, 2007, J KOREAN MED SCI, V22, P1042, DOI 10.3346/jkms.2008.22.6.1042; Lee Seung Hun, 2005, Am J Nephrol, V25, P64, DOI 10.1159/000084275; Leskinen Y, 2004, ATHEROSCLEROSIS, V175, P315, DOI 10.1016/j.atherosclerosis.2004.04.002; Li HY, 2005, AM J PHYSIOL-RENAL, V289, pF145, DOI 10.1152/ajprenal.00317.2004; Lipsic E, 2006, CARDIOVASC DRUG THER, V20, P135, DOI 10.1007/s10557-006-7680-5; Liu XM, 2006, INDIAN J MED RES, V124, P343; Lu KY, 2010, CIRCULATION, V121, P1828, DOI 10.1161/CIRCULATIONAHA.109.876839; Madjid M, 2004, ARTERIOSCL THROM VAS, V24, P1775, DOI 10.1161/01.ATV.0000142373.72662.20; Massy ZA, 2005, J AM SOC NEPHROL, V16, P109, DOI 10.1681/ASN.2004060495; Maurin N, 2010, MED KLIN, V105, P339, DOI 10.1007/s00063-010-1062-2; Meng R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053557; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Onoue K, 2009, CIRCULATION, V120, P2470, DOI 10.1161/CIRCULATIONAHA.109.867929; OPPENHEIMERMARKS N, 1991, J IMMUNOL, V147, P2913; Owczarek A, 2011, KARDIOL POL, V69, P388; Parsa CJ, 2003, J CLIN INVEST, V112, P999, DOI 10.1172/JCI200318200; Pasceri V, 2000, CIRCULATION, V102, P2165; Paul A, 2004, CIRCULATION, V109, P647, DOI 10.1161/01.CIR.0000114526.50618.24; Rao SV, 2002, CLIN AUTON RES, V12, P141, DOI 10.1007/s10286-002-0031-0; Rosenfeld ME, 2000, ARTERIOSCL THROM VAS, V20, P2587, DOI 10.1161/01.ATV.20.12.2587; Schwarz U, 2000, NEPHROL DIAL TRANSPL, V15, P218, DOI 10.1093/ndt/15.2.218; Schwedler SB, 2005, CIRCULATION, V112, P1016, DOI 10.1161/CIRCULATIONAHA.105.556530; Stohlawetz PJ, 2000, BLOOD, V95, P2983, DOI 10.1182/blood.V95.9.2983.009k27_2983_2989; Tsirpanlis G, 2007, BLOOD PURIFICAT, V25, P179, DOI 10.1159/000099011; Tyralla K, 2003, KIDNEY INT, V63, pS80, DOI 10.1046/j.1523-1755.63.s84.1.x; U. S. Renal Data System, 2007, USRDS ANN REP 2007 A; Van Biesen W, 2007, EUR HEART J, V28, P478, DOI 10.1093/eurheartj/ehl455; Warren JS, 2011, J CARDIOVASC PHARM, V57, P424, DOI 10.1097/FJC.0b013e31820d92fd; Woollard KJ, 2013, CLIN SCI, V125, P221, DOI 10.1042/CS20120576; Yamamoto S, 2011, ARTERIOSCL THROM VAS, V31, P2856, DOI 10.1161/ATVBAHA.111.237198; Yu J, 2010, BIOCHEM BIOPH RES CO, V391, P261, DOI 10.1016/j.bbrc.2009.11.046; Zhou XH, 1998, J CLIN INVEST, V101, P1717, DOI 10.1172/JCI1216; Zwaka TP, 2001, CIRCULATION, V103, P1194	66	5	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e88601	10.1371/journal.pone.0088601	http://dx.doi.org/10.1371/journal.pone.0088601			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586350	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200024
J	Hudecova, I; Sahota, D; Heung, MMS; Jin, YJ; Lee, WS; Leung, TY; Lo, YMD; Chiu, RWK				Hudecova, Irena; Sahota, Daljit; Heung, Macy M. S.; Jin, Yongjie; Lee, Wing S.; Leung, Tak Y.; Lo, Yuk Ming Dennis; Chiu, Rossa W. K.			Maternal Plasma Fetal DNA Fractions in Pregnancies with Low and High Risks for Fetal Chromosomal Aneuploidies	PLOS ONE			English	Article							CELL-FREE DNA; TRISOMIES 21	Recently published international guidelines recommend the clinical use of noninvasive prenatal test (NIPT) for aneuploidy screening only among pregnant women whose fetuses are deemed at high risk. The applicability of NIPT to aneuploidy screening among average risk pregnancies requires additional supportive evidence. A key determinant of the reliability of aneuploidy NIPT is the fetal DNA fraction in maternal plasma. In this report, we investigated if differences in fetal DNA fractions existed between different pregnancy risk groups. One hundred and ninety-five singleton pregnancies with male fetuses divided into 3 groups according to first trimester screening parameters were examined for fetal DNA percentage by counting Y chromosome DNA sequences using massively parallel sequencing. Fetal DNA fractions were compared between risk groups and assessed for correlations with first trimester screening parameters. There was no statistically significant difference in fetal DNA fractions across the high, intermediate and low risk groups. Fetal DNA fraction showed a strong negative correlation with maternal weight. Fetal DNA fraction also showed weak but significant correlations with gestational age, crown-rump length, multiple of medians of free beta-subunit of human chorionic gonadotropin and pregnancy-associated plasma protein A. Similar fetal DNA fractions in maternal plasma between high, intermediate and low risk pregnant women is a precondition for uniform performance of the aneuploidy NIPTs for the general population. This study thus shows that the aneuploidy screening by NIPT is likely to offer similar analytical reliability without respect to the a priori fetal aneuploidy risk.	[Hudecova, Irena; Heung, Macy M. S.; Jin, Yongjie; Lee, Wing S.; Lo, Yuk Ming Dennis; Chiu, Rossa W. K.] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Ctr Res Circulating Fetal Nucle Acids, Shatin, Hong Kong, Peoples R China; [Hudecova, Irena; Heung, Macy M. S.; Jin, Yongjie; Lee, Wing S.; Lo, Yuk Ming Dennis; Chiu, Rossa W. K.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China; [Sahota, Daljit; Leung, Tak Y.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Chiu, RWK (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Ctr Res Circulating Fetal Nucle Acids, Shatin, Hong Kong, Peoples R China.	rossachiu@cuhk.edu.hk	Lo, Yuk Ming Dennis/D-4468-2011	Lo, Yuk Ming Dennis/0000-0001-8746-0293; Sahota, Daljit/0000-0002-3755-2701	University Grants Committee of the Government of the Hong Kong Special Administrative Region, China, under the Areas of Excellence Scheme [AoE/M-04/06]; Sequenom, Inc.; S.K. Yee Foundation; Li Ka Shing Foundation	University Grants Committee of the Government of the Hong Kong Special Administrative Region, China, under the Areas of Excellence Scheme; Sequenom, Inc.; S.K. Yee Foundation; Li Ka Shing Foundation	This study was supported by the University Grants Committee of the Government of the Hong Kong Special Administrative Region, China, under the Areas of Excellence Scheme (AoE/M-04/06), a Sponsored Research Agreement from Sequenom, Inc. and funding from the S.K. Yee Foundation. Y.M.D. Lo is supported by an endowed chair from the Li Ka Shing Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, OBSTET GYNECOL, V120, P1532, DOI 10.1097/01.AOG.0000423819.85283.f4; Ashoor G, 2013, ULTRASOUND OBST GYN, V41, P26, DOI 10.1002/uog.12331; Ashoor G, 2012, FETAL DIAGN THER, V31, P237, DOI 10.1159/000337373; Benn P, 2012, PRENATAL DIAG, V32, P1, DOI 10.1002/pd.2919; Brar H, 2013, J MATERN-FETAL NEO M, V26, P143, DOI 10.3109/14767058.2012.722731; Canick JA, 2013, PRENAT DIAGN, P1; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Dan S, 2012, PRENATAL DIAG, V32, P1225, DOI 10.1002/pd.4002; Ehrich M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.060; Fairbrother G, 2013, PRENATAL DIAG, V33, P580, DOI 10.1002/pd.4092; Gregg AR, 2013, GENET MED, V15, P395, DOI 10.1038/gim.2013.29; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Nicolaides K H, 2013, PRENAT DIAGN, V33, P1; Nicolaides KH, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.033; Norton ME, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.021; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Sahota DS, 2010, ULTRASOUND OBST GYN, V36, P15, DOI 10.1002/uog.7677; Sparks A, 2012, AM J OBSTET GYNECOL, V206, pS314, DOI 10.1016/j.ajog.2011.10.725	18	71	92	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e88484	10.1371/journal.pone.0088484	http://dx.doi.org/10.1371/journal.pone.0088484			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586333	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200021
J	Robillard, R; Naismith, SL; Smith, KL; Rogers, NL; White, D; Terpening, Z; Ip, TKC; Hermens, DF; Whitwell, B; Scott, EM; Hickie, IB				Robillard, Rebecca; Naismith, Sharon L.; Smith, Kristie Leigh; Rogers, Naomi L.; White, Django; Terpening, Zoe; Ip, Tony K. C.; Hermens, Daniel F.; Whitwell, Bradley; Scott, Elizabeth M.; Hickie, Ian B.			Sleep-Wake Cycle in Young and Older Persons with a Lifetime History of Mood Disorders	PLOS ONE			English	Article							HUMAN CIRCADIAN-RHYTHMS; MENTAL-HEALTH-SERVICES; AGE-RELATED-CHANGES; PHYSICAL-ACTIVITY; MAJOR DEPRESSION; DAYTIME SLEEPINESS; PHASE ADVANCE; UNITED-STATES; LIGHT THERAPY; EEG SLEEP	Considering the marked changes in sleep and circadian rhythms across the lifespan, age may contribute to the heterogeneity in sleep-wake profiles linked to mood disorders. This study aimed to investigate the contributions of age and depression severity to sleep-wake disturbances. The Hamilton Depression Rating Scale (HDRS) was administered to assess current symptoms severity in 238 persons with a history of a mood disorder between 12 and 90 years of age (y.o.). Actigraphy was recorded over five to 22 days. Regression analyses and analyses of variance [age (12-19 y.o., 20-39 y.o., 40-59 y.o., and >= 60 y.o.) by depression severity (HDRS< and >= 8)] were conducted. The 12-19 y.o. and 20-39 y.o. groups had a delayed sleep schedule and acrophase compared to all other groups. The >= 60 y.o. group had a lower rhythmicity and amplitude (p <=.006) than the 12-19 y.o. group (p <=.046). Participants with a HDRS >= 8 spent longer time in bed, had later sleep offset times and had lower circadian rhythmicity than those with a HDRS < 8 (p <=.036). Younger age and higher HDRS score correlated with later sleep onset and offset times, longer time in bed, higher WASO, lower sleep efficiency and later acrophase (p <=.023). Age was a significant predictor of delayed sleep and activity schedules (p <=.001). The profile of sleep-wake cycle disturbances associated with mood disorders changes with age, with prominent sleep phase delay during youth and reduced circadian strength in older persons. Conversely, disruptions in sleep consolidation seem more stable across age.	[Robillard, Rebecca; Naismith, Sharon L.; Smith, Kristie Leigh; White, Django; Terpening, Zoe; Ip, Tony K. C.; Hermens, Daniel F.; Whitwell, Bradley; Scott, Elizabeth M.; Hickie, Ian B.] Univ Sydney, Clin Res Unit, Brain & Mind Res Inst, Camperdown, NSW, Australia; [Naismith, Sharon L.; Terpening, Zoe] Univ Sydney, Hlth Brain Ageing Clin, Brain & Mind Res Inst, Camperdown, NSW, Australia; [Rogers, Naomi L.] Univ Sydney, Concord Clin Sch, Concord, NSW, Australia	University of Sydney; University of Sydney; University of Sydney	Hickie, IB (corresponding author), Univ Sydney, Clin Res Unit, Brain & Mind Res Inst, Camperdown, NSW, Australia.	ian.hickie@sydney.edu.au	Hickie, Ian B/K-8975-2015; Robillard, Rebecca/G-9045-2017	Hickie, Ian B/0000-0001-8832-9895; Hermens, Daniel/0000-0002-8570-2663; Naismith, Sharon/0000-0001-9076-2778	National Health and Medical Research Council (NHMRC) Australia Fellowship; Fonds de la recherche en sante du Quebec; NHMRC Career Development Award; National Health and Medical Research Council Australia Fellowship [464914]; Servier; Pfizer; AstraZeneca; Eli Lilly	National Health and Medical Research Council (NHMRC) Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); NHMRC Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Servier(Servier); Pfizer(Pfizer); AstraZeneca(AstraZeneca); Eli Lilly(Eli Lilly)	This study was funded from a National Health and Medical Research Council (NHMRC) Australia Fellowship awarded to IBH. RR received a postdoctoral training award from the Fonds de la recherche en sante du Quebec. Associate SLN is supported by an NHMRC Career Development Award. DFH has received honoraria for educational seminars from Janssen-Cilag and Eli Lilly. EMS is the (unpaid) Clinical Director of Headspace Services at the BMRI, the (unpaid) Coordinator of the Youth Mental Health Research Program at the BMRI, and Deputy Director of St Vincent's Private Hospital Young Adult Mental Health Unit. She has received honoraria for educational seminars related to the clinical management of depressive disorders supported by Servier and Eli Lilly pharmaceuticals. She has participated in a national advisory board for the antidepressant compound Pristiq, manufactured by Pfizer. IBH is supported by a National Health and Medical Research Council Australia Fellowship (No. 464914). He was a director of headspace: the national youth mental health foundation until January 2012. He is the executive director of the Brain and Mind Research Institute, which operates two early-intervention youth services under contract to headspace. He is a member of the new Australian National Mental Health commission and was previously the CEO of beyondblue: the national depression initiative. He has led a range of community-based and pharmaceutical industry-supported depression awareness and education and training programs. He has led depression and other mental health research projects that have been supported by a variety of pharmaceutical partners. Current investigator-initiated studies are supported by Servier and Pfizer. He has received honoraria for his contributions to professional educational seminars supported by the pharmaceutical industry (including Servier, Pfizer, AstraZeneca, and Eli Lilly. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker A, 1997, J PSYCHOSOM RES, V43, P359, DOI 10.1016/S0022-3999(97)00126-8; BENCA RM, 1992, ARCH GEN PSYCHIAT, V49, P651; Benedetti F, 2007, CHRONOBIOL INT, V24, P921, DOI 10.1080/07420520701649455; Bertocci MA, 2005, J AM ACAD CHILD PSY, V44, P1158, DOI 10.1097/01.chi.0000179057.54419.17; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Buysse DJ, 1997, BIOL PSYCHIAT, V41, P406, DOI 10.1016/S0006-3223(96)00041-8; Campbell IG, 2009, P NATL ACAD SCI USA, V106, P5177, DOI 10.1073/pnas.0812947106; Carrier J, 2002, NEUROSCI LETT, V320, P1, DOI 10.1016/S0304-3940(02)00038-1; Carrier J, 2009, PRINCIPLES PRACTICE, P22; Cho HJ, 2008, AM J PSYCHIAT, V165, P1543, DOI 10.1176/appi.ajp.2008.07121882; Colrain IM, 2011, SLEEP, V34, P1287, DOI 10.5665/SLEEP.1260; Dijk DJ, 1999, J PHYSIOL-LONDON, V516, P611, DOI 10.1111/j.1469-7793.1999.0611v.x; DOYNE EJ, 1987, J CONSULT CLIN PSYCH, V55, P748, DOI 10.1037/0022-006X.55.5.748; DRENNAN MD, 1991, J AFFECT DISORDERS, V23, P93, DOI 10.1016/0165-0327(91)90096-B; FEINBERG M, 1982, BIOL PSYCHIAT, V17, P305; Flausino NH, 2012, PSYCHOPHYSIOLOGY, V49, P186, DOI 10.1111/j.1469-8986.2011.01300.x; FOLEY DJ, 1995, SLEEP, V18, P425, DOI 10.1093/sleep/18.6.425; Germain A, 2008, HUM PSYCHOPHARM CLIN, V23, P571, DOI 10.1002/hup.964; Gibson EM, 2009, EXP GERONTOL, V44, P51, DOI 10.1016/j.exger.2008.05.007; GILLIN JC, 1981, PSYCHIAT RES, V4, P73, DOI 10.1016/0165-1781(81)90010-X; GISLASON T, 1993, J INTERN MED, V234, P31, DOI 10.1111/j.1365-2796.1993.tb00701.x; Glozier N, 2010, SLEEP, V33, P1139, DOI 10.1093/sleep/33.9.1139; Goodwin RD, 2003, PREV MED, V36, P698, DOI 10.1016/S0091-7435(03)00042-2; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Harris AHS, 2006, J AFFECT DISORDERS, V93, P79, DOI 10.1016/j.jad.2006.02.013; Hickie I, 2001, PSYCHOL MED, V31, P1403, DOI 10.1017/S0033291701004731; Hickie IB, 2009, INTERN MED J, V39, P720, DOI 10.1111/j.1445-5994.2009.02016.x; Hickie IB, 2007, PSYCHIAT RES-NEUROIM, V155, P211, DOI 10.1016/j.pscychresns.2007.01.006; Hickie IB, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-79; Hickie IB, 2011, LANCET, V378, P621, DOI 10.1016/S0140-6736(11)60095-0; Hickie IB, 1996, MED J AUSTRALIA, V164, P585, DOI 10.5694/j.1326-5377.1996.tb122199.x; Huang YL, 2002, PHYSIOL BEHAV, V76, P597, DOI 10.1016/S0031-9384(02)00733-3; Iglowstein I, 2003, PEDIATRICS, V111, P302, DOI 10.1542/peds.111.2.302; KERKHOFS M, 1988, ACTA PSYCHIAT SCAND, V77, P463, DOI 10.1111/j.1600-0447.1988.tb05152.x; Klerman EB, 2005, J BIOL RHYTHM, V20, P375, DOI 10.1177/0748730405278353; KNOWLES JB, 1990, NEUROPSYCHOPHARMACOL, V3, P251; LAUER CJ, 1991, BIOL PSYCHIAT, V29, P979, DOI 10.1016/0006-3223(91)90355-P; LEWY AJ, 1987, SCIENCE, V235, P352, DOI 10.1126/science.3798117; Manber R, 2003, SLEEP, V26, P130, DOI 10.1093/sleep/26.2.130; Manber R, 2009, CURR PSYCHIAT REP, V11, P437, DOI 10.1007/s11920-009-0066-1; Mansour HA, 2005, CHRONOBIOL INT, V22, P571, DOI 10.1081/CBI-200062413; Marler MR, 2006, STAT MED, V25, P3893, DOI 10.1002/sim.2466; Mendlowicz MV, 1999, AUST NZ J PSYCHIAT, V33, P553, DOI 10.1080/j.1440-1614.1999.00585.x; Naismith SL, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.47; Naismith SL, 2012, PROG NEUROBIOL, V98, P99, DOI 10.1016/j.pneurobio.2012.05.009; Naismith SL, 2011, J AFFECT DISORDERS, V132, P139, DOI 10.1016/j.jad.2011.02.027; Naismith SL, 2010, J GERIATR PSYCH NEUR, V23, P123, DOI 10.1177/0891988710363710; Nowakowski S, 2009, CURR NEUROL NEUROSCI, V9, P165, DOI 10.1007/s11910-009-0025-6; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Ohayon MM, 1997, ARCH INTERN MED, V157, P2645, DOI 10.1001/archinte.157.22.2645; Pandi-Perumal SR, 2009, PRINCIPLES PRACTICE, P3; Perlis ML, 1997, J AFFECT DISORDERS, V42, P209, DOI 10.1016/S0165-0327(96)01411-5; Redlin U, 1997, CHRONOBIOL INT, V14, P221, DOI 10.3109/07420529709001157; Robert JJT, 2006, SLEEP, V29, P351, DOI 10.1093/sleep/29.3.351; Robillard R, 2013, EUROPEAN PS IN PRESS; Robillard R, 2013, J AFFECT DISORDERS, V145, P260, DOI 10.1016/j.jad.2012.06.006; Robillard R, 2010, J SLEEP RES, V19, P455, DOI 10.1111/j.1365-2869.2010.00820.x; SADEH A, 1995, J AM ACAD CHILD PSY, V34, P813, DOI 10.1097/00004583-199506000-00023; Sadeh A, 2009, SLEEP, V32, P1602, DOI 10.1093/sleep/32.12.1602; Schmitt FA, 1996, SLEEP, V19, P59; Scott E, 2009, AUSTRALAS PSYCHIATRY, V17, P189, DOI 10.1080/10398560802657322; Scott EM, 2012, MED J AUSTRALIA, V196, P136, DOI 10.5694/mja11.10481; SHAPIRO CM, 1981, SCIENCE, V214, P1253, DOI 10.1126/science.7302594; SPIKER DG, 1978, BIOL PSYCHIAT, V13, P485; STEPHENS T, 1988, PREV MED, V17, P35, DOI 10.1016/0091-7435(88)90070-9; Strohle A, 2009, J NEURAL TRANSM, V116, P777, DOI 10.1007/s00702-008-0092-x; Touitou Y, 2000, CHRONOBIOL INT, V17, P369, DOI 10.1081/CBI-100101052; TUREK FW, 1989, J BIOL RHYTHM, V4, P135; VUORI I, 1988, ACTA PHYSL SCAND S, V574, P3; WEYERER S, 1992, INT J SPORTS MED, V13, P492, DOI 10.1055/s-2007-1021304; Wirz-Justice A, 2009, J AFFECT DISORDERS, V116, P159, DOI 10.1016/j.jad.2009.04.024; Youngstedt SD, 1997, SLEEP, V20, P203, DOI 10.1093/sleep/20.3.203; Zhang JH, 2013, SLEEP, V36, P671, DOI 10.5665/sleep.2624	73	45	45	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e87763	10.1371/journal.pone.0087763	http://dx.doi.org/10.1371/journal.pone.0087763			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC2ZX	24586290	Green Published, Green Submitted, gold			2022-12-27	WOS:000332385900008
J	Kittel, A; Muller, F; Konig, J; Mieth, M; Sticht, H; Zolk, O; Kralj, A; Heinrich, MR; Fromm, MF; Maas, R				Kittel, Anja; Mueller, Fabian; Koenig, Joerg; Mieth, Maren; Sticht, Heinrich; Zolk, Oliver; Kralj, Ana; Heinrich, Markus R.; Fromm, Martin F.; Maas, Renke			Alanine-glyoxylate aminotransferase 2 (AGXT2) Polymorphisms Have Considerable Impact on Methylarginine and beta-aminoisobutyrate Metabolism in Healthy Volunteers	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MASS-SPECTROMETRIC DETERMINATION; SYMMETRIC DIMETHYLARGININE; ASYMMETRIC DIMETHYLARGININE; ENDOGENOUS METHYLARGININES; RISK; INHIBITOR; MORTALITY; DISEASE; EVENTS	Elevated plasma concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine have repeatedly been linked to adverse clinical outcomes. Both methylarginines are substrates of alanine-glyoxylate aminotransferase 2 (AGXT2). It was the aim of the present study to simultaneously investigate the functional relevance and relative contributions of common AGXT2 single nucleotide polymorphisms (SNPs) to plasma and urinary concentrations of methylarginines as well as beta-aminoisobutyrate (BAIB), a prototypic substrate of AGXT2. In a cohort of 400 healthy volunteers ADMA, SDMA and BAIB concentrations were determined in plasma and urine using HPLC-MS/MS and were related to the coding AGXT2 SNPs rs37369 (p.Val140Ile) and rs16899974 (p.Val498Leu). Volunteers heterozygous or homozygous for the AGXT2 SNP rs37369 had higher SDMA plasma concentrations by 5% and 20% (p = 0.002) as well as higher BAIB concentrations by 54% and 146%, respectively, in plasma and 237% and 1661%, respectively, in urine (both p < 0.001). ADMA concentrations were not affected by both SNPs. A haplotype analysis revealed that the second investigated AGXT2 SNP rs16899974, which was not significantly linked to the other AGXT2 SNP, further aggravates the effect of rs37369 with respect to BAIB concentrations in plasma and urine. To investigate the impact of the amino acid exchange p.Val140Ile, we established human embryonic kidney cell lines stably overexpressing wild-type or mutant (p.Val140Ile) AGXT2 protein and assessed enzyme activity using BAIB and stable-isotope labeled [H-2(6)]-SDMA as substrate. In vitro, the amino acid exchange of the mutant protein resulted in a significantly lower enzyme activity compared to wild-type AGXT2 (p < 0.05). In silico modeling of the SNPs indicated reduced enzyme stability and substrate binding. In conclusion, SNPs of AGXT2 affect plasma as well as urinary BAIB and SDMA concentrations linking methylarginine metabolism to the common genetic trait of hyper-beta-aminoisobutyric aciduria.	[Kittel, Anja; Mueller, Fabian; Koenig, Joerg; Mieth, Maren; Zolk, Oliver; Fromm, Martin F.; Maas, Renke] Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, D-91054 Erlangen, Germany; [Sticht, Heinrich] Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany; [Kralj, Ana; Heinrich, Markus R.] Univ Erlangen Nurnberg, Dept Chem & Pharm, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Maas, R (corresponding author), Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, D-91054 Erlangen, Germany.	renke.maas@pharmakologie.uni-erlangen.de		Koenig, Joerg/0000-0001-7016-5482; Sticht, Heinrich/0000-0001-5644-045X; Zolk, Oliver/0000-0002-8220-3834; Heinrich, Markus/0000-0001-7113-2025	Medical Faculty of the Friedrich-Alexander-Universitat Erlangen-Nurnberg to Renke Maas; Jorg Konig [Interdisciplinary Center for Clinical Research (IZKF)] [TP F02]	Medical Faculty of the Friedrich-Alexander-Universitat Erlangen-Nurnberg to Renke Maas; Jorg Konig [Interdisciplinary Center for Clinical Research (IZKF)]	The present study was supported in part by a grant of the Medical Faculty of the Friedrich-Alexander-Universitat Erlangen-Nurnberg to Renke Maas and Jorg Konig [Interdisciplinary Center for Clinical Research (IZKF): TP F02], which included a PhD scholarship for Anja Kittel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atzler D, 2011, J CHROMATOGR B, V879, P2294, DOI 10.1016/j.jchromb.2011.06.016; BLUMBERG BS, 1959, NATURE, V184, P1990, DOI 10.1038/1841990a0; BOGER RH, 2009, INT J PHARM RES, V60, P481, DOI DOI 10.1016/J.PHRS.2009.07.001; Caplin B, 2012, ARTERIOSCL THROM VAS, V32, P2892, DOI 10.1161/ATVBAHA.112.254078; Cardounel AJ, 2007, J BIOL CHEM, V282, P879, DOI 10.1074/jbc.M603606200; CRUMPLER HR, 1951, NATURE, V167, P307, DOI 10.1038/167307a0; DEGROUCHY J, 1957, AM J HUM GENET, V9, P76; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Jacobi J, 2008, AM J PHYSIOL-HEART C, V294, pH1058, DOI 10.1152/ajpheart.01103.2007; Kielstein JT, 2006, NEPHROL DIAL TRANSPL, V21, P2446, DOI 10.1093/ndt/gfl292; Kittel A, 2013, BIOCHEM BIOPH RES CO, V430, P84, DOI 10.1016/j.bbrc.2012.11.008; KLEBER M, 2013, CLIN RES CONTROL S1, V102, pV944; KONTANI Y, 1993, BIOCHIM BIOPHYS ACTA, V1156, P161, DOI 10.1016/0304-4165(93)90131-Q; Leiper J, 2007, NAT MED, V13, P198, DOI 10.1038/nm1543; Luneburg N, 2011, BRIT J CLIN PHARMACO, V72, P42; Lueneburg N, 2011, CIRCULATION, V124; Maas R, 2009, PHARMACOL RES, V60, P475, DOI 10.1016/j.phrs.2009.07.012; Malashkevich VN, 1999, J MOL BIOL, V294, P193, DOI 10.1006/jmbi.1999.3254; Meinitzer A, 2011, CLIN CHEM, V57, P112, DOI 10.1373/clinchem.2010.150854; Nicholson G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002270; OGAWA T, 1987, ARCH BIOCHEM BIOPHYS, V252, P526, DOI 10.1016/0003-9861(87)90060-9; Rhee EP, 2013, CELL METAB, V18, P130, DOI 10.1016/j.cmet.2013.06.013; Rodionov RN, 2010, J BIOL CHEM, V285, P5385, DOI 10.1074/jbc.M109.091280; Sanchez R, 2000, METH MOL B, V143, P97; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Schepers E, 2009, NEPHROL DIAL TRANSPL, V24, P1429, DOI 10.1093/ndt/gfn670; Schmidt C, 2005, J INHERIT METAB DIS, V28, P1109, DOI 10.1007/s10545-005-0133-7; Schnabel R, 2005, CIRC RES, V97, P53, DOI 10.1161/01.RES.0000181286.44222.61; Schulze F, 2010, ATHEROSCLEROSIS, V208, P518, DOI 10.1016/j.atherosclerosis.2009.06.039; Schwedhelm E, 2007, J CHROMATOGR B, V851, P211, DOI 10.1016/j.jchromb.2006.11.052; Schwedhelm E, 2011, CLIN CHEM LAB MED, V49, P1907, DOI 10.1515/CCLM.2011.679; SEPPALA I, 2013, EUR HEART J; Siegerink B, 2013, CLIN RES CARDIOL, V102, P193, DOI 10.1007/s00392-012-0515-4; Strobel J, 2012, J MOL CELL CARDIOL, V53, P392, DOI 10.1016/j.yjmcc.2012.06.002; Suhre K, 2011, NAT GENET, V43, P565, DOI 10.1038/ng.837; VALLANCE P, 1992, LANCET, V339, P572; Wang SJ, 2012, CLIN ANAT, V25, P12, DOI 10.1002/ca.21209	38	31	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e88544	10.1371/journal.pone.0088544	http://dx.doi.org/10.1371/journal.pone.0088544			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586340	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700007
J	Hsieh, KP; Chen, LC; Cheung, KL; Chang, CS; Yang, YH				Hsieh, Kun-Pin; Chen, Li-Chia; Cheung, Kwok-Leung; Chang, Chao-Sung; Yang, Yi-Hsin			Interruption and Non-Adherence to Long-Term Adjuvant Hormone Therapy Is Associated with Adverse Survival Outcome of Breast Cancer Women - An Asian Population-Based Study	PLOS ONE			English	Article							ENDOCRINE THERAPY; ADHERENCE; TAMOXIFEN; RECURRENCE; MORTALITY; COHORT; RATES	This study aimed to evaluate the survival rate of women with breast cancer (BC) comparing persistence versus interruption and adherence versus non-adherence to adjuvant hormonal therapy (HT) in Asian population. Newly-diagnosed BC women from 2003 to 2010 were retrospectively identified from the Taiwan National Health Insurance Research Database. HT prescriptions were extracted to define treatment interruption and medication possession ratio. Their impacts on mortality were estimated by Cox regression with time dependent covariates. Interruption (HR: 1.32; 95% CI: 1.20, 1.46; P<0.0001) and non-adherence (HR: 1.45; 95% CI: 1.32, 1.59; P<0.0001) to adjuvant HT were significantly associated with increased mortality. Interruption to tamoxifen in younger patients and in patients receiving surgery (OP) with adjuvant chemotherapy (CT) was associated with increasing mortality rate when compared with their counterparts. Non-adherence to AIs in both younger and senior age groups and in OP with CT group also resulted in increasing risk. Treatment interruption and non-adherence to adjuvant HT were found to be associated with the increasing all-cause mortality of the Asian BC women; a greater impact of interruption and non-adherence on mortality was especially found in the younger BC population.	[Hsieh, Kun-Pin; Yang, Yi-Hsin] Kaohsiung Med Univ, Coll Pharm, Sch Pharm, Kaohsiung, Taiwan; [Hsieh, Kun-Pin] Kaohsiung Med Univ Hosp, Dept Pharm, Kaohsiung, Taiwan; [Chen, Li-Chia] Univ Nottingham, Sch Pharm, Div Social Res Med & Hlth, Nottingham NG7 2RD, England; [Cheung, Kwok-Leung] Univ Nottingham, Sch Grad Entry Med & Hlth, Div Breast Surg, Derby, England; [Chang, Chao-Sung] Kaohsiung Med Univ, Coll Hlth Sci, Dept Hlth Adm & Med Informat, Kaohsiung, Taiwan; [Yang, Yi-Hsin] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; University of Nottingham; University of Nottingham; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Yang, YH (corresponding author), Kaohsiung Med Univ, Coll Pharm, Sch Pharm, Kaohsiung, Taiwan.	yihsya@kmu.edu.tw	Yang, Yi-Hsin/D-6471-2012; Thomas, Kendra/Y-2600-2019	Yang, Yi-Hsin/0000-0002-9581-2778; Hsieh, Kun-Pin/0000-0003-1565-2936; Cheung, Kwok-Leung/0000-0003-2973-0755; Chen, Li-Chia/0000-0002-6158-6645	National Science Council, Taiwan [NSC 101-2320-B-037-028]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council (NSC 101-2320-B-037-028), Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Barron TI, 2007, CANCER-AM CANCER SOC, V109, P832, DOI 10.1002/cncr.22485; Bureau of Health Promotion, 2012, CANC REG ANN REP 200; Chlebowski RT, 2006, ONCOLOGY-BASEL, V71, P1, DOI 10.1159/000100444; Grymonpre R, 2006, MED CARE, V44, P471, DOI 10.1097/01.mlr.0000207817.32496.cb; Hershman DL, 2011, BREAST CANCER RES TR, V126, P529, DOI 10.1007/s10549-010-1132-4; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Leong SPL, 2010, WORLD J SURG, V34, P2308, DOI 10.1007/s00268-010-0683-1; Makubate B, 2013, BRIT J CANCER, V108, P1515, DOI 10.1038/bjc.2013.116; McCowan C, 2008, BRIT J CANCER, V99, P1763, DOI 10.1038/sj.bjc.6604758; Murphy CC, 2012, BREAST CANCER RES TR, V134, P459, DOI 10.1007/s10549-012-2114-5; NCCN Clinical Practice Guidelines in Oncology, 2012, NCCN CLIN PRACT GUID; Nekhlyudov L, 2011, BREAST CANCER RES TR, V130, P681, DOI 10.1007/s10549-011-1703-z; Osborne CK, 1998, NEW ENGL J MED, V339, P1609, DOI 10.1056/NEJM199811263392207; Partridge AH, 2008, J CLIN ONCOL, V26, P556, DOI 10.1200/JCO.2007.11.5451; Ruddy KJ, 2009, ANN ONCOL, V20, P401, DOI 10.1093/annonc/mdp039; Rutqvist LE, 1996, J NATL CANCER I, V88, P1543; Saphner T, 1996, J CLIN ONCOL, V14, P2738, DOI 10.1200/JCO.1996.14.10.2738; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Winer EP, 2005, J CLIN ONCOL, V23, P619, DOI 10.1200/JCO.2005.09.121	20	50	50	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e87027	10.1371/journal.pone.0087027	http://dx.doi.org/10.1371/journal.pone.0087027			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586261	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900007
J	Horta, MAC; Vicentini, R; Delabona, PD; Laborda, P; Crucello, A; Freitas, S; Kuroshu, RM; Polikarpov, I; Pradella, JGD; Souza, AP				Crivelente Horta, Maria Augusta; Vicentini, Renato; Delabona, Priscila da Silva; Laborda, Prianda; Crucello, Aline; Freitas, Sindelia; Kuroshu, Reginaldo Massanobu; Polikarpov, Igor; da Cruz Pradella, Jose Geraldo; Souza, Anete Pereira			Transcriptome Profile of Trichoderma harzianum IOC-3844 Induced by Sugarcane Bagasse	PLOS ONE			English	Article							SEQUENCE-BASED CLASSIFICATION; CELLULASE PRODUCTION; CELLOBIOHYDROLASE-I; GENE-EXPRESSION; HYDROLYSIS; BIOETHANOL; ENZYMES; LACTOSE; FAMILY; SCALE	Profiling the transcriptome that underlies biomass degradation by the fungus Trichoderma harzianum allows the identification of gene sequences with potential application in enzymatic hydrolysis processing. In the present study, the transcriptome of T. harzianum IOC-3844 was analyzed using RNA-seq technology. The sequencing generated 14.7 Gbp for downstream analyses. De novo assembly resulted in 32,396 contigs, which were submitted for identification and classified according to their identities. This analysis allowed us to define a principal set of T. harzianum genes that are involved in the degradation of cellulose and hemicellulose and the accessory genes that are involved in the depolymerization of biomass. An additional analysis of expression levels identified a set of carbohydrate-active enzymes that are upregulated under different conditions. The present study provides valuable information for future studies on biomass degradation and contributes to a better understanding of the role of the genes that are involved in this process.	[Crivelente Horta, Maria Augusta; Vicentini, Renato; Laborda, Prianda; Crucello, Aline; Souza, Anete Pereira] Univ Campinas UNICAMP, CBMEG, Campinas, SP, Brazil; [Delabona, Priscila da Silva; Freitas, Sindelia; da Cruz Pradella, Jose Geraldo] Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Bioethanol Sci & Technol Lab CTBE, Campinas, SP, Brazil; [Kuroshu, Reginaldo Massanobu; Polikarpov, Igor] Univ Sao Paulo, Phys Inst Sao Carlos, Sao Carlos, SP, Brazil; [Kuroshu, Reginaldo Massanobu] Fed Univ Sao Paulo UNIFESP, Inst Sci & Technol, Sao Jose Dos Campos, SP, Brazil; [Souza, Anete Pereira] Univ Campinas UNICAMP, Dept Plant Biol, Inst Biol, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Estadual de Campinas	Souza, AP (corresponding author), Univ Campinas UNICAMP, CBMEG, Campinas, SP, Brazil.	anete@unicamp.br	Horta, Maria/Q-6194-2019; Laborda, Prianda/E-9911-2013; DE SOUZA, ANETE PEREIRA/B-8663-2012; da Silva Delabona, Priscila/Q-9515-2016; DA CRUZ PRADELLA, JOSE GERALDO/AAA-7022-2019; Polikarpov, Igor/D-2575-2012; Horta, Maria/N-5051-2016; Vicentini, Renato/C-5967-2012; Crucello, Aline/AHD-3584-2022	Horta, Maria/0000-0003-2159-5296; DE SOUZA, ANETE PEREIRA/0000-0003-3831-9829; DA CRUZ PRADELLA, JOSE GERALDO/0000-0002-2902-0983; Horta, Maria/0000-0003-2159-5296; Polikarpov, Igor/0000-0001-9496-4174; Freitas, Sindelia/0000-0002-9641-8844	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPq	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (http://www.fapesp.br/) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPq (http://www.cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Banerjee G, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-22; Banerjee G, 2010, BIOENERG RES, V3, P82, DOI 10.1007/s12155-009-9067-5; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Colussi F, 2011, J MICROBIOL BIOTECHN, V21, P808, DOI 10.4014/jmb.1010.10037; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; de Castro AM, 2010, APPL BIOCHEM BIOTECH, V162, P1612, DOI 10.1007/s12010-010-8942-z; Delabona PD, 2012, BIORESOURCE TECHNOL, V107, P517, DOI 10.1016/j.biortech.2011.12.048; Eriksson T, 2002, APPL BIOCHEM BIOTECH, V101, P41, DOI 10.1385/ABAB:101:1:41; Fang X, 2008, J BIOSCI BIOENG, V106, P115, DOI 10.1263/jbb.106.115; Fuglsang CC, 2000, J BIOL CHEM, V275, P2009, DOI 10.1074/jbc.275.3.2009; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Hermosa R, 2012, MICROBIOL-SGM, V158, P17, DOI 10.1099/mic.0.052274-0; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; JONES JDG, 1985, EMBO J, V4, P2411, DOI 10.1002/j.1460-2075.1985.tb03949.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Karaffa L, 2006, MICROBIOL-SGM, V152, P1507, DOI 10.1099/mic.0.28719-0; Liu HQ, 2012, BIODEGRADATION, V23, P465, DOI 10.1007/s10532-011-9525-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo CM, 2010, PROCESS BIOCHEM, V45, P1494, DOI 10.1016/j.procbio.2010.05.031; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; Maeda RN, 2011, PROCESS BIOCHEM, V46, P1196, DOI 10.1016/j.procbio.2011.01.022; Mandel M, 1969, ADV CHEM SER, V95, P391, DOI [10.1021/ba-1969-0095.ch023, DOI 10.1021/BA-1969-0095.CH023]; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Meyer AS, 2009, J CEREAL SCI, V50, P337, DOI 10.1016/j.jcs.2009.01.010; Pearson WR, 2013, CURRENT PROTOCOLS BI, V42; Rocha GJM, 2012, IND CROP PROD, V35, P274, DOI 10.1016/j.indcrop.2011.07.010; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; Soccol CR, 2010, BIORESOURCE TECHNOL, V101, P4820, DOI 10.1016/j.biortech.2009.11.067; Sorensen A, 2011, APPL BIOCHEM BIOTECH, V164, P1058, DOI 10.1007/s12010-011-9194-2; Steindorff AS, 2012, BIOL CONTROL, V61, P134, DOI 10.1016/j.biocontrol.2012.01.014; Teeri TT, 1997, TRENDS BIOTECHNOL, V15, P160, DOI 10.1016/S0167-7799(97)01032-9; Urbanszki K, 2000, BIOTECHNOL LETT, V22, P65, DOI 10.1023/A:1005654514980; Van Dyk JS, 2012, BIOTECHNOL ADV, V30, P1458, DOI 10.1016/j.biotechadv.2012.03.002; van Vliet AHM, 2010, FEMS MICROBIOL LETT, V302, P1, DOI 10.1111/j.1574-6968.2009.01767.x; Vinale F, 2008, SOIL BIOL BIOCHEM, V40, P1, DOI 10.1016/j.soilbio.2007.07.002	47	22	23	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88689	10.1371/journal.pone.0088689	http://dx.doi.org/10.1371/journal.pone.0088689			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558413	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700059
J	Geng, PL; Li, JJ; Ou, JJ; Xie, GF; Wang, N; Xiang, LS; Sa, RN; Liu, C; Li, HT; Liang, HJ				Geng, Peiliang; Li, Jianjun; Ou, Juanjuan; Xie, Ganfeng; Wang, Ning; Xiang, Lisha; Sa, Rina; Liu, Chen; Li, Hongtao; Liang, Houjie			Association of Fas-1377 G/A Polymorphism with Susceptibility to Cancer	PLOS ONE			English	Article							DEATH PATHWAY GENES; FAS LIGAND GENES; SYSTEMIC-LUPUS-ERYTHEMATOSUS; FUNCTIONAL POLYMORPHISMS; CELL-DEATH; LUNG-CANCER; RISK; APOPTOSIS; METAANALYSIS; LYMPHOCYTES	Background: The relationship between Fas - 1377 G/A polymorphism and cancer susceptibility has been implicated in accumulating data. However, the data presented inconsistent results. This study was devised to investigate the association of Fas - 1377 G/A polymorphism and cancer susceptibility in a large number of participants. Methods: The databases of PubMed, Embase, and Web of Science were searched and a total of 27 case-control studies including 13,355 cases and 16,078 controls were included in this meta-analysis. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using the fixed-effects model. Statistical analyses were performed by using Stata software. Results: The results suggested that Fas - 1377 G/A polymorphism was overall associated with cancer susceptibility (additive model: OR, 1.16, 95% CI = 1.06-1.27, P-heterogeneity = 0.381; recessive model: OR, 1.19, 95% CI = 1.10-1.29, P-heterogeneity = 0.137). In the subgroup analysis by cancer type, significantly increased risk was observed in breast cancer (additive model: OR, 1.24, 95% CI = 1.04-1.58, P-heterogeneity = 0.614; recessive model: OR, 1.24, 95% CI = 1.02-1.51, P-heterogeneity = 0.349) and lung cancer (recessive model: OR, 1.25, 95% CI = 1.04-1.49, P-heterogeneity = 0.090). Similarly, elevated cancer risk associated with Fas - 1377 G/A polymorphism was revealed in Asians. Conclusions: The combined results suggest that Fas - 1377 G/A polymorphism might modulate cancer susceptibility in an Asian-specific manner.	[Liang, Houjie] Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China; Third Mil Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing, Peoples R China	Army Medical University; Army Medical University	Liang, HJ (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China.	lianghoujie@sina.com			National Natural Science Foundation of China [30973430]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by grant number 30973430 from the National Natural Science Foundation of China (to HJ.L). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bredberg A, 2011, CANCER-AM CANCER SOC, V117, P440, DOI 10.1002/cncr.25440; Cao Y, 2010, MOL CARCINOGEN, V49, P944, DOI 10.1002/mc.20676; Crew KD, 2007, CARCINOGENESIS, V28, P2548, DOI 10.1093/carcin/bgm211; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gormus U, 2007, IN VIVO, V21, P663; Hajra KM, 2004, APOPTOSIS, V9, P691, DOI 10.1023/B:APPT.0000045786.98031.1d; Hashemi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053075; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; INAZAWA J, 1992, GENOMICS, V14, P821, DOI 10.1016/S0888-7543(05)80200-9; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kang S, 2008, CANCER GENET CYTOGEN, V180, P1, DOI 10.1016/j.cancergencyto.2007.09.002; Karimi MY, 2013, CANCER INVEST, V31, P1, DOI 10.3109/07357907.2012.743555; Kim HJ, 2010, DNA CELL BIOL, V29, P619, DOI 10.1089/dna.2010.1032; Koshkina NV, 2007, J PEDIAT HEMATOL ONC, V29, P815, DOI 10.1097/MPH.0b013e3181581506; Krippl P, 2004, J NATL CANCER I, V96, P1478, DOI 10.1093/jnci/djh289; Kupcinskas J, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-112; Lai HC, 2005, GYNECOL ONCOL, V99, P113, DOI 10.1016/j.ygyno.2005.05.010; Lee YH, 2012, MOL BIOL REP, V39, P10671, DOI 10.1007/s11033-012-1957-5; Li CP, 2006, PHARMACOGENET GENOM, V16, P245, DOI 10.1097/01.fpc.0000194425.58511.a7; Li CY, 2006, PHARMACOGENET GENOM, V16, P253, DOI 10.1097/01.fpc.0000199501.54466.de; Li LH, 2009, MOL BIOL REP, V36, P2047, DOI 10.1007/s11033-008-9415-0; Lu MM, 2012, EXP THER MED, V4, P497, DOI 10.3892/etm.2012.625; MANTEL N, 1959, J NATL CANCER I, V22, P719; Park SH, 2006, LUNG CANCER, V54, P303, DOI 10.1016/j.lungcan.2006.09.002; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Qiu LX, 2009, HUM GENET, V125, P431, DOI 10.1007/s00439-009-0639-4; Raff M, 1998, NATURE, V396, P119, DOI 10.1038/24055; Shivapurkar N, 2003, J CELL BIOCHEM, V88, P885, DOI 10.1002/jcb.10440; Sibley K, 2003, CANCER RES, V63, P4327; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sun T, 2004, JNCI-J NATL CANCER I, V96, P1030, DOI 10.1093/jnci/djh187; Sun T, 2005, J EXP MED, V202, P967, DOI 10.1084/jem.20050707; Ter-Minassian M, 2008, CARCINOGENESIS, V29, P2147, DOI 10.1093/carcin/bgn205; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Wang LH, 2010, J ORAL PATHOL MED, V39, P155, DOI 10.1111/j.1600-0714.2009.00873.x; Wang WM, 2012, ONCOL LETT, V3, P625, DOI 10.3892/ol.2011.541; Xiang N, 2013, MOL BIOL REP, V40, P407, DOI 10.1007/s11033-012-2075-0; Yang M, 2008, CLIN CANCER RES, V14, P3230, DOI 10.1158/1078-0432.CCR-08-0177; Zhang BL, 2007, CARCINOGENESIS, V28, P1067, DOI 10.1093/carcin/bgl250; Zhang H, 2007, CANCER J, V13, P233, DOI 10.1097/PPO.0b013e318046f214; Zhang X, 2005, J MED GENET, V42, P479, DOI 10.1136/jmg.2004.030106; Zhang Z, 2006, CLIN CANCER RES, V12, P5596, DOI 10.1158/1078-0432.CCR-05-1739; Zhou RM, 2010, J GASTROEN HEPATOL, V25, P555, DOI 10.1111/j.1440-1746.2009.06116.x; Zhu JA, 2010, MOL CARCINOGEN, V49, P810, DOI 10.1002/mc.20656	47	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88748	10.1371/journal.pone.0088748	http://dx.doi.org/10.1371/journal.pone.0088748			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558420	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700066
J	Katz, SS; Gimble, FS; Storici, F				Katz, Samantha S.; Gimble, Frederick S.; Storici, Francesca			To Nick or Not to Nick: Comparison of I-SceI Single- and Double-Strand Break-Induced Recombination in Yeast and Human Cells	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; DNA DOUBLE-STRAND; EMBRYONIC STEM-CELLS; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; HOMING ENDONUCLEASE; MAMMALIAN-CELLS; GENE CONVERSION; HUMAN GENOME; REPAIR	Genetic modification of a chromosomal locus to replace an existing dysfunctional allele with a corrected sequence can be accomplished through targeted gene correction using the cell's homologous recombination (HR) machinery. Gene targeting is stimulated by generation of a DNA double-strand break (DSB) at or near the site of correction, but repair of the break via non-homologous end-joining without using the homologous template can lead to deleterious genomic changes such as in/del mutations, or chromosomal rearrangements. By contrast, generation of a DNA single-strand break (SSB), or nick, can stimulate gene correction without the problems of DSB repair because the uncut DNA strand acts as a template to permit healing without alteration of genetic material. Here, we examine the ability of a nicking variant of the I-SceI endonuclease (K223I I-SceI) to stimulate gene targeting in yeast Saccharomyces cerevisiae and in human embryonic kidney (HEK-293) cells. K223I I-SceI is proficient in both yeast and human cells and promotes gene correction up to 12-fold. We show that K223I I-SceI-driven recombination follows a different mechanism than wild-type I-SceI-driven recombination, thus indicating that the initial DNA break that stimulates recombination is not a low-level DSB but a nick. We also demonstrate that K223I I-SceI efficiently elevates gene targeting at loci distant from the break site in yeast cells. These findings establish the capability of the I-SceI nickase to enhance recombination in yeast and human cells, strengthening the notion that nicking enzymes could be effective tools in gene correction strategies for applications in molecular biology, biotechnology, and gene therapy.	[Katz, Samantha S.; Storici, Francesca] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Gimble, Frederick S.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA	University System of Georgia; Georgia Institute of Technology; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Storici, F (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	storici@gatech.edu		Katz, Samantha/0000-0001-8481-3444	Georgia Cancer Coalition [R9028]; National Science Foundation [MCB-1021763]; Graduate Assistance in Areas of National Need (GAANN) fellowship	Georgia Cancer Coalition; National Science Foundation(National Science Foundation (NSF)); Graduate Assistance in Areas of National Need (GAANN) fellowship(US Department of Education)	This work was supported by the Georgia Cancer Coalition (grant R9028), the National Science Foundation (grant MCB-1021763), and a Graduate Assistance in Areas of National Need (GAANN) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT CB, 1993, P NATL ACAD SCI USA, V90, P5613, DOI 10.1073/pnas.90.12.5613; Bonetti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014142; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE; Davis L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023981; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0; Donoho G, 1998, MOL CELL BIOL, V18, P4070, DOI 10.1128/MCB.18.7.4070; Galli A, 1998, GENETICS, V149, P1235; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; HINNEN A, 1978, P NATL ACAD SCI USA, V75, P1929, DOI 10.1073/pnas.75.4.1929; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Ivanov EL, 1996, GENETICS, V142, P693; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Karran P, 2000, CURR OPIN GENET DEV, V10, P144, DOI 10.1016/S0959-437X(00)00069-1; Kim E, 2012, GENOME RES, V22, P1327, DOI 10.1101/gr.138792.112; Kim PM, 2002, NUCLEIC ACIDS RES, V30, P2727, DOI 10.1093/nar/gkf413; Kleinstiver BP, 2012, P NATL ACAD SCI USA, V109, P8061, DOI 10.1073/pnas.1117984109; Lam KN, 2011, NUCLEIC ACIDS RES, V39, P4680, DOI 10.1093/nar/gkq1303; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Mali P, 2013, SCIENCE; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; MCDONALD JP, 1994, GENETICS, V137, P393; Metzger MJ, 2011, NUCLEIC ACIDS RES, V39, P926, DOI 10.1093/nar/gkq826; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Niu Y, 2008, J MOL BIOL, V382, P188, DOI 10.1016/j.jmb.2008.07.010; ORRWEAVER TL, 1981, P NATL ACAD SCI-BIOL, V78, P6354, DOI 10.1073/pnas.78.10.6354; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Ramirez CL, 2012, NUCLEIC ACIDS RES, V40, P5560, DOI 10.1093/nar/gks179; Richardson C, 1998, GENE DEV, V12, P3831, DOI 10.1101/gad.12.24.3831; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; Shen Y, 2011, MUTAT RES-FUND MOL M, V717, P91, DOI 10.1016/j.mrfmmm.2011.03.016; Smith AM, 2009, P NATL ACAD SCI USA, V106, P5099, DOI 10.1073/pnas.0810588106; Sokal R. R., 1981, BIOMETRY; Storici F, 2003, GENET ENG P, V25, P189; Storici F, 2003, P NATL ACAD SCI USA, V100, P14994, DOI 10.1073/pnas.2036296100; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; Storici F, 2006, MOL CELL BIOL, V26, P7645, DOI 10.1128/MCB.00672-06; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; STRATHERN JN, 1991, GENETICS, V127, P61; Stuckey S, 2013, METHODS MOL IN PRESS; Stuckey S, 2013, METHOD ENZYMOL, V533, P103, DOI 10.1016/B978-0-12-420067-8.00008-8; Stuckey S, 2011, METHODS MOL BIOL, V745, P173, DOI 10.1007/978-1-61779-129-1_11; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Wang JB, 2012, GENOME RES, V22, P1316, DOI 10.1101/gr.122879.111	48	18	20	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88840	10.1371/journal.pone.0088840	http://dx.doi.org/10.1371/journal.pone.0088840			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558436	Green Submitted, Green Published, gold			2022-12-27	WOS:000331706700082
J	Radivojevic, T; Anselmi, J; Scalas, E				Radivojevic, Tijana; Anselmi, Jonatha; Scalas, Enrico			Ergodic Transition in a Simple Model of the Continuous Double Auction	PLOS ONE			English	Article							DYNAMICS; MARKETS	We study a phenomenological model for the continuous double auction, whose aggregate order process is equivalent to two independent M/M/1 queues. The continuous double auction defines a continuous-time random walk for trade prices. The conditions for ergodicity of the auction are derived and, as a consequence, three possible regimes in the behavior of prices and logarithmic returns are observed. In the ergodic regime, prices are unstable and one can observe a heteroskedastic behavior in the logarithmic returns. On the contrary, non-ergodicity triggers stability of prices, even if two different regimes can be seen.	[Radivojevic, Tijana; Anselmi, Jonatha; Scalas, Enrico] BCAM, Bilbao, Basque Country, Spain; [Scalas, Enrico] Univ Sussex, Sch Math & Phys Sci, Dept Math, Brighton, E Sussex, England	Basque Center for Applied Mathematics (BCAM); University of Sussex	Scalas, E (corresponding author), Univ Sussex, Sch Math & Phys Sci, Dept Math, Brighton, E Sussex, England.	E.Scalas@sussex.ac.uk	Anselmi, Jonatha/ADK-5182-2022; Anselmi, Jonatha/AAG-2704-2022	Scalas, Enrico/0000-0002-1516-9285; Radivojevic, Tijana/0000-0002-7165-2909	University of Sussex	University of Sussex	This study was supported by the University of Sussex. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmussen S., 2003, APPL PROBABILITY QUE, Vsecond; Barabasi A.-L., 2010, BURSTS HIDDEN PATTER; Brandouy O, 2012, J ECON INTERACT COOR, V7, P223, DOI 10.1007/s11403-012-0099-0; Cont R, 2013, SIAM J FINANC MATH, V4, P1, DOI 10.1137/110856605; Cont R, 2010, OPER RES, V58, P549, DOI 10.1287/opre.1090.0780; Garibaldi U., 2010, FINITARY PROBABILIST, DOI DOI 10.1017/CBO9780511777585; GODE DK, 1993, J POLIT ECON, V101, P119, DOI 10.1086/261868; KENDALL DG, 1953, ANN MATH STAT, V24, P338, DOI 10.1214/aoms/1177728975; Radivojevic T., 2012, LECT NOTES EC MATH S, V662, P115; Scalas E, 2006, PHYSICA A, V362, P225, DOI 10.1016/j.physa.2005.11.024; Scalas E, 2006, PHYSICA A, V366, P463, DOI 10.1016/j.physa.2005.09.047; Smith E, 2003, QUANT FINANC, V3, P481, DOI 10.1088/1469-7688/3/6/307; Zuo S, 2009, 22 AUSTR FIN BANK C	13	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88095	10.1371/journal.pone.0088095	http://dx.doi.org/10.1371/journal.pone.0088095			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3RA	24558377	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000331706700023
J	Zhang, J; Wang, YZ; Li, GL; Yu, HT; Xie, XY				Zhang, Jun; Wang, Yanzhong; Li, Guiling; Yu, Haitao; Xie, Xinyou			Down-Regulation of Nicotinamide N-methyltransferase Induces Apoptosis in Human Breast Cancer Cells via the Mitochondria-Mediated Pathway	PLOS ONE			English	Article							CYTOCHROME-C; SH-SY5Y NEUROBLASTOMA; PROTEIN EXPRESSION; TUMOR-MARKER; CARCINOMA; IDENTIFICATION; BCL-2; GENE; BAX; ACTIVATION	Nicotinamide N-methyltransferase (NNMT) has been found involved in cell proliferation of several malignancies. However, the functional role of NNMT in breast cancer has not been elucidated. In the present study, we showed that NNMT was selectively expressed in some breast cancer cell lines, down-regulation of NNMT expression in Bcap-37 and MDA-MB-231 cell lines by NNMT shRNA significantly inhibited cell growth in vitro, decreased tumorigenicity in mice and induced apoptosis. The silencing reciprocal effect of NNMT was confirmed by over-expressing NNMT in the MCF-7 and SK-BR-3 breast cancer cell lines which lack constitutive expression of NNMT. In addition, down-regulation of NNMT expression resulted in reducing expression of Bcl-2 and Bcl-xL, up-regulation of Bax, Puma, cleaved caspase-9, cleaved caspase-3 and cleaved PARP, increasing reactive oxygen species production and release of cytochrome c from mitochondria, and decreasing the phosphorylation of Akt and ERK1/2. These data suggest that down-regulation of NNMT induces apoptosis via the mitochondria-mediated pathway in breast cancer cells.	[Zhang, Jun; Wang, Yanzhong; Li, Guiling; Yu, Haitao; Xie, Xinyou] Zhejiang Univ, Sch Med, Sir RunRun Shaw Hosp, Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Xie, Xinyou] Key Lab Biotherapy Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Xie, XY (corresponding author), Zhejiang Univ, Sch Med, Sir RunRun Shaw Hosp, Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China.	scottxie@mail.hz.zj.cn			National natural Science Foundation of China [81271914]; Zhejiang Provincial Natural Science Foundation [LY12H16025]; Science Foundation of Health Bureau of Zhejiang Province [2008B114, 2011KYA081]; Science Foundation of Education Bureau of Zhejiang Province [Y201121182]; Funds for Key Program of the Science Technology Department Zhejiang Province [2012C13019-2]	National natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Science Foundation of Health Bureau of Zhejiang Province; Science Foundation of Education Bureau of Zhejiang Province; Funds for Key Program of the Science Technology Department Zhejiang Province	This study was supported partly by the grants from National natural Science Foundation of China (81271914), Zhejiang Provincial Natural Science Foundation (LY12H16025), Science Foundation of Health Bureau of Zhejiang Province (Nos. 2008B114 and 2011KYA081), Science Foundation of Education Bureau of Zhejiang Province (Y201121182) and Funds for Key Program of the Science Technology Department Zhejiang Province (2012C13019-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; AKSOY S, 1994, J BIOL CHEM, V269, P14835; AKSOY S, 1995, GENOMICS, V29, P555, DOI 10.1006/geno.1995.9966; Bhattarai G, 2012, BIOL PHARM BULL, V35, P1711, DOI 10.1248/bpb.b12-00297; Brenner C, 2000, ONCOGENE, V19, P329, DOI 10.1038/sj.onc.1203298; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; El-Najjar N, 2010, APOPTOSIS, V15, P183, DOI 10.1007/s10495-009-0421-z; Gehrmann ML, 2004, J PROTEOME RES, V3, P403, DOI 10.1021/pr0340577; He J., 2012, CHINESE CANC REGISTR; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Iacobuzio-Donahue CA, 2002, AM J PATHOL, V160, P1239, DOI 10.1016/S0002-9440(10)62551-5; Indran IR, 2011, BBA-BIOENERGETICS, V1807, P735, DOI 10.1016/j.bbabio.2011.03.010; Jang JS, 2004, ONCOL RES, V14, P491, DOI 10.3727/0965040042380441; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kassem HS, 2002, INT J CANCER, V101, P454, DOI 10.1002/ijc.10631; Kim BM, 2009, TOXICOL APPL PHARM, V239, P87, DOI 10.1016/j.taap.2009.05.020; Kim DS, 2010, J PROTEOME RES, V9, P3710, DOI 10.1021/pr100236r; Kim J, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-20; Krech T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-287; Liao KA, 2011, J PROTEOME RES, V10, P2347, DOI 10.1021/pr101146w; Lim BH, 2006, EXP MOL MED, V38, P455, DOI 10.1038/emm.2006.54; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Parsons RB, 2011, BIOCHEM J, V436, P145, DOI 10.1042/BJ20101685; Pei JS, 2012, IN VIVO, V26, P963; Pozzi V, 2011, INT J IMMUNOPATH PH, V24, P69, DOI 10.1177/039463201102400109; Pozzi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071272; Raha S, 2001, AM J MED GENET, V106, P62, DOI 10.1002/ajmg.1398; RINI J, 1990, CLIN CHIM ACTA, V186, P359, DOI 10.1016/0009-8981(90)90322-J; Roessler M, 2005, CLIN CANCER RES, V11, P6550, DOI 10.1158/1078-0432.CCR-05-0983; Rogers CD, 2006, CANCER BIOL THER, V5, P1383, DOI 10.4161/cbt.5.10.3323; Sartini D, 2007, MOL MED, V13, P415, DOI 10.2119/2007-00035.Sartini; Sartini D, 2006, J UROLOGY, V176, P2248, DOI 10.1016/j.juro.2006.07.046; Shi XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064266; Shiozaki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043646; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Skulachev VP, 1998, FEBS LETT, V423, P275, DOI 10.1016/S0014-5793(98)00061-1; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Smith ML, 1998, BBA-GENE STRUCT EXPR, V1442, P238, DOI 10.1016/S0167-4781(98)00177-8; Tang SW, 2011, CARCINOGENESIS, V32, P138, DOI 10.1093/carcin/bgq225; Thomas MG, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.200; Tomida M, 2008, J CANCER RES CLIN, V134, P551, DOI 10.1007/s00432-007-0318-6; Tomida M, 2009, J CANCER RES CLIN, V135, P1223, DOI 10.1007/s00432-009-0563-y; Tsuchiya A, 2003, AM J PATHOL, V163, P2503, DOI 10.1016/S0002-9440(10)63605-X; Vyssokikh MY, 2002, MOL BIOL REP, V29, P93, DOI 10.1023/A:1020383108620; Williams AC, 2005, MED HYPOTHESES, V65, P353, DOI 10.1016/j.mehy.2005.01.042; Win KT, 2013, NICOTINAMIDE N METHY, P1010; Xu JM, 2003, J CLIN ENDOCR METAB, V88, P4990, DOI 10.1210/jc.2002-021843; Yamada K, 2010, J NUTR SCI VITAMINOL, V56, P83, DOI 10.3177/jnsv.56.83; Yao M, 2005, J PATHOL, V205, P377, DOI 10.1002/path.1693; Zhang J, 2010, J ZHEJIANG UNIV-SC B, V11, P136, DOI 10.1631/jzus.B0900249; Zhang YF, 2010, ANTI-CANCER DRUG, V21, P494, DOI 10.1097/CAD.0b013e328336e927; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	54	53	54	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89202	10.1371/journal.pone.0089202	http://dx.doi.org/10.1371/journal.pone.0089202			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558488	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700134
J	Bedo, N; Ribary, U; Ward, LM				Bedo, Nicolas; Ribary, Urs; Ward, Lawrence M.			Fast Dynamics of Cortical Functional and Effective Connectivity during Word Reading	PLOS ONE			English	Article							INFERIOR PREFRONTAL CORTEX; FORM AREA; PLANUM-TEMPORALE; ANGULAR GYRUS; EEG DYNAMICS; SYNCHRONIZATION; RECOGNITION; LANGUAGE; NETWORK; MODEL	We describe for the first time the fast dynamics of functional and effective (causal) connectivity during word reading. Independent component analysis of high-density EEG recorded during a word reading task recovered multiple sources of electrical brain activity previously identified by fMRI and PET. Results confirmed the ventral occipito-temporal cortex (vOT) as a central hub for word reading, showing a progression of theta-band (3-7 Hz) and gamma-band (30-50 Hz) phase synchronization and directed theta-band and gamma-band information flow with both early visual areas and high-level language-processing areas. These results highlight the interplay between local and long-distance neural dynamics involved at each stage of the reading process. Moreover, these measures of functional and causal connectivity dynamics may be used as a benchmark for comparison with clinical populations (e.g. individuals with developmental dyslexia), such that disturbances in connectivity dynamics may provide insight as to underlying neurological problems with language processing, and their potential remediation.	[Bedo, Nicolas; Ward, Lawrence M.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Ribary, Urs] Simon Fraser Univ, Behav & Cognit Neurosci Inst, Burnaby, BC V5A 1S6, Canada; [Ribary, Urs] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; [Ward, Lawrence M.] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; Simon Fraser University; Simon Fraser University; University of British Columbia	Ward, LM (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	lward@psych.ubc.ca		Ward, Lawrence/0000-0003-4431-5015; Ribary, Urs/0000-0002-1182-8052	Natural Sciences and Engineering Research Council (NSERC) of Canada [A9958]	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by a Discovery Grant (A9958) from the Natural Sciences and Engineering Research Council (NSERC) of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) to LMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastiaansen MCM, 2005, J COGNITIVE NEUROSCI, V17, P530, DOI 10.1162/0898929053279469; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Buchsbaum BR, 2005, NEURON, V48, P687, DOI 10.1016/j.neuron.2005.09.029; Cao F, 2009, HUM BRAIN MAPP, V30, P797, DOI 10.1002/hbm.20546; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Cohen L, 2004, NEUROPSYCHOLOGIA, V42, P1768, DOI 10.1016/j.neuropsychologia.2004.04.018; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Dehaene S, 2002, NEUROREPORT, V13, P321, DOI 10.1097/00001756-200203040-00015; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030135; DEMB JB, 1995, J NEUROSCI, V15, P5870; Devlin JT, 2003, J COGNITIVE NEUROSCI, V15, P71, DOI 10.1162/089892903321107837; Di Lollo V, 2000, J EXP PSYCHOL GEN, V129, P481, DOI 10.1037/0096-3445.129.4.481; Doesburg SM, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006142, 10.1371/journal.pone.0006802]; Epelbaum S, 2008, CORTEX, V44, P962, DOI 10.1016/j.cortex.2008.05.003; Gaillard R, 2006, NEURON, V50, P191, DOI 10.1016/j.neuron.2006.03.031; Gomez-Herrero G, 2010, ASSESSING COUPLING D; Griffiths TD, 2002, TRENDS NEUROSCI, V25, P348, DOI 10.1016/S0166-2236(02)02191-4; Herdman AT, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00199; Herdman AT, 2011, J CLIN NEUROPHYSIOL, V28, P441, DOI 10.1097/WNP.0b013e318230da5f; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; LARSEN JP, 1990, BRAIN LANG, V39, P289, DOI 10.1016/0093-934X(90)90015-9; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; Mainy N, 2008, HUM BRAIN MAPP, V29, P1215, DOI 10.1002/hbm.20457; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Marinkovic K, 2003, NEURON, V38, P487, DOI 10.1016/S0896-6273(03)00197-1; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; McDonnell MD, 2011, NAT REV NEUROSCI, V12, P415, DOI 10.1038/nrn3061; Molinaro N, 2013, NEUROIMAGE, V72, P120, DOI 10.1016/j.neuroimage.2013.01.031; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Price CJ, 2011, TRENDS COGN SCI, V15, P246, DOI 10.1016/j.tics.2011.04.001; Pugh KR, 2000, PSYCHOL SCI, V11, P51, DOI 10.1111/1467-9280.00214; Ramus F, 2004, TRENDS NEUROSCI, V27, P720, DOI 10.1016/j.tins.2004.10.004; Ribary U, 2005, PROG BRAIN RES, V150, P127, DOI 10.1016/S0079-6123(05)50010-4; RIBARY U, 1991, P NATL ACAD SCI USA, V88, P11037, DOI 10.1073/pnas.88.24.11037; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; SEIDENBERG MS, 1989, PSYCHOL REV, V96, P523, DOI 10.1037/0033-295X.96.4.523; Stone J.V., 2004, INDEPENDENT COMPONEN; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tarkiainen A, 2002, BRAIN, V125, P1125, DOI 10.1093/brain/awf112; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Vidal JR, 2012, J NEUROSCI, V32, P6421, DOI 10.1523/JNEUROSCI.4363-11.2012; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Viola FC, 2009, CLIN NEUROPHYSIOL, V120, P868, DOI 10.1016/j.clinph.2009.01.015; Wandell BA, 2012, ANNU REV PSYCHOL, V63, P31, DOI 10.1146/annurev-psych-120710-100434; Weiss S, 2000, COGNITIVE BRAIN RES, V9, P299, DOI 10.1016/S0926-6410(00)00011-2; Wheat KL, 2010, J NEUROSCI, V30, P5229, DOI 10.1523/JNEUROSCI.4448-09.2010; Wibral M, 2011, PROG BIOPHYS MOL BIO, V105, P80, DOI 10.1016/j.pbiomolbio.2010.11.006; Yvert G, 2012, J NEUROSCI, V32, P4297, DOI 10.1523/JNEUROSCI.6434-11.2012	60	25	25	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88940	10.1371/journal.pone.0088940	http://dx.doi.org/10.1371/journal.pone.0088940			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551193	Green Published, Green Submitted, gold			2022-12-27	WOS:000331271500083
J	Krop, EJM; Jacobs, JH; Sander, I; Raulf-Heimsoth, M; Heederik, DJJ				Krop, Esmeralda J. M.; Jacobs, Jose H.; Sander, Ingrid; Raulf-Heimsoth, Monika; Heederik, Dick J. J.			Allergens and beta-Glucans in Dutch Homes and Schools: Characterizing Airborne Levels	PLOS ONE			English	Article							FLUORESCENT MULTIPLEX ARRAY; IN-HOUSE DUST; CAT ALLERGEN; EXPOSURE ASSESSMENT; ENDOTOXIN EXPOSURE; EXTRACELLULAR POLYSACCHARIDES; RESPIRATORY HEALTH; DOG ALLERGEN; CHILDREN; ASTHMA	Background: Indoor air quality has an effect on respiratory health. Children are more vulnerable to a decreased indoor air quality as their lungs are still developing. We measured levels of allergens and beta-(1,3)-glucans in 19 school buildings and determined whether measured levels could be reproduced. School levels were compared to those in 169 homes and the effect of building characteristics on both home and school exposure was explored. Methods: Electrostatic Dust fall Collectors were placed in school buildings for 8 weeks and in homes for 2 weeks to collect settled airborne dust. Cat, dog, and mouse allergen levels, domestic mite antigen levels and beta-(1,3)-glucans were measured in the extracts from the collectors. Results were corrected for sampling duration. Using questionnaire data, relations between measured levels and building and classroom characteristics were explored. Results: In schools, exposure levels were highest in classrooms and were influenced by the socioeconomic status of the children, the season measurements were performed, moisture status of the building and pet ownership. Repeated measurements in different seasons and over the years showed significantly different levels. Home exposure was influenced by socioeconomic status, occupancy and pet ownership. Domestic mite antigen was found in higher levels in extracts from homes compared to schools while pet allergen levels were 13 times higher in schools compared to homes without pets. For mouse allergen overall levels of exposure were low but still two times higher in schools compared to homes. Levels of beta-(1,3)-glucans were also approximately two times higher in schools than in homes. Conclusion: Exposure levels of several allergens and beta-(1,3)-glucans in schools differ over time and are higher than in homes. For children, exposure levels measured at school could contribute to their total exposure as especially animal allergen levels can be much higher in schools compared to homes.	[Krop, Esmeralda J. M.; Jacobs, Jose H.; Heederik, Dick J. J.] Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands; [Sander, Ingrid; Raulf-Heimsoth, Monika] Inst Ruhr Univ Bochum IPA, Inst Prevent & Occupat Med German Social Accid In, Bochum, Germany	Utrecht University; Ruhr University Bochum	Krop, EJM (corresponding author), Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands.	e.j.m.krop@uu.nl	Sander, Ingrid/R-8940-2017	Sander, Ingrid/0000-0002-5014-4112; Heederik, Dick/0000-0002-4550-1437; Krop, Esmeralda/0000-0002-6009-1181	European Commission [211488]; Lung Foundation Netherlands [3.2.08.018]; Stichting Astma Bestrijding [SAB2011/013]	European Commission(European CommissionEuropean Commission Joint Research Centre); Lung Foundation Netherlands; Stichting Astma Bestrijding	The cohort described in the study and exposure assessment in schools were financially supported by the European Commission, Grant agreement no: 211488 under the Seventh Framework Programme, Topic ENV.2007.1.2.1.1 (http://cordis.europa.eu/fp7/home_en.html). The exposure assessment in the homes and HDM and pet allergen measurements in schools were financially supported by the Lung Foundation Netherlands, project no: 3.2.08.018 (http://research.longfonds.nl/). The measurements of Mus m 1 were supported by a grant from Stichting Astma Bestrijding, project no: SAB2011/013 (http://www.astmabestrijding.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almqvist C, 1999, J ALLERGY CLIN IMMUN, V103, P1012, DOI 10.1016/S0091-6749(99)70172-7; Almqvist C, 2001, AM J RESP CRIT CARE, V163, P694, DOI 10.1164/ajrccm.163.3.2006114; Arbes SJ, 2004, J ALLERGY CLIN IMMUN, V114, P111, DOI 10.1016/j.jaci.2004.04.036; Berge M, 1998, PEDIATR ALLERGY IMMU, V9, P25, DOI 10.1111/j.1399-3038.1998.tb00296.x; Borras-Santos A, 2013, OCCUP ENVIRON MED, V70, P681, DOI 10.1136/oemed-2012-101286; Casas L, 2013, INDOOR AIR, V23, P208, DOI 10.1111/ina.12017; Dotterud LK, 1997, CLIN EXP ALLERGY, V27, P252, DOI 10.1111/j.1365-2222.1997.tb00703.x; Douwes J, 2000, AM J RESP CRIT CARE, V162, P1348, DOI 10.1164/ajrccm.162.4.9909118; Earle CD, 2007, J ALLERGY CLIN IMMUN, V119, P428, DOI 10.1016/j.jaci.2006.11.004; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Foarde K, 2004, J EXPO ANAL ENV EPID, V14, pS41, DOI 10.1038/sj.jea.7500357; Giovannangelo MECA, 2007, ENVIRON INT, V33, P9, DOI 10.1016/j.envint.2006.06.018; Haverinen-Shaughnessy U, 2012, INDOOR AIR, V22, P457, DOI 10.1111/j.1600-0668.2012.00780.x; Heederik D, 2012, J ALLERGY CLIN IMMUN, V130, P44, DOI 10.1016/j.jaci.2012.01.067; Jacobs JH, 2014, INDOOR AIR, V24, P148, DOI 10.1111/ina.12064; Jacobs JH, 2013, EUR RESPIR J, V42, P314, DOI 10.1183/09031936.00084612; Karlsson AS, 2005, ALLERGY, V60, P961, DOI 10.1111/j.1398-9995.2005.00796.x; Karlsson AS, 2002, CLIN EXP ALLERGY, V32, P1776, DOI 10.1046/j.1365-2222.2002.01553.x; Karlsson AS, 2002, ALLERGY, V57, P164, DOI 10.1034/j.1398-9995.2002.1s3297.x; King EM, 2013, J IMMUNOL METHODS, V387, P89, DOI 10.1016/j.jim.2012.09.015; Kitch BT, 2000, ENVIRON HEALTH PERSP, V108, P301, DOI 10.2307/3454347; Krop EJM, 2007, OCCUP ENVIRON MED, V64, P267, DOI 10.1136/oem.2006.028845; Leaderer BP, 2002, ENVIRON HEALTH PERSP, V110, P419, DOI 10.1289/ehp.02110419; MUNIR AKM, 1993, J ALLERGY CLIN IMMUN, V91, P1067, DOI 10.1016/0091-6749(93)90221-Z; Muti D, 2012, EUR ANN ALLERGY CLIN, V44, P93; Noss I, 2008, APPL ENVIRON MICROB, V74, P5621, DOI 10.1128/AEM.00619-08; Noss I, 2010, ANN OCCUP HYG, V54, P651, DOI 10.1093/annhyg/meq026; Noss I, 2010, APPL ENVIRON MICROB, V76, P1158, DOI 10.1128/AEM.01486-09; Permaul P, 2012, PEDIAT ALLERG IMM-UK, V23, P543, DOI 10.1111/j.1399-3038.2012.01327.x; Perzanowski MS, 1999, J ALLERGY CLIN IMMUN, V103, P1018, DOI 10.1016/S0091-6749(99)70173-9; Samadi S, 2010, OCCUP ENVIRON MED, V67, P486, DOI 10.1136/oem.2009.051342; Sander I, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0052981, DOI 10.1371/J0URNAL.P0NE.0052981]; Sheehan WJ, 2012, ANN ALLERG ASTHMA IM, V108, P418, DOI 10.1016/j.anai.2012.04.003; Sheehan WJ, 2009, ANN ALLERG ASTHMA IM, V102, P125, DOI 10.1016/S1081-1206(10)60242-6; Simpson A, 2002, CLIN EXP ALLERGY, V32, P1413, DOI 10.1046/j.1365-2745.2002.01496.x; Tischer C, 2011, EUR RESPIR J, V37, P1050, DOI 10.1183/09031936.00091210; Zhang L, 1997, CLIN EXP ALLERGY, V27, P876, DOI 10.1111/j.1365-2222.1997.tb01227.x; Zhao ZH, 2006, INDOOR AIR, V16, P404, DOI 10.1111/j.1600-0668.2006.00433.x	38	36	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88871	10.1371/journal.pone.0088871	http://dx.doi.org/10.1371/journal.pone.0088871			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551183	Green Submitted, Green Published, gold			2022-12-27	WOS:000331271500078
J	Lu, P; Qiao, JJ; He, W; Wang, J; Jia, YX; Sun, Y; Tang, SW; Fu, L; Qin, YR				Lu, Pei; Qiao, Junjing; He, Wei; Wang, Jin; Jia, Yongxu; Sun, Yan; Tang, Senwei; Fu, Li; Qin, Yanru			Genome-Wide Gene Expression Profile Analyses Identify CTTN as a Potential Prognostic Marker in Esophageal Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TUMOR-SUPPRESSOR GENE; TISSUE MICROARRAYS; CORTACTIN; GROWTH; OVEREXPRESSION; CARCINOGENESIS; IDENTIFICATION; OSTEOSARCOMA; PREDICTION	Aim: Esophageal squamous cell carcinoma (ESCC) is one of the most common fatal malignances of the digestive tract. Its prognosis is poor mainly due to the lack of reliable markers for early detection and prognostic prediction. Here we aim to identify the molecules involved in ESCC carcinogenesis and those as potential markers for prognosis and as new molecular therapeutic targets. Methods: We performed genome-wide gene expression profile analyses of 10 primary ESCCs and their adjacent normal tissues by cDNA microarrays representing 47,000 transcripts and variants. Candidate genes were then validated by semi quantitative reverse transcription-PCR (RT-PCR), tissue microarrays (TMAs) and immunohistochemistry (IHC) staining. Results: Using an arbitrary cutoff line of signal log ratio of >= 1.5 or <=-1.5, we observed 549 up-regulated genes and 766 down-regulated genes in ESCCs compared with normal esophageal tissues. The functions of 302 differentially expressed genes were associated with cell metabolism, cell adhesion and immune response. Several candidate deregulated genes including four overexpressed (CTTN, DMRT2, MCM10 and SCYA26) and two underexpressed (HMGCS2 and SORBS2) were subsequently verified, which can be served as biomarkers for ESCC. Moreover, overexpression of cortactin (CTTN) was observed in 126/198 (63.6%) of ESCC cases and was significantly associated with lymph node metastasis (P = 0.000), pathologic stage (P = 0.000) and poor survival (P<0.001) of ESCC patients. Furthermore, a significant correlation between CTTN overexpression and shorter disease-specific survival rate was found in different subgroups of ESCC patient stratified by the pathologic stage (P<0.05). Conclusion: Our data provide valuable information for establishing molecules as candidates for prognostic and/or as therapeutic targets.	[Lu, Pei; Qiao, Junjing; He, Wei; Wang, Jin; Jia, Yongxu; Sun, Yan; Qin, Yanru] Zhengzhou Univ, Affiliated Hosp 1, Dept Clin Oncol, Zhengzhou, Peoples R China; [Tang, Senwei; Fu, Li] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	Zhengzhou University; Chinese University of Hong Kong	Qin, YR (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Clin Oncol, Zhengzhou, Peoples R China.	yanruqin@zzu.edu.cn	Tang, Senwei/F-2278-2015; Fu, Li/F-7182-2010	Tang, Senwei/0000-0001-6112-4232; Fu, Li/0000-0003-2643-6278	National Natural Science Foundation of China [81150010, 81272227, 81372583]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (81150010, 81272227 and 81372583). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Ashburner M, 2001, GENOME RES, V11, P1425; Bird-Lieberman EL, 2009, BRIT J CANCER, V101, P1, DOI 10.1038/sj.bjc.6605126; Buday L, 2007, BBA-REV CANCER, V1775, P263, DOI 10.1016/j.bbcan.2006.12.002; Callagy G, 2005, J PATHOL, V205, P388, DOI 10.1002/path.1694; Callagy G, 2003, DIAGN MOL PATHOL, V12, P27, DOI 10.1097/00019606-200303000-00004; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; Folio C, 2011, CANCER BIOMARK, V10, P35, DOI 10.3233/CBM-2012-0227; Fu L, 2007, CANCER RES, V67, P10720, DOI 10.1158/0008-5472.CAN-07-2411; Hu JG, 2011, TOHOKU J EXP MED, V223, P161, DOI 10.1620/tjem.223.161; Hu YC, 2001, CLIN CANCER RES, V7, P2213; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kakiuchi S, 2004, HUM MOL GENET, V13, P3029, DOI 10.1093/hmg/ddh331; Kan T, 2001, BIOCHEM BIOPH RES CO, V286, P792, DOI 10.1006/bbrc.2001.5400; Kato T, 2005, CANCER RES, V65, P5638, DOI 10.1158/0008-5472.CAN-05-0600; Kirkbride KC, 2011, CELL ADHES MIGR, V5, P187, DOI 10.4161/cam.5.2.14773; Kitahara O, 2001, CANCER RES, V61, P3544; Lambert R, 2007, BEST PRACT RES CL GA, V21, P921, DOI 10.1016/j.bpg.2007.10.001; Li LW, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-52; Li LW, 2009, INT J CANCER, V125, P1505, DOI 10.1002/ijc.24513; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Mimura K, 2011, INT J CANCER, V129, P2408, DOI 10.1002/ijc.25896; Ochi K, 2004, INT J ONCOL, V24, P647; Portale G, 2006, J AM COLL SURGEONS, V202, P588, DOI 10.1016/j.jamcollsurg.2005.12.022; Sarwar CMS, 2010, INT J SURG, V8, P417, DOI 10.1016/j.ijsu.2010.06.011; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Takikita M, 2011, ANTICANCER RES, V31, P945; van Rossum AGSH, 2006, EXP CELL RES, V312, P1658, DOI 10.1016/j.yexcr.2006.01.033; Zhao G, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-74; Zhao P, 2010, JPN J CLIN ONCOL, V40, P281, DOI 10.1093/jjco/hyp187	30	32	34	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88918	10.1371/journal.pone.0088918	http://dx.doi.org/10.1371/journal.pone.0088918			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551190	Green Submitted, Green Published, gold			2022-12-27	WOS:000331271500081
J	Haddad, LE; Sirois, MG				Haddad, Lydia E.; Sirois, Martin G.			Angiopoietin-1 Upregulates De Novo Expression of II-1 beta and II1-Ra, and the Exclusive Release of II1-Ra from Human Neutrophils	PLOS ONE			English	Article							ENDOTHELIAL-CELL SURVIVAL; ACTIVATED PROTEIN-KINASE; P-SELECTIN TRANSLOCATION; RECEPTOR ANTAGONIST; TNF-ALPHA; IL-1-BETA; CYTOKINE; INTERLEUKIN-1-BETA; MONOCYTES; IL-8	The expression of the angiopoietin (Ang) receptor, Tie2, on both endothelial and inflammatory cells supports the idea that Ang signaling may play a fundamental role in initiating and maintaining the inflammatory response. We have previously shown that Ang1 and/or Ang2 alter the innate immune response by enhancing human neutrophil survival, chemotaxis and production of inflammatory cytokine interleukin-8 (IL-8) in vitro. Thus, we hypothesized that Ang1 and Ang2 could modulate other inflammatory signals in neutrophils, a possibility we explored through a gene-based assay looking at changes in the mRNA expression of 84 inflammatory cytokines and their receptors. We observed that Ang1 (10(-8) M), but not Ang2, increased mRNA expression of prominent pro-inflammatory cytokine IL-1 beta and its natural antagonist IL-1RA, by up to 32.6- and 10.0-fold respectively, compared to PBS-control. The effects of Ang1 extended to the proteins, as Ang1 increased intracellular levels of precursor and mature IL-1 beta, and extracellular levels of IL-1RA proteins, by up to 4.2-, 5.0- and 4.4-fold respectively, compared to PBS-control. Interestingly, Ang1 failed at inducing IL-1 beta protein release or at increasing intracellular IL-1RA, but the ratio of IL-1RA to mature IL-1 beta remained above 100-fold molar excess inside and outside the cells. The above-noted effects of Ang1 were mediated by MAP kinases, whereby inhibiting MEK1/2 lead to up to 70% effect reduction, whereas the blockade of p38MAPK activity doubled Ang1's effect. These findings suggest that Ang1 selectively alters the balance of neutrophil-derived inflammatory cytokines, favoring the blockade of IL-1 activity, a consideration for future therapies of inflammatory diseases.	[Haddad, Lydia E.; Sirois, Martin G.] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Haddad, Lydia E.; Sirois, Martin G.] Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Sirois, MG (corresponding author), Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada.	Martin.Sirois@Icm-Mhi.Org			Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Quebec;  [MOP-97943]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Quebec; 	Contract grant sponsor: Canadian Institutes of Health Research (CIHR); Contract grant number: MOP-97943; http://www.cihr-irsc.gc.ca/. Contract grant sponsor: Heart and Stroke Foundation of Quebec; http://www.heartandstroke.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2010, HYPERTENSION, V56, P477, DOI 10.1161/HYPERTENSIONAHA.110.155556; Alvarez ME, 2006, J IMMUNOL, V177, P4037, DOI 10.4049/jimmunol.177.6.4037; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; AREND WP, 1991, J IMMUNOL, V147, P1530; Arroyo AG, 2010, CARDIOVASC RES, V86, P226, DOI 10.1093/cvr/cvq049; Baldassare JJ, 1999, J IMMUNOL, V162, P5367; Brkovic A, 2007, J LEUKOCYTE BIOL, V81, P1093, DOI 10.1189/jlb.0906580; Brough D, 2002, MOL CELL NEUROSCI, V19, P272, DOI 10.1006/mcne.2001.1054; Carter AB, 1999, AM J RESP CELL MOL, V20, P751, DOI 10.1165/ajrcmb.20.4.3420; CASSATELLA MA, 1995, IMMUNOL TODAY, V16, P21, DOI 10.1016/0167-5699(95)80066-2; CHIN J, 1993, J IMMUNOL, V151, P5574; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dumas E, 2012, BBA-MOL CELL RES, V1823, P358, DOI 10.1016/j.bbamcr.2011.12.002; ELY EW, 1995, BBA-LIPID LIPID MET, V1258, P135; Fagiani E, 2013, CANCER LETT, V328, P18, DOI 10.1016/j.canlet.2012.08.018; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Feistritzer C, 2004, J ALLERGY CLIN IMMUN, V114, P1077, DOI 10.1016/j.jaci.2004.06.045; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Guma M, 2009, ARTHRITIS RHEUM-US, V60, P3642, DOI 10.1002/art.24959; Harfouche R, 2003, FASEB J, V17, P1523, DOI 10.1096/fj.02-0698fje; HOGQUIST KA, 1991, J IMMUNOL, V147, P2181; Jablonska E, 2001, ARCH IMMUNOL THER EX, V49, P63; Kim I, 2000, ONCOGENE, V19, P4549, DOI 10.1038/sj.onc.1203800; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Kim I, 2001, FASEB J, V15, P126, DOI 10.1096/fj.01-0556fje; Kim I, 2001, CIRC RES, V89, P477, DOI 10.1161/hh1801.097034; Kuhns D, 1998, J IMMUNOL, V161, P4332; Langereis JD, 2011, EUR RESPIR J, V37, P406, DOI 10.1183/09031936.00170409; Lapinet JA, 2000, INFECT IMMUN, V68, P6917, DOI 10.1128/IAI.68.12.6917-6923.2000; Lee JC, 1996, J LEUKOCYTE BIOL, V59, P152, DOI 10.1002/jlb.59.2.152; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lemieux C, 2005, BLOOD, V105, P1523, DOI 10.1182/blood-2004-09-3531; Lu PR, 2003, AM J PATHOL, V162, P1249, DOI 10.1016/S0002-9440(10)63921-1; Maliba R, 2008, J LEUKOCYTE BIOL, V83, P352, DOI 10.1189/jlb.0107056; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Neagoe PE, 2012, J CELL PHYSIOL, V227, P3099, DOI 10.1002/jcp.23061; Neagoe PE, 2009, GROWTH FACTORS, V27, P335, DOI 10.3109/08977190903155043; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Oubaha M, 2009, BLOOD, V114, P3343, DOI 10.1182/blood-2008-12-196584; PERREGAUX D, 1992, J IMMUNOL, V149, P1294; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Perregaux DG, 1996, J BIOL CHEM, V271, P29830, DOI 10.1074/jbc.271.47.29830; Pizurki L, 2003, BRIT J PHARMACOL, V139, P329, DOI 10.1038/sj.bjp.0705259; Riedemann NC, 2003, FASEB J, V17, P370, DOI 10.1096/fj.03-0708fje; Rollin S, 2004, BLOOD, V103, P3789, DOI 10.1182/blood-2003-07-2272; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Sturn DH, 2005, MICROCIRCULATION, V12, P393, DOI 10.1080/10739680590960296; Sun J, 2009, FASEB J, V23, P997, DOI 10.1096/fj.08-121756; Theoret JF, 2001, J PHARMACOL EXP THER, V298, P658; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Xing LY, 2003, SHOCK, V20, P10, DOI 10.1097/01.shk.0000065704.84144.a4; Young RE, 2004, J IMMUNOL, V172, P4493, DOI 10.4049/jimmunol.172.7.4493	59	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88980	10.1371/journal.pone.0088980	http://dx.doi.org/10.1371/journal.pone.0088980			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24563688	Green Submitted, gold, Green Published			2022-12-27	WOS:000331262600123
J	Hoskins, LM; Werner-Lin, A; Greene, MH				Hoskins, Lindsey M.; Werner-Lin, Allison; Greene, Mark H.			In Their Own Words: Treating Very Young BRCA1/2 Mutation-Positive Women with Care and Caution	PLOS ONE			English	Article							OVARIAN-CANCER RISK; BREAST-CANCER; CARRIERS; TAMOXIFEN; MULTICENTER; MASTECTOMY; PREVENTION; MANAGEMENT; IMPACT	Purpose: Young women who have been identified as carrying a deleterious mutation in BRCA1 or BRCA2 face a unique set of challenges related to managing cancer risk during a demographically-dense stage of life. They may struggle with decision-making in the absence of clear age-specific guidelines for medical management and because they have not yet fully developed the capacity to make life-altering decisions confidently. This study sought a patient-centered perspective on the dilemmas faced by 18-24 year olds who completed BRCA1/2 gene mutation testing prior to their 25th birthdays. Patients and Method: This study integrated qualitative data from three independent investigations of BRCA1/2-positive women recruited through cancer risk clinics, hospital-based research centers, and online organizations. All 32 participants were women aged 21-25 who tested positive for a BRCA1/2 gene mutation between 2 and 60 months prior to data collection. Investigators used techniques of grounded theory and interpretive description to conduct both within and cross-study analysis. Results: Participants expressed needs for (1) greater clarity in recommendations for screening and prevention before age 25, especially with consideration of early and regular exposure to radiation associated with mammography or to hormones used in birth control, and (2) ongoing contact with providers to discuss risk management protocols as they become available. Conclusions: Health care needs during the young adult years evolve with the cognitive capacity to address abrupt and pressing change. Specific needs of women in this population include a desire to balance autonomous decision-making with supportive guidance, a need for clear, accurate and consistent medical recommendations. Optimally, these women are best cared for by a team of genetically-oriented providers as part of a sustained program of ongoing support, rather than seen in an episodic, crisis-driven fashion. A discussion of insurance issues and provider-patient cultural differences is presented.	[Hoskins, Lindsey M.; Greene, Mark H.] NCI, Clin Genet Branch, Bethesda, MD 20892 USA; [Werner-Lin, Allison] Univ Penn, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Pennsylvania	Werner-Lin, A (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.	awer@sp2.upenn.edu			intramural program of the National Cancer Institute, Division of Cancer Genetics and Epidemiology, Clinical Genetics Branch	intramural program of the National Cancer Institute, Division of Cancer Genetics and Epidemiology, Clinical Genetics Branch	This study was funded through the intramural program of the National Cancer Institute, Division of Cancer Genetics and Epidemiology, Clinical Genetics Branch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou AC, 2009, CANCER EPIDEM BIOMAR, V18, P601, DOI 10.1158/1055-9965.EPI-08-0546; Arnett J., 2004, EMERGING ADULTHOOD W; de Gonzalez A, 2009, JNCI-J NATL CANCER I, V101, P205, DOI 10.1093/jnci/djn440; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Chen SN, 2006, J CLIN ONCOL, V24, P863, DOI 10.1200/JCO.2005.03.6772; Clark AS, 2011, J MAMMARY GLAND BIOL, V16, P17, DOI 10.1007/s10911-011-9200-x; Crum CP, 2009, MOL ONCOL, V3, P165, DOI 10.1016/j.molonc.2009.01.004; Daly MB, 2010, J NATL COMPR CANC NE, V8, P562, DOI 10.6004/jnccn.2010.0043; Evans James P, 2005, Breast Dis, V23, P17; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Gail MH, 1999, J NATL CANCER I, V91, P1829, DOI 10.1093/jnci/91.21.1829; Greene MH, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.05.038; Halbert CH, 2006, PREV MED, V43, P385, DOI 10.1016/j.ypmed.2006.06.003; Hoskins LM, 2012, QUAL HEALTH RES, V22, P1633, DOI 10.1177/1049732312458182; Hoskins LM, 2012, FAM SYST HEALTH, V30, P32, DOI 10.1037/a0027276; Hoskins Lindsey M, 2008, Fam Syst Health, V26, P296, DOI 10.1037/a0012914; Hoskins LM, 2010, NEGOTIATION HLTH RIS; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Iodice S, 2010, EUR J CANCER, V46, P2275, DOI 10.1016/j.ejca.2010.04.018; Kauff ND, 2008, J CLIN ONCOL, V26, P1331, DOI 10.1200/JCO.2007.13.9626; Lea DH, 2011, PUBLIC HEALTH GENOM, V14, P279, DOI 10.1159/000294191; Mandelson MT, 2000, J NATL CANCER I, V92, P1081, DOI 10.1093/jnci/92.13.1081; Nanda R, 2005, JAMA-J AM MED ASSOC, V294, P1925, DOI 10.1001/jama.294.15.1925; Narod SA, 2006, LANCET ONCOL, V7, P402, DOI 10.1016/S1470-2045(06)70624-6; Narod SA, 2010, NAT REV CLIN ONCOL, V7, P702, DOI 10.1038/nrclinonc.2010.166; NEWCOMB PA, 1991, J NATL CANCER I, V83, P260, DOI 10.1093/jnci/83.4.260; Petrucelli N, 2010, GENET MED, V12, P245, DOI 10.1097/GIM.0b013e3181d38f2f; Pruthi S, 2010, MAYO CLIN PROC, V85, P1111, DOI 10.4065/mcp.2010.0414; Rebbeck TR, 2004, J CLIN ONCOL, V22, P1055, DOI 10.1200/JCO.2004.04.188; Samuel Jonathan C, 2005, Breast Dis, V23, P31; Segev Y, 2013, GYNECOL ONCOL, V130, P127, DOI 10.1016/j.ygyno.2013.03.027; Sivell Stephanie, 2008, J Genet Couns, V17, P30, DOI 10.1007/s10897-007-9132-1; Trepanier Angela, 2004, J Genet Couns, V13, P83, DOI 10.1023/B:JOGC.0000018821.48330.77; van Oostrom I, 2003, J CLIN ONCOL, V21, P3867, DOI 10.1200/JCO.2003.10.100; Visvanathan K, 2009, J CLIN ONCOL, V27, P3235, DOI 10.1200/JCO.2008.20.5179; Watson M, 2004, BRIT J CANCER, V91, P1787, DOI 10.1038/sj.bjc.6602207; Werner-Lin A, 2010, J SOC SOC WORK RES, V1, P26; Werner-Lin A, 2008, J PSYCHOSOC ONCOL, V26, P111, DOI 10.1080/07347330802359776; Werner-Lin A, 2012, HEALTH-LONDON, V16, P636, DOI 10.1177/1363459312442420; Werner-Lin A, 2008, SOC WORK HEALTH CARE, V47, P416, DOI 10.1080/00981380802173509; Werner-Lin AV, 2007, FAM PROCESS, V46, P335, DOI 10.1111/j.1545-5300.2007.00215.x	41	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e87696	10.1371/journal.pone.0087696	http://dx.doi.org/10.1371/journal.pone.0087696			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586286	Green Submitted, gold, Green Published			2022-12-27	WOS:000332396200014
J	Lu, ZH; Yang, L; Yu, JW; Lu, M; Zhang, XT; Li, J; Zhou, J; Wang, XC; Gong, JF; Gao, J; Li, J; Li, Y; Shen, L				Lu, Zhihao; Yang, Li; Yu, Jingwei; Lu, Ming; Zhang, Xiaotian; Li, Jian; Zhou, Jun; Wang, Xicheng; Gong, Jifang; Gao, Jing; Li, Jie; Li, Yan; Shen, Lin			Change of Body Weight and Macrophage Inhibitory Cytokine-1 during Chemotherapy in Advanced Gastric Cancer: What Is Their Clinical Significance?	PLOS ONE			English	Article							NUTRITIONAL-STATUS; MIC-1; SUPPLEMENTATION; CACHEXIA; SURVIVAL; EXERCISE; ANOREXIA; PLASMA; SERUM; TRIAL	Background: Weight loss in advanced gastric cancer (GC) has been widely acknowledged to be a predictor for poor survival. However, very few studies have investigated the weight loss that occurs during chemotherapy. Therefore, we focused on weight loss during chemotherapy in patients with advanced GC and investigated the concentrations of macrophage inhibitory cytokine-1 (MIC-1), which has been recognized as a probable etiological factor in anorexia and weight loss. Methods: We analyzed 384 patients with inoperable locally advanced or metastatic GC receiving first-line chemotherapy. Patients were assigned to one of two groups on the basis of their weight change during chemotherapy: >3% weight loss and <= 3% weight loss. Serum MIC-1 and C-reactive protein (CRP) concentrations were also assessed in these patients. Results: The >3% weight loss group had shorter overall survival (OS; 12.0 months vs. 17.5 months, P = 0.000) than the <= 3% weight loss group, and the survival rates improved if the weight loss was reversed during chemotherapy. Although the MIC-1 concentrations were not correlated with weight loss before (P = 0.156) or during chemotherapy (P = 0.164), it correlated significantly with the CRP concentration (P = 0.001). Furthermore, elevated MIC-1 concentrations before chemotherapy (P = 0.017) and increased MIC-1 concentrations during chemotherapy (P = 0.001) were both found to be predictors of poor OS. Conclusions: Changes in the body weight during chemotherapy could influence the prognosis in patients with advanced GC, and the MIC-1 might be a potential predictive and prognostic biomarker in those patients.	[Lu, Zhihao; Yu, Jingwei; Lu, Ming; Zhang, Xiaotian; Li, Jian; Zhou, Jun; Wang, Xicheng; Gong, Jifang; Gao, Jing; Li, Jie; Li, Yan; Shen, Lin] Peking Univ, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Med Oncol, Minist Educ,Sch Oncol,Beijing Canc Hosp & Inst, Beijing 100871, Peoples R China; [Yang, Li] Zhangzhou Municipal Hosp, Dept Oncol, Zhangzhou, Fujian Province, Peoples R China	Peking University	Shen, L (corresponding author), Peking Univ, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Med Oncol, Minist Educ,Sch Oncol,Beijing Canc Hosp & Inst, Beijing 100871, Peoples R China.	lin100@medmail.com.cn		Yu, jingwei/0000-0002-7587-754X				Andreyev HJN, 1998, EUR J CANCER, V34, P503, DOI 10.1016/S0959-8049(97)10090-9; Argiles JM, 2012, J CACHEXIA SARCOPENI, V3, P73, DOI 10.1007/s13539-012-0067-5; Baek KE, 2009, CLIN CHIM ACTA, V401, P128, DOI 10.1016/j.cca.2008.12.008; Baldwin C, 2012, JNCI-J NATL CANCER I, V104, P371, DOI 10.1093/jnci/djr556; Bauskin AR, 2006, CANCER RES, V66, P4983, DOI 10.1158/0008-5472.CAN-05-4067; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Bosaeus I, 2002, J NUTR, V132, p3465S, DOI 10.1093/jn/132.11.3465S; Boyle GM, 2009, J INVEST DERMATOL, V129, P383, DOI 10.1038/jid.2008.270; Brown DA, 2003, CLIN CANCER RES, V9, P2642; Brown DA, 2002, BIOTECHNIQUES, V33, P118, DOI 10.2144/02331rr03; Brown DA, 2002, LANCET, V359, P2159, DOI 10.1016/S0140-6736(02)09093-1; Bruera E, 1997, BRIT MED J, V315, P1219, DOI 10.1136/bmj.315.7117.1219; de Luis DA, 2005, ANN NUTR METAB, V49, P95, DOI 10.1159/000084742; DEEG HJ, 1995, BONE MARROW TRANSPL, V15, P461; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Fairlie WD, 1999, J LEUKOCYTE BIOL, V65, P2, DOI 10.1002/jlb.65.1.2; Fearon K, 2013, NAT REV CLIN ONCOL, V10, P90, DOI 10.1038/nrclinonc.2012.209; Fox KM, 2009, J ONCOL, V2009, DOI 10.1155/2009/693458; Gianotti L, 2002, GASTROENTEROLOGY, V122, P1763, DOI 10.1053/gast.2002.33587; Gordon JN, 2005, GUT, V54, P540, DOI 10.1136/gut.2004.047563; Hess LM, 2007, GYNECOL ONCOL, V107, P260, DOI 10.1016/j.ygyno.2007.06.010; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Jones PJL, 1992, POSITIVE APPROACH NU; Lee DH, 2003, CANCER RES, V63, P4648; Miyata H, 2012, CLIN NUTR, V31, P330, DOI 10.1016/j.clnu.2011.11.002; Moore AG, 2000, J CLIN ENDOCR METAB, V85, P4781, DOI 10.1210/jc.85.12.4781; Oldervoll LM, 2011, ONCOLOGIST, V16, P1649, DOI 10.1634/theoncologist.2011-0133; Ross PJ, 2004, BRIT J CANCER, V90, P1905, DOI 10.1038/sj.bjc.6601781; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Skipworth RJE, 2010, BRIT J CANCER, V102, P665, DOI 10.1038/sj.bjc.6605532; Sornsuvit C, 2008, J INT MED RES, V36, P1383, DOI 10.1177/147323000803600628; Tsai VWW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055174; van der Meij BS, 2010, J NUTR, V140, P1774, DOI 10.3945/jn.110.121202; Welsh JB, 2003, P NATL ACAD SCI USA, V100, P3410, DOI 10.1073/pnas.0530278100; Wiklund FE, 2010, AGING CELL, V9, P1057, DOI 10.1111/j.1474-9726.2010.00629.x; Yamashita H, 2010, WORLD J SURG, V34, P2399, DOI 10.1007/s00268-010-0703-1; Zimmerman MA, 2003, ARCH SURG-CHICAGO, V138, P220, DOI 10.1001/archsurg.138.2.220	37	25	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e88553	10.1371/journal.pone.0088553	http://dx.doi.org/10.1371/journal.pone.0088553			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586342	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200022
J	Murmann, T; Carrillo-Garcia, C; Veit, N; Courts, C; Glassmann, A; Janzen, V; Madea, B; Reinartz, M; Harzen, A; Nowak, M; Perner, S; Winter, J; Probstmeier, R				Murmann, Tamara; Carrillo-Garcia, Carmen; Veit, Nadine; Courts, Cornelius; Glassmann, Alexander; Janzen, Viktor; Madea, Burkhard; Reinartz, Markus; Harzen, Anne; Nowak, Michael; Perner, Sven; Winter, Jochen; Probstmeier, Rainer			Staurosporine and Extracellular Matrix Proteins Mediate the Conversion of Small Cell Lung Carcinoma Cells into a Neuron-Like Phenotype	PLOS ONE			English	Article							CANCER CELLS; INDUCED APOPTOSIS; DIFFERENTIATION; NEUROENDOCRINE; PROLIFERATION; EXPRESSION; ACTIVATION; OUTGROWTH; ARREST; GROWTH	Small cell lung carcinomas (SCLCs) represent highly aggressive tumors with an overall five-year survival rate in the range of 5 to 10%. Here, we show that four out of five SCLC cell lines reversibly develop a neuron-like phenotype on extracellular matrix constituents such as fibronectin, laminin or thrombospondin upon staurosporine treatment in an RGD/integrinmediated manner. Neurite-like processes extend rapidly with an average speed of 10 mm per hour. Depending on the cell line, staurosporine treatment affects either cell cycle arrest in G2/M phase or induction of polyploidy. Neuron-like conversion, although not accompanied by alterations in the expression pattern of a panel of neuroendocrine genes, leads to changes in protein expression as determined by two-dimensional gel electrophoresis. It is likely that SCLC cells already harbour the complete molecular repertoire to convert into a neuron-like phenotype. More extensive studies are needed to evaluate whether the conversion potential of SCLC cells is suitable for therapeutic interventions.	[Murmann, Tamara; Veit, Nadine; Probstmeier, Rainer] Univ Hosp Bonn, Dept Nucl Med, Neuro & Tumor Cell Biol Grp, Bonn, Germany; [Carrillo-Garcia, Carmen; Janzen, Viktor] Univ Hosp Bonn, Dept Hematol & Oncol, Bonn, Germany; [Courts, Cornelius; Madea, Burkhard] Univ Bonn, Inst Legal Med, Bonn, Germany; [Glassmann, Alexander] Univ Bonn, Inst Anat & Cell Biol, Bonn, Germany; [Reinartz, Markus; Winter, Jochen] Dept Periodontol Operat & Prevent Dent, Oral Cell Biol Grp, Bonn, Germany; [Harzen, Anne] Max Planck Inst Plant Breeding Res, Prote Grp, Cologne, Germany; [Nowak, Michael; Perner, Sven] Univ Hosp Bonn, Inst Pathol, Dept Prostate Canc Res, Bonn, Germany	University of Bonn; University of Bonn; University of Bonn; University of Bonn; Max Planck Society; University of Bonn	Probstmeier, R (corresponding author), Univ Hosp Bonn, Dept Nucl Med, Neuro & Tumor Cell Biol Grp, Bonn, Germany.	r.probstmeier@uni-bonn.de		Glassmann, Alexander/0000-0001-9600-8610; Carrillo Garcia, Carmen/0000-0003-1692-7460; Harzen, Anne/0000-0001-7370-4939; Courts, Cornelius/0000-0002-9811-8482				Ablain J, 2011, BLOOD, V117, P5795, DOI 10.1182/blood-2011-02-329367; Arriola E, 2008, CLIN TRANSL ONCOL, V10, P189, DOI 10.1007/s12094-008-0181-1; Azzi S, 2011, J NATL CANCER I, V103, P1884, DOI 10.1093/jnci/djr451; Bernard B, 2001, CELL DEATH DIFFER, V8, P234, DOI 10.1038/sj.cdd.4400796; Borges M, 1997, NATURE, V386, P852, DOI 10.1038/386852a0; Busby EC, 2000, CANCER RES, V60, P2108; Buttery R, 2004, HISTOPATHOLOGY, V44, P339, DOI 10.1111/j.1365-2559.2004.01815.x; Campos B, 2010, CLIN CANCER RES, V16, P2715, DOI 10.1158/1078-0432.CCR-09-1800; D'Angelo SP, 2010, CANCER BIOL THER, V10, P1, DOI 10.4161/cbt.10.1.12045; DELEIJ L, 1985, CANCER RES, V45, P6024; Deshmukh M, 2000, CELL DEATH DIFFER, V7, P250, DOI 10.1038/sj.cdd.4400641; Dunai ZA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041945; Elstner E, 1998, P NATL ACAD SCI USA, V95, P8806, DOI 10.1073/pnas.95.15.8806; Faghihi F, 2008, YAKHTEH, V10, P33; Gabius HJ, 2002, ANTICANCER RES, V22, P405; GIACCONE G, 1992, BRIT J CANCER, V66, P488, DOI 10.1038/bjc.1992.301; Glassmann A, 2011, INT J ONCOL, V39, P1567, DOI 10.3892/ijo.2011.1165; Grigoriou V, 2005, J BIOL CHEM, V280, P1733, DOI 10.1074/jbc.M402550200; Guo NH, 2000, CANCER RES, V60, P457; Haddadin S, 2011, CLIN LUNG CANCER, V12, P87, DOI 10.1016/j.cllc.2011.03.002; Hodkinson PS, 2007, INT J RADIAT BIOL, V83, P733, DOI 10.1080/09553000701570204; Hodkinson PS, 2006, CELL DEATH DIFFER, V13, P1776, DOI 10.1038/sj.cdd.4401849; Jiang TY, 2009, CANCER RES, V69, P845, DOI 10.1158/0008-5472.CAN-08-2762; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kobayashi N, 2002, MICROSC RES TECHNIQ, V57, P217, DOI 10.1002/jemt.10077; Konig K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057996; Kohmo S, 2010, CANCER RES, V70, P8025, DOI 10.1158/0008-5472.CAN-10-0996; Lahm H, 2001, J CANCER RES CLIN, V127, P375, DOI 10.1007/s004320000207; McGahren-Murray M, 2006, CANCER RES, V66, P9744, DOI 10.1158/0008-5472.CAN-06-1809; Missale C, 1998, P NATL ACAD SCI USA, V95, P5366, DOI 10.1073/pnas.95.9.5366; Park KS, 2011, CELL CYCLE, V10, P2806, DOI 10.4161/cc.10.16.17012; Pedersen N, 2003, CANCER RES, V63, P1943; Peng HY, 2011, ANN HEMATOL, V90, P1017, DOI 10.1007/s00277-011-1186-3; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; Riaz SP, 2012, LUNG CANCER, V75, P280, DOI 10.1016/j.lungcan.2011.08.004; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Schumacher A, 2003, MOL CELL NEUROSCI, V23, P669, DOI 10.1016/S1044-7431(03)00170-2; Senderowicz AM, 2003, ONCOGENE, V22, P6609, DOI 10.1038/sj.onc.1206954; Stovold R, 2012, LUNG CANCER, V76, P263, DOI 10.1016/j.lungcan.2011.11.015; SUTHERLAND K, 2011, TLS TIMES LIT S 0422, P19; Thompson AF, 2010, NEUROCHEM INT, V56, P554, DOI 10.1016/j.neuint.2009.12.018; Travis WD, 2010, ANN ONCOL, V21, P65, DOI 10.1093/annonc/mdq380; William WN, 2011, NAT REV CLIN ONCOL, V8, P611, DOI 10.1038/nrclinonc.2011.90; Yao RJ, 1997, J BIOL CHEM, V272, P18261, DOI 10.1074/jbc.272.29.18261; Yuste VJ, 2002, J NEUROCHEM, V80, P126, DOI 10.1046/j.0022-3042.2001.00695.x	45	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e86910	10.1371/journal.pone.0086910	http://dx.doi.org/10.1371/journal.pone.0086910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586258	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200010
J	Groger, JP; Hinrichsen, HH; Polte, P				Groeger, Joachim P.; Hinrichsen, Hans-Harald; Polte, Patrick			Broad-Scale Climate Influences on Spring-Spawning Herring (Clupea harengus, L.) Recruitment in the Western Baltic Sea	PLOS ONE			English	Article							NORTH-ATLANTIC OSCILLATION; SPRAT SPRATTUS-SPRATTUS; COD GADUS-MORHUA; POPULATION-DYNAMICS; PLANKTON PRODUCTION; TEMPERATURE; LARVAL; VARIABILITY; ENVIRONMENT; ABUNDANCE	Climate forcing in complex ecosystems can have profound implications for ecosystem sustainability and may thus challenge a precautionary ecosystem management. Climatic influences documented to affect various ecological functions on a global scale, may themselves be observed on quantitative or qualitative scales including regime shifts in complex marine ecosystems. This study investigates the potential climatic impact on the reproduction success of spring-spawning herring (Clupea harengus) in the Western Baltic Sea (WBSS herring). To test for climate effects on reproduction success, the regionally determined and scientifically well-documented spawning grounds of WBSS herring represent an ideal model system. Climate effects on herring reproduction were investigated using two global indices of atmospheric variability and sea surface temperature, represented by the North Atlantic Oscillation (NAO) and the Atlantic Multi-decadal Oscillation (AMO), respectively, and the Baltic Sea Index (BSI) which is a regional-scale atmospheric index for the Baltic Sea. Moreover, we combined a traditional approach with modern time series analysis based on a recruitment model connecting parental population components with reproduction success. Generalized transfer functions (ARIMAX models) allowed evaluating the dynamic nature of exogenous climate processes interacting with the endogenous recruitment process. Using different model selection criteria our results reveal that in contrast to NAO and AMO, the BSI shows a significant positive but delayed signal on the annual dynamics of herring recruitment. The westward influence of the Siberian high is considered strongly suppressing the influence of the NAO in this area leading to a higher explanatory power of the BSI reflecting the atmospheric pressure regime on a North-South transect between Oslo, Norway and Szczecin, Poland. We suggest incorporating climate-induced effects into stock and risk assessments and management strategies as part of the EU ecosystem approach to support sustainable herring fisheries in the Western Baltic Sea.	[Groeger, Joachim P.] Thunen Inst Sea Fisheries, Hamburg, Germany; [Groeger, Joachim P.] Univ Rostock, Inst Biosci, D-18055 Rostock, Germany; [Hinrichsen, Hans-Harald] GEOMAR Helmholtz Ctr Ocean Res, Kiel, Germany; [Polte, Patrick] Thunen Inst Balt Sea Fisheries, Rostock, Germany	Johann Heinrich von Thunen Institute; University of Rostock; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Johann Heinrich von Thunen Institute	Groger, JP (corresponding author), Thunen Inst Sea Fisheries, Hamburg, Germany.	joachim.groeger@t-online.de			European Community [266445]	European Community(European Commission)	For one of the authors (Hans-Harald Hinrichsen) the research leading to these results has received funding from the European Community's Seventh Framework Program (FP7/2007-2013) under Grant Agreement No. 266445 for the project "Vectors of Change in Oceans and Seas Marine Life, Impact on Economic Sectors (VECTORS).'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arula T, 2012, THESIS U TARTU ESTON, V226; BAKUN A, 1991, ICES J MAR SCI, V48, P343, DOI 10.1093/icesjms/48.3.343; Baumann H, 2006, CAN J FISH AQUAT SCI, V63, P2191, DOI 10.1139/F06-112; Biester E, 1979, ICES CM J; BLAXTER JHS, 1985, CAN J FISH AQUAT SCI, V42, P21; Borja A, 1998, FISH OCEANOGR, V7, P375, DOI 10.1046/j.1365-2419.1998.00064.x; Box G., 1970, TIME SERIES ANAL; BOX GEP, 1975, J AM STAT ASSOC, V70, P70, DOI 10.2307/2285379; Brander K, 2004, CAN J FISH AQUAT SCI, V61, P1558, DOI 10.1139/F04-087; Brodziak J, 2005, ICES J MAR SCI, V62, P1394, DOI 10.1016/j.icesjms.2005.04.019; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2004, AMST WORKSH MOD SEL; Cardinale M, 2009, MAR ECOL PROG SER, V388, P221, DOI 10.3354/meps08125; Clark RA, 2003, GLOBAL CHANGE BIOL, V9, P1669, DOI 10.1046/j.1365-2486.2003.00685.x; Cushing D.H., 1982, CLIMATE FISHERIES; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Cushing DH, 1975, MARINE ECOLOGY FISHE; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; Fahrmeir  L., 1996, MULTIVARIATE STAT VE; Fassler SMM, 2011, FISH OCEANOGR, V20, P530, DOI 10.1111/j.1365-2419.2011.00600.x; Finney BP, 2000, SCIENCE, V290, P795, DOI 10.1126/science.290.5492.795; Fogarty M, 2008, MITIG ADAPT STRAT GL, V13, P453, DOI 10.1007/s11027-007-9131-4; Fogarty MJ, 2002, GLO CH IGBP, P27; Glantz M. H., 1992, CLIMATE VARIABILITY; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Groger J, 2006, J SEA RES, V55, P266, DOI 10.1016/j.seares.2005.11.005; Groger JP, 2011, ICES J MAR SCI, V68, P592, DOI 10.1093/icesjms/fsq196; Groger JP, 2010, ICES J MAR SCI, V67, P454, DOI 10.1093/icesjms/fsp259; Groger JP, 2007, FISH RES, V84, P189, DOI 10.1016/j.fishres.2006.10.018; Groger JP, 2011, ECOL INDIC, V11, P1084, DOI 10.1016/j.ecolind.2010.12.008; Hare JA, 2010, ECOL APPL, V20, P452, DOI 10.1890/08-1863.1; Hartung J, 2002, STATISTIK; Hinrichsen HH, 2007, OCEANOLOGIA, V49, P381; Hinrichsen HH, 2003, J SEA RES, V49, P187, DOI 10.1016/S1385-1101(03)00006-6; Hinrichsen HH, 2002, J MARINE SYST, V32, P281, DOI 10.1016/S0924-7963(02)00040-4; Hjort J., 1914, RAPP P V REUN CONS I, V20, P1; Hurrell JW, 1997, CLIMATIC CHANGE, V36, P301, DOI 10.1023/A:1005314315270; Hurvich CM., 1993, J TIME SER ANAL, V14, P271, DOI DOI 10.1111/J.1467-9892.1993.TB00144.X; ICES, 2012, REP ICES WORK GROUP; ICES, 2011, REP ICES HELCOM WORK; Lehmann A, 2002, TELLUS A, V54, P299, DOI 10.1034/j.1600-0870.2002.00289.x; Lindegren M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038410; Luatkepohl H., 1993, INTRO MULTIPLE TIME, DOI 10.1007/978-3-642-61695-2; Mollmann C, 2005, ICES J MAR SCI, V62, P1270, DOI 10.1016/j.icesjms.2005.04.021; Nielsen JR, 2001, FISH RES, V50, P235; Nissling A, 2003, J FISH BIOL, V63, P280, DOI 10.1046/j.1095-8649.2003.00139.x; Noakes D, 1987, NAT RESOUR MODEL, V2, P213; Osborn TJ, 1999, CLIM DYNAM, V15, P685, DOI 10.1007/s003820050310; Ottersen G, 2006, FISH OCEANOGR, V15, P230, DOI 10.1111/j.1365-2419.2006.00404.x; Petereit C, 2009, SCI MAR, V73, P59, DOI 10.3989/scimar.2009.73s1059; Planque B, 1999, CAN J FISH AQUAT SCI, V56, P2069, DOI 10.1139/cjfas-56-11-2069; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Polte P, 2014, ICES J MAR SCI, V71, P982, DOI 10.1093/icesjms/fst050; Post E, 2004, MARINE ECOSYSTEMS AND CLIMATE VARIATION, P165; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; Reum JCP, 2011, MAR ECOL PROG SER, V425, P203, DOI 10.3354/meps08997; Schlittgen R., 2001, ANGEW ZEITREIHENANAL; Schlittgen R, 2001, ZEITREIHENANALYSE; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sissenwine M.P., 1988, P129; Skogen MD, 2005, FISH OCEANOGR, V14, P64, DOI 10.1111/j.1365-2419.2004.00324.x; Solow AR, 2001, CLIMATIC CHANGE, V49, P359, DOI 10.1023/A:1010720408793; Stenseth N., 2004, MARINE ECOSYSTEMS CL; Tunberg BG, 1998, MAR ECOL PROG SER, V170, P85, DOI 10.3354/meps170085; van Deurs Mikael, 2007, Acta Ichthyologica et Piscatoria, V37, P73, DOI 10.3750/AIP2007.37.2.01; Wood C.M., 1997, GLOBAL WARMING IMPLI; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	72	13	13	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e87525	10.1371/journal.pone.0087525	http://dx.doi.org/10.1371/journal.pone.0087525			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586279	Green Accepted, Green Published, gold			2022-12-27	WOS:000332385900007
J	Valdiani, A; Talei, D; Tan, SG; Kadir, MA; Maziah, M; Rafii, MY; Sagineedu, SR				Valdiani, Alireza; Talei, Daryush; Tan, Soon Guan; Kadir, Mihdzar Abdul; Maziah, Mahmood; Rafii, Mohd Yusop; Sagineedu, Sreenivasa Rao			A Classical Genetic Solution to Enhance the Biosynthesis of Anticancer Phytochemicals in Andrographis paniculata Nees	PLOS ONE			English	Article							PLANT-GROWTH REGULATORS; QUANTITATIVE CHARACTERS; INBREEDING DEPRESSION; ACTIVE DITERPENOIDS; DIALLEL CROSS; YIELD; HETEROSIS; 14-DEOXY-11,12-DIDEHYDROANDROGRAPHOLIDE; DIFFERENTIATION; DOMINANCE	Andrographolides, the diterpene lactones, are major bioactive phytochemicals which could be found in different parts of the medicinal herb Andrographis paniculata. A number of such compounds namely andrographolide (AG), neoandrographolide (NAG), and 14-deoxy-11,12-didehydroandrographolide (DDAG) have already attracted a great deal of attention due to their potential therapeutic effects in hard-to-treat diseases such as cancers and HIV. Recently, they have also been considered as substrates for the discovery of novel pharmaceutical compounds. Nevertheless, there is still a huge gap in knowledge on the genetic pattern of the biosynthesis of these bioactive compounds. Hence, the present study aimed to investigate the genetic mechanisms controlling the biosynthesis of these phytochemicals using a diallel analysis. The high performance liquid chromatography analysis of the three andrographolides in 210 F-1 progenies confirmed that the biosynthesis of these andrographolides was considerably increased via intraspecific hybridization. The results revealed high, moderate and low heterosis for DDAG, AG and NAG, respectively. Furthermore, the preponderance of non-additive gene actions was affirmed in the enhancement of the three andrographolides contents. The consequence of this type of gene action was the occurrence of high broad-sense and low narrow-sense heritabilities for the above mentioned andrographolides. The prevalence of non-additive gene action suggests the suitability of heterosis breeding and hybrid seed production as a preferred option to produce new plant varieties with higher andrographolide contents using the wild accessions of A. paniculata. Moreover, from an evolutionary point of view, the occurrence of population bottlenecks in the Malaysian accessions of A. paniculata was unveiled by observing a low level of additive genetic variance (V-A) for all the andrographolides.	[Valdiani, Alireza; Maziah, Mahmood] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Biochem, Serdang, Selangor De, Malaysia; [Talei, Daryush; Tan, Soon Guan] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Cell & Mol Biol, Serdang, Selangor De, Malaysia; [Talei, Daryush] Shahed Univ, Med Plant Res Ctr, Tehran, Iran; [Kadir, Mihdzar Abdul] Univ Putra Malaysia, Fac Agr, Dept Agr Technol, Serdang, Selangor De, Malaysia; [Rafii, Mohd Yusop] Univ Putra Malaysia, Inst Trop Agr, Serdang, Selangor De, Malaysia; [Sagineedu, Sreenivasa Rao] Int Med Univ, Dept Pharmaceut Chem, Sch Pharm, Kuala Lumpur 57000, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Shahed University; Universiti Putra Malaysia; Universiti Putra Malaysia; International Medical University Malaysia	Valdiani, A (corresponding author), Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Biochem, Serdang, Selangor De, Malaysia.	alireza.valdiani@gmail.com	Rafii, M.Y./G-9925-2015; Tan, S G/B-2448-2010; Talei, Daryush/V-9062-2019; Sagineedu, Sreenivasa Rao/G-3910-2013; Tan, Soon Guan/V-1782-2019	Rafii, M.Y./0000-0003-4763-6367; Tan, S G/0000-0001-9960-4493; Talei, Daryush/0000-0001-8699-850X; Sagineedu, Sreenivasa Rao/0000-0002-4746-1432; Tan, Soon Guan/0000-0001-9960-4493; Valdiani, Alireza/0000-0003-4290-8730	Universiti Putra Malaysia	Universiti Putra Malaysia	Authors appreciate Universiti Putra Malaysia for supporting this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaah G., 2012, PRINCIPLES PLANT GEN; Alireza Biabani, 2012, Australian Journal of Crop Science, V6, P1030; Anuradha VE, 2010, PESTIC BIOCHEM PHYS, V98, P312, DOI 10.1016/j.pestbp.2010.07.002; Aromdee C, 2012, EXPERT OPIN THER PAT, V22, P169, DOI 10.1517/13543776.2012.661718; BAKER RJ, 1978, CROP SCI, V18, P533, DOI 10.2135/cropsci1978.0011183X001800040001x; BALMAIN A, 1973, J CHEM SOC PERK T 1, P1247, DOI 10.1039/p19730001247; Barth S, 2003, HEREDITY, V91, P36, DOI 10.1038/sj.hdy.6800276; Birchler JA, 2006, P NATL ACAD SCI USA, V103, P12957, DOI 10.1073/pnas.0605627103; BOORSMA WA, 1896, MEDS LANDS PLANT, V18, P63; CHAKRABORTY R, 1982, GENET RES, V39, P303, DOI 10.1017/S0016672300020978; Chao W. W., 2010, CHIN MED, V5, P1, DOI DOI 10.1186/1749-8546-5-17; CRUSIO WE, 1984, BEHAV GENET, V14, P81, DOI 10.1007/BF01066070; Dabholkar A.R., 1999, ELEMENTS BIOMETRICAL; Daryush Talei, 2011, American-Eurasian Journal of Agricultural & Environmental Sciences, V10, P639; Dordevic R, 2010, GENETIKA-BELGRADE, V42, P575, DOI 10.2298/GENSR1003575D; Falconer D. S., 1989, Introduction to quantitative genetics.; Gjuvsland AB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009379; Gorter K., 1911, REC TRAV CHIM, V30, P151; GRIFFING B., 1956, AUSTRALIAN JOUR BIOL SCI, V9, P463; Gudhate PP, 2009, PHARMACOGN MAG, V5, P249; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Holt-Gimenez E., 2009, FOOD REBELLIONS CRIS; Jebril A.A., 2003, 5 NAT GEN C KUAL LUM; KLEIPOOL RJC, 1952, NATURE, V169, P33, DOI 10.1038/169033c0; Laddha K. S., 2010, International Journal of Pharma and Bio Sciences, V1, P1, DOI 10.5138/ijaps.2010.0976.1055.01001; Lee MJ, 2010, J ETHNOPHARMACOL, V132, P497, DOI 10.1016/j.jep.2010.07.057; Leimu R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012614; Li ZK, 2001, GENETICS, V158, P1737; Lomlim L, 2003, CHEM PHARM BULL, V51, P24, DOI 10.1248/cpb.51.24; LYNCH M, 1986, EVOLUTION, V40, P915, DOI 10.1111/j.1558-5646.1986.tb00561.x; LYNCH M, 1991, EVOLUTION, V45, P622, DOI [10.1111/j.1558-5646.1991.tb04333.x, 10.2307/2409915]; Man Singh, 2011, Agricultural Journal, V6, P115, DOI 10.3923/aj.2011.115.118; MATSUDA T, 1994, CHEM PHARM BULL, V42, P1216, DOI 10.1248/cpb.42.1216; Mc-Whirter K. S., 1979, PLANT BREEDING, P79; Omholt SW, 2000, GENETICS, V155, P969; Ooi JP, 2011, LIFE SCI, V88, P447, DOI 10.1016/j.lfs.2010.12.019; PETR FC, 1966, CROP SCI, V6, P259, DOI 10.2135/cropsci1966.0011183X000600030013x; Pholphana N, 2004, PHYTOCHEM ANALYSIS, V15, P365, DOI 10.1002/pca.789; Rajpar I, 2011, J MED PLANTS RES, V5, P5528; Sanjay Patidar, 2011, World Applied Sciences Journal, V15, P1095; Sanjutha S., 2008, Research Journal of Agriculture and Biological Sciences, V4, P141; Saravanan R, 2008, INDIAN J HORTIC, V65, P220; *SAS I INC, 2009, JMP 8 US GUID; SAS Institute Inc, 2009, SAS SAS SAT US GUID; Schmidt J., 1919, COMPT REND LAB CALSB, V14, P33; SECANSKI M., 2004, GENETIKA, V36, P121; Sprague G. F., 1942, JOUR AMER SOC AGRON, V34, P923; Subbaraju, 2007, INT J APPL SCI ENG, V5, P27; Talei D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/319047; Talei D, 2013, EUPHYTICA, V189, P147, DOI 10.1007/s10681-012-0782-1; Tan ML, 2012, FOOD CHEM TOXICOL, V50, P431, DOI 10.1016/j.fct.2011.11.001; Tang CL, 2012, ARCH PHARM, V345, P647, DOI 10.1002/ardp.201200008; Teklewold A, 2005, CROP SCI, V45, P2629, DOI 10.2135/cropsci2005.0085; Thisoda P, 2006, EUR J PHARMACOL, V553, P39, DOI 10.1016/j.ejphar.2006.09.052; Tzeng YM, 2012, LIFE SCI, V90, P257, DOI 10.1016/j.lfs.2011.11.004; UNDP, 2002, PROMOTING HERBAL DRU, V10, P45; Valdiani A, 2013, MOL BIOL REP, V40, P1775, DOI 10.1007/s11033-012-2231-6; Valdiani A, 2012, SCI WORLD J, DOI 10.1100/2012/297545; Valdiani A, 2012, GENE, V505, P23, DOI 10.1016/j.gene.2012.05.056; Valdiani A, 2012, MOL BIOL REP, V39, P5409, DOI 10.1007/s11033-011-1341-x; van Heerwaarden B, 2008, GENETICS, V179, P2135, DOI 10.1534/genetics.107.082768; Wang JL, 1998, GENETICS, V150, P435; Williams CG, 2001, GENETICS, V159, P1283; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Xu J, 2012, INT J BIOL MACROMOL, V51, P738, DOI 10.1016/j.ijbiomac.2012.06.035; Zdravkovic J, 2000, ACTA PHYSIOL PLANT, V22, P261, DOI 10.1007/s11738-000-0027-0; Zhang YD, 2005, AGRON J, V97, P1097, DOI 10.2134/agronj2004.0260; Zhang ZG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054129, 10.1371/journal.pone.0056344, 10.1371/journal.pone.0054577, 10.1371/journal.pone.0065268]; Zhao YF, 2006, J PHARMACEUT BIOMED, V40, P157, DOI 10.1016/j.jpba.2005.04.003; Zivanovic T., 2005, Journal of Agricultural Sciences, Belgrade, V50, P9	70	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e87034	10.1371/journal.pone.0087034	http://dx.doi.org/10.1371/journal.pone.0087034			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586262	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000332385900005
J	Cruz-Guilloty, F; Saeed, AM; Duffort, S; Cano, M; Ebrahimi, KB; Ballmick, A; Tan, YH; Wang, H; Laird, JM; Salomon, RG; Handa, JT; Perez, VL				Cruz-Guilloty, Fernando; Saeed, Ali M.; Duffort, Stephanie; Cano, Marisol; Ebrahimi, Katayoon B.; Ballmick, Asha; Tan, Yaohong; Wang, Hua; Laird, James M.; Salomon, Robert G.; Handa, James T.; Perez, Victor L.			T Cells and Macrophages Responding to Oxidative Damage Cooperate in Pathogenesis of a Mouse Model of Age-Related Macular Degeneration	PLOS ONE			English	Article							FACTOR-H POLYMORPHISM; ADAPTIVE IMMUNITY; DRUSEN; ACTIVATION; BIOMARKERS; RISK; IDENTIFICATION; POLARIZATION; PLASTICITY; INDUCTION	Age-related macular degeneration (AMD) is a major disease affecting central vision, but the pathogenic mechanisms are not fully understood. Using a mouse model, we examined the relationship of two factors implicated in AMD development: oxidative stress and the immune system. Carboxyethylpyrrole (CEP) is a lipid peroxidation product associated with AMD in humans and AMD-like pathology in mice. Previously, we demonstrated that CEP immunization leads to retinal infiltration of pro-inflammatory M1 macrophages before overt retinal degeneration. Here, we provide direct and indirect mechanisms for the effect of CEP on macrophages, and show for the first time that antigen-specific T cells play a leading role in AMD pathogenesis. In vitro, CEP directly induced M1 macrophage polarization and production of M1-related factors by retinal pigment epithelial (RPE) cells. In vivo, CEP eye injections in mice induced acute pro-inflammatory gene expression in the retina and human AMD eyes showed distinctively diffuse CEP immunolabeling within RPE cells. Importantly, interferon-gamma (IFN-gamma ) and interleukin-17 (IL-17)-producing CEP-specific T cells were identified ex vivo after CEP immunization and promoted M1 polarization in co-culture experiments. Finally, T cell immunosuppressive therapy inhibited CEP-mediated pathology. These data indicate that T cells and M1 macrophages activated by oxidative damage cooperate in AMD pathogenesis.	[Cruz-Guilloty, Fernando; Saeed, Ali M.; Duffort, Stephanie; Ballmick, Asha; Tan, Yaohong; Perez, Victor L.] Univ Miami, Miller Sch Med, Dept Ophthalmol, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Cruz-Guilloty, Fernando; Perez, Victor L.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Cano, Marisol; Ebrahimi, Katayoon B.; Handa, James T.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Wang, Hua; Laird, James M.; Salomon, Robert G.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA	Bascom Palmer Eye Institute; University of Miami; University of Miami; Johns Hopkins University; Johns Hopkins Medicine; Case Western Reserve University	Cruz-Guilloty, F (corresponding author), Univ Miami, Miller Sch Med, Dept Ophthalmol, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	fcruzguilloty@gmail.com; Vperez4@med.miami.edu	Wang, Hua/N-9400-2015; Perez, Victor L./AAY-8633-2020	Wang, Hua/0000-0002-2109-5497; Salomon, Robert/0000-0001-9456-3557	Edward N. & Della L. Thome Memorial Foundation Bank of America N.A. Trustee Award Program in Macular Degeneration Research; NIH [P30EY14801]; Prevent Blindness (Unrestricted Grant to the Bascom Palmer Eye Institute) [NIH R01-GM21249, NIH EY14005, EY019904]; RPB Senior Scientist Award; Sheila and David Fuente Graduate Program in Cancer Biology, Sylvester Comprehensive Cancer Center; Howard Hughes Medical Institute Fellowship of the Life Sciences Research Foundation; NATIONAL EYE INSTITUTE [P30EY014801, R01EY019904, R01EY014005, R01EY016813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021249] Funding Source: NIH RePORTER	Edward N. & Della L. Thome Memorial Foundation Bank of America N.A. Trustee Award Program in Macular Degeneration Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prevent Blindness (Unrestricted Grant to the Bascom Palmer Eye Institute); RPB Senior Scientist Award; Sheila and David Fuente Graduate Program in Cancer Biology, Sylvester Comprehensive Cancer Center; Howard Hughes Medical Institute Fellowship of the Life Sciences Research Foundation(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by The Edward N. & Della L. Thome Memorial Foundation Bank of America N.A. Trustee Award Program in Macular Degeneration Research (VLP, JTH); NIH P30EY14801 (Center Grant); Research to Prevent Blindness (Unrestricted Grant to the Bascom Palmer Eye Institute); NIH R01-GM21249 (RGS), NIH EY14005 (JTH), EY019904 (JTH), and RPB Senior Scientist Award (JTH). JTH is the Robert Bond Welch Professor. A. M. S. acknowledges partial support and assistance from the Sheila and David Fuente Graduate Program in Cancer Biology, Sylvester Comprehensive Cancer Center. FCG was supported by a Howard Hughes Medical Institute Fellowship of the Life Sciences Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Ambati J, 2013, NAT REV IMMUNOL, V13, P438, DOI 10.1038/nri3459; Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; Barshes NR, 2004, FRONT BIOSCI-LANDMRK, V9, P411, DOI 10.2741/1249; Binder CJ, 2004, J CLIN INVEST, V114, P427, DOI 10.1172/jci200420479; Bird AC, 2010, J CLIN INVEST, V120, P3033, DOI 10.1172/JCI42437; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; BRESSLER SB, 1990, ARCH OPHTHALMOL-CHIC, V108, P1442, DOI 10.1001/archopht.1990.01070120090035; Buschini E, 2011, PROG NEUROBIOL, V95, P14, DOI 10.1016/j.pneurobio.2011.05.011; Cao XG, 2011, PATHOL INT, V61, P528, DOI 10.1111/j.1440-1827.2011.02695.x; Cherepanoff S, 2010, BRIT J OPHTHALMOL, V94, P918, DOI 10.1136/bjo.2009.165563; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; Cousins SW, 2004, ARCH OPHTHALMOL-CHIC, V122, P1013, DOI 10.1001/archopht.122.7.1013; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Cruz-Guilloty F, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/503725; Cruz-Guilloty F, 2011, NATURE, V478, P42, DOI 10.1038/478042a; Doyle SL, 2012, NAT MED, V18, P791, DOI 10.1038/nm.2717; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Faber C, 2013, OPHTHALMOLOGY; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Gu JY, 2010, ADV EXP MED BIOL, V664, P411, DOI 10.1007/978-1-4419-1399-9_47; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Handa JT, 2012, MOL ASPECTS MED, V33, P418, DOI 10.1016/j.mam.2012.03.006; Hermansson A, 2010, J EXP MED, V207, P1081, DOI 10.1084/jem.20092243; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hollyfield JG, 2010, MOL NEUROBIOL, V41, P290, DOI 10.1007/s12035-010-8110-z; Kadl A, 2010, CIRC RES, V107, P737, DOI 10.1161/CIRCRESAHA.109.215715; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kelly J, 2007, J CLIN INVEST, V117, P3421, DOI 10.1172/JCI32430; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lichtman AH, 2013, J CLIN INVEST, V123, P27, DOI 10.1172/JCI63108; Liu BY, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-111; Lu L, 2009, BIOORGAN MED CHEM, V17, P7548, DOI 10.1016/j.bmc.2009.09.009; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Lugo-Villarino G, 2003, P NATL ACAD SCI USA, V100, P7749, DOI 10.1073/pnas.1332767100; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Morohoshi K, 2012, EXP MOL PATHOL, V93, P193, DOI 10.1016/j.yexmp.2012.03.007; Morohoshi K, 2012, EXP MOL PATHOL, V92, P64, DOI 10.1016/j.yexmp.2011.09.017; Morohoshi K, 2009, J AUTOIMMUN, V33, P247, DOI 10.1016/j.jaut.2009.09.003; Nussenblatt RB, 2007, AM J OPHTHALMOL, V144, P618, DOI 10.1016/j.ajo.2007.06.025; Nussenblatt RB, 2009, CURR OPIN INVEST DR, V10, P434; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Parmeggiani F, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/546786; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; SARKS SH, 1980, T OPHTHAL SOC UK, V100, P414; Sene A, 2013, CELL METAB, V17, P549, DOI 10.1016/j.cmet.2013.03.009; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Tuo JS, 2012, OCUL IMMUNOL INFLAMM, V20, P27, DOI 10.3109/09273948.2011.628432; Wei L, 2012, CELL REP, V2, P1151, DOI 10.1016/j.celrep.2012.10.013; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Whitcup SM, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/348092; Yamane H, 2012, NAT IMMUNOL, V13, P1037, DOI 10.1038/ni.2431; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yuan C, 1998, COMP BIOCHEM PHYS B, V120, P785, DOI 10.1016/S0305-0491(98)10079-2; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303	60	48	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88201	10.1371/journal.pone.0088201	http://dx.doi.org/10.1371/journal.pone.0088201			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586307	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900025
J	Lenz, PH; Roncalli, V; Hassett, RP; Wu, LS; Cieslak, MC; Hartline, DK; Christie, AE				Lenz, Petra H.; Roncalli, Vittoria; Hassett, R. Patrick; Wu, Le-Shin; Cieslak, Matthew C.; Hartline, Daniel K.; Christie, Andrew E.			De Novo Assembly of a Transcriptome for Calanus finmarchicus (Crustacea, Copepoda) - The Dominant Zooplankter of the North Atlantic Ocean	PLOS ONE			English	Article							GATED SODIUM-CHANNELS; INTERNATIONAL-UNION; GENE-EXPRESSION; NERVOUS-SYSTEM; GENOME; MODEL; IDENTIFICATION; DIAPAUSE; SEA; PHARMACOLOGY	Assessing the impact of global warming on the food web of the North Atlantic will require difficult-to-obtain physiological data on a key copepod crustacean, Calanus finmarchicus. The de novo transcriptome presented here represents a new resource for acquiring such data. It was produced from multiplexed gene libraries using RNA collected from six developmental stages: embryo, early nauplius (NI-II), late nauplius (NV-VI), early copepodite (CI-II), late copepodite (CV) and adult (CVI) female. Over 400,000,000 paired-end reads (100 base-pairs long) were sequenced on an Illumina instrument, and assembled into 206,041 contigs using Trinity software. Coverage was estimated to be at least 65%. A reference transcriptome comprising 96,090 unique components ("comps'') was annotated using Blast2GO. 40% of the comps had significant blast hits. 11% of the comps were successfully annotated with gene ontology (GO) terms. Expression of many comps was found to be near zero in one or more developmental stages suggesting that 35 to 48% of the transcriptome is "silent'' at any given life stage. Transcripts involved in lipid biosynthesis pathways, critical for the C. finmarchicus life cycle, were identified and their expression pattern during development was examined. Relative expression of three transcripts suggests wax ester biosynthesis in late copepodites, but triacylglyceride biosynthesis in adult females. Two of these transcripts may be involved in the preparatory phase of diapause. A key environmental challenge for C. finmarchicus is the seasonal exposure to the dinoflagellate Alexandrium fundyense with high concentrations of saxitoxins, neurotoxins that block voltage-gated sodium channels. Multiple contigs encoding putative voltage-gated sodium channels were identified. They appeared to be the result of both alternate splicing and gene duplication. This is the first report of multiple Na(V)1 genes in a protostome. These data provide new insights into the transcriptome and physiology of this environmentally important zooplankter.	[Lenz, Petra H.; Roncalli, Vittoria; Cieslak, Matthew C.; Hartline, Daniel K.; Christie, Andrew E.] Univ Hawaii Manoa, Bekesy Lab Neurobiol, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA; [Hassett, R. Patrick] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA; [Wu, Le-Shin] Indiana Univ, Natl Ctr Genome Anal Support, UITS, Bloomington, IN USA	University of Hawaii System; University of Hawaii Manoa; University System of Ohio; Ohio University; Indiana University System; Indiana University Bloomington	Lenz, PH (corresponding author), Univ Hawaii Manoa, Bekesy Lab Neurobiol, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA.	petra@pbrc.hawaii.edu; crabman@pbrc.hawaii.edu	Lenz, Petra H/ABE-4940-2021	Roncalli, Vittoria/0000-0003-3024-7568	National Science Foundation [OCE-1040597, ABI-1062432]; Cades Foundation of Honolulu, Hawaii; Direct For Biological Sciences [1062432] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Cades Foundation of Honolulu, Hawaii; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research is based upon work supported by the National Science Foundation under grants OCE-1040597 to PHL and ABI-1062432 to Indiana University and support from the Cades Foundation of Honolulu, Hawaii. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation, the National Center for Genome Analysis Support, or Indiana University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aruda AM, 2011, J INSECT PHYSIOL, V57, P665, DOI 10.1016/j.jinsphys.2011.03.007; Barzilai MG, 2012, CELL REP, V2, P242, DOI 10.1016/j.celrep.2012.06.016; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Bron JE, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-22; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2003, PHARMACOL REV, V55, P575, DOI 10.1124/pr.55.4.7; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Christie AE, 2008, GEN COMP ENDOCR, V155, P526, DOI 10.1016/j.ygcen.2007.09.002; Christie AE, 2014, GEN COMP ENDOCR, V195, P28, DOI 10.1016/j.ygcen.2013.10.003; Christie AE, 2013, COMP BIOCHEM PHYS D, V8, P165, DOI 10.1016/j.cbd.2013.04.002; Christie AE, 2013, GEN COMP ENDOCR, V187, P117, DOI 10.1016/j.ygcen.2013.03.018; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; Goldin AL, 2002, J EXP BIOL, V205, P575; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hansen BH, 2008, AQUAT TOXICOL, V86, P157, DOI 10.1016/j.aquatox.2007.10.009; Hansen BH, 2013, SCI TOTAL ENVIRON, V449, P276, DOI 10.1016/j.scitotenv.2013.01.020; Helaouet P, 2007, MAR ECOL PROG SER, V345, P147, DOI 10.3354/meps06775; Hull JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055105; Johnson CL, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016491, 10.1371/journal.pone.0021046, 10.1371/journal.pone.0019210]; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Kiko R, 2009, 3 INT S ENV PHYS EC; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee RF, 2006, MAR ECOL PROG SER, V307, P273, DOI 10.3354/meps307273; Lenz PH, 2012, COMP BIOCHEM PHYS D, V7, P110, DOI 10.1016/j.cbd.2011.12.001; Lin WH, 2009, J NEUROGENET, V23, pS30; Mallatt JM, 2004, MOL PHYLOGENET EVOL, V31, P178, DOI 10.1016/j.ympev.2003.07.013; Maps F, 2012, J PLANKTON RES, V34, P36, DOI 10.1093/plankt/fbr088; MCLAREN IA, 1988, HYDROBIOLOGIA, V167, P275, DOI 10.1007/BF00026315; Miller CB, 1998, LIMNOL OCEANOGR, V43, P488, DOI 10.4319/lo.1998.43.3.0488; Neuheimer AB, 2010, PROG OCEANOGR, V87, P94, DOI 10.1016/j.pocean.2010.09.008; Ning J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063741; Regier JC, 2005, P ROY SOC B-BIOL SCI, V272, P395, DOI 10.1098/rspb.2004.2917; Reynolds JA, 2012, J INSECT PHYSIOL, V58, P966, DOI 10.1016/j.jinsphys.2012.04.013; Reynolds JA, 2009, J EXP BIOL, V212, P2074, DOI 10.1242/jeb.027367; Riesgo A, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-33; Sargent J.R., 1986, P59; Saumweber WJ, 2006, DEEP-SEA RES PT II, V53, P2597, DOI 10.1016/j.dsr2.2006.08.003; Sim C, 2009, PHYSIOL GENOMICS, V39, P202, DOI 10.1152/physiolgenomics.00095.2009; Sousa GL, 2008, GEN COMP ENDOCR, V156, P454, DOI 10.1016/j.ygcen.2008.03.008; Speirs DC, 2010, FISH RES, V106, P474, DOI 10.1016/j.fishres.2010.09.023; Strausfeld NJ, 2011, ARTHROPOD STRUCT DEV, V40, P276, DOI 10.1016/j.asd.2011.02.002; Tan JG, 2002, J NEUROSCI, V22, P5300; Tarrant AM, 2008, MAR ECOL PROG SER, V355, P193, DOI 10.3354/meps07207; Turchetto-Zolet AC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-263; Unal E, 2013, J EXP MAR BIOL ECOL, V446, P76, DOI 10.1016/j.jembe.2013.04.020; Utne KR, 2012, MAR BIOL RES, V8, P527, DOI 10.1080/17451000.2011.642804; Vrablik TL, 2012, GENE DEV, V26, P631, DOI 10.1101/gad.190777.112; Wilson CH, 2010, GEN COMP ENDOCR, V167, P252, DOI 10.1016/j.ygcen.2010.03.012; Zeng V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-581; Zhang TX, 2011, INSECT BIOCHEM MOLEC, V41, P451, DOI 10.1016/j.ibmb.2011.04.010	54	89	90	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88589	10.1371/journal.pone.0088589	http://dx.doi.org/10.1371/journal.pone.0088589			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586345	Green Submitted, Green Published, gold			2022-12-27	WOS:000331711900030
J	Amouzou, A; Banda, B; Kachaka, W; Joos, O; Kanyuka, M; Hill, K; Bryce, J				Amouzou, Agbessi; Banda, Benjamin; Kachaka, Willie; Joos, Olga; Kanyuka, Mercy; Hill, Kenneth; Bryce, Jennifer			Monitoring Child Mortality through Community Health Worker Reporting of Births and Deaths in Malawi: Validation against a Household Mortality Survey	PLOS ONE			English	Article							STATISTICS; SYSTEMS	Background: The rate of decline in child mortality is too slow in most African countries to achieve the Millennium Development Goal of reducing under-five mortality by two-thirds between 1990 and 2015. Effective strategies to monitor child mortality are needed where accurate vital registration data are lacking to help governments assess and report on progress in child survival. We present results from a test of a mortality monitoring approach based on recording of births and deaths by specially trained community health workers (CHWs) in Malawi. Methods and Findings: Government-employed community health workers in Malawi are responsible for maintaining a Village Health Register, in which they record births and deaths that occur in their catchment area. We expanded on this system to provide additional training, supervision and incentives. We tested the equivalence between child mortality rates obtained from data on births and deaths collected by 160 randomly-selected and trained CHWs over twenty months in two districts to those computed through a standard household mortality survey. CHW reports produced an under-five mortality rate that was 84% (95% CI: [0.71,1.00]) of the household survey mortality rate and statistically equivalent to it. However, CHW data consistently underestimated under-five mortality, with levels of under-estimation increasing over time. Under-five deaths were more likely to be missed than births. Neonatal and infant deaths were more likely to be missed than older deaths. Conclusion: This first test of the accuracy and completeness of vital events data reported by CHWs in Malawi as a strategy for monitoring child mortality shows promising results but underestimated child mortality and was not stable over the four periods assessed. Given the Malawi government's commitment to strengthen its vital registration system, we are working with the Ministry of Health to implement a revised version of the approach that provides increased support to CHWs.	[Amouzou, Agbessi; Joos, Olga; Hill, Kenneth; Bryce, Jennifer] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Inst Int Programs, Baltimore, MD 21205 USA; [Banda, Benjamin; Kachaka, Willie; Kanyuka, Mercy] Malawi Natl Stat Off, Zomba, Malawi	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Amouzou, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Inst Int Programs, Baltimore, MD 21205 USA.	aamouzou@jhsph.edu		Amouzou, Agbessi/0000-0002-6262-3866; Joos, Olga/0000-0003-0335-4982	Canadian Cooperation through the Real-Time Results Tracking grant [7056791]	Canadian Cooperation through the Real-Time Results Tracking grant	The RMM project was funded by the Canadian Cooperation through the Real-Time Results Tracking grant (#7056791) implemented by the Institute for International Programs (IIP) at the Johns Hopkins Bloomberg School of Public Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouZahr C, 2005, B WORLD HEALTH ORGAN, V83, P578; [Anonymous], LEV TRENDS CHILD MOR; Arudo J, 2003, AM J TROP MED HYG, V68, P30, DOI 10.4269/ajtmh.2003.68.30; Commission on Information and Accountability for Women's and Children's Health, 2011, KEEP PROM MEAS RES; Edward A, 2007, T ROY SOC TROP MED H, V101, P814, DOI 10.1016/j.trstmh.2007.02.025; International Programs Center for Technical Assistance, 2013, CSPRO US GUID VERS 5; Kok MC, 2013, MALAWI MED J, V25, P5; Korenromp EL, 2004, INT J EPIDEMIOL, V33, P1293, DOI 10.1093/ije/dyh182; Lohr SL, 1999, SAMPLING DESIGN ANAL, P489; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Mahapatra P, 2007, LANCET, V370, P1653, DOI 10.1016/S0140-6736(07)61308-7; Mathers C, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000265; Ministry of Health, 2008, HLTH SURV ASS TRAIN; National Statistical Office (NSO), 2009, POP HOUS CENS 2008; National Statistical Office (NSO) and ICF Macro, 2011, MAL DEM HLTH SURV 20; Nsona H, 2012, AM J TROP MED HYG, V87, P54, DOI 10.4269/ajtmh.2012.11-0759; Requejo J, 2012, COUNTDOWN 2015 BUILD; Rosner B., 2000, FUNDAMENTALS BIOSTAT, P792; Setel PW, 2007, LANCET, V370, P1569, DOI 10.1016/S0140-6736(07)61307-5; StataCorp, 2011, STAT REL 12 STAT SOF; The Institute for International Programs, 2007, EXP CONS METH ALT MO	21	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88939	10.1371/journal.pone.0088939	http://dx.doi.org/10.1371/journal.pone.0088939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558453	Green Submitted, Green Published, gold			2022-12-27	WOS:000331706700099
J	de Ronde, JJ; Bonder, MJ; Lips, EH; Rodenhuis, S; Wessels, LFA				de Ronde, Jorma J.; Bonder, Marc Jan; Lips, Esther H.; Rodenhuis, Sjoerd; Wessels, Lodewyk F. A.			Breast Cancer Subtype Specific Classifiers of Response to Neoadjuvant Chemotherapy Do Not Outperform Classifiers Trained on All Subtypes	PLOS ONE			English	Article							PATHOLOGICAL COMPLETE RESPONSE; GENE-EXPRESSION PROFILES; CYCLOPHOSPHAMIDE CHEMOTHERAPY; PREOPERATIVE CHEMOTHERAPY; DOXORUBICIN; PACLITAXEL; FLUOROURACIL; PREDICTOR; TRASTUZUMAB; RESISTANCE	Introduction: Despite continuous efforts, not a single predictor of breast cancer chemotherapy resistance has made it into the clinic yet. However, it has become clear in recent years that breast cancer is a collection of molecularly distinct diseases. With ever increasing amounts of breast cancer data becoming available, we set out to study if gene expression based predictors of chemotherapy resistance that are specific for breast cancer subtypes can improve upon the performance of generic predictors. Methods: We trained predictors of resistance that were specific for a subtype and generic predictors that were not specific for a particular subtype, i.e. trained on all subtypes simultaneously. Through a rigorous double-loop cross-validation we compared the performance of these two types of predictors on the different subtypes on a large set of tumors all profiled on the same expression platform (n = 394). We evaluated predictors based on either mRNA gene expression or clinical features. Results: For HER2+, ER- breast cancer, subtype specific predictor based on clinical features outperformed the generic, nonspecific predictor. This can be explained by the fact that the generic predictor included HER2 and ER status, features that are predictive over the whole set, but not within this subtype. In all other scenarios the generic predictors outperformed the subtype specific predictors or showed equal performance. Conclusions: Since it depends on the specific context which type of predictor - subtype specific or generic-performed better, it is highly recommended to evaluate both specific and generic predictors when attempting to predict treatment response in breast cancer.	[de Ronde, Jorma J.; Bonder, Marc Jan; Wessels, Lodewyk F. A.] Netherlands Canc Inst, Dept Mol Carcinogenesis, Amsterdam, Netherlands; [de Ronde, Jorma J.; Lips, Esther H.] Netherlands Canc Inst, Dept Mol Pathol, Amsterdam, Netherlands; [Lips, Esther H.] Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands; [Rodenhuis, Sjoerd] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands; [Wessels, Lodewyk F. A.] Delft Univ Technol, Fac EEMCS, Delft, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Delft University of Technology	de Ronde, JJ (corresponding author), Netherlands Canc Inst, Dept Mol Carcinogenesis, Amsterdam, Netherlands.	jorma.deronde@gmail.com		Bonder, Marc Jan/0000-0002-8431-3180	CTMM, the Center for Translational Molecular Medicine, project Breast CARE [03O-104]	CTMM, the Center for Translational Molecular Medicine, project Breast CARE	JR and EL were funded by CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project Breast CARE (Grant 03O-104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 2011, BRIEFINGS BIOINFORMA; Ayers M, 2004, J CLIN ONCOL, V22, P2284, DOI 10.1200/JCO.2004.05.166; Bertucci F, 2004, CANCER RES, V64, P8558, DOI 10.1158/0008-5472.CAN-04-2696; Borst P, 2010, CELL CYCLE, V9, P4836, DOI 10.4161/cc.9.24.14326; Cleator S, 2006, BREAST CANCER RES TR, V95, P229, DOI 10.1007/s10549-005-9009-7; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fisher B, 1998, J CLIN ONCOL, V16, P2672, DOI 10.1200/JCO.1998.16.8.2672; Gyorffy B, 2006, INT J CANCER, V118, P1699, DOI 10.1002/ijc.21570; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Horiguchi J, 2011, ANTICANCER RES, V31, P3041; Hornik K, 2009, COMPUTATION STAT, V24, P225, DOI 10.1007/s00180-008-0119-7; Kaufmann M, 2006, J CLIN ONCOL, V24, P1940, DOI 10.1200/JCO.2005.02.6187; Kuerer HM, 1999, J CLIN ONCOL, V17, P460, DOI 10.1200/JCO.1999.17.2.460; Miyake T, 2012, CANCER SCI, V103, P913, DOI 10.1111/j.1349-7006.2012.02231.x; Naoi Y, 2011, CANCER-AM CANCER SOC, V117, P3682, DOI 10.1002/cncr.25953; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Popovici V, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2468; R Development Core Team, 2012, R LANG ENV STAT COMP; Romanski P, 2009, FSELECTOR SELECTING; Sorlie T, 2006, MOL CANCER THER, V5, P2914, DOI 10.1158/1535-7163.MCT-06-0126; Tabchy A, 2010, CLIN CANCER RES, V16, P5351, DOI 10.1158/1078-0432.CCR-10-1265; Valachis A, 2011, BREAST, V20, P485, DOI 10.1016/j.breast.2011.06.009; Wessels LFA, 2005, BIOINFORMATICS, V21, P3755, DOI 10.1093/bioinformatics/bti429; Witten IH, 2011, MOR KAUF D, P1; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683	25	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88551	10.1371/journal.pone.0088551	http://dx.doi.org/10.1371/journal.pone.0088551			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558399	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700045
J	Hu, G; Lu, F; Zhai, BP; Lu, MH; Liu, WC; Zhu, F; Wu, XW; Chen, GH; Zhang, XX				Hu, Gao; Lu, Fang; Zhai, Bao-Ping; Lu, Ming-Hong; Liu, Wan-Cai; Zhu, Feng; Wu, Xiang-Wen; Chen, Gui-Hua; Zhang, Xiao-Xi			Outbreaks of the Brown Planthopper Nilaparvata lugens (Stal) in the Yangtze River Delta: Immigration or Local Reproduction?	PLOS ONE			English	Article							RICE PLANTHOPPERS; MIGRATION; DELPHACIDAE; HOMOPTERA; FLIGHT; PESTS; CHINA	An effective control strategy for migratory pests is difficult to implement because the cause of infestation (i.e., immigration or local reproduction) is often not established. In particular, the outbreak mechanisms of the brown planthopper, Nilaparvata lugens (Stal), an insect causing massive losses in rice fields in the Yangtze River Delta in China, are frequently unclear. Field surveys of N. lugens were performed in Jiangsu and Zhejiang Provinces in 2008 to 2010 and related historical data from 2003 onwards were collected and analyzed to clarify the cause of these infestations. Results showed that outbreaks of N. lugens in the Yangtze River Delta were mostly associated with an extremely high increase in population. Thus, reproduction rather than immigration from distant sources were the cause of the infestations. Although mass migration occurred late in the season (late August and early September), the source areas of N. lugens catches in the Yangtze River Delta were mainly located in nearby areas, including the Yangtze River Delta itself, Anhui and northern Jiangxi Provinces. These regions collectively form the lower-middle reaches of the Yangtze River, and the late migration can thus be considered as an internal bioflow within one population.	[Hu, Gao; Lu, Fang; Zhai, Bao-Ping; Zhang, Xiao-Xi] Nanjing Agr Univ, Coll Plant Protect, Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China; [Lu, Ming-Hong; Liu, Wan-Cai] China Natl Agrotec Extens & Serv Ctr, Div Pest Forecasting, Beijing, Peoples R China; [Zhu, Feng] Plant Protect Stn Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Wu, Xiang-Wen] Plant Protect Stn Shanghai City, Shanghai, Peoples R China; [Chen, Gui-Hua] Plant Protect Stn Jinhua City, Jinhua, Peoples R China	Nanjing Agricultural University	Hu, G (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China.	hugao@njau.edu.cn		Hu, Gao/0000-0002-1000-5687	National '973' Program of China [2010CB126200]; Shanghai City Sci-Tech Joint Research Project in Yangtze River Delta of Shanghai Municipal Science and Technology Commission [13395810100]	National '973' Program of China(National Basic Research Program of China); Shanghai City Sci-Tech Joint Research Project in Yangtze River Delta of Shanghai Municipal Science and Technology Commission	Funding provided by the National '973' Program of China (2010CB126200), Shanghai City Sci-Tech Joint Research Project in Yangtze River Delta of Shanghai Municipal Science and Technology Commission (13395810100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[包云轩 BAO Yunxuan], 2008, [中国农业气象, Chinese Journal of Agrometeorology], V29, P347; Bottrell DG, 2012, J ASIA-PAC ENTOMOL, V15, P122, DOI 10.1016/j.aspen.2011.09.004; Brar D.S., 2009, PLANT HOPPERS NEW TH, P401; CHANG SS, 1980, ACTA ENTOMOL SINICA, V23, P130; CHEN JC, 1979, ACTA ENTOMOL SINICA, V22, P280; CHEN RC, 1984, ACTA ENTOMOL SINICA, V27, P121; CHEN RC, 1980, J NANJING AGR U, V2, P42; Chen Y. Y., 1996, JIANGSU AGR SCI, V24, P29; Cheng J. A., 1992, Chinese Journal of Rice Science, V6, P21; [程家安 Cheng Jiaan], 2006, [植物保护, Plant Protection], V32, P1; CHENG SN, 1979, ACTA ENTOMOL SINICA, V22, P1; Cheng X. N., 2003, BROWN PLANTHOPPER OC; DAY RK, 1995, INSECT MIGRATION: TRACKING RESOURCES THROUGH SPACE AND TIME, P323; Deng W., 1981, ACTA PHYTOPHYL SIN, V8, P73; Deveson ED, 2005, AUSTRAL ECOL, V30, P928, DOI 10.1111/j.1442-9993.2005.01536.x; Ding ZZ, 1985, JIANGSU AGR SCI, V13, P1; Draxier RR, 1998, AUST METEOROL MAG, V47, P295; GUO R, 2006, CHIN AGR YB, P376; [侯婷婷 Hou Tingting], 2004, [中国农业气象, Agricultural Meteorology of China], V25, P28; Hu G, 2011, B ENTOMOL RES, V101, P187, DOI 10.1017/S0007485310000313; Hu G, 2010, ENVIRON ENTOMOL, V39, P1705, DOI 10.1603/EN09214; Kisimoto R., 1985, Chinese Journal of Entomology, V4, P39; Kisimoto R, 1995, INSECT MIGRATION TRA, P93; Li Y. D., 1984, ACTA PHYTOPHYLACICA, V11, P101; [芦芳 Lu Fang], 2010, [生态学报, Acta Ecologica Sinica], V30, P3215; MA S. C., 1958, ACTA ENT SINICA, V8, P1; (MAPRC) Ministry of Agriculture of the People's Republic of China, 1995, 157941995 MAPRC GBT; Ohkubo N, 1971, Japanese Journal of Applied Entomology and Zoology, V15, P8; Otuka A, 2008, APPL ENTOMOL ZOOL, V43, P527, DOI 10.1303/aez.2008.527; PEDGLEY DE, 1993, INT J PEST MANAGE, V39, P3, DOI 10.1080/09670879309371751; PU MH, 1979, PLANT PROTECTION, V5, P1; Qi Guojun, 2010, Acta Phytophylacica Sinica, V37, P193; RILEY JR, 1994, B ENTOMOL RES, V84, P389, DOI 10.1017/S0007485300032521; RILEY JR, 1991, ECOL ENTOMOL, V16, P471, DOI 10.1111/j.1365-2311.1991.tb00240.x; ROSENBERG LJ, 1987, J ANIM ECOL, V56, P39, DOI 10.2307/4798; Sogawa K, 2003, CHINESE J RICE SCI, V17, P20; Wang YH, 2008, J ECON ENTOMOL, V101, P515, DOI 10.1603/0022-0493(2008)101[515:ISSASR]2.0.CO;2; Ye ZC, 1981, CHINESE BULL ENTOMOL, V18, P97; Zang Wei, 1997, Nanjing Nongye Daxue Xuebao, V20, P32; Zhai B.-P., 2006, CHINESE BULL ENTOMOL, V43, P585; Zhai Bao-Ping, 2011, Chinese Journal of Applied Entomology, V48, P1184; Zhao S. F, 1992, JIANGXI NONGYE DAXUE, V4, P74; Zheng DB, 2014, J APPL ENTOMOL, V138, P67, DOI 10.1111/jen.12067; Zhong DL, 1984, CHINESE BULL ENTOMOL, V22, P97; Zhu M, 2006, AGR FOREST METEOROL, V138, P192, DOI 10.1016/j.agrformet.2006.05.001	45	64	76	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88973	10.1371/journal.pone.0088973	http://dx.doi.org/10.1371/journal.pone.0088973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558459	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700105
J	Lu, FM; Huo, YJ; Li, ML; Chen, H; Liu, F; Wang, YF; Long, ZL; Duan, XJ; Zhang, J; Zeng, L; Chen, HF				Lu, Fengmei; Huo, Yajun; Li, Meiling; Chen, Heng; Liu, Feng; Wang, Yifeng; Long, Zhiliang; Duan, Xujun; Zhang, Jiang; Zeng, Ling; Chen, Huafu			Relationship between Personality and Gray Matter Volume in Healthy Young Adults: A Voxel-Based Morphometric Study	PLOS ONE			English	Article							REGIONAL BRAIN VOLUME; EXTROVERSION-INTROVERSION; CEREBELLUM; AMYGDALA; STIMULATION; NEUROTICISM; MATURATION; FMRI; SELF	This study aims to investigate the neurostructural foundations of the human personality in young adults. High-resolution structural T1-weighted MR images of 71 healthy young individuals were processed using voxel-based morphometric (VBM) approach. Multiple regression analyses were performed to identify the associations between personality traits and gray matter volume (GMV). The Eysenck Personality Questionnaire-Revised, Short Scale for Chinese was chosen to assess the personality traits. This scale includes four dimensions, namely, extraversion, neuroticism, psychoticism, and lie. Particularly, we studied on two dimensions (extraversion and neuroticism) of Eysenck's personality. Our results showed that extraversion was negatively correlated with GMV of the bilateral amygdala, the bilateral parahippocampal gyrus, the right middle temporal gyrus, and the left superior frontal gyrus, all of which are involved in emotional and social cognitive processes. These results might suggest an association between extraversion and affective processing. In addition, a positive correlation was detected between neuroticism and GMV of the right cerebellum, a key brain region for negative affect coordination. Meanwhile, a negative association was revealed between GMV of the left superior frontal gyrus and neuroticism. These results may prove that neuroticism is related to several brain regions involved in regulating negative emotions. Based on those findings, we concluded that brain regions involved in social cognition and affective process accounted for modulation and shaping of personality traits among young individuals. Results of this study may serve as a basis for elucidating the anatomical factors of personality.	[Lu, Fengmei; Huo, Yajun; Li, Meiling; Chen, Heng; Liu, Feng; Wang, Yifeng; Long, Zhiliang; Duan, Xujun; Zhang, Jiang; Zeng, Ling; Chen, Huafu] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab Neuroinformat, Chengdu 610054, Sichuan, Peoples R China	University of Electronic Science & Technology of China	Chen, HF (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab Neuroinformat, Chengdu 610054, Sichuan, Peoples R China.	chenhf@uestc.edu.cn	Li, Meiling/AAF-1917-2020; Liu, Feng/W-7572-2019	Li, Meiling/0000-0001-6378-5579; Liu, Feng/0000-0002-3570-4222	973 project [2012CB517901]; Natural Science Foundation of China [61035006, 61125304, 81171406, 61273361]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20120185110028]; Key Technology R&D Program of Sichuan Province [2012SZ0159]	973 project(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Key Technology R&D Program of Sichuan Province	This work was supported by the 973 project 2012CB517901; and Natural Science Foundation of China (Grant Nos. 61035006, 61125304, 81171406 and 61273361), and the Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20120185110028), and the Key Technology R&D Program of Sichuan Province (Grant No. 2012SZ0159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelstein JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027633; [Anonymous], 1985, PERSONALITY INDIVIDU, DOI 13877; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Barros-Loscertales A, 2006, EUR J NEUROSCI, V24, P2071, DOI 10.1111/j.1460-9568.2006.05084.x; Blankstein U, 2009, NEUROPSYCHOLOGIA, V47, P599, DOI 10.1016/j.neuropsychologia.2008.10.014; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Canli T, 2001, BEHAV NEUROSCI, V115, P33, DOI 10.1037//0735-7044.115.1.33; Canli T, 2002, SCIENCE, V296, P2191, DOI 10.1126/science.1068749; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; COSTA PT, 1988, J PERS SOC PSYCHOL, V54, P853, DOI 10.1037/0022-3514.54.5.853; Coutinho J. F., 2013, BRAIN IMAGING BEHAV, P1; Cremers H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028421; Depue RA, 1999, BEHAV BRAIN SCI, V22, P541, DOI 10.1017/S0140525X99462041; Depue RA, 1999, BEHAV BRAIN SCI, V22, P491; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Eysenck H.J., 1975, MANUAL EYSENCK PERSO; EYSENCK HJ, 1992, PERS INDIV DIFFER, V13, P757, DOI 10.1016/0191-8869(92)90050-Y; Eysenck HJ, 1997, J PERS SOC PSYCHOL, V73, P1224, DOI 10.1037/0022-3514.73.6.1224; EYSENCK HJ, 1946, P ROY SOC MED, V40, P75, DOI 10.1177/003591574604000209; Eysenck HJ, 1967, T PUB, V199, P1031; Eysenck HJ., 1993, MANUAL EYSENCK PERSO, DOI 10.1037/t05461-000; Eysenck HJ, 1990, BIOL DIMENSIONS PERS, P244; Ferrucci R, 2012, COGNITION EMOTION, V26, P786, DOI 10.1080/02699931.2011.619520; Forsman LJ, 2012, NEUROSCI RES, V72, P59, DOI 10.1016/j.neures.2011.10.001; Foti F, 2010, CEREBELLUM, V9, P29, DOI 10.1007/s12311-009-0134-4; Goldberg II, 2006, NEURON, V50, P329, DOI 10.1016/j.neuron.2006.03.015; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hagemann D, 2009, PERS INDIV DIFFER, V47, P717, DOI 10.1016/j.paid.2009.06.009; HEATH RG, 1978, BIOL PSYCHIAT, V13, P501; Jackson J, 2011, NEUROBIOL AGING, V32, P2162, DOI 10.1016/j.neurobiolaging.2009.12.009; Kim SH, 2008, NEUROREPORT, V19, P883, DOI 10.1097/WNR.0b013e328300080f; Kunisato Y, 2011, NEUROSCI LETT, V492, P109, DOI 10.1016/j.neulet.2011.01.067; Laricchiuta D, 2012, HUMAN BRAIN MAPPING; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; Lieberman MD, 2001, J PERS SOC PSYCHOL, V80, P294, DOI 10.1037//0022-3514.80.2.294; Liu F, 2012, PROGR NEUROPSYCHOPHA; Liu F, 2012, J AFFECTIVE DISORDER; Liu F, 2015, BRAIN STRUCT FUNCT, V220, P101, DOI 10.1007/s00429-013-0641-4; Liu F, 2014, NEUROIMAGE, V84, P466, DOI 10.1016/j.neuroimage.2013.09.015; Liu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040968; Mak AKY, 2009, NEUROSCI LETT, V457, P101, DOI 10.1016/j.neulet.2009.03.094; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Mingyi Q., 2000, ACTA PSYCHOL SIN, V32, P317, DOI DOI 10.1007/S11769-000-0010-0; Mobbs D, 2005, P NATL ACAD SCI USA, V102, P16502, DOI 10.1073/pnas.0408457102; Nater UM, 2010, PSYCHONEUROENDOCRINO, V35, P1573, DOI 10.1016/j.psyneuen.2010.02.017; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; O'Gorman RL, 2006, NEUROIMAGE, V31, P489, DOI 10.1016/j.neuroimage.2005.12.048; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveri M, 2007, CEREBELLUM, V6, P95, DOI 10.1080/14734220701213421; Oliveri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007933; Omura K, 2005, NEUROREPORT, V16, P1905, DOI 10.1097/01.wnr.0000186596.64458.76; Picerni E, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00133; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; Rusting C, 1997, PERSONALITY INDIVIDU; Rusting CL, 1997, PERS INDIV DIFFER, V22, P607, DOI 10.1016/S0191-8869(96)00246-2; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schmahmann JD, 2007, CEREBELLUM, V6, P254, DOI 10.1080/14734220701490995; Schutter DJLG, 2005, CEREBELLUM, V4, P290, DOI 10.1080/14734220500348584; Shaywitz SE, 1999, JAMA-J AM MED ASSOC, V281, P1197, DOI 10.1001/jama.281.13.1197; SNIDER RS, 1976, J NEUROSCI RES, V2, P133, DOI 10.1002/jnr.490020204; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Sowell ER, 2001, J INT NEUROPSYCH SOC, V7, P312, DOI 10.1017/S135561770173305X; Tran Y, 2001, PERS INDIV DIFFER, V30, P205, DOI 10.1016/S0191-8869(00)00027-1; Tranel D, 1997, NEUROPSYCHOLOGIA, V35, P1319, DOI 10.1016/S0028-3932(97)00085-7; Turner BM, 2007, NEUROPSYCHOLOGIA, V45, P1331, DOI 10.1016/j.neuropsychologia.2006.09.023; Vince G, 2006, DANA FDN BRAIN NEWS, V13, P2; Wei L, 2012, HUM BRAIN MAPP; Wei LQ, 2011, BRAIN RES, V1419, P68, DOI 10.1016/j.brainres.2011.08.060; Wright CI, 2006, CEREB CORTEX, V16, P1809, DOI 10.1093/cercor/bhj118; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013	75	43	45	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88763	10.1371/journal.pone.0088763	http://dx.doi.org/10.1371/journal.pone.0088763			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7IR	24551159	Green Published, Green Submitted, gold			2022-12-27	WOS:000331271500067
J	Bediou, B; Scherer, KR				Bediou, Benoit; Scherer, Klaus R.			Egocentric Fairness Perception: Emotional Reactions and Individual Differences in Overt Responses	PLOS ONE			English	Article							SOCIAL VALUE ORIENTATION; ENDOWMENT HETEROGENEITY; DECISION-MAKING; APPRAISAL; ANGER; COOPERATION; PREFERENCES; DILEMMAS; FEELINGS; JUSTICE	Extensive research documents the existence of egocentric biases in the perception and application of justice norms. The origin of these biases remains poorly understood. We investigated both inter-and intra-individual differences in egocentric justice biases. Participants played an ultimatum game presumably with different anonymous players (simulated by a computer) in which they contributed differentially to the joint production of the initial endowment. We examined how contributions (low vs. high) affect proposers' offers and responders' acceptance decisions, as well as their fairness judgments and their emotional reactions to different types of offers (equal, equitable, unfair, and hyperfair). An egocentric bias in proposers' offers (indicating more flexible preferences) was found only in individualists and not in prosocials, suggesting differences in the motivations (or cognitions) underlying their choice of justice norms. Responders also showed egocentric biases in their judgments of fairness and in their emotional reactions to equal and equitable offers, but not in their acceptance decisions. Such dissociation might suggest that some form of emotion regulation occurred. Responders may evaluate offers on valence dimensions (e.g., goal conduciveness/ outcome favorability and norm compatibility/justice) that are multiply interacting and potentially conflicting. The individual's acceptance/rejection decision reflects the relative weight attributed to competing appraisals. For this overt behavioral decision, the (personal) appraisal of outcome favorability that drives (analytical) acceptance of goal-conducive outcome seems to be stronger than the (social) appraisal of outcome fairness, which may trigger covert (emotional) rejection of offers that are incompatible with justice norms. Our data show that the emotional reaction patterns provide a more fine-grained readout of the overall evaluation of the proposer's action, the underlying emotional dynamics of which may, in real life, strongly determine future interactions with specific partners. Further research on the relationship between emotion and behavior in economic games is needed to explore potential dissociations and long-term effects.	[Bediou, Benoit; Scherer, Klaus R.] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland; [Bediou, Benoit] Univ Geneva, Brain & Learning Lab, Geneva, Switzerland	University of Geneva; University of Geneva	Bediou, B (corresponding author), Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland.	benoit.bediou@unige.ch		bediou, benoit/0000-0002-3477-7948	European Science Foundation [105514-123671]; Swiss National Science Foundation; European Research Council [230331]; Swiss National Centre of Competence in Research in the Affective Sciences [51NF40-128911]	European Science Foundation(European Science Foundation (ESF)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); Swiss National Centre of Competence in Research in the Affective Sciences	This study was supported by a grant (No. 105514-123671) from the European Science Foundation and the Swiss National Science Foundation, and a grant (No. 230331) from the European Research Council, both to Klaus Scherer. The study also received financial support from the Swiss National Centre of Competence in Research in the Affective Sciences, project No. 51NF40-128911. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almas I, 2010, SCIENCE, V328, P1176, DOI 10.1126/science.1187300; Andreoni J, 2009, ECONOMETRICA, V77, P1607, DOI 10.3982/ECTA7384; Babcock L, 1995, AM ECON REV, V85, P1337; Balliet D, 2009, GROUP PROCESS INTERG, V12, P533, DOI 10.1177/1368430209105040; Bediou B, 2012, SOC JUSTICE RES, V25, P25, DOI 10.1007/s11211-012-0151-1; Bicchieri C, 2008, NOUS, P229; Bogaert S, 2008, BRIT J SOC PSYCHOL, V47, P453, DOI 10.1348/014466607X244970; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Cappelen AW, 2007, AM ECON REV, V97, P818, DOI 10.1257/aer.97.3.818; Cappelen AW, 2010, EUR ECON REV, V54, P429, DOI 10.1016/j.euroecorev.2009.08.005; Charness G, 2002, Q J ECON, V117, P817, DOI 10.1162/003355302760193904; Cherry TL, 2005, J ECON BEHAV ORGAN, V57, P357, DOI 10.1016/j.jebo.2003.11.010; Cherry TL, 2002, AM ECON REV, V92, P1218, DOI 10.1257/00028280260344740; Ellsworth PC, 2003, SER AFFECTIVE SCI, P572; Engel C, 2011, EXP ECON, V14, P583, DOI 10.1007/s10683-011-9283-7; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; Francis-Gladney L, 2010, J APPL SOC PSYCHOL, V40, P182, DOI 10.1111/j.1559-1816.2009.00569.x; Frijda N, 2009, OXFORD COMPANION EMO, P132; FRIJDA NH, 1989, J PERS SOC PSYCHOL, V57, P212, DOI 10.1037/0022-3514.57.2.212; Frohlich N, 2004, PUBLIC CHOICE, V119, P91, DOI 10.1023/B:PUCH.0000024169.08329.eb; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; GUTH W, 1995, J ECON BEHAV ORGAN, V27, P329, DOI 10.1016/0167-2681(94)00071-L; Handgraaf M. J. J., 2003, SOCIAL JUSTICE RES, V16, P263, DOI DOI 10.1023/A:1025940829543; Harrison F, 2011, PLOS ONE, V6; HOMANS GC, 1961, SOCIAL BEHAV ITS ELE; Kahneman D., 1986, J BUS, V59, P285, DOI DOI 10.1086/296367; KOMORITA SS, 1973, PSYCHOL REV, V80, P149, DOI 10.1037/h0034341; Konow J, 2001, J ECON BEHAV ORGAN, V46, P137, DOI 10.1016/S0167-2681(01)00194-9; Krehbiel P. J., 2000, SOCIAL JUSTICE RES, V15, P339, DOI DOI 10.1023/A:1007670909889; Kroll S, 2007, EXP ECON, V10, P411, DOI 10.1007/s10683-006-9144-y; Kuppens P, 2007, COGNITION EMOTION, V21, P689, DOI 10.1080/02699930600859219; Kuppens P, 2003, EMOTION, V3, P254, DOI 10.1037/1528-3542.3.3.254; Lieberman MD, 2007, PSYCHOL SCI, V18, P421, DOI 10.1111/j.1467-9280.2007.01916.x; LOEWENSTEIN G, 1993, J LEGAL STUD, V22, P135, DOI 10.1086/468160; MESSICK DM, 1979, J EXP SOC PSYCHOL, V15, P418, DOI 10.1016/0022-1031(79)90047-7; Mikula G, 1998, PERS SOC PSYCHOL B, V24, P769, DOI 10.1177/0146167298247009; Moretti L, 2010, EMOTION, V10, P169, DOI 10.1037/a0017826; Ordonez LD, 2000, J BEHAV DECIS MAKING, V13, P329, DOI 10.1002/1099-0771(200007/09)13:3<329::AID-BDM356>3.0.CO;2-Q; PILLUTLA MM, 1995, ACAD MANAGE J, V38, P1408, DOI 10.2307/256863; Pillutla MM, 1996, ORGAN BEHAV HUM DEC, V68, P208, DOI 10.1006/obhd.1996.0100; Rodriguez-Lara I, 2012, EXP ECON, V15, P158, DOI 10.1007/s10683-011-9295-3; Sander D.E., 2009, OXFORD COMPANION EMO; Scherer K.R, 1992, JUSTICE INTERDISCIPL; Scherer K.R., 2013, COMPONENTS EMOTIONAL, P281; Scherer KR, 2009, COGNITION EMOTION, V23, P1307, DOI 10.1080/02699930902928969; Scherer KR, 1997, J PERS SOC PSYCHOL, V73, P902, DOI 10.1037/0022-3514.73.5.902; Shuman V, 2013, FRONTIERS P IN PRESS, V4; Skitka LJ., 2003, SOC JUSTICE RES, V16, P309, DOI [10.1023/A:1026336131206, DOI 10.1023/A:1026336131206]; Stephen AT, 2008, PSYCHOL SCI, V19, P1051, DOI 10.1111/j.1467-9280.2008.02198.x; THOMPSON L, 1992, ORGAN BEHAV HUM DEC, V51, P176, DOI 10.1016/0749-5978(92)90010-5; van Prooijen JW, 2008, J EXP SOC PSYCHOL, V44, P1303, DOI 10.1016/j.jesp.2008.05.006; van't Wout M, 2006, EXP BRAIN RES, V169, P564, DOI 10.1007/s00221-006-0346-5; VanLange PAM, 1997, J PERS SOC PSYCHOL, V73, P733, DOI 10.1037/0022-3514.73.4.733; Walster E, 1978, EQUITY THEORY RES; Weiss HM, 1999, J APPL PSYCHOL, V84, P786, DOI 10.1037/0021-9010.84.5.786; Xiao E, 2005, P NATL ACAD SCI USA, V102, P7398, DOI 10.1073/pnas.0502399102	59	37	37	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e88432	10.1371/journal.pone.0088432	http://dx.doi.org/10.1371/journal.pone.0088432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3DW	24586326	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200019
J	Rocha, DN; Brites, P; Fonseca, C; Pego, AP				Rocha, Daniela Nogueira; Brites, Pedro; Fonseca, Carlos; Pego, Ana Paula			Poly(Trimethylene Carbonate-co-epsilon-Caprolactone) Promotes Axonal Growth	PLOS ONE			English	Article							INJURED SPINAL-CORD; TRIMETHYLENE CARBONATE; EPSILON-CAPROLACTONE; NEURAL CELLS; REGENERATION; MYELIN; INHIBITION; OUTGROWTH; NEURONS; IDENTIFICATION	Mammalian central nervous system (CNS) neurons do not regenerate after injury due to the inhibitory environment formed by the glial scar, largely constituted by myelin debris. The use of biomaterials to bridge the lesion area and the creation of an environment favoring axonal regeneration is an appealing approach, currently under investigation. This work aimed at assessing the suitability of three candidate polymers - poly(epsilon-caprolactone), poly(trimethylene carbonate-co-epsilon-caprolactone) (P(TMC-CL)) (11: 89 mol%) and poly(trimethylene carbonate) - with the final goal of using these materials in the development of conduits to promote spinal cord regeneration. Poly(L-lysine) (PLL) coated polymeric films were tested for neuronal cell adhesion and neurite outgrowth. At similar PLL film area coverage conditions, neuronal polarization and axonal elongation was significantly higher on P(TMC-CL) films. Furthermore, cortical neurons cultured on P(TMC-CL) were able to extend neurites even when seeded onto myelin. This effect was found to be mediated by the glycogen synthase kinase 3 beta (GSK3 beta) signaling pathway with impact on the collapsin response mediator protein 4 (CRMP4), suggesting that besides surface topography, nanomechanical properties were implicated in this process. The obtained results indicate P(TMC-CL) as a promising material for CNS regenerative applications as it promotes axonal growth, overcoming myelin inhibition.	[Rocha, Daniela Nogueira; Fonseca, Carlos; Pego, Ana Paula] Univ Porto, INEB Inst Engn Biomed, Rua Campo Alegre 823, P-4100 Oporto, Portugal; [Rocha, Daniela Nogueira; Fonseca, Carlos; Pego, Ana Paula] FEUP, Oporto, Portugal; [Brites, Pedro] Univ Porto, IBMC, Nerve Regenerat Grp, P-4100 Oporto, Portugal; [Pego, Ana Paula] Univ Porto, ICBAS, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto	Pego, AP (corresponding author), Univ Porto, INEB Inst Engn Biomed, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	apego@ineb.up.pt	Pêgo, Ana Paula/C-6942-2012; Brites, Pedro/K-4231-2013; Rocha, Daniela/J-4242-2014	Pêgo, Ana Paula/0000-0001-5169-328X; Brites, Pedro/0000-0003-1754-1543; Rocha, Daniela/0000-0003-3034-9871; Fonseca, Carlos/0000-0002-2759-0384	FEDER funds through the Programa Operacional Factores de Competitividade - COMPETE; Portuguese funds through the Fundacao para a Ciencia e a Tecnologia (FCT) [HMSP-ICT/0020/2010, PEst-C/SAU/LA0002/2011]; European Commission FP6 NEST Program [02847]; Daniela N. Rocha PhD scholarship [SFRH/BD/64079/2009]	FEDER funds through the Programa Operacional Factores de Competitividade - COMPETE; Portuguese funds through the Fundacao para a Ciencia e a Tecnologia (FCT); European Commission FP6 NEST Program; Daniela N. Rocha PhD scholarship	This work was done with the financial support of the FEDER funds through the Programa Operacional Factores de Competitividade - COMPETE and Portuguese funds through the Fundacao para a Ciencia e a Tecnologia (FCT) (contracts HMSP-ICT/0020/2010 and PEst-C/SAU/LA0002/2011), as well as of the European Commission FP6 NEST Program (Contract 028473); as well as Daniela N. Rocha PhD scholarship (SFRH/BD/64079/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Rub MT, 2011, SOFT MATTER, V7, P2770, DOI 10.1039/c0sm01062f; Alabed YZ, 2007, J NEUROSCI, V27, P1702, DOI 10.1523/JNEUROSCI.5055-06.2007; Alabed YZ, 2010, J NEUROSCI, V30, P5635, DOI 10.1523/JNEUROSCI.6154-09.2010; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; BATES CA, 1993, EXP NEUROL, V123, P106, DOI 10.1006/exnr.1993.1144; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Brunetti V, 2010, P NATL ACAD SCI USA, V107, P6264, DOI 10.1073/pnas.0914456107; Cafferty WBJ, 2001, J NEUROSCI, V21, P7161, DOI 10.1523/JNEUROSCI.21-18-07161.2001; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; Castano Z, 2010, J NEUROCHEM, V113, P117, DOI 10.1111/j.1471-4159.2010.06581.x; Chen BK, 2009, J NEUROTRAUM, V26, P1759, DOI [10.1089/neu.2008.0610, 10.1089/neu.2008-0610]; Chen CS, 2008, J CELL SCI, V121, P3285, DOI 10.1242/jcs.023507; Dergham P, 2002, J NEUROSCI, V22, P6570; Dill J, 2008, J NEUROSCI, V28, P8914, DOI 10.1523/JNEUROSCI.1178-08.2008; Domke J, 1998, LANGMUIR, V14, P3320, DOI 10.1021/la9713006; Fan YW, 2002, APPL SURF SCI, V187, P313, DOI 10.1016/S0169-4332(01)01046-7; Fan YW, 2002, J NEUROSCI METH, V120, P17, DOI 10.1016/S0165-0270(02)00181-4; Fioretta ES, 2012, J BIOMECH, V45, P736, DOI 10.1016/j.jbiomech.2011.11.013; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Friedman JA, 2002, NEUROSURGERY, V51, P742, DOI 10.1097/00006123-200209000-00024; Fu Q, 2007, J NEUROSCI, V27, P4154, DOI 10.1523/JNEUROSCI.4353-06.2007; Geller HM, 2002, EXP NEUROL, V174, P125, DOI 10.1006/exnr.2002.7865; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; HASAN SJ, 1993, J NEUROSCI, V13, P492; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Garrido JJ, 2007, FEBS LETT, V581, P1579, DOI 10.1016/j.febslet.2007.03.018; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Kim WY, 2006, NEURON, V52, P981, DOI 10.1016/j.neuron.2006.10.031; Kinney JH, 1999, ARCH ORAL BIOL, V44, P813, DOI 10.1016/S0003-9969(99)00080-1; Kol N, 2007, BIOPHYS J, V92, P1777, DOI 10.1529/biophysj.106.093914; Kurland NE, 2012, MICRON, V43, P116, DOI 10.1016/j.micron.2011.07.017; Leach JB, 2007, J NEURAL ENG, V4, P26, DOI 10.1088/1741-2560/4/2/003; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Li R, 2005, CURR BIOL, V15, pR198, DOI 10.1016/j.cub.2005.03.008; Madigan NN, 2009, RESP PHYSIOL NEUROBI, V169, P183, DOI 10.1016/j.resp.2009.08.015; Marshall GW, 2001, J BIOMED MATER RES, V54, P87, DOI 10.1002/1097-4636(200101)54:1<87::AID-JBM10>3.0.CO;2-Z; Muller H-J, 2006, MICROARRAYS; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Novikova LN, 2003, CURR OPIN NEUROL, V16, P711, DOI 10.1097/00019052-200312000-00011; Pego AP, 2003, J BIOMED MATER RES A, V67A, P1044, DOI 10.1002/jbm.a.10121; Pego AP, 2002, MACROMOL BIOSCI, V2, P411, DOI 10.1002/mabi.200290000; Pego AP, 2001, J BIOMAT SCI-POLYM E, V12, P35; Pego AP, 2012, J CELLULAR MOL MED; Peineau S, 2008, BRIT J PHARMACOL, V153, pS428, DOI 10.1038/bjp.2008.2; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Pires LR, 2016, J TISSUE ENG REGEN M, V10, pE154, DOI 10.1002/term.1792; Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; Schuh E, 2011, J TISSUE ENG REGENER; Schwab JM, 2006, PROG NEUROBIOL, V78, P91, DOI 10.1016/j.pneurobio.2005.12.004; Siera O, 2010, J NEUROCHEM, V113, P1644; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; VanLandingham MR, 2001, MACROMOL SYMP, V167, P15, DOI 10.1002/1521-3900(200103)167:1<15::AID-MASY15>3.0.CO;2-T; Vleggeert-Lankamp CLAM, 2008, J NEUROSURG, V109, P294, DOI 10.3171/JNS/2008/109/8/0294; Vleggeert-Lankamp CLAM, 2005, EUR J NEUROSCI, V21, P1249, DOI 10.1111/j.1460-9568.2005.03954.x; Wei YT, 2010, J BIOMED MATER RES B, V95B, P110, DOI 10.1002/jbm.b.31689; Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014; Wong DY, 2008, J NEUROTRAUM, V25, P1027, DOI 10.1089/neu.2007.0473; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010; Zhang N, 2005, BRAIN RES REV, V49, P48, DOI 10.1016/j.brainresrev.2004.11.002	64	22	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e88593	10.1371/journal.pone.0088593	http://dx.doi.org/10.1371/journal.pone.0088593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586346	gold, Green Published, Green Submitted			2022-12-27	WOS:000332390800005
J	Jayasekera, N; Aprato, A; Villar, RN				Jayasekera, Narlaka; Aprato, Alessandro; Villar, Richard N.			Fat Pad Entrapment at the Hip: A New Diagnosis	PLOS ONE			English	Article							FINITE-ELEMENT MODEL; FEMOROACETABULAR IMPINGEMENT; ACETABULAR LABRUM; JOINT; OSTEOARTHRITIS; ARTHROSCOPY; PATHOLOGY; CARTILAGE; LESIONS; TEARS	Purpose: To establish if a positive impingement sign in femoroacetabular impingement (FAI) may result from entrapment of the fat pad located at the anterior head-neck junction of the upper femur. This fat pad is routinely removed before any cam lesion excision. Methods: We report a prospective study of 142 consecutive hip arthroscopies for symptomatic FAI where the aim was to remove the arthroscopically identified area of impingement, not necessarily to create a spherical femoral head. Patients were divided into two groups. Group 1 (n = 92; 34 females, 58 males), where a cam-type bony FAI lesion was identified and excised in addition to the fat pad which overlay it, and Group 2 (n = 50; 29 females, 21 males) where the only identified point of impingement was a prominent fat pad. In this situation the fat pad was excised in isolation and the underlying bone preserved. Patients were assessed preoperatively, at six weeks, six months, one year and two years with a modified Harris hip score (mHHS). Results: Both groups were comparable preoperatively for mean age, mean alpha angle and mean anterior offset ratio. Both groups improved significantly after surgery at all time points. However, Group 1 (fat pad and bone resection) demonstrated 16.0% improvement in mHHS by two years while for Group 2 (fat pad resection only) the improvement was 18.9% (p = 0.628). Conclusions: The fat pad found at the anterior head/neck junction of the hip joint can be a source of pain and we propose fat pad entrapment as a new, previously undescribed diagnosis. Our findings also suggest that a large number of cam lesions are being excised unnecessarily and that further efforts should be made to understand the role of the fat pad as a source of groin discomfort.	[Jayasekera, Narlaka; Aprato, Alessandro; Villar, Richard N.] Spire Cambridge Lea Hosp, Cambridge, England		Jayasekera, N (corresponding author), Spire Cambridge Lea Hosp, Cambridge, England.	naja01@doctors.org.uk	Aprato, Alessandro/J-9592-2014	Aprato, Alessandro/0000-0002-2514-4719				ALTENBERG AR, 1977, SOUTHERN MED J, V70, P174, DOI 10.1097/00007611-197702000-00019; Bastiaansen-Jenniskens YM, 2012, ANN RHEUM DIS, V71, P288, DOI 10.1136/ard.2011.153858; Byrd JWT, 1996, ARTHROSCOPY, V12, P603, DOI 10.1016/S0749-8063(96)90201-7; Clockaerts S, 2010, OSTEOARTHR CARTILAGE, V18, P876, DOI 10.1016/j.joca.2010.03.014; Dragoo JL, 2012, SPORTS MED, V42, P51, DOI 10.2165/11595680-000000000-00000; Eijer H, 2001, HIP INT, V11, P37, DOI DOI 10.1177/112070000101100104; Farjo LA, 1999, ARTHROSCOPY, V15, P132, DOI 10.1053/ar.1999.v15.015013; Ferguson SJ, 2003, J BIOMECH, V36, P171, DOI 10.1016/S0021-9290(02)00365-2; Ferguson SJ, 2000, J BIOMECH, V33, P953, DOI 10.1016/S0021-9290(00)00042-7; Ferguson SJ, 2000, CLIN BIOMECH, V15, P463, DOI 10.1016/S0268-0033(99)00099-6; Ganz R, 2003, CLIN ORTHOP RELAT R, P112, DOI 10.1097/01.blo.0000096804.78689.c2; Hoffa A, 1904, J AMER MED ASSOC, V43, P0795; Hogervorst T, 2012, BONE JOINT 360, V1, P2; Jacobson JA, 1997, RADIOGRAPHICS, V17, P675, DOI 10.1148/radiographics.17.3.9153705; Kapandji IA, 1985, FUNKTIONELLE ANATOMI, P24; Kemp JL, 2012, BRIT J SPORT MED, V46, P632, DOI 10.1136/bjsports-2011-090428; KLAUE K, 1991, J BONE JOINT SURG BR, V73, P423, DOI 10.1302/0301-620X.73B3.1670443; Matsuda DK, 2011, ARTHROSCOPY, V27, P870, DOI 10.1016/j.arthro.2010.12.002; McCarthy JC, 2001, CLIN ORTHOP RELAT R, P25; Notzli HP, 2002, J BONE JOINT SURG BR, V84B, P556, DOI 10.1302/0301-620X.84B4.12014; OGILVIEHARRIS DJ, 1994, ARTHROSCOPY, V10, P184, DOI 10.1016/S0749-8063(05)80091-X; Pollard TCB, 2010, ACTA ORTHOP, V81, P134, DOI 10.3109/17453671003619011; Robertson WJ, 2007, CLIN ORTHOP RELAT R, P88, DOI 10.1097/BLO0b013e31802c7e0f; Souza BGSE, 2010, ARTHROSCOPY, V26, P1053, DOI 10.1016/j.arthro.2009.12.021; Schwab JH., 2007, ADULT HIP, P559; Seldes RM, 2001, CLIN ORTHOP RELAT R, V382, P32; Simpson J, 2010, ORTHOP TRAUMATOL-SUR, V96, pS68, DOI 10.1016/j.otsr.2010.09.010; Thorborg K, 2010, BRIT J SPORT MED, V44, P1186, DOI 10.1136/bjsm.2009.060889; Engelhardt LVV, 2010, ARCH ORTHOP TRAUM SU, V130, P1041, DOI 10.1007/s00402-010-1133-0	29	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e83503	10.1371/journal.pone.0083503	http://dx.doi.org/10.1371/journal.pone.0083503			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586225	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000001
J	Maetzler, W; Apel, A; Langkamp, M; Deuschle, C; Dilger, SS; Stirnkorb, JG; Schulte, C; Schleicher, E; Gasser, T; Berg, D				Maetzler, Walter; Apel, Anja; Langkamp, Markus; Deuschle, Christian; Dilger, Sarah Selina; Stirnkorb, Johannes Georg; Schulte, Claudia; Schleicher, Erwin; Gasser, Thomas; Berg, Daniela			Comparable Autoantibody Serum Levels against Amyloid- and Inflammation-Associated Proteins in Parkinson's Disease Patients and Controls	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; INTRAVENOUS IMMUNOGLOBULIN; CEREBROSPINAL-FLUID; GENETIC-VARIATION; SNCA GENE; POLYMORPHISMS; BLOOD; IDENTIFICATION; ANTIBODIES	Naturally occurring autoantibodies (NAbs) against a number of potentially disease-associated cellular proteins, including Amyloid-beta(1-42) (Abeta(1-42)), Alpha-synuclein (Asyn), myelin basic protein (MBP), myelin oligodendrocyte glycoprotein (MOG), and S100 calcium binding protein B (S100B) have been suggested to be associated with neurodegenerative disorders, in particular Alzheimer's (AD) and Parkinson's disease (PD). Whereas the (reduced) occurrence of specific NAbs in AD is widely accepted, previous literature examining the relation of these NAb titres between PD patients and controls, as well as comparing these levels with demographic and clinical parameters in PD patients have produced inconsistent findings. We therefore aimed, in a cross-sectional approach, to determine serum titres of the above NAbs in a cohort of 93 PD patients (31 of them demented) and 194 controls. Levels were correlated with demographic and clinical variables, cerebrospinal fluid Abeta1-42, total tau and phospho-tau levels, as well as with single nucleotide polymorphisms (SNPs) of genes which either have been reported to influence the immune system, the amyloid cascade or the occurrence of PD (ApoE, GSK3B, HLA-DRA, HSPA5, SNCA, and STK39). The investigated NAb titres were neither significantly associated with the occurrence of PD, nor with demographic and clinical parameters, neurodegenerative markers or genetic variables. These results argue against a major potential of blood-borne parameters of the adaptive immune system to serve as trait or state markers in PD.	[Maetzler, Walter; Apel, Anja; Deuschle, Christian; Dilger, Sarah Selina; Stirnkorb, Johannes Georg; Schulte, Claudia; Gasser, Thomas; Berg, Daniela] Univ Tubingen, Dept Neurodegenerat, Ctr Neurol, Tubingen, Germany; [Maetzler, Walter; Apel, Anja; Deuschle, Christian; Dilger, Sarah Selina; Stirnkorb, Johannes Georg; Schulte, Claudia; Gasser, Thomas; Berg, Daniela] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Maetzler, Walter; Apel, Anja; Deuschle, Christian; Dilger, Sarah Selina; Stirnkorb, Johannes Georg; Schulte, Claudia; Gasser, Thomas; Berg, Daniela] Univ Tubingen, German Ctr Neurodegenerat Dis, DZNE, Tubingen, Germany; [Langkamp, Markus] Mediagnost, Reutlingen, Germany; [Schleicher, Erwin] Univ Hosp Tuebingen, Dept Internal Med 4, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Maetzler, W (corresponding author), Univ Tubingen, Dept Neurodegenerat, Ctr Neurol, Tubingen, Germany.	Walter.maetzler@uni-tuebingen.de	Maetzler, Walter/AAE-5831-2020; Berg, Daniela/A-8728-2019; Maetzler, Walter/A-6796-2011; Gasser, Thomas/GNH-5293-2022	Maetzler, Walter/0000-0002-5945-4694; Berg, Daniela/0000-0001-5796-5442; Maetzler, Walter/0000-0002-5945-4694; Gasser, Thomas/0000-0002-1069-1146; Schulte, Claudia/0000-0003-4006-1265	Hertie Institute; DZNE; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Tuebingen University	Hertie Institute; DZNE; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Tuebingen University	We thank all participants who took part in this study. Samples were obtained from the Neuro-Biobank of the University of Tuebingen, Germany (http://www.hih-tuebingen.de/nd/biobank/for-researchers/). This biobank is supported by the Hertie Institute and the DZNE. We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University.	Bach JP, 2012, ADV EXP MED BIOL, V750, P91, DOI 10.1007/978-1-4614-3461-0_7; Besong-Agbo D, 2013, NEUROLOGY, V80, P169, DOI 10.1212/WNL.0b013e31827b90d1; Britschgi M, 2009, P NATL ACAD SCI USA, V106, P12145, DOI 10.1073/pnas.0904866106; Chen LY, 2012, INT J CARDIOL, V154, P122, DOI 10.1016/j.ijcard.2010.09.007; Dodel R, 2013, LANCET NEUROL, V12, P233, DOI 10.1016/S1474-4422(13)70014-0; Du JL, 2012, PROTEIN ENG DES SEL, V25, P337, DOI 10.1093/protein/gzs026; Fetissov SO, 2011, METHODS MOL BIOL, V789, P295, DOI 10.1007/978-1-61779-310-3_19; Fuchs J, 2008, FASEB J, V22, P1327, DOI 10.1096/fj.07-9348com; Gruden MA, 2011, J NEUROIMMUNOL, V233, P221, DOI 10.1016/j.jneuroim.2010.12.001; Guo Y, 2011, NEUROSCI LETT, V501, P185, DOI 10.1016/j.neulet.2011.05.245; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Heinzel S, 2013, NEUROBIOL AGING, V34, P439, DOI 10.1016/j.neurobiolaging.2012.05.021; Hobert MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027831; Hu JG, 1998, BRAIN RES, V785, P195, DOI 10.1016/S0006-8993(97)01318-8; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Inkster B, 2009, ARCH GEN PSYCHIAT, V66, P721, DOI 10.1001/archgenpsychiatry.2009.70; Izzo G, 2013, CLINICS, V68, P277, DOI [10.6061/clinics/2013(02)RC01, 10.6061/CLINICS/2013(02)RC01]; Kakiuchi C, 2005, BIOCHEM BIOPH RES CO, V336, P1136, DOI 10.1016/j.bbrc.2005.08.248; Klaver AC, 2010, J NEUROSCI METH, V187, P263, DOI 10.1016/j.jneumeth.2010.01.018; Koehler NKU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064649; Kwekkeboom J, 2012, ADV EXP MED BIOL, V750, P133, DOI 10.1007/978-1-4614-3461-0_10; Langkamp M, 2009, CLIN CHEM LAB MED, V47, P1395, DOI 10.1515/CCLM.2009.313; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Maetzler W, 2012, J ALZHEIMERS DIS, V32, P95, DOI 10.3233/JAD-2012-120625; Maetzler W, 2011, J ALZHEIMERS DIS, V26, P171, DOI 10.3233/JAD-2011-110221; Maetzler W, 2011, MOVEMENT DISORD, V26, P176, DOI 10.1002/mds.23358; Mata IF, 2010, ARCH NEUROL-CHICAGO, V67, P1350, DOI 10.1001/archneurol.2010.279; Neff F, 2008, AUTOIMMUN REV, V7, P501, DOI 10.1016/j.autrev.2008.04.010; Notkins AL, 2004, TRENDS IMMUNOL, V25, P174, DOI 10.1016/j.it.2004.02.004; Pan FH, 2012, PARKINSONISM RELAT D, V18, P632, DOI 10.1016/j.parkreldis.2012.01.025; Papachroni KK, 2007, J NEUROCHEM, V101, P749, DOI 10.1111/j.1471-4159.2006.04365.x; Reddy MM, 2011, CELL, V144, P132, DOI 10.1016/j.cell.2010.11.054; Rubinsztein DC, 1999, DEMENT GERIATR COGN, V10, P199, DOI 10.1159/000017120; Sathe K, 2012, BRAIN, V135, P3336, DOI 10.1093/brain/aws250; Seripa D, 2011, ARCH NEUROL-CHICAGO, V68, P622, DOI 10.1001/archneurol.2011.90; Storace D, 2010, ARCH NEUROL-CHICAGO, V67, P867, DOI 10.1001/archneurol.2010.137; Szabo P, 2010, J NEUROIMMUNOL, V227, P167, DOI 10.1016/j.jneuroim.2010.06.010; Wilhelm KR, 2007, EUR J NEUROL, V14, P327, DOI 10.1111/j.1468-1331.2006.01667.x; Yanamandra K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018513; Zhu X, 2009, INT J CANCER, V125, P1352, DOI 10.1002/ijc.24487	40	25	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e88604	10.1371/journal.pone.0088604	http://dx.doi.org/10.1371/journal.pone.0088604			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586351	Green Submitted, Green Published, gold			2022-12-27	WOS:000331717900020
J	Sufiawati, I; Tugizov, SM				Sufiawati, Irna; Tugizov, Sharof M.			HIV-Associated Disruption of Tight and Adherens Junctions of Oral Epithelial Cells Facilitates HSV-1 Infection and Spread	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; TAT-FUSION PROTEINS; ACTIVE ANTIRETROVIRAL THERAPY; FIBROBLAST-GROWTH-FACTOR; ENTRY MEDIATOR; GLYCOPROTEIN-D; KINASE-C; ENDOTHELIAL-CELLS; HEPARAN-SULFATE; HIV-1-INFECTED PATIENTS	Herpes simplex virus (HSV) types 1 and 2 are the most common opportunistic infections in HIV/ AIDS. In these immunocompromised individuals, HSV-1 reactivates and replicates in oral epithelium, leading to oral disorders such as ulcers, gingivitis, and necrotic lesions. Although the increased risk of HSV infection may be mediated in part by HIV-induced immune dysfunction, direct or indirect interactions of HIV and HSV at the molecular level may also play a role. In this report we show that prolonged interaction of the HIV proteins tat and gp120 and cell-free HIV virions with polarized oral epithelial cells leads to disruption of tight and adherens junctions of epithelial cells through the mitogen-activated protein kinase signaling pathway. HIV-induced disruption of oral epithelial junctions facilitates HSV-1 paracellular spread between the epithelial cells. Furthermore, HIV-associated disruption of adherens junctions exposes sequestered nectin-1, an adhesion protein and critical receptor for HSV envelope glycoprotein D (gD). Exposure of nectin-1 facilitates binding of HSV-1 gD, which substantially increases HSV-1 infection of epithelial cells with disrupted junctions over that of cells with intact junctions. Exposed nectin-1 from disrupted adherens junctions also increases the cell-to-cell spread of HSV-1 from infected to uninfected oral epithelial cells. Antibodies to nectin-1 and HSV-1 gD substantially reduce HSV-1 infection and cell-to-cell spread, indicating that HIV-promoted HSV infection and spread are mediated by the interaction of HSV gD with HIV-exposed nectin-1. Our data suggest that HIV-associated disruption of oral epithelial junctions may potentiate HSV-1 infection and its paracellular and cell-to-cell spread within the oral mucosal epithelium. This could be one of the possible mechanisms of rapid development of HSV-associated oral lesions in HIV-infected individuals.	[Sufiawati, Irna; Tugizov, Sharof M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Tugizov, Sharof M.] Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tugizov, SM (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	sharof.tugizov@ucsf.edu		Sufiawati, Irna/0000-0002-2506-5105	National Institutes of Health [R01 DE023315, R21 DE016009, R21 DE021011]; NCI/UCSF Cancer Center grant [P30 CA 82103]; Directorate General of Higher Education, Ministry of National Education Indonesia, through the Doctoral Sandwich Program Scholarship; NATIONAL CANCER INSTITUTE [P30CA082103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE021011, R21DE016009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI/UCSF Cancer Center grant; Directorate General of Higher Education, Ministry of National Education Indonesia, through the Doctoral Sandwich Program Scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This project was supported by National Institutes of Health grants R01 DE023315, R21 DE016009, and R21 DE021011, and the NCI/UCSF Cancer Center grant P30 CA 82103 (to ST). The authors acknowledge the financial support of Directorate General of Higher Education, Ministry of National Education Indonesia, through the Doctoral Sandwich Program Scholarship (to IS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AS, 2009, CANCER TREAT REV, V35, P1, DOI 10.1016/j.ctrv.2008.07.006; Andras IE, 2005, J CEREBR BLOOD F MET, V25, P1159, DOI 10.1038/sj.jcbfm.9600115; Andreoletti L, 2005, J CLIN MICROBIOL, V43, P4215, DOI 10.1128/JCM.43.8.4215-4217.2005; Bai L, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-77; Barillari G, 1999, BLOOD, V94, P663; Barillari G, 1999, J IMMUNOL, V163, P1929; Barisoni L, 2000, KIDNEY INT, V58, P173, DOI 10.1046/j.1523-1755.2000.00152.x; Bruggeman LA, 2000, J AM SOC NEPHROL, V11, P2079, DOI 10.1681/ASN.V11112079; BUCHMAN TG, 1979, J INFECT DIS, V140, P295, DOI 10.1093/infdis/140.3.295; Cai H, 1997, MOL CELL BIOL, V17, P732, DOI 10.1128/MCB.17.2.732; Carbone A, 2009, BLOOD, V113, P1213, DOI 10.1182/blood-2008-09-180315; Chakraborty N, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-147; Chen YH, 2000, MOL BIOL CELL, V11, P849, DOI 10.1091/mbc.11.3.849; Chou LL, 2000, J ORAL PATHOL MED, V29, P394, DOI 10.1034/j.1600-0714.2000.290805.x; CLEMETSON DBA, 1993, JAMA-J AM MED ASSOC, V269, P2860, DOI 10.1001/jama.269.22.2860; Cocchi F, 1998, P NATL ACAD SCI USA, V95, P15700, DOI 10.1073/pnas.95.26.15700; Cocchi F, 2000, J VIROL, V74, P3909, DOI 10.1128/JVI.74.8.3909-3917.2000; Cocchi F, 2001, J VIROL, V75, P7987, DOI 10.1128/JVI.75.17.7987-7994.2001; Connolly SA, 2005, J VIROL, V79, P1282, DOI 10.1128/JVI.79.2.1282-1295.2005; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; Crowe SM, 2000, J LEUKOCYTE BIOL, V68, P345; Delboy MG, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-105; Epple HJ, 2009, GUT, V58, P220, DOI 10.1136/gut.2008.150425; Even DL, 2006, VIRUS RES, V119, P195, DOI 10.1016/j.virusres.2006.01.012; Feller L, 2008, SADJ, V63, P556; Feller L, 2007, SADJ, V62, P432; Feller L, 2008, SADJ, V63, P556; Feller L, 2008, SADJ, V63, P554; Ferrari A, 2003, MOL THER, V8, P284, DOI 10.1016/S1525-0016(03)00122-9; Fittipaldi A, 2003, J BIOL CHEM, V278, P34141, DOI 10.1074/jbc.M303045200; Gianni T, 2004, J VIROL, V78, P12268, DOI 10.1128/JVI.78.22.12268-12276.2004; GOTO Y, 1991, AIDS RES HUM RETROV, V7, P343, DOI 10.1089/aid.1991.7.343; Griffin E, 2008, J MED VIROL, V80, P1153, DOI 10.1002/jmv.21214; Gulino D, 1998, J BIOL CHEM, V273, P29786, DOI 10.1074/jbc.273.45.29786; Hagan H, 2010, INT J STD AIDS, V21, P580, DOI 10.1258/ijsa.2010.010137; Henning TR, 2010, J INFECT DIS, V202, P1543, DOI 10.1086/656720; Kakizawa J, 1996, ACTA PAEDIATR JAPON, V38, P218; Kanmogne GD, 2005, J NEUROPATH EXP NEUR, V64, P498, DOI 10.1093/jnen/64.6.498; Kanmogne Georgette D, 2007, J Cereb Blood Flow Metab, V27, P123, DOI 10.1038/sj.jcbfm.9600330; Kapembwa MS, 1996, AIDS, V10, P1509, DOI 10.1097/00002030-199611000-00008; KAPEMBWA MS, 1991, CLIN SCI, V81, P327, DOI 10.1042/cs0810327; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Karaba AH, 2011, J VIROL, V85, P10041, DOI 10.1128/JVI.05445-11; Kawakami Y, 2004, J BIOL CHEM, V279, P47720, DOI 10.1074/jbc.M408797200; Kebede Y, 2004, J INFECT DIS, V190, P365, DOI 10.1086/422038; Kinet S, 2002, BLOOD, V100, P2546, DOI 10.1182/blood-2002-03-0819; Krautkramer E, 2008, J VIROL, V82, P4257, DOI 10.1128/JVI.02210-07; Krummenacher C, 2004, VIROLOGY, V322, P286, DOI 10.1016/j.virol.2004.02.005; Krummenacher C, 2003, J VIROL, V77, P8985, DOI 10.1128/JVI.77.16.8985-8999.2003; Krummenacher C, 1999, J VIROL, V73, P8127, DOI 10.1128/JVI.73.10.8127-8137.1999; Krummenacher C, 1998, J VIROL, V72, P7064, DOI 10.1128/JVI.72.9.7064-7074.1998; Krummenacher C, 2000, J VIROL, V74, P10863, DOI 10.1128/JVI.74.23.10863-10872.2000; Kuang YQ, 2012, EUR J IMMUNOL, V42, P299, DOI 10.1002/eji.201141801; Kuphal S, 2004, ONCOGENE, V23, P8509, DOI 10.1038/sj.onc.1207831; Lau MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059083; Lee C, 2003, J LEUKOCYTE BIOL, V74, P676, DOI 10.1189/jlb.0503206; Leigh JE, 2004, AIDS PATIENT CARE ST, V18, P443, DOI 10.1089/1087291041703665; Levy JA, 2009, AIDS, V23, P147, DOI 10.1097/QAD.0b013e3283217f9f; Liuzzi G, 1996, AIDS, V10, pF51, DOI 10.1097/00002030-199612000-00001; Lopez-Bergami P, 2005, MOL CELL, V19, P309, DOI 10.1016/j.molcel.2005.06.025; Lu TC, 2008, J BIOL CHEM, V283, P8173, DOI 10.1074/jbc.M708920200; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Maertzdorf J, 1999, J CLIN MICROBIOL, V37, P3518, DOI 10.1128/JCM.37.11.3518-3523.1999; Maingat F, 2011, FASEB J, V25, P2211, DOI 10.1096/fj.10-175992; MANN DA, 1991, EMBO J, V10, P1733, DOI 10.1002/j.1460-2075.1991.tb07697.x; Marshall CJ, 1996, NATURE, V383, P127, DOI 10.1038/383127a0; Maticic M, 2000, J DENT RES, V79, P1496, DOI 10.1177/00220345000790071101; Mbopi-Keou FX, 2002, LANCET INFECT DIS, V2, P416, DOI 10.1016/S1473-3099(02)00317-1; Medapalli RK, 2011, CURR OPIN NEPHROL HY, V20, P306, DOI 10.1097/MNH.0b013e328345359a; MONTAGNIER L, 1985, VIROLOGY, V144, P283, DOI 10.1016/0042-6822(85)90326-5; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nakamuta S, 2008, J NEUROVIROL, V14, P186, DOI 10.1080/13550280801993630; NAVARRO D, 1992, VIROLOGY, V186, P99, DOI 10.1016/0042-6822(92)90064-V; Nazh A, 2010, PLOS PATHOG, V6; Nicola AV, 2004, J VIROL, V78, P7508, DOI 10.1128/JVI.78.14.7508-7517.2004; NUOVO GJ, 1993, AM J PATHOL, V143, P40; OBINNA FC, 1995, AIDS, V9, P1009, DOI 10.1097/00002030-199509000-00005; OH SK, 1992, J ACQ IMMUN DEF SYND, V5, P251; Pertel PE, 2001, VIROLOGY, V279, P313, DOI 10.1006/viro.2000.0713; Poggi A, 2006, CLIN DEV IMMUNOL, V13, P369, DOI 10.1080/17402520600645712; Posavad CM, 2004, J INFECT DIS, V190, P693, DOI 10.1086/422755; Preiss S, 2007, CARDIOVASC RES, V73, P833, DOI 10.1016/j.cardiores.2006.12.019; Pu H, 2005, J CEREBR BLOOD F MET, V25, P1325, DOI 10.1038/sj.jcbfm.9600125; Qureshi M N, 1997, Oral Dis, V3 Suppl 1, pS73; QURESHI MN, 1995, J INFECT DIS, V171, P190, DOI 10.1093/infdis/171.1.190; Remeijer L, 2002, INVEST OPHTH VIS SCI, V43, P358; Rodriguez-Inigo E, 2005, J MED VIROL, V77, P17, DOI [10.1002/jmv.20409, 10.1002/JMV.20409]; Roest RW, 2006, J INFECT DIS, V194, P1115, DOI 10.1086/507683; Roizman B, 1993, HUMAN HERPESVIRUSEES; Rychert J, 2010, AIDS RES HUM RETROV, V26, P1139, DOI 10.1089/aid.2009.0290; Sankaran S, 2008, J VIROL, V82, P538, DOI 10.1128/JVI.01449-07; Santosuosso M, 2009, J INFECT DIS, V200, P1050, DOI 10.1086/605695; Schwartz EJ, 2001, J AM SOC NEPHROL, V12, P1677, DOI 10.1681/ASN.V1281677; Shen L, 2005, MOL BIOL CELL, V16, P3919, DOI 10.1091/mbc.E04-12-1089; SHIEH MT, 1992, J CELL BIOL, V116, P1273, DOI 10.1083/jcb.116.5.1273; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Shukla SY, 2009, INVEST OPHTH VIS SCI, V50, P2878, DOI 10.1167/iovs.08-2981; SISK WP, 1994, J VIROL, V68, P766, DOI 10.1128/JVI.68.2.766-775.1994; Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739; Song L, 2007, BLOOD, V109, P1515, DOI 10.1182/blood-2006-07-034009; Sonza S, 2001, AIDS, V15, P17, DOI 10.1097/00002030-200101050-00005; Stadler SC, 2012, SEMIN CANCER BIOL, V22, P404, DOI 10.1016/j.semcancer.2012.06.007; Stanberry LR, 2000, CLIN INFECT DIS, V30, P549, DOI 10.1086/313687; Struyf F, 2002, J INFECT DIS, V185, P36, DOI 10.1086/338116; Su YH, 2006, J VIROL, V80, P11589, DOI 10.1128/JVI.01869-06; Sucato G, 1998, J INFECT DIS, V177, P1069, DOI 10.1086/515261; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Takai Y, 2003, CANCER SCI, V94, P655, DOI 10.1111/j.1349-7006.2003.tb01499.x; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Terry-Allison T, 1998, J VIROL, V72, P5802, DOI 10.1128/JVI.72.7.5802-5810.1998; Tiwari V, 2008, FEBS J, V275, P5272, DOI 10.1111/j.1742-4658.2008.06655.x; Toschi E, 2006, MOL BIOL CELL, V17, P1985, DOI 10.1091/mbc.E05-08-0717; Trushin SA, 2007, J IMMUNOL, V178, P4846, DOI 10.4049/jimmunol.178.8.4846; Tugizov SM, 2013, VIROLOGY, V446, P378, DOI 10.1016/j.virol.2013.08.018; Tugizov SM, 2013, J VIROL, V87, P8179, DOI 10.1128/JVI.00443-13; Tugizov SM, 2012, J VIROL, V86, P2556, DOI 10.1128/JVI.06578-11; Tugizov SM, 2011, VIROLOGY, V409, P211, DOI 10.1016/j.virol.2010.10.004; Tugizov SM, 2003, NAT MED, V9, P307, DOI 10.1038/nm830; Turner KR, 2003, SEX TRANSM DIS, V30, P331, DOI 10.1097/00007435-200304000-00011; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Van de Perre P, 2008, LANCET INFECT DIS, V8, P490, DOI 10.1016/S1473-3099(08)70181-6; VOGEL BE, 1993, J CELL BIOL, V121, P461, DOI 10.1083/jcb.121.2.461; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wald A, 2004, SEX TRANSM INFECT, V80, P272, DOI 10.1136/sti.2003.007823; Wang Y, 2004, EXP EYE RES, V78, P125, DOI 10.1016/j.exer.2003.09.002; Watson K, 1999, BIOCHEM PHARMACOL, V58, P1521, DOI 10.1016/S0006-2952(99)00209-9; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Xiao JQ, 2007, VIROLOGY, V359, P382, DOI 10.1016/j.virol.2006.09.047; Xiao JQ, 2009, VIROLOGY, V388, P335, DOI 10.1016/j.virol.2009.03.030; Yoon M, 2002, J VIROL, V76, P7203, DOI 10.1128/JVI.76.14.7203-7208.2002; Zhong Y, 2008, J NEUROSCI, V28, P7788, DOI 10.1523/JNEUROSCI.0061-08.2008; Zhou HP, 2003, AM J PHYSIOL-GASTR L, V284, pG472, DOI 10.1152/ajpgi.00345.2002; Zuckerman RA, 2003, J INFECT DIS, V188, P142, DOI 10.1086/375741	136	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e88803	10.1371/journal.pone.0088803	http://dx.doi.org/10.1371/journal.pone.0088803			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586397	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900029
J	Bruzzese, E; Callegari, ML; Raia, V; Viscovo, S; Scotto, R; Ferrari, S; Morelli, L; Buccigrossi, V; Lo Vecchio, A; Ruberto, E; Guarino, A				Bruzzese, Eugenia; Callegari, Maria Luisa; Raia, Valeria; Viscovo, Sara; Scotto, Riccardo; Ferrari, Susanna; Morelli, Lorenzo; Buccigrossi, Vittoria; Lo Vecchio, Andrea; Ruberto, Eliana; Guarino, Alfredo			Disrupted Intestinal Microbiota and Intestinal Inflammation in Children with Cystic Fibrosis and Its Restoration with Lactobacillus GG: A Randomised Clinical Trial	PLOS ONE			English	Article							DIET-INDUCED OBESITY; FECAL MICROBIOTA; PULMONARY EXACERBATIONS; PEDIATRIC-PATIENTS; GUT MICROBIOTA; SUPPLEMENTATION; MICROFLORA; PCR	Background & Aims: Intestinal inflammation is a hallmark of cystic fibrosis (CF). Administration of probiotics can reduce intestinal inflammation and the incidence of pulmonary exacerbations. We investigated the composition of intestinal microbiota in children with CF and analyzed its relationship with intestinal inflammation. We also investigated the microflora structure before and after Lactobacillus GG (LGG) administration in children with CF with and without antibiotic treatment. Methods: The intestinal microbiota were analyzed by denaturing gradient gel electrophoresis (DGGE), real-time polymerase chain reaction (RT-PCR), and fluorescence in situ hybridization (FISH). Intestinal inflammation was assessed by measuring fecal calprotectin (CLP) and rectal nitric oxide (rNO) production in children with CF as compared with healthy controls. We then carried out a small double-blind randomized clinical trial with LGG. Results: Twenty-two children with CF children were enrolled in the study (median age, 7 years; range, 2-9 years). Fecal CLP and rNO levels were higher in children with CF than in healthy controls (184 +/- 146 mu g/g vs. 52 +/- 46 mu g/g; 18 +/- 15 vs. 2.6 +/- 1.2 mu mol/L NO2-, respectively; P<0.01). Compared with healthy controls, children with CF had significantly different intestinal microbial core structures. The levels of Eubacterium rectale, Bacteroides uniformis, Bacteroides vulgatus, Bifidobacterium adolescentis, Bifidobacterium catenulatum, and Faecalibacterium prausnitzii were reduced in children with CF. A similar but more extreme pattern was observed in children with CF who were taking antibiotics. LGG administration reduced fecal CLP and partially restored intestinal microbiota. There was a significant correlation between reduced microbial richness and intestinal inflammation. Conclusions: CF causes qualitative and quantitative changes in intestinal microbiota, which may represent a novel therapeutic target in the treatment of CF. Administration of probiotics restored gut microbiota, supporting the efficacy of probiotics in reducing intestinal inflammation and pulmonary exacerbations.	[Bruzzese, Eugenia; Raia, Valeria; Viscovo, Sara; Scotto, Riccardo; Buccigrossi, Vittoria; Lo Vecchio, Andrea; Ruberto, Eliana; Guarino, Alfredo] Univ Naples Federico II, Sect Pediat, Dept Translat Med Sci, Naples, Italy; [Callegari, Maria Luisa; Ferrari, Susanna; Morelli, Lorenzo] Univ Cattolica Sacro Cuore, Ctr Ric Biotecnol, Cremona, Italy	University of Naples Federico II; Catholic University of the Sacred Heart	Guarino, A (corresponding author), Univ Naples Federico II, Sect Pediat, Dept Translat Med Sci, Naples, Italy.	alfguari@unina.it	Guarino, Alfredo/AAC-4812-2022; Buccigrossi, Vittoria/AAA-1226-2020; Bruzzese, Eugenia/AAC-5988-2022; Luisa, Callegari Maria/AAB-3153-2021; Scotto, Riccardo/AAA-9953-2019; Vecchio, Andrea Lo/AAC-6042-2022; Raia, Valeria/AAC-3029-2022	Guarino, Alfredo/0000-0003-0199-0336; Luisa, Callegari Maria/0000-0002-7811-5305; Scotto, Riccardo/0000-0002-0178-2986; Lo Vecchio, Andrea/0000-0003-4181-6842	Cystic Fibrosis Foundation and Therapeutics [GUARIN10A0/2009]; Fondazione Italiana Ricerca Fibrosi Cistica [FC 23/2009]	Cystic Fibrosis Foundation and Therapeutics; Fondazione Italiana Ricerca Fibrosi Cistica(Italian Cystic Fibrosis Research Foundation)	The study was partially supported by a grant of "Cystic Fibrosis Foundation and Therapeutics'' (Account number GUARIN10A0/2009) and "Fondazione Italiana Ricerca Fibrosi Cistica'' (Account number FC 23/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2007, APPL ENVIRON MICROB, V73, P7435, DOI 10.1128/AEM.01143-07; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; Belenguer A, 2007, APPL ENVIRON MICROB, V73, P6526, DOI 10.1128/AEM.00508-07; Bruzzese E, 2004, ALIMENT PHARM THER, V20, P813, DOI 10.1111/j.1365-2036.2004.02174.x; Bruzzese E, 2007, CLIN NUTR, V26, P322, DOI 10.1016/j.clnu.2007.01.004; Buccigrossi V, 2013, CURR OPIN GASTROEN, V29, P31, DOI 10.1097/MOG.0b013e32835a3500; Canani RB, 2002, AM J GASTROENTEROL, V97, P1574; Conte MP, 2006, GUT, V55, P1760, DOI 10.1136/gut.2005.078824; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; DUYTSCHAEVER G, 2012, J CYST FIBROS; Duytschaever G, 2011, APPL ENVIRON MICROB, V77, P8015, DOI 10.1128/AEM.05933-11; Fagerberg UL, 2003, J PEDIATR GASTR NUTR, V37, P468, DOI 10.1097/00005176-200310000-00013; Guarino A, 2011, CURR OPIN GASTROEN, V27, P24, DOI 10.1097/MOG.0b013e3283413750; Kerem E, 2005, PEDIATR PULM, V40, P183, DOI 10.1002/ppul.20200; Lee JM, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/948367; Madan JC, 2012, MBIO, V3, DOI 10.1128/mBio.00251-12; Marteau P, 2009, DIGEST DIS, V27, P99, DOI 10.1159/000268128; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; Noor SO, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-134; Penders J, 2005, FEMS MICROBIOL LETT, V243, P141, DOI 10.1016/j.femsle.2004.11.052; Scanlan PD, 2006, J CLIN MICROBIOL, V44, P3980, DOI 10.1128/JCM.00312-06; Scanlan PD, 2012, J CYST FIBROS, V11, P454, DOI 10.1016/j.jcf.2012.03.007; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Swidsinski A, 2008, GASTROENTEROLOGY, V135, P568, DOI 10.1053/j.gastro.2008.04.017; Takaishi H, 2008, INT J MED MICROBIOL, V298, P463, DOI 10.1016/j.ijmm.2007.07.016; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Walter J, 2000, APPL ENVIRON MICROB, V66, P297, DOI 10.1128/AEM.66.1.297-303.2000; Weiss B, 2010, PEDIATR PULM, V45, P536, DOI 10.1002/ppul.21138; Werlin SL, 2010, J PEDIATR GASTR NUTR, V51, P304, DOI 10.1097/MPG.0b013e3181d1b013; Wu XK, 2010, CURR MICROBIOL, V61, P69, DOI 10.1007/s00284-010-9582-9	34	134	142	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e87796	10.1371/journal.pone.0087796	http://dx.doi.org/10.1371/journal.pone.0087796			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586292	gold, Green Published, Green Submitted			2022-12-27	WOS:000331711900018
J	Dhole, S; Pfennig, KS				Dhole, Sumit; Pfennig, Karin S.			Age-Dependent Male Mating Investment in Drosophila pseudoobscura	PLOS ONE			English	Article							SEMINAL FLUID PROTEINS; CRYPTIC MALE CHOICE; SPERM COMPETITION; FERTILIZATION SUCCESS; COPULATION DURATION; PLASTIC RESPONSES; MATE CHOICE; FRUIT-FLY; MELANOGASTER; EVOLUTION	Male mating investment can strongly influence fitness gained from a mating. Yet, male mating investment often changes with age. Life history theory predicts that mating investment should increase with age, and males should become less discriminatory about their mate as they age. Understanding age-dependent changes in male behavior and their effects on fitness is important for understanding how selection acts in age-structured populations. Although the independent effects of male or female age have been studied in many species, how these interact to influence male mating investment and fitness is less well understood. We mated Drosophila pseudoobscura males of five different age classes (4-, 8-, 11-, 15-, 19-day old) to either young (4-day) or old (11-day) females, and measured copulation duration and early post-mating fecundity. Along with their independent effects, we found a strong interaction between the effects of male and female ages on male mating investment and fitness from individual matings. Male mating investment increased with male age, but this increase was more prominent in matings with young females. Male D. pseudoobscura made smaller investments when mating with old females. The level of such discrimination based on female age, however, also changed with male age. Intermediate aged males were most discriminatory, while the youngest and the oldest males did not discriminate between females of different ages. We also found that larger male mating investments resulted in higher fitness payoffs. Our results show that male and female ages interact to form a complex pattern of age-specific male mating investment and fitness.	[Dhole, Sumit; Pfennig, Karin S.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Dhole, S (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	sumit@live.unc.edu			Sigma Xi; Office of The Director, National Institutes of Health [1 DP2 OD004436-01]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004436] Funding Source: NIH RePORTER	Sigma Xi; Office of The Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Sigma Xi grants-in-aid of research award to SD and a New Innovator Award from the Office of The Director, National Institutes of Health (1 DP2 OD004436-01) to KSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundsen T, 2000, TRENDS ECOL EVOL, V15, P149, DOI 10.1016/S0169-5347(99)01800-5; Andersson Malte, 1994; Avent TD, 2008, ANIM BEHAV, V75, P1413, DOI 10.1016/j.anbehav.2007.09.015; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Barbosa F, 2012, BEHAV ECOL, V23, P815, DOI 10.1093/beheco/ars035; Barbosa F, 2011, BEHAV ECOL, V22, P1332, DOI 10.1093/beheco/arr137; Barron AB, 2000, J INSECT PHYSIOL, V46, P439, DOI 10.1016/S0022-1910(99)00129-8; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Birkhead TR, 1998, SPERM COMPETITION SE; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; Bretman A, 2011, TRENDS ECOL EVOL, V26, P467, DOI 10.1016/j.tree.2011.05.002; Bretman A, 2010, BEHAV ECOL, V21, P317, DOI 10.1093/beheco/arp189; Bretman A, 2009, P ROY SOC B-BIOL SCI, V276, P1705, DOI 10.1098/rspb.2008.1878; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chapman T, 2004, PEPTIDES, V25, P1477, DOI 10.1016/j.peptides.2003.10.023; Chapman T, 2001, HEREDITY, V87, P511, DOI 10.1046/j.1365-2540.2001.00961.x; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; Cornwallis CK, 2007, AM NAT, V170, P758, DOI 10.1086/521955; DICKINSON JL, 1986, BEHAV ECOL SOCIOBIOL, V18, P331, DOI 10.1007/BF00299664; Dobzhansky T, 1943, GENETICS, V28, P304; Engqvist L, 2003, J EVOLUTION BIOL, V16, P1196, DOI 10.1046/j.1420-9101.2003.00613.x; Engqvist L, 2002, BEHAV ECOL, V13, P632, DOI 10.1093/beheco/13.5.632; Friberg U, 2006, ANIM BEHAV, V72, P1259, DOI 10.1016/j.anbehav.2006.03.021; GADGIL M, 1970, American Naturalist, V104, P1, DOI 10.1086/282637; Galvani A, 1998, BEHAV ECOL SOCIOBIOL, V44, P161, DOI 10.1007/s002650050528; Gilchrist AS, 2000, EVOLUTION, V54, P534, DOI 10.1111/j.0014-3820.2000.tb00056.x; Goshima S, 1996, J EXP MAR BIOL ECOL, V196, P131, DOI 10.1016/0022-0981(95)00127-1; HALL JC, 1978, BEHAV GENET, V8, P125, DOI 10.1007/BF01066870; Ingleby FC, 2010, ANIM BEHAV, V80, P37, DOI 10.1016/j.anbehav.2010.03.022; Jones TM, 2004, P ROY SOC B-BIOL SCI, V271, P1311, DOI 10.1098/rspb.2004.2723; LEWIS SM, 1995, ANIM BEHAV, V50, P1157, DOI 10.1016/0003-3472(95)80031-X; Lupold S, 2011, BEHAV ECOL, V22, P184, DOI 10.1093/beheco/arq193; Martin OY, 2002, ANIM BEHAV, V63, P541, DOI 10.1006/anbe.2001.1929; MICHOD RE, 1979, AM NAT, V113, P531, DOI 10.1086/283411; Monaghan P, 2008, FUNCT ECOL, V22, P371, DOI 10.1111/j.1365-2435.2008.01418.x; Noor MAF, 1997, J INSECT BEHAV, V10, P305, DOI 10.1007/BF02765563; Nussey DH, 2008, FUNCT ECOL, V22, P393, DOI 10.1111/j.1365-2435.2008.01408.x; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Parker GA, 2010, BIOL REV, V85, P897, DOI 10.1111/j.1469-185X.2010.00140.x; Price TAR, 2008, EVOLUTION, V62, P1644, DOI 10.1111/j.1558-5646.2008.00386.x; Price TAR, 2012, J INSECT PHYSIOL, V58, P1669, DOI 10.1016/j.jinsphys.2012.10.008; R Development Core Team, 2012, R LANG ENV STAT COMP; Ram KR, 2007, INTEGR COMP BIOL, V47, P427, DOI 10.1093/icb/icm046; Reinhold K, 2002, J EVOLUTION BIOL, V15, P201, DOI 10.1046/j.1420-9101.2002.00390.x; Simmons L. W., 2001, MG BEH ECOL; Simmons LW, 1998, SEXUAL SELECTION SPE, P503; Sirot LK, 2011, P NATL ACAD SCI USA, V108, P9922, DOI 10.1073/pnas.1100905108; Sirot LK, 2009, BEHAV ECOL SOCIOBIOL, V63, P1505, DOI 10.1007/s00265-009-0806-6; Siva-Jothy MT, 2003, P ROY SOC B-BIOL SCI, V270, P649, DOI 10.1098/rspb.2002.2260; Snook RR, 2001, J INSECT PHYSIOL, V47, P957, DOI 10.1016/S0022-1910(01)00070-1; Snook RR, 1998, ANIM BEHAV, V56, P1497, DOI 10.1006/anbe.1998.0930; Stasinopoulos DM, 2012, R PACKAGE GEN ADDITI; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Thomas ML, 2007, AM NAT, V170, P190, DOI 10.1086/519404; Thornhill R., 1983, pi; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Wigby S, 2009, CURR BIOL, V19, P751, DOI 10.1016/j.cub.2009.03.036; Wolfner MF, 1997, INSECT BIOCHEM MOLEC, V27, P179, DOI 10.1016/S0965-1748(96)00084-7; Xu J, 2009, BEHAV ECOL SOCIOBIOL, V63, P801, DOI 10.1007/s00265-009-0713-x; Yasui Y, 1996, J INSECT BEHAV, V9, P517, DOI 10.1007/BF02214027	60	11	11	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88700	10.1371/journal.pone.0088700	http://dx.doi.org/10.1371/journal.pone.0088700			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586373	gold, Green Published, Green Submitted			2022-12-27	WOS:000331711900040
J	Gavasso, S; Mosleth, EF; Maroy, T; Jorgensen, K; Nakkestad, HL; Gjertsen, BT; Myhr, KM; Vedeler, C				Gavasso, Sonia; Mosleth, Ellen Faergestad; Maroy, Tove; Jorgensen, Katarina; Nakkestad, Hanne-Linda; Gjertsen, Bjorn-Tore; Myhr, Kjell-Morten; Vedeler, Christian			Deficient Phosphorylation of Stat1 in Leukocytes Identifies Neutralizing Antibodies in Multiple Sclerosis Patients Treated with Interferon-Beta	PLOS ONE			English	Article							IMMUNE CELLS; THERAPY; BIOACTIVITY	Background: Anti interferon-beta (IFN-beta) neutralizing antibodies (NAb) affect efficacy of treatment of multiple sclerosis patients, but exactly when the detrimental effects of NAbs offset therapeutic efficacy is debated. Quantification of intracellular pathway-specific phosphorylation by phospho-specific flow cytometry (phosphoflow) is a promising tool for evaluation of these effects in primary immune cells from treated patients at the single-cell level. Method: Samples for phosphoflow and gene expression changes were collected before administration of IFN-beta and at four, six, and eight hours thereafter. Patients were NAb negative (n = 3) or were NAb positive with low/ medium (n = 1) or high (n = 2) NAb titers. Levels of phosphorylation of six Stat transcription factors (pStat) in seven cell subtypes and expression levels of 71 pathway-specific genes in whole blood were measured. The data was subjected to principal component analysis (PCA), fifty-fifty MANOVA, ANOVA, and partial least square regression (PLSR). Results: PCA of pStat levels clustered patients according to NAb class independently of time. PCA of gene expression data clustered patients according to NAb class but was affected by time and treatment. In the fifty-fifty MANOVA, NAb class was significant for both pStat levels and gene expression data. The ANOVA identified pStat1 protein in several cell subtypes as significantly affected by NAb class. The best fitting model for NAb prediction based on PLSR included pStat1 in monocytes, T cells, or lymphocytes and pStat3 in monocytes (r = 0.97). Gene expression data were slightly less predictive of NAb titers. Conclusion: Based on this proof of concept study, we hypothesize that NAb effects can be monitored by evaluation of a single biomarker, pStat1, in either monocytes or T cells by phosphoflow directly after IFN-beta administration. The method will significantly reduce cost relative to labor intensive in vitro methods and offers a patient-specific approach to NAb evaluation.	[Gavasso, Sonia; Myhr, Kjell-Morten; Vedeler, Christian] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway; [Gavasso, Sonia; Maroy, Tove; Myhr, Kjell-Morten] Haukeland Hosp, Norwegian Multiple Sclerosis Competence Ctr, Dept Neurol, N-5021 Bergen, Norway; [Gavasso, Sonia; Nakkestad, Hanne-Linda; Myhr, Kjell-Morten; Vedeler, Christian] Univ Bergen, Dept Clin Med, Bergen, Norway; [Mosleth, Ellen Faergestad] Nofima, As, Norway; [Jorgensen, Katarina; Gjertsen, Bjorn-Tore] Univ Bergen, Dept Clin Sci, Hematol Sect, Bergen, Norway; [Gjertsen, Bjorn-Tore] Haukeland Hosp, Dept Internal Med, N-5021 Bergen, Norway; [Myhr, Kjell-Morten; Vedeler, Christian] Univ Bergen, KG Jebsen Ctr MS Res, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Nofima; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen	Gavasso, S (corresponding author), Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.	sonia.gavasso@helse-bergen.no	Gjertsen, Bjorn T/O-1542-2015; Myhr, Kjell-Morten/H-1528-2018; Gjertsen, Bjørn T/AAP-3281-2020	Gjertsen, Bjorn T/0000-0001-9358-9704; Myhr, Kjell-Morten/0000-0002-0980-510X; Gjertsen, Bjørn T/0000-0001-9358-9704	Western Norway Regional Health Authority; KG Jebsen Center for MS Research, University of Bergen, Norway	Western Norway Regional Health Authority; KG Jebsen Center for MS Research, University of Bergen, Norway	This study was supported by The Western Norway Regional Health Authority and the KG Jebsen Center for MS Research, University of Bergen, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarskog NK, 2009, J NEUROIMMUNOL, V212, P148, DOI 10.1016/j.jneuroim.2009.04.012; Deisenhammer F, 2009, CNS DRUGS, V23, P379, DOI 10.2165/00023210-200923050-00003; Dubois BD, 2003, J NEUROL NEUROSUR PS, V74, P946, DOI 10.1136/jnnp.74.7.946; Gavasso S, 2006, ACTA NEUROL SCAND, V113, P58, DOI 10.1111/j.1600-0404.2006.00618.x; Gavasso S, 2012, MULT SCLER J, V18, P1116, DOI 10.1177/1352458511434066; Gavasso Sonia, 2009, V514, P35, DOI 10.1007/978-1-60327-527-9_4; Goertsches RH, 2011, PHARMACOGENOMICS, V12, P423, DOI [10.2217/PGS.10.190, 10.2217/pgs.10.190]; Hartung HP, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-129; Hesse D, 2009, NEUROLOGY, V73, P372, DOI 10.1212/WNL.0b013e3181b04c98; Killestein J, 2011, NAT REV NEUROL, V7, P221, DOI 10.1038/nrneurol.2011.22; Langsrud O, 2005, STAT COMPUT, V15, P53, DOI 10.1007/s11222-005-4789-5; Martens H, 2000, FOOD QUAL PREFER, V11, P5, DOI 10.1016/S0950-3293(99)00039-7; Pachner AR, 2009, NEUROLOGY, V73, P1493, DOI 10.1212/WNL.0b013e3181bf98db; Polman CH, 2010, LANCET NEUROL, V9, P740, DOI 10.1016/S1474-4422(10)70103-4; Sominanda A, 2008, J NEUROL NEUROSUR PS, V79, P57, DOI 10.1136/jnnp.2007.122549	15	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88632	10.1371/journal.pone.0088632	http://dx.doi.org/10.1371/journal.pone.0088632			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586361	gold, Green Submitted, Green Published			2022-12-27	WOS:000331711900036
J	Christensen, AS; Steinmann, C; Fedorov, DG; Jensen, JH				Christensen, Anders S.; Steinmann, Casper; Fedorov, Dmitri G.; Jensen, Jan H.			Hybrid RHF/MP2 Geometry Optimizations with the Effective Fragment Molecular Orbital Method	PLOS ONE			English	Article							TRANSITION-STATE STABILIZATION; QUANTUM-CHEMICAL CALCULATION; CHORISMATE MUTASE; ENZYME CATALYSIS; COMPUTATIONAL METHOD; REACTION BARRIERS; REACTION PATHS; LEVEL; PREDICTION; CHEMISTRY	The frozen domain effective fragment molecular orbital method is extended to allow for the treatment of a single fragment at the MP2 level of theory. The approach is applied to the conversion of chorismate to prephenate by Chorismate Mutase, where the substrate is treated at the MP2 level of theory while the rest of the system is treated at the RHF level. MP2 geometry optimization is found to lower the barrier by up to 3.5 kcal/mol compared to RHF optimzations and ONIOM energy refinement and leads to a smoother convergence with respect to the basis set for the reaction profile. For double zeta basis sets the increase in CPU time relative to RHF is roughly a factor of two.	[Christensen, Anders S.; Jensen, Jan H.] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Steinmann, Casper] Univ Southern Denmark, Dept Phys Chem & Pharm, Odense, Denmark; [Fedorov, Dmitri G.] Natl Inst Adv Ind Sci & Technol, NRI, Tsukuba, Ibaraki, Japan	University of Copenhagen; University of Southern Denmark; National Institute of Advanced Industrial Science & Technology (AIST)	Jensen, JH (corresponding author), Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark.	jhjensen@chem.ku.dk	Jensen, Jan Halborg/G-4338-2010; Svendsen, Casper/T-6775-2018	Jensen, Jan Halborg/0000-0002-1465-1010; Svendsen, Casper/0000-0002-5638-1346	Novo Nordisk STAR PhD program; Next Generation Super Computing Project, Nanoscience Program (NEXT, Japan); Computational Materials Science Initiative (CMSI, Japan)	Novo Nordisk STAR PhD program(Novo Nordisk); Next Generation Super Computing Project, Nanoscience Program (NEXT, Japan); Computational Materials Science Initiative (CMSI, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	ASC is funded by the Novo Nordisk STAR PhD program. DGF is supported by the Next Generation Super Computing Project, Nanoscience Program (NEXT, Japan) and Computational Materials Science Initiative (CMSI, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen XH, 2004, J THEOR COMPUT CHEM, V3, P277, DOI 10.1142/S0219633604001045; Claeyssens F, 2005, CHEM COMMUN, P5068, DOI 10.1039/b508181e; Claeyssens F, 2006, ANGEW CHEM INT EDIT, V45, P6856, DOI 10.1002/anie.200602711; Claeyssens F, 2011, ORG BIOMOL CHEM, V9, P1578, DOI 10.1039/c0ob00691b; Fedorov DG, 2004, J CHEM PHYS, V120, P6832, DOI 10.1063/1.1687334; Fedorov DG, 2004, J COMPUT CHEM, V25, P872, DOI 10.1002/jcc.20018; Fedorov DG, 2008, J PHYS CHEM A, V112, P11808, DOI 10.1021/jp805435n; Fedorov DG, 2007, J PHYS CHEM A, V111, P6904, DOI 10.1021/jp0716740; Fedorov DG, 2012, PHYS CHEM CHEM PHYS, V14, P7562, DOI 10.1039/c2cp23784a; Fedorov DG, 2011, J PHYS CHEM LETT, V2, P282, DOI 10.1021/jz1016894; Flick JC, 2012, J CHEM THEORY COMPUT, V8, P2835, DOI 10.1021/ct200673a; Frank A, 2012, J CHEM THEORY COMPUT, V8, P1480, DOI 10.1021/ct200913r; Gao JL, 1997, J PHYS CHEM B, V101, P657, DOI 10.1021/jp962833a; Gordon MS, 2012, CHEM REV, V112, P632, DOI 10.1021/cr200093j; Gordon MS, 2009, J PHYS CHEM B, V113, P9646, DOI 10.1021/jp811519x; Hediger MR, 2013, PEERJ, V1, DOI 10.7717/peerj.111; Huang LL, 2012, FUTURE MED CHEM, V4, P1479, DOI [10.4155/fmc.12.92, 10.4155/FMC.12.92]; Ishida T, 2006, J PHYS CHEM B, V110, P1457, DOI 10.1021/jp0557159; Kast P, 1996, P NATL ACAD SCI USA, V93, P5043, DOI 10.1073/pnas.93.10.5043; Kitaura K, 1999, CHEM PHYS LETT, V313, P701, DOI 10.1016/S0009-2614(99)00874-X; Kobayashi M, 2012, PHYS CHEM CHEM PHYS, V14, P7629, DOI 10.1039/c2cp40153c; Korchowiec J, 2005, INT J QUANTUM CHEM, V105, P875, DOI 10.1002/qua.20684; Kurbanov EK, 2012, J CHEM THEORY COMPUT, V8, P1, DOI 10.1021/ct200637v; LYNE PD, 1995, J AM CHEM SOC, V117, P11345, DOI 10.1021/ja00150a037; OTTO P, 1975, CHEM PHYS, V8, P192, DOI 10.1016/0301-0104(75)80107-8; Ranaghan KE, 2004, CHEM COMMUN, P1238, DOI 10.1039/b402388a; Ranaghan KE, 2003, MOL PHYS, V101, P2695, DOI 10.1080/00268970310001593286; Sahu N, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4793706; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Senn HM, 2009, ANGEW CHEM INT EDIT, V48, P1198, DOI 10.1002/anie.200802019; Soderhjelm P, 2010, J CHEM THEORY COMPUT, V6, P1726, DOI 10.1021/ct9006986; Steinmann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060602; Steinmann C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044480; Steinmann C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041117; Steinmann C, 2010, J PHYS CHEM A, V114, P8705, DOI 10.1021/jp101498m; Szefczyk B, 2004, J AM CHEM SOC, V126, P16148, DOI 10.1021/ja049376t; Szefczyk B, 2007, INT J QUANTUM CHEM, V107, P2274, DOI 10.1002/qua.21354	37	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88800	10.1371/journal.pone.0088800	http://dx.doi.org/10.1371/journal.pone.0088800			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558430	gold, Green Published, Green Submitted			2022-12-27	WOS:000331706700076
J	Heikkila, K; Madsen, IEH; Nyberg, ST; Fransson, EI; Ahola, K; Alfredsson, L; Bjorner, JB; Borritz, M; Burr, H; Dragano, N; Ferrie, JE; Knutsson, A; Koskenvuo, M; Koskinen, A; Nielsen, ML; Nordin, M; Pejtersen, JH; Pentti, J; Rugulies, R; Oksanen, T; Shipley, MJ; Suominen, SB; Theorell, T; Vaananen, A; Vahtera, J; Virtanen, M; Westerlund, H; Westerholm, PJM; Batty, GD; Singh-Manoux, A; Kivimaki, M				Heikkila, Katriina; Madsen, Ida E. H.; Nyberg, Solja T.; Fransson, Eleonor I.; Ahola, Kirsi; Alfredsson, Lars; Bjorner, Jakob B.; Borritz, Marianne; Burr, Hermann; Dragano, Nico; Ferrie, Jane E.; Knutsson, Anders; Koskenvuo, Markku; Koskinen, Aki; Nielsen, Martin L.; Nordin, Maria; Pejtersen, Jan H.; Pentti, Jaana; Rugulies, Reiner; Oksanen, Tuula; Shipley, Martin J.; Suominen, Sakari B.; Theorell, Tores; Vaananen, Ari; Vahtera, Jussi; Virtanen, Marianna; Westerlund, Hugo; Westerholm, Peter J. M.; Batty, G. David; Singh-Manoux, Archana; Kivimaki, Mika		IPD-Work Consortium	Job Strain and the Risk of Inflammatory Bowel Diseases: Individual-Participant Meta-Analysis of 95 000 Men and Women	PLOS ONE			English	Article							CROHNS-DISEASE; PSYCHOLOGICAL STRESS; ULCERATIVE-COLITIS	Background and Aims: Many clinicians, patients and patient advocacy groups believe stress to have a causal role in inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis. However, this is not corroborated by clear epidemiological research evidence. We investigated the association between work-related stress and incident Crohn's disease and ulcerative colitis using individual-level data from 95 000 European adults. Methods: We conducted individual-participant data meta-analyses in a set of pooled data from 11 prospective European studies. All studies are a part of the IPD-Work Consortium. Work-related psychosocial stress was operationalised as job strain (a combination of high demands and low control at work) and was self-reported at baseline. Crohn's disease and ulcerative colitis were ascertained from national hospitalisation and drug reimbursement registers. The associations between job strain and inflammatory bowel disease outcomes were modelled using Cox proportional hazards regression. The study-specific results were combined in random effects meta-analyses. Results: Of the 95 379 participants who were free of inflammatory bowel disease at baseline, 111 men and women developed Crohn's disease and 414 developed ulcerative colitis during follow-up. Job strain at baseline was not associated with incident Crohn's disease (multivariable-adjusted random effects hazard ratio: 0.83, 95% confidence interval: 0.48, 1.43) or ulcerative colitis (hazard ratio: 1.06, 95% CI: 0.76, 1.48). There was negligible heterogeneity among the study-specific associations. Conclusions: Our findings suggest that job strain, an indicator of work-related stress, is not a major risk factor for Crohn's disease or ulcerative colitis.	[Heikkila, Katriina; Nyberg, Solja T.; Ahola, Kirsi; Koskinen, Aki; Vaananen, Ari; Virtanen, Marianna; Kivimaki, Mika] Finnish Inst Occupat Hlth, Helsinki, Finland; [Madsen, Ida E. H.; Bjorner, Jakob B.; Rugulies, Reiner] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Fransson, Eleonor I.; Alfredsson, Lars] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Fransson, Eleonor I.] Jonkoping Univ, Sch Hlth Sci, Jonkoping, Sweden; [Fransson, Eleonor I.; Theorell, Tores; Westerlund, Hugo] Stockholm Univ, Stress Res Inst, Stockholm, Sweden; [Borritz, Marianne; Nielsen, Martin L.] Bispebjerg Hosp, Dept Occupat & Environm Med, Copenhagen, Denmark; [Burr, Hermann] Fed Inst Occupat Safety & Hlth BAuA, Berlin, Germany; [Dragano, Nico] Univ Dusseldorf, Inst Med Sociol, Fac Med, Dusseldorf, Germany; [Ferrie, Jane E.] Univ Bristol, Sch Community & Social Med, Bristol, Avon, England; [Ferrie, Jane E.; Shipley, Martin J.; Batty, G. David; Singh-Manoux, Archana; Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Knutsson, Anders] Mid Sweden Univ, Dept Hlth Sci, Sundsvall, Sweden; [Koskenvuo, Markku] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Nordin, Maria] Umea Univ, Dept Psychol, S-90187 Umea, Sweden; [Pejtersen, Jan H.] Danish Natl Ctr Social Res, Copenhagen, Denmark; [Pentti, Jaana; Oksanen, Tuula; Vahtera, Jussi] Finnish Inst Occupat Hlth, Helsinki, Finland; [Pentti, Jaana; Oksanen, Tuula; Vahtera, Jussi] Finnish Inst Occupat Hlth, Tampere, Finland; [Pentti, Jaana; Oksanen, Tuula; Vahtera, Jussi] Finnish Inst Occupat Hlth, Turku, Finland; [Rugulies, Reiner] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Rugulies, Reiner] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark; [Suominen, Sakari B.] Folkhalsan Res Ctr, Helsinki, Finland; [Suominen, Sakari B.; Vahtera, Jussi] Univ Turku, Dept Publ Hlth, Turku, Finland; [Suominen, Sakari B.] Nord Sch Publ Hlth, Gothenburg, Sweden; [Westerholm, Peter J. M.] Uppsala Univ, Uppsala, Sweden; [Batty, G. David] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Singh-Manoux, Archana] Ctr Res Epidemiol & Populat Hlth, INSERM, U1018, Villejuif, France	Finnish Institute of Occupational Health; National Research Centre for the Working Environment; Karolinska Institutet; Jonkoping University; Stockholm University; Aarhus University; University of Copenhagen; Bispebjerg Hospital; Heinrich Heine University Dusseldorf; University of Bristol; University of London; University College London; Mid-Sweden University; University of Helsinki; Umea University; Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; University of Copenhagen; University of Copenhagen; Folkhalsan Research Center; University of Turku; Uppsala University; University of Edinburgh; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Heikkila, K (corresponding author), Finnish Inst Occupat Hlth, Helsinki, Finland.	katriina.heikkila@ttl.fi	Pejtersen, Jan/AAP-2383-2020; Nielsen, Martin Lindhardt/E-3071-2012; Oksanen, Tuula/AAK-5599-2021; Rugulies, Reiner/E-8140-2010; Batty, GD/Y-4401-2018; Westerlund, Hugo/A-3049-2012; Kivimaki, Mika/B-3607-2012; Ferrie, Jane/AAZ-2009-2020; Alfredsson, Lars/AAC-9007-2019; Fransson, Eleonor I/J-7792-2013; Singh-Manoux, Archana/F-6804-2013	Nielsen, Martin Lindhardt/0000-0002-1523-0453; Rugulies, Reiner/0000-0002-7752-131X; Batty, GD/0000-0003-1822-5753; Westerlund, Hugo/0000-0002-8806-5698; Kivimaki, Mika/0000-0002-4699-5627; Alfredsson, Lars/0000-0003-1688-6697; Fransson, Eleonor I/0000-0001-9042-4832; Singh-Manoux, Archana/0000-0002-1244-5037; Suominen, Sakari B./0000-0001-6648-603X; Theorell, Tores/0000-0003-1956-7931; Heikkila, Katriina/0000-0001-6269-6881; Vahtera, Jussi/0000-0002-6036-061X; Madsen, Ida/0000-0003-3635-3900; Burr, Hermann/0000-0002-3864-6347	EU New OSH ERA research programme; Finnish Work Environment Fund, Finland; Swedish Research Council for Working Life and Social Research; Sweden and the Danish National Research Centre for the Working Environment, Denmark; Academy of Finland [132944]; BUPA Foundation [22094477]; British Heart Foundation; Medical Research Council, UK [K013351]; US National Institutes of Health [R01HL036310, R01AG034454]; Economic and Social Research Council, UK; ESRC [ES/J023299/1] Funding Source: UKRI; MRC [MR/K013351/1] Funding Source: UKRI; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; Medical Research Council [MR/K013351/1] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034454] Funding Source: NIH RePORTER	EU New OSH ERA research programme; Finnish Work Environment Fund, Finland; Swedish Research Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Sweden and the Danish National Research Centre for the Working Environment, Denmark; Academy of Finland(Academy of Finland); BUPA Foundation; British Heart Foundation(British Heart Foundation); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Economic and Social Research Council, UK(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	IPD-Work Consortium is supported by the EU New OSH ERA research programme (funded by the Finnish Work Environment Fund, Finland, the Swedish Research Council for Working Life and Social Research, Sweden and the Danish National Research Centre for the Working Environment, Denmark), the Academy of Finland (grant no. 132944), the BUPA Foundation (grant 22094477), and the British Heart Foundation. Mika KivimAki is supported by the Medical Research Council, UK (grant no. K013351), the US National Institutes of Health (grant nos. R01HL036310, R01AG034454), and a professorial fellowship from the Economic and Social Research Council, UK. Funding bodies for the individual studies are listed on the study websites. The funding bodies had no role in the study design, data collection and analysis, decision to publish the findings or preparation of the manuscript.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Bernstein CN, 2010, AM J GASTROENTEROL, V105, P1994, DOI 10.1038/ajg.2010.140; Bitton A, 2008, GUT, V57, P1386, DOI 10.1136/gut.2007.134817; Bonaz BL, 2013, GASTROENTEROLOGY, V144, P36, DOI 10.1053/j.gastro.2012.10.003; Cabre E, 2012, WORLD J GASTROENTERO, V18, P3814, DOI 10.3748/wjg.v18.i29.3814; Carbonnel F, 2009, GASTROEN CLIN BIOL, V33, pS145, DOI 10.1016/S0399-8320(09)73150-1; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Danese S, 2011, NEW ENGL J MED, V365, P1713, DOI 10.1056/NEJMra1102942; Elovainio M, 2007, SOC SCI MED, V65, P187, DOI 10.1016/j.socscimed.2007.02.052; Fransson EI, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-62; Gadinger MC, 2010, INT ARCH OCC ENV HEA, V83, P531, DOI 10.1007/s00420-009-0477-7; Goyal RK, 1996, NEW ENGL J MED, V334, P1106, DOI 10.1056/NEJM199604253341707; Han DY, 2010, MUTAT RES-FUND MOL M, V690, P116, DOI 10.1016/j.mrfmmm.2009.09.002; Heikkila K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035463; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jacobsson A., 2013, KODNINGSKVALITET PAT; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; Karasek R, 1990, HLTH WORK STRESS PRO; Kivimaki M, 2012, LANCET, V380, P1491, DOI 10.1016/S0140-6736(12)60994-5; Lerebours E, 2007, AM J GASTROENTEROL, V102, P122, DOI 10.1111/j.1572-0241.2006.00931.x; Li J, 2004, AM J GASTROENTEROL, V99, P1129, DOI 10.1111/j.1572-0241.2004.04155.x; Lidwall Ulrik, 2006, Work, V27, P153; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Martikainen J, 2002, DRUG REIMBURSEMENT S; Maunder RG, 2008, CURR MOL MED, V8, P247, DOI 10.2174/156652408784533832; Mawdsley JE, 2005, GUT, V54, P1481, DOI 10.1136/gut.2005.064261; Mendall MA, 2011, DIGEST DIS SCI, V56, P837, DOI 10.1007/s10620-010-1541-6; Nyberg ST, 2012, J INTERN MED, V272, P65, DOI 10.1111/j.1365-2796.2011.02482.x; Pellissier S, 2010, PSYCHONEUROENDOCRINO, V35, P653, DOI 10.1016/j.psyneuen.2009.10.004; Sajadinejad MS, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/106502; Singh S, 2011, CLIN GASTROENTEROL H, V9, P769, DOI 10.1016/j.cgh.2011.05.016	31	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88711	10.1371/journal.pone.0088711	http://dx.doi.org/10.1371/journal.pone.0088711			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558416	Green Published, Green Accepted, gold			2022-12-27	WOS:000331706700062
J	Samuel, A; Housset, M; Fant, B; Lamonerie, T				Samuel, Alexander; Housset, Michael; Fant, Bruno; Lamonerie, Thomas			Otx2 ChIP-seq Reveals Unique and Redundant Functions in the Mature Mouse Retina	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSCRIPTION FACTORS; REGULATORY ELEMENTS; ROSTRAL HEAD; PHOTORECEPTOR; CRX; CELLS; MUTATIONS; IDENTIFICATION; DEGENERATION	During mouse retinal development and into adulthood, the transcription factor Otx2 is expressed in pigment epithelium, photoreceptors and bipolar cells. In the mature retina, Otx2 ablation causes photoreceptor degeneration through a non-cell-autonomous mechanism involving Otx2 function in the supporting RPE. Surprisingly, photoreceptor survival does not require Otx2 expression in the neural retina, where the related Crx homeobox gene, a major regulator of photoreceptor development, is also expressed. To get a deeper view of mouse Otx2 activities in the neural retina, we performed chromatin-immunoprecipitation followed by massively parallel sequencing (ChIP-seq) on Otx2. Using two independent ChIP-seq assays, we identified consistent sets of Otx2-bound cis-regulatory elements. Comparison with our previous RPE-specific Otx2 ChIP-seq data shows that Otx2 occupies different functional domains of the genome in RPE cells and in neural retina cells and regulates mostly different sets of genes. To assess the potential redundancy of Otx2 and Crx, we compared our data with Crx ChIP-seq data. While Crx genome occupancy markedly differs from Otx2 genome occupancy in the RPE, it largely overlaps that of Otx2 in the neural retina. Thus, in accordance with its essential role in the RPE and its non-essential role in the neural retina, Otx2 regulates different gene sets in the RPE and the neural retina, and shares an important part of its repertoire with Crx in the neural retina. Overall, this study provides a better understanding of gene-regulatory networks controlling photoreceptor homeostasis and disease.	[Samuel, Alexander; Housset, Michael; Fant, Bruno; Lamonerie, Thomas] Univ Nice Sophia Antipolis, Inst Biol Valrose, INSERM, U1091,CNRS,UMR7277, F-06189 Nice, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Lamonerie, T (corresponding author), Univ Nice Sophia Antipolis, Inst Biol Valrose, INSERM, U1091,CNRS,UMR7277, F-06189 Nice, France.	lamonerie@unice.fr	Samuel, Alexander/GYA-5341-2022	Samuel, Alexander/0000-0003-4547-5280; Lamonerie, Thomas/0000-0003-2371-2708	CNRS [7277]; ARC; Retina France; French Research Ministry; University of Nice; Fondation Recherche Medicale	CNRS(Centre National de la Recherche Scientifique (CNRS)); ARC(Australian Research Council); Retina France; French Research Ministry(Ministry of Research, France); University of Nice; Fondation Recherche Medicale	This work was supported by grants from the CNRS to UMR 7277, ARC-projet 2011-2013 and Retina France-2012 to TL. AS was supported by a fellowship from French Research Ministry and University of Nice, MH was supported by a fellowship from the French Research Ministry and The Fondation Recherche Medicale, BF was supported by a fellowship from French Research Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora D, 1999, DEVELOPMENT, V126, P1417; Akagi T, 2004, INVEST OPHTH VIS SCI, V45, P4570, DOI 10.1167/iovs.04-0697; Apostolou E, 2013, NATURE, V502, P462, DOI 10.1038/nature12749; Barbosa-Sabanero K, 2012, BIOCHEM J, V447, P321, DOI 10.1042/BJ20120813; Beby F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011673; Boucherie C, 2013, STEM CELLS, V31, P408, DOI 10.1002/stem.1268; Cai X, 2010, EXP EYE RES, V91, P186, DOI 10.1016/j.exer.2010.04.017; Chatelain G, 2006, J MOL MED, V84, P604, DOI 10.1007/s00109-006-0048-2; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Corbo JC, 2010, GENOME RES, V20, P1512, DOI 10.1101/gr.109405.110; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Fong SL, 1999, CURR EYE RES, V18, P283, DOI 10.1076/ceyr.18.4.283.5360; Fossat N, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-122; Fraser B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055410; Freund CL, 1998, NAT GENET, V18, P311, DOI 10.1038/ng0498-311; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hennig AK, 2008, BRAIN RES, V1192, P114, DOI 10.1016/j.brainres.2007.06.036; Housset M, 2013, J NEUROSCI, V33, P9890, DOI 10.1523/JNEUROSCI.1099-13.2013; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Kizilyaprak C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011039; Klepper K, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-9; Kobi D, 2010, PIGM CELL MELANOMA R, V23, P404, DOI 10.1111/j.1755-148X.2010.00697.x; Koike C, 2007, MOL CELL BIOL, V27, P8318, DOI 10.1128/MCB.01209-07; Kusakabe T, 2001, DEV GENES EVOL, V211, P145, DOI 10.1007/s004270100136; Lerner LE, 2005, J BIOL CHEM, V280, P20642, DOI 10.1074/jbc.M500957200; Loots GG, 2008, ADV GENET, V61, P269, DOI 10.1016/S0065-2660(07)00010-7; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; MAROTTE LR, 1980, J COMP NEUROL, V193, P319, DOI 10.1002/cne.901930202; Martinez-Morales JR, 2003, J BIOL CHEM, V278, P21721, DOI 10.1074/jbc.M301708200; Martinez-Morales JR, 2001, DEVELOPMENT, V128, P2019; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; Nandi S, 2013, NUCLEIC ACIDS RES, V41, P8822, DOI 10.1093/nar/gkt578; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Pires-daSilva A, 2003, NAT REV GENET, V4, P39, DOI 10.1038/nrg977; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ragge NK, 2005, AM J HUM GENET, V76, P1008, DOI 10.1086/430721; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Spieler D, 2004, DEV BIOL, V269, P567, DOI 10.1016/j.ydbio.2004.01.044; Suda Y, 1999, DEVELOPMENT, V126, P743; Terrell D, 2012, DEV DYNAM, V241, P215, DOI 10.1002/dvdy.22782; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; White MA, 2013, P NATL ACAD SCI USA, V110, P11952, DOI 10.1073/pnas.1307449110; Yin J, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-56; Young JE, 2003, INVEST OPHTH VIS SCI, V44, P4076, DOI 10.1167/iovs.03-0197	48	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89110	10.1371/journal.pone.0089110	http://dx.doi.org/10.1371/journal.pone.0089110			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558479	gold, Green Published, Green Submitted			2022-12-27	WOS:000331706700125
J	Smith, J; Nyamukapa, C; Gregson, S; Lewis, J; Magutshwa, S; Schumacher, C; Mushati, P; Hallett, T; Garnett, G				Smith, Jennifer; Nyamukapa, Constance; Gregson, Simon; Lewis, James; Magutshwa, Sitholubuhle; Schumacher, Christina; Mushati, Phyllis; Hallett, Tim; Garnett, Geoff			The Distribution of Sex Acts and Condom Use within Partnerships in a Rural Sub-Saharan African Population	PLOS ONE			English	Article							HIV-1 INFECTION; BEHAVIOR; TRANSMISSION; PREVALENCE; ZIMBABWE; TRENDS; WOMEN; PROXIMATE; EPIDEMIC; IMPACT	Introduction: In an HIV/AIDS epidemic driven primarily by heterosexual transmission, it is important to have an understanding of the human sexual behaviour patterns that influence transmission. We analysed the distribution and predictors of within-partnership sexual behaviour and condom use in rural Zimbabwe and generated parameters for use in future modelling analyses. Methods: A population-based cohort was recruited from a household census in 12 communities. A baseline survey was carried out in 1998-2000 with follow-up surveys after 3 and 5 years. Statistical distributions were fitted to reported within-partnership numbers of total, unprotected and protected sex acts in the past two weeks. Multilevel linear and logistic regression models were constructed to assess predictors of the frequency of unprotected sex and consistent condom use. Results: A normal distribution of ln(sex acts+1) provided the best fit for total and unprotected sex acts for men and women. A negative binomial distribution applied to the untransformed data provided the best fit for protected sex acts. Condom use within partnerships was predominantly bimodal with at least 88% reporting zero or 100% use. Both men and women reported fewer unprotected sex acts with non-regular compared to regular partners (men: 0.26 fewer every two weeks (95% confidence interval 0.18-0.34); women: 0.16 (0.07-0.23)). Never and previously married individuals reported fewer unprotected sex acts than currently married individuals (never married men: 0.64 (0.60-0.67); previously married men: 0.59 (0.50-0.67); never married women: 0.51 (0.45-0.57); previously married women: 0.42 (0.37-0.47)). These variables were also associated with more consistent condom use. Discussion: We generated parameters that will be useful for defining transmission models of HIV and other STIs, which rely on a valid representation of the underlying sexual network that determines spread of an infection. This will enable a better understanding of the spread of HIV and other STDs in this rural sub-Saharan population.	[Smith, Jennifer; Nyamukapa, Constance; Gregson, Simon; Hallett, Tim] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Nyamukapa, Constance; Gregson, Simon; Magutshwa, Sitholubuhle; Mushati, Phyllis] Biomed Res & Training Inst, Harare, Zimbabwe; [Lewis, James] London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London WC1, England; [Schumacher, Christina] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD USA; [Garnett, Geoff] Bill & Melinda Gates Fdn, Seattle, WA USA	Imperial College London; Biomedical Research Training Institute; University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; Johns Hopkins Medicine; Bill & Melinda Gates Foundation	Smith, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.	jennifer.smith@imperial.ac.uk	Lewis, James/F-6333-2013; Garnett, Geoffrey P/A-9312-2008	Hallett, Timothy/0000-0002-9681-0424; Gregson, Simon/0000-0003-2707-0714; Nyamukapa, Constance/0000-0001-6779-4069; Smith, Jennifer/0000-0002-8809-8553	Wellcome Trust [090285/Z/09/Z, 084401/Z/07/Z]; MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1B, MR/K010174/1, MR/K012126/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding for this study was provided by Wellcome Trust grants 090285/Z/09/Z and 084401/Z/07/Z (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2001, AIDS, V15, P2171, DOI 10.1097/00002030-200111090-00013; ANDERSON R M, 1986, IMA Journal of Mathematics Applied in Medicine and Biology, V3, P229; Bauni E., 2003, AFRICAN POPULATION S, V18, P51; Biomedical Research and Training Institute Zimbabwe and Imperial College London, 2013, MAN HIV STD PREV PRO; Biraro S, 2009, SEX TRANSM INFECT, V85, pI3, DOI 10.1136/sti.2008.033928; Brown MS, 2000, J BIOSOC SCI, V32, P145, DOI 10.1017/S0021932000001450; Brown TM, 2003, AM J PUBLIC HEALTH, V93, P896, DOI 10.2105/AJPH.93.6.896; Buve A, 2001, AIDS, V15, pS117, DOI 10.1097/00002030-200108004-00013; CARAEL M, 1995, AIDS, V9, P1171, DOI 10.1097/00002030-199510000-00009; CATANIA JA, 1990, PSYCHOL BULL, V108, P339, DOI 10.1037/0033-2909.108.3.339; Chimbiri AM, 2007, SOC SCI MED, V64, P1102, DOI 10.1016/j.socscimed.2006.10.012; Cleland J, 1995, SEXUAL BEHAV AIDS DE; Cleland J, 2006, REPROD HEALTH MATTER, V14, P17, DOI 10.1016/S0968-8080(06)28250-8; Cleland J, 2006, LANCET, V368, P1788, DOI 10.1016/S0140-6736(06)69738-9; Cremin I, 2010, AIDS BEHAV, V14, P708, DOI 10.1007/s10461-009-9592-4; Enel C, 1994, Health Transit Rev, V4 Suppl, P111; Fylkesnes K, 2001, AIDS, V15, P907, DOI 10.1097/00002030-200105040-00011; Gardner R, 1999, POPULATION REPORTS H, V9; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Gregson S, 2004, SEX TRANSM INFECT, V80, P36, DOI 10.1136/sti.2004.012088; Gregson S, 2002, LANCET, V359, P1896, DOI 10.1016/S0140-6736(02)08780-9; Gregson S, 2001, INT J STD AIDS, V12, P189, DOI 10.1258/0956462011917009; Hallett T. B., 2008, PLOS ONE, V3; Hallett TB, 2011, SEX TRANSM INFECT, V87, P88, DOI 10.1136/sti.2010.043372; Hartung TK, 2002, INT J STD AIDS, V13, P829, DOI 10.1258/095646202321020107; Hendriksen ES, 2007, AM J PUBLIC HEALTH, V97, P1241, DOI 10.2105/AJPH.2006.086009; Holmes KK, 2004, B WORLD HEALTH ORGAN, V82, P454; Johnson AM, 1994, SEXUAL ATTITUDES LIF; Kamali A, 2000, AIDS, V14, P427, DOI 10.1097/00002030-200003100-00017; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; Kinsey Alfred, 1953, SEXUAL BEHAV HUMAN F; KONINGS E, 1994, AIDS, V8, P987, DOI 10.1097/00002030-199407000-00018; Lagarde E, 2001, AIDS, V15, pS71, DOI 10.1097/00002030-200108004-00008; Laumann O, 1994, SOCIAL ORG SEXUALITY; Lopman BA, 2009, SEX TRANSM INFECT, V85, pI41, DOI 10.1136/sti.2008.033043; Lopman B, 2008, INT J EPIDEMIOL, V37, P88, DOI 10.1093/ije/dym255; Low-Beer D, 2010, AIDS, V24, pS12, DOI 10.1097/01.aids.0000390085.37812.79; Maharaj P, 2004, STUD FAMILY PLANN, V35, P116, DOI 10.1111/j.1728-4465.2004.00013.x; MAY RM, 1987, NATURE, V326, P137, DOI 10.1038/326137a0; MCLEAN AR, 1993, P ROY SOC B-BIOL SCI, V253, P9, DOI 10.1098/rspb.1993.0075; Mmbaga EJ, 2007, AIDS RES THERAPY, V4; MORRIS M, 1993, NATURE, V365, P437, DOI 10.1038/365437a0; Mumtaz Z., 2005, FOCUS GENDER COLLECT, P117; Myer L, 2002, INT J STD AIDS, V13, P62; Nnko S, 2004, SOC SCI MED, V59, P299, DOI 10.1016/j.socscimed.2003.10.031; Pinkerton SD, 1997, SOC SCI MED, V44, P1303, DOI 10.1016/S0277-9536(96)00258-4; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; R Core Development Team, 2008, R LANG ENV STAT COMP; Reidy WJ, 2010, EPIDEMIOLOGY, V21, P349, DOI 10.1097/EDE.0b013e3181d62147; Schmid GP, 2004, LANCET, V363, P482, DOI 10.1016/S0140-6736(04)15497-4; SPIRA A, 1994, SEXUAL BEHAV AIDS; Supervie V, 2010, P NATL ACAD SCI USA, V107, P12381, DOI 10.1073/pnas.1006061107; Udry JR, 1993, BIOMEDICAL DEMOGRAPH, P85; Ukwuani FA, 2003, JAIDS-J ACQ IMM DEF, V34, P203, DOI 10.1097/00126334-200310010-00011; *UNAIDS, 2004, REP GLOB AIDS EP; Vickerman P, 2010, SEX TRANSM INFECT, V86, P163, DOI 10.1136/sti.2008.034678	56	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88378	10.1371/journal.pone.0088378	http://dx.doi.org/10.1371/journal.pone.0088378			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3RA	24558387	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000331706700033
J	Sollis, KA; Smit, PW; Fiscus, S; Ford, N; Vitoria, M; Essajee, S; Barnett, D; Cheng, B; Crowe, SM; Denny, T; Landay, A; Stevens, W; Habiyambere, V; Perrins, J; Peeling, RW				Sollis, Kimberly A.; Smit, Pieter W.; Fiscus, Susan; Ford, Nathan; Vitoria, Marco; Essajee, Shaffiq; Barnett, David; Cheng, Ben; Crowe, Suzanne M.; Denny, Thomas; Landay, Alan; Stevens, Wendy; Habiyambere, Vincent; Perrins, Jos; Peeling, Rosanna W.			Systematic Review of the Performance of HIV Viral Load Technologies on Plasma Samples	PLOS ONE			English	Review							AMPLIPREP/COBAS(R) TAQMAN(R) HIV-1; ANTIRETROVIRAL TREATMENT FAILURE; VIRUS TYPE-1 RNA; TEST VERSION 2.0; ABBOTT REALTIME; COBAS-TAQMAN; QUANTITATIVE DETECTION; DIAGNOSTIC-ACCURACY; GROUP-O; ASSAY	Background: Viral load (VL) monitoring is the standard of care in developing country settings for detecting HIV treatment failure. Since 2010 the World Health Organization has recommended a phase-in approach to VL monitoring in resource-limited settings. We conducted a systematic review of the accuracy and precision of HIV VL technologies for treatment monitoring. Methods and Findings: A search of Medline and Embase was conducted for studies evaluating the accuracy or reproducibility of commercially available HIV VL assays. 37 studies were included for review including evaluations of the Amplicor Monitor HIV-1 v1.5 (n=25), Cobas TaqMan v2.0 (n=11), Abbott RealTime HIV-1 (n=23), Versant HIV-1 RNA bDNA 3.0 (n=15), Versant HIV-1 RNA kPCR 1.0 (n=2), ExaVir Load v3 (n=2), and NucliSens EasyQ v2.0 (n=1). All currently available HIV VL assays are of sufficient sensitivity to detect plasma virus levels at a lower detection limit of 1,000 copies/mL. Bias data comparing the Abbott RealTime HIV-1, TaqMan v2.0 to the Amplicor Monitor v1.5 showed a tendency of the Abbott RealTime HIV-1 to under-estimate results while the TaqMan v2.0 overestimated VL counts. Compared to the Amplicor Monitor v1.5, 2-26% and 9-70% of results from the Versant bDNA 3.0 and Abbott RealTime HIV-1 differed by greater than 0.5log(10). The average intra and inter-assay variation of the Abbott RealTime HIV-1 were 2.95% (range 2.0-5.1%) and 5.44% (range 1.17-30.00%) across the range of VL counts (2log(10)-7log(10)). Conclusions: This review found that all currently available HIV VL assays are of sufficient sensitivity to detect plasma VL of 1,000 copies/mL as a threshold to initiate investigations of treatment adherence or possible treatment failure. Sources of variability between VL assays include differences in technology platform, plasma input volume, and ability to detect HIV-1 subtypes. Monitoring of individual patients should be performed on the same technology platform to ensure appropriate interpretation of changes in VL. Prospero registration #CD42013003603.	[Sollis, Kimberly A.; Smit, Pieter W.; Peeling, Rosanna W.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Fiscus, Susan] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Ford, Nathan; Vitoria, Marco; Habiyambere, Vincent; Perrins, Jos] WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland; [Essajee, Shaffiq] Clinton Hlth Access Initiat, New York, NY USA; [Barnett, David] United Kingdom Natl External Qual Assessment Serv, Dept Haematol, Sheffield, S Yorkshire, England; [Cheng, Ben] Pangaea Global AIDS Fdn, Dept Technol & Innovat, San Francisco, CA USA; [Crowe, Suzanne M.] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Denny, Thomas] Duke Human Vaccine Inst, Dept Med, Durham, NC USA; [Denny, Thomas] Ctr HIV AIDS Vaccine Immunol, Durham, NC USA; [Landay, Alan] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA; [Stevens, Wendy] Univ Witwatersrand, Dept Mol Med & Haematol, Johannesburg, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of North Carolina; University of North Carolina Chapel Hill; World Health Organization; Burnet Institute; Rush University; University of Witwatersrand	Peeling, RW (corresponding author), London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England.	rosanna.peeling@lshtm.ac.uk		Barnett, David/0000-0002-7658-5856	World Health Organization [HQHIV0801828]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	World Health Organization(World Health Organization); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the World Health Organization (grant number HQHIV0801828). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisson GP, 2006, AIDS, V20, P1613, DOI 10.1097/01.aids.0000238407.00874.dc; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bossuyt PM, 2003, CLIN CHEM, V49, P7, DOI 10.1373/49.1.7; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Braun P, 2007, CLIN CHEM LAB MED, V45, P93, DOI 10.1515/CCLM.2007.008; Choi JY, 2009, J VIROL METHODS, V161, P7, DOI 10.1016/j.jviromet.2009.02.003; Church D, 2011, J CLIN MICROBIOL, V49, P118, DOI 10.1128/JCM.00685-10; Clarke JR, 2000, J MED VIROL, V62, P445, DOI 10.1002/1096-9071(200012)62:4&lt;445::AID-JMV8&gt;3.0.CO;2-N; Crowe S, 2003, CLIN INFECT DIS, V37, pS25, DOI 10.1086/375369; Crump JA, 2009, J VIROL METHODS, V162, P218, DOI 10.1016/j.jviromet.2009.08.013; Damond F, 2010, J CLIN MICROBIOL, V48, P1413, DOI 10.1128/JCM.01409-09; Do T, 2011, J CLIN VIROL, V52, pS83, DOI 10.1016/j.jcv.2011.09.022; Elbeik T, 2002, J ACQ IMMUN DEF SYND, V29, P330; Fiscus S. A, 2006, PLOS MED, V3; Galli R, 2005, J CLIN VIROL, V34, P245, DOI 10.1016/j.jcv.2004.12.012; Greengrass VL, 2009, J CLIN MICROBIOL, V47, P3011, DOI 10.1128/JCM.00805-09; Gueudin M, 2007, JAIDS-J ACQ IMM DEF, V44, P500, DOI 10.1097/QAI.0b013e31803260df; Hughes MD, 1997, ANN INTERN MED, V126, P929, DOI 10.7326/0003-4819-126-12-199706150-00001; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Karasi JC, 2011, J CLIN VIROL, V52, P181, DOI 10.1016/j.jcv.2011.07.002; Katsoulidou A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-10; Labbett W, 2009, J CLIN MICROBIOL, V47, P3266, DOI 10.1128/JCM.00715-09; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Moore DM, 2008, JAIDS-J ACQ IMM DEF, V49, P477, DOI 10.1097/QAI.0b013e318186eb18; Muyldermans G, 2000, CLIN MICROBIOL INFEC, V6, P213, DOI 10.1046/j.1469-0691.2000.00048.x; OBrien WA, 1997, ANN INTERN MED, V126, P939, DOI 10.7326/0003-4819-126-12-199706150-00002; Oliver AR, 2007, J CLIN MICROBIOL, V45, P3616, DOI 10.1128/JCM.00221-07; Paba P, 2011, J VIROL METHODS, V173, P399, DOI 10.1016/j.jviromet.2011.03.014; Pas S, 2010, J CLIN MICROBIOL, V48, P1195, DOI 10.1128/JCM.01832-09; Poveda E, 2003, AIDS PATIENT CARE ST, V17, P321, DOI 10.1089/108729103322231259; Pyne MT, 2009, J MOL DIAGN, V11, P347, DOI 10.2353/jmoldx.2009.080166; Reynolds SJ, 2009, AIDS, V23, P697, DOI 10.1097/QAD.0b013e3283262a78; Ruelle J, 2009, J CLIN VIROL, V44, P297, DOI 10.1016/j.jcv.2009.01.004; Saag MS, 1996, NAT MED, V2, P625, DOI 10.1038/nm0696-625; Schutten M, 2007, J CLIN VIROL, V40, P99, DOI 10.1016/j.jcv.2007.07.013; Scott LE, 2009, J CLIN MICROBIOL, V47, P2209, DOI 10.1128/JCM.01761-08; Sire JM, 2011, JAIDS-J ACQ IMM DEF, V56, P239, DOI 10.1097/QAI.0b013e3182099891; Sivapalasingam S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006828; Sizmann D, 2010, J CLIN VIROL, V49, P41, DOI 10.1016/j.jcv.2010.06.004; Sloma CR, 2009, J CLIN MICROBIOL, V47, P889, DOI 10.1128/JCM.02231-08; Ssebugenyi I, 2011, INT J STD AIDS, V22, P373, DOI 10.1258/ijsa.2009.009526; Stevens W, 2007, J CLIN MICROBIOL, V45, P1244, DOI 10.1128/JCM.01540-06; Stevens W, 2008, NAT REV MICROBIOL, V6, pS29, DOI 10.1038/nrmicro2000; Swanson P, 2007, J VIROL METHODS, V141, P49, DOI 10.1016/j.jviromet.2006.11.026; Tang N, 2007, J VIROL METHODS, V146, P236, DOI 10.1016/j.jviromet.2007.07.003; Troppan KT, 2009, J CLIN VIROL, V46, P69, DOI 10.1016/j.jcv.2009.06.012; UNITAID, 2012, HIV AIDS DIAGN TECHN; University of York, 2008, SYST REV CRDS GUID U; van Rensburg EJ, 2011, J CLIN MICROBIOL, V49, P377, DOI 10.1128/JCM.01285-10; Weissman S, 2009, J CLIN OUTCOMES MANA, V16, P75; WHO, 2010, ANT THER HIV INF AD; Wirden M, 2009, J CLIN MICROBIOL, V47, P1543, DOI 10.1128/JCM.02134-08; World Health Organization, 2010, ANT THER HIV INF INF; Xu SH, 2012, J CLIN VIROL, V53, P33, DOI 10.1016/j.jcv.2011.10.001; Young TP, 2011, J CLIN MICROBIOL, V49, P1631, DOI 10.1128/JCM.02253-10	56	37	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e85869	10.1371/journal.pone.0085869	http://dx.doi.org/10.1371/journal.pone.0085869			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558359	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700005
J	Zhou, ZJ; Zhang, JF; Xia, P; Wang, JY; Chen, S; Fang, XQ; Fan, SW				Zhou, Zhi-Jie; Zhang, Jian-Feng; Xia, Ping; Wang, Ji-Ying; Chen, Shuai; Fang, Xiang-Qian; Fan, Shun-Wu			Selection of Suitable Reference Genes for Normalization of Quantitative Real-Time Polymerase Chain Reaction in Human Cartilage Endplate of the Lumbar Spine	PLOS ONE			English	Article							HOUSEKEEPING GENES; RNA EXPRESSION; MODIC CHANGES; PCR DATA; VALIDATION	The quantitative real-time polymerase chain reaction (qRT-PCR) is one of the most widely used methods to study gene expression profiles, and it requires appropriate normalization for accurate and reliable results. Although several genes are commonly used as reference genes (such as GAPDH, ACTB, and 18S rRNA), they are also regulated and can be expressed at varying levels. In this study, we evaluated twelve well-known reference genes to identify the most suitable housekeeping gene for normalization of qRT-PCR in human lumbar vertebral endplate with Modic changes, by using the geNorm, NormFinder, and BestKeeper algorithms. Our results showed that the rarely-used SDHA was the most stable single reference gene, and a combination of three, SDHA, B2M, and LDHA, was the most suitable gene set for normalization in all samples. In addition, the commonly-used genes, GAPDH, ACTB and 18S rRNA, were all inappropriate as internal standards. The rankings of reference genes for the three types of Modic change differed, although SDHA and RPL13A uniformly ranked in the first and last position, respectively. Further simulated expression analysis validated that the arbitrary use of a reference gene could lead to the misinterpretation of data. Our study confirmed the necessity of exploring the expression stability of potential reference genes in each specific tissue and experimental situation before quantitative evaluation of gene expression by qRT-PCR.	[Zhou, Zhi-Jie; Zhang, Jian-Feng; Wang, Ji-Ying; Chen, Shuai; Fang, Xiang-Qian; Fan, Shun-Wu] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Orthopaed Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Xia, Ping] Zhejiang Univ, Sch Med, Dept Neurol, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Zhi-Jie; Zhang, Jian-Feng; Xia, Ping; Wang, Ji-Ying; Chen, Shuai; Fang, Xiang-Qian; Fan, Shun-Wu] Zhejiang Univ, Sir Run Run Shaw Inst Clin Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Fang, XQ (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Orthopaed Surg, Hangzhou 310003, Zhejiang, Peoples R China.	fangxq@srrsh.com; zzj-0708@163.com			National Natural Science Fund of China [81301587, 81271971, 81171739, 81101378]; Natural Science Fund of Zhejiang Province [Y2110372, LQ13H060002]; Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents	The study was supported by the National Natural Science Fund of China (81301587, 81271971, 81171739, 81101378), the Natural Science Fund of Zhejiang Province (Y2110372, LQ13H060002), and the Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert HB, 2007, EUR SPINE J, V16, P977, DOI 10.1007/s00586-007-0336-8; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Chen DL, 2011, J CELL PHYSIOL, V226, P2469, DOI 10.1002/jcp.22725; Cong F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-743; Dehne T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2800; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Gebhardt FM, 2010, ALZHEIMERS DEMENT, V6, P465, DOI 10.1016/j.jalz.2009.11.002; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jensen TS, 2008, EUR SPINE J, V17, P1407, DOI 10.1007/s00586-008-0770-2; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Ko CS, 2009, J BIOSCI BIOENG, V107, P177, DOI 10.1016/j.jbiosc.2008.09.020; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Mallein-Gerin F, 2004, METH MOLEC MED, V100, P101; Markova DZ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4301; MODIC MT, 1988, RADIOLOGY, V168, P177, DOI 10.1148/radiology.168.1.3289089; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pombo-Suarez M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-17; Price JS, 2002, AGING CELL, V1, P57, DOI 10.1046/j.1474-9728.2002.00008.x; Ren SW, 2010, MOL VIS, V16, P1076; Subkhankulova T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r18; Untergasser A., 2008, RNAPREP TRIZOL COMBI; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang J, 2003, BIOTECHNIQUES, V34, P396; Warzybok A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072887; Zhang YH, 2008, EUR SPINE J, V17, P1289, DOI 10.1007/s00586-008-0758-y	27	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88892	10.1371/journal.pone.0088892	http://dx.doi.org/10.1371/journal.pone.0088892			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558443	gold, Green Submitted, Green Published			2022-12-27	WOS:000331706700089
J	Sato, S; Yamamoto, H; Mukaisho, K; Saito, S; Hattori, T; Yamamoto, G; Sugihara, H				Sato, Sho; Yamamoto, Hiroto; Mukaisho, Ken-ichi; Saito, Shota; Hattori, Takanori; Yamamoto, Gaku; Sugihara, Hiroyuki			Continuous Taurocholic Acid Exposure Promotes Esophageal Squamous Cell Carcinoma Progression Due to Reduced Cell Loss Resulting from Enhanced Vascular Development	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; DUODENAL-CONTENTS REFLUX; CONJUGATED BILE-SALTS; GASTROESOPHAGEAL-REFLUX; BARRETTS-ESOPHAGUS; DUODENOGASTRIC REFLUX; FILOPODIA FORMATION; CIGARETTE-SMOKING; POOR-PROGNOSIS; CANCER	Background: Refluxogenic effects of smoking and alcohol abuse may be related to the risk of esophageal squamous cell carcinoma (ESCC). The present study attempts to clarify the effects of continuous taurocholic acid (TCA) exposure, which is neither mutagenic nor genotoxic, on ESCC progression. Methods: A squamous carcinoma cell line (ESCC-DR) was established from a tumor induced in a rat model of gastroduodenal reflux. ESCC-DR cells were incubated with 2 mM TCA for >= 2 months. The effects of continuous TCA exposure were evaluated in vitro on cell morphology, growth, and invasion and in vivo on xenograft tumor growth in nude mice. Moreover, the mean level of secreted transforming growth factor (TGF)-beta 1 and vascular endothelial growth factor (VEGF) proteins in cell culture supernatants and mRNA synthesis of TGF-beta 1 and VEGF-A of ESCC cells were measured. The angiogenic potential was further examined by a migration assay using human umbilical vein endothelial cells (HUVECs). Results: Continuous TCA exposure induced marked formation of filopodia in vitro. Expression levels of angiogenic factors were significantly higher in the cells treated with TCA than in control cells. Tumor xenografts derived from cells pre-exposed to TCA were larger and more vascularized than those derived from control cells. In addition, TCA exposure increased HUVEC migration. Conclusion: Continuous TCA exposure enhanced ESCC progression due to reduced cell loss in vivo. Cell loss was inhibited by TCA-induced vascular endothelial cell migration, which was mediated by TGF-beta 1 and VEGF-A released from ESCC cells.	[Sato, Sho; Yamamoto, Hiroto; Mukaisho, Ken-ichi; Saito, Shota; Hattori, Takanori; Sugihara, Hiroyuki] Shiga Univ Med Sci, Div Mol & Diagnost Pathol, Dept Pathol, Shiga, Japan; [Sato, Sho; Saito, Shota; Yamamoto, Gaku] Shiga Univ Med Sci, Dept Oral & Maxillofacial Surg, Shiga, Japan	Shiga University of Medical Science; Shiga University of Medical Science	Mukaisho, K (corresponding author), Shiga Univ Med Sci, Div Mol & Diagnost Pathol, Dept Pathol, Shiga, Japan.	mukaisho@belle.shiga-med.ac.jp	Mukaisho, Ken-ichi/AAI-7262-2020					Barthlen W, 1994, DIS ESO, V7, P27; Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0; Burnat G, 2007, SCAND J GASTROENTERO, V42, P1460, DOI 10.1080/00365520701452209; Chen KH, 2007, CANCER SCI, V98, P1683, DOI 10.1111/j.1349-7006.2007.00605.x; Chen KH, 2007, ANTICANCER RES, V27, P175; DENNISH GW, 1971, NEW ENGL J MED, V284, P1136, DOI 10.1056/NEJM197105202842007; DOWLING RH, 1968, GASTROENTEROLOGY, V54, P1291; Faix J, 2006, CURR OPIN CELL BIOL, V18, P18, DOI 10.1016/j.ceb.2005.11.002; Fein M, 2000, CARCINOGENESIS, V21, P2079, DOI 10.1093/carcin/21.11.2079; FOLKMAN J, 1974, CANCER RES, V34, P2109; FUJITA S, 1978, PATHOL RES PRACT, V163, P297, DOI 10.1016/S0344-0338(78)80028-4; Fukuchi M, 2004, CLIN CANCER RES, V10, P2738, DOI 10.1158/1078-0432.CCR-1096-03; Gandy KAO, 2013, BIOCHEM J, V449, P661, DOI 10.1042/BJ20120213; GRAFFNER H, 1984, SCAND J GASTROENTERO, V19, P116, DOI 10.1080/00365521.1984.12005695; Hashimoto N, 2006, DIS ESOPHAGUS, V19, P346, DOI 10.1111/j.1442-2050.2006.00599.x; HEUMAN DM, 1994, GASTROENTEROLOGY, V106, P1333, DOI 10.1016/0016-5085(94)90027-2; IFTIKHAR SY, 1993, ANN ROY COLL SURG, V75, P411; Jurgens S, 2012, Z GASTROENTEROL, V50, P1028, DOI 10.1055/s-0032-1312922; KADAKIA SC, 1995, AM J GASTROENTEROL, V90, P1785; KAUFMAN SE, 1978, GUT, V19, P336, DOI 10.1136/gut.19.4.336; Kleespies A, 2004, J SURG ONCOL, V87, P95, DOI 10.1002/jso.20070; Kumagai H, 2004, CARCINOGENESIS, V25, P723, DOI 10.1093/carcin/bgh067; Kumagai H, 2003, SCAND J GASTROENTERO, V38, P687, DOI 10.1080/00365520310003435; Lamireau T, 2003, LIFE SCI, V72, P1401, DOI 10.1016/S0024-3205(02)02408-6; MAETA M, 1986, SURGERY, V99, P87; McQuaid KR, 2011, ALIMENT PHARM THER, V34, P146, DOI 10.1111/j.1365-2036.2011.04709.x; Miwa K, 1996, INT J CANCER, V67, P269, DOI 10.1002/(SICI)1097-0215(19960717)67:2<269::AID-IJC19>3.0.CO;2-6; MOORADIAN DL, 1992, J NATL CANCER I, V84, P523, DOI 10.1093/jnci/84.7.523; Nishioka K, 2006, J SURG RES, V132, P130, DOI 10.1016/j.jss.2005.09.024; Nozoe T, 2002, CANCER LETT, V184, P49, DOI 10.1016/S0304-3835(02)00188-X; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; PERA M, 1993, ANN THORAC SURG, V55, P1386, DOI 10.1016/0003-4975(93)91077-Z; Pera M, 1993, ANN THORAC SURG, V55, P1392; Perez MJ, 2009, WORLD J GASTROENTERO, V15, P1677, DOI 10.3748/wjg.15.1677; Prins MJD, 2012, J GASTROINTEST SURG, V16, P956, DOI 10.1007/s11605-011-1814-1; SEARS RJ, 1995, AM J GASTROENTEROL, V90, P211; SHEARMAN DJ, 1970, LANCET, V1, P581; SILVERMAN SJ, 1977, J NATL CANCER I, V59, P1557, DOI 10.1093/jnci/59.5.1557; Small J. Victor, 1994, Seminars in Cell Biology, V5, P157, DOI 10.1006/scel.1994.1020; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Smit CF, 2001, ANN OTO RHINOL LARYN, V110, P190, DOI 10.1177/000348940111000216; Soma T, 2006, INT J CANCER, V119, P771, DOI 10.1002/ijc.21917; Song S, 2007, GUT, V56, P1512, DOI 10.1136/gut.2007.121244; Stamp DH, 2002, MED HYPOTHESES, V59, P398, DOI 10.1016/S0306-9877(02)00125-1; Sun JW, 2011, J BIOL CHEM, V286, P38865, DOI 10.1074/jbc.M111.270413; Tatsugami M, 2012, CANCER EPIDEM BIOMAR, V21, P2101, DOI 10.1158/1055-9965.EPI-12-0730; VITALE GC, 1987, JAMA-J AM MED ASSOC, V258, P2077, DOI 10.1001/jama.258.15.2077; von Rahden BHA, 2006, MOL CARCINOGEN, V45, P786, DOI 10.1002/mc.20259; Yokoyama A, 1996, INT J CANCER, V68, P313, DOI 10.1002/(SICI)1097-0215(19961104)68:3&lt;313::AID-IJC8&gt;3.0.CO;2-4; Zhang R, 2005, WORLD J GASTROENTERO, V11, P5109	50	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88831	10.1371/journal.pone.0088831	http://dx.doi.org/10.1371/journal.pone.0088831			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551170	gold, Green Published, Green Submitted			2022-12-27	WOS:000331271500071
J	Yang, X; Zeng, ZY; Hou, YX; Yuan, TX; Gao, C; Jia, W; Yi, XY; Liu, MR				Yang, Xin; Zeng, Zongyue; Hou, Yixuan; Yuan, Taixian; Gao, Chao; Jia, Wei; Yi, Xiaoyan; Liu, Manran			MicroRNA-92a as a Potential Biomarker in Diagnosis of Colorectal Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							PLASMA MICRORNAS; COLON-CANCER; SERUM; RNA; PUBLICATION; EXPRESSION; MIR-92A; MARKERS; PROFILE; MIR-29A	Introduction: Previous studies demonstrated that MicroRNA-92a (miR-92a) was significantly differential expressed between colorectal cancer (CRC) patients and control cohorts, which provide timely relevant evidence for miR-92a as a novel promising biomarker in the colorectal cancer patients. This meta-analysis aimed to evaluate potential diagnostic value of plasma miR-92a. Methods: Relevant literatures were collected in PubMed, Embase, Chinese Biomedical Literature Database (CBM), Chinese National Knowledge Infrastructure (CNKI) and Technology of Chongqing (VIP), and Wan Fang Data. Sensitivity, specificity and diagnostic odds ratio (DOR) for miR-92a in the diagnosis of CRC were pooled using random effects models. Summary receiver operating characteristic (SROC) curve analysis and the area under the curve (AUC) were used to estimate the overall test performance. Results: This Meta-analysis included six studies with a total of 521 CRC patients and 379 healthy controls. For miR-92a, the pooled sensitivity, specificity and DOR to predict CRC patients were 76% (95% confidence interval [CI]: 72%-79%), 64% (95% confidence interval [CI]: 59%-69%) and 8.05 (95% CI: 3.50-18.56), respectively. In addition, the AUC of miR-92a in diagnosis CRC is 0.7720. Conclusions: MicroRNA-92a might be a novel potential biomarker in the diagnosis of colorectal cancer, and more studies are needed to highlight the theoretical strengths.	[Yang, Xin; Zeng, Zongyue; Hou, Yixuan; Yuan, Taixian; Gao, Chao; Jia, Wei; Yi, Xiaoyan; Liu, Manran] Chongqing Med Univ, Chinese Minist Educ, Key Lab Lab Med Diagnost, Chongqing, Peoples R China; [Hou, Yixuan] Chongqing Med Univ, Expt Teaching Ctr Basic Med Sci, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Liu, MR (corresponding author), Chongqing Med Univ, Chinese Minist Educ, Key Lab Lab Med Diagnost, Chongqing, Peoples R China.	martinliu12345@gmail.com		Zeng, Zongyue/0000-0002-4333-5412	National Natural Science Foundation of China [NSFC 81072147, NSFC 30940096]; Doctoral Fund of Ministry of Education, China [20105503110001, 20125503110001]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Education, China [[2011]508]; Major Program of Chongqing Medical University [XBZD201006]; Scientific Research Foundation for the Returned Overseas Scholars of Chongqing Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education, China; Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Education, China(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Major Program of Chongqing Medical University; Scientific Research Foundation for the Returned Overseas Scholars of Chongqing Medical University	This work was supported in part by National Natural Science Foundation of China (NSFC 81072147, NSFC 30940096); the Doctoral Fund of Ministry of Education, China (20105503110001, 20125503110001); the Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Education, China ([2011]508); the Major Program of Chongqing Medical University XBZD201006; and the Scientific Research Foundation for the Returned Overseas Scholars of Chongqing Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed FE, 2012, CANCER GENOM PROTEOM, V9, P179; Barbarotto E, 2008, INT J CANCER, V122, P969, DOI 10.1002/ijc.23343; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Vega AB, 2013, ONCOL REP, V30, P320, DOI 10.3892/or.2013.2475; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Collins JF, 2005, ANN INTERN MED, V142, P81, DOI 10.7326/0003-4819-142-2-200501180-00006; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Faltejskova P, 2012, CANCER BIOMARK, V12, P199, DOI 10.3233/CBM-130308; Gellad ZF, 2010, GASTROENTEROLOGY, V138, P2177, DOI 10.1053/j.gastro.2010.01.056; Giraldez MD, 2013, CLIN GASTROENTEROL H, V11, P681, DOI 10.1016/j.cgh.2012.12.009; Giraldez MD, 2011, GASTROENTEROLOGY, V140, pS410; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jones CM, 2005, ANN THORAC SURG, V79, P16, DOI 10.1016/j.athoracsur.2004.09.040; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li GM, 2008, CELL RES, V18, P1, DOI 10.1038/cr.2008.9; Lijmer JG, 2002, STAT MED, V21, P1525, DOI 10.1002/sim.1185; Liu GH, 2013, TUMOR BIOL, V34, P2175, DOI 10.1007/s13277-013-0753-8; Lo KW, 1999, CLIN CHEM, V45, P1292; Luo X, 2013, PLOS ONE, V8; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Ng EKO, 2002, CLIN CHEM, V48, P1212; Nugent M, 2012, J SURG ONCOL, V106, P947, DOI 10.1002/jso.23174; Silva JM, 2002, GUT, V50, P530, DOI 10.1136/gut.50.4.530; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Sung JJ, 2009, GASTROENTEROLOGY, V136, pA165; THOMSON DMP, 1969, P NATL ACAD SCI USA, V64, P161, DOI 10.1073/pnas.64.1.161; Walsh JME, 2003, JAMA-J AM MED ASSOC, V289, P1288, DOI 10.1001/jama.289.10.1288; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wittmann J, 2010, BBA-REV CANCER, V1806, P200, DOI 10.1016/j.bbcan.2010.07.002; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31	37	43	45	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88745	10.1371/journal.pone.0088745	http://dx.doi.org/10.1371/journal.pone.0088745			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551148	Green Published, gold, Green Submitted			2022-12-27	WOS:000331271500062
J	Suzuki, M; Minh, LN; Yoshimine, H; Inoue, K; Yoshida, LM; Morimoto, K; Ariyoshi, K				Suzuki, Motoi; Minh, Le Nhat; Yoshimine, Hiroyuki; Inoue, Kenichiro; Yoshida, Lay Myint; Morimoto, Konosuke; Ariyoshi, Koya			Vaccine Effectiveness against Medically Attended Laboratory-Confirmed Influenza in Japan, 2011-2012 Season	PLOS ONE			English	Article							INFECTIONS	The objective of this study was to estimate influenza vaccine effectiveness (VE) against medically attended, laboratory-confirmed influenza during the 2011-2012 season in Japan using a test-negative case-control study design. The effect of co-circulating non-influenza respiratory viruses (NIRVs) on VE estimates was also explored. Nasopharyngeal swab samples were collected from outpatients with influenza-like illnesses (ILIs) in a community hospital in Nagasaki, Japan. Thirteen respiratory viruses (RVs), including influenza A and B, were identified from the samples using a multiplex polymerase chain reaction. The difference in VE point estimates was assessed using three different controls: ILI patients that tested negative for influenza, those that tested negative for all RVs, and those that tested positive for NIRVs. The adjusted VE against medically attended, laboratory-confirmed influenza using all influenza-negative controls was 5.3% (95% confidence interval [CI], -60.5 to 44.1). The adjusted VEs using RV-negative and NIRV-positive controls were -1.5% (95% CI, -74.7 to 41) and 50% (95% CI, -43.2 to 82.5), respectively. Influenza VE was limited in Japan during the 2011-2012 season. Although the evidence is not conclusive, co-circulating NIRVs may affect influenza VE estimates in test-negative case-control studies.	[Suzuki, Motoi; Minh, Le Nhat; Morimoto, Konosuke; Ariyoshi, Koya] Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki 852, Japan; [Yoshimine, Hiroyuki; Inoue, Kenichiro] Inoue Hosp, Nagasaki, Japan; [Yoshida, Lay Myint] Nagasaki Univ, Inst Trop Med, Dept Paediat Infect Dis, Nagasaki 852, Japan	Nagasaki University; Nagasaki University	Ariyoshi, K (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki 852, Japan.	kari@nagasaki-u.ac.jp		Suzuki, Motoi/0000-0002-8340-0880; YOSHIDA, LAYMYINT/0000-0002-7567-3248	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); "Improvement of Research Environment for Young Researchers'' program	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); "Improvement of Research Environment for Young Researchers'' program	This work was supported by the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) and the "Improvement of Research Environment for Young Researchers'' program organised by the Japanese Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Castilla J, 2013, EURO SURVEILL, V18; Castilla J, 2011, EURO SURVEILL, V16; *CNRL ECDC, 2013, INFL VIR CHAR; Cowling BJ, 2012, EPIDEMIOLOGY, V23, P930, DOI 10.1097/EDE.0b013e31826b300e; Cowling BJ, 2012, CLIN INFECT DIS, V54, P1778, DOI 10.1093/cid/cis307; Huong TTV, 2011, PEDIATR INFECT DIS J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2; Jackson ML, 2013, VACCINE, V31, P2165, DOI 10.1016/j.vaccine.2013.02.053; KELLY H, 2013, EURO SURVEILL, V18; Kelly H, 2011, PEDIATR INFECT DIS J, V30, P107, DOI 10.1097/INF.0b013e318201811c; Kissling E, 2013, EURO SURVEILL, V18; Li DJ, 2008, J CLIN MICROBIOL, V46, P399, DOI 10.1128/JCM.01549-07; *MIN HLTH LAB WELF, 2011, VACC INFL; NIID J, 2012, INFECT DIS WEEKLY RE; Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Pebody R., 2013, EURO SURVEILL, V18; Pebody RG, 2012, EPIDEMIOL INFECT, P1; Sundaram ME, 2013, CLIN INFECT DIS; Suzuki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052103; WHO, 2012, REC COMP INFL VIR VA; World Health Organization (WHO), 2011, REC COMP INFL VIR VA; Yoshida LM, 2010, PEDIATR INFECT DIS J, V29, P75, DOI 10.1097/INF.0b013e3181af61e9; Yoshida LM, 2013, EUR RESPIR J, V42, P461, DOI 10.1183/09031936.00101812	24	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88813	10.1371/journal.pone.0088813	http://dx.doi.org/10.1371/journal.pone.0088813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551167	Green Published, gold, Green Submitted			2022-12-27	WOS:000331266000071
J	Ure, AE; Forslund, O				Ure, Agustin Enrique; Forslund, Ola			Characterization of Human Papillomavirus Type 154 and Tissue Tropism of Gammapapillomaviruses	PLOS ONE			English	Article							CUTANEOUS HUMAN PAPILLOMAVIRUSES; EPIDERMODYSPLASIA-VERRUCIFORMIS; MOLECULAR-CLONING; BINDING-SITE; HEALTHY SKIN; HPV; DNA; CLASSIFICATION; INFECTIONS; SEQUENCES	The novel human papillomavirus type 154 (HPV154) was characterized from a wart on the crena ani of a three-year-old boy. It was previously designated as the putative HPV type FADI3 by sequencing of a subgenomic FAP amplicon. We obtained the complete genome by combined methods including rolling circle amplification (RCA), genome walking through an adapted method for detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR), long-range PCR, and finally by cloning of four overlapping amplicons. Phylogenetically, the HPV154 genome clustered together with members of the proposed species Gammapapillomavirus 11, and demonstrated the highest identity in L1 to HPV136 (68.6%). The HPV154 was detected in 3% (2/62) of forehead skin swabs from healthy children. In addition, the different detection sites of 62 gammapapillomaviruses were summarized in order to analyze their tissue tropism. Several of these HPV types have been detected from multiple sources such as skin, oral, nasal, and genital sites, suggesting that the gammapapillomaviruses are generalists with a broader tissue tropism than previously appreciated. The study expands current knowledge concerning genetic diversity and tropism among HPV types in the rapidly growing gammapapillomavirus genus.	[Ure, Agustin Enrique; Forslund, Ola] Lund Univ, Dept Lab Med, Sect Med Microbiol, Malmo, Sweden	Lund University	Forslund, O (corresponding author), Lund Univ, Dept Lab Med, Sect Med Microbiol, Malmo, Sweden.	ola.forslund@med.lu.se	Ure, Agustín Enrique/AAG-9078-2021	Ure, Agustín Enrique/0000-0001-6494-2003	Swedish Cancer Society [CAN2009/67]; Skane Regional Research Funds [ALF12711]	Swedish Cancer Society(Swedish Cancer Society); Skane Regional Research Funds	This work was supported by the Swedish Cancer Society (http://www.cancerfonden.se/), grant CAN2009/67, and by the Skane Regional Research Funds (http://www.skane.se), grant ALF12711. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonsson A, 2003, J GEN VIROL, V84, P1881, DOI 10.1099/vir.0.18836-0; Antonsson A, 2003, J CLIN MICROBIOL, V41, P2509, DOI 10.1128/JCM.41.6.2509-2514.2003; Antonsson A, 2000, J VIROL, V74, P11636, DOI 10.1128/JVI.74.24.11636-11641.2000; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bernard HU, 2012, VIRUS TAXONOMY, P235; Bottalico D, 2012, J GEN VIROL, V93, P1774, DOI 10.1099/vir.0.041897-0; Bottalico D, 2011, J INFECT DIS, V204, P787, DOI 10.1093/infdis/jir383; Bzhalava D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065953; Chen G, 2001, J VIROL, V75, P292, DOI 10.1128/JVI.75.1.292-302.2001; Chen ZG, 2007, VIROLOGY, V360, P447, DOI 10.1016/j.virol.2006.10.022; Chouhy D, 2013, J GEN VIROL, V94, P524, DOI 10.1099/vir.0.048157-0; Dahiya A, 2000, MOL CELL BIOL, V20, P6799, DOI 10.1128/MCB.20.18.6799-6805.2000; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; de Villiers EM, 2013, VIROLOGY, V445, P2, DOI 10.1016/j.virol.2013.04.023; Doorbar J, 1996, E4 PROTEIN HUMAN PAP, P58; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Egawa K, 2005, BRIT J DERMATOL, V153, P688, DOI 10.1111/j.1365-2133.2005.06825.x; EGAWA K, 1993, VIROLOGY, V194, P789, DOI 10.1006/viro.1993.1320; Egawa N, 2012, VIROLOGY, V422, P99, DOI 10.1016/j.virol.2011.10.011; Ekstrom J, 2010, VIROLOGY, V397, P331, DOI 10.1016/j.virol.2009.11.027; FAVRE M, 1989, J VIROL, V63, P4910, DOI 10.1128/JVI.63.11.4910-.1989; Forslund O, 2004, J INVEST DERMATOL, V123, P388, DOI 10.1111/j.0022-202X.2004.23205.x; Forslund O, 2003, BRIT J DERMATOL, V149, P64, DOI 10.1046/j.1365-2133.2003.05376.x; Forslund O, 1999, J GEN VIROL, V80, P2437, DOI 10.1099/0022-1317-80-9-2437; Forslund O, 2013, J INFECT DI IN PRESS; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; GISSMANN L, 1977, VIROLOGY, V76, P569, DOI 10.1016/0042-6822(77)90239-2; Glez-Pena D, 2010, NUCLEIC ACIDS RES, V38, pW14, DOI 10.1093/nar/gkq321; Hazard K, 2007, J INVEST DERMATOL, V127, P116, DOI 10.1038/sj.jid.5700570; HEGDE RS, 1992, NATURE, V359, P505, DOI 10.1038/359505a0; Hegde RS, 2002, ANNU REV BIOPH BIOM, V31, P343, DOI 10.1146/annurev.biophys.31.100901.142129; Hsu JYC, 2009, J MED VIROL, V81, P1444, DOI 10.1002/jmv.21529; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jablonska S, 1994, Curr Top Microbiol Immunol, V186, P157; JABLONSKA S, 1972, CANCER RES, V32, P583; Johansson H, 2013, VIROLOGY, V440, P1, DOI 10.1016/j.virol.2013.01.023; Kohler A, 2011, J GEN VIROL, V92, P1585, DOI 10.1099/vir.0.030593-0; Kovanda A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022529; Kullander J, 2008, INT J CANCER, V122, P477, DOI 10.1002/ijc.23115; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li JJ, 2012, J VIROL, V86, P11936, DOI 10.1128/JVI.01988-12; Li LL, 2009, J GEN VIROL, V90, P2413, DOI 10.1099/vir.0.012344-0; Liu XF, 2010, J VIROL, V84, P4264, DOI 10.1128/JVI.02214-09; LORINCZ AT, 1992, OBSTET GYNECOL, V79, P328, DOI 10.1097/00006250-199203000-00002; Luft F, 2001, INT J CANCER, V92, P9, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1144>3.0.CO;2-L; MATSUKURA T, 1992, VIROLOGY, V190, P561, DOI 10.1016/0042-6822(92)91254-R; Mokili JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058404; MULLER M, 1989, J VIROL, V63, P4907; Nobre RJ, 2009, J VIROL, V83, P2907, DOI 10.1128/JVI.02490-08; Nordin P, 2007, ACTA DERM-VENEREOL, V87, P219, DOI 10.2340/00015555-0235; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Phan TG, 2013, GENOME ANNOUNC, V1; RADULESCU RT, 1995, BIOCHEM BIOPH RES CO, V206, P97, DOI 10.1006/bbrc.1995.1014; RAMBAUT A, 2009, FIGTREE V1 3; Rector A, 2004, J VIROL, V78, P4993, DOI 10.1128/JVI.78.10.4993-4998.2004; Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006; Sichero L, 2013, VIROLOGY IN PRESS; Soederlund-Strand A, 2009, J CLIN MICROBIOL, V47, P541, DOI 10.1128/JCM.02007-08; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sturegard E, 2013, SEX TRANSM DIS, V40, P123, DOI 10.1097/OLQ.0b013e31827aa9b3; Ullman CG, 1996, BIOCHEM J, V319, P229, DOI 10.1042/bj3190229; USTAV E, 1993, P NATL ACAD SCI USA, V90, P898, DOI 10.1073/pnas.90.3.898; van Regenmortel MHV, 2000, VIRUS TAXONOMY, P3; Vasiljevic N, 2008, J GEN VIROL, V89, P2467, DOI 10.1099/vir.0.2008/001925-0; Vasiljevic N, 2007, J GEN VIROL, V88, P1479, DOI 10.1099/vir.0.82679-0; Venuti A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-140; Weissenborn S, 2012, MED MICROBIOL IMMUN, V201, P117, DOI 10.1007/s00430-011-0212-3; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zakrzewska K, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-309; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	73	12	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89342	10.1371/journal.pone.0089342	http://dx.doi.org/10.1371/journal.pone.0089342			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551244	Green Published, Green Submitted, gold			2022-12-27	WOS:000331266000109
J	Swinnen, TW; Scheers, T; Lefevre, J; Dankaerts, W; Westhovens, R; de Vlam, K				Swinnen, Thijs Willem; Scheers, Tineke; Lefevre, Johan; Dankaerts, Wim; Westhovens, Rene; de Vlam, Kurt			Physical Activity Assessment in Patients with Axial Spondyloarthritis Compared to Healthy Controls: A Technology-Based Approach	PLOS ONE			English	Article							SPONDYLITIS DISEASE-ACTIVITY; ANKYLOSING-SPONDYLITIS; ARTHRITIS; CLASSIFICATION; INTERVENTIONS; LIMITATION; RELEVANT; MONITORS; EXERCISE; UPDATE	Introduction: Traditionally, assessment in axial Spondyloarthritis (aSpA) includes the evaluation of the capacity to execute tasks, conceptualized as physical function. The role of physical activity, defined as movement-related energy expenditure, is largely unknown and almost exclusively studied using patient-reported outcome measures. The aims of this observational cross-sectional study are to compare physical activity between patients with aSpA and healthy controls (HC) and to evaluate the contribution of disease activity to physical activity differences between groups. Methods: Forty patients with aSpA were matched by age, gender, period of data acquisition in terms of days and season to 40 HC. Physical activity was measured during five consecutive days (three weekdays and two weekend days) using ambulatory monitoring (SenseWear Armband). Self-reported disease activity was measured by the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). Differences in physical activity between patients with aSpA and HC were examined with Wilcoxon signed-rank tests and a mixed linear model. Difference scores between patients and HC were correlated with disease activity. Results: Average weekly physical activity level (Med(IQR); HC: 1.54(1.41-1.73); aSpA: 1.45(1.31-1.67), MET) and energy expenditure (HC: 36.40(33.43-41.01); aSpA: 34.55(31.08-39.41), MET. hrs/day) were significantly lower in patients with aSpA. Analyses across intensity levels revealed no significant differences between groups for inactivity and time spent at light or moderate physical activities. In contrast, weekly averages of vigorous (HC: 4.02(1.20-12.60); aSpA: 0.00(0.00-1.20), min/d), very vigorous physical activities (HC0.00(0.00-1.08); aSpA: 0.00(0.00-0.00), mind/d) and moderate/(very) vigorous combined (HC2.41(1.62-3.48); aSpA: 1.63(1.20-2.82), hrs/d) were significantly lower in patients with aSpA. Disease activity did not interact with differences in physical activity between patients with aSpA and HC, evidenced by non-significant and very low correlations (range: 20.06-0.17) between BASDAI and HC-aSpA patients' difference scores. Conclusions: Patients with aSpA exhibit lower physical activity compared to HC and these differences are independent of self-reported disease activity. Further research on PA in patients with aSpA should be prioritized.	[Swinnen, Thijs Willem; Westhovens, Rene; de Vlam, Kurt] Katholieke Univ Leuven Hosp, Louvain, Belgium; [Swinnen, Thijs Willem; Westhovens, Rene; de Vlam, Kurt] Katholieke Univ Leuven, Dept Dev & Regenerat, Louvain, Belgium; [Swinnen, Thijs Willem; Dankaerts, Wim] Katholieke Univ Leuven, Dept Rehabil Sci, Heverlee, Belgium; [Scheers, Tineke; Lefevre, Johan] Katholieke Univ Leuven, Dept Kinesiol, Heverlee, Belgium; [Scheers, Tineke] Res Fdn Flanders, Brussels, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; KU Leuven	de Vlam, K (corresponding author), Katholieke Univ Leuven Hosp, Louvain, Belgium.	kurt.devlam@uzleuven.be	de Vlam, Kurt/AAF-2842-2019		Division of Rheumatology, University Hospitals Leuven; Research Foundation Flanders (F.W.O. Vlaanderen) [1134711N/1134709N]	Division of Rheumatology, University Hospitals Leuven; Research Foundation Flanders (F.W.O. Vlaanderen)(FWO)	Thijs Swinnen was funded by the Division of Rheumatology, University Hospitals Leuven (www.uzleuven.be) and Tineke Scheers was funded by the Research Foundation Flanders (F.W.O. Vlaanderen, www.fwo.be, 1134711N/1134709N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; [Anonymous], 2001, HUMAN ENERGY REQUIRE; [Anonymous], 2001, INT CLASSIFICATION F; Baruth M, 2011, ARTHRIT CARE RES, V63, P1038, DOI 10.1002/acr.20463; Benjamin M, 2009, ADV EXP MED BIOL, V649, P57; Biasi D, 1996, J RHEUMATOL, V23, P407; Boonen A, 2010, ANN RHEUM DIS, V69, P102, DOI 10.1136/ard.2008.104117; Boonen A, 2009, J RHEUMATOL, V36, P2501, DOI 10.3899/jrheum.090156; Boonen A, 2009, RHEUMATOLOGY, V48, P997, DOI 10.1093/rheumatology/kep150; Brady TJ, 2009, J WOMENS HEALTH, V18, P1905, DOI 10.1089/jwh.2009.1571; Braun J, 2011, ANN RHEUM DIS, V70, P896, DOI 10.1136/ard.2011.151027; Brazeau AS, 2011, APPL PHYSIOL NUTR ME, V36, P339, DOI [10.1139/H11-016, 10.1139/h11-016]; Brionez TF, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2874; CALIN A, 1994, J RHEUMATOL, V21, P2281; Calin A, 1999, RHEUMATOLOGY, V38, P878, DOI 10.1093/rheumatology/38.9.878; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V0100; Cieza A, 2009, DISABIL REHABIL, V31, P528, DOI 10.1080/09638280802173475; Cohen J.E., 1988, STAT POWER ANAL BEHA; Conn VS, 2008, SEMIN ARTHRITIS RHEU, V37, P307, DOI 10.1016/j.semarthrit.2007.07.006; D'Ambrosia P, 2010, EUR SPINE J, V19, P1330, DOI 10.1007/s00586-010-1371-4; Da Costa D, 2004, ARTHRIT RHEUM-ARTHR, V51, P1004, DOI 10.1002/art.20841; Dagfinrud H, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002822.pub3; Dagfinrud H, 2005, J RHEUMATOL, V32, P516; Dagfinrud H, 2011, ARTHRIT CARE RES, V63, P597, DOI 10.1002/acr.20415; DOUGADOS M, 1991, ARTHRITIS RHEUM, V34, P1218, DOI 10.1002/art.1780341003; Dunlop DD, 2011, ARTHRITIS RHEUM-US, V63, P127, DOI 10.1002/art.27760; Farr JN, 2008, ARTHRIT RHEUM-ARTHR, V59, P1229, DOI 10.1002/art.24007; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Haglund E, 2012, ARTHRITIS CARE RES H; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Johannsen DL, 2010, MED SCI SPORT EXER, V42, P2134, DOI 10.1249/MSS.0b013e3181e0b3ff; Langer D, 2009, THORAX, V64, P641, DOI 10.1136/thx.2008.112102; Luyten FR, 2006, BEST PRACT RES CL RH, V20, P829, DOI 10.1016/j.berh.2006.06.009; Marcora S, 2006, RHEUMATOLOGY, V45, P1385, DOI 10.1093/rheumatology/kel127; Mathieu S, 2011, ARTHRIT CARE RES, V63, P557, DOI 10.1002/acr.20364; Matthews CE, 2002, MED SCI SPORT EXER, V34, P1376, DOI 10.1097/00005768-200208000-00021; Mihai B, 2005, Eura Medicophys, V41, P149; Piva SR, 2010, ARTHRIT CARE RES, V62, P1144, DOI 10.1002/acr.20177; Plasqui G, 2012, ARTHRIT CARE RES, V64, P101, DOI 10.1002/acr.20566; Rudwaleit M, 2005, ARTHRITIS RHEUM, V52, P1000, DOI 10.1002/art.20990; Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993; Scaglioni F, 2012, CLIN RES HEPATOL GAS; Scheers T, 2011, EUR J APPL PHYSL; Shih M, 2006, AM J PREV MED, V30, P385, DOI 10.1016/j.amepre.2005.12.005; Sieper J, 2009, ANN RHEUM DIS, V68, P1, DOI 10.1136/ard.2008.104018; van der Heijde D, 1999, J RHEUMATOL, V26, P951; van der Heijde D, 1999, J RHEUMATOL, V26, P1003; Ward MM, 2008, ARTHRIT RHEUM-ARTHR, V59, P822, DOI 10.1002/art.23704; Wilcox S, 2006, ARTHRIT RHEUM-ARTHR, V55, P616, DOI 10.1002/art.22098; Woolf CJ, 2010, J CLIN INVEST, V120, P3742, DOI 10.1172/JCI45178	50	56	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e85309	10.1371/journal.pone.0085309	http://dx.doi.org/10.1371/journal.pone.0085309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586239	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200006
J	Lederman, M; Hagbi-Levi, S; Grunin, M; Obolensky, A; Berenshtein, E; Banin, E; Chevion, M; Chowers, I				Lederman, Michal; Hagbi-Levi, Shira; Grunin, Michelle; Obolensky, Alexey; Berenshtein, Eduard; Banin, Eyal; Chevion, Mordechai; Chowers, Itay			Degeneration Modulates Retinal Response to Transient Exogenous Oxidative Injury	PLOS ONE			English	Article							CONE CELL-DEATH; PHOTORECEPTOR DEGENERATION; MITOCHONDRIAL DYSFUNCTION; SPECTROPHOTOMETRIC METHOD; PIGMENT EPITHELIUM; IRON; STRESS; DAMAGE; MOUSE; PROTECTS	Purpose Oxidative injury is involved in retinal and macular degeneration. We aim to assess if retinal degeneration associated with genetic defect modulates the retinal threshold for encountering additional oxidative challenges. Methods: Retinal oxidative injury was induced in degenerating retinas (rd10) and in control mice (WT) by intravitreal injections of paraquat (PQ). Retinal function and structure was evaluated by electroretinogram (ERG) and histology, respectively. Oxidative injury was assessed by immunohistochemistry for 4-Hydroxy-2-nonenal (HNE), and by Thiobarbituric Acid Reactive Substances (TBARS) and protein carbonyl content (PCC) assays. Anti-oxidant mechanism was assessed by quantitative real time PCR (QPCR) for mRNA of antioxidant genes and genes related to iron metabolism, and by catalase activity assay. Results: Three days following PQ injections (1 mu l of 0.25, 0.75, and 2 mM) the average ERG amplitudes decreased more in the WT mice compared with the rd10 mice. For example, following 2 mM PQ injection, ERG amplitudes reduced 1.84-fold more in WT compared with rd10 mice (p = 0.02). Injection of 4 mM PQ resulted in retinal destruction. Altered retina morphology associated with PQ was substantially more severe in WT eyes compared with rd10 eyes. Oxidative injury according to HNE staining and TBARS assay increased 1.3-fold and 2.1-fold more, respectively, in WT compared with rd10 mice. At baseline, prior to PQ injection, mRNA levels of antioxidant genes (Superoxide Dismutase1, Glutathione Peroxidase1, Catalase) and of Transferrin measured by quantitative PCR were 2.1-7.8-fold higher in rd10 compared with WT mice (p < 0.01 each), and catalase activity was 1.7-fold higher in rd10 (p = 0.0006). Conclusions: This data suggests that degenerating rd10 retinas encounter a relatively lower degree of damage in response to oxidative injury compared with normal retinas. Constitutive up-regulation of the oxidative defense mechanism in degenerating retinas may confer such relative protection from oxidative injury.	[Lederman, Michal; Hagbi-Levi, Shira; Grunin, Michelle; Obolensky, Alexey; Banin, Eyal; Chowers, Itay] Hadassah Hebrew Univ, Med Ctr, Dept Ophthalmol, Jerusalem, Israel; [Lederman, Michal; Hagbi-Levi, Shira; Grunin, Michelle; Obolensky, Alexey; Berenshtein, Eduard; Banin, Eyal; Chevion, Mordechai; Chowers, Itay] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel; [Lederman, Michal; Obolensky, Alexey; Berenshtein, Eduard; Chevion, Mordechai] Hadassah Hebrew Univ, Med Ctr, Dept Cellular Biochem & Human Genet, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center	Chowers, I (corresponding author), Hadassah Hebrew Univ, Med Ctr, Dept Ophthalmol, Jerusalem, Israel.	chowers@hadassah.org.il	Grunin, Michelle/O-6044-2019	Grunin, Michelle/0000-0002-3155-2858; Hagbi-Levi, Shira/0000-0002-2891-0079	research grant from the Israeli Science Fund [ISF 849/08]	research grant from the Israeli Science Fund	This study was supported by a research grant from the Israeli Science Fund (ISF 849/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RE, 1994, ADV EXP MED BIOL, V366, P73; Banin E, 2000, FREE RADICAL BIO MED, V28, P315, DOI 10.1016/S0891-5849(99)00227-0; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012; Chang B, 2007, VISION RES, V47, P624, DOI 10.1016/j.visres.2006.11.020; Chen HY, 2009, NEUROBIOL AGING, V30, P1865, DOI 10.1016/j.neurobiolaging.2008.01.002; Chen M, 2013, INVEST OPHTH VIS SCI, V54, P682, DOI 10.1167/iovs.12-10888; Chevion M, 2000, FREE RADICAL RES, V33, pS99; Chowers I, 2006, INVEST OPHTH VIS SCI, V47, P2135, DOI 10.1167/iovs.05-1135; Cingolani C, 2006, FREE RADICAL BIO MED, V40, P660, DOI 10.1016/j.freeradbiomed.2005.09.032; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Deleon E, 2009, INVEST OPHTH VIS SCI, V50, P1360, DOI 10.1167/iovs.08-1856; Dong A, 2006, J CELL PHYSIOL, V208, P516, DOI 10.1002/jcp.20683; Dunaief JL, 2011, FREE RADICAL BIO MED, V51, P1480, DOI 10.1016/j.freeradbiomed.2011.05.009; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Hadziahmetovic M, 2012, INVEST OPHTH VIS SCI, V53, P5231, DOI 10.1167/iovs.12-10204; Hahn P, 2003, ARCH OPHTHALMOL-CHIC, V121, P1099, DOI 10.1001/archopht.121.8.1099; He XN, 2007, PROG RETIN EYE RES, V26, P649, DOI 10.1016/j.preteyeres.2007.07.004; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; JOHANSSON LH, 1988, ANAL BIOCHEM, V174, P331, DOI 10.1016/0003-2697(88)90554-4; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; KONIJN AM, 1982, J IMMUNOL METHODS, V54, P297, DOI 10.1016/0022-1759(82)90314-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meir T, 2007, INVEST OPHTH VIS SCI, V48, P4890, DOI 10.1167/iovs.07-0215; Mori K, 2001, J CELL PHYSIOL, V188, P253, DOI 10.1002/jcp.1114; Obolensky A, 2008, FREE RADICAL BIO MED, V44, P1286, DOI 10.1016/j.freeradbiomed.2007.10.060; Obolensky A, 2011, FREE RADICAL BIO MED, V51, P1482, DOI 10.1016/j.freeradbiomed.2011.07.014; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Picard E, 2010, MOL VIS, V16, P2612; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; REZNICK AZ, 1992, BIOCHEM J, V286, P607, DOI 10.1042/bj2860607; Sacca SC, 2007, EXP EYE RES, V84, P389, DOI 10.1016/j.exer.2006.10.008; Shen JK, 2007, HISTOL HISTOPATHOL, V22, P1301, DOI 10.14670/HH-22.1301; Shen JK, 2005, J CELL PHYSIOL, V203, P457, DOI 10.1002/jcp.20346; Song DL, 2012, FREE RADICAL BIO MED, V53, P64, DOI 10.1016/j.freeradbiomed.2012.04.020; Trushina E, 2007, NEUROSCIENCE, V145, P1233, DOI 10.1016/j.neuroscience.2006.10.056; Usui S, 2011, FREE RADICAL BIO MED, V51, P1347, DOI 10.1016/j.freeradbiomed.2011.06.010; Usui S, 2009, MOL THER, V17, P778, DOI 10.1038/mt.2009.47; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yoshida N, 2013, OPHTHALMOLOGY, V120, pE5, DOI 10.1016/j.ophtha.2012.07.008; Zhu X, 2007, CELL MOL LIFE SCI, V64, P2202, DOI 10.1007/s00018-007-7218-4	42	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e87751	10.1371/journal.pone.0087751	http://dx.doi.org/10.1371/journal.pone.0087751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586289	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900013
J	Al-Mubarak, M; Tibau, A; Templeton, AJ; Cescon, DW; Ocana, A; Seruga, B; Amir, E				Al-Mubarak, Mustafa; Tibau, Ariadna; Templeton, Arnoud J.; Cescon, David W.; Ocana, Alberto; Seruga, Bostjan; Amir, Eitan			Extended Adjuvant Tamoxifen for Early Breast Cancer: A Meta-Analysis	PLOS ONE			English	Article							ENDOMETRIAL CANCER; POSTMENOPAUSAL WOMEN; ENDOCRINE THERAPY; UPDATED FINDINGS; TRIAL; LETROZOLE; RISK; ANASTROZOLE; MORTALITY; CARCINOMA	Background: Hormone receptor positive breast cancer is characterized by the potential for disease recurrence many years after initial diagnosis. Endocrine therapy has been shown to reduce the risk of such recurrence, but the optimal duration of endocrine therapy remains unclear. Methods: We conducted a systematic review and meta-analysis to quantify the benefits and harms of extended adjuvant tamoxifen (>5 years of therapy) compared with adjuvant tamoxifen (5 years of therapy). Odds ratios (ORs) and 95% confidence intervals (CIs) were computed for disease recurrence, death and adverse events. Subgroup analyses by timing of recurrence and baseline lymph node and menopause status were carried. Results: Five trials comprising 21,554 patients were included. Extended adjuvant tamoxifen was not associated with a significant reduction in the risk of recurrence (OR: 0.89, 95% CI 0.76-1.05, p = 0.17). There was no association between extended adjuvant tamoxifen and all-cause death (OR: 0.99, 95% CI 0.84-1.16, p = 0.88). There was an apparent reduction in risk of recurrence occurring after completion of extended adjuvant tamoxifen with little evidence of effect during therapy, however, this difference was not significant (p for difference 0.10). Subgroup analysis suggested that a greater effect size among lymph node positive patients compared with those who are lymph node negative (NNT: 25 vs. 49). There was no apparent difference in the effect between pre-and post-menopausal patients. Endometrial carcinoma was substantially more frequent with extended adjuvant tamoxifen (OR: 2.06, 95% CI 1.65-2.58, p<0.001, number needed to harm: 89). Conclusion: In unselected patients, extended adjuvant tamoxifen is not associated with a significant reduction in recurrence, or a reduction in all-cause death. Patients with lymph node positive breast cancer may derive some benefit. Reduction in the risk of recurrence appears to occur only after completion of extended adjuvant therapy.	[Al-Mubarak, Mustafa; Tibau, Ariadna; Templeton, Arnoud J.; Cescon, David W.; Amir, Eitan] Univ Toronto, Div Med Oncol & Hematol, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Al-Mubarak, Mustafa; Tibau, Ariadna; Templeton, Arnoud J.; Cescon, David W.; Amir, Eitan] Univ Toronto, Dept Med, Toronto, ON, Canada; [Al-Mubarak, Mustafa] Minist Higher Educ, Riyadh, Saudi Arabia; [Ocana, Alberto] Albacete Univ Hosp, Dept Med Oncol, Albacete, Spain; [Ocana, Alberto] Albacete Univ Hosp, Translat Res Unit, Albacete, Spain; [Seruga, Bostjan] Inst Oncol Ljubljana, Sect Med Oncol, Ljubljana, Slovenia	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Institute of Oncology - Slovenia	Amir, E (corresponding author), Univ Toronto, Div Med Oncol & Hematol, Princess Margaret Canc Ctr, Toronto, ON, Canada.	eitan.amir@uhn.ca	Tibau, Ariadna/AGS-6563-2022; Amir, Eitan/L-6052-2019	Tibau, Ariadna/0000-0003-0229-6987; Ocana, Alberto/0000-0002-1067-9630; Amir, Eitan/0000-0002-3706-525X				BARAKAT RR, 1994, GYNECOL ONCOL, V55, P164, DOI 10.1006/gyno.1994.1271; Baum M, 2002, LANCET, V359, P2131; Bergman L, 2000, LANCET, V356, P881, DOI 10.1016/S0140-6736(00)02677-5; BERTELLI G, 1988, BREAST CANCER RES TR, V12, P307, DOI 10.1007/BF01811244; Black WC, 2002, JNCI-J NATL CANCER I, V94, P167, DOI 10.1093/jnci/94.3.167; Bryant J, 2001, J Natl Cancer Inst Monogr, P56; Burstein HJ, 2010, J CLIN ONCOL, V28, P3784, DOI 10.1200/JOP.000082; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Davies C, 2012, LANCET, V4, P61963; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; Delozier T, 2000, J CLIN ONCOL, V18, P3507, DOI 10.1200/JCO.2000.18.20.3507; DEWAR JA, 1992, BRIT MED J, V305, P225, DOI 10.1136/bmj.305.6847.225; Fisher B, 2001, JNCI-J NATL CANCER I, V93, P684, DOI 10.1093/jnci/93.9.684; FISHER B, 1994, J NATL CANCER I, V86, P527, DOI 10.1093/jnci/86.7.527; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Goss PE, 2008, J CLIN ONCOL, V26, P1948, DOI 10.1200/JCO.2007.11.6798; Goss PE, 2005, JNCI-J NATL CANCER I, V97, P1262, DOI 10.1093/jnci/dji250; Goss PE, 2009, CANC RES S, V69; Gray RG, 2013, J CLIN ONCOL S, V31, P2013, DOI DOI 10.1200/JCO.2012.47.5301; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Hershman DL, 2010, J CLIN ONCOL, V28, P4120, DOI 10.1200/JCO.2009.25.9655; Hozumi Y, 1998, J CLIN ENDOCR METAB, V83, P1633, DOI 10.1210/jc.83.5.1633; Jakesz R, 2007, JNCI-J NATL CANCER I, V99, P1845, DOI 10.1093/jnci/djm246; Jones LW, 2007, J AM COLL CARDIOL, V50, P1435, DOI 10.1016/j.jacc.2007.06.037; Jones ME, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3206; Jordan VC, 1995, CLIN CANCER RES, V1, P467; Kennecke HF, 2007, ANN ONCOL, V18, P45, DOI 10.1093/annonc/mdl334; Liauw WS, 2003, MED J AUSTRALIA, V179, P426, DOI 10.5694/j.1326-5377.2003.tb05621.x; Liu CL, 2003, BREAST CANCER RES TR, V79, P11, DOI 10.1023/A:1023348021773; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mamounas EP, 2008, J CLIN ONCOL, V26, P1965, DOI 10.1200/JCO.2007.14.0228; Mignotte H, 1998, INT J CANCER, V76, P325, DOI 10.1002/(SICI)1097-0215(19980504)76:3<325::AID-IJC7>3.0.CO;2-X; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Muss HB, 2008, J CLIN ONCOL, V26, P1956, DOI 10.1200/JCO.2007.12.6334; Patnaik JL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2901; Rea DW, 2013, EUROPEAN J CANC S2, V49, pS298; Saphner T, 1996, J CLIN ONCOL, V14, P2738, DOI 10.1200/JCO.1996.14.10.2738; Stewart HJ, 2001, JNCI-J NATL CANCER I, V93, P456, DOI 10.1093/jnci/93.6.456; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Swerdlow AJ, 2005, JNCI-J NATL CANCER I, V97, P375, DOI 10.1093/jnci/dji057; Tormey DC, 1996, JNCI-J NATL CANCER I, V88, P1828, DOI 10.1093/jnci/88.24.1828	41	37	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88238	10.1371/journal.pone.0088238	http://dx.doi.org/10.1371/journal.pone.0088238			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586311	Green Submitted, Green Published, gold			2022-12-27	WOS:000331714700011
J	Macia, J; Sole, R				Macia, Javier; Sole, Ricard			How to Make a Synthetic Multicellular Computer	PLOS ONE			English	Article							MICROBIAL CONSORTIA; BIOLOGY; NETWORKS; LOGIC; CIRCUITS; DESIGN; COMMUNICATION; OPTIMIZATION; CELLS; GATES	Biological systems perform computations at multiple scales and they do so in a robust way. Engineering metaphors have often been used in order to provide a rationale for modeling cellular and molecular computing networks and as the basis for their synthetic design. However, a major constraint in this mapping between electronic and wet computational circuits is the wiring problem. Although wires are identical within electronic devices, they must be different when using synthetic biology designs. Moreover, in most cases the designed molecular systems cannot be reused for other functions. A new approximation allows us to simplify the problem by using synthetic cellular consortia where the output of the computation is distributed over multiple engineered cells. By evolving circuits in silico, we can obtain the minimal sets of Boolean units required to solve the given problem at the lowest cost using cellular consortia. Our analysis reveals that the basic set of logic units is typically non-standard. Among the most common units, the so called inverted IMPLIES (N-Implies) appears to be one of the most important elements along with the NOT and AND functions. Although NOR and NAND gates are widely used in electronics, evolved circuits based on combinations of these gates are rare, thus suggesting that the strategy of combining the same basic logic gates might be inappropriate in order to easily implement synthetic computational constructs. The implications for future synthetic designs, the general view of synthetic biology as a standard engineering domain, as well as potencial drawbacks are outlined.	[Macia, Javier; Sole, Ricard] Univ Pompeu Fabra, ICREA Complex Syst Lab, Barcelona, Spain; [Macia, Javier; Sole, Ricard] UPF CSIC, Inst Biol Evolut, Barcelona, Spain; [Sole, Ricard] Santa Fe Inst, Santa Fe, NM 87501 USA	ICREA; Pompeu Fabra University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; The Santa Fe Institute	Macia, J (corresponding author), Univ Pompeu Fabra, ICREA Complex Syst Lab, Barcelona, Spain.	javier.macia@upf.edu; ricard.sole@upf.edu	Solé, Ricard/I-3379-2015	Sole, Ricard/0000-0001-6974-1008	EU ERC Advanced Grant; James S. McDonnell Foundation; Fundaci'on Botin; Santa Fe Institute; ICREA Funding Source: Custom	EU ERC Advanced Grant; James S. McDonnell Foundation; Fundaci'on Botin; Santa Fe Institute; ICREA(ICREA)	This work has been supported by and EU ERC Advanced Grant, the James S. McDonnell Foundation, the Fundaci'on Botin and the Santa Fe Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos, 2005, THEORETICAL EXPT DNA; Amos M, 2004, SER SYST BIOL, P3; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Auslander S, 2012, METAB ENG, V14, P252, DOI 10.1016/j.ymben.2011.06.003; Banga JR, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-47; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Benenson Y, 2004, NATURE, V429, P423, DOI 10.1038/nature02551; Benenson Y, 2012, NAT REV GENET, V13, P455, DOI 10.1038/nrg3197; Benenson Y, 2009, MOL BIOSYST, V5, P675, DOI 10.1039/b902484k; Bernstein HC, 2012, COMPUT STRUCT BIOTEC, V3, DOI 10.5936/csbj.201210017; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; Brenner K, 2007, P NATL ACAD SCI USA, V104, P17300, DOI 10.1073/pnas.0704256104; Brenner S, 2012, NATURE, V482, P461, DOI 10.1038/482461a; Cao Hongqing, 2010, Syst Synth Biol, V4, P55, DOI 10.1007/s11693-009-9050-7; Chang TMS, 2005, NAT REV DRUG DISCOV, V4, P221, DOI 10.1038/nrd1659; Dasika MS, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-24; DENEUBOURG JL, 1989, ETHOL ECOL EVOL, V1, P295, DOI 10.1080/08927014.1989.9525500; Enderton H., 2001, MATH INTRO LOGIC; Fernando CT, 2009, J R SOC INTERFACE, V6, P463, DOI 10.1098/rsif.2008.0344; Francois P, 2004, P NATL ACAD SCI USA, V101, P580, DOI 10.1073/pnas.0304532101; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Goni-Moreno A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065986; HJELMFELT A, 1991, P NATL ACAD SCI USA, V88, P10983, DOI 10.1073/pnas.88.24.10983; Hogeweg P, 2002, BIOSYSTEMS, V64, P97, DOI 10.1016/S0303-2647(01)00178-2; HOPFIELD JJ, 1994, J THEOR BIOL, V171, P53, DOI 10.1006/jtbi.1994.1211; Istrail S, 2007, DEV BIOL, V310, P187, DOI 10.1016/j.ydbio.2007.08.009; Kauffman S, 2003, P NATL ACAD SCI USA, V100, P14796, DOI 10.1073/pnas.2036429100; Kauffman S. A., 1993, ORIGINS ORDER; Klemm K, 2005, P NATL ACAD SCI USA, V102, P18414, DOI 10.1073/pnas.0509132102; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kramer BP, 2004, BIOTECHNOL BIOENG, V87, P478, DOI 10.1002/bit.20142; Kwok R, 2010, NATURE, V463, P288, DOI 10.1038/463288a; Li BC, 2011, NATURE, V469, P171, DOI 10.1038/469171a; Huynh L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035529; Macia J, 2012, TRENDS BIOTECHNOL, V30, P342, DOI 10.1016/j.tibtech.2012.03.006; Marchisio MA, 2009, CURR OPIN BIOTECH, V20, P479, DOI 10.1016/j.copbio.2009.08.007; McGregor S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002739; Moon TS, 2011, J MOL BIOL, V406, P215, DOI 10.1016/j.jmb.2010.12.019; Nurse P, 2008, NATURE, V454, P424, DOI 10.1038/454424a; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Perkins TJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.83; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Reed MA, 2000, SCI AM, V282, P86, DOI 10.1038/scientificamerican0600-86; Regot S, 2011, NATURE, V469, P207, DOI 10.1038/nature09679; Rodrigo G, 2007, BIOINFORMATICS, V23, P1857, DOI 10.1093/bioinformatics/btm237; Rodrigo Guillermo, 2007, Syst Synth Biol, V1, P183, DOI 10.1007/s11693-008-9017-0; Ruder WC, 2011, SCIENCE, V333, P1248, DOI 10.1126/science.1206843; Sauro HM, 2004, PROG BIOPHYS MOL BIO, V86, P5, DOI 10.1016/j.pbiomolbio.2004.03.002; Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104; Simpson ML, 2001, TRENDS BIOTECHNOL, V19, P317, DOI 10.1016/S0167-7799(01)01691-2; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; Smaldon James, 2010, Syst Synth Biol, V4, P157, DOI 10.1007/s11693-010-9060-5; Sole R. V., 1996, Complexity, V2, P49, DOI 10.1002/(SICI)1099-0526(199611/12)2:2<49::AID-CPLX13>3.0.CO;2-T; Sole RV, 2007, PHILOS T R SOC B, V362, P1727, DOI 10.1098/rstb.2007.2065; Song H, 2009, NAT CHEM BIOL, V5, P929, DOI 10.1038/nchembio.244; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Tan CM, 2007, MOL BIOSYST, V3, P343, DOI 10.1039/b618473c; Tinder RF, 2000, ENG DIGITAL DESIGN; Tononi G, 1999, P NATL ACAD SCI USA, V96, P3257, DOI 10.1073/pnas.96.6.3257; VerBerkmoes NC, 2009, NAT REV MICROBIOL, V7, P196, DOI 10.1038/nrmicro2080; Wang BJ, 2013, BIOSENS BIOELECTRON, V40, P368, DOI 10.1016/j.bios.2012.08.011; Wang BJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1516; Weber W, 2007, P NATL ACAD SCI USA, V104, P10435, DOI 10.1073/pnas.0701382104; Weber W, 2012, NAT REV GENET, V13, P21, DOI 10.1038/nrg3094; Wintermute EH, 2010, GENE DEV, V24, P2603, DOI 10.1101/gad.1985210; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	69	17	17	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e81248	10.1371/journal.pone.0081248	http://dx.doi.org/10.1371/journal.pone.0081248			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586222	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900001
J	Barbosa, RL; Legrand, P; Wien, F; Pineau, B; Thompson, A; Guimaraes, BG				Barbosa, Rosicler L.; Legrand, Pierre; Wien, Frank; Pineau, Blandine; Thompson, Andrew; Guimaraes, Beatriz G.			RRP6 from Trypanosoma brucei : Crystal Structure of the Catalytic Domain, Association with EAP3 and Activity towards Structured and Non-Structured RNA Substrates	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; YEAST EXOSOME CORE; HUMAN PM-SCL; SUBUNIT; EXPRESSION; BINDING; RRP47P	RRP6 is a 3'-5' exoribonuclease associated to the eukaryotic exosome, a multiprotein complex essential for various RNA processing and degradation pathways. In Trypanosoma brucei, RRP6 associates with the exosome in stoichiometric amounts and was localized in both cytoplasm and nucleus, in contrast to yeast Rrp6 which is exclusively nuclear. Here we report the biochemical and structural characterization of T. brucei RRP6 (TbRRP6) and its interaction with the so-called T. brucei Exosome Associated Protein 3 (TbEAP3), a potential orthologue of the yeast Rrp6 interacting protein, Rrp47. Recombinant TbEAP3 is a thermo stable homodimer in solution, however it forms a heterodimeric complex with TbRRP6 with 1: 1 stoichiometry. The crystallographic structure of the TbRRP6 catalytic core exposes for the first time the native catalytic site of this RNase and also reveals a disulfide bond linking two helices of the HRDC domain. RNA degradation assays show the distributive exoribonuclease activity of TbRRP6 and novel findings regarding the structural range of its RNA substrates. TbRRP6 was able to degrade single and double-stranded RNAs and also RNA substrates containing stem-loops including those with 39 stem-loop lacking single-stranded extensions. Finally, association with TbEAP3 did not significantly interfere with the TbRRP6 catalytic activity in vitro.	[Barbosa, Rosicler L.; Legrand, Pierre; Wien, Frank; Pineau, Blandine; Thompson, Andrew; Guimaraes, Beatriz G.] Synchrotron SOLEIL, Gif Sur Yvette, France	SOLEIL Synchrotron	Guimaraes, BG (corresponding author), Synchrotron SOLEIL, Gif Sur Yvette, France.	beatriz.guimaraes@synchrotron-soleil.fr	LEGRAND, Pierre/G-7709-2011; Wien, Frank/B-7846-2012; Guimarães, Beatriz G/D-3858-2014	LEGRAND, Pierre/0000-0003-2431-2255; Wien, Frank/0000-0002-0752-8735; 	Synchrotron Soleil, France; CNPq, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil	Synchrotron Soleil, France; CNPq, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Synchrotron Soleil, France. RLB received a fellowship from CNPq, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Bricogne G., 2009, BUSTER VERSION 2 9 1; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Costello JL, 2011, J BIOL CHEM, V286, P4535, DOI 10.1074/jbc.M110.162826; Cristodero M, 2008, MOL BIOCHEM PARASIT, V159, P24, DOI 10.1016/j.molbiopara.2007.12.012; CUDNY H, 1981, J BIOL CHEM, V256, P5633; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Estevez AM, 2003, J BIOL CHEM, V278, P34943, DOI 10.1074/jbc.M305333200; Estevez AM, 2001, EMBO J, V20, P3831, DOI 10.1093/emboj/20.14.3831; Fadda A, 2013, RNA, V19, P937, DOI 10.1261/rna.038430.113; Feigenbutz M, 2013, J BIOL CHEM, V288, P15959, DOI 10.1074/jbc.M112.445759; Fernandez-Moya SM, 2010, WIRES RNA, V1, P34, DOI 10.1002/wrna.6; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Giuliani A, 2009, J SYNCHROTRON RADIAT, V16, P835, DOI 10.1107/S0909049509034049; Haile S, 2007, MOL BIOCHEM PARASIT, V151, P52, DOI 10.1016/j.molbiopara.2006.10.005; Januszyk K, 2011, RNA, V17, P1566, DOI 10.1261/rna.2763111; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Midtgaard SF, 2006, P NATL ACAD SCI USA, V103, P11898, DOI 10.1073/pnas.0604731103; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Palenchar JB, 2006, MOL BIOCHEM PARASIT, V146, P135, DOI 10.1016/j.molbiopara.2005.12.008; Refregiers M, 2012, J SYNCHROTRON RADIAT, V19, P831, DOI 10.1107/S0909049512030002; Schilders G, 2007, NUCLEIC ACIDS RES, V35, P2564, DOI 10.1093/nar/gkm082; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; Sorrentino S, 2003, BIOCHEMISTRY-US, V42, P10182, DOI 10.1021/bi030040q; Stead JA, 2007, NUCLEIC ACIDS RES, V35, P5556, DOI 10.1093/nar/gkm614; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Van Dijk EL, 2007, RNA, V13, P1027, DOI 10.1261/rna.575107; Wasmuth EV, 2012, MOL CELL, V48, P133, DOI 10.1016/j.molcel.2012.07.012; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wien F, 2005, APPL SPECTROSC, V59, P1109, DOI 10.1366/0003702055012546; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	46	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89138	10.1371/journal.pone.0089138	http://dx.doi.org/10.1371/journal.pone.0089138			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558481	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700127
J	Malone, M; Castillo, RD; Kloos, H; Holden, JG; Richardson, MJ				Malone, MaryLauren; Castillo, Ramon D.; Kloos, Heidi; Holden, John G.; Richardson, Michael J.			Dynamic Structure of Joint-Action Stimulus-Response Activity	PLOS ONE			English	Article							COORDINATION; INTERFERENCE; PERCEPTION	The mere presence of a co-actor can influence an individual's response behavior. For instance, a social Simon effect has been observed when two individuals perform a Go/No-Go response to one of two stimuli in the presence of each other, but not when they perform the same task alone. Such effects are argued to provide evidence that individuals co-represent the task goals and the to-be-performed actions of a co-actor. Motivated by the complex-systems approach, the present study was designed to investigate an alternative hypothesis - that such joint-action effects are due to a dynamical (time-evolving) interpersonal coupling that operates to perturb the behavior of socially situated actors. To investigate this possibility, participants performed a standard Go/No-Go Simon task in joint and individual conditions. The dynamic structure of recorded reaction times was examined using fractal statistics and instantaneous cross-correlation. Consistent with our hypothesis that participants responding in a shared space would become behaviorally coupled, the analyses revealed that reaction times in the joint condition displayed decreased fractal structure (indicative of interpersonal perturbation processes modulating ongoing participant behavior) compared to the individual condition, and were more correlated across a range of time-scales compared to the reaction times of pseudo-pair controls. Collectively, the findings imply that dynamic processes might underlie social stimulus-response compatibility effects and shape joint cognitive processes in general.	[Malone, MaryLauren; Castillo, Ramon D.; Kloos, Heidi; Holden, John G.; Richardson, Michael J.] Univ Cincinnati, Dept Psychol, Ctr Cognit Act & Percept, Cincinnati, OH 45221 USA; [Castillo, Ramon D.] Univ Talca, Talca, Chile	University of Cincinnati; Universidad de Talca	Malone, M (corresponding author), Univ Cincinnati, Dept Psychol, Ctr Cognit Act & Percept, Cincinnati, OH 45221 USA.	malonemo@mail.uc.edu	Castillo, Ramon Daniel/AAK-9828-2021; Castillo, Ramon D./A-3161-2008	Castillo, Ramon Daniel/0000-0002-8505-5179; Holden, John/0000-0001-8644-9500; Richardson, Michael/0000-0001-9159-2774				Aks D.J., 2002, NONLINEAR DYNAMICS P, V6, P1, DOI 10.1023/A:1012222601935; Bae GY, 2009, Q J EXP PSYCHOL, V62, P746, DOI 10.1080/17470210802303883; Barbosa AV, 2012, J ACOUST SOC AM, V131, P2162, DOI 10.1121/1.3682040; Bassingthwaighte J. B., 1994, FRACTAL PHYSL; Blakemore SJ, 2001, NAT REV NEUROSCI, V2, P561, DOI 10.1038/35086023; Brown C., 2010, FRACTAL ANAL; Buetti S, 2008, ACTA PSYCHOL, V129, P420, DOI 10.1016/j.actpsy.2008.09.007; Ivonne B, 2007, J EXP PSYCHOL HUMAN, V33, P1269, DOI 10.1037/0096-1523.33.6.1269; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Chen YQ, 2001, J MOTOR BEHAV, V33, P3, DOI 10.1080/00222890109601897; Cho YS, 2008, Q J EXP PSYCHOL, V61, P1020, DOI 10.1080/17470210701467979; Coey CA, COMPLEXITIE IN PRESS; CRAFT JL, 1970, J EXP PSYCHOL, V83, P415, DOI 10.1037/h0028843; Delignieres D, 2006, J MATH PSYCHOL, V50, P525, DOI 10.1016/j.jmp.2006.07.004; Delignieres Didier, 2004, Nonlinear Dynamics Psychol Life Sci, V8, P479; Delignieres D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007822; Dolk T, 2013, J EXP PSYCHOL HUMAN, V39, P1248, DOI 10.1037/a0031031; Eke A, 2002, PHYSIOL MEAS, V23, pR1, DOI 10.1088/0967-3334/23/1/201; Engel AK, 2013, TRENDS COGN SCI, V17, P202, DOI 10.1016/j.tics.2013.03.006; Figliozzi F, 2010, NEUROPSYCHOLOGIA, V48, P1011, DOI 10.1016/j.neuropsychologia.2009.11.025; Fowler CA, 2008, UNDERST COMPLEX SYST, P261, DOI 10.1007/978-3-540-74479-5_13; GILDEN DL, 1995, SCIENCE, V267, P1837, DOI 10.1126/science.7892611; Gilden DL, 2001, PSYCHOL REV, V108, P33, DOI 10.1037/0033-295X.108.1.33; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448, DOI 10.1152/jappl.1996.80.5.1448; Holden J.G., 2005, TUTORIALS CONT NONLI, P267; Holden JG, 2011, J EXP PSYCHOL HUMAN, V37, P935, DOI 10.1037/a0020991; Jensen H.J., 1998, SELF ORG CRITICALITY; Jung C, 2011, EXP BRAIN RES, V211, P471, DOI 10.1007/s00221-011-2665-4; Kello CT, 2007, J EXP PSYCHOL GEN, V136, P551, DOI 10.1037/0096-3445.136.4.551; Kloos H, 2010, MIND MATTER, V8, P19; Knoblich G, 2006, CURR DIR PSYCHOL SCI, V15, P99, DOI 10.1111/j.0963-7214.2006.00415.x; Mandelbrot B.B, 1982, FRACTAL GEOMETRY NAT; Marsh KL, 2009, TOP COGN SCI, V1, P320, DOI 10.1111/j.1756-8765.2009.01022.x; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Philipp AM, 2010, Q J EXP PSYCHOL, V63, P2159, DOI 10.1080/17470211003802426; Richardson M. J., 2010, MIND CONTEXT, P307; Richardson MJ, 2009, NEUROSCI LETT, V449, P117, DOI 10.1016/j.neulet.2008.10.092; Richardson MJ, 2012, BIO WEB C, V1; Riley MA, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00038; Schmidt RC, 2011, HUM MOVEMENT SCI, V30, P834, DOI 10.1016/j.humov.2010.05.014; Schmidt RC, 2008, UNDERST COMPLEX SYST, P281, DOI 10.1007/978-3-540-74479-5_14; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Sebanz N, 2005, J EXP PSYCHOL HUMAN, V31, P1234, DOI 10.1037/0096-1523.31.6.1234; Sebanz N, 2003, COGNITION, V88, pB11, DOI 10.1016/S0010-0277(03)00043-X; Sebanz N, 2009, TOP COGN SCI, V1, P353, DOI 10.1111/j.1756-8765.2009.01024.x; Tsai CC, 2006, EXP BRAIN RES, V175, P353, DOI 10.1007/s00221-006-0557-9; Van Orden GC, 2003, J EXP PSYCHOL GEN, V132, P331, DOI 10.1037/0096-3445.132.3.331; Van Orden G, 2010, MEDICINA-LITHUANIA, V46, P581, DOI 10.3390/medicina46090083; Vesper C, 2011, EXP BRAIN RES, V211, P517, DOI 10.1007/s00221-011-2706-z; West B.J., 1995, LURE MODERN SCI FRAC; WING AM, 1973, PERCEPT PSYCHOPHYS, V14, P5, DOI 10.3758/BF03198607	51	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89032	10.1371/journal.pone.0089032	http://dx.doi.org/10.1371/journal.pone.0089032			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3RA	24558467	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700113
J	Prendergast, AJ; Rukobo, S; Chasekwa, B; Mutasa, K; Ntozini, R; Mbuya, MNN; Jones, A; Moulton, LH; Stoltzfus, RJ; Humphrey, JH				Prendergast, Andrew J.; Rukobo, Sandra; Chasekwa, Bernard; Mutasa, Kuda; Ntozini, Robert; Mbuya, Mduduzi N. N.; Jones, Andrew; Moulton, Lawrence H.; Stoltzfus, Rebecca J.; Humphrey, Jean H.			Stunting Is Characterized by Chronic Inflammation in Zimbabwean Infants	PLOS ONE			English	Article							GROWTH-FACTOR-I; CHILD UNDERNUTRITION; INTESTINAL PERMEABILITY; DIARRHEA; DISEASE; MALNUTRITION; ENTEROPATHY; IMPAIRMENT; PREVALENCE; MECHANISMS	Background: Stunting affects one-third of children in developing countries, but the causes remain unclear. We hypothesized that enteropathy leads to low-grade inflammation, which suppresses the growth hormone-IGF axis and mediates stunting. Methods: We conducted a case-control study of 202 HIV-unexposed Zimbabwean infants who were stunted (height-for-age Z-score (HAZ), <-2; cases) or non-stunted (HAZ >-0.5; controls) at 18 months. We measured biomarkers of intestinal damage (I-FABP), inflammation (CRP, AGP, IL-6) and growth hormone-IGF axis (IGF-1, IGFBP3) in infant plasma at 6 weeks and 3, 6, 12 and 18 months, and in paired maternal-infant plasma at birth. Adjusted mean differences between biomarkers were estimated using regression models. Multivariate odds ratios of stunting were estimated by logistic regression. Results: At birth, cases were shorter (median (IQR) HAZ -1.00 (-1.53, -0.08) vs 0.03 (-0.57, 0.62,); P<0.001) than controls and their mothers had lower levels of IGF-1 (adjusted mean difference (95% CI) -21.4 (-39.8, -3.1) ng/mL). From 6 weeks to 12 months of age, levels of CRP and AGP were consistently higher and IGF-1 and IGFBP3 lower in cases versus controls; IGF-1 correlated inversely with inflammatory markers at all time-points. I-FABP increased between 3-12 months, indicating extensive intestinal damage during infancy, which was similar in cases and controls. In multivariate analysis, higher log(10) levels of CRP (aOR 3.06 (95% CI 1.34, 6.99); P = 0.008) and AGP (aOR 7.87 (95% CI 0.74, 83.74); P = 0.087) during infancy were associated with stunting. There were no associations between levels of I-FABP, IL-6, sCD14 or EndoCAb and stunting. Conclusions: Stunting began in utero and was associated with low maternal IGF-1 levels at birth. Inflammatory markers were higher in cases than controls from 6 weeks of age and were associated with lower levels of IGF-1 throughout infancy. Higher levels of CRP and AGP during infancy were associated with stunting. These findings suggest that an extensive enteropathy occurs during infancy and that low-grade chronic inflammation may impair infant growth.	[Prendergast, Andrew J.] Queen Mary Univ London, Blizard Inst, Ctr Paediat, London, England; [Prendergast, Andrew J.; Rukobo, Sandra; Chasekwa, Bernard; Mutasa, Kuda; Ntozini, Robert; Mbuya, Mduduzi N. N.; Humphrey, Jean H.] Zvitambo Inst Maternal Child Hlth Res, Harare, Zimbabwe; [Prendergast, Andrew J.; Mbuya, Mduduzi N. N.; Moulton, Lawrence H.; Humphrey, Jean H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Jones, Andrew] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Stoltzfus, Rebecca J.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	University of London; Queen Mary University London; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Michigan System; University of Michigan; Cornell University	Prendergast, AJ (corresponding author), Queen Mary Univ London, Blizard Inst, Ctr Paediat, London, England.	a.prendergast@qmul.ac.uk	Ntozini, Robert/AFU-4878-2022; Mbuya, Mduduzi/AAJ-2833-2021	Ntozini, Robert/0000-0002-8543-2835; Moulton, Lawrence/0000-0001-7041-7387; Chasekwa, Bernard/0000-0001-8080-7573; Prendergast, Andrew/0000-0001-7904-7992	Wellcome Trust [093768/Z/10/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (wellcome.ac.uk), grant number 093768/Z/10/Z to AJP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baalwa J, 2010, AFR HEALTH SCI, V10, P367; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; BRIEND A, 1990, EUR J CLIN NUTR, V44, P611; BRIEND A, 1989, LANCET, V2, P319; Campbell DI, 2003, J NUTR, V133, P1332; DeBenedetti F, 1997, J CLIN INVEST, V99, P643, DOI 10.1172/JCI119207; Derikx JPM, 2010, CRIT CARE MED, V38, P133, DOI 10.1097/CCM.0b013e3181b4a5ed; Derikx JPM, 2009, J CLIN GASTROENTEROL, V43, P727, DOI 10.1097/MCG.0b013e31819194b0; DESAI H G, 1969, Indian Journal of Medical Sciences, V23, P1; Dewey K. G., 2008, SYSTEMATIC REV EFFIC; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; GAULDIE J, 1987, P NATL ACAD SCI USA, V84, P7251, DOI 10.1073/pnas.84.20.7251; Gibson RS, 1990, Q REV BIOL; Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8; Humphrey JH, 2006, J INFECT DIS, V193, P960; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; Jensen RB, 2005, HORM RES, V63, P15, DOI 10.1159/000082456; Keusch GT, 2013, FOOD NUTR BULL, V34, P357, DOI 10.1177/156482651303400308; Kitchens RL, 2005, J ENDOTOXIN RES, V11, P225, DOI 10.1179/096805105X46565; Kosek M, 2013, AM J TROP MED HYG, V88, P390, DOI 10.4269/ajtmh.2012.12-0549; Lieberman JM, 1997, SURGERY, V121, P335, DOI 10.1016/S0039-6060(97)90363-9; Lin A, 2013, AM J TROP MED HYG, V89, P130, DOI 10.4269/ajtmh.12-0629; Liu JR, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-129; LUNN PG, 1991, LANCET, V338, P907, DOI 10.1016/0140-6736(91)91772-M; Menzies IS, 1999, GUT, V44, P483, DOI 10.1136/gut.44.4.483; MOY RJD, 1994, EUR J CLIN NUTR, V48, P810; Newson R, 2002, STATA J, V2, P45, DOI 10.1177/1536867X0200200103; Peterson KM, 2013, AM J CLIN NUTR, V97, P1129, DOI 10.3945/ajcn.112.048306; Poskitt EME, 1999, ARCH DIS CHILD, V80, P115, DOI 10.1136/adc.80.2.115; Prendergast A, 2012, AM J TROP MED HYG, V86, P756, DOI 10.4269/ajtmh.2012.11-0743; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; SCHENK EA, 1968, AM J CLIN NUTR, V21, P944, DOI 10.1093/ajcn/21.9.944; Semple S, 2010, ENVIRON HEALTH PERSP, V118, P988, DOI 10.1289/ehp.0901605; Shayo GA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-365; SOLOMONS NW, 1993, NUTR REV, V51, P327, DOI 10.1111/j.1753-4887.1993.tb03758.x; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Vreugdenhil AC, 2011, SCAND J GASTROENTERO, V46, P1435, DOI 10.3109/00365521.2011.627447; Walters TD, 2009, NAT REV GASTRO HEPAT, V6, P513, DOI 10.1038/nrgastro.2009.124; Yuksel B, 2011, J CLIN RES PEDIATR E, V3, P84, DOI 10.4274/jcrpe.v3i2.17	40	160	161	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e86928	10.1371/journal.pone.0086928	http://dx.doi.org/10.1371/journal.pone.0086928			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558364	Green Published, gold			2022-12-27	WOS:000331706700010
J	Su, Q; Xie, W; Wang, SL; Wu, QJ; Liu, BM; Fang, Y; Xu, BY; Zhang, YJ				Su, Qi; Xie, Wen; Wang, Shaoli; Wu, Qingjun; Liu, Baiming; Fang, Yong; Xu, Baoyun; Zhang, Youjun			The Endosymbiont Hamiltonella Increases the Growth Rate of Its Host Bemisia tabaci during Periods of Nutritional Stress	PLOS ONE			English	Article							CANDIDATUS PORTIERA ALEYRODIDARUM; SECONDARY SYMBIONTS; ACYRTHOSIPHON-PISUM; OBLIGATE SYMBIONT; GENOME SEQUENCE; METABOLIC INTERDEPENDENCE; BACTERIAL ENDOSYMBIONTS; HORIZONTAL TRANSFER; PEA APHID; BENEFITS	The whitefly Bemisia tabaci (Gennadius) (Hemiptera: Aleyrodidae) harbors several bacterial symbionts. Among the secondary (facultative) symbionts, Hamiltonella has high prevalence and high infection frequencies, suggesting that it may be important for the biology and ecology of its hosts. Previous reports indicated that Hamiltonella increases whitefly fitness and, based on the complete sequencing of its genome, may have the ability to synthesize cofactors and amino acids that are required by its host but that are not sufficiently synthesized by the host or by the primary endosymbiont, Portiera. Here, we assessed the effects of Hamiltonella infection on the growth of B. tabaci reared on low-, standard-, or high-nitrogen diets. When B. tabaci was reared on a standard-nitrogen diet, no cost or benefit was associated with Hamiltonella infection. But, if we reared whiteflies on low-nitrogen diets, Hamiltonella-infected whiteflies often grew better than uninfected whiteflies. Furthermore, nitrogen levels in field-collected whiteflies indicated that the nutritional conditions in the field were comparable to the low-nitrogen diet in our laboratory experiment. These data suggest that Hamiltonella may play a previously unrecognized role as a nutritional mutualist in B. tabaci.	[Su, Qi] Hunan Agr Univ, Coll Plant Protect, Changsha, Hunan, Peoples R China; [Su, Qi; Xie, Wen; Wang, Shaoli; Wu, Qingjun; Liu, Baiming; Fang, Yong; Xu, Baoyun; Zhang, Youjun] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Dept Plant Protect, Beijing 100193, Peoples R China	Hunan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS	Zhang, YJ (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Dept Plant Protect, Beijing 100193, Peoples R China.	zhangyoujun@caas.cn	Zhang, Youjun/AAY-7948-2020	Zhang, Youjun/0000-0003-3508-6695	National Science Fund for Distinguished Young Scholars [31025020]; 973 Program [2013CB127602]; National Natural Science Foundation of China [31171857]; Beijing Natural Science Foundation [6131002]; Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables	This research was supported by the National Science Fund for Distinguished Young Scholars (31025020), the 973 Program (2013CB127602), the National Natural Science Foundation of China (31171857), the Beijing Natural Science Foundation (6131002), and the Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akman L, 2002, NAT GENET, V32, P402, DOI 10.1038/ng986; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Baumann P, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 1, THIRD EDITION, P403, DOI 10.1007/0-387-30741-9_16; Ben-Yosef M, 2008, J APPL ENTOMOL, V132, P690, DOI 10.1111/j.1439-0418.2008.01330.x; Bourtzis K, 2003, INSECT SYMBIOSIS, V1; Brummel T, 2004, P NATL ACAD SCI USA, V101, P12974, DOI 10.1073/pnas.0405207101; Buchanan B.B., 2000, BIOCH MOL BIOL PLANT; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; BYRNE DN, 1990, J INSECT PHYSIOL, V36, P433, DOI 10.1016/0022-1910(90)90061-J; Chu D, 2011, B ENTOMOL RES, V101, P477, DOI 10.1017/S0007485311000083; Chu D, 2010, ENVIRON ENTOMOL, V39, P1028, DOI 10.1603/EN09161; Darby AC, 2001, FEMS MICROBIOL ECOL, V36, P43, DOI 10.1111/j.1574-6941.2001.tb00824.x; Dasch GA, 1984, BERGEYS MANUAL SYSTE, V1, P811; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Feldhaar H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-48; Goodacre SL, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-32; Gosalbes MJ, 2008, J BACTERIOL, V190, P6026, DOI 10.1128/JB.00525-08; Gottlieb Y, 2008, FASEB J, V22, P2591, DOI 10.1096/fj.07-101162; Gottlieb Y, 2010, J VIROL, V84, P9310, DOI 10.1128/JVI.00423-10; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Hosokawa T, 2007, P ROY SOC B-BIOL SCI, V274, P1979, DOI 10.1098/rspb.2007.0620; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Jancovich JK, 1997, J ECON ENTOMOL, V90, P628, DOI 10.1093/jee/90.2.628; Jiang ZF, 2012, J BACTERIOL, V194, P6678, DOI 10.1128/JB.01841-12; Koga R, 2003, P ROY SOC B-BIOL SCI, V270, P2543, DOI 10.1098/rspb.2003.2537; Kontsedalov S, 2008, PEST MANAG SCI, V64, P789, DOI 10.1002/ps.1595; Liu SS, 2012, J INTEGR AGR, V11, P176, DOI 10.1016/S2095-3119(12)60002-1; Lopez-Sanchez MJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000721; Lukasik P, 2013, ECOL LETT, V16, P214, DOI 10.1111/ele.12031; McCutcheon JP, 2007, P NATL ACAD SCI USA, V104, P19392, DOI 10.1073/pnas.0708855104; Montllor C.B., 1991, P125; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; NOGGE G, 1981, PARASITOLOGY, V82, P101; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Pan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030760; Rao Q, 2012, J BACTERIOL, V194, P3558, DOI 10.1128/JB.00069-12; Ridley EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036765; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; Russell JA, 2003, MOL ECOL, V12, P1061, DOI 10.1046/j.1365-294X.2003.01780.x; Sabree ZL, 2009, P NATL ACAD SCI USA, V106, P19521, DOI 10.1073/pnas.0907504106; Sakurai M, 2005, APPL ENVIRON MICROB, V71, P4069, DOI 10.1128/AEM.71.7.4069-4075.2005; Sandstrom JP, 2001, MOL ECOL, V10, P217, DOI 10.1046/j.1365-294X.2001.01189.x; Santos-Garcia D, 2012, J BACTERIOL, V194, P6654, DOI 10.1128/JB.01793-12; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Skaljac M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-142; Sloan DB, 2012, BIOL LETTERS, V8, P986, DOI 10.1098/rsbl.2012.0664; Su Q, 2013, ENVIRON ENTOMOL, V42, P1265, DOI 10.1603/EN13182; Su Q, 2013, SCI REP-UK, V3, DOI 10.1038/srep01367; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; Tsuchida T, 2010, SCIENCE, V330, P1102, DOI 10.1126/science.1195463; Vorburger C, 2010, BIOL LETTERS, V6, P109, DOI 10.1098/rsbl.2009.0642; Wernegreen JJ, 2012, CURR OPIN MICROBIOL, V15, P255, DOI 10.1016/j.mib.2012.02.001; White JA, 2009, HEREDITY, V102, P483, DOI 10.1038/hdy.2009.5; Wilson ACC, 2010, INSECT MOL BIOL, V19, P249, DOI 10.1111/j.1365-2583.2009.00942.x; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188; Xie JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012149; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004; [No title captured]	60	41	44	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89002	10.1371/journal.pone.0089002	http://dx.doi.org/10.1371/journal.pone.0089002			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558462	gold, Green Published, Green Submitted			2022-12-27	WOS:000331706700108
J	Yang, WT; Zheng, PS				Yang, Wen-Ting; Zheng, Peng-Sheng			Promoter Hypermethylation of KLF4 Inactivates Its Tumor Suppressor Function in Cervical Carcinogenesis	PLOS ONE			English	Article							DOWN-REGULATION; EPIGENETIC INACTIVATION; DNA-METHYLATION; CANCER; GENE; EXPRESSION; KRUPPEL-LIKE-FACTOR-4; TRANSFORMATION; GROWTH; TRANSCRIPTION	Objective: The KLF4 gene has been shown to be inactivated in cervical carcinogenesis as a tumor suppressor. However, the mechanism of KLF4 silencing in cervical carcinomas has not yet been identified. DNA methylation plays a key role in stable suppression of gene expression. Methods: The methylation status of the KLF4 promoter CpG islands was analyzed by bisulfite sequencing (BSQ) in tissues of normal cervix and cervical cancer. KLF4 gene expression was detected by RT-PCR, immunohistochemistry and western blot. KLF4 promoter methylation in cervical cancer cell line was determined by BSQ and methylation-specific polymerase chain reaction (MS-PCR). Cell proliferation ability was detected by cell growth curve and MTT assay. Results: The methylated allele was found in 41.90% of 24 cervical cancer tissues but only in 11.11% of 11 normal cervix tissues (P<0.005). KLF4 mRNA levels were significantly reduced in cervical cancer tissues compared with normal cervix tissues (P<0.01) and KLF4 mRNA expression showed a significant negative correlation with the promoter hypermethylation (r = -0.486, P = 0.003). Cervical cancer cell lines also showed a significant negative correlation between KLF4 expression and hypermethylation. After treatment with the demethylating agent 5-Azacytidine (5-Aza), the expression of KLF4 in the cervical cancer cell lines at both mRNA and protein levels was drastically increased, the cell proliferation ability was inhibited and the chemosensitivity for cisplatin was significantly increased. Conclusion: KLF4 gene is inactivated by methylation-induced silencing mechanisms in a large subset of cervical carcinomas and KLF4 promoter hypermethylation inactivates the gene's function as a tumor suppressor in cervical carcinogenesis.	[Yang, Wen-Ting; Zheng, Peng-Sheng] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Reprod Med, Xian 710049, Peoples R China; [Yang, Wen-Ting; Zheng, Peng-Sheng] Xi An Jiao Tong Univ, Sch Med, Dept Biochem & Mol Biol, Xian 710049, Peoples R China; [Zheng, Peng-Sheng] Minist Educ Peoples Republ China, Key Lab Environm & Genes Related Dis, Sect Canc Stem Cell Res, Xian, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Ministry of Education, China	Zheng, PS (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Reprod Med, Xian 710049, Peoples R China.	zpsheng@mail.xjtu.edu.cn			special scientific Distinguished Young Scientists Fund [30725043]; National Natural Science Foundation of China; Young grant from the National Natural Science Foundation [81302278];  [30571951]	special scientific Distinguished Young Scientists Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young grant from the National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); 	This work was supported by a general grant (No. 30571951) and a special scientific Distinguished Young Scientists Fund grant (No. 30725043) to Prof. Peng-Sheng Zheng from the National Natural Science Foundation of China and a Young grant (No. 81302278) from the National Natural Science Foundation to Wen-ting Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abudukadeer A, 2012, INT J MOL SCI, V13, P8353, DOI 10.3390/ijms13078353; Bajaj J, 2011, CANCER RES, V71, P4888, DOI 10.1158/0008-5472.CAN-11-0543; Bhattacharjee B, 2006, VIROLOGY, V354, P280, DOI 10.1016/j.virol.2006.06.018; Chen CL, 2003, EUR J CANCER, V39, P517, DOI 10.1016/S0959-8049(02)00175-2; Cho YG, 2007, APMIS, V115, P802, DOI 10.1111/j.1600-0463.2007.apm_643.x; Clarke MA, 2012, CANC EPIDEMIOL BIOMA; Coronel J, 2011, MED ONCOL, V28, pS540, DOI 10.1007/s12032-010-9700-3; Eiben GL, 2003, VIRAL IMMUNOL, V16, P111, DOI 10.1089/088282403322017866; Ghaleb AM, 2007, CANCER RES, V67, P7147, DOI 10.1158/0008-5472.CAN-07-1302; Huang LW, 2002, GYNECOL ONCOL, V85, P524, DOI 10.1006/gyno.2002.6666; Jeong DH, 2006, INT J GYNECOL CANCER, V16, P1234, DOI 10.1111/j.1525-1438.2006.00522.x; Jha AK, 2012, ONCOL LETT, V3, P1331, DOI 10.3892/ol.2012.655; Kang WS, 2012, J CANC RES CLIN ONCO; Lambertini C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010369; Liu ZL, 2009, CANCER BIOL THER, V8, P1840, DOI 10.4161/cbt.8.19.9440; Maliekal TT, 2008, ONCOGENE, V27, P5110, DOI 10.1038/onc.2008.224; Masuda K, 2012, ONCOL REP, V28, P1146, DOI 10.3892/or.2012.1912; Mazumder D, 2011, GYNECOL ONCOL, V123, P597, DOI 10.1016/j.ygyno.2011.08.004; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nakahara Y, 2010, NEOPLASIA, V12, P20, DOI 10.1593/neo.91122; Ohnishi S, 2003, BIOCHEM BIOPH RES CO, V308, P251, DOI 10.1016/S0006-291X(03)01356-1; Ramachandran I, 2012, ONCOGENE, V31, P2725, DOI 10.1038/onc.2011.455; Snijders PJF, 2006, J PATHOL, V208, P152, DOI 10.1002/path.1866; Song LL, 2008, ONCOGENE, V27, P5833, DOI 10.1038/onc.2008.190; Tai SK, 2011, CANC SCI; Uren A, 2005, CANCER RES, V65, P6199, DOI 10.1158/0008-5472.CAN-05-0455; Van de Putte G, 2003, GYNECOL ONCOL, V89, P140, DOI 10.1016/S0090-8258(03)00010-6; Wei DY, 2008, CANCER RES, V68, P4631, DOI 10.1158/0008-5472.CAN-07-5953; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Wei DY, 2005, CANCER RES, V65, P2746, DOI 10.1158/0008-5472.CAN-04-3619; Xu J, 2008, J CANCER RES CLIN, V134, P891, DOI 10.1007/s00432-008-0353-y; Yang WT, 2012, CANCER-AM CANCER SOC, V118, P3691, DOI 10.1002/cncr.26698; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Yue W, 2013, AUTOPHAGY, V9, P714, DOI 10.4161/auto.23997; Zammarchi F, 2011, AM J PATHOL, V178, P361, DOI 10.1016/j.ajpath.2010.11.021; Zhang G, 2009, BIOL CHEM, V390, P463, DOI 10.1515/BC.2009.060; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067; Zheng H, 2009, AM J PHYSIOL-GASTR L, V296, pG490, DOI 10.1152/ajpgi.90393.2008; Zhou YB, 2010, CANCER BIOL THER, V9, P507, DOI 10.4161/cbt.9.7.11106; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	40	40	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88827	10.1371/journal.pone.0088827	http://dx.doi.org/10.1371/journal.pone.0088827			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551169	gold, Green Published, Green Submitted			2022-12-27	WOS:000331271500070
J	Bush, AA; Nipperess, DA; Duursma, DE; Theischinger, G; Turak, E; Hughes, L				Bush, Alex A.; Nipperess, David A.; Duursma, Daisy E.; Theischinger, Gunther; Turak, Eren; Hughes, Lesley			Continental-Scale Assessment of Risk to the Australian Odonata from Climate Change	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; FRESH-WATER BIODIVERSITY; MULTIPLE STRESSORS; FOOD-WEB; DISTRIBUTIONS; RANGE; VULNERABILITY; CONSERVATION; RIVER; PREDICTION	Climate change is expected to have substantial impacts on the composition of freshwater communities, and many species are threatened by the loss of climatically suitable habitat. In this study we identify Australian Odonata (dragonflies and damselflies) vulnerable to the effects of climate change on the basis of exposure, sensitivity and pressure to disperse in the future. We used an ensemble of species distribution models to predict the distribution of 270 (85%) species of Australian Odonata, continent-wide at the subcatchment scale, and for both current and future climates using two emissions scenarios each for 2055 and 2085. Exposure was scored according to the departure of temperature, precipitation and hydrology from current conditions. Sensitivity accounted for change in the area and suitability of projected climatic habitat, and pressure to disperse combined measurements of average habitat shifts and the loss experienced with lower dispersal rates. Streams and rivers important to future conservation efforts were identified based on the sensitivity-weighted sum of habitat suitability for the most vulnerable species. The overall extent of suitable habitat declined for 56-69% of the species modelled by 2085 depending on emissions scenario. The proportion of species at risk across all components (exposure, sensitivity, pressure to disperse) varied between 7 and 17% from 2055 to 2085 and a further 3-17% of species were also projected to be at high risk due to declines that did not require range shifts. If dispersal to Tasmania was limited, many south-eastern species are at significantly increased risk. Conservation efforts will need to focus on creating and preserving freshwater refugia as part of a broader conservation strategy that improves connectivity and promotes adaptive range shifts. The significant predicted shifts in suitable habitat could potentially exceed the dispersal capacity of Odonata and highlights the challenge faced by other freshwater species.	[Bush, Alex A.; Nipperess, David A.; Duursma, Daisy E.; Hughes, Lesley] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Theischinger, Gunther; Turak, Eren] Off Environm & Heritage, Sydney, NSW, Australia	Macquarie University; Office of Environment & Heritage - New South Wales	Bush, AA (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.		Nipperess, David/H-2707-2019	Hughes, Lesley/0000-0003-0313-9780; Bush, Alex/0000-0002-0679-6666; Turak, Eren/0000-0001-7383-9112	Macquarie University	Macquarie University	Research was part of Alex Bush's PhD, funded by Macquarie University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell R, 2007, BIOL CONSERV, V134, P48, DOI 10.1016/j.biocon.2006.08.017; Acevedo P, 2012, J BIOGEOGR, V39, P1383, DOI 10.1111/j.1365-2699.2012.02713.x; Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Alexander LV, 2009, INT J CLIMATOL, V29, P417, DOI 10.1002/joc.1730; Angert AL, 2011, ECOL LETT, V14, P677, DOI 10.1111/j.1461-0248.2011.01620.x; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Arribas P, 2012, GLOBAL CHANGE BIOL, V18, P2135, DOI 10.1111/j.1365-2486.2012.02691.x; ARTHINGTON AH, 1982, AUST J MAR FRESH RES, V33, P77; Balint M, 2011, NAT CLIM CHANGE, V1, P313, DOI 10.1038/NCLIMATE1191; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Barmuta L, 2013, JOINING DOTS HYDROLO; Bateman BL, 2013, DIVERS DISTRIB, V19, P1224, DOI 10.1111/ddi.12107; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Beaumont LJ, 2011, P NATL ACAD SCI USA, V108, P2306, DOI 10.1073/pnas.1007217108; Bond N, 2011, MAR FRESHWATER RES, V62, P1043, DOI 10.1071/MF10286; Brook BW, 2009, BIOL LETTERS, V5, P723, DOI 10.1098/rsbl.2009.0480; Buisson L, 2013, GLOBAL CHANGE BIOL, V19, P387, DOI 10.1111/gcb.12056; Bush A, 2013, DIVERS DISTRIB, V19, P86, DOI 10.1111/ddi.12007; Bush A, 2012, FRESHWATER BIOL, V57, P1689, DOI 10.1111/j.1365-2427.2012.02835.x; Cao Y, 2013, ECOL MODEL, V259, P30, DOI 10.1016/j.ecolmodel.2013.03.012; Cardoso P, 2011, BIOL CONSERV, V144, P2647, DOI 10.1016/j.biocon.2011.07.024; Chessman BC, 2009, GLOBAL CHANGE BIOL, V15, P2791, DOI 10.1111/j.1365-2486.2008.01840.x; Chester ET, 2011, FRESHWATER BIOL, V56, P2094, DOI 10.1111/j.1365-2427.2011.02644.x; Chiew FHS, 2002, HYDROL PROCESS, V16, P1235, DOI 10.1002/hyp.1059; Comte L, 2013, FRESHWATER BIOL, V58, P625, DOI 10.1111/fwb.12081; Conrad KF, 1999, ECOGRAPHY, V22, P524, DOI 10.1111/j.1600-0587.1999.tb00541.x; Cordellier M, 2009, MOL ECOL, V18, P534, DOI 10.1111/j.1365-294X.2008.04042.x; Crossman ND, 2012, DIVERS DISTRIB, V18, P60, DOI 10.1111/j.1472-4642.2011.00851.x; Darwall WRT, 2011, CONSERV LETT, V4, P474, DOI 10.1111/j.1755-263X.2011.00202.x; Davis J, 2013, GLOBAL CHANGE BIOL, V19, P1970, DOI 10.1111/gcb.12203; Doll P, 2010, HYDROL EARTH SYST SC, V14, P783, DOI 10.5194/hess-14-783-2010; Domisch S, 2013, ECOL MODEL, V257, P1, DOI 10.1016/j.ecolmodel.2013.02.019; Domisch S, 2013, GLOBAL CHANGE BIOL, V19, P752, DOI 10.1111/gcb.12107; Donohue RJ, 2012, J HYDROL, V436, P35, DOI 10.1016/j.jhydrol.2012.02.033; Durance I, 2007, GLOBAL CHANGE BIOL, V13, P942, DOI 10.1111/j.1365-2486.2007.01340.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Flenner I, 2008, INSECT CONSERV DIVER, V1, P169, DOI 10.1111/j.1752-4598.2008.00020.x; Flenner I, 2010, FRESHWATER BIOL, V55, P397, DOI 10.1111/j.1365-2427.2009.02289.x; Floury M, 2013, GLOBAL CHANGE BIOL, V19, P1085, DOI 10.1111/gcb.12124; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Fordham DA, 2011, ECOL APPL, V21, P3317, DOI 10.1890/11-0314.1; Fordham DA, 2012, ECOGRAPHY, V35, P4, DOI 10.1111/j.1600-0587.2011.07398.x; Gallant JC, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001426; Garnett S., 2013, CLIMATE CHANGE ADAPT; GEOFABRIC, 2011, AUSTR HYDR GEOSP FAB; Gillingham PK, 2012, DIVERS DISTRIB, V18, P990, DOI 10.1111/j.1472-4642.2012.00933.x; Grewe Y, 2013, GLOBAL ECOL BIOGEOGR, V22, P403, DOI 10.1111/geb.12004; Hagger V, 2013, AUSTRAL ECOL, V38, P465, DOI 10.1111/j.1442-9993.2012.02437.x; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hassall C, 2007, GLOBAL CHANGE BIOL, V13, P933, DOI 10.1111/j.1365-2486.2007.01318.x; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Heino J, 2011, FRESHWATER BIOL, V56, P1703, DOI 10.1111/j.1365-2427.2011.02610.x; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hickling R, 2005, GLOBAL CHANGE BIOL, V11, P502, DOI 10.1111/j.1365-2486.2005.00904.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hobday AJ, 2011, MAR FRESHWATER RES, V62, P1000, DOI 10.1071/MF10302; Hughes JM, 2013, FRESHWATER BIOL, V58, P951, DOI 10.1111/fwb.12099; Jaeschke A, 2013, INSECT CONSERV DIVER, V6, P93, DOI 10.1111/j.1752-4598.2012.00194.x; James C., 2013, IDENTIFYING CLIMATE; Kalkman VJ, 2012, HYDROBIOLOGIA, V693, P55, DOI 10.1007/s10750-012-1086-0; Keller D, 2010, BIOL CONSERV, V143, P2658, DOI 10.1016/j.biocon.2010.07.008; Kennard MJ, 2010, IDENTIFYING HIGH CON; Klamt M, 2011, GLOBAL CHANGE BIOL, V17, P3011, DOI 10.1111/j.1365-2486.2011.02472.x; Lake PS, 2003, FRESHWATER BIOL, V48, P1161, DOI 10.1046/j.1365-2427.2003.01086.x; Langhammer PF, 2007, IDENTIFICATION GAP A, P29; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lorenz AW, 2013, HYDROBIOLOGIA, V704, P489, DOI 10.1007/s10750-012-1326-3; Lough JM, 2011, MAR FRESHWATER RES, V62, P984, DOI 10.1071/MF10272; Maloney KO, 2011, FRESHWATER BIOL, V56, P611, DOI 10.1111/j.1365-2427.2010.02522.x; McPeek MA, 1998, ECOL MONOGR, V68, P1, DOI 10.1890/0012-9615(1998)068[0001:TCOCTT]2.0.CO;2; Meier ES, 2012, GLOBAL ECOL BIOGEOGR, V21, P164, DOI 10.1111/j.1466-8238.2011.00669.x; Morimoto M, 2010, ODONATOLOGICA, V39, P333; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Nelson KC, 2009, J APPL ECOL, V46, DOI 10.1111/j.1365-2664.2008.01599.x; Nicola GG, 2010, AQUAT SCI, V72, P419, DOI 10.1007/s00027-010-0145-8; Ormerod SJ, 2010, FRESHWATER BIOL, V55, P1, DOI 10.1111/j.1365-2427.2009.02395.x; Ott J, 2010, BIORISK, V5; Pace G, 2013, FRESHWATER BIOL, V58, P1313, DOI 10.1111/fwb.12129; Palmer TN, 2002, NATURE, V415, P512, DOI 10.1038/415512a; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pellissier L, 2013, J BIOGEOGR, V40, P1939, DOI 10.1111/jbi.12140; Perkins SE, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053361; Peters GP, 2013, NAT CLIM CHANGE, V3, P4, DOI 10.1038/nclimate1783; PINDER AM, 2010, RECORDS W AUSTR MUSE, V78, P205, DOI DOI 10.18195/ISSN.0313-122X.78(1).2010.205-246; Pineda E, 2012, GLOBAL ECOL BIOGEOGR, V21, P935, DOI 10.1111/j.1466-8238.2011.00741.x; R Core Team, 2016, R FDN STAT COMP; Radic V, 2014, CLIM DYNAM, V42, P37, DOI 10.1007/s00382-013-1719-7; Reside A. E., 2013, CLIMATE CHANGE REFUG; Reside AE, 2012, ECOL EVOL, V2, P705, DOI 10.1002/ece3.197; Ricciardi A, 1999, CONSERV BIOL, V13, P1220, DOI 10.1046/j.1523-1739.1999.98380.x; Rogelj J, 2012, NAT CLIM CHANGE, V2, P248, DOI [10.1038/NCLIMATE1385, 10.1038/nclimate1385]; Rohr JR, 2013, CONSERV BIOL, V27, P741, DOI 10.1111/cobi.12086; Rosset V, 2011, BIOL CONSERV, V144, P2311, DOI 10.1016/j.biocon.2011.06.009; Sawyer SC, 2011, J APPL ECOL, V48, P668, DOI 10.1111/j.1365-2664.2011.01970.x; Shoo LP, 2013, CLIMATIC CHANGE, V119, P239, DOI 10.1007/s10584-013-0699-2; Simaika JP, 2013, BIOL CONSERV, V157, P245, DOI 10.1016/j.biocon.2012.08.039; Simaika JP, 2009, BIODIVERS CONSERV, V18, P1171, DOI 10.1007/s10531-008-9484-3; Sinclair SJ, 2010, ECOL SOC, V15, DOI 10.5751/ES-03089-150108; Smith AB, 2013, DIVERS DISTRIB, V19, P867, DOI 10.1111/ddi.12031; Stein JL, 2002, LANDSCAPE URBAN PLAN, V60, P1, DOI 10.1016/S0169-2046(02)00048-8; Storlie CJ, 2013, DIVERS DISTRIB, V19, P1106, DOI 10.1111/ddi.12068; Suhling I, 2013, FRESHWATER BIOL, V58, P705, DOI 10.1111/fwb.12074; Taubmann J, 2011, CONSERV GENET, V12, P503, DOI 10.1007/s10592-010-0157-x; Theischinger G., 2009, IDENTIFICATION GUIDE; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; VanDerWal J, 2012, CLIMATES METHODS WOR; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Warfe DM, 2006, OECOLOGIA, V150, P141, DOI 10.1007/s00442-006-0505-1; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Wikelski M, 2006, BIOL LETTERS, V2, P325, DOI 10.1098/rsbl.2006.0487; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Winn KO, 2006, J COASTAL RES, V22, P137, DOI 10.2112/05A-0011.1; Winterbourn MJ, 2011, NEW ZEAL J ZOOL, V38, P173, DOI 10.1080/03014223.2010.548561; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Woodward G, 2010, PHILOS T R SOC B, V365, P2093, DOI 10.1098/rstb.2010.0055	122	34	38	5	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88958	10.1371/journal.pone.0088958	http://dx.doi.org/10.1371/journal.pone.0088958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551197	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000331266000086
J	Bui, THH; Lee, SY				Thi Hong Hanh Bui; Lee, Shing Yip			Does "You Are What You Eat' Apply to Mangrove Grapsid Crabs?	PLOS ONE			English	Article							NITROGEN-STABLE-ISOTOPES; ORGANIC-MATTER; LEAF-LITTER; FATTY-ACIDS; FOOD-WEB; DISCRIMINATION FACTORS; PRIMARY PRODUCERS; CARBON ISOTOPES; SESARMA-MESSA; SALT-MARSH	In tropical mangroves, brachyuran crabs have been observed to consume high percentages of leaf litter production. However, questions concerning their ability to assimilate this low-quality food remain, as stable isotope analysis of C and N does not seem to support assimilation. Individuals of the common eastern Australian mangrove grapsid Parasesarma erythodactyla feeding on a mangrove leaf litter or mangrove+microphytobenthos diet developed a significantly higher hepatosomatic index than those with access to only sediment. Lipid biomarker analysis and feeding experiments using C-13 and N-15-enriched mangrove leaf litter confirmed rapid assimilation of mangrove C and N by P. erythodactyla. Eight-week feeding experiments utilizing three food types (mangrove leaf litter, microphytobenthos and prawn muscle) established different food-specific trophic discrimination values (Delta delta C-13 and Delta delta N-15) that are significantly different from those commonly applied to mixing model calculations. The mean Delta delta C-13((crab-mangrove)) of +5.45 parts per thousand was close to the mean and median literature values for grapsid-mangrove pairs in 29 past studies (+5.2 +/- 1.8 parts per thousand and +5.6 parts per thousand, respectively), suggesting that this large discrimination may generally be characteristic of detritivorous grapsid crabs. Solutions from the IsoConc mixing model using our determined trophic discrimination values suggest significantly higher and dominant contributions of mangrove C to the diet than those based on the global mean trophic discrimination values. Our results reaffirm the physiological capacity for and important mediating role of grapsid crabs in processing low-quality mangrove C in tropical estuaries, and caution against the use of global trophic discrimination values in stable isotope analysis of food-web data, especially those involving detritivores. While recent studies have questioned the trophic significance of mangrove detritus in coastal food chains, the contribution of this productive carbon source needs to be re-assessed in the light of these data.	[Lee, Shing Yip] Griffith Univ, Australian Rivers Inst, Southport, Qld 4215, Australia; Griffith Univ, Sch Environm, Southport, Qld 4215, Australia	Griffith University; Griffith University	Lee, SY (corresponding author), Griffith Univ, Australian Rivers Inst, Gold Coast Campus, Southport, Qld 4215, Australia.	joe.lee@griffith.edu.au	Lee, Joe S. Y./B-9185-2008	Lee, Joe S. Y./0000-0001-9336-2323; Bui, Thi Hong Hanh/0000-0002-9193-011X	Australian Endeavour Postgraduate Award	Australian Endeavour Postgraduate Award(Australian GovernmentDepartment of Industry, Innovation and Science)	THHB is supported by an Australian Endeavour Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkadir S, 2008, J EXP MAR BIOL ECOL, V354, P1, DOI 10.1016/j.jembe.2007.08.024; Adachi K, 2012, FISHERIES SCI, V78, P1309, DOI 10.1007/s12562-012-0547-8; Adams TS, 2000, LIMNOL OCEANOGR, V45, P601, DOI 10.4319/lo.2000.45.3.0601; Alongi DM, 2012, CARBON MANAG, V3, P313, DOI [10.4155/CMT.12.20, 10.4155/cmt.12.20]; ALONGI DM, 1994, OECOLOGIA, V98, P320, DOI 10.1007/BF00324220; Alongi DM, 2009, ENERGETICS MANGROVE; [Anonymous], 2007, WORLDS MANGR 1980 20; Bishop MJ, 2008, MAR ECOL PROG SER, V354, P75, DOI 10.3354/meps07219; Bouillon S, 2002, OECOLOGIA, V130, P441, DOI 10.1007/s004420100814; Bouillon S, 2004, MAR ECOL PROG SER, V278, P77, DOI 10.3354/meps278077; Bouillon S, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003052; Bromand S, 2001, PLANT SOIL, V235, P253, DOI 10.1023/A:1011922103323; Buchheister A, 2010, CAN J FISH AQUAT SCI, V67, P445, DOI 10.1139/F09-196; CAMILLERI J, 1989, MAR BIOL, V102, P453, DOI 10.1007/BF00438346; CAMILLERI JC, 1992, MAR BIOL, V114, P139; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Chong VC, 2001, MAR BIOL, V138, P77, DOI 10.1007/s002270000434; CONOVER RJ, 1966, LIMNOL OCEANOGR, V11, P338, DOI 10.4319/lo.1966.11.3.0338; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Dungait JAJ, 2010, PHYTOCHEMISTRY, V71, P415, DOI 10.1016/j.phytochem.2009.10.010; EMMERSON WD, 1992, J EXP MAR BIOL ECOL, V157, P41, DOI 10.1016/0022-0981(92)90073-J; Florin ST, 2011, FUNCT ECOL, V25, P519, DOI 10.1111/j.1365-2435.2010.01799.x; Fratini S, 2004, MAR BIOL, V144, P1173, DOI 10.1007/s00227-003-1282-6; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; GIDDINS RL, 1986, MAR ECOL PROG SER, V33, P147, DOI 10.3354/meps033147; Gorokhova E, 1999, CAN J FISH AQUAT SCI, V56, P2203, DOI 10.1139/cjfas-56-11-2203; Guelinckx J, 2007, MAR ECOL PROG SER, V341, P205, DOI 10.3354/meps341205; Guest MA, 2004, AQUAT ECOL, V38, P599, DOI 10.1007/s10452-004-0442-1; Hall D, 2006, J EXP MAR BIOL ECOL, V336, P42, DOI 10.1016/j.jembe.2006.04.004; Herbon CM, 2013, MAR ECOL PROG SER, V490, P91, DOI 10.3354/meps10421; HOBSON KA, 1993, CONDOR, V95, P388, DOI 10.2307/1369361; Hsieh HL, 2002, MAR ECOL PROG SER, V227, P145, DOI 10.3354/meps227145; Hyodo F, 2010, ECOL RES, V25, P745, DOI 10.1007/s11284-010-0719-x; Kennish R, 1997, OECOLOGIA, V109, P209, DOI 10.1007/s004420050075; Kristensen DK, 2010, ESTUAR COAST SHELF S, V87, P583, DOI 10.1016/j.ecss.2010.02.016; KWOK PW, 1995, HYDROBIOLOGIA, V295, P141, DOI 10.1007/BF00029121; Larsen T, 2012, RAPID COMMUN MASS SP, V26, P1541, DOI 10.1002/rcm.6259; Larsen T, 2009, ECOLOGY, V90, P3526, DOI 10.1890/08-1695.1; Layman CA, 2012, BIOL REV, V87, P545, DOI 10.1111/j.1469-185X.2011.00208.x; Lee SY, 2008, J SEA RES, V59, P16, DOI 10.1016/j.seares.2007.05.002; Lee S. Y., 2005, INT J ECOLOGY ENV SC, V31, P163; Lee SY, 2000, MAR ECOL PROG SER, V205, P1, DOI 10.3354/meps205001; LEE SY, 1990, MAR BIOL, V106, P453, DOI 10.1007/BF01344326; LEE SY, 1989, J EXP MAR BIOL ECOL, V131, P23, DOI 10.1016/0022-0981(89)90009-9; Lee SY, 1997, MAR ECOL PROG SER, V159, P275, DOI 10.3354/meps159275; LEE SY, 1995, HYDROBIOLOGIA, V295, P203, DOI 10.1007/BF00029127; Lopez B, 2013, CRUSTACEANA, V86, P1051, DOI 10.1163/15685403-00003220; MACKO SA, 1991, CHEM GEOL, V93, P147, DOI 10.1016/0009-2541(91)90069-4; MALLEY DF, 1978, MAR BIOL, V49, P377, DOI 10.1007/BF00455032; Malpica-Cruz L, 2012, CAN J FISH AQUAT SCI, V69, P551, DOI 10.1139/F2011-172; Mazumder D, 2010, WETLANDS, V30, P375, DOI 10.1007/s13157-010-0021-2; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Meziane T, 2000, MAR ECOL PROG SER, V200, P49, DOI 10.3354/meps200049; MICHELI F, 1993, J EXP MAR BIOL ECOL, V171, P149, DOI 10.1016/0022-0981(93)90001-5; MOERS MEC, 1993, ORG GEOCHEM, V20, P927, DOI 10.1016/0146-6380(93)90104-J; Nerot C, 2009, MAR BIOL, V156, P2343, DOI 10.1007/s00227-009-1262-6; NEWELL RIE, 1995, MAR BIOL, V123, P595, DOI 10.1007/BF00349238; Niiyama T, 2012, JARQ-JPN AGR RES Q, V46, P355, DOI 10.6090/jarq.46.355; Oakes JM, 2010, LIMNOL OCEANOGR, V55, P393, DOI 10.4319/lo.2010.55.1.0393; Odum E.P., 1980, ESTUARINE PERSPECTIV, P485; Odum WE, 1975, ESTUARINE RES, P265; Oelbermann K, 2002, OECOLOGIA, V130, P337, DOI 10.1007/s004420100813; Olive PJW, 2003, J ANIM ECOL, V72, P608, DOI 10.1046/j.1365-2656.2003.00730.x; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2002, OECOLOGIA, V130, P114, DOI 10.1007/s004420100786; Poovachiranon Sombat, 1991, Phuket Marine Biological Center Research Bulletin, V56, P63; QUINN RH, 1980, J EXP MAR BIOL ECOL, V43, P49, DOI 10.1016/0022-0981(80)90146-X; ROBERTSON AI, 1989, OECOLOGIA, V78, P191, DOI 10.1007/BF00377155; RODELLI MR, 1984, OECOLOGIA, V61, P326, DOI 10.1007/BF00379629; SCRIMGEOUR CM, 1995, ISOT ENVIRON HEALT S, V31, P107, DOI 10.1080/10256019508036256; Sheaves M, 2000, MAR ECOL PROG SER, V199, P97, DOI 10.3354/meps199097; Skov MW, 2002, OECOLOGIA, V131, P1, DOI 10.1007/s00442-001-0847-7; Spalding M., 2010, WETLANDS, V31, P1003, DOI 10.1007/s13157-011-0224-1; TEAL JM, 1962, ECOLOGY, V43, P614, DOI 10.2307/1933451; Thongtham N, 2005, ESTUAR COAST SHELF S, V65, P213, DOI 10.1016/j.ecss.2005.05.014; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Unsicker SB, 2005, ENTOMOL EXP APPL, V116, P219, DOI 10.1111/j.1570-7458.2005.00327.x; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Webb SC, 1998, J EXP BIOL, V201, P2903; Werry J, 2005, MAR ECOL PROG SER, V293, P165, DOI 10.3354/meps293165	83	51	53	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89074	10.1371/journal.pone.0089074	http://dx.doi.org/10.1371/journal.pone.0089074			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551220	gold, Green Published, Green Submitted			2022-12-27	WOS:000331266000099
J	Casoni, GL; Tomassetti, S; Cavazza, A; Colby, TV; Dubini, A; Ryu, JH; Carretta, E; Tantalocco, P; Piciucchi, S; Ravaglia, C; Gurioli, C; Romagnoli, M; Gurioli, C; Chilosi, M; Poletti, V				Casoni, Gian Luca; Tomassetti, Sara; Cavazza, Alberto; Colby, Thomas V.; Dubini, Alessandra; Ryu, Jay H.; Carretta, Elisa; Tantalocco, Paola; Piciucchi, Sara; Ravaglia, Claudia; Gurioli, Christian; Romagnoli, Micaela; Gurioli, Carlo; Chilosi, Marco; Poletti, Venerino			Transbronchial Lung Cryobiopsy in the Diagnosis of Fibrotic Interstitial Lung Diseases	PLOS ONE			English	Article							PULMONARY-FIBROSIS; RISK-FACTORS; BIOPSY; PNEUMONIA; MORTALITY; SURGERY	Background: Histology is a key element for the multidisciplinary diagnosis of fibrotic diffuse parenchymal lung diseases (f-DPLD) when the clinical-radiological picture is nondiagnostic. Transbronchial lung cryobiopsy (TBLC) have been shown to be useful for obtaining large and well-preserved biopsies of lung parenchyma, but experience with TBLC in f-DPLD is limited. Objectives: To evaluate safety, feasibility and diagnostic yield of TBLC in f-DPLD. Method: Prospective study of 69 cases of TBLC using flexible cryoprobe in the clinical-radiological setting of f-DPLD with nondiagnostic high resolution computed tomography (HRCT) features. Results: Safety: pneumothorax occurred in 19 patients (28%). One patient (1.4%) died of acute exacerbation. Feasibility: adequate cryobiopsies were obtained in 68 cases (99%). The median size of cryobiopsies was 43.11 mm(2) (range, 11.94-76.25). Diagnostic yield: among adequate TBLC the pathologists were confident ("high confidence") that histopathologic criteria sufficient to define a specific pattern in 52 patients (76%), including 36 of 47 with UIP (77%) and 9 nonspecific interstitial pneumonia (6 fibrosing and 3 cellular), 2 desquamative interstitial pneumonia/respiratory bronchiolitis-interstitial lung disease, 1 organizing pneumonia, 1 eosinophilic pneumonia, 1 diffuse alveolar damage, 1 hypersensitivity pneumonitis and 1 follicular bronchiolitis. In 11 diagnoses of UIP the pathologists were less confident ("low confidence"). Agreement between pathologists in the detection of UIP was very good with a Kappa coefficient of 0.83 (95% CI, 0.69-0.97). Using the current consensus guidelines for clinical-radiologic-pathologic correlation 32% (20/63) of cases were classified as Idiopathic Pulmonary Fibrosis (IPF), 30% (19/63) as possible IPF, 25% (16/63) as other f-DPLDs and 13% (8/63) were unclassifiable. Conclusions: TBLC in the diagnosis of f-DPLD appears safe and feasible. TBLC has a good diagnostic yield in the clinical-radiological setting of f-DPLD without diagnostic HRCT features of usual interstitial pneumonia. Future studies should consider TBLC as a potential alternative to SLBx in f-DPLD.	[Casoni, Gian Luca; Tomassetti, Sara; Tantalocco, Paola; Ravaglia, Claudia; Gurioli, Christian; Romagnoli, Micaela; Gurioli, Carlo; Poletti, Venerino] GB Morgagni L Pierantoni Hosp, Dept Dis Thorax, Forli, Italy; [Cavazza, Alberto] S Maria Nuova Hosp IRCCS, Dept Pathol, Reggio Emilia, Italy; [Colby, Thomas V.] Mayo Clin, Dept Pathol, Scottsdale, AZ USA; [Dubini, Alessandra] GB Morgagni L Pierantoni Hosp, Dept Pathol, Forli, Italy; [Ryu, Jay H.] Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN USA; [Carretta, Elisa] Ist Sci Romagnolo Studio & Cura Tumori, Biostat & Clin Trials Unit, Meldola Forli Cesena, Italy; [Piciucchi, Sara] GB Morgagni L Pierantoni Hosp, Dept Radiol, Forli, Italy; [Chilosi, Marco] Univ Verona, Dept Pathol, I-37100 Verona, Italy	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; IRCCS Meldola (IRST); University of Verona	Poletti, V (corresponding author), GB Morgagni L Pierantoni Hosp, Dept Dis Thorax, Forli, Italy.	venerino.poletti@gmail.com	Poletti, Venerino/K-8821-2016; Casoni, Gian Luca/K-6113-2016; CHILOSI, MARCO/ABB-8028-2021; Cavazza, Alberto/K-2531-2018	Poletti, Venerino/0000-0002-8634-2284; Cavazza, Alberto/0000-0003-3590-319X; Casoni, Gian Luca/0000-0002-7218-7914; Ryu, Jay/0000-0002-9576-2272	Associazione Morgagni Malattie Polmonari	Associazione Morgagni Malattie Polmonari	This study is supported by Associazione Morgagni Malattie Polmonari. The sponsor covers only the publication's costs. The entire study was realized without any financial support. In particular the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiak A, 2009, RESPIRATION, V78, P203, DOI 10.1159/000203987; Berbescu EA, 2006, CHEST, V129, P1126, DOI 10.1378/chest.129.5.1126; Casoni G L, 2008, Monaldi Arch Chest Dis, V69, P59; Cavazza A, 2010, RESP MED, V104, pS11, DOI 10.1016/j.rmed.2010.03.013; Churg A, 2006, CHEST, V129, P1117, DOI 10.1378/chest.129.5.1117; Griff S, 2011, DIAGN PATHOL, V16, P6; Katzenstein ALA, 2008, HUM PATHOL, V39, P1275, DOI 10.1016/j.humpath.2008.05.009; Kondoh Y, 2006, RESP MED, V100, P1753, DOI 10.1016/j.rmed.2006.02.002; Kreider ME, 2007, ANN THORAC SURG, V83, P1140, DOI 10.1016/j.athoracsur.2006.10.002; Matsuoka K, 2013, ANN THORAC CARDIOVAS, V19, P18, DOI 10.5761/atcs.oa.12.01909; Meyer KC, 2012, AM J RESP CRIT CARE, V185, P1004, DOI 10.1164/rccm.201202-0320ST; Monaghan H, 2004, CHEST, V125, P522, DOI 10.1378/chest.125.2.522; Nicholson AG, 2004, THORAX, V59, P500, DOI 10.1136/thx.2003.011734; Pajares V, 2010, ARCH BRONCONEUMOL, V46, P111, DOI 10.1016/j.arbres.2009.09.012; Park JH, 2007, EUR J CARDIO-THORAC, V31, P1115, DOI 10.1016/j.ejcts.2007.02.035; Plones T, 2013, RESP MED, V107, P629, DOI 10.1016/j.rmed.2012.11.020; Poletti V, 1996, EUR RESPIR J, V9, P2513, DOI 10.1183/09031936.96.09122513; Poletti V, 2004, RESPIRATION, V71, P107, DOI 10.1159/000076670; POLETTI V, 1988, Respiration, V54, P66; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rena O, 1999, EUR J CARDIO-THORAC, V16, P624, DOI 10.1016/S1010-7940(99)00320-6; Shim HS, 2010, PATHOL INT, V60, P373, DOI 10.1111/j.1440-1827.2010.02528.x; Sverzellati N, 2010, RADIOLOGY, V254, P957, DOI 10.1148/radiol.0990898; Tomassetti S, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-96; Trahan S, 2008, CHEST, V134, P126, DOI 10.1378/chest.08-0033; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Utz JP, 2001, EUR RESPIR J, V17, P175, DOI 10.1183/09031936.01.17201750; Yarmus L, 2013, CHEST, V143, P621, DOI 10.1378/chest.12-2290	28	222	234	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e86716	10.1371/journal.pone.0086716	http://dx.doi.org/10.1371/journal.pone.0086716			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586252	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200009
J	Kong, L; Welge, JA; Powell, EA; Blackard, JT				Kong, Ling; Welge, Jeffrey A.; Powell, Eleanor A.; Blackard, Jason T.			HIV Infection of Hepatocytes Results in a Modest Increase in Hepatitis C Virus Expression In Vitro	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; HUMAN HEPATOMA-CELLS; ENVELOPE PROTEINS; TYPE-1 INFECTION; HCV REPLICATION; LIVER FIBROSIS; COINFECTION; INTERLEUKIN-8; MECHANISM	Previous studies demonstrate that soluble HIV proteins impact both hepatocyte function and HCV replication in vitro. It has also been reported that HIV can productively infect hepatocytes. We therefore investigated the impact of HIV infection of hepatocytes on HCV expression. The Huh7.5(JFH1) cell line that constitutively expresses infectious HCV was infected with the lab-adapted strains HIVNL4-3 or HIVYK-JRCSF. HCV expression was quantified via HCV core antigen ELISA, Western blot, and strand-specific real-time PCR for positive-sense and negative-sense HCV RNA. After HIVNL4-3 infection of Huh7.5JFH1 cells, positive-sense and negative-sense HCV RNA levels were elevated compared to HIV uninfected cells. Increased HCV RNA synthesis was also observed after infection of Huh7.5(JFH1) cells with HIVYK-JRCSF. HIV-induced HCV core production was decreased in the presence of the anti-HIV drugs AZT, T20, and raltegravir, although these medications had a minimal effect on HCV expression in the absence of HIV. HCV core, NS3, and NS5A protein expression were increased after HIV infection of Huh7.5(JFH1) cells. Chemically inactivated HIV had a minimal effect on HCV expression in Huh7.5(JFH1) cells suggesting that ongoing viral replication was critical. These data demonstrate that HIV induces HCV RNA synthesis and protein production in vitro and complement previous in vivo reports that HCV RNA levels are elevated in individuals with HIV/HCV co-infection compared to those with HCV mono-infection. These findings suggest that HIV suppression may be a critical factor in controlling liver disease, particularly if the underlying liver disease is not treated.	[Kong, Ling; Powell, Eleanor A.; Blackard, Jason T.] Univ Cincinnati, Coll Med, Dept Internal Med, Div Digest Dis, Cincinnati, OH 45221 USA; [Welge, Jeffrey A.] Univ Cincinnati, Coll Med, Dept Psychiat, Cincinnati, OH USA; [Welge, Jeffrey A.] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Blackard, JT (corresponding author), Univ Cincinnati, Coll Med, Dept Internal Med, Div Digest Dis, Cincinnati, OH 45221 USA.	jason.blackard@uc.edu			Merck, Inc.; National Center for Research Resources, National Institutes of Health; National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR000077-04]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	Merck, Inc.(Merck & Company); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Merck, Inc. and the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health (UL1 TR000077-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Mata-Marin JA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-181; Babu CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004623; Balasubramanian A, 2005, CLIN INFECT DIS, V41, pS32, DOI 10.1086/429493; Balasubramanian A, 2003, J BIOL CHEM, V278, P35755, DOI 10.1074/jbc.M302889200; Balasubramanian A, 2006, J INFECT DIS, V194, P670, DOI 10.1086/505708; Bansal M, 2012, EFFECTS HIV LIVER CE; Beld M, 1998, VIROLOGY, V244, P504, DOI 10.1006/viro.1998.9130; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; Blackard JT, 2008, J VIRAL HEPATITIS, V15, P323, DOI 10.1111/j.1365-2893.2008.00970.x; Blackard JT, 2011, CLIN INFECT DIS, V52, P674, DOI 10.1093/cid/ciq199; Blackard JT, 2005, J INFECT DIS, V192, P258, DOI 10.1086/430949; BONACINI M, 1992, AM J MED, V92, P404, DOI 10.1016/0002-9343(92)90271-C; Cai ZH, 2005, J VIROL, V79, P13963, DOI 10.1128/JVI.79.22.13963-13973.2005; CAO YZ, 1990, J VIROL, V64, P2553, DOI 10.1128/JVI.64.6.2553-2559.1990; CAO YZ, 1992, AIDS, V6, P65, DOI 10.1097/00002030-199201000-00008; Chen YJ, 2010, J MICROBIOL IMMUNOL, V43, P175, DOI 10.1016/S1684-1182(10)60028-X; Fromentin R, 2010, VIROLOGY, V398, P168, DOI 10.1016/j.virol.2009.12.008; HALTINER M, 1985, NUCLEIC ACIDS RES, V13, P1015, DOI 10.1093/nar/13.3.1015; HODA SA, 1991, MODERN PATHOL, V4, P578; HOUSSET C, 1990, RES VIROLOGY, V141, P153, DOI 10.1016/0923-2516(90)90017-D; Ingiliz P, 2009, HEPATOLOGY, V49, P436, DOI 10.1002/hep.22665; Iser DM, 2010, J VIROL, V84, P5860, DOI 10.1128/JVI.02594-09; Jia YT, 2007, J GASTROEN HEPATOL, V22, P1278, DOI 10.1111/j.1440-1746.2007.04957.x; Jiang Tian-jun, 2005, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V19, P152; Kahn JO, 1998, NEW ENGL J MED, V339, P33, DOI 10.1056/NEJM199807023390107; Keaveny AP, 1998, AIDS PATIENT CARE ST, V12, P347, DOI 10.1089/apc.1998.12.347; Kim AY, 2009, GASTROENTEROLOGY, V137, P795, DOI 10.1053/j.gastro.2009.06.040; Kong L, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-157; Lang Zhen-wei, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P930; Lin W, 2008, GASTROENTEROLOGY, V134, P803, DOI 10.1053/j.gastro.2008.01.005; Lin WY, 2006, J VIROL, V80, P9226, DOI 10.1128/JVI.00459-06; Lin WY, 2005, GASTROENTEROLOGY, V128, P1034, DOI 10.1053/j.gastro.2005.02.006; Mendeni M, 2011, CLIN INFECT DIS, V52, P1164, DOI 10.1093/cid/cir071; Munshi N, 2003, J INFECT DIS, V188, P1192, DOI 10.1086/378643; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Polyak SJ, 2001, J VIROL, V75, P6095, DOI 10.1128/JVI.75.13.6095-6106.2001; Polyak SJ, 2001, J VIROL, V75, P6209, DOI 10.1128/JVI.75.13.6209-6211.2001; Price JC, 2012, J INFECT DIS, V205, P1005, DOI 10.1093/infdis/jir885; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Rotman Y, 2009, J VIROL, V83, P7366, DOI 10.1128/JVI.00191-09; Sherman KE, 1996, HEPATOLOGY, V23, P688, DOI 10.1002/hep.510230405; Sterling RK, 2004, CLIN GASTROENTEROL H, V2, P432, DOI 10.1016/S1542-3565(04)00129-6; Tedaldi EM, 2003, CLIN INFECT DIS, V36, P363, DOI 10.1086/345953; Thomas DL, 2001, J INFECT DIS, V183, P973, DOI 10.1086/319256; Towner WJ, 2012, JAIDS-J ACQ IMM DEF, V60, P321, DOI 10.1097/QAI.0b013e31824e9ef2; Xiao P, 2008, AIDS, V22, P1749, DOI 10.1097/QAD.0b013e328308937c; Yokozaki S, 2000, BLOOD, V96, P4293; Zhang XZ, 2012, J MED VIROL, V84, P1344, DOI 10.1002/jmv.23315	49	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e83728	10.1371/journal.pone.0083728	http://dx.doi.org/10.1371/journal.pone.0083728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586227	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200004
J	Shin, MR; Natsuume, M; Matsumoto, T; Hanaoka, M; Imai, M; Iijima, K; Oka, S; Adachi, E; Kodama, H				Shin, Mi-Rae; Natsuume, Masaya; Matsumoto, Takashi; Hanaoka, Mitsumasa; Imai, Misaki; Iijima, Ken; Oka, Shin-ichiro; Adachi, Eri; Kodama, Hiroaki			Sense Transgene-Induced Post-Transcriptional Gene Silencing in Tobacco Compromises the Splicing of Endogenous Counterpart Genes	PLOS ONE			English	Article							CALMODULIN-RELATED PROTEIN; DIRECTED DNA METHYLATION; CHALCONE-SYNTHASE-A; VIRUS-RESISTANCE; RNA-POLYMERASE; CO-SUPPRESSION; PETUNIA; ARABIDOPSIS; PLANTS; DEGRADATION	Sense transgene-induced post-transcriptional gene silencing (S-PTGS) is thought to be a type of RNA silencing in which ARGONAUTE1 directs the small interfering RNA (siRNA)-mediated cleavage of a target mRNA in the cytoplasm. Here, we report that the altered splicing of endogenous counterpart genes is a main cause for the reduction of their mature mRNA levels. After the S-PTGS of a tobacco endoplasmic reticulum omega-3 fatty acid desaturase (NtFAD3) gene, 3'-truncated, polyadenylated endo-NtFAD3 transcripts and 5'-truncated, intron-containing endo-NtFAD3 transcripts were detected in the total RNA fraction. Although transcription proceeded until the last exon of the endogenous NtFAD3 gene, intron-containing NtFAD3 transcripts accumulated in the nucleus of the S-PTGS plants. Several intron-containing NtFAD3 transcripts harboring most of the exon sequences were generated when an endogenous silencing suppressor gene, rgs-CaM, was overexpressed in the S-PTGS plants. These intron-containing NtFAD3 splice variants were generated in the presence of NtFAD3 siRNAs that are homologous to the nucleotide sequences of these splice variants. The results of this study indicate that the inhibition of endo-NtFAD3 gene expression is primarily directed via the alteration of splicing and not by cytoplasmic slicer activity. Our results suggest that the transgene and intron-containing endogenous counterpart genes are differentially suppressed in SPTGS plants.	[Shin, Mi-Rae; Kodama, Hiroaki] Chiba Univ, Grad Sch Adv Integrat Sci, Inage Ku, Chiba, Japan; [Natsuume, Masaya; Hanaoka, Mitsumasa; Oka, Shin-ichiro] Chiba Univ, Grad Sch Hort, Chiba, Japan; [Matsumoto, Takashi; Imai, Misaki] Tokyo Univ Agr, Genome Res Ctr, NODAI Res Inst, Setagaya Ku, Tokyo, Japan; [Iijima, Ken] Tokyo Univ Agr, Dept Appl Biol & Chem, Setagaya Ku, Tokyo, Japan; [Adachi, Eri] Chiba Univ, Grad Sch Sci & Technol, Inage Ku, Chiba 260, Japan	Chiba University; Chiba University; Tokyo University of Agriculture; Tokyo University of Agriculture; Chiba University	Kodama, H (corresponding author), Chiba Univ, Grad Sch Adv Integrat Sci, Inage Ku, Chiba, Japan.	kodama@faculty.chiba-u.jp	Hanaoka, Mitsumasa/M-9904-2015		Ministry of Education, Science and Culture, Japan [17570030]; MEXT; Program for the Strategic Research Foundation at Private Universities; Grants-in-Aid for Scientific Research [24117505, 26292191] Funding Source: KAKEN	Ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for the Strategic Research Foundation at Private Universities; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was partly supported by Grants-in-Aid from the Ministry of Education, Science and Culture, Japan (17570030), and in part by MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2008-2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; Anandalakshmi R, 2000, SCIENCE, V290, P142, DOI 10.1126/science.290.5489.142; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; De Paoli E, 2009, RNA, V15, P1965, DOI 10.1261/rna.1706109; Dubrovina AS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/264314; English JJ, 1996, PLANT CELL, V8, P179, DOI 10.1105/tpc.8.2.179; Gao ZH, 2010, NATURE, V465, P106, DOI 10.1038/nature09025; Gazzani S, 2004, SCIENCE, V306, P1046, DOI 10.1126/science.1101092; Grangeon Romain, 2010, Commun Integr Biol, V3, P363; HAMADA T, 1994, GENE, V147, P293, DOI 10.1016/0378-1119(94)90084-1; Han YH, 2004, FEBS LETT, V563, P123, DOI 10.1016/S0014-5793(04)00280-7; Han YH, 2002, PLANT J, V29, P509, DOI 10.1046/j.1365-313x.2002.01236.x; Hanaoka M, 2008, PLANT J, V56, P327, DOI 10.1111/j.1365-313X.2008.03600.x; Hanaoka M, 2012, INT J MOL SCI, V13, P12182, DOI 10.3390/ijms131012182; Hirai S, 2010, FEBS J, V277, P1695, DOI 10.1111/j.1742-4658.2010.07591.x; Hoffer P, 2011, P NATL ACAD SCI USA, V108, P409, DOI 10.1073/pnas.1009805108; Jorgensen RA, 1996, PLANT MOL BIOL, V31, P957, DOI 10.1007/BF00040715; Kasai M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-63; Kasai M, 2012, PLANT MOL BIOL, V78, P259, DOI 10.1007/s11103-011-9863-0; Litiere K, 1999, RNA, V5, P1364, DOI 10.1017/S1355838299990799; Metzlaff M, 2000, PLANT J, V23, P63, DOI 10.1046/j.1365-313x.2000.00793.x; Mishra KK, 1998, PLANT J, V14, P583, DOI 10.1046/j.1365-313X.1998.00157.x; Mitsuhara I, 1996, PLANT CELL PHYSIOL, V37, P49, DOI 10.1093/oxfordjournals.pcp.a028913; Mlotshwa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001755; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; MUELLER E, 1995, PLANT J, V7, P1001, DOI 10.1046/j.1365-313X.1995.07061001.x; Nakahara KS, 2012, P NATL ACAD SCI USA, V109, P10113, DOI 10.1073/pnas.1201628109; Nakamura H, 2014, PLANT CELL TISS ORG, V116, P47, DOI 10.1007/s11240-013-0381-4; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Pomeranz MC, 2010, PLANT PHYSIOL, V152, P151, DOI 10.1104/pp.109.145656; Saze H, 2012, PLANT CELL PHYSIOL, V53, P766, DOI 10.1093/pcp/pcs008; Schaad MC, 1997, EMBO J, V16, P4049, DOI 10.1093/emboj/16.13.4049; Thran M, 2012, PLANT J, V72, P368, DOI 10.1111/j.1365-313X.2012.05066.x; Tomita R, 2004, FEBS LETT, V573, P117, DOI 10.1016/j.febslet.2004.07.063; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van Eldik GJ, 1998, NUCLEIC ACIDS RES, V26, P5176, DOI 10.1093/nar/26.22.5176; VANBLOKLAND R, 1994, PLANT J, V6, P861, DOI 10.1046/j.1365-313X.1994.6060861.x; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; Zhang HM, 2011, CURR OPIN PLANT BIOL, V14, P142, DOI 10.1016/j.pbi.2011.02.003	41	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e87869	10.1371/journal.pone.0087869	http://dx.doi.org/10.1371/journal.pone.0087869			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586294	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900014
J	Yang, SS; Zheng, F; Luo, X; Cai, SX; Wu, YF; Liu, KZ; Wu, MH; Chen, J; Krishnan, S				Yang, Shanshan; Zheng, Fang; Luo, Xin; Cai, Suxian; Wu, Yunfeng; Liu, Kaizhi; Wu, Meihong; Chen, Jian; Krishnan, Sridhar			Effective Dysphonia Detection Using Feature Dimension Reduction and Kernel Density Estimation for Patients with Parkinson's Disease	PLOS ONE			English	Article							SPEECH; PROGRESSION; IMPAIRMENT	Detection of dysphonia is useful for monitoring the progression of phonatory impairment for patients with Parkinson's disease (PD), and also helps assess the disease severity. This paper describes the statistical pattern analysis methods to study different vocal measurements of sustained phonations. The feature dimension reduction procedure was implemented by using the sequential forward selection (SFS) and kernel principal component analysis (KPCA) methods. Four selected vocal measures were projected by the KPCA onto the bivariate feature space, in which the class-conditional feature densities can be approximated with the nonparametric kernel density estimation technique. In the vocal pattern classification experiments, Fisher's linear discriminant analysis (FLDA) was applied to perform the linear classification of voice records for healthy control subjects and PD patients, and the maximum a posteriori (MAP) decision rule and support vector machine (SVM) with radial basis function kernels were employed for the nonlinear classification tasks. Based on the KPCA-mapped feature densities, the MAP classifier successfully distinguished 91.8% voice records, with a sensitivity rate of 0.986, a specificity rate of 0.708, and an area value of 0.94 under the receiver operating characteristic (ROC) curve. The diagnostic performance provided by the MAP classifier was superior to those of the FLDA and SVM classifiers. In addition, the classification results indicated that gender is insensitive to dysphonia detection, and the sustained phonations of PD patients with minimal functional disability are more difficult to be correctly identified.	[Yang, Shanshan; Zheng, Fang; Luo, Xin; Cai, Suxian; Wu, Yunfeng; Liu, Kaizhi; Wu, Meihong] Xiamen Univ, Sch Informat Sci & Technol, Xiamen, Fujian, Peoples R China; [Chen, Jian] Xiamen Univ, Zhongshan Hosp, Dept Rehabil, Xiamen, Fujian, Peoples R China; [Krishnan, Sridhar] Ryerson Univ, Dept Elect & Comp Engn, Toronto, ON, Canada	Xiamen University; Xiamen University; Toronto Metropolitan University	Wu, YF (corresponding author), Xiamen Univ, Sch Informat Sci & Technol, Xiamen, Fujian, Peoples R China.	y.wu@ieee.org	Wu, Yunfeng/B-9337-2009; Krishnan, Sridhar/AAA-2542-2019; Wu, Yunfeng/AAU-8937-2021	Wu, Yunfeng/0000-0002-3612-7818; Wu, Yunfeng/0000-0002-3612-7818; Krishnan, Sridhar/0000-0002-4659-564X	National Natural Science Foundation of China [81101115, 31200769, 81272168]; Natural Science Foundation of Fujian [2011J01371]; Fundamental Research Funds for the Central Universities of China [2010121061]; Program for New Century Excellent Talents in Fujian Province University; Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chairs Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian(Natural Science Foundation of Fujian Province); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in Fujian Province University(Program for New Century Excellent Talents in University (NCET)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs Program(Canada Research Chairs)	This work was supported by the National Natural Science Foundation of China (grant no. 81101115, 31200769, 81272168), the Natural Science Foundation of Fujian (grant no. 2011J01371), and the Fundamental Research Funds for the Central Universities of China (grant no. 2010121061). Yunfeng Wu was also supported by the 2013 Program for New Century Excellent Talents in Fujian Province University. Sridhar Krishnan was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canada Research Chairs Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JB, 2001, EURASIP J ADV SIG PR, V2001; Bache Kevin, 2013, UCI MACHINE LEARNING; Behroozmand R, 2007, COMPUT BIOL MED, V37, P474, DOI 10.1016/j.compbiomed.2006.08.016; Benninger MS, 1998, J VOICE, V12, P540, DOI 10.1016/S0892-1997(98)80063-5; Cnockaert L, 2008, SPEECH COMMUN, V50, P288, DOI 10.1016/j.specom.2007.10.003; Duda R.O., 2006, PATTERN CLASSIFICATI; Goberman A, 2002, J COMMUN DISORD, V35, P217, DOI 10.1016/S0021-9924(01)00072-7; Goberman AM, 2003, J FLUENCY DISORD, V28, P55, DOI 10.1016/S0094-730X(03)00005-6; Godino-Llorente JI, 2004, IEEE T BIO-MED ENG, V51, P380, DOI 10.1109/TBME.2003.820386; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; HARTELIUS L, 1994, FOLIA PHONIATR LOGO, V46, P9, DOI 10.1159/000266286; HERTRICH I, 1995, ANN OTO RHINOL LARYN, V104, P197, DOI 10.1177/000348949510400304; Ho AK, 1998, BEHAV NEUROL, V11, P131, DOI 10.1155/1999/327643; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Holmes RJ, 2000, INT J LANG COMM DIS, V35, P407; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Little MA, 2009, IEEE T BIO-MED ENG, V56, P1015, DOI 10.1109/TBME.2008.2005954; Little MA, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-23; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Pell MD, 2006, BRAIN LANG, V97, P123, DOI 10.1016/j.bandl.2005.08.010; Rahn DA, 2007, J VOICE, V21, P64, DOI 10.1016/j.jvoice.2005.08.011; Sakar CO, 2010, J MED SYST, V34, P591, DOI 10.1007/s10916-009-9272-y; Scholkopf B, 1998, NEURAL COMPUT, V10, P1299, DOI 10.1162/089976698300017467; Sewall GK, 2006, LARYNGOSCOPE, V116, P1740, DOI 10.1097/01.mlg.0000232537.58310.22; Tsanas A, 2010, IEEE T BIO-MED ENG, V57, P884, DOI 10.1109/TBME.2009.2036000; Vapnik V., 1998, STAT LEARNING THEORY; Vaziri G, 2010, COMPUT BIOL MED, V40, P54, DOI 10.1016/j.compbiomed.2009.10.011; Wu YF, 2013, ENTROPY-SWITZ, V15, P1375, DOI 10.3390/e15041375; Wu YF, 2011, MED ENG PHYS, V33, P347, DOI 10.1016/j.medengphy.2010.10.023; Wu YF, 2010, IEEE T NEUR SYS REH, V18, P150, DOI 10.1109/TNSRE.2009.2033062; ZWIRNER P, 1992, J SPEECH HEAR RES, V35, P761, DOI 10.1044/jshr.3504.761	31	28	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88825	10.1371/journal.pone.0088825	http://dx.doi.org/10.1371/journal.pone.0088825			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586406	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700035
J	Friedrichs, K; Adam, M; Remane, L; Mollenhauer, M; Rudolph, V; Rudolph, TK; Andrie, RP; Stockigt, F; Schrickel, JW; Ravekes, T; Deuschl, F; Nickenig, G; Willems, S; Baldus, S; Klinke, A				Friedrichs, Kai; Adam, Matti; Remane, Lisa; Mollenhauer, Martin; Rudolph, Volker; Rudolph, Tanja K.; Andrie, Rene P.; Stoeckigt, Florian; Schrickel, Jan W.; Ravekes, Thorben; Deuschl, Florian; Nickenig, Georg; Willems, Stephan; Baldus, Stephan; Klinke, Anna			Induction of Atrial Fibrillation by Neutrophils Critically Depends on CD11b/CD18 Integrins	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CATHETER ABLATION; MAC-1 CD11B/CD18; INFLAMMATION; MYELOPEROXIDASE; MARKERS; OVEREXPRESSION; INTERLEUKIN-6; ARRHYTHMIAS; RECURRENCE	Background: Recent observational clinical and ex-vivo studies suggest that inflammation and in particular leukocyte activation predisposes to atrial fibrillation (AF). However, whether local binding and extravasation of leukocytes into atrial myocardium is an essential prerequisite for the initiation and propagation of AF remains elusive. Here we investigated the role of atrial CD11b/CD18 mediated infiltration of polymorphonuclear neutrophils (PMN) for the susceptibility to AF. Methods and Results: C57bl/6J wildtype (WT) and CD11b/CD18 knock-out (CD11b(-/-)) mice were treated for 14 days with subcutaneous infusion of angiotensin II (Ang II), a known stimulus for PMN activation. Atria of Ang II-treated WT mice were characterized by increased PMN infiltration assessed in immunohistochemically stained sections. In contrast, atrial sections of CD11b(-/-) mice lacked a significant increase in PMN infiltration upon Ang II infusion. PMN infiltration was accompanied by profoundly enhanced atrial fibrosis in Ang II treated WT as compared to CD11b(-/-) mice. Upon in-vivo electrophysiological investigation, Ang II treatment significantly elevated the susceptibility for AF in WT mice if compared to vehicle treated animals given an increased number and increased duration of AF episodes. In contrast, animals deficient of CD11b/CD18 were entirely protected from AF induction. Likewise, epicardial activation mapping revealed decreased electrical conduction velocity in atria of Ang II treated WT mice, which was preserved in CD11b(-/-) mice. In addition, atrial PMN infiltration was enhanced in atrial appendage sections of patients with persistent AF as compared to patients without AF. Conclusions: The current data critically link CD11b-integrin mediated atrial PMN infiltration to the formation of fibrosis, which promotes the initiation and propagation of AF. These findings not only reveal a mechanistic role of leukocytes in AF but also point towards a potential novel avenue of treatment in AF.	[Friedrichs, Kai; Remane, Lisa; Mollenhauer, Martin; Rudolph, Volker; Rudolph, Tanja K.; Ravekes, Thorben; Baldus, Stephan; Klinke, Anna] Univ Cologne, Ctr Heart, D-50931 Cologne, Germany; [Friedrichs, Kai; Remane, Lisa; Mollenhauer, Martin; Rudolph, Volker; Rudolph, Tanja K.; Ravekes, Thorben; Baldus, Stephan; Klinke, Anna] Univ Cologne, Cologne Cardiovasc Res Ctr, D-50931 Cologne, Germany; [Adam, Matti; Deuschl, Florian] Univ Heart Ctr Hamburg, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Andrie, Rene P.; Stoeckigt, Florian; Schrickel, Jan W.; Nickenig, Georg] Univ Hosp Bonn, Dept Med Cardiol, Bonn, Germany; [Willems, Stephan] Univ Heart Ctr Hamburg, Dept Electrophysiol, Hamburg, Germany	University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf	Klinke, A (corresponding author), Univ Cologne, Ctr Heart, D-50931 Cologne, Germany.	anna.klinke@uk-koeln.de		Adam, Matti/0000-0002-6990-8135; Stockigt, Florian/0000-0002-0885-679X	Deutsche Forschungsgemeinschaft [DFG BA 1870/7-1, BA 1870/9-1, BA 1870/10-1, DFG KL 2516/1-1, DFG RU 1876/1-1]; Deutsches Zentrum fur Herz-Kreislaufforschung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsches Zentrum fur Herz-Kreislaufforschung	This work was supported by the Deutsche Forschungsgemeinschaft, http://www.dfg.de/index.jsp (DFG BA 1870/7-1, BA 1870/9-1 and BA 1870/10-1 And DFG KL 2516/1-1 And DFG RU 1876/1-1) and the Deutsches Zentrum fur Herz-Kreislaufforschung, http://dzhk.de/(DZHK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; Bapat A, 2012, AM J PHYSIOL-HEART C, V302, pH2331, DOI 10.1152/ajpheart.00094.2012; Bruins P, 1997, CIRCULATION, V96, P3542; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Conway DSG, 2004, AM HEART J, V148, P462, DOI 10.1016/j.ahj.2004.01.026; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; Dernellis J, 2004, EUR HEART J, V25, P1100, DOI 10.1016/j.ehj.2004.04.025; Ding ZM, 1999, J IMMUNOL, V163, P5029; Disertori M, 2009, NEW ENGL J MED, V360, P1606, DOI 10.1056/NEJMoa0805710; Friedrichs K, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00214; Friedrichs K, 2011, TRENDS MOL MED, V17, P556, DOI 10.1016/j.molmed.2011.05.007; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Gao XP, 2005, PHYSIOL GENOMICS, V21, P230, DOI 10.1152/physiolgenomics.00291.2004; Goudis CA, 2012, EUROPACE, V14, P623, DOI 10.1093/europace/eur398; Harris ES, 2000, J BIOL CHEM, V275, P23409, DOI 10.1074/jbc.R000004200; Henningsen KMA, 2009, SCAND J CLIN LAB INV, V69, P425, DOI 10.1080/00365510802676848; Huang G, 2011, EUR J CLIN INVEST, V41, P719, DOI 10.1111/j.1365-2362.2010.02460.x; HUGHES BJ, 1992, J CLIN INVEST, V90, P1687, DOI 10.1172/JCI116041; Jerke U, 2013, J BIOL CHEM, V288, P12910, DOI 10.1074/jbc.M112.434613; KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703; Khatib R, 2013, INT J CARDIOL, V165, P17, DOI 10.1016/j.ijcard.2012.02.009; Kirchhof P, 2007, EUR HEART J, V28, P2803, DOI 10.1093/eurheartj/ehm358; Lamm G, 2006, J CARDIOTHOR VASC AN, V20, P51, DOI 10.1053/j.jvca.2005.03.026; Lau D, 2005, P NATL ACAD SCI USA, V102, P431, DOI 10.1073/pnas.0405193102; Leftheriotis DI, 2009, INT J CARDIOL, V135, P361, DOI 10.1016/j.ijcard.2008.04.012; Letsas KP, 2009, EUROPACE, V11, P158, DOI 10.1093/europace/eun309; Marcus GM, 2010, HEART RHYTHM, V7, P149, DOI 10.1016/j.hrthm.2009.10.004; Masson S, 2010, HEART, V96, P1909, DOI 10.1136/hrt.2009.191460; Mocsai A, 1999, J IMMUNOL, V162, P1120; Murdoch C, 2000, BLOOD, V95, P3032; Novo G, 2008, BRIT J CLIN PHARMACO, V66, P345, DOI 10.1111/j.1365-2125.2008.03234.x; Okumura Y, 2011, J CARDIOVASC ELECTR, V22, P987, DOI 10.1111/j.1540-8167.2011.02059.x; Ouyang F, 2010, CIRCULATION, V122, P2368, DOI 10.1161/CIRCULATIONAHA.110.946806; Psychari SN, 2005, AM J CARDIOL, V95, P764, DOI 10.1016/j.amjcard.2004.11.032; Ramlawi B, 2007, ANN THORAC SURG, V84, P1166, DOI 10.1016/j.athoracsur.2007.04.126; Reil JC, 2010, CARDIOVASC RES, V87, P485, DOI 10.1093/cvr/cvq079; Ross GD, 2002, IMMUNOL RES, V25, P219, DOI 10.1385/IR:25:3:219; Rudolph V, 2010, NAT MED, V16, P470, DOI 10.1038/nm.2124; Sah VP, 1999, J CLIN INVEST, V103, P1627, DOI 10.1172/JCI6842; Schnabel RB, 2010, CIRCULATION, V121, P200, DOI 10.1161/CIRCULATIONAHA.109.882241; Schrickel JW, 2007, CARDIOVASC RES, V76, P257, DOI 10.1016/j.cardiores.2007.07.001; Smith JG, 2010, J AM COLL CARDIOL, V56, P1713, DOI 10.1016/j.jacc.2010.05.049; Soriano SG, 1999, STROKE, V30, P134, DOI 10.1161/01.STR.30.1.134; Sovari AA, 2008, REDOX REP, V13, P242, DOI 10.1179/135100008X309000; SPODICK DH, 1976, JAMA-J AM MED ASSOC, V235, P39, DOI 10.1001/jama.235.1.39; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; WALZOG B, 1995, EXP CELL RES, V218, P28, DOI 10.1006/excr.1995.1127; Weerasooriya R, 2011, J AM COLL CARDIOL, V57, P160, DOI 10.1016/j.jacc.2010.05.061; ZHOU MJ, 1994, J CELL BIOL, V125, P1407, DOI 10.1083/jcb.125.6.1407	49	35	38	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89307	10.1371/journal.pone.0089307	http://dx.doi.org/10.1371/journal.pone.0089307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558493	Green Submitted, Green Published, gold			2022-12-27	WOS:000331706700139
J	Goryaynov, A; Yang, WD				Goryaynov, Alexander; Yang, Weidong			Role of Molecular Charge in Nucleocytoplasmic Transport	PLOS ONE			English	Article							NUCLEAR-PORE COMPLEX; SINGLE-MOLECULE; IMPORTIN-BETA; PROTEIN IMPORT; TRANSLOCATION; NUCLEOPORINS; ARCHITECTURE; CELLS; HYDROPHOBICITY; SELECTIVITY	Transport of genetic materials and proteins between the nucleus and cytoplasm of eukaryotic cells is mediated by nuclear pore complexes (NPCs). A selective barrier formed by phenylalanine-glycine (FG) nucleoporins (Nups) with net positive charges in the NPC allows for passive diffusion of signal-independent small molecules and transport-receptor facilitated translocation of signal-dependent cargo molecules. Recently, negative surface charge was postulated to be another essential criterion for selective passage through the NPC. However, the charge-driven mechanism in determining the transport kinetics and spatial transport route for either passive diffusion or facilitated translocation remains obscure. Here we employed high-speed single-molecule fluorescence microscopy with an unprecedented spatiotemporal resolution of 9 nm and 400 ms to uncover these mechanistic fundamentals for nuclear transport of charged substrates through native NPCs. We found that electrostatic interaction between negative surface charges on transiting molecules and the positively charged FG Nups, although enhancing their probability of binding to the NPC, never plays a dominant role in determining their nuclear transport mode or spatial transport route. A 3D reconstruction of transport routes revealed that small signal-dependent endogenous cargo protein constructs with high positive surface charges that are destined to the nucleus, rather than repelled from the NPC as suggested in previous models, passively diffused through an axial central channel of the NPC in the absence of transport receptors. Finally, we postulated a comprehensive map of interactions between transiting molecules and FG Nups during nucleocytoplasmic transport by combining the effects of molecular size, signal and surface charge.	[Goryaynov, Alexander; Yang, Weidong] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Yang, WD (corresponding author), Temple Univ, Dept Biol, Philadelphia, PA 19122 USA.	weidong.yang@temple.edu	Goryaynov, Alexander/I-4848-2015	Goryaynov, Alexander/0000-0001-8654-9042	National Institute of Health [NIH GM094041, GM097037]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM094041, R01GM097037] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project is supported by grants from the National Institute of Health (NIH GM094041 & GM097037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Carmody SR, 2009, J CELL SCI, V122, P1933, DOI 10.1242/jcs.041236; Colwell LJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000747; Cronican JJ, 2010, ACS CHEM BIOL, V5, P747, DOI 10.1021/cb1001153; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dange T, 2008, J CELL BIOL, V183, P77, DOI 10.1083/jcb.200806173; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Golich D, 1995, NATURE, V377; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Goryaynov A, 2012, INTEGR BIOL-UK, V4, P10, DOI 10.1039/c1ib00041a; Hetzer MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000539; Hetzer MW, 2009, DEV CELL, V17, P606, DOI 10.1016/j.devcel.2009.10.007; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kapon R, 2010, NUCLEUS-PHILA, V1, P475, DOI 10.4161/nucl.1.6.13112; Kramer A, 2008, PFLUG ARCH EUR J PHY, V456, P155, DOI 10.1007/s00424-007-0396-y; Kumeta M, 2012, J CELL SCI, V125, P4979, DOI 10.1242/jcs.109520; Ma J, 2012, P NATL ACAD SCI USA, V109, P7326, DOI 10.1073/pnas.1201724109; Ma J, 2010, P NATL ACAD SCI USA, V107, P7305, DOI 10.1073/pnas.0908269107; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; McNaughton BR, 2009, P NATL ACAD SCI USA, V106, P6111, DOI 10.1073/pnas.0807883106; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Naim B, 2007, J BIOL CHEM, V282, P3881, DOI 10.1074/jbc.M608329200; Naim B, 2009, EMBO J, V28, P2697, DOI 10.1038/emboj.2009.225; Otsuka S, 2008, P NATL ACAD SCI USA, V105, P16101, DOI 10.1073/pnas.0802647105; Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Powers MA, 2012, CURR BIOL, V22, pR1006, DOI 10.1016/j.cub.2012.10.037; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Rout MP, 2001, J BIOL CHEM, V276, P16593, DOI 10.1074/jbc.R100015200; Schoch RL, 2012, P NATL ACAD SCI USA, V109, P16911, DOI 10.1073/pnas.1208440109; Shi YQ, 2004, EXP CELL RES, V296, P337, DOI 10.1016/j.yexcr.2004.02.009; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Tagliazucchi M, 2013, P NATL ACAD SCI USA, V110, P3363, DOI 10.1073/pnas.1212909110; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Wool IG, 1995, BIOCHEM CELL BIOL, V73, P933, DOI 10.1139/o95-101; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4; Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101; Yang WD, 2006, J CELL BIOL, V174, P951, DOI 10.1083/jcb.200605053; Yang WD, 2013, NUCLEUS-AUSTIN, V4, P166, DOI 10.4161/nucl.24874; Yang WD, 2011, NUCLEUS-AUSTIN, V2, P10, DOI 10.4161/nucl.2.1.13818	52	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88792	10.1371/journal.pone.0088792	http://dx.doi.org/10.1371/journal.pone.0088792			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558427	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700073
J	Luo, W; Yin, PF; Di, Q; Hardisty, F; MacEachren, AM				Luo, Wei; Yin, Peifeng; Di, Qian; Hardisty, Frank; MacEachren, Alan M.			A Geovisual Analytic Approach to Understanding Geo-Social Relationships in the International Trade Network	PLOS ONE			English	Article							SPACE-TIME; VISUALIZATION; PATTERNS; MOBILITY; SYSTEM	The world has become a complex set of geo-social systems interconnected by networks, including transportation networks, telecommunications, and the internet. Understanding the interactions between spatial and social relationships within such geo-social systems is a challenge. This research aims to address this challenge through the framework of geovisual analytics. We present the GeoSocialApp which implements traditional network analysis methods in the context of explicitly spatial and social representations. We then apply it to an exploration of international trade networks in terms of the complex interactions between spatial and social relationships. This exploration using the GeoSocialApp helps us develop a two-part hypothesis: international trade network clusters with structural equivalence are strongly 'balkanized' (fragmented) according to the geography of trading partners, and the geographical distance weighted by population within each network cluster has a positive relationship with the development level of countries. In addition to demonstrating the potential of visual analytics to provide insight concerning complex geo-social relationships at a global scale, the research also addresses the challenge of validating insights derived through interactive geovisual analytics. We develop two indicators to quantify the observed patterns, and then use a Monte-Carlo approach to support the hypothesis developed above.	[Luo, Wei; Hardisty, Frank; MacEachren, Alan M.] Penn State Univ, Dept Geog, GeoVISTA Ctr, University Pk, PA 16802 USA; [Yin, Peifeng] Penn State Univ, Dept Comp Sci & Engn, PDA Grp, University Pk, PA 16802 USA; [Di, Qian] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Harvard University; Harvard T.H. Chan School of Public Health	Luo, W (corresponding author), Penn State Univ, Dept Geog, GeoVISTA Ctr, University Pk, PA 16802 USA.	wul132@psu.edu	luo, wei/ABA-2578-2020; luo, wei/A-9940-2016	luo, wei/0000-0002-8465-5607; luo, wei/0000-0002-8013-672X; Di, Qian/0000-0002-1584-4770	United States Department of Homeland Security [2009-ST-061-CI0001]; Gates Foundation	United States Department of Homeland Security(United States Department of Homeland Security (DHS)); Gates Foundation(Bill & Melinda Gates Foundation)	This material is based, in part, upon work supported by the United States Department of Homeland Security under Award #: 2009-ST-061-CI0001. Here is the website: http://www.dhs.gov/st-oup. The views and conclusions contained in this document are those of the authors and should not be interpreted as necessarily representing the official policies, either expressed or implied, of the United States Department of Homeland Security; a grant from the Gates Foundation also provided partial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2012, SOC NETWORKS, V34, P1, DOI 10.1016/j.socnet.2011.10.007; Ahmed A, 2010, VISUAL INFORMATION COMMUNICATION, P25, DOI 10.1007/978-1-4419-0312-9_2; Anderson JL, 2012, MON WEATHER REV, V140, P2359, DOI 10.1175/MWR-D-11-00013.1; Andrienko G, 2011, J VISUAL LANG COMPUT, V22, P251, DOI 10.1016/j.jvlc.2011.04.001; Andrienko G, 2010, INT J GEOGR INF SCI, V24, P1577, DOI 10.1080/13658816.2010.508043; Andrienko G, 2009, LECT NOTES GEOINF CA, P3, DOI 10.1007/978-3-642-00304-2_1; Andrienko N., 2010, IEEE T VISUALIZATION, V17, P205, DOI [10.1109/TVCG.2010.44, DOI 10.1109/TVCG.2010.44]; Andrienko N, 2013, INFORM VISUAL, V12, P3, DOI 10.1177/1473871612457601; Andris C., 2011, Proceedings of the 2011 IEEE International Conference on Spatial Data Mining and Geographical Knowledge Services (ICSDM 2011), P192, DOI 10.1109/ICSDM.2011.5969030; Andris C, 2011, METRICS METHODS SOCI; [Anonymous], 1996, HIDDEN ORDER ADAPTAT; Bailey T, 1995, INTERACTIVE SPATIAL; Batty M, 2003, REPRESENTING GIS, P149; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Breiger R., 1981, CONTINUITIES STRUCTU, P353; BREIGER RL, 1975, J MATH PSYCHOL, V12, P328, DOI 10.1016/0022-2496(75)90028-0; Carriere J., 1995, Proceedings. Information Visualization (Cat. No.95TB100000), P74, DOI 10.1109/INFVIS.1995.528689; Cassi L, 2012, ECON GEOGR, V88, P311, DOI 10.1111/j.1944-8287.2012.01154.x; Clark R, 2010, SOC FORCES, V88, P1123; Cusumano-Towner M, 2009, EXPLORING FUNCTIONAL; De Benedictis L, 2011, WORLD ECON, V34, P1417, DOI 10.1111/j.1467-9701.2011.01360.x; Demsar U, 2010, INT J GEOGR INF SCI, V24, P1527, DOI 10.1080/13658816.2010.511223; Ercsey-Ravasz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037810; Fagiolo G, 2010, J ECON INTERACT COOR, V5, P1, DOI 10.1007/s11403-010-0061-y; Fagiolo G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036115; Gentle J., 2003, RANDOM NUMBER GENERA; Guo DS, 2006, IEEE T VIS COMPUT GR, V12, P1461, DOI 10.1109/TVCG.2006.84; Guo DS, 2010, J LOCAT BASED SERV, V4, P183, DOI 10.1080/17489725.2010.537449; Guo DS, 2009, IEEE T VIS COMPUT GR, V15, P1041, DOI 10.1109/TVCG.2009.143; Hardisty F, 2011, INT J GEOGR INF SCI, V25, P191, DOI 10.1080/13658810903214203; Harrower M, 2003, CARTOGR J, V40, P27, DOI 10.1179/000870403235002042; Jeong C, 1998, RECONFIGURABLE DISC, P19; Kali R, 2007, J INT BUS STUD, V38, P595, DOI 10.1057/palgrave.jibs.8400286; Keim D, 2011, MASTERING INFORM AGE; Larsen J., 2006, MOBILITIES-UK, V1, P261, DOI [DOI 10.1080/17450100600726654, 10.1080/17450100600726654]; Liu J.S., 2008, SPRINGER SERIES STAT, DOI [10.1007/978-0-387-76371-2, DOI 10.1007/978-0-387-76371-2]; Luo W, 2011, SPATIAL SOCIAL NETWO; Luo W, 2013, J SPATIAL I IN PRESS; MacEachren AM, 2011, SENSEPLACE2 GEOTWITT, P181; Mao L, 2010, T GIS, V14, P533, DOI 10.1111/j.1467-9671.2010.01201.x; Mao L, 2010, COMPUT ENVIRON URBAN, V34, P204, DOI 10.1016/j.compenvurbsys.2010.03.004; Mercken L, 2009, SOC SCI MED, V69, P1506, DOI 10.1016/j.socscimed.2009.08.003; Nemeth R. J., 1985, REV FERNAND BRAUDEL, V8, P517; Onnela JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016939; Pollins, 2008, CORRELATES WAR PROJE; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Rosner B., 2011, FUNDAMENTALS BIOSTAT, V7th ed; Shutters ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039756; SMITH DA, 1992, SOC FORCES, V70, P857, DOI 10.2307/2580193; SNYDER D, 1979, AM J SOCIOL, V84, P1096, DOI 10.1086/226902; Thiemann C, 2011, SPATO VISUAL EXPLORE; Verdery AM, 2012, SOC NETWORKS, V34, P112, DOI 10.1016/j.socnet.2011.04.003; Wallerstein I., 1974, MODERN WORLD SYSTEM; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; WHITE HC, 1976, AM J SOCIOL, V81, P730, DOI 10.1086/226141; Wood J, 2010, CARTOGR J, V47, P117, DOI 10.1179/000870410X12658023467367; Zhou M, 2012, INT SOCIOL, V27, P502, DOI 10.1177/0268580912443577; Zhou M, 2011, SOC SCI RES, V40, P193, DOI 10.1016/j.ssresearch.2010.07.002	58	12	12	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88666	10.1371/journal.pone.0088666	http://dx.doi.org/10.1371/journal.pone.0088666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3RA	24558409	Green Submitted, Green Published, gold			2022-12-27	WOS:000331706700055
J	Mori, S; Nada, S; Kimura, H; Tajima, S; Takahashi, Y; Kitamura, A; Oneyama, C; Okada, M				Mori, Shunsuke; Nada, Shigeyuki; Kimura, Hironobu; Tajima, Shoji; Takahashi, Yusuke; Kitamura, Ayaka; Oneyama, Chitose; Okada, Masato			The mTOR Pathway Controls Cell Proliferation by Regulating the FoxO3a Transcription Factor via SGK1 Kinase	PLOS ONE			English	Article							PROTEIN-KINASE; BINDING PARTNER; RAG GTPASES; AKT; PHOSPHORYLATION; SERUM; ACTIVATION; EXPRESSION; COMPLEX; RICTOR	The mechanistic target of rapamycin (mTOR) functions as a component of two large complexes, mTORC1 and mTORC2, which play crucial roles in regulating cell growth and homeostasis. However, the molecular mechanisms by which mTOR controls cell proliferation remain elusive. Here we show that the FoxO3a transcription factor is coordinately regulated by mTORC1 and mTORC2, and plays a crucial role in controlling cell proliferation. To dissect mTOR signaling, mTORC1 was specifically inactivated by depleting p18, an essential anchor of mTORC1 on lysosomes. mTORC1 inactivation caused a marked retardation of cell proliferation, which was associated with upregulation of cyclin-dependent kinase inhibitors (CDKIs). Although Akt was activated by mTORC1 inactivation, FoxO3a was upregulated via an epigenetic mechanism and hypophosphorylated at Ser314, which resulted in its nuclear accumulation. Consistently, mTORC1 inactivation induced downregulation of serum- and glucocorticoid-inducible kinase 1 (SGK1), the kinase responsible for Ser314 phosphorylation. Expression of FoxO3a mutated at Ser314 suppressed cell proliferation by inducing CDKI expression. SGK1 overexpression suppressed CDKI expression in p18-deficient cells, whereas SGK1 knockdown induced CDKI expression in wild-type cells, resulting in the suppression of cell proliferation. These results suggest that mTORC1, in coordination with mTORC2, controls cell proliferation by regulating FoxO3a gene expression and SGK1-mediated phosphorylation of FoxO3a at Ser314.	[Mori, Shunsuke; Nada, Shigeyuki; Takahashi, Yusuke; Kitamura, Ayaka; Oneyama, Chitose; Okada, Masato] Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, Suita, Osaka 565, Japan; [Kimura, Hironobu; Tajima, Shoji] Osaka Univ, Inst Prot Res, Lab Epigenet, Suita, Osaka 565, Japan	Osaka University; Osaka University	Okada, M (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, 3-1 Yamadaoka, Suita, Osaka 565, Japan.	okadam@biken.osaka-u.ac.jp	Kimura, Hironobu/B-3731-2010	Mori, Shunsuke/0000-0001-6151-4425	Uehara Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan [22240088, 25117716]; Grants-in-Aid for Scientific Research [26640078, 25117716] Funding Source: KAKEN	Uehara Foundation(Uehara Memorial Foundation); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Uehara Foundation and a Grant-in-Aid for scientific research (22240088 and 25117716) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese C, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-4; Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Arteaga MF, 2007, MOL BIOL CELL, V18, P2072, DOI 10.1091/mbc.E06-10-0968; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Belova L, 2006, BIOCHEM J, V400, P235, DOI 10.1042/BJ20060905; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Bruhn Maressa A, 2013, Cancer Manag Res, V5, P281, DOI 10.2147/CMAR.S35178; Bruhn MA, 2010, GROWTH FACTORS, V28, P394, DOI 10.3109/08977194.2010.518616; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Gao DM, 2010, MOL CELL, V39, P797, DOI 10.1016/j.molcel.2010.08.016; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hales EC, 2013, CELLULAR SIGNALLING, V26, P149; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hay N, 2011, BBA-MOL CELL RES, V1813, P1965, DOI 10.1016/j.bbamcr.2011.03.013; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lang F, 2010, INT J BIOCHEM CELL B, V42, P1571, DOI 10.1016/j.biocel.2010.05.016; Laplante M, 2013, J CELL SCI, V126, P1713, DOI 10.1242/jcs.125773; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Loffing J, 2006, ANNU REV PHYSIOL, V68, P461, DOI 10.1146/annurev.physiol.68.040104.131654; Moniz Larissa S, 2013, Biochem J, V452, pe11, DOI 10.1042/BJ20130617; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Pozharny Y, 2010, MT SINAI J MED, V77, P225, DOI 10.1002/msj.20176; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Soma-Nagae T, 2013, J CELL SCI, V126, P3575, DOI 10.1242/jcs.121913; Sommer EM, 2013, BIOCHEM J, V452, P499, DOI 10.1042/BJ20130342; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Szmulewitz RZ, 2012, PROSTATE, V72, P157, DOI 10.1002/pros.21416; Takahashi Y, 2012, BIOCHEM BIOPH RES CO, V417, P1151, DOI 10.1016/j.bbrc.2011.12.082; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Xie Q, 2012, EMBO REP, V13, P371, DOI 10.1038/embor.2012.25; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010; Zhou RF, 2005, J BIOL CHEM, V280, P4518, DOI 10.1074/jbc.M411053200	55	65	66	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88891	10.1371/journal.pone.0088891	http://dx.doi.org/10.1371/journal.pone.0088891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558442	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700088
J	Orozovic, G; Orozovic, K; Jarhult, JD; Olsen, B				Orozovic, Goran; Orozovic, Kanita; Jarhult, Josef D.; Olsen, Bjorn			Study of Oseltamivir and Zanamivir Resistance-Related Mutations in Influenza Viruses Isolated from Wild Mallards in Sweden	PLOS ONE			English	Article							NEURAMINIDASE INHIBITOR RESISTANCE; A VIRUS; H1N1; SUSCEPTIBILITY; SURVEILLANCE; H5N1	Resistance to neuraminidase inhibitors (NAIs) is a growing problem in battle against influenza A virus. However, little is known about the resistance of viruses isolated from dabbling ducks, the natural reservoir of the influenza virus. To our knowledge, no low-pathogenic avian influenza (LPAI) virus resistant to NAIs has been detected. The aim of this study was to investigate mallard isolates of influenza A virus previously identified to carry oseltamivir carboxylate (OC) or zanamivir (ZA) resistance-related mutations. In this work, 21 viruses belonging to the N1, N3, N6 and N9 subtypes were analyzed using a colorimetric NA inhibition assay. The results of assay showed no NAIs-resistant phenotype for any of the viruses. The R118K mutation was the most recurrent, as it was observed in all subtypes except for N6. IC50 values confirmed the differences in sensitivity to OC or ZA observed in the N1 and N2 groups of NAs. Furthermore, both wild types (WTs) in the N6 and one WT in the N9 subtype were less sensitive to ZA than were genotypically related mutants with R152K and R118K change in the respective subtypes. This may indicate that these and probably even other NAIs resistance-related mutations found in our virus collection were not induced by NAIs residuals in the environment and that the impact of such mutations in an avian influenza could be dependent on subtype, strain and host species.	[Orozovic, Goran; Jarhult, Josef D.; Olsen, Bjorn] Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden; [Orozovic, Kanita] Swedish Univ Agr Sci, Dept Plant Biol & Forest Genet, Uppsala, Sweden	Uppsala University; Swedish University of Agricultural Sciences	Orozovic, G (corresponding author), Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden.	goran.orozovic@hotmail.com	Jarhult, Josef D./ABE-8149-2020	Jarhult, Josef D./0000-0002-7075-1059; Olsen, Bjorn/0000-0002-4646-691X	Swedish Research Council; Swedish Research Council Formas; EU network "New Flubird"	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); EU network "New Flubird"	This study was financially supported by the Swedish Research Council, the Swedish Research Council Formas and EU network "New Flubird". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Ferraris O, 2005, ANTIVIR RES, V68, P43, DOI 10.1016/j.antiviral.2005.07.004; Ferraris O, 2008, J CLIN VIROL, V41, P13, DOI 10.1016/j.jcv.2007.10.020; Fick J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000986; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ghosh GC, 2010, ENVIRON HEALTH PERSP, V118, P103, DOI 10.1289/ehp.0900930; Gillman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071230; Govorkova EA, 2001, ANTIMICROB AGENTS CH, V45, P2723, DOI 10.1128/AAC.45.10.2723-2732.2001; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hurt AC, 2009, ANTIMICROB AGENTS CH, V53, P4433, DOI 10.1128/AAC.00334-09; Ilyushina NA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000933; Jarhult JD, 2012, INFECT ECOLOGY EPIDE, V2; Jarhult JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024742; Khanna M, 2009, INDIAN J MICROBIOL, V49, P365, DOI 10.1007/s12088-009-0064-3; Kramarz P, 2009, EUROSURVEILLANCE, V14; Lee CW, 2009, COMP IMMUNOL MICROB, V32, P301, DOI 10.1016/j.cimid.2008.01.007; Lewis DB, 2006, ANNU REV MED, V57, P139, DOI 10.1146/annurev.med.57.121304.131333; Meijer A, 2009, EMERG INFECT DIS, V15, P552, DOI [10.3201/eid1504.081280, 10.3201/eid1504.181280]; Mishin VP, 2005, ANTIMICROB AGENTS CH, V49, P4515, DOI 10.1128/AAC.49.11.4515-4520.2005; Moscona A, 2008, ANNU REV MED, V59, P397, DOI 10.1146/annurev.med.59.061506.213121; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Nguyen HT, 2010, ANTIMICROB AGENTS CH, V54, P3671, DOI 10.1128/AAC.00581-10; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Orozovic G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016028; Orozovic G, 2010, J VIROL METHODS, V170, P94, DOI 10.1016/j.jviromet.2010.09.006; Rameix-Welti MA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000103; Richard M, 2008, J CLIN VIROL, V41, P20, DOI 10.1016/j.jcv.2007.10.021; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Sacca ML, 2009, CHEMOSPHERE, V75, P28, DOI 10.1016/j.chemosphere.2008.11.060; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Singer AC, 2007, ENVIRON HEALTH PERSP, V115, P102, DOI 10.1289/ehp.9574; Soderstrom H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006064; Stoner TD, 2010, J VIROL, V84, P9800, DOI 10.1128/JVI.00296-10; Taubenberger JK, 2009, REV SCI TECH OIE, V28, P187, DOI 10.20506/rst.28.1.1879; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Ward P, 2005, J ANTIMICROB CHEMOTH, V55, P5, DOI 10.1093/jac/dki018; WARREN L, 1959, J BIOL CHEM, V234, P1971; Webster R, 2002, WHOCDSCSRNCS20025, P40; Weinstock DM, 2009, JAMA-J AM MED ASSOC, V301, P1066, DOI 10.1001/jama.2009.324; Yen HL, 2006, J VIROL, V80, P8787, DOI 10.1128/JVI.00477-06	43	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89306	10.1371/journal.pone.0089306	http://dx.doi.org/10.1371/journal.pone.0089306			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558492	Green Submitted, Green Published, gold			2022-12-27	WOS:000331706700138
J	Smeti, I; Watabe, I; Savary, E; Fontbonne, A; Zine, A				Smeti, Ibtihel; Watabe, Isabelle; Savary, Etienne; Fontbonne, Arnaud; Zine, Azel			HMGA2, the Architectural Transcription Factor High Mobility Group, Is Expressed in the Developing and Mature Mouse Cochlea	PLOS ONE			English	Article							INNER-EAR; HAIR CELL; SENSORY EPITHELIA; GENE-EXPRESSION; SELF-RENEWAL; SOX2; FATE; ORGAN; LET-7; DIFFERENTIATION	Hmga2 protein belongs to the non-histone chromosomal high-mobility group (HMG) protein family. HMG proteins have been shown to function as architectural transcription regulators, facilitating enhanceosome formation on a variety of mammalian promoters. Hmga2 are expressed at high levels in embryonic and transformed cells. Terminally differentiated cells, however, have been reported to express only minimal, if any, Hmga2. Our previous affymetrix array data showed that Hmga2 is expressed in the developing and adult mammalian cochleas. However, the spatio-temporal expression pattern of Hmga2 in the murine cochlea remained unknown. In this study, we report the expression of Hmga2 in developing and adult cochleas using immunohistochemistry and quantitative real time PCR analysis. Immunolabeling of Hmga2 in the embryonic, postnatal, and mature cochleas showed broad Hmga2 expression in embryonic cochlea (E14.5) at the level of the developing organ of Corti in differentiating hair cells, supporting cells, in addition to immature cells in the GER and LER areas. By postnatal stage (P0-P3), Hmga2 is predominantly expressed in the hair and supporting cells, in addition to cells in the LER area. By P12, Hmga2 immunolabeling is confined to the hair cells and supporting cells. In the adult ear, Hmga2 expression is maintained in the hair and supporting cell subtypes (i.e. Deiters' cells, Hensen cells, pillar cells, inner phalangeal and border cells) in the cochlear epithelium. Using quantitative real time PCR, we found a decrease in transcript level for Hmga2 comparable to other known inner ear developmental genes (Sox2, Atoh1, Jagged1 and Hes5) in the cochlear epithelium of the adult relative to postnatal ears. These data provide for the first time the tissue-specific expression and transcription level of Hmga2 during inner ear development and suggest its potential dual role in early differentiation and maintenance of both hair and supporting cell phenotypes.	[Smeti, Ibtihel; Watabe, Isabelle; Savary, Etienne; Fontbonne, Arnaud; Zine, Azel] CNRS UMR 7260 Aix Marseille Univ, Marseille, France; [Smeti, Ibtihel; Zine, Azel] Univ Montpellier I, Fac Pharm, Montpellier, France	Universite de Montpellier	Zine, A (corresponding author), CNRS UMR 7260 Aix Marseille Univ, Marseille, France.	azel.zine@univ-amu.fr			ANR (Agence Nationale de Recherche) [ANR-2010-BLAN-1107-01-b]	ANR (Agence Nationale de Recherche)(French National Research Agency (ANR))	This study was funded by ANR (Agence Nationale de Recherche; ANR-2010-BLAN-1107-01-b). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2012, DEVELOPMENT, V139, P1965, DOI 10.1242/dev.071670; Barald KF, 2004, DEVELOPMENT, V131, P4119, DOI 10.1242/dev.01339; Bouchard M, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-89; Chen JC, 2013, HEARING RES, V297, P3, DOI 10.1016/j.heares.2012.11.018; Chen P, 2002, DEVELOPMENT, V129, P2495; Cleynen I, 2008, INT J ONCOL, V32, P289; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Duncan JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062046; Fedele M, 2006, CANCER CELL, V9, P459, DOI 10.1016/j.ccr.2006.04.024; Fedele M, 2010, MOL CELL ENDOCRINOL, V326, P19, DOI 10.1016/j.mce.2010.03.019; Ferguson M, 2003, NUCLEIC ACIDS RES, V31, P3123, DOI 10.1093/nar/gkg403; Fritzsch B, 2006, BIOESSAYS, V28, P1181, DOI 10.1002/bies.20502; Hammond SM, 2008, CELL, V135, P1013, DOI 10.1016/j.cell.2008.11.026; HINOJOSA R, 1977, ACTA OTO-LARYNGOL, V84, P238, DOI 10.3109/00016487709123963; Hirning-Folz U, 1998, GENE CHROMOSOME CANC, V23, P350, DOI 10.1002/(SICI)1098-2264(199812)23:4<350::AID-GCC10>3.0.CO;2-E; Hume CR, 2007, GENE EXPR PATTERNS, V7, P798, DOI 10.1016/j.modgep.2007.05.002; Kelley MW, 2007, INT J DEV BIOL, V51, P571, DOI 10.1387/ijdb.072388mk; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kopecky BJ, 2012, J MICROSC-OXFORD, V248, P292, DOI 10.1111/j.1365-2818.2012.03673.x; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Li O, 2007, FEBS LETT, V581, P3533, DOI 10.1016/j.febslet.2007.06.072; LIM DJ, 1986, HEARING RES, V22, P117, DOI 10.1016/0378-5955(86)90089-4; Lim DJ, 1992, STRUCTURAL DEV COCHL, P33; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mak ACY, 2009, GENE EXPR PATTERNS, V9, P444, DOI 10.1016/j.gep.2009.04.003; Malini E, 2011, BIOCHEMISTRY-US, V50, P3462, DOI 10.1021/bi200101f; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Morsli H, 1998, J NEUROSCI, V18, P3327; National Center for Biotechnology Information, GUID CAR US LAB AN; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; PUJOL R, 1973, ACTA OTO-LARYNGOL, V76, P1, DOI 10.3109/00016487309121476; Puligilla C, 2010, J NEUROSCI, V30, P714, DOI 10.1523/JNEUROSCI.3852-09.2010; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Seo E, 2011, MOL CELL BIOL, V31, P4593, DOI 10.1128/MCB.05798-11; Slattery EL, 2009, JARO-J ASSOC RES OTO, V10, P341, DOI 10.1007/s10162-009-0166-y; Smeti I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042987; Smeti I, 2011, GENE EXPR PATTERNS, V11, P22, DOI 10.1016/j.gep.2010.08.008; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Tay Y, 2009, STEM CELL REV REP, V5, P328, DOI 10.1007/s12015-009-9095-8; Tsonis PA, 2007, BIOCHEM BIOPH RES CO, V362, P940, DOI 10.1016/j.bbrc.2007.08.077; Weston MD, 2006, BRAIN RES, V1111, P95, DOI 10.1016/j.brainres.2006.07.006; Wong EYM, 2013, HEARING RES, V297, P13, DOI 10.1016/j.heares.2012.09.009; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zou D, 2008, HUM MOL GENET, V17, P3340, DOI 10.1093/hmg/ddn229	46	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88757	10.1371/journal.pone.0088757	http://dx.doi.org/10.1371/journal.pone.0088757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551154	Green Published, gold			2022-12-27	WOS:000331271500065
J	Jiang, LZ; Liu, C; Tong, JB; Mao, RR; Chen, D; Wang, H; Huang, JF; Li, LJ				Jiang, Lizhu; Liu, Chen; Tong, Jianbin; Mao, Rongrong; Chen, Dan; Wang, Hui; Huang, Jufang; Li, Lingjiang			Fluoxetine Pretreatment Promotes Neuronal Survival and Maturation after Auditory Fear Conditioning in the Rat Amygdala	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; PROGENITOR-CELL PROLIFERATION; POSTTRAUMATIC-STRESS-DISORDER; DENTATE GYRUS; SYNAPTIC PLASTICITY; GRANULE CELLS; MEMORY; MICE; EXTINCTION; MECHANISMS	The amygdala is a critical brain region for auditory fear conditioning, which is a stressful condition for experimental rats. Adult neurogenesis in the dentate gyrus (DG) of the hippocampus, known to be sensitive to behavioral stress and treatment of the antidepressant fluoxetine (FLX), is involved in the formation of hippocampus-dependent memories. Here, we investigated whether neurogenesis also occurs in the amygdala and contributes to auditory fear memory. In rats showing persistent auditory fear memory following fear conditioning, we found that the survival of new-born cells and the number of new-born cells that differentiated into mature neurons labeled by BrdU and NeuN decreased in the amygdala, but the number of cells that developed into astrocytes labeled by BrdU and GFAP increased. Chronic pretreatment with FLX partially rescued the reduction in neurogenesis in the amygdala and slightly suppressed the maintenance of the long-lasting auditory fear memory 30 days after the fear conditioning. The present results suggest that adult neurogenesis in the amygdala is sensitive to antidepressant treatment and may weaken long-lasting auditory fear memory.	[Jiang, Lizhu; Li, Lingjiang] Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, Changsha, Hunan, Peoples R China; [Jiang, Lizhu; Li, Lingjiang] Cent S Univ, Key Lab Psychiat & Mental Hlth Hunan Prov, Changsha, Hunan, Peoples R China; [Liu, Chen; Chen, Dan; Wang, Hui; Huang, Jufang] Cent S Univ, Sch Basic Med Sci, Dept Anat & Neurobiol, Changsha, Hunan, Peoples R China; [Tong, Jianbin] Cent S Univ, Xiangya Hosp 3, Changsha, Hunan, Peoples R China; [Mao, Rongrong] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Peoples R China; [Jiang, Lizhu] Dali Univ, Dept Neuropsychopathy, Sch Clin Med, Dali, Peoples R China	Central South University; Central South University; Central South University; Central South University; Chinese Academy of Sciences; Kunming Institute of Zoology; Dali University	Huang, JF (corresponding author), Cent S Univ, Sch Basic Med Sci, Dept Anat & Neurobiol, Changsha, Hunan, Peoples R China.	huangjufang@csu.edu.cn; llj2920@163.com	Chen, Dan/GRY-2691-2022; Jufang, Huang/AAW-1847-2020; Mao, Rong/Q-2595-2019	Chen, Dan/0000-0002-1570-9034; Jufang, Huang/0000-0002-9161-1055; Mao, Rong/0000-0002-0469-2281	National Natural Science Foundation of China [3086008, 31100786, 930830046, 81171286, 91232714]; National 973 Program of China [2009CB918303]; Program of the Chinese Ministry of Education [20090162110011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Program of China(National Basic Research Program of China); Program of the Chinese Ministry of Education(Ministry of Education, China)	This work was supported by grants from the National Natural Science Foundation of China (3086008 to Lizhu Jiang; 31100786 to Rongrong Mao; 930830046, 81171286, and 91232714 to Lingjiang Li), the National 973 Program of China (2009CB918303 to Lingjiang Li), and the Program of the Chinese Ministry of Education (20090162110011 to Lingjiang Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Bailey CH, 2004, NEURON, V44, P49, DOI 10.1016/j.neuron.2004.09.017; Bekinschtein P, 2010, NEUROTOX RES, V18, P377, DOI 10.1007/s12640-010-9155-5; Bernier PJ, 2002, P NATL ACAD SCI USA, V99, P11464, DOI 10.1073/pnas.172403999; Carlen M, 2002, CURR BIOL, V12, P606, DOI 10.1016/S0960-9822(02)00771-6; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Grillon C, 1996, MOL PSYCHIATR, V1, P278; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; Karpova NN, 2011, SCIENCE, V334, P1731, DOI 10.1126/science.1214592; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Keilhoff Gerburg, 2006, Neuropsychopharmacology, V31, P1165; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Lieberwirth C, 2012, HORM BEHAV, V62, P357, DOI 10.1016/j.yhbeh.2012.03.005; Linnarsson S, 2000, MOL BRAIN RES, V75, P61, DOI 10.1016/S0169-328X(99)00295-8; Marcussen AB, 2008, ACTA NEUROL SCAND, V117, P94, DOI 10.1111/j.1600-0404.2007.00910.x; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Milad MR, 2006, BIOL PSYCHOL, V73, P61, DOI 10.1016/j.biopsycho.2006.01.008; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Nakagawa S, 2002, J NEUROSCI, V22, P9868; Okuda H, 2009, J NEUROSCI RES, V87, P3546, DOI 10.1002/jnr.22160; Pan YY, 2012, PLOS ONE, V7; Pham K, 2005, NEUROSCIENCE, V130, P17, DOI 10.1016/j.neuroscience.2004.09.015; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Siegmund A, 2007, J PSYCHIATR RES, V41, P848, DOI 10.1016/j.jpsychires.2006.07.017; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; Tamaki K, 2008, J NEUROCHEM, V105, P1642, DOI 10.1111/j.1471-4159.2008.05253.x; Tong JB, 2013, EMBO J, V32, P1917, DOI 10.1038/emboj.2013.122; Wang JW, 2008, J NEUROSCI, V28, P1374, DOI 10.1523/JNEUROSCI.3632-07.2008; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	38	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89147	10.1371/journal.pone.0089147	http://dx.doi.org/10.1371/journal.pone.0089147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551236	Green Submitted, Green Published, gold			2022-12-27	WOS:000331266000108
J	Ma, HY; Jiang, W; Liu, P; Feng, NN; Ma, QQ; Ma, CY; Li, SJ; Liu, YX; Qiao, ZG; Ma, LB				Ma, Hongyu; Jiang, Wei; Liu, Ping; Feng, Nana; Ma, Qunqun; Ma, Chunyan; Li, Shujuan; Liu, Yuexing; Qiao, Zhenguo; Ma, Lingbo			Identification of Transcriptome-Derived Microsatellite Markers and Their Association with the Growth Performance of the Mud Crab (Scylla paramamosain)	PLOS ONE			English	Article							EXPLOITING EST DATABASES; SSR-MARKERS; GENE; POPULATION; TRAITS	Microsatellite markers from a transcriptome sequence library were initially isolated, and their genetic variation was characterized in a wild population of the mud crab (Scylla paramamosain). We then tested the association between these microsatellite markers and the growth performance of S. paramamosain. A total of 129 polymorphic microsatellite markers were identified, with an observed heterozygosity ranging from 0.19 to 1.00 per locus, an expected heterozygosity ranging from 0.23 to 0.96 per locus, and a polymorphism information content (PIC) ranging from 0.21 to 0.95 per locus. Of these microsatellite markers, 30 showed polymorphism in 96 full-sib individuals of a first generation family. Statistical analysis indicated that three microsatellite markers were significantly associated with 12 growth traits of S. paramamosain. Of these three markers, locus Scpa36 was significantly associated with eight growth traits, namely, carapace length, abdomen width (AW), body height (BH), fixed finger length of the claw, fixed finger width of the claw, fixed finger height of the claw, meropodite length of pereiopod 2, and meropodite length of pereiopod 3 (MLP3) (P<0.05). Locus Scpa75 was significantly associated with five growth traits, namely, internal carapace width, AW, carapace width at spine 8, distance between lateral spine 2 (DLS2), and MLP3 (P<0.05). Locus Spm30 was significantly associated with BH, DLS2, and body weight (P<0.05). Further analysis suggested a set of genotypes (BC at Scpa36, BC and BD at Scpa75, and AC at Spm30) that have great potential in the selection of S. paramamosain for growth traits. These findings will facilitate the development of population conservation genetics and molecular marker-assisted selective breeding of S. paramamosain and other closely related species.	[Ma, Hongyu; Jiang, Wei; Feng, Nana; Ma, Qunqun; Ma, Chunyan; Li, Shujuan; Liu, Yuexing; Qiao, Zhenguo; Ma, Lingbo] Chinese Acad Fishery Sci, East China Sea Fisheries Res Inst, Shanghai, Peoples R China; [Ma, Hongyu; Jiang, Wei; Feng, Nana; Ma, Qunqun; Ma, Chunyan; Li, Shujuan; Liu, Yuexing; Qiao, Zhenguo; Ma, Lingbo] Minist Agr, Key Lab East China Sea & Ocean Fishery Resources, Shanghai, Peoples R China; [Ma, Hongyu; Liu, Ping] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China	Chinese Academy of Fishery Sciences; East China Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS	Ma, LB (corresponding author), Chinese Acad Fishery Sci, East China Sea Fisheries Res Inst, Shanghai, Peoples R China.	malingbo@vip.sina.com			National Natural Science Foundation of China [31001106]; National Non-Profit Institutes (East China Sea Fisheries Research Institute) [2011M05]; Fund of Key Laboratory of Sustainable Development of Marine Fisheries in Ministry of Agriculture of China (Yellow Sea Fisheries Research Institute) [2014]; Science and Technology Commission of Shanghai Municipality [10JC1418600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Non-Profit Institutes (East China Sea Fisheries Research Institute); Fund of Key Laboratory of Sustainable Development of Marine Fisheries in Ministry of Agriculture of China (Yellow Sea Fisheries Research Institute); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was supported by the National Natural Science Foundation of China (grant number 31001106), the National Non-Profit Institutes (East China Sea Fisheries Research Institute, grant number 2011M05), the Fund of Key Laboratory of Sustainable Development of Marine Fisheries in Ministry of Agriculture of China (Yellow Sea Fisheries Research Institute, grant number 2014), and the Science and Technology Commission of Shanghai Municipality (grant number 10JC1418600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chatterjee R, 2010, BIOCHEM GENET, V48, P71, DOI 10.1007/s10528-009-9296-5; Chen Meng, 2009, Dalian Shuichan Xueyuan Xuebao, V24, P311; Cui Hai-yu, 2011, Marine Fisheries, V33, P274; Du HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033311; Dudaniec RY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014333; Ellis JR, 2007, HEREDITY, V99, P125, DOI 10.1038/sj.hdy.6801001; Fishery Bureau of Ministry of Agriculture of China, 2012, MIN AGR CHIN CHIN FI; Fuji K, 2007, AQUACULTURE, V272, P291, DOI 10.1016/j.aquaculture.2007.07.210; [高保全 GAO Baoquan], 2008, [海洋水产研究, Marine Fisheries Research], V29, P44; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Jiang W, 2013, GENET MOL R IN PRESS; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Keenan C., 1999, ACAIR P; Keenan CP, 1998, RAFFLES B ZOOL, V46, P217; [李建林 LI Jian-lin], 2009, [中国水产科学, Journal of Fishery Sciences of China], V16, P824; Li SJ, 2013, BIOTECHNOL B, V11, P123; Li XH, 2009, FISHERIES SCI, V75, P351, DOI 10.1007/s12562-008-0051-3; Liu Lei, 2012, Journal of Fisheries of China, V36, P1034; Ma HY, 2013, GENE, V519, P120, DOI 10.1016/j.gene.2013.01.028; Ma HY, 2012, J EXP BIOL, V215, P3120, DOI 10.1242/jeb.071654; Ma HY, 2011, BIOCHEM SYST ECOL, V39, P419, DOI 10.1016/j.bse.2011.05.024; Ma HY, 2011, BIOCHEM SYST ECOL, V39, P371, DOI 10.1016/j.bse.2011.05.007; Ma HY, 2011, J WORLD AQUACULT SOC, V42, P591, DOI 10.1111/j.1749-7345.2011.00503.x; Ma HY, 2011, MOL BIOL REP, V38, P4749, DOI 10.1007/s11033-010-0612-2; Ma HY, 2010, J CRUSTACEAN BIOL, V30, P441, DOI 10.1651/09-3263.1; Ma HongYu, 2009, Wuhan University Journal of Natural Sciences, V14, P267, DOI 10.1007/s11859-009-0315-5; Ma QQ, 2013, BIOCHEM SYST ECOL, V49, P62, DOI 10.1016/j.bse.2013.03.013; Mukherjee K, 2009, J WORLD AQUACULT SOC, V40, P274, DOI 10.1111/j.1749-7345.2009.00250.x; Nguyen MT, 2010, AQUACULTURE, V301, P7, DOI 10.1016/j.aquaculture.2010.02.001; Perrine D., 1979, MANGROVE CRAB PONAPE; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Sanchez-Molano E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-473; Song WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052097; Takano M, 2005, MOL ECOL NOTES, V5, P794, DOI 10.1111/j.1471-8286.2005.01065.x; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Wang YP, 2007, MAR BIOTECHNOL, V9, P500, DOI 10.1007/s10126-007-9011-7; Weller J.I., 1994, EC ASPECTS ANIMAL BR; Xu XJ, 2009, CONSERV GENET, V10, P1877, DOI 10.1007/s10592-009-9843-y; Yalin S., 1994, Naga, V17, P28; [杨晶 Yang Jing], 2010, [中国水产科学, Journal of Fishery Sciences of China], V17, P721; Yeh F.C., 1999, MICROSOFT WINDOWS BA; Yu H, 2008, J HERED, V99, P208, DOI 10.1093/jhered/esm124; Yue GH, 2004, AQUACULTURE, V234, P85, DOI 10.1016/j.aquaculture.2003.12.021	43	16	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89134	10.1371/journal.pone.0089134	http://dx.doi.org/10.1371/journal.pone.0089134			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551232	Green Submitted, Green Published, gold			2022-12-27	WOS:000331266000106
J	Mukherjee, S; Heithaus, MR; Trexler, JC; Ray-Mukherjee, J; Vaudo, J				Mukherjee, Shomen; Heithaus, Michael R.; Trexler, Joel C.; Ray-Mukherjee, Jayanti; Vaudo, Jeremy			Perceived Risk of Predation Affects Reproductive Life-History Traits in Gambusia holbrooki, but Not in Heterandria formosa	PLOS ONE			English	Article							MATERNAL CORTISOL EXPOSURE; FARMED ATLANTIC SALMON; LIVEBEARING FISH; INDUCED STRESS; CLUTCH SIZE; QUALITY; IMPACT; EVOLUTION; ECOLOGY; GROWTH	Key to predicting impacts of predation is understanding the mechanisms through which predators impact prey populations. While consumptive effects are well-known, non-consumptive predator effects (risk effects) are increasingly being recognized as important. Studies of risk effects, however, have focused largely on how trade-offs between food and safety affect fitness. Less documented, and appreciated, is the potential for predator presence to directly suppress prey reproduction and affect life-history characteristics. For the first time, we tested the effects of visual predator cues on reproduction of two prey species with different reproductive modes, lecithotrophy (i.e. embryonic development primarily fueled by yolk) and matrotrophy (i.e. energy for embryonic development directly supplied by the mother to the embryo through a vascular connection). Predation risk suppressed reproduction in the lecithotrophic prey (Gambusia holbrokii) but not the matrotroph (Heterandria formosa). Predator stress caused G. holbrooki to reduce clutch size by 43%, and to produce larger and heavier offspring compared to control females. H. formosa, however, did not show any such difference. In G. holbrooki we also found a significantly high percentage (14%) of stillbirths in predator-exposed treatments compared to controls (2%). To the best of our knowledge, this is the first direct empirical evidence of predation stress affecting stillbirths in prey. Our results suggest that matrotrophy, superfetation (clutch overlap), or both decrease the sensitivity of mothers to environmental fluctuation in resource (food) and stress (predation risk) levels compared to lecithotrophy. These mechanisms should be considered both when modeling consequences of perceived risk of predation on prey-predator population dynamics and when seeking to understand the evolution of reproductive modes.	[Mukherjee, Shomen; Heithaus, Michael R.; Trexler, Joel C.; Ray-Mukherjee, Jayanti; Vaudo, Jeremy] Florida Int Univ, Dept Biol Sci, North Miami, FL USA; [Mukherjee, Shomen; Ray-Mukherjee, Jayanti] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa	State University System of Florida; Florida International University; University of Kwazulu Natal	Mukherjee, S (corresponding author), Florida Int Univ, Dept Biol Sci, North Miami, FL USA.	shomenm@gmail.com	Trexler, Joel C/I-5265-2012; Heithaus, Michael/AAF-9914-2020	Heithaus, Michael/0000-0002-3219-1003; Mukherjee, Shomen/0000-0002-2974-4447	School of Environment, Arts and Society; Florida International University Open Access Publishing Fund; Florida Coastal Everglades Long-Term Ecological Research program under National Science Foundation [DBI-0620409]; Division Of Environmental Biology [1237517] Funding Source: National Science Foundation	School of Environment, Arts and Society; Florida International University Open Access Publishing Fund; Florida Coastal Everglades Long-Term Ecological Research program under National Science Foundation; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	SM was supported by School of Environment, Arts and Society. Publication of this article was funded in part by Florida International University Open Access Publishing Fund. This material was developed in collaboration with the Florida Coastal Everglades Long-Term Ecological Research program under National Science Foundation Grant No. DBI-0620409. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banet AI, 2008, FUNCT ECOL, V22, P323, DOI 10.1111/j.1365-2435.2007.01367.x; Blessing JJ, 2010, J FISH BIOL, V76, P2571, DOI 10.1111/j.1095-8649.2010.02633.x; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Boonstra R, 1998, ECOL MONOGR, V68, P371, DOI 10.1890/0012-9615(1998)068[0371:TIOPIS]2.0.CO;2; Clinchy M, 2004, P ROY SOC B-BIOL SCI, V271, P2473, DOI 10.1098/rspb.2004.2913; Clinchy M, 2013, FUNCT ECOL, V27, P56, DOI 10.1111/1365-2435.12007; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; Creel S, 2007, SCIENCE, V315, P960, DOI 10.1126/science.1135918; Creel S, 2009, P NATL ACAD SCI USA, V106, P12388, DOI 10.1073/pnas.0902235106; CROWL TA, 1990, SCIENCE, V247, P949, DOI 10.1126/science.247.4945.949; Edwards TM, 2006, ENVIRON HEALTH PERSP, V114, P69, DOI 10.1289/ehp.8056; Eggers S, 2006, P ROY SOC B-BIOL SCI, V273, P701, DOI 10.1098/rspb.2005.3373; Eriksen MS, 2006, J FISH BIOL, V69, P114, DOI 10.1111/j.1095-8649.2006.01071.x; Espmark AM, 2008, APPL ANIM BEHAV SCI, V110, P404, DOI 10.1016/j.applanim.2007.04.003; Evans JP, 2007, BEHAV ECOL SOCIOBIOL, V61, P719, DOI 10.1007/s00265-006-0302-1; FRASER DF, 1992, ECOLOGY, V73, P959, DOI 10.2307/1940172; Giesing ER, 2011, P ROY SOC B-BIOL SCI, V278, P1753, DOI 10.1098/rspb.2010.1819; Haake PW, 1983, SFRC8303; Hawlena D, 2010, AM NAT, V176, P537, DOI 10.1086/656495; Konnert TJ, 2002, THESIS; Leips J, 2009, EVOLUTION, V63, P1341, DOI 10.1111/j.1558-5646.2009.00631.x; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; MARSH-MATTHEWS E., 2010, VIVIPAROUS FISHES, P255; McCormick MI, 1998, ECOLOGY, V79, P1873, DOI 10.1890/0012-9658(1998)079[1873:BIMSIA]2.0.CO;2; Norrdahl K, 2000, MAMMAL REV, V30, P147, DOI 10.1046/j.1365-2907.2000.00064.x; PECKARSKY BL, 1993, ECOLOGY, V74, P1836, DOI 10.2307/1939941; Pires Marcelo N., 2011, P28; Pollux BJA, 2011, FUNCT ECOL, V25, P747, DOI 10.1111/j.1365-2435.2011.01831.x; Pyke GH, 2005, REV FISH BIOL FISHER, V15, P339, DOI 10.1007/s11160-006-6394-x; REZNICK D, 1993, ECOLOGY, V74, P2011, DOI 10.2307/1940844; Reznick D, 1996, AM ZOOL, V36, P147; REZNICK D, 1982, EVOLUTION, V36, P160, DOI 10.1111/j.1558-5646.1982.tb05021.x; Reznick DN, 2001, GENETICA, V112, P183, DOI 10.1023/A:1013352109042; Riesch R, 2013, AM NAT, V181, P78, DOI 10.1086/668597; Ruxton GD, 1997, P ROY SOC B-BIOL SCI, V264, P409, DOI 10.1098/rspb.1997.0058; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Schreck CB, 2001, AQUACULTURE, V197, P3, DOI 10.1016/S0044-8486(01)00580-4; Schurch R, 2005, BEHAVIOUR, V142, P265, DOI 10.1163/1568539053778274; SCRIMSHAW NS, 1945, BIOL BULL, V88, P233, DOI 10.2307/1538312; Sheriff MJ, 2013, ECOL LETT, V16, P271, DOI 10.1111/ele.12042; Sheriff MJ, 2010, ECOLOGY, V91, P2983, DOI 10.1890/09-1108.1; Sheriff MJ, 2009, J ANIM ECOL, V78, P1249, DOI 10.1111/j.1365-2656.2009.01552.x; Stearns S.C., 1992, pi; THIBAULT RE, 1978, EVOLUTION, V32, P320, DOI 10.1111/j.1558-5646.1978.tb00648.x; Travers M, 2010, ECOL LETT, V13, P980, DOI 10.1111/j.1461-0248.2010.01488.x; TRAVIS J, 1987, ECOLOGY, V68, P611, DOI 10.2307/1938466; Trexler JC, 1997, ECOLOGY, V78, P1370, DOI 10.1890/0012-9658(1997)078[1370:RAAPIO]2.0.CO;2; Trexler JC, 2003, AM NAT, V162, P574, DOI 10.1086/378822; TREXLER JC, 1992, ECOLOGY, V73, P2224, DOI 10.2307/1941470; Trexler Joel C., 2011, P95; Turner CL, 1940, J MORPHOL, V67, P59, DOI 10.1002/jmor.1050670103; WERNER EE, 1986, AM NAT, V128, P319, DOI 10.1086/284565; Wingfield JC, 2003, J NEUROENDOCRINOL, V15, P711, DOI 10.1046/j.1365-2826.2003.01033.x; Wingfield JC, 1998, AM ZOOL, V38, P191, DOI 10.1093/icb/38.1.191; YLONER H, 1989, OIKOS, V55, P138, DOI 10.2307/3565886; Zanette LY, 2011, SCIENCE, V334, P1398, DOI 10.1126/science.1210908; Zuniga-Vega JJ, 2007, OIKOS, V116, P995, DOI 10.1111/j.2007.0030-1299.15763.x	58	29	29	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88832	10.1371/journal.pone.0088832	http://dx.doi.org/10.1371/journal.pone.0088832			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551171	Green Published, Green Submitted, gold			2022-12-27	WOS:000331266000073
J	Yiengprugsawan, V; Berecki-Gisolf, J; McClure, R; Kelly, M; Seubsman, SA; Sleigh, AC				Yiengprugsawan, Vasoontara; Berecki-Gisolf, Janneke; McClure, Roderick; Kelly, Matthew; Seubsman, Sam-ang; Sleigh, Adrian C.		Cohort Study Team	The Effect of Injuries on Health Measured by Short Form 8 among a Large Cohort of Thai Adults	PLOS ONE			English	Article							ROAD TRAFFIC INJURIES; GLOBAL BURDEN; UNINTENTIONAL INJURY; HOUSEHOLD SURVEYS; OPEN-UNIVERSITY; RISK-FACTORS; LOW-INCOME; PREVENTION; QUALITY	Introduction: We investigate the links between health and injury in Thailand. This is important because of the high burden of injury in transitional countries and limited information for public health. Methods: We analyse 2005 baseline and 2009, 4-year follow-up data from distance learning students of Sukhothai Thammathirat Open University residing nationwide (n = 60569). Injury was reported for the past year in both periods. Medical Outcome Study Short-Form (SF-8 (TM)) health status was reported and Physical and Mental Component Summary Scores (PCS and MCS) were calculated. Analyses used covariate-adjusted multivariate linear regression. Results: In 2009, increasing numbers of traffic injuries (0, 1, 2, 3, 4+) associated with declining PCS scores (49.8, 48.4, 46.9, 46.2, 44.0), along with a similar monotonic decline for MCS scores (47.6, 46.0, 44.2, 42.7, 40.6). A similar (but smaller) dose-response gradient was found between non-traffic injuries and SF-8 scores. Longitudinal analyses showed those with incident injury (no injury 2005, injury 2009) had lower PCS and MCS scores compared to those with no injury in both periods. Individuals with reverting injury status (injury 2005, no injury 2009) reported improvement in PCS and MCS scores over the four-year period. Conclusion: We found significant and epidemiologically important associations between increasing injury frequency and worse health in the past year, especially traffic injuries. Longitudinal 2005-2009 results were supportive and revealed statistically significant adverse 4-year effects of incident injury on health. If injury reverted over four years, low initial scores improved greatly. Findings highlight the importance of injury prevention as a public health priority.	[Yiengprugsawan, Vasoontara; Kelly, Matthew; Seubsman, Sam-ang; Sleigh, Adrian C.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Berecki-Gisolf, Janneke; McClure, Roderick] Monash Univ, Monash Injury Res Inst, Melbourne, Vic 3004, Australia; [Seubsman, Sam-ang] Sukhothai Thammathirat Open Univ, Sch Human Ecol, Nonthaburi, Thailand	Australian National University; Monash University; Sukhothai Thammathirat Open University	Yiengprugsawan, V (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia.	vasoontara.yieng@anu.edu.au	Harley, David O/C-1326-2010; Yiengprugsawan, Vas Sbirakos/G-3176-2011; Yiengprugsawan, Vasoontara/N-7072-2013; Harley, David/B-4910-2017; Kelly, Matthew/ABC-1069-2020; sleigh, adrian/J-4540-2019	Yiengprugsawan, Vas Sbirakos/0000-0001-9101-4704; Yiengprugsawan, Vasoontara/0000-0001-9101-4704; Harley, David/0000-0001-6691-5420; Kelly, Matthew/0000-0001-7963-2139; sleigh, adrian/0000-0001-8443-7864; McClure, Roderick/0000-0002-9067-8282; Seubsman, Sam-ang/0000-0002-7451-3218	International Collaborative Research Grants Scheme; Wellcome Trust UK [GR071587MA]; Australian National Health and Medical Research Council -NHMRC [268055]; global health grant from the NHMRC [585426]	International Collaborative Research Grants Scheme; Wellcome Trust UK(Wellcome Trust); Australian National Health and Medical Research Council -NHMRC(National Health and Medical Research Council (NHMRC) of Australia); global health grant from the NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the International Collaborative Research Grants Scheme with joint grants from the Wellcome Trust UK (GR071587MA) and the Australian National Health and Medical Research Council -NHMRC (268055), and as a global health grant from the NHMRC (585426). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhalla K, 2009, PLOS MED, V6, P22, DOI 10.1371/journal.pmed.1000001; Bundhamcharoen K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-53; Cameron CM, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-114; Chadbunchachai Witaya, 2012, J Med Assoc Thai, V95 Suppl 7, pS274; Cohen L, 2003, J SAFETY RES, V34, P473, DOI 10.1016/j.jsr.2003.03.005; Connor J, 2004, EPIDEMIOLOGY, V15, P337, DOI 10.1097/01.ede.0000120045.58295.86; Cunningham R, 2010, NEW ZEAL MED J, V123, P35; Ditsuwan V, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-2; Fingerhut LA, 2005, AM J PUBLIC HEALTH, V95, P1089, DOI 10.2105/AJPH.2005.064469; Fitzharris Michael, 2007, Traffic Inj Prev, V8, P309, DOI 10.1080/15389580701216533; Forchheimer M, 2004, AM J PHYS MED REHAB, V83, P390, DOI 10.1097/01.PHM.0000124441.78275.C9; Gamsiz Bilgin N, 2012, ACTA ORTHOP TRAUMATO, V46, P168, DOI 10.3944/AOTT.2012.2673; Ham OK, 2008, PUBLIC HEALTH NURS, V25, P37, DOI 10.1111/j.1525-1446.2008.00678.x; Heinen M, 2004, INJURY PREV, V10, P327, DOI 10.1136/ip.2004.005991; Herbert HK, 2011, INFECT DIS CLIN N AM, V25, P653, DOI 10.1016/j.idc.2011.06.004; Hong TT, 2009, HEALTH INF MANAG J, V38, P15, DOI 10.1177/183335830903800103; Johnston BD, 2008, INJURY PREV, V14, P145, DOI 10.1136/ip.2008.019265; Laursen B, 2012, DAN MED J, V59; Li WJ, 2006, AM J PUBLIC HEALTH, V96, P1192, DOI 10.2105/AJPH.2005.083055; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; LIN KH, 2013, J OCCUP REHABIL; Littleton SM, 2012, INJURY, V43, P1586, DOI 10.1016/j.injury.2011.03.002; Lyons R, 2010, INJURY PREV, V16, P145, DOI 10.1136/ip.2009.025833; Nakahara S, 2006, J TRAUMA, V61, P768, DOI 10.1097/01.ta.0000236033.25861.aa; O'Donnell ML, 2013, J CLIN PSYCHIAT, V74, pE137, DOI 10.4088/JCP.12m08011; Palmer KT, 2008, OCCUP ENVIRON MED, V65, P757, DOI 10.1136/oem.2007.037440; Peden M, 2002, BRIT MED J, V324, P1153, DOI 10.1136/bmj.324.7346.1153; Petridou E, 2004, EPIDEMIOLOGY, V15, P428, DOI 10.1097/01.ede.0000129519.76945.0d; Polinder S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-783; Seubsman SA, 2012, ASEAN J OPEN DISTANC, V4, P58; Siriruttanapruk S, 2004, IND HEALTH, V42, P135, DOI 10.2486/indhealth.42.135; Sleet DA, 2004, AM J HEALTH BEHAV, V28, pS6; Sleigh AC, 2008, INT J EPIDEMIOL, V37, P266, DOI 10.1093/ije/dym161; Stephan K, 2011, ACCIDENT ANAL PREV, V43, P1062, DOI 10.1016/j.aap.2010.12.011; Stephan K, 2010, SE ASIAN J TROP MED, V41, P1220; Stevenson M, 2009, INJURY PREV, V15, P1, DOI 10.1136/ip.2008.020792; Tawatsupa B, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001396; Tawatsupa B, 2013, IND HEALTH, V51, P34, DOI 10.2486/indhealth.2012-0138; Thepaksorn P, 2007, INT J OCCUP ENV HEAL, V13, P290, DOI 10.1179/oeh.2007.13.3.290; Toft AMH, 2010, J TRAUMA, V69, P26, DOI 10.1097/TA.0b013e3181d3cbf2; Ware JE Jr, 2001, SCORE INTERPRET SING; Wibulpolprasert S., 2011, THAILAND HLTH PROFIL; Yiengprugsawan V, 2012, PUBLIC HEALTH, V126, P33, DOI 10.1016/j.puhe.2011.09.027; Yiengprugsawan V, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-172; Zaloshnja E, 2005, AM J PREV MED, V28, P88, DOI 10.1016/j.amepre.2004.09.016	45	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88903	10.1371/journal.pone.0088903	http://dx.doi.org/10.1371/journal.pone.0088903			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7GP	24551187	Green Published, gold			2022-12-27	WOS:000331266000081
J	Barbey, AK; Colom, R; Paul, E; Forbes, C; Krueger, F; Goldman, D; Grafman, J				Barbey, Aron K.; Colom, Roberto; Paul, Erick; Forbes, Chad; Krueger, Frank; Goldman, David; Grafman, Jordan			Preservation of General Intelligence following Traumatic Brain Injury: Contributions of the Met66 Brain-Derived Neurotrophic Factor	PLOS ONE			English	Article							BDNF VAL66MET POLYMORPHISM; ACTIVITY-DEPENDENT SECRETION; FAMILY-BASED ASSOCIATION; CARD SORTING TEST; ALZHEIMERS-DISEASE; NEURONAL DEVELOPMENT; RECEPTOR SORTILIN; BIPOLAR DISORDER; EPISODIC MEMORY; WORKING-MEMORY	Brain-derived neurotrophic factor (BDNF) promotes survival and synaptic plasticity in the human brain. The Val66Met polymorphism of the BDNF gene interferes with intracellular trafficking, packaging, and regulated secretion of this neurotrophin. The human prefrontal cortex (PFC) shows lifelong neuroplastic adaption implicating the Val66Met BDNF polymorphism in the recovery of higher-order executive functions after traumatic brain injury (TBI). In this study, we examined the effect of this BDNF polymorphism on the preservation of general intelligence following TBI. We genotyped a sample of male Vietnam combat veterans (n = 156) consisting of a frontal lobe lesion group with focal penetrating head injuries for the Val66Met BDNF polymorphism. Val/Met did not differ from Val/Val genotypes in general cognitive ability before TBI. However, we found substantial average differences between these groups in general intelligence (approximate to half a standard deviation or 8 IQ points), verbal comprehension (6 IQ points), perceptual organization (6 IQ points), working memory (8 IQ points), and processing speed (8 IQ points) after TBI. These results support the conclusion that Val/Met genotypes preserve general cognitive functioning, whereas Val/Val genotypes are largely susceptible to TBI.	[Barbey, Aron K.; Paul, Erick] Univ Illinois, Decis Neurosci Lab, Urbana, IL 61801 USA; [Barbey, Aron K.; Paul, Erick] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Barbey, Aron K.] Univ Illinois, Dept Internal Med, Champaign, IL 61820 USA; [Barbey, Aron K.] Univ Illinois, Dept Psychol, Champaign, IL 61820 USA; [Barbey, Aron K.] Univ Illinois, Dept Speech & Hearing Sci, Champaign, IL 61820 USA; [Barbey, Aron K.] Univ Illinois, Neurosci Program, Champaign, IL 61820 USA; [Colom, Roberto] Univ Autonoma Madrid, Fdn CIEN, Fdn Reina Sofia, Madrid, Spain; [Forbes, Chad] Univ Delaware, Dept Psychol, Delaware, MD USA; [Krueger, Frank] George Mason Univ, Dept Mol Neurosci, Fairfax, VA USA; [Goldman, David] NIAAA, Neurogenet Lab, NIH, Bethesda, MD USA; [Grafman, Jordan] Rehabil Inst Chicago, Traumat Brain Injury Res Lab, Chicago, IL 60611 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Autonomous University of Madrid; University of Delaware; George Mason University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Shirley Ryan AbilityLab	Barbey, AK (corresponding author), Univ Illinois, Decis Neurosci Lab, Urbana, IL 61801 USA.	barbey@illinois.edu; jgrafman@ric.edu	Goldman, David/F-9772-2010; Colom, Roberto/F-8779-2010; Barbey, Aron/L-7312-2015; Majid, Salma/AAT-2616-2020	Goldman, David/0000-0002-1724-5405; Colom, Roberto/0000-0001-5865-163X; Barbey, Aron/0000-0002-6092-0912; Majid, Salma/0000-0002-1724-5405	U.S. National Institute of Neurological Disorders and Stroke; United States Army Medical Research and Material Command [DAMD17-01-1-0675]; Ministerio de Ciencia e Innovacion [Ministry of Science and Innovation, Spain] [PSI2010-20364]; Universidad Autonoma de Madrid [CEMU-2012-004]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000301] Funding Source: NIH RePORTER	U.S. National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); United States Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Ministerio de Ciencia e Innovacion [Ministry of Science and Innovation, Spain](Ministry of Science and Innovation, Spain (MICINN)); Universidad Autonoma de Madrid; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by funding from the U.S. National Institute of Neurological Disorders and Stroke intramural research program and a project grant from the United States Army Medical Research and Material Command administered by the Henry M. Jackson Foundation (Vietnam Head Injury Study Phase III: a 30-year post-injury follow-up study, grant number DAMD17-01-1-0675). R. Colom was supported by grant PSI2010-20364 from Ministerio de Ciencia e Innovacion [Ministry of Science and Innovation, Spain] and and CEMU-2012-004 [Universidad Autonoma de Madrid]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shawi R, 2008, EUR J NEUROSCI, V27, P2103, DOI 10.1111/j.1460-9568.2008.06152.x; Arbuckle J. L., 2006, AMOS VERSION 7 0 COM; Bamdad MJ, 2003, BRAIN INJURY, V17, P1011, DOI 10.1080/0269905031000110553; Barbey AK, 2012, CORTEX; Barbey AK, 2011, CEREB CORTEX, V21, P789, DOI 10.1093/cercor/bhq153; Bath KG, 2006, COGN AFFECT BEHAV NE, V6, P79, DOI 10.3758/CABN.6.1.79; Beste C, 2010, NEUROSCIENCE, V166, P178, DOI 10.1016/j.neuroscience.2009.12.022; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Chiaretti A, 2003, INTENS CARE MED, V29, P1329, DOI 10.1007/s00134-003-1852-6; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Dempster E, 2005, AM J MED GENET B, V134B, P73, DOI 10.1002/ajmg.b.30150; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Frustaci A, 2008, NEUROPSYCHOBIOLOGY, V58, P163, DOI 10.1159/000182892; Gratacos M, 2007, BIOL PSYCHIAT, V61, P911, DOI 10.1016/j.biopsych.2006.08.025; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Ho BC, 2007, AM J PSYCHIAT, V164, P1890, DOI 10.1176/appi.ajp.2007.05111903; Ho BC, 2006, ARCH GEN PSYCHIAT, V63, P731, DOI 10.1001/archpsyc.63.7.731; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Joober R, 2002, ARCH GEN PSYCHIAT, V59, P662, DOI 10.1001/archpsyc.59.7.662; Koenigs M, 2009, J NEUROSCI, V29, P14980, DOI 10.1523/JNEUROSCI.3706-09.2009; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Kunugi H, 2001, MOL PSYCHIATR, V6, P83, DOI 10.1038/sj.mp.4000792; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; Lu B, 2003, NEURON, V39, P735, DOI 10.1016/S0896-6273(03)00538-5; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister TW, 2012, J NEUROTRAUM, V29, P1111, DOI 10.1089/neu.2011.1930; Montag C, 2009, PSYCHOL MED, V39, P1831, DOI 10.1017/S0033291709005509; Neves-Pereira M, 2002, AM J HUM GENET, V71, P651, DOI 10.1086/342288; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Oroszi G, 2006, ANN RHEUM DIS, V65, P1330, DOI 10.1136/ard.2006.051623; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Riemenschneider M, 2002, MOL PSYCHIATR, V7, P782, DOI 10.1038/sj.mp.4001073; Romanczyk TB, 2002, EUR J NEUROSCI, V15, P269, DOI 10.1046/j.0953-816x.2001.01858.x; Rostami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027389; Rybakowski JK, 2003, BIPOLAR DISORD, V5, P468, DOI 10.1046/j.1399-5618.2003.00071.x; Rybakowski JK, 2006, MOL PSYCHIATR, V11, P122, DOI 10.1038/sj.mp.4001765; Siironen J, 2007, STROKE, V38, P2858, DOI 10.1161/STROKEAHA.107.485441; Sklar P, 2002, MOL PSYCHIATR, V7, P579, DOI 10.1038/sj.mp.4001058; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Tan YL, 2005, SCHIZOPHR RES, V77, P355, DOI 10.1016/j.schres.2005.03.012; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ventriglia M, 2002, MOL PSYCHIATR, V7, P136, DOI 10.1038/sj.mp.4000952; Volosin M, 2006, J NEUROSCI, V26, P7756, DOI 10.1523/JNEUROSCI.1560-06.2006; Wechsler D., 1997, WECHSLER ADULT INTEL; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; Zivadinov R, 2007, HUM MOL GENET, V16, P2659, DOI 10.1093/hmg/ddm189	59	47	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e88733	10.1371/journal.pone.0088733	http://dx.doi.org/10.1371/journal.pone.0088733			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586380	Green Published, gold, Green Submitted			2022-12-27	WOS:000332389000017
J	Yu, WJ; Li, NN; Tan, EK; Cheng, L; Zhang, JH; Mao, XY; Chang, L; Zhao, DM; Liao, Q; Peng, R				Yu, Wen Juan; Li, Nan Nan; Tan, Eng King; Cheng, Lan; Zhang, Jin Hong; Mao, Xue Ye; Chang, Li; Zhao, Dong Mei; Liao, Qiao; Peng, Rong			No Association of Four Candidate Genetic Variants in MnSOD and SYNIII with Parkinson's Disease in Two Chinese Populations	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; SYNAPSIN-III; POLYMORPHISMS; EXPRESSION; RISK	Background: The manganese superoxide dismutase (MnSOD) gene, which encodes a chief reactive oxygen species (ROS) scavenging enzyme, has been reported to be associated with the risk of developing sporadic Parkinson's disease (PD) in some Asian races and the synapsin III (SYN3) gene with some neuropsychiatric diseases. Objective: To explore the associations between the MnSOD and SYN III variations and PD in two Chinese populations from mainland China and Singapore. Methods: We recruited 2342 subjects including 1200 sporadic PD patients and 1142 healthy controls from two independent Asian countries. Using a case-control methodology, we genotyped the single nucleotide polymorphisms (SNP) in MnSOD (rs4880) and SYN III (rs3788470, rs3827336, rs5998557) to explore the associations with risk of PD. Results: The results showed the genotype distributions and minor allele frequencies (MAF) of MnSOD (rs4880) and SYN III (rs3788470, rs3827336, rs5998557) were not significantly different between PD patients and healthy controls in mainland China and Singapore, as well as in merged populations. Conclusions: The variations of MnSOD (rs4880) and SYN III (rs3788470, rs3827336, rs5998557) were not major risk factors for PD among Chinese, at least in our study populations.	[Yu, Wen Juan; Li, Nan Nan; Cheng, Lan; Zhang, Jin Hong; Mao, Xue Ye; Chang, Li; Zhao, Dong Mei; Liao, Qiao; Peng, Rong] Sichuan Univ, West China Hosp, Dept Neurol, Chengdu 610064, Sichuan Provinc, Peoples R China; [Tan, Eng King] Duke NUS Grad Med Sch, Singapore, Singapore; [Tan, Eng King] Singapore Gen Hosp, Natl Inst Neurosci, Dept Neurol, Singapore, Singapore; [Zhang, Jin Hong] Sichuan Univ, Wangjiang Hosp, Dept Internal Med, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University; National University of Singapore; National Neuroscience Institute (NNI); Singapore General Hospital; Sichuan University	Peng, R (corresponding author), Sichuan Univ, West China Hosp, Dept Neurol, Chengdu 610064, Sichuan Provinc, Peoples R China.	qrpeng@hotmail.com			Science and Technology Support Program, Science and Technology Department of Sichuan province [2013SZ0003]	Science and Technology Support Program, Science and Technology Department of Sichuan province	This work was supported by the Science and Technology Support Program, Science and Technology Department of Sichuan province. The grant numbers are 2013SZ0003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Callio J, 2005, J BIOL CHEM, V280, P18536, DOI 10.1074/jbc.M413224200; Chen Q, 2009, NEUROSCI LETT, V465, P248, DOI 10.1016/j.neulet.2009.09.032; D'Alfonso S, 1999, EUR J HUM GENET, V7, P377, DOI 10.1038/sj.ejhg.5200301; deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10; Farin FM, 2001, MOVEMENT DISORD, V16, P705, DOI 10.1002/mds.1153; Feng J, 2002, J NEUROSCI, V22, P4372, DOI 10.1523/JNEUROSCI.22-11-04372.2002; Ferreira A, 2000, J NEUROSCI, V20, P3736, DOI 10.1523/JNEUROSCI.20-10-03736.2000; Fong CS, 2007, CLIN CHIM ACTA, V378, P136, DOI 10.1016/j.cca.2006.11.006; Grasbon-Frodl EM, 1999, BIOCHEM BIOPH RES CO, V255, P749, DOI 10.1006/bbrc.1998.9998; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Kile BM, 2010, J NEUROSCI, V30, P9762, DOI 10.1523/JNEUROSCI.2071-09.2010; Makkar R, 2007, PSYCHIAT GENET, V17, P109, DOI 10.1097/YPG.0b013e328012a0c6; Otaegui D, 2009, MULT SCLER J, V15, P124, DOI 10.1177/1352458508096682; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; PARBOOSINGH JS, 1995, ARCH NEUROL-CHICAGO, V52, P1160, DOI 10.1001/archneur.1995.00540360038013; Rajaraman P, 2008, NEURO-ONCOLOGY, V10, P709, DOI 10.1215/15228517-2008-037; ShimodaMatsubayashi S, 1997, NEUROLOGY, V49, P1257, DOI 10.1212/WNL.49.5.1257; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Vallada H, 1998, SCHIZOPHR RES, V32, P115; Warner TT, 2003, ANN NEUROL, V53, pS16, DOI 10.1002/ana.10487; Wiener HW, 2007, GENES BRAIN BEHAV, V6, P770, DOI 10.1111/j.1601-183X.2007.00308.x; Yoo MS, 2003, MOL BRAIN RES, V110, P76, DOI 10.1016/S0169-328X(02)00586-7; ZHANG P, 1994, NEUROSCIENCE, V61, P317, DOI 10.1016/0306-4522(94)90234-8; ZHANG P, 1993, NEUROSCIENCE, V55, P167, DOI 10.1016/0306-4522(93)90463-P	25	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e88050	10.1371/journal.pone.0088050	http://dx.doi.org/10.1371/journal.pone.0088050			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586301	Green Submitted, Green Published, gold			2022-12-27	WOS:000332389000007
J	Su, SH; Wang, F; Hai, J; Liu, NT; Yu, F; Wu, YF; Zhu, YH				Su, Shao-Hua; Wang, Fei; Hai, Jian; Liu, Ning-Tao; Yu, Fei; Wu, Yi-Fang; Zhu, You-Hou			The Effects of Intracranial Pressure Monitoring in Patients with Traumatic Brain Injury	PLOS ONE			English	Article							SEVERE HEAD-INJURY; INTENSIVE-CARE; EUROPEAN-BRAIN; MANAGEMENT; MORTALITY	Background: Although international guideline recommended routine intracranial pressure (ICP) monitoring for patients with severe traumatic brain injury(TBI), there were conflicting outcomes attributable to ICP monitoring according to the published studies. Hence, we conducted a meta-analysis to evaluate the efficacy and safety of ICP monitoring in patients with TBI. Methods: Based on previous reviews, PubMed and two Chinese databases (Wangfang and VIP) were further searched to identify eligible studies. The primary outcome was mortality. Secondary outcomes included unfavourable outcome, adverse events, length of ICU stay and length of hospital stay. Weighted mean difference (WMD), odds ratio (OR) and 95% confidence intervals (CIs) were calculated and pooled using fixed-effects or random-effects model. Results: two randomized controlled trials (RCTs) and seven cohort studies involving 11,038 patients met the inclusion criteria. ICP monitoring was not associated with a significant reduction in mortality (OR, 1.16; 95% CI, 0.87-1.54), with substantial heterogeneity (I-2 = 80%, P < 0.00001), which was verified by the sensitivity analyses. No significant difference was found in the occurrence of unfavourable outcome (OR, 1.40; 95% CI, 0.99-1.98; I-2 = 4%, P = 0.35) and advese events (OR, 1.04; 95% CI, 0.64-1.70; I-2 = 78%, P = 0.03). However, we should be cautious to the result of adverse events because of the substantial heterogeneity in the comparison. Furthermore, longer ICU and hospital stay were the consistent tendency according to the pooled studies. Conclusions: No benefit was found in patients with TBI who underwent ICP monitoring. Considering substantial clinical heterogeneity, further large sample size RCTs are needed to confirm the current findings.	[Su, Shao-Hua; Wang, Fei; Hai, Jian; Liu, Ning-Tao; Yu, Fei; Wu, Yi-Fang; Zhu, You-Hou] Tongji Univ, Sch Med, Tongji Hosp, Dept Neurosurg, Shanghai 200092, Peoples R China	Tongji University	Wang, F (corresponding author), Tongji Univ, Sch Med, Tongji Hosp, Dept Neurosurg, Shanghai 200092, Peoples R China.	wangfeidoc@163.com		Su, Shao-Hua/0000-0001-7911-5406				Andrews PJD, 2008, INTENS CARE MED, V34, P1362, DOI 10.1007/s00134-008-1103-y; Biersteker HAR, 2012, CRIT CARE MED, V40, P1914, DOI 10.1097/CCM.0b013e3182474bde; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Enblad P, 2004, INTENS CARE MED, V30, P1058, DOI 10.1007/s00134-004-2206-8; Forsyth RJ, 2010, COCHRANE DB SYST REV, V17; Griesdale DEG, 2010, CAN J NEUROL SCI, V37, P43, DOI 10.1017/S031716710000963X; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Kostic Aleksandar, 2011, Med Pregl, V64, P461; Kristiansson H, 2013, J NEUROSURG ANESTH, V25, P372, DOI 10.1097/ANA.0b013e31829795ce; Lane PL, 2000, CAN J SURG, V43, P442; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; Mauritz W, 2007, WIEN KLIN WOCHENSCHR, V119, P46, DOI 10.1007/s00508-006-0763-2; Mendelson AA, 2012, CAN J NEUROL SCI, V39, P571, DOI 10.1017/S0317167100015286; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; OConnell D, 2019, NEWCASTLE OTTAWA SCA; Padayachy LC, 2010, CHILD NERV SYST, V26, P441, DOI 10.1007/s00381-009-1034-0; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A	25	22	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e87432	10.1371/journal.pone.0087432	http://dx.doi.org/10.1371/journal.pone.0087432			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586276	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900011
J	Liu, ZL; Ke, LN; Liu, HF; Huang, WH; Hu, ZH				Liu, Zhiliang; Ke, Lining; Liu, Huafeng; Huang, Wenhua; Hu, Zhenghui			Changes in Topological Organization of Functional PET Brain Network with Normal Aging	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; SMALL-WORLD NETWORKS; AGE-RELATED-CHANGES; COMPLEX NETWORKS; CORTICAL NETWORKS; ANATOMICAL NETWORK; CLINICAL-DIAGNOSIS; ALZHEIMERS-DISEASE; DEFAULT NETWORK; METABOLIC-RATE	Recent studies about brain network have suggested that normal aging is associated with alterations in coordinated patterns of the large-scale brain functional and structural systems. However, age-related changes in functional networks constructed via positron emission tomography (PET) data are still barely understood. Here, we constructed functional brain networks composed of 90 regions in younger (mean age = 36:5 years) and older (mean age = 56:3 years) age groups with PET data. 113 younger and 110 older healthy individuals were separately selected for two age groups, from a physical examination database. Corresponding brain functional networks of the two groups were constructed by thresholding average cerebral glucose metabolism correlation matrices of 90 regions and analysed using graph theoretical approaches. Although both groups showed normal small-world architecture in the PET networks, increased clustering and decreased efficiency were found in older subjects, implying a degeneration process that brain system shifts from a small-world network to regular one along with normal aging. Moreover, normal senescence was related to changed nodal centralities predominantly in association and paralimbic cortex regions, e.g. increasing in orbitofrontal cortex (middle) and decreasing in left hippocampus. Additionally, the older networks were about equally as robust to random failures as younger counterpart, but more vulnerable against targeted attacks. Finally, methods in the construction of the PET networks revealed reasonable robustness. Our findings enhanced the understanding about the topological principles of PET networks and changes related to normal aging.	[Liu, Zhiliang; Liu, Huafeng; Hu, Zhenghui] Zhejiang Univ, State Key Lab Modern Opt Instrumentat, Dept Opt Engn, Hangzhou 310003, Zhejiang, Peoples R China; [Ke, Lining; Huang, Wenhua] Southern Med Univ, Inst Clin Anat, Sch Basic Med Sci, Guangzhou, Guangdong, Peoples R China	Zhejiang University; Southern Medical University - China	Huang, WH (corresponding author), Southern Med Univ, Inst Clin Anat, Sch Basic Med Sci, Guangzhou, Guangdong, Peoples R China.	huangwenhua2009@139.com; zhenghui@zju.edu.cn	huang, wenhua/AAO-5990-2020; Hu, Zhenghui/F-1959-2015	huang, wenhua/0000-0003-2382-9180; Hu, Zhenghui/0000-0002-5775-0481	National Basic Research Program of China [2010CB732500]; National High Technology Research and Development Program of China [2012AA011600]; National Natural Science Foundation of China [81271645]; Fundamental Research Funds for the Central Universities [2012XZZX001]; Zhejiang Provincial Natural Science Foundation of China [LY 12H18004]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work is supported in part by the National Basic Research Program of China under Grant 2010CB732500, in part by the National High Technology Research and Development Program of China under Grant 2012AA011600, in part by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) under Grant 81271645, in part by the Fundamental Research Funds for the Central Universities under Grant 2012XZZX001, and in part by the Zhejiang Provincial Natural Science Foundation of China under Grant LY 12H18004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Aine CJ, 2011, BRAIN TOPOGR, V24, P323, DOI 10.1007/s10548-011-0178-x; Albert M, 1994, CLIN NEUROLOGY AGING; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Bluhm RL, 2008, NEUROREPORT, V19, P887, DOI 10.1097/WNR.0b013e328300ebbf; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Catani M, 2005, BRAIN, V128, P2224, DOI 10.1093/brain/awh622; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Chiappe P, 2000, MEM COGNITION, V28, P8, DOI 10.3758/BF03211570; Cohen Jacob, 1975, APPL MULTIPLE REGRES; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Dukart J, 2010, NEUROIMAGE, V49, P1490, DOI 10.1016/j.neuroimage.2009.09.017; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Ferrarelli F, 2004, BRAIN RES BULL, V64, P103, DOI 10.1016/j.brainresbull.2004.04.020; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Gavrilescu M, 2002, NEUROIMAGE, V17, P532, DOI 10.1006/nimg.2002.1226; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2009, BRAIN, V132, P3366, DOI 10.1093/brain/awp089; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Horwitz B, 1999, TRENDS COGN SCI, V3, P91, DOI 10.1016/S1364-6613(99)01282-6; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jhoo JH, 2010, PSYCHIAT RES-NEUROIM, V183, P237, DOI 10.1016/j.pscychresns.2010.03.006; Kaiser M, 2004, BIOL CYBERN, V90, P311, DOI 10.1007/s00422-004-0479-1; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Koch W, 2010, NEUROIMAGE, V51, P280, DOI 10.1016/j.neuroimage.2009.12.008; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lerch JP, 2006, NEUROIMAGE, V31, P993, DOI 10.1016/j.neuroimage.2006.01.042; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Madden DJ, 1999, HUM BRAIN MAPP, V7, P115, DOI 10.1002/(SICI)1097-0193(1999)7:2<115::AID-HBM5>3.0.CO;2-N; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mattay VS, 2002, NEUROLOGY, V58, P630, DOI 10.1212/WNL.58.4.630; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Micheloyannis S, 2009, HUM BRAIN MAPP, V30, P200, DOI 10.1002/hbm.20492; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Pardo JV, 2007, NEUROIMAGE, V35, P1231, DOI 10.1016/j.neuroimage.2006.12.044; Petit-Taboue MC, 1998, NEUROIMAGE, V7, P176, DOI 10.1006/nimg.1997.0318; PHELPS ME, 1979, ANN NEUROL, V6, P371, DOI 10.1002/ana.410060502; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010; Seo EH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053922, 10.1371/journal.pone.0076875]; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Sun JF, 2012, AGING DIS, V3, P181; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Veen V, 2009, NAT NEUROSCI, V12, P1469, DOI 10.1038/nn.2413; Wang L, 2009, HUM BRAIN MAPP, V30, P638, DOI 10.1002/hbm.20530; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Worsley KJ, 2005, PHILOS T R SOC B, V360, P913, DOI 10.1098/rstb.2005.1637; Wu K, 2012, HUM BRAIN MAPP, V33, P552, DOI 10.1002/hbm.21232; Xiao Fan Wang, 2003, IEEE Circuits and Systems Magazine, V3, P6, DOI 10.1109/MCAS.2003.1228503	66	33	33	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88690	10.1371/journal.pone.0088690	http://dx.doi.org/10.1371/journal.pone.0088690			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586370	Green Submitted, Green Published, gold			2022-12-27	WOS:000331714700025
J	Mupepele, AC; Muller, T; Dittrich, M; Floren, A				Mupepele, Anne-Christine; Mueller, Tobias; Dittrich, Marcus; Floren, Andreas			Are Temperate Canopy Spiders Tree-Species Specific?	PLOS ONE			English	Article							HABITAT STRUCTURE; PREY SELECTION; ARANEAE; FAUNA; DIVERSITY; FOREST; ASSEMBLAGES; ARANEIDAE; RICHNESS; WEB	Arboreal spiders in deciduous and coniferous trees were investigated on their distribution and diversity. Insecticidal knockdown was used to comprehensively sample spiders from 175 trees from 2001 to 2003 in the Bialowieza forest and three remote forests in Poland. We identified 140 species from 9273 adult spiders. Spider communities were distinguished between deciduous and coniferous trees. The richest fauna was collected from Quercus where beta diversity was also highest. A tree-species-specific pattern was clearly observed for Alnus, Carpinus, Picea and Pinus trees and also for those tree species that were fogged in only four or three replicates, namely Betula and Populus. This hitherto unrecognised association was mainly due to the community composition of common species identified in a Dufrene-Legendre indicator species analysis. It was not caused by spatial or temporal autocorrelation. Explaining tree-species specificity for generalist predators like spiders is difficult and has to involve physical and ecological tree parameters like linkage with the abundance of prey species. However, neither did we find a consistent correlation of prey group abundances with spiders nor could differences in spider guild composition explain the observed pattern. Our results hint towards the importance of deterministic mechanisms structuring communities of generalist canopy spiders although the casual relationship is not yet understood.	[Mupepele, Anne-Christine] Univ Freiburg, D-79106 Freiburg, Germany; [Mueller, Tobias; Dittrich, Marcus] Univ Wurzburg, Dept Bioinformat, D-97070 Wurzburg, Germany; [Floren, Andreas] Univ Wurzburg, Dept Anim Ecol & Trop Biol, D-97070 Wurzburg, Germany	University of Freiburg; University of Wurzburg; University of Wurzburg	Floren, A (corresponding author), Univ Wurzburg, Dept Anim Ecol & Trop Biol, D-97070 Wurzburg, Germany.	floren@biozentrum.uni-wuerzburg.de	Müller, Tobias/A-8952-2008; Mupepele, Anne-Christine/J-3855-2014	Mupepele, Anne-Christine/0000-0002-5671-0963	German Research Foundation (DFG); University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blick T., 2004, CHECKLIST SPIDERS CE; Blick Theo, 2006, Fragmenta Faunistica (Warsaw), V49, P115; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brandle M, 2001, J ANIM ECOL, V70, P491, DOI 10.1046/j.1365-2656.2001.00506.x; Brierton BM, 2003, J ARACHNOL, V31, P350, DOI 10.1636/0161-8202(2003)031[0350:SFOSMA]2.0.CO;2; Cardoso P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021710; Coddington JA, 2009, J ANIM ECOL, V78, P573, DOI 10.1111/j.1365-2656.2009.01525.x; Copley CR, 2010, CAN J FOREST RES, V40, P904, DOI 10.1139/X10-043; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Falinski J.B., 1986, VEGETATION DYNAMICS; Finch OD, 2008, BIODIVERS CONSERV, V17, P2849, DOI 10.1007/s10531-008-9400-x; Floren Andreas, 2010, Abc Taxa, V8, P158; Floren Andreas, 2008, P489; Floren Andreas, 2008, P279; Halaj J, 2000, OIKOS, V90, P139, DOI 10.1034/j.1600-0706.2000.900114.x; Halaj J, 1998, J ARACHNOL, V26, P203; Horstmann Klaus, 2008, P469; Hsieh YL, 2011, BIODIVERS CONSERV, V20, P2953, DOI 10.1007/s10531-011-0158-1; Jedrzejewska B, 1998, ECOLOGICAL STUDIES P, P4; JENNINGS DT, 1986, J ARACHNOL, V14, P315; Jost L., 2009, ECOL ECON, V68, P925, DOI DOI 10.1016/J.ECOLECON.2008.10.015; Larrivee M, 2009, AGR FOREST ENTOMOL, V11, P225, DOI 10.1111/j.1461-9563.2008.00421.x; Legendre P., 2012, NUMERICAL ECOLOGY; Ludy C, 2007, AGR ECOSYST ENVIRON, V119, P368, DOI 10.1016/j.agee.2006.08.005; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Mestre L, 2011, ANIM BEHAV, V81, P741, DOI 10.1016/j.anbehav.2011.01.002; NENTWIG W, 1986, OECOLOGIA, V68, P595, DOI 10.1007/BF00378777; NENTWIG W, 1985, OECOLOGIA, V66, P580, DOI 10.1007/BF00379353; Nicolai Volker, 1993, Spixiana, V16, P61; Nyffeler M, 1999, J ARACHNOL, V27, P317; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Otto Stefan, 2007, Fragmenta Faunistica (Warsaw), V50, P57; Pateiro-Lopez B., 2009, ALPHAHULL GEN CONVEX; Pinzon J, 2011, ENVIRON ENTOMOL, V40, P797, DOI 10.1603/EN11081; Platen R, 1999, NATURSCHUTZ LANDSCHA, V8, P1; Prieto-Benitez S, 2011, BIOL CONSERV, V144, P683, DOI 10.1016/j.biocon.2010.11.024; R Core Team, 2012, R LANG ENV STAT COMP; Roberts DW., 2012, LABDSV ORDINATION MU; Schmidt JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049223; Schmidt JM, 2010, OECOLOGIA, V164, P899, DOI 10.1007/s00442-010-1785-z; Sorensen LL, 2004, BIODIVERS CONSERV, V13, P437, DOI 10.1023/B:BIOC.0000006510.49496.1e; SOUTHWOOD TRE, 1982, ECOL ENTOMOL, V7, P331, DOI 10.1111/j.1365-2311.1982.tb00674.x; Sprick Peter, 2008, P225; Uetz GW, 1999, J ARACHNOL, V27, P270; Wise DH, 1993, SPIDERS ECOLOGICAL W; Ziesche TM, 2008, FOREST ECOL MANAG, V255, P738, DOI 10.1016/j.foreco.2007.09.060	46	14	14	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e86571	10.1371/journal.pone.0086571	http://dx.doi.org/10.1371/journal.pone.0086571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586251	Green Published, gold			2022-12-27	WOS:000331714700004
J	Hayashi, K; Watanabe, B; Nakagawa, Y; Minami, S; Morita, T				Hayashi, Ken'ichiro; Watanabe, Bunta; Nakagawa, Yoshiaki; Minami, Saki; Morita, Tsuyoshi			RPEL Proteins Are the Molecular Targets for CCG-1423, an Inhibitor of Rho Signaling	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; TRANSCRIPTION FACTOR; MEGAKARYOBLASTIC LEUKEMIA; NUCLEAR-LOCALIZATION; MRTF-A; MYOCARDIN; GENE; DIFFERENTIATION; EXPRESSION; CELLS	Epithelial-msenchymal transition (EMT) is closely associated with cancer and tissue fibrosis. The nuclear accumulation of myocardin-related transcription factor A (MRTF-A/MAL/MKL1) plays a vital role in EMT. In various cells treated with CCG-1423, a novel inhibitor of Rho signaling, the nuclear accumulation of MRTF-A is inhibited. However, the molecular target of this inhibitor has not yet been identified. In this study, we investigated the mechanism of this effect of CCG-1423. The interaction between MRTF-A and importin alpha/beta 1 was inhibited by CCG-1423, but monomeric G-actin binding to MRTF-A was not inhibited. We coupled Sepharose with CCG-1423 (CCG-1423 Sepharose) to investigate this mechanism. A pull-down assay using CCG-1423 Sepharose revealed the direct binding of CCG-1423 to MRTF-A. Furthermore, we found that the N-terminal basic domain (NB) of MRTF-A, which acts as a functional nuclear localization signal (NLS) of MRTF-A, was the binding site for CCG-1423. G-actin did not bind to CCG-1423 Sepharose, but the interaction between MRTF-A and CCG-1423 Sepharose was reduced in the presence of G-actin. We attribute this result to the high binding affinity of MRTF-A for G-actin and the proximity of NB to G-actin-binding sites (RPEL motifs). Therefore, when MRTF-A forms a complex with G-actin, the binding of CCG-1423 to NB is expected to be blocked. NF-E2 related factor 2, which contains three distinct basic amino acid-rich NLSs, did not bind to CCG-1423 Sepharose, but other RPEL-containing proteins such as MRTF-B, myocardin, and Phactr1 bound to CCG-1423 Sepharose. These results suggest that the specific binding of CCG-1423 to the NLSs of RPEL-containing proteins. Our proposal to explain the inhibitory action of CCG-1423 is as follows: When the G-actin pool is depleted, CCG-1423 binds specifically to the NLS of MRTF-A/B and prevents the interaction between MRTF-A/B and importin alpha/beta 1, resulting in inhibition of the nuclear import of MRTF-A/B.	[Hayashi, Ken'ichiro; Morita, Tsuyoshi] Osaka Univ, Grad Sch Med, Dept Neurosci D13, Osaka, Japan; [Watanabe, Bunta] Kyoto Univ, Inst Chem Res, Kyoto 606, Japan; [Nakagawa, Yoshiaki; Minami, Saki] Kyoto Univ, Div Appl Life Sci, Grad Sch Agr, Kyoto, Japan	Osaka University; Kyoto University; Kyoto University	Hayashi, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Neurosci D13, Osaka, Japan.	khayashi@nbiochem.med.osaka-u.ac.jp		Watanabe, Bunta/0000-0003-3645-5712	Ministry of Education, Science, Sports and Culture of Japan [23590332]; Project MEET, Osaka University Graduate School of Medicine; Grants-in-Aid for Scientific Research [23590332] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Project MEET, Osaka University Graduate School of Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan (23590332 to K. H.) and Project MEET, Osaka University Graduate School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beer PD, 2000, J CHEM SOC DALTON, P1805, DOI 10.1039/b000079p; Bell JL, 2013, BEILSTEIN J ORG CHEM, V9, P966, DOI 10.3762/bjoc.9.111; Du KL, 2004, J BIOL CHEM, V279, P17578, DOI 10.1074/jbc.M400961200; Elberg G, 2008, AM J PHYSIOL-RENAL, V294, pF1116, DOI 10.1152/ajprenal.00142.2007; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; Hayashi K, 2006, MOL CELL BIOL, V26, P9456, DOI 10.1128/MCB.00759-06; Hayashi K, 2013, J BIOL CHEM, V288, P5743, DOI 10.1074/jbc.M112.408120; Hinson JS, 2007, AM J PHYSIOL-HEART C, V292, pH1170, DOI 10.1152/ajpheart.00864.2006; Iwasaki K, 2008, J BIOL CHEM, V283, P21230, DOI 10.1074/jbc.M710525200; Jin WZ, 2011, J CLIN INVEST, V121, P918, DOI 10.1172/JCI41940; Kanoh N, 2003, ANGEW CHEM INT EDIT, V42, P5584, DOI 10.1002/anie.200352164; Li SJ, 2006, MOL CELL BIOL, V26, P5797, DOI 10.1128/MCB.00211-06; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; MCINTYRE GD, 1983, BIOCHEM J, V211, P519, DOI 10.1042/bj2110519; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Minami T, 2012, EMBO J, V31, P4428, DOI 10.1038/emboj.2012.296; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Nakamura S, 2010, J BIOL CHEM, V285, P37314, DOI 10.1074/jbc.M110.180786; Oh JY, 2005, P NATL ACAD SCI USA, V102, P15122, DOI 10.1073/pnas.0507346102; Pawlowski R, 2010, EMBO J, V29, P3448, DOI 10.1038/emboj.2010.216; Scharenberg M. A., 2010, INT J BIOCHEM CELL B, V53, P8627; Small EM, 2010, CIRC RES, V107, P294, DOI 10.1161/CIRCRESAHA.110.223172; Theodore M, 2008, J BIOL CHEM, V283, P8984, DOI 10.1074/jbc.M709040200; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wiezlak M, 2012, J CELL SCI, V125, P5860, DOI 10.1242/jcs.112078	29	65	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89016	10.1371/journal.pone.0089016	http://dx.doi.org/10.1371/journal.pone.0089016			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558465	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700111
J	Ingrasciotta, Y; Sultana, J; Giorgianni, F; Caputi, AP; Arcoraci, V; Tari, DU; Linguiti, C; Perrotta, M; Nucita, A; Pellegrini, F; Fontana, A; Cavagna, L; Santoro, D; Trifiro, G				Ingrasciotta, Ylenia; Sultana, Janet; Giorgianni, Francesco; Caputi, Achille Patrizio; Arcoraci, Vincenzo; Tari, Daniele Ugo; Linguiti, Claudio; Perrotta, Margherita; Nucita, Andrea; Pellegrini, Fabio; Fontana, Andrea; Cavagna, Lorenzo; Santoro, Domenico; Trifiro, Gianluca			The Burden of Nephrotoxic Drug Prescriptions in Patients with Chronic Kidney Disease: A Retrospective Population-Based Study in Southern Italy	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PRESCRIBING PATTERN; GENERAL-PRACTICE; INTERACTION RISK; PREVALENCE; CARE; PROGRESSION; OUTCOMES; TRENDS	Background: The use of nephrotoxic drugs can further worsening renal function in chronic kidney disease (CKD) patients. It is therefore imperative to explore prescribing practices that can negatively affect CKD patients. Aim: To analyze the use of nephrotoxic drugs in CKD patients in a general population of Southern Italy during the years 2006-2011. Methods: The general practice "Arianna" database contains data from 158,510 persons, registered with 123 general practitioners (GPs) of Caserta. CKD patients were identified searching: CKD-related ICD-9 CM codes among causes of hospitalization; CKD-relevant procedures undergone in hospital (e.g. dialysis); drug prescriptions issued for a CKD-related indication. A list of nephrotoxic drugs was compiled and validated by pharmacologists and nephrologists. The summary of product characteristics was used to classify drugs as 'contraindicated' or 'to be used with caution' in renal diseases. Frequency of nephrotoxic drug use, overall, by drug class and single compounds, by GPs within one year prior or after first CKD diagnosis and within one year after dialysis entry was calculated. Results: Overall, 1,989 CKD patients and 112 dialysed patients were identified. Among CKD patients, 49.8% and 45.2% received at least one prescription for a contraindicated nephrotoxic drug within one year prior or after first CKD diagnosis, respectively. In detail, 1,119 CKD patients (56.3%) had at least one nonsteroidal anti-inflammatory drugs (NSAIDs) prescription between CKD diagnosis and end of follow-up. A large proportion of CKD patients (35.6%) were treated with NSAIDs for periods exceeding 90 days. Contraindicated nephrotoxic drugs were used commonly in CKD, with nimesulide (16.6%) and diclofenac (11.0%) being most frequently used. Conclusions: Contraindicated nephrotoxic drugs were highly prescribed in CKD patients from a general population of Southern Italy. CKD diagnosis did not seem to reduce significantly the prescription of nephrotoxic drugs, which may increase the risk of preventable renal function deterioration.	[Ingrasciotta, Ylenia; Sultana, Janet; Giorgianni, Francesco; Caputi, Achille Patrizio; Arcoraci, Vincenzo; Santoro, Domenico; Trifiro, Gianluca] Univ Messina, Dept Clin & Expt Med, Messina, Italy; [Tari, Daniele Ugo; Linguiti, Claudio; Perrotta, Margherita] Caserta Local Hlth Serv, Caserta, Italy; [Nucita, Andrea] Univ Messina, Dept Cognit Sci Educ & Cultural Studies CSECS, Messina, Italy; [Pellegrini, Fabio; Fontana, Andrea] IRCCS Casa Sollievo Sofferenza, Unit Biostat, San Giovanni Rotondo, FG, Italy; [Cavagna, Lorenzo] Univ Pavia, Div Rheumatol, I-27100 Pavia, Italy; [Cavagna, Lorenzo] IRCCS Fdn Policlin S Matteo, Pavia, Italy	University of Messina; University of Messina; IRCCS Casa Sollievo Della Sofferenza; University of Pavia; IRCCS Fondazione San Matteo	Trifiro, G (corresponding author), Univ Messina, Dept Clin & Expt Med, Messina, Italy.	trifirog@unime.it	Tari, Daniele Ugo/AAY-8658-2021; Trifiro, Gianluca/K-9744-2016; Arcoraci, Vincenzo/HGA-3713-2022; santoro, domenico/P-7902-2014; Sultana, Janet/Z-4817-2019; Nucita, Andrea/F-3826-2014; santoro, domenico/L-2482-2013; Fontana, Andrea/J-8584-2016; Cavagna, Lorenzo/AAU-3943-2021	Tari, Daniele Ugo/0000-0002-7312-419X; Trifiro, Gianluca/0000-0003-1147-7296; Arcoraci, Vincenzo/0000-0003-0061-0477; santoro, domenico/0000-0002-4279-6559; santoro, domenico/0000-0002-4279-6559; Fontana, Andrea/0000-0002-6660-5315; Cavagna, Lorenzo/0000-0003-3292-1528; Giorgianni, Francesco/0000-0003-1779-0822; Sultana, Janet/0000-0001-9622-169X; Perrotta, Margherita/0000-0001-8498-2838; Nucita, Andrea/0000-0001-6257-5529				Adams RJ, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-70; Alacqua M, 2008, ARTHRIT RHEUM-ARTHR, V59, P568, DOI 10.1002/art.23526; Alacqua M, 2009, EPILEPSY RES, V85, P107, DOI 10.1016/j.eplepsyres.2009.03.002; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Broadbent A, 2003, PROG PALLIAT CARE, V11, P183; Cavagna L, 2013, INT J IMMUNOPATH PH, V26, P279, DOI 10.1177/039463201302600132; Cirillo M, 2006, KIDNEY INT, V70, P800, DOI 10.1038/sj.ki.5001641; CLIVE DM, 1984, NEW ENGL J MED, V310, P563, DOI 10.1056/NEJM198403013100905; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Coresh J, 2005, J AM SOC NEPHROL, V16, P180, DOI 10.1681/ASN.2004070539; De Berardis G, 2004, DIABETES CARE, V27, P398, DOI 10.2337/diacare.27.2.398; De Nicola L, 2011, CLIN J AM SOC NEPHRO, V6, P2421, DOI 10.2215/CJN.01180211; Delzell E, 1998, MEDICINE, V77, P102, DOI 10.1097/00005792-199803000-00003; Disney APS, 1998, NEPHROL DIAL TRANSPL, V13, P854, DOI 10.1093/ndt/13.4.854; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gooch K, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.02.015; Henry D, 1997, BRIT J CLIN PHARMACO, V44, P85, DOI 10.1046/j.1365-2125.1997.00631.x; Jardine MJ, 2010, J AM COLL CARDIOL, V56, P956, DOI 10.1016/j.jacc.2010.02.068; Khan S, 2008, J EVAL CLIN PRACT, V14, P422, DOI 10.1111/j.1365-2753.2007.00883.x; Kuo HW, 2010, PHARMACOEPIDEM DR S, V19, P743, DOI 10.1002/pds.1962; Montecucco C, 2009, EUR J PAIN SUPP, P105, DOI 10.1016/j.eujps.2009.07.006; Murtagh F, 2007, OPIOIDS CANC PAIN, P131; Nderitu P, 2013, FAM PRACT, V30, P247, DOI 10.1093/fampra/cms086; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; Niscola Pasquale, 2011, G Ital Nefrol, V28, P269; Obrador GT, 2010, KIDNEY INT, V77, pS2, DOI 10.1038/ki.2009.540; Oteri A, 2010, BRIT J CLIN PHARMACO, V70, P514, DOI 10.1111/j.1365-2125.2010.03619.x; Ottawa V, 2001, DIALYSIS RENAL TRANS; Pannu N, 2008, CRIT CARE MED, V36, pS216, DOI 10.1097/CCM.0b013e318168e375; Piacentini N, 2005, EUR J CLIN PHARMACOL, V61, P615, DOI 10.1007/s00228-005-0972-z; Radulescu Daniela, 2009, J Med Life, V2, P199; Santoro Domenico, 2013, Clin Nephrol, V79 Suppl 1, pS2; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Schetz M, 2005, CURR OPIN CRIT CARE, V11, P555, DOI 10.1097/01.ccx.0000184300.68383.95; Schnijder T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd ed; Singh AK, 2003, NEW ENGL J MED, V349, P2055, DOI 10.1056/NEJMcpc030028; Snively CS, 2004, AM FAM PHYSICIAN, V70, P1921; Trescot AM, 2008, PAIN PHYSICIAN, V11, pS133; Trifiro G, 2008, EUR J CLIN PHARMACOL, V64, P619, DOI 10.1007/s00228-007-0459-1; Trifiro G, 2008, PARKINSONISM RELAT D, V14, P420, DOI 10.1016/j.parkreldis.2007.10.010; Trifiro G, 2006, BRIT J CLIN PHARMACO, V62, P582, DOI 10.1111/j.1365-2125.2006.02687.x; Usami T, 2002, CURR OPIN NEPHROL HY, V11, P343, DOI 10.1097/00041552-200205000-00012; Weigert AL, 1998, AM J MED SCI, V316, P94, DOI 10.1097/00000441-199808000-00005; WHELTON A, 1991, J CLIN PHARMACOL, V31, P588, DOI 10.1002/j.1552-4604.1991.tb03743.x; Zager RA, 1997, SEMIN NEPHROL, V17, P3	45	39	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89072	10.1371/journal.pone.0089072	http://dx.doi.org/10.1371/journal.pone.0089072			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558471	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700117
J	Xiong, FF; Xia, LL; Wang, JF; Wu, B; Wang, DY; Yuan, LF; Cheng, YT; Zhu, HY; Che, XY; Zhang, QH; Zhao, GP; Wang, Y				Xiong, Feifei; Xia, Liliang; Wang, Jingfang; Wu, Biao; Wang, Dengyu; Yuan, Longfang; Cheng, Yating; Zhu, Hongying; Che, Xiaoyan; Zhang, Qinghua; Zhao, Guoping; Wang, Ying			A High-Affinity CDR-Grafted Antibody against Influenza A H5N1 Viruses Recognizes a Conserved Epitope of H5 Hemagglutinin	PLOS ONE			English	Article							T-CELL EPITOPES; COMPLEMENTARITY-DETERMINING REGIONS; MONOCLONAL-ANTIBODY; PATHOGENIC H5N1; ANTIGENIC VARIATION; MOLECULAR-DYNAMICS; DUAL-SPECIFICITY; BINDING; IDENTIFICATION; HUMANIZATION	Highly pathogenic avian influenza (HPAI) H5N1 virus infection is still a potential threat to public health worldwide. While vaccines and antiviral drugs are currently under development, neutralizing antibodies could offer an alternative strategy to prevent and treat H5N1 virus infection. In the present study, we had developed a humanized antibody against H5N1 viruses from mouse-derived hybridoma in order to minimize its immunogenicity for potential clinical application. The humanized antibody hH5M9 was generated by transferring the mouse complementarity determining region (CDR) residues together with four key framework region (FR) residues onto the FR of the human antibody. This humanized antibody exhibited high affinity and specificity comparable to the parental mouse or chimeric counterpart with broad and strong neutralization activity against all H5N1 clades and subclades except for Egypt clades investigated. Furthermore, through epitope mapping we identified a linear epitope on the top region of hemagglutinin (HA) that was H5N1 specific and conserved. Our results for the first time reported a humanized antibody against H5N1 viruses by CDR grafting method. With the expected lower immunogenicity, this humanized antibody was expected to be more efficacious than murine or human-mouse chimeric antibodies for future application in humans.	[Xiong, Feifei; Zhang, Qinghua] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Xiong, Feifei; Xia, Liliang; Wu, Biao; Wang, Dengyu; Yuan, Longfang; Cheng, Yating; Zhu, Hongying; Zhao, Guoping; Wang, Ying] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China; [Wang, Jingfang] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Shanghai 200030, Peoples R China; [Che, Xiaoyan] Southern Med Univ, Cent Lab, Zhujiang Hosp, Guangzhou, Guangdong, Peoples R China; [Wang, Ying] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Sch Med, Shanghai 200030, Peoples R China	Tongji University; Shanghai Jiao Tong University; Southern Medical University - China; Chinese Academy of Sciences; Shanghai Jiao Tong University	Wang, Y (corresponding author), Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China.	ywang@sibs.ac.cn	Wang, Jingfang/Q-2597-2018	Wang, Jingfang/0000-0002-1355-5481; Zhao, Guo-Ping/0000-0002-7621-6620	National High Technology Research and Development Program of China (863 Program) [2006AA 02A 252]; National Science and Technology Major Project of the Ministry of Science and Technology of China [2011ZX09506-001]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Science and Technology Major Project of the Ministry of Science and Technology of China	This work was supported by National High Technology Research and Development Program of China (863 Program, Grant No. 2006AA 02A 252) http://www.863.gov.cn/; and National Science and Technology Major Project of the Ministry of Science and Technology of China (Grant No. 2011ZX09506-001) http://www. nmp.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro JC, 2004, J MOL RECOGNIT, V17, P132, DOI 10.1002/jmr.659; Babon JAB, 2009, HUM IMMUNOL, V70, P711, DOI 10.1016/j.humimm.2009.06.004; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; COLCHER D, 1990, JNCI-J NATL CANCER I, V82, P1191, DOI 10.1093/jnci/82.14.1191; Collis AVJ, 2003, J MOL BIOL, V325, P337, DOI 10.1016/S0022-2836(02)01222-6; Cusick MF, 2009, J IMMUNOL, V183, P6432, DOI 10.4049/jimmunol.0901617; Eisen MB, 1997, VIROLOGY, V232, P19, DOI 10.1006/viro.1997.8526; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fleury D, 2000, PROTEINS, V40, P572; Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3; Hu HX, 2012, J VIROL, V86, P2978, DOI 10.1128/JVI.06665-11; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huston James S., 2001, Human Antibodies, V10, P127; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Kabat EA, 1991, SEQUENCES PROTEINS I; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; Kaverin NV, 2002, J GEN VIROL, V83, P2497, DOI 10.1099/0022-1317-83-10-2497; KETTLEBOROUGH CA, 1991, PROTEIN ENG, V4, P773, DOI 10.1093/protein/4.7.773; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; Knossow M, 2002, VIROLOGY, V302, P294, DOI 10.1006/viro.2002.1625; Laisney IL, 1999, IMMUNOL LETT, V67, P185, DOI 10.1016/S0165-2478(99)00010-3; Li BH, 2007, BIOCHEM BIOPH RES CO, V357, P951, DOI 10.1016/j.bbrc.2007.04.039; Li J, 2009, EUR J IMMUNOL, V39, P3498, DOI 10.1002/eji.200939532; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Lim APC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-80; Luke TC, 2006, ANN INTERN MED, V145, P599, DOI 10.7326/0003-4819-145-8-200610170-00139; Mahmood K, 2008, VACCINE, V26, P5393, DOI 10.1016/j.vaccine.2008.07.084; Mazor Y, 2005, MOL IMMUNOL, V42, P55, DOI 10.1016/j.molimm.2004.07.013; NAKATANI T, 1994, PROTEIN ENG, V7, P435, DOI 10.1093/protein/7.3.435; Ofran Y, 2008, J IMMUNOL, V181, P6230, DOI 10.4049/jimmunol.181.9.6230; Pappaioanou M, 2009, COMP IMMUNOL MICROB, V32, P287, DOI 10.1016/j.cimid.2008.01.003; Paquet ME, 2005, METHODS, V35, P338, DOI 10.1016/j.ymeth.2004.10.005; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prabhu N, 2009, J VIROL, V83, P2553, DOI 10.1128/JVI.02165-08; QUEEN C, 1989, P NATL ACAD SCI USA, V86, P10029, DOI 10.1073/pnas.86.24.10029; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; Sawyer LA, 2000, ANTIVIR RES, V47, P57, DOI 10.1016/S0166-3542(00)00111-X; SECCAMANI E, 1989, NUCL MED BIOL, V16, P167, DOI 10.1016/0883-2897(89)90191-8; Shen S, 2008, J MED VIROL, V80, P1972, DOI 10.1002/jmv.21298; Simmons CP, 2007, PLOS MED, V4, P928, DOI 10.1371/journal.pmed.0040178; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; SKEHEL JJ, 1984, P NATL ACAD SCI-BIOL, V81, P1779, DOI 10.1073/pnas.81.6.1779; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Sun LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005476; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Wang SF, 2010, VIRAL IMMUNOL, V23, P585, DOI 10.1089/vim.2010.0058; Wang SF, 2009, BIOCHEM BIOPH RES CO, V382, P691, DOI 10.1016/j.bbrc.2009.03.119; WEBSTER RG, 1991, VACCINE, V9, P303, DOI 10.1016/0264-410X(91)90055-B; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Workman CJ, 1998, J PROTEIN CHEM, V17, P599, DOI 10.1007/BF02780961; Workman CJ, 1997, J MOL RECOGNIT, V10, P225, DOI 10.1002/(SICI)1099-1352(199709/10)10:5<225::AID-JMR372>3.0.CO;2-1; World Health Organization, CUM NUMB CONF HUM CA; WRIGHT A, 1992, CRIT REV IMMUNOL, V12, P125; Yang JB, 2009, VACCINE, V27, P3862, DOI 10.1016/j.vaccine.2009.04.019; Zhou BP, 2007, NEW ENGL J MED, V357, P1450, DOI 10.1056/NEJMc070359; Zhu XY, 2013, J VIROL, V87, P12619, DOI 10.1128/JVI.01577-13	57	4	4	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88777	10.1371/journal.pone.0088777	http://dx.doi.org/10.1371/journal.pone.0088777			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558425	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700071
J	Zhou, MZ; Yu, H; Yin, XH; Sabour, PM; Chen, W; Gong, J				Zhou, Mengzhou; Yu, Hai; Yin, Xianhua; Sabour, Parviz M.; Chen, Wei; Gong, Joshua			Lactobacillus zeae Protects Caenorhabditis elegans from Enterotoxigenic Escherichia coli-Caused Death by Inhibiting Enterotoxin Gene Expression of the Pathogen	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; POSTWEANING DIARRHEA; VIRULENCE GENES; HEAT-LABILE; MODEL HOST; PROBIOTICS; INFECTION; DEFENSE; SCREEN; CELLS	Background: The nematode Caenorhabditis elegans has become increasingly used for screening antimicrobials and probiotics for pathogen control. It also provides a useful tool for studying microbe-host interactions. This study has established a C. elegans life-span assay to preselect probiotic bacteria for controlling K88(+) enterotoxigenic Escherichia coli (ETEC), a pathogen causing pig diarrhea, and has determined a potential mechanism underlying the protection provided by Lactobacillus. Methodology/Principal Findings: Life-span of C. elegans was used to measure the response of worms to ETEC infection and protection provided by lactic acid-producing bacteria (LAB). Among 13 LAB isolates that varied in their ability to protect C. elegans from death induced by ETEC strain JG280, Lactobacillus zeae LB1 offered the highest level of protection (86%). The treatment with Lactobacillus did not reduce ETEC JG280 colonization in the nematode intestine. Feeding E. coli strain JFF4 (K88+ but lacking enterotoxin genes of estA, estB, and elt) did not cause death of worms. There was a significant increase in gene expression of estA, estB, and elt during ETEC JG280 infection, which was remarkably inhibited by isolate LB1. The clone with either estA or estB expressed in E. coli DH5 alpha was as effective as ETEC JG280 in killing the nematode. However, the elt clone killed only approximately 40% of worms. The killing by the clones could also be prevented by isolate LB1. The same isolate only partially inhibited the gene expression of enterotoxins in both ETEC JG280 and E. coli DH5a in-vitro. Conclusions/Significance: The established life-span assay can be used for studies of probiotics to control ETEC (for effective selection and mechanistic studies). Heat-stable enterotoxins appeared to be the main factors responsible for the death of C. elegans. Inhibition of ETEC enterotoxin production, rather than interference of its intestinal colonization, appears to be the mechanism of protection offered by Lactobacillus.	[Zhou, Mengzhou; Chen, Wei] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China; [Zhou, Mengzhou; Yu, Hai; Yin, Xianhua; Sabour, Parviz M.; Gong, Joshua] Agr & Agri Food Canada, Guelph Food Res Ctr, Guelph, ON, Canada	Jiangnan University; Agriculture & Agri Food Canada	Chen, W (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China.	chenwei66@jiangnan.edu.cn; joshua.gong@agr.gc.ca	Chen, Wei/GZK-7348-2022		Agriculture and Agri-Food Canada	Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada)	This work was funded by Agriculture and Agri-Food Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Anyanful A, 2009, CELL HOST MICROBE, V5, P450, DOI 10.1016/j.chom.2009.04.012; Borchers AT, 2009, J GASTROENTEROL, V44, P26, DOI 10.1007/s00535-008-2296-0; Carey CM, 2008, J MICROBIOL METH, V73, P125, DOI 10.1016/j.mimet.2008.01.014; Daniel C, 2006, APPL ENVIRON MICROB, V72, P5799, DOI 10.1128/AEM.00109-06; Daudelin JF, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-69; De Mitchell I, 1976, J Appl Bacteriol, V41, P163; FAO/WHO, 2001, EV HLTH NUTR PROP PO; Frydendahl K, 2002, VET MICROBIOL, V85, P169, DOI 10.1016/S0378-1135(01)00504-1; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Goldin BR, 2008, CLIN INFECT DIS, V46, pS96, DOI 10.1086/523333; Haesebrouck F, 2004, VET MICROBIOL, V100, P255, DOI 10.1016/j.vetmic.2004.03.002; HARVILLE BA, 1995, INFECT IMMUN, V63, P745, DOI 10.1128/IAI.63.3.745-750.1995; Ikeda T, 2007, APPL ENVIRON MICROB, V73, P6404, DOI 10.1128/AEM.00704-07; Jin LZ, 2000, J SCI FOOD AGR, V80, P619, DOI 10.1002/(SICI)1097-0010(200004)80:5&lt;619::AID-JSFA583&gt;3.0.CO;2-7; Kim Y, 2012, INFECT IMMUN, V80, P2500, DOI 10.1128/IAI.06350-11; Komura T, 2013, BIOGERONTOLOGY, V14, P73, DOI 10.1007/s10522-012-9411-6; Kwok TCY, 2006, NATURE, V441, P91, DOI 10.1038/nature04657; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Moy TI, 2009, ACS CHEM BIOL, V4, P527, DOI 10.1021/cb900084v; Nadeau E, 2011, US patent, Patent No. [20070218035 A1., 20070218035]; Nagy B, 2005, INT J MED MICROBIOL, V295, P443, DOI 10.1016/j.ijmm.2005.07.003; Nagy S, 1999, J CLIN MICROBIOL, V37, P1642, DOI 10.1128/JCM.37.5.1642-1645.1999; Nair GB, 1998, MICROB PATHOGENESIS, V24, P123, DOI 10.1006/mpat.1997.0177; Nemcova R, 2007, VET RES COMMUN, V31, P791, DOI 10.1007/s11259-007-0048-x; Noamani BN, 2003, VET MICROBIOL, V97, P87, DOI 10.1016/j.vetmic.2003.08.006; Paupard MC, 2001, J HISTOCHEM CYTOCHEM, V49, P949, DOI 10.1177/002215540104900803; Pujol N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000105; Roselli M, 2007, J NUTR, V137, P2709, DOI 10.1093/jn/137.12.2709; Roselli M, 2006, BRIT J NUTR, V95, P1177, DOI 10.1079/BJN20051681; Sears CL, 1996, MICROBIOL REV, V60, P167, DOI 10.1128/MMBR.60.1.167-215.1996; Si W, 2007, APPL ENVIRON MICROB, V73, P7110, DOI 10.1128/AEM.01108-07; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Stiernagle Theresa, 2006, WormBook, P1; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; TURNBULL PCB, 1978, J APPL BACTERIOL, V45, P157, DOI 10.1111/j.1365-2672.1978.tb04211.x; Vaandrager AB, 2002, MOL CELL BIOCHEM, V230, P73, DOI 10.1023/A:1014231722696; Wang CY, 2011, J FOOD PROTECT, V74, P86, DOI 10.4315/0362-028X.JFP-10-155; Wuyts J, 2002, NUCLEIC ACIDS RES, V30, P183, DOI 10.1093/nar/30.1.183; Yin XH, 2009, APPL ENVIRON MICROB, V75, P4975, DOI 10.1128/AEM.00297-09; YOKOYAMA H, 1992, INFECT IMMUN, V60, P998, DOI 10.1128/IAI.60.3.998-1007.1992; Zhang L, 2010, VET MICROBIOL, V141, P142, DOI 10.1016/j.vetmic.2009.09.003; Zhang WP, 2006, INFECT IMMUN, V74, P3107, DOI 10.1128/IAI.01338-05; Zhu J, 2011, INFECT IMMUN, V79, P1688, DOI 10.1128/IAI.01281-10	44	39	40	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89004	10.1371/journal.pone.0089004	http://dx.doi.org/10.1371/journal.pone.0089004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558463	gold, Green Published, Green Submitted			2022-12-27	WOS:000331706700109
J	Zhu, ZF; Meng, K; Zhong, YC; Qi, L; Mao, XB; Yu, KW; Zhang, W; Zhu, PF; Ren, ZP; Wu, BW; Ji, QW; Wang, X; Zeng, QT				Zhu, Zheng-Feng; Meng, Kai; Zhong, Yu-Cheng; Qi, Liang; Mao, Xiao-Bo; Yu, Kun-Wu; Zhang, Wei; Zhu, Peng-Fei; Ren, Ze-Peng; Wu, Bang-Wei; Ji, Qin-Wei; Wang, Xiang; Zeng, Qiu-Tang			Impaired Circulating CD4(+)LAP(+) Regulatory T Cells in Patients with Acute Coronary Syndrome and Its Mechanistic Study	PLOS ONE			English	Article							LATENCY-ASSOCIATED PEPTIDE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TGF-BETA ACTIVATION; NERVOUS-SYSTEM; MYOCARDIAL-INFARCTION; AMELIORATES LUPUS; CUTTING EDGE; ATHEROSCLEROSIS; INFLAMMATION; GARP	Objective: CD4(+) latency-associated peptide (LAP)(+) regulatory T cells (Tregs) are a newly discovered T cell subset in humans and the role of these cells in patients with acute coronary syndrome (ACS) has not been explored. We designed to investigate whether circulating frequency and function of CD4(+)LAP(+) Tregs are defective in ACS. Methods: One hundred eleven ACS patients (acute myocardial infarction and unstable angina) and 117 control patients were enrolled in the study. The control patients consisted of chronic stable angina (CSA) and chest pain syndrome (CPS). The frequencies of circulating CD4(+)LAP(+) Tregs and the expression of the transmembrane protein glycoprotein-A repetitions predominant (GARP) on CD4(+) T cells were determined by flow cytometry. The function of CD4(+)LAP(+) Tregs was detected using thymidine uptake. Serum interleukin-10 (IL-10) and transforming growth factor-beta protein (TGF-beta) levels were detected using ELISA and expression of GARP mRNA in peripheral blood mononuclear cells (PBMCs) was measured by real time-polymerase chain reaction. Results: We found ACS patients had a significantly lower frequency of circulating CD4(+)LAP(+) Tregs, and the function of these cells was reduced compared to controls. The expression of GARP in CD4(+) T cells and the serum levels of TGF-b in ACS patients were lower than those of control patients. The serum levels of IL-10 were similar between the two cohorts. Conclusions: A novel regulatory T cell subset, defined as CD4(+)LAP(+) T cells is defective in ACS patients.	[Zhu, Zheng-Feng; Meng, Kai; Zhong, Yu-Cheng; Mao, Xiao-Bo; Yu, Kun-Wu; Zhang, Wei; Zhu, Peng-Fei; Ren, Ze-Peng; Wu, Bang-Wei; Wang, Xiang; Zeng, Qiu-Tang] Huazhong Univ Sci & Technol, Key Lab Biol Targeted Therapy, Lab Cardiovasc Immunol,Union Hosp, Minist Educ,Inst Cardiol,Tongji Med Coll, Wuhan 430074, Peoples R China; [Qi, Liang] Nanjing Med Univ, Affiliated Hosp 1, Dept Radiol, Nanjing, Jiangsu, Peoples R China; [Ji, Qin-Wei] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Cardiol, Nanning, Peoples R China	Huazhong University of Science & Technology; Nanjing Medical University	Wang, X (corresponding author), Huazhong Univ Sci & Technol, Key Lab Biol Targeted Therapy, Lab Cardiovasc Immunol,Union Hosp, Minist Educ,Inst Cardiol,Tongji Med Coll, Wuhan 430074, Peoples R China.	wxiang128@yahoo.com.cn; zengqiutang@gmail.com		Wu, Bangwei/0000-0002-2765-4640	National Natural Science Foundation of China [81070237, 81270354]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by two grants from the National Natural Science Foundation of China (number 81070237 and number 81270354 to QTZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Askenasy N, 2008, AUTOIMMUN REV, V7, P370, DOI 10.1016/j.autrev.2008.03.001; Battaglia M, 2009, EUR J IMMUNOL, V39, P3296, DOI 10.1002/eji.200940117; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Boswell S, 2011, IMMUNOLOGY, V133, P278, DOI 10.1111/j.1365-2567.2011.03425.x; Cheatem D, 2009, CLIN IMMUNOL, V131, P260, DOI 10.1016/j.clim.2008.12.001; Chen ML, 2008, J IMMUNOL, V180, P7327, DOI 10.4049/jimmunol.180.11.7327; Cheng X, 2008, CLIN IMMUNOL, V127, P89, DOI 10.1016/j.clim.2008.01.009; Crispin JC, 2003, J AUTOIMMUN, V21, P273, DOI 10.1016/S0896-8411(03)00121-5; de Boer OJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000779; Duan W, 2011, J IMMUNOL, V187, P6499, DOI 10.4049/jimmunol.1101398; Erren M, 1999, ARTERIOSCL THROM VAS, V19, P2355, DOI 10.1161/01.ATV.19.10.2355; Gandhi R, 2010, J IMMUNOL, V184, P4620, DOI 10.4049/jimmunol.0903329; Ganta CK, 2006, AM J PHYSIOL-REG I, V291, pR558, DOI 10.1152/ajpregu.00846.2005; Han SF, 2007, CLIN IMMUNOL, V124, P90, DOI 10.1016/j.clim.2007.03.546; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ishikawa H, 2007, DIABETES, V56, P2103, DOI 10.2337/db06-1632; Keski-Oja J, 2004, TRENDS CELL BIOL, V14, P657, DOI 10.1016/j.tcb.2004.10.003; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Mor A, 2006, EUR HEART J, V27, P2530, DOI 10.1093/eurheartj/ehl222; Nakamura-Wakatsuki T, 2012, EXP DERMATOL, V21, P189, DOI 10.1111/j.1600-0625.2011.01419.x; Ochi H, 2006, NAT MED, V12, P627, DOI 10.1038/nm1408; Oida T, 2003, J IMMUNOL, V170, P2516, DOI 10.4049/jimmunol.170.5.2516; Oida T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015523; OLLENDORFF V, 1994, CELL GROWTH DIFFER, V5, P213; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sardella G, 2007, THROMB RES, V120, P631, DOI 10.1016/j.thromres.2006.12.005; Sharabi A, 2006, P NATL ACAD SCI USA, V103, P8810, DOI 10.1073/pnas.0603201103; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Stockis J, 2009, EUR J IMMUNOL, V39, P3315, DOI 10.1002/eji.200939684; Tang TT, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0232-6; Tang TT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024272; Tang TT, 2010, CELL PHYSIOL BIOCHEM, V25, P451, DOI 10.1159/000303050; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; VIGLIETTA V, 2004, J EXP MED, V971, P9; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wang R, 2012, MOL BIOL CELL, V23, P1129, DOI 10.1091/mbc.E11-12-1018; Wang R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002705; Wu HY, 2009, LUPUS, V18, P586, DOI 10.1177/0961203308100511; Wu HY, 2008, J IMMUNOL, V181, P6038, DOI 10.4049/jimmunol.181.9.6038; YASUE H, 1986, CIRCULATION, V74, P955, DOI 10.1161/01.CIR.74.5.955; Zhang WC, 2012, J BIOL CHEM, V287, P34157, DOI 10.1074/jbc.M112.382978; Zhong YC, 2012, J CLIN IMMUNOL, V32, P1104, DOI 10.1007/s10875-012-9699-7	51	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88775	10.1371/journal.pone.0088775	http://dx.doi.org/10.1371/journal.pone.0088775			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558424	gold, Green Submitted, Green Published			2022-12-27	WOS:000331706700070
J	Aoyama, J; Watanabe, S; Miller, MJ; Mochioka, N; Otake, T; Yoshinaga, T; Tsukamoto, K				Aoyama, Jun; Watanabe, Shun; Miller, Michael J.; Mochioka, Noritaka; Otake, Tsuguo; Yoshinaga, Tatsuki; Tsukamoto, Katsumi			Spawning Sites of the Japanese Eel in Relation to Oceanographic Structure and the West Mariana Ridge	PLOS ONE			English	Article							NORTH EQUATORIAL CURRENT; FRESH-WATER EELS; REAL-TIME PCR; ANGUILLA-JAPONICA; EUROPEAN EEL; LARVAL TRANSPORT; SARGASSO SEA; SPECIES IDENTIFICATION; OCEANIC MIGRATION; ATLANTIC EELS	The Japanese eel, Anguilla japonica, spawns within the North Equatorial Current that bifurcates into both northward and southward flows in its westward region, so its spawning location and larval transport dynamics seem important for understanding fluctuations in its recruitment to East Asia. Intensive research efforts determined that Japanese eels spawn along the western side of the West Mariana Ridge during new moon periods, where all oceanic life history stages have been collected, including eggs and spawning adults. However, how the eels decide where to form spawning aggregations is unknown because spawning appears to have occurred at various latitudes. A salinity front formed from tropical rainfall was hypothesized to determine the latitude of its spawning locations, but an exact spawning site was only found once by collecting eggs in May 2009. This study reports on the collections of Japanese eel eggs and preleptocephali during three new moon periods in June 2011 and May and June 2012 at locations indicating that the distribution of lower salinity surface water or salinity fronts influence the latitude of spawning sites along the ridge. A distinct salinity front may concentrate spawning south of the front on the western side of the seamount ridge. It was also suggested that eels may spawn at various latitudes within low-salinity water when the salinity fronts appeared unclear. Eel eggs were distributed within the 150-180 m layer near the top of the thermocline, indicating shallow spawning depths. Using these landmarks for latitude (salinity front), longitude (seamount ridge), and depth (top of the thermocline) to guide the formation of spawning aggregations could facilitate finding mates and help synchronize their spawning.	[Aoyama, Jun; Watanabe, Shun; Miller, Michael J.; Otake, Tsuguo; Tsukamoto, Katsumi] Univ Tokyo, Atmosphere & Ocean Res Inst, Chiba, Japan; [Watanabe, Shun; Tsukamoto, Katsumi] Nihon Univ, Coll Bioresource Sci, Tokyo, Kanagawa, Japan; [Mochioka, Noritaka] Kyushu Univ, Fac Agr, Fukuoka 812, Japan; [Yoshinaga, Tatsuki] Kitasato Univ, Sch Marine Biosci, Tokyo, Kanagawa, Japan	University of Tokyo; Nihon University; Kyushu University; Kitasato University	Aoyama, J (corresponding author), Univ Tokyo, Atmosphere & Ocean Res Inst, Chiba, Japan.	jaoyama@aori.u-tokyo.ac.jp		Yoshinaga, Tatsuki/0000-0003-3920-0459	Grants-in-Aid for Scientific Research [21228005] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Aarestrup K, 2009, SCIENCE, V325, P1660, DOI 10.1126/science.1178120; Ahn H, 2012, AQUACULTURE, V330, P100, DOI 10.1016/j.aquaculture.2011.12.020; Als TD, 2011, MOL ECOL, V20, P1333, DOI 10.1111/j.1365-294X.2011.05011.x; [Anonymous], 2003, FISHERIES, V28, P28; Aoyama J, 2012, FISHERIES SCI, V78, P1195, DOI 10.1007/s12562-012-0544-y; Aoyama Jun, 2009, Aqua-Bioscience Monographs, V2, P1; Bonhommeau S, 2008, MAR ECOL PROG SER, V373, P71, DOI 10.3354/meps07696; Bonhommeau S, 2008, FISH OCEANOGR, V17, P32, DOI 10.1111/j.1365-2419.2007.00453.x; Chow S, 2009, FISHERIES SCI, V75, P257, DOI 10.1007/s12562-008-0017-5; Cote CL, 2013, MOL ECOL, V22, P1763, DOI 10.1111/mec.12142; Dannewitz J, 2005, P ROY SOC B-BIOL SCI, V272, P1129, DOI 10.1098/rspb.2005.3064; Dou SZ, 2007, AQUACULTURE, V266, P117, DOI 10.1016/j.aquaculture.2007.02.032; Dufour S, 2009, FISH FISHERIES SERIE, V30; Durif CMF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059212; Durif CMF, 2011, P ROY SOC B-BIOL SCI, V278, P464, DOI 10.1098/rspb.2010.1547; Friedland KD, 2007, ICES J MAR SCI, V64, P519, DOI 10.1093/icesjms/fsm022; Gardner JV, 2010, GEOL SOC AM BULL, V122, P1378, DOI 10.1130/B30149.1; Han YS, 2010, MAR ECOL PROG SER, V401, P221, DOI 10.3354/meps08422; Ishikawa S, 2001, FISHERIES SCI, V67, P1097, DOI 10.1046/j.1444-2906.2001.00366.x; Jellyman D, 2005, MAR ECOL PROG SER, V286, P261, DOI 10.3354/meps286261; Jellyman D, 2010, MAR ECOL PROG SER, V404, P241, DOI 10.3354/meps08468; Kaneko I, 1998, J GEOPHYS RES-OCEANS, V103, P12959, DOI 10.1029/97JC03761; Kettle AJ, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000589; Kim H, 2007, ICES J MAR SCI, V64, P1387, DOI 10.1093/icesjms/fsm091; Kim YY, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002013; Kimura S, 2001, FISH OCEANOGR, V10, P51, DOI 10.1046/j.1365-2419.2001.00159.x; Kimura S, 1994, PRELIMINARY REPORT H, P9; Kimura S, 2006, DEEP-SEA RES PT II, V53, P315, DOI 10.1016/j.dsr2.2006.01.009; KLECKNER RC, 1988, J MAR RES, V46, P647, DOI 10.1357/002224088785113469; Knights B, 2003, SCI TOTAL ENVIRON, V310, P237, DOI 10.1016/S0048-9697(02)00644-7; Kurogi H, 2011, FISHERIES SCI, V77, P199, DOI 10.1007/s12562-010-0318-3; Manabe R, 2011, MAR ECOL PROG SER, V437, P229, DOI 10.3354/meps09266; McCleave J.D., 1987, P102; McCleave J.D., 1985, Contributions in Marine Science, V27, P316; McCleave JD, 1987, AM FISH SOC S SERIES, V1, P286; Miller MJ, 2009, AM FISH S S, V69, P231; Minegishi Y, 2009, ICES J MAR SCI, V66, P1915, DOI 10.1093/icesjms/fsp158; Mochioka N, 1995, PRELIMINARY REPORT H, P33; Munk P, 2010, P ROY SOC B-BIOL SCI, V277, P3593, DOI 10.1098/rspb.2010.0900; Nishi T, 2005, J FISH BIOL, V67, P1213, DOI 10.1111/j.1095-8649.2005.00817.x; Nishi T, 2004, J EXP BIOL, V207, P2965, DOI 10.1242/jeb.01131; Qiu B, 2010, J PHYS OCEANOGR, V40, P2525, DOI 10.1175/2010JPO4462.1; REVERDIN G, 1994, J GEOPHYS RES-OCEANS, V99, P20323, DOI 10.1029/94JC01477; ROBINS CR, 1979, B MAR SCI, V29, P401; Schabetsberger R, 2013, MAR ECOL PROG SER, V475, P177, DOI 10.3354/meps10254; Schmidt J, 1923, PHILOS T R SOC LON B, V211, P179, DOI 10.1098/rstb.1923.0004; SCHOTH M, 1982, HELGOLANDER MEERESUN, V35, P309, DOI 10.1007/BF02006139; Shinoda A, 2011, REV FISH BIOL FISHER, V21, P591, DOI 10.1007/s11160-010-9195-1; Tesch F.-W., 2003, EEL BIOL MANAGEMENT; Tsukamoto K, 2003, ENVIRON BIOL FISH, V66, P221, DOI 10.1023/A:1023926705906; Tsukamoto K, 2002, CAN J FISH AQUAT SCI, V59, P1989, DOI 10.1139/F02-165; Tsukamoto K, 2009, J FISH BIOL, V74, P1833, DOI 10.1111/j.1095-8649.2009.02242.x; Tsukamoto K, 2006, NATURE, V439, P929, DOI 10.1038/439929a; TSUKAMOTO K, 1992, NATURE, V356, P789, DOI 10.1038/356789a0; Tsukamoto K, 2013, FISHERIES SCI, V79, P407, DOI 10.1007/s12562-013-0611-z; Tsukamoto K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1174; Tsukamoto Katsumi, 2009, P21; Tsukamoto K, 2009, MAR BIOL, V156, P835, DOI 10.1007/s00227-008-1123-8; Tzeng WN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030805; Van Ginneken V, 2005, ANIM BIOL, V55, P203, DOI 10.1163/1570756054472791; van Ginneken V, 2005, J EXP BIOL, V208, P1329, DOI 10.1242/jeb.01524; Watanabe S, 2004, MAR BIOTECHNOL, V6, P566, DOI 10.1007/s10126-004-1000-5; Wirth T, 2003, P ROY SOC B-BIOL SCI, V270, P681, DOI 10.1098/rspb.2002.2301; Yoshinaga T, 2011, FISHERIES SCI, V77, P983, DOI 10.1007/s12562-011-0418-8; Zenimoto K, 2009, J FISH BIOL, V74, P1878, DOI 10.1111/j.1095-8649.2009.02295.x; Zenimoto K, 2012, PRELIMINARY REPORT H, P10	66	54	55	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88759	10.1371/journal.pone.0088759	http://dx.doi.org/10.1371/journal.pone.0088759			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551155	gold, Green Submitted, Green Published			2022-12-27	WOS:000331266000063
J	Small, R; Watson, L; Gunn, J; Mitchell, C; Brown, S				Small, Rhonda; Watson, Lyndsey; Gunn, Jane; Mitchell, Creina; Brown, Stephanie			Improving Population-Level Maternal Health: A Hard Nut to Crack? Long Term Findings and Reflections on a 16-Community Randomised Trial in Australia to Improve Maternal Emotional and Physical Health after Birth [ISRCTN03464021]	PLOS ONE			English	Article							DEPRESSIVE SYMPTOMS; COMPLEX INTERVENTIONS; POSTPARTUM DEPRESSION; POSTNATAL DEPRESSION; REDUCE DEPRESSION; MENTAL-DISORDERS; PRISM PROGRAM; RISK-FACTORS; CHILDBIRTH; PREVALENCE	Background: Community level interventions to improve maternal and child health have been supported and well evaluated in resource poor settings, but less so in developed countries. PRISM - Program of Resources, Information and Support for Mothers - was a primary care and community-based cluster-randomised trial in sixteen municipalities in Victoria, Australia, which aimed to reduce depression in mothers and improve their physical health. The aim of this paper is to report the longer term outcomes of PRISM and to reflect on lessons learned from this universal community intervention to improve maternal health. Methods: Maternal health outcome data in PRISM were collected by postal questionnaire at six months and two years. At two years, the main outcome measures included the Edinburgh Postnatal Depression Scale (EPDS) and the SF-36. Secondary outcome measures included the Experience of Motherhood Scale (EOM) and the Parenting Stress Index (PSI). A primary intention to treat analysis was conducted, adjusting for the randomisation by cluster. Results: 7,169/18,424 (39%) women responded to the postal questionnaire at two years -3,894 (40%) in the intervention arm and 3,275 (38%) in the comparison arm. Respondents were mostly representative on available population data comparisons. There were no differences in depression prevalence (EPDS >= 13) between the intervention and comparison arms (13.4% vs 13.1%; ORadj = 1.06, 95% CI 0.91-1.24). Nor did women's mental health (MCS: 48.6 vs 49.1) or physical health scores (PCS: 49.1 vs 49.0) on the SF-36 differ between the trial arms. Conclusion: Improvement in maternal mental and physical health outcomes at the population level in the early years after childbirth remains a largely unmet challenge. Despite the lack of effectiveness of PRISM intervention strategies, important lessons about systems change, sustained investment and contextual understanding of the workability of intervention strategies can be drawn from the experience of PRISM.	[Small, Rhonda; Watson, Lyndsey] La Trobe Univ, Judith Lumley Ctr, Melbourne, Vic, Australia; [Gunn, Jane] Univ Melbourne, Dept Gen Practice, Carlton, Vic 3053, Australia; [Mitchell, Creina] Griffith Univ, Griffith Hlth Inst, Sch Nursing & Midwifery, Southport, Qld 4215, Australia; [Brown, Stephanie] Murdoch Childrens Res Inst, Hlth Mothers Hlth Families Grp, Parkville, Vic, Australia	La Trobe University; University of Melbourne; Griffith University; Menzies Health Institute Queensland; Murdoch Children's Research Institute	Small, R (corresponding author), La Trobe Univ, Judith Lumley Ctr, Melbourne, Vic, Australia.	r.small@latrobe.edu.au	Mitchell, Creina/E-1573-2011; Brown, Stephanie/AAE-1662-2019	Mitchell, Creina/0000-0003-3195-1848; Brown, Stephanie/0000-0001-9812-0067; Gunn, Jane/0000-0001-8836-7525; Small, Rhonda/0000-0003-0345-4676	La Trobe University; Victorian Department of Human Services; National Health and Medical Research Council [974083, 990978, 191215]; Victorian Health Promotion Foundation; Alfred Felton Bequest; Sidney Myer Fund; Beyondblue	La Trobe University; Victorian Department of Human Services; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Health Promotion Foundation; Alfred Felton Bequest; Sidney Myer Fund; Beyondblue	PRISM was funded by the following agencies: La Trobe University and the Victorian Department of Human Services with a Collaborative Industry grant 1997, the National Health and Medical Research Council with project grants in 1997 (ID 974083), 1999 (ID 990978) and 2001 (ID 191215), the Victorian Department of Human Services program implementation and data collection grants 1998-2000, the Victorian Health Promotion Foundation grants for program resources and implementation 1998-2000. We also received funding from the Alfred Felton Bequest in 1998, the Sidney Myer Fund in 1999, Beyondblue in 2002 and throughout the project received in-kind contributions from participating municipalities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding body websites: La Trobe University: http://www.latrobe.edu.au/ National Health and Medical Research Council (NHMRC): http://www.nhmrc.gov.au/ Victorian Health Promotion Foundation: http://www.vichealth.vic.gov.au/ Victorian Department of Human Services, now Victorian Department of Health: http://www.health.vic.gov.au/ Beyondblue: http://www.beyondblue.org.au/ Sidney Myer Fund: http://www.myerfoundation.org.au/ Alfred Felton Bequest, managed by ANZ Trustees: http://www.anz.com/personal/private-bank-trustees/trustees/	Abidin RR., 1995, PSYCHOL ASSESSMENT R; Armstrong KL, 1999, J PAEDIATR CHILD H, V35, P237, DOI 10.1046/j.1440-1754.1999.00348.x; ASTBURY J, 1994, AUST J PUBLIC HEALTH, V18, P176; Astbury J., 1994, J REPROD INFANT PSYC, V12, P79, DOI [10.1080/02646839408408871, DOI 10.1080/02646839408408871]; Austin MP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005124.pub2; Australian Bureau of Statistics, 1997, NAT HLTH SURV SF 36; Bandyopadhyay M, 2010, AUST NZ J PUBL HEAL, V34, P412, DOI 10.1111/j.1753-6405.2010.00575.x; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Bonetti D, 2005, SOC SCI MED, V60, P2135, DOI 10.1016/j.socscimed.2004.08.072; Brown S, 2000, BRIT J OBSTET GYNAEC, V107, P1194, DOI 10.1111/j.1471-0528.2000.tb11607.x; Brown S, 1998, BRIT J OBSTET GYNAEC, V105, P156, DOI 10.1111/j.1471-0528.1998.tb10045.x; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; C-L D, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006116.pub2; DIEHR P, 1995, STAT MED, V14, P1491, DOI 10.1002/sim.4780141309; Dollery B, 2003, RESHAPING AUSTR LOCA, p[93, 129, 117]; Fisher J, 2012, AUST NZ J OBSTET GYN, V52, P559, DOI 10.1111/ajo.12000; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; Fisher JRW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-432; Francis JJ, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-35; Gartland D, 2011, MATERN CHILD HLTH J, V15, P570, DOI 10.1007/s10995-010-0638-z; Gold L, 2007, HEALTH EDUC RES, V22, P648, DOI 10.1093/her/cyl127; Gunn J, 2003, FAM PRACT, V20, P382, DOI 10.1093/fampra/cmg408; Gunn J, 1996, J PAEDIATR CHILD H, V32, P310; Halbreich U, 2006, J AFFECT DISORDERS, V91, P97, DOI 10.1016/j.jad.2005.12.051; Hawe P, 2004, BMJ-BRIT MED J, V328, P1561, DOI 10.1136/bmj.328.7455.1561; Hawe P, 2009, AM J COMMUN PSYCHOL, V43, P267, DOI 10.1007/s10464-009-9229-9; Heinicke CM, 1999, INFANT MENT HEALTH J, V20, P28; JENKINSON C, 1993, BRIT MED J, V306, P1437, DOI 10.1136/bmj.306.6890.1437; Lumley J, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-36; Lumley J, 2004, INT J TECHNOL ASSESS, V20, P128, DOI 10.1017/S0266462304000911; Lumley J, 1997, AUSTRALAS EPIDEMIOLO, V4, P23; Lumley J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-37; MacArthur C, 2003, Health Technol Assess, V7, P1; Marmot Review, 2010, FAIR SOC HLTH LIV ST; May CR, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-42; Medical Research Council (MRC), 2000, FRAM DEV EV RCTS COM; Michie S, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-40; Milgrom J, 2008, J AFFECT DISORDERS, V108, P147, DOI 10.1016/j.jad.2007.10.014; MRC (Medical Research Council UK), 2008, DEV EVALUATING COMPL; National Preventative Health Taskforce, 2009, AUSTR HLTH COUNTR 20; Oakley A, 2007, BMJ-BRIT MED J, V332, P413; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Pawson R., 2009, EVIDENCE BASED PUBLI, P43, DOI [DOI 10.1093/ACPROF:OSO/9780199563623.003.04, DOI 10.1093/ACPROF:0S0/9780199563623.001.0001]; Rahman A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001442; Rich-Edwards JW, 2006, J EPIDEMIOL COMMUN H, V60, P221, DOI 10.1136/jech.2005.039370; Rubertsson C, 2005, ARCH WOMEN MENT HLTH, V8, P97, DOI 10.1007/s00737-005-0078-8; Shaw E, 2006, BIRTH-ISS PERINAT C, V33, P210, DOI 10.1111/j.1523-536X.2006.00106.x; SMALL R, 1994, MED J AUSTRALIA, V161, P473, DOI 10.5694/j.1326-5377.1994.tb127559.x; Small R, 2004, AUST NZ J PUBL HEAL, V28, P471, DOI 10.1111/j.1467-842X.2004.tb00030.x; Small R., 1994, J REPROD INFANT PSYC, V12, P89, DOI DOI 10.1080/02646839408408872; StataCorp, 2021, STATA STAT SOFTWARE; Sutter-Dallay AL, 2011, EUR PSYCHIAT, V26, P484, DOI 10.1016/j.eurpsy.2010.05.004; Watson L, 2004, CONTROL CLIN TRIALS, V25, P235, DOI 10.1016/j.cct.2003.12.002; Woolhouse H, 2012, BJOG-INT J OBSTET GY, V119, P315, DOI 10.1111/j.1471-0528.2011.03219.x; Yelland J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-771	56	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e88457	10.1371/journal.pone.0088457	http://dx.doi.org/10.1371/journal.pone.0088457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3DW	24586327	Green Published, gold			2022-12-27	WOS:000332396200020
J	Schweingruber, FH; Riha, P; Dolezal, J				Schweingruber, Fritz Hans; Riha, Pavel; Dolezal, Jiri			Variation in Stem Anatomical Characteristics of Campanuloideae Species in Relation to Evolutionary History and Ecological Preferences	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; TRACHEID DIAMETER; INDUCED EMBOLISM; CAMPANULACEAE; PHYLOGENY	Background: The detailed knowledge of plant anatomical characters and their variation among closely related taxa is key to understanding their evolution and function. We examined anatomical variation in 46 herbaceous taxa from the subfamily Campanuloideae (Campanulaceae) to link this information with their phylogeny, ecology and comparative material of 56 woody tropical taxa from the subfamily Lobelioideae. The species studied covered major environmental gradients from Mediterranean to Arctic zones, allowing us to test hypotheses on the evolution of anatomical structure in relation to plant competitive ability and ecological preferences. Methodology/Principal Findings: To understand the evolution of anatomical diversity, we reconstructed the phylogeny of studied species from nucleotide sequences and examined the distribution of anatomical characters on the resulting phylogenetic tree. Redundancy analysis, with phylogenetic corrections, was used to separate the evolutionary inertia from the adaptation to the environment. A large anatomical diversity exists within the Campanuloideae. Traits connected with the quality of fibres were the most congruent with phylogeny, and the Rapunculus 2 ("phyteumoid'') clade was especially distinguished by a number of characters (absence of fibres, pervasive parenchyma, type of rays) from two other clades (Campanula s. str. and Rapunculus 1) characterized by the dominance of fibres and the absence of parenchyma. Septate fibres are an exclusive trait in the Lobelioideae, separating it clearly from the Campanuloideae where annual rings, pervasive parenchyma and crystals in the phellem are characteristic features. Conclusions/Significance: Despite clear phylogenetic inertia in the anatomical features studied, the ecological attributes and plant height had a significant effect on anatomical divergence. From all three evolutionary clades, the taller species converged towards similar anatomical structure, characterized by a smaller number of early wood vessels of large diameter, thinner cell-walls and alternate intervessel pits, while the opposite trend was found in small Arctic and alpine taxa. This supports the existing generalization that narrower vessels allow plants to grow in colder places where they can avoid freezing-induced embolism, while taller plants have wider vessels to minimize hydraulic resistance with their greater path lengths.	[Schweingruber, Fritz Hans] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Riha, Pavel; Dolezal, Jiri] Acad Sci Czech Republ, Inst Bot, Sect Plant Ecol, Trebon, Czech Republic; [Riha, Pavel; Dolezal, Jiri] Univ South Bohemia, Dept Bot, Ceske Budejovice, Czech Republic	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Dolezal, J (corresponding author), Swiss Fed Res Inst WSL, Birmensdorf, Switzerland.	jiriddolezal@gmail.com	Doležal, Jiří/H-1583-2014	Dolezal, Jiri/0000-0002-5829-4051	Grant Agency of the Czech Republic [13-13368S, P505/11/1617]; institutional long-term research plan [AV0Z60050516]; grant OP Education for Competitiveness [CZ.1.07/2.3.00/30.0048]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); institutional long-term research plan; grant OP Education for Competitiveness	The study was funded by research grants GACR 13-13368S, GACR P505/11/1617 of the Grant Agency of the Czech Republic, institutional long-term research plan AV0Z60050516, and the grant OP Education for Competitiveness CZ.1.07/2.3.00/30.0048. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2000, EVOLUTION, V54, P1480, DOI 10.1111/j.0014-3820.2000.tb00694.x; Adachi J., 1996, COMPUT SCI MONOGR, V28, P1; B?cher TygeW., 1968, FLORA GREENLAND; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Carlquist S., 1969, Biotropica, V1, P47, DOI 10.2307/2989761; Desdevises Y, 2003, EVOLUTION, V57, P2647; Diniz JAF, 1998, EVOLUTION, V52, P1247, DOI 10.1111/j.1558-5646.1998.tb02006.x; Dubuisson JY, 2011, CR BIOL, V334, P880, DOI 10.1016/j.crvi.2011.07.009; Eddie WMM, 2003, ANN MO BOT GARD, V90, P554, DOI 10.2307/3298542; Foster AS., 1974, COMP MORPHOLOGY VASC; Gagnidze R., 2005, VASCULAR PLANTS GEOR; Haberle RC, 2009, TAXON, V58, P715, DOI 10.1002/tax.583003; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HARVEY PH, 1995, J ECOL, V83, P535, DOI 10.2307/2261606; IAWA Committee, 1989, IAWA B N S, V10, P219, DOI DOI 10.1163/22941932-90000496; Jahn R, 1995, EXKURSIONSFLORA KRET; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kitching I. J., 1998, CLADISTICS THEORY PR; Klimesova J, 2011, OIKOS, V120, P1110, DOI 10.1111/j.1600-0706.2011.19332.x; Lammers TG, 2007, FAMILIES GENERA VASC, V8, P26, DOI DOI 10.1007/978-3-540-31051-8_5; Lauber K., 2018, FLORA HELVETICA; Legendre P., 2012, NUMERICAL ECOLOGY; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Maddison WP, 2019, MESQUITE MODULAR SYS; Mansion G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050076; Metcalf CR, 1957, ANATOMY DICOTYLEDONE; NIKLAS KJ, 1985, EVOLUTION, V39, P1110, DOI 10.1111/j.1558-5646.1985.tb00451.x; PEAT HJ, 1994, BIOL REV, V69, P95, DOI 10.1111/j.1469-185X.1994.tb01487.x; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Pittermann J, 2003, TREE PHYSIOL, V23, P907, DOI 10.1093/treephys/23.13.907; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roquet C, 2009, MOL PHYLOGENET EVOL, V52, P575, DOI 10.1016/j.ympev.2009.05.014; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Schweingruber F. H., 2012, ATLAS STEM ANATOMY H, V2; Schweingruber FH, 2012, IAWA J, V33, P457, DOI 10.1163/22941932-90000107; Schweingruber Fritz Hans, 2011, P1; Sevanto S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00107; SHUL'KINA T V, 1980, Botanicheskii Zhurnal (St. Petersburg), V65, P627; Smilauerova M, 2007, J ECOL, V95, P406, DOI 10.1111/j.1365-2745.2007.01218.x; Sperry JS, 2003, INT J PLANT SCI, V164, pS115, DOI 10.1086/368398; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; TUTIN T. G., 1964, FLORA EUROPAEA, V4; Wendling BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023559; Willson CJ, 2006, PHYSIOL PLANTARUM, V127, P374, DOI 10.1111/j.1399-3054.2006.00644.x; Zhao Da-chang, 2007, BOT ATLAS CHANGBAI M	47	8	8	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e88199	10.1371/journal.pone.0088199	http://dx.doi.org/10.1371/journal.pone.0088199			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586306	Green Accepted, Green Published, gold			2022-12-27	WOS:000331717900016
J	Wu, PY; Liao, YF; Juan, HF; Huang, HC; Wang, BJ; Lu, YL; Yu, IS; Shih, YY; Jeng, YM; Hsu, WM; Lee, HY				Wu, Pei-Yi; Liao, Yung-Feng; Juan, Hsueh-Fen; Huang, Hsuan-Cheng; Wang, Bo-Jeng; Lu, Yen-Lin; Yu, I-Shing; Shih, Yu-Yin; Jeng, Yung-Ming; Hsu, Wen-Ming; Lee, Hsinyu			Aryl Hydrocarbon Receptor Downregulates MYCN Expression and Promotes Cell Differentiation of Neuroblastoma	PLOS ONE			English	Article							N-MYC; CANCER-MORTALITY; GENE; PROTEIN; WORKERS; ARREST; E2F; PROLIFERATION; AMPLIFICATION; PREDICTS	Neuroblastoma (NB) is the most common malignant disease of infancy. MYCN amplification is a prognostic factor for NB and is a sign of highly malignant disease and poor patient prognosis. In this study, we aimed to investigate novel MYCN-related genes and assess how they affect NB cell behavior. The different gene expression found in 10 MYCN amplification NB tumors and 10 tumors with normal MYCN copy number were analyzed using tissue oligonucleotide microarrays. Ingenuity Pathway Analysis was subsequently performed to identify the potential genes involved in MYCN regulation pathways. Aryl hydrocarbon receptor (AHR), a receptor for dioxin-like compounds, was found to be inversely correlated with MYCN expression in NB tissues. This correlation was confirmed in a further 14 human NB samples. Moreover, AHR expression in NB tumors was found to correlate highly with histological grade of differentiation. In vitro studies revealed that AHR overexpression in NB cells induced spontaneous cell differentiation. In addition, it was found that ectopic expression of AHR suppressed MYCN promoter activity resulting in downregulation of MYCN expression. The suppression effect of AHR on the transcription of MYCN was compensated for by E2F1 overexpression, indicating that E2F1 is involved in the AHR-regulating MYCN pathway. Furthermore, AHR shRNA promotes the expression of E2F1 and MYCN in NB cells. These findings suggest that AHR is one of the upstream regulators of MYCN. Through the modulation of E2F1, AHR regulates MYCN gene expression, which may in turn affect NB differentiation.	[Wu, Pei-Yi; Liao, Yung-Feng; Juan, Hsueh-Fen; Lee, Hsinyu] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Liao, Yung-Feng; Wang, Bo-Jeng; Shih, Yu-Yin] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Huang, Hsuan-Cheng] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Lu, Yen-Lin] Natl Taiwan Univ, Acad Sinica, Degree Program Translat Med, Taipei 10764, Taiwan; [Yu, I-Shing] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Jeng, Yung-Ming] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan; [Jeng, Yung-Ming; Hsu, Wen-Ming] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Hsu, Wen-Ming] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan	National Taiwan University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Hsu, WM (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan.	billwmhsu@gmail.com; hsinyu@ntu.edu.tw	Huang, Hsuan-Cheng/C-7266-2011; Liao, Yung-Feng/A-9761-2011	Huang, Hsuan-Cheng/0000-0002-3386-0934; JENG, YUNG-MING/0000-0002-3878-4491; JUAN, HSUEH-FEN/0000-0003-4876-3309; HSU, WEN-MING/0000-0002-5145-9538; Lee, Hsinyu/0000-0002-1477-0183	National Science Council of Taiwan [NSC 97-2314-B-002-029-MY2, NSC 97-2311-B-002 -002 -MY3]; National Taiwan University Hospital, Taipei, Taiwan [NTUH 98-S1094, UN102-051]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital, Taipei, Taiwan	Funding was provided by (1) National Science Council of Taiwan (NSC 97-2314-B-002-029-MY2 to W.-M. H. and NSC 97-2311-B-002 -002 -MY3 to H. L.), http://web1.nsc.gov.tw/; and (2) National Taiwan University Hospital, Taipei, Taiwan (NTUH 98-S1094 and UN102-051 to W.-M. H.), http://www.ntuh.gov.tw/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahoshi Eiichi, 2006, Environ Health, V5, P24, DOI 10.1186/1476-069X-5-24; BERTAZZI PA, 1991, SCI TOTAL ENVIRON, V106, P5, DOI 10.1016/0048-9697(91)90016-8; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; BRODEUR GM, 1995, EUR J CANCER, V31A, P505, DOI 10.1016/0959-8049(95)00040-P; Cheng KC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-411; Cohn SL, 2004, EUR J CANCER, V40, P2639, DOI 10.1016/j.ejca.2004.07.025; Collins LL, 2008, TOXICOL SCI, V103, P125, DOI 10.1093/toxsci/kfn017; COOPER MJ, 1992, J CLIN INVEST, V90, P2402, DOI 10.1172/JCI116131; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; FINGERHUT MA, 1991, NEW ENGL J MED, V324, P212, DOI 10.1056/NEJM199101243240402; FLESCHJANYS D, 1995, AM J EPIDEMIOL, V142, P1165, DOI 10.1093/oxfordjournals.aje.a117575; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Hoehner JC, 1996, LAB INVEST, V75, P659; Huang TC, 2011, FEBS LETT, V585, P3582, DOI 10.1016/j.febslet.2011.10.025; Ijiri R, 2000, AM J SURG PATHOL, V24, P807, DOI 10.1097/00000478-200006000-00005; ISRAEL MA, 1993, CANCER, V71, P3310, DOI 10.1002/1097-0142(19930515)71:10+<3310::AID-CNCR2820711728>3.0.CO;2-G; Janardhanan R, 2009, BIOCHEM PHARMACOL, V78, P1105, DOI 10.1016/j.bcp.2009.06.009; Jin DQ, 2004, NEUROSCI LETT, V363, P69, DOI 10.1016/j.neulet.2004.03.047; Kerr MA, 2000, CANCER CAUSE CONTROL, V11, P635, DOI 10.1023/A:1008951632482; Kopf I, 1996, ANTICANCER RES, V16, P2533; Latchney SE, 2013, J NEUROCHEM, V125, P430, DOI 10.1111/jnc.12130; Lutz W, 1996, ONCOGENE, V13, P803; MANZ A, 1991, LANCET, V338, P959, DOI 10.1016/0140-6736(91)91835-I; Maris JM, 1999, J CLIN ONCOL, V17, P2264, DOI 10.1200/JCO.1999.17.7.2264; Marlowe JL, 2008, MOL BIOL CELL, V19, P3263, DOI 10.1091/mbc.E08-04-0359; Marlowe JL, 2004, J BIOL CHEM, V279, P29013, DOI 10.1074/jbc.M404315200; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; NAKAGAWARA A, 1993, NEW ENGL J MED, V328, P847, DOI 10.1056/NEJM199303253281205; Nishihira H, 2000, J CLIN ONCOL, V18, P3012, DOI 10.1200/JCO.2000.18.16.3012; Norris MD, 1996, NEW ENGL J MED, V334, P231, DOI 10.1056/NEJM199601253340405; Norris MD, 2000, MED PEDIATR ONCOL, V35, P585, DOI 10.1002/1096-911X(20001201)35:6<585::AID-MPO20>3.3.CO;2-G; Ohira M, 2005, CANCER CELL, V7, P337, DOI 10.1016/j.ccr.2005.03.019; Ossewaarde JM, 1996, APPL ENVIRON MICROB, V62, P328, DOI 10.1128/AEM.62.2.328-331.1996; Peverali FA, 1996, ONCOGENE, V12, P457; PRITCHARD J, 1994, LANCET, V344, P869, DOI 10.1016/S0140-6736(94)92834-7; Puga A, 2000, J BIOL CHEM, V275, P2943, DOI 10.1074/jbc.275.4.2943; Qin HT, 2004, DEV BIOL, V270, P64, DOI 10.1016/j.ydbio.2004.02.004; Shimada H, 2003, Pathologica, V95, P240; Shimba S, 2002, J BIOCHEM, V132, P795, DOI 10.1093/oxfordjournals.jbchem.a003289; Sommer RJ, 1999, TOXICOL APPL PHARM, V155, P177, DOI 10.1006/taap.1998.8597; Strieder V, 2003, J BIOL CHEM, V278, P2983, DOI 10.1074/jbc.M207596200; Tajiri T, 1999, J PEDIATR SURG, V34, P1615, DOI 10.1016/S0022-3468(99)90628-0; TONINI GP, 1993, STEM CELLS, V11, P276, DOI 10.1002/stem.5530110404; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Tseng CW, 2012, INT J MOL SCI, V13, P6352, DOI 10.3390/ijms13056352; Vehlow C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S19-S2; Watabe Y, 2010, BIOL PHARM BULL, V33, P389, DOI 10.1248/bpb.33.389	48	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e88795	10.1371/journal.pone.0088795	http://dx.doi.org/10.1371/journal.pone.0088795			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586395	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900028
J	Krakauer, NY; Krakauer, JC				Krakauer, Nir Y.; Krakauer, Jesse C.			Dynamic Association of Mortality Hazard with Body Shape	PLOS ONE			English	Article							INTENTIONAL WEIGHT-LOSS; ALL-CAUSE MORTALITY; WAIST CIRCUMFERENCE; MASS INDEX; US ADULTS; CARDIOVASCULAR-DISEASE; OVERWEIGHT; OBESITY; HEALTH; MEN	Background: A Body Shape Index (ABSI) had been derived from a study of the United States National Health and Nutrition Examination Survey (NHANES) 1999-2004 mortality data to quantify the risk associated with abdominal obesity (as indicated by a wide waist relative to height and body mass index). A national survey with longer follow-up, the British Health and Lifestyle Survey (HALS), provides another opportunity to assess the predictive power for mortality of ABSI. HALS also includes repeat observations, allowing estimation of the implications of changes in ABSI. Methods and Findings: We evaluate ABSI z score relative to population normals as a predictor of all-cause mortality over 24 years of follow-up to HALS. We found that ABSI is a strong indicator of mortality hazard in this population, with death rates increasing by a factor of 1.13 (95% confidence interval, 1.09-1.16) per standard deviation increase in ABSI and a hazard ratio of 1.61 (1.40-1.86) for those with ABSI in the top 20% of the population compared to those with ABSI in the bottom 20%. Using the NHANES normals to compute ABSI z scores gave similar results to using z scores derived specifically from the HALS sample. ABSI outperformed as a predictor of mortality hazard other measures of abdominal obesity such as waist circumference, waist to height ratio, and waist to hip ratio. Moreover, it was a consistent predictor of mortality hazard over at least 20 years of follow-up. Change in ABSI between two HALS examinations 7 years apart also predicted mortality hazard: individuals with a given initial ABSI who had rising ABSI were at greater risk than those with falling ABSI. Conclusions: ABSI is a readily computed dynamic indicator of health whose correlation with lifestyle and with other risk factors and health outcomes warrants further investigation.	[Krakauer, Nir Y.] CUNY City Coll, Dept Civil Engn, New York, NY 10031 USA; [Krakauer, Jesse C.] Alzohaili Med Consultants, Southfield, MI USA	City University of New York (CUNY) System; City College of New York (CUNY)	Krakauer, NY (corresponding author), CUNY City Coll, Dept Civil Engn, New York, NY 10031 USA.	nkrakauer@ccny.cuny.edu	Krakauer, Jesse/AAV-2692-2021					Afsar B, 2013, NUTRITION; Ahima RS, 2013, SCIENCE, V341, P856, DOI 10.1126/science.1241244; Atlantis E, 2010, AGE AGEING, V39, P643, DOI 10.1093/ageing/afq073; Boniface DR., 2013, EUR J PUBLIC HEALTH, V23, P16; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cambridge University School of Clinical Medicine, 2001, TECHNICAL REPORT; Cheung YB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085421; Cox BD, 1998, INT J OBESITY, V22, P966, DOI 10.1038/sj.ijo.0800705; Cox BD, 2009, HLTH LIFESTYLE SURVE, DOI [10.5255/UKDA-SN-6339-1, DOI 10.5255/UKDA-SN-6339-1]; Cox BD, 1996, BRIT MED J, V7, P313; Cox BD, 1995, HLTH LIFESTYLE SURVE, DOI [10.5255/UKDA-SN-3279-1, DOI 10.5255/UKDA-SN-3279-1]; Cox BD, 1988, HLTH LIFESTYLE SURVE, DOI [10.5255/UKDA-SN-2218-1, DOI 10.5255/UKDA-SN-2218-1]; Duncan MJ, 2013, ANN HUM BIOL, V40, P163, DOI 10.3109/03014460.2012.752861; Field AE, 2009, ARCH INTERN MED, V169, P881, DOI 10.1001/archinternmed.2009.67; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Gregg EW, 2004, DIABETES CARE, V27, P657, DOI 10.2337/diacare.27.3.657; Gregg EW, 2003, ANN INTERN MED, V138, P383, DOI 10.7326/0003-4819-138-5-200303040-00007; Han TS, 1997, INT J OBESITY, V21, P127, DOI 10.1038/sj.ijo.0800377; He S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050573; King NA, 2009, BRIT J SPORT MED, V43, P924, DOI 10.1136/bjsm.2009.065557; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; Kvaavik E, 2010, ARCH INTERN MED, V170, P711, DOI 10.1001/archinternmed.2010.76; Lee DC, 2011, CIRCULATION, V124, P2483, DOI 10.1161/CIRCULATIONAHA.111.038422; Matsha TE, 2013, INT J CARDIOL, V168, P2954, DOI 10.1016/j.ijcard.2013.03.150; Mayhew L, 2009, TECHNICAL REPORT; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Romaguera D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011588; Ross R, 2008, OBES REV, V9, P312, DOI 10.1111/j.1467-789X.2007.00411.x; Ross R, 2000, ANN INTERN MED, V133, P92, DOI 10.7326/0003-4819-133-2-200007180-00008; Shea MK, 2011, AM J CLIN NUTR, V94, P839, DOI 10.3945/ajcn.110.006379; Shea MK, 2010, J GERONTOL A-BIOL, V65, P519, DOI 10.1093/gerona/glp217; Therneau T.M., 2000, MODELING SURVIVAL DA; Wannamethee SG, 2005, ARCH INTERN MED, V165, P1035, DOI 10.1001/archinte.165.9.1035; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914	36	88	90	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88793	10.1371/journal.pone.0088793	http://dx.doi.org/10.1371/journal.pone.0088793			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586394	Green Published, gold			2022-12-27	WOS:000331714700030
J	Chen, KH; Chen, LR; Wang, YK				Chen, Kuo-Hu; Chen, Li-Ru; Wang, Ying-Kuan			Contamination of Medical Charts: An Important Source of Potential Infection in Hospitals	PLOS ONE			English	Article							INTENSIVE-CARE UNITS; HAND HYGIENE; BACTERIAL-CONTAMINATION; PATHOGENS	Objective: This prospective study aims to identify and compare the incidence of bacterial contamination of hospital charts and the distribution of species responsible for chart contamination in different units of a tertiary hospital. Methods: All beds in medical, surgical, pediatric, and obstetric-gynecologic general wards (556) and those in corresponding special units (125) including medical, surgical, pediatric intensive care units (ICUs), the obstetric tocolytic unit and delivery room were surveyed for possible chart contamination. The outer surfaces of included charts were sampled by one experienced investigator with sterile cotton swabs rinsed with normal saline. Results: For general wards and special units, the overall sampling rates were 81.8% (455/556) and 85.6% (107/125) (p = 0.316); the incidence of chart contamination was 63.5% and 83.2%, respectively (p<0.001). Except for obstetric-gynecologic charts, the incidence was significantly higher in each and in all ICUs than in corresponding wards. Coagulase-negative staphylococci was the most common contaminant in general wards (40.0%) and special units (34.6%) (p>0.05). Special units had a significantly higher incidence of bacterial contamination due to Staphylococcus aureus (17.8%), Methicillin-resistant Staphylococcus aureus (9.3%), Streptococcus viridans (9.4%), Escherichia coli (11.2%), Klebsiella pneumoniae (7.5%), and Acinetobacter baumannii (7.5%). Logistic regression analysis revealed the incidence of chart contamination was 2- to 4-fold higher in special units than in general wards [odds ratios: 1.97-4.00]. Conclusions: Noting that most hospital charts are contaminated, our study confirms that a hospital chart is not only a medical record but also an important source of potential infection. The plastic cover of the medical chart can harbor potential pathogens, thus acting as a vector of bacteria. Additionally, chart contamination is more common in ICUs. These findings highlight the importance of effective hand-washing before and after handling medical charts. However, managers and clinical staff should pay more attention to the issue and may consider some interventions.	[Chen, Kuo-Hu] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Chen, Kuo-Hu] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Chen, Li-Ru] Mackay Mem Hosp, Taipei, Taiwan; [Chen, Li-Ru] Natl Chiao Tung Univ, Dept Mech Engn, Hsinchu, Taiwan; [Wang, Ying-Kuan] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Dept Nursing, Taipei, Taiwan	Tzu Chi University; Mackay Memorial Hospital; National Yang Ming Chiao Tung University	Chen, KH (corresponding author), Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Dept Obstet & Gynecol, Taipei, Taiwan.	alexgfctw@yahoo.com.tw			Buddhist Tzu-Chi General Hospital, Taipei Branch, Taiwan [TCRD-TPE-99-20]	Buddhist Tzu-Chi General Hospital, Taipei Branch, Taiwan	This research was supported by a grant from Buddhist Tzu-Chi General Hospital, Taipei Branch, Taiwan (TCRD-TPE-99-20); (http://www.tzuchi.com.tw/tzuchi_en/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegranzi B, 2009, J HOSP INFECT, V73, P305, DOI 10.1016/j.jhin.2009.04.019; Alothman A, 2003, J HOSP INFECT, V55, P304, DOI 10.1016/j.jhin.2003.08.003; Aragon D, 2005, AACN ADV CRIT CARE, V16, P121, DOI 10.1097/00044067-200504000-00002; Bebbington A, 2003, J HOSP INFECT, V55, P299, DOI 10.1016/j.jhin.2003.08.016; Brady RR, 2011, CLIN MICROBIOL INFEC, V17, P830, DOI 10.1111/j.1469-0691.2011.03493.x; Bures S, 2000, AM J INFECT CONTROL, V28, P465, DOI 10.1067/mic.2000.107267; Cohen SR, 2003, J HOSP INFECT, V55, P236, DOI 10.1016/S0195-6701(03)00297-4; Dancer SJ, 2004, J HOSP INFECT, V56, P10, DOI 10.1016/j.jhin.2003.09.017; Ducel G., 2002, WHOCDSCSREPH200212; Garcia-Vazquez E, 2011, CLIN MICROBIOL INFEC, V17, P894, DOI 10.1111/j.1469-0691.2010.03391.x; Halton K, 2011, CLIN MICROBIOL INFEC, V17, P868, DOI 10.1111/j.1469-0691.2011.03494.x; Hamza N, 2007, ANN ROY COLL SURG, V89, P665, DOI 10.1308/003588407X205341; Huebner J, 1999, ANNU REV MED, V50, P223, DOI 10.1146/annurev.med.50.1.223; Jeans AR, 2010, J HOSP INFECT, V74, P16, DOI 10.1016/j.jhin.2009.06.032; Loh W, 2000, J HOSP INFECT, V45, P65, DOI 10.1053/jhin.1999.0702; Marinella MA, 2000, INFECT DIS CLIN PRAC, V9, P39, DOI 10.1097/00019048-200009010-00011; Panhotra BR, 2005, AM J INFECT CONTROL, V33, P398, DOI 10.1016/j.ajic.2004.12.009; Panhotra BR, 2016, BRIT J INFECT CONTRO, V5, P15, DOI [10.1177/14690446040050030401, DOI 10.1177/14690446040050030401]; Pittet D, 2011, J HOSP INFECT, V77, P299, DOI 10.1016/j.jhin.2010.10.013; Pittet D, 2001, LANCET, P9; Randle J, 2010, J HOSP INFECT, V76, P252, DOI 10.1016/j.jhin.2010.06.027; Sax H, 2009, AM J INFECT CONTROL, V37, P827, DOI 10.1016/j.ajic.2009.07.003; Scheithauer S, 2009, AM J INFECT CONTROL, V37, P835, DOI 10.1016/j.ajic.2009.06.005; Slekovec C, 2011, J HOSP INFECT, V78, P133, DOI 10.1016/j.jhin.2011.03.011; Tacconelli E, 2011, CLIN MICROBIOL INFEC, V17, P794, DOI 10.1111/j.1469-0691.2011.03499.x; Tekerekoglu MS, 2011, AM J INFECT CONTROL, V39, P379, DOI 10.1016/j.ajic.2010.10.026; Teng SO, 2009, J MICROBIOL IMMUNOL, V42, P86; World Health Organization, 2009, WHO GUID HAND HYG HL; Zimbudzi E, 2011, AUSTRALAS MED J, V4, P538, DOI 10.4066/AMJ.2011.726	29	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e78512	10.1371/journal.pone.0078512	http://dx.doi.org/10.1371/journal.pone.0078512			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558355	Green Submitted, Green Published, gold			2022-12-27	WOS:000331706700001
J	Kim, GS; Cho, S; Nelson, JW; Zipfel, GJ; Han, BH				Kim, Gab Seok; Cho, Seongeun; Nelson, James W.; Zipfel, Gregory J.; Han, Byung Hee			TrkB Agonist Antibody Pretreatment Enhances Neuronal Survival and Long-Term Sensory Motor Function Following Hypoxic Ischemic Injury in Neonatal Rats	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; NEUROTROPHIC FACTOR; BRAIN-INJURY; AFFORDS NEUROPROTECTION; SYNAPTIC PLASTICITY; SIGNALING PATHWAY; DOWN-REGULATION; BDNF PROTECTS; GRANULE CELLS; INFARCT SIZE	Perinatal hypoxic ischemia (H-I) causes brain damage and long-term neurological impairments, leading to motor dysfunctions and cerebral palsy. Many studies have demonstrated that the TrkB-ERK1/2 signaling pathway plays a key role in mediating the protective effect of brain-derived neurotrophic factor (BDNF) following perinatal H-I brain injury in experimental animals. In the present study, we explored the neuroprotective effects of the TrkB-specific agonist monoclonal antibody 29D7 on H-I brain injury in neonatal rats. First, we found that intracerebroventricular (icv) administration of 29D7 in normal P7 rats markedly increased the levels of phosphorylated ERK1/2 and phosphorylated AKT in neurons up to 24 h. Second, P7 rats received icv administration of 29D7 and subjected to H-I injury induced by unilateral carotid artery ligation and exposure to hypoxia (8% oxygen). We found that 29D7, to a similar extent to BDNF, significantly inhibited activation of caspase-3, a biochemical hallmark of apoptosis, following H-I injury. Third, we found that this 29D7-mediated neuroprotective action persisted at least up to 5 weeks post-H-I injury as assessed by brain tissue loss, implicating long-term neurotrophic effects rather than an acute delay of cell death. Moreover, the long-term neuroprotective effect of 29D7 was tightly correlated with sensorimotor functional recovery as assessed by a tape-removal test, while 29D7 did not significantly improve rotarod performance. Taken together, these findings demonstrate that pretreatment with the TrkB-selective agonist 29D7 significantly increases neuronal survival and behavioral recovery following neonatal hypoxicischemic brain injury.	[Kim, Gab Seok; Han, Byung Hee] Seoul Natl Univ, Coll Pharm, Dept Pharmacol, Seoul, South Korea; [Cho, Seongeun] Wyeth Neurosci Discovery Res, Princeton, NJ USA; [Nelson, James W.; Zipfel, Gregory J.; Han, Byung Hee] Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO USA; [Nelson, James W.; Zipfel, Gregory J.; Han, Byung Hee] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO USA; [Zipfel, Gregory J.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Seoul National University (SNU); Pfizer; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Han, BH (corresponding author), Seoul Natl Univ, Coll Pharm, Dept Pharmacol, Seoul, South Korea.	hanh@wudosis.wustl.edu			Brain Research Center of the 21st Century Frontier Research Program grant; Ministry of Science and Technology; Republic of Korea; Department of Neurological Surgery, Washington University in St. Louis, Missouri, United States of America	Brain Research Center of the 21st Century Frontier Research Program grant; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Republic of Korea; Department of Neurological Surgery, Washington University in St. Louis, Missouri, United States of America	This research was supported in part by the Brain Research Center of the 21st Century Frontier Research Program grant funded by the Ministry of Science and Technology, the Republic of Korea, and by the Department of Neurological Surgery, Washington University in St. Louis, Missouri, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsmeier M, 2007, RESUSCITATION, V74, P552, DOI 10.1016/j.resuscitation.2007.01.040; Almli CR, 2000, EXP NEUROL, V166, P99, DOI 10.1006/exnr.2000.7492; Andsberg G, 2002, NEUROBIOL DIS, V9, P187, DOI 10.1006/nbdi.2001.0456; Balaratnasingam S, 2012, PHARMACOL THERAPEUT, V134, P116, DOI 10.1016/j.pharmthera.2012.01.006; Barnea A, 2004, BRAIN RES, V1020, P106, DOI 10.1016/j.brainres.2004.06.018; Beck M, 2005, AMYOTROPH LATERAL SC, V6, P100, DOI 10.1080/14660820510028412; Bhakar AL, 2003, J NEUROSCI, V23, P11373; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Chang SH, 2004, J NEUROSCI, V24, P2277, DOI 10.1523/JNEUROSCI.4868-03.2004; Chen J, 2011, NEUROSCI LETT, V499, P181, DOI 10.1016/j.neulet.2011.05.054; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; Cheng Y, 1998, J CLIN INVEST, V101, P1992, DOI 10.1172/JCI2169; Cho S, 2003, BRAIN RES, V982, P146, DOI 10.1016/S0006-8993(03)02846-4; Colbourne F, 2003, P NATL ACAD SCI USA, V100, P2906, DOI 10.1073/pnas.2628027100; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Edwards AD, 1995, BIOCHEM BIOPH RES CO, V217, P1193, DOI 10.1006/bbrc.1995.2895; Ezquer ME, 2006, EXP NEUROL, V197, P391, DOI 10.1016/j.expneurol.2005.10.015; Fouad K, 2010, J NEUROTRAUMA; Gill MB, 2008, J NEUROSCI RES, V86, P3584, DOI 10.1002/jnr.21795; Gottschalk WA, 1999, LEARN MEMORY, V6, P243; Han BH, 2000, NEUROBIOL DIS, V7, P38; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Han BH, 2002, J BIOL CHEM, V277, P30128, DOI 10.1074/jbc.M202931200; Han BH, 2001, NAT MED, V7, P338, DOI 10.1038/85487; Han BH, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-86; Hu Y, 2010, INVEST OPHTH VIS SCI, V51, P1747, DOI 10.1167/iovs.09-4450; Kishino A, 1997, EXP NEUROL, V144, P273, DOI 10.1006/exnr.1996.6367; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; Koda M, 2004, J NEUROTRAUM, V21, P329, DOI 10.1089/089771504322972112; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; KOKAIA Z, 1994, NEUROREPORT, V5, P1241, DOI 10.1097/00001756-199406020-00021; Kurozumi K, 2004, MOL THER, V9, P189, DOI 10.1016/j.ymthe.2003.10.012; La Torre A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.99; Leeds P, 2005, NEUROCHEM INT, V46, P61, DOI 10.1016/j.neuint.2004.07.001; LEVINE S, 1960, AM J PATHOL, V36, P1; Li Q, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.33; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; LINDHOLM D, 1993, EUR J NEUROSCI, V5, P1455, DOI 10.1111/j.1460-9568.1993.tb00213.x; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; MacLellan CL, 2006, STROKE, V37, P1266, DOI 10.1161/01.STR.0000217268.81963.78; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Namiki J, 2000, J NEUROTRAUM, V17, P1219, DOI 10.1089/neu.2000.17.1219; NEWELL DW, 1995, J NEUROSCI, V15, P7702; Northington FJ, 2001, NEUROBIOL DIS, V8, P207, DOI 10.1006/nbdi.2000.0371; Northington FJ, 2011, ANN NEUROL, V69, P743, DOI 10.1002/ana.22419; Nurse S, 1996, J CEREBR BLOOD F MET, V16, P474, DOI 10.1097/00004647-199605000-00014; Ochs G, 2000, AMYOTROPH LATERAL SC, V1, P201, DOI 10.1080/14660820050515197; ORTIZ J, 1995, J NEUROSCI, V15, P1285; Park HY, 2012, ONCOL REP, V28, P353, DOI 10.3892/or.2012.1773; Paxinos G, 2005, RAT BRAIN STEROTAXIC, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Pizzorusso T, 2000, J NEUROSCI, V20, P2809; Qian MD, 2006, J NEUROSCI, V26, P9394, DOI 10.1523/JNEUROSCI.1118-06.2006; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Rosenblum K, 2002, J NEUROSCI, V22, P5432; Schabitz WR, 2004, STROKE, V35, P992, DOI 10.1161/01.STR.0000119754.85848.0D; Schabitz WR, 2000, STROKE, V31, P2212, DOI 10.1161/01.STR.31.9.2212; Schabitz WR, 2007, STROKE, V38, P2165, DOI 10.1161/STROKEAHA.106.477331; Shin DH, 2006, J NEUROCHEM, V96, P561, DOI 10.1111/j.1471-4159.2005.03582.x; Sughrue ME, 2006, J NEUROSCI METH, V151, P83, DOI 10.1016/j.jneumeth.2005.04.023; Suzuki K, 1997, MOL CHEM NEUROPATHOL, V30, P101, DOI 10.1007/BF02815153; Tang XN, 2010, AGEING RES REV, V9, P61, DOI 10.1016/j.arr.2009.10.002; Thoresen M, 1996, ARCH DIS CHILD-FETAL, V74, pF3, DOI 10.1136/fn.74.1.F3; Tomimatsu T, 2001, NEUROSCI LETT, V312, P21, DOI 10.1016/S0304-3940(01)02178-4; Uluc K, 2013, CNS NEUROL DISORD-DR, V12, P360, DOI 10.2174/18715273113129990061; Yager JY, 2006, BEHAV BRAIN RES, V173, P171, DOI 10.1016/j.bbr.2006.06.019; Zhang Y, 2001, STROKE, V32, P1378, DOI 10.1161/01.STR.32.6.1378; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387	69	19	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88962	10.1371/journal.pone.0088962	http://dx.doi.org/10.1371/journal.pone.0088962			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551199	Green Submitted, Green Published, gold			2022-12-27	WOS:000331271500086
J	Wolinski, K; Czarnywojtek, A; Ruchala, M				Wolinski, Kosma; Czarnywojtek, Agata; Ruchala, Marek			Risk of Thyroid Nodular Disease and Thyroid Cancer in Patients with Acromegaly - Meta-Analysis and Systematic Review	PLOS ONE			English	Review							MALIGNANT-TUMORS; BASAL EVALUATION; FOLLOW-UP; PREVALENCE; BENIGN; EPIDEMIOLOGY; MORBIDITY; MORTALITY; GOITER	Introduction: Acromegaly is a quite rare chronic disease caused by the increased secretion of growth hormone (GH) and subsequently insulin -like growth factor 1. Although cardiovascular diseases remains the most common cause of mortality among acromegalic patients, increased prevalence of malignant and benign neoplasms remains a matter of debate. The aim of this study is to evaluate the risk of thyroid nodular disease (TND) and thyroid cancer in patients with acromegaly. Materials and Methods: PubMed, Cochrane Library, Scopus, Cinahl, Academic Search Complete, Web of Knowledge, PubMed Central, PubMed Central Canada and Clinical Key databases were searched to identify studies containing. Random-effects model was used to calculate pooled odds ratios and risk ratios of TND in acromegaly. Studies which not included control groups were systematically reviewed. Results: TND was more frequent in acromegaly than in control groups (OR = 6.9, RR = 2.1). The pooled prevalence of TND was 59.2%. Also thyroid cancer (TC) proved to be more common in acromegalic patients (OR = 7.5, RR = 7.2), prevalence was 4.3%. The pooled rate of malignancy (calculated per patient) was equal to 8.7%. Conclusions: This study confirms that both TND and TC occur significantly more often in acromegalic patients than in general population. These results indicate that periodic thyroid ultrasound examination and careful evaluation of eventual lesions should be an important part of follow-up of patients with acromegaly.	[Wolinski, Kosma; Czarnywojtek, Agata; Ruchala, Marek] Poznan Univ Med Sci, Dept Endocrinol Metab & Internal Med, Poznan, Poland	Poznan University of Medical Sciences	Ruchala, M (corresponding author), Poznan Univ Med Sci, Dept Endocrinol Metab & Internal Med, Poznan, Poland.	mruchala@ump.edu.pl		Wolinski, Kosma/0000-0001-9800-7881; Czarnywojtek, Agata/0000-0003-3595-8449				Anagnostis P, 2011, INT J CLIN PRACT, V65, P896, DOI 10.1111/j.1742-1241.2011.02682.x; Baldys-Waligorska A, 2010, ENDOKRYNOL POL, V61, P29; Baris D, 2002, CANCER CAUSE CONTROL, V13, P395, DOI 10.1023/A:1015713732717; BARZILAY J, 1991, ARCH INTERN MED, V151, P1629, DOI 10.1001/archinte.151.8.1629; Bolanowski M, 2006, NEUROENDOCRINOL LETT, V27, P828; Borenstein M., 2009, INTRO METAANALYSIS; Cannavo S, 2000, HORM METAB RES, V32, P190, DOI 10.1055/s-2007-978620; dos Santos MCC, 2013, PITUITARY, V16, P109, DOI 10.1007/s11102-012-0383-y; Cheung NW, 1997, CLIN ENDOCRINOL, V46, P545, DOI 10.1046/j.1365-2265.1997.1680985.x; Colao A, 2004, ENDOCR REV, V25, P102, DOI 10.1210/er.2002-0022; Gasperi M, 2002, J ENDOCRINOL INVEST, V25, P240, DOI 10.1007/BF03343997; Golkowski F, 2011, Endocr Regul, V45, P191; Gullu BE, 2010, PITUITARY, V13, P242, DOI 10.1007/s11102-010-0224-9; Herrmann BL, 2004, EXP CLIN ENDOCR DIAB, V112, P225, DOI 10.1055/s-2004-817967; Higuchi Y, 2000, ENDOCR J, V47, pS57, DOI 10.1507/endocrj.47.SupplMarch_S57; Jenkins PJ, 2001, J CLIN ENDOCR METAB, V86, P2935, DOI 10.1210/jc.86.7.2935; Junik R, 1997, J ENDOCRINOL INVEST, V20, P134, DOI 10.1007/BF03346891; Kasagi K, 1999, THYROID, V9, P791, DOI 10.1089/thy.1999.9.791; Kurimoto M, 2008, ENDOCR J, V55, P67, DOI 10.1507/endocrj.K07E-010; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Mestron A, 2004, EUR J ENDOCRINOL, V151, P439, DOI 10.1530/eje.0.1510439; NABARRO JDN, 1987, CLIN ENDOCRINOL, V26, P481, DOI 10.1111/j.1365-2265.1987.tb00805.x; Orme SM, 1998, J CLIN ENDOCR METAB, V83, P2730, DOI 10.1210/jc.83.8.2730; Popovic V, 1998, CLIN ENDOCRINOL, V49, P441, DOI 10.1046/j.1365-2265.1998.00536.x; Rogozinski A, 2012, ARQ BRAS ENDOCRINOL, V56, P300, DOI 10.1590/S0004-27302012000500004; Rokkas T, 2008, WORLD J GASTROENTERO, V14, P3484, DOI 10.3748/wjg.14.3484; RON E, 1991, CANCER, V68, P1673, DOI 10.1002/1097-0142(19911015)68:8<1673::AID-CNCR2820680802>3.0.CO;2-0; Ruchala M, 2011, ONCOREVIEW, V4, P240; Ruchala M, 2012, WSPOLCZESNA ONKOL, V16, P111, DOI 10.5114/wo.2012.28790; Ruchala M, 2009, NEUROENDOCRINOL LETT, V30, P382; Scaroni C, 2008, J ENDOCRINOL INVEST, V31, P602, DOI 10.1007/BF03345609; Tan GH, 1997, ANN INTERN MED, V126, P226, DOI 10.7326/0003-4819-126-3-199702010-00009; Terzolo M, 2005, J CLIN ENDOCR METAB, V90, P84, DOI 10.1210/jc.2004-0240; Tita P, 2005, CLIN ENDOCRINOL, V63, P161, DOI 10.1111/j.1365-2265.2005.02316.x; WUSTER C, 1991, HORM METAB RES, V23, P131, DOI 10.1055/s-2007-1003632	35	61	69	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88787	10.1371/journal.pone.0088787	http://dx.doi.org/10.1371/journal.pone.0088787			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551163	Green Published, gold, Green Submitted			2022-12-27	WOS:000331271500068
J	Echeverry-Galvis, MA; Peterson, JK; Sulo-Caceres, R				Angela Echeverry-Galvis, Maria; Peterson, Jennifer K.; Sulo-Caceres, Rajmonda			The Social Nestwork: Tree Structure Determines Nest Placement in Kenyan Weaverbird Colonies	PLOS ONE			English	Article							INFORMATION-CENTERS; SITE SELECTION; RANDOM FORESTS; EVOLUTION; BEHAVIOR; MICROCLIMATE; AGGREGATION; POPULATION; REPULSION; DYNAMICS	Group living is a life history strategy employed by many organisms. This strategy is often difficult to study because the exact boundaries of a group can be unclear. Weaverbirds present an ideal model for the study of group living, because their colonies occupy a space with discrete boundaries: a single tree. We examined one aspect of group living. nest placement, in three Kenyan weaverbird species: the Black-capped Weaver (Pseudonigrita cabanisi), Grey-capped Weaver (P. arnaudi) and White-browed Sparrow Weaver (Ploceropasser mahali). We asked which environmental, biological, and/or abiotic factors influenced their nest arrangement and location in a given tree. We used machine learning to analyze measurements taken from 16 trees and 516 nests outside the breeding season at the Mpala Research Station in Laikipia Kenya, along with climate data for the area. We found that tree architecture, number of nests per tree, and nest-specific characteristics were the main variables driving nest placement. Our results suggest that different Kenyan weaverbird species have similar priorities driving the selection of where a nest is placed within a given tree. Our work illustrates the advantage of using machine learning techniques to investigate biological questions.	[Angela Echeverry-Galvis, Maria; Peterson, Jennifer K.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Sulo-Caceres, Rajmonda] Univ Illinois, Dept Math Stat & Comp Sci, Chicago, IL 60680 USA; [Angela Echeverry-Galvis, Maria] Pontificia Univ Javeriana, Dept Ecol & Terr, Bogota, Colombia	Princeton University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Pontificia Universidad Javeriana	Echeverry-Galvis, MA (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	mayayito@gmail.com	Peterson, Jennifer K/ABC-6548-2020	Peterson, Jennifer K/0000-0002-0274-6143; Echeverry-Galvis, Maria Angela/0000-0002-5273-8694	Department of Ecology and Evolutionary Biology of Princeton University; Bert Kerstetter; Bill Unger; UIC College of Engineering; Department of Computer Science at UIC; UIC Women in Science and Engineering; National Science Foundation [IIS0705822]; NSF [III-CXT-0705311, IIS-0747369]	Department of Ecology and Evolutionary Biology of Princeton University; Bert Kerstetter; Bill Unger; UIC College of Engineering; Department of Computer Science at UIC; UIC Women in Science and Engineering; National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	Funding was provided by the Department of Ecology and Evolutionary Biology of Princeton University, Bert Kerstetter, Bill Unger, UIC College of Engineering, Department of Computer Science at UIC, UIC Women in Science and Engineering, National Science Foundation IIS0705822 (T. Berger-Wolf), NSF III-CXT-0705311 D.I. Rubenstein), Collaborative Research: Computational Methods for Understanding Social Interactions in Animal Populations (Berger-Wolf and Rubenstein) and NSF IIS-0747369, CAREER: Computational Tools for Population Biology (Berger-Wolf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Asokan S, 2008, J ENVIRON BIOL, V29, P393; Barta Z, 2001, BEHAV ECOL, V12, P121, DOI 10.1093/beheco/12.2.121; Bijleveld AI, 2010, OIKOS, V119, P277, DOI 10.1111/j.1600-0706.2009.17892.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BURGER J, 1985, CONDOR, V87, P364, DOI 10.2307/1367217; Chen Z, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002956; Collias N. E., 1964, University of California Publications in Zoology, V73, P1; COLLIAS NE, 1964, AM ZOOL, V4, P175; COLLIAS NE, 1977, AUK, V94, P50; COLLIAS NE, 1978, AUK, V95, P472; COLLIAS NE, 1980, AUK, V97, P213; Cordoba-Cordoba Sergio, 2010, Marine Ornithology, V38, P79; Couzin ID, 2003, SELF ORG COLLECTIVE; Craig A, 2004, BIRDS AFRICA, VVII; Crook J. H., 1956, British Journal of Animal Behaviour, V4, P76, DOI 10.1016/S0950-5601(56)80028-2; CROOK JOHN HURRELL, 1963, IBIS, V105, P238, DOI 10.1111/j.1474-919X.1963.tb02498.x; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; DARLINGTON PJ, 1972, P NATL ACAD SCI USA, V69, P3151, DOI 10.1073/pnas.69.11.3151; Dray S., 2007, R NEWS, V7, P47; FERGUSON JWH, 1989, CONDOR, V91, P100, DOI 10.2307/1368152; Ferguson JWH, 2002, J COMP PHYSIOL B, V172, P137, DOI 10.1007/s00360-001-0236-x; Fry CH, 2004, BIRDS AFRICA; Giesselmann UC, 2008, AUSTRAL ECOL, V33, P607, DOI 10.1111/j.1442-9993.2007.01826.x; Goldstein BA, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1691; Gueron S, 1996, J THEOR BIOL, V182, P85, DOI 10.1006/jtbi.1996.0144; Hamer Keith C., 2002, P217; Hartman CA, 2003, CONDOR, V105, P158, DOI 10.1650/0010-5422(2003)105[158:OAMOHL]2.0.CO;2; Hatcher L., 1994, STEP BY STEP APPROAC; HILL MO, 1976, TAXON, V25, P249, DOI 10.2307/1219449; HOOGLAND JL, 1976, ECOL MONOGR, V46, P33, DOI 10.2307/1942393; HORN H S, 1970, Condor, V72, P15, DOI 10.2307/1366470; HORN H S, 1971, P144; HORN HS, 1968, ECOLOGY, V49, P682, DOI 10.2307/1935532; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Jovani R, 2007, P ROY SOC B-BIOL SCI, V274, P2465, DOI 10.1098/rspb.2007.0527; Jovani R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001992; Katz Y, 2011, P NATL ACAD SCI USA, V108, P18720, DOI 10.1073/pnas.1107583108; Krause DJ, 2002, LIVING GROUPS; LEWIS DM, 1982, CONDOR, V84, P306, DOI 10.2307/1367373; Newell FL, 2011, FOREST ECOL MANAG, V262, P739, DOI 10.1016/j.foreco.2011.05.006; Oliveira S, 2012, FOREST ECOL MANAG, V275, P117, DOI 10.1016/j.foreco.2012.03.003; Pitman C, 1958, B BR ORNITHOL CLUB; Rubenstein D., 1978, SOCIAL BEHAV PERSPEC, P205, DOI [10.1007/978-1-4684-2901-5_9, DOI 10.1007/978-1-4684-2901-5_9]; Rubenstein DR, 2007, CURR BIOL, V17, P1414, DOI 10.1016/j.cub.2007.07.032; Rubenstein DR, 2011, P NATL ACAD SCI USA, V108, P10816, DOI 10.1073/pnas.1100303108; Schellinck J, 2011, ECOL MODEL, V222, P1897, DOI 10.1016/j.ecolmodel.2011.03.013; SCHNELL GD, 1973, IBIS, V115, P93, DOI 10.1111/j.1474-919X.1973.tb02626.x; Segal M.R., 2004, INT C BIOINF, DOI DOI 10.2307/2404188; Sendova-Franks AB, 2010, ANIM BEHAV, V79, P473, DOI 10.1016/j.anbehav.2009.11.035; Sibbald AM, 2000, APPL ANIM BEHAV SCI, V70, P49, DOI 10.1016/S0168-1591(00)00145-3; Smit B, 2013, ECOLOGY, V94, P1142, DOI 10.1890/12-1511.1; Waltz E.C., 1983, Colonial Waterbirds, V6, P31, DOI 10.2307/1520964; WARD P, 1973, IBIS, V115, P517, DOI 10.1111/j.1474-919X.1973.tb01990.x; Yazid M., 2009, APPL MATH SCI, V3, P2085; YEOMANS KA, 1982, J ROY STAT SOC D-STA, V31, P221; Zhang GY, 2012, J APPL STAT, V39, P151, DOI 10.1080/02664763.2011.578621; Zimmerman D.A., 1996, BIRDS KENYA NO TANZA	58	6	7	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88761	10.1371/journal.pone.0088761	http://dx.doi.org/10.1371/journal.pone.0088761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551157	Green Published, gold, Green Submitted			2022-12-27	WOS:000331266000065
J	Chen, X; Shen, L; Chou, HH				Chen, Xi; Shen, Lu; Chou, Hui-Hsien			MicroRNA-Target Binding Structures Mimic MicroRNA Duplex Structures in Humans	PLOS ONE			English	Article							ARGONAUTE PROTEINS; SIRNA BIOGENESIS; MESSENGER-RNA; RECOGNITION; PREDICTION; EVOLUTION; GENES; RISC; MIRNAS; DETERMINANTS	Traditionally, researchers match a microRNA guide strand to mRNA sequences using sequence comparisons to predict its potential target genes. However, many of the predictions can be false positives due to limitations in sequence comparison alone. In this work, we consider the association of two related RNA structures that share a common guide strand: the microRNA duplex and the microRNA-target binding structure. We have analyzed thousands of such structure pairs and found many of them share high structural similarity. Therefore, we conclude that when predicting microRNA target genes, considering just the microRNA guide strand matches to gene sequences may not be sufficient - The microRNA duplex structure formed by the guide strand and its companion passenger strand must also be considered. We have developed software to translate RNA binding structure into encoded representations, and we have also created novel automatic comparison methods utilizing such encoded representations to determine RNA structure similarity. Our software and methods can be utilized in the other RNA secondary structure comparisons as well.	[Chen, Xi; Chou, Hui-Hsien] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Shen, Lu] Johns Hopkins Univ, Dept Biostat, Baltimore, MD USA; [Chou, Hui-Hsien] Iowa State Univ, Dept Comp Sci, Ames, IA USA	Iowa State University; Johns Hopkins University; Iowa State University	Chou, HH (corresponding author), Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA.	hhchou@iastate.edu			National Science Foundataion [DBI-0850195]; Direct For Biological Sciences [0850195] Funding Source: National Science Foundation	National Science Foundataion; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work is supported by National Science Foundataion Grant DBI-0850195, (http://www.nsf.gov/awardsearch/showAward?AWD_ID = 0850195). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests exist.	Ahmed F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-105; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; BARBATO C, 2009, BIOMED RES INT; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Betancur Juan G., 2012, Frontiers in Genetics, V3, P127, DOI 10.3389/fgene.2012.00127; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Chi SW, 2012, NAT STRUCT MOL BIOL, V19, P321, DOI 10.1038/nsmb.2230; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Dimitrov RA, 2004, BIOPHYS J, V87, P215, DOI 10.1529/biophysj.103.020743; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; DUECK A, 2012, NUCL ACIDS RES; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guerra-Assuncao JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-218; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hochsmann M, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P159, DOI 10.1109/CSB.2003.1227315; HOCHSMANN M, 2005, TREE ALIGNMENT MODEL; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kawamata T, 2010, TRENDS BIOCHEM SCI, V35, P368, DOI 10.1016/j.tibs.2010.03.009; Kawamata T, 2009, NAT STRUCT MOL BIOL, V16, P953, DOI 10.1038/nsmb.1630; Kaya E, 2012, SCIENCE, V336, P985, DOI 10.1126/science.1223549; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krol J, 2004, J BIOL CHEM, V279, P42230, DOI 10.1074/jbc.M404931200; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LI N, 2013, NUCL ACIDS RES; Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Manavella PA, 2012, P NATL ACAD SCI USA, V109, P2461, DOI 10.1073/pnas.1200169109; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Seitz Herve, 2011, Silence, V2, P4, DOI 10.1186/1758-907X-2-4; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Wang DM, 2012, GENE DEV, V26, P693, DOI 10.1101/gad.182758.111; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Witkos TM, 2011, CURR MOL MED, V11, P93; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100; Zhu Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-718	55	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88806	10.1371/journal.pone.0088806	http://dx.doi.org/10.1371/journal.pone.0088806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551166	gold, Green Published, Green Submitted			2022-12-27	WOS:000331266000070
J	Park, SH; Jang, SY; Kim, H; Lee, SW				Park, So Hyun; Jang, Shin Yi; Kim, Ho; Lee, Seung Wook			An Association Rule Mining-Based Framework for Understanding Lifestyle Risk Behaviors	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; PUBLIC-HEALTH; METAANALYSIS; PREVALENCE; PATTERNS; SLEEP; DISEASE; OBESITY; ADULTS; MASS	Objectives: This study investigated the prevalence and patterns of lifestyle risk behaviors in Korean adults. Methods: We utilized data from the Fourth Korea National Health and Nutrition Examination Survey for 14,833 adults (>20 years of age). We used association rule mining to analyze patterns of lifestyle risk behaviors by characterizing nonadherence to public health recommendations related to the Alameda 7 health behaviors. The study variables were current smoking, heavy drinking, physical inactivity, obesity, inadequate sleep, breakfast skipping, and frequent snacking. Results: Approximately 72% of Korean adults exhibited two or more lifestyle risk behaviors. Among women, current smoking, obesity, and breakfast skipping were associated with inadequate sleep. Among men, breakfast skipping with additional risk behaviors such as physical inactivity, obesity, and inadequate sleep was associated with current smoking. Current smoking with additional risk behaviors such as inadequate sleep or breakfast skipping was associated with physical inactivity. Conclusion: Lifestyle risk behaviors are intercorrelated in Korea. Information on patterns of lifestyle risk behaviors could assist in planning interventions targeted at multiple behaviors simultaneously.	[Park, So Hyun; Kim, Ho; Lee, Seung Wook] Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea; [Jang, Shin Yi] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Cardiovasc Imaging Ctr, Seoul, South Korea	Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, H (corresponding author), Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea.	hokim@snu.ac.kr; leeswook@snu.ac.kr	Kim, Ho/AAS-2402-2021	Kim, Ho/0000-0001-7472-3752; Jang, Shin Yi/0000-0003-4319-7029				Bagnardi V, 2001, BRIT J CANCER, V85, P1700, DOI 10.1054/bjoc.2001.2140; Belloc N B, 1973, Prev Med, V2, P67, DOI 10.1016/0091-7435(73)90009-1; Berrigan D, 2003, PREV MED, V36, P615, DOI 10.1016/S0091-7435(02)00067-1; Buxton OM, 2010, SOC SCI MED, V71, P1027, DOI 10.1016/j.socscimed.2010.05.041; Centers for Disease Controland Prevention, 2009, PREV TRENDS DAT NAT; Chou KL, 2008, J AGING HEALTH, V20, P788, DOI 10.1177/0898264308321082; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; Fine LJ, 2004, AM J PREV MED, V27, P18, DOI 10.1016/j.amepre.2004.04.017; Gangwisch JE, 2005, SLEEP, V28, P1289, DOI 10.1093/sleep/28.10.1289; HALL SM, 1992, AM J PUBLIC HEALTH, V82, P799, DOI 10.2105/AJPH.82.6.799; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Imamura T, 2007, MED BIOL ENG COMPUT, V45, P51, DOI 10.1007/s11517-006-0121-6; Johansson SE, 1999, INT J EPIDEMIOL, V28, P1073, DOI 10.1093/ije/28.6.1073; Kang Kiwon, 2010, J Prev Med Public Health, V43, P73, DOI 10.3961/jpmph.2010.43.1.73; Katanoda K, 2008, J EPIDEMIOL, V18, P14; Keski-Rahkonen A, 2003, EUR J CLIN NUTR, V57, P842, DOI 10.1038/sj.ejcn.1601618; Kool J, 2004, J REHABIL MED, V36, P49, DOI 10.1080/16501970310020104; Korea Centers for Disease Control and Prevention, 2007, 4 KOR NAT HLTH NUTR; Korea Institute for Health Social Affairs, 2006, DET HLTH KOR; Laaksonen M, 2001, EUR J PUBLIC HEALTH, V11, P294, DOI 10.1093/eurpub/11.3.294; Lee DG, 2013, J MED SYST, V37, DOI 10.1007/s10916-012-9896-1; LeMarchand L, 1997, CANCER RES, V57, P4787; Lemon SC, 2003, ANN BEHAV MED, V26, P172, DOI 10.1207/S15324796ABM2603_02; Mistry R, 2009, PREV MED, V48, P291, DOI 10.1016/j.ypmed.2008.12.013; Myers J, 2004, AM J MED, V117, P912, DOI 10.1016/j.amjmed.2004.06.047; Nahar J, 2011, J MED SYST, V35, P353, DOI 10.1007/s10916-009-9372-8; OECD, WHAT AR EQ SCAL; Poortinga W, 2007, PREV MED, V44, P124, DOI 10.1016/j.ypmed.2006.10.006; Sakata K, 2001, Nihon Koshu Eisei Zasshi, V48, P837; Schuit AJ, 2002, PREV MED, V35, P219, DOI 10.1006/pmed.2002.1064; Strawbridge WJ, 2002, AM J EPIDEMIOL, V156, P328, DOI 10.1093/aje/kwf047; Strine TW, 2005, SLEEP MED, V6, P23, DOI 10.1016/j.sleep.2004.06.003; Tai YM, 2009, INT J MED INFORM, V78, pE75, DOI 10.1016/j.ijmedinf.2009.09.005; Tan PN, 2004, INFORM SYST, V29, P293, DOI 10.1016/S0306-4379(03)00072-3; Taylor AH, 2005, PSYCHOPHARMACOLOGY, V181, P1, DOI 10.1007/s00213-005-2216-4; Weisell RC, 2002, ASIA PAC J CLIN NUTR, V11, pS681, DOI 10.1046/j.1440-6047.11.s8.5.x; Wolff I, 1999, OSTEOPOROSIS INT, V9, P1, DOI 10.1007/s001980050109; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	39	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88859	10.1371/journal.pone.0088859	http://dx.doi.org/10.1371/journal.pone.0088859			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7GP	24551181	Green Published, Green Submitted, gold			2022-12-27	WOS:000331266000077
J	Fan, KH; Lin, CY; Kang, CJ; Lee, LY; Huang, SF; Liao, CT; Chen, IH; Ng, SH; Wang, HM; Chang, JTC				Fan, Kang-Hsing; Lin, Chien-Yu; Kang, Chung-Jan; Lee, Li-Yu; Huang, Shiang-Fu; Liao, Chun-Ta; Chen, I-How; Ng, Shu-Hang; Wang, Hung-Ming; Chang, Joseph Tung-Chieh			Postoperative Concomitant Chemoradiotherapy Improved Treatment Outcomes of Patients with Oral Cavity Cancer with Multiple-Node Metastases but No Other Major Risk Factors	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; LOCALLY ADVANCED HEAD; INTENSITY-MODULATED RADIOTHERAPY; STAGE NASOPHARYNGEAL CARCINOMA; NECK-CANCER; RANDOMIZED-TRIAL; CISPLATIN; CHEMOTHERAPY; RADIATION	Purpose: To investigate the results of postoperative radiotherapy (PORT) for the treatment of pathologic N2b/c squamous cell carcinoma of the oral cavity (OSCC). Mterials and Methods: This study reviewed cancer registry data collected in our hospital from 1998 to 2009 with the following inclusion criteria: primary OSCC, treatment with radical surgery, and multiple nodal metastases. Patients who had extracapsular spreading of the lymph node metastases or positive resection margins or who refused to undergo PORT were excluded. The prescribed dose of PORT was 60-66 Gy. Concurrent chemotherapy was optional. Patient characteristics, treatment parameters and clinical outcome were recorded. The primary end point was overall survival, and the secondary endpoint was disease status. Results: There were 138 eligible cases, and the median follow-up period was 35 months. The 3-year overall survival rate was 56%. Univariate analysis revealed that pathologic T4 status (pT4), bone marrow invasion, and lymphatic invasion were significantly correlated with poor outcome (p < 0.05). Multivariate analysis showed that pT4, lymphatic invasion, and the no concurrent chemotherapy were independent poor prognostic factors (p < 0.05). Fifty-four patients had tumor recurrence. The 3-year recurrence-free survival rate was 59%. Skin invasion, pT4, and bone marrow invasion were correlated with poor prognosis in the univariate analysis (p < 0.05). Only pT4 (p, 0.01) and no concurrent chemotherapy (p = 0.03) were independently correlated with poor recurrence-free survival. Conclusion: For OSCC patients with multiple-node metastases without extracapsular spreading or positive resection margins, PORT without concurrent chemotherapy correlated to inferior outcome. Multiple lymph node metastases might be considered an indication for concurrent chemotherapy.	[Fan, Kang-Hsing; Lin, Chien-Yu; Chang, Joseph Tung-Chieh] Chang Gung Mem Hosp, Dept Radiat Oncol, Tao Yuan, Taiwan; [Wang, Hung-Ming] Chang Gung Mem Hosp, Dept Hematol & Oncol, Tao Yuan, Taiwan; [Kang, Chung-Jan; Huang, Shiang-Fu; Liao, Chun-Ta; Chen, I-How] Chang Gung Mem Hosp, Dept Head & Neck Surg, Tao Yuan, Taiwan; [Lee, Li-Yu] Chang Gung Mem Hosp, Dept Pathol, Tao Yuan, Taiwan; [Ng, Shu-Hang] Chang Gung Mem Hosp, Dept Diagnost Radiol, Tao Yuan, Taiwan; [Fan, Kang-Hsing; Lin, Chien-Yu; Huang, Shiang-Fu] Chang Gung Univ, Sch Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Ng, Shu-Hang; Chang, Joseph Tung-Chieh] Chang Gung Univ, Sch Med, Dept Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Wang, HM (corresponding author), Chang Gung Mem Hosp, Dept Hematol & Oncol, Tao Yuan, Taiwan.	whm526@adm.cgmh.org.tw; cgmhnog@gmail.com	Fan, K/GXH-3734-2022; Li-yu, Lee/G-5055-2010	Fan, Kang-Hsing/0000-0002-0910-7803	Chang Gung Memorial Hospital in Taiwan [CMRPG 300061-2]	Chang Gung Memorial Hospital in Taiwan(Chang Gung Memorial Hospital)	This work was supported by grant CMRPG 300061-2 from the Chang Gung Memorial Hospital in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang KK, 2001, INT J RADIAT ONCOL, V51, P571, DOI 10.1016/S0360-3016(01)01690-X; Bachaud JM, 1996, INT J RADIAT ONCOL, V36, P999, DOI 10.1016/S0360-3016(96)00430-0; Bernier J, 2005, HEAD NECK-J SCI SPEC, V27, P843, DOI 10.1002/hed.20279; Bernier J, 2004, NEW ENGL J MED, V350, P1945, DOI 10.1056/NEJMoa032641; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; Edge SB, 2010, AJCC CANC STAGING MA; Fan KH, 2007, INT J RADIAT ONCOL, V67, P453, DOI 10.1016/j.ijrobp.2006.06.026; Fan KH, 2010, INT J RADIAT ONCOL, V77, P1024, DOI 10.1016/j.ijrobp.2009.06.064; Greenberg JS, 2003, CANCER, V98, P508, DOI 10.1002/cncr.11526; Greenberg JS, 2003, CANCER, V97, P1464, DOI 10.1002/cncr.11202; Ho KF, 2008, ACTA ONCOL, V47, P1513, DOI 10.1080/02841860701846160; Kam MKM, 2007, J CLIN ONCOL, V25, P4873, DOI 10.1200/JCO.2007.11.5501; Koutcher L, 2011, INT J RADIAT ONCOL, V81, P915, DOI 10.1016/j.ijrobp.2010.07.008; Liao CT, 2007, CANCER, V110, P1501, DOI 10.1002/cncr.22959; Liao CT, 2007, CANCER, V110, P564, DOI 10.1002/cncr.22814; Lin CY, 2008, INT J RADIAT ONCOL, V70, P1373, DOI 10.1016/j.ijrobp.2007.08.022; Nutting CM, 2011, LANCET ONCOL, V12, P127, DOI 10.1016/S1470-2045(10)70290-4; Osman N, 2013, EUR ARCH OTORHINOLAR; PETERS LJ, 1993, INT J RADIAT ONCOL, V26, P3, DOI 10.1016/0360-3016(93)90167-T; Porceddu SV, 2004, INT J RADIAT ONCOL, V60, P365, DOI 10.1016/j.ijrobp.2004.03.011; Pow EHN, 2006, INT J RADIAT ONCOL, V66, P981, DOI 10.1016/j.ijrobp.2006.06.013; Steinmann D, 2009, STRAHLENTHER ONKOL, V185, P682, DOI 10.1007/s00066-009-1989-5; Tsan DL, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-215; Wang HM, 2002, CANCER, V94, P2989, DOI 10.1002/cncr.10570	25	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e86922	10.1371/journal.pone.0086922	http://dx.doi.org/10.1371/journal.pone.0086922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586259	Green Published, Green Submitted, gold			2022-12-27	WOS:000331880700005
J	Loren, JG; Farfan, M; Fuste, MC				Loren, J. Gaspar; Farfan, Maribel; Fuste, M. Carmen			Molecular Phylogenetics and Temporal Diversification in the Genus Aeromonas Based on the Sequences of Five Housekeeping Genes	PLOS ONE			English	Article							DNA-DNA HYBRIDIZATION; MAXIMUM-LIKELIHOOD; MICROBIAL DIVERSITY; DIVERGENCE TIMES; 2 MODELS; RATES; EVOLUTION; EXTINCTION; SPECIATION; STATISTICS	Several approaches have been developed to estimate both the relative and absolute rates of speciation and extinction within clades based on molecular phylogenetic reconstructions of evolutionary relationships, according to an underlying model of diversification. However, the macroevolutionary models established for eukaryotes have scarcely been used with prokaryotes. We have investigated the rate and pattern of cladogenesis in the genus Aeromonas (gamma-Proteobacteria, Proteobacteria, Bacteria) using the sequences of five housekeeping genes and an uncorrelated relaxed-clock approach. To our knowledge, until now this analysis has never been applied to all the species described in a bacterial genus and thus opens up the possibility of establishing models of speciation from sequence data commonly used in phylogenetic studies of prokaryotes. Our results suggest that the genus Aeromonas began to diverge between 248 and 266 million years ago, exhibiting a constant divergence rate through the Phanerozoic, which could be described as a pure birth process.	[Loren, J. Gaspar; Farfan, Maribel; Fuste, M. Carmen] Univ Barcelona, Fac Farm, Dept Microbiol & Parasitol Sanitaries, E-08028 Barcelona, Spain; [Farfan, Maribel; Fuste, M. Carmen] Univ Barcelona, Inst Recerca Biodiversitat IRBio, Barcelona, Spain	University of Barcelona; University of Barcelona	Farfan, M (corresponding author), Univ Barcelona, Fac Farm, Dept Microbiol & Parasitol Sanitaries, E-08028 Barcelona, Spain.	mfarfan@ub.edu	Farfán, Maribel/L-1240-2014; Fuste, M Carmen/L-1245-2014; Lorén, José Gaspar/L-3388-2014	Farfán, Maribel/0000-0002-2671-5739; 	Ministerio de Educacion y Ciencia, Spain [CGL2008-03281/BOS]; University of Barcelona [ARZ00F01]	Ministerio de Educacion y Ciencia, Spain(Spanish Government); University of Barcelona	This work was supported by projects from the Ministerio de Educacion y Ciencia, Spain [CGL2008-03281/BOS] and from the University of Barcelona [ARZ00F01]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Agapow PM, 2002, SYST BIOL, V51, P866, DOI 10.1080/10635150290155845; Aldous DJ, 2001, STAT SCI, V16, P23, DOI 10.1214/ss/998929474; Barraclough TG, 2001, TRENDS ECOL EVOL, V16, P391, DOI 10.1016/S0169-5347(01)02161-9; Barraclough TG, 2009, BIOL LETTERS, V5, P425, DOI 10.1098/rsbl.2009.0091; Battistuzzi FU, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-44; BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; Blum MGB, 2005, MATH BIOSCI, V195, P141, DOI 10.1016/j.mbs.2005.03.003; Blum MGB, 2006, ANN APPL PROBAB, V16, P2195, DOI 10.1214/105051606000000547; Bortolussi N, 2011, APTREESHAPE ANAL PHY; Butlin R, 2012, TRENDS ECOL EVOL, V27, P27, DOI 10.1016/j.tree.2011.09.002; Butterfield NJ, 2011, TRENDS ECOL EVOL, V26, P81, DOI 10.1016/j.tree.2010.11.012; Cohan FM, 2002, GENETICA, V116, P359, DOI 10.1023/A:1021232409545; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Colless D.H., 1982, SYST ZOOL, V31, P100, DOI DOI 10.2307/2413420; Daubin V, 2002, GENOME RES, V12, P1080, DOI 10.1101/gr.187002; de Queiroz K, 2005, P NATL ACAD SCI USA, V102, P6600, DOI 10.1073/pnas.0502030102; Degnan PH, 2004, SYST BIOL, V53, P95, DOI 10.1080/10635150490264842; Doolittle RF, 1996, SCIENCE, V271, P470, DOI 10.1126/science.271.5248.470; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Euzeby JP, 2013, LPSN LIST PROKARYOTI; Farfan M, 2010, SYST APPL MICROBIOL, V33, P427, DOI 10.1016/j.syapm.2010.09.005; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Fierer Noah, 2008, P95; Finlay BJ, 1999, NATURE, V400, P828, DOI 10.1038/23616; Fontaneto D, 2012, EVOL BIOL, V39, P262, DOI 10.1007/s11692-012-9161-z; Fordyce JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011781; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; Fraser C, 2009, SCIENCE, V323, P741, DOI 10.1126/science.1159388; Fuste M. C., 2012, STUDIES POPULATION G, P39; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Horner-Devine MC, 2004, P ROY SOC B-BIOL SCI, V271, P113, DOI 10.1098/rspb.2003.2549; Huelsenbeck JP, 2000, GENETICS, V154, P1879; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Konstantinidis KT, 2007, CURR OPIN MICROBIOL, V10, P504, DOI 10.1016/j.mib.2007.08.006; Kuo CH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-35; Kupfer M, 2006, INT J SYST EVOL MICR, V56, P2743, DOI 10.1099/ijs.0.63650-0; Kurland CG, 2003, P NATL ACAD SCI USA, V100, P9658, DOI 10.1073/pnas.1632870100; Lan R, 2001, TRENDS MICROBIOL, V9, P419, DOI 10.1016/S0966-842X(01)02133-3; Lemey P, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P362; Lepage T, 2007, MOL BIOL EVOL, V24, P2669, DOI 10.1093/molbev/msm193; Lerat E, 2003, PLOS BIOL, V1, P101, DOI 10.1371/journal.pbio.0000019; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Majewski J, 2000, J BACTERIOL, V182, P1016, DOI 10.1128/JB.182.4.1016-1023.2000; Martin AP, 2004, EVOLUTION, V58, P946; Martin-Carnahan A, 2005, BERGEYS MANUAL SYSTE, V2, P557; Martinez-Murcia AJ, 2011, SYST APPL MICROBIOL, V34, P189, DOI 10.1016/j.syapm.2010.11.014; Martino ME, 2011, APPL ENVIRON MICROB, V77, P4986, DOI 10.1128/AEM.00708-11; McKenzie A, 2000, MATH BIOSCI, V164, P81, DOI 10.1016/S0025-5564(99)00060-7; McPeek MA, 2007, AM NAT, V169, pE97, DOI 10.1086/512135; Minana-Galbis D, 2009, INT J SYST EVOL MICR, V59, P1976, DOI 10.1099/ijs.0.005413-0; Morlon H, 2012, EVOLUTION, V66, P2577, DOI 10.1111/j.1558-5646.2012.01598.x; Morlon H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000493; NEE S, 1994, PHILOS T ROY SOC B, V344, P305, DOI 10.1098/rstb.1994.0068; Nee S, 2001, EVOLUTION, V55, P661, DOI 10.1554/0014-3820(2001)055[0661:ISRFP]2.0.CO;2; Nee S, 2006, ANNU REV ECOL EVOL S, V37, P1, DOI 10.1146/annurev.ecolsys.37.091305.110035; Nhung PH, 2007, INT J SYST EVOL MICR, V57, P1232, DOI 10.1099/ijs.0.64957-0; Ochman H, 2003, MOL BIOL EVOL, V20, P2091, DOI 10.1093/molbev/msg229; OCHMAN H, 1987, J MOL EVOL, V26, P74, DOI 10.1007/BF02111283; Ochman H, 1987, ESCHERICHIA COLI SAL, P1649; Ovaskainen O, 2003, ANN ZOOL FENN, V40, P81; Papke RT, 2004, FEMS MICROBIOL ECOL, V48, P293, DOI 10.1016/j.femsec.2004.03.013; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2013, MOL PHYLOGENET EVOL, V67, P436, DOI 10.1016/j.ympev.2013.02.008; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; R Development Core Team, R LANG ENV STAT COMP; Rabosky D, 2009, LASER LIKELIHOOD ANA; Rabosky DL, 2008, EVOLUTION, V62, P1866, DOI 10.1111/j.1558-5646.2008.00409.x; Rabosky Daniel L., 2006, Evolutionary Bioinformatics Online, V2, P257; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rambaut A., 2007, TRACER V1 4; Ricklefs RE, 2007, TRENDS ECOL EVOL, V22, P601, DOI 10.1016/j.tree.2007.06.013; Roger F, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-62; Rohde RA, 2005, NATURE, V434, P208, DOI 10.1038/nature03339; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; Sahney S, 2008, P ROY SOC B-BIOL SCI, V275, P759, DOI 10.1098/rspb.2007.1370; Sahney S, 2010, BIOL LETTERS, V6, P544, DOI 10.1098/rsbl.2009.1024; Sanderson MJ, 1996, TRENDS ECOL EVOL, V11, P15, DOI 10.1016/0169-5347(96)81059-7; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sepkoski J.J., 2002, B AM PALEONTOL, V363, P1; Soler L, 2004, INT J SYST EVOL MICR, V54, P1511, DOI 10.1099/ijs.0.03048-0; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI [10.1099/ijs.0.02360-0, 10.1099/00207713-52-3-1043]; Stadler T., 2010, TREESIM R SIMULATING; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vinuesa P, 2005, MOL PHYLOGENET EVOL, V34, P29, DOI 10.1016/j.ympev.2004.08.020; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yoder AD, 2000, MOL BIOL EVOL, V17, P1081, DOI 10.1093/oxfordjournals.molbev.a026389; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	96	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88805	10.1371/journal.pone.0088805	http://dx.doi.org/10.1371/journal.pone.0088805			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586399	Green Submitted, Green Published, gold			2022-12-27	WOS:000331714700032
J	Illmer, P; Reitschuler, C; Wagner, AO; Schwarzenauer, T; Lins, P				Illmer, Paul; Reitschuler, Christoph; Wagner, Andreas Otto; Schwarzenauer, Thomas; Lins, Philipp			Microbial Succession during Thermophilic Digestion: The Potential of Methanosarcina sp.	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; ACETATE CONCENTRATIONS; ANAEROBIC-DIGESTION; START-UP; METHANE; COMMUNITY; GENES; METHANOGENESIS; TEMPERATURE; PATHWAYS	A distinct succession from a hydrolytic to a hydrogeno- and acetotrophic community was well documented by DGGE (denaturing gradient gel electrophoresis) and dHPLC (denaturing high performance liquid chromatography), and confirmed by qPCR (quantitative PCR) measurements and DNA sequence analyses. We could prove that Methanosarcina thermophila has been the most important key player during the investigated anaerobic digestion process. This organism was able to terminate a stagnation phase, most probable caused by a decreased pH and accumulated acetic acid following an initial hydrolytic stage. The lack in Methanosarcina sp. could not be compensated by high numbers of Methanothermobacter sp. or Methanoculleus sp., which were predominant during the initial or during the stagnation phase of the fermentation, respectively.	[Illmer, Paul; Reitschuler, Christoph; Wagner, Andreas Otto; Schwarzenauer, Thomas; Lins, Philipp] Univ Innsbruck, Inst Microbiol, A-6020 Innsbruck, Austria	University of Innsbruck	Illmer, P (corresponding author), Univ Innsbruck, Inst Microbiol, A-6020 Innsbruck, Austria.	Paul.Illmer@uibk.ac.at	Wagner, Andreas Otto/L-3082-2013	Wagner, Andreas Otto/0000-0002-6009-8498; Illmer, Paul/0000-0003-3368-3015				Beckmann S, 2011, APPL ENVIRON MICROB, V77, P3749, DOI 10.1128/AEM.02818-10; Chae KJ, 2008, BIORESOURCE TECHNOL, V99, P1, DOI 10.1016/j.biortech.2006.11.063; Chandra R, 2012, RENEW SUST ENERG REV, V16, P1462, DOI 10.1016/j.rser.2011.11.035; CLARENS M, 1990, APPL MICROBIOL BIOT, V33, P239, DOI 10.1007/BF00176532; De Vrieze J, 2012, BIORESOURCE TECHNOL, V112, P1, DOI 10.1016/j.biortech.2012.02.079; Demirel Burak, 2008, Reviews in Environmental Science and Bio/Technology, V7, P173, DOI 10.1007/s11157-008-9131-1; Esposito G, 2012, REV ENVIRON SCI BIO, V11, P325, DOI 10.1007/s11157-012-9277-8; FERGUSON TJ, 1983, APPL ENVIRON MICROB, V46, P348, DOI 10.1128/AEM.46.2.348-355.1983; Goevert D, 2009, APPL ENVIRON MICROB, V75, P2605, DOI 10.1128/AEM.02680-08; Grosskopf R, 1998, APPL ENVIRON MICROB, V64, P960; Hao LP, 2013, BIORESOURCE TECHNOL, V140, P319, DOI 10.1016/j.biortech.2013.04.113; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; Illmer P, 2009, WASTE MANAGE, V29, P162, DOI 10.1016/j.wasman.2008.02.005; Illmer P, 2009, WASTE MANAGE, V29, P1838, DOI 10.1016/j.wasman.2009.02.003; Kulkarni G, 2009, P NATL ACAD SCI USA, V106, P15915, DOI 10.1073/pnas.0905914106; Lins P, 2009, MULL ABFALL, V12, P604; Lins P, 2014, BIORESOURCE TECHNOL, V152, P347, DOI 10.1016/j.biortech.2013.11.020; Lins P, 2012, BIORESOURCE TECHNOL, V110, P167, DOI 10.1016/j.biortech.2012.01.145; Lins P, 2010, FEMS MICROBIOL ECOL, V71, P469, DOI 10.1111/j.1574-6941.2009.00821.x; Lockhart RJ, 2006, APPL ENVIRON MICROB, V72, P5659, DOI 10.1128/AEM.01057-06; Lu F, 2013, WATER RES, V47, P2297, DOI 10.1016/j.watres.2013.01.049; Malin C, 2008, MICROBIOL RES, V163, P503, DOI 10.1016/j.micres.2007.07.004; Mountfort D., 1994, ANAEROBIC FUNGI BIOL, V1st Edn, DOI [10.1201/9781003067085, DOI 10.1201/9781003067085]; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nielsen HB, 2011, WATER SCI TECHNOL, V64, P1723, DOI 10.2166/wst.2011.654; Pereyra LP, 2010, APPL ENVIRON MICROB, V76, P2192, DOI 10.1128/AEM.01285-09; Reitschuler C, 2014, WORLD J MICROB BIOT, V30, P293, DOI 10.1007/s11274-013-1450-x; Schwarzenauer T, 2012, WORLD J MICROB BIOT, V28, P755, DOI 10.1007/s11274-011-0847-7; Sekiguchi H, 2001, BIOTECHNOL LETT, V23, P1205, DOI 10.1023/A:1010517117046; Shimada H, 2008, J BACTERIOL, V190, P5404, DOI 10.1128/JB.00415-08; Sonnichsen M, 1999, LIPIDS, V34, P1347, DOI 10.1007/s11745-999-0488-z; Supaphol S, 2011, BIORESOURCE TECHNOL, V102, P4021, DOI 10.1016/j.biortech.2010.11.124; Wagner AO, 2012, MICROBIOL RES, V167, P630, DOI 10.1016/j.micres.2011.11.007; Wagner AO, 2010, WASTE MANAGE, V30, P1822, DOI 10.1016/j.wasman.2010.05.013; Wagner AO, 2009, APPL ENVIRON MICROB, V75, P956, DOI 10.1128/AEM.01411-08; Watanabe T, 2004, FEMS MICROBIOL LETT, V232, P153, DOI 10.1016/S0378-1097(04)00045-X; Weiland P, 2010, APPL MICROBIOL BIOT, V85, P849, DOI 10.1007/s00253-009-2246-7; WESTERMANN P, 1989, APPL ENVIRON MICROB, V55, P514, DOI 10.1128/AEM.55.2.514-515.1989; WHITE DC, 1979, OECOLOGIA, V40, P51, DOI 10.1007/BF00388810; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347	40	15	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e86967	10.1371/journal.pone.0086967	http://dx.doi.org/10.1371/journal.pone.0086967			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586260	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900007
J	Kappers, AML; Tiest, WMB				Kappers, Astrid M. L.; Tiest, Wouter M. Bergmann			Influence of Shape on the Haptic Size Aftereffect	PLOS ONE			English	Article							CURVED SURFACES; PERCEPTION; TOUCH	Recently, we showed a strong haptic size aftereffect by means of a size bisection task: after adaptation to a large sphere, subsequently grasped smaller test spheres felt even smaller, and vice versa. In the current study, we questioned whether the strength of this aftereffect depends on shape. In four experimental conditions, we determined the aftereffect after adaptation to spheres and tetrahedra and subsequent testing also with spheres and tetrahedra. The results showed a clear influence of shape: the haptic aftereffect was much stronger if adaptation and test stimuli were identical in shape than if their shapes were different. Therefore, it would be more appropriate to term such aftereffects haptic shape-size aftereffects, as size alone could not be the determining factor. This influence of shape suggests that higher cortical areas are involved in this aftereffect and that it cannot be due to adaptation of peripheral receptors. An additional finding is that the geometric property or combination of properties participants use in the haptic size bisection task varies widely over participants, although participants themselves are quite consistent.	[Kappers, Astrid M. L.; Tiest, Wouter M. Bergmann] Vrije Univ Amsterdam, MOVE Res Inst, Fac Human Movement Sci, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Kappers, AML (corresponding author), Vrije Univ Amsterdam, MOVE Res Inst, Fac Human Movement Sci, Amsterdam, Netherlands.	a.m.l.kappers@vu.nl	Tiest, Wouter M Bergmann/N-8535-2013		European Commission with the Collaborative Project [248587]; "THE Hand Embodied' [FP7-ICT2009-4-2-1]	European Commission with the Collaborative Project; "THE Hand Embodied'	This work has been supported by the European Commission with the Collaborative Project no. 248587, "THE Hand Embodied'', within the FP7-ICT2009-4-2-1 program Cognitive Systems and Robotics. http://www.thehandembodied.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAMERON P, 1965, PERCEPT MOTOR SKILL, V20, P1131, DOI 10.2466/pms.1965.20.3c.1131; Coren S, 1992, LEFT HANDER SYNDROME; Gibson JJ, 1933, J EXP PSYCHOL, V16, P1, DOI 10.1037/h0074626; Kahrimanovic M, 2010, ATTEN PERCEPT PSYCHO, V72, P517, DOI 10.3758/APP.72.2.517; Kappers AML, 2013, 2013 WORLD HAPTICS CONFERENCE (WHC), P335, DOI 10.1109/WHC.2013.6548431; Kappers AML, 2011, PHILOS T R SOC B, V366, P3106, DOI 10.1098/rstb.2011.0171; Kitada R, 2010, NEUROIMAGE, V49, P1677, DOI 10.1016/j.neuroimage.2009.09.014; Kohler W., 1947, MISCELLANEA PSYCHOL, P196; Lederman SJ, 2011, IEEE T HAPTICS, V4, P273, DOI [10.1109/TOH.2011.2, 10.1109/ToH.2011.2]; Locke John, 1690, ESSAY HUMAN UNDERSTA, VII, pS11; Maravita A, 1997, NEUROREPORT, V8, P1671, DOI 10.1097/00001756-199705060-00022; Matsumiya K, 2012, I-PERCEPTION, V3, P97, DOI 10.1068/i0496sas; Uznadze D., 1966, PSYCHOL SET; van der Horst BJ, 2008, NEUROPSYCHOLOGIA, V46, P2966, DOI 10.1016/j.neuropsychologia.2008.06.003; Vogels IMLC, 1996, PERCEPTION, V25, P109, DOI 10.1068/p250109; Vogels IMLC, 1997, PERCEPTION, V26, P101, DOI 10.1068/p260101; WALKER JT, 1974, J EXP PSYCHOL, V103, P668, DOI 10.1037/h0037136	17	5	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88729	10.1371/journal.pone.0088729	http://dx.doi.org/10.1371/journal.pone.0088729			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586379	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900044
J	Morisaki, N; Belfort, MB; McCormick, MC; Mori, R; Noma, H; Kusuda, S; Fujimura, M				Morisaki, Naho; Belfort, Mandy B.; McCormick, Marie C.; Mori, Rintaro; Noma, Hisashi; Kusuda, Satoshi; Fujimura, Masanori		Neonatal Res Network Japan	Brief Parenteral Nutrition Accelerates Weight Gain, Head Growth Even in Healthy VLBWs	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; PRETERM INFANTS; PREMATURE-INFANTS; PROTEIN-INTAKE; OUTCOMES; MORBIDITY; MORTALITY; JAPAN; AGE; SUPPLEMENTATION	Introduction:Whether parenteral nutrition benefits growth of very low birth weight (VLBW) preterm infants in the setting of rapid enteral feeding advancement is unclear. Our aim was to examine this issue using data from Japan, where enteral feeding typically advances at a rapid rate. Methods: We studied 4005 hospitalized VLBW, very preterm (23-32 weeks' gestation) infants who reached full enteral feeding (100 ml/kg/day) by day 14, from 75 institutions in the Neonatal Research Network Japan (2003-2007). Main outcomes were weight gain, head growth, and extra-uterine growth restriction (EUGR, measurement,10 th percentile for postmenstrual age) at discharge. Results: 40% of infants received parenteral nutrition. Adjusting for maternal, infant, and institutional characteristics, infants who received parenteral nutrition had greater weight gain [0.09 standard deviation (SD), 95% CI: 0.02, 0.16] and head growth (0.16 SD, 95% CI: 0.05, 0.28); lower odds of EUGR by head circumference (OR 0.66, 95% CI: 0.49, 0.88). No statistically significant difference was seen in the proportion of infants with EUGR at discharge. SGA infants and infants who took more than a week until full feeding had larger estimates. Discussion: Even in infants who are able to establish enteral nutrition within 2 weeks, deprivation of parenteral nutrition in the first weeks of life could lead to under nutrition, but infants who reached full feeding within one week benefit least. It is important to predict which infants are likely or not likely to advance on enteral feedings within a week and balance enteral and parenteral nutrition for these infants.	[Morisaki, Naho; Mori, Rintaro; Noma, Hisashi] Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Setagaya Ku, Tokyo, Japan; [Morisaki, Naho] Univ Tokyo, Dept Pediat, Bunkyo Ku, Tokyo, Japan; [Belfort, Mandy B.] Boston Childrens Hosp, Div Newborn Med, Boston, MA USA; [Belfort, Mandy B.] Harvard Univ, Sch Med, Boston, MA USA; [McCormick, Marie C.] Beth Israel Deaconess Med Ctr, Dept Neonatol, Boston, MA 02215 USA; [McCormick, Marie C.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Noma, Hisashi] Inst Stat Math, Dept Data Sci, Tachikawa, Tokyo, Japan; [Kusuda, Satoshi] Tokyo Womens Med Univ, Dept Neonatol, Maternal & Perinatal Ctr, Shinjuku Ku, Tokyo, Japan; [Fujimura, Masanori] Osaka Med Ctr & Res Inst Maternal & Child Hlth, Dept Neonatol, Osaka, Japan	National Center for Child Health & Development - Japan; University of Tokyo; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan; Tokyo Women's Medical University	Morisaki, N (corresponding author), Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Setagaya Ku, Tokyo, Japan.	naho0330@gmail.com	Belfort, Mandy/AAN-2024-2021	Morisaki, Naho/0000-0001-6151-4513; Mori, Rintaro/0000-0001-7656-6156; Noma, Hisashi/0000-0002-2520-9949	Ministry of Health, Labor and Welfare [H22-JISEDAI-IPPAN-006]	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study was funded by a Health Labor Sciences Research Grant by the Ministry of Health, Labor and Welfare, in 2004-2008(H22-JISEDAI-IPPAN-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroor Amitha R, 2012, Sultan Qaboos Univ Med J, V12, P33; Belfort MB, 2013, NESTLE NUTR WORKS SE, V71, P171, DOI 10.1159/000342610; Belfort MB, 2011, PEDIATRICS, V128, pE899, DOI 10.1542/peds.2011-0282; Blanco CL, 2012, J PEDIATR GASTR NUTR, V54, P601, DOI 10.1097/MPG.0b013e31824887a0; Blanco CL, 2008, J PEDIATR-US, V153, P535, DOI 10.1016/j.jpeds.2008.04.059; Bombell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000504.pub3; Dinerstein A, 2006, J PERINATOL, V26, P436, DOI 10.1038/sj.jp.7211539; Dusick AM, 2003, SEMIN PERINATOL, V27, P302, DOI 10.1016/S0146-0005(03)00044-2; Ehrenkranz RA, 2006, PEDIATRICS, V117, P1253, DOI 10.1542/peds.2005-1368; Ehrenkranz RA, 2007, SEMIN PERINATOL, V31, P48, DOI 10.1053/j.semperi.2007.02.001; Ehrenkranz RA, 2011, PEDIATR RES, V69, P522, DOI 10.1203/PDR.0b013e318217f4f1; Ehrenkranz RA, 2010, EARLY HUM DEV, V86, pS21, DOI 10.1016/j.earlhumdev.2010.01.014; Higgins RD, 2012, J PEDIATR-US, V160, P511, DOI 10.1016/j.jpeds.2011.12.024; Horbar JD, 2002, PEDIATRICS, V110, P143, DOI 10.1542/peds.110.1.143; HUGHES CA, 1983, GUT, V24, P241, DOI 10.1136/gut.24.3.241; Isayama T, 2012, PEDIATRICS, V130, pE957, DOI 10.1542/peds.2012-0336; Janeiro P, 2010, EUR J PEDIATR, V169, P99, DOI 10.1007/s00431-009-0995-z; KENNEDY KA, 2000, COCHRANE DB SYST REV; Kono Y, 2008, PEDIATR INT, V50, P23, DOI 10.1111/j.1442-200X.2007.02516.x; Kono Y, 2011, PEDIATR INT, V53, P1051, DOI 10.1111/j.1442-200X.2011.03480.x; Kusuda S, 2006, PEDIATRICS, V118, pE1130, DOI 10.1542/peds.2005-2724; Kusuda S, 2012, PEDIATR RES, V72, P531, DOI 10.1038/pr.2012.114; Maggio L, 2007, J PEDIATR GASTR NUTR, V44, P124, DOI 10.1097/01.mpg.0000237927.00105.f7; Martin CR, 2009, PEDIATRICS, V124, P649, DOI 10.1542/peds.2008-3258; Moyses HE, 2013, AM J CLIN NUTR, V97, P816, DOI 10.3945/ajcn.112.042028; Poindexter BB, 2006, J PEDIATR-US, V148, P300, DOI 10.1016/j.jpeds.2005.10.038; Stephens BE, 2009, PEDIATRICS, V123, P1337, DOI 10.1542/peds.2008-0211; Trintis J, 2010, J PERINATOL, V30, P403, DOI 10.1038/jp.2009.173; Uehara R, 2011, J EPIDEMIOL, V21, P217, DOI 10.2188/jea.JE20100123; Uhing MR, 2009, CLIN PERINATOL, V36, P165, DOI 10.1016/j.clp.2008.09.010; Garcia LV, 2012, AN PEDIATR, V76, P127, DOI 10.1016/j.anpedi.2011.04.007; Yee WH, 2012, PEDIATRICS, V129, pE298, DOI 10.1542/peds.2011-2022	32	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88392	10.1371/journal.pone.0088392	http://dx.doi.org/10.1371/journal.pone.0088392			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586323	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900027
J	Punj, S; Kopparapu, P; Jang, HS; Phillips, JL; Pennington, J; Rohlman, D; O'Donnell, E; Iversen, PL; Kolluri, SK; Kerkvliet, NI				Punj, Sumit; Kopparapu, Prasad; Jang, Hyo Sang; Phillips, Jessica L.; Pennington, Jamie; Rohlman, Diana; O'Donnell, Edmond; Iversen, Patrick L.; Kolluri, Siva Kumar; Kerkvliet, Nancy I.			Benzimidazoisoquinolines: A New Class of Rapidly Metabolized Aryl Hydrocarbon Receptor (AhR) Ligands that Induce AhR-Dependent Tregs and Prevent Murine Graft-Versus-Host Disease	PLOS ONE			English	Article							REGULATORY T-CELLS; GENE-EXPRESSION; ACTIVATION; DIFFERENTIATION; SUPPRESSION; DIOXIN; TCDD; KYNURENINE; INHIBITOR; CD4(+)	The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that plays multiple roles in regulation of immune and inflammatory responses. The ability of certain AhR ligands to induce regulatory T cells (Tregs) has generated interest in developing AhR ligands for therapeutic treatment of immune-mediated diseases. To this end, we designed a screen for novel Treg-inducing compounds based on our understanding of the mechanisms of Treg induction by the well-characterized immunosuppressive AhR ligand, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). We screened a ChemBridge small molecule library and identified 10-chloro-7H-benzimidazo[2,1-a] benzo[de] Iso-quinolin-7-one (10-Cl-BBQ) as a potent AhR ligand that was rapidly metabolized and not cytotoxic to proliferating T cells. Like TCDD, 10-Cl-BBQ altered donor CD4(+) T cell differentiation during the early stages of a graft versus host (GVH) response resulting in expression of high levels of CD25, CTLA-4 and ICOS, as well as several genes associated with Treg function. The Treg phenotype required AhR expression in the donor CD4(+) T cells. Foxp3 was not expressed in the AhR-induced Tregs implicating AhR as an independent transcription factor for Treg induction. Structure-activity studies showed that unsubstituted BBQ as well as 4, 11-dichloro-BBQ were capable of inducing AhR-Tregs. Other substitutions reduced activation of AhR. Daily treatment with 10-Cl-BBQ during the GVH response prevented development of GVH disease in an AhR-dependent manner with no overt toxicity. Together, our data provide strong support for development of select BBQs that activate the AhR to induce Tregs for treatment of immune-mediated diseases.	[Punj, Sumit; Kopparapu, Prasad; Jang, Hyo Sang; Phillips, Jessica L.; Pennington, Jamie; Rohlman, Diana; O'Donnell, Edmond; Iversen, Patrick L.; Kolluri, Siva Kumar; Kerkvliet, Nancy I.] Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA; [Kolluri, Siva Kumar; Kerkvliet, Nancy I.] Oregon State Univ, Environm Hlth Sci Ctr, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Kerkvliet, NI (corresponding author), Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA.	Nancy.kerkvliet@oregonstate.edu	Iversen, Patrick L./L-5454-2019; Iversen, Patrick L/D-8854-2019	Iversen, Patrick L./0000-0003-0106-9790; Iversen, Patrick L/0000-0003-0106-9790; Rohlman, Diana/0000-0002-3982-0327; Jang, Hyo Sang/0000-0003-0460-9924	NIH [5RO1ES016651]; NIEHS Center grant [P01ES00210]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016651, P30ES000210] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS Center grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was funded by NIH grant 5RO1ES016651 to NIK and SKK. Technical support in flow cytometry and mass spectroscopy was provided by the Environmental Health Sciences Core Center at OSU, funded by NIEHS Center grant P01ES00210. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisson WH, 2009, J MED CHEM, V52, P5635, DOI 10.1021/jm900199u; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; Elizondo G, 2011, INT J BIOL SCI, V7, P1220, DOI 10.7150/ijbs.7.1220; FOREMAN MI, 1985, BRIT J DERMATOL, V112, P323, DOI 10.1111/j.1365-2133.1985.tb04860.x; Funatake CJ, 2008, J IMMUNOTOXICOL, V5, P81, DOI 10.1080/15476910802019037; Funatake CJ, 2005, J IMMUNOL, V175, P4184, DOI 10.4049/jimmunol.175.7.4184; GASIEWICZ TA, 1982, ANAL BIOCHEM, V124, P1, DOI 10.1016/0003-2697(82)90212-3; Hauben E, 2008, BLOOD, V112, P1214, DOI 10.1182/blood-2007-08-109843; Hu W, 2013, J BIOL CHEM; Huang Z, 2013, MOL IMMUNOL, V53, P335, DOI 10.1016/j.molimm.2012.09.007; Karaca F, 2009, RAPID COMMUN MASS SP, V23, P2087, DOI 10.1002/rcm.4104; Kerkvliet NI, 2012, TOXICOL PATHOL, V40, P138, DOI 10.1177/0192623311427710; Kerkvliet NI, 2009, IMMUNOTHERAPY-UK, V1, P539, DOI 10.2217/IMT.09.24; Kerkvliet NI, 2002, TOXICOL APPL PHARM, V185, P146, DOI 10.1006/taap.2002.9537; Kerkvliet NI, 1996, J IMMUNOL, V157, P2310; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; KOBAYASHI Y, 1993, J BIOCHEM-TOKYO, V114, P697, DOI 10.1093/oxfordjournals.jbchem.a124239; Koller A, 2010, PROG TRANSPLANT, V20, P40, DOI 10.7182/prtr.20.1.1817728501066246; Leslie M, 2011, SCIENCE, V332, P1020, DOI 10.1126/science.332.6033.1020; Marshall NB, 2008, J IMMUNOL, V181, P2382, DOI 10.4049/jimmunol.181.4.2382; Marshall NB, 2010, ANN NY ACAD SCI, V1183, P25, DOI 10.1111/j.1749-6632.2009.05125.x; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Monteiro P, 2008, MOL PHARMACOL, V73, P769, DOI 10.1124/mol.107.043125; Monteiro P, 2008, DRUG METAB DISPOS, V36, P2556, DOI 10.1124/dmd.108.023333; Nguyen NT, 2010, P NATL ACAD SCI USA, V107, P19961, DOI 10.1073/pnas.1014465107; O'Donnell EF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040926; O'Donnell EF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013128; Paghdal KV, 2009, J AM ACAD DERMATOL, V61, P294, DOI 10.1016/j.jaad.2008.11.024; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Quintana FJ, 2010, P NATL ACAD SCI USA, V107, P20768, DOI 10.1073/pnas.1009201107; Rodriguez-Sosa M, 2005, FEBS LETT, V579, P6403, DOI 10.1016/j.febslet.2005.10.023; Roelofzen JHJ, 2012, TOXICOL LETT, V213, P39, DOI 10.1016/j.toxlet.2011.06.030; Roelofzen JHJ, 2010, J INVEST DERMATOL, V130, P953, DOI 10.1038/jid.2009.389; Schulz VJ, 2011, TOXICOL SCI, V123, P491, DOI 10.1093/toxsci/kfr175; Smith G, 2006, BRIT J DERMATOL, V155, P275, DOI 10.1111/j.1365-2133.2006.07317.x; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Vaeth M, 2012, P NATL ACAD SCI USA, V109, P16258, DOI 10.1073/pnas.1203870109; van den Bogaard EH, 2013, J CLIN INVEST, V123, P917, DOI 10.1172/JCI65642; Vocanson M, 2010, J ALLERGY CLIN IMMUN, V126, P280, DOI 10.1016/j.jaci.2010.05.022; Yeste A, 2012, P NATL ACAD SCI USA, V109, P11270, DOI 10.1073/pnas.1120611109; Zhang LN, 2010, INVEST OPHTH VIS SCI, V51, P2109, DOI 10.1167/iovs.09-3993; Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007	43	32	35	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88726	10.1371/journal.pone.0088726	http://dx.doi.org/10.1371/journal.pone.0088726			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586378	gold, Green Published, Green Submitted			2022-12-27	WOS:000331711900043
J	Kolfschoten, NE; Marang-van de Mheen, PJ; Wouters, MWJM; Eddes, EH; Tollenaar, RAEM; Stijnen, T; Kievit, J				Kolfschoten, Nikki E.; Marang-van de Mheen, Perla J.; Wouters, Michel W. J. M.; Eddes, Eric-Hans; Tollenaar, Rob A. E. M.; Stijnen, Theo; Kievit, Job		Dutch Surgical Colorectal Audit	A Combined Measure of Procedural Volume and Outcome to Assess Hospital Quality of Colorectal Cancer Surgery, a Secondary Analysis of Clinical Audit Data	PLOS ONE			English	Article							AFFAIRS SURGICAL RISK; VETERANS-AFFAIRS; OF-CARE; MORTALITY; NETHERLANDS; ADJUSTMENT	Objective: To identify, on the basis of past performance, those hospitals that demonstrate good outcomes in sufficient numbers to make it likely that they will provide adequate quality of care in the future, using a combined measure of volume and outcome (CM-V&O). To compare this CM-V&O with measures using outcome-only (O-O) or volume-only (V-O), and verify 2010-quality of care assessment on 2011 data. Design: Secondary analysis of clinical audit data. Setting: The Dutch Surgical Colorectal Audit database of 2010 and 2011, the Netherlands. Participants: 8911 patients (test population, treated in 2010) and 9212 patients (verification population, treated in 2011) who underwent a resection of primary colorectal cancer in 89 Dutch hospitals. Main Outcome Measures: Outcome was measured by Observed/Expected (O/E) postoperative mortality and morbidity. CM-V&O states 2 criteria; 1) outcome is not significantly worse than average, and 2) outcome is significantly better than substandard, with 'substandard care' being defined as an unacceptably high O/E threshold for mortality and/or morbidity (which we set at 2 and 1.5 respectively). Results: Average mortality and morbidity in 2010 were 4.1 and 24.3% respectively. 84 (94%) hospitals performed 'not worse than average' for mortality, but only 21 (24%) of those were able to prove they were also 'better than substandard' (O/E, 2). For morbidity, 42 hospitals (47%) met the CM-V&O. Morbidity in 2011 was significantly lower in these hospitals (19.8 vs. 22.8% p<0.01). No relationship was found between hospitals' 2010 performance on O-O en V-O, and the quality of their care in 2011. Conclusion: CM-V&O for morbidity can be used to identify hospitals that provide adequate quality and is associated with better outcomes in the subsequent year.	[Kolfschoten, Nikki E.; Tollenaar, Rob A. E. M.; Kievit, Job] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; [Kolfschoten, Nikki E.; Marang-van de Mheen, Perla J.; Kievit, Job] Leiden Univ, Med Ctr, Dept Med Decis Making, Leiden, Netherlands; [Wouters, Michel W. J. M.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Surg Oncol, Amsterdam, Netherlands; [Eddes, Eric-Hans] Deventer Hosp, Dept Surg, Deventer, Netherlands; [Stijnen, Theo] Leiden Univ, Med Ctr, Dept Biostat, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Cancer Institute; Deventer Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kievit, J (corresponding author), Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands.	j.kievit@lumc.nl	de Mheen, Perla J. Marang-van/I-2783-2015; Rutten, Harm J/H-9595-2017; Meijerink, Wilhelmus JHJ/T-3619-2017; Wouters, Michel/B-5882-2019	de Mheen, Perla J. Marang-van/0000-0003-1439-0989; Meijerink, Wilhelmus JHJ/0000-0002-5402-0811; Wouters, Michel/0000-0001-6173-0662				Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; BLAMEY RW, 2006, EUROPEAN GUIDELINES, P343; Daley J, 1997, J AM COLL SURGEONS, V185, P328, DOI 10.1016/S1072-7515(01)00939-5; DALY L, 1992, COMPUT BIOL MED, V22, P351, DOI 10.1016/0010-4825(92)90023-G; Dimick JB, 2004, JAMA-J AM MED ASSOC, V292, P847, DOI 10.1001/jama.292.7.847; Dimick JB, 2009, HEALTH AFFAIR, V28, P1189, DOI 10.1377/hlthaff.28.4.1189; Elferink M A G, 2010, Eur J Surg Oncol, V36 Suppl 1, pS74, DOI 10.1016/j.ejso.2010.06.028; Khuri SF, 1997, J AM COLL SURGEONS, V185, P315, DOI 10.1016/S1072-7515(01)00938-3; Khuri SF, 2002, ARCH SURG-CHICAGO, V137, P20, DOI 10.1001/archsurg.137.1.20; Kolfschoten NE, 2013, EJSO-EUR J SURG ONC, V39, P156, DOI 10.1016/j.ejso.2012.10.007; Kolfschoten NE, 2011, EJSO-EUR J SURG ONC, V37, P956, DOI 10.1016/j.ejso.2011.08.137; Medicine Io, 1990, MED STRAT QUAL ASS C, V1, P468; Simunovic M, ANN SURG ONCOL, V17, P2537; Sonnenday CJ, 2010, ANN SURG ONCOL, V17, P2535, DOI 10.1245/s10434-010-1117-x; van Dishoeck AM, 2011, BMJ QUAL SAF, V20, P869, DOI 10.1136/bmjqs.2010.048058; van Gijn W, 2010, Eur J Surg Oncol, V36 Suppl 1, pS55, DOI 10.1016/j.ejso.2010.06.027; Van Gijn W, 2009, J SURG ONCOL, V99, P491, DOI 10.1002/jso.21203; Van Leersum NJ, 2013, EUR J SURG ONCOL; Westaby S, 2007, BRIT MED J, V335, P759, DOI 10.1136/bmj.39318.644549.AE; Wouters MWJM, 2009, J SURG ONCOL, V99, P481, DOI 10.1002/jso.21191; Wouters M, 2008, J SURG ONCOL, V98, P307, DOI 10.1002/jso.21100	21	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88737	10.1371/journal.pone.0088737	http://dx.doi.org/10.1371/journal.pone.0088737			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558418	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700064
J	Niitsu, S; Toga, K; Tomizuka, S; Maekawa, K; Machida, R; Kamito, T				Niitsu, Shuhei; Toga, Kouhei; Tomizuka, Shigekazu; Maekawa, Kiyoto; Machida, Ryuichiro; Kamito, Takehiko			Ecdysteroid-Induced Programmed Cell Death Is Essential for Sex-Specific Wing Degeneration of the Wingless-Female Winter Moth	PLOS ONE			English	Article							BAGWORM MOTH; LEPIDOPTERA; APOPTOSIS; FLIGHTLESSNESS; PUPAE; AUTOPHAGY; EVOLUTION; ECDYSONE; DIAPAUSE; DISCS	The winter moth, Nyssiodes lefuarius, has a unique life history in that adults appear during early spring after a long pupal diapause from summer to winter. The moth exhibits striking sexual dimorphism in wing form; males have functional wings of normal size, whereas females lack wings. We previously found that cell death of the pupal epithelium of females appears to display condensed chromatin within phagocytes. To provide additional detailed data for interpreting the role of cell death, we performed light microscopy, transmission electron microscopy, and TUNEL assay. We consequently detected two modes of cell death, i.e., dying cells showed both DNA fragmentation derived from epithelial nuclei and autophagic vacuole formation. To elucidate the switching mechanism of sex-specific wing degeneration in females of N. lefuarius, we tested the effects of the steroid hormone 20-hydroxyecdysone (20E) on pupal diapause termination and wing morphogenesis in both sexes. When 20E (5.4 mu g) was injected into both sexes within 2 days of pupation, wing degeneration started 4 days after 20E injection in females, whereas wing morphogenesis and scale formation started 6 days after 20E injection in males. We discuss two important findings: (1) degeneration of the pupal wing epithelium of females was not only due to apoptosis and phagocytotic activation but also to autophagy and epithelial cell shrinkage; and (2) 20E terminated the summer diapause of pupae, and triggered selective programmed cell death only of the female-pupal wing epithelium in the wingless female winter moth.	[Niitsu, Shuhei; Kamito, Takehiko] Int Christian Univ, Dept Life Sci, Tokyo, Japan; [Niitsu, Shuhei] Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo, Japan; [Toga, Kouhei; Maekawa, Kiyoto] Toyama Univ, Grad Sch Sci & Engn, Toyama 930, Japan; [Tomizuka, Shigekazu] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Tomizuka, Shigekazu; Machida, Ryuichiro] Univ Tsukuba, Sugadaira Montane Res Ctr, Ueda, Nagano, Japan	International Christian University; Tokyo Metropolitan University; University of Toyama; University of Tsukuba; University of Tsukuba	Niitsu, S (corresponding author), Int Christian Univ, Dept Life Sci, Tokyo, Japan.	shu-30@aioros.ocn.ne.jp	Toga, Kouhei/AHC-4090-2022	Toga, Kouhei/0000-0001-7244-5920; Maekawa, Kiyoto/0000-0002-2354-1059				ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Andersen Nils Moller, 1997, Memoires du Museum National d'Histoire Naturelle, V173, P91; [Anonymous], 1998, TINEA; ARPAGAUS M, 1986, REPROD NUTR DEV, V26, P1305; Bergmann A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145re8; BODNARYK RP, 1985, J INSECT PHYSIOL, V31, P53, DOI 10.1016/0022-1910(85)90042-3; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Common IFB, 1970, INSECTS AUSTR; Fedotov DM, 1939, CR ACAD SCI URSS, V24, P616; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Fujiwara H, 2001, DEV GENES EVOL, V211, P118, DOI 10.1007/s004270000131; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; HACKMAN WALTER, 1966, NOTULAE ENTOMOL, V46, P1; Hafez M., 1969, Bulletin de la Societe Entomologique d'Egypte, V53, P161; Hamilton WD, 1978, DIVERSITY INSECT FAU; HEPPNER J B, 1991, Tropical Lepidoptera, V2, P11; Ishizuya-Oka A, 2010, APOPTOSIS, V15, P350, DOI 10.1007/s10495-009-0422-y; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KIMURA T, 1977, Kontyu, V45, P97; KODAMA R, 1995, ROUX ARCH DEV BIOL, V204, P418, DOI 10.1007/BF00360849; Koenuma A, 1987, J FS SHINSHU U, V22, P67; Kourtis N, 2009, CELL DEATH DIFFER, V16, P21, DOI 10.1038/cdd.2008.120; Lee CY, 2001, DEVELOPMENT, V128, P1443; Lobbia S, 2007, ARCH INSECT BIOCHEM, V65, P152, DOI 10.1002/arch.20192; Lobbia S, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.11; Lockshin RA, 2001, NAT REV MOL CELL BIO, V2, P545, DOI 10.1038/35080097; Matsuda R., 1979, P137; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Montero JA, 2010, APOPTOSIS, V15, P365, DOI 10.1007/s10495-009-0444-5; Nakajima K, 2003, DEV DYNAM, V227, P246, DOI 10.1002/dvdy.10300; NARDI JB, 1991, J MORPHOL, V209, P121, DOI 10.1002/jmor.1052090110; Niitsu S, 2003, J MORPHOL, V257, P164, DOI 10.1002/jmor.10116; Niitsu S, 2008, CELL TISSUE RES, V333, P169, DOI 10.1007/s00441-008-0615-7; Niitsu S, 2011, TISSUE CELL, V43, P143, DOI 10.1016/j.tice.2011.01.003; Niitsu Shuhei, 2001, Entomological Science, V4, P1; Niitsu S, 2008, EUR J ENTOMOL, V105, P697, DOI 10.14411/eje.2008.095; QUENNEDEY A, 1990, TISSUE CELL, V22, P721, DOI 10.1016/0040-8166(90)90067-J; Riddiford L.M., 1985, P37; ROFF DA, 1990, ECOL MONOGR, V60, P389, DOI 10.2307/1943013; Sameshima SY, 2004, EVOL DEV, V6, P336, DOI 10.1111/j.1525-142X.2004.04041.x; SATO T, 1977, JPN J APPL ENTOMOL Z, V21, P6, DOI 10.1303/jjaez.21.6; Sattler K., 1991, Bulletin of the British Museum (Natural History) Entomology, V60, P243; SCHWEICHEL JU, 1973, TERATOLOGY, V7, P253, DOI 10.1002/tera.1420070306; Suzanne M, 2013, CELL DEATH DIFFER, V20, P669, DOI 10.1038/cdd.2013.11; Suzuki D, 2009, DEV BIOL, V335, P396, DOI 10.1016/j.ydbio.2009.09.014; WAGNER DL, 1992, TRENDS ECOL EVOL, V7, P216, DOI 10.1016/0169-5347(92)90047-F; WILLIAMS CM, 1968, BIOL BULL, V134, P344, DOI 10.2307/1539610; Zuzarte-Luis V, 2002, INT J DEV BIOL, V46, P871	49	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89435	10.1371/journal.pone.0089435	http://dx.doi.org/10.1371/journal.pone.0089435			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558499	gold, Green Submitted, Green Published			2022-12-27	WOS:000331706700145
J	Paquet, F; Delalande, O; Goffinont, S; Culard, F; Loth, K; Asseline, U; Castaing, B; Landon, C				Paquet, Francoise; Delalande, Olivier; Goffinont, Stephane; Culard, Francoise; Loth, Karine; Asseline, Ulysse; Castaing, Bertrand; Landon, Celine			Model of a DNA-Protein Complex of the Architectural Monomeric Protein MC1 from Euryarchaea	PLOS ONE			English	Article							INTEGRATION HOST FACTOR; CHROMOSOMAL-PROTEIN; MINOR-GROOVE; CRYSTAL-STRUCTURE; THERMOPLASMA-ACIDOPHILUM; TRANSCRIPTION FACTOR; WEB SERVER; BINDING; RECOGNITION; CHROMATIN	In Archaea the two major modes of DNA packaging are wrapping by histone proteins or bending by architectural nonhistone proteins. To supplement our knowledge about the binding mode of the different DNA-bending proteins observed across the three domains of life, we present here the first model of a complex in which the monomeric Methanogen Chromosomal protein 1 (MC1) from Euryarchaea binds to the concave side of a strongly bent DNA. In laboratory growth conditions MC1 is the most abundant architectural protein present in Methanosarcina thermophila CHTI55. Like most proteins that strongly bend DNA, MC1 is known to bind in the minor groove. Interaction areas for MC1 and DNA were mapped by Nuclear Magnetic Resonance (NMR) data. The polarity of protein binding was determined using paramagnetic probes attached to the DNA. The first structural model of the DNA-MC1 complex we propose here was obtained by two complementary docking approaches and is in good agreement with the experimental data previously provided by electron microscopy and biochemistry. Residues essential to DNA-binding and -bending were highlighted and confirmed by site-directed mutagenesis. It was found that the Arg25 side-chain was essential to neutralize the negative charge of two phosphates that come very close in response to a dramatic curvature of the DNA.	[Paquet, Francoise; Goffinont, Stephane; Culard, Francoise; Loth, Karine; Asseline, Ulysse; Castaing, Bertrand; Landon, Celine] Univ Orleans, CNRS, UPR 4301, Ctr Biophys Mol, Orleans, France; [Delalande, Olivier] Univ Rennes 1, CNRS, UMR 6290, Fac Sci Pharmaceut & Biol,Inst Genet & Dev Rennes, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Orleans; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	Paquet, F (corresponding author), Univ Orleans, CNRS, UPR 4301, Ctr Biophys Mol, Orleans, France.	francoise.paquet@cnrs-orleans.fr		Castaing, Bertrand/0000-0001-5077-8978; PAQUET, Francoise/0000-0001-8838-3445	CNRS	CNRS(Centre National de la Recherche Scientifique (CNRS))	Funds result from the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ababneh AM, 2008, J THEOR BIOL, V252, P742, DOI 10.1016/j.jtbi.2008.02.033; Agback P, 1998, NAT STRUCT BIOL, V5, P579, DOI 10.1038/836; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bao QY, 2007, J MOL BIOL, V367, P731, DOI 10.1016/j.jmb.2006.09.082; Bewley CA, 1998, ANNU REV BIOPH BIOM, V27, P105, DOI 10.1146/annurev.biophys.27.1.105; Blanchet C, 2011, NUCLEIC ACIDS RES, V39, pW68, DOI 10.1093/nar/gkr316; Bure C, 2008, J MOL BIOL, V376, P120, DOI 10.1016/j.jmb.2007.11.057; CHARTIER F, 1988, BIOCHIM BIOPHYS ACTA, V951, P149, DOI 10.1016/0167-4781(88)90035-8; Chen CY, 2005, NUCLEIC ACIDS RES, V33, P430, DOI 10.1093/nar/gki191; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; Cordeiro TN, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002380; Culard F, 2003, J MOL BIOL, V328, P1185, DOI 10.1016/S0022-2836(03)00361-9; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; De Vuyst G, 2005, BIOCHEMISTRY-US, V44, P10369, DOI 10.1021/bi0474416; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DELANGE RJ, 1981, J BIOL CHEM, V256, P900; DELANGE RJ, 1981, J BIOL CHEM, V256, P905; DeLano W, 2002, PYMOL 0 99; ElHassan MA, 1997, PHILOS T R SOC A, V355, P43, DOI 10.1098/rsta.1997.0002; Ellenberger T, 1997, STRUCTURE, V5, P153, DOI 10.1016/S0969-2126(97)00174-3; Escalante CR, 2007, MOL CELL, V26, P703, DOI 10.1016/j.molcel.2007.04.022; Feng YG, 2010, PROTEIN SCI, V19, P1253, DOI 10.1002/pro.385; Flick KE, 1998, NATURE, V394, P96, DOI 10.1038/27952; Gao YG, 1998, NAT STRUCT BIOL, V5, P782, DOI 10.1038/1822; Huber EM, 2012, STRUCTURE, V20, P1757, DOI 10.1016/j.str.2012.07.012; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; Klass J, 2003, NUCLEIC ACIDS RES, V31, P2852, DOI 10.1093/nar/gkg389; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krzeminski M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-51; Le Cam E, 1999, J MOL BIOL, V285, P1011, DOI 10.1006/jmbi.1998.2321; Luijsterburg MS, 2008, CRIT REV BIOCHEM MOL, V43, P393, DOI [10.1080/10409230802528488, 10.1080/10409230802528488 ]; Lynch TW, 2003, J MOL BIOL, V330, P493, DOI 10.1016/S0022-2836(03)00529-1; Masse JE, 2002, J MOL BIOL, V323, P263, DOI 10.1016/S0022-2836(02)00938-5; Mouw KW, 2007, MOL MICROBIOL, V63, P1319, DOI 10.1111/j.1365-2958.2007.05586.x; Murphy EC, 2001, J MOL BIOL, V312, P481, DOI 10.1006/jmbi.2001.4977; Palasingam P, 2009, J MOL BIOL, V388, P619, DOI 10.1016/j.jmb.2009.03.055; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Paquet F, 2004, BIOCHEMISTRY-US, V43, P14971, DOI 10.1021/bi048382z; Paquet F, 2010, FEBS J, V277, P5133, DOI 10.1111/j.1742-4658.2010.07927.x; Paradinas C, 1998, EUR J BIOCHEM, V257, P372, DOI 10.1046/j.1432-1327.1998.2570372.x; Pyrkov TV, 2009, BIOINFORMATICS, V25, P1201, DOI 10.1093/bioinformatics/btp111; Reeve JN, 2003, MOL MICROBIOL, V48, P587, DOI 10.1046/j.1365-2958.2003.03439.x; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Rubio-Cosials A, 2011, NAT STRUCT MOL BIOL, V18, P1281, DOI 10.1038/nsmb.2160; Saladin A, 2010, NUCLEIC ACIDS RES, V38, P6313, DOI 10.1093/nar/gkq459; Sandman K, 2005, CURR OPIN MICROBIOL, V8, P656, DOI 10.1016/j.mib.2005.10.007; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Stella S, 2010, GENE DEV, V24, P814, DOI 10.1101/gad.1900610; Stott K, 2006, J MOL BIOL, V360, P90, DOI 10.1016/j.jmb.2006.04.059; Stratmann D, 2011, PROTEINS, V79, P2662, DOI 10.1002/prot.23090; Su SY, 2000, J MOL BIOL, V303, P395, DOI 10.1006/jmbi.2000.4112; Swinger KK, 2007, J MOL BIOL, V365, P1005, DOI 10.1016/j.jmb.2006.10.024; Swinger KK, 2003, EMBO J, V22, P3749, DOI 10.1093/emboj/cdg351; Swinger KK, 2004, CURR OPIN STRUC BIOL, V14, P28, DOI 10.1016/j.sbi.2003.12.003; TEYSSIER C, 1994, BIOCHEM J, V303, P567, DOI 10.1042/bj3030567; Teyssier C, 1996, BIOCHEMISTRY-US, V35, P7954, DOI 10.1021/bi952414o; Tolstorukov MY, 2007, J MOL BIOL, V371, P725, DOI 10.1016/j.jmb.2007.05.048; van Dijk M, 2010, NUCLEIC ACIDS RES, V38, P5634, DOI 10.1093/nar/gkq222; van Dijk M, 2009, NUCLEIC ACIDS RES, V37, pW235, DOI 10.1093/nar/gkp287; White MF, 2002, TRENDS GENET, V18, P621, DOI 10.1016/S0168-9525(02)02808-1; Williams DC, 2004, J BIOL CHEM, V279, P1449, DOI 10.1074/jbc.M309790200; Zhang ZF, 2010, MOL MICROBIOL, V76, P749, DOI 10.1111/j.1365-2958.2010.07136.x; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	67	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88809	10.1371/journal.pone.0088809	http://dx.doi.org/10.1371/journal.pone.0088809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558431	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700077
J	Santoro, M; Mattiucci, S; Cipriani, P; Bellisario, B; Romanelli, F; Cimmaruta, R; Nascetti, G				Santoro, Mario; Mattiucci, Simonetta; Cipriani, Paolo; Bellisario, Bruno; Romanelli, Francesco; Cimmaruta, Roberta; Nascetti, Giuseppe			Parasite Communities of Icefish (Chionodraco hamatus) in the Ross Sea (Antarctica): Influence of the Host Sex on the Helminth Infracommunity Structure	PLOS ONE			English	Article							SOUTH-SHETLAND ISLANDS; METAZOAN PARASITES; FISH; ACANTHOCEPHALA; SPECIFICITY; INFECTION; PATTERNS; NEMATODA; CYCLE; RANK	Parasite communities of Chionodraco hamatus were investigated from Terra Nova Bay (Ross Sea, Antarctica) during host spawning time. Special attention was given to helminth infracommunities and effect of host sex on its structure. A total of 21 taxa including 5 ecto-parasites and 16 endo-parasites were identified. The number of ecto and endo-parasite species per individual host ranged from 1 to 3 and 3 to 10, respectively, while the mean numbers of parasite specimens per individual host were 4.7 and 1309.7, respectively. The rich abundance of infection suggests a rich concentration of helminth intermediate/paratenic hosts in the coastal waters of Terra Nova Bay. Chionodraco hamatus serves as a definitive host for 10 helminth taxa, while it acts as an intermediate/paratenic host for 6 helminth taxa. Larvae of 6 helminth taxa for which C. hamatus serves as intermediate/paratenic host represented 98.7% of all specimens found. Of these, the tetraphyllidean and diphyllobothridean cestodes and the nematode Contracaecum osculatum s.l. were the most prevalent and abundant. 'Larval' infracommunities had significantly higher species richness, total abundance and diversity than 'adult' infracommunities, suggesting the important role of C. hamatus in supporting the life cycles of those parasites in the study area as a paratenic/intermediate host. Significant differences in the pattern of helminth infracommunities of larval forms between male and female fish were found. These differences could be caused by physiological, and most probably by behavioral differences between sexes suggesting that sex is an important factor influencing parasite burden in C. hamatus during reproductive season.	[Santoro, Mario; Mattiucci, Simonetta; Cipriani, Paolo] Univ Roma La Sapienza, Sect Parasitol, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy; [Bellisario, Bruno; Cimmaruta, Roberta; Nascetti, Giuseppe] Univ Tuscia, Dept Ecol & Biol Sci, Viterbo, Italy; [Romanelli, Francesco] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy	Sapienza University Rome; Tuscia University; Sapienza University Rome	Santoro, M (corresponding author), Univ Roma La Sapienza, Sect Parasitol, Dept Publ Hlth & Infect Dis, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	marisant@libero.it	Bellisario, Bruno/D-5766-2015; Cimmaruta, Roberta/AAC-9151-2020; Bellisario, Bruno/S-2651-2019; Romanelli, Francesco/A-7925-2012; Santoro, Mario/K-3251-2019; Mattiucci, Simonetta/K-5285-2018; Nascetti, Giuseppe/AAA-6396-2020	Bellisario, Bruno/0000-0002-5339-0757; cipriani, paolo/0000-0003-4599-7724; Cimmaruta, Roberta/0000-0002-1421-5155; Nascetti, Giuseppe/0000-0002-1159-8103	Italian Ministry of Education and Research (MIUR), Programma Nazionale di Ricerche in Antartide	Italian Ministry of Education and Research (MIUR), Programma Nazionale di Ricerche in Antartide(Ministry of Education, Universities and Research (MIUR))	This study was supported by Italian Ministry of Education and Research (MIUR), Programma Nazionale di Ricerche in Antartide. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley D, 2006, 0607 CCAMLR; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ARDUINO P, 1995, SYST PARASITOL, V30, P1, DOI 10.1007/BF00009238; Bartoli P, 2000, J HELMINTHOL, V74, P289; BOLGER T, 1989, J FISH BIOL, V34, P171, DOI 10.1111/j.1095-8649.1989.tb03300.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Gaevskaya A.V., 1982, Nauchnye Doklady Vysshei Shkoly Biologicheskie Nauki, V1982, P27; Garcia A, 2008, J FISH BIOL, V73, P2274, DOI 10.1111/j.1095-8649.2008.02072.x; George-Nascimento M, 2004, ECOL LETT, V7, P527, DOI 10.1111/j.1461-0248.2004.00609.x; George-Nascimento M, 2002, REV CHIL HIST NAT, V75, P835; GROSSMAN CJ, 1985, SCIENCE, V227, P257, DOI 10.1126/science.3871252; Holmes J.C., 1986, P187; Klimpel S, 2003, PARASITOL RES, V91, P290, DOI 10.1007/s00436-003-0957-8; Klimpel S, 2006, MAR ECOL PROG SER, V315, P249, DOI 10.3354/meps315249; Kock KH, 2005, POLAR BIOL, V28, P897, DOI [10.1007/s00300-005-0019-z, 10.1007/s00300-005-0020-6]; KOCK KH, 1991, ANTARCT SCI, V3, P125, DOI 10.1017/S0954102091000172; Kruskal J, 1978, MULTIDIMENSIONAL SCA; La Mesa M, 2004, POLAR BIOL, V27, P321, DOI 10.1007/s00300-004-0599-z; Lagrue C, 2011, J FISH BIOL, V79, P466, DOI 10.1111/j.1095-8649.2011.03041.x; Laskowski Z, 2010, ACTA PARASITOL, V55, P161, DOI 10.2478/s11686-010-0022-6; LECREN ED, 1951, J ANIM ECOL, V20, P201, DOI 10.2307/1540; Marcogliese DJ, 2002, PARASITOLOGY, V124, pS83, DOI 10.1017/S003118200200149X; Mattiucci S, 2008, ADV PARASIT, V66, P47, DOI 10.1016/S0065-308X(08)00202-9; ORECCHIA P, 1994, INT J PARASITOL, V24, P367, DOI 10.1016/0020-7519(94)90084-1; Palm HW, 2007, POLAR BIOL, V30, P1513, DOI 10.1007/s00300-007-0312-0; Poulin R, 1996, AM NAT, V147, P287, DOI 10.1086/285851; Poulin R., 2007, EVOL ECOL, V2; Poulin R, 2007, INT J PARASITOL, V37, P359, DOI 10.1016/j.ijpara.2006.11.009; Reiczigel J, 2003, STAT MED, V22, P611, DOI 10.1002/sim.1320; Rocka A, 2006, ACTA PARASITOL, V51, P26, DOI 10.2478/s11686-006-0003-y; Rocka Anna, 2003, Polish Polar Research, V24, P261; Rokicki Jerzy, 1992, Polish Polar Research, V13, P53; Rozsa L, 2000, J PARASITOL, V86, P228, DOI 10.1645/0022-3395(2000)086[0228:QPISOH]2.0.CO;2; Santoro M, 2013, J HELMINTHOL, V87, P277, DOI 10.1017/S0022149X12000338; Santoro M, 2013, DIS AQUAT ORGAN, V105, P139, DOI 10.3354/dao02626; Santoro M, 2010, PARASITOL INT, V59, P367, DOI 10.1016/j.parint.2010.04.009; SAWYER RT, 1986, LEECH BIOL BEHAV FEE; SIEGEL V, 1980, MEERESFORSCHUNG, V28, P146; Simkova A, 2005, PARASITOL RES, V95, P65, DOI 10.1007/s00436-004-1261-y; Sutton CP, 2008, CCAMLR SCI, V15, P139; Tompkins DM, 1999, PARASITOLOGY, V118, P417, DOI 10.1017/S0031182098003886; Wojciechowska Anna, 1993, Acta Parasitologica, V38, P15; Zdzitowiecki K., 1999, Parassitologia (Rome), V41, P575; Zdzitowiecki K, 2001, ACTA PARASITOL, V46, P202; ZDZITOWIECKI K, 1997, SYNOPSES ANTARCTIC B, V8; ZDZITOWIECKI K, 1991, SYNOPSES ANTARCTIC B, V3; Zdzitowiecki Krzysztof, 2001, Polish Polar Research, V22, P205; Zdzitowiecki Krzysztof, 1999, Polish Polar Research, V20, P59	49	16	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88876	10.1371/journal.pone.0088876	http://dx.doi.org/10.1371/journal.pone.0088876			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558440	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700086
J	Hu, JJ; Lu, J; Lian, GW; Zhang, JP; Hecht, JL; Sheen, VL				Hu, Jianjun; Lu, Jie; Lian, Gewei; Zhang, Jingping; Hecht, Jonathan L.; Sheen, Volney L.			Filamin B Regulates Chondrocyte Proliferation and Differentiation through Cdk1 Signaling	PLOS ONE			English	Article							CELL-CYCLE; INDIAN-HEDGEHOG; SKELETAL DEVELOPMENT; BONE-GROWTH; STEM-CELLS; MUTATIONS; CARTILAGE; MITOSIS; BINDING; FLNB	Humans who harbor loss of function mutations in the actin-associated filamin B (FLNB) gene develop spondylocarpotarsal syndrome (SCT), a disorder characterized by dwarfism (delayed bone formation) and premature fusion of the vertebral, carpal and tarsal bones (premature differentiation). To better understand the cellular and molecular mechanisms governing these seemingly divergent processes, we generated and characterized FlnB knockdown ATDC5 cell lines. We found that FlnB knockdown led to reduced proliferation and enhanced differentiation in chondrocytes. Within the shortened growth plate of postnatal FlnB(-/-) mice long bone, we observed a similarly progressive decline in the number of rapidly proliferating chondrocytes and premature differentiation characterized by an enlarged prehypertrophic zone, a widened Col2a1(+)/Col10a1(+) overlapping region, but relatively reduced hypertrophic zone length. The reduced chondrocyte proliferation and premature differentiation were, in part, attributable to enhanced G2/M phase progression, where fewer FlnB deficient ATDC5 chondrocytes resided in the G2/M phase of the cell cycle. FlnB loss reduced Cdk1 phosphorylation (an inhibitor of G2/M phase progression) and Cdk1 inhibition in chondrocytes mimicked the null FlnB, premature differentiation phenotype, through a beta 1-integrin receptor-Pi3k/Akt (a key regulator of chondrocyte differentiation) mediated pathway. In this context, the early prehypertrophic differentiation provides an explanation for the premature differentiation seen in this disorder, whereas the progressive decline in proliferating chondrocytes would ultimately lead to reduced chondrocyte production and shortened bone length. These findings begin to define a role for filamin proteins in directing both cell proliferation and differentiation through indirect regulation of cell cycle associated proteins.	[Hu, Jianjun; Lu, Jie; Lian, Gewei; Zhang, Jingping; Sheen, Volney L.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Hu, Jianjun; Lu, Jie; Lian, Gewei; Zhang, Jingping; Hecht, Jonathan L.; Sheen, Volney L.] Harvard Univ, Sch Med, Boston, MA USA; [Hecht, Jonathan L.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Sheen, VL (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.	vsheen@bidmc.harvard.edu	Zhang, Jingping/ABA-4179-2020	Zhang, Jingping/0000-0002-7800-9617; Lu, Jie/0000-0001-6843-9720	National Institutes of Health [NS063997-01]; Empire State Stem Cell Fund [the New York State Department of Health] [C024324]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063997, R01NS092062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Empire State Stem Cell Fund [the New York State Department of Health]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the National Institutes of Health [NS063997-01 to VLS]. This work was also supported in part by the Empire State Stem Cell Fund [the New York State Department of Health Contract # C024324 to VLS]. The opinions expressed here are solely those of the authors and do not necessarily reflect those of the Empire State Stem Cell Board, the New York State Department of Health, or the State of New York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreani A, 1996, ANTICANCER RES, V16, P3585; Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; Berdnik D, 2002, CURR BIOL, V12, P640, DOI 10.1016/S0960-9822(02)00766-2; Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198; Bicknell LS, 2007, J MED GENET, V44, P89, DOI 10.1136/jmg.2006.043687; Bicknell LS, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029967; Calder A, 2013, STEM CELLS DEV, V22, P279, DOI 10.1089/scd.2012.0168; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Farrington-Rock C, 2008, HUM MOL GENET, V17, P631, DOI 10.1093/hmg/ddm188; Farrington-Rock C, 2006, HUM MUTAT, V27, P705, DOI 10.1002/humu.20348; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Irniger S, 2002, FEBS LETT, V532, P7, DOI 10.1016/S0014-5793(02)03657-8; James CG, 2005, MOL BIOL CELL, V16, P5316, DOI 10.1091/mbc.E05-01-0084; Kita K, 2008, GENES CELLS, V13, P839, DOI 10.1111/j.1365-2443.2008.01209.x; Krakow D, 2004, NAT GENET, V36, P405, DOI 10.1038/ng1319; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; LEFEBVRE V, 1994, MATRIX BIOL, V14, P329, DOI 10.1016/0945-053X(94)90199-6; Leise WF, 2002, DEV BIOL, V249, P156, DOI 10.1006/dbio.2002.0743; Lian GW, 2012, J NEUROSCI, V32, P7672, DOI 10.1523/JNEUROSCI.0894-12.2012; Loeser RF, 2000, BIORHEOLOGY, V37, P109; Loo DT, 1998, J BIOL CHEM, V273, P23304, DOI 10.1074/jbc.273.36.23304; Lu J, 2007, HUM MOL GENET, V16, P1661, DOI 10.1093/hmg/ddm114; Lunstrum GP, 1999, J HISTOCHEM CYTOCHEM, V47, P1, DOI 10.1177/002215549904700101; MacPherson M, 2010, AM J PHYSIOL-CELL PH, V298, pC206, DOI 10.1152/ajpcell.00505.2009; Meech R, 2005, DEVELOPMENT, V132, P2135, DOI 10.1242/dev.01811; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; PINES J, 1991, CELL GROWTH DIFFER, V2, P305; Razinia Z, 2011, J CELL SCI, V124, P2631, DOI 10.1242/jcs.084343; REICHENBERGER E, 1991, DEV BIOL, V148, P562, DOI 10.1016/0012-1606(91)90274-7; Reichert H, 2011, RESULTS PROBL CELL D, V53, P529, DOI 10.1007/978-3-642-19065-0_21; SARTOR H, 1992, GENOMICS, V13, P911, DOI 10.1016/0888-7543(92)90190-4; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sebastian A, 2011, J ORTHOP RES, V29, P375, DOI 10.1002/jor.21262; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Yoshida CA, 2002, NAT GENET, V32, P633, DOI 10.1038/ng1015; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Zheng L, 2007, J CELL BIOL, V178, P121, DOI 10.1083/jcb.200703113; Zhou X, 2007, P NATL ACAD SCI USA, V104, P3919, DOI 10.1073/pnas.0608360104	43	5	5	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89352	10.1371/journal.pone.0089352	http://dx.doi.org/10.1371/journal.pone.0089352			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551245	gold, Green Submitted, Green Published			2022-12-27	WOS:000331271500109
J	Lu, QY; Zhao, L; Li, DM; Hao, DQ; Zhan, Y; Li, WB				Lu, Qingyao; Zhao, Lin; Li, Dongmei; Hao, Diqiu; Zhan, Yong; Li, Wenbin			A GMRAV Ortholog Is Involved in Photoperiod and Sucrose Control of Flowering Time in Soybean	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; LOCUS-T; SUGAR; GENE; EXPRESSION; MUTANTS; PHOTOSYNTHESIS; TRANSCRIPTION; SIGNALS; GLUCOSE	Photoperiod and sucrose levels play a key role in the control of flowering. GmRAV reflected a diurnal rhythm with the highest expression at 4 h after the beginning of a dark period in soybean leaves, and was highly up-regulated under shortday (SD) conditions, despite of not following a diurnal pattern under long-day (LD) conditions. GmRAV-i (GmRAV-inhibition) transgenic soybean exhibited early flowering phenotype. Two of the FT Arabidopsis homologs, GmFT2a and GmFT5a, were highly expressed in the leaves of soybeans with inhibition (-i) of GmRAV under SD conditions. Moreover, the transcript levels of the two FT homologs in GmRAV-i soybeans were more sensitive to SD conditions than LD conditions compared to the WT plant. GmRAV-i soybeans and Arabidopsis rav mutants showed more sensitive hypocotyl elongation responses when compared with wild-type seedlings, and GmRAV-ox overevpressed in tobacco revealed no sensitive changes in hypocotyl length. These indicated that GmRAV was a novel negative regulator of SD-mediated flowering and hypocotyl elongation. Although sucrose has been suggested to promote flowering induction in many plant species, high concentration of sucrose (4% [w/v]) applied into media defer flowering time in Arabidopsis wild-type and rav mutant. This delayed flowering stage might be caused by reduction of LEAFY expression. Furthermore, Arabidopsis rav mutants and GmRAV-i soybean plants were less sensitive to sucrose by the inhibition assays of hypocotyls and roots growth. In contrast, transgenic GmRAV overexpressing (-ox) tobacco plants displayed more sensitivity to sucrose. In conclusion, GmRAV was inferred to have a fundamental function in photoperiod, darkness, and sucrose signaling responses to regulate plant development and flowering induction.	[Lu, Qingyao; Zhao, Lin; Li, Dongmei; Hao, Diqiu; Li, Wenbin] Northeast Agr Univ, Key Lab Biol & Genet & Breeding Soybean Northeast, Minist Agr, Key Lab Soybean Biol,Chinese Educ Minist, Harbin, Peoples R China; [Zhan, Yong] Agr Acad Shi He Zi, Shihezi City, Xinjiang Provin, Peoples R China	Ministry of Agriculture & Rural Affairs; Northeast Agricultural University - China	Zhao, L (corresponding author), Northeast Agr Univ, Key Lab Biol & Genet & Breeding Soybean Northeast, Minist Agr, Key Lab Soybean Biol,Chinese Educ Minist, Harbin, Peoples R China.	zhaolinneau@126.com; wenbinli@neau.edu.cn			National Core Soybean Genetic Engineering Project [2013ZX08004-1 003]; Chinese National Natural Science Foundation [31271748, 60932008, 31101169, 31201227]; National 973 Project [2012CB126311]; National 863 Project [2013AA102602, 2012AA101106-1-9]; Chinese Key Projects of Soybean Transformation [2013ZX08004-005]; Provincial/National Education Ministry project [1252G014, 1252-NCET-005, 20122325120012]; Provincial/National Education Ministry; Youth Backbone Research program of Provincial Education Department [1253G010]	National Core Soybean Genetic Engineering Project; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National 973 Project(National Basic Research Program of China); National 863 Project(National High Technology Research and Development Program of China); Chinese Key Projects of Soybean Transformation; Provincial/National Education Ministry project; Provincial/National Education Ministry; Youth Backbone Research program of Provincial Education Department	This study was conducted in the Key Laboratory of Soybean Biology of Chinese Education Ministry, Soybean Research & Development Center, CARS and the key Laboratory of Northeastern Soybean Biology and Breeding/Genetics of Chinese Agriculture Ministry, financially supported by National Core Soybean Genetic Engineering Project (Contract No. 2013ZX08004-1 003), Chinese National Natural Science Foundation (31271748, 60932008, 31101169, 31201227), National 973 Project (2012CB126311), National 863 Project (2013AA102602, 2012AA101106-1-9), Chinese Key Projects of Soybean Transformation (2013ZX08004-005), Provincial/National Education Ministry project (1252G014, 1252-NCET-005, 20122325120012), and Provincial/National Education Ministry for the team of soybean molecular design. Youth Backbone Research program of Provincial Education Department (1253G010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Amasino RM, 1996, CURR OPIN GENET DEV, V6, P480, DOI 10.1016/S0959-437X(96)80071-2; BERNIER G, 1993, PLANT CELL, V5, P1147, DOI 10.1105/tpc.5.10.1147; Boxall SF, 1997, PLANT PHYSIOL, V114, pS247; Castillejo C, 2008, CURR BIOL, V18, P1338, DOI 10.1016/j.cub.2008.07.075; CHEN MH, 1994, PLANT J, V6, P625, DOI 10.1046/j.1365-313X.1994.6050625.x; Corbesier L, 1998, PLANTA, V206, P131, DOI 10.1007/s004250050383; COUPLAND G, 1995, TRENDS GENET, V11, P393, DOI 10.1016/S0168-9525(00)89122-2; Dangl JL, 1995, CELL, V83, P1071, DOI 10.1016/0092-8674(95)90134-5; Destro D., 2001, Crop Breeding and Applied Biotechnology, V1, P72; Dijkwel PP, 1997, PLANT CELL, V9, P583, DOI 10.1105/tpc.9.4.583; HADLEY P, 1984, ANN BOT-LONDON, V53, P669, DOI 10.1093/oxfordjournals.aob.a086732; Heyer AG, 2004, PLANT J, V39, P161, DOI 10.1111/j.1365-313X.2004.02124.x; Hiraoka K, 2008, PLANT MORPHOL, V19, P3; Huang HR, 2012, NEW PHYTOL, V194, P676, DOI 10.1111/j.1469-8137.2012.04101.x; JEFFERSON RA, 1987, EMBO J, V6, P3901; King RW, 2012, RUSS J PLANT PHYSL+, V59, P479, DOI 10.1134/S1021443712040061; Komeda Y, 2004, ANNU REV PLANT BIOL, V55, P521, DOI 10.1146/annurev.arplant.55.031903.141644; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Koornneef M, 1998, ANNU REV PLANT PHYS, V49, P345, DOI 10.1146/annurev.arplant.49.1.345; Koornneef M, 1998, GENETICS, V148, P885; Laby RJ, 2000, PLANT J, V23, P587, DOI 10.1046/j.1365-313x.2000.00833.x; Martin T, 1997, PLANT J, V11, P53, DOI 10.1046/j.1365-313X.1997.11010053.x; Mita S, 1997, PLANT J, V11, P841, DOI 10.1046/j.1365-313X.1997.11040841.x; Moreno-Cortes A, 2012, NEW PHYTOL, V194, P83, DOI 10.1111/j.1469-8137.2011.04023.x; Ohto M, 2001, PLANT PHYSIOL, V127, P252, DOI 10.1104/pp.127.1.252; Osnato M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1810; Pego JV, 2000, J EXP BOT, V51, P407, DOI 10.1093/jexbot/51.suppl_1.407; Pineiro M, 1998, PLANT PHYSIOL, V117, P1, DOI 10.1104/pp.117.1.1; PRIEM B, 1992, PLANT PHYSIOL, V98, P399, DOI 10.1104/pp.98.1.399; Roldan M, 1999, PLANT J, V20, P581, DOI 10.1046/j.1365-313X.1999.00632.x; Rolland F, 2002, PLANT CELL, V14, pS185, DOI 10.1105/tpc.010455; Rolland F, 2001, TRENDS BIOCHEM SCI, V26, P310, DOI 10.1016/S0968-0004(01)01805-9; Rook F, 2003, J EXP BOT, V54, P495, DOI 10.1093/jxb/erg054; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Sheen J, 1999, CURR OPIN PLANT BIOL, V2, P410, DOI 10.1016/S1369-5266(99)00014-X; SHEEN J, 1990, PLANT CELL, V2, P1027, DOI 10.1105/tpc.2.10.1027; SHEEN J, 1994, PHOTOSYNTH RES, V39, P427, DOI 10.1007/BF00014596; Shibuya N, 2001, PHYSIOL MOL PLANT P, V59, P223, DOI 10.1006/pmpp.2001.0364; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Stevenson CC, 2009, PLANT GROWTH REGUL, V59, P255, DOI 10.1007/s10725-009-9412-x; Tsuji H, 2008, RICE, V1, P25, DOI 10.1007/s12284-008-9005-8; YORK WS, 1984, PLANT PHYSIOL, V75, P295, DOI 10.1104/pp.75.2.295; Zhang LX, 2001, AGRON J, V93, P944, DOI 10.2134/agronj2001.934944x; Zhao L, 2008, PLANTA, V227, P1389, DOI 10.1007/s00425-008-0711-7; Zhao L, 2012, J EXP BOT, V63, P3257, DOI 10.1093/jxb/ers056; Zhou L, 1998, P NATL ACAD SCI USA, V95, P10294, DOI 10.1073/pnas.95.17.10294	47	23	27	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89145	10.1371/journal.pone.0089145	http://dx.doi.org/10.1371/journal.pone.0089145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551235	Green Published, gold, Green Submitted			2022-12-27	WOS:000331271500101
J	Wilson, CB; Ebenezer, PJ; McLaughlin, LD; Francis, J				Wilson, C. Brad; Ebenezer, Philip J.; McLaughlin, Leslie D.; Francis, Joseph			Predator Exposure/Psychosocial Stress Animal Model of Post-Traumatic Stress Disorder Modulates Neurotransmitters in the Rat Hippocampus and Prefrontal Cortex	PLOS ONE			English	Article							TRAUMATIC MEMORY; SEROTONIN; DOPAMINE; NOREPINEPHRINE; PTSD; ANXIETY; SYMPTOMS; AMYGDALA; BINDING; PROTEIN	Post-Traumatic Stress Disorder (PTSD) can develop in response to a traumatic event involving a threat to life. To date, no diagnostic biomarkers have been identified for PTSD. Recent research points toward physiological abnormalities in the hypothalamic-pituitary-adrenal (HPA) axis, sympathoadrenal medullary and immune system that may be implicated in the disorder. The modulation of neurotransmitters is another possible mechanism, but their role in the progression of PTSD is poorly understood. Low serotonin (5-HT) may be a factor, but it may not be the only neurotransmitter affected as modulation affects levels of other neurotransmitters. In this study, we hypothesized the predator exposure/psychosocial stress rodent model of PTSD may alter levels of 5-HT and other neurotransmitters in the rat hippocampus and prefrontal cortex (PFC). Male Sprague-Dawley rats were used in this experiment. We induced PTSD via a predator exposure/psychosocial stress model, whereby rats were placed in a cage with a cat for 1 hour on days 1 and 11 of the 31-day experiment. Rats also received psychosocial stress via daily cage cohort changes. On day 32, the rats were sacrificed and the brains dissected to remove the hippocampus and PFC. Norepinephrine (NE), 5-Hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA), dopamine (DA), and 3,4-Dihydroxyphenylacetic acid (DOPAC), and 5-HT levels in the hippocampus and PFC were measured with high-performance liquid chromatography (HPLC). In the hippocampus, 5-HT and HVA were lower, while NE and DOPAC were higher, in the PTSD group vs. controls. In the PFC, only 5-HT was lower, while NE, DA, and DOPAC were higher, in the PTSD group vs. controls. The rate limiting enzymes tyrosine hydroxylase and tryptophan hydroxylase were also examined and confirmed our findings. These results demonstrate that the predator exposure/psychosocial stress model of PTSD produces neurotransmitter changes similar to those seen in human patients and may cause a heightened noradrenergic response.	[Wilson, C. Brad; Ebenezer, Philip J.; McLaughlin, Leslie D.; Francis, Joseph] Louisiana State Univ, Sch Vet Med, Baton Rouge, LA 70803 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	McLaughlin, LD (corresponding author), Louisiana State Univ, Sch Vet Med, Baton Rouge, LA 70803 USA.	lmclaughlin@vetmed.lsu.edu; jfrancis@vetmed.lsu.edu			LSU SVM corps grant	LSU SVM corps grant	Funding provided via LSU SVM corps grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal D, 2011, BASIC RES CARDIOL, V106, P1069, DOI 10.1007/s00395-011-0231-7; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; ARORA RC, 1993, LIFE SCI, V53, P919, DOI 10.1016/0024-3205(93)90444-8; BLANCHARD RJ, 1975, J COMP PHYSIOL PSYCH, V88, P81, DOI 10.1037/h0076213; Bourin M, 2007, FUND CLIN PHARMACOL, V21, P567, DOI 10.1111/j.1472-8206.2007.00526.x; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Butts KA, 2011, P NATL ACAD SCI USA, V108, P18459, DOI 10.1073/pnas.1111746108; Cabib S, 2012, NEUROSCI BIOBEHAV R, V36, P79, DOI 10.1016/j.neubiorev.2011.04.012; Berumen LC, 2012, SCI WORLD J, DOI 10.1100/2012/823493; Dansie EJ, 2012, PSYCHOSOMATICS, V53, P250, DOI 10.1016/j.psym.2011.08.007; De Bellis MD, 1999, BIOL PSYCHIAT, V45, P1259, DOI 10.1016/S0006-3223(99)00044-X; Delamothe T, 2005, BRIT MED J, V331, P1489, DOI 10.1136/bmj.331.7531.1489; Deyama S, 2008, J NEUROSCI, V28, P7728, DOI 10.1523/JNEUROSCI.1480-08.2008; Diamond David M., 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/60803; DUBOVSKY SL, 1994, J CLIN PSYCHIAT, V55, P34; Edmondson D, 2013, PROG CARDIOVASC DIS, V55, P548, DOI 10.1016/j.pcad.2013.03.004; FINLAY JM, 1995, NEUROSCIENCE, V64, P619, DOI 10.1016/0306-4522(94)00331-X; Fisher PM, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-2; FRANCIS GS, 1993, CIRCULATION, V87, P40; GANGULY PK, 1986, CIRC RES, V59, P684, DOI 10.1161/01.RES.59.6.684; Geracioti TD, 2001, AM J PSYCHIAT, V158, P1227, DOI 10.1176/appi.ajp.158.8.1227; Geracioti TD, 2013, J PSYCHIATR RES, V47, P995, DOI 10.1016/j.jpsychires.2013.01.023; Glover DA, 2003, BEHAV BRAIN RES, V144, P137, DOI 10.1016/S0166-4328(03)00074-3; Gupta MA, 2013, INT REV PSYCHIATR, V25, P86, DOI 10.3109/09540261.2012.736367; Jurgens CWD, 2005, J PHARMACOL EXP THER, V314, P552, DOI 10.1124/jpet.105.085332; Liberzon I, 1999, NEUROPSYCHOPHARMACOL, V21, P40, DOI 10.1016/S0893-133X(98)00128-6; Joca SRL, 2007, STRESS, V10, P227, DOI 10.1080/10253890701223130; Lukaschek K, 2013, J PSYCHOSOM RES, V74, P340, DOI 10.1016/j.jpsychores.2012.12.011; Muldoon MF, 2004, J CLIN ENDOCR METAB, V89, P266, DOI 10.1210/jc.2003-031295; Nemeroff CB, 2006, J PSYCHIATR RES, V40, P1, DOI 10.1016/j.jpsychires.2005.07.005; Oosthuizen Frasia, 2005, Neuropsychiatr Dis Treat, V1, P109, DOI 10.2147/nedt.1.2.109.61049; Paterlini M, 2005, NAT NEUROSCI, V8, P1586, DOI 10.1038/nn1562; Peirson AR, 2000, PSYCHOL REP, V87, P707, DOI 10.2466/PR0.87.7.707-716; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Sondergaard HP, 2004, CLIN CHIM ACTA, V342, P93, DOI 10.1016/j.cccn.2003.12.019; Southwick S M, 1999, Semin Clin Neuropsychiatry, V4, P242; Williams E, 2006, BIOL PSYCHOL, V71, P171, DOI 10.1016/j.biopsycho.2005.03.002; Wilson CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076146; YEHUDA R, 1992, J NERV MENT DIS, V180, P321, DOI 10.1097/00005053-199205000-00006; Zhang ZG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054129, 10.1371/journal.pone.0056344, 10.1371/journal.pone.0054577, 10.1371/journal.pone.0065268]; Zoladz PR, 2012, PSYCHONEUROENDOCRINO, V37, P1531, DOI 10.1016/j.psyneuen.2012.02.007; Zoladz PR, 2008, STRESS, V11, P259, DOI 10.1080/10253890701768613; Zoladz PR, 2013, PROG NEURO-PSYCHOPH, V44, P1, DOI 10.1016/j.pnpbp.2013.01.001	43	72	77	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89104	10.1371/journal.pone.0089104	http://dx.doi.org/10.1371/journal.pone.0089104			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551226	Green Published, Green Submitted, gold			2022-12-27	WOS:000331271500098
J	Liao, JY; Hu, N; Zhou, NA; Lin, LB; Zhao, C; Yi, SX; Fan, TX; Bao, W; Liang, X; Chen, H; Xu, W; Chen, C; Cheng, Q; Zeng, YM; Si, WK; Yang, Z; Huang, W				Liao, Junyi; Hu, Ning; Zhou, Nian; Lin, Liangbo; Zhao, Chen; Yi, Shixiong; Fan, Tingxu; Bao, Wei; Liang, Xi; Chen, Hong; Xu, Wei; Chen, Cheng; Cheng, Qiang; Zeng, Yongming; Si, Weike; Yang, Zhong; Huang, Wei			Sox9 Potentiates BMP2-Induced Chondrogenic Differentiation and Inhibits BMP2-Induced Osteogenic Differentiation (Publication with Expression of Concern. See vol. 16, 2021) (Publication with Expression of Concern. See vol. 16, 2021)	PLOS ONE			English	Article; Publication with Expression of Concern							MESENCHYMAL STEM-CELLS; MEDIATED GENE-TRANSFER; ENDOCHONDRAL OSSIFICATION; CARTILAGE DEVELOPMENT; TRANSCRIPTION FACTOR; BONE; GROWTH; RUNX2; CHONDROCYTES; EXPRESSION	Bone morphogenetic protein 2 (BMP2) is one of the key chondrogenic growth factors involved in the cartilage regeneration. However, it also exhibits osteogenic abilities and triggers endochondral ossification. Effective chondrogenesis and inhibition of BMP2-induced osteogenesis and endochondral ossification can be achieved by directing the mesenchymal stem cells (MSCs) towards chondrocyte lineage with chodrogenic factors, such as Sox9. Here we investigated the effects of Sox9 on BMP2-induced chondrogenic and osteogenic differentiation of MSCs. We found exogenous overexpression of Sox9 enhanced the BMP2-induced chondrogenic differentiation of MSCs in vitro. Also, it inhibited early and late osteogenic differentiation of MSCs in vitro. Subcutaneous stem cell implantation demonstrated Sox9 potentiated BMP2-induced cartilage formation and inhibited endochondral ossification. Mouse limb cultures indicated that BMP2 and Sox9 acted synergistically to stimulate chondrocytes proliferation, and Sox9 inhibited BMP2-induced chondrocytes hypertrophy and ossification. This study strongly suggests that Sox9 potentiates BMP2-induced MSCs chondrogenic differentiation and cartilage formation, and inhibits BMP2-induced MSCs osteogenic differentiation and endochondral ossification. Thus, exogenous overexpression of Sox9 in BMP2-induced mesenchymal stem cells differentiation may be a new strategy for cartilage tissue engineering.	[Liao, Junyi; Hu, Ning; Zhou, Nian; Lin, Liangbo; Zhao, Chen; Yi, Shixiong; Fan, Tingxu; Bao, Wei; Chen, Hong; Xu, Wei; Chen, Cheng; Cheng, Qiang; Huang, Wei] Chongqing Med Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Chongqing, Peoples R China; [Zeng, Yongming] Chongqing Med Univ, Affiliated Hosp 1, Dept Radiol, Chongqing, Peoples R China; [Si, Weike; Yang, Zhong] Third Mil Med Univ, Dept Clin Hematol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Army Medical University	Huang, W (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Chongqing, Peoples R China.	huangwei68@263.net	Junyi, Liao/AAP-9076-2020; CHEN, Hong/AAC-7879-2019	CHEN, Hong/0000-0002-4152-624X; Cheng, Chen/0000-0002-8767-7895	National Natural Science Foundation of China [81371972, 31070875]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (grant81371972 and 31070875). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2008, MOD RHEUMATOL, V18, P213, DOI 10.1007/s10165-008-0048-x; An CH, 2010, ANN BIOMED ENG, V38, P1647, DOI 10.1007/s10439-009-9892-x; Augello A, 2010, EUR CELLS MATER, V20, P121; Bakker AC, 2001, OSTEOARTHR CARTILAGE, V9, P128, DOI 10.1053/joca.2000.0368; Benthien JP, 2011, KNEE SURG SPORT TR A, V19, P543, DOI 10.1007/s00167-010-1271-5; Cairns DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039642; Cao L, 2011, BIOMATERIALS, V32, P3910, DOI 10.1016/j.biomaterials.2011.02.014; Chen HM, 2009, J ORTHOP RES, V27, P1432, DOI 10.1002/jor.20905; Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Chun JS, 2008, BMB REP, V41, P485, DOI 10.5483/BMBRep.2008.41.7.485; Cucchiarini M, 2012, J MOL MED; Cucchiarini M, 2011, TISSUE ENG PT A, V17, P1921, DOI [10.1089/ten.tea.2011.0018, 10.1089/ten.TEA.2011.0018]; Danisovic L, 2012, TISSUE CELL, V44, P69, DOI 10.1016/j.tice.2011.11.005; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Dhinsa BS, 2012, CURR STEM CELL RES T, V7, P143; Ding M, 2012, J CELL PHYSIOL, V227, P3446, DOI 10.1002/jcp.24045; Dy P, 2012, DEV CELL, V22, P597, DOI 10.1016/j.devcel.2011.12.024; Garza-Veloz I, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4260; Guerit D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062582; Handorf AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022887; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hollander AP, 2010, STEM CELLS, V28, P1992, DOI 10.1002/stem.534; Hu N, 2013, CELL PHYSIOL BIOCHEM, V32, P486, DOI 10.1159/000354453; Hu N, 2013, J CELL SCI, V126, P532, DOI 10.1242/jcs.114231; Ikeda T, 2004, ARTHRITIS RHEUM-US, V50, P3561, DOI 10.1002/art.20611; Jang WG, 2012, J BIOL CHEM, V287, P905, DOI 10.1074/jbc.M111.253187; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kao YJ, 2011, PHYSICIAN SPORTSMED, V39, P60, DOI 10.3810/psm.2011.11.1940; Kawato Y, 2011, BIOCHEM BIOPH RES CO, V416, P205, DOI 10.1016/j.bbrc.2011.11.026; Keller B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016421; Kim EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055296; Kurth T, 2007, OSTEOARTHR CARTILAGE, V15, P1178, DOI 10.1016/j.joca.2007.03.015; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Lengner CJ, 2004, J CELL PHYSIOL, V200, P327, DOI 10.1002/jcp.20118; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Lin L, 2011, MOL THER, V19, P1426, DOI 10.1038/mt.2011.101; Longo UG, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/168385; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Mahmoudifar N, 2010, BIOMATERIALS, V31, P3858, DOI 10.1016/j.biomaterials.2010.01.090; Matricali GA, 2010, ACTA ORTHOP BELG, V76, P669; Mi Z, 2003, ARTHRITIS RES THER, V5, pR132, DOI 10.1186/ar745; Nishimura R, 2012, FRONT BIOSCI-LANDMRK, V17, P2657, DOI 10.2741/4076; Nishimura R, 2012, J BIOCHEM, V151, P247, DOI 10.1093/jb/mvs004; Pan QH, 2008, J CELL PHYSIOL, V217, P228, DOI 10.1002/jcp.21496; Park JS, 2011, BIOMATERIALS, V32, P3679, DOI 10.1016/j.biomaterials.2011.01.063; Pelttari K, 2008, INJURY, V39, pS58, DOI 10.1016/j.injury.2008.01.038; Prockop DJ, 2010, J CELL MOL MED, V14, P2190, DOI 10.1111/j.1582-4934.2010.01151.x; Rodriguez-Merchan EC, 2012, RHEUMATOL INT; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Shintani N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053086; Steinert AF, 2008, INJURY, V39, pS97, DOI 10.1016/j.injury.2008.01.034; Steinert AF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2195; Venkatesan JK, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt113; Wang JH, 2013, BONE, V57, P311, DOI 10.1016/j.bone.2013.08.015; Wang Y, 2013, DEV BIOL, V381, P301, DOI 10.1016/j.ydbio.2013.07.016; Woo EJ, 2013, CLIN ORTHOP RELAT R, V471, P1707, DOI 10.1007/s11999-012-2684-x; Yamashita S, 2009, EXP CELL RES, V315, P2231, DOI 10.1016/j.yexcr.2009.03.008; Yang HN, 2011, BIOMATERIALS, V32, P7695, DOI 10.1016/j.biomaterials.2011.06.059; Yoon BS, 2004, J CELL BIOCHEM, V93, P93, DOI 10.1002/jcb.20211; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Yu L, 2012, DEV BIOL, V372, P263, DOI 10.1016/j.ydbio.2012.09.021; Yu YY, 2010, BONE, V47, P65, DOI 10.1016/j.bone.2010.03.012	63	47	54	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89025	10.1371/journal.pone.0089025	http://dx.doi.org/10.1371/journal.pone.0089025			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551211	Green Published, gold, Green Submitted			2022-12-27	WOS:000331266000092
J	Charitos, EI; Ziegler, PD; Stierle, U; Robinson, DR; Graf, B; Sievers, HH; Hanke, T				Charitos, Efstratios I.; Ziegler, Paul D.; Stierle, Ulrich; Robinson, Derek R.; Graf, Bernhard; Sievers, Hans-Hinrich; Hanke, Thorsten			How Often Should We Monitor for Reliable Detection of Atrial Fibrillation Recurrence? Efficiency Considerations and Implications for Study Design	PLOS ONE			English	Article							SURGICAL ABLATION; FOLLOW-UP; MANAGEMENT; CATHETER; TRIAL; ACCURACY; EPISODES; TIME	Objective: Although atrial fibrillation (AF) recurrence is unpredictable in terms of onset and duration, current intermittent rhythm monitoring (IRM) diagnostic modalities are short-termed and discontinuous. The aim of the present study was to investigate the necessary IRM frequency required to reliably detect recurrence of various AF recurrence patterns. Methods: The rhythm histories of 647 patients (mean AF burden: 12 +/- 22% of monitored time; 687 patient-years) with implantable continuous monitoring devices were reconstructed and analyzed. With the use of computationally intensive simulation, we evaluated the necessary IRM frequency to reliably detect AF recurrence of various AF phenotypes using IRM of various durations. Results: The IRM frequency required for reliable AF detection depends on the amount and temporal aggregation of the AF recurrence (p<0.0001) as well as the duration of the IRM (p<0.001). Reliable detection (>95% sensitivity) of AF recurrence required higher IRM frequencies (>12 24-hour; >6 7-day; >4 14-day; >3 30-day IRM per year; p<0.0001) than currently recommended. Lower IRM frequencies will under-detect AF recurrence and introduce significant bias in the evaluation of therapeutic interventions. More frequent but of shorter duration, IRMs (24-hour) are significantly more time effective (sensitivity per monitored time) than a fewer number of longer IRM durations (p<0.0001). Conclusions: Reliable AF recurrence detection requires higher IRM frequencies than currently recommended. Current IRM frequency recommendations will fail to diagnose a significant proportion of patients. Shorter duration but more frequent IRM strategies are significantly more efficient than longer IRM durations.	[Charitos, Efstratios I.; Stierle, Ulrich; Graf, Bernhard; Sievers, Hans-Hinrich; Hanke, Thorsten] Med Univ Lubeck, Dept Cardiac & Thorac Vasc Surg, D-23538 Lubeck, Germany; [Ziegler, Paul D.] Medtronic Inc, Minneapolis, MN USA; [Robinson, Derek R.] Univ Sussex, Sch Math & Phys Sci, Dept Math, Brighton, E Sussex, England	University of Lubeck; Medtronic; University of Sussex	Charitos, EI (corresponding author), Med Univ Lubeck, Dept Cardiac & Thorac Vasc Surg, D-23538 Lubeck, Germany.	efstratios.charitos@gmail.com	Charitos, Efstratios/AAG-2005-2020		AWS WA, USA (Education Coursework Grant) [EDU_Charitos_ULuebeckResearch_Fall2012]	AWS WA, USA (Education Coursework Grant)	The computational resources for this work were kindly provided by AWS WA, USA (Education Coursework Grant Award: EDU_Charitos_ULuebeckResearch_Fall2012). The grant donor had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, R LANG ENV STAT COMP; Calkins H, 2012, J INTERV CARD ELECTR, V33, P171, DOI 10.1007/s10840-012-9672-7; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Charitos EI, 2012, CIRCULATION, V126, P806, DOI 10.1161/CIRCULATIONAHA.112.098079; Charitos EI., 2013, ACP-APPL CARDIOPUL P, V17, P3; Crossley GH, 2011, J AM COLL CARDIOL, V57, P1181, DOI 10.1016/j.jacc.2010.12.012; Fusaro VA, 2013, CIRCULATION, V127, P517, DOI 10.1161/CIRCULATIONAHA.112.123034; Fusaro VA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002147; Hanke T, 2009, CIRCULATION, V120, pS177, DOI 10.1161/CIRCULATIONAHA.108.838474; Henry L, 2010, INNOVATIONS, V5, P259, DOI 10.1097/IMI.0b013e3181ee5b42; Hindricks G, 2010, CIRC-ARRHYTHMIA ELEC, V3, P141, DOI 10.1161/CIRCEP.109.877852; Kaemmerer WF, 2001, J CARDIOVASC ELECTR, V12, P121, DOI 10.1046/j.1540-8167.2001.00121.x; Kamel H, 2013, STROKE, V44, P528, DOI 10.1161/STROKEAHA.112.679100; Kirchhof P, 2007, EUR HEART J, V28, P2803, DOI 10.1093/eurheartj/ehm358; Kottkamp H, 2004, J AM COLL CARDIOL, V44, P869, DOI 10.1016/j.jacc.2004.047.049; Passman RS, 2004, J CARDIOVASC ELECTR, V15, P773, DOI 10.1046/j.1540-8167.2004.03537.x; Purerfellner H, 2004, PACE, V27, P983, DOI 10.1111/j.1540-8159.2004.00569.x; Rosenberg MA, 2013, PACE, V36, P328, DOI 10.1111/pace.12053; Senatore G, 2005, J AM COLL CARDIOL, V45, P873, DOI 10.1016/j.jacc.2004.11.050; Strickberger SA, 2005, HEART RHYTHM, V2, P125, DOI 10.1016/j.hrthm.2004.10.042; Vasamreddy CR, 2006, J CARDIOVASC ELECTR, V17, P134, DOI 10.1111/j.1540-8167.2006.00359.x; Verma A, 2013, JAMA INTERN MED, V173, P149, DOI 10.1001/jamainternmed.2013.1561; Ziegler PD, 2006, HEART RHYTHM, V3, P1445, DOI 10.1016/j.hrthm.2006.07.030	23	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e89022	10.1371/journal.pone.0089022	http://dx.doi.org/10.1371/journal.pone.0089022			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24563690	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600128
J	Ives, JA; van Wijk, EPA; Bat, N; Crawford, C; Walter, A; Jonas, WB; van Wijk, R; van der Greef, J				Ives, John A.; van Wijk, Eduard P. A.; Bat, Namuun; Crawford, Cindy; Walter, Avi; Jonas, Wayne B.; van Wijk, Roeland; van der Greef, Jan			Ultraweak Photon Emission as a Non-Invasive Health Assessment: A Systematic Review	PLOS ONE			English	Review							YEAST SACCHAROMYCES-CEREVISIAE; SPONTANEOUS CHEMI-LUMINESCENCE; OXIDATIVE RADICAL REACTIONS; BIOPHOTON EMISSION; WEAK CHEMILUMINESCENCE; MITOGENETIC RADIATION; HUMAN SKIN; IN-VIVO; ANATOMIC CHARACTERIZATION; MULTIPLE-SCLEROSIS	We conducted a systematic review (SR) of the peer reviewed scientific literature on ultraweak photon emissions (UPE) from humans. The question was: Can ultraweak photon emissions from humans be used as a non-invasive health assessment? A systematic search was conducted across eight relevant databases: PubMed/MEDLINE, BIOSIS, CINAHL, PSYCHINFO, All of Cochrane EBM databases, GIDEON, DoD Biomedical Research, and clinicaltrials.gov from database inception to October 2011. Of the 1315 studies captured by the search strategy, 56 met the inclusion criteria, out of which 1 was a RCT, 27 were CCT, and 28 were observational and descriptive studies. There were no systematic reviews/meta-analyses that fit the inclusion criteria. In this report, the authors provide an assessment of the quality of the RCT included; describe the characteristics of all the included studies, the outcomes assessed, and the effectiveness of photon emission as a potential health assessment tool. This report demonstrates that the peer reviewed literature on UPE and human UPE measurement in particular is surprisingly large. Most of the human UPE literature is of good to high quality based on our systematic evaluation. However, an evaluation tool for systematically evaluating this type of "bio-evaluation" methodology is not currently available and would be worth developing. Publications in the peer reviewed literature over the last 50 years demonstrate that the use of "off-the-shelf" technologies and well described methodologies for the detection of human photon emissions are being used on a regular basis in medical and research settings. The overall quality of this literature is good and the use of this approach for determining inflammatory and oxidative states of patients indicate the growing use and value of this approach as both a medical and research tool.	[Ives, John A.; Bat, Namuun; Crawford, Cindy; Walter, Avi; Jonas, Wayne B.] Samueli Inst, Alexandria, VA USA; [van Wijk, Eduard P. A.; van der Greef, Jan] Leiden Univ, Leiden Acad Ctr Drug Res, Div Analyt Biosci, Netherlands Metabol Ctr, Leiden, Netherlands; [van Wijk, Eduard P. A.; van Wijk, Roeland; van der Greef, Jan] Leiden Univ, Ctr Photon Living Syst, Sino Dutch Ctr Prevent & Personalized Med, Leiden, Netherlands; [van Wijk, Eduard P. A.; van Wijk, Roeland] Meluna Res, Amersfoort, Netherlands; [van der Greef, Jan] Netherlands Org Appl Sci Res, Zeist, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Netherlands Organization Applied Science Research	Ives, JA (corresponding author), Samueli Inst, Alexandria, VA USA.	jives@siib.org	Crawford, Cindy/AAI-3891-2021		Laurance S. Rockefeller Fund; Samueli Institute; Netherlands Genomics Initiative	Laurance S. Rockefeller Fund; Samueli Institute; Netherlands Genomics Initiative	Funding for this project was provided through the Laurance S. Rockefeller Fund, with matching funds from the Samueli Institute. The Netherlands Genomics Initiative is acknowledged for financing the Netherlands Metabolomics Centre and the Sino-Dutch Centre for Preventive and Personalized Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSUMA S, 1992, CLIN CHEM, V38, P48; ALEXEYEV OA, 1994, INFECTION, V22, P281, DOI 10.1007/BF01739917; ALLEN RC, 1981, J INFECT DIS, V144, P344, DOI 10.1093/infdis/144.4.344; ALLEN RC, 1982, ARCH SURG-CHICAGO, V117, P133; ALLEN RC, 1982, ADV EXP MED BIOL, V141, P411; AMANO T, 1990, J UROLOGY, V144, P370, DOI 10.1016/S0022-5347(17)39463-6; Bajpai RP, 2008, J ACUPUNCT MERIDIAN, V1, P114, DOI 10.1016/S2005-2901(09)60031-5; Barbieri ER, 1999, J ANDROL, V20, P713; BENSCHOTEN M M V, 1992, American Journal of Acupuncture, V20, P257; BLAKE DR, 1981, LANCET, V2, P1142; BOVERIS A, 1980, P NATL ACAD SCI-BIOL, V77, P347, DOI 10.1073/pnas.77.1.347; BOVERIS A, 1981, FED PROC, V40, P195; CADENAS E, 1981, EUR J BIOCHEM, V119, P531, DOI 10.1111/j.1432-1033.1981.tb05640.x; CADENAS E, 1984, PHOTOCHEM PHOTOBIOL, V40, P823, DOI 10.1111/j.1751-1097.1984.tb04657.x; Calabrese V, 1998, DRUG EXP CLIN RES, V24, P125; CLARK CJ, 1988, LANCET, V2, P872, DOI 10.1016/S0140-6736(88)92471-3; Cohen S., 2003, Indian Journal of Experimental Biology, V41, P440; DORMANDY TL, 1989, J ROY COLL PHYS LOND, V23, P221; GISLER GC, 1982, PHYSIOL CHEM PHYS M, V14, P335; Goi N, 2007, J HEALTH SCI, V53, P161, DOI 10.1248/jhs.53.161; GRASSO F, 1992, EXPERIENTIA, V48, P10, DOI 10.1007/BF01923595; Hagens R, 2008, SKIN RES TECHNOL, V14, P112, DOI 10.1111/j.1600-0846.2007.00207.x; HALLIWELL B, 1982, CELL BIOL INT REP, V6, P529, DOI 10.1016/0309-1651(82)90175-8; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; HALLIWELL B, 1991, AM J MED, V91, pS14, DOI 10.1016/0002-9343(91)90279-7; HALLIWELL B, 1986, ARCH BIOCHEM BIOPHYS, V246, P501, DOI 10.1016/0003-9861(86)90305-X; HALLIWELL B, 1984, LANCET, V1, P1396; Halliwell B, 2007, FREE RADICAL BIO MED, V1, P331; HAMMANN KP, 1987, J NEUROL, V234, P25, DOI 10.1007/BF00314005; Hans P, 1997, J NEUROSURG ANESTH, V9, P234, DOI 10.1097/00008506-199707000-00006; Ho KJ, 2000, ANN RHEUM DIS, V59, P338, DOI 10.1136/ard.59.5.338; Holzer K, 2010, LANGENBECK ARCH SURG, V395, P643, DOI 10.1007/s00423-009-0557-x; HORAN TD, 1982, CLIN IMMUNOL IMMUNOP, V22, P259, DOI 10.1016/0090-1229(82)90042-3; Hossu M, 2006, J ALTERN COMPLEM MED, V12, P119, DOI 10.1089/acm.2006.12.119; INABA H, 1988, EXPERIENTIA, V44, P550, DOI 10.1007/BF01953302; INABA H, 1982, OPT LASER ENG, V3, P125, DOI 10.1016/0143-8166(82)90006-9; Jain A, 2010, SKIN PHARMACOL PHYS, V23, P266, DOI 10.1159/000314701; Jung HH, 2005, J PHOTOCH PHOTOBIO B, V78, P149, DOI 10.1016/j.jphotobiol.2004.08.002; Jung Hyun-Hee, 2003, Indian Journal of Experimental Biology, V41, P446; Jung Hyun-Hee, 2003, Indian Journal of Experimental Biology, V41, P452; KESHAVARZIAN A, 1992, GASTROENTEROLOGY, V103, P177, DOI 10.1016/0016-5085(92)91111-G; Kim TJ, 2002, ACUPUNCTURE ELECTRO, V27, P85, DOI 10.3727/036012902816026068; Kobayashi M, 2005, Biophotonics: Optical Science and Engineering for the 21st Century, P155, DOI 10.1007/0-387-24996-6_12; Kobayashi M, 1999, J NEUROSCI METH, V93, P163, DOI 10.1016/S0165-0270(99)00140-5; Kobayashi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006256; Koval'chuk LV, 1998, B EXP BIOL MED+, V126, P1035, DOI 10.1007/BF02447314; Laager F, 2008, EUR J APPL PHYSIOL, V102, P463, DOI 10.1007/s00421-007-0607-4; MARTON JJ, 1992, INT ENDOD J, V25, P229; Mayer Michal, 1992, Acta Universitatis Palackianae Olomucensis Facultatis Medicae, V134, P97; METCALF WS, 1967, NATURE, V216, P169, DOI 10.1038/216169a0; Nakamura K, 2005, J PHOTOCH PHOTOBIO B, V80, P156, DOI 10.1016/j.jphotobiol.2005.02.005; Park SH, 2009, J ACUPUNCT MERIDIAN, V2, P40, DOI 10.1016/S2005-2901(09)60014-5; Park YK, 2003, MUTAT RES-FUND MOL M, V529, P77, DOI 10.1016/S0027-5107(03)00109-X; PARNHAM MJ, 1981, AGENTS ACTIONS, V11, P617, DOI 10.1007/BF01978765; QUICKENDEN TI, 1974, BIOCHEM BIOPH RES CO, V60, P764, DOI 10.1016/0006-291X(74)90306-4; QUICKENDEN TI, 1983, PHOTOCHEM PHOTOBIOL, V37, P337, DOI 10.1111/j.1751-1097.1983.tb04482.x; QUICKENDEN TI, 1976, PHOTOCHEM PHOTOBIOL, V23, P201, DOI 10.1111/j.1751-1097.1976.tb07242.x; QUICKENDEN TI, 1985, PHOTOCHEM PHOTOBIOL, V41, P611, DOI 10.1111/j.1751-1097.1985.tb03534.x; Raschke T, 2004, SKIN PHARMACOL PHYS, V17, P200, DOI 10.1159/000078824; Rastogi A, 2010, SKIN RES TECHNOL, V16, P365, DOI 10.1111/j.1600-0846.2010.00442.x; Safronova VG, 2006, B EXP BIOL MED+, V142, P333, DOI 10.1007/s10517-006-0359-x; Safronova VG, 2003, B EXP BIOL MED+, V136, P257, DOI 10.1023/B:BEBM.0000008977.57795.69; Schutgens FWG, 2009, PHYTOTHER RES, V23, P1103, DOI 10.1002/ptr.2753; Scottish Intercollegiate Guidelines Network, 2008, SIGN 50 GUID DEV HDB; Sies H., 1985, OXIDATIVE STRESS; SLAWINSKA D, 1983, PHOTOCHEM PHOTOBIOL, V37, P709, DOI 10.1111/j.1751-1097.1983.tb04544.x; STAUFF J, 1963, NATURE, V198, P281, DOI 10.1038/198281a0; Stauff J, 1962, Z PHYS CHEM, V33, P274; SWINBANKS D, 1986, NATURE, V324, P203, DOI 10.1038/324203a0; Takagi K, 2005, STRESS HEALTH, V21, P263, DOI 10.1002/smi.1064; Takeda M, 2004, CANCER SCI, V95, P656, DOI 10.1111/j.1349-7006.2004.tb03325.x; TARUSOV B N, 1961, Biofizika, V6(4), P490; TARUSOV BN, 1961, RADIOBIOLOGIYA, V1, P150; Terpigorev SA, 2003, B EXP BIOL MED+, V135, P582, DOI 10.1023/A:1025489604819; TILBURY RN, 1988, PHOTOCHEM PHOTOBIOL, V47, P145, DOI 10.1111/j.1751-1097.1988.tb02704.x; TILBURY RN, 1992, EXPERIENTIA, V48, P1030, DOI 10.1007/BF01947991; TNO Quality of Life, 2007, EXPL EARL DIAGN DIAB; Tsai CH, 2004, J BIOMED SCI, V11, P692, DOI 10.1159/000079682; Tsuboi H, 2008, BRAIN BEHAV IMMUN, V22, P209, DOI 10.1016/j.bbi.2007.07.006; Van Wijk EPA, 2008, J ALTERN COMPLEM MED, V14, P241, DOI 10.1089/acm.2007.7185; Van Wijk EPA, 2008, INDIAN J EXP BIOL, V46, P345; Van Wijk EPA, 2010, J PHOTOCH PHOTOBIO B, V98, P199, DOI 10.1016/j.jphotobiol.2010.01.003; Van Wijk EPA, 2006, J ALTERN COMPLEM MED, V12, P31; Van Wijk EPA, 2005, FORSCH KOMP KLAS NAT, V12, P107, DOI 10.1159/000084028; Van Wijk EPA, 2005, FORSCH KOMP KLAS NAT, V12, P96, DOI 10.1159/000083935; Van Wijk R, 2006, J PHOTOCH PHOTOBIO B, V83, P69, DOI 10.1016/j.jphotobiol.2005.12.005; Van Wijk R, 2005, EXPLORE-NY, V1, P102, DOI 10.1016/j.explore.2004.12.003; Van Wijk R, 2008, INDIAN J EXP BIOL, V46, P273; Van Wijk R, 2006, J ALTERN COMPLEM MED, V12, P955, DOI 10.1089/acm.2006.12.955; Van Wijk R, 2006, J PHOTOCH PHOTOBIO B, V84, P46, DOI 10.1016/j.jphotobiol.2006.01.010; VASSILEV RF, 1962, NATURE, V194, P1276, DOI 10.1038/1941276a0; Vladimirov Y.A., 1966, ULTRAWEAK LUMINESCEN; WILLIAMS MD, 1983, J BIOL CHEM, V258, P3628; Yang JM, 2004, ACUPUNCTURE ELECTRO, V29, P197, DOI 10.3727/036012904815901425; YODA B, 1985, ARCH ENVIRON HEALTH, V40, P148, DOI 10.1080/00039896.1985.10545907; Zimmermann B, 1999, INTENS CARE MED, V25, P44, DOI 10.1007/s001340050785	96	31	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e87401	10.1371/journal.pone.0087401	http://dx.doi.org/10.1371/journal.pone.0087401			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586274	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200013
J	Casale, FP; Giurato, G; Nassa, G; Armond, JW; Oates, CJ; Cora, D; Gamba, A; Mukherjee, S; Weisz, A; Nicodemi, M				Casale, Francesco Paolo; Giurato, Giorgio; Nassa, Giovanni; Armond, Jonathan W.; Oates, Chris J.; Cora, Davide; Gamba, Andrea; Mukherjee, Sach; Weisz, Alessandro; Nicodemi, Mario			Single-Cell States in the Estrogen Response of Breast Cancer Cell Lines	PLOS ONE			English	Article							LARGE GENE LISTS; SPATIAL-ORGANIZATION; ANGIOGENIC SWITCH; GRANULAR MEDIA; RETINOIC ACID; EXPRESSION; BIOINFORMATICS; TRANSCRIPTOME; MECHANISMS; MULTIPLE	Estrogen responsive breast cancer cell lines have been extensively studied to characterize transcriptional patterns in hormone-responsive tumors. Nevertheless, due to current technological limitations, genome-wide studies have typically been limited to population averaged data. Here we obtain, for the first time, a characterization at the single-cell level of the states and expression signatures of a hormone-starved MCF-7 cell system responding to estrogen. To do so, we employ a recently proposed model that allows for dissecting single-cell states from time-course microarray data. We show that within 32 hours following stimulation, MCF-7 cells traverse, most likely, six states, with a faster early response followed by a progressive deceleration. We also derive the genome-wide transcriptional profiles of such single-cell states and their functional characterization. Our results support a scenario where estrogen promotes cell cycle progression by controlling multiple, sequential regulatory steps, whose single-cell events are here identified.	[Casale, Francesco Paolo] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England; [Giurato, Giorgio; Nassa, Giovanni; Weisz, Alessandro] Univ Salerno, Lab Mol Med & Genom, Dept Med & Surg, I-84100 Salerno, Italy; [Armond, Jonathan W.; Oates, Chris J.] Univ Warwick, Ctr Complex Sci, Coventry CV4 7AL, W Midlands, England; [Cora, Davide] Univ Turin Sch Med, Inst Canc Res & Treatment IRCC, Turin, Italy; [Gamba, Andrea] Univ Turin, Ist Nazl Fis Nucl, Dept Appl Sci & Technol, Human Genet Fdn HuGeF, Turin, Italy; [Mukherjee, Sach] Netherlands Canc Inst, Amsterdam, Netherlands; [Nicodemi, Mario] Univ Naples Federico II, Dept Phys, Ist Nazl Fis Nucl, Naples, Italy	European Molecular Biology Laboratory (EMBL); University of Salerno; University of Warwick; IRCCS Fondazione del Piemonte per l'Oncologia; Istituto Nazionale di Fisica Nucleare (INFN); University of Turin; Netherlands Cancer Institute; Istituto Nazionale di Fisica Nucleare (INFN); University of Naples Federico II	Mukherjee, S (corresponding author), Netherlands Canc Inst, Amsterdam, Netherlands.	s.mukherjee@nki.nl; aweisz@unisa.it; mario.nicodemi@na.infn.it	Weisz, Alessandro/A-1317-2014; Nassa, Giovanni/AAB-2059-2022; Nicodemi, Mario/K-1815-2015; GAMBA, ANDREA ANTONIO/B-9097-2008; Giurato, Giorgio/K-3859-2018; GAMBA, ANDREA ANTONIO/AAJ-3203-2021; Armond, Jonathan/B-2773-2011	Weisz, Alessandro/0000-0003-0455-2083; Nicodemi, Mario/0000-0002-8416-6416; GAMBA, ANDREA ANTONIO/0000-0002-2591-2722; Giurato, Giorgio/0000-0002-0538-8978; GAMBA, ANDREA ANTONIO/0000-0002-2591-2722; Armond, Jonathan/0000-0001-5146-0910; Cora', Davide/0000-0003-4123-1705	Italian Association for Cancer Research [IG-13176]; PRIN of the Italian Ministry for Education, University and Research [PRIN 2010LC747T 002]; Italian Foundation for Cancer Research	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); PRIN of the Italian Ministry for Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Foundation for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	The authors acknowledge funding for this work from the Italian Association for Cancer Research (http://www.airc.it/- Grant IG-13176) and the PRIN of the Italian Ministry for Education, University and Research (http://prin.miur.it/- Grant PRIN 2010LC747T 002) and a "Mario e Valeria Rindi'' postdoctoral fellowship to GN from the Italian Foundation for Cancer Research (http://www.fondazionefirc.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altucci L, 1996, ONCOGENE, V12, P2315; Armond JW, 2014, SCI REP-UK, V4, DOI 10.1038/srep03692; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barbieri M, 2013, SOFT MATTER, V9, P8631, DOI 10.1039/c3sm51436f; Barbieri M, 2012, P NATL ACAD SCI USA, V109, P16173, DOI 10.1073/pnas.1204799109; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bourdeau V, 2008, NUCLEIC ACIDS RES, V36, P76, DOI 10.1093/nar/gkm945; Brewer BJ, 2007, ASTROPHYS J, V654, P551, DOI 10.1086/508766; Caglioti E, 1998, EUROPHYS LETT, V43, P591, DOI 10.1209/epl/i1998-00402-x; Castro-Rivera E, 2001, J BIOL CHEM, V276, P30853, DOI 10.1074/jbc.M103339200; CATAUDELLA V, 1994, PHYS REV LETT, V72, P1541, DOI 10.1103/PhysRevLett.72.1541; Cicatiello L, 2000, MOL CELL ENDOCRINOL, V165, P199, DOI 10.1016/S0303-7207(00)00243-4; Cicatiello L, 2004, J MOL ENDOCRINOL, V32, P719, DOI 10.1677/jme.0.0320719; Cicatiello L, 2010, AM J PATHOL, V176, P2113, DOI 10.2353/ajpath.2010.090837; Coniglio A, 2000, J PHYS-CONDENS MAT, V12, P6601, DOI 10.1088/0953-8984/12/29/331; Dong LA, 1999, J BIOL CHEM, V274, P32099, DOI 10.1074/jbc.274.45.32099; Elgort MG, 1996, MOL ENDOCRINOL, V10, P477, DOI 10.1210/me.10.5.477; Elowitz M, 2002, SCIENCE; Gamerman HFLD., 2006, MARKOV CHAIN MONTE C; Gee JMW, 2009, J PATHOL, V217, P32, DOI 10.1002/path.2430; Gilks W. R., 1995, MARKOV CHAIN MONTE C, DOI 10.1201/b14835; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Indraccolo S, 2006, CELL CYCLE, V5, P1751, DOI 10.4161/cc.5.16.2985; Louie MC, 2004, MOL CELL BIOL, V24, P5157, DOI 10.1128/MCB.24.12.5157-5171.2004; Madak-Erdogan Z, 2008, MOL ENDOCRINOL, V22, P2116, DOI 10.1210/me.2008-0059; Naumov GN, 2006, CELL CYCLE, V5, P1779, DOI 10.4161/cc.5.16.3018; Neal RM, 2001, STAT COMPUT, V11, P125, DOI 10.1023/A:1008923215028; Nicodemi M, 2001, PHYS REV LETT, V86, P4378, DOI 10.1103/PhysRevLett.86.4378; Nicodemi M, 2008, GENETICS, V179, P717, DOI 10.1534/genetics.107.083154; Nicodemi M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108104; Nicodemi M, 2009, BIOPHYS J, V96, P2168, DOI 10.1016/j.bpj.2008.12.3919; Ochsner SA, 2009, CANCER RES, V69, P23, DOI 10.1158/0008-5472.CAN-08-3492; Pettitt Friel, 2005, J ROY STAT SOC, P1; Scialdone A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002229; STACK G, 1985, ENDOCRINOLOGY, V117, P2017, DOI 10.1210/endo-117-5-2017; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tarzia M, 2004, EUROPHYS LETT, V66, P531, DOI 10.1209/epl/i2004-10015-y; Vyshemirsky V, 2008, BIOINFORMATICS, V24, P833, DOI 10.1093/bioinformatics/btm607; Weisz A, 2004, J CELL PHYSIOL, V200, P440, DOI 10.1002/jcp.20039; Wilkinson DJ, 2007, BRIEF BIOINFORM, V8, P109, DOI 10.1093/bib/bbm007; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; Zhu YL, 2006, INT J ONCOL, V29, P1581	45	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e88485	10.1371/journal.pone.0088485	http://dx.doi.org/10.1371/journal.pone.0088485			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586334	Green Published, Green Submitted, gold			2022-12-27	WOS:000332385900011
J	Wang, X; Beitler, JJ; Wang, H; Lee, MJ; Huang, W; Koenig, L; Nannapaneni, S; Amin, ARMR; Bonner, M; Shin, HJC; Chen, ZG; Arbiser, JL; Shin, DM				Wang, Xu; Beitler, Jonathan J.; Wang, Hong; Lee, Michael J.; Huang, Wen; Koenig, Lydia; Nannapaneni, Sreenivas; Amin, A. R. M. Ruhul; Bonner, Michael; Shin, Hyung Ju C.; Chen, Zhuo Georgia; Arbiser, Jack L.; Shin, Dong M.			Honokiol Enhances Paclitaxel Efficacy in Multi-Drug Resistant Human Cancer Model through the Induction of Apoptosis	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; SQUAMOUS-CELL CARCINOMA; KAPPA-B ACTIVATION; DRUG-RESISTANCE; DOWN-REGULATION; EXPRESSION; HEAD; INHIBITORS; SURVIVAL; PRODUCT	Resistance to chemotherapy remains a major obstacle in cancer therapy. This study aimed to evaluate the molecular mechanism and efficacy of honokiol in inducing apoptosis and enhancing paclitaxel chemotherapy in pre-clinical multi-drug resistant (MDR) cancer models, including lineage-derived human MDR (KB-8-5, KB-C1, KB-V1) and their parental drug sensitive KB-3-1 cancer cell lines. In vitro analyses demonstrated that honokiol effectively inhibited proliferation in KB-3-1 cells and the MDR derivatives (IC50 ranging 3.35 +/- 0.13 mu g/ml to 2.77 +/- 0.22 mu g/ml), despite their significant differences in response to paclitaxel (IC50 ranging 1.66 +/- 0.09 ng/ml to 6560.9 +/- 439.52 ng/ml). Honokiol induced mitochondria-dependent and death receptor-mediated apoptosis in MDR KB cells, which was associated with inhibition of EGFR-STAT3 signaling and downregulation of STAT3 target genes. Combined treatment with honokiol and paclitaxel synergistically augmented cytotoxicity in MDR KB cells, compared with treatment with either agent alone in vitro. Importantly, the combined treatment significantly inhibited in vivo growth of KB-8-5 tumors in a subcutaneous model. Tumor tissues from the combination group displayed a significant inhibition of Ki-67 expression and an increase in TUNEL-positive cells compared with the control group. These results suggest that targeting multidrug resistance using honokiol in combination with chemotherapy drugs may provide novel therapeutic opportunities.	[Wang, Xu; Koenig, Lydia; Nannapaneni, Sreenivas; Amin, A. R. M. Ruhul; Chen, Zhuo Georgia; Shin, Dong M.] Emory Univ Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA USA; [Beitler, Jonathan J.; Wang, Hong; Huang, Wen] Emory Univ Sch Med, Winship Canc Inst, Dept Radiat Oncol & Otolaryngol, Atlanta, GA USA; [Lee, Michael J.] Emory Coll Arts & Sci, Atlanta, GA USA; [Shin, Hyung Ju C.] Quest Diagnost, Atlanta, GA USA; [Bonner, Michael; Arbiser, Jack L.] Emory Univ Sch Med, Winship Canc Inst, Dept Dermatol, Atlanta, GA USA; [Bonner, Michael; Arbiser, Jack L.] Atlanta Vet Adm Med Ctr, Atlanta, GA USA	Emory University; Emory University; Emory University	Shin, DM (corresponding author), Emory Univ Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA USA.	dmshin@emory.edu	Bonner, Michael Yi/ABD-6756-2021; Shin, Dong Moon/G-9649-2013	Bonner, Michael Yi/0000-0002-8184-0954; Shin, Dong Moon/0000-0002-8245-4174; AMIN, ARM/0000-0001-9144-2960	National Cancer Institute (NCI) through a Head and Neck Cancer SPORE award [P50CA128613, P30 CA138292, AR47901]; Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE [P50CA128613, P30CA138292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047901] Funding Source: NIH RePORTER	National Cancer Institute (NCI) through a Head and Neck Cancer SPORE award; Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by the National Cancer Institute (NCI) through a Head and Neck Cancer SPORE award (P50CA128613), P30 CA138292, and AR47901. D.M.S., J.J.B., and Z.G.C. would also like to acknowledge the Georgia Cancer Coalition for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KS, 2006, MOL CANCER RES, V4, P621, DOI 10.1158/1541-7786.MCR-06-0076; AKIYAMA SI, 1985, SOMAT CELL MOLEC GEN, V11, P117, DOI 10.1007/BF01534700; Ang KK, 2002, CANCER RES, V62, P7350; Bai XH, 2003, J BIOL CHEM, V278, P35501, DOI 10.1074/jbc.M302967200; DASSONVILLE O, 1993, J CLIN ONCOL, V11, P1873, DOI 10.1200/JCO.1993.11.10.1873; Gilbert J, 2012, CLIN CANC RES; Goldsmith KC, 2012, CANCER RES, V72, P2565, DOI 10.1158/0008-5472.CAN-11-3603; Grandis JR, 1998, JNCI-J NATL CANCER I, V90, P824, DOI 10.1093/jnci/90.11.824; Hahm ER, 2008, CLIN CANCER RES, V14, P1248, DOI 10.1158/1078-0432.CCR-07-1926; HORIO M, 1991, BIOCHIM BIOPHYS ACTA, V1061, P106, DOI 10.1016/0005-2736(91)90274-C; Ishitsuka K, 2005, BLOOD, V106, P1794, DOI 10.1182/blood-2005-01-0346; Khan Z, 2010, CURR CANCER DRUG TAR, V10, P660, DOI 10.2174/156800910793605866; Knauer SK, 2012, HUM MUTAT; Leeman-Neill RJ, 2010, CLIN CANCER RES, V16, P2571, DOI 10.1158/1078-0432.CCR-10-0333; Li L, 2007, CANCER RES, V67, P4894, DOI 10.1158/0008-5472.CAN-06-3818; Nicholson KM, 1999, BRIT J CANCER, V81, P423, DOI 10.1038/sj.bjc.6690711; Park EJ, 2009, CANCER LETT, V277, P133, DOI 10.1016/j.canlet.2008.11.029; SANTINI J, 1991, HEAD NECK-J SCI SPEC, V13, P132, DOI 10.1002/hed.2880130209; Shigemura K, 2007, CANCER-AM CANCER SOC, V109, P1279, DOI 10.1002/cncr.22551; Sivapackiam J, 2010, DALTON T, V39, P5842, DOI 10.1039/c002361b; Sreekanth CN, 2011, ONCOGENE, V30, P3139, DOI 10.1038/onc.2011.23; Supino-Rosin L, 2000, J BIOL CHEM, V275, P21850, DOI 10.1074/jbc.M001834200; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tse AKW, 2005, BIOCHEM PHARMACOL, V70, P1443, DOI 10.1016/j.bcp.2005.08.011; Wang X, 2011, ACS NANO, V5, P6184, DOI 10.1021/nn200739q; Wang X, 2009, ACS NANO, V3, P3165, DOI 10.1021/nn900649v; Xu D, 2006, CANCER LETT, V243, P274, DOI 10.1016/j.canlet.2005.11.031; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442; Zhai H, 2005, EUR J PHARMACOL, V516, P112, DOI 10.1016/j.ejphar.2005.04.035	29	35	37	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e86369	10.1371/journal.pone.0086369	http://dx.doi.org/10.1371/journal.pone.0086369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586249	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900004
J	Volova, T; Kiselev, E; Vinogradova, O; Nikolaeva, E; Chistyakov, A; Sukovatiy, A; Shishatskaya, E				Volova, Tatiana; Kiselev, Evgeniy; Vinogradova, Olga; Nikolaeva, Elena; Chistyakov, Anton; Sukovatiy, Aleksey; Shishatskaya, Ekaterina			A Glucose-Utilizing Strain, Cupriavidus euthrophus B-10646: Growth Kinetics, Characterization and Synthesis of Multicomponent PHAs	PLOS ONE			English	Article							RALSTONIA-EUTROPHA; POLYHYDROXYALKANOATE COPOLYMERS; MOLECULAR-WEIGHT; SURFACE-ENERGY; NORTH PACIFIC; TERPOLYESTER; BIOSYNTHESIS; POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYVALERATE-CO-3-HYDROXYHEXANOATE); BIOCOMPATIBILITY; TERPOLYMERS	This study investigates kinetic and production parameters of a glucose-utilizing bacterial strain, C. eutrophus B-10646, and its ability to synthesize PHA terpolymers. Optimization of a number of parameters of bacterial culture (cell concentration in the inoculum, physiological activity of the inoculum, determined by the initial intracellular polymer content, and glucose concentration in the culture medium during cultivation) provided cell concentrations and PHA yields reaching 110 g/L and 80%, respectively, under two-stage batch culture conditions. Addition of precursor substrates (valerate, hexanoate, propionate, c-butyrolactone) to the culture medium enabled synthesis of PHA terpolymers, P(3HB/3HV/4HB) and P(3HB/3HV/3HHx), with different composition and different molar fractions of 3HB, 3HV, 4HB, and 3HHx. Different types of PHA terpolymers synthesized by C. eutrophus B-10646 were used to prepare films, whose physicochemical and physicalmechanical properties were investigated. The properties of PHA terpolymers were significantly different from those of the P3HB homopolymer: they had much lower degrees of crystallinity and lower melting points and thermal decomposition temperatures, with the difference between these temperatures remaining practically unchanged. Films prepared from all PHA terpolymers had higher mechanical strength and elasticity than P3HB films. In spite of dissimilar surface structures, all films prepared from PHA terpolymers facilitated attachment and proliferation of mouse fibroblast NIH 3T3 cells more effectively than polystyrene and the highly crystalline P3HB.	[Volova, Tatiana; Kiselev, Evgeniy; Nikolaeva, Elena; Sukovatiy, Aleksey; Shishatskaya, Ekaterina] Russian Acad Sci, Inst Biophys, Siberian Branch, Krasnoyarsk, Russia; [Volova, Tatiana; Vinogradova, Olga; Shishatskaya, Ekaterina] Siberian Fed Univ, Krasnoyarsk, Russia; [Chistyakov, Anton] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia	Russian Academy of Sciences; Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences; Biophysics Institute, Siberian Branch, Russian Academy of Sciences; Siberian Federal University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Volova, T (corresponding author), Russian Acad Sci, Inst Biophys, Siberian Branch, Krasnoyarsk, Russia.	volova45@mail.ru	Volova, Tatiana/P-3767-2015; Kiselev, Evgeniy G/Q-5365-2016; Kiselev, Evgeniy Pavlovich/GYQ-9325-2022; Zalygin, Anton/AAC-9031-2022; Shishatskaya, Ekaterina/I-8684-2014; Nikolaeva, Elena D/I-8679-2014; sukovatiy, aleksey/I-8992-2014; Shishatskaya, Ekaterina/ABC-8374-2021; Chistyakov, Anton/E-2509-2014	Kiselev, Evgeniy G/0000-0003-4472-7087; Zalygin, Anton/0000-0003-0132-0674; sukovatiy, aleksey/0000-0002-5412-8267; Nikolaeva, Elena/0000-0002-5298-828X; Shishatskaya, Ekaterina/0000-0001-7967-243X; Volova, Tatiana/0000-0001-9392-156X	Project "Biotechnologies of novel biomaterials: Innovative Biopolymers and Biomedicine Devices" [11.G34.31.0013]	Project "Biotechnologies of novel biomaterials: Innovative Biopolymers and Biomedicine Devices"	This study was financially supported by Project "Biotechnologies of novel biomaterials: Innovative Biopolymers and Biomedicine Devices" (Agreement No. 11.G34.31.0013 with Amendment No. 1 of 15 February 2013) in accordance with Resolution No. 220 of the Government of the Russian Federation of April 9, 2010, "On measures designed to attract leading scientists to the Russian institutions of higher learning." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Aziz N, 2012, J CHEM TECHNOL BIOT, V87, P1607, DOI 10.1002/jctb.3817; Agus J, 2010, POLYM DEGRAD STABIL, V95, P2250, DOI 10.1016/j.polymdegradstab.2010.09.009; Amirul AA, 2008, WORLD J MICROB BIOT, V24, P1327, DOI 10.1007/s11274-007-9605-2; Andrade JD., 1985, SURFACE INTERFACIAL, P15; [Anonymous], 1982, 4681982 ISO; Bengtsson S, 2010, J BIOTECHNOL, V147, P172, DOI 10.1016/j.jbiotec.2010.03.022; Bhubalan K, 2008, POLYM DEGRAD STABIL, V93, P17, DOI 10.1016/j.polymdegradstab.2007.11.004; Bhubalan K, 2010, POLYM DEGRAD STABIL, V95, P1436, DOI 10.1016/j.polymdegradstab.2009.12.018; Boskhomdzhiev AP, 2010, THESIS AN BACH I BIO; BRANDL H, 1988, APPL ENVIRON MICROB, V54, P1977, DOI 10.1128/AEM.54.8.1977-1982.1988; BRAUNEGG G, 1978, EUR J APPL MICROBIOL, V6, P29, DOI 10.1007/BF00500854; Cavalheiro JMBT, 2012, BIORESOURCE TECHNOL, V111, P391, DOI 10.1016/j.biortech.2012.01.176; Chanprateep S, 2006, J BIOSCI BIOENG, V101, P51, DOI 10.1263/jbb.101.51; Chanprateep S, 2010, J BIOSCI BIOENG, V110, P621, DOI 10.1016/j.jbiosc.2010.07.014; Chen GQ, 2010, MICROBIOL MONOGR, V14, P121, DOI 10.1007/978-3-642-03287_5_6; Chen GQ, 2009, CHEM SOC REV, V38, P2434, DOI 10.1039/b812677c; De Gennes PG, 1987, ADV PHYS SCI, V151, P619; Green PR, 2002, BIOMACROMOLECULES, V3, P208, DOI 10.1021/bm015620m; Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297; Hasirci V., 2000, BIOMATERIALS BIOENGI, P141; Hu YJ, 2009, ACTA BIOMATER, V5, P1115, DOI 10.1016/j.actbio.2008.09.021; Ishizaki A, 2001, APPL MICROBIOL BIOT, V57, P6; Ji GZ, 2009, J BIOMAT SCI-POLYM E, V20, P325, DOI 10.1163/156856209X412191; Ji Y, 2008, BIOMATERIALS, V29, P3807, DOI 10.1016/j.biomaterials.2008.06.008; Kennedy SB, 2006, BIOMATERIALS, V27, P3817, DOI 10.1016/j.biomaterials.2006.02.044; Khosravi-Darani K, 2013, APPL MICROBIOL BIOT, V97, P1407, DOI 10.1007/s00253-012-4649-0; Kijchavengkul T, 2008, POLYM INT, V57, P793, DOI 10.1002/pi.2420; Laycock B, 2013, PROG POLYM SCI, V38, P536, DOI 10.1016/j.progpolymsci.2012.06.003; Lee SY, 1996, TRENDS BIOTECHNOL, V14, P431, DOI 10.1016/0167-7799(96)10061-5; Li QA, 2011, NEW BIOTECHNOL, V28, P92, DOI 10.1016/j.nbt.2010.08.007; Liang YS, 2008, J BIOMED MATER RES A, V87A, P441, DOI 10.1002/jbm.a.31801; Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6; Liu Q, 2008, J BIOMAT SCI-POLYM E, V19, P1521, DOI 10.1163/156856208786140391; Lopez-Cuellar MR, 2011, INT J BIOL MACROMOL, V48, P74, DOI 10.1016/j.ijbiomac.2010.09.016; Madden LA, 2000, POLYMER, V41, P3499, DOI 10.1016/S0032-3861(99)00611-4; Moore CJ, 2001, MAR POLLUT BULL, V42, P1297, DOI 10.1016/S0025-326X(01)00114-X; Ou WF, 2011, BIOMATERIALS, V32, P3178, DOI 10.1016/j.biomaterials.2011.01.031; Ramachandran H, 2011, APPL BIOCHEM BIOTECH, V164, P867, DOI 10.1007/s12010-011-9180-8; SCHLEGEL HG, 1961, ARCH MIKROBIOL, V38, P209, DOI 10.1007/BF00422356; Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6; Sudesh K., 2010, PRACTICAL GUIDE MICR; Sun JA, 2010, BIOSCI BIOTECH BIOCH, V74, P1716, DOI 10.1271/bbb.100242; Tanabe S, 2004, ENVIRON SCI TECHNOL, V38, P403, DOI 10.1021/es034966x; Tezcaner A, 2003, BIOMATERIALS, V24, P4573, DOI 10.1016/S0142-9612(03)00302-8; Vandamme P, 2004, INT J SYST EVOL MICR, V54, P2285, DOI 10.1099/ijs.0.63247-0; VANDERVALK P, 1983, J BIOMED MATER RES, V17, P807, DOI 10.1002/jbm.820170508; Volova TG, 2006, APPL MICROBIOL BIOT, V73, P429, DOI 10.1007/s00253-006-0460-0; Volova TG, 2013, POLYM SCI SER A+, V55, P427, DOI 10.1134/S0965545X13070080; Volova T G, 2011, Prikl Biokhim Mikrobiol, V47, P544; Volova T.G., 2004, POLYHYDROXYALKANOATE; Volova T.G., 2013, DEGRADABLE POLYM PRO; Volova TG, 2008, MACROMOL SYMP, V269, P1, DOI 10.1002/masy.200850901; [Волова Т.Г. Volova Tatiana G.], 2012, [Журнал Сибирского федерального университета. Серия: Биология, Zhurnal Sibirskogo federal'nogo universiteta. Seriya: Biologiya], V5, P280; Volova TG, 1998, MICROBIOLOGY+, V67, P420; Volova TG, 2009, HYDROGEN-BASED BIOSYNTHESIS, P1; Volova TG, 2006, POLYOXYALKANOATES BI; Wang L, 2010, BIOMATERIALS, V31, P1691, DOI 10.1016/j.biomaterials.2009.11.053; Wei X, 2009, J BIOMED MATER RES A, V90A, P894, DOI 10.1002/jbm.a.32146; Wu ACK, 2006, BIOMATERIALS, V27, P4715, DOI 10.1016/j.biomaterials.2006.05.010; Xavier SP, 2003, J DENT, V31, P173, DOI 10.1016/S0300-5712(03)00027-7; Ying TH, 2008, BIOMATERIALS, V29, P1307, DOI 10.1016/j.biomaterials.2007.11.031; Zhang HF, 2009, BIOTECHNOL BIOENG, V104, P582, DOI 10.1002/bit.22409; Zhao W, 2007, PROCESS BIOCHEM, V42, P1342, DOI 10.1016/j.procbio.2007.07.006; Zhou J, 2010, BIOMATERIALS, V31, P7512, DOI 10.1016/j.biomaterials.2010.06.044	64	42	49	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e87551	10.1371/journal.pone.0087551	http://dx.doi.org/10.1371/journal.pone.0087551			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586280	gold, Green Published, Green Submitted			2022-12-27	WOS:000331880700006
J	Wang, C; Zhang, N; Gao, CQ; Cui, ZY; Sun, D; Yang, CP; Wang, YC				Wang, Chao; Zhang, Nan; Gao, Caiqiu; Cui, Zhiyuan; Sun, Dan; Yang, Chuanping; Wang, Yucheng			Comprehensive Transcriptome Analysis of Developing Xylem Responding to Artificial Bending and Gravitational Stimuli in Betula platyphylla	PLOS ONE			English	Article							TENSION WOOD; ARABINOGALACTAN-PROTEINS; LIGNIN BIOSYNTHESIS; RNA-SEQ; CELLULOSE; GENES; ARABIDOPSIS; EXPRESSION; REGULATORS; TOOL	Betula platyphylla Suk (birch) is a fast-growing woody species that is important in pulp industries and the biofuels. However, as an important pulp species, few studies had been performed on its wood formation. In the present study, we investigated the molecular responses of birch xylem to artificial bending and gravitational stimuli. After trunks of birch trees were subjected to bending for 8 weeks, the cellulose content was significantly greater in tension wood (TW) than in opposite wood (OW) or normal wood (NW), whereas the lignin content in TW was significantly lower than that in OW and NW. In addition, TW grew more rapidly than OW and generated TW-specific fibers with an additional G-layer. Three transcriptome libraries were constructed from TW, OW and NW of B. platyphylla, respectively, after the plants were subjected to artificial bending. Overall, 80,909 nonredundant unigenes with a mean size of 768 nt were assembled. Expression profiles were generated, and 9,684 genes were found to be significantly differentially expressed among the TW, OW and NW libraries. These included genes involved in secondary cell wall structure, wood composition, and cellulose or lignin biosynthesis. Our study showed that during TW formation, genes involved in cellulose synthesis were induced, while the expression of lignin synthesis-related genes decreased, resulting in increased cellulose content and decreased lignin levels in TW. In addition, fasciclin-like arabinogalactan proteins play important role in TW formation. These findings may provide important insights into wood formation at the molecular level.	[Wang, Chao; Zhang, Nan; Gao, Caiqiu; Cui, Zhiyuan; Sun, Dan; Yang, Chuanping; Wang, Yucheng] Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin, Peoples R China	Northeast Forestry University - China	Yang, CP (corresponding author), Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin, Peoples R China.	yangchuanpingnefu@yahoo.com; ychngwang@yahoo.com			National High Technology Research and Development Program ("863" Program) of China [2011AA100202]; Fundamental Research Funds for the Central Universities [DL11EA02]	National High Technology Research and Development Program ("863" Program) of China(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National High Technology Research and Development Program ("863" Program) of China (2011AA100202), and the Fundamental Research Funds for the Central Universities (DL11EA02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson-Gunneras S, 2006, PLANT J, V45, P144, DOI 10.1111/j.1365-313X.2005.02584.x; Baba K, 2009, MOL PLANT, V2, P893, DOI 10.1093/mp/ssp054; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bowling AJ, 2008, AM J BOT, V95, P655, DOI 10.3732/ajb.2007368; Brereton NJB, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-13; Chung SK, 2012, BIORESOURCE TECHNOL, V110, P423, DOI 10.1016/j.biortech.2012.01.046; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cuddapah S, 2009, COLD SPRING HARBOR P; Decou R, 2009, PHYTOCHEMISTRY, V70, P163, DOI 10.1016/j.phytochem.2008.12.019; Demura T, 2007, TRENDS PLANT SCI, V12, P64, DOI 10.1016/j.tplants.2006.12.006; Doblin MS, 2002, PLANT CELL PHYSIOL, V43, P1407, DOI 10.1093/pcp/pcf164; Du J, 2010, J INTEGR PLANT BIOL, V52, P17, DOI 10.1111/j.1744-7909.2010.00901.x; Ehlting J, 2005, PLANT J, V42, P618, DOI 10.1111/j.1365-313X.2005.02403.x; Fornale S, 2010, PLANT J, V64, P633, DOI 10.1111/j.1365-313X.2010.04363.x; Fukuda H, 2004, NAT REV MOL CELL BIO, V5, P379, DOI 10.1038/nrm1364; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haigler CH, 2001, PLANT MOL BIOL, V47, P29, DOI 10.1023/A:1010615027986; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hemm MR, 2001, TRENDS PLANT SCI, V6, P135, DOI 10.1016/S1360-1385(01)01915-X; Jin H, 2011, PLANTA, V234, P959, DOI 10.1007/s00425-011-1449-1; Lafarguette F, 2004, NEW PHYTOL, V164, P107, DOI 10.1111/j.1469-8137.2004.01175.x; Legay S, 2010, NEW PHYTOL, V188, P774, DOI 10.1111/j.1469-8137.2010.03432.x; Li RQ, 2010, NAT BIOTECHNOL, V28, P57, DOI 10.1038/nbt.1596; Mitsuda N, 2007, PLANT CELL, V19, P270, DOI 10.1105/tpc.106.047043; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; No EG, 2000, PHYSIOL PLANTARUM, V110, P524, DOI 10.1111/j.1399-3054.2000.1100415.x; Paux E, 2005, NEW PHYTOL, V167, P89, DOI 10.1111/j.1469-8137.2005.01396.x; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pilate G, 2004, CR BIOL, V327, P889, DOI 10.1016/j.crvi.2004.07.006; Qiu D, 2008, NEW PHYTOL, V179, P94, DOI 10.1111/j.1469-8137.2008.02439.x; Richet N, 2011, J EXP BOT, V62, P3575, DOI 10.1093/jxb/err047; Taylor NG, 1999, PLANT CELL, V11, P769, DOI 10.1105/tpc.11.5.769; TIMELL TE, 1973, WOOD SCI TECHNOL, V7, P1, DOI 10.1007/BF00353373; Wang GF, 2011, PLANT BIOTECHNOL J, V9, P486, DOI 10.1111/j.1467-7652.2010.00569.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Winter H, 2000, CRIT REV PLANT SCI, V19, P31, DOI 10.1016/S0735-2689(01)80002-2; Yamashita S, 2008, TREE PHYSIOL, V28, P1331, DOI 10.1093/treephys/28.9.1331; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yeats TH, 2008, PROTEIN SCI, V17, P191, DOI 10.1110/ps.073300108; Zenoni S, 2004, PLANT CELL, V16, P295, DOI 10.1105/tpc.018705; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Zhong RQ, 2007, PLANTA, V225, P1603, DOI 10.1007/s00425-007-0498-y	43	22	24	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e87566	10.1371/journal.pone.0087566	http://dx.doi.org/10.1371/journal.pone.0087566			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586282	gold, Green Published, Green Submitted			2022-12-27	WOS:000331714700006
J	De Schutter, I; Vergison, A; Tuerlinckx, D; Raes, M; Smet, J; Smeesters, PR; Verhaegen, J; Mascart, F; Surmont, F; Malfroot, A				De Schutter, Iris; Vergison, Anne; Tuerlinckx, David; Raes, Marc; Smet, Julie; Smeesters, Pierre R.; Verhaegen, Jan; Mascart, Francoise; Surmont, Filip; Malfroot, Anne			Pneumococcal Aetiology and Serotype Distribution in Paediatric Community-Acquired Pneumonia	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; BELGIAN CHILDREN; EPIDEMIOLOGY; INFECTIONS; DIAGNOSIS; EMPYEMA; DECLINE; DISEASE	Community-acquired pneumonia (CAP) is a major cause of morbidity in children. This study estimated the proportion of children with pneumococcal CAP among children hospitalised with CAP in Belgium and describes the causative serotype distribution after implementation of the 7-valent pneumococcal conjugate vaccine. Children 0-14 years hospitalised with X-ray-confirmed CAP were prospectively enrolled in a multicentre observational study. Acute and convalescent blood samples were collected. Pneumococcal aetiology was assessed by conventional methods (blood or pleural fluid cultures with Quellung reaction capsular typing or polymerase chain reaction [PCR] in pleural fluid), and recently developed methods (real-time PCR in blood and World Health Organization-validated serotype-specific serology). A total of 561 children were enrolled. Pneumococcal aetiology was assessed by conventional methods in 539, serology in 171, and real-time PCR in blood in 154. Pneumococcal aetiology was identified in 12.2% (66/539) of the children by conventional methods alone but in 73.9% by the combination of conventional and recently developed methods. The pneumococcal detection rate adjusted for the whole study population was 61.7%. Serotypes 1 (42.3%), 5 (16.0%), and 7F(7A) (12.8%) were predominant. In conclusion, Streptococcus pneumoniae remains the predominant bacteria in children hospitalised for CAP in Belgium after implementation of 7-valent pneumococcal conjugate vaccine, with non-vaccine-serotypes accounting for the majority of cases. The use of recently developed methods improves diagnosis of pneumococcal aetiology.	[De Schutter, Iris; Malfroot, Anne] Univ Ziekenhuis Brussel UZ Brussel, Cyst Fibrosis Clin, Dept Pediat Pulmonol, Brussels, Belgium; [De Schutter, Iris; Malfroot, Anne] Univ Ziekenhuis Brussel UZ Brussel, Brussels, Belgium; [Vergison, Anne] Univ Libre Bruxelles, Hop Univ Enfants Reine Fabiola, Infect Control & Hosp Epidemiol Unit, Pediat Infect Dis Dept, Brussels, Belgium; [Tuerlinckx, David] Catholic Univ Louvain, Dept Pediat, Univ Hosp Mt Godinne, Yvoir, Belgium; [Raes, Marc] Virga Jesse Hosp, Dept Pediat, Hasselt, Belgium; [Smet, Julie; Mascart, Francoise] Free Univ Brussels, Hop Erasme, Immunobiol Clin, B-1070 Brussels, Belgium; [Smet, Julie; Mascart, Francoise] Univ Libre Bruxelles, Lab Vaccinol & Mucosal Immun, Brussels, Belgium; [Smeesters, Pierre R.] Univ Libre Bruxelles, Bacterial Genet & Physiol Lab, Gosselies, Belgium; [Smeesters, Pierre R.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Verhaegen, Jan] Katholieke Univ Leuven, Univ Ziekenhuis, Dept Lab Med Microbiol, Pneumococcal Reference Lab, Louvain, Belgium; [Surmont, Filip] Pfizer Inc, Brussels, Belgium	University Hospital Brussels; Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Universite Catholique Louvain; Universite Catholique Louvain Hospital; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Murdoch Children's Research Institute; KU Leuven; Pfizer	De Schutter, I (corresponding author), Univ Ziekenhuis Brussel UZ Brussel, Cyst Fibrosis Clin, Dept Pediat Pulmonol, Brussels, Belgium.	iris.deschutter@uzbrussel.be	Pedreira, Joice Neves Reis/AAO-3536-2021; Smeesters, Pierre/I-7723-2012	Pedreira, Joice Neves Reis/0000-0001-5273-2658; Smeesters, Pierre/0000-0002-2642-9919	Pfizer, Inc.	Pfizer, Inc.(Pfizer)	This study was financially supported by Pfizer, Inc. Filip Surmont, was at the time of the study an employee of Pfizer, Inc. and he contributed to all study stages, including study design, data collection and statistical analysis.	Albrich WC, 2012, CLIN INFECT DIS, V54, P601, DOI 10.1093/cid/cir859; Byington CL, 2010, J CLIN MICROBIOL, V48, P520, DOI 10.1128/JCM.01200-09; Byington CL, 2006, PEDIATR INFECT DIS J, V25, P250, DOI 10.1097/01.inf.0000202137.37642.ab; Cevey-Macherel M, 2009, EUR J PEDIATR, V168, P1429, DOI 10.1007/s00431-009-0943-y; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; De Schutter I, 2006, PEDIATR PULM, V41, P765, DOI 10.1002/ppul.20437; Don M, 2005, SCAND J INFECT DIS, V37, P806, DOI 10.1080/00365540500262435; Elemraid MA, 2013, EUR RESP J; Elemraid MA, 2012, EPIDEMIOL INFECT, V140, P1; Esposito S, 2002, CLIN INFECT DIS, V35, P1345, DOI 10.1086/344191; Esposito S, 2012, PEDIATR INFECT DIS J, V31, P705, DOI 10.1097/INF.0b013e31825384ae; Grijalva CG, 2007, LANCET, V369, P1179, DOI 10.1016/S0140-6736(07)60564-9; Hanquet G, 2011, VACCINE, V29, P2856, DOI 10.1016/j.vaccine.2011.02.016; Harboe ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051460; Harris M, 2011, THORAX, V66, pII1, DOI 10.1136/thoraxjnl-2011-200598; Hausdorff WP, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-4; Hsu KK, 2010, PEDIATR INFECT DIS J, V29, P289, DOI 10.1097/INF.0b013e3181c15471; Juven T, 2000, PEDIATR INFECT DIS J, V19, P293, DOI 10.1097/00006454-200004000-00006; Kaplan SL, 2010, PEDIATRICS, V125, P429, DOI 10.1542/peds.2008-1702; McIntosh K, 2002, NEW ENGL J MED, V346, P429, DOI 10.1056/NEJMra011994; Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701; O'Brien KL, 2009, VACCINE, V27, P1863, DOI 10.1016/j.vaccine.2008.12.060; Obando I, 2008, EMERG INFECT DIS, V14, P1390, DOI 10.3201/eid1409.071094; Resti M, 2010, CLIN INFECT DIS, V51, P1042, DOI 10.1086/656579; Tuerlinckx D, 2013, PEDIATR INFECT DIS J, V32, pE277, DOI 10.1097/INF.0b013e31828c363f; Vergison A, 2006, PEDIATRICS, V118, pE801, DOI 10.1542/peds.2005-3195; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	29	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89013	10.1371/journal.pone.0089013	http://dx.doi.org/10.1371/journal.pone.0089013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558464	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700110
J	Ghosh, R; Ray, U; Jana, P; Bhattacharya, R; Banerjee, D; Sinha, A				Ghosh, Rajeshwary; Ray, Udayan; Jana, Pradipta; Bhattacharya, Rabindra; Banerjee, Debipriya; Sinha, Asru			Reduction of Death Rate Due to Acute Myocardial Infarction in Subjects with Cancers through Systemic Restoration of Impaired Nitric Oxide	PLOS ONE			English	Article							CORONARY-ARTERY; CARDIOVASCULAR-DISEASE; PLASMINOGEN-ACTIVATOR; PLATELET-AGGREGATION; INSULIN; ASPIRIN; BLOOD; PROSTACYCLIN; STIMULATION; RISK	Introduction: Excessive aggregation of platelets at the site of plaque rupture on the coronary artery led to the formation of thrombus which is reported to precipitate acute myocardial infarction (AMI). Nitric oxide (NO) has been reported to inhibit platelet aggregation and induce thrombolysis through the in situ formation of plasmin. As the plasma NO level in AMI patients from two different ethnic groups was reduced to 0 mu M (median) compared to 4.0 mM (median) in normal controls, the effect of restoration of the NO level to normal ranges on the rate of death due to AMI was determined. Methods and Results: The restoration of plasma NO level was achieved by a sticking small cotton pad (10625 mm) containing 0.28 mmol sodium nitroprusside (SNP) in 0.9% NaCl to the abdominal skin of the participants using non-toxic adhesive tape which was reported to normalize the plasma NO level. The participants (8,283) were volunteers in an independent study who had different kinds of cancers and did not wish to use any conventional therapy for their condition but opted to receive SNP "pad'' for their condition for 3 years. The use of SNP "pad'' which normalized (approximate to 4.0 mu M) the plasma NO level that in consequence reduced the death rate due to AMI, among the participants, was found to be significantly reduced compared to the death due to AMI in normal population. Conclusion: Our data suggested that the use of SNP "pad'' significantly reduced the death due to AMI. Trial Registration: www.ctri.nic.in CTRI/2013/12/004236	[Ghosh, Rajeshwary; Jana, Pradipta; Banerjee, Debipriya; Sinha, Asru] Sinha Inst Med Sci & Technol, Kolkata, India; [Ray, Udayan] Univ Tasmania, Royal Hobart Hosp, Hobart, Tas 7001, Australia; [Bhattacharya, Rabindra] Kalyani Gandhi Mem Hosp, Kolkata, W Bengal, India	Royal Hobart Hospital; University of Tasmania	Sinha, A (corresponding author), Sinha Inst Med Sci & Technol, Kolkata, India.	asruksinha@yahoo.com		JANA, PRADIPTA/0000-0001-8744-5755; Ghosh, Rajeshwary/0000-0002-6576-4242; Ghosh, Rajeshwary/0000-0001-6528-2940; Mitra, Debipriya/0000-0001-5034-5646	Defence Research and Development Organization, Govt. of India [DLS/81/48222/LSRB-247/EPB/2012]	Defence Research and Development Organization, Govt. of India(Defence Research & Development Organisation (DRDO))	This study was supported in part by the Defence Research and Development Organization, Govt. of India (DLS/81/48222/LSRB-247/EPB/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya K, 2001, BIOSCI RES B, V17, P47; Antman Elliott M., 1998, HARRISONS PRINCIPLES, P1352; ARNESEN H, 1982, ACTA MED SCAND, V211, P65; BELKIN M, 1986, ARCH SURG-CHICAGO, V121, P769; Bhattacharya S., 2001, Archives of Physiology and Biochemistry, V109, P441, DOI 10.1076/apab.109.5.441.8042; Bhattacharyya M, 2009, J THROMB THROMBOLYS, V28, P173, DOI 10.1007/s11239-008-0283-1; BOIVIN JF, 1992, CANCER, V69, P1241; Chakraborty K, 2003, PLATELETS, V14, P421, DOI 10.1080/095371032000158763; Chakraborty K, 2004, BIOESSAYS, V26, P91, DOI 10.1002/bies.10375; Chakraborty S, 2009, J AM SOC HYPERTENS, V3, P119, DOI 10.1016/j.jash.2008.11.002; Coles B, 2002, J BIOL CHEM, V277, P5832, DOI 10.1074/jbc.M105209200; COX RD, 1982, J ANAL TOXICOL, V6, P148, DOI 10.1093/jat/6.3.148; DURHAM JD, 1989, RADIOLOGY, V172, P83, DOI 10.1148/radiology.172.1.2740523; Furman MI, 1998, J AM COLL CARDIOL, V31, P352, DOI 10.1016/S0735-1097(97)00510-X; Fuster V, 1996, HAEMOSTASIS, V26, P269; Ghosh R, 2012, EXP CLIN ENDOCR DIAB, V120, P145, DOI 10.1055/s-0031-1291298; Ghosh R, 2011, J THROMB THROMBOLYS, V31, P13, DOI 10.1007/s11239-010-0515-z; GOLDHABER SZ, 1988, LANCET, V2, P293; GRUETTER CA, 1979, J CYCLIC NUCL PROT, V5, P211; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Hooning MJ, 2007, JNCI-J NATL CANCER I, V99, P365, DOI 10.1093/jnci/djk064; Iwakura K, 2003, J AM COLL CARDIOL, V41, P1, DOI 10.1016/S0735-1097(02)02626-8; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; KAHN NN, 1992, AM J CARDIOL, V70, P582, DOI 10.1016/0002-9149(92)90195-5; Kalgutkar AS, 1998, SCIENCE, V280, P1268, DOI 10.1126/science.280.5367.1268; Karmohapatra SK, 2007, AM J HEMATOL, V82, P986, DOI 10.1002/ajh.20955; Loscalzo J, 2001, CIRC RES, V88, P756, DOI 10.1161/hh0801.089861; Maraveyas A, 2012, EUR J CANCER, V48, P1283, DOI 10.1016/j.ejca.2011.10.017; MELLION BT, 1981, BLOOD, V57, P946; Mills DCB, 1996, THROMB HAEMOSTASIS, V76, P835; Ogawa A, 1995, J MED, V26, P221; Palumbo A, 2011, J CLIN ONCOL, V29, P986, DOI 10.1200/JCO.2010.31.6844; ROTH GJ, 1975, J CLIN INVEST, V56, P624, DOI 10.1172/JCI108132; Sinha AK, 2002, J CANCER RES CLIN, V128, P659, DOI 10.1007/s00432-002-0376-8; Sinha AK, 1999, LIFE SCI, V65, P2687, DOI 10.1016/S0024-3205(99)00537-8; Sinha Asru K., 1998, Indian Journal of Physiology and Allied Sciences, V52, P148; SMITH JB, 1971, NATURE-NEW BIOL, V231, P235, DOI 10.1038/newbio231235a0; TATESON JE, 1977, PROSTAGLANDINS, V13, P389, DOI 10.1016/0090-6980(77)90019-3; Trovati M, 1997, DIABETES, V46, P742, DOI 10.2337/diabetes.46.5.742; Van Hemelrijck M, 2010, J CLIN ONCOL, V28, P3448, DOI 10.1200/JCO.2010.29.1567; VANDEWERF F, 1984, NEW ENGL J MED, V310, P609; WHITTLE BJR, 1978, PROSTAG OTH LIPID M, V16, P373, DOI 10.1016/0090-6980(78)90216-2; Yusuf SW, 2012, CLIN CARDIOL, V35, P443, DOI 10.1002/clc.22007	43	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88639	10.1371/journal.pone.0088639	http://dx.doi.org/10.1371/journal.pone.0088639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558405	gold, Green Submitted, Green Published			2022-12-27	WOS:000331706700051
J	Grondahl-Yli-Hannuksela, K; Vuononvirta, J; Peltola, V; Mertsola, J; He, QS				Grondahl-Yli-Hannuksela, Kirsi; Vuononvirta, Juho; Peltola, Ville; Mertsola, Jussi; He, Qiushui			Lack of Association between Mannose Binding Lectin and Antibody Responses after Acellular Pertussis Vaccinations	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; BORDETELLA-PERTUSSIS; BOOSTER IMMUNIZATION; INNATE IMMUNITY; DEFICIENCY; GENE; VACCINE; PROTEIN; ADOLESCENCE; RESURGENCE	Background: Mannose-binding lectin (MBL) is one of the key molecules in innate immunity and its role in human vaccine responses is poorly known. This study aimed to investigate the possible association of MBL polymorphisms with antibody production after primary and booster vaccinations with acellular pertussis vaccines in infants and adolescents. Methodology/Principal Findings: Five hundred and sixty eight subjects were included in this study. In the adolescent cohort 355 subjects received a dose of diphtheria and tetanus toxoids and acellular pertussis (dTpa) vaccine ten years previously. Follow-up was performed at 3, 5 and 10 years. Infant cohort consisted of 213 subjects, who had received three primary doses of DTaP vaccine at 3, 5, and 12 months of age according to Finnish immunization program. Blood samples were collected before the vaccinations at 2,5 months of age and after the vaccinations at 13 months and 2 years of age. Concentrations of IgG antibodies to pertussis toxin, filamentous hemagglutinin, and pertactin and antibodies to diphtheria and tetanus toxoids were measured by standardized enzyme-linked immunosorbant assay. Single nucleotide polymorphisms of MBL2 gene exon1 (codons 52, 54, 57) were examined. MBL serum concentration was also measured from the adolescent cohort. No association was found with MBL2 exon 1 polymorphisms and antibody responses against vaccine antigens, after primary and booster dTpa vaccination. Conclusions: This study indicates that MBL polymorphisms do not affect the production and persistence of antibodies after acellular pertussis vaccination. Our finding also suggests that MBL might not be involved in modulating antibody responses to the vaccines made of purified bacterial proteins.	[Grondahl-Yli-Hannuksela, Kirsi; Vuononvirta, Juho; He, Qiushui] Natl Inst Hlth & Welf THL, Dept Infect Dis Surveillance & Control, Turku, Finland; [Peltola, Ville; Mertsola, Jussi] Turku Univ Hosp, Dept Pediat, FIN-20520 Turku, Finland	Finland National Institute for Health & Welfare; University of Turku	He, QS (corresponding author), Natl Inst Hlth & Welf THL, Dept Infect Dis Surveillance & Control, Turku, Finland.	qiushui.he@thl.fi	Mertsola, Jussi/AAE-3460-2021		Academy of Finland [122833]; Special Governmental Fund for University Hospitals; Finnish Cultural Foundation the Varsinais-Suomi Regional Fund	Academy of Finland(Academy of Finland); Special Governmental Fund for University Hospitals; Finnish Cultural Foundation the Varsinais-Suomi Regional Fund	This work was supported by the Academy of Finland [grant no 122833], the Special Governmental Fund for University Hospitals, and Finnish Cultural Foundation the Varsinais-Suomi Regional Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkoff AM, 2012, VACCINE, V30, P6897, DOI 10.1016/j.vaccine.2012.09.003; Celentano LP, 2005, PEDIATR INFECT DIS J, V24, P761, DOI 10.1097/01.inf.0000177282.53500.77; Cherry JD, 1998, VACCINE, V16, P1901, DOI 10.1016/S0264-410X(98)00226-6; Devyatyrova-Johnson M, 2000, INFECT IMMUN, V68, P3894, DOI 10.1128/IAI.68.7.3894-3899.2000; Dommett RM, 2006, TISSUE ANTIGENS, V68, P193, DOI 10.1111/j.1399-0039.2006.00649.x; Edelman K, 2007, CLIN INFECT DIS, V44, P1271, DOI 10.1086/514338; Edelman KJ, 2004, CLIN INFECT DIS, V39, P179, DOI 10.1086/421943; Eisen DP, 2008, CLIN INFECT DIS, V47, P510, DOI 10.1086/590006; Garred P, 2008, BIOCHEM SOC T, V36, P1461, DOI 10.1042/BST0361461; Grondahl-Yli-Hannuksela K, 2013, APMIS, V121, P311, DOI 10.1111/apm.12000; Grondahl-Yli-Hannuksela K, 2012, J INFECT DIS, V205, P1214, DOI 10.1093/infdis/jis182; Guttormsen HK, 2009, CLIN IMMUNOL, V130, P264, DOI 10.1016/j.clim.2008.09.012; He QS, 2008, FUTURE MICROBIOL, V3, P329, DOI 10.2217/17460913.3.3.329; Heitzeneder S, 2012, CLIN IMMUNOL, V143, P22, DOI 10.1016/j.clim.2011.11.002; Higgs R, 2012, MUCOSAL IMMUNOL, V5, P485, DOI 10.1038/mi.2012.54; Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x; Juul-Madsen HR, 2011, VACCINE, V29, P9499, DOI 10.1016/j.vaccine.2011.10.016; Kimman TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003665; Lagstrom H, 2013, INT J EPIDEMIOL, V42, P1273, DOI 10.1093/ije/dys150; Lipscombe R. J., 1992, Human Molecular Genetics, V1, P709, DOI 10.1093/hmg/1.9.709; MADSEN HO, 1995, J IMMUNOL, V155, P3013; MADSEN HO, 1994, IMMUNOGENETICS, V40, P37, DOI 10.1007/BF00163962; Mertsola J, 2010, CLIN INFECT DIS, V51, P656, DOI 10.1086/655825; Minchinton RM, 2002, SCAND J IMMUNOL, V56, P630, DOI 10.1046/j.1365-3083.2002.01167.x; Minh NNT, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.6.e70; Mooi FR, 2001, EMERG INFECT DIS, V7, P526, DOI 10.3201/eid0707.017708; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; Rantala A, 2008, J INFECT DIS, V198, P1247, DOI 10.1086/591912; REIZENSTEIN E, 1995, J IMMUNOL METHODS, V183, P279, DOI 10.1016/0022-1759(95)00067-K; Roos A, 2006, J IMMUNOL METHODS, V309, P108, DOI 10.1016/j.jim.2005.11.017; Ruseva M, 2009, IMMUNOLOGY, V127, P279, DOI 10.1111/j.1365-2567.2008.03016.x; Storsaeter J, 1998, VACCINE, V16, P1907, DOI 10.1016/S0264-410X(98)00227-8; SUMIYA M, 1991, LANCET, V337, P1569, DOI 10.1016/0140-6736(91)93263-9; Takahashi K, 2006, CURR OPIN IMMUNOL, V18, P16, DOI 10.1016/j.coi.2005.11.014; Tang YW, 2007, J INFECT DIS, V196, P1021, DOI 10.1086/521370; Vuononvirta J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026198; Xing D, 2011, J IMMUNOL METHODS, V372, P137, DOI 10.1016/j.jim.2011.07.005	37	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88919	10.1371/journal.pone.0088919	http://dx.doi.org/10.1371/journal.pone.0088919			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558451	gold, Green Submitted, Green Published			2022-12-27	WOS:000331706700097
J	Jayasundar, JJ; Xing, J; Robinson, JM; Cheung, HC; Dong, WJ				Jayasundar, Jayant James; Xing, Jun; Robinson, John M.; Cheung, Herbert C.; Dong, Wen-Ji			Molecular Dynamics Simulations of the Cardiac Troponin Complex Performed with FRET Distances as Restraints	PLOS ONE			English	Article							C CENTRAL HELIX; REGULATORY DOMAIN; STRUCTURAL-CHANGES; INHIBITORY REGION; HYPERTROPHIC CARDIOMYOPATHY; CONFORMATIONAL TRANSITION; CONTAINING-FILAMENTS; TERMINAL DOMAIN; THIN FILAMENT; N-DOMAIN	Cardiac troponin (cTn) is the Ca2+-sensitive molecular switch that controls cardiac muscle activation and relaxation. However, the molecular detail of the switching mechanism and how the Ca2+ signal received at cardiac troponin C (cTnC) is communicated to cardiac troponin I (cTnI) are still elusive. To unravel the structural details of troponin switching, we performed ensemble Forster resonance energy transfer (FRET) measurements and molecular dynamic (MD) simulations of the cardiac troponin core domain complex. The distance distributions of forty five inter-residue pairs were obtained under Ca2+-free and saturating Ca2+ conditions from time-resolved FRET measurements. These distances were incorporated as restraints during the MD simulations of the cardiac troponin core domain. Compared to the Ca2+-saturated structure, the absence of regulatory Ca2+ perturbed the cTnC N-domain hydrophobic pocket which assumed a closed conformation. This event partially unfolded the cTnI regulatory region/switch. The absence of Ca2+, induced flexibility to the D/E linker and the cTnI inhibitory region, and rotated the cTnC N-domain with respect to rest of the troponin core domain. In the presence of saturating Ca2+ the above said phenomenon were absent. We postulate that the secondary structure perturbations experienced by the cTnI regulatory region held within the cTnC N-domain hydrophobic pocket, coupled with the rotation of the cTnC N-domain would control the cTnI mobile domain interaction with actin. Concomitantly the rotation of the cTnC N-domain and perturbation of the D/E linker rigidity would control the cTnI inhibitory region interaction with actin to effect muscle relaxation.	[Jayasundar, Jayant James; Xing, Jun; Dong, Wen-Ji] Washington State Univ, Voiland Sch Chem Engn & Bioengn, Pullman, WA 99164 USA; [Jayasundar, Jayant James; Xing, Jun; Dong, Wen-Ji] Washington State Univ, Dept Integrated Physiol & Neurosci, Pullman, WA 99164 USA; [Robinson, John M.] S Dakota State Univ, Dept Chem & Biochem, Brookings, SD 57007 USA; [Cheung, Herbert C.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL USA	Washington State University; Washington State University; South Dakota State University; University of Alabama System; University of Alabama Birmingham	Dong, WJ (corresponding author), Washington State Univ, Voiland Sch Chem Engn & Bioengn, Pullman, WA 99164 USA.	wdong@vetmed.wsu.edu		Jayasundar, Jayant James/0000-0001-9963-9629	National Institutes of Health [HL80186, HL52508]; M. J. Murdock Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080186, R01HL052508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M. J. Murdock Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was partially supported by National Institutes of Health Grant HL80186 (WJD), National Institutes of Health Grant HL52508 (HCC) and M. J. Murdock Charitable Trust (WJD). This work was supported in part by the research computing resources acquired and managed by UAB IT Research Computing. Any opinions, findings and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the University of Alabama at Birmingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott MB, 2000, J BIOL CHEM, V275, P20610, DOI 10.1074/jbc.M909252199; BABU A, 1993, J BIOL CHEM, V268, P19232; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Calvert MJ, 2000, J BIOL CHEM, V275, P32508, DOI 10.1074/jbc.M005764200; Chandra M, 1997, BIOCHEMISTRY-US, V36, P13305, DOI 10.1021/bi9710129; Cordina NM, 2013, BIOCHEMISTRY-US, V52, P1950, DOI 10.1021/bi4000172; Cordina NM, 2012, PROTEIN SCI, V21, P1376, DOI 10.1002/pro.2124; DOBROWOLSKI Z, 1991, J BIOL CHEM, V266, P5703; Dong WJ, 2008, J BIOL CHEM, V283, P3424, DOI 10.1074/jbc.M703822200; Dong WJ, 2007, BIOCHEMISTRY-US, V46, P9752, DOI 10.1021/bi700574n; Dong WJ, 2006, ARCH BIOCHEM BIOPHYS, V456, P135, DOI 10.1016/j.abb.2006.08.007; Dong WJ, 1997, BIOCHEMISTRY-US, V36, P6754, DOI 10.1021/bi9622276; Dong WJ, 1999, J BIOL CHEM, V274, P31382, DOI 10.1074/jbc.274.44.31382; Dong WJ, 2003, J BIOL CHEM, V278, P8686, DOI 10.1074/jbc.M212886200; Dong WJ, 2001, J MOL BIOL, V314, P51, DOI 10.1006/jmbi.2001.5118; DOSREMEDIOS CG, 1995, J STRUCT BIOL, V115, P175, DOI 10.1006/jsbi.1995.1042; EBASHI S, 1969, Quarterly Reviews of Biophysics, V2, P351; FARAH CS, 1995, FASEB J, V9, P755, DOI 10.1096/fasebj.9.9.7601340; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Franklin AJ, 2012, BIOPHYS J, V102, P2536, DOI 10.1016/j.bpj.2012.04.037; Gaponenko V, 1999, J BIOL CHEM, V274, P16681, DOI 10.1074/jbc.274.24.16681; Genchev GZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058313; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; HASELGROVE JC, 1973, COLD SPRING HARB SYM, V37, P341, DOI 10.1101/SQB.1973.037.01.044; Howarth JW, 2007, J MOL BIOL, V373, P706, DOI 10.1016/j.jmb.2007.08.035; HUXLEY HE, 1973, COLD SPRING HARB SYM, V37, P361, DOI 10.1101/SQB.1973.037.01.046; JIN JP, 1989, J BIOL CHEM, V264, P14471; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Kowlessur D, 2010, J BIOL CHEM, V285, P2686, DOI 10.1074/jbc.M109.062349; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Manning EP, 2011, BIOCHEMISTRY-US, V50, P7405, DOI 10.1021/bi200506k; PARKER CA, 1960, ANALYST, V85, P587, DOI 10.1039/an9608500587; PARRY DAD, 1973, J MOL BIOL, V75, P33, DOI 10.1016/0022-2836(73)90527-5; Pirani A, 2006, J MOL BIOL, V357, P707, DOI 10.1016/j.jmb.2005.12.050; POTTER JD, 1975, J BIOL CHEM, V250, P4628; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Ramakrishnan S, 1995, BIOCHEMISTRY-US, V34, P16789, DOI 10.1021/bi00051a029; Ritchie DW, 2005, J APPL CRYSTALLOGR, V38, P808, DOI 10.1107/S002188980502474X; ROBERTSON SP, 1981, BIOPHYS J, V34, P559, DOI 10.1016/S0006-3495(81)84868-0; Robinson JM, 2004, J MOL BIOL, V340, P295, DOI 10.1016/j.jmb.2004.04.046; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Schmidtmann A, 2005, FEBS J, V272, P6087, DOI 10.1111/j.1742-4658.2005.05001.x; Sheldahl C, 2003, BIOPHYS J, V84, P1057, DOI 10.1016/S0006-3495(03)74922-4; SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234; Spyracopoulos L, 1997, BIOCHEMISTRY-US, V36, P12138, DOI 10.1021/bi971223d; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Varughese JF, 2010, J BIOMOL STRUCT DYN, V28, P159, DOI 10.1080/07391102.2010.10507350; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Xing J, 2009, J BIOL CHEM, V284, P16432, DOI 10.1074/jbc.M808075200	54	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e87135	10.1371/journal.pone.0087135	http://dx.doi.org/10.1371/journal.pone.0087135			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558365	Green Submitted, gold, Green Published			2022-12-27	WOS:000331706700011
J	Mondhe, M; Chessher, A; Goh, S; Good, L; Stach, JEM				Mondhe, Madhav; Chessher, Ashley; Goh, Shan; Good, Liam; Stach, James E. M.			Species-Selective Killing of Bacteria by Antimicrobial Peptide-PNAs	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; ANTIBIOTIC-RESISTANCE; NONCODING RNA; INHIBITION; GROWTH; SEQUENCE; TRANSLATION; DATABASE; CORE	Broad-spectrum antimicrobials kill indiscriminately, a property that can lead to negative clinical consequences and an increase in the incidence of resistance. Species-specific antimicrobials that could selectively kill pathogenic bacteria without targeting other species in the microbiome could limit these problems. The pathogen genome presents an excellent target for the development of such antimicrobials. In this study we report the design and evaluation of species-selective peptide nucleic acid (PNA) antibacterials. Selective growth inhibition of B. subtilis, E. coli, K. pnuemoniae and S. enterica serovar Typhimurium in axenic or mixed culture could be achieved with PNAs that exploit species differences in the translation initiation region of essential genes. An S. Typhimurium-specific PNA targeting ftsZ resulted in elongated cells that were not observed in E. coli, providing phenotypic evidence of the selectivity of PNA-based antimicrobials. Analysis of the genomes of E. coli and S. Typhimurium gave a conservative estimate of >150 PNA targets that could potentially discriminate between these two closely related species. This work provides a basis for the development of a new class of antimicrobial with a tuneable spectrum of activity.	[Mondhe, Madhav; Chessher, Ashley; Stach, James E. M.] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Goh, Shan] Univ London, Royal Vet Coll, Dept Pathol & Infect Dis, London, England	Newcastle University - UK; University of London; University of London Royal Veterinary College	Stach, JEM (corresponding author), Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	jem.stach@ncl.ac.uk	Goh, Shan/A-7261-2010	Goh, Shan/0000-0002-9028-0303; Good, Liam/0000-0002-2798-8640; Stach, James/0000-0001-8787-2407	Nuffield Foundation [NAL/01166/G]	Nuffield Foundation	Nuffield Foundation (NAL/01166/G) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P29, DOI 10.1093/jac/48.suppl_1.29; Andrews JM, 2009, BSAC METHODS ANTIMIC; Casadevall A, 2009, EXPERT OPIN PHARMACO, V10, P1699, DOI 10.1517/14656560903066837; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dryselius R, 2003, OLIGONUCLEOTIDES, V13, P427, DOI 10.1089/154545703322860753; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Faridani OR, 2006, NUCLEIC ACIDS RES, V34, P5915, DOI 10.1093/nar/gkl750; Foliaki S, 2009, J ALLERGY CLIN IMMUN, V124, P982, DOI 10.1016/j.jaci.2009.08.017; Fowler S, 2007, J ANTIMICROB CHEMOTH, V59, P990, DOI 10.1093/jac/dkm014; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; Ghosal A, 2013, ACS CHEM BIOL, V8, P360, DOI 10.1021/cb300434e; Giesen U, 1998, NUCLEIC ACIDS RES, V26, P5004, DOI 10.1093/nar/26.21.5004; Goh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006061; Good L, 2001, NAT BIOTECHNOL, V19, P360, DOI 10.1038/86753; Good L, 2000, MICROBIOL-SGM, V146, P2665, DOI 10.1099/00221287-146-10-2665; Good L, 1998, P NATL ACAD SCI USA, V95, P2073, DOI 10.1073/pnas.95.5.2073; Good Liam, 2002, Methods Mol Biol, V208, P237; Hacek DM, 1999, J CLIN MICROBIOL, V37, P1881, DOI 10.1128/JCM.37.6.1881-1884.1999; Harth G, 2000, P NATL ACAD SCI USA, V97, P418, DOI 10.1073/pnas.97.1.418; Hatamoto M, 2009, APPL MICROBIOL BIOT, V84, P1161, DOI 10.1007/s00253-009-2099-0; Hoban Daryl J, 2003, Clin Cornerstone, VSuppl 3, pS12; Jayaraman R, 2009, CURR SCI INDIA, V96, P1475; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Knuth K, 2004, MOL MICROBIOL, V51, P1729, DOI 10.1046/j.1365-2958.2003.03944.x; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kurupati P, 2007, ANTIMICROB AGENTS CH, V51, P805, DOI 10.1128/AAC.00709-06; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lemon KP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004183; Levin PA, 2002, METHOD MICROBIOL, V31, P115, DOI 10.1016/S0580-9517(02)31007-9; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Menossi M, 2000, BIOTECHNIQUES, V28, P424, DOI 10.2144/00283bm06; Nekhotiaeva N, 2004, MOL THER, V10, P652, DOI 10.1016/j.ymthe.2004.07.006; Pfeiffer V, 2007, MOL MICROBIOL, V66, P1174, DOI 10.1111/j.1365-2958.2007.05991.x; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Shen N, 2009, P NATL ACAD SCI USA, V106, P8163, DOI 10.1073/pnas.0903491106; Tilley LD, 2006, ANTIMICROB AGENTS CH, V50, P2789, DOI 10.1128/AAC.01286-05; Velicer CM, 2004, JAMA-J AM MED ASSOC, V291, P827, DOI 10.1001/jama.291.7.827; Vogel J, 2009, MOL MICROBIOL, V71, P1, DOI 10.1111/j.1365-2958.2008.06505.x; White DG, 1997, ANTIMICROB AGENTS CH, V41, P2699, DOI 10.1128/AAC.41.12.2699; Yates CM, 2006, BIOL LETT-UK, V2, P463, DOI 10.1098/rsbl.2006.0478; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858	42	49	54	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89082	10.1371/journal.pone.0089082	http://dx.doi.org/10.1371/journal.pone.0089082			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558473	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700119
J	Uda, A; Sekizuka, T; Tanabayashi, K; Fujita, O; Kuroda, M; Hotta, A; Sugiura, N; Sharma, N; Morikawa, S; Yamada, A				Uda, Akihiko; Sekizuka, Tsuyoshi; Tanabayashi, Kiyoshi; Fujita, Osamu; Kuroda, Makoto; Hotta, Akitoyo; Sugiura, Naoko; Sharma, Neekun; Morikawa, Shigeru; Yamada, Akio			Role of Pathogenicity Determinant Protein C (PdpC) in Determining the Virulence of the Francisella tularensis Subspecies tularensis SCHU	PLOS ONE			English	Article							INTRAMACROPHAGE GROWTH; FUNCTIONAL-CHARACTERIZATION; IDENTIFICATION; CELLS; MACROPHAGES; TULAREMIA; INFECTION; STRAIN; GENES; MICE	Francisella tularensis subspecies tularensis, the etiological agent of tularemia, is highly pathogenic to humans and animals. However, the SCHU strain of F. tularensis SCHU P0 maintained by passaging in artificial media has been found to be attenuated. To better understand the molecular mechanisms behind the pathogenicity of F. tularensis SCHU, we attempted to isolate virulent bacteria by serial passages in mice. SCHU P5 obtained after 5th passages in mice remained avirulent, while SCHU P9 obtained after 9th passages was completely virulent in mice. Moreover, SCHU P9 grew more efficiently in J774.1 murine macrophages compared with that in the less pathogenic SCHU P0 and P5. Comparison of the nucleotide sequences of the whole genomes of SCHU P0, P5, and P9 revealed only 1 nucleotide difference among P0, P5 and P9 in 1 of the 2 copies of pathogenicity determinant protein C (pdpC) gene. An adenine residue deletion was observed in the pdpC1 gene of SCHU P0, P5, and P9 and in the pdpC2 gene of SCHU P0, and P5, while P9 was characterized by the wild type pdpC2 gene. Thus, SCHU P0 and P5 expressed only truncated forms of PdpC protein, while SCHU P9 expressed both wild type and truncated versions. To validate the pathogenicity of PdpC, both copies of the pdpC gene in SCHU P9 have been inactivated by Targetron mutagenesis. SCHU P9 mutants with inactivated pdpC gene showed low intracellular growth in J774.1 cells and did not induce severe disease in experimentally infected mice, while virulence of the mutants was restored by complementation with expression of the intact PdpC. These results demonstrate that PdpC is crucial in determining the virulence of F. tularensis SCHU.	[Uda, Akihiko; Tanabayashi, Kiyoshi; Fujita, Osamu; Hotta, Akitoyo; Sugiura, Naoko; Sharma, Neekun; Morikawa, Shigeru] Natl Inst Infect Dis, Dept Vet Sci, Shinjuku Ku, Tokyo, Japan; [Sekizuka, Tsuyoshi; Kuroda, Makoto] Natl Inst Infect Dis, Pathogen Genom Ctr, Shinjuku Ku, Tokyo, Japan; [Sugiura, Naoko; Sharma, Neekun] Gifu Univ, United Grad Sch Vet Sci, Gifu, Japan; [Yamada, Akio] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Vet Publ Hlth, Bunkyo Ku, Tokyo, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Gifu University; University of Tokyo	Tanabayashi, K (corresponding author), Natl Inst Infect Dis, Dept Vet Sci, Shinjuku Ku, Tokyo, Japan.	ktana@nih.go.jp		MORIKAWA, SHIGERU/0000-0001-6249-6716; Sekizuka, Tsuyoshi/0000-0002-1302-5472; Sharma, Neekun/0000-0002-4456-8074	Ministry of Health, Labour and Welfare of Japan [H22-Shinkou-Ippan-010]; Japan Society for the Promotion of Science [23790489]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was partly supported by the Health Science Research Grants from the Ministry of Health, Labour and Welfare of Japan (H22-Shinkou-Ippan-010; http://www.mhlw.go.jp/seisakunitsuite/bunya/hokabunya/kenkyujigyou/) and Grant-in-Aid for Young Scientists (B) from Japan Society for the Promotion of Science (23790489; http://www.jsps.go.jp/j-grantsinaid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlund MK, 2010, INFECT IMMUN, V78, P3118, DOI 10.1128/IAI.00146-10; Alkhuder K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008966; Andersson H, 2006, J MED MICROBIOL, V55, P263, DOI 10.1099/jmm.0.46313-0; Baron GS, 1998, MOL MICROBIOL, V29, P247, DOI 10.1046/j.1365-2958.1998.00926.x; Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792; Broms JE, 2009, J BACTERIOL, V191, P2431, DOI 10.1128/JB.01759-08; Cheung KKM, 2007, THESIS U VICTORIA; Chong A, 2008, INFECT IMMUN, V76, P5488, DOI 10.1128/IAI.00682-08; Clemens DL, 2005, INFECT IMMUN, V73, P5892, DOI 10.1128/IAI.73.9.5892-5902.2005; CONLAN JW, 1992, INFECT IMMUN, V60, P5164, DOI 10.1128/IAI.60.12.5164-5171.1992; de Bruin OM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-1; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; EIGELSBACH HT, 1951, J BACTERIOL, V61, P557, DOI 10.1128/JB.61.5.557-569.1951; Eliasson H, 2007, SCAND J INFECT DIS, V39, P880, DOI 10.1080/00365540701402970; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Fortier A H, 1994, Immunol Ser, V60, P349; FORTIER AH, 1995, INFECT IMMUN, V63, P1478, DOI 10.1128/IAI.63.4.1478-1483.1995; FORTIER AH, 1992, INFECT IMMUN, V60, P817, DOI 10.1128/IAI.60.3.817-825.1992; FUJITA H, 1993, MICROBIOL IMMUNOL, V37, P837, DOI 10.1111/j.1348-0421.1993.tb01713.x; Golovliov I, 1997, INFECT IMMUN, V65, P2183, DOI 10.1128/IAI.65.6.2183-2189.1997; Golovliov I, 2003, INFECT IMMUN, V71, P5940, DOI 10.1128/IAI.71.10.5940-5950.2003; He YQ, 2007, COMPARATIVE MED, V57, P18; HESSELBROCK W, 1945, J BACTERIOL, V49, P209, DOI 10.1128/JB.49.3.209-231.1945; Kadzhaev K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005463; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lindgren H, 2009, INFECT IMMUN, V77, P4429, DOI 10.1128/IAI.00702-09; Lindgren M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-20; Long ME, 2012, INFECT IMMUN; Nano FE, 2004, J BACTERIOL, V186, P6430, DOI 10.1128/JB.186.19.6430-6436.2004; Pandya GA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-213; Pechous RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002487; Petersen JM, 2009, VET RES, V40, DOI 10.1051/vetres:2008045; Pomerantsev AP, 2001, PLASMID, V46, P86, DOI 10.1006/plas.2001.1538; Qin AP, 2009, INFECT IMMUN, V77, P152, DOI 10.1128/IAI.01113-08; Read A, 2008, J MED ENTOMOL, V45, P1108, DOI 10.1603/0022-2585(2008)45[1108:FGRFRI]2.0.CO;2; Rodriguez SA, 2008, APPL ENVIRON MICROB, V74, P2619, DOI 10.1128/AEM.02905-07; Russo BC, 2011, INFECT IMMUN, V79, P3665, DOI 10.1128/IAI.00135-11; SATO KYUZO, 1960, JAPANESE JOUR BACT, V15, P51; Schulert GS, 2009, INFECT IMMUN, V77, P1324, DOI 10.1128/IAI.01318-08; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Sjodin A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011556; Sullivan JT, 2006, J BACTERIOL, V188, P3785, DOI 10.1128/JB.00027-06; THORPE BD, 1964, J IMMUNOL, V93, P558; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Twine SM, 2006, BIOCHEM BIOPH RES CO, V345, P1621, DOI 10.1016/j.bbrc.2006.05.070; Zaide G, 2011, APPL ENVIRON MICROB, V77, P1608, DOI 10.1128/AEM.01862-10	47	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89075	10.1371/journal.pone.0089075	http://dx.doi.org/10.1371/journal.pone.0089075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558472	gold, Green Published, Green Submitted			2022-12-27	WOS:000331706700118
J	Vanneste, S; Joos, K; Langguth, B; To, WT; De Ridder, D				Vanneste, Sven; Joos, Kathleen; Langguth, Berthold; To, Wing Ting; De Ridder, Dirk			Neuronal Correlates of Maladaptive Coping: An EEG-Study in Tinnitus Patients	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; DEFAULT-MODE NETWORK; ALPHA OSCILLATIONS; PREFRONTAL CORTEX; BRAIN; PERCEPTION; DEPRESSION; SEVERITY; PAIN; DYSREGULATION	Here we aimed to investigate the neuronal correlates of different coping styles in patients suffering from chronic tinnitus. Adaptive and maladaptive coping styles were determined in 85 tinnitus patients. Based on resting state EEG recordings, coping related differences in brain activity and connectivity were found. Maladaptive coping behavior was related to increases in subjective tinnitus loudness and distress, higher tinnitus severity and higher depression scores. EEG recordings demonstrated increased alpha activity over the left dorsolateral prefrontal cortex (DLPFC) and subgenual anterior cingulate cortex (sgACC) as well as increased connectivity in the default (i.e. resting state) network in tinnitus patients with a maladaptive coping style. Correlation analysis revealed that the changes in the DLPFC correlate primarily with maladaptive coping behavior, whereas the changes in the sgACC correlate with tinnitus severity and depression. Our findings are in line with previous research in the field of depression that during resting state a alpha band hyperconnectivity exists within the default network for patients who use a maladaptive coping style, with the sgACC as the dysfunctional node and that the strength of the connectivity is related to focusing on negative mood and catastrophizing about the consequences of tinnitus.	[Vanneste, Sven; Joos, Kathleen] Univ Antwerp, Dept Translat Neurosci, Fac Med, B-2020 Antwerp, Belgium; [Vanneste, Sven] Univ Texas Richardson, Sch Behav & Brain Sci, Richardson, TX USA; [Langguth, Berthold] Univ Regensburg, Dept Psychiat & Psychotherapy, D-93053 Regensburg, Germany; [To, Wing Ting] Univ Coll Ghent, Fac Social Work & Welf Studies, Ghent, Belgium; [De Ridder, Dirk] Univ Otago, Dunedin Sch Med, Dept Surg Sci, Dunedin, New Zealand; [De Ridder, Dirk] Sint Augustinus Hosp, BRAI2N, Antwerp, Belgium	University of Antwerp; University of Texas System; University of Texas Dallas; University of Regensburg; HOGENT University College of Applied Sciences & Arts; University of Otago	Vanneste, S (corresponding author), Univ Antwerp, Dept Translat Neurosci, Fac Med, B-2020 Antwerp, Belgium.	sven.vanneste@utdallas.edu	Langguth, Berthold/AAP-2638-2021	Vanneste, Sven/0000-0003-1513-5752				Abler B, 2008, NEUROREPORT, V19, P21, DOI 10.1097/WNR.0b013e3282f3adeb; Andolina D, 2013, NEUROPSYCHOPHARMACOL, V38, P2057, DOI 10.1038/npp.2013.107; AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Berman M.G., 2010, SOC COGN AFFECT NEUR; Bijttebier P, 1997, PERS INDIV DIFFER, V23, P157, DOI 10.1016/S0191-8869(97)00012-3; Botteron KN, 2002, BIOL PSYCHIAT, V51, P342, DOI 10.1016/S0006-3223(01)01280-X; BOUMAN TK, 1985, GEDRAG GEZOND, V13, P13; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Budd RJ, 1995, J PSYCHOSOM RES, V39, P1015, DOI 10.1016/0022-3999(95)00512-9; Budd RJ, 1996, J PSYCHOSOM RES, V41, P327, DOI 10.1016/S0022-3999(96)00171-7; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Cohen J., 2003, APPL MULTIPLE REGRES; Congedo M., 2002, EUREKA VERSION 3 0 C; Congedo M, 2010, BRAIN TOPOGR, V23, P134, DOI 10.1007/s10548-009-0113-6; Cooney RE, 2010, COGN AFFECT BEHAV NE, V10, P470, DOI 10.3758/CABN.10.4.470; De Ridder D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024273; Dobie RA, 2003, OTOLARYNG CLIN N AM, V36, P383, DOI 10.1016/S0030-6665(02)00168-8; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Faber M, 2011, BRAIN STIMUL; Fletcher K, 2013, COMPR PSYCHIAT; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Frank E., 2011, J NEUROL; Fregni F, 2006, EUR J NEUROL, V13, P996, DOI 10.1111/j.1468-1331.2006.01414.x; Freund W, 2007, SOMATOSENS MOT RES, V24, P203, DOI 10.1080/08990220701723636; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; Geyer MA, 2008, TRENDS PHARMACOL SCI, V29, P445, DOI 10.1016/j.tips.2008.06.006; GOEBEL G, 1994, HNO, V42, P166; Green MJ, 2011, ACTA PSYCHIAT SCAND, V124, P307, DOI 10.1111/j.1600-0447.2011.01718.x; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hamilton JP, 2011, BIOL PSYCHIAT; Jann K, 2009, NEUROIMAGE, V45, P903, DOI 10.1016/j.neuroimage.2009.01.001; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Joos K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040544; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Kirschner A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00139; Kleinjung T, 2008, OTOLARYNG HEAD NECK, V138, P497, DOI 10.1016/j.otohns.2007.12.022; Knyazev GG, 2013, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00348; Knyazev GG, 2012, NEUROSCI BIOBEHAV R, V36, P677, DOI 10.1016/j.neubiorev.2011.10.002; Knyazev GG, 2011, BRAIN RES, V1402, P67, DOI 10.1016/j.brainres.2011.05.052; Kross E, 2009, BIOL PSYCHIAT, V65, P361, DOI 10.1016/j.biopsych.2008.10.019; Landgrebe M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005026; Langguth B, 2011, WORLD J BIOL PSYCHIA, V12, P489, DOI 10.3109/15622975.2011.575178; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; MARRIAGE J, 1995, J LARYNGOL OTOL, V109, P915, DOI 10.1017/S0022215100131676; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Meeus O, 2007, B-ENT, P11; Mirz F, 2000, ACTA OTO-LARYNGOL, P241; Mo J, 2013, NEUROIMAGE, V68, P112, DOI 10.1016/j.neuroimage.2012.11.058; Moisset X, 2007, NEUROIMAGE, V37, pS80, DOI 10.1016/j.neuroimage.2007.03.054; Moller AR, 2007, PROG BRAIN RES, V166, P47, DOI 10.1016/S0079-6123(07)66004-X; Muhlau M, 2006, CEREB CORTEX, V16, P1283, DOI 10.1093/cercor/bhj070; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; Nejad AB, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00666; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pascual-Marqui R. D., 2007, ARXIV07111455; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pascual-Marqui RD, 2011, PHILOS T R SOC A, V369, P3768, DOI 10.1098/rsta.2011.0081; Piccirillo JF, 2013, JAMA OTOLARYNGOL, V139, P388, DOI 10.1001/jamaoto.2013.233; Plazier M., 2011, BRAIN STIMUL; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Schacter DL, 2012, NEURON, V76, P677, DOI 10.1016/j.neuron.2012.11.001; Schacter Daniel L, 2012, Dialogues Clin Neurosci, V14, P7; Schwarzer R, 1995, HDB COPING THEORY RE; Scott B, 2000, PSYCHOSOMATICS, V41, P347, DOI 10.1176/appi.psy.41.4.347; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Simpson JJ, 2000, HEARING RES, V145, P1, DOI 10.1016/S0378-5955(00)00093-9; Vanneste S, 2013, CEREB CORTEX; Vanneste S, 2012, BRAIN TOPOGR, V25, P97, DOI 10.1007/s10548-011-0191-0; Vanneste S, 2011, BRAIN STIMUL, V4, P242, DOI 10.1016/j.brs.2010.12.001; Vanneste S, 2011, EXP BRAIN RES, V210, P217, DOI 10.1007/s00221-011-2617-z; Vanneste S, 2010, NEUROIMAGE, V52, P470, DOI 10.1016/j.neuroimage.2010.04.029; Vanneste S, 2010, EXP BRAIN RES, V202, P779, DOI 10.1007/s00221-010-2183-9; von Leupoidt A, 2009, AM J RESP CRIT CARE, V180, P232, DOI 10.1164/rccm.200902-0300OC; von Leupoldt A, 2009, NEUROIMAGE, V48, P200, DOI 10.1016/j.neuroimage.2009.06.015; Weisz N, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00073	81	25	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88253	10.1371/journal.pone.0088253	http://dx.doi.org/10.1371/journal.pone.0088253			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558383	Green Submitted, gold, Green Published			2022-12-27	WOS:000331706700029
J	Polanska, E; Pospisilova, S; Stros, M				Polanska, Eva; Pospisilova, Sarka; Stros, Michal			Binding of Histone H1 to DNA Is Differentially Modulated by Redox State of HMGB1	PLOS ONE			English	Article							CHROMOSOMAL-PROTEIN HMG1; LINKER HISTONES; CHROMATIN; DOMAINS; ASSOCIATION; CYTOKINE; B4	HMGB1 is an architectural protein in chromatin, acting also as a signaling molecule outside the cell. Recent reports from several laboratories provided evidence that a number of both the intracellular and extracellular functions of HMGB1 may depend on redox-sensitive cysteine residues of the protein. In this study we demonstrate that redox state of HMGB1 can significantly modulate the ability of the protein to bind and bend DNA, as well as to promote DNA end-joining. We also report a high affinity binding of histone H1 to hemicatenated DNA loops and DNA minicircles. Finally, we show that reduced HMGB1 can readily displace histone H1 from DNA, while oxidized HMGB1 has limited capacity for H1 displacement. Our results suggested a novel mechanism for the HMGB1-mediated modulation of histone H1 binding to DNA. Possible biological consequences of linker histones H1 replacement by HMGB1 for the functioning of chromatin are discussed.	[Polanska, Eva; Stros, Michal] Acad Sci Czech Republ, Inst Biophys, Lab Anal Chromosomal Prot, CS-61265 Brno, Czech Republic; [Pospisilova, Sarka; Stros, Michal] Masaryk Univ, Ctr Mol Med, Cent European Inst Technol CEITEC, Brno, Czech Republic	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Masaryk University Brno	Stros, M (corresponding author), Acad Sci Czech Republ, Inst Biophys, Lab Anal Chromosomal Prot, Kralovopolska 135, CS-61265 Brno, Czech Republic.	stros@ibp.cz	Pospisilova, Sarka/D-7200-2012	Pospisilova, Sarka/0000-0001-7136-2680	Grant Agency of the Czech Republic [P305/12/2475]; EU [286154-SYLICA]; European Regional Development Fund [CEITEC CZ. 1.05/1.1.00/02.0068]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); EU(European Commission); European Regional Development Fund(European Commission)	Financial support was provided through the Grant Agency of the Czech Republic (Grant P305/12/2475 awarded to MS.). The research was also supported by the EU 7th Framework program under the "Capacities'' specific program (contract No. 286154-SYLICA) and by European Regional Development Fund CEITEC CZ. 1.05/1.1.00/02.0068. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; BILLINGS PC, 1992, BIOCHEM BIOPH RES CO, V188, P1286, DOI 10.1016/0006-291X(92)91371-V; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; CARBALLO M, 1983, EMBO J, V2, P1759, DOI 10.1002/j.1460-2075.1983.tb01654.x; Catez F, 2004, MOL CELL BIOL, V24, P4321, DOI 10.1128/MCB.24.10.4321-4328.2004; Cato L, 2008, J MOL BIOL, V384, P1262, DOI 10.1016/j.jmb.2008.10.001; CHOW CS, 1995, BIOCHEMISTRY-US, V34, P2956, DOI 10.1021/bi00009a027; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; Gaillard Claire, 2000, BMC Biochemistry, V1, P1; Grabarz A, 2012, AM J CANCER RES, V2, P249; Hendzel MJ, 2004, J BIOL CHEM, V279, P20028, DOI 10.1074/jbc.M400070200; Hoppe G, 2006, EXP CELL RES, V312, P3526, DOI 10.1016/j.yexcr.2006.07.020; Izzo A, 2008, BIOL CHEM, V389, P333, DOI 10.1515/BC.2008.037; JACKSON JB, 1979, BIOCHEMISTRY-US, V18, P3739, DOI 10.1021/bi00584a015; Jaouen S, 2005, J MOL BIOL, V353, P822, DOI 10.1016/j.jmb.2005.08.073; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Li GQ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00068; Lu X, 2004, J BIOL CHEM, V279, P8701, DOI 10.1074/jbc.M311348200; Lyubchenko YL, 2002, NUCLEIC ACIDS RES, V30, P4902, DOI 10.1093/nar/gkf626; Nagaki S, 1998, BIOCHEM BIOPH RES CO, V246, P137, DOI 10.1006/bbrc.1998.8589; NER SS, 1994, EMBO J, V13, P1817, DOI 10.1002/j.1460-2075.1994.tb06450.x; Nightingale K, 1996, EMBO J, V15, P548, DOI 10.1002/j.1460-2075.1996.tb00387.x; OGAWA Y, 1995, J BIOL CHEM, V270, P9272, DOI 10.1074/jbc.270.16.9272; Park S, 2011, BIOCHEMISTRY-US, V50, P2567, DOI 10.1021/bi2000214; SHEFLIN LG, 1993, BIOCHEMISTRY-US, V32, P3238, DOI 10.1021/bi00064a005; SIROTKIN AM, 1995, P NATL ACAD SCI USA, V92, P6434, DOI 10.1073/pnas.92.14.6434; Stros M, 1998, EUR J BIOCHEM, V251, P427, DOI 10.1046/j.1432-1327.1998.2510427.x; STROS M, 1990, INT J BIOL MACROMOL, V12, P282, DOI 10.1016/0141-8130(90)90014-2; Stros M, 1998, J BIOL CHEM, V273, P10355; Stros M, 2004, BIOCHEMISTRY-US, V43, P7215, DOI 10.1021/bi049928k; STROS M, 1994, FEBS LETT, V344, P201, DOI 10.1016/0014-5793(94)00364-5; Stros M, 2000, EUR J BIOCHEM, V267, P4088, DOI 10.1046/j.1432-1327.2000.01450.x; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Tang DL, 2012, MOL MED, V18, P1360, DOI 10.2119/molmed.2012.00314; Ura K, 1996, EMBO J, V15, P4959, DOI 10.1002/j.1460-2075.1996.tb00876.x; VARGAWEISZ P, 1993, J BIOL CHEM, V268, P20699; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Villar-Garea A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001553; Webb M, 2001, J MOL BIOL, V309, P79, DOI 10.1006/jmbi.2001.4667; Yaneva J, 1997, P NATL ACAD SCI USA, V94, P13448, DOI 10.1073/pnas.94.25.13448; Zlatanova J, 1998, BIOESSAYS, V20, P584, DOI 10.1002/(SICI)1521-1878(199807)20:7<584::AID-BIES10>3.0.CO;2-W	41	20	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89070	10.1371/journal.pone.0089070	http://dx.doi.org/10.1371/journal.pone.0089070			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551219	Green Submitted, gold, Green Published			2022-12-27	WOS:000331266000098
J	Solano, E; Taylor, PJ; Rautenbach, A; Ropiquet, A; Castiglia, R				Solano, Emanuela; Taylor, Peter J.; Rautenbach, Anita; Ropiquet, Anne; Castiglia, Riccardo			Cryptic Speciation and Chromosomal Repatterning in the South African Climbing Mice Dendromus (Rodentia, Nesomyidae)	PLOS ONE			English	Article							MUROID RODENTS; EVOLUTION; DIVERGENCE; PHYLOGENY; AUTOSOME; TRANSLOCATIONS; PHYLOGEOGRAPHY; DIVERSITY; PATTERNS; MAMMALS	We evaluate the intra-and interspecific diversity in the four South African rodent species of the genus Dendromus. The molecular phylogenetic analysis on twenty-three individuals have been conducted on a combined dataset of nuclear and mitochondrial markers. Moreover, the extent and processes underlying chromosomal variation, have been investigated on three species by mean of G-, C-bands, NORs and Zoo-FISH analysis. The molecular analysis shows the presence of six monophyletic lineages corresponding to D. mesomelas, D. mystacalis and four lineages within D. cfr. melanotis with high divergence values (ranges: 10.6% - 18.3%) that raises the question of the possible presence of cryptic species. The first description of the karyotype for D. mesomelas and D. mystacalis and C-and G-banding for one lineage of D. cfr. melanotis are reported highlighting an extended karyotype reorganization in the genus. Furthermore, the G-banding and Zoo-FISH evidenced an autosome-sex chromosome translocation characterizing all the species and our timing estimates this mutation date back 7.4 mya (Late Miocene). Finally, the molecular clock suggests that cladogenesis took place since the end of Miocene to Plio-Pleistocene, probably due to ecological factors, isolation in refugia followed by differential adaptation to the mesic or dry habitat.	[Solano, Emanuela; Castiglia, Riccardo] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, I-00185 Rome, Italy; [Taylor, Peter J.] Sch Environm Sci, Dept Ecol & Resource Management, Thohoyandou, South Africa; [Taylor, Peter J.; Rautenbach, Anita] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa; [Ropiquet, Anne] Univ London Imperial Coll Sci Technol & Med, Ascot, Berks, England	Sapienza University Rome; University of Kwazulu Natal; Imperial College London	Solano, E (corresponding author), Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	emanuela.solano@uniroma1.it	Taylor, Peter/E-8655-2011; Ropiquet, Anne/E-6154-2011; Taylor, Peter John/N-3172-2019; Ropiquet, Anne/AAC-5042-2021	Taylor, Peter/0000-0001-9048-7366; Ropiquet, Anne/0000-0003-3755-5467; Castiglia, Riccardo/0000-0002-9011-302X; solano, emanuela/0000-0001-8482-9243	University of Stellenbosch; South African National Research Foundation	University of Stellenbosch; South African National Research Foundation(National Research Foundation - South Africa)	Part of this study was carried out during the post-doctoral fellowship of E. Solano at the University of Stellenbosch and the work was supported by the South African National Research Foundation and the University of Stellenbosch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley T, 2002, CYTOGENET GENOME RES, V96, P33, DOI 10.1159/000063030; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; Castiglia R, 2006, J ZOOL SYST EVOL RES, V44, P223, DOI 10.1111/j.1439-0469.2006.00356.x; Castiglia R, 2014, MAMMAL REV, V44, P1, DOI 10.1111/mam.12009; Chase BM, 2007, EARTH-SCI REV, V84, P103, DOI 10.1016/j.earscirev.2007.06.002; CONROY GC, 1992, NATURE, V356, P144, DOI 10.1038/356144a0; Denys C, 2012, MAMMALIA, V76, P295, DOI 10.1515/mammalia-2011-0012; Deuve JL, 2008, CHROMOSOMA, V117, P211, DOI 10.1007/s00412-007-0140-6; Deuve JL, 2006, CHROMOSOME RES, V14, P681, DOI 10.1007/s10577-006-1080-3; Dippenaar N. J., 1983, ANN MUS ROY AFR, V237, P1; Dobigny G, 2002, CYTOGENET GENOME RES, V98, P75, DOI 10.1159/000068541; Dobigny G, 2002, CYTOGENET GENOME RES, V96, P117, DOI 10.1159/000063044; Drummond AJ, 2007, ROUGH GUIDE BEAST 1; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; ELLERY WN, 1991, S AFR J SCI, V87, P499; GOODPASTURE C, 1975, CHROMOSOMA, V53, P37, DOI 10.1007/BF00329389; GRAVES JAM, 1994, INT REV CYTOL, V154, P191; GU X, 1995, MOL BIOL EVOL, V12, P546; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; JAEGER JJ, 1986, CR ACAD SCI II, V302, P917; Jansa SA, 2004, MOL PHYLOGENET EVOL, V31, P256, DOI 10.1016/j.ympev.2003.07.002; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MATTHEY R, 1970, Mammalia, V34, P459, DOI 10.1515/mamm.1970.34.3.459; MATTHEY ROBERT, 1967, MAMMALIA, V31, P281, DOI 10.1515/mamm.1967.31.2.281; McKenna MC, 1997, CLASSIFICATION MAMMA; Meester JAJ, 1986, TRANSVAAL MUS MONOGR, V5, P1; Michaux J, 2001, MOL BIOL EVOL, V18, P2017, DOI 10.1093/oxfordjournals.molbev.a003743; Montgelard C, 2012, ACTA OECOL, V42, P50, DOI 10.1016/j.actao.2012.02.001; Musser GG, 2005, MAMMAL SPECIES WORLD, P1; NESBITT MN, 1973, CHROMOSOMA, V41, P145, DOI 10.1007/BF00319691; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Rambau RV, 2003, MOL PHYLOGENET EVOL, V28, P564, DOI 10.1016/S1055-7903(03)00058-7; Rambaut A., 1996, SEQUENCE ALIGNMENT E; Rens W, 2006, NAT PROTOC, V1, P783, DOI 10.1038/nprot.2006.91; SEABRIGH.M, 1971, LANCET, V2, P971; SEARLE JB, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P309; Seddon JM, 2001, MOL ECOL, V10, P2187, DOI 10.1046/j.0962-1083.2001.01357.x; Skinner J.D., 2005, MAMMALS SO AFRICAN S, DOI DOI 10.1017/CBO9781107340992; Solano E, 2011, J ZOOL, V285, P110, DOI 10.1111/j.1469-7998.2011.00820.x; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor P., 1998, SMALLER MAMMALS KWAZ; Taylor PJ, 2009, J ZOOL, V277, P317, DOI 10.1111/j.1469-7998.2008.00542.x; Taylor PJ, 2000, J MAMMAL, V81, P317, DOI 10.1644/1545-1542(2000)081<0317:POCVIS>2.0.CO;2; Tougard C, 2013, BIOL J LINN SOC, V108, P434, DOI 10.1111/j.1095-8312.2012.02034.x; Veyrunes F, 2004, CHROMOSOME RES, V12, P369, DOI 10.1023/B:CHRO.0000034098.09885.e6; Wilson D. E., 2005, MAMMAL SPECIES WORLD	51	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88799	10.1371/journal.pone.0088799	http://dx.doi.org/10.1371/journal.pone.0088799			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551165	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000331266000069
J	Jamal, MS; Parveen, S; Beg, MA; Suhail, M; Chaudhary, AGA; Damanhouri, GA; Abuzenadah, AM; Rehan, M				Jamal, Mohammad S.; Parveen, Shadma; Beg, Mohd A.; Suhail, Mohd; Chaudhary, Adeel G. A.; Damanhouri, Ghazi A.; Abuzenadah, Adel M.; Rehan, Mohd			Anticancer Compound Plumbagin and Its Molecular Targets: A Structural Insight into the Inhibitory Mechanisms Using Computational Approaches	PLOS ONE			English	Article							NF-KAPPA-B; PAN-ACTIVE INHIBITORS; CELL-CYCLE ARREST; BCL-2 FAMILY; CANCER CELLS; INDUCED APOPTOSIS; SCORING FUNCTIONS; IN-VITRO; PROTEIN; STAT3	Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) is a naphthoquinone derivative from the roots of plant Plumbago zeylanica and belongs to one of the largest and diverse groups of plant metabolites. The anticancer and antiproliferative activities of plumbagin have been observed in animal models as well as in cell cultures. Plumbagin exerts inhibitory effects on multiple cancer-signaling proteins, however, the binding mode and the molecular interactions have not yet been elucidated for most of these protein targets. The present study is the first attempt to provide structural insights into the binding mode of plumbagin to five cancer signaling proteins viz. PI3K gamma, AKT1/PKB alpha, Bcl-2, NF-kappa B, and Stat3 using molecular docking and (un) binding simulation analysis. We validated plumbagin docking to these targets with previously known important residues. The study also identified and characterized various novel interacting residues of these targets which mediate the binding of plumbagin. Moreover, the exact modes of inhibition when multiple mode of inhibition existed was also shown. Results indicated that the engaging of these important interacting residues in plumbagin binding leads to inhibition of these cancer-signaling proteins which are key players in the pathogenesis of cancer and thereby ceases the progression of the disease.	[Jamal, Mohammad S.; Beg, Mohd A.; Suhail, Mohd; Chaudhary, Adeel G. A.; Damanhouri, Ghazi A.; Rehan, Mohd] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21413, Saudi Arabia; [Parveen, Shadma] MJP Rohilkhand Univ, Bareilly Coll, Bareilly, UP, India; [Abuzenadah, Adel M.] King Abdulaziz Univ, KACST Technol Innovat Ctr Personalized Med, Jeddah 21413, Saudi Arabia	King Abdulaziz University; Mahatma Jyotiba Phule Rohilkhand University; King Abdulaziz University	Rehan, M (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21413, Saudi Arabia.	mrehan786@gmail.com	Suhail, Mohd/K-2086-2014; Rehan, Mohd/H-9835-2012; Beg, Mohd A/K-3366-2013; Damanhouri, Ghazi/Q-7901-2019; Suhail, Mohd/H-9626-2012	Suhail, Mohd/0000-0002-1641-4633; Beg, Mohd A/0000-0002-8495-4738; Rehan, Mohd/0000-0003-4898-6043	King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia	King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia	The work presented in the research paper was financially supported by the King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya BR, 2008, BIOCHEMISTRY-US, V47, P7838, DOI 10.1021/bi800730q; ACS, 2008, GLOB CANC FACTS FIG, P1; Ahmad A, 2008, J CELL BIOCHEM, V105, P1461, DOI 10.1002/jcb.21966; Aziz MH, 2008, CANCER RES, V68, P9024, DOI 10.1158/0008-5472.CAN-08-2494; Baell JB, 2002, BIOCHEM PHARMACOL, V64, P851, DOI 10.1016/S0006-2952(02)01148-6; Bajwa N, 2012, EXPERT OPIN THER PAT, V22, P37, DOI 10.1517/13543776.2012.644274; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bruncko M, 2007, J MED CHEM, V50, P641, DOI 10.1021/jm061152t; Chen CA, 2009, PANCREATOLOGY, V9, P797, DOI 10.1159/000210028; Cheng HM, 2013, ACS MED CHEM LETT, V4, P91, DOI 10.1021/ml300309h; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Cortes J, 2005, BIOINFORMATICS, V21, pI116, DOI 10.1093/bioinformatics/bti1017; Dandawate P, 2012, BIOORG MED CHEM LETT, V22, P3104, DOI 10.1016/j.bmcl.2012.03.060; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Demma J, 2009, TOXICOL IN VITRO, V23, P266, DOI 10.1016/j.tiv.2008.12.007; Devaurs D, 2013, NUCLEIC ACIDS RES, V41, pW297, DOI 10.1093/nar/gkt380; Dewson G, 2010, CELL HEALTH CYTOSKEL, V2, P9; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Enyedy IJ, 2001, J MED CHEM, V44, P4313, DOI 10.1021/jm010016f; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; FINCO TS, 1994, P NATL ACAD SCI USA, V91, P11884, DOI 10.1073/pnas.91.25.11884; Ghosh KS, 2009, BIOPOLYMERS, V91, P737, DOI 10.1002/bip.21220; Gomathinayagam R, 2008, ANTICANCER RES, V28, P785; Green CJ, 2008, J BIOL CHEM, V283, P27653, DOI 10.1074/jbc.M802623200; Hazra B, 2002, PHYTOTHER RES, V16, P133, DOI 10.1002/ptr.867; He JX, 2012, J BIOSCIENCES, V37, P243, DOI 10.1007/s12038-012-9202-x; Hsu YL, 2006, J PHARMACOL EXP THER, V318, P484, DOI 10.1124/jpet.105.098863; Hubbard S. J., 1993, TECHNICAL REPORT; Jing N, 2005, ANTI-CANCER DRUG, V16, P601, DOI 10.1097/00001813-200507000-00002; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kim HJ, 2006, CELL DEATH DIFFER, V13, P738, DOI 10.1038/sj.cdd.4401877; Kirkin V, 2004, BBA-MOL CELL RES, V1644, P229, DOI 10.1016/j.bbamcr.2003.08.009; Klasa RJ, 2002, ANTISENSE NUCLEIC A, V12, P193, DOI 10.1089/108729002760220798; Knight SD, 2010, ACS MED CHEM LETT, V1, P39, DOI 10.1021/ml900028r; KRISHNASWAMY M, 1980, INDIAN J EXP BIOL, V18, P876; Kuo PL, 2006, MOL CANCER THER, V5, P3209, DOI 10.1158/1535-7163.MCT-06-0478; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lawrie AM, 1997, NAT STRUCT BIOL, V4, P796, DOI 10.1038/nsb1097-796; Letai A, 2004, CANCER CELL, V6, P241, DOI 10.1016/j.ccr.2004.07.011; Lindsley CW, 2007, CURR TOP MED CHEM, V7, P1349; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Loercher A, 2004, CANCER RES, V64, P6511, DOI 10.1158/0008-5472.CAN-04-0852; Ma J, 2003, J BIOL CHEM, V278, P29252, DOI 10.1074/jbc.M304196200; MAHON TM, 1995, J BIOL CHEM, V270, P28557, DOI 10.1074/jbc.270.48.28557; Mandelker D, 2009, P NATL ACAD SCI USA, V106, P16996, DOI 10.1073/pnas.0908444106; Martelli AM, 2006, CELL SIGNAL, V18, P1101, DOI 10.1016/j.cellsig.2006.01.011; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Naresh RAR, 1996, J PHARM PHARMACOL, V48, P1128, DOI 10.1111/j.2042-7158.1996.tb03907.x; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Nazeem S, 2009, MUTAGENESIS, V24, P413, DOI 10.1093/mutage/gep023; PARIMALA R, 1993, MOL CELL BIOCHEM, V125, P59, DOI 10.1007/BF00926835; Persidis A, 1999, NAT BIOTECHNOL, V17, P94, DOI 10.1038/5289; Pikarsky E, 2006, EUR J CANCER, V42, P779, DOI 10.1016/j.ejca.2006.01.011; Powolny AA, 2008, PHARM RES-DORDR, V25, P2171, DOI 10.1007/s11095-008-9533-3; Ravindra KC, 2009, J BIOL CHEM, V284, P24453, DOI 10.1074/jbc.M109.023861; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Reed JC, 1997, J NATL CANCER I, V89, P988, DOI 10.1093/jnci/89.14.988; Robe PA, 2004, CLIN CANCER RES, V10, P5595, DOI 10.1158/1078-0432.CCR-03-0392; Russo GL, 2007, BIOCHEM PHARMACOL, V74, P533, DOI 10.1016/j.bcp.2007.02.014; Sakamoto S, 2009, BIOL PHARM BULL, V32, P434, DOI 10.1248/bpb.32.434; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sandur SK, 2006, J BIOL CHEM, V281, P17023, DOI 10.1074/jbc.M601595200; Sandur SK, 2010, MOL CANCER RES, V8, P107, DOI 10.1158/1541-7786.MCR-09-0257; Shih YW, 2009, HEPATOL RES, V39, P998, DOI 10.1111/j.1872-034X.2009.00540.x; Shukla S, 2007, MOL CANCER THER, V6, P3279, DOI 10.1158/1535-7163.MCT-07-0564; Shuttleworth SJ, 2011, CURR MED CHEM, V18, P2686; Singh U. V., 1997, Indian Journal of Physiology and Pharmacology, V41, P171; Souissi I, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-12; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Steelman LS, 2008, EXPERT OPIN THER TAR, V12, P1139, DOI [10.1517/14728222.12.9.1139, 10.1517/14728222.12.9.1139 ]; Sugie S, 1998, CANCER LETT, V127, P177, DOI 10.1016/S0304-3835(98)00035-4; Thasni KA, 2008, ANN ONCOL, V19, P696, DOI 10.1093/annonc/mdm557; Thasni KA, 2013, MOL CARCINOGEN, V52, P392, DOI 10.1002/mc.21877; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Tzung SP, 2001, NAT CELL BIOL, V3, P183, DOI 10.1038/35055095; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang CCC, 2008, CANCER LETT, V259, P82, DOI 10.1016/j.canlet.2007.10.005; Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124; Wang RX, 2003, J MED CHEM, V46, P2287, DOI 10.1021/jm0203783; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; Wei J, 2010, J MED CHEM, V53, P8000, DOI 10.1021/jm100746q; Wei J, 2009, J MED CHEM, V52, P4511, DOI 10.1021/jm900472s; Ye KQ, 2005, J CELL BIOCHEM, V96, P463, DOI 10.1002/jcb.20549; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yue P, 2009, EXPERT OPIN INV DRUG, V18, P45, DOI 10.1517/13543780802565791 ; Zhao Yan-Li, 2006, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V14, P208	91	47	48	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e87309	10.1371/journal.pone.0087309	http://dx.doi.org/10.1371/journal.pone.0087309			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586269	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800003
J	Harper, M; Gronenberg, L; Liao, J; Lee, C				Harper, Marc; Gronenberg, Luisa; Liao, James; Lee, Christopher			Comprehensive Detection of Genes Causing a Phenotype Using Phenotype Sequencing and Pathway Analysis	PLOS ONE			English	Article							NITRO-N-NITROSOGUANIDINE; COLI K-12 MG1655; ESCHERICHIA-COLI; PHOSPHOENOLPYRUVATE CARBOXYKINASE; SUCCINATE PRODUCTION; METABOLIC EVOLUTION; ADAPTIVE EVOLUTION; MUTATION; OVEREXPRESSION; FERMENTATION	Discovering all the genetic causes of a phenotype is an important goal in functional genomics. We combine an experimental design for detecting independent genetic causes of a phenotype with a high-throughput sequencing analysis that maximizes sensitivity for comprehensively identifying them. Testing this approach on a set of 24 mutant strains generated for a metabolic phenotype with many known genetic causes, we show that this pathway-based phenotype sequencing analysis greatly improves sensitivity of detection compared with previous methods, and reveals a wide range of pathways that can cause this phenotype. We demonstrate our approach on a metabolic re-engineering phenotype, the PEP/OAA metabolic node in E. coli, which is crucial to a substantial number of metabolic pathways and under renewed interest for biofuel research. Out of 2157 mutations in these strains, pathway-phenoseq discriminated just five gene groups (12 genes) as statistically significant causes of the phenotype. Experimentally, these five gene groups, and the next two high-scoring pathway-phenoseq groups, either have a clear connection to the PEP metabolite level or offer an alternative path of producing oxaloacetate (OAA), and thus clearly explain the phenotype. These high-scoring gene groups also show strong evidence of positive selection pressure, compared with strictly neutral selection in the rest of the genome.	[Harper, Marc; Liao, James; Lee, Christopher] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Lee, Christopher] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Lee, Christopher] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90024 USA; [Lee, Christopher] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Gronenberg, Luisa; Liao, James] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Harper, M (corresponding author), Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA.	marcharper@ucla.edu		Liao, James/0000-0002-4580-7276	Oce of Science (BER), U. S. Department of Energy [DE-FC02-02ER63421]	Oce of Science (BER), U. S. Department of Energy	This research was supported by the Oce of Science (BER), U. S. Department of Energy, Cooperative Agreement No. DE-FC02-02ER63421. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsumi S, 2008, METAB ENG, V10, P305, DOI 10.1016/j.ymben.2007.08.003; Atsumi S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.98; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; CHAO YP, 1993, APPL ENVIRON MICROB, V59, P4261, DOI 10.1128/AEM.59.12.4261-4265.1993; Chatterjee R, 2001, APPL ENVIRON MICROB, V67, P148, DOI 10.1128/AEM.67.1.148-154.2001; Chen PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012397; Conrad TM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r118; Cover TM, 2012, ELEMENTS INFORM THEO, DOI DOI 10.1002/047174882X; Cozzone AJ, 2005, J MOL MICROB BIOTECH, V9, P132, DOI 10.1159/000089642; Dharmadi Y, 2006, BIOTECHNOL BIOENG, V94, P821, DOI 10.1002/bit.21025; Erlich Y, 2009, GENOME RES, V19, P1243, DOI 10.1101/gr.092957.109; Ewens WJ., 2004, MATH POPULATION GENE, V27; Fong NL, 2013, FEMS MICROBIOLOGY LE; Fong SS, 2006, J BIOL CHEM, V281, P8024, DOI 10.1074/jbc.M510016200; Fury Wen, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P5531; Harper M, 2012, MUTAT RES-FUND MOL M, V731, P64, DOI 10.1016/j.mrfmmm.2011.10.011; Harper MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016517; Herring CD, 2006, NAT GENET, V38, P1406, DOI 10.1038/ng1906; Honisch C, 2004, GENOME RES, V14, P2495, DOI 10.1101/gr.2977704; HUCHO F, 1975, ANGEW CHEM INT EDIT, V14, P591, DOI 10.1002/anie.197505911; Jantama K, 2008, BIOTECHNOL BIOENG, V99, P1140, DOI 10.1002/bit.21694; Jones E., 2001, SCIPY OPEN SOURCE SC; Keseler IM, 2009, NUCLEIC ACIDS RES, V37, pD464, DOI 10.1093/nar/gkn751; Kim HJ, 2012, APPL MICROBIOL BIOT, V94, P1079, DOI 10.1007/s00253-011-3779-0; Kim P, 2004, APPL ENVIRON MICROB, V70, P1238, DOI 10.1128/AEM.70.2.1238-1241.2004; Klockgether J, 2010, J BACTERIOL, V192, P1113, DOI 10.1128/JB.01515-09; Le Crom S, 2009, P NATL ACAD SCI USA, V106, P16151, DOI 10.1073/pnas.0905848106; Lee C, 2009, SCIPY, V8, P62; Lee DH, 2010, APPL ENVIRON MICROB, V76, P4158, DOI 10.1128/AEM.00373-10; Lee J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S2-S11; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LIAO JC, 1994, ANN NY ACAD SCI, V745, P21; Liu RM, 2012, APPL MICROBIOL BIOT, V94, P959, DOI 10.1007/s00253-012-3896-4; MALOY SR, 1982, J BACTERIOL, V149, P173, DOI 10.1128/JB.149.1.173-180.1982; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Miller J.H., 1972, EXPT MOL GENETICS, V60; Minty JJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-18; Nam D, 2010, NUCLEIC ACIDS RES, V38, pW749, DOI 10.1093/nar/gkq428; Ohnishi J, 2008, MUTAT RES-GEN TOX EN, V649, P239, DOI 10.1016/j.mrgentox.2007.10.003; Park S, 2013, BIOPROC BIOSYST ENG, V36, P127, DOI [10.1007/s00449-012-0759-4, 10.1007/s00449-012-0821-2]; Peng L, 2006, FEMS MICROBIOLOGY LE, V235, P17; Peng L, 2004, APPL MICROBIOLOGY BI; Peng LF, 2004, FEMS MICROBIOL LETT, V235, P17, DOI 10.1016/j.femsle.2004.04.003; R Core Team, 2012, R LANG ENV STAT COMP; Raineri E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-239; Reyes LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017678; Sarin S, 2010, GENETICS, V185, P417, DOI 10.1534/genetics.110.116319; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; Silhavy T.J., 1984, EXPT GENE FUSIONS; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108; Srivatsan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000139; Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107; Umland TC, 2012, MBIO, V3, DOI 10.1128/mBio.00113-12; Velicer GJ, 2006, P NATL ACAD SCI USA, V103, P8107, DOI 10.1073/pnas.0510740103; Waegeman H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-70; Zhang B, 2012, METAB ENG; Zhang X, 2009, APPL ENVIRON MICROB, V75, P7807, DOI 10.1128/AEM.01758-09; Zhang XL, 2009, P NATL ACAD SCI USA, V106, P20180, DOI 10.1073/pnas.0905396106; Zhu Y, 2012, GENETICS, V192, P139, DOI 10.1534/genetics.112.141986	60	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e88072	10.1371/journal.pone.0088072	http://dx.doi.org/10.1371/journal.pone.0088072			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586303	Green Submitted, Green Published, gold			2022-12-27	WOS:000332389000008
J	Liegl, R; Koenig, S; Siedlecki, J; Haritoglou, C; Kampik, A; Kernt, M				Liegl, Raffael; Koenig, Susanna; Siedlecki, Jakob; Haritoglou, Christos; Kampik, Anselm; Kernt, Marcus			Temsirolimus Inhibits Proliferation and Migration in Retinal Pigment Epithelial and Endothelial Cells via mTOR Inhibition and Decreases VEGF and PDGF Expression	PLOS ONE			English	Article							DIABETIC MACULAR EDEMA; GROWTH-FACTOR; MAMMALIAN TARGET; HYPOXIC REGULATION; DEGENERATION; ANGIOGENESIS; RAPAMYCIN; EFFICACY; RANIBIZUMAB; SAFETY	Due to their high prevalence, retinal vascular diseases including age related macular degeneration (AMD), retinal vein occlusions (RVO), diabetic retinopathy (DR) and diabetic macular edema have been major therapeutic targets over the last years. The pathogenesis of these diseases is complex and yet not fully understood. However, increased proliferation, migration and angiogenesis are characteristic cellular features in almost every retinal vascular disease. The introduction of vascular endothelial growth factor (VEGF) binding intravitreal treatment strategies has led to great advances in the therapy of these diseases. While the predominant part of affected patients benefits from the specific binding of VEGF by administering an anti-VEGF antibody into the vitreous cavity, a small number of non-responders exist and alternative or additional therapeutic strategies should therefore be evaluated. The mammalian target of rapamycin (mTOR) is a central signaling pathway that eventually triggers up-regulation of cellular proliferation, migration and survival and has been identified to play a key role in angiogenesis. In the present study we were able to show that both retinal pigment epithelial (RPE) cells as wells as human umbilical vein endothelial cells (HUVEC) are inhibited in proliferating and migrating after treatment with temsirolimus in non-toxic concentrations. Previous studies suggest that the production of VEGF, platelet derived growth factor (PDGF) and other important cytokines is not only triggered by hypoxia but also by mTOR itself. Our results indicate that temsirolimus decreases VEGF and PDGF expression on RNA and protein levels significantly. We therefore believe that the mTOR inhibitor temsirolimus might be a promising drug in the future and it seems worthwhile to evaluate complementary therapeutic effects with anti-VEGF drugs for patients not profiting from mono anti-VEGF therapy alone.	[Liegl, Raffael; Koenig, Susanna; Siedlecki, Jakob; Haritoglou, Christos; Kampik, Anselm; Kernt, Marcus] Univ Munich, Dept Ophthalmol, Munich, Germany	University of Munich	Liegl, R (corresponding author), Univ Munich, Dept Ophthalmol, Munich, Germany.	Raffael.Liegl@med.uni-muenchen.de						AIELLO LP, 1995, ARCH OPHTHALMOL-CHIC, V113, P1538, DOI 10.1001/archopht.1995.01100120068012; Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Borders EB, 2010, AM J HEALTH-SYST PH, V67, P2095, DOI 10.2146/ajhp100020; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Browning DJ, 2012, AM J OPHTHALMOL, V154, P222, DOI 10.1016/j.ajo.2012.04.020; Bukowski RM, 2012, EXPERT OPIN DRUG SAF, V11, P861, DOI 10.1517/14740338.2012.713344; Campochiaro PA, 2013, J MOL MED, V91, P311, DOI 10.1007/s00109-013-0993-5; Cheung L. K, 2013, AGE RELATED MACULAR; Claesson-Welsh L, 2013, J INTERN MED, V273, P114, DOI 10.1111/joim.12019; Cohen SY, 2012, RETINA-J RET VIT DIS, V32, P1480, DOI 10.1097/IAE.0b013e318240a516; Cohen SY, 2013, GRAEFES ARCH CLIN EX; Danesi R, 2013, CANC TREAT REV; Deming DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060709; Ding J, 2012, CURR DIABETES REP, V12, P346, DOI 10.1007/s11892-012-0283-6; Eshleman JS, 2002, CANCER RES, V62, P7291; Feng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068149; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Frey T, 2011, ANTIOXID REDOX SIGN, V15, P1271, DOI 10.1089/ars.2011.3906; Frost P, 2013, J ONCOL, V2013, DOI 10.1155/2013/897025; Gibbons James J, 2009, Semin Oncol, V36 Suppl 3, pS3, DOI 10.1053/j.seminoncol.2009.10.011; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Ho AC, 2012, OPHTHALMOLOGY, V119, P2179, DOI 10.1016/j.ophtha.2012.07.058; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Kehler AK, 2012, CURR EYE RES, V37, P500, DOI 10.3109/02713683.2012.663855; Kernt M, 2010, BRIT J OPHTHALMOL, V94, P1533, DOI 10.1136/bjo.2010.182162; Kernt M, BR J OPHTHALMOL, V94, P1533; Kernt M, 2012, GROWTH FACTORS, V30, P49, DOI 10.3109/08977194.2011.639300; Kernt M, 2009, J CATARACT REFR SURG, V35, P354, DOI 10.1016/j.jcrs.2008.10.052; Kokkinopoulos I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018921; Kuhn JG, 2007, CLIN CANCER RES, V13, P7401, DOI 10.1158/1078-0432.CCR-07-0781; Kwon YS, 2005, INVEST OPHTH VIS SCI, V46, P454, DOI 10.1167/iovs.04-0753; Lee WJ, 2012, BRIT J OPHTHALMOL, V96, P1426, DOI 10.1136/bjophthalmol-2012-301913; Li SY, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/426769; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Lin CH, 2013, BRIT J PHARMACOL, V168, P920, DOI 10.1111/j.1476-5381.2012.02227.x; LoRusso PM, 2013, ONCOLOGY-BASEL, V84, P43, DOI 10.1159/000343063; Maity A, 2000, CANCER RES, V60, P5879; Martin LA, 2013, CANC TREAT REV; Massacesi C, 2013, ANN NY ACAD SCI, V1280, P19, DOI 10.1111/nyas.12060; Massin P, 2010, DIABETES CARE, V33, P2399, DOI 10.2337/dc10-0493; Miller JW, 2013, OPHTHALMOLOGY, V120, P106, DOI 10.1016/j.ophtha.2012.07.038; Mizukami Y, 2006, J BIOL CHEM, V281, P13957, DOI 10.1074/jbc.M511763200; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muether PS, 2013, RETINA; Negrier S, 2011, LANCET ONCOL, V12, P673, DOI 10.1016/S1470-2045(11)70124-3; Nguyen QD, 2013, J OPHTHALMIC INFLAMM, V3, DOI 10.1186/1869-5760-3-32; Reinmuth N, 2002, CLIN CANCER RES, V8, P3259; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Schmucker C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042701; Semenza GL, 2001, J CLIN INVEST, V108, P39, DOI 10.1172/JCI13374; Sheri A, 2010, CLIN BREAST CANCER, V10, pS79, DOI 10.3816/CBC.2010.s.016; SHIMA DT, 1995, MOL MED, V1, P182, DOI 10.1007/BF03401566; Spunt SL, 2011, J CLIN ONCOL, V29, P2933, DOI 10.1200/JCO.2010.33.4649; Stewart MW, 2012, CURR DIABETES REV, V8, P237, DOI 10.2174/157339912800840488; Stitt AW, 2013, CLIN SCI, V125, P1, DOI 10.1042/CS20120588; Sun Y, 2012, JPN J CLIN ONCOL, V42, P836, DOI 10.1093/jjco/hys110; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Wan XL, 2006, NEOPLASIA, V8, P394, DOI 10.1593/neo.05820; Wilkinson-Berka JL, 2013, CLIN SCI, V124, P597, DOI 10.1042/CS20120212; Yuan TL, 2008, P NATL ACAD SCI USA, V105, P9739, DOI 10.1073/pnas.0804123105; Zask A, 2011, EXPERT OPIN THER PAT, V21, P1109, DOI 10.1517/13543776.2011.584871; Zhang HD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065277, 10.1371/journal.pone.0054510, 10.1371/journal.pone.0068634, 10.1371/journal.pone.0079454]; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303; Zheng YF, 2012, INDIAN J OPHTHALMOL, V60, P428, DOI 10.4103/0301-4738.100542; Zhou HY, 2010, CURR PROTEIN PEPT SC, V11, P409, DOI 10.2174/138920310791824093	67	28	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e88203	10.1371/journal.pone.0088203	http://dx.doi.org/10.1371/journal.pone.0088203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586308	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000009
J	Newman, EJ; Sanson, M; Miller, EK; Quigley-McBride, A; Foster, JL; Bernstein, DM; Garry, M				Newman, Eryn J.; Sanson, Mevagh; Miller, Emily K.; Quigley-McBride, Adele; Foster, Jeffrey L.; Bernstein, Daniel M.; Garry, Maryanne			People with Easier to Pronounce Names Promote Truthiness of Claims	PLOS ONE			English	Article							NONPROBATIVE PHOTOGRAPHS; PERCEPTUAL FLUENCY; JUDGMENTS; PERSUASION	When people make judgments about the truth of a claim, related but nonprobative information rapidly leads them to believe the claim-an effect called "truthiness" [1]. Would the pronounceability of others' names also influence the truthiness of claims attributed to them? We replicated previous work by asking subjects to evaluate people's names on a positive dimension, and extended that work by asking subjects to rate those names on negative dimensions. Then we addressed a novel theoretical issue by asking subjects to read that same list of names, and judge the truth of claims attributed to them. Across all experiments, easily pronounced names trumped difficult names. Moreover, the effect of pronounceability produced truthiness for claims attributed to those names. Our findings are a new instantiation of truthiness, and extend research on the truth effect as well as persuasion by showing that subjective, tangential properties such as ease of processing can matter when people evaluate information attributed to a source.	[Newman, Eryn J.; Sanson, Mevagh; Miller, Emily K.; Quigley-McBride, Adele; Foster, Jeffrey L.; Garry, Maryanne] Victoria Univ Wellington, Sch Psychol, Wellington, New Zealand; [Bernstein, Daniel M.] Kwantlen Polytech Univ, Dept Psychol, Richmond, BC, Canada	Victoria University Wellington	Newman, EJ (corresponding author), Victoria Univ Wellington, Sch Psychol, Wellington, New Zealand.	eryn.newman@vuw.ac.nz		Newman, Eryn/0000-0001-8663-7173; Foster, Jeffrey/0000-0002-9783-0312				Alter AL, 2007, J EXP PSYCHOL GEN, V136, P569, DOI 10.1037/0096-3445.136.4.569; Alter AL, 2006, P NATL ACAD SCI USA, V103, P9369, DOI 10.1073/pnas.0601071103; Alter AL, 2009, PERS SOC PSYCHOL REV, V13, P219, DOI 10.1177/1088868309341564; BEGG IM, 1992, J EXP PSYCHOL GEN, V121, P446, DOI 10.1037/0096-3445.121.4.446; Bernstein DM, 2002, MEM COGNITION, V30, P432, DOI 10.3758/BF03194943; Brinol P, 2009, EUR REV SOC PSYCHOL, V20, P49, DOI 10.1080/10463280802643640; CHAIKEN S, 1980, J PERS SOC PSYCHOL, V39, P752, DOI 10.1037/0022-3514.39.5.752; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Cumming G., 2013, UNDERSTANDING NEW ST; Dechene A, 2010, PERS SOC PSYCHOL REV, V14, P238, DOI 10.1177/1088868309352251; Fenn E, 2013, ACTA PSYCHOL, V144, P207, DOI 10.1016/j.actpsy.2013.06.004; HASHER L, 1977, J VERB LEARN VERB BE, V16, P107, DOI 10.1016/S0022-5371(77)80012-1; HORN JL, 1967, ACTA PSYCHOL, V26, P107, DOI 10.1016/0001-6918(67)90011-X; Hovland CI, 1951, PUBLIC OPIN QUART, V15, P635, DOI 10.1086/266350; Jacoby L. L., 1989, VARIETIES MEMORY CON, P391, DOI DOI 10.1002/ACP.2350050509; Kahneman D., 2011, THINKING FAST SLOW; Labroo AA, 2008, J CONSUM RES, V34, P819, DOI 10.1086/523290; Laham SM, 2012, J EXP SOC PSYCHOL, V48, P752, DOI 10.1016/j.jesp.2011.12.002; Marewski JN, 2011, PSYCHOL REV, V118, P393, DOI 10.1037/a0024143; Newman EJ, TRUTHINESS IN PRESS; Newman EJ, 2012, PSYCHON B REV, V19, P969, DOI 10.3758/s13423-012-0292-0; Oppenheimer DM, 2006, APPL COGNITIVE PSYCH, V20, P139, DOI 10.1002/acp.1178; Reber R, 1999, CONSCIOUS COGN, V8, P338, DOI 10.1006/ccog.1999.0386; Schwarz N, 2010, MIND CONTEXT; Song HJ, 2009, PSYCHOL SCI, V20, P135, DOI 10.1111/j.1467-9280.2009.02267.x; STEPPER S, 1993, J PERS SOC PSYCHOL, V64, P211, DOI 10.1037/0022-3514.64.2.211; Strack F, 2000, PERS SOC PSYCHOL B, V26, P762, DOI 10.1177/0146167200269002; Unkelbach C, 2007, J EXP PSYCHOL LEARN, V33, P219, DOI 10.1037/0278-7393.33.1.219; Wechsler D., 2012, WAIS 4 KASIKIRJA; Weisbuch M, 2003, PERS SOC PSYCHOL B, V29, P691, DOI 10.1177/0146167203029006002; Whittlesea BWA, 2000, J EXP PSYCHOL GEN, V129, P84, DOI 10.1037/0096-3445.129.1.84	31	22	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e88671	10.1371/journal.pone.0088671	http://dx.doi.org/10.1371/journal.pone.0088671			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3BC	24586368	gold, Green Published			2022-12-27	WOS:000332389000016
J	Hartfield, EM; Yamasaki-Mann, M; Fernandes, HJR; Vowles, J; James, WS; Cowley, SA; Wade-Martins, R				Hartfield, Elizabeth M.; Yamasaki-Mann, Michiko; Fernandes, Hugo J. Ribeiro; Vowles, Jane; James, William S.; Cowley, Sally A.; Wade-Martins, Richard			Physiological Characterisation of Human iPS-Derived Dopaminergic Neurons	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; HUMAN ES; HIGHLY EFFICIENT; GENE-EXPRESSION; ALPHA-SYNUCLEIN; CALCIUM; VULNERABILITY; DIFFERENTIATION	Human induced pluripotent stem cells (hiPSCs) offer the potential to study otherwise inaccessible cell types. Critical to this is the directed differentiation of hiPSCs into functional cell lineages. This is of particular relevance to research into neurological disease, such as Parkinson's disease (PD), in which midbrain dopaminergic neurons degenerate during disease progression but are unobtainable until post-mortem. Here we report a detailed study into the physiological maturation over time of human dopaminergic neurons in vitro. We first generated and differentiated hiPSC lines into midbrain dopaminergic neurons and performed a comprehensive characterisation to confirm dopaminergic functionality by demonstrating dopamine synthesis, release, and re-uptake. The neuronal cultures include cells positive for both tyrosine hydroxylase (TH) and G protein-activated inward rectifier potassium channel 2 (Kir3.2, henceforth referred to as GIRK2), representative of the A9 population of substantia nigra pars compacta (SNc) neurons vulnerable in PD. We observed for the first time the maturation of the slow autonomous pace-making (<10 Hz) and spontaneous synaptic activity typical of mature SNc dopaminergic neurons using a combination of calcium imaging and electrophysiology. hiPSC-derived neurons exhibited inositol tri-phosphate (IP3) receptor-dependent release of intracellular calcium from the endoplasmic reticulum in neuronal processes as calcium waves propagating from apical and distal dendrites, and in the soma. Finally, neurons were susceptible to the dopamine neuron-specific toxin 1-methyl-4-phenylpyridinium (MPP+) which reduced mitochondrial membrane potential and altered mitochondrial morphology. Mature hiPSC-derived dopaminergic neurons provide a neurophysiologically-defined model of previously inaccessible vulnerable SNc dopaminergic neurons to bridge the gap between clinical PD and animal models.	[Hartfield, Elizabeth M.; Yamasaki-Mann, Michiko; Fernandes, Hugo J. Ribeiro; Vowles, Jane; James, William S.; Cowley, Sally A.; Wade-Martins, Richard] Univ Oxford, Oxford Parkinsons Dis Ctr, Oxford, England; [Hartfield, Elizabeth M.; Yamasaki-Mann, Michiko; Fernandes, Hugo J. Ribeiro; Wade-Martins, Richard] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Vowles, Jane; James, William S.; Cowley, Sally A.] Univ Oxford, Sir William Dunn Sch Pathol, James Martin Stem Cell Facil, Oxford OX1 3RE, England	University of Oxford; University of Oxford; University of Oxford	Wade-Martins, R (corresponding author), Univ Oxford, Oxford Parkinsons Dis Ctr, Oxford, England.	richard.wade-martins@dpag.ox.ac.uk	james, william/H-4289-2013; Fernandes, Hugo/G-5309-2015	james, william/0000-0002-2506-1198; Fernandes, Hugo/0000-0002-1404-5045; Wade-Martins, Richard/0000-0001-6691-580X; Cowley, Sally/0000-0003-0297-6675	Monument Trust Discovery Award from Parkinson's UK; Oxford James Martin Stem Cell Facility; James Martin Research Fellowship; Wellcome Trust Career Re-Entry Fellowship [WT082260/Z/07/Z]; Parkinson&quot;s UK [J-0901] Funding Source: researchfish	Monument Trust Discovery Award from Parkinson's UK; Oxford James Martin Stem Cell Facility; James Martin Research Fellowship; Wellcome Trust Career Re-Entry Fellowship(Wellcome Trust); Parkinson&quot;s UK(Parkinson&apos;s UK)	The work was supported by the Monument Trust Discovery Award from Parkinson's UK and The Oxford James Martin Stem Cell Facility. MYM holds a James Martin Research Fellowship, and SC holds a Wellcome Trust Career Re-Entry Fellowship (WT082260/Z/07/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini B, 1999, J NEUROPHYSIOL, V82, P2249, DOI 10.1152/jn.1999.82.5.2249; Badger JL, 2014, NEUROPHARMACOLOGY, V76, P88, DOI 10.1016/j.neuropharm.2013.08.035; Bolam JP, 2012, MOVEMENT DISORD, V27, P1478, DOI 10.1002/mds.25135; Byers B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026159; Cai JL, 2010, STEM CELLS DEV, V19, P1017, DOI 10.1089/scd.2009.0319; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chia R, 2005, NAT GENET, V37, P1181, DOI 10.1038/ng1665; Cho MS, 2008, P NATL ACAD SCI USA, V105, P3392, DOI 10.1073/pnas.0712359105; Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178; Cooper O., 2012, SCI TRANSL MED, V4; Cooper O, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003985; Cooper O, 2010, MOL CELL NEUROSCI, V45, P258, DOI 10.1016/j.mcn.2010.06.017; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; GARDNER RL, 1982, J EMBRYOL EXP MORPH, V68, P175; Guzman JN, 2009, J NEUROSCI, V29, P11011, DOI 10.1523/JNEUROSCI.2519-09.2009; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hahn J, 2006, J NEUROSCI, V26, P5240, DOI 10.1523/JNEUROSCI.4976-05.2006; Hernandez Felix, 2008, Curr Aging Sci, V1, P56; HEYER EJ, 1984, BRAIN RES, V310, P142, DOI 10.1016/0006-8993(84)90018-0; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Iovino M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013947; Jiang HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1669; KANG Y, 1993, NEUROSCI RES, V18, P195, DOI 10.1016/0168-0102(93)90055-U; Kitayama S, 1998, BBA-MOL CELL RES, V1404, P305, DOI 10.1016/S0167-4889(98)00071-8; KITAYAMA S, 1992, P NATL ACAD SCI USA, V89, P7782, DOI 10.1073/pnas.89.16.7782; Koyanagi M, 2008, J NEUROSCI RES, V86, P270, DOI 10.1002/jnr.21502; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; Moralli D, 2011, STEM CELL REV REP, V7, P471, DOI 10.1007/s12015-010-9224-4; Morikawa H, 2000, J NEUROSCI, V20, part. no.; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; Muller FJ, 2010, CELL STEM CELL, V6, P412, DOI 10.1016/j.stem.2010.04.009; NEDERGAARD S, 1993, J PHYSIOL-LONDON, V466, P727; Patani R, 2012, J NEUROCHEM, V122, P738, DOI 10.1111/j.1471-4159.2012.07825.x; Patel S, 2011, CELL CALCIUM, V50, P157, DOI 10.1016/j.ceca.2011.03.011; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Porras G, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009308; Reyes S, 2012, J COMP NEUROL, V520, P2591, DOI 10.1002/cne.23051; Rhee YH, 2011, J CLIN INVEST, V121, P2326, DOI 10.1172/JCI45794; Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215; Schneider BL, 2007, HUM MOL GENET, V16, P651, DOI 10.1093/hmg/ddm008; Seibler P, 2011, J NEUROSCI, V31, P5970, DOI 10.1523/JNEUROSCI.4441-10.2011; STROMBERG I, 1991, EXP NEUROL, V112, P140, DOI 10.1016/0014-4886(91)90064-J; Sundberg M, 2013, STEM CELLS, V31, P1548, DOI 10.1002/stem.1415; Surmeier DJ, 2007, LANCET NEUROL, V6, P933, DOI 10.1016/S1474-4422(07)70246-6; Surmeier DJ, 2013, J BIOL CHEM, V288, P10736, DOI 10.1074/jbc.R112.410530; Surmeier DJ, 2010, CELL CALCIUM, V47, P175, DOI 10.1016/j.ceca.2009.12.003; Surmeier DJ, 2011, ANTIOXID REDOX SIGN, V14, P1289, DOI 10.1089/ars.2010.3521; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; TEPPER JM, 1990, DEV BRAIN RES, V54, P21, DOI 10.1016/0165-3806(90)90061-3; Tian LP, 2012, BIOTECHNOL LETT, V34, P1167, DOI 10.1007/s10529-012-0888-5; Watmuff B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031999; Wilson CJ, 2000, J NEUROPHYSIOL, V83, P3084, DOI 10.1152/jn.2000.83.5.3084; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018271	63	97	98	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e87388	10.1371/journal.pone.0087388	http://dx.doi.org/10.1371/journal.pone.0087388			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586273	Green Submitted, Green Published, gold			2022-12-27	WOS:000331717900009
J	Ben-Ner, A; Hamann, DJ; Koepp, G; Manohar, CU; Levine, J				Ben-Ner, Avner; Hamann, Darla J.; Koepp, Gabriel; Manohar, Chimnay U.; Levine, James			Treadmill Workstations: The Effects of Walking while Working on Physical Activity and Work Performance	PLOS ONE			English	Article							HEALTH-PROMOTION PROGRAMS; BODY-MASS INDEX; CARDIORESPIRATORY FITNESS; INTERVENTIONS; OVERWEIGHT; WEIGHT; IMPACT; TIME	We conducted a 12-month-long experiment in a financial services company to study how the availability of treadmill workstations affects employees' physical activity and work performance. We enlisted sedentary volunteers, half of whom received treadmill workstations during the first two months of the study and the rest in the seventh month of the study. Participants could operate the treadmills at speeds of 0-2 mph and could use a standard chair-desk arrangement at will. (a) Weekly online performance surveys were administered to participants and their supervisors, as well as to all other sedentary employees and their supervisors. Using within-person statistical analyses, we find that overall work performance, quality and quantity of performance, and interactions with coworkers improved as a result of adoption of treadmill workstations. (b) Participants were outfitted with accelerometers at the start of the study. We find that daily total physical activity increased as a result of the adoption of treadmill workstations.	[Ben-Ner, Avner; Manohar, Chimnay U.] Univ Minnesota Twin Cities, Carlson Sch Management, Minneapolis, MN 55455 USA; [Hamann, Darla J.] Univ Texas Arlington, Sch Urban & Publ Affairs, Arlington, TX 76019 USA; [Koepp, Gabriel; Levine, James] Mayo Clin, Scottsdale, AZ USA; [Koepp, Gabriel; Levine, James] Arizona State Univ, Scottsdale, AZ USA	University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Arlington; Mayo Clinic; Mayo Clinic Phoenix; Arizona State University	Ben-Ner, A (corresponding author), Univ Minnesota Twin Cities, Carlson Sch Management, Minneapolis, MN 55455 USA.	benne001@umn.edu			Minnesota Obesity Center [DK56650, DK63226, DK66270, DK50456]; US Public Health Service [RR-0585]; Mayo Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066270, R01DK063226, P30DK050456, R01DK056650] Funding Source: NIH RePORTER	Minnesota Obesity Center; US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Mayo Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants DK56650, DK63226, DK66270, DK50456 (Minnesota Obesity Center); grant RR-0585 from the US Public Health Service; the Mayo Foundation, and by a grant to the Mayo Foundation from Mr. R Stuart and ECMC (Educational Credit Management Corporation, Oakdale, Minnesota, USA, http://www.ecmc.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, HEALTH PSYCHOL REV, V3, P108, DOI 10.1080/17437190903151096; Aldana SG, 2001, AM J HEALTH PROMOT, V15, P296, DOI 10.4278/0890-1171-15.5.296; Baltagi BH, 1999, ECONOMET THEOR, V15, P814, DOI 10.1017/S0266466699156020; BECKER GS, 1988, J POLIT ECON, V96, P675, DOI 10.1086/261558; Bernaards CM, 2007, J OCCUP ENVIRON MED, V49, P633, DOI 10.1097/JOM.0b013e318058202c; Bertheussen GF, 2011, MED SCI SPORT EXER, V43, P1220, DOI 10.1249/MSS.0b013e318206c66e; Brownell KD, 1995, EATING DISORDERS OBE, P473; Charness G, 2009, ECONOMETRICA, V77, P909, DOI 10.3982/ECTA7416; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Coulson JC, 2008, INT J WORKPLACE HEAL, V1, P176, DOI 10.1108/17538350810926534; DellaVigna S, 2006, AM ECON REV, V96, P694, DOI 10.1257/aer.96.3.694; Dishman RK, 1998, AM J PREV MED, V15, P344, DOI 10.1016/S0749-3797(98)00077-4; Drukker DM, 2003, STATA J, V3, P168, DOI 10.1177/1536867X0300300206; Emmons KM, 1999, J OCCUP ENVIRON MED, V41, P545, DOI 10.1097/00043764-199907000-00003; Engbers LH, 2005, AM J PREV MED, V29, P61, DOI 10.1016/j.amepre.2005.03.001; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; FALKENBERG LE, 1987, ACAD MANAGE REV, V12, P511, DOI 10.2307/258517; Fehr E., 1998, EC VALUES ORG, P337, DOI DOI 10.1017/CBO9781139174855.015; Goetzel RZ, 2010, J OCCUP ENVIRON MED, V52, pS52, DOI 10.1097/JOM.0b013e3181c95b84; Golaszewski T, 2001, AM J HEALTH PROMOT, V15, P332, DOI 10.4278/0890-1171-15.5.332; Gould W, 2010, MAXIMUM LIKELIHOOD E; Groeneveld IF, 2010, SCAND J WORK ENV HEA, V36, P202, DOI 10.5271/sjweh.2891; Hoehner CM, 2005, AM J PREV MED, V28, P105, DOI 10.1016/j.amepre.2004.10.023; Hughes MC, 2007, J OCCUP ENVIRON MED, V49, P1212, DOI 10.1097/JOM.0b013e318159489d; Jago R, 2011, MED SCI SPORT EXER, V43, P1513, DOI 10.1249/MSS.0b013e31820c9797; John D, 2011, J PHYS ACT HEALTH, V8, P1034, DOI 10.1123/jpah.8.8.1034; John D, 2009, J PHYS ACT HEALTH, V6, P617, DOI 10.1123/jpah.6.5.617; Katzmarzyk PT, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000828; Koepp GA, 2013, OBESITY, V21, P705, DOI 10.1002/oby.20121; Lakdawalla D, 2005, AM ECON REV, V95, P253, DOI 10.1257/000282805774670266; McCrady SK, 2009, OBESITY, V17, P2103, DOI 10.1038/oby.2009.117; Mummery WK, 2005, AM J PREV MED, V29, P91, DOI 10.1016/j.amepre.2005.04.003; Ployhart RE, 2010, J MANAGE, V36, P94, DOI 10.1177/0149206309352110; Powell KE, 2011, ANNU REV PUBL HEALTH, V32, P349, DOI 10.1146/annurev-publhealth-031210-101151; Pronk NP, 2004, J OCCUP ENVIRON MED, V46, P19, DOI 10.1097/01.jom.0000105910.69449.b7; Proper KI, 2002, SCAND J WORK ENV HEA, V28, P75, DOI 10.5271/sjweh.651; Proper KI, 2008, WHO WEF JOINT EV PRE; Puterman E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010837; Ricci JA, 2005, J OCCUP ENVIRON MED, V47, P1227, DOI 10.1097/01.jom.0000184871.20901.c3; Straker LM, 2009, HUM FACTORS, V51, P831, DOI 10.1177/0018720810362079; Tompa E., 2002, REV EC PERFORMANCE S, V45, P181; Verweij LM, 2011, OBES REV, V12, P406, DOI 10.1111/j.1467-789X.2010.00765.x; WHO (World Health Organization), 2009, INT PHYS ACT WHAT WO; World Health Organization, 2002, WORLD HLTH REP 2002R	44	56	56	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88620	10.1371/journal.pone.0088620	http://dx.doi.org/10.1371/journal.pone.0088620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3UC	24586359	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700022
J	Ryu, S; Chang, Y; Zhang, YY; Woo, HY; Kwon, MJ; Park, H; Lee, KB; Son, HJ; Cho, J; Guallar, E				Ryu, Seungho; Chang, Yoosoo; Zhang, Yiyi; Woo, Hee-Yeon; Kwon, Min-Jung; Park, Hyosoon; Lee, Kyu-Beck; Son, Hee Jung; Cho, Juhee; Guallar, Eliseo			Higher Serum Direct Bilirubin Levels Were Associated with a Lower Risk of Incident Chronic Kidney Disease in Middle Aged Korean Men	PLOS ONE			English	Article							RACE-RELATED DIFFERENCES; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; INVERSE RELATIONSHIP; INSULIN-RESISTANCE; METABOLIC SYNDROME; NATIONAL-HEALTH; BILE-PIGMENTS; RENAL-DISEASE; UNITED-STATES	Background: The association between serum bilirubin levels and incident chronic kidney disease (CKD) in the general population is unknown. We aimed to examine the association between serum bilirubin concentration (total, direct, and indirect) and the risk of incident CKD. Methods and Findings: Longitudinal cohort study of 12,823 Korean male workers 30 to 59 years old without CKD or proteinuria at baseline participating in medical health checkup program in a large worksite. Study participants were followed for incident CKD from 2002 through 2011. Estimated glomerular filtration rate (eGFR) was estimated by using the CKD-EPI equation. CKD was defined as eGFR <60 mL/min per 1.73 m(2). Parametric Cox models and pooled logistic regression models were used to estimate adjusted hazard ratios for incident CKD. We observed 238 incident cases of CKD during 70,515.8 person-years of follow-up. In age-adjusted models, the hazard ratios for CKD comparing quartiles 2-4 vs. quartile 1 of serum direct bilirubin were 0.93 (95% CI 0.67-1.28), 0.88 (0.60-1.27) and 0.60 (0.42-0.88), respectively. In multivariable models, the adjusted hazard ratio for CKD comparing the highest to the lowest quartile of serum direct bilirubin levels was 0.60 (95% CI 0.41-0.87; P trend = 0.01). Neither serum total nor indirect bilirubin levels were significantly associated with the incidence of CKD. Conclusions: Higher serum direct bilirubin levels were significantly associated with a lower risk of developing CKD, even adjusting for a variety of cardiometabolic parameters. Further research is needed to elucidate the mechanisms underlying this association and to establish the role of serum direct bilirubin as a marker for CKD risk.	[Ryu, Seungho; Chang, Yoosoo] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Occupat & Environm Med, Seoul, South Korea; [Ryu, Seungho; Chang, Yoosoo; Zhang, Yiyi; Son, Hee Jung; Cho, Juhee; Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Ryu, Seungho; Chang, Yoosoo] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Ctr Cohort Studies,Total Healthcare Ctr, Seoul, South Korea; [Zhang, Yiyi; Cho, Juhee; Guallar, Eliseo] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA; [Zhang, Yiyi; Cho, Juhee; Guallar, Eliseo] Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; [Woo, Hee-Yeon; Kwon, Min-Jung; Park, Hyosoon] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Lab Med, Seoul, South Korea; [Lee, Kyu-Beck] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Internal Med, Seoul, South Korea; [Son, Hee Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med, Seoul, South Korea; [Cho, Juhee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Comprehens Canc Ctr, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Sungkyunkwan University (SKKU); Samsung Medical Center; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center	Guallar, E (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	eguallar@jhsph.edu	zhang, yiyi/J-2592-2012; Cho, Juhee/ABD-2280-2021	Chang, Yoosoo/0000-0002-6945-9050; Ryu, Seungho/0000-0002-3927-8646	Kangbuk Samsung Hospital	Kangbuk Samsung Hospital(Samsung)	This study was funded by the Kangbuk Samsung Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adin CA, 2005, AM J PHYSIOL-RENAL, V288, pF778, DOI 10.1152/ajprenal.00215.2004; Akaba K, 1998, BIOCHEM MOL BIOL INT, V46, P21; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Chang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037241; Chen J, 2003, J AM SOC NEPHROL, V14, P469, DOI 10.1097/01.ASN.0000046029.53933.09; Chin HJ, 2009, J KOREAN MED SCI, V24, pS22, DOI 10.3346/jkms.2009.24.S1.S22; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins AJ, 2003, KIDNEY INT, V64, pS24, DOI 10.1046/j.1523-1755.64.s87.5.x; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Djousse L, 2001, AM J CARDIOL, V87, P1196, DOI 10.1016/S0002-9149(01)01494-1; Djousse L, 2003, AM J CARDIOL, V91, P485, DOI 10.1016/S0002-9149(02)03256-3; Erdogan D, 2006, ATHEROSCLEROSIS, V184, P431, DOI 10.1016/j.atherosclerosis.2005.05.011; Farrera J A, 1994, Bioorg Med Chem, V2, P181, DOI 10.1016/S0968-0896(00)82013-1; FISCHER AF, 1988, J PEDIATR GASTR NUTR, V7, P27, DOI 10.1097/00005176-198801000-00007; Franchini M, 2010, ADV CLIN CHEM, V50, P47, DOI 10.1016/S0065-2423(10)50003-9; Fried L, 2004, J AM SOC NEPHROL, V15, P3184, DOI 10.1097/01.ASN.0000146422.45434.35; Fukui M, 2008, KIDNEY INT, V74, P1197, DOI 10.1038/ki.2008.398; Han SS, 2010, TOHOKU J EXP MED, V221, P133, DOI 10.1620/tjem.221.133; Hopkins PN, 1996, ARTERIOSCL THROM VAS, V16, P250, DOI 10.1161/01.ATV.16.2.250; Huang SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042594; Hwang HJ, 2010, CLIN CHIM ACTA, V411, P1496, DOI 10.1016/j.cca.2010.06.003; Jo J, 2011, ENDOCRINE, V39, P182, DOI 10.1007/s12020-010-9417-2; Kotal P, 1996, GASTROENTEROLOGY, V111, P217, DOI 10.1053/gast.1996.v111.pm8698202; Lee DH, 2004, FREE RADICAL RES, V38, P535, DOI 10.1080/10715760410001694026; Leung N, 2001, KIDNEY INT, V60, P1047, DOI 10.1046/j.1523-1755.2001.0600031047.x; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Lin LY, 2009, ATHEROSCLEROSIS, V203, P563, DOI 10.1016/j.atherosclerosis.2008.07.021; Maines MD, 1999, J PHARMACOL EXP THER, V291, P911; MANOLIO TA, 1992, CLIN CHEM, V38, P1853; NAKAGAMI T, 1993, BIOCHIM BIOPHYS ACTA, V1158, P189, DOI 10.1016/0304-4165(93)90013-X; Nakao A, 2005, AM J TRANSPLANT, V5, P282, DOI 10.1111/j.1600-6143.2004.00695.x; Novotny L, 2003, EXP BIOL MED, V228, P568, DOI 10.1177/15353702-0322805-29; Perlstein TS, 2008, AM J MED, V121, P781, DOI 10.1016/j.amjmed.2008.03.045; Perlstein TS, 2008, ARTERIOSCL THROM VAS, V28, P166, DOI 10.1161/ATVBAHA.107.153262; Rodrigues C, 2012, AM J MED SCI, V343, P114, DOI 10.1097/MAJ.0b013e318223460f; ROSENTHAL P, 1984, CLIN CHEM, V30, P1380; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Ryu S, 2008, J AM SOC NEPHROL, V19, P1798, DOI 10.1681/ASN.2007121286; Ryu S, 2007, CLIN CHEM, V53, P71, DOI 10.1373/clinchem.2006.078980; SCHACHTER D, 1957, SCIENCE, V126, P507, DOI 10.1126/science.126.3272.507-a; Schnackenberg CG, 2000, AM J PHYSIOL-RENAL, V279, pF302, DOI 10.1152/ajprenal.2000.279.2.F302; Setia S, 2002, ARCH PEDIAT ADOL MED, V156, P276, DOI 10.1001/archpedi.156.3.276; Shin HS, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-29; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Taaffe DR, 2003, ANN HUM BIOL, V30, P329, DOI 10.1080/0301446031000089588; Tapan S, 2009, CLIN BIOCHEM, V42, P791, DOI 10.1016/j.clinbiochem.2009.02.005; Targher G, 2009, CLIN CHEM LAB MED, V47, P1055, DOI 10.1515/CCLM.2009.244; Targher G, 2009, KIDNEY INT, V75, P863, DOI 10.1038/ki.2008.677; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Thorp Micah L, 2006, Dis Manag, V9, P115, DOI 10.1089/dis.2006.9.115; Troughton JA, 2007, EUR J CARDIOV PREV R, V14, P79, DOI 10.1097/01.hjr.0000230097.81202.9f; Wen CP, 2009, PUBLIC HEALTH NUTR, V12, P497, DOI 10.1017/S1368980008002802; YAMAUCHI Y, 1989, Acta Paediatrica Japonica, V31, P65; Yang XF, 2009, INTERNAL MED, V48, P1595, DOI 10.2169/internalmedicine.48.2286; Zou AP, 2001, HYPERTENSION, V37, P547, DOI 10.1161/01.HYP.37.2.547	57	25	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e75178	10.1371/journal.pone.0075178	http://dx.doi.org/10.1371/journal.pone.0075178			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586219	gold, Green Published, Green Submitted			2022-12-27	WOS:000331714700001
J	Preston, J; Smith, AD; Schofield, EJ; Chadwick, AV; Jones, MA; Watts, JEM				Preston, Joanne; Smith, Andrew D.; Schofield, Eleanor J.; Chadwick, Alan V.; Jones, Mark A.; Watts, Joy E. M.			The Effects of Mary Rose Conservation Treatment on Iron Oxidation Processes and Microbial Communities Contributing to Acid Production in Marine Archaeological Timbers	PLOS ONE			English	Article							SULFUR ACCUMULATION; FERROUS IRON; BACTERIA; WOOD	The Tudor warship the Mary Rose has reached an important transition point in her conservation. The 19 year long process of spraying with polyethylene glycol (PEG) has been completed (April 29th 2013) and the hull is air drying under tightly controlled conditions. Acidophilic bacteria capable of oxidising iron and sulfur have been previously identified and enriched from unpreserved timbers of the Mary Rose, demonstrating that biological pathways of iron and sulfur oxidization existed potentially in this wood, before preservation with PEG. This study was designed to establish if the recycled PEG spray system was a reservoir of microorganisms capable of iron and sulfur oxidization during preservation of the Mary Rose. Microbial enrichments derived from PEG impregnated biofilm collected from underneath the Mary Rose hull, were examined to better understand the processes of cycling of iron. X-ray absorption spectroscopy was utilised to demonstrate the biological contribution to production of sulfuric acid in the wood. Using molecular microbiological techniques to examine these enrichment cultures, PEG was found to mediate a shift in the microbial community from a co-culture of Stenotrophomonas and Brevunidimonas sp, to a co-culture of Stenotrophomonas and the iron oxidising Alicyclobacillus sp. Evidence is presented that PEG is not an inert substance in relation to the redox cycling of iron. This is the first demonstration that solutions of PEG used in the conservation of the Mary Rose are promoting the oxidation of ferrous iron in acidic solutions, in which spontaneous abiotic oxidation does not occur in water. Critically, these results suggest PEG mediated redox cycling of iron between valence states in solutions of 75% PEG 200 and 50% PEG 2000 (v/v) at pH 3.0, with serious implications for the future use of PEG as a conservation material of iron rich wooden archaeological artefacts.	[Preston, Joanne; Watts, Joy E. M.] Univ Portsmouth, Portsmouth, Hants, England; [Smith, Andrew D.] STFC Daresbury Lab, Warrington, Cheshire, England; [Schofield, Eleanor J.; Jones, Mark A.] Mary Rose Trust, HM Naval Base, Portsmouth, Hants, England; [Chadwick, Alan V.] Univ Kent, Sch Phys Sci, Canterbury, Kent, England	University of Portsmouth; STFC Daresbury Laboratory; University of Kent	Watts, JEM (corresponding author), Univ Portsmouth, Portsmouth, Hants, England.	joy.watts@port.ac.uk		Chadwick, Alan/0000-0002-6485-9207; Watts, Joy/0000-0001-9595-0540; Preston, Joanne/0000-0002-2268-4998	Mary Rose Trust; University of Portsmouth; EU Marie Curie [FP7-RG 276948]	Mary Rose Trust; University of Portsmouth; EU Marie Curie(European Commission)	Funding to support this work was obtained from the Mary Rose Trust, and the University of Portsmouth. JEMW was supported by a EU Marie Curie (FP7-RG 276948) award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amouric A, 2011, MICROBIOL-SGM, V157, P111, DOI 10.1099/mic.0.044537-0; Benz M, 1998, ARCH MICROBIOL, V169, P159, DOI 10.1007/s002030050555; Bonnefoy V, 2012, ENVIRON MICROBIOL, V14, P1597, DOI 10.1111/j.1462-2920.2011.02626.x; Bruckner CG, 2008, APPL ENVIRON MICROB, V74, P7740, DOI 10.1128/AEM.01399-08; Christensen M, 2006, J RAMAN SPECTROSC, V37, P1171, DOI 10.1002/jrs.1589; de Oliveira-Garcia D, 2003, CELL MICROBIOL, V5, P625, DOI 10.1046/j.1462-5822.2003.00306.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Drewniak L, 2008, ENVIRON POLLUT, V156, P1069, DOI 10.1016/j.envpol.2008.04.019; Fors Y, 2008, INT BIODETER BIODEGR, V62, P336, DOI 10.1016/j.ibiod.2007.11.008; Guilminot E, 2002, CORROS SCI, V44, P2199, DOI 10.1016/S0010-938X(02)00010-0; Hafors B., 2001, CONSERVATION SWEDISH; Hoffmann P, 2004, HOLZFORSCHUNG, V58, P211, DOI 10.1515/HF.2004.033; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jones M, 2003, ARCHAEOLOGY MARY ROS; Kawai F, 2002, APPL MICROBIOL BIOT, V58, P30, DOI 10.1007/s00253-001-0850-2; Krausova VI, 2006, HYDROBIOLOGIA, V559, P77, DOI 10.1007/s10750-004-0571-5; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; LOVLEY DR, 1986, APPL ENVIRON MICROB, V51, P683, DOI 10.1128/AEM.51.4.683-689.1986; Marsden P., 2003, SEALED TIME LOSS REC; Mosselmans JFW, 2009, J SYNCHROTRON RADIAT, V16, P818, DOI 10.1107/S0909049509032282; Pearson C, 1979, USE POLYETHYLENE GLY, p[24, 51]; Preston J, 2012, APPL ENV MICROBIOLOG; Rickard D, 2007, CHEM REV, V107, P514, DOI 10.1021/cr0503658; Rimstidt JD, 2003, GEOCHIM COSMOCHIM AC, V67, P873, DOI 10.1016/S0016-7037(02)01165-1; Ryan RP, 2009, NAT REV MICROBIOL, V7, P514, DOI 10.1038/nrmicro2163; Sandstrom M, 2005, P NATL ACAD SCI USA, V102, P14165, DOI 10.1073/pnas.0504490102; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanner MA, 1998, APPL ENVIRON MICROB, V64, P3110; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Wetherall KM, 2008, J ARCHAEOL SCI, V35, P1317, DOI 10.1016/j.jas.2007.09.007	31	23	23	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e84169	10.1371/journal.pone.0084169	http://dx.doi.org/10.1371/journal.pone.0084169			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586230	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000331711900003
J	Huang, XJ; Sun, K; Zhao, YDD; Vogel, SM; Song, YL; Mahmud, N; Zhao, YY				Huang, Xiaojia; Sun, Kai; Zhao, Yidan D.; Vogel, Stephen M.; Song, Yuanling; Mahmud, Nadim; Zhao, You-Yang			Human CD34(+) Progenitor Cells Freshly Isolated from Umbilical Cord Blood Attenuate Inflammatory Lung Injury following LPS Challenge	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; RESPIRATORY-DISTRESS-SYNDROME; STROMAL CELLS; MONOCLONAL-ANTIBODY; ESCHERICHIA-COLI; ENDOTHELIAL-CELLS; LONG-TERM; MICE; NEOVASCULARIZATION; TRANSPLANTATION	Adult stem cell-based therapy is a promising novel approach for treatment of acute lung injury. Here we investigated the therapeutic potential of freshly isolated human umbilical cord blood CD34(+) progenitor cells (fCB-CD34(+) cells) in a mouse model of acute lung injury. At 3 h post-lipopolysaccharide (LPS) challenge, fCB-CD34(+) cells were transplanted i.v. to mice while CD34(-) cells or PBS were administered as controls in separate cohorts of mice. We observed that fCB-CD34(+) cell treatment inhibited lung vascular injury evident by decreased lung vascular permeability. In contrast, CD34(-) cells had no effects on lung vascular injury. Lung inflammation determined by myeloperoxidase activity, neutrophil sequestration and expression of pro-inflammatory mediators was attenuated in fCB-CD34(+) cell-treated mice at 26 h post-LPS challenge compared to PBS or CD34(-) cell-treated controls. Importantly, lung inflammation in fCB-CD34(+) cell-treated mice was returned to normal levels as seen in basal mice at 52 h post-LPS challenge whereas PBS or CD34(-) cell-treated control mice exhibited persistent lung inflammation. Accordingly, fCB-CD34(+) cell-treated mice exhibited a marked increase of survival rate. Employing in vivo 5-bromo-2'-deoxyuridine incorporation assay, we found a drastic induction of lung endothelial proliferation in fCB-CD34(+) cell-treated mice at 52 h post-LPS compared to PBS or CD34(-) cell-treated controls, which contributed to restoration of vascular integrity and thereby inhibition of lung inflammation. Taken together, these data have demonstrated the protective effects of fCB-CD34(+) cell on acute lung injury induced by LPS challenge, suggesting fCB-CD34(+) cells are an important source of stem cells for the treatment of acute lung injury.	[Huang, Xiaojia; Sun, Kai; Zhao, Yidan D.; Vogel, Stephen M.; Zhao, You-Yang] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60607 USA; [Huang, Xiaojia; Sun, Kai; Zhao, Yidan D.; Vogel, Stephen M.; Zhao, You-Yang] Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL USA; [Huang, Xiaojia] Jiangsu Univ, Sch Med Sci & Lab Med, Dept Pharmacol, Zhenjiang, Peoples R China; [Song, Yuanling] Fudan Univ, Zhongshan Hosp, Dept Pulm Med, Shanghai 200433, Peoples R China; [Mahmud, Nadim] Univ Illinois, Coll Med, Dept Med, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Jiangsu University; Fudan University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Zhao, YY (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60607 USA.	yyzhao@uic.edu		ZHAO, YOU-YANG/0000-0002-0041-0339	NIH [R01HL085462, R56HL085462, P01HL077806]; National Center for Research Resources [UL1RR029879]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029879] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL085462, R01HL085462, P01HL077806] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported in part through NIH grants R01HL085462, R56HL085462, and P01HL077806 to YYZ; The National Center for Research Resources grant UL1RR029879 to the UIC Center for Clinical & Translational Science. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS RG, 1986, BLOOD, V67, P842; Araki H, 2007, BLOOD, V109, P3570, DOI 10.1182/blood-2006-07-035287; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Chang YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052419; CIVIN CI, 1984, J IMMUNOL, V133, P157; Danchuk S, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt68; De Paepe ME, 2011, AM J PATHOL, V178, P1329, DOI 10.1016/j.ajpath.2010.11.062; Dreher L, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0051; Gao XP, 2001, J IMMUNOL, V167, P2895, DOI 10.4049/jimmunol.167.5.2895; Geissler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052700; Gonzalez-Rey E, 2009, GUT, V58, P929, DOI 10.1136/gut.2008.168534; Gotts JE, 2011, CRIT CARE CLIN, V27, P719, DOI 10.1016/j.ccc.2011.04.004; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Huang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050094; Ionescu L, 2012, AM J PHYSIOL-LUNG C, V303, pL967, DOI 10.1152/ajplung.00144.2011; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; ITO A, 1995, LAB INVEST, V72, P532; Izadpanah R, 2008, CANCER RES, V68, P4229, DOI 10.1158/0008-5472.CAN-07-5272; Kawamoto A, 2003, CIRCULATION, V107, P461, DOI 10.1161/01.CIR.0000046450.89986.50; Kim ES, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-108; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Krasnodembskaya A, 2012, AM J PHYSIOL-LUNG C, V302, pL1003, DOI 10.1152/ajplung.00180.2011; Krasnodembskaya A, 2010, STEM CELLS, V28, P2229, DOI 10.1002/stem.544; Lee JW, 2013, AM J RESP CRIT CARE, V187, P751, DOI 10.1164/rccm.201206-0990OC; Lee JW, 2009, P NATL ACAD SCI USA, V106, P16357, DOI 10.1073/pnas.0907996106; Losordo DW, 2012, CIRC-CARDIOVASC INTE, V5, P821, DOI 10.1161/CIRCINTERVENTIONS.112.968321; Mao QF, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-37; Matthay MA, 2005, AM J RESP CELL MOL, V33, P319, DOI 10.1165/rcmb.F305; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Mirza MK, 2010, AM J PATHOL, V176, P2344, DOI 10.2353/ajpath.2010.091088; Moodley Y, 2009, AM J PATHOL, V175, P303, DOI 10.2353/ajpath.2009.080629; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; O'Reilly MA, 2001, AM J PHYSIOL-LUNG C, V281, pL291, DOI 10.1152/ajplung.2001.281.2.L291; Pierro M, 2013, THORAX, V68, P475, DOI 10.1136/thoraxjnl-2012-202323; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rubio D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001398; Schatteman GC, 2000, J CLIN INVEST, V106, P571, DOI 10.1172/JCI9087; Shyu WC, 2006, J NEUROSCI, V26, P3444, DOI 10.1523/JNEUROSCI.5165-05.2006; SIMMONS DL, 1992, J IMMUNOL, V148, P267; SOLIGO D, 1991, LEUKEMIA, V5, P1026; SUBRAMANIAM M, 1995, J EXP MED, V181, P2277, DOI 10.1084/jem.181.6.2277; Sullivan MJ, 2008, NAT REV CANCER, V8, P554, DOI 10.1038/nrc2418; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Tarte K, 2010, BLOOD, V115, P1549, DOI 10.1182/blood-2009-05-219907; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Weiss Daniel J, 2008, Proc Am Thorac Soc, V5, P637, DOI 10.1513/pats.200804-037DW; WIENERKRONISH JP, 1991, J CLIN INVEST, V88, P864, DOI 10.1172/JCI115388; Zhao YD, 2010, AM J PHYSIOL-LUNG C, V298, pL36, DOI 10.1152/ajplung.00064.2009; Zhao YDD, 2009, CIRC RES, V105, P696, DOI 10.1161/CIRCRESAHA.109.199778; Zhao YY, 2006, J CLIN INVEST, V116, P2333, DOI 10.1172/JCI27154	52	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88814	10.1371/journal.pone.0088814	http://dx.doi.org/10.1371/journal.pone.0088814			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558433	gold, Green Submitted, Green Published			2022-12-27	WOS:000331706700079
J	Huang, XP; Wang, X; Lv, YH; Xu, LL; Lin, JS; Diao, Y				Huang, Xiaoping; Wang, Xiao; Lv, Yinghui; Xu, Luli; Lin, Junsheng; Diao, Yong			Protection Effect of Kallistatin on Carbon Tetrachloride-Induced Liver Fibrosis in Rats via Antioxidative Stress	PLOS ONE			English	Article							OXIDATIVE STRESS; ANGIOGENESIS; INFLAMMATION; INJURY; INHIBITION; EXPRESSION	Prolonged inflammation and oxidative stress are emerging as key causes of pathological wound healing and the development of liver fibrosis. We have investigated the effects of recombinant human kallistatin, produced in Pichia. pastoris, on preventing carbon tetrachloride (CCl4)-induced liver fibrosis in rats. Daily administration of kallistatin prevented development of CCl4-induced liver fibrosis, which was evidenced by histological study. In all kallistatin treated rats, activation of hepatic stellate cells (HSC) as assessed by s-smooth muscle actin staining was attenuated, TGF- beta 1 expression was inhibited, class I serum biomarkers associated with the process of fibrogenesis, such as hyaluronic acid, laminin, and procollagen III, were lowered, compared with that in the model control group. Furthermore, residual hepatic functional reserve was improved by kallistatin treatment. CCl4 induced elevation of malondialdehyde level and reduced superoxide dismutase activity in the liver, while kallistatin reduced these oxidative parameters. We also investigated the effects of kallistatin on rat primary HSC and LX-2, the human HSC cell line. Kallistatin scavenged H2O2-induced ROS in the LX-2 cells, and suppressed the activation of primary HSC. These results suggest recombinant human kallistatin might be a promising drug candidate for therapeutic intervention of liver fibrosis.	[Huang, Xiaoping; Wang, Xiao; Lv, Yinghui; Xu, Luli; Lin, Junsheng; Diao, Yong] Huaqiao Univ, Inst Mol Med, Quanzhou, Peoples R China	Huaqiao University	Lin, JS (corresponding author), Huaqiao Univ, Inst Mol Med, Quanzhou, Peoples R China.	junshenglin@hqu.edu.cn; diaoyong@hqu.edu.cn			National Natural Science Foundation of China [81271691, 81201183, 81270734]; Program for International S&T Cooperation Projects of China [2011DFG33320]; Key Science & Technology Project of the Fujian Province in China [2013N5007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for International S&T Cooperation Projects of China; Key Science & Technology Project of the Fujian Province in China	This research is funded by National Natural Science Foundation of China (81271691, 81201183, 81270734); Program for International S&T Cooperation Projects of China (No. 2011DFG33320); Key Science & Technology Project of the Fujian Province in China (No. 2013N5007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chao JL, 1996, J LAB CLIN MED, V127, P612, DOI 10.1016/S0022-2143(96)90152-3; Chao J, 2006, HUM GENE THER, V17, P1201, DOI 10.1089/hum.2006.17.1201; Cohen-Naftaly Michal, 2011, Therap Adv Gastroenterol, V4, P391, DOI 10.1177/1756283X11413002; Diao Y, 2007, WORLD J GASTROENTERO, V13, P4615, DOI 10.3748/wjg.v13.i34.4615; Diao Y, 2011, WORLD J GASTROENTERO, V17, P111, DOI 10.3748/wjg.v17.i1.111; Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97; Gao L, 2008, LAB INVEST, V88, P1157, DOI 10.1038/labinvest.2008.85; Guillaume M, 2013, J HEPATOL, V58, P240, DOI 10.1016/j.jhep.2012.09.010; Hsieh JL, 2009, HUM GENE THER, V20, P147, DOI 10.1089/hum.2008.096; Huang Xiaoping, 2010, Sheng Wu Gong Cheng Xue Bao, V26, P249; Itoh A, 2010, BIOL PHARM BULL, V33, P983, DOI 10.1248/bpb.33.983; Iwaisako K, 2012, P NATL ACAD SCI USA, V109, pE1369, DOI 10.1073/pnas.1202464109; Kim HJ, 2008, FOOD CHEM TOXICOL, V46, P3407, DOI 10.1016/j.fct.2008.08.012; Kisseleva T, 2011, BEST PRACT RES CL GA, V25, P305, DOI 10.1016/j.bpg.2011.02.011; Liu YY, 2012, AM J PHYSIOL-RENAL, V303, pF1230, DOI 10.1152/ajprenal.00257.2012; Luo QL, 2007, AM J PHYSIOL-GASTR L, V292, pG1272, DOI 10.1152/ajpgi.00474.2006; Miao RQ, 2003, AM J PHYSIOL-CELL PH, V284, pC1604, DOI 10.1152/ajpcell.00524.2002; Miao RQ, 2002, BLOOD, V100, P3245, DOI 10.1182/blood-2002-01-0185; Pellicoro A, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S26; Shaker ME, 2011, FUND CLIN PHARMACOL, V25, P248, DOI 10.1111/j.1472-8206.2010.00824.x; Shen B, 2008, HYPERTENSION, V51, P1358, DOI 10.1161/HYPERTENSIONAHA.107.108514; Valva P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023218; Wang CR, 2007, J RHEUMATOL, V34, P2171; Wang CR, 2005, ARTHRITIS RHEUM-US, V52, P1319, DOI 10.1002/art.20991; Xu R, 2006, MOL THER, V13, P1093, DOI 10.1016/j.ymthe.2005.11.027; Yin H, 2010, HYPERTENSION, V56, P260, DOI 10.1161/HYPERTENSIONAHA.110.152330; Zhu H, 2012, METABOLISM	27	37	43	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88498	10.1371/journal.pone.0088498	http://dx.doi.org/10.1371/journal.pone.0088498			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558397	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700043
J	Piai, V; Roelofs, A; Jensen, O; Schoffelen, JM; Bonnefond, M				Piai, Vitoria; Roelofs, Ardi; Jensen, Ole; Schoffelen, Jan-Mathijs; Bonnefond, Mathilde			Distinct Patterns of Brain Activity Characterise Lexical Activation and Competition in Spoken Word Production	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SEMANTIC INTERFERENCE; TIME-COURSE; DISTRACTOR FREQUENCY; LANGUAGE PRODUCTION; SELECTIVE ATTENTION; TEMPORAL SIGNATURES; PREFRONTAL CORTEX; SPEECH PRODUCTION; TASK	According to a prominent theory of language production, concepts activate multiple associated words in memory, which enter into competition for selection. However, only a few electrophysiological studies have identified brain responses reflecting competition. Here, we report a magnetoencephalography study in which the activation of competing words was manipulated by presenting pictures (e.g., dog) with distractor words. The distractor and picture name were semantically related (cat), unrelated (pin), or identical (dog). Related distractors are stronger competitors to the picture name because they receive additional activation from the picture relative to other distractors. Picture naming times were longer with related than unrelated and identical distractors. Phase-locked and non-phase-locked activity were distinct but temporally related. Phase-locked activity in left temporal cortex, peaking at 400 ms, was larger on unrelated than related and identical trials, suggesting differential activation of alternative words by the picture-word stimuli. Non-phase-locked activity between roughly 350-650 ms (4-10 Hz) in left superior frontal gyrus was larger on related than unrelated and identical trials, suggesting differential resolution of the competition among the alternatives, as reflected in the naming times. These findings characterise distinct patterns of activity associated with lexical activation and competition, supporting the theory that words are selected by competition.	[Piai, Vitoria; Roelofs, Ardi; Jensen, Ole; Schoffelen, Jan-Mathijs; Bonnefond, Mathilde] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Piai, Vitoria] Max Planck Inst Psycholinguist, Int Max Planck Res Sch Language Sci, Nijmegen, Netherlands; [Schoffelen, Jan-Mathijs] Max Planck Inst Psycholinguist, Neurobiol Language Dept, Nijmegen, Netherlands	Radboud University Nijmegen; Max Planck Society; Max Planck Society	Piai, V (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	v.piai@donders.ru.nl	Jensenq, Ole/D-2120-2010; Schoffelen, Jan-Mathijs/D-3716-2009; Roelofs, Ardi/A-5311-2010; Bonnefond, Mathilde/J-7572-2012; Piai, Vitória/D-5777-2012	Jensenq, Ole/0000-0001-8193-8348; Schoffelen, Jan-Mathijs/0000-0003-0923-6610; Piai, Vitória/0000-0002-4860-5952	Netherlands Organization for Scientific Research [MaGW 400-09-138, VICI 453-09-002, 056-14-011]; Fyssen Funding Scheme	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Fyssen Funding Scheme	This research was supported by grants from the Netherlands Organization for Scientific Research under grant number MaGW 400-09-138 (to A.R.), and VICI 453-09-002 and 056-14-011 (to O.J.), and by a grant from the Fyssen Funding Scheme (to M. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts E, 2009, NEUROPSYCHOLOGIA, V47, P2089, DOI 10.1016/j.neuropsychologia.2009.03.019; Alario FX, 2006, BRAIN RES, V1076, P129, DOI 10.1016/j.brainres.2005.11.104; Aristei S, 2011, J COGNITIVE NEUROSCI, V23, P1567, DOI 10.1162/jocn.2010.21474; Bastiaansen MCM, 2000, CLIN NEUROPHYSIOL, V111, P1300, DOI 10.1016/S1388-2457(00)00272-8; Belke E, 2013, Q J EXP PSYCHOL, V66, P2135, DOI 10.1080/17470218.2013.775318; Blackford T, 2012, COGNITION, V123, P84, DOI 10.1016/j.cognition.2011.12.007; Chen CC, 2012, NEUROIMAGE, V59, P340, DOI 10.1016/j.neuroimage.2011.07.066; Costa A, 2009, P NATL ACAD SCI USA, V106, P21442, DOI 10.1073/pnas.0908921106; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Zubicaray GI, 2002, NEUROIMAGE, V16, P1084, DOI 10.1006/nimg.2002.1135; de Zubicaray GI, 2001, HUM BRAIN MAPP, V14, P218, DOI 10.1002/hbm.1054; de Zubicaray GI, 2013, J EXP PSYCHOL GEN, V142, P131, DOI 10.1037/a0028717; de Zubicaray GI, 2009, COGN AFFECT BEHAV NE, V9, P260, DOI 10.3758/CABN.9.3.260; Dell'Acqua R, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00177; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dhooge E, 2010, J EXP PSYCHOL LEARN, V36, P878, DOI 10.1037/a0019128; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Ewald A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00166; Finkbeiner M, 2006, CORTEX, V42, P790, DOI 10.1016/S0010-9452(08)70419-2; Finkbeiner M, 2006, CORTEX, V42, P1032, DOI 10.1016/S0010-9452(08)70210-7; GLASER WR, 1984, J EXP PSYCHOL HUMAN, V10, P640, DOI 10.1037/0096-1523.10.5.640; Greenham SL, 2000, BIOL PSYCHOL, V55, P79, DOI 10.1016/S0301-0511(00)00070-3; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Halgren E, 2002, NEUROIMAGE, V17, P1101, DOI 10.1006/nimg.2002.1268; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; Hantsch A, 2013, LANG COGNITIVE PROC, V28, P684, DOI 10.1080/01690965.2011.595725; Hillebrand A, 2005, HUM BRAIN MAPP, V25, P199, DOI 10.1002/hbm.20102; Hirschfeld G, 2008, NEUROREPORT, V19, P1227, DOI 10.1097/WNR.0b013e328309ecd1; Hutson J, 2013, LANG COGNITIVE PROC, V28, P615, DOI 10.1080/01690965.2011.605599; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Indefrey P, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00255; Janssen N, 2008, J EXP PSYCHOL LEARN, V34, P249, DOI 10.1037/0278-7393.34.1.249; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; LA HEIJ W, 1990, BRIT J PSYCHOL, V81, P511; La Heij W, 2006, CORTEX, V42, P1028; Laaksonen H, 2012, NEUROIMAGE, V60, P29, DOI 10.1016/j.neuroimage.2011.11.087; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Levelt WJM, 2001, P NATL ACAD SCI USA, V98, P13464, DOI 10.1073/pnas.231459498; Liljestrom M, 2005, NEUROIMAGE, V25, P734, DOI 10.1016/j.neuroimage.2004.11.034; LUPKER SJ, 1979, MEM COGNITION, V7, P485, DOI 10.3758/BF03198265; Madebach A, 2011, J EXP PSYCHOL LEARN, V37, P522, DOI 10.1037/a0021970; Maess B, 2002, J COGNITIVE NEUROSCI, V14, P455, DOI 10.1162/089892902317361967; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mulatti C, 2013, CORTEX, DOI [10.1016/j.cortex.2013.08.018, DOI 10.1016/J.C0RTEX.2013.08.018]; Mulatti C, 2012, CORTEX, V48, P363, DOI 10.1016/j.cortex.2011.04.025; Neumann O., 1986, 1111986 U BIEL; Nigbur R, 2011, CLIN NEUROPHYSIOL, V122, P2185, DOI 10.1016/j.clinph.2011.03.030; Nolte G, 2003, PHYS MED BIOL, V48, P3637, DOI 10.1088/0031-9155/48/22/002; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Oppenheim GM, 2010, COGNITION, V114, P227, DOI 10.1016/j.cognition.2009.09.007; Piai V, 2012, MEM COGNITION, V40, P614, DOI 10.3758/s13421-011-0171-3; Piai V, 2012, BRAIN RES, V1450, P87, DOI 10.1016/j.brainres.2012.02.050; Piai V, 2011, J MEM LANG, V64, P404, DOI 10.1016/j.jml.2011.01.004; Rahman RA, 2010, PSYCHON B REV, V17, P657, DOI 10.3758/PBR.17.5.657; Rahman RA, 2009, LANG COGNITIVE PROC, V24, P713, DOI 10.1080/01690960802597250; Rahman RA, 2009, LANG COGNITIVE PROC, V24, P749, DOI 10.1080/01690960802648491; ROELOFS A, 1992, COGNITION, V42, P107, DOI 10.1016/0010-0277(92)90041-F; Roelofs A, 2003, PSYCHOL REV, V110, P88, DOI 10.1037/0033-295X.110.1.88; Roelofs A, 2002, COGNITIVE BRAIN RES, V15, P85, DOI 10.1016/S0926-6410(02)00218-5; Roelofs A, 2006, P NATL ACAD SCI USA, V103, P13884, DOI 10.1073/pnas.0606265103; Roelofs A, 2013, LANG COGNITIVE PROC, V28, P655, DOI 10.1080/01690965.2011.615663; Roelofs A, 2013, CORTEX, V49, P1767, DOI 10.1016/j.cortex.2013.03.001; Roelofs A, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00307; Roelofs A, 2011, J EXP PSYCHOL LEARN, V37, P1032, DOI 10.1037/a0023328; Sauseng P, 2005, INT J PSYCHOPHYSIOL, V57, P97, DOI 10.1016/j.ijpsycho.2005.03.018; Sauseng P, 2010, NEUROSCI BIOBEHAV R, V34, P1015, DOI 10.1016/j.neubiorev.2009.12.006; Schnur TT, 2009, P NATL ACAD SCI USA, V106, P322, DOI 10.1073/pnas.0805874106; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; SCHRIEFERS H, 1990, J MEM LANG, V29, P86, DOI 10.1016/0749-596X(90)90011-N; Schwartz MF, 2009, BRAIN, V132, P3411, DOI 10.1093/brain/awp284; Spalek K, 2008, BRAIN LANG, V107, P220, DOI 10.1016/j.bandl.2008.05.005; Starreveld PA, 1996, J EXP PSYCHOL LEARN, V22, P896, DOI 10.1037/0278-7393.22.4.896; Starreveld PA, 2013, LANG COGNITIVE PROC, V28, P633, DOI 10.1080/01690965.2011.608026; Stolk A, 2013, NEUROIMAGE, V68, P39, DOI 10.1016/j.neuroimage.2012.11.047; Strijkers K, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00356; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Tse CY, 2007, P NATL ACAD SCI USA, V104, P17157, DOI 10.1073/pnas.0707901104; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Wang L, 2012, HUM BRAIN MAPP, V33, P2898, DOI 10.1002/hbm.21410	86	66	66	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88674	10.1371/journal.pone.0088674	http://dx.doi.org/10.1371/journal.pone.0088674			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3RA	24558410	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700056
J	Yang, EJ; Lee, J; Lee, SY; Kim, EK; Moon, YM; Jung, YO; Park, SH; Cho, ML				Yang, Eun-Ji; Lee, Jennifer; Lee, Seon-Young; Kim, Eun-Kyung; Moon, Young-Mee; Jung, Young Ok; Park, Sung-Hwan; Cho, Mi-La			EGCG Attenuates Autoimmune Arthritis by Inhibition of STAT3 and HIF-1 alpha with Th17/Treg Control	PLOS ONE			English	Article							GREEN TEA; RHEUMATOID-ARTHRITIS; TNF-ALPHA; CELLS; EPIGALLOCATECHIN-3-GALLATE; PATHWAY; MICE; DIFFERENTIATION; MECHANISMS; EXPRESSION	Epigallocatechin-3-gallate (EGCG) is a green tea polyphenol exerting potent anti-oxidant and anti-inflammatory effects by inhibiting signaling and gene expression. The objective of the study was to evaluate the effect of EGCG on interleukin (IL)-1 receptor antagonist knockout (IL-1RaKO) autoimmune arthritis models. IL-1RaKO arthritis models were injected intraperitoneally with EGCG three times per week after the first immunization. EGCG decreased the arthritis index and showed protective effects against joint destruction in the IL-1RaKO arthritis models. The expression of pro-inflammatory cytokines, oxidative stress proteins, and p-STAT3 (Y705) and p-STAT3 (S727), mTOR and HIF-1 alpha were significantly lower in mice treated with EGCG. EGCG reduced osteoclast markers in vivo and in vitro along with anti-osteoclastic activity was observed in EGCG-treated IL-1RaKO mice. The proportion of Foxp3(+) Treg cells increased in the spleens of mice treated with EGCG, whereas the proportion of Th17 cells reduced. In vitro, p-STAT3 (Y705) and p-STAT3 (S727), HIF1 alpha and glycolytic pathway molecules were decreased by EGCG. EGCG suppressed the activation of mTOR and subsequently HIF-1 alpha, which is considered as a metabolic check point of Th17/Treg differentiation supporting the therapeutic potential of EGCG in autoimmune arthritis.	[Yang, Eun-Ji; Lee, Seon-Young; Kim, Eun-Kyung; Moon, Young-Mee; Cho, Mi-La] Catholic Univ Korea, Catholic Res Inst Med Sci, Rheumatism Res Ctr, Seoul, South Korea; [Lee, Jennifer; Park, Sung-Hwan] Catholic Univ Korea, Seoul St Marys Hosp, Dept Internal Med, Ctr Rheumat Dis,Div Rheumatol, Seoul, South Korea; [Yang, Eun-Ji; Lee, Seon-Young; Kim, Eun-Kyung; Moon, Young-Mee; Cho, Mi-La] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Lab Immune Network,Conversant Res Consortium Immu, Seoul, South Korea; [Jung, Young Ok] Hallym Univ, Kang Nam Sacred Heart Hosp, Dept Internal Med, Div Rheumatol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Hallym University	Cho, ML (corresponding author), Catholic Univ Korea, Catholic Res Inst Med Sci, Rheumatism Res Ctr, Seoul, South Korea.	iammila@catholic.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2009-0081791]; Korea Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A092258]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (grant number 2009-0081791) and by a grant of the Korea Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (grant number A092258). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2008, P NATL ACAD SCI USA, V105, P14692, DOI 10.1073/pnas.0802675105; Aktas O, 2004, J IMMUNOL, V173, P5794, DOI 10.4049/jimmunol.173.9.5794; Chen D, 2012, BIOORGAN MED CHEM, V20, P3031, DOI 10.1016/j.bmc.2012.03.002; Coccia M, 2012, J EXP MED; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Domingo DS, 2010, INT J CLIN EXP PATHO, V3, P706; Dryden GW, 2013, INFLAMM BOWEL DIS, V19, P1904, DOI 10.1097/MIB.0b013e31828f5198; Haqqi TM, 1999, P NATL ACAD SCI USA, V96, P4524, DOI 10.1073/pnas.96.8.4524; Hoffmann J, 2011, BIOCHEM PHARMACOL, V82, P1153, DOI 10.1016/j.bcp.2011.07.063; Kim HR, 2008, J NUTR, V138, P2111, DOI 10.3945/jn.108.089912; Lin SK, 2008, ARCH OTOLARYNGOL, V134, P522, DOI 10.1001/archotol.134.5.522; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mori T, 2011, INT IMMUNOL, V23, P701, DOI 10.1093/intimm/dxr077; Morinobu A, 2008, ARTHRITIS RHEUM, V58, P2012, DOI 10.1002/art.23594; Nie H, 2013, NAT MED, V19, P322, DOI 10.1038/nm.3085; Oz HS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00132; Riegsecker S, 2013, LIFE SCI, V93, P307, DOI 10.1016/j.lfs.2013.07.006; Shankar Sharmila, 2008, J Mol Signal, V3, P7, DOI 10.1186/1750-2187-3-7; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Van Aller GS, 2011, BIOCHEM BIOPH RES CO, V406, P194, DOI 10.1016/j.bbrc.2011.02.010; Wu DY, 2012, MOL ASPECTS MED, V33, P107, DOI 10.1016/j.mam.2011.10.001; Zhou F, 2005, ARTHRITIS RHEUM-US, V52, P3731, DOI 10.1002/art.21481	24	76	81	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e86062	10.1371/journal.pone.0086062	http://dx.doi.org/10.1371/journal.pone.0086062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558360	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700006
J	Yazawa, S; Yokobori, T; Ueta, G; Ide, M; Altan, B; Thongprachum, A; Nishimura, T; Nakajima, T; Kominato, Y; Asao, T; Saniabadi, AR; Furukawa, K; Kuwano, H; Le Pendu, J; Ushijima, H				Yazawa, Shin; Yokobori, Takehiko; Ueta, Gen; Ide, Munenori; Altan, Bolag; Thongprachum, Aksara; Nishimura, Toyo; Nakajima, Tamiko; Kominato, Yoshihiko; Asao, Takayuki; Saniabadi, Abby R.; Furukawa, Kiyoshi; Kuwano, Hiroyuki; Le Pendu, Jacques; Ushijima, Hiroshi			Blood Group Substances as Potential Therapeutic Agents for the Prevention and Treatment of Infection with Noroviruses Proving Novel Binding Patterns in Human Tissues	PLOS ONE			English	Article							NORWALK VIRUS-INFECTION; SIALYL-LEWIS-X; GROUP ANTIGENS; GENETIC-ANALYSIS; GENOGROUP-II; GROUP-A; VIRAL GASTROENTERITIS; MONOCLONAL-ANTIBODY; GII-4 NOROVIRUS; GASTRIC MUCIN	Blood group-related glycans determining ABO and Lewis blood groups are known to function as attachment factors for most of the norovirus (NoV) strains. To identify binding specificity of each NoV, recombinant norovirus-like particles (VLPs) and human saliva samples with different ABO, Lewis phenotypes and secretor status have been commonly applied. When binding specificities of VLPs prepared from 16 different genotypes of NoVs in GI and GII genogroups were characterized in samples of human gastric mucosa compared to human saliva based on blood group phenotypes, considerable differences were observed for several strains. Novel binding specificities determined by an ELISA using preparations from human gastric mucosa were also ascertained by immunohistochemical analyses using human jejunal mucosa, widely believed to be susceptible to NoV infection. Further, A, B and O(H) blood group substances prepared from porcine and squid tissues were found to be effective for preventing ABO blood group-specific binding of VLPs to both saliva and mucosa samples. Therefore, these blood group substances might have potential for the prevention and treatment of NoV infection.	[Yazawa, Shin; Yokobori, Takehiko; Altan, Bolag; Asao, Takayuki; Kuwano, Hiroyuki] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gunma 371, Japan; [Yazawa, Shin; Nishimura, Toyo] Otsuka Pharmaceut Co Ltd, Tokushima Res Inst, Tokushima, Japan; [Ueta, Gen; Furukawa, Kiyoshi] Nagaoka Univ Technol, Dept Bioengn, Lab Glycobiol, Nagaoka, Niigata 94021, Japan; [Ide, Munenori] Gunma Univ, Grad Sch Med, Dept Diagnost Pathol, Maebashi, Gunma 371, Japan; [Thongprachum, Aksara; Ushijima, Hiroshi] Univ Tokyo, Dept Dev Med Sci, Sch Int Hlth, Grad Sch Med, Tokyo, Japan; [Thongprachum, Aksara; Ushijima, Hiroshi] Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Microbiol, Tokyo, Japan; [Nakajima, Tamiko; Kominato, Yoshihiko] Gunma Univ, Grad Sch Med, Dept Legal Med, Maebashi, Gunma 371, Japan; [Saniabadi, Abby R.] JIMRO Co Ltd, Tokyo, Japan; [Le Pendu, Jacques] Univ Nantes, INSERM, UMR892, CNRS,UMR 6299, Nantes, France	Gunma University; Otsuka Pharmaceutical; Nagaoka University of Technology; Gunma University; University of Tokyo; Nihon University; Gunma University; Centre National de la Recherche Scientifique (CNRS); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Yazawa, S (corresponding author), Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gunma 371, Japan.	syazawa@titan.ocn.ne.jp	Le Pendu, Jacques/F-4760-2013	Le Pendu, Jacques/0000-0002-4856-0387				Asao T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/834790; BENDICH A, 1946, J EXP MED, V83, P485, DOI 10.1084/jem.83.6.485; BENDICH A, 1947, J AM CHEM SOC, V69, P2163, DOI 10.1021/ja01201a031; Bok K, 2009, J VIROL, V83, P11890, DOI 10.1128/JVI.00864-09; CHADWICK DW, 1949, NATURE, V164, P61, DOI 10.1038/164061a0; Chan MCW, 2011, J VIROL, V85, P8427, DOI 10.1128/JVI.05016-11; Cheetham S, 2007, J VIROL, V81, P3535, DOI 10.1128/JVI.01306-06; Chen YT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002152; Daniels G, 1995, HUMAN BLOOD GROUPS, P8; de Rougemont A, 2011, J VIROL, V85, P4057, DOI 10.1128/JVI.02077-10; DOLIN R, 1972, P SOC EXP BIOL MED, V140, P578, DOI 10.3181/00379727-140-36508; Estes MK, 2003, MICROBIAL PATHOGENESIS AND THE INTESTINAL EPITHELIAL CELL, P525; Frenck R, 2012, J INFECT DIS, V206, P1386, DOI 10.1093/infdis/jis514; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Green F R, 1988, Subcell Biochem, V12, P119; Harrington PR, 2004, J VIROL, V78, P3035, DOI 10.1128/JVI.78.6.3035-3045.2004; Harrington PR, 2002, J VIROL, V76, P12335, DOI 10.1128/JVI.76.23.12335-12343.2002; Horowitz MI, 1977, GLYCOCONJUGATES, V1, P189; Huang PW, 2009, GLYCOCONJUGATE J, V26, P1085, DOI 10.1007/s10719-009-9229-x; Huang PW, 2005, J VIROL, V79, P6714, DOI 10.1128/JVI.79.11.6714-6722.2005; Huang PW, 2003, J INFECT DIS, V188, P19, DOI 10.1086/375742; Hutson AM, 2005, J MED VIROL, V77, P116, DOI 10.1002/jmv.20423; Hutson AM, 2004, TRENDS MICROBIOL, V12, P279, DOI 10.1016/j.tim.2004.04.005; Hutson AM, 2002, J INFECT DIS, V185, P1335, DOI 10.1086/339883; Inouye S, 2000, J INFECT DIS, V181, pS270, DOI 10.1086/315593; Iseki S, 1956, P JAPAN ACAD, V32, P201; Iseki S, 1977, HUMAN BLOOD GROUPS, P126; Iseki S, 1951, P JAPAN ACAD, V27, P455; Issa S, 2010, GLYCOBIOLOGY, V20, P1046, DOI 10.1093/glycob/cwq066; KAPIKIAN AZ, 1972, J VIROL, V10, P1075, DOI 10.1128/JVI.10.5.1075-1081.1972; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; KELLY RJ, 1995, J BIOL CHEM, V270, P4640, DOI 10.1074/jbc.270.9.4640; Koda Y, 1996, AM J HUM GENET, V59, P343; Kubota T, 2012, J VIROL, V86, P11138, DOI 10.1128/JVI.00278-12; Kudo T, 1996, J BIOL CHEM, V271, P9830, DOI 10.1074/jbc.271.16.9830; Le Pendu J, 2006, SEMIN IMMUNOL, V18, P375, DOI 10.1016/j.smim.2006.07.009; LEVY AG, 1976, GASTROENTEROLOGY, V70, P321; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Lopman B, 2004, LANCET, V363, P682, DOI 10.1016/S0140-6736(04)15641-9; Marionneau S, 2005, J INFECT DIS, V192, P1071, DOI 10.1086/432546; Marionneau S, 2002, GASTROENTEROLOGY, V122, P1967, DOI 10.1053/gast.2002.33661; MOLLICONE R, 1985, LAB INVEST, V53, P219; Morgan WTJ, 1943, BIOCHEM J, V37, P640, DOI 10.1042/bj0370640; Morrow AL, 2004, J PEDIATR-US, V145, P297, DOI 10.1016/j.jpeds.2004.04.054; Nasir W, 2012, GLYCOBIOLOGY, V22, P1163, DOI 10.1093/glycob/cws084; Noel JS, 1999, J INFECT DIS, V179, P1334, DOI 10.1086/314783; Okada M, 2005, J CLIN MICROBIOL, V43, P4391, DOI 10.1128/JCM.43.9.4391-4401.2005; Okame M, 2007, J MED VIROL, V79, P1180, DOI 10.1002/jmv.20906; Okame M, 2006, J MED VIROL, V78, P1318, DOI 10.1002/jmv.20696; Phan TG, 2006, J MED VIROL, V78, P971, DOI 10.1002/jmv.20649; Ruvoen-Clouet N, 2006, BIOCHEM J, V393, P627, DOI 10.1042/BJ20050898; Schenkel-Brunner H, 1995, HUMAN BLOOD GROUPS; SCHREIBER DS, 1973, NEW ENGL J MED, V288, P1318, DOI 10.1056/NEJM197306212882503; Shiota T, 2007, J VIROL, V81, P12298, DOI 10.1128/JVI.00891-07; Shirato H, 2008, J VIROL, V82, P10756, DOI 10.1128/JVI.00802-08; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; SLOMIANY BL, 1978, EUR J BIOCHEM, V90, P39, DOI 10.1111/j.1432-1033.1978.tb12572.x; Tan M, 2005, TRENDS MICROBIOL, V13, P285, DOI 10.1016/j.tim.2005.04.004; Tan M, 2008, VIROLOGY, V379, P324, DOI 10.1016/j.virol.2008.06.041; Tan M, 2008, J MED VIROL, V80, P1296, DOI 10.1002/jmv.21200; Tan M, 2011, TRENDS MICROBIOL, V19, P382, DOI 10.1016/j.tim.2011.05.007; Tan M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000983; Teunis PFM, 2008, J MED VIROL, V80, P1468, DOI 10.1002/jmv.21237; Thomsson KA, 2005, GLYCOBIOLOGY, V15, P791, DOI 10.1093/glycob/cwi059; Tian P, 2005, LETT APPL MICROBIOL, V41, P315, DOI 10.1111/j.1472-765X.2005.01775.x; Tian P, 2007, RES VET SCI, V83, P410, DOI 10.1016/j.rvsc.2007.01.017; Tsuboi K, 2007, ANN SURG ONCOL, V14, P1880, DOI 10.1245/s10434-007-9363-2; Varki A, 1999, ESSENTIALS GLYCOBIOL, P429; Watkins W.M., 1995, GLYCOPROTEINS, P313; XI JA, 1992, J VIROL, V66, P6527, DOI 10.1128/JVI.66.11.6527-6532.1992; Yang Y, 2010, J VIROL, V84, P9595, DOI 10.1128/JVI.02614-09; Yazawa S, 2002, GLYCOBIOLOGY, V12, P545, DOI 10.1093/glycob/cwf070; YAZAWA S, 1984, J BIOCHEM-TOKYO, V96, P1737, DOI 10.1093/oxfordjournals.jbchem.a135006; YAZAWA S, 1983, J IMMUNOGENET, V10, P349; YAZAWA S, 1995, CANCER RES, V55, P1473; Yazawa S, 1996, TRANSFUSION, V36, P286, DOI 10.1046/j.1537-2995.1996.36396182149.x; YAZAWA S, 1990, IMMUNOL INVEST, V19, P319, DOI 10.3109/08820139009050773; YAZAWA S, 1993, JPN J CANCER RES, V84, P641, DOI 10.1111/j.1349-7006.1993.tb02024.x; Yazawa S, 2008, Protection against norovirus infection or removal of norovirus by using substance associated with blood type, Patent No. [WO2010/010948 A1, PCT/JP2009/063273, 2010010948]; Zheng DP, 2010, J CLIN MICROBIOL, V48, P168, DOI 10.1128/JCM.01622-09	80	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89071	10.1371/journal.pone.0089071	http://dx.doi.org/10.1371/journal.pone.0089071			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558470	gold, Green Published, Green Submitted			2022-12-27	WOS:000331706700116
J	Peiffer, M; Felton, GW				Peiffer, Michelle; Felton, Gary W.			Insights into the Saliva of the Brown Marmorated Stink Bug Halyomorpha halys (Hemiptera: Pentatomidae)	PLOS ONE			English	Article							PLANT BUGS; ACYRTHOSIPHON-PISUM; SOYBEAN SEED; PEA APHID; PROTEINS; IDENTIFICATION; HETEROPTERA; PHYSIOLOGY; DEFENSE; PEROXIDASE	We examined the salivary gland structure of the brown marmorated stink bug (Pentatomidae: Halyomorpha halys) and developed methods for independent collection of watery saliva and sheath saliva. This stink bug has become a serious invasive pest of agriculture in the United States and its saliva is largely responsible for the damage it causes. We determined by protein gel analysis and shotgun proteomics that the suite of proteins comprising the sheath and watery saliva are very distinct. Our results indicate that a substantial amount of sheath proteins are derived from tomato when stink bugs feed on tomato fruit. Consequently, the sheath saliva is comprised of both insect and plant-derived proteins. Both sheath and watery saliva possessed amylase activities, but polyphenol oxidase and glucose oxidase activities were not detected in either saliva. Peroxidase activity was only detected in salivary sheaths, but only when stink bugs fed on tomato. Proteomic analysis indicated that the peroxidase was likely of plant origin. We also determined that sheath saliva, but not watery saliva elicited the jasmonate inducible defense gene proteinase inhibitor 2 (Pin2), but this induction was only observed when sheaths had been collected from tomato. This indicates that the eliciting factor of the saliva is likely of plant origin. Lastly, neither watery or sheath saliva affected the expression of the salicylate inducible gene pathogenesis related gene (Pr1a-P4).	[Peiffer, Michelle; Felton, Gary W.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Felton, GW (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	gwf10@psu.edu			USDA NIFA [59- 1931-2-225]	USDA NIFA(United States Department of Agriculture (USDA))	Research was supported by USDA NIFA Cooperative Agreement Grant 59- 1931-2-225. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin S, 2011, STRATEGY PRIORITIZIN; Alhaddad H, 2011, ANN ENTOMOL SOC AM, V104, P543, DOI 10.1603/AN10137; Bezdi MS, 2012, ARCH INSECT BIOCH PH; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; BOWLING CC, 1980, J ECON ENTOMOL, V73, P1, DOI 10.1093/jee/73.1.1; Brennan EB, 2001, BIOTECH HISTOCHEM, V76, P59, DOI 10.1080/714028130; Carolan JC, 2009, PROTEOMICS, V9, P2457, DOI 10.1002/pmic.200800692; Celorio-Mancera MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026676; Cherqui A, 2000, J INSECT PHYSIOL, V46, P1177, DOI 10.1016/S0022-1910(00)00037-8; CLARKE RG, 1970, J ECON ENTOMOL, V63, P200, DOI 10.1093/jee/63.1.200; Correa-Ferreira BS, 2002, AGR FOREST ENTOMOL, V4, P145, DOI 10.1046/j.1461-9563.2002.00136.x; De Vos M, 2009, PLANT CELL ENV, V9999; Depieri RA, 2011, NEOTROP ENTOMOL, V40, P197, DOI 10.1590/S1519-566X2011000200007; Eichenseer H, 1999, ARCH INSECT BIOCHEM, V42, P99, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;99::AID-ARCH10&gt;3.0.CO;2-B; Eichenseer H, 2010, J CHEM ECOL, V36, P885, DOI 10.1007/s10886-010-9830-2; Erb M, 2012, TRENDS PLANT SCI, V17, P250, DOI 10.1016/j.tplants.2012.01.003; FELTON GW, 1989, J CHEM ECOL, V15, P2667, DOI 10.1007/BF01014725; Ferrari S., 2013, Frontiers in Plant Science, V4, P49; Francis F, 2006, INSECT BIOCHEM MOLEC, V36, P219, DOI 10.1016/j.ibmb.2006.01.018; Harmel N, 2008, INSECT MOL BIOL, V17, P165, DOI 10.1111/j.1365-2583.2008.00790.x; Hattori M, 2010, INSECT BIOCHEM MOLEC, V40, P331, DOI 10.1016/j.ibmb.2010.02.009; Hoebeke ER, 2003, P ENTOMOL SOC WASH, V105, P225; Hogenhout SA, 2011, CURR OPIN PLANT BIOL, V14, P422, DOI 10.1016/j.pbi.2011.05.003; Kaloshian I, 2005, ANNU REV PHYTOPATHOL, V43, P491, DOI 10.1146/annurev.phyto.43.040204.135944; Kotkar HM, 2009, J INSECT PHYSIOL, V55, P663, DOI 10.1016/j.jinsphys.2009.05.004; Kuhar TP, 2012, ONLINE PLANT HLTH PR, DOI 101094/PHP-2012-0523-01-BR; Kumar SKS, 2012, J AM DENT ASSOC, V143, P12, DOI 10.14219/jada.archive.2012.0003; Leskey TC, 2012, PSYCHE J ENTOMOLOGY, V2012; Liu F, 2004, J CHEM ECOL, V30, P2439, DOI 10.1007/s10886-004-7944-0; Louis J, 2013, NEW PHYTOL, DOI [10.1111/nph.12308, DOI 10.1111/NPH.12308:N/A-N/A]; Martinson HM, 2013, ANN ENTOMOL SOC AM, V106, P47, DOI 10.1603/AN12088; Mathews MC, 1997, ARCH INSECT BIOCHEM, V34, P57, DOI 10.1002/(SICI)1520-6327(1997)34:1<57::AID-ARCH5>3.0.CO;2-T; Maxwell CA, 2003, MOL BIOL CELL, V14, P2262, DOI 10.1091/mbc.E02-07-0377; Medrano EG, 2011, SOUTHWEST ENTOMOL, V36, P233, DOI 10.3958/059.036.0302; Miles P.W., 1972, Advances Insect Physiol, V9, P183, DOI 10.1016/S0065-2806(08)60277-5; MILES PW, 1964, J INSECT PHYSIOL, V10, P147, DOI 10.1016/0022-1910(64)90103-9; MILES PW, 1989, J INSECT PHYSIOL, V35, P865, DOI 10.1016/0022-1910(89)90102-9; Moreno A, 2011, ENTOMOL EXP APPL, V139, P145, DOI 10.1111/j.1570-7458.2011.01117.x; Musser RO, 2005, ARCH INSECT BIOCHEM, V58, P138, DOI 10.1002/arch.20031; Musser RO, 2002, NATURE, V416, P599, DOI 10.1038/416599a; Mutti NS, 2008, P NATL ACAD SCI USA, V105, P9965, DOI 10.1073/pnas.0708958105; Ni XZ, 2010, J ECON ENTOMOL, V103, P2072, DOI 10.1603/EC09301; Nicholson SJ, 2012, J PROTEOMICS, V75, P2252, DOI 10.1016/j.jprot.2012.01.031; Nielsen AL, 2009, ANN ENTOMOL SOC AM, V102, P608, DOI 10.1603/008.102.0405; Nielsen AL, 2009, J ECON ENTOMOL, V102, P1133, DOI 10.1603/029.102.0335; Olson DM, 2011, ENTOMOL EXP APPL, V139, P161, DOI 10.1111/j.1570-7458.2011.01116.x; Papoulas O, 2005, NAT CELL BIOL, V7, P612, DOI 10.1038/ncb1264; Peng L, 2013, ENTOMOL EXP APPL, V147, P282, DOI 10.1111/eea.12068; PENG Z, 1988, J INSECT PHYSIOL, V34, P1027, DOI 10.1016/0022-1910(88)90202-8; Ramzi S, 2010, J ASIA-PAC ENTOMOL, V13, P215, DOI 10.1016/j.aspen.2010.03.009; Redwine WB, 2012, SCIENCE, V337, P1532, DOI 10.1126/science.1224151; Silva FAC, 2012, NEOTROP ENTOMOL, P1; Tian DL, 2012, PLANTA, V236, P1053, DOI 10.1007/s00425-012-1651-9; Tian DL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036168, 10.1371/journal.pone.0042833]; Velikova V, 2010, J CHEM ECOL, V36, P629, DOI 10.1007/s10886-010-9801-7; Weech MH, 2008, J EXP BOT, V59, P2437, DOI 10.1093/jxb/ern108; Will T, 2007, P NATL ACAD SCI USA, V104, P10536, DOI 10.1073/pnas.0703535104; Will T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046903; Will T, 2008, PLANT SIGNAL BEHAV, V3, P427, DOI 10.4161/psb.3.6.5473; Wu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041947; Zanic M, 2013, NAT CELL BIOL, V15, P688, DOI 10.1038/ncb2744; Zhang QP, 2002, GENOMICS, V80, P473, DOI 10.1006/geno.2002.6859; Zhu GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031246	64	67	68	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e88483	10.1371/journal.pone.0088483	http://dx.doi.org/10.1371/journal.pone.0088483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586332	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000012
J	Redjadj, C; Darmon, G; Maillard, D; Chevrier, T; Bastianelli, D; Verheyden, H; Loison, A; Said, S				Redjadj, Claire; Darmon, Gaelle; Maillard, Daniel; Chevrier, Thierry; Bastianelli, Denis; Verheyden, Helene; Loison, Anne; Said, Sonia			Intra- and Interspecific Differences in Diet Quality and Composition in a Large Herbivore Community	PLOS ONE			English	Article							DEER CERVUS-ELAPHUS; NEAR-INFRARED SPECTROSCOPY; RED-DEER; ROE DEER; BODY-MASS; POPULATION-DENSITY; GUT FILL; RUMINANTS; PATTERNS; FOREST	Species diversity in large herbivore communities is often explained by niche segregation allowed by differences in body mass and digestive morphophysiological features. Based on large number of gut samples in fall and winter, we analysed the temporal dynamics of diet composition, quality and interspecific overlap of 4 coexisting mountain herbivores. We tested whether the relative consumption of grass and browse differed among species of different rumen types (moose-type and intermediate-type), whether diet was of lower quality for the largest species, whether we could identify plant species which determined diet quality, and whether these plants, which could be "key-food-resources'' were similar for all herbivores. Our analyses revealed that (1) body mass and rumen types were overall poor predictors of diet composition and quality, although the roe deer, a species with a moose-type rumen was confirmed as an "obligatory non grazer'', while red deer, the largest species, had the most lignified diet; (2) diet overlap among herbivores was well predicted by rumen type (high among species of intermediate types only), when measured over broad plant groups, (3) the relationship between diet composition and quality differed among herbivore species, and the actual plant species used during winter which determined the diet quality, was herbivore species-specific. Even if diets overlapped to a great extent, the species-specific relationships between diet composition and quality suggest that herbivores may select different plant species within similar plant group types, or different plant parts and that this, along with other behavioural mechanisms of ecological niche segregation, may contribute to the coexistence of large herbivores of relatively similar body mass, as observed in mountain ecosystems.	[Redjadj, Claire; Darmon, Gaelle; Loison, Anne] Univ Savoie, CNRS, Lab Ecol Alpine, Le Bourget Du Lac, France; [Redjadj, Claire; Maillard, Daniel; Chevrier, Thierry; Said, Sonia] Ctr Natl Etud & Rech Appl Faune Montagne & Cervid, Off Natl Chasse & Faune Sauvage, Le Perray En Yvelines, France; [Darmon, Gaelle] Univ Laval, Dept Biol, Chaire Rech Ind Prod Forestiers Anticosti, Quebec City, PQ G1K 7P4, Canada; [Bastianelli, Denis] Ctr Cooperat Int Rech Agron Dev, Montpellier, France; [Verheyden, Helene] INRA, Comportement & Ecol Faune Sauvage, Castanet Tolosan, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; Laval University; CIRAD; INRAE	Loison, A (corresponding author), Univ Savoie, CNRS, Lab Ecol Alpine, Le Bourget Du Lac, France.	anne.loison@univ-savoie.fr	Bastianelli, Denis/A-5572-2011	Bastianelli, Denis/0000-0002-6394-5920; SAID, Sonia/0000-0003-1485-8297	Centre National de la Recherche Scientifique (CNRS)-ATIP fund; Office National de la Chasse et de la Faune Sauvage (ONCFS)	Centre National de la Recherche Scientifique (CNRS)-ATIP fund; Office National de la Chasse et de la Faune Sauvage (ONCFS)	This project was funded by a Centre National de la Recherche Scientifique (CNRS)-ATIP fund and by the Office National de la Chasse et de la Faune Sauvage (ONCFS). CNRS was involved as a funder only. ONCFS was involved in study design, data collection, decision to publish and the preparation of the manuscript.	Abbas F, 2011, OECOLOGIA, V167, P401, DOI 10.1007/s00442-011-1994-0; ABRAMS P, 1980, ECOLOGY, V61, P44, DOI 10.2307/1937153; Behrend A, 2004, ACTA THERIOL, V49, P503, DOI 10.1007/BF03192594; Bell R.H.V., 1970, ANIMAL POPULATIONS R, P111; BELL RHV, 1971, SCI AM, V225, P86, DOI 10.1038/scientificamerican0771-86; Bertolino S, 2009, J ZOOL, V277, P63, DOI 10.1111/j.1469-7998.2008.00512.x; Boissier J, 2005, CONSERVATOIRE BOT NA, P140; Bonenfant C, 2002, ECOGRAPHY, V25, P446, DOI 10.1034/j.1600-0587.2002.250407.x; BRYANT JP, 1991, ANNU REV ECOL SYST, V22, P431, DOI 10.1146/annurev.es.22.110191.002243; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cerling TE, 2003, J MAMMAL, V84, P456, DOI 10.1644/1545-1542(2003)084&lt;0456:DOEABB&gt;2.0.CO;2; CHAMRAD ALBERT D., 1964, J WILDL MAGMT, V28, P473, DOI 10.2307/3798199; Chessel D., 2004, R NEWS, V4, P5; Clauss M, 2006, EUR J WILDLIFE RES, V52, P88, DOI 10.1007/s10344-005-0024-0; Clauss M, 2003, OIKOS, V102, P253, DOI 10.1034/j.1600-0706.2003.12406.x; Clauss M, 2010, ANIMAL, V4, P979, DOI 10.1017/S1751731110000388; Clauss M, 2010, J ZOOL, V281, P26, DOI 10.1111/j.1469-7998.2009.00675.x; Clauss M, 2008, OECOLOGIA, V157, P377, DOI 10.1007/s00442-008-1093-z; Clauss M, 2009, ZOOLOGY, V112, P195, DOI 10.1016/j.zool.2008.08.001; Clauss M, 2009, COMP BIOCHEM PHYS A, V152, P398, DOI 10.1016/j.cbpa.2008.11.009; Codron D, 2007, J ZOOL, V273, P21, DOI 10.1111/j.1469-7998.2007.00292.x; Codron D, 2008, OIKOS, V117, P344, DOI 10.1111/j.2007.0030-1299.16387.x; Codron D, 2007, EUR J WILDLIFE RES, V53, P100, DOI 10.1007/s10344-006-0071-1; Codron D, 2010, CAN J ZOOL, V88, P1129, DOI 10.1139/Z10-077; Cransac N, 1997, REV ECOL-TERRE VIE, V52, P21; Cromsigt JPGM, 2009, DIVERS DISTRIB, V15, P513, DOI 10.1111/j.1472-4642.2008.00554.x; Darmon G, 2007, CAN J ZOOL, V85, P634, DOI 10.1139/Z07-040; Darmon G, 2012, ECOGRAPHY, V35, P44, DOI 10.1111/j.1600-0587.2011.06664.x; de Iongh HH, 2011, J TROP ECOL, V27, P503, DOI 10.1017/S0266467411000307; DEMMENT MW, 1985, AM NAT, V125, P641, DOI 10.1086/284369; Dixon R, 2009, J NEAR INFRARED SPEC, V17, P1, DOI 10.1255/jnirs.822; DOLEDEC S, 1987, ACTA OECOL-OEC GEN, V8, P403; Dray S, 2003, ECOLOGY, V84, P3078, DOI 10.1890/03-0178; Duncan Alan J., 2008, V195, P89, DOI 10.1007/978-3-540-72422-3_4; Fritz H, 2011, ECOGRAPHY, V34, P196, DOI 10.1111/j.1600-0587.2010.06537.x; Fritz Herve, 2006, Conservation Biology Series (Cambridge), V11, P19; Fritz J, 2009, OIKOS, V118, P1623, DOI 10.1111/j.1600-0706.2009.17807.x; Gagnon M, 2000, J MAMMAL, V81, P490, DOI 10.1644/1545-1542(2000)081&lt;0490:DPIEAB&gt;2.0.CO;2; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; GarciaGonzalez R, 1996, FOREST ECOL MANAG, V88, P15, DOI 10.1016/S0378-1127(96)03805-4; Garel M, 2007, ECOL APPL, V17, P1607, DOI 10.1890/06-0898.1; Gebert C, 2001, MAMMAL REV, V31, P189, DOI 10.1046/j.1365-2907.2001.00090.x; Gonzalez G, 2001, CAN J ZOOL, V79, P2072, DOI 10.1139/cjz-79-11-2072; GORDON IJ, 1989, OECOLOGIA, V79, P383, DOI 10.1007/BF00384318; Gross J, 2006, MORTEST TESTS NORMAL; HANSKI I, 1978, ECOLOGY, V59, P168, DOI 10.2307/1936644; Heroldova M, 1996, FOREST ECOL MANAG, V88, P139, DOI 10.1016/S0378-1127(96)03819-4; HOBBS NT, 1990, J WILDLIFE MANAGE, V54, P515, DOI 10.2307/3809344; HOFMANN R R, 1972, Mammalia, V36, P226, DOI 10.1515/mamm.1972.36.2.226; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; Homolka M, 2001, FOLIA ZOOL, V50, P89; Hopcraft JGC, 2010, TRENDS ECOL EVOL, V25, P119, DOI 10.1016/j.tree.2009.08.001; Illius Andrew W., 2006, Conservation Biology Series (Cambridge), V11, P71; Illius AW, 2000, OIKOS, V89, P283, DOI 10.1034/j.1600-0706.2000.890209.x; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Kamler J, 2001, SMALL RUMINANT RES, V41, P101, DOI 10.1016/S0921-4488(01)00206-1; Kleynhans EJ, 2011, OIKOS, V120, P591, DOI 10.1111/j.1600-0706.2010.18712.x; Loison A., 2003, Ecological Studies, V167, P351; Marchand P, 2013, MAMMAL REV, V43, P275, DOI 10.1111/mam.12000; Muller DWH, 2013, COMP BIOCHEM PHYS A, V164, P129, DOI 10.1016/j.cbpa.2012.09.018; Mysterud A, 2000, OECOLOGIA, V124, P130, DOI 10.1007/s004420050032; Pettorelli N, 2002, P ROY SOC B-BIOL SCI, V269, P747, DOI 10.1098/rspb.2001.1791; Pinheiro JC, 2000, LINEAR MIXED EFFECTS; Prins Herbert H. T., 2008, V195, P179, DOI 10.1007/978-3-540-72422-3_7; Prins HHT, 2006, AFR J ECOL, V44, P186, DOI 10.1111/j.1365-2028.2006.00619.x; Putman R. J., 1996, COMPETITION RESOURCE; Raye G, 2011, ECOL RES, V26, P265, DOI 10.1007/s11284-010-0780-5; Relyea RA, 2000, J WILDLIFE MANAGE, V64, P146, DOI 10.2307/3802984; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Schroder J, 1984, ACTA ZOOL FENN; Storms D, 2008, WILDLIFE BIOL, V14, P237, DOI 10.2981/0909-6396(2008)14[237:SVIDCA]2.0.CO;2; Stuth J, 2003, FIELD CROP RES, V84, P45, DOI 10.1016/S0378-4290(03)00140-0; Tenenhaus M., 1995, REV STAT APPLIQUEE, V43, P7; Thuries L, 2005, J NEAR INFRARED SPEC, V13, P187, DOI 10.1255/jnirs.537; Tixier H, 1996, REV ECOL-TERRE VIE, V51, P3; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Van Wieren SE, 1996, THESIS U WAGENINGEN; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Verheyden-Tixier H, 2008, OECOLOGIA, V156, P715, DOI 10.1007/s00442-008-1020-3; Yoccoz NG, 2011, REV GEOGR ALP, V98, DOI [10.4000/rga.1279, DOI 10.4000/RGA.1279]; Zuur Alain F., 2009, P1	82	41	41	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e84756	10.1371/journal.pone.0084756	http://dx.doi.org/10.1371/journal.pone.0084756			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586233	gold, Green Submitted, Green Published			2022-12-27	WOS:000331880700003
J	Dotu, I; Mechery, V; Clote, P				Dotu, Ivan; Mechery, Vinodh; Clote, Peter			Energy Parameters and Novel Algorithms for an Extended Nearest Neighbor Energy Model of RNA	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; NUCLEIC-ACID OLIGOMERS; THERMODYNAMIC PARAMETERS; PARTITION-FUNCTION; WEB SERVER; SEQUENCES; TRANSITION; DERIVATION; COMMON; HELIX	We describe the first algorithm and software, RNAenn, to compute the partition function and minimum free energy secondary structure for RNA with respect to an extended nearest neighbor energy model. Our next-nearest-neighbor triplet energy model appears to lead to somewhat more cooperative folding than does the nearest neighbor energy model, as judged by melting curves computed with RNAenn and with two popular software implementations for the nearestneighbor energy model.	[Dotu, Ivan; Clote, Peter] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Mechery, Vinodh] Hofstra North Shore LIJ Sch Med, Hempstead, NY USA	Boston College; Hofstra University; Northwell Health	Clote, P (corresponding author), Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA.	clote@bc.edu		Dotu, Ivan/0000-0002-0438-9557	NSF [DMS-1016618, DBI-1262439]; Direct For Biological Sciences [1262439] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funded by NSF (http://www.nsf.gov) grant DMS-1016618, entitled "Energy parameters and novel algorithms for an extended nearest neighbor energy model of RNA'', as well as NSF DBI-1262439. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andronescu M, 2007, BIOINFORMATICS, V23, pI19, DOI 10.1093/bioinformatics/btm223; BAUMGARTNER A, 1979, J CHEM PHYS, V70, P429, DOI 10.1063/1.437206; Bekaert M, 2003, BIOINFORMATICS, V19, P327, DOI 10.1093/bioinformatics/btf868; Binder H, 2004, J PHYS CHEM B, V108, P18015, DOI 10.1021/jp049592o; Bompfunewerer AF, 2008, J MATH BIOL, V56, P129, DOI 10.1007/s00285-007-0107-5; Bon M, 2009, THESIS ECOLE POLYTEC; Brown D. T., 1959, INFORM CONTROL, V4, P386, DOI DOI 10.1016/S0019-9958(59)80016-4; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chiu WLAK, 2003, NUCLEIC ACIDS RES, V31, P483, DOI 10.1093/nar/gkg114; Clote Peter, 2009, Journal of Bioinformatics and Computational Biology, V7, P869, DOI 10.1142/S0219720009004333; Dill KA, 2002, MOL DRIVING FORCES S; Ding Y, 2004, NUCL ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Gray DM, 1997, BIOPOLYMERS, V42, P795, DOI 10.1002/(SICI)1097-0282(199712)42:7<795::AID-BIP5>3.0.CO;2-O; Gray DM, 1997, BIOPOLYMERS, V42, P783, DOI 10.1002/(SICI)1097-0282(199712)42:7<783::AID-BIP4>3.0.CO;2-P; Gray DM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-252; Gutell R., 2005, CURR OPIN STRUC BIOL, V12, P301; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hofacker IL, 1998, DISCRETE APPL MATH, V88, P207, DOI 10.1016/S0166-218X(98)00073-0; IRELAND CT, 1968, BIOMETRIKA, V55, P179; Ising E, 1925, Z PHYS, V31, P253, DOI 10.1007/BF02980577; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Kazan H, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000832; Kihara D, 2001, P NATL ACAD SCI USA, V98, P10125, DOI 10.1073/pnas.181328398; Kiryu H, 2007, BIOINFORMATICS, V23, P434, DOI 10.1093/bioinformatics/btl636; Kryukov GV, 1999, J BIOL CHEM, V274, P33888, DOI 10.1074/jbc.274.48.33888; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lyngso RB, 1999, BIOINFORMATICS, V15, P440, DOI 10.1093/bioinformatics/15.6.440; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mathews DH, 2002, J MOL BIOL, V317, P191, DOI 10.1006/jmbi.2001.5351; Mathews DH, 2005, BIOINFORMATICS, V21, P2246, DOI 10.1093/bioinformatics/bti349; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; Mikulecky PJ, 2004, NUCLEIC ACIDS RES, V32, P3967, DOI 10.1093/nar/gkh723; Najafabadi HS, 2006, J THEOR BIOL, V238, P657, DOI 10.1016/j.jtbi.2005.06.014; NUSSINOV R, 1980, P NATL ACAD SCI-BIOL, V77, P6309, DOI 10.1073/pnas.77.11.6309; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Reeder J, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-104; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Serganov A, 2005, NAT STRUCT MOL BIOL, V12, P218, DOI 10.1038/nsmb906; Silverman SK, 1999, BIOCHEMISTRY-US, V38, P8691, DOI 10.1021/bi9906118; SIPPL MJ, 1990, J MOL BIOL, V213, P859, DOI 10.1016/S0022-2836(05)80269-4; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Turner D. H., 2009, NUCL ACIDS RES, V0; Vashishta A, 2007, INT J ONCOL, V30, P1223; Wakeman CA, 2007, TRENDS BIOCHEM SCI, V32, P415, DOI 10.1016/j.tibs.2007.08.005; Waldispuhl J, 2007, J COMPUT BIOL, V14, P190, DOI 10.1089/cmb.2006.0012; Waldminghaus T, 2008, BIOL CHEM, V389, P1319, DOI 10.1515/BC.2008.150; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; ZIMM BH, 1959, J CHEM PHYS, V31, P526, DOI 10.1063/1.1730390; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Zuker M, 1999, NATO ASI 3 HIGH TECH, V70, P11	57	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e85412	10.1371/journal.pone.0085412	http://dx.doi.org/10.1371/journal.pone.0085412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586240	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900004
J	Evangeli, M; Newell, ML; Richter, L; McGrath, N				Evangeli, Michael; Newell, Marie-Louise; Richter, Linda; McGrath, Nuala			The Association between Self-Reported Stigma and Loss-to-Follow Up in Treatment Eligible HIV Positive Adults in Rural Kwazulu-Natal, South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT PROGRAM; TREATMENT COHORT; THERAPY; RISK; CARE; MORTALITY; PEOPLE; INITIATION; RETENTION; OUTCOMES	Background: The relationship between loss-to-follow-up (LTFU) in HIV treatment and care programmes and psychosocial factors, including self-reported stigma, is important to understand. This prospective cohort study explored stigma and LTFU in treatment eligible adults who had yet not started antiretroviral therapy (ART). Methods: Psychosocial, clinical and demographic data were collected at a baseline interview. Self-reported stigma was measured with a multi-item scale. LTFU was defined as not attending clinic in the 90 days since last appointment or before death. Data was collected between January 2009 and January 2013 and analysed using Cox Regression. Results: 380 individuals were recruited (median time in study 3.35 years, total time at risk 1065.81 person-years). 203 were retained (53.4%), 109 were LTFU (28.7%), 48 had died and were not LTFU at death (12.6%) and 20 had transferred out (5.3%). The LTFU rate was 10.65 per 100 person-years (95% CI: 8.48-12.34). 362 individuals (95.3%) started ART. Stigma total score (categorised in quartiles) was not significantly associated with LTFU in either univariable or multivariable analysis (adjusting for other variables in the final model): second quartile aHR 0.77 (95% CI: 0.41-1.46), third quartile aHR 1.20(95% CI: 0.721-2.04), fourth quartile aHR 0.62 (95% CI: 0.35-1.11). In the final multivariable model, higher LTFU rates were associated with male gender, increased openness with friends/family and believing that community problems would be solved at higher levels. Lower LTFU rates were independently associated with increased year of age, greater reliance on family/friends, and having children. Conclusions: Demographic and other psychosocial factors were more closely related to LTFU than self-reported stigma. This may be consistent with high levels of social exposure to HIV and ART and with stigma affecting LTFU less than other stages of care. Research and clinical implications are discussed.	[Evangeli, Michael] Royal Holloway Univ London, Dept Psychol, London, England; [Newell, Marie-Louise; McGrath, Nuala] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, South Africa; [Newell, Marie-Louise] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Richter, Linda] Human Sci Res Council, Durban, South Africa; [McGrath, Nuala] Univ Southampton, Acad Unit Primary Care & Populat Sci, Southampton, Hants, England; [McGrath, Nuala] Univ Southampton, Div Social Stat & Demog, Southampton, Hants, England	University of London; Royal Holloway University London; University of Kwazulu Natal; University of Southampton; Human Sciences Research Council-South Africa; University of Southampton; University of Southampton	Evangeli, M (corresponding author), Royal Holloway Univ London, Dept Psychol, London, England.	michael.evangeli@rhul.ac.uk	Newell, Marie-Louise/AAE-8222-2019	Newell, Marie-Louise/0000-0002-1074-7699; McGrath, Nuala/0000-0002-1039-0159	Wellcome Trust [WT083495MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	Nuala McGrath was supported by a Wellcome Trust fellowship grant (# WT083495MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amico KR, 2011, J HEALTH PSYCHOL, V16, P1071, DOI 10.1177/1359105311398727; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Bassett IV, 2012, JAIDS-J ACQ IMM DEF, V59, P25, DOI 10.1097/QAI.0b013e31823d3aba; Bor J, 2011, TROP MED INT HEALTH, V16, P988, DOI 10.1111/j.1365-3156.2011.02795.x; Braitstein P, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-7; Bygrave H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013198; Charurat M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010584; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; De Silva MJ, 2006, SOC SCI MED, V62, P941, DOI 10.1016/j.socscimed.2005.06.050; Dlamini PS, 2009, AIDS PATIENT CARE ST, V23, P377, DOI 10.1089/apc.2008.0164; Earnshaw VA, 2009, AIDS BEHAV, V13, P1160, DOI 10.1007/s10461-009-9593-3; Elford J, 2007, AIDS, V21, pS63, DOI 10.1097/01.aids.0000255087.62223.ff; Fatti G, 2012, INT AIDS C WASH DC U; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Health Do, 2010, S AFR ANT TREATM GUI; Health Do, 2004, NAT ANT TREATM GUID; Herbst AJ, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-47; Hills M, 2009, SHORT INTRO STATA BI; Holzemer WL, 2007, J ADV NURS, V58, P541, DOI 10.1111/j.1365-2648.2007.04244.x; Houlihan CF, 2011, INT J EPIDEMIOL, V40, P318, DOI 10.1093/ije/dyp402; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; Karcher H, 2007, TROP MED INT HEALTH, V12, P687, DOI 10.1111/j.1365-3156.2007.01830.x; Kunutsor S, 2010, AIDS BEHAV, V14, P1347, DOI 10.1007/s10461-010-9780-2; McGrath N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-121; McMahon JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056047; Mutevedzi PC, LOSS FOLLOW UP UNPUB; Mutevedzi PC, 2013, TROP MED INT HEALTH, V18, P934, DOI 10.1111/tmi.12135; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Myer L, 2008, SOC SCI MED, V66, P1828, DOI 10.1016/j.socscimed.2008.01.025; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Peoples A, 2008, 3 ANN GLOB HLTH S; Plazy M, 2013, RETENTION CARE ART I; Pronyk PM, 2008, SOC SCI MED, V66, P1999, DOI 10.1016/j.socscimed.2008.01.023; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; (SANAC) SANAC, 2011, M S AFR NAT AIDS COU; Sayles JN, 2008, AIDS BEHAV, V12, P748, DOI 10.1007/s10461-008-9375-3; Shisana O, 2013, S AFR AIDS C DURB S; Somi G, 2012, TROP MED INT HEALTH, V17, P497, DOI 10.1111/j.1365-3156.2011.02952.x; StataCorp, 2021, STATA STAT SOFTWARE; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Tayler-Smith K, 2011, TROP MED INT HEALTH, V16, P579, DOI 10.1111/j.1365-3156.2011.02740.x; Togun T, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-24; UNAIDS, 2009, S AFR COUNTR SIT; Van Cutsem G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014684; Wang BX, 2011, SAMJ S AFR MED J, V101, P253, DOI 10.7196/SAMJ.4078; Ware NC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001369; Wills TA., 1991, PROSOCIAL BEHAV, P265; Zachariah R, 2007, T ROY SOC TROP MED H, V101, P79, DOI 10.1016/j.trstmh.2006.05.010; Zaidi J, 2013, DRAMATIC INCREASES H	51	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88235	10.1371/journal.pone.0088235	http://dx.doi.org/10.1371/journal.pone.0088235			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3UC	24586310	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000331714700010
J	Thumbi, SM; Bronsvoort, BMD; Poole, EJ; Kiara, H; Toye, PG; Mbole-Kariuki, MN; Conradie, I; Jennings, A; Handel, IG; Coetzer, JAW; Steyl, JCA; Hanotte, O; Woolhouse, MEJ				Thumbi, Samuel M.; Bronsvoort, Barend Mark de Clare; Poole, Elizabeth Jane; Kiara, Henry; Toye, Philip G.; Mbole-Kariuki, Mary Ndila; Conradie, Ilana; Jennings, Amy; Handel, Ian Graham; Coetzer, Jacobus Andries Wynand; Steyl, Johan C. A.; Hanotte, Olivier; Woolhouse, Mark E. J.			Parasite Co-Infections and Their Impact on Survival of Indigenous Cattle	PLOS ONE			English	Article							HELMINTH COINFECTION; MALARIA; INFECTIONS; EPIDEMIOLOGY; DISEASES; WORMS; POPULATIONS; DYNAMICS; ANEMIA; RISK	In natural populations, individuals may be infected with multiple distinct pathogens at a time. These pathogens may act independently or interact with each other and the host through various mechanisms, with resultant varying outcomes on host health and survival. To study effects of pathogens and their interactions on host survival, we followed 548 zebu cattle during their first year of life, determining their infection and clinical status every 5 weeks. Using a combination of clinical signs observed before death, laboratory diagnostic test results, gross-lesions on post-mortem examination, histo-pathology results and survival analysis statistical techniques, cause-specific aetiology for each death case were determined, and effect of co-infections in observed mortality patterns. East Coast fever (ECF) caused by protozoan parasite Theileria parva and haemonchosis were the most important diseases associated with calf mortality, together accounting for over half (52%) of all deaths due to infectious diseases. Co-infection with Trypanosoma species increased the hazard for ECF death by 6 times (1.4-25; 95% CI). In addition, the hazard for ECF death was increased in the presence of Strongyle eggs, and this was burden dependent. An increase by 1000 Strongyle eggs per gram of faeces count was associated with a 1.5 times (1.4-1.6; 95% CI) increase in the hazard for ECF mortality. Deaths due to haemonchosis were burden dependent, with a 70% increase in hazard for death for every increase in strongyle eggs per gram count of 1000. These findings have important implications for disease control strategies, suggesting a need to consider co-infections in epidemiological studies as opposed to singlepathogen focus, and benefits of an integrated approach to helminths and East Coast fever disease control.	[Thumbi, Samuel M.; Woolhouse, Mark E. J.] Univ Edinburgh, Ctr Immunol Infect & Evolut, Edinburgh, Midlothian, Scotland; [Bronsvoort, Barend Mark de Clare; Jennings, Amy; Handel, Ian Graham] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Bronsvoort, Barend Mark de Clare; Jennings, Amy; Handel, Ian Graham] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland; [Poole, Elizabeth Jane; Kiara, Henry; Toye, Philip G.; Mbole-Kariuki, Mary Ndila] Int Livestock Res Inst, Nairobi, Kenya; [Hanotte, Olivier] Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England; [Conradie, Ilana; Coetzer, Jacobus Andries Wynand] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, ZA-0110 Onderstepoort, South Africa; [Steyl, Johan C. A.] Univ Pretoria, Fac Vet Sci, Dept Paraclin Sci, ZA-0110 Onderstepoort, South Africa	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; CGIAR; International Livestock Research Institute (ILRI); University of Nottingham; University of Pretoria; University of Pretoria	Thumbi, SM (corresponding author), Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.	samthumbi@gmail.com	Mwangi, Thumbi/L-2216-2019	Mwangi, Thumbi/0000-0002-5754-0556; Bronsvoort, Mark/0000-0002-3271-8485; Steyl, Johan/0000-0002-5940-6799; Hanotte, Olivier/0000-0002-2877-4767; Poole, Elizabeth Jane/0000-0002-8570-794X	Wellcome Trust [079445]; BBSRC [BBS/E/D/05191133] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/05191133] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors would like to thank the Wellcome Trust (grant No. 079445) for the financial support for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; Adegnika AA, 2012, CURR OPIN HIV AIDS, V7, P221, DOI 10.1097/COH.0b013e3283524d90; Alizon S, 2008, AM NAT, V172, pE150, DOI 10.1086/590958; Behnke JM, 2008, PARASITOLOGY, V135, P751, DOI 10.1017/S0031182008000334; Bronsvoort BMD, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-171; Brooker S, 2007, AM J TROP MED HYG, V77, P88, DOI 10.4269/ajtmh.2007.77.88; Brutus L, 2006, AM J TROP MED HYG, V75, P194, DOI 10.4269/ajtmh.2006.75.194; Cox FEG, 2001, PARASITOLOGY, V122, pS23, DOI 10.1017/S003118200001698X; Craig BH, 2008, PARASITOLOGY, V135, P433, DOI 10.1017/S0031182008004137; Drake L. J., 2001, Parasitology, V122, pS73, DOI 10.1017/S0031182000017662; Druilhe P, 2005, TRENDS PARASITOL, V21, P359, DOI 10.1016/j.pt.2005.06.011; Ezeamama AE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000245; Ezenwa VO, 2011, INTEGR COMP BIOL, V51, P540, DOI 10.1093/icb/icr058; Graham AL, 2008, P NATL ACAD SCI USA, V105, P566, DOI 10.1073/pnas.0707221105; Harms G, 2002, TROP MED INT HEALTH, V7, P479, DOI 10.1046/j.1365-3156.2002.00893.x; Hartgers FC, 2006, PARASITE IMMUNOL, V28, P497, DOI 10.1111/j.1365-3024.2006.00901.x; King D., 2006, NECROPSY BOOK GUIDE, V4th; Lello J, 2004, NATURE, V428, P840, DOI 10.1038/nature02490; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336; Mwangi TW, 2006, ANN TROP MED PARASIT, V100, P551, DOI 10.1179/136485906X118468; Nacher M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-259; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; Perry B, 2007, SCIENCE, V315, P333, DOI 10.1126/science.1138614; Petney TN, 1998, INT J PARASITOL, V28, P377, DOI 10.1016/S0020-7519(97)00189-6; R Core Team, 2016, R FDN STAT COMP; Rich KM, 2011, PREV VET MED, V101, P133, DOI 10.1016/j.prevetmed.2010.08.002; Spiegel A, 2003, T ROY SOC TROP MED H, V97, P198, DOI 10.1016/S0035-9203(03)90117-9; Supali T, 2010, INT J PARASITOL, V40, P1171, DOI 10.1016/j.ijpara.2010.05.003; Telfer S, 2008, PARASITOLOGY, V135, P767, DOI 10.1017/S0031182008000395; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Therneau T.M., 2012, PACKAGE SURVIVAL ANA; Thumbi SM, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-175	33	29	30	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e76324	10.1371/journal.pone.0076324	http://dx.doi.org/10.1371/journal.pone.0076324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586220	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700002
J	Warren, IA; Vera, JC; Johns, A; Zinna, R; Marden, JH; Emlen, DJ; Dworkin, I; Lavine, LC				Warren, Ian A.; Vera, J. Cristobal; Johns, Annika; Zinna, Robert; Marden, James H.; Emlen, Douglas J.; Dworkin, Ian; Lavine, Laura C.			Insights into the Development and Evolution of Exaggerated Traits Using De Novo Transcriptomes of Two Species of Horned Scarab Beetles	PLOS ONE			English	Article							LENGTH DIMORPHISM; COLEOPTERA; SIZE; RNA; DIVERSITY; SELECTION; GENES; DIVERSIFICATION; SEPTENTRIONALIS; SCARABAEOIDEA	Scarab beetles exhibit an astonishing variety of rigid exo-skeletal outgrowths, known as "horns". These traits are often sexually dimorphic and vary dramatically across species in size, shape, location, and allometry with body size. In many species, the horn exhibits disproportionate growth resulting in an exaggerated allometric relationship with body size, as compared to other traits, such as wings, that grow proportionately with body size. Depending on the species, the smallest males either do not produce a horn at all, or they produce a disproportionately small horn for their body size. While the diversity of horn shapes and their behavioural ecology have been reasonably well studied, we know far less about the proximate mechanisms that regulate horn growth. Thus, using 454 pyrosequencing, we generated transcriptome profiles, during horn growth and development, in two different scarab beetle species: the Asian rhinoceros beetle, Trypoxylus dichotomus, and the dung beetle, Onthophagus nigriventris. We obtained over half a million reads for each species that were assembled into over 6,000 and 16,000 contigs respectively. We combined these data with previously published studies to look for signatures of molecular evolution. We found a small subset of genes with horn-biased expression showing evidence for recent positive selection, as is expected with sexual selection on horn size. We also found evidence of relaxed selection present in genes that demonstrated biased expression between horned and horn-less morphs, consistent with the theory of developmental decoupling of phenotypically plastic traits.	[Warren, Ian A.; Zinna, Robert; Lavine, Laura C.] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [Warren, Ian A.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Vera, J. Cristobal; Marden, James H.] Penn State Univ, Dept Biol, State Coll, PA USA; [Johns, Annika; Emlen, Douglas J.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Dworkin, Ian] Michigan State Univ, Program Ecol Evolutionary Biol & Behav, E Lansing, MI 48824 USA; [Dworkin, Ian] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA	Washington State University; University of Bristol; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of Montana System; University of Montana; Michigan State University; Michigan State University	Warren, IA (corresponding author), Washington State Univ, Dept Entomol, Pullman, WA 99164 USA.	ianawarren.work@gmail.com		Lavine, Laura/0000-0002-0262-359X; Dworkin, Ian/0000-0002-2874-287X	National Science Foundation [IOS-0919781, IOS-0919730, IOS-0920142, IOS- 0950416]	National Science Foundation(National Science Foundation (NSF))	The National Science Foundation (IOS-0919781, IOS-0919730, IOS-0920142, IOS- 0950416) provided funding for this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; Andersson Malte, 1994; [Anonymous], 2010, GS FLX TITANIUM SERI; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Arrow G.J., 1951, HORNED BEETLES; Bailey NW, 2013, G3-GENES GENOM GENET, V3, P225, DOI 10.1534/g3.112.004341; Browne J, 1998, SYST ENTOMOL, V23, P307, DOI 10.1046/j.1365-3113.1998.00059.x; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Carvalho AB, 1999, NATURE, V401, P344, DOI 10.1038/43827; Carvalho RA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-695; Choi JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-703; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cotton S, 2004, J EVOLUTION BIOL, V17, P1310, DOI 10.1111/j.1420-9101.2004.00754.x; Darlington P.J., 1957, ZOOGEOGRAPHY GEOGRAP; Darwin C., 1871, P423; Davis ALV, 2002, J BIOGEOGR, V29, P1217, DOI 10.1046/j.1365-2699.2002.00776.x; Eberhard, 1978, PSYCHE, V83, P292; Emlen DJ, 2006, HEREDITY, V97, P179, DOI 10.1038/sj.hdy.6800868; Emlen DJ, 2000, BIOSCIENCE, V50, P403, DOI 10.1641/0006-3568(2000)050[0403:IDWEAC]2.0.CO;2; Emlen DJ, 2005, EVOLUTION, V59, P1060; Emlen DJ, 2003, INTEGR COMP BIOL, V43, P617, DOI 10.1093/icb/43.5.617; Emlen DJ, 1999, J INSECT PHYSIOL, V45, P45, DOI 10.1016/S0022-1910(98)00096-1; EMLEN DJ, 1994, P ROY SOC B-BIOL SCI, V256, P131, DOI 10.1098/rspb.1994.0060; Emlen DJ, 2012, SCIENCE, V337, P860, DOI 10.1126/science.1224286; Enrodi S., 1985, DYNASTINAE WORLD; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; HALFFTNER G, 1982, NESTING BEHAV DUNG B; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; Hongo Y, 2012, ACTA ETHOL, V15, P195, DOI 10.1007/s10211-012-0128-y; Hunt BG, 2011, P NATL ACAD SCI USA, V108, P15936, DOI 10.1073/pnas.1104825108; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Iguchi Y, 1998, ANN ENTOMOL SOC AM, V91, P845, DOI 10.1093/aesa/91.6.845; Karino K, 2004, ECOL RES, V19, P663, DOI 10.1111/j.1440-1703.2004.00681.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kijimoto T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-504; Krell FT, 2000, INVERTEBR TAXON, V14, P871, DOI 10.1071/IT00031; Kusui Y., 1976, Entomological Rev Japan, V29, P51; Lai J, 2008, LOVE RHINOCEROS STAG; Lavine LC, 2013, ARCH INSECT BIOCHEM, V82, P43, DOI 10.1002/arch.21072; Madhi SA, 2021, SAFETY EFFICACY CHAD, DOI 10.1101/2021.02.10.21251247; Markusson E, 1997, OECOLOGIA, V110, P501, DOI 10.1007/s004420050186; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; Moczek AP, 2005, EVOL DEV, V7, P175, DOI 10.1111/j.1525-142X.2005.05020.x; Moczek AP, 2002, EVOL ECOL RES, V4, P587; Moczek AP, 1999, J EVOLUTION BIOL, V12, P27, DOI 10.1046/j.1420-9101.1999.00004.x; Moczek AP, 2009, P NATL ACAD SCI USA, V106, P8992, DOI 10.1073/pnas.0809668106; Muller GB, 2005, J EXP ZOOL PART B, V304B, P487, DOI 10.1002/jez.b.21081; MULLER GB, 1991, ANNU REV ECOL SYST, V22, P229, DOI 10.1146/annurev.es.22.110191.001305; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ohlsson T, 2002, P ROY SOC B-BIOL SCI, V269, P21, DOI 10.1098/rspb.2001.1848; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Pitchers W, 2013, EVOLUTION, V67, P438, DOI 10.1111/j.1558-5646.2012.01774.x; Plaistow SJ, 2005, ECOL ENTOMOL, V30, P692, DOI 10.1111/j.0307-6946.2005.00740.x; Quinlan AR, 2008, NAT METHODS, V5, P454; R Foundation for Statistical Computing, 2012, R LANG ENV STAT COMP; Robinson GE, 2011, SCIENCE, V331, P1386, DOI 10.1126/science.331.6023.1386; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Snell-Rood EC, 2013, J EXP ZOOL PART B, V320B, P22, DOI 10.1002/jez.b.22479; Snell-Rood EC, 2011, EVOLUTION, V65, P231, DOI 10.1111/j.1558-5646.2010.01106.x; Snell-Rood EC, 2010, BIOESSAYS, V32, P71, DOI 10.1002/bies.200900132; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tyndale-Briscoe M, 1990, COMMON DUNG BEETLES; Vanhooydonck B, 2005, BEHAV ECOL SOCIOBIOL, V59, P157, DOI 10.1007/s00265-005-0022-y; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vera JC, 2012, FUNCTIONAL TRANSCRIP; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Wasik BR, 2012, GENESIS, V50, P404, DOI 10.1002/dvg.20814; West-Eberhard M.J., 1984, Symposia of the Royal Entomological Society of London, V12, P283; West-Eberhard Mary Jane, 2003, pi; Winnebeck EC, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14119; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2	74	14	14	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88364	10.1371/journal.pone.0088364	http://dx.doi.org/10.1371/journal.pone.0088364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586317	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700015
J	Graybeal, C; Bachu, M; Mozhui, K; Saksida, LM; Bussey, TJ; Sagalyn, E; Williams, RW; Holmes, A				Graybeal, Carolyn; Bachu, Munisa; Mozhui, Khyobeni; Saksida, Lisa M.; Bussey, Timothy J.; Sagalyn, Erica; Williams, Robert W.; Holmes, Andrew			Strains and Stressors: An Analysis of Touchscreen Learning in Genetically Diverse Mouse Strains	PLOS ONE			English	Article							REPEATED MATERNAL SEPARATION; BEHAVIORAL PROFILES; COGNITIVE SYMPTOMS; MAZE PERFORMANCE; OPERANT PLATFORM; INBRED STRAINS; DBA/2J MICE; GO/NO-GO; MEMORY; C57BL/6J	Touchscreen-based systems are growing in popularity as a tractable, translational approach for studying learning and cognition in rodents. However, while mouse strains are well known to differ in learning across various settings, performance variation between strains in touchscreen learning has not been well described. The selection of appropriate genetic strains and backgrounds is critical to the design of touchscreen-based studies and provides a basis for elucidating genetic factors moderating behavior. Here we provide a quantitative foundation for visual discrimination and reversal learning using touchscreen assays across a total of 35 genotypes. We found significant differences in operant performance and learning, including faster reversal learning in DBA/2J compared to C57BL/6J mice. We then assessed DBA/2J and C57BL/6J for differential sensitivity to an environmental insult by testing for alterations in reversal learning following exposure to repeated swim stress. Stress facilitated reversal learning (selectively during the late stage of reversal) in C57BL/6J, but did not affect learning in DBA/2J. To dissect genetic factors underlying these differences, we phenotyped a family of 27 BXD strains generated by crossing C57BL/6J and DBA/2J. There was marked variation in discrimination, reversal and extinction learning across the BXD strains, suggesting this task may be useful for identifying underlying genetic differences. Moreover, different measures of touchscreen learning were only modestly correlated in the BXD strains, indicating that these processes are comparatively independent at both genetic and phenotypic levels. Finally, we examined the behavioral structure of learning via principal component analysis of the current data, plus an archival dataset, totaling 765 mice. This revealed 5 independent factors suggestive of "reversal learning,'' "motivation-related late reversal learning,'' "discrimination learning,'' "speed to respond,'' and "motivation during discrimination.'' Together, these findings provide a valuable reference to inform the choice of strains and genetic backgrounds in future studies using touchscreen-based tasks.	[Graybeal, Carolyn; Bachu, Munisa; Sagalyn, Erica; Holmes, Andrew] NIAAA, Lab Behav & Genom Neurosci, NIH, Bethesda, MD 20892 USA; [Mozhui, Khyobeni; Williams, Robert W.] Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Memphis, TN 38163 USA; [Williams, Robert W.] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Saksida, Lisa M.; Bussey, Timothy J.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; [Saksida, Lisa M.; Bussey, Timothy J.] Med Res Council & Wellcome Trust, Behav & Clin Neurosci Inst, Cambridge, England	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Cambridge; University of Cambridge	Graybeal, C (corresponding author), NIAAA, Lab Behav & Genom Neurosci, NIH, Bethesda, MD 20892 USA.	carolyn_graybeal@alumni.brown.edu	Saksida, Lisa M/M-2753-2016; Bussey, Timothy J/M-2758-2016; Bachu, Mahesh/I-4343-2015; Williams, Robert W./H-8789-2016	Saksida, Lisa M/0000-0002-8416-8171; Bussey, Timothy J/0000-0001-7518-4041; Bachu, Mahesh/0000-0002-6494-6642; Williams, Robert W./0000-0001-8924-4447	NIAAA Intramural Research Program; NIAAA INIA [U01 11016662, U01 AA013499]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA013499, ZIAAA000411, U01AA016662] Funding Source: NIH RePORTER	NIAAA Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA INIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Research supported by the NIAAA Intramural Research Program and NIAAA INIA grants U01 11016662 and U01 AA013499. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032489; Barkus C, 2012, NEUROPHARMACOLOGY, V62, P1263, DOI 10.1016/j.neuropharm.2011.06.005; Baron SP, 2001, BEHAV BRAIN RES, V118, P143, DOI 10.1016/S0166-4328(00)00322-3; Bogue MA, 2004, GENETICA, V122, P71, DOI 10.1007/s10709-004-1438-4; Boyce-Rustay JM, 2007, PHYSIOL BEHAV, V91, P77, DOI 10.1016/j.physbeh.2007.01.024; Brigman JL, 2013, NAT NEUROSC IN PRESS; Brigman JL, 2007, BEHAV BRAIN RES; BRIGMAN JL, 2013, NAT NEUROSCI; Brigman JL, 2008, LEARN MEMORY, V15, P50, DOI 10.1101/lm.777308; Brigman JL, 2006, BEHAV NEUROSCI, V120, P984, DOI 10.1037/0735-7044.120.4.984; Brigman JL, 2010, CEREB CORTEX, V20, P1955, DOI 10.1093/cercor/bhp266; Brigman JL, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.002.2009; Brigman JL, 2009, BEHAV PHARMACOL, V20, P204, DOI 10.1097/FBP.0b013e32830c368c; Brooks SP, 2005, GENES BRAIN BEHAV, V4, P307, DOI 10.1111/j.1601-183X.2004.00109.x; Brown RE, 2007, LEARN MEMORY, V14, P134, DOI 10.1101/lm.473907; Bussey TJ, 2012, NEUROPHARMACOLOGY, V62, P1191, DOI 10.1016/j.neuropharm.2011.04.011; Camp M, 2009, GENES BRAIN BEHAV, V8, P744, DOI 10.1111/j.1601-183X.2009.00519.x; Colelli V, 2010, GENES BRAIN BEHAV, V9, P703, DOI 10.1111/j.1601-183X.2010.00604.x; Crusio WE, 2009, GENES BRAIN BEHAV, V8, P1, DOI 10.1111/j.1601-183X.2008.00438.x; CRUSIO WE, 1987, BRAIN RES, V425, P182, DOI 10.1016/0006-8993(87)90498-7; D'Este L, 2007, J CHEM NEUROANAT, V33, P67, DOI 10.1016/j.jchemneu.2006.12.005; Depoy L, 2013, P NATL ACAD SCI USA, V110, P14783, DOI 10.1073/pnas.1308198110; FRANCIS DD, 1995, PHYSIOL BEHAV, V58, P57, DOI 10.1016/0031-9384(95)00009-8; Graybeal C, 2011, NAT NEUROSCI, V14, P1507, DOI 10.1038/nn.2954; Gubner NR, 2010, ALCOHOL CLIN EXP RES, V34, P1353, DOI 10.1111/j.1530-0277.2010.01219.x; Hefner K, 2008, J NEUROSCI, V28, P8074, DOI 10.1523/JNEUROSCI.4904-07.2008; HEGMANN JP, 1981, BEHAV GENET, V11, P103, DOI 10.1007/BF01065621; Helms CM, 2006, PSYCHOPHARMACOLOGY, V188, P144, DOI 10.1007/s00213-006-0478-0; Hitzemann R, 2003, ALCOHOL CLIN EXP RES, V27, P1, DOI 10.1097/01.ALC.000047862.40562.27; Holmes A, 1998, PHARMACOL BIOCHEM BE, V60, P473, DOI 10.1016/S0091-3057(98)00008-2; Holmes A, 2002, GENES BRAIN BEHAV, V1, P55, DOI 10.1046/j.1601-1848.2001.00005.x; Horner AE, 2013, NAT PROTOC, V8, P1961, DOI 10.1038/nprot.2013.122; Isles AR, 2004, J NEUROSCI, V24, P6733, DOI 10.1523/JNEUROSCI.1650-04.2004; Izquierdo A, 2006, BEHAV BRAIN RES, V171, P181, DOI 10.1016/j.bbr.2006.03.029; Izquierdo A, 2012, PSYCHOPHARMACOLOGY, V219, P607, DOI 10.1007/s00213-011-2579-7; Karlsson RM, 2009, NEUROPSYCHOPHARMACOL, V34, P1578, DOI 10.1038/npp.2008.215; Kiselycznyk C, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00010; Knapman A, 2010, NEUROBIOL LEARN MEM, V94, P145, DOI 10.1016/j.nlm.2010.04.010; Laughlin RE, 2011, BIOL PSYCHIAT, V69, P1109, DOI 10.1016/j.biopsych.2011.01.014; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lederle L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015536; Loos M, 2010, BEHAV BRAIN RES, V214, P216, DOI 10.1016/j.bbr.2010.05.027; Mar AC, 2013, NAT PROTOC, V8, P1985, DOI 10.1038/nprot.2013.123; Mihalick SM, 2000, J COMP PSYCHOL, V114, P365; Millstein RA, 2006, GENES BRAIN BEHAV, V5, P346, DOI 10.1111/j.1601-183X.2005.00172.x; Millstein RA, 2007, NEUROSCI BIOBEHAV R, V31, P3, DOI 10.1016/j.neubiorev.2006.05.003; Mineur YS, 2007, NEUROSCIENCE, V150, P251, DOI 10.1016/j.neuroscience.2007.09.045; Mozhui K, 2010, J NEUROSCI, V30, P5357, DOI 10.1523/JNEUROSCI.5017-09.2010; Nguyen PV, 2000, LEARN MEMORY, V7, P170, DOI 10.1101/lm.7.3.170; Nithianantharajah J, 2013, NAT NEUROSCI, V16, P16, DOI 10.1038/nn.3276; O'Leary TP, 2011, BEHAV BRAIN RES, V216, P531, DOI 10.1016/j.bbr.2010.08.030; Owen EH, 1997, NEUROSCIENCE, V80, P1087, DOI 10.1016/S0306-4522(97)00165-6; Passino E, 2002, HIPPOCAMPUS, V12, P63, DOI 10.1002/hipo.10007; Patel S, 2006, BEHAV BRAIN RES, V170, P197, DOI 10.1016/j.bbr.2006.02.019; PAYLOR R, 1993, PSYCHOBIOLOGY, V21, P11; PuglisiAllegra S, 1997, PROG NEUROBIOL, V51, P637, DOI 10.1016/S0301-0082(97)00008-7; Siegmund A, 2005, BEHAV BRAIN RES, V157, P291, DOI 10.1016/j.bbr.2004.07.007; Sokoloff G, 2011, GENES BRAIN BEHAV, V10, P604, DOI 10.1111/j.1601-183X.2011.00699.x; Taylor B. A., 1978, ORIGINS INBRED MICE, P423, DOI [10.1016/B978-0-12-507850-4.50032-9, DOI 10.1016/B978-0-12-507850-4.50032-9]; Tsang SH, 2007, HUM MUTAT, V28, P243, DOI 10.1002/humu.20425; Wong AA, 2006, GENES BRAIN BEHAV, V5, P389, DOI 10.1111/j.1601-183X.2005.00173.x	61	46	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e87745	10.1371/journal.pone.0087745	http://dx.doi.org/10.1371/journal.pone.0087745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586288	gold, Green Published, Green Submitted			2022-12-27	WOS:000331711900016
J	Wang, LM; Tang, WF; Chen, SC; Sun, YY; Fan, Y; Shi, YJ; Zhu, JF; Wang, X; Zheng, L; Shao, AZ; Ding, GW; Liu, C; Liu, RP; Yin, J; Gu, HY				Wang, Liming; Tang, Weifeng; Chen, Suocheng; Sun, Yangyong; Fan, Yu; Shi, Yijun; Zhu, Jingfeng; Wang, Xu; Zheng, Liang; Shao, Aizhong; Ding, Guowen; Liu, Chao; Liu, Ruiping; Yin, Jun; Gu, Haiyong			N-acetyltransferase 2 Polymorphisms and Risk of Esophageal Cancer in a Chinese Population	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; GENETIC POLYMORPHISMS; SUSCEPTIBILITY; NAT2; ASSOCIATION	Esophageal cancer was the fifth most commonly diagnosed cancer and the fourth leading cause of cancer-related death in China in 2009. Genetic factors might play an important role in the carcinogenesis of esophageal squamous cell carcinoma (ESCC). We conducted a hospital-based case-control study to evaluate ten NAT2 tagging single nucleotide polymorphisms (SNPs) on the risk of ESCC. Six hundred and twenty-nine ESCC cases and 686 controls were recruited. Their genotypes were determined using the ligation detection reaction method. In the single locus analyses, there was a borderline statistically significant difference in genotype frequencies of NAT2 rs1565684 T>C SNP between the cases and the controls (p = 0.057). The NAT2 rs1565684 CC genotype was associated with a borderline significantly increased risk for ESCC (CC vs. TT: adjusted OR = 1.77, 95% Cl = 0.97-3.21, p = 0.063 and CC vs. TT/TC: adjusted OR = 1.68, 95% Cl = 0.93-3.04, p = 0.085). The association was evident among older patients and patients who never drunk. After the Bonferroni correction, in all comparison models, NAT2 rs1565684 T>C SNP was not associated with ESCC risk (p>0.05). For the other nine NAT2 SNPs, after Bonferroni correction, in all comparison models, the nine SNPs were also not associated with ESCC risk (p>0.05). Thus, nine NAT2 tagging SNPs were not associated with risk of ESCC. NAT2 rs1565684 T>C SNP might play a slight role in ESCC etiology. Additional, larger studies and tissue-specific biological characterization are required to confirm the current findings.	[Wang, Liming; Fan, Yu] Jiangsu Univ, Affiliated Peoples Hosp, Dept Chemotherapy, Inst Canc, Zhenjiang, Jiangsu, Peoples R China; [Tang, Weifeng; Chen, Suocheng; Sun, Yangyong; Shi, Yijun; Zhu, Jingfeng; Wang, Xu; Shao, Aizhong; Ding, Guowen; Liu, Chao; Yin, Jun; Gu, Haiyong] Jiangsu Univ, Affiliated Peoples Hosp, Dept Cardiothorac Surg, Zhenjiang, Peoples R China; [Zheng, Liang] Suzhou Univ, Peoples Hosp Changzhou 1, Dept Cardiothorac Surg, Changzhou, Peoples R China; [Zheng, Liang] Suzhou Univ, Affiliated Hosp 3, Changzhou, Peoples R China; [Liu, Ruiping] Nanjing Med Univ, Changzhou Second Peoples Hosp, Affiliated Hosp, Dept Orthoped, Changzhou, Peoples R China	Jiangsu University; Jiangsu University; Nanjing Medical University	Yin, J (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp, Dept Cardiothorac Surg, Zhenjiang, Peoples R China.	yin912@126.com; haiyong_gu@hotmail.com			National Natural Science Foundation of China [81370001, 81371927, 81101889, 81000028]; Jiangsu Province Natural Science Foundation [BK2010333, BK2011481]; Social Development Foundation of Zhenjiang [SH2010017]; Changzhou Young Talents and ScienceTechnology Foundation of Health Bureau [QN201102]; Affiliated People's Hospital of Jiangsu University fund [Y200913]; Jiangsu University Clinical medicine science and technology development fund [JLY20120004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Social Development Foundation of Zhenjiang; Changzhou Young Talents and ScienceTechnology Foundation of Health Bureau; Affiliated People's Hospital of Jiangsu University fund; Jiangsu University Clinical medicine science and technology development fund	This study was supported in part by National Natural Science Foundation of China (81370001, 81371927, 81101889, 81000028), Jiangsu Province Natural Science Foundation (BK2010333, BK2011481), Social Development Foundation of Zhenjiang (SH2010017), Changzhou Young Talents and Science-Technology Foundation of Health Bureau (QN201102), Affiliated People's Hospital of Jiangsu University fund (Y200913) and Jiangsu University Clinical medicine science and technology development fund (JLY20120004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLUM M, 1990, DNA CELL BIOL, V9, P193, DOI 10.1089/dna.1990.9.193; Chen WQ, 2013, J THORAC DIS, V5, P19, DOI 10.3978/j.issn.2072-1439.2013.01.04; Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732; Cui D, 2011, LUNG CANCER, V73, P153, DOI 10.1016/j.lungcan.2010.12.012; Garcia-Martin E, 2008, CURR DRUG METAB, V9, P487, DOI 10.2174/138920008784892155; Gong CM, 2011, MED ONCOL, V28, P365, DOI 10.1007/s12032-010-9423-5; Gu HY, 2012, MOL BIOL REP, V39, P9105, DOI 10.1007/s11033-012-1782-x; Jain M, 2007, CANCER INVEST, V25, P340, DOI 10.1080/07357900701358074; LAYTON DW, 1995, CARCINOGENESIS, V16, P39, DOI 10.1093/carcin/16.1.39; Lee JM, 2000, INT J CANCER, V89, P458, DOI 10.1002/1097-0215(20000920)89:5<458::AID-IJC10>3.0.CO;2-R; Liao G., 2013, ORAL DIS; Liu L, 2009, CHEM RES TOXICOL, V22, P1962, DOI 10.1021/tx9002676; Malik MA, 2009, ARCH MED RES, V40, P416, DOI 10.1016/j.arcmed.2009.06.009; MANABE S, 1991, CARCINOGENESIS, V12, P1945, DOI 10.1093/carcin/12.10.1945; Morita S, 1998, INT J CANCER, V79, P517, DOI 10.1002/(SICI)1097-0215(19981023)79:5<517::AID-IJC12>3.0.CO;2-Z; Walker K, 2009, J TOXICOL ENV HEAL B, V12, P440, DOI 10.1080/10937400903158383; Wei JS, 2013, HUM IMMUNOL, V74, P1199, DOI 10.1016/j.humimm.2013.06.012; Yin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076294; Zhang J, 2010, BREAST CANCER RES TR, V123, P877, DOI 10.1007/s10549-010-0807-1; Zhong X, 2010, ARCH MED RES, V41, P275, DOI 10.1016/j.arcmed.2010.06.001	20	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e87783	10.1371/journal.pone.0087783	http://dx.doi.org/10.1371/journal.pone.0087783			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586291	Green Submitted, Green Published, gold			2022-12-27	WOS:000331711900017
J	Ormond, DR; Shannon, C; Oppenheim, J; Zeman, R; Das, K; Murali, R; Jhanwar-Uniyal, M				Ormond, D. Ryan; Shannon, Craig; Oppenheim, Julius; Zeman, Richard; Das, Kaushik; Murali, Raj; Jhanwar-Uniyal, Meena			Stem Cell Therapy and Curcumin Synergistically Enhance Recovery from Spinal Cord Injury	PLOS ONE			English	Article							NF-KAPPA-B; NEURAL STEM/PROGENITOR CELLS; FUNCTIONAL RECOVERY; PROGENITOR-CELLS; ISCHEMIA/REPERFUSION INJURY; HISTOLOGICAL OUTCOMES; IMPROVES LOCOMOTOR; BODY-WEIGHT; IN-VIVO; PROLIFERATION	Acute traumatic spinal cord injury (SCI) is marked by the enhanced production of local cytokines and pro-inflammatory substances that induce gliosis and prevent reinnervation. The transplantation of stem cells is a promising treatment strategy for SCI. In order to facilitate functional recovery, we employed stem cell therapy alone or in combination with curcumin, a naturally-occurring anti-inflammatory component of turmeric (Curcuma longa), which potently inhibits NF-kappa B. Spinal cord contusion following laminectomy (T9-10) was performed using a weight drop apparatus (10 g over a 12.5 or 25 mm distance, representing moderate or severe SCI, respectively) in Sprague-Dawley rats. Neural stem cells (NSC) were isolated from subventricular zone (SVZ) and transplanted at the site of injury with or without curcumin treatment. Functional recovery was assessed by BBB score and body weight gain measured up to 6 weeks following SCI. At the conclusion of the study, the mass of soleus muscle was correlated with BBB score and body weight. Stem cell therapy improved recovery from moderate SCI, however, it had a limited effect on recovery after severe SCI. Curcumin stimulated NSC proliferation in vitro, and in combination with stem cell therapy, induced profound recovery from severe SCI as evidenced by improved functional locomotor recovery, increased body weight, and soleus muscle mass. These findings demonstrate that curcumin in conjunction with stem cell therapy synergistically improves recovery from severe SCI. Furthermore, our results indicate that the effect of curcumin extends beyond its known anti-inflammatory properties to the regulation of stem cell proliferation.	[Ormond, D. Ryan; Shannon, Craig; Oppenheim, Julius; Das, Kaushik; Murali, Raj; Jhanwar-Uniyal, Meena] New York Med Coll, Dept Neurosurg, Valhalla, NY 10595 USA; [Zeman, Richard] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA	New York Medical College; New York Medical College	Jhanwar-Uniyal, M (corresponding author), New York Med Coll, Dept Neurosurg, Valhalla, NY 10595 USA.	meena_jhanwar@nymc.edu	Ormond, David R/R-4847-2017; Oppenheim, Julius/AAP-9428-2020	Ormond, David R/0000-0001-7027-2915; Oppenheim, Julius/0000-0002-5988-0677	American Association of Neurological Surgeons NREF/Medtronic Research Fellowship grant	American Association of Neurological Surgeons NREF/Medtronic Research Fellowship grant	This work was funded from the American Association of Neurological Surgeons NREF/Medtronic Research Fellowship grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010; AMMON HPT, 1991, PLANTA MED, V57, P1, DOI 10.1055/s-2006-960004; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; [Anonymous], 2009, ON DEGR SEP PAR SPIN; Avci G, 2012, J SURG RES, V172, pE39, DOI 10.1016/j.jss.2011.08.021; Barnabe-Heider F, 2008, CELL STEM CELL, V3, P16, DOI 10.1016/j.stem.2008.06.011; Barzegar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026012; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Begum AN, 2008, J PHARMACOL EXP THER, V326, P196, DOI 10.1124/jpet.108.137455; Bernardo A, 2003, J NEUROPATH EXP NEUR, V62, P509, DOI 10.1093/jnen/62.5.509; Bottai D, 2008, MOL MED, V14, P634, DOI 10.2119/2008-00077.Bottai; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Brambilla R, 2009, J NEUROCHEM, V110, P765, DOI 10.1111/j.1471-4159.2009.06190.x; Cao QL, 2002, J NEUROSCI RES, V68, P501, DOI 10.1002/jnr.10240; Cemil B, 2010, ACTA NEUROCHIR, V152, P1583, DOI 10.1007/s00701-010-0702-x; Chainani-Wu N, 2003, J ALTERN COMPLEM MED, V9, P161, DOI 10.1089/107555303321223035; Dolgun H, 2010, J CLIN NEUROSCI, V17, P486, DOI 10.1016/j.jocn.2009.07.108; Dupont-Versteegden EE, 1998, AM J PHYSIOL-CELL PH, V275, pC1124, DOI 10.1152/ajpcell.1998.275.4.C1124; Fansa I, 2009, J INT MED RES, V37, P520, DOI 10.1177/147323000903700228; Fehlings MG, 2011, NEUROTHERAPEUTICS, V8, P704, DOI 10.1007/s13311-011-0076-7; GANESHAIAH KN, 1980, INDIAN J EXP BIOL, V18, P700; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Guizar-Sahagun G, 2005, NEUROSCIENCE, V130, P639, DOI 10.1016/j.neuroscience.2004.09.056; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Holly LT, 2012, J NEUROSURG-SPINE, V17, P134, DOI 10.3171/2012.5.SPINE1216; Horner PJ, 2000, J NEUROSCI, V20, P2218; Jakeman LB, 1998, EXP NEUROL, V154, P170, DOI 10.1006/exnr.1998.6924; JHANWARUNIYAL M, 1993, BRAIN RES, V631, P97, DOI 10.1016/0006-8993(93)91192-U; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Joseph MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041288; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Kavakli HS, 2011, ULUS TRAVMA ACIL CER, V17, P14, DOI 10.5505/tjtes.2011.31391; Kim SJ, 2008, J BIOL CHEM, V283, P14497, DOI 10.1074/jbc.M708373200; Kojima A, 2002, J NEUROTRAUM, V19, P223, DOI 10.1089/08977150252806974; Kuo CP, 2011, ANESTHESIOLOGY, V115, P1229, DOI 10.1097/ALN.0b013e31823306f0; Landry E, 2004, J NEUROTRAUM, V21, P1008, DOI 10.1089/0897715041651060; Lee SG, 2008, ONCOGENE, V27, P1114, DOI 10.1038/sj.onc.1210713; Lee YS, 2007, J APPL PHYSIOL, V103, P1808, DOI 10.1152/japplphysiol.00588.2007; Lin MS, 2011, J NEUROTRAUM, V28, P1259, DOI 10.1089/neu.2011.1768; Lin MS, 2011, J SURG RES, V166, P280, DOI 10.1016/j.jss.2009.07.001; Liu M, 2006, EUR J APPL PHYSIOL, V97, P355, DOI 10.1007/s00421-006-0199-4; Liu M, 2010, EUR J APPL PHYSIOL, V109, P709, DOI 10.1007/s00421-010-1392-z; Marshall Gregory P. II, 2008, V438, P135, DOI 10.1007/978-1-59745-133-8_12; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; Miller RH, 2012, NEUROSCI LETT, V519, P87, DOI 10.1016/j.neulet.2012.01.043; Morell Pierre, 1999, P69; Moreno-Manzano V, 2009, STEM CELLS, V27, P733, DOI 10.1002/stem.24; Namiki J, 1999, J NEUROPATH EXP NEUR, V58, P489, DOI 10.1097/00005072-199905000-00008; Nesathurai S, 1998, J TRAUMA, V45, P1088, DOI 10.1097/00005373-199812000-00021; Ormond DR, 2012, J NEUROSURG-SPINE, V16, P497, DOI 10.3171/2012.1.SPINE11769; Parr AM, 2008, NEUROSCIENCE, V155, P760, DOI 10.1016/j.neuroscience.2008.05.042; Parr AM, 2007, J NEUROTRAUM, V24, P835, DOI 10.1089/neu.2006.3771; Parr AM, 2008, SURG NEUROL, V70, P600, DOI 10.1016/j.surneu.2007.09.043; Pfeifer K, 2004, EUR J NEUROSCI, V20, P1695, DOI 10.1111/j.1460-9568.2004.03657.x; Pogue AI, 2011, J INORG BIOCHEM, V105, P1434, DOI 10.1016/j.jinorgbio.2011.05.012; Rabchevsky AG, 1997, J NEUROSCI RES, V47, P34; Rafati DS, 2008, J NEUROSCI RES, V86, P566, DOI 10.1002/jnr.21508; Renault-Mihara F, 2008, INT J BIOCHEM CELL B, V40, P1649, DOI 10.1016/j.biocel.2008.03.009; Ruff CA, 2012, EXP NEUROL, V235, P78, DOI 10.1016/j.expneurol.2011.02.010; Saito T, 2011, ANESTH ANALG, V113, P565, DOI 10.1213/ANE.0b013e318224ac35; SATOSKAR RR, 1986, INT J CLIN PHARM TH, V24, P651; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Sharma RA, 2007, ADV EXP MED BIOL, V595, P453; Sharma S, 2009, NEUROSCIENCE, V161, P1037, DOI 10.1016/j.neuroscience.2009.04.042; Singh A, 2011, J NEUROTRAUM, V28, P2405, DOI 10.1089/neu.2010.1660; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177; Vroemen M, 2003, EUR J NEUROSCI, V18, P743, DOI 10.1046/j.1460-9568.2003.02804.x; Weiss S, 1996, J NEUROSCI, V16, P7599; Yan J, 2004, J COMP NEUROL, V480, P101, DOI 10.1002/cne.20344; Zeman RJ, 2006, J NEUROTRAUM, V23, P170, DOI 10.1089/neu.2006.23.170; Zeman RJ, 2001, EXP NEUROL, V172, P228, DOI 10.1006/exnr.2001.7803; Zeman RJ, 1999, EXP NEUROL, V159, P267, DOI 10.1006/exnr.1999.7146; Ziv Y, 2006, P NATL ACAD SCI USA, V103, P13174, DOI 10.1073/pnas.0603747103	76	48	50	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88916	10.1371/journal.pone.0088916	http://dx.doi.org/10.1371/journal.pone.0088916			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558450	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700096
J	Staud, R; Weyl, EE; Riley, JL; Fillingim, RB				Staud, Roland; Weyl, Elizabeth E.; Riley, Joseph L., III; Fillingim, Roger B.			Slow Temporal Summation of Pain for Assessment of Central Pain Sensitivity and Clinical Pain of Fibromyalgia Patients	PLOS ONE			English	Article							C-FIBER REFLEX; 2ND PAIN; CENTRAL SENSITIZATION; CENTRAL MODULATION; WIDESPREAD PAIN; HEAT PAIN; WIND-UP; RESPONSES; CONTACT; HYPERSENSITIVITY	Background: In healthy individuals slow temporal summation of pain or wind-up (WU) can be evoked by repetitive heat-pulses at frequencies of >.33 Hz. Previous WU studies have used various stimulus frequencies and intensities to characterize central sensitization of human subjects including fibromyalgia (FM) patients. However, many trials demonstrated considerable WU-variability including zero WU or even wind-down (WD) at stimulus intensities sufficient for activating C-nociceptors. Additionally, few WU-protocols have controlled for contributions of individual pain sensitivity to WU-magnitude, which is critical for WU-comparisons. We hypothesized that integration of 3 different WU-trains into a single WU-response function (WU-RF) would not only control for individuals' pain sensitivity but also better characterize their central pain responding including WU and WD. Methods: 33 normal controls (NC) and 38 FM patients participated in a study of heat-WU. We systematically varied stimulus intensities of. 4 Hz heat-pulse trains applied to the hands. Pain summation was calculated as difference scores of 1st and 5th heat-pulse ratings. WU-difference (WU-D) scores related to 3 heat-pulse trains (44 degrees C, 46 degrees C, 48 degrees C) were integrated into WU-response functions whose slopes were used to assess group differences in central pain sensitivity. WU-aftersensations (WU-AS) at 15 s and 30 s were used to predict clinical FM pain intensity. Results: WU-D scores linearly accelerated with increasing stimulus intensity (p,. 001) in both groups of subjects (FM. NC) from WD to WU. Slope of WU-RF, which is representative of central pain sensitivity, was significantly steeper in FM patients than NC (p,. 003). WU-AS predicted clinical FM pain intensity (Pearson's r=.4; p<.04). Conclusions: Compared to single WU series, WU-RFs integrate individuals' pain sensitivity as well as WU and WD. Slope of WU-RFs was significantly different between FM patients and NC. Therefore WU-RF may be useful for assessing central sensitization of chronic pain patients in research and clinical practice.	[Staud, Roland; Weyl, Elizabeth E.] Univ Florida, Dept Med, Gainesville, FL 32611 USA; [Riley, Joseph L., III; Fillingim, Roger B.] Univ Florida, Dept Community Dent & Behav Sci, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Staud, R (corresponding author), Univ Florida, Dept Med, Gainesville, FL 32611 USA.	staudr@ufl.edu	Fillingim, Roger/K-3569-2019; Staud, Roland/A-8442-2008	Fillingim, Roger/0000-0002-7699-8183	NIH [AR053541, NR014049]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR014049] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	The work was funded by NIH grants AR053541 and NR014049. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RJ, 2013, EUR J PAIN, V17, P67, DOI 10.1002/j.1532-2149.2012.00190.x; Banic B, 2004, PAIN, V107, P7, DOI 10.1016/j.pain.2003.05.001; BEYDOUN A, 1993, ELECTROEN CLIN NEURO, V88, P173, DOI 10.1016/0168-5597(93)90002-7; Chen L, 2009, PAIN, V143, P65, DOI 10.1016/j.pain.2009.01.022; CODERRE TJ, 1993, PAIN, V52, P259, DOI 10.1016/0304-3959(93)90161-H; Cohen J.E., 1988, STAT POWER ANAL BEHA; Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; DICKENSON AH, 1991, PAIN, V46, P344, DOI 10.1016/0304-3959(91)90118-H; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Edwards RR, 2006, CLIN J PAIN, V22, P730, DOI 10.1097/01.ajp.0000210914.72794.bc; FIELDS HL, 1984, AM J MED, V77, P2, DOI 10.1016/S0002-9343(84)80097-2; Fillingim RB, 2005, BIOL PSYCHOL, V69, P97, DOI 10.1016/j.biopsycho.2004.11.008; George SZ, 2007, J PAIN, V8, P2, DOI 10.1016/j.jpain.2006.05.009; Gozariu M, 2000, EUR J PHARMACOL, V394, P75, DOI 10.1016/S0014-2999(00)00114-X; Gozariu M, 1998, BRAIN RES, V792, P168, DOI 10.1016/S0006-8993(98)00214-5; Gozariu M, 1997, J NEUROPHYSIOL, V78, P3165, DOI 10.1152/jn.1997.78.6.3165; Granot M, 2003, EUR J PAIN, V7, P139, DOI 10.1016/S1090-3801(02)00087-3; Granot M, 2006, PAIN, V122, P295, DOI 10.1016/j.pain.2006.02.003; Greenspan JD, 2011, J PAIN, V12, pT61, DOI 10.1016/j.jpain.2011.08.006; Herrero JF, 2000, PROG NEUROBIOL, V61, P169, DOI 10.1016/S0301-0082(99)00051-9; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lautenbacher S, 1997, CLIN J PAIN, V13, P189, DOI 10.1097/00002508-199709000-00003; Li J, 1999, PAIN, V79, P75, DOI 10.1016/S0304-3959(98)00154-7; Maier C, 2010, PAIN, V150, P439, DOI 10.1016/j.pain.2010.05.002; Mason P, 2005, J NEUROPHYSIOL, V94, P1659, DOI 10.1152/jn.00249.2005; Mason P, 2006, HAND CLINIC, V81, P211, DOI 10.1016/S0072-9752(06)80019-9; Meeus M, 2007, CLIN RHEUMATOL, V26, P465, DOI 10.1007/s10067-006-0433-9; MENDELL LM, 1966, EXP NEUROL, V16, P316, DOI 10.1016/0014-4886(66)90068-9; Nielsen CS, 2009, J PAIN, V10, P231, DOI 10.1016/j.jpain.2008.09.010; Nielsen J, 1998, SOMATOSENS MOT RES, V15, P220, DOI 10.1080/08990229870781; Oaklander AL, 2013, PEDIATRICS, V131, pE1091, DOI 10.1542/peds.2012-2597; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; PRICE DD, 1972, EXP NEUROL, V37, P371, DOI 10.1016/0014-4886(72)90081-7; PRICE DD, 1977, PAIN, V3, P57, DOI 10.1016/0304-3959(77)90035-5; Price DD, 2002, PAIN, V99, P49, DOI 10.1016/S0304-3959(02)00053-2; PRICE DD, 1994, PROG PAIN RES MANAG, V1, P61; PRICE DD, 1978, J NEUROPHYSIOL, V41, P933, DOI 10.1152/jn.1978.41.4.933; Price DD, 1992, HDB PAIN ASSESSMENT, P114; Raphael KG, 2009, J OROFAC PAIN, V23, P54; Staud R, 2005, J PAIN, V6, P323, DOI 10.1016/j.jpain.2005.01.357; Staud R, 2004, PAIN, V110, P689, DOI 10.1016/j.pain.2004.05.009; Staud R, 2003, PAIN, V102, P87, DOI 10.1016/s0304-3959(02)00344-5; Staud R, 2003, PAIN, V105, P215, DOI 10.1016/S0304-3959(03)00208-2; Staud R, 2001, PAIN, V91, P165, DOI 10.1016/S0304-3959(00)00432-2; Staud R, 2008, PAIN, V139, P315, DOI 10.1016/j.pain.2008.04.024; Staud R, 2008, EUR J PAIN, V12, P1078, DOI 10.1016/j.ejpain.2008.02.002; Staud R, 2007, J PAIN, V8, P893, DOI 10.1016/j.jpain.2007.06.006; Staud R, 2007, PAIN, V129, P130, DOI 10.1016/j.pain.2006.10.010; Staud Roland, 2005, Curr Pain Headache Rep, V9, P316, DOI 10.1007/s11916-005-0006-7; Staud R, 2006, J PAIN, V7, P575, DOI 10.1016/j.jpain.2006.02.005; TOREBJORK HE, 1974, J NEUROL NEUROSUR PS, V37, P653, DOI 10.1136/jnnp.37.6.653; Uceyler N, 2013, BRAIN, V136, P1857, DOI 10.1093/brain/awt053; Vera-Portocarrero LP, 2006, NEUROSCIENCE, V140, P1311, DOI 10.1016/j.neuroscience.2006.03.016; Vierck CJ, 2013, PAIN, V154, P334, DOI 10.1016/j.pain.2012.10.021; Vierck CJ, 1997, J NEUROPHYSIOL, V78, P992, DOI 10.1152/jn.1997.78.2.992; Wade JB, 1996, PAIN, V68, P157, DOI 10.1016/S0304-3959(96)03162-4; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Zhou QQ, 2011, J PAIN, V12, P297, DOI 10.1016/j.jpain.2010.09.002	59	66	67	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89086	10.1371/journal.pone.0089086	http://dx.doi.org/10.1371/journal.pone.0089086			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558475	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700121
J	Wu, GG; Li, WH; He, WG; Jiang, N; Zhang, GX; Chen, W; Yang, HF; Liu, QL; Huang, YN; Zhang, L; Zhang, T; Zeng, XC				Wu, Geng-Gang; Li, Wen-Hong; He, Wen-Guang; Jiang, Nan; Zhang, Guang-Xian; Chen, Wei; Yang, Hai-Feng; Liu, Qi-Long; Huang, Yan-Nian; Zhang, Lei; Zhang, Tong; Zeng, Xian-Cheng			Mir-184 Post-Transcriptionally Regulates SOX7 Expression and Promotes Cell Proliferation in Human Hepatocellular Carcinoma	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; MICRORNAS; CANCER; BIOGENESIS; ONCOMIRS; GENOMICS; PROSTATE; MODEL	Hepatocellular carcinoma (HCC) is one of the most common human malignancies and the third leading cause of cancer mortality worldwide. The development and progression of HCC is a complicated process, involving the deregulation of multiple genes that are essential to cell biological processes. Recently, microRNAs (miRNAs) have been suggested to be closely associated with tumorigenesis. Our study showed that miR-184 is upregulated in HCC cell lines and tissues. Overexpression of miR-184 in HCC cells increased cell proliferation, tumorigenicity, and cell cycle progression, whereas inhibition of miR-184 reduced cell proliferation, tumorigenicity, and cell cycle progression. Additionally, we identified SOX7 as a direct target of miR-184. Ectopic expression of miR-184 led to downregulation of the SOX7 protein, resulting in upregulation of c-Myc, Cyclin D1, and phosphorylation of Rb. Our findings suggested that miR-184 represents a potential onco-miR and plays an important role in HCC progression by suppressing SOX7 expression.	[Wu, Geng-Gang; Li, Wen-Hong; He, Wen-Guang; Liu, Qi-Long; Huang, Yan-Nian; Zeng, Xian-Cheng] Sun Yat Sen Univ, BoJi Affiliated Hosp, Zengcheng Peoples Hosp, Dept Gen Surg, Zengcheng, Peoples R China; [Jiang, Nan; Zhang, Tong] Sun Yat Sen Univ, Affiliated Hosp 3, Liver Transplantat Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Guang-Xian] Guangzhou Univ Chinese Med, Sch Basic Med Sci, Guangzhou, Guangdong, Peoples R China; [Chen, Wei] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Hepatopancreatobiliary Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Hai-Feng] Guangzhou Univ Chinese Med, Guangdong Prov Hosp TCM, Affiliated Hosp 2, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Zhang, Lei; Zeng, Xian-Cheng] Sun Yat Sen Univ, BoJi Affiliated Hosp, Zengcheng Peoples Hosp, Dept Clin Lab, Zengcheng, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangzhou University of Chinese Medicine; Zhejiang University; Guangzhou University of Chinese Medicine; Sun Yat Sen University	Zhang, T (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Liver Transplantat Ctr, Guangzhou 510275, Guangdong, Peoples R China.	zhjeff72@sina.com; zxcheng1974@163.com	JIANG, NAN/AHB-1945-2022		Guangdong Natural Science Foundation [10451130001004472, S2013010016023]; Science and Technology Programme of Guangzhou Municipal Government [2013J4100081]; Supported Foundation of Science and Technology Innovation of Zengcheng [ZC201004]; National Natural Science Foundation of China [81000959]; Science and Technology Planning Project of Guangdong Province, China [2009B030801007]; Fundamental Research Funds for the Central Universities [12ykpy47]; National 12th Five-Year Science and Technology Plan Major Projects of China [2012ZX10002017-005]; National Science Foundation of China [81201781]	Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Science and Technology Programme of Guangzhou Municipal Government; Supported Foundation of Science and Technology Innovation of Zengcheng; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province, China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National 12th Five-Year Science and Technology Plan Major Projects of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported as follows: Study design, data collection and analysis-Guangdong Natural Science Foundation(No. 10451130001004472, No. S2013010016023), Science and Technology Programme of Guangzhou Municipal Government(No. 2013J4100081), and the Supported Foundation of Science and Technology Innovation of Zengcheng (No. ZC201004); decision to publish, or preparation of the manuscript-National Natural Science Foundation of China (No. 81000959), Science and Technology Planning Project of Guangdong Province, China (No. 2009B030801007), The Fundamental Research Funds for the Central Universities(No. 12ykpy47), National 12th Five-Year Science and Technology Plan Major Projects of China (No. 2012ZX10002017-005), and the Youth Project of National Science Foundation of China (No. 81201781).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cermenati S, 2008, BLOOD, V111, P2657, DOI 10.1182/blood-2007-07-100412; Chan DW, 2012, ONCOTARGET, V3, P1546; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Farazi TA, 2013, ADV EXP MED BIOL, V774, P1, DOI 10.1007/978-94-007-5590-1_1; Foley NH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-83; Francois M, 2010, INT J BIOCHEM CELL B, V42, P445, DOI 10.1016/j.biocel.2009.08.017; Gandillet A, 2009, BLOOD, V114, P4813, DOI 10.1182/blood-2009-06-226290; Gao B, 2013, BIOMED PHAR IN PRESS; Guo LH, 2008, MOL CANCER RES, V6, P1421, DOI 10.1158/1541-7786.MCR-07-2175; Hagan JP, 2007, CYTOGENET GENOME RES, V118, P252, DOI 10.1159/000108308; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hayano T, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-17; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang LL, 2012, J CLIN INVEST, V122, P33, DOI 10.1172/JCI58849; Katoh M, 2002, INT J MOL MED, V9, P363; Katoh Y, 2005, ONCOL REP, V14, P797; Kormish JD, 2010, DEV DYNAM, V239, P56, DOI 10.1002/dvdy.22046; Kusenda Branislav, 2006, Biomedical Papers (Olomouc), V150, P205; Lei JY, 2012, J GASTROINTEST SURG, V16, P2120, DOI 10.1007/s11605-012-2019-y; Li B, 2012, PATHOL ONCOL RES, V18, P1039, DOI 10.1007/s12253-012-9542-8; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; Markou A, 2011, CLIN CHEM LAB MED, V49, P1591, DOI 10.1515/CCLM.2011.661; Savage J, 2009, STEM CELLS, V27, P1231, DOI 10.1002/stem.57; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Takash W, 2001, NUCLEIC ACIDS RES, V29, P4274, DOI 10.1093/nar/29.21.4274; Takayama T, 2011, JPN J CLIN ONCOL, V41, P447, DOI 10.1093/jjco/hyr016; Tivnan A, 2010, ANTICANCER RES, V30, P4391; Walter BA, 2013, J CANCER, V4, P350, DOI 10.7150/jca.6394; Willatt JM, 2012, CANCER IMAGING, V12, P79, DOI 10.1102/1470-7330.2012.0011; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Xu Y, 2013, PLOS ONE, V8; Zhang Y, 2009, CANCER LETT, V277, P29, DOI 10.1016/j.canlet.2008.11.014	36	58	61	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88796	10.1371/journal.pone.0088796	http://dx.doi.org/10.1371/journal.pone.0088796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558429	gold, Green Published, Green Submitted			2022-12-27	WOS:000331706700075
J	Beall, CJ; Campbell, AG; Dayeh, DM; Griffen, AL; Podar, M; Leys, EJ				Beall, Clifford J.; Campbell, Alisha G.; Dayeh, Daniel M.; Griffen, Ann L.; Podar, Mircea; Leys, Eugene J.			Single Cell Genomics of Uncultured, Health-Associated Tannerella BU063 (Oral Taxon 286) and Comparison to the Closely Related Pathogen Tannerella forsythia	PLOS ONE			English	Article							GINGIVAL EPITHELIAL-CELLS; S-LAYER; BACTEROIDES-FORSYTHUS; PROTEIN; SURFACE; EXPRESSION; IDENTIFICATION; PERIODONTITIS; PORPHYROMONAS; KARILYSIN	The uncultivated bacterium Tannerella BU063 (oral taxon 286) is the closest relative to the periodontal pathogen Tannerella forsythia, but is not disease-associated itself. Using a single cell genomics approach, we isolated 12 individual BU063 cells by flow cytometry, and we amplified and sequenced their genomes. Comparative analyses of the assembled genomic scaffolds and their gene contents allowed us to study the diversity of this taxon within the oral community of a single human donor that provided the sample. Eight different BU063 genotypes were represented, all about 5% divergent at the nucleotide level. There were 2 pairs of cells and one group of three that were more highly identical, and may represent clonal populations. We did pooled assemblies on the nearly identical genomes to increase the assembled genomic coverage. The presence of a set of 66 "core'' housekeeping genes showed that two of the single cell assemblies and the assembly derived from the three putatively identical cells were essentially complete. As expected, the genome of BU063 is more similar to Tannerella forsythia than any other known genome, although there are significant differences, including a 44% difference in gene content, changes in metabolic pathways, loss of synteny, and an 8-9% difference in GC content. Several identified virulence genes of T. forsythia are not found in BU063 including karilysin, prtH, and bspA. The absence of these genes may explain the lack of periodontal pathogenesis by this species and provides a new foundation to further understand the genome evolution and mechanisms of bacterial-host interaction in closely related oral microbes with different pathogenicity potential.	[Beall, Clifford J.; Dayeh, Daniel M.; Leys, Eugene J.] Ohio State Univ, Coll Dent, Div Oral Biol, Columbus, OH 43210 USA; [Campbell, Alisha G.; Podar, Mircea] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA; [Campbell, Alisha G.; Podar, Mircea] Univ Tennessee, Genome Sci & Technol Program, Knoxville, TN USA; [Griffen, Ann L.] Ohio State Univ, Coll Dent, Div Pediat Dent & Community Oral Hlth, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University System of Ohio; Ohio State University	Beall, CJ (corresponding author), Ohio State Univ, Coll Dent, Div Oral Biol, Columbus, OH 43210 USA.	beall.3@osu.edu	Podar, Mircea/B-7299-2012; Griffen, Ann/AAC-5999-2019; t, lf/AAJ-4924-2020	Podar, Mircea/0000-0003-2776-0205; 	NIDCR [DE021567]; National Human Genome Research Institute [R01 HG004857]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE021567] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work was supported by NIDCR grant DE021567 (nidcr.nih.gov) and grant #R01 HG004857 from the National Human Genome Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abusleme L, 2013, ISME J, V7, P1016, DOI 10.1038/ismej.2012.174; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bliven KA, 2012, INFECT IMMUN, V80, P4061, DOI 10.1128/IAI.00740-12; Campbell AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059361; Campbell JH, 2013, P NATL ACAD SCI USA, V110, P5540, DOI 10.1073/pnas.1303090110; Chitsaz H, 2011, NAT BIOTECHNOL, V29, P915, DOI 10.1038/nbt.1966; de Lillo A, 2004, J CLIN MICROBIOL, V42, P5523, DOI 10.1128/JCM.42.12.5523-5527.2004; Dewhirst FE, 2010, J BACTERIOL; Downes J, 2013, INT J SYST EVOL MICR, V63, P1214, DOI 10.1099/ijs.0.041376-0; Duran-Pinedo AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028438; Fletcher CM, 2007, P NATL ACAD SCI USA, V104, P2413, DOI 10.1073/pnas.0608797104; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041294; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Griffen AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019051; Hentschel U, 2001, MICROBES INFECT, V3, P545, DOI 10.1016/S1286-4579(01)01410-1; Hildebrand F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001107; Honma K, 2007, MICROB PATHOGENESIS, V42, P156, DOI 10.1016/j.micpath.2007.01.003; Honma K, 2011, INFECT IMMUN, V79, P393, DOI 10.1128/IAI.00629-10; Inagaki S, 2006, INFECT IMMUN, V74, P5023, DOI 10.1128/IAI.00062-06; Jusko M, 2012, J IMMUNOL, V188, P2338, DOI 10.4049/jimmunol.1101240; Karim AY, 2010, BIOL CHEM, V391, P105, DOI 10.1515/BC.2010.009; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kesavalu L, 2007, INFECT IMMUN, V75, P1704, DOI 10.1128/IAI.00733-06; Lasken RS, 2012, NAT REV MICROBIOL, V10, P631, DOI 10.1038/nrmicro2857; Lee SW, 2006, GENE, V371, P102, DOI 10.1016/j.gene.2005.11.027; Leys EJ, 2002, J CLIN MICROBIOL, V40, P821, DOI 10.1128/JCM.40.3.821-825.2002; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Maiden MFJ, 2004, ANAEROBE, V10, P27, DOI 10.1016/j.anaerobe.2003.12.001; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Mello LV, 2010, FEBS LETT, V584, P2421, DOI 10.1016/j.febslet.2010.04.045; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Nakajima T, 2006, BIOCHEM BIOPH RES CO, V351, P133, DOI 10.1016/j.bbrc.2006.10.012; Onishi S, 2008, INFECT IMMUN, V76, P198, DOI 10.1128/IAI.01139-07; Pei JM, 2009, CELL CYCLE, V8, P1453, DOI 10.4161/cc.8.9.8243; Posch G, 2011, J BIOL CHEM, V286, P38714, DOI 10.1074/jbc.M111.284893; Roy S, 2011, MICROBIOL-SGM, V157, P3195, DOI 10.1099/mic.0.052498-0; Roy S, 2010, J BACTERIOL, V192, P2285, DOI 10.1128/JB.00079-10; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Saito T, 1997, INFECT IMMUN, V65, P4888, DOI 10.1128/IAI.65.11.4888-4891.1997; Sakakibara J, 2007, MICROBIOL-SGM, V153, P866, DOI 10.1099/mic.0.29275-0; Sakamoto M, 2010, BERGEYS MANUAL SYSTE, V4, P78; Schwarz E. M., 2013, REFERENCE FREE ALGOR; Settem RP, 2013, MUCOSAL IMMUNOL, V6, P415, DOI 10.1038/mi.2012.85; Sharma A, 1998, INFECT IMMUN, V66, P5703, DOI 10.1128/IAI.66.12.5703-5710.1998; Sharma A, 2005, J DENT RES, V84, P462, DOI 10.1177/154405910508400512; Sharma A, 2010, PERIODONTOL 2000, V54, P106, DOI 10.1111/j.1600-0757.2009.00332.x; Shimotahira N, 2013, INFECT IMMUN, V81, P1198, DOI 10.1128/IAI.00983-12; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tomi N, 2008, J PERIODONTAL RES, V43, P136, DOI 10.1111/j.1600-0765.2007.01003.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zuger J, 2007, MICROBIOL-SGM, V153, P3809, DOI 10.1099/mic.0.2007/010926-0	57	20	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89398	10.1371/journal.pone.0089398	http://dx.doi.org/10.1371/journal.pone.0089398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551246	Green Published, Green Submitted, gold			2022-12-27	WOS:000331271500110
J	Marshall, JM; Flechtner, AD; La Perle, KM; Gunn, JS				Marshall, Joanna M.; Flechtner, Alan D.; La Perle, Krista M.; Gunn, John S.			Visualization of Extracellular Matrix Components within Sectioned Salmonella Biofilms on the Surface of Human Gallstones	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; O-ANTIGEN CAPSULE; COMMON BILE-DUCT; ELECTRON-MICROSCOPY; PIGMENT GALLSTONES; ESCHERICHIA-COLI; CHOLESTEROL STONES; TYPHOID-FEVER; CARRIER STATE; IDENTIFICATION	Chronic carriage of Salmonella Typhi is mediated primarily through the formation of bacterial biofilms on the surface of cholesterol gallstones. Biofilms, by definition, involve the formation of a bacterial community encased within a protective macromolecular matrix. Previous work has demonstrated the composition of the biofilm matrix to be complex and highly variable in response to altered environmental conditions. Although known to play an important role in bacterial persistence in a variety of contexts, the Salmonella biofilm matrix remains largely uncharacterized under physiological conditions. Initial attempts to study matrix components and architecture of the biofilm matrix on gallstone surfaces were hindered by the auto-fluorescence of cholesterol. In this work we describe a method for sectioning and direct visualization of extracellular matrix components of the Salmonella biofilm on the surface of human cholesterol gallstones and provide a description of the major matrix components observed therein. Confocal micrographs revealed robust biofilm formation, characterized by abundant but highly heterogeneous expression of polysaccharides such as LPS, Vi and O-antigen capsule. CsgA was not observed in the biofilm matrix and flagellar expression was tightly restricted to the biofilm-cholesterol interface. Images also revealed the presence of preexisting Enterobacteriaceae encased within the structure of the gallstone. These results demonstrate the use and feasibility of this method while highlighting the importance of studying the native architecture of the gallstone biofilm. A better understanding of the contribution of individual matrix components to the overall biofilm structure will facilitate the development of more effective and specific methods to disrupt these bacterial communities.	[Marshall, Joanna M.; Gunn, John S.] Ohio State Univ, Ctr Microbial Interface Biol, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Flechtner, Alan D.; La Perle, Krista M.] Ohio State Univ, Dept Vet Biosci Comparat Pathol & Mouse Phenotypi, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Gunn, JS (corresponding author), Ohio State Univ, Ctr Microbial Interface Biol, Dept Microbial Infect & Immun, Columbus, OH 43210 USA.	gunn.43@osu.edu	La Perle, Krista Marie DuBray/B-3099-2015	Marshall, Joanna/0000-0002-5829-9688	NIH T32 Graduate Research Fellowship [AI65411-5]; US National Institutes of Health [AI066208, P30 CA016058]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066208, R56AI109002, T32AI065411] Funding Source: NIH RePORTER	NIH T32 Graduate Research Fellowship; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by an NIH T32 Graduate Research Fellowship (AI65411-5 to JMM) and grants from the US National Institutes of Health (AI066208 to JSG and P30 CA016058 to KML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson EK, 2013, CHEM BIOL, V20, P5, DOI 10.1016/j.chembiol.2013.01.004; Barak JD, 2007, MOL PLANT MICROBE IN, V20, P1083, DOI 10.1094/MPMI-20-9-1083; Bhutta ZA, 2009, JAMA-J AM MED ASSOC, V302, P898, DOI 10.1001/jama.2009.1259; Brandstetter KA, 2013, LARYNGOSCOPE; BUCHWALD DS, 1984, REV INFECT DIS, V6, P345; CETTA F, 1995, DIGEST DIS SCI, V40, P2189, DOI 10.1007/BF02209004; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Crawford RW, 2008, INFECT IMMUN, V76, P5341, DOI 10.1128/IAI.00786-08; Crawford RW, 2010, J BACTERIOL, V192, P2981, DOI 10.1128/JB.01620-09; Crawford RW, 2010, P NATL ACAD SCI USA, V107, P4353, DOI 10.1073/pnas.1000862107; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Csendes A, 1996, ARCH SURG-CHICAGO, V131, P389; DIEHL AK, 1995, AM J GASTROENTEROL, V90, P967; DOLGIN SM, 1981, NEW ENGL J MED, V304, P808, DOI 10.1056/NEJM198104023041402; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Gerstel U, 2003, RES MICROBIOL, V154, P659, DOI 10.1016/j.resmic.2003.08.005; Giannella R, 2010, SLEISENGER FORTRANS; Gibson DL, 2006, J BACTERIOL, V188, P7722, DOI 10.1128/JB.00809-06; Gonzalez-Escobedo G, 2011, NAT REV MICROBIOL, V9, P9, DOI 10.1038/nrmicro2490; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; Hazrah P, 2004, HPB (Oxford), V6, P28, DOI 10.1080/13651820310025192; Jonas K, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-70; KAUFMAN HS, 1989, ANN SURG, V209, P584, DOI 10.1097/00000658-198905000-00011; Kawai M, 2002, AM J GASTROENTEROL, V97, P83; Kim IS, 2003, YONSEI MED J, V44, P561, DOI 10.3349/ymj.2003.44.4.561; Kurtin W E, 2000, Int J Surg Investig, V2, P299; LAI CW, 1992, AM J GASTROENTEROL, V87, P1198; Lambou-Gianoukos S, 2008, SURG CLIN N AM, V88, P1175, DOI 10.1016/j.suc.2008.07.009; Latasa C, 2005, MOL MICROBIOL, V58, P1322, DOI 10.1111/j.1365-2958.2005.04907.x; Ledeboer NA, 2005, J BACTERIOL, V187, P3214, DOI 10.1128/JB.187.9.3214-3226.2005; LEUNG JWC, 1989, J CLIN MICROBIOL, V27, P915, DOI 10.1128/JCM.27.5.915-921.1989; LEVINE MM, 1982, J INFECT DIS, V146, P724, DOI 10.1093/infdis/146.6.724; Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104; Maurer KJ, 2009, GASTROENTEROLOGY, V136, P425, DOI 10.1053/j.gastro.2008.12.031; Maurer KJ, 2005, GASTROENTEROLOGY, V128, P1023, DOI 10.1053/j.gastro.2005.01.008; MERSELIS JG, 1964, AM J TROP MED HYG, V13, P425, DOI 10.4269/ajtmh.1964.13.425; Monds RD, 2009, TRENDS MICROBIOL, V17, P73, DOI 10.1016/j.tim.2008.11.001; Morosini MI, 2010, J ANTIMICROB CHEMOTH, V65, P1545, DOI 10.1093/jac/dkq168; Parry CM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-107; Prouty AM, 2004, FEMS IMMUNOL MED MIC, V41, P177, DOI 10.1016/j.femsim.2004.03.002; Prouty AM, 2003, INFECT IMMUN, V71, P7154, DOI 10.1128/IAI.71.12.7154-7158.2003; Prouty AM, 2002, J BACTERIOL, V184, P1270, DOI 10.1128/JB.184.5.1270-1276.2002; Prouty AM, 2002, INFECT IMMUN, V70, P2640, DOI 10.1128/IAI.70.5.2640-2649.2002; Qiao T, 2013, MICROSC RES TECHNIQ, V76, P443, DOI 10.1002/jemt.22185; Raffatellu M, 2005, INFECT IMMUN, V73, P3367, DOI 10.1128/IAI.73.6.3367-3374.2005; Ristori C, 1982, Bull Pan Am Health Organ, V16, P361; Romling U, 1998, MOL MICROBIOL, V28, P249, DOI 10.1046/j.1365-2958.1998.00791.x; Romling U, 1998, J BACTERIOL, V180, P722; Schafmayer C, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-36; Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x; SPEER AG, 1988, ANN INTERN MED, V108, P546, DOI 10.7326/0003-4819-108-4-546; Speranza B, 2011, J FOOD SCI, V76, pM12, DOI 10.1111/j.1750-3841.2010.01936.x; STEWART L, 1987, ANN SURG, V206, P242, DOI 10.1097/00000658-198709000-00002; Stewart L, 2002, J GASTROINTEST SURG, V6, P891, DOI 10.1016/S1091-255X(02)00035-5; Stewart L, 2007, J GASTROINTEST SURG, V11, P977, DOI 10.1007/s11605-007-0168-1; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; SWIDSINSKI A, 1995, GASTROENTEROLOGY, V108, P860, DOI 10.1016/0016-5085(95)90461-1; Vanhoof R, 2012, EUR J CLIN MICROBIOL, V31, P491, DOI 10.1007/s10096-011-1336-5; Venneman NG, 2010, GASTROENTEROL CLIN N, V39, P171, DOI 10.1016/j.gtc.2010.02.010; Villarreal JV, 2013, J MICROBIOL METH, V94, P161, DOI 10.1016/j.mimet.2013.06.009; Wang SW, 2013, ENVIRON MICROBIOL, V15, P2238, DOI 10.1111/1462-2920.12095; White AP, 2003, J BACTERIOL, V185, P5398, DOI 10.1128/JB.185.18.5398-5407.2003; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x	63	23	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89243	10.1371/journal.pone.0089243	http://dx.doi.org/10.1371/journal.pone.0089243			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551241	gold, Green Submitted, Green Published			2022-12-27	WOS:000331271500106
J	Quesada-Moraga, E; Lopez-Diaz, C; Landa, BB				Quesada-Moraga, Enrique; Lopez-Diaz, Cristina; Beatriz Landa, Blanca			The Hidden Habit of the Entomopathogenic Fungus Beauveria bassiana: First Demonstration of Vertical Plant Transmission	PLOS ONE			English	Article							ENDOPHYTES; PATHOGENS; DIVERSITY; STRAIN	Beauveria bassiana strain 04/01-Tip, obtained from a larva of the opium poppy stem gall wasp Iraella luteipes (Hymenoptera; Cynipidae), endophytically colonizes opium poppy (Papaver somniferum L.) plants and protects them against this pest. The goal of this study was to monitor the dynamics of endophytic colonization of opium poppy by B. bassiana after the fungus was applied to the seed and to ascertain whether the fungus is transmitted vertically via seeds. Using a species-specific nested PCR protocol and DNA extracted from surface-sterilised leaf pieces or seeds of B. bassiana-inoculated opium poppy plants, the fungus was detected within the plant beginning at the growth stage of rosette building and them throughout the entire plant growth cycle (about 120-140 days after sowing). The fungus was also detected in seeds from 50% of the capsules sampled. Seeds that showed positive amplification for B. bassiana were planted in sterile soil and the endophyte was again detected in more than 42% of the plants sampled during all plant growth stages. Beauveria bassiana was transmitted to seeds in 25% of the plants from the second generation that formed a mature capsule. These results demonstrate for the first time the vertical transmission of an entomopathogenic fungus from endophytically colonised maternal plants. This information is crucial to better understand the ecological role of entomopathogenic fungi as plant endophytes and may allow development of a sustainable and cost effective strategy for I. luteipes management in P. somniferum.	[Quesada-Moraga, Enrique; Lopez-Diaz, Cristina] Univ Cordoba, Agr & Forestry Engn Sch, Dept Agr & Forest Sci & Resources, Cordoba, Spain; [Beatriz Landa, Blanca] Spanish Natl Res Council, Inst Sustainable Agr, Cordoba, Spain	Universidad de Cordoba; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS)	Quesada-Moraga, E (corresponding author), Univ Cordoba, Agr & Forestry Engn Sch, Dept Agr & Forest Sci & Resources, Cordoba, Spain.	equesada@uco.es	QUESADA-MORAGA, ENRIQUE/K-3419-2014; Landa, Blanca B/K-9629-2014	QUESADA-MORAGA, ENRIQUE/0000-0003-4021-3900; Landa, Blanca B/0000-0002-9511-3731; Lopez- Diaz, Cristina/0000-0002-7532-163X	Consejeria de Innovacion, Ciencia y Empresa de la Junta de Andalucia, Spain [AGR-7681]	Consejeria de Innovacion, Ciencia y Empresa de la Junta de Andalucia, Spain(Junta de Andalucia)	This research was supported by project AGR-7681 from the Consejeria de Innovacion, Ciencia y Empresa de la Junta de Andalucia, Spain. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlholm JU, 2002, OIKOS, V99, P173, DOI 10.1034/j.1600-0706.2002.990118.x; Gallery RE, 2007, ECOLOGY, V88, P582, DOI 10.1890/05-1207; Giordano L, 2013, MYCOL PROG, V12, P127, DOI 10.1007/s11557-012-0822-1; Jaber LR, 2010, ECOL ENTOMOL, V35, P25, DOI 10.1111/j.1365-2311.2009.01152.x; Landa BB, 2013, J INVERTEBR PATHOL, V114, P128, DOI 10.1016/j.jip.2013.06.007; Landa BB, 2007, PHYTOPATHOLOGY, V97, P1380, DOI 10.1094/PHYTO-97-11-1380; Ownley BH, 2010, BIOCONTROL, V55, P113, DOI 10.1007/s10526-009-9241-x; Quesada-Moraga E, 2006, MYCOPATHOLOGIA, V161, P323, DOI 10.1007/s11046-006-0014-0; Quesada-Moraga E, 2009, ENVIRON ENTOMOL, V38, P723, DOI 10.1603/022.038.0324; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Saikkonen K, 2002, P ROY SOC B-BIOL SCI, V269, P1397, DOI 10.1098/rspb.2002.2006; Sasan RK, 2012, AM J BOT, V99, P101, DOI 10.3732/ajb.1100136; Vega FE, 2010, FUNGAL ECOL, V3, P122, DOI [10.1016/j.funeco.2009.05.001, 10.1016/j.funeco.2009.07.002]; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Zabalgogeazcoa I, 2008, SPAN J AGRIC RES, V6, P138, DOI 10.5424/sjar/200806S1-382	15	62	68	2	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89278	10.1371/journal.pone.0089278	http://dx.doi.org/10.1371/journal.pone.0089278			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551242	Green Published, gold, Green Submitted			2022-12-27	WOS:000331271500107
J	Ruther, J; McCaw, J; Bocher, L; Pothmann, D; Putz, I				Ruther, Joachim; McCaw, Jennifer; Boecher, Lisa; Pothmann, Daniela; Putz, Irina			Pheromone Diversification and Age-Dependent Behavioural Plasticity Decrease Interspecific Mating Costs in Nasonia	PLOS ONE			English	Article							LOCAL MATE COMPETITION; MALE SEX-PHEROMONE; JEWEL WASP NASONIA; PARASITIC WASP; VITRIPENNIS HYMENOPTERA; NATURAL-POPULATIONS; NORTH-AMERICA; RATIO; PTEROMALIDAE; FEMALES	Interspecific mating can cause severe fitness costs due to the fact that hybrids are often non-viable or less fit. Thus, theory predicts the selection of traits that lessen reproductive interactions between closely related sympatric species. Males of the parasitic wasp Nasonia vitripennis differ from all other Nasonia species by an additional sex pheromone component, but the ecological selective forces underlying this pheromone diversification are unknown. Here we present data from lab experiments suggesting that costly interspecific sexual interactions with the sympatric species N. giraulti might have been responsible for the pheromone evolution and some courtship-related behavioural adaptations in N. vitripennis. Most N. giraulti females are inseminated already within the host, but N. giraulti males still invest in costly sex pheromones after emergence. Furthermore, they do not discriminate between N. vitripennis females and conspecifics during courtship. Therefore, N. vitripennis females, most of which emerge as virgins, face the risk of mating with N. giraulti resulting in costly all-male broods due to Wolbachia-induced cytoplasmic incompatibility. As a counter adaptation, young N. vitripennis females discriminate against N. giraulti males using the more complex conspecific sex pheromone and reject most of them during courtship. With increasing age, however, N. vitripennis females become less choosy, but often compensate mating errors by re-mating with a conspecific. By doing so, they can principally avoid suboptimal offspring sex ratios, but a microcosm experiment suggests that under more natural conditions N. vitripennis females cannot completely avoid fitness costs due to heterospecific mating. Our study provides support for the hypothesis that communication interference of closely related sympatric species using similar sexual signals can generate selective pressures that lead to their divergence.	[Ruther, Joachim; McCaw, Jennifer; Boecher, Lisa; Pothmann, Daniela; Putz, Irina] Univ Regensburg, Inst Zool, D-93053 Regensburg, Germany	University of Regensburg	Ruther, J (corresponding author), Univ Regensburg, Inst Zool, Univ Str 31, D-93053 Regensburg, Germany.	joachim.ruther@biologie.uni-regensburg.de	Ruther, Joachim/AAE-3568-2019	Ruther, Joachim/0000-0002-1295-347X	Deutsch Forschungsgemeinschaft (DFG);  [RU 717/10-2]	Deutsch Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); 	This research was funded by the Deutsch Forschungsgemeinschaft (DFG) (http://www.dfg.de/); grant RU 717/10-2 to JR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, PHEROMONES ANIMAL BE; Blaul B, 2011, P ROY SOC B-BIOL SCI, V278, P3286, DOI 10.1098/rspb.2011.0001; Bordenstein SR, 1998, GENETICS, V148, P1833; Bordenstein SR, 2000, EVOLUTION, V54, P567, DOI 10.1111/j.0014-3820.2000.tb00059.x; BREEUWER JAJ, 1990, NATURE, V346, P558, DOI 10.1038/346558a0; Buellesbach J, 2013, J EVOLUTION BIOL, V26, P2467, DOI 10.1111/jeb.12242; Burton-Chellew MN, 2008, AM NAT, V172, P393, DOI 10.1086/589895; BUTLIN R, 1987, TRENDS ECOL EVOL, V2, P8, DOI 10.1016/0169-5347(87)90193-5; DARLING DC, 1990, ANN ENTOMOL SOC AM, V83, P352, DOI 10.1093/aesa/83.3.352; Drapeau MD, 1999, EVOL ECOL RES, V1, P223; ElSayed A.M., 2013, PHEROBASE DATABASE P; Grillenberger BK, 2008, MOL ECOL, V17, P2854, DOI 10.1111/j.1365-294X.2008.03800.x; Grillenberger BK, 2009, J EVOLUTION BIOL, V22, P460, DOI 10.1111/j.1420-9101.2008.01677.x; Groning J, 2008, Q REV BIOL, V83, P257, DOI 10.1086/590510; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; KING B, 1993, J INSECT BEHAV, V6, P313, DOI 10.1007/BF01048112; King BH, 2000, ENVIRON ENTOMOL, V29, P927, DOI 10.1603/0046-225X-29.5.927; Klein AL, 2012, J ARACHNOL, V40, P138, DOI 10.1636/H11-31.1; Marshall JL, 2002, TRENDS ECOL EVOL, V17, P558, DOI 10.1016/S0169-5347(02)02636-8; Mautz BS, 2008, J INSECT BEHAV, V21, P203, DOI 10.1007/s10905-008-9120-9; Moore PJ, 2001, P NATL ACAD SCI USA, V98, P9171, DOI 10.1073/pnas.161154598; Niehuis O, 2013, NATURE, V494, P345, DOI 10.1038/nature11838; Raychoudhury R, 2010, HEREDITY, V104, P278, DOI 10.1038/hdy.2009.147; Raychoudhury R, 2010, HEREDITY, V104, P318, DOI 10.1038/hdy.2009.160; Ruther J., 2013, CHEM ECOLOGY INSECT, P112; Ruther J, 2008, J CHEM ECOL, V34, P99, DOI 10.1007/s10886-007-9411-1; Ruther J, 2007, J EXP BIOL, V210, P2163, DOI 10.1242/jeb.02789; Ruther J, 2010, ANIM BEHAV, V80, P1035, DOI 10.1016/j.anbehav.2010.09.008; Ruther J, 2009, P ROY SOC B-BIOL SCI, V276, P3303, DOI 10.1098/rspb.2009.0738; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; Shuker DM, 2004, P NATL ACAD SCI USA, V101, P10363, DOI 10.1073/pnas.0308034101; Smadja C, 2009, HEREDITY, V102, P77, DOI 10.1038/hdy.2008.55; Steiger S, 2010, P ROY SOC LOND B BIO, P970, DOI DOI 10.1098/RSPB.2010.2285; Steiner S, 2006, J CHEM ECOL, V32, P1687, DOI 10.1007/s10886-006-9102-3; Steiner S, 2009, BEHAV ECOL, V20, P570, DOI 10.1093/beheco/arp033; Tanner ME, 2002, ACCOUNTS CHEM RES, V35, P237, DOI 10.1021/ar000056y; Tinghitella RM, 2013, ECOL EVOL, V3, P2820, DOI 10.1002/ece3.666; van de Zande L, 2014, MOL ECOL RESOUR, V14, P578, DOI 10.1111/1755-0998.12201; VANDENASSEM J, 1980, BEHAVIOUR, V75, P301, DOI 10.1163/156853980X00456; VANDENASSEM J, 1980, NETH J ZOOL, V30, P208, DOI 10.1163/002829679X00386; Wathes DC, 2007, BIOL REPROD, V77, P190, DOI 10.1095/biolreprod.107.060558; WERREN JH, 1983, EVOLUTION, V37, P116, DOI [10.2307/2408180, 10.1111/j.1558-5646.1983.tb05520.x]; WERREN JH, 1980, SCIENCE, V208, P1157, DOI 10.1126/science.208.4448.1157; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028	44	20	21	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89214	10.1371/journal.pone.0089214	http://dx.doi.org/10.1371/journal.pone.0089214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551238	Green Published, gold, Green Submitted			2022-12-27	WOS:000331271500103
J	Hosokawa, T; Nikoh, N; Fukatsu, T				Hosokawa, Takahiro; Nikoh, Naruo; Fukatsu, Takema			Fine-Scale Geographical Origin of an Insect Pest Invading North America	PLOS ONE			English	Article							HEMIPTERA HETEROPTERA PLATASPIDAE	Invasive species may rapidly spread throughout new areas once introduced, which may potentially lead to serious damage to local fauna and flora. Information on geographical origins, introduction routes, and biology in native regions of such invasive species is of critical importance in identifying means of transport, preventing reintroduction, and establishing control/eradication methods. The plataspid stinkbug Megacopta cribraria, known as kudzu bug, recently invaded North America and now has become not only an agricultural pest of soybean but also a nuisance pest. Here we investigate the geographical origin of the invasive M. cribraria populations. Phylogeographical analyses based on 8.7 kb mitochondrial DNA sequences of the introduced and East Asian native Megacopta populations identified a well-supported clade consisting of the introduced populations and M. punctatissima populations in the Kyushu region of Japan, which strongly suggests that the invading M. cribraria populations are derived from a M. punctatissima population in the Kyushu region. Therefore, the region is proposed as a promising source of natural enemies for biological control of the invasive pest. Based on the phylogenetic information, relationship and treatment of the two Megacopta species are discussed.	[Hosokawa, Takahiro; Fukatsu, Takema] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Nikoh, Naruo] Open Univ Japan, Dept Liberal Arts, Chiba, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Hosokawa, T (corresponding author), Univ Ryukyus, Trop Biosphere Res Ctr, Nishihara, Okinawa 90301, Japan.	h133053@comb.u-ryukyu.ac.jp		Hosokawa, Takahiro/0000-0001-7618-1774	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN)	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN)	This study was financially supported by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown AMV, 2014, MOL ECOL, V23, P1516, DOI 10.1111/mec.12366; Eger J.E. Jr., 2010, Insecta Mundi, V0121, P1; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Gardner WA, 2013, J ENTOMOL SCI, V48, P118; Hosokawa T, 2007, P ROY SOC B-BIOL SCI, V274, P1979, DOI 10.1098/rspb.2007.0620; Ishikawa T, 2012, TERRESTRIAL HETEROPT, V3; Jenkins Tracie M., 2011, Insects, V2, P264, DOI 10.3390/insects2030264; Jenkins TM, 2010, J ENTOMOL SCI, V45, P62, DOI 10.18474/0749-8004-45.1.62; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Montandon A. L., 1896, Annales de la Societe Entomologique de Belgique, Vxl, P86; Pimentel D, 2001, AGR ECOSYST ENVIRON, V84, P1, DOI 10.1016/S0167-8809(00)00178-X; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruberson JR, 2013, APPL ENTOMOL ZOOL, V48, P3, DOI 10.1007/s13355-012-0146-2; Sax D. F., 2005, SPECIES INVASIONS IN; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suiter DR, 2010, J INTEGR PEST MANAG, V1, DOI 10.1603/IPM10009; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tomokuni M, 1993, FIELD GUIDE JAPANESE; YANG WE-I, 1934, BULL FAN MEM INST BIOL [ZOOL], V5, P137	20	27	28	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89107	10.1371/journal.pone.0089107	http://dx.doi.org/10.1371/journal.pone.0089107			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551228	Green Published, Green Submitted, gold			2022-12-27	WOS:000331266000102
J	Choudhury, BI; Khan, ML; Dayanandan, S				Choudhury, Baharul Islam; Khan, Mohammed Latif; Dayanandan, Selvadurai			Functional Androdioecy in Critically Endangered Gymnocladus assamicus (Leguminosae) in the Eastern Himalayan Region of Northeast India	PLOS ONE			English	Article							SEX-RATIOS; EVOLUTION; DIOECY; MAINTENANCE; POPULATIONS; GYNODIOECY; SYSTEMS	Gymnocladus assamicus is a critically endangered tree species endemic to Northeast India, and shows sexual dimorphism with male and hermaphrodite flowers on separate trees. We studied phenology, reproductive biology and mating system of the species. The flowers are small, tubular, odorless and last for about 96 hours. Pollen grains in both morphs were viable and capable of fertilization leading to fruit and seed set. Scanning electron micrographs revealed morphologically similar pollen in both male and hermaphrodite flowers. The fruit set in open pollinated flowers was 43.61 percent, while controlled autogamous and geitonogamous pollinations yielded 76.81 and 65.58 percent fruit set respectively. Xenogamous pollinations between male and hermaphrodite flowers resulted in 56.85 percent fruit set and pollinations between hermaphrodite flowers yielded 67.90 percent fruit set. This indicates a functionally androdioecious mating system and pollination limited fruit set in G. assamicus. Phylogenetic analyses of Gymnocladus and the sister genus Gleditsia are needed to assess if the androdioecious mating system in G. assamicus evolved from dioecy as a result of selection for hermaphrodites for reproductive assurance during colonization of pollination limited high altitude ecosystems.	[Choudhury, Baharul Islam; Dayanandan, Selvadurai] Concordia Univ, Forest & Evolutionary Genom Lab, Quebec City, PQ, Canada; [Choudhury, Baharul Islam; Dayanandan, Selvadurai] Concordia Univ, Ctr Struct & Funct Genom, Dept Biol, Quebec City, PQ, Canada; [Choudhury, Baharul Islam; Dayanandan, Selvadurai] Quebec Ctr Biodivers Sci, Montreal, PQ, Canada; [Choudhury, Baharul Islam; Khan, Mohammed Latif] North Eastern Reg Inst Sci & Technol, Dept Forestry, Nirjuli, Arunachal Prade, India	Concordia University - Canada; Concordia University - Canada; North Eastern Regional Institute of Science & Technology (NERIST)	Choudhury, BI (corresponding author), Concordia Univ, Forest & Evolutionary Genom Lab, Quebec City, PQ, Canada.	baharulchoudhury@gmail.com	KHAN, MOHAMMED LATIF/Q-7641-2019; Choudhury, Baharul I/AAU-9440-2020	KHAN, MOHAMMED LATIF/0000-0001-6849-0307; Choudhury, Baharul/0000-0002-6624-6439	Department of Science and Technology, New Delhi [SR/SO/PS-16/2002]; FRQNT; NSERC	Department of Science and Technology, New Delhi(Department of Science & Technology (India)); FRQNT; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Department of Science and Technology, New Delhi (Sanction no. SR/SO/PS-16/2002) to M.L.K. Partial support of FRQNT and NSERC to BC and SD is greatly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto J, 1999, AM J BOT, V86, P880, DOI 10.2307/2656708; Astrop TI, 2012, PALAEONTOL ELECTRON, V15; Barrett SCH, 2002, NAT REV GENET, V3, P274, DOI 10.1038/nrg776; Barrett SCH, 1998, TRENDS PLANT SCI, V3, P335, DOI 10.1016/S1360-1385(98)01299-0; Bawa K.S., 1983, P394; BAWA KS, 1980, ANNU REV ECOL SYST, V11, P15, DOI 10.1146/annurev.es.11.110180.000311; BAWA KS, 1981, ANN MO BOT GARD, V68, P254, DOI 10.2307/2398798; BREWBAKE JL, 1963, AM J BOT, V50, P859, DOI 10.2307/2439772; Carlson JE, 2007, AM J BOT, V94, P674, DOI 10.3732/ajb.94.4.674; CHARLESWORTH B, 1978, AM NAT, V112, P975, DOI 10.1086/283342; CHARLESWORTH D, 1984, BIOL J LINN SOC, V22, P333, DOI 10.1111/j.1095-8312.1984.tb01683.x; Chasnov JR, 2010, J EVOLUTION BIOL, V23, P539, DOI 10.1111/j.1420-9101.2009.01919.x; Choudhury B. I., 2007, Research Letters in Ecology, V2007, P59282, DOI 10.1155/2007/59282; Dafni A., 1992, POLLINATION ECOLOGY; Dai C, 2012, NEW PHYTOL, V193, P787, DOI 10.1111/j.1469-8137.2011.03966.x; Darwin C, 1877, EFFECTS CROSS SELF F; Delannay X, 1978, NATURALISTES BELGES, V99, P169; Dezhao C, 2010, FLORA CHINA, V10, P36; Dixon KW, 2009, SCIENCE, V325, P571, DOI 10.1126/science.1176295; Dorken ME, 2002, EVOLUTION, V56, P31, DOI 10.1111/j.0014-3820.2002.tb00847.x; FEINSINGER P, 1978, ECOL MONOGR, V48, P269, DOI 10.2307/2937231; FRITSCH P, 1992, NATURE, V359, P633, DOI 10.1038/359633a0; Heilbuth JC, 2000, AM NAT, V156, P221, DOI 10.1086/303389; Herendeen PS, 2003, INT J PLANT SCI, V164, pS393, DOI 10.1086/376881; LEE YT, 1976, J ARNOLD ARBORETUM, V57, P91, DOI 10.5962/bhl.part.28162; LISTON A, 1990, NATURE, V343, P641, DOI 10.1038/343641a0; LLOYD DG, 1975, GENETICA, V45, P325, DOI 10.1007/BF01508307; LLOYD DG, 1977, BOT REV, V43, P177, DOI 10.1007/BF02860717; Matsuyama S, 2009, PLANT SPEC BIOL, V24, P215, DOI 10.1111/j.1442-1984.2009.00258.x; MAYER SS, 1991, TRENDS ECOL EVOL, V6, P320, DOI 10.1016/0169-5347(91)90039-Z; Menon Shaily, 2010, Endangered Species Research, V11, P175, DOI 10.3354/esr00275; MUENCHOW GE, 1987, AM J BOT, V74, P287, DOI 10.2307/2444031; Nishide Masato, 2009, APG Acta Phytotaxonomica et Geobotanica, V60, P61; OPLER PA, 1980, BIOTROPICA, V12, P40, DOI 10.2307/2388155; Pacini Ettore, 2007, P167, DOI 10.1007/978-1-4020-5937-7_4; Pannell J, 1997, J ECOL, V85, P57, DOI 10.2307/2960627; Pannell JR, 2002, ANNU REV ECOL SYST, V33, P397, DOI 10.1146/annurev.ecolsys.33.010802.150419; Pannell JR, 2002, FUNCT ECOL, V16, P862, DOI 10.1046/j.1365-2435.2002.06893.x; Philbrick C. Thomas, 1994, Plant Species Biology, V9, P43, DOI 10.1111/j.1442-1984.1994.tb00081.x; RIESEBERG LH, 1992, SYST BOT, V17, P324, DOI 10.2307/2419526; Roskov Y., 2005, ILDIS WORLD DATABASE; Sanjappa M, 2002, ADV LEGUME RES INDIA, P27; Schnabel A, 2003, AM J BOT, V90, P310, DOI 10.3732/ajb.90.2.310; Shivanna K.R., 1992, POLLEN BIOL LAB MANU; Stephenson A.G., 1983, POLLINATION BIOL, P109; TURNER BJ, 1992, P NATL ACAD SCI USA, V89, P10643, DOI 10.1073/pnas.89.22.10643; Watson L., 1993, GENERA LEGUMINOSAE C; Weeks SC, 2008, INVERTEBR BIOL, V127, P336, DOI 10.1111/j.1744-7410.2008.00130.x; Weeks SC, 2006, INTEGR COMP BIOL, V46, P449, DOI 10.1093/icb/icj048; Weeks SC, 2012, EVOLUTION, V66, P3670, DOI 10.1111/j.1558-5646.2012.01714.x; Wolf DE, 2004, AM NAT, V163, P122, DOI 10.1086/380493; Wolf DE, 2001, GENETICS, V159, P1243; Yampolsky C., 1922, BIBL GENET, V3, P4; Zierold T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-161	54	4	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e87287	10.1371/journal.pone.0087287	http://dx.doi.org/10.1371/journal.pone.0087287			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586267	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000332396200012
J	Lorenzo-Redondo, R; Delgado, S; Moran, F; Lopez-Galindez, C				Lorenzo-Redondo, Ramon; Delgado, Soledad; Moran, Federico; Lopez-Galindez, Cecilio			Realistic Three Dimensional Fitness Landscapes Generated by Self Organizing Maps for the Analysis of Experimental HIV-1 Evolution	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; IN-VIVO FITNESS; RNA VIRUS; DYNAMICS; RECOVERY; PROTEASE	Human Immunodeficiency Virus type 1 (HIV-1) because of high mutation rates, large population sizes, and rapid replication, exhibits complex evolutionary strategies. For the analysis of evolutionary processes, the graphical representation of fitness landscapes provides a significant advantage. The experimental determination of viral fitness remains, in general, difficult and consequently most published fitness landscapes have been artificial, theoretical or estimated. Self-Organizing Maps (SOM) are a class of Artificial Neural Network (ANN) for the generation of topological ordered maps. Here, three-dimensional (3D) data driven fitness landscapes, derived from a collection of sequences from HIV-1 viruses after "in vitro" passages and labelled with the corresponding experimental fitness values, were created by SOM. These maps were used for the visualization and study of the evolutionary process of HIV-1 "in vitro" fitness recovery, by directly relating fitness values with viral sequences. In addition to the representation of the sequence space search carried out by the viruses, these landscapes could also be applied for the analysis of related variants like members of viral quasiespecies. SOM maps permit the visualization of the complex evolutionary pathways in HIV-1 fitness recovery. SOM fitness landscapes have an enormous potential for the study of evolution in related viruses of "in vitro" works or from "in vivo" clinical studies with human, animal or plant viral infections.	[Lorenzo-Redondo, Ramon; Lopez-Galindez, Cecilio] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain; [Delgado, Soledad] Univ Politecn Madrid, Escuela Univ Informat, Dept Org & Estruct Informac, Madrid, Spain; [Moran, Federico] Univ Complutense Madrid, Dept Bioquim & Biol Mol 1, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Universidad Politecnica de Madrid; Complutense University of Madrid	Moran, F (corresponding author), Univ Complutense Madrid, Dept Bioquim & Biol Mol 1, Madrid, Spain.	fmoran@ucm.es; clopez@isciii.es	Delgado, M. Soledad/AAA-1544-2019; Moran, Federico/L-1297-2014; Lopez-Galindez, Cecilio/A-3603-2008	Moran, Federico/0000-0003-3992-8829; Lopez-Galindez, Cecilio/0000-0002-2324-9584; DELGADO SANZ, MARIA SOLEDAD/0000-0003-4868-3712; Lorenzo-Redondo, Ramon/0000-0002-5462-9483	MINECO Spain [SAF 2007-61036, 2010-17226]; FIPSE Spain [36558/06, 36641/07, 36779/08, 360766/09]; RETIC de Investigacion en SIDA (Red de grupos 173) of the Fondo de Investigaciones Sanitarias (FISss); MICINN [BFU 2009-12895-C02-02]; MINECO (Spain) [BFU2012-39816-C02-02]	MINECO Spain(Spanish Government); FIPSE Spain; RETIC de Investigacion en SIDA (Red de grupos 173) of the Fondo de Investigaciones Sanitarias (FISss); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); MINECO (Spain)(Spanish Government)	Work in CNM is supported by grant SAF 2007-61036 and 2010-17226 from MINECO Spain, by grants 36558/06, 36641/07, 36779/08, 360766/09 from FIPSE Spain, and in part by the RETIC de Investigacion en SIDA (Red de grupos 173) of the Fondo de Investigaciones Sanitarias (FISss). Work in UCM is supported by grants BFU 2009-12895-C02-02 MICINN and BFU2012-39816-C02-02 from MINECO (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biebricher CK, 2005, VIRUS RES, V107, P117, DOI 10.1016/j.virusres.2004.11.002; Borderia AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010319; Bull JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027796; Burch CL, 2000, NATURE, V406, P625, DOI 10.1038/35020564; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; da Silva J, 2010, GENETICS, V185, P293, DOI 10.1534/genetics.109.112458; Deforche K, 2008, BIOINFORMATICS, V24, P34, DOI 10.1093/bioinformatics/btm540; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Escarmis C, 1999, J MOL BIOL, V285, P495, DOI 10.1006/jmbi.1998.2366; Fernandez G, 2007, J VIROL, V81, P2485, DOI 10.1128/JVI.01594-06; FONTANA W, 1987, BIOPHYS CHEM, V26, P123, DOI 10.1016/0301-4622(87)80017-0; Fontana W, 1998, SCIENCE, V280, P1451, DOI 10.1126/science.280.5368.1451; FONTANA W, 1989, PHYS REV A, V40, P3301, DOI 10.1103/PhysRevA.40.3301; Hamming RW, 1986, CODING INFORM THEORY; Hinkley T, 2011, NAT GENET, V43, P487, DOI 10.1038/ng.795; Huynen MA, 1996, P NATL ACAD SCI USA, V93, P397, DOI 10.1073/pnas.93.1.397; Kohonen T., 2001, SELF ORG MAPS; Kouyos RD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002551; Lauring AS, 2011, J VIROL, V85, P3780, DOI 10.1128/JVI.02217-10; Lobkovsky AE, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002302; Lorenzo-Redondo R, 2011, J VIROL, V85, P1861, DOI 10.1128/JVI.01254-10; Marconi V, 2008, JAIDS-J ACQ IMM DEF, V48, P572, DOI 10.1097/QAI.0b013e31817bbc4e; Pitt JN, 2010, SCIENCE, V330, P376, DOI 10.1126/science.1192001; Poelwijk FJ, 2007, NATURE, V445, P383, DOI 10.1038/nature05451; Quinones-Mateu ME, 2006, CURR TOP MICROBIOL, V299, P83; SANCHEZPALOMINO S, 1993, J VIROL, V67, P2938; Sardanyes J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024884; SCHUSTER P, 1988, B MATH BIOL, V50, P635, DOI 10.1016/S0092-8240(88)80059-4; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; STADLER PF, 1990, B MATH BIOL, V52, P485; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ultsch S, 1990, KOHONENS SELF ORG MA, P305; Unneberg P, 2001, PROTEINS, V42, P460, DOI 10.1002/1097-0134(20010301)42:4<460::AID-PROT50>3.0.CO;2-U; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537; Wright S, 1931, GENETICS, V16, P0097; Yuste E, 2005, J VIROL, V79, P5421, DOI 10.1128/JVi.79.9.5421-5427.2005; Yuste E, 1999, J VIROL, V73, P2745, DOI 10.1128/JVI.73.4.2745-2751.1999	40	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e88579	10.1371/journal.pone.0088579	http://dx.doi.org/10.1371/journal.pone.0088579			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586344	gold, Green Published			2022-12-27	WOS:000332396200023
J	Rost, MS; Sumanas, S				Rost, Megan S.; Sumanas, Saulius			Hyaluronic Acid Receptor Stabilin-2 Regulates Erk Phosphorylation and Arterial - Venous Differentiation in Zebrafish	PLOS ONE			English	Article							MICROARRAY ANALYSIS; GENE-EXPRESSION; IDENTIFICATION; PATHWAY; PROTEIN; KINASE; HEMATOPOIESIS; PROGENITORS; UPSTREAM; HEDGEHOG	The hyaluronic acid receptor for endocytosis Stabilin-2/HARE mediates systemic clearance of multiple glycosaminoglycans from the vascular and lymphatic circulations. In addition, recent in vitro studies indicate that Stab2 can participate in signal transduction by interacting with hyaluronic acid (HA), which results in Erk phosphorylation. However, it is not known whether Stab2 function or HA-Stab2 signaling play any role in embryonic development. Here we show that Stab2 functions in a signal transduction pathway regulating arterial-venous differentiation during zebrafish embryogenesis. Stab2 morpholino knockdown embryos (morphants) display an absence of intersegmental vessels and defects in the axial vessel formation. In addition, Stab2 morphants show defects in arterial-venous differentiation including the expansion of venous marker expression. Simultaneous knockdown of Stabilin-2 and Has2, an HA synthetase, results in a synergistic effect, arguing that HA and Stab2 interact during vasculature formation. Stab2 morphants display reduced Erk phosphorylation in the arterial progenitors, which is a known transducer of VEGF signaling, previously associated with arterial-venous differentiation. In addition, VEGF signaling acts as a negative feedback loop to repress stab2 expression. These results argue that Stab2 is involved in a novel signaling pathway that plays an important role in regulating Erk phosphorylation and establishing arterial-venous identity.	[Rost, Megan S.; Sumanas, Saulius] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Sumanas, Saulius] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Sumanas, S (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.	saulius.sumanas@cchmc.org		Griffin, Megan/0000-0002-1611-1958	research National Institutes of Health [R01HL107369]; Cincinnati Children's Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107369] Funding Source: NIH RePORTER	research National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cincinnati Children's Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by research National Institutes of Health grant R01HL107369 (S.S.) and Cincinnati Children's Research Foundation Trustee Award (S.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakkers J, 2004, DEVELOPMENT, V131, P525, DOI 10.1242/dev.00954; Blum S, 2001, J BIOL CHEM, V276, P33428, DOI 10.1074/jbc.M105474200; Cannon JE, 2012, MECH DEV; Ellertsdottir E, 2010, DEV BIOL, V341, P56, DOI 10.1016/j.ydbio.2009.10.035; Fishman MC, 1997, DEVELOPMENT, V124, P2099; Harris EN, 2007, J BIOL CHEM, V282, P2785, DOI 10.1074/jbc.M607787200; Harris EN, 2004, J BIOL CHEM, V279, P36201, DOI 10.1074/jbc.M405322200; Herbert SP, 2009, SCIENCE, V326, P294, DOI 10.1126/science.1178577; Hirose Y, 2012, P NATL ACAD SCI USA, V109, P4263, DOI 10.1073/pnas.1117560109; Hong CC, 2008, CIRC RES, V103, P573, DOI 10.1161/CIRCRESAHA.108.180745; Hong CC, 2006, CURR BIOL, V16, P1366, DOI 10.1016/j.cub.2006.05.046; Hyatt TM, 1999, METHOD CELL BIOL, V59, P117; Jiang YJ, 1996, DEVELOPMENT, V123, P205; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Jowett T, 1999, METHOD CELL BIOL, V59, P63; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kohli V, 2013, DEV CELL, V25, P196, DOI 10.1016/j.devcel.2013.03.017; Kyosseva SV, 2008, J BIOL CHEM, V283, P15047, DOI 10.1074/jbc.M709921200; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Liang D, 2001, MECH DEVELOP, V108, P29, DOI 10.1016/S0925-4773(01)00468-3; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Pandey MS, 2013, J BIOL CHEM, V288, P14068, DOI 10.1074/jbc.M112.442889; Politz O, 2002, BIOCHEM J, V362, P155, DOI 10.1042/0264-6021:3620155; Qian F, 2007, PLOS BIOL, V5, P1110, DOI 10.1371/journal.pbio.0050132; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Schier AF, 1996, DEVELOPMENT, V123, P165; Schledzewski K, 2011, J CLIN INVEST, V121, P703, DOI 10.1172/JCI44740; Stoll SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058311; Sumanas S, 2005, BLOOD, V106, P534, DOI 10.1182/blood-2004-12-4653; Takahashi T, 1999, ONCOGENE, V18, P2221, DOI 10.1038/sj.onc.1202527; Thisse B, 2004, ZFIN DIRECT DATA SUB; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Wong KS, 2012, DEV BIOL, V361, P377, DOI 10.1016/j.ydbio.2011.11.004; Wong KS, 2009, DEV DYNAM, V238, P1836, DOI 10.1002/dvdy.21990; Zhong TP, 2005, CURR TOP DEV BIOL, V71, P53, DOI 10.1016/S0070-2153(05)71002-4; Zhou B, 2003, GLYCOBIOLOGY, V13, P339, DOI 10.1093/glycob/cwg029	38	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e88614	10.1371/journal.pone.0088614	http://dx.doi.org/10.1371/journal.pone.0088614			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586357	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200025
J	Campbell, RD; Hecker, KG; Biau, DJ; Pang, DSJ				Campbell, Robert D.; Hecker, Kent G.; Biau, David J.; Pang, Daniel S. J.			Student Attainment of Proficiency in a Clinical Skill: The Assessment of Individual Learning Curves	PLOS ONE			English	Article								The aims of this study were to determine if the learning curve cumulative summation test (LC-CUSUM) can differentiate proficiency in placing intravenous catheters by novice learners, and identify the cause of failure when it occurred. In a prospective, observational study design 6 undergraduate students with no previous experience of placing intravenous catheters received standardized training by a board certified veterinary anesthesiologist in intravenous catheter placement technique. Immediately following training, each student attempted 60 intravenous catheterizations in a dog mannequin thoracic limb model. Results were scored as a success or failure based upon completion of four specific criteria, and where catheter placement failure occurred, the cause was recorded according to pre-defined criteria. Initial acceptable and unacceptable failure rates were set by the study team and the LC-CUSUM was used to generate a learning curve for each student. Using 10% and 25% acceptable and unacceptable failure rates, 3 out of 6 students attained proficiency, requiring between 26 to 48 attempts. Applying 25% and 50% acceptable and unacceptable failure rates, 5 of 6 students obtained proficiency, requiring between 18 and 55 attempts. Wide inter-individual variability was observed and the majority of failed catheterisation attempts were limited to two of the four pre-defined criteria. These data indicate that the LC-CUSUM can be used to generate individual learning curves, inter-individual variability in catheter placement ability is wide, and that specific steps in catheter placement are responsible for the majority of failures. These findings may have profound implications for how we teach and assess technical skills.	[Campbell, Robert D.] Calgary Anim Referral & Emergency Ctr, Calgary, AB, Canada; [Campbell, Robert D.; Hecker, Kent G.; Pang, Daniel S. J.] Univ Calgary, Fac Vet Med, Calgary, AB, Canada; [Biau, David J.] Hop St Louis, AP HP, Dept Biostat & Informat Med, Paris, France; [Pang, Daniel S. J.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Calgary	Pang, DSJ (corresponding author), Univ Calgary, Fac Vet Med, Calgary, AB, Canada.	dsjpang@ucalgary.ca	BIAU, DAVID/P-5355-2016	Hecker, Kent/0000-0001-9129-6166; Pang, Daniel/0000-0002-6420-477X	Veterinary Education Research Fund of the Faculty of Veterinary Medicine, University of Calgary	Veterinary Education Research Fund of the Faculty of Veterinary Medicine, University of Calgary	Funding for this study was provided by the Veterinary Education Research Fund of the Faculty of Veterinary Medicine, University of Calgary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biau DJ, 2008, BRIT J SURG, V95, P925, DOI 10.1002/bjs.6056; Biau DJ, 2010, STAT MED, V29, P1900, DOI 10.1002/sim.3947; Dagash H, 2003, J PEDIATR SURG, V38, P720, DOI 10.1016/jpsu.2003.50192; de Oliveira GR, 2002, ANESTH ANALG, V95, P411, DOI 10.1213/01.ANE.0000021360.03491.B7; DELEVAL MR, 1994, J THORAC CARDIOV SUR, V107, P914; Dessolle L, 2010, HUM REPROD, V25, P380, DOI 10.1093/humrep/dep391; Kennedy I, BRISTOL ROYAL INFIRM; Konrad C, 1998, ANESTH ANALG, V86, P635; Marshall C, 2004, J R STAT SOC A STAT, V167, P541, DOI 10.1111/j.1467-985X.2004.apm10.x; Naik VN, 2003, CAN J ANAESTH, V50, P694, DOI 10.1007/BF03018712; PAGE ES, 1954, BIOMETRIKA, V41, P100, DOI 10.1093/biomet/41.1-2.100; Papanna R, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.10.910; Rush BR, 2011, J VET MED EDUC, V38, P242, DOI 10.3138/jvme.38.3.242; Spiegelhalter D, 2003, INT J QUAL HEALTH C, V15, P7, DOI 10.1093/intqhc/15.1.7	14	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88526	10.1371/journal.pone.0088526	http://dx.doi.org/10.1371/journal.pone.0088526			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3UC	24586337	Green Submitted, Green Published, gold			2022-12-27	WOS:000331714700019
J	Iida, J; Clancy, R; Dorchak, J; Somiari, RI; Somiari, S; Cutler, ML; Mural, RJ; Shriver, CD				Iida, Joji; Clancy, Rebecca; Dorchak, Jesse; Somiari, Richard I.; Somiari, Stella; Cutler, Mary Lou; Mural, Richard J.; Shriver, Craig D.			DNA Aptamers against Exon v10 of CD44 Inhibit Breast Cancer Cell Migration	PLOS ONE			English	Article							MUC1 TUMOR-MARKER; MOLECULAR MARKERS; EPH RECEPTORS; RNA APTAMERS; IDENTIFICATION; PROTEIN; SELECTION; MELANOMA; ISOFORMS; LIGANDS	CD44 adhesion molecules are expressed in many breast cancer cells and have been demonstrated to play a key role in regulating malignant phenotypes such as growth, migration, and invasion. CD44 is an integral transmembrane protein encoded by a single 20-exon gene. The diversity of the biological functions of CD44 is the result of the various splicing variants of these exons. Previous studies suggest that exon v10 of CD44 plays a key role in promoting cancer invasion and metastasis, however, the molecular mechanisms are not clear. Given the fact that exon v10 is in the ectodomain of CD44, we hypothesized that CD44 forms a molecular complex with other cell surface molecules through exon v10 in order to promote migration of breast cancer cells. In order to test this hypothesis, we selected DNA aptamers that specifically bound to CD44 exon v10 using Systematic Evolution of Ligands by Exponential Enrichment (SELEX). We selected aptamers that inhibited migration of breast cancer cells. Co-immunoprecipitation studies demonstrated that EphA2 was co-precipitated with CD44. Pull-down studies demonstrated that recombinant CD44 exon v10 bound to EphA2 and more importantly aptamers that inhibited migration also prevented the binding of EphA2 to exon v10. These results suggest that CD44 forms a molecular complex with EphA2 on the breast cancer cell surface and this complex plays a key role in enhancing breast cancer migration. These results provide insight not only for characterizing mechanisms of breast cancer migration but also for developing target-specific therapy for breast cancers and possibly other cancer types expressing CD44 exon v10.	[Iida, Joji; Clancy, Rebecca; Dorchak, Jesse; Somiari, Stella] Windber Res Inst, Dept Cell Biol, Windber, PA 15963 USA; [Somiari, Richard I.] ITSI Biosci, Johnstown, PA USA; [Cutler, Mary Lou] Uniformed Serv Univ Hlth Sci, Dept Pathol, Bethesda, MD 20814 USA; [Mural, Richard J.] Windber Res Inst, Windber, PA USA; [Shriver, Craig D.] Walter Reed Army Med Ctr, Dept Surg, Bethesda, MD USA	Windber Research Institute; Uniformed Services University of the Health Sciences - USA; Windber Research Institute; United States Department of Defense; United States Army	Iida, J (corresponding author), Windber Res Inst, Dept Cell Biol, Windber, PA 15963 USA.	g.iida@wriwindber.org	Cutler, Mary L/G-5735-2017	Cutler, Mary L/0000-0001-9727-4320	United States Department of Defense (Military Molecular Medicine Initiative) [MDA W81XWHH-05-20075, Protocol 01-20006]; USMCI [MDA-905-02-2-0005]	United States Department of Defense (Military Molecular Medicine Initiative)(United States Department of Defense); USMCI	This research was supported by a grant from the United States Department of Defense (Military Molecular Medicine Initiative MDA W81XWHH-05-20075, Protocol 01-20006) and USMCI (MDA-905-02-2-0005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinion and assertions contained herein are the private views of the authors and are not to be construed as official or as representing the views of the Department of the Army or the Department of Defense.	Ahmad KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027051; Bell C, 1999, IN VITRO CELL DEV-AN, V35, P533; Berner HS, 2001, BREAST CANCER RES TR, V65, P23, DOI 10.1023/A:1006417412046; Borbas KE, 2007, BIOCONJUGATE CHEM, V18, P1205, DOI 10.1021/bc0700741; Carrasquillo KG, 2003, INVEST OPHTH VIS SCI, V44, P290, DOI 10.1167/iovs.01-1156; Da Pieve C, 2009, NUCL MED BIOL, V36, P703, DOI 10.1016/j.nucmedbio.2009.04.004; Daniels DA, 2003, P NATL ACAD SCI USA, V100, P15416, DOI 10.1073/pnas.2136683100; Eisenmann KM, 1999, NAT CELL BIOL, V1, P507, DOI 10.1038/70302; Famulok M, 2007, CHEM REV, V107, P3715, DOI 10.1021/cr0306743; Ferreira CSM, 2008, ANAL BIOANAL CHEM, V390, P1039, DOI 10.1007/s00216-007-1470-1; Ferreira CSM, 2006, TUMOR BIOL, V27, P289, DOI 10.1159/000096085; Fitzwater T, 1996, METHOD ENZYMOL, V267, P275; Fox BP, 2004, BIOCHEM BIOPH RES CO, V318, P882, DOI 10.1016/j.bbrc.2004.04.102; Freyschmidt-Paul P, 2000, J INVEST DERMATOL, V115, P653, DOI 10.1046/j.1523-1747.2000.00113.x; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Hicke BJ, 2001, J BIOL CHEM, V276, P48644, DOI 10.1074/jbc.M104651200; Holm Ruth, 2008, Int J Med Sci, V5, P121; Huang F, 2007, CANCER RES, V67, P2226, DOI 10.1158/0008-5472.CAN-06-3633; Iida J, 2001, J BIOL CHEM, V276, P18786, DOI 10.1074/jbc.M010053200; Iida J, 2007, BIOCHEM J, V403, P553, DOI 10.1042/BJ20061176; Iida J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044418; Iida N, 1997, J CELL PHYSIOL, V171, P152, DOI 10.1002/(SICI)1097-4652(199705)171:2<152::AID-JCP5>3.3.CO;2-6; IIDA N, 1995, J CELL PHYSIOL, V162, P127, DOI 10.1002/jcp.1041620115; Jeong S, 2010, OLIGONUCLEOTIDES, V20, P155, DOI 10.1089/oli.2010.0231; Kalish Eric D., 1999, Frontiers in Bioscience, V4, pA1, DOI 10.2741/Kalish; KAN M, 1995, JPN J CANCER RES, V86, P847, DOI 10.1111/j.1349-7006.1995.tb03095.x; Kimoto M, 2002, EUR J BIOCHEM, V269, P697, DOI 10.1046/j.0014-2956.2001.02703.x; Krishnamachary B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044078; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020299; Lupold SE, 2002, CANCER RES, V62, P4029; Mi ZY, 2009, MOL THER, V17, P153, DOI 10.1038/mt.2008.235; Murohashi M, 2010, BRIT J CANCER, V102, P206, DOI 10.1038/sj.bjc.6605468; Nakamoto M, 2002, MICROSC RES TECHNIQ, V59, P58, DOI 10.1002/jemt.10177; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Noblitt LW, 2004, CANCER GENE THER, V11, P757, DOI 10.1038/sj.cgt.7700761; Olsson E, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-418; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Petty A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042120; Rosel M, 1999, EXP HEMATOL, V27, P698, DOI 10.1016/S0301-472X(98)00082-4; Rosenberg JE, 2013, INVEST NEW DRUGS; Saleh F, 2008, NEOPLASMA, V55, P246; Somasunderam A, 2010, BIOCHEMISTRY-US, V49, P9106, DOI 10.1021/bi1009503; Tandon M, 2011, EXPERT OPIN THER TAR, V15, P31, DOI 10.1517/14728222.2011.538682; Weiss S, 1997, J VIROL, V71, P8790, DOI 10.1128/JVI.71.11.8790-8797.1997; Xu W, 1996, P NATL ACAD SCI USA, V93, P7475, DOI 10.1073/pnas.93.15.7475; Zoller M, 2007, J LEUKOCYTE BIOL, V82, P57, DOI 10.1189/jlb.0107063	47	28	28	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88712	10.1371/journal.pone.0088712	http://dx.doi.org/10.1371/journal.pone.0088712			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586375	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900041
J	Nielsen, S; Akerstrom, T; Rinnov, A; Yfanti, C; Scheele, C; Pedersen, BK; Laye, MJ				Nielsen, Soren; Akerstrom, Thorbjorn; Rinnov, Anders; Yfanti, Christina; Scheele, Camilla; Pedersen, Bente K.; Laye, Matthew J.			The miRNA Plasma Signature in Response to Acute Aerobic Exercise and Endurance Training	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; IMPAIRS GLUCOSE-METABOLISM; MICRORNA EXPRESSION; GENE-EXPRESSION; CIRCULATING MICRORNAS; RESISTANCE EXERCISE; CARDIAC-HYPERTROPHY; MICROARRAY ANALYSIS; MESSENGER-RNAS; BIOMARKERS	MiRNAs are potent intracellular posttranscriptional regulators and are also selectively secreted into the circulation in a cellspecific fashion. Global changes in miRNA expression in skeletal muscle in response to endurance exercise training have been reported. Therefore, our aim was to establish the miRNA signature in human plasma in response to acute exercise and chronic endurance training by utilizing a novel methodological approach. RNA was isolated from human plasma collected from young healthy men before and after an acute endurance exercise bout and following 12 weeks of endurance training. Global miRNA (742 miRNAs) measurements were performed as a screening to identify detectable miRNAs in plasma. Using customized qPCR panels we quantified the expression levels of miRNAs detected in the screening procedure (188 miRNAs). We demonstrate a dynamic regulation of circulating miRNA (ci-miRNA) levels following 0 hour (miR-106a, miR-221, miR-30b, miR-151-5p, let-7i, miR-146, miR-652 and miR-151-3p), 1 hour (miR-338-3p, miR-330-3p, miR-223, miR-139-5p and miR-143) and 3 hours (miR-1) after an acute exercise bout (P<0.00032). Where ci-miRNAs were all downregulated immediately after an acute exercise bout (0 hour) the 1 and 3 hour post exercise timepoints were followed by upregulations. In response to chronic training, we identified seven ci-miRNAs with decreased levels in plasma (miR-342-3p, let-7d, miR-766, miR-25, miR148a, miR-185 and miR-21) and two miRNAs that were present at higher levels after the training period (miR-103 and miR-107) (P<0.00032). In conclusion, acute exercise and chronic endurance training, likely through specific mechanisms unique to each stimulus, robustly modify the miRNA signature of human plasma.	[Nielsen, Soren; Akerstrom, Thorbjorn; Rinnov, Anders; Yfanti, Christina; Scheele, Camilla; Pedersen, Bente K.; Laye, Matthew J.] Univ Copenhagen, Dept Infect Dis, Ctr Inflammat & Metab, Copenhagen, Denmark; [Nielsen, Soren; Akerstrom, Thorbjorn; Rinnov, Anders; Yfanti, Christina; Scheele, Camilla; Pedersen, Bente K.; Laye, Matthew J.] Univ Copenhagen, Fac Hlth Sci, Rigshosp, CMRC, Copenhagen, Denmark; [Laye, Matthew J.] Buck Inst Res Aging, Novato, CA USA; [Akerstrom, Thorbjorn] Univ Copenhagen, Fac Sci, August Krogh Ctr, Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; Buck Institute for Research on Aging; University of Copenhagen	Nielsen, S (corresponding author), Univ Copenhagen, Dept Infect Dis, Ctr Inflammat & Metab, Copenhagen, Denmark.	soren_nielsen@inflammation-metabolism.dk	Åkerström, Thorbjörn CA/D-9884-2015; Yfanti, Christina/AHB-7627-2022; Scheele, Camilla/S-6401-2017; Nielsen, Søren/AAC-2325-2020; Laye, Matthew J/AAQ-1897-2020; Scheele, Camilla/AAA-3599-2020; Pedersen, Bente Klarlund/AGR-3217-2022	Åkerström, Thorbjörn CA/0000-0002-7330-1723; Yfanti, Christina/0000-0002-5656-8370; Scheele, Camilla/0000-0002-6055-9709; Nielsen, Søren/0000-0002-3119-750X; Laye, Matthew J/0000-0003-3214-3113; Scheele, Camilla/0000-0002-6055-9709; Pedersen, Bente Klarlund/0000-0001-6508-6288; Rinnov, Anders Rasmussen/0000-0003-3859-3289	Danish National Research Foundation [DNRF55]; Danish Council for Independent Research - Medical Sciences; Lundbeck Foundation [R67-A6473]; Danish Ministry of Science, Technology, and Innovation; Capital Region of Denmark; CIM is a member of DD2 - the Danish Center for Strategic Research in Type 2 Diabetes (the Danish Council for Strategic Research) [09-067009, 09-075724]	Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Council for Independent Research - Medical Sciences(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); Danish Ministry of Science, Technology, and Innovation; Capital Region of Denmark; CIM is a member of DD2 - the Danish Center for Strategic Research in Type 2 Diabetes (the Danish Council for Strategic Research)	The Centre of Inflammation and Metabolism (CIM) is supported by a grant from the Danish National Research Foundation (DNRF55). This study was further supported by the Danish Council for Independent Research - Medical Sciences and by grants from the Lundbeck Foundation (grant no. R67-A6473). CIM is part of the UNIK Project: Food, Fitness & Pharma for Health and Disease, supported by the Danish Ministry of Science, Technology, and Innovation. CIM is a member of DD2 - the Danish Center for Strategic Research in Type 2 Diabetes (the Danish Council for Strategic Research, grant no. 09-067009 and 09-075724). The Copenhagen Muscle Research Centre is supported by a grant from the Capital Region of Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoi W, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00080; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Baggish AL, 2011, J PHYSIOL-LONDON, V589, P3983, DOI 10.1113/jphysiol.2011.213363; Boon RA, 2013, ARTERIOSCL THROM VAS, V33, P186, DOI 10.1161/ATVBAHA.112.300139; Bye A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057496; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002360; Colombo M, 2005, METABOLISM, V54, P1571, DOI 10.1016/j.metabol.2005.06.003; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Davidsen PK, 2011, J APPL PHYSIOL, V110, P309, DOI 10.1152/japplphysiol.00901.2010; Drummond MJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE1333, DOI 10.1152/ajpendo.90562.2008; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guescini M, 2010, EXP CELL RES, V316, P1977, DOI 10.1016/j.yexcr.2010.04.006; Alvarez-Lopez MJ, 2013, J ALZHEIMERS DIS, V33, P1177, DOI 10.3233/JAD-121264; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Keller P, 2011, J APPL PHYSIOL, V110, P46, DOI 10.1152/japplphysiol.00634.2010; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kornfeld JW, 2013, NATURE, V494, P111, DOI 10.1038/nature11793; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee KY, 2006, OBESITY, V14, P1294, DOI 10.1038/oby.2006.147; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lira FS, 2009, EUR J APPL PHYSIOL, V107, P203, DOI 10.1007/s00421-009-1115-5; Listowski MA, 2013, CELL MOL BIOL LETT, V18, P34, DOI 10.2478/s11658-012-0038-z; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; McCarthy JJ, 2007, J APPL PHYSIOL, V102, P306, DOI 10.1152/japplphysiol.00932.2006; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Merlet E, 2013, CARDIOVASC RES; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moncini S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020038; Nielsen S, 2010, J PHYSIOL-LONDON, V588, P4029, DOI 10.1113/jphysiol.2010.189860; Olesen J, 2010, PFLUG ARCH EUR J PHY, V460, P153, DOI 10.1007/s00424-010-0834-0; Palanisamy V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008577; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pigati L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013515; Russell AP, 2013, J PHYSIOL-LONDON, V591, P4637, DOI 10.1113/jphysiol.2013.255695; Russell AP, 2013, NEUROBIOL DIS, V49, P107, DOI 10.1016/j.nbd.2012.08.015; Safdar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005610; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Ucar A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2090; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang XNH, 2011, J AM SOC NEPHROL, V22, P2068, DOI 10.1681/ASN.2010121278; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Yfanti C, 2012, J APPL PHYSIOL, V112, P990, DOI 10.1152/japplphysiol.01027.2010	50	198	203	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e87308	10.1371/journal.pone.0087308	http://dx.doi.org/10.1371/journal.pone.0087308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586268	Green Submitted, Green Published, gold			2022-12-27	WOS:000331711900010
J	Hanlon, C; Luitel, NP; Kathree, T; Murhar, V; Shrivasta, S; Medhin, G; Ssebunnya, J; Fekadu, A; Shidhaye, R; Petersen, I; Jordans, M; Kigozi, F; Thornicroft, G; Patel, V; Tomlinson, M; Lund, C; Breuer, E; De Silva, M; Prince, M				Hanlon, Charlotte; Luitel, Nagendra P.; Kathree, Tasneem; Murhar, Vaibhav; Shrivasta, Sanjay; Medhin, Girmay; Ssebunnya, Joshua; Fekadu, Abebaw; Shidhaye, Rahul; Petersen, Inge; Jordans, Mark; Kigozi, Fred; Thornicroft, Graham; Patel, Vikram; Tomlinson, Mark; Lund, Crick; Breuer, Erica; De Silva, Mary; Prince, Martin			Challenges and Opportunities for Implementing Integrated Mental Health Care: A District Level Situation Analysis from Five Low- and Middle-Income Countries	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; RURAL ETHIOPIA; DISORDERS; SCHIZOPHRENIA; COMMUNITY; BUTAJIRA; INTERVENTION; CONFLICT; SERVICES; AFRICA	Background: Little is known about how to tailor implementation of mental health services in low-and middle-income countries (LMICs) to the diverse settings encountered within and between countries. In this paper we compare the baseline context, challenges and opportunities in districts in five LMICs (Ethiopia, India, Nepal, South Africa and Uganda) participating in the PRogramme for Improving Mental health carE (PRIME). The purpose was to inform development and implementation of a comprehensive district plan to integrate mental health into primary care. Methods: A situation analysis tool was developed for the study, drawing on existing tools and expert consensus. Cross-sectional information obtained was largely in the public domain in all five districts. Results: The PRIME study districts face substantial contextual and health system challenges many of which are common across sites. Reliable information on existing treatment coverage for mental disorders was unavailable. Particularly in the low-income countries, many health service organisational requirements for mental health care were absent, including specialist mental health professionals to support the service and reliable supplies of medication. Across all sites, community mental health literacy was low and there were no models of multi-sectoral working or collaborations with traditional or religious healers. Nonetheless health system opportunities were apparent. In each district there was potential to apply existing models of care for tuberculosis and HIV or non-communicable disorders, which have established mechanisms for detection of drop-out from care, outreach and adherence support. The extensive networks of community-based health workers and volunteers in most districts provide further opportunities to expand mental health care. Conclusions: The low level of baseline health system preparedness across sites underlines that interventions at the levels of health care organisation, health facility and community will all be essential for sustainable delivery of quality mental health care integrated into primary care.	[Hanlon, Charlotte; Fekadu, Abebaw] Univ Addis Ababa, Dept Psychiat, Sch Med, Coll Hlth Sci, Addis Ababa, Ethiopia; [Luitel, Nagendra P.] Transcultural Psychosocial Org Nepal, Kathmandu, Nepal; [Kathree, Tasneem; Petersen, Inge] Univ KwaZulu Natal, Sch Psychol, Durban, South Africa; [Medhin, Girmay] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Ssebunnya, Joshua; Kigozi, Fred] Butabika Natl Mental Hosp, Kampala, Uganda; [Shidhaye, Rahul] Publ Hlth Fdn India, Ctr Mental Hlth, New Delhi, India; [Jordans, Mark] HealthNet Transcultural Psychosocial Org, Dept Res & Dev, Amsterdam, Netherlands; [Jordans, Mark] London Sch Hyg & Trop Med, Ctr Global Mental Hlth, London WC1, England; [Thornicroft, Graham] Kings Coll London, Inst Psychiat, Hlth Serv, London, England; [Thornicroft, Graham] Kings Coll London, Inst Psychiat, Populat Res Dept, London, England; [Tomlinson, Mark] Univ Stellenbosch, Dept Psychol, Ctr Publ Mental Hlth, Cape Town, South Africa; [Tomlinson, Mark] Univ Cape Town, Dept Psychiat & Mental Hlth, ZA-7925 Cape Town, South Africa; [Lund, Crick; Breuer, Erica] Univ Cape Town, Dept Psychiat & Mental Hlth, Alan J Flisher Ctr Publ Mental Hlth, ZA-7925 Cape Town, South Africa; [Patel, Vikram; De Silva, Mary] London Sch Hyg & Trop Med, Ctr Global Mental Hlth, London WC1, England; [Prince, Martin] Kings Coll London, Inst Psychiat, Ctr Global Mental Hlth, London, England	Addis Ababa University; University of Kwazulu Natal; Addis Ababa University; Public Health Foundation of India; University of London; London School of Hygiene & Tropical Medicine; University of London; King's College London; University of London; King's College London; Stellenbosch University; University of Cape Town; University of Cape Town; University of London; London School of Hygiene & Tropical Medicine; University of London; King's College London	Hanlon, C (corresponding author), Univ Addis Ababa, Dept Psychiat, Sch Med, Coll Hlth Sci, Addis Ababa, Ethiopia.	charlotte.hanlon@kcl.ac.uk	Prince, Martin J/A-9170-2010; Shidhaye, Rahul/I-1329-2019; Thornicroft, Graham/B-4027-2010; Hanlon, Charlotte/AAH-7769-2020	Prince, Martin J/0000-0003-1379-7146; Shidhaye, Rahul/0000-0001-9365-7164; Thornicroft, Graham/0000-0003-0662-0879; Hanlon, Charlotte/0000-0002-7937-3226; Petersen, Inge/0000-0002-3573-4229; Wassie, Abebaw Fekadu/0000-0003-2219-0952; Patel, Vikram/0000-0003-1066-8584; Breuer, Erica/0000-0003-0952-6650; Lund, Crick/0000-0002-5159-8220; Murhar, Vaibhav/0000-0002-1028-0363; Medhin, Girmay/0000-0003-2146-4261	UK Government; National Institute for Health Research [NF-SI-0611-10053] Funding Source: researchfish; Department for International Development (DFID) [201446] Funding Source: researchfish	UK Government; National Institute for Health Research(National Institute for Health Research (NIHR)); Department for International Development (DFID)	This document is an output from the PRIME Research Programme Consortium which has been funded by UK Aid from the UK Government; however the views expressed do not necessarily reflect the UK Government's official policies. All authors have declared that no competing interests exist. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alem A, 1999, ACTA PSYCHIAT SCAND, V100, P77, DOI 10.1111/j.1600-0447.1999.tb10698.x; Alem A, 1999, ACTA PSYCHIAT SCAND, V100, P40, DOI 10.1111/j.1600-0447.1999.tb10693.x; Alem A, 2009, SCHIZOPHRENIA BULL, V35, P646, DOI 10.1093/schbul/sbn029; Awas M, 1999, ACTA PSYCHIAT SCAND, V100, P56, DOI 10.1111/j.1600-0447.1999.tb10695.x; Barbui C, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000322; BasicNeeds, 2009, COMM MENT HLTH PRACT; Bhana A, 2010, INT REV PSYCHIATR, V22, P599, DOI 10.3109/09540261.2010.536152; Bruckner TA, 2011, B WORLD HEALTH ORGAN, V89, P184, DOI 10.2471/BLT.10.082784; CBM, 2012, CBM PROGR ETH; Cohen A., 2001, EFFECTIVENESS MENTAL; Cohen A, 2011, INT J MENT HEALTH SY, V5, DOI 10.1186/1752-4458-5-3; Dua T, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001122; Epping-Jordan JE, 2004, QUAL SAF HEALTH CARE, V13, P299, DOI 10.1136/qshc.2004.010744; Funk M., 2008, INT MENT HLTH PRIM C; Hanlon C, 2010, WORLD PSYCHIATRY, V9, P185; Herman SS, 2009, S AFR MED J, V99, P339; Jordans MJD, 2010, J CHILD PSYCHOL PSYC, V51, P818, DOI 10.1111/j.1469-7610.2010.02209.x; Jorm AF, 2000, BRIT J PSYCHIAT, V177, P396, DOI 10.1192/bjp.177.5.396; Kaaya S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001447; Kebede D, 2005, East Afr Med J, V82, P34; Kebede D, 2005, SCHIZOPHR RES, V78, P171, DOI 10.1016/j.schres.2005.05.028; Kebede D, 2004, SCHIZOPHR RES, V69, P133, DOI 10.1016/S0920-9964(03)00089-6; Kohn R, 2004, B WORLD HEALTH ORGAN, V82, P858; Luitel NP, 2013, SOC PSYCH PSYCH EPID, V48, P183, DOI 10.1007/s00127-012-0539-0; Lund C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001359; Lund C, 2010, SOC SCI MED, V71, P517, DOI 10.1016/j.socscimed.2010.04.027; Ngo VK, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001443; Patel V, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001448; Patel V, 2010, LANCET, V376, P2086, DOI 10.1016/S0140-6736(10)61508-5; Petersen I, 2011, CURR OPIN PSYCHIATR, V24, P318, DOI 10.1097/YCO.0b013e3283477afb; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Rahman A, 2008, LANCET, V372, P902, DOI 10.1016/S0140-6736(08)61400-2; Shibre T, 2001, SOC PSYCH PSYCH EPID, V36, P299, DOI 10.1007/s001270170048; Shibre Teshome, 2006, ETHIOP J HEALTH DEV, V20, P170; Teferra S, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-165; Thornicroft G, 2013, PSYCHOL MED, V43, P849, DOI 10.1017/S0033291712001420; Thornicroft G, 2012, EPIDEMIOL PSYCH SCI, V21, P241, DOI 10.1017/S2045796012000261; Thornicroft G, 2010, WORLD PSYCHIATRY, V9, P67; Thornicroft G, 2009, LANCET, V373, P408, DOI 10.1016/S0140-6736(08)61817-6; Wang PS, 2007, WORLD PSYCHIATRY, V6, P177; WHO, 2008, MENT HLTH GAP ACT PR; WHO, 2001, WORLD HLTH REPORT 20; WHO, 2010, MENT HLTH GAP ACT PR; World Health Organization, 2011, MENT HLTH ATL; World Health Organization, 2022, MENT DIS	45	165	169	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88437	10.1371/journal.pone.0088437	http://dx.doi.org/10.1371/journal.pone.0088437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3RA	24558389	Green Published, gold, Green Accepted			2022-12-27	WOS:000331706700035
J	Li, Q; Nan, WZ; Wang, K; Liu, X				Li, Qi; Nan, Weizhi; Wang, Kai; Liu, Xun			Independent Processing of Stimulus-Stimulus and Stimulus-Response Conflicts	PLOS ONE			English	Article							COGNITIVE CONTROL MECHANISMS; DIMENSIONAL OVERLAP; ATTENTIONAL CONTROL; HUMAN BRAIN; STROOP-LIKE; SIMON; COMPATIBILITY; MODEL; TASK; INTERFERENCE	The dimensional overlap (DO) model proposes distinct mechanisms for stimulus-stimulus (S-S) and stimulus-response (S-R) conflict effects. Many studies have examined the independence of S-S and S-R conflict effects in the color-word Stroop and Simon tasks. However, confounds exist between the distinction of DO (i.e., S-S dimensional overlap compared with S-R dimensional overlap) and the distinction of stimulus attributes (e.g., color compared with spatial location; semantic compared with nonsemantic information), which may hinder interpretation of the independence of S-S and S-R conflicts. A spatial Stroop (word) task and a spatial Stroop (arrow) task were combined with a Simon task in Experiments 1 and 2, respectively to eliminate these confounds of stimulus attributes. The results showed that S-S and S-R conflicts affected performance additively. There was no significant correlation across participants. These findings lend further support to independent processing of S-S and S-R conflicts as it is outlined in the taxonomy of DO.	[Li, Qi; Nan, Weizhi; Wang, Kai; Liu, Xun] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Nan, Weizhi; Wang, Kai] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, Q (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	liqi@psych.ac.cn; liux@psych.ac.cn	Liu, Xun/C-2400-2009; qi, li/GWV-7143-2022; WANG, KAI/W-3057-2019	Liu, Xun/0000-0003-1366-8926; WANG, KAI/0000-0002-0392-9275	National Natural Science Foundation of China [31200782, 31271194, 31070987]; Beijing Natural Science Foundation [7133250]; Young Scientists Fund of the Institute of Psychology [Y1CX242005]; National Key Technologies R&D Program of China [2012BAI36B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Young Scientists Fund of the Institute of Psychology; National Key Technologies R&D Program of China(National Key Technology R&D Program)	This research was supported by National Natural Science Foundation of China (Grants 31200782, 31271194, 31070987), Beijing Natural Science Foundation (Grant 7133250), Young Scientists Fund of the Institute of Psychology (Grant Y1CX242005), and National Key Technologies R&D Program of China (Grant 2012BAI36B01). Experimental data of this study may be requested via email. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay C, 2011, PSYCHON B REV, V18, P505, DOI 10.3758/s13423-011-0084-y; Augustinova M, 2010, PSYCHON B REV, V17, P827, DOI 10.3758/PBR.17.6.827; DEJONG R, 1994, J EXP PSYCHOL HUMAN, V20, P731, DOI 10.1037/0096-1523.20.4.731; Egner T, 2008, TRENDS COGN SCI, V12, P374, DOI 10.1016/j.tics.2008.07.001; Egner T, 2007, NEUROIMAGE, V35, P940, DOI 10.1016/j.neuroimage.2006.11.061; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Fruhholz S, 2011, NEUROIMAGE, V54, P622, DOI 10.1016/j.neuroimage.2010.07.071; Funes MJ, 2010, COGNITION, V114, P338, DOI 10.1016/j.cognition.2009.10.007; Funes MJ, 2010, J EXP PSYCHOL HUMAN, V36, P147, DOI 10.1037/a0017598; Jiang J, 2013, CEREBRAL CO IN PRESS; Kerzel D, 2012, PSYCHON B REV, V19, P456, DOI 10.3758/s13423-012-0246-6; Kim C, 2012, BRAIN RES, V1444, P55, DOI 10.1016/j.brainres.2012.01.023; Kim C, 2011, HUM BRAIN MAPP, V32, P304, DOI 10.1002/hbm.21020; Kim C, 2010, NEUROSCI LETT, V476, P156, DOI 10.1016/j.neulet.2010.04.019; Kornblum S, 1999, J EXP PSYCHOL HUMAN, V25, P688, DOI 10.1037/0096-1523.25.3.688; KORNBLUM S, 1994, PSYCHOL RES-PSYCH FO, V56, P130, DOI 10.1007/BF00419699; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Liu X, 2004, NEUROIMAGE, V22, P1097, DOI 10.1016/j.neuroimage.2004.02.033; Liu X, 2010, ATTEN PERCEPT PSYCHO, V72, P1710, DOI 10.3758/APP.72.6.1710; Luo CR, 1999, PSYCHOL SCI, V10, P35, DOI 10.1111/1467-9280.00103; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Milham MP, 2001, COGNITIVE BRAIN RES, V12, P467, DOI 10.1016/S0926-6410(01)00076-3; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Proctor R. W., 1990, STIMULUS RESPONSE CO; SIMON JR, 1990, ACTA PSYCHOL, V73, P159, DOI 10.1016/0001-6918(90)90077-S; SIMON JR, 1969, J APPL PSYCHOL, V53, P433, DOI 10.1037/h0028034; Simon JR., 1990, STIMULUS RESPONSE CO; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sturz BR, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00842; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Torres-Quesada M, 2013, ACTA PSYCHOL, V142, P203, DOI 10.1016/j.actpsy.2012.11.015; Ullsperger M, 2005, COGN AFFECT BEHAV NE, V5, P467, DOI 10.3758/CABN.5.4.467; Wang HB, 2007, J COGNITIVE NEUROSCI, V19, P1678, DOI 10.1162/jocn.2007.19.10.1678; Wang K, 2010, NEUROSCIENCE, V165, P101, DOI 10.1016/j.neuroscience.2009.09.070; Wang K, 2013, NEUROIMAGE IN PRESS; Yamaguchi M, 2012, PSYCHOL REV, V119, P272, DOI 10.1037/a0026620	39	18	21	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89249	10.1371/journal.pone.0089249	http://dx.doi.org/10.1371/journal.pone.0089249			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3RA	24558489	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700135
J	Naudin, M; Carl, T; Surguladze, S; Guillen, C; Gaillard, P; Belzung, C; El-Hage, W; Atanasova, B				Naudin, Marine; Carl, Tatiana; Surguladze, Simon; Guillen, Catherine; Gaillard, Philippe; Belzung, Catherine; El-Hage, Wissam; Atanasova, Boriana			Perceptive Biases in Major Depressive Episode	PLOS ONE			English	Article							FACIAL EXPRESSIONS; EMOTIONAL RESPONSES; ODOR PERCEPTION; AMYGDALA; RECOGNITION; SENSITIVITY; INTENSITY; ANHEDONIA; UNIPOLAR; STIMULI	Introduction: Alterations in emotional processing occur during a major depressive episode (MDE), and olfaction and facial expressions have implications in emotional and social interactions. To gain a better understanding of these processes, we characterized the perceptive sensorial biases, potential links, and potential remission after antidepressant treatment of MDE. Methods: We recruited 22 patients with acute MDE, both before and after three months of antidepressant treatment, and 41 healthy volunteers matched by age and smoking status. The participants underwent a clinical assessment (Mini International Neuropsychiatry Interview, Montgomery-Asberg Depression Rating Scale, State-Trait Anxiety Inventory, Physical and Social Anhedonia scales, Pleasure-Displeasure Scale), an olfactory evaluation (hedonic aspect, familiarity and emotional impact of odors), and a computerized Facial Affect Recognition task. Results: MDE was associated with an olfactory bias concerning hedonic and emotional aspects, including negative olfactory alliesthesia (unpleasant odorants perceived as more unpleasant), facial emotion expression recognition (happy facial expressions), and in part olfactory anhedonia (pleasant odorants perceived as less pleasant). In addition, the results revealed that these impairments represent state markers of MDE, suggesting that the patients recovered the same sensory processing as healthy subjects after antidepressant treatment. Discussion: This study demonstrated that MDE is associated with negative biases toward olfactory perception and the recognition of facial emotional expressions. The link between these two sensory parameters suggests common underlying processes.	[Naudin, Marine; Gaillard, Philippe; Belzung, Catherine; El-Hage, Wissam; Atanasova, Boriana] Univ Tours, INSERM U930, Tours, France; [Carl, Tatiana; Guillen, Catherine; Gaillard, Philippe; El-Hage, Wissam] CHRU Tours, Clin Psychiat Univ, Tours, France; [Surguladze, Simon] Kings Coll London, Inst Psychiat, London WC2R 2LS, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; University of London; King's College London	Atanasova, B (corresponding author), Univ Tours, INSERM U930, Tours, France.	atanasova@univ-tours.fr	Gaillard, Philippe/E-7256-2019; EL-HAGE, WISSAM/S-5014-2019; Belzung, Catherine/P-6512-2016	EL-HAGE, WISSAM/0000-0003-3877-0855; Belzung, Catherine/0000-0001-6095-5974; ATANASOVA, Boriana/0000-0002-5877-4645				Abler B, 2007, J PSYCHIATR RES, V41, P511, DOI 10.1016/j.jpsychires.2006.07.020; *AM PSYCH ASS, 1994, DIAGN STAT MAN MENTA; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; ASSOULYBESSE F, 1995, ENCEPHALE, V21, P273; Atanasova B, 2010, PSYCHIAT RES, V176, P190, DOI 10.1016/j.psychres.2008.11.016; Beck A.T., 1979, COGNITIVE THERAPY EM; Bensafi M, 2002, NEUROPHYSIOL CLIN, V32, P326, DOI 10.1016/S0987-7053(02)00339-8; CHAPMAN LJ, 1976, J ABNORM PSYCHOL, V85, P374, DOI 10.1037/0021-843X.85.4.374; Chu S, 2002, MEM COGNITION, V30, P511, DOI 10.3758/BF03194952; Clepce M, 2010, NEUROSCI LETT, V471, P139, DOI 10.1016/j.neulet.2010.01.027; Corwin J, 1994, NEUROPSYCHOLOGY, V8, P110, DOI 10.1037/0894-4105.8.1.110; Croy I, 2011, EMOTION, V11, P1331, DOI 10.1037/a0024437; Drevets WC, 2003, ANN NY ACAD SCI, V985, P420, DOI 10.1111/j.1749-6632.2003.tb07098.x; Gottfried JA, 2002, J NEUROSCI, V22, P10819; HARDY P, 1986, Encephale, V12, P149; Hudry J, 2002, CHEM SENSES, V27, P407, DOI 10.1093/chemse/27.5.407; LAING DG, 1983, PERCEPTION, V12, P99, DOI 10.1068/p120099; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; LESSER IM, 1994, ARCH GEN PSYCHIAT, V51, P677; Levkovitz Y, 2003, J AFFECT DISORDERS, V75, P19, DOI 10.1016/S0165-0327(02)00024-1; Lombion-Pouthier S, 2006, J AFFECT DISORDERS, V90, P187, DOI 10.1016/j.jad.2005.11.012; Martzke JS, 1997, BIOL PSYCHIAT, V42, P721, DOI 10.1016/S0006-3223(96)00442-8; Mikhailova ES, 1996, BIOL PSYCHIAT, V40, P697, DOI 10.1016/0006-3223(96)00032-7; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Murphy FC, 1999, PSYCHOL MED, V29, P1307, DOI 10.1017/S0033291799001233; Naudin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046938; Negoias S, 2010, NEUROSCIENCE, V169, P415, DOI 10.1016/j.neuroscience.2010.05.012; Neumeister A, 2005, BIOL PSYCHIAT, V57, P935, DOI 10.1016/j.biopsych.2005.01.016; Pause BM, 2001, J PSYCHIAT RES, V35, P271, DOI 10.1016/S0022-3956(01)00029-2; PERSAD SM, 1993, J ABNORM PSYCHOL, V102, P358, DOI 10.1037/0021-843X.102.3.358; Ribot Th., 1911, PSYCHOL EMOTIONS; Robin O, 1998, J DENT RES, V77, P1638, DOI 10.1177/00220345980770081201; Royet JP, 2003, NEUROIMAGE, V20, P713, DOI 10.1016/S1053-8119(03)00388-4; Sato W, 2001, NEUROREPORT, V12, P709, DOI 10.1097/00001756-200103260-00019; Savic I, 2004, HUM BRAIN MAPP, V21, P271, DOI 10.1002/hbm.20009; Siegle GJ, 2002, BIOL PSYCHIAT, V51, P693, DOI 10.1016/S0006-3223(02)01314-8; Soudry Y, 2011, EUR ANN OTORHINOLARY, V128, P18, DOI 10.1016/j.anorl.2010.09.007; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Surguladze SA, 2004, NEUROPSYCHOLOGY, V18, P212, DOI 10.1037/0894-4105.18.2.212; Surguladze SA, 2010, J PSYCHIATR RES, V44, P894, DOI 10.1016/j.jpsychires.2010.02.010; Suslow T, 2001, PERCEPT MOTOR SKILL, V92, P857, DOI 10.2466/PMS.92.3.857-868; Swiecicki L, 2009, PROG NEURO-PSYCHOPH, V33, P827, DOI 10.1016/j.pnpbp.2009.03.030; Thomas HJ, 2002, NERVENARZT, V73, P71, DOI 10.1007/s115-002-8150-9; Vennemann MM, 2008, J NEUROL, V255, P1121, DOI 10.1007/s00415-008-0807-9; Victor TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046439; Yoon KL, 2009, J ABNORM PSYCHOL, V118, P223, DOI 10.1037/a0014658; Young AW, 2002, COMPUT SOFTW; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119	48	24	24	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e86832	10.1371/journal.pone.0086832	http://dx.doi.org/10.1371/journal.pone.0086832			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3RA	24558363	gold, Green Published, Green Submitted			2022-12-27	WOS:000331706700009
J	Priest, JR; Nead, KT; Wehner, MR; Cooke, JP; Leeper, NJ				Priest, James R.; Nead, Kevin T.; Wehner, Mackenzie R.; Cooke, John P.; Leeper, Nicholas J.			Self-Reported History of Childhood Smoking Is Associated with an Increased Risk for Peripheral Arterial Disease Independent of Lifetime Smoking Burden	PLOS ONE			English	Article							PREDICTION	Atherosclerotic disorders are well known to be associated with obesity, lipid profile, smoking, hypertension and other medical comorbidities, and large cohort studies have explored the childhood correlates to these adult risk factors. However, there has been little investigation into the childhood risk factors for peripheral arterial disease (PAD). We endeavored to better understand the role of smoking in childhood in the risk for PAD in a well described cohort of 1,537 adults at high risk for cardiovascular disease. In a multivariate regression model, we observed an increased risk of PAD among those who reported a history of smoking during childhood (OR = 2.86; 95% CI, 1.99-4.11; P<0.001), which remained statistically significant after controlling for lifetime smoking burden (OR = 1.55; 95% CI, 1.00-2.41; P = 0.049). Our novel observation of disproportionate risk of PAD conferred by a history of childhood smoking may reflect an unrecognized biological mechanism such as a unique susceptibility to vascular injury or an unaccounted for covariate such as secondhand smoke exposure in childhood. This observation suggests further investigation is required into the pathophysiology of smoking in the developing vasculature and the need for detailed clinical data about patterns of childhood smoking and smoke exposure.	[Priest, James R.] Stanford Univ, Sch Med, Div Pediat Cardiol, Stanford, CA 94305 USA; [Nead, Kevin T.] Stanford Univ, Div Cardiovasc Med, Sch Med, Stanford, CA 94305 USA; [Wehner, Mackenzie R.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Cooke, John P.] Methodist DeBakey Heart & Vasc Ctr, Ctr Cardiovasc Regenerat, Houston, TX USA; [Priest, James R.; Cooke, John P.; Leeper, Nicholas J.] Stanford Univ, Sch Med, Cardiovasc Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Stanford University	Leeper, NJ (corresponding author), Stanford Univ, Sch Med, Div Vasc Surg, Stanford, CA 94305 USA.	nleeper@stanford.edu		Wehner, Mackenzie/0000-0002-5579-2282; Cooke, John/0000-0003-0033-9138	National Institutes of Health [K12HD000850, K12HL087746, K08HL10360501A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL010360, K12HL087746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (K12HD000850 to Dr. Priest, K12HL087746 to Dr Cooke, and K08HL10360501A1 to Dr. Leeper). There are no relevant relationships with industry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Galal W, 2008, CHEST, V134, P925, DOI 10.1378/chest.08-0418; Launay JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007959; Leeper NJ, 2012, CIRCULATION, V125, P3220, DOI 10.1161/CIRCULATIONAHA.111.033878; Nead KT, 2013, J AM COLL CARDIOL, V62, P553, DOI 10.1016/j.jacc.2013.04.061; Nead KT, 2013, CIRC-CARDIOVASC QUAL, V6, P255, DOI 10.1161/CIRCOUTCOMES.111.000070; Nead KT, 2013, AM J CARDIOL, V111, P851, DOI 10.1016/j.amjcard.2012.11.055; Rafie AHS, 2010, VASC MED, V15, P443, DOI 10.1177/1358863X10388345; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tynan Michael A., 2012, Morbidity and Mortality Weekly Report, V61, P565	9	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88972	10.1371/journal.pone.0088972	http://dx.doi.org/10.1371/journal.pone.0088972			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558458	Green Submitted, Green Published, gold			2022-12-27	WOS:000331706700104
J	Ye, AY; Liu, QR; Li, CY; Zhao, M; Qu, H				Ye, Adam Y.; Liu, Qing-Rong; Li, Chuan-Yun; Zhao, Min; Qu, Hong			Human Transporter Database: Comprehensive Knowledge and Discovery Tools in the Human Transporter Genes	PLOS ONE			English	Article							MEMBRANE TRANSPORTERS; METABOLIC PATHWAYS; RESOURCE; SYSTEMS; SERVER	Transporters are essential in homeostatic exchange of endogenous and exogenous substances at the systematic, organic, cellular, and subcellular levels. Gene mutations of transporters are often related to pharmacogenetics traits. Recent developments in high throughput technologies on genomics, transcriptomics and proteomics allow in depth studies of transporter genes in normal cellular processes and diverse disease conditions. The flood of high throughput data have resulted in urgent need for an updated knowledgebase with curated, organized, and annotated human transporters in an easily accessible way. Using a pipeline with the combination of automated keywords query, sequence similarity search and manual curation on transporters, we collected 1,555 human non-redundant transporter genes to develop the Human Transporter Database (HTD) (http://htd.cbi.pku.edu.cn). Based on the extensive annotations, global properties of the transporter genes were illustrated, such as expression patterns and polymorphisms in relationships with their ligands. We noted that the human transporters were enriched in many fundamental biological processes such as oxidative phosphorylation and cardiac muscle contraction, and significantly associated with Mendelian and complex diseases such as epilepsy and sudden infant death syndrome. Overall, HTD provides a well-organized interface to facilitate research communities to search detailed molecular and genetic information of transporters for development of personalized medicine.	[Ye, Adam Y.; Zhao, Min; Qu, Hong] Peking Univ, Coll Life Sci, Ctr Bioinformat, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Liu, Qing-Rong] NIDA, Behav Neurosci Res Branch, NIH, IRP, Baltimore, MD USA; [Li, Chuan-Yun] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China; [Ye, Adam Y.] Peking Univ, Coll Life Sci, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China	Peking University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Peking University; Peking University	Zhao, M (corresponding author), Peking Univ, Coll Life Sci, Ctr Bioinformat, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	zhaomin.2006@gmail.com; quh@mail.cbi.pku.edu.cn	Zhao, Min/J-6588-2019; Ye, Yongxin/AAR-4486-2020; Liu, Qing-Rong/A-3059-2012	Zhao, Min/0000-0001-5498-3434; Ye, Yongxin/0000-0002-1542-0740; Liu, Qing-Rong/0000-0001-8477-6452	National Natural Science Foundation of China [31171270]; National Basic Research Program of China [2011CB518000]; NIDA-NIH	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); NIDA-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	This work was supported by the National Natural Science Foundation of China [grant number 31171270] and the National Basic Research Program of China [grant number 2011CB518000]. QL is supported by the intramural research program of NIDA-NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Burge S., 2012, DATABASE OXFORD, V2012; Cardoso AR, 2010, BBA-BIOENERGETICS, V1797, P832, DOI 10.1016/j.bbabio.2009.12.017; Davis AP, 2011, NUCLEIC ACIDS RES, V39, pD1067, DOI 10.1093/nar/gkq813; Fichant G, 2006, FEMS MICROBIOL LETT, V256, P333, DOI 10.1111/j.1574-6968.2006.00139.x; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Hodges LM, 2011, PHARMACOGENET GENOM, V21, P152, DOI 10.1097/FPC.0b013e3283385a1c; Huang Y, 2007, CANCER METAST REV, V26, P183, DOI 10.1007/s10555-007-9050-6; Hwang D, 2005, P NATL ACAD SCI USA, V102, P17296, DOI 10.1073/pnas.0508647102; Jones AR, 2009, NAT REV NEUROSCI, V10, P821, DOI 10.1038/nrn2722; Kalyana-Sundaram S, 2012, CELL, V149, P1622, DOI 10.1016/j.cell.2012.04.041; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kong L, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat063; Li CY, 2007, CELL RES, V17, P357, DOI 10.1038/cr.2007.27; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Longo N, 2011, AM J MED GENET C, V157C, P72, DOI 10.1002/ajmg.c.30292; Miao ZY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-60; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Oshiro C, 2010, PHARMACOGENET GENOM, V20, P211, DOI 10.1097/FPC.0b013e328333b99c; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; Relling MV, 2011, CLIN PHARMACOL THER, V89, P387, DOI 10.1038/clpt.2010.320; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Takahashi N, 2010, J HUM GENET, V55, P731, DOI 10.1038/jhg.2010.98; Ueda K, 2011, BIOSCI BIOTECH BIOCH, V75, P401, DOI 10.1271/bbb.100816; van Veen HW, 2010, NATURE, V467, P926, DOI 10.1038/467926a; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Ware JA, 2006, MOL PHARMACEUT, V3, P1, DOI 10.1021/mp058084b; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yan Q, 2000, AAPS PHARMSCI, V2, part. no.; Yan Q, 2010, METHODS MOL BIOL, V637, P1, DOI 10.1007/978-1-60761-700-6_1; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916; Zhao FQ, 2007, CURR GENOMICS, V8, P113, DOI 10.2174/138920207780368187; Zhao M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S10; Zhao M, 2011, SCI CHINA LIFE SCI, V54, P60, DOI 10.1007/s11427-010-4125-y; Zhao M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S13; Zhao M, 2009, CELL RES, V19, P793, DOI 10.1038/cr.2009.61; Zhao Min, 2009, BMC Genomics, V10 Suppl 3, pS31, DOI 10.1186/1471-2164-10-S3-S31	50	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88883	10.1371/journal.pone.0088883	http://dx.doi.org/10.1371/journal.pone.0088883			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558441	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700087
J	Zhao, H; Liu, KJ; Lei, ZD; Lei, SL; Tian, YQ				Zhao, Hua; Liu, Kui-Jie; Lei, Zhen-Dong; Lei, San-Lin; Tian, Yong-Quan			Meta-Analysis of the Aldehyde Dehydrogenases-2 (ALDH2) Glu487Lys Polymorphism and Colorectal Cancer Risk	PLOS ONE			English	Article							GENETIC POLYMORPHISMS; ESOPHAGEAL CANCER; ALCOHOL-DEHYDROGENASE; ACETALDEHYDE; ASSOCIATION; METABOLISM; NEOPLASIA; CARCINOMA; GENOTYPES; DRINKING	A number of studies have explored the association of the aldehyde dehydrogenases-2 (ALDH2) Glu487Lys polymorphism and risk of colorectal cancer; however, the results are inconsistent. We performed this meta-analysis to clarify this issue using all the available evidence. Relevant studies were retrieved by searching PubMed. Eleven case-control studies were included in the meta-analysis, representing 2909 cases and 4903 controls. The pooled results based on all included studies showed a decreased colorectal cancer risk in the analysis of the GA genotype vs. the GG genotype (OR = 0.81, 95% CI = 0.68-0.98, p = 0.03) and in the dominant genetic model analysis (OR = 0.81, 95% CI = 0.67-0.98, p = 0.03). However, there was no statistical difference in the AA vs. GG analysis (OR = 0.74, 95% CI = 0.52-1.06, p = 0.11) and the recessive genetic model analysis (OR = 0.86, 95% CI = 0.69-1.07, p = 0.17). Cumulative meta-analysis based on publication time confirmed these findings. Patients with colorectal cancer had a higher frequency of the GG genotype (OR = 1.10, 95% CI = 1.02-1.20, p = 0.02) and a lower frequency of the GA genotype (OR = 0.89, 95% CI = 0.81-0.98, p = 0.02) comparing with control population. Our results suggested that the ALDH2 Glu487Lys polymorphism may be associated with a decreased risk of colorectal cancer.	[Zhao, Hua; Tian, Yong-Quan] Cent South Univ, Sch Publ Hlth, Changsha, Hunan, Peoples R China; [Zhao, Hua; Liu, Kui-Jie; Lei, Zhen-Dong; Lei, San-Lin] Cent South Univ, Xiangya Hosp 2, Dept Gen Surg, Changsha, Hunan, Peoples R China	Central South University; Central South University	Tian, YQ (corresponding author), Cent South Univ, Sch Publ Hlth, Changsha, Hunan, Peoples R China.	yongquantian2013@163.com						Boccia S, 2009, CANCER EPIDEM BIOMAR, V18, P248, DOI 10.1158/1055-9965.EPI-08-0462; Chao You-Chen, 1994, Proceedings of the National Science Council Republic of China Part B Life Sciences, V18, P101; Chiang CP, 2012, ALCOHOL, V46, P37, DOI 10.1016/j.alcohol.2011.08.004; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ENOMOTO N, 1991, ALCOHOL CLIN EXP RES, V15, P141, DOI 10.1111/j.1530-0277.1991.tb00532.x; Eriksson CJP, 2001, ALCOHOL CLIN EXP RES, V25, p15S, DOI 10.1111/j.1530-0277.2001.tb02369.x; Fang P, 2011, ASIAN PAC J CANCER P, V12, P2623; Fedirko V, 2011, ANN ONCOL, V22, P1958, DOI 10.1093/annonc/mdq653; Ferrari P, 2012, EUR J CLIN NUTR, V66, P1303, DOI 10.1038/ejcn.2012.173; Gao CM, 2008, WORLD J GASTROENTERO, V14, P5078, DOI 10.3748/wjg.14.5078; Haas SL, 2012, CURR OPIN CLIN NUTR, V15, P457, DOI 10.1097/MCO.0b013e3283566699; Hirose M, 2005, CANCER SCI, V96, P513, DOI 10.1111/j.1349-7006.2005.00077.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kuriki Kiyonori, 2005, Asian Pac J Cancer Prev, V6, P62; Landi S, 2005, PHARMACOGENET GENOM, V15, P535, DOI 10.1097/01.fpc.0000165904.48994.3d; Lewis SJ, 2005, CANCER EPIDEM BIOMAR, V14, P1967, DOI 10.1158/1055-9965.EPI-05-0196; Li FQ, 2013, TUMOR BIOL, V34, P1825, DOI 10.1007/s13277-013-0723-1; Li H, 2009, ANN HUM GENET, V73, P335, DOI 10.1111/j.1469-1809.2009.00517.x; Liang J, 2013, AM J EPIDEMIOL, V177, P1169, DOI 10.1093/aje/kws382; Luo HR, 2005, BIOCHEM GENET, V43, P223, DOI 10.1007/s10528-005-5213-8; Matsuo K, 2006, CARCINOGENESIS, V27, P1018, DOI 10.1093/carcin/bgi282; Matsuo K, 2013, CARCINOGENESIS, V34, P1510, DOI 10.1093/carcin/bgt080; Matsuo Keitaro, 2002, J Epidemiol, V12, P70; Miyasaka K, 2010, GERIATR GERONTOL INT, V10, pS120, DOI 10.1111/j.1447-0594.2010.00616.x; MIZOI Y, 1994, ALCOHOL ALCOHOLISM, V29, P707; Otani T, 2005, NUTR CANCER, V53, P42, DOI 10.1207/s15327914nc5301_5; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; THOMASSON HR, 1991, AM J HUM GENET, V48, P677; Wang J, 2011, COLORECTAL DIS, V13, pE71, DOI 10.1111/j.1463-1318.2010.02530.x; Wu CF, 2005, WORLD J GASTROENTERO, V11, P5103, DOI 10.3748/wjg.v11.i33.5103; Xiang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059665; Yamagishi Y, 2004, HEPATOL RES, V28, P177, DOI 10.1016/j.hepres.2003.11.009; Yang H, 2009, CANCER EPIDEM BIOMAR, V18, P2522, DOI 10.1158/1055-9965.EPI-09-0398; Yang SJ, 2010, WORLD J GASTROENTERO, V16, P4210, DOI 10.3748/wjg.v16.i33.4210; Yin G, 2007, CANCER SCI, V98, P1248, DOI 10.1111/j.1349-7006.2007.00519.x; YIN SJ, 1994, ALCOHOL CLIN EXP RES, V18, P1256, DOI 10.1111/j.1530-0277.1994.tb00115.x; Yokoyama A, 1998, CARCINOGENESIS, V19, P1383, DOI 10.1093/carcin/19.8.1383; Zhang GH, 2010, WORLD J GASTROENTERO, V16, P6020, DOI 10.3748/wjg.v16.i47.6020	38	13	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88656	10.1371/journal.pone.0088656	http://dx.doi.org/10.1371/journal.pone.0088656			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558407	gold, Green Submitted, Green Published			2022-12-27	WOS:000331706700053
J	Kopp, R; Bauer, I; Ramalingam, A; Egg, M; Schwerte, T				Kopp, Renate; Bauer, Ines; Ramalingam, Anil; Egg, Margit; Schwerte, Thorsten			Prolonged Hypoxia Increases Survival Even in Zebrafish (Danio rerio) Showing Cardiac Arrhythmia	PLOS ONE			English	Article							GENE-EXPRESSION; LARVAL ZEBRAFISH; MITOCHONDRIAL BIOGENESIS; OXYGEN-TRANSPORT; SKELETAL-MUSCLE; CHANNEL PROTEIN; ANDEAN NATIVES; MESSENGER-RNA; FISHES; HERG	Tolerance towards hypoxia is highly pronounced in zebrafish. In this study even beneficial effects of hypoxia, specifically enhanced survival of zebrafish larvae, could be demonstrated. This effect was actually more pronounced in breakdance mutants, which phenotypically show cardiac arrhythmia. Breakdance mutants (bre) are characterized by chronically reduced cardiac output. Despite an about 50% heart rate reduction, they become adults, but survival rate significantly drops to 40%. Normoxic bre animals demonstrate increased hypoxia inducible factor 1 a (Hif-1 alpha) expression, which indicates an activated hypoxic signaling pathway. Consequently, cardiovascular acclimation, like cardiac hypertrophy and increased erythrocyte concentration, occurs. Thus, it was hypothesized, that under hypoxic conditions survival might be even more reduced. When bre mutants were exposed to hypoxic conditions, they surprisingly showed higher survival rates than under normoxic conditions and even reached wildtype values. In hypoxic wildtype zebrafish, survival yet exceeded normoxic control values. To specify physiological acclimation, cardiovascular and metabolic parameters were measured before hypoxia started (3 dpf), when the first differences in survival rate occurred (7 dpf) and when survival rate plateaued (15 dpf). Hypoxic animals expectedly demonstrated Hif-1 alpha accumulation and consequently enhanced convective oxygen carrying capacity. Moreover, bre animals showed a significantly enhanced heart rate under hypoxic conditions, which reached normoxic wildtype values. This improvement in convective oxygen transport ensured a sufficient oxygen and nutrient supply and was also reflected in the significantly higher mitochondrial activity. The highly optimized energy metabolism observed in hypoxic zebrafish larvae might be decisive for periods of higher energy demand due to organ development, growth and increased activity. However, hypoxia increased survival only during a short period of development and starting hypoxia before or after this phase reduced survival, particularly in bre animals. Thus, the physiological plasticity, which enables zebrafish larvae to benefit from a hypoxia, occurs only within a narrow developmental window.	[Kopp, Renate] Univ Innsbruck, Inst Zool, A-6020 Innsbruck, Austria; Univ Innsbruck, Ctr Mol Biol, A-6020 Innsbruck, Austria	University of Innsbruck; University of Innsbruck	Kopp, R (corresponding author), Univ Innsbruck, Inst Zool, A-6020 Innsbruck, Austria.	Renate.Kopp@uibk.ac.at	Schwerte, Thorsten/K-6549-2019; Schwerte, Thorsten/A-6088-2009	Schwerte, Thorsten/0000-0002-6330-8817				Achard-Joris M, 2006, BIOMETALS, V19, P237, DOI 10.1007/s10534-005-5671-9; Allen RG, 1999, J CELL PHYSIOL, V180, P114, DOI 10.1002/(SICI)1097-4652(199907)180:1<114::AID-JCP13>3.0.CO;2-0; Bagatto B, 2001, J EXP BIOL, V204, P4335; Barrionuevo WR, 1999, O2 CONSUMPTION HEART; Bennett MR, 2001, CIRC RES, V88, P648, DOI 10.1161/hh0701.089955; Burggren WW, 2011, RESP PHYSIOL NEUROBI, V178, P13, DOI 10.1016/j.resp.2011.05.001; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Crockett EL, 1999, J EXP ZOOL, V284, P276, DOI 10.1002/(SICI)1097-010X(19990801)284:3<276::AID-JEZ5>3.0.CO;2-N; Dayan F, 2009, J THEOR BIOL, V259, P304, DOI 10.1016/j.jtbi.2009.03.009; Egg M, 2013, CHRONOBIOL INT, V30, P510, DOI 10.3109/07420528.2012.754447; Engeszer RE, 2007, ZEBRAFISH, V4, P21, DOI 10.1089/zeb.2006.9997; GORDON GB, 1977, AM J PATHOL, V88, P663; Grillitsch S, 2005, J EXP BIOL, V208, P309, DOI 10.1242/jeb.01410; He LP, 2004, ACTA OBSTET GYN SCAN, V83, P144, DOI 10.1111/j.0001-6349.2004.00345.x; HOCHACHKA PW, 1991, J APPL PHYSIOL, V70, P1720, DOI 10.1152/jappl.1991.70.4.1720; Isomoto S, 1997, J CARDIOVASC ELECTR, V8, P1431, DOI 10.1111/j.1540-8167.1997.tb01040.x; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jacob E, 2002, AM J PHYSIOL-REG I, V283, pR911, DOI 10.1152/ajpregu.00673.2001; JOSE AD, 1969, CIRC RES, V25, P53, DOI 10.1161/01.RES.25.1.53; Kopp R, 2005, J EXP BIOL, V208, P2123, DOI 10.1242/jeb.01620; Kopp R, 2011, PHYSIOL GENOMICS, V43, P506, DOI 10.1152/physiolgenomics.00250.2010; Kopp R, 2010, PHYSIOL GENOMICS, V42A, P8, DOI 10.1152/physiolgenomics.00052.2010; Langheinrich U, 2003, TOXICOL APPL PHARM, V193, P370, DOI 10.1016/j.taap.2003.07.012; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Liu HP, 2002, BIOCHEM PHARMACOL, V64, P1745, DOI 10.1016/S0006-2952(02)01456-9; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; MATHESON GO, 1991, J APPL PHYSIOL, V70, P1963, DOI 10.1152/jappl.1991.70.5.1963; McMullen DC, 2008, INSECT BIOCHEM MOLEC, V38, P367, DOI 10.1016/j.ibmb.2007.12.003; Mendelsohn BA, 2008, DEV DYNAM, V237, P1780, DOI 10.1002/dvdy.21581; Milkiewicz M, 2005, AM J PHYSIOL-HEART C, V289, pH336, DOI 10.1152/ajpheart.01105.2004; Nanduri J, 2008, BIOCHEM BIOPH RES CO, V373, P309, DOI 10.1016/j.bbrc.2008.06.028; Nanduri J, 2009, BIOCHEM BIOPH RES CO, V388, P212, DOI 10.1016/j.bbrc.2009.07.149; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Nikinmaa M, 2005, AM J PHYSIOL-REG I, V288, pR1079, DOI 10.1152/ajpregu.00626.2004; O'Brien KM, 2011, J EXP BIOL, V214, P275, DOI 10.1242/jeb.046854; O'Connor EA, 2011, FISH PHYSIOL BIOCHEM, V37, P461, DOI 10.1007/s10695-010-9447-y; Padilla PA, 2001, P NATL ACAD SCI USA, V98, P7331, DOI 10.1073/pnas.131213198; Pelster B, 1996, CIRC RES, V79, P358, DOI 10.1161/01.RES.79.2.358; Richards JG, 2008, AM J PHYSIOL-REG I, V295, pR979, DOI 10.1152/ajpregu.00192.2008; Rombough P, 2009, J EXP BIOL, V212, P778, DOI 10.1242/jeb.026575; Tadolini B, 2000, FREE RADICAL RES, V33, P105, DOI 10.1080/10715760000300661; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Tingaud-Sequeira A, 2011, J LIPID RES, V52, P1765, DOI 10.1194/jlr.D017012; Ton C, 2003, PHYSIOL GENOMICS, V13, P97, DOI 10.1152/physiolgenomics.00128.2002; Uchida T, 2004, J BIOL CHEM, V279, P14871, DOI 10.1074/jbc.M400461200; van der Meer DLM, 2005, AM J PHYSIOL-REG I, V289, pR1512, DOI 10.1152/ajpregu.00089.2005; van der Velden YU, 2011, P NATL ACAD SCI USA, V108, P4358, DOI 10.1073/pnas.1010210108; Vidal-Puig AJ, 2000, NAT GENET, V26, P387, DOI 10.1038/82489; Yaqoob N, 2010, COMP BIOCHEM PHYS A, V156, P475, DOI 10.1016/j.cbpa.2010.03.033	49	15	16	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89099	10.1371/journal.pone.0089099	http://dx.doi.org/10.1371/journal.pone.0089099			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551224	Green Published, gold, Green Submitted			2022-12-27	WOS:000331271500096
J	Remmers, T; van Grieken, A; Renders, CM; Hirasing, RA; Broeren, SML; Raat, H				Remmers, Teun; van Grieken, Amy; Renders, Carry M.; Hirasing, Remy A.; Broeren, Suzanne M. L.; Raat, Hein			Correlates of Parental Misperception of Their Child's Weight Status: The 'Be Active, Eat Right' Study	PLOS ONE			English	Article							OVERWEIGHT PREVENTION; MATERNAL PERCEPTIONS; OBESE CHILDREN; RISK; PEDIATRICIANS; PRESCHOOLERS; RECOGNIZE	Objective: This study reported on correlates of parental perception of their child's weight status. Associations between parental misperception (i.e., underestimation of the child's weight) and parental intention to improve their child's overweight-related health behaviors and their child meeting guidelines regarding these behaviors were also investigated. Methods: Baseline data from the population-based 'Be active, eat right study' were used. The population for analysis consisted of 630 overweight and 153 obese five year-old children and their parents. Questionnaires were used to measure parental perception of the child's weight status, correlates of misperception (i.e., child age, child gender, child BMI, parental age, parental gender, parental country of birth, parental educational level and parental weight status), overweight-related health behaviors (i.e., child playing outside, having breakfast, drinking sweet beverages, and watching TV), and parental intention to improve these behaviors. Height and weight were measured using standardized protocols. Multivariable logistic regression analyses were performed. Results: In total, 44.40% of the parents misperceived their child's weight status. Parental misperception was associated with lower child BMI, the parent being the father, a foreign parental country of birth, and a lower parental education level (p<0.05). Parental misperception was not associated with parental intention to improve child overweight-related health behavior, nor with child meeting the guidelines of these behaviors. Discussion: This study showed that almost half of the parents with an overweight or obese child misperceived their child's weight status. A correct parental perception may be a small stepping-stone in improving the health of overweight and obese children.	[Remmers, Teun; van Grieken, Amy; Broeren, Suzanne M. L.; Raat, Hein] Erasmus MC Univ, Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands; [Hirasing, Remy A.] Vrije Univ Amsterdam, Med Ctr Amsterdam, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Renders, Carry M.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Inst Hlth Sci, Amsterdam, Netherlands; [Remmers, Teun] Maastricht Univ, Med Ctr, CAPHRI Sch Publ Hlth & Primary Care, Dept Epidemiol, Maastricht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Maastricht University	Raat, H (corresponding author), Erasmus MC Univ, Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands.	h.raat@erasmusmc.nl	van Grieken, Amy/N-1583-2014	van Grieken, Amy/0000-0001-6767-9159; Renders, Carry/0000-0001-6688-1312	major funding body ZonMW; Netherlands Organization for Health Research and Development [50-501 10-98]	major funding body ZonMW; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development)	This study is funded by a grant from the major funding body ZonMW, the Netherlands Organization for Health Research and Development (project no. 50-501 10-98). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qaoud NM, 2010, J DEV BEHAV PEDIATR, V31, P505, DOI 10.1097/DBP.0b013e3181e56dc7; ANDERSON DR, 1985, CHILD DEV, V56, P1345, DOI 10.1111/j.1467-8624.1985.tb00202.x; Bar-on ME, 2001, PEDIATRICS, V107, P423, DOI 10.1542/peds.107.2.423; Baughcum AE, 2000, PEDIATRICS, V106, P1380, DOI 10.1542/peds.106.6.1380; Bonnet-Breusers AJM, 2004, PRAKTIJKBOEK JEUGDGE, P12; Boutelle K, 2004, OBES RES, V12, P1754, DOI 10.1038/oby.2004.217; Brown R, 2004, HEALTH EDUC RES, V19, P261, DOI 10.1093/her/cyg040; BULKBUNSCHOTEN AMW, 2005, OVERBRUGGINGSPLAN KI; Campbell MWC, 2006, MED J AUSTRALIA, V184, P274, DOI 10.5694/j.1326-5377.2006.tb00236.x; Carnell S, 2005, INT J OBESITY, V29, P353, DOI 10.1038/sj.ijo.0802889; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Contento IR, 2003, J NUTR EDUC BEHAV, V35, P236, DOI 10.1016/S1499-4046(06)60054-7; Corp I. B. M, 2011, IBM SPSS STAT WIND V; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Driessen G, 2000, COMP EDUC, V36, P55, DOI 10.1080/03050060027764; Eckstein KC, 2006, PEDIATRICS, V117, P681, DOI 10.1542/peds.2005-0910; Epstein LH, 1996, INT J OBESITY, V20, pS14; Etelson D, 2003, OBES RES, V11, P1362, DOI 10.1038/oby.2003.184; Fredriks AM, 2005, ACTA PAEDIATR, V94, P496, DOI [10.1080/08035250410024240, 10.1111/j.1651-2227.2005.tb01923.x]; Genovesi S, 2005, ACTA PAEDIATR, V94, P747, DOI 10.1080/08035250510028894; Hautvast JGAJ, 2003, OVERGEWICHT OBESITAS; Hernandez RG, 2010, CLIN PEDIATR, V49, P790, DOI 10.1177/0009922810368288; Holm-Denoma JM, 2005, INT J EAT DISORDER, V38, P228, DOI 10.1002/eat.20180; Jain A, 2001, PEDIATRICS, V107, P1138, DOI 10.1542/peds.107.5.1138; Jansen W, 2006, EUR J PUBLIC HEALTH, V16, P645, DOI 10.1093/eurpub/ckl100; Jeffery AN, 2005, BRIT MED J, V330, P23, DOI 10.1136/bmj.38315.451539.F7; Kocken PL, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-867; Kumanyika S, 2006, FUTURE CHILD, V16, P187, DOI 10.1353/foc.2006.0005; Latner JD, 2005, OBES RES, V13, P1226, DOI 10.1038/oby.2005.145; Mackett R., 2007, BUILD ENVIRON, V33, P454, DOI [DOI 10.2148/BENV.33.4.454, 10.2148/benv.33.4.454]; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Maynard LM, 2003, PEDIATRICS, V111, P1226; Myers S, 2000, Pediatr Nurs, V26, P23; Nagel G, 2009, EUR J PEDIATR, V168, P1259, DOI 10.1007/s00431-009-1016-y; Rich SS, 2005, FAM COMMUNITY HEALTH, V28, P130, DOI 10.1097/00003727-200504000-00005; Rietmeijer-Mentink M, 2013, MATERN CHILD NUTR, V9, P3, DOI 10.1111/j.1740-8709.2012.00462.x; Sallis JF, 2002, PEDIATR EXERC SCI, V14, P30, DOI 10.1123/pes.14.1.30; Saxena S, 2004, ARCH DIS CHILD, V89, P30; Schonbeck Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027608; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Statistics N, 2004, DUTCH STAND CLASS ED; Story M, 2009, PREVENTING CHRONIC D, V6; Trost SG, 2003, AM J PREV MED, V25, P277, DOI 10.1016/S0749-3797(03)00217-4; Van Assema Patricia, 2002, Nutrition and Health (Bicester), V16, P85; Veldhuis L, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-74; Veldhuis L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-177; Warschburger P, 2009, PEDIATRICS, V124, pE60, DOI 10.1542/peds.2008-1845; Whitaker RC, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.3.e5; Young-Hyman D, 2000, OBES RES, V8, P241, DOI 10.1038/oby.2000.28	49	17	17	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88931	10.1371/journal.pone.0088931	http://dx.doi.org/10.1371/journal.pone.0088931			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7IR	24551191	Green Published, gold, Green Submitted			2022-12-27	WOS:000331271500082
J	Rosenthal, M; Aiello, AE; Chenoweth, C; Goldberg, D; Larson, E; Gloor, G; Foxman, B				Rosenthal, Mariana; Aiello, Allison E.; Chenoweth, Carol; Goldberg, Deborah; Larson, Elaine; Gloor, Gregory; Foxman, Betsy			Impact of Technical Sources of Variation on the Hand Microbiome Dynamics of Healthcare Workers	PLOS ONE			English	Article							SEQUENCING PLATFORMS; DIVERSITY	We assessed the dynamics of hand microbial community structure of 34 healthcare workers from a single surgical intensive care unit over a short (3 week) time period, whilst taking into account the technical sources of variability introduced by specimen collection, DNA extraction, and sequencing. Sample collection took place at 3 different time points. Only the sampling collection method appeared to have a significant impact on the observed hand microbial community structure among the healthcare workers. Analysis of samples collected using glove-juice showed a slightly more similar microbial composition within individual hand samples over time than between the hands of different individuals over time. This was not true for samples collected using a swab, where samples from a single individual were no more similar to each other over time than those among other individuals over time, suggesting they were essentially independent. DNA extraction techniques (lysozyme only versus enzyme cocktail) and sequencing (replicate set 1 versus 2) using Ion Torrent Personal Genome Machine, were not influential to the microbial community structures. Glove-juice sample collection may likely be the method of choice in hand hygiene studies in the healthcare setting.	[Rosenthal, Mariana; Aiello, Allison E.; Chenoweth, Carol; Foxman, Betsy] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Goldberg, Deborah] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Larson, Elaine] Columbia Univ, Sch Nursing, New York, NY USA; [Larson, Elaine] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Gloor, Gregory] Schulich Sch Med & Dent, Dept Biochem, London, ON, Canada	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Columbia University; Columbia University	Rosenthal, M (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.	rosenbr@umich.edu; bfoxman@umich.edu	Gloor, Greg B/D-1671-2013	Gloor, Gregory/0000-0001-5803-3380; Foxman, Betsy/0000-0001-6682-238X	National Institute of Allergy and Infectious Diseases of the National Institutes of Health Interdisciplinary Program in Infectious Diseases Training Grant [T32 AI049816]; Robert Wood Johnson Foundation Health & Society Scholars (RWJF HSS) Small Grants Program [N012550-399789]; University of Michigan Rackham Graduate Student Research Grant; University of Michigan School of Public Health Department of Epidemiology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI049816] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health Interdisciplinary Program in Infectious Diseases Training Grant; Robert Wood Johnson Foundation Health & Society Scholars (RWJF HSS) Small Grants Program; University of Michigan Rackham Graduate Student Research Grant(University of Michigan System); University of Michigan School of Public Health Department of Epidemiology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding support was provided by The National Institute of Allergy and Infectious Diseases of the National Institutes of Health funded Interdisciplinary Program in Infectious Diseases Training Grant (T32 AI049816), the Robert Wood Johnson Foundation Health & Society Scholars (RWJF HSS) Small Grants Program (#N012550-399789), The University of Michigan Rackham Graduate Student Research Grant, and The University of Michigan School of Public Health Department of Epidemiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Vercoe E, 2012, CAN J GASTROENTEROL, V26, P457, DOI 10.1155/2012/213828; Banfield KR, 2005, J HOSP INFECT, V61, P183, DOI 10.1016/j.jhin.2005.03.016; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Junemann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041606; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Petrof EO, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-3; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Rosenthal M, 2014, PATHOGENS, V3, P1, DOI 10.3390/pathogens3010001; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Salazar O, 2007, BIOTECHNOL LETT, V29, P985, DOI 10.1007/s10529-007-9345-2; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Scholz MB, 2012, CURR OPIN BIOTECH, V23, P9, DOI 10.1016/j.copbio.2011.11.013; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865	27	14	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88999	10.1371/journal.pone.0088999	http://dx.doi.org/10.1371/journal.pone.0088999			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551205	Green Published, Green Submitted			2022-12-27	WOS:000331271500091
J	Staunton, KM; Robson, SKA; Burwell, CJ; Reside, AE; Williams, SE				Staunton, Kyran M.; Robson, Simon K. A.; Burwell, Chris J.; Reside, April E.; Williams, Stephen E.			Projected Distributions and Diversity of Flightless Ground Beetles within the Australian Wet Tropics and Their Environmental Correlates	PLOS ONE			English	Article							RAIN-FOREST; LATITUDINAL GRADIENTS; CLIMATE-CHANGE; PREDICTIVE PERFORMANCE; SPECIES DISTRIBUTIONS; GLOBAL BIODIVERSITY; RANGE SHIFTS; MODELS; EXTINCTIONS; PATTERNS	With the impending threat of climate change, greater understanding of patterns of species distributions and richness and the environmental factors driving them are required for effective conservation efforts. Species distribution models enable us to not only estimate geographic extents of species and subsequent patterns of species richness, but also generate hypotheses regarding environmental factors determining these spatial patterns. Projected changes in climate can then be used to predict future patterns of species distributions and richness. We created distribution models for most of the flightless ground beetles (Carabidae) within the Wet Tropics World Heritage Area of Australia, a major component of regionally endemic invertebrates. Forty-three species were modelled and the environmental correlates of these distributions and resultant patterns of species richness were examined. Flightless ground beetles generally inhabit upland areas characterised by stable, cool and wet environmental conditions. These distribution and richness patterns are best explained using the time-stability hypothesis as this group's primary habitat, upland rainforest, is considered to be the most stable regional habitat. Projected changes in distributions indicate that as upward shifts in distributions occur, species currently confined to lower and drier mountain ranges will be more vulnerable to climate change impacts than those restricted to the highest and wettest mountains. Distribution models under projected future climate change suggest that there will be reductions in range size, population size and species richness under all emission scenarios. Eighty-eight per cent of species modelled are predicted to decline in population size by over 80%, for the most severe emission scenario by the year 2080. These results suggest that flightless ground beetles are among the most vulnerable taxa to climate change impacts so far investigated in the Wet Tropics World Heritage Area. These findings have dramatic implications for all other flightless insect taxa and the future biodiversity of this region.	[Staunton, Kyran M.; Robson, Simon K. A.; Reside, April E.; Williams, Stephen E.] James Cook Univ, Ctr Trop Biodivers & Climate Change, Townsville, Qld 4811, Australia; [Staunton, Kyran M.; Robson, Simon K. A.; Reside, April E.; Williams, Stephen E.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Burwell, Chris J.] Queensland Museum, Brisbane, Qld 4101, Australia; [Burwell, Chris J.] Griffith Univ, Environm Futures Ctr, Brisbane, Qld 4111, Australia; [Burwell, Chris J.] Griffith Univ, Griffith Sch Environm, Brisbane, Qld 4111, Australia	James Cook University; James Cook University; Queensland Museum; Griffith University; Griffith University	Staunton, KM (corresponding author), James Cook Univ, Ctr Trop Biodivers & Climate Change, Townsville, Qld 4811, Australia.	staunton.k@gmail.com	Reside, April/H-4940-2011; Staunton, Kyran/W-2263-2019; Williams, Stephen E/A-7250-2008; Robson, Simon/D-1168-2011	Reside, April/0000-0002-0760-9527; Staunton, Kyran/0000-0001-6812-3320; Williams, Stephen E/0000-0002-2510-7408; Robson, Simon/0000-0001-8870-1933	MTSRF; Skyrail Rainforest Cableway; James Cook University	MTSRF; Skyrail Rainforest Cableway; James Cook University	This study was funded by MTSRF, Skyrail Rainforest Cableway and James Cook University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam P., 1992, AUSTR RAINFOREST; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; [Anonymous], R LANG ENV STAT COMP; Bonell M., 2008, LIVING DYNAMIC TROPI, P23; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; CHURCHFIELD S, 1991, OIKOS, V60, P283, DOI 10.2307/3545069; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Conservation Society of Queensland Rainforest, 1986, SPEC AUSTR HER PUBL, V3; Coulson JC, 1978, PRODUCTION ECOLOGY B; Darlington P. J., 1943, ECOL MONOGR, V13, P37, DOI 10.2307/1943589; DARLINGTON P J JR, 1970, Biotropica, V2, P7, DOI 10.2307/2989782; Darlington PJ, 1961, PSYCHE, V68, P1; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fisher Brian L., 1998, Fieldiana Zoology, V90, P39; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Graham CH, 2006, P NATL ACAD SCI USA, V103, P632, DOI 10.1073/pnas.0505754103; Hannah L, 2011, CLIMATE CHANGE BIOLOGY, P1; Heneghan L, 1998, APPL SOIL ECOL, V9, P33, DOI 10.1016/S0929-1393(98)00050-X; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hilbert D. W., 2008, LIVING DYNAMIC TROPI, P107; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; KIM KC, 1993, BIODIVERS CONSERV, V2, P189, DOI 10.1007/BF00056667; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lovei GL, 1996, ANNU REV ENTOMOL, V41, P231, DOI 10.1146/annurev.en.41.010196.001311; Mac Nally R, 2000, BIODIVERS CONSERV, V9, P655, DOI 10.1023/A:1008985925162; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; Marchetto KM, 2010, ECOLOGY, V91, P2485, DOI 10.1890/09-1069.1; McDonald TE, 2000, SECURING WET TROPICS; McJannet D, 2007, HYDROL PROCESS, V21, P1703, DOI 10.1002/hyp.6346; McMahon J.P., 1995, ANUCLIM USERS GUIDE; MONTEITH G. B, 2008, LIVING DYNAMIC TROPI, P178, DOI DOI 10.1002/9781444300321.CH13; Monteith GB, 1994, DISTRIBUTION ALTIT 3; Nakicenovic N., 2000, IPCC SPECIAL REPORT, P570; New TR, 1998, ANN ZOOL FENN, V35, P163; NIEMELA P, 1987, J APPL ENTOMOL, V103, P84, DOI 10.1111/j.1439-0418.1987.tb00962.x; Ohlemuller R, 2008, BIOL LETTERS, V4, P568, DOI 10.1098/rsbl.2008.0097; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Pyrcz TW, 2002, GLOBAL ECOL BIOGEOGR, V11, P211, DOI 10.1046/j.1466-822X.2002.00285.x; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Raxworthy CJ, 2008, GLOBAL CHANGE BIOL, V14, P1703, DOI 10.1111/j.1365-2486.2008.01596.x; Reside AE, 2012, ECOLOGY EVOLUTION, P213; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Rykken JJ, 1997, CONSERV BIOL, V11, P522, DOI 10.1046/j.1523-1739.1997.95336.x; Santika T, 2011, GLOBAL ECOL BIOGEOGR, V20, P181, DOI 10.1111/j.1466-8238.2010.00581.x; Shoo LP, 2005, BIOL CONSERV, V125, P335, DOI 10.1016/j.biocon.2005.04.003; Shoo LP, 2005, THESIS J COOK U TOWN; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stork NE, 2009, LIVING DYNAMIC TROPI, P4; Storlie CJ, 2013, DIVERS DISTRIB, V19, P1; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas CD, 2010, DIVERS DISTRIB, V16, P488, DOI 10.1111/j.1472-4642.2010.00642.x; VanDerWal J, 2009, J BIOGEOGR, V36, P291, DOI 10.1111/j.1365-2699.2008.01993.x; VanDerWal J, 2013, NAT CLIM CHANGE, V3, P239, DOI [10.1038/nclimate1688, 10.1038/NCLIMATE1688]; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Williams S.E., 2009, LIVING DYNAMIC TROPI, P133; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; Williams SE, 2001, BIOL CONSERV, V98, P1, DOI 10.1016/S0006-3207(99)00093-2; Williams SE, 1997, WILDLIFE RES, V24, P513, DOI 10.1071/WR96040; Williams SE, 1997, P ROY SOC B-BIOL SCI, V264, P709, DOI 10.1098/rspb.1997.0101; Williams SE, 2008, LIVING DYNAMIC TROPI, P282; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Wilson E.O., 1988, P3; Wilson RD, 2010, THESIS J COOK U TOWN; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Yeates DK, 2002, INVERTEBR SYST, V16, P605, DOI 10.1071/IT01032	74	18	18	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88635	10.1371/journal.pone.0088635	http://dx.doi.org/10.1371/journal.pone.0088635			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586362	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000331714700023
J	Babel, M; McGuire, G; King, J				Babel, Molly; McGuire, Grant; King, Joseph			Towards a More Nuanced View of Vocal Attractiveness	PLOS ONE			English	Article							VOICE PITCH; MENSTRUAL-CYCLE; FUNDAMENTAL-FREQUENCY; FORMANT FREQUENCIES; ACOUSTIC CUES; SPEAKER SIZE; BODY-SIZE; SPEECH; FEMALE; SEX	This study reports on male and female Californians' ratings of vocal attractiveness for 30 male and 30 female voices reading isolated words. While ratings by both sexes were highly correlated, males generally rated fellow males as less attractive than females did, but both females and males had similar ratings of female voices. Detailed acoustic analyses of multiple parameters followed by principal component analyses on vowel and voice quality measures were conducted. Relevant principal components, along with additional independent acoustic measures, were entered into regression models to assess which acoustic properties predict attractiveness ratings. These models suggest that a constellation of acoustic features which indicate apparent talker size and conformity to community speech norms contribute to perceived vocal attractiveness. These results suggest that judgments of vocal attractiveness are more complex than previously described.	[Babel, Molly] Univ British Columbia, Dept Linguist, Vancouver, BC V5Z 1M9, Canada; [McGuire, Grant; King, Joseph] Univ Calif Santa Cruz, Dept Linguist, Santa Cruz, CA 95064 USA	University of British Columbia; University of California System; University of California Santa Cruz	Babel, M (corresponding author), Univ British Columbia, Dept Linguist, Vancouver, BC V5Z 1M9, Canada.	molly.babel@ubc.ca; gmcguir1@ucsc.edu; josephking9@gmail.com			University of British Columbia; University of California at Santa Cruz	University of British Columbia; University of California at Santa Cruz	This work was supported by funds from the University of British Columbia and the University of California at Santa Cruz. The funders had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	Aiello A, 2010, THESIS U CALIFORNIA; Apicella CL, 2007, BIOL LETTERS, V3, P682, DOI 10.1098/rsbl.2007.0410; APPLE W, 1979, J PERS SOC PSYCHOL, V37, P715, DOI 10.1037/0022-3514.37.5.715; Babel M., 2009, THESIS U CALIFORNIA; Babel M, 2012, J PHONETICS, V40, P177, DOI 10.1016/j.wocn.2011.09.001; Bradlow AR, 1996, SPEECH COMMUN, V20, P255, DOI 10.1016/S0167-6393(96)00063-5; Bruckert L, 2010, CURR BIOL, V20, P116, DOI 10.1016/j.cub.2009.11.034; BYRD D, 1994, SPEECH COMMUN, V15, P39, DOI 10.1016/0167-6393(94)90039-6; CHAIKEN S, 1979, J PERS SOC PSYCHOL, V37, P1387, DOI 10.1037/0022-3514.37.8.1387; Collins SA, 2003, ANIM BEHAV, V65, P997, DOI 10.1006/anbe.2003.2123; Danoff B, 1976, AFTERNOON DELIGHT; DION K, 1972, J PERS SOC PSYCHOL, V24, P285, DOI 10.1037/h0033731; Eckert P, 2008, INT J BILINGUAL, V12, P25, DOI 10.1177/13670069080120010301; Fant G, 1971, 2 ACOUSTIC THEORY SP; Feinberg DR, 2008, PERCEPTION, V37, P615, DOI 10.1068/p5514; Feinberg DR, 2006, HORM BEHAV, V49, P215, DOI 10.1016/j.yhbeh.2005.07.004; Fitch WT, 1999, J ACOUST SOC AM, V106, P1511, DOI 10.1121/1.427148; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Gonzalez J, 2004, J PHONETICS, V32, P277, DOI 10.1016/S0095-4470(03)00049-4; Gordon M, 2001, J PHONETICS, V29, P383, DOI 10.1006/jpho.2001.0147; Grammer K, 2003, BIOL REV, V78, P385, DOI 10.1017/S1464793102006085; Hagiwara R, 1997, J ACOUST SOC AM, V102, P655, DOI 10.1121/1.419712; Hall-Lew L, 2011, P INT C PHON SCI, V17, P807; HENTON CG, 1985, LANG COMMUN, V5, P221, DOI 10.1016/0271-5309(85)90012-6; Hodges-Simeon CR, 2010, HUM NATURE-INT BIOS, V21, P406, DOI 10.1007/s12110-010-9101-5; Hughes SM, 2002, EVOL HUM BEHAV, V23, P173, DOI 10.1016/S1090-5138(01)00099-X; Hughes SM, 2008, J NONVERBAL BEHAV, V32, P93, DOI 10.1007/s10919-007-0042-6; Johnson K, 2006, J PHONETICS, V34, P485, DOI 10.1016/j.wocn.2005.08.004; Keating P.A., 2007, P 11 AUSTR INT C SPE; KLATT DH, 1990, J ACOUST SOC AM, V87, P820, DOI 10.1121/1.398894; LANGLOIS JH, 1990, PSYCHOL SCI, V1, P115, DOI 10.1111/j.1467-9280.1990.tb00079.x; LASS NJ, 1976, J ACOUST SOC AM, V59, P675, DOI 10.1121/1.380917; Laver J, 1968, INT J LANG COMM DIS, V3, P43; Ni Chasaide Ailbhe, 1997, HDB PHONETIC SCI, P427; OHALA JJ, 1984, PHONETICA, V41, P1, DOI 10.1159/000261706; Ohala John J., 1983, PRODUCTION SPEECH, P189, DOI DOI 10.1007/978-1-4613-8202-7_9; Ohara Y., 1992, LOCATING POWER, V2, P468; Pipitone RN, 2008, EVOL HUM BEHAV, V29, P268, DOI 10.1016/j.evolhumbehav.2008.02.001; Pisanski K, 2011, J ACOUST SOC AM, V129, P2201, DOI 10.1121/1.3552866; PTACEK PH, 1966, J SPEECH HEAR RES, V9, P273, DOI 10.1044/jshr.0902.273; Puts DA, 2005, EVOL HUM BEHAV, V26, P388, DOI 10.1016/j.evolhumbehav.2005.03.001; Puts DA, 2013, HORM BEHAV, V63, P13, DOI 10.1016/j.yhbeh.2012.11.007; Puts DA, 2012, P ROY SOC B-BIOL SCI, V279, P601, DOI 10.1098/rspb.2011.0829; Puts DA, 2007, EVOL HUM BEHAV, V28, P340, DOI 10.1016/j.evolhumbehav.2007.05.002; Puts DA, 2006, EVOL HUM BEHAV, V27, P283, DOI 10.1016/j.evolhumbehav.2005.11.003; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Rendall D, 2007, J EXP PSYCHOL HUMAN, V33, P1208, DOI 10.1037/0096-1523.33.5.1208; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Riding D, 2006, J NONVERBAL BEHAV, V30, P55, DOI 10.1007/s10919-006-0005-3; Saxton TK, 2006, ETHOLOGY, V112, P1179, DOI 10.1111/j.1439-0310.2006.01278.x; Scherer KR, 2001, J CROSS CULT PSYCHOL, V32, P76, DOI 10.1177/0022022101032001009; Simpson AP, 2009, LANG LINGUIST COMPAS, V3, P621, DOI 10.1111/j.1749-818x.2009.00125.x; Simpson AP, 2002, J PHONETICS, V30, P417, DOI 10.1006/jpho.2002.0171; Simpson AP, 2001, J ACOUST SOC AM, V109, P2153, DOI 10.1121/1.1356020; TITZE IR, 1989, J ACOUST SOC AM, V85, P1699, DOI 10.1121/1.397959; TUOMI SK, 1979, FOLIA PHONIATR, V31, P242, DOI 10.1159/000264171; Van Borsel J, 2009, J VOICE, V23, P291, DOI 10.1016/j.jvoice.2007.08.002; vanBezooijen R, 1995, LANG SPEECH, V38, P253, DOI 10.1177/002383099503800303; vanDommelen WA, 1995, LANG SPEECH, V38, P267, DOI 10.1177/002383099503800304; Wadnerkar MB, 2006, NEUROSCI LETT, V408, P21, DOI 10.1016/j.neulet.2006.07.032; WALTON JH, 1994, J SPEECH HEAR RES, V37, P738, DOI 10.1044/jshr.3704.738; Whiteside SR, 2004, NEUROSCI LETT, V367, P44, DOI 10.1016/j.neulet.2004.05.076; YUMOTO E, 1982, J ACOUST SOC AM, V71, P1544, DOI 10.1121/1.387808; ZUCKERMAN M, 1993, J NONVERBAL BEHAV, V17, P119, DOI 10.1007/BF01001960; ZUCKERMAN M, 1989, J NONVERBAL BEHAV, V13, P67	65	49	51	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88616	10.1371/journal.pone.0088616	http://dx.doi.org/10.1371/journal.pone.0088616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3TA	24586358	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900034
J	Buon, M; Jacob, P; Margules, S; Brunet, I; Dutat, M; Cabrol, D; Dupoux, E				Buon, Marine; Jacob, Pierre; Margules, Sylvie; Brunet, Isabelle; Dutat, Michel; Cabrol, Dominique; Dupoux, Emmanuel			Friend or Foe? Early Social Evaluation of Human Interactions	PLOS ONE			English	Article							GOAL-DIRECTED ACTIONS; MORAL JUDGMENT; PREVERBAL INFANTS; NEGATIVITY BIAS; YOUNG-CHILDREN; CHIMPANZEES; PERCEPTION; PSYCHOLOGY; INTENTION; CAUSALITY	We report evidence that 29-month-old toddlers and 10-month-old preverbal infants discriminate between two agents: a pro-social agent, who performs a positive (comforting) action on a human patient and a negative (harmful) action on an inanimate object, and an anti-social agent, who does the converse. The evidence shows that they prefer the former to the latter even though the agents perform the same bodily movements. Given that humans can cause physical harm to their conspecifics, we discuss this finding in light of the likely adaptive value of the ability to detect harmful human agents.	[Buon, Marine; Margules, Sylvie; Brunet, Isabelle; Dutat, Michel; Dupoux, Emmanuel] Ecole Normale Super, CNRS, Ecole Hautes Etud Sci Sociales, Lab Sci Cognit & Psycholinguist,Dept Etud Cognit, Paris, France; [Cabrol, Dominique] Univ Paris 05, Maternite Port Royal, AP HP, Fac Med Port Royal Cochin, Paris, France; [Jacob, Pierre] Ecole Normale Super, CNRS, Ecole Hautes Etud Sci Sociales, Inst Jean Nicod,Dept Etud Cognit, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Buon, M (corresponding author), Ecole Normale Super, CNRS, Ecole Hautes Etud Sci Sociales, Lab Sci Cognit & Psycholinguist,Dept Etud Cognit, Paris, France.	marinebuon@gmail.com		Dupoux, Emmanuel/0000-0002-7814-2952	French Ministry of Research (Cognitique program); EU FP6 (Neurocom); Agence Nationale de la Recherche [ANR-09-BLAN-0327 SOCODEV]; Region IIe-de-France	French Ministry of Research (Cognitique program); EU FP6 (Neurocom); Agence Nationale de la Recherche(French National Research Agency (ANR)); Region IIe-de-France(Region Ile-de-France)	This work was supported by grants from the French Ministry of Research (Cognitique program), the EU FP6 (Neurocom), the Agence Nationale de la Recherche (ANR-09-BLAN-0327 SOCODEV) and grants from Region IIe-de-France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alicke MD, 2000, PSYCHOL BULL, V126, P556, DOI 10.1037//0033-2909.126.4.556; Behne T, 2005, DEV PSYCHOL, V41, P328, DOI 10.1037/0012-1649.41.2.328; Brandone AC, 2009, PSYCHOL SCI, V20, P85, DOI 10.1111/j.1467-9280.2008.02246.x; Buon M, 2013, COGNITION, V126, P149, DOI 10.1016/j.cognition.2012.09.006; Cacioppo JT, 1999, ANNU REV PSYCHOL, V50, P191, DOI 10.1146/annurev.psych.50.1.191; COSMIDES L, 1989, COGNITION, V31, P187, DOI 10.1016/0010-0277(89)90023-1; Cushman F, 2008, COGNITION, V108, P353, DOI 10.1016/j.cognition.2008.03.006; D'Entremont B, 1999, INFANT BEHAV DEV, V22, P527, DOI 10.1016/S0163-6383(00)00021-7; Decety J, 2012, CEREB CORTEX, V22, P209, DOI 10.1093/cercor/bhr111; Geraci A, 2011, DEVELOPMENTAL SCI, V14, P1012, DOI 10.1111/j.1467-7687.2011.01048.x; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Hamlin JK, 2013, COGNITION, V128, P451, DOI 10.1016/j.cognition.2013.04.004; Hamlin JK, 2011, COGNITIVE DEV, V26, P30, DOI 10.1016/j.cogdev.2010.09.001; Hamlin JK, 2010, DEVELOPMENTAL SCI, V13, P923, DOI 10.1111/j.1467-7687.2010.00951.x; HEBBLE PW, 1971, CHILD DEV, V42, P1203, DOI 10.2307/1127804; Keeley L.H., 1996, WAR CIVILIZATION MYT; Kinzler KD, 2007, P NATL ACAD SCI USA, V104, P12577, DOI 10.1073/pnas.0705345104; Leslie AM, 2006, SOC NEUROSCI-UK, V1, P270, DOI 10.1080/17470910600992197; LESLIE AM, 1982, PERCEPTION, V11, P173, DOI 10.1068/p110173; LESLIE AM, 1987, COGNITION, V25, P265, DOI 10.1016/S0010-0277(87)80006-9; Mikhail J, 2007, TRENDS COGN SCI, V11, P143, DOI 10.1016/j.tics.2006.12.007; Mumme DL, 2003, CHILD DEV, V74, P221, DOI 10.1111/1467-8624.00532; NELSON SA, 1980, CHILD DEV, V51, P823, DOI 10.1111/j.1467-8624.1980.tb02619.x; NELSONLEGALL SA, 1985, DEV PSYCHOL, V21, P332, DOI 10.1037/0012-1649.21.2.332; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; Piaget J, 1997, MORAL JUDGMENT CHILD; Premack D, 1997, J COGNITIVE NEUROSCI, V9, P848, DOI 10.1162/jocn.1997.9.6.848; Schmidt MFH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023223; Sloane S, 2012, PSYCHOL SCI, V23, P196, DOI 10.1177/0956797611422072; SMETANA JG, 1981, CHILD DEV, V52, P1333, DOI 10.2307/1129527; Vaish A, 2008, PSYCHOL BULL, V134, P383, DOI 10.1037/0033-2909.134.3.383; Vaish A, 2010, CHILD DEV, V81, P1661, DOI 10.1111/j.1467-8624.2010.01500.x; Vaish A, 2009, DEV PSYCHOL, V45, P534, DOI 10.1037/a0014322; WalkerAndrews AS, 1997, PSYCHOL BULL, V121, P437, DOI 10.1037/0033-2909.121.3.437; Walle EA, 2012, EMOT REV, V4, P413, DOI 10.1177/1754073912445812; Warneken F, 2006, CHILD DEV, V77, P640, DOI 10.1111/j.1467-8624.2006.00895.x; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Warneken F, 2007, PLOS BIOL, V5, P1414, DOI 10.1371/journal.pbio.0050184; Warneken F, 2007, INFANCY, V11, P271, DOI 10.1111/j.1532-7078.2007.tb00227.x; Warneken F, 2009, TRENDS COGN SCI, V13, P397, DOI 10.1016/j.tics.2009.06.008; Weisberg DS, 2012, REV PHILOS PSYCHOL, DOI [10.1007/s13164-012-0101-8. 19., DOI 10.1007/S13164-012-0101-8.19]; Zelazo PD, 1996, CHILD DEV, V67, P2478, DOI 10.2307/1131635	43	46	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88612	10.1371/journal.pone.0088612	http://dx.doi.org/10.1371/journal.pone.0088612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3TA	24586355	Green Submitted, Green Published, gold			2022-12-27	WOS:000331711900032
J	Haye, PA; Segovia, NI; Munoz-Herrera, NC; Galvez, FE; Martinez, A; Meynard, A; Pardo-Gandarillas, MC; Poulin, E; Faugeron, S				Haye, Pilar A.; Segovia, Nicolas I.; Munoz-Herrera, Natalia C.; Galvez, Francisca E.; Martinez, Andrea; Meynard, Andres; Pardo-Gandarillas, Maria C.; Poulin, Elie; Faugeron, Sylvain			Phylogeographic Structure in Benthic Marine Invertebrates of the Southeast Pacific Coast of Chile with Differing Dispersal Potential	PLOS ONE			English	Article							ALGA MAZZAELLA-LAMINARIOIDES; PELAGIC LARVAL DURATION; HUMBOLDT CURRENT SYSTEM; OXIDASE SUBUNIT-I; GENE FLOW; SEA-STAR; NONSYNONYMOUS SUBSTITUTIONS; PROPAGULE DISPERSAL; MOLECULAR PHYLOGENY; EASTERN PACIFIC	The role of dispersal potential on phylogeographic structure, evidenced by the degree of genetic structure and the presence of coincident genetic and biogeographic breaks, was evaluated in a macrogeographic comparative approach along the north-central coast of Chile, across the biogeographic transition zone at 30 degrees S. Using 2,217 partial sequences of the mitochondrial Cytochrome Oxidase I gene of eight benthic invertebrate species along ca. 2,600 km of coast, we contrasted dispersal potential with genetic structure and determined the concordance between genetic divergence between biogeographic regions and the biogeographic transition zone at 30 degrees S. Genetic diversity and differentiation highly differed between species with high and low dispersal potential. Dispersal potential, sometimes together with biogeographic region, was the factor that best explained the genetic structure of the eight species. The three low dispersal species, and one species assigned to the high dispersal category, had a phylogeographic discontinuity coincident with the biogeographic transition zone at 30 degrees S. Furthermore, coalescent analyses based on the isolation-with-migration model validate that the split between biogeographic regions north and south of 30 degrees S has a historic origin. The signatures of the historic break in high dispersers is parsimoniously explained by the homogenizing effects of gene flow that have erased the genetic signatures, if ever existed, in high dispersers. Of the four species with structure across the break, only two had significant albeit very low levels of asymmetric migration across the transition zone. Historic processes have led to the current biogeographic and phylogeographic structure of marine species with limited dispersal along the north-central coast of Chile, with a strong lasting impact in their genetic structure.	[Haye, Pilar A.; Segovia, Nicolas I.; Munoz-Herrera, Natalia C.; Galvez, Francisca E.] Univ Catolica Norte, Fac Ciencias Mar, Dept Biol Marina, Lab Diversidad Mol, Coquimbo, Chile; [Haye, Pilar A.; Segovia, Nicolas I.; Munoz-Herrera, Natalia C.; Galvez, Francisca E.] Ctr Estudios Avanzados Zonas Aridas CEAZA, Coquimbo, Chile; [Haye, Pilar A.; Munoz-Herrera, Natalia C.] Univ Concepcion, Interdisciplinary Ctr Aquaculture Res INCAR, Concepcion, Chile; [Segovia, Nicolas I.; Martinez, Andrea; Pardo-Gandarillas, Maria C.; Poulin, Elie] Univ Chile, Inst Ecol & Biodiversidad, Dept Ciencias Ecol, Santiago, Chile; [Meynard, Andres; Pardo-Gandarillas, Maria C.; Faugeron, Sylvain] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Conservac Marina, Santiago, Chile	Universidad Catolica del Norte; Universidad de Concepcion; Universidad de Chile; Pontificia Universidad Catolica de Chile	Haye, PA (corresponding author), Univ Catolica Norte, Fac Ciencias Mar, Dept Biol Marina, Lab Diversidad Mol, Coquimbo, Chile.	phaye@ucn.cl	Poulin, Elie/C-2654-2012; Haye, Pilar A/B-7082-2015; Pardo-Gandarillas, Maria/L-3790-2017	Poulin, Elie/0000-0001-7736-0969; Haye, Pilar A/0000-0002-1093-9076; Pardo-Gandarillas, Maria/0000-0003-2626-8243; Martinez Salinas, Andrea Paz/0000-0002-4555-4096; Faugeron, Sylvain/0000-0001-7258-5229	Chilean National Fund of Science and Technology FONDECYT [Fondecyt 1090670]; Iniciativa Cientifica Mileno [ICM P05-002, PFB-23, ICM P10-033F]; INCAR [FONDAP 15110027]	Chilean National Fund of Science and Technology FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Iniciativa Cientifica Mileno; INCAR	This research was mainly funded by the Chilean National Fund of Science and Technology FONDECYT (grant Fondecyt 1090670 to PH and SF). Partial funding was provided by Iniciativa Cientifica Mileno (ICM P05-002 and PFB-23 to A. Martinez and EP; ICM P10-033F to A. Meynard and SF) and INCAR (grant FONDAP 15110027 to PH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayre DJ, 2009, MOL ECOL, V18, P1887, DOI 10.1111/j.1365-294X.2009.04127.x; BARKER MF, 1983, J MAR BIOL ASSOC UK, V63, P745, DOI 10.1017/S0025315400071198; BARKER MF, 1977, J EXP MAR BIOL ECOL, V30, P95, DOI 10.1016/0022-0981(77)90030-2; BARKER MF, 1978, BIOL BULL-US, V154, P32, DOI 10.2307/1540772; Bird CE, 2007, MOL ECOL, V16, P3173, DOI 10.1111/j.1365-294X.2007.03385.x; BIRKELAND C, 1971, BIOL BULL-US, V141, P99, DOI 10.2307/1539994; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Bradbury IR, 2008, P ROY SOC B-BIOL SCI, V275, P1803, DOI 10.1098/rspb.2008.0216; Brante A, 2012, J HERED, V103, P630, DOI 10.1093/jhered/ess030; Briones C, 2013, MAR BIOL, V160, P3143, DOI 10.1007/s00227-013-2301-x; BYRNE M, 1995, BIOL BULL, V188, P293, DOI 10.2307/1542306; Camus PA, 2001, REV CHIL HIST NAT, V74, P587, DOI 10.4067/S0716-078X2001000300008; Cardenas L, 2009, J BIOGEOGR, V36, P969, DOI 10.1111/j.1365-2699.2008.02056.x; CARLTON JT, 1993, SCIENCE, V261, P78, DOI 10.1126/science.261.5117.78; CARLTON JT, 1995, MAR BIOL, V121, P721, DOI 10.1007/BF00349308; CHIA FS, 1966, BIOL BULL, V130, P304, DOI 10.2307/1539738; Daneri G, 2000, MAR ECOL PROG SER, V197, P41, DOI 10.3354/meps197041; Dawson MN, 2014, J BIOGEOGR, V41, P52, DOI 10.1111/jbi.12190; Dawson MN, 2011, J BIOGEOGR, V38, P1600, DOI 10.1111/j.1365-2699.2011.02499.x; Dawson MN, 2001, J BIOGEOGR, V28, P723, DOI 10.1046/j.1365-2699.2001.00572.x; Dawson MN, 2005, J BIOGEOGR, V32, P515, DOI 10.1111/j.1365-2699.2004.01193.x; Drummond AJ., 2011, GENEIOUS PRO 5 4; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Faugeron S, 2001, J PHYCOL, V37, P705, DOI 10.1046/j.1529-8817.2001.01072.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foltz DW, 2010, EVOL DEV, V12, P222, DOI 10.1111/j.1525-142X.2010.00406.x; Foltz DW, 2004, GENETICA, V122, P115, DOI 10.1023/B:GENE.0000041002.97173.1e; Foltz DW, 2003, J MOL EVOL, V57, P607, DOI 10.1007/s00239-003-2495-5; Fuentes I, 2000, INVERTEBR REPROD DEV, V37, P201, DOI 10.1080/07924259.2000.9652420; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; GEYER CJ, 1991, COMPUTING SCIENCE AND STATISTICS, P156; Goldstien SJ, 2006, MOL ECOL, V15, P3259, DOI 10.1111/j.1365-294X.2006.02977.x; GORE RH, 1971, BIOL BULL, V141, P485, DOI 10.2307/1540263; Grantham BA, 2003, ECOL APPL, V13, pS108; GRANTHAM TA, 1995, ANNU REV ECOL SYST, V26, P301; HANSEN TA, 1983, SCIENCE, V220, P501, DOI 10.1126/science.220.4596.501; HANSEN TA, 1978, SCIENCE, V199, P885, DOI 10.1126/science.199.4331.885; Haye PA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-252; Haye PA, 2012, MAR ECOL PROG SER, V455, P111, DOI 10.3354/meps09673; Haye PA, 2010, EVOL DEV, V12, P628, DOI 10.1111/j.1525-142X.2010.00447.x; Hellberg ME, 2002, B MAR SCI, V70, P273; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Hoareau TB, 2010, MOL ECOL RESOUR, V10, P960, DOI 10.1111/j.1755-0998.2010.02848.x; Hudson RR, 2000, GENETICS, V155, P2011; Ibanez CM, 2011, MAR ECOL PROG SER, V431, P163, DOI 10.3354/meps09133; Irwin DE, 2002, EVOLUTION, V56, P2383; JABLONSKI D, 1986, B MAR SCI, V39, P565; JABLONSKI D, 1983, BIOL REV, V58, P21, DOI 10.1111/j.1469-185X.1983.tb00380.x; JANSON K, 1987, BIOL J LINN SOC, V30, P245, DOI 10.1111/j.1095-8312.1987.tb00299.x; JOHNSON CR, 1994, MAR BIOL, V120, P305, DOI 10.1007/BF00349692; Johnson MW, 1939, J MAR RES, V2, P236; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Kitazawa C, 2001, ECHINODERMS 2000, P177; Kolbin KG, 2011, RUSS J MAR BIOL+, V37, P239, DOI 10.1134/S1063074011030072; Komatsu M, 2006, ZOOL SCI, V23, P699, DOI 10.2108/zsj.23.699; Kritzer J.P., 2006, MARINE METAPOPULATIO; Kulikova VA, 2000, RUSS J MAR BIOL, V26; Kuo CH, 2005, GENETICA, V124, P179, DOI 10.1007/s10709-005-2095-y; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lomolino M.V., 2010, BIOGEOGRAPHY, Vfourth; Mah C, 2011, ZOOL J LINN SOC-LOND, V162, P646, DOI 10.1111/j.1096-3642.2010.00688.x; Marko PB, 2012, EVOL ECOL, V26, P291, DOI 10.1007/s10682-011-9467-9; Marko PB, 2011, TRENDS ECOL EVOL, V26, P448, DOI 10.1016/j.tree.2011.05.007; Martin P, 2012, PHYCOL RES, V60, P276, DOI 10.1111/j.1440-1835.2012.00658.x; MCEDWARD LR, 1992, BIOL BULL, V182, P177, DOI 10.2307/1542111; McGovern TM, 2010, MOL ECOL, V19, P5043, DOI 10.1111/j.1365-294X.2010.04854.x; Montecinos A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-97; Nielsen R, 2001, GENETICS, V158, P885; Page LR, 2002, BIOL BULL, V202, P6, DOI 10.2307/1543218; Paik Sang-Gyu, 2005, Ocean Science Journal, V40, P65; Palumbi Stephen R., 1991, Molecular Marine Biology and Biotechnology, V1, P27; Pearse JS, 2009, SMITHSONIAN AT THE POLES: CONTRIBUTIONS TO INTERNATIONAL POLAR YEAR SCIENCE, P181, DOI 10.5479/si.097884601X.13; Pelc RA, 2009, J BIOGEOGR, V36, P1881, DOI 10.1111/j.1365-2699.2009.02138.x; Plouviez S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-220; R Development Core Team, 2011, R LANG ENV STAT COMP; Riginos C, 2011, ECOGRAPHY, V34, P566, DOI 10.1111/j.1600-0587.2010.06511.x; Ross PM, 2009, NEW ZEAL J MAR FRESH, V43, P1009, DOI 10.1080/00288330.2009.9626525; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanchez R, 2011, MAR ECOL PROG SER, V434, P121, DOI 10.3354/meps09184; SASAKI R, 1985, AQUACULTURE, V32, P199; Selkoe KA, 2011, MAR ECOL PROG SER, V436, P291, DOI 10.3354/meps09238; Shanks AL, 2003, ECOL APPL, V13, pS159; Shanks AL, 2009, BIOL BULL-US, V216, P373; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; SLATKIN M, 1995, GENETICS, V139, P457; Strathmann MF, 1897, REPROD DEV MARINE IN; Tellier F, 2011, J PHYCOL, V47, P894, DOI 10.1111/j.1529-8817.2011.01019.x; Tellier F, 2009, MOL PHYLOGENET EVOL, V53, P679, DOI 10.1016/j.ympev.2009.07.030; Teske PR, 2011, MOL ECOL, V20, P5025, DOI 10.1111/j.1365-294X.2011.05307.x; Thiel M, 2007, OCEANOGR MAR BIOL, V45, P195; Vickery MS, 2000, BIOL BULL, V199, P298, DOI 10.2307/1543186; Wares JP, 2001, EVOLUTION, V55, P295; Waters JM, 2005, MOL ECOL, V14, P2789, DOI 10.1111/j.1365-294X.2005.02635.x; Waters JM, 2004, MOL ECOL, V13, P2797, DOI 10.1111/j.1365-294X.2004.02282.x; Waters JM, 2008, DIVERS DISTRIB, V14, P692, DOI 10.1111/j.1472-4642.2008.00481.x; Waters JM, 2007, J BIOGEOGR, V34, P678, DOI 10.1111/j.1365-2699.2006.01615.x; Watts PC, 1998, PHILOS T R SOC B, V353, P453, DOI 10.1098/rstb.1998.0222; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; Wehrtmann IS, 1997, CRUSTACEANA, V70, P562, DOI 10.1163/156854097X00681; Werding B, 2001, HYDROBIOLOGIA, V449, P105, DOI 10.1023/A:1017545120296; Young CM, 1997, BIODIVERS CONSERV, V6, P1507, DOI 10.1023/A:1018314403123; Zakas C, 2009, MAR ECOL PROG SER, V394, P165, DOI 10.3354/meps08265	107	112	114	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88613	10.1371/journal.pone.0088613	http://dx.doi.org/10.1371/journal.pone.0088613			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586356	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900033
J	Ning, LL; Guo, JJ; Bai, QF; Jin, NZ; Liu, HX; Yao, XJ				Ning, Lulu; Guo, Jingjing; Bai, Qifeng; Jin, Nengzhi; Liu, Huanxiang; Yao, Xiaojun			Structural Diversity and Initial Oligomerization of PrP106-126 Studied by Replica-Exchange and Conventional Molecular Dynamics Simulations	PLOS ONE			English	Article							PRION PROTEIN-FRAGMENT; SECONDARY STRUCTURE; NMR STRUCTURE; CONFORMATIONAL POLYMORPHISM; PEPTIDE OLIGOMERIZATION; AMYLOID OLIGOMERS; ENERGY LANDSCAPE; AQUEOUS-SOLUTION; BETA-OLIGOMERS; SCRAPIE PRION	Prion diseases are marked by cerebral accumulation of the abnormal isoform of the prion protein. A fragment of prion protein composed of residues 106-126 (PrP106-126) exhibits similar properties to full length prion and plays a key role in the conformational conversion from cellular prion to its pathogenic pattern. Soluble oligomers of PrP106-126 have been proposed to be responsible for neurotoxicity. However, the monomeric conformational space and initial oligomerization of PrP106-126 are still obscure, which are very important for understanding the conformational conversion of PrP106-126. In this study, replica exchange molecular dynamics simulations were performed to investigate monomeric and dimeric states of PrP106-126 in implicit solvent. The structural diversity of PrP106-126 was observed and this peptide did not acquire stable structure. The dimeric PrP106-126 also displayed structural diversity and hydrophobic interaction drove the dimerization. To further study initial oligomerization of PrP106-126, 1 mu s conventional molecular dynamics simulations of trimer and tetramer formation were carried out in implicit solvent. We have observed the spontaneous formation of several basic oligomers and stable oligomers with high beta-sheet contents were sampled in the simulations of trimer and tetramer formation. The beta-hairpin formed in hydrophobic tail of PrP106-126 with residues 118-120 in turn may stabilize these oligomers and seed the formation oligomers. This study can provide insight into the detailed information about the structure of PrP106-126 and the dynamics of aggregation of monomeric PrP106-126 into oligomers in atomic level.	[Ning, Lulu; Guo, Jingjing; Bai, Qifeng; Liu, Huanxiang; Yao, Xiaojun] Lanzhou Univ, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China; [Ning, Lulu; Guo, Jingjing; Bai, Qifeng; Liu, Huanxiang; Yao, Xiaojun] Lanzhou Univ, Dept Chem, Lanzhou 730000, Peoples R China; [Jin, Nengzhi] Gansu Comp Ctr, Lanzhou, Peoples R China; [Guo, Jingjing; Liu, Huanxiang] Lanzhou Univ, Sch Pharm, Lanzhou 730000, Peoples R China; [Yao, Xiaojun] Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Taipa, Macau, Peoples R China	Lanzhou University; Lanzhou University; Lanzhou University; Macau University of Science & Technology	Liu, HX (corresponding author), Lanzhou Univ, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China.	hxliu@lzu.edu.cn; xjyao@lzu.edu.cn	Guo, Jingjing/GZL-0645-2022; Bai, Qifeng/A-2950-2019	Guo, Jingjing/0000-0002-4632-4364; Bai, Qifeng/0000-0001-7296-6187; Liu, Huanxiang/0000-0002-9284-3667	National Natural Science Foundation of China [21103075, 20905033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant Nos: 21103075 and 20905033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Alonso DOV, 2001, P NATL ACAD SCI USA, V98, P2985, DOI 10.1073/pnas.061555898; [Anonymous], 2008, AMBER 10; Baumketner A, 2007, J MOL BIOL, V366, P275, DOI 10.1016/j.jmb.2006.11.015; Beauchamp KA, 2012, J CHEM THEORY COMPUT, V8, P1409, DOI 10.1021/ct2007814; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Brown DR, 1996, NATURE, V380, P345, DOI 10.1038/380345a0; BROWN DR, 1994, NEUROREPORT, V5, P2057, DOI 10.1097/00001756-199410270-00017; Brown DR, 2000, MOL CELL NEUROSCI, V15, P66, DOI 10.1006/mcne.1999.0796; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Chebaro Y, 2009, J PHYS CHEM B, V113, P6942, DOI 10.1021/jp900334s; Cheon M, 2007, PLOS COMPUT BIOL, V3, P1727, DOI 10.1371/journal.pcbi.0030173; Chiesa R, 2001, NEUROBIOL DIS, V8, P743, DOI 10.1006/nbdi.2001.0433; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Cote S, 2012, J PHYS CHEM B, V116, P4043, DOI 10.1021/jp2126366; Daidone I, 2011, BIOPHYS J, V100, P3000, DOI 10.1016/j.bpj.2011.04.053; DEGIOIA L, 1994, J BIOL CHEM, V269, P7859; Derreumaux P, 2001, BIOPHYS J, V81, P1657, DOI 10.1016/S0006-3495(01)75819-5; Di Natale G, 2005, ORG BIOMOL CHEM, V3, P490, DOI 10.1039/b407928k; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Florio T, 1998, J NEUROSCI RES, V54, P341, DOI 10.1002/(SICI)1097-4547(19981101)54:3<341::AID-JNR5>3.0.CO;2-G; Fogolari F, 2007, BIOPHYS J, V92, P1673, DOI 10.1529/biophysj.106.098483; FORLONI G, 1994, EUR J NEUROSCI, V6, P1415, DOI 10.1111/j.1460-9568.1994.tb01003.x; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; Freddolino PL, 2009, BIOPHYS J, V96, P3772, DOI 10.1016/j.bpj.2009.02.033; Frishman D, 2004, PROTEIN-STRUCT FUNCT, V23, P566; Garcia FL, 2000, P NATL ACAD SCI USA, V97, P8334, DOI 10.1073/pnas.97.15.8334; Grabenauer M, 2010, J AM CHEM SOC, V132, P532, DOI 10.1021/ja905595k; Higo J, 2001, PROTEIN SCI, V10, P1160, DOI 10.1110/ps.44901; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huet A, 2006, BIOPHYS J, V91, P3829, DOI 10.1529/biophysj.106.090993; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jobling MF, 1999, J NEUROCHEM, V73, P1557, DOI 10.1046/j.1471-4159.1999.0731557.x; Jobling MF, 2001, BIOCHEMISTRY-US, V40, P8073, DOI 10.1021/bi0029088; Kim S, 2010, BIOPHYS J, V99, P1949, DOI 10.1016/j.bpj.2010.07.008; Kourie JI, 2000, J NEUROSCI RES, V62, P120, DOI 10.1002/1097-4547(20001001)62:1<120::AID-JNR13>3.0.CO;2-2; Kuwata K, 2003, P NATL ACAD SCI USA, V100, P14790, DOI 10.1073/pnas.2433563100; Laghaei R, 2011, J PHYS CHEM B, V115, P3146, DOI 10.1021/jp108870q; Levy Y, 2001, PROTEINS, V45, P382, DOI 10.1002/prot.1157; Lin MX, 1997, J BIOL CHEM, V272, P44; Lu Y, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4732761; Lu Y, 2011, J PHYS CHEM B, V115, P1282, DOI 10.1021/jp110269a; Ma BY, 2002, P NATL ACAD SCI USA, V99, P14126, DOI 10.1073/pnas.212206899; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Melquiond A, 2006, PROTEINS, V65, P180, DOI 10.1002/prot.21100; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Muramoto T, 1996, P NATL ACAD SCI USA, V93, P15457, DOI 10.1073/pnas.93.26.15457; Nguyen PH, 2011, PHYS CHEM CHEM PHYS, V13, P9778, DOI 10.1039/c1cp20323a; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Patriksson A, 2008, PHYS CHEM CHEM PHYS, V10, P2073, DOI 10.1039/b716554d; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Ragg E, 1999, EUR J BIOCHEM, V266, P1192, DOI 10.1046/j.1432-1327.1999.00985.x; Riek R, 1998, P NATL ACAD SCI USA, V95, P11667, DOI 10.1073/pnas.95.20.11667; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Santini S, 2004, J AM CHEM SOC, V126, P11509, DOI 10.1021/ja047286i; Santini S, 2004, CELL MOL LIFE SCI, V61, P951, DOI 10.1007/s00018-003-3455-3; Santini S, 2003, PROTEINS, V51, P258, DOI 10.1002/prot.10348; SELVAGGINI C, 1993, BIOCHEM BIOPH RES CO, V194, P1380, DOI 10.1006/bbrc.1993.1977; Sondag CM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-1; Song W, 2008, J PHYS CHEM B, V112, P4410, DOI 10.1021/jp710592v; STAHL N, 1991, FASEB J, V5, P2799, DOI 10.1096/fasebj.5.13.1916104; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Tsai HH, 2005, P NATL ACAD SCI USA, V102, P8174, DOI 10.1073/pnas.0408653102; Urbanc B, 2004, BIOPHYS J, V87, P2310, DOI 10.1529/biophysj.104.040980; van der Kamp MW, 2011, TOP CURR CHEM, V305, P169, DOI 10.1007/128_2011_158; Villa A, 2006, J PHYS CHEM B, V110, P1423, DOI 10.1021/jp052722o; Walsh P, 2010, J AM CHEM SOC, V132, P7684, DOI 10.1021/ja100431q; Walsh P, 2009, BIOCHEMISTRY-US, V48, P5779, DOI 10.1021/bi9007319; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang L, 1999, PROTEIN SCI, V8, P1292, DOI 10.1110/ps.8.6.1292; Wang YL, 2011, INORG CHEM, V50, P4340, DOI 10.1021/ic102331x; Wu C, 2004, BIOPHYS J, V87, P3000, DOI 10.1529/biophysj.104.047076; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zhang ZQ, 2007, BIOPHYS J, V93, P1484, DOI 10.1529/biophysj.106.100537; Zhu XX, 2012, J PHYS CHEM B, V116, P4405, DOI 10.1021/jp210019h	81	12	12	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e87266	10.1371/journal.pone.0087266	http://dx.doi.org/10.1371/journal.pone.0087266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586266	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900009
J	Lesser, IA; Gasevic, D; Lear, SA				Lesser, Iris A.; Gasevic, Danijela; Lear, Scott A.			The Association between Acculturation and Dietary Patterns of South Asian Immigrants	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PHYSICAL-ACTIVITY; RISK-FACTORS; FOOD-HABITS; HEALTH; CHINESE; CONSUMPTION; PREVALENCE; MIGRATION; RESIDENCE	Dietary acculturation, specifically the adoption of western dietary habits, may result in adverse health effects such as obesity and type 2 diabetes. Therefore, it is necessary to explore the role of acculturation in dietary patterns as well as awareness and knowledge of healthy nutrition among South Asian immigrants. This is an especially important population to target as South Asians have higher prevalence rates of type 2 diabetes and cardiovascular disease, which may be magnified with immigration. The current investigation is a sub-study of the Multi-Cultural Community Health Assessment Trial (M-CHAT). There were 207 participants of South Asian origin included in the initial study, 129 were born outside of Canada and had immigrated after the age of 18. The length of residence in Canada was used as a marker for acculturation. A questionnaire addressing perceived changes in dietary patterns, food preparation, and nutrition knowledge and awareness since immigration was used to assess dietary practices. The association between length of residence and variables related to perceived changes in dietary patterns was explored with Spearman correlation and significant associations were subsequently analyzed with ordinal logistic regression analysis adjusted for age, sex, education and body mass index. South Asian immigrants in Canada reported a variety of positive dietary practices, including an increased consumption of fruits and vegetables and an improvement in food preparation (including an increase in grilling and a decrease in deep frying when cooking). However, there was a reported increase in the consumption of convenience foods, sugar-sweetened beverages, red meat and in dining out. South Asian immigrants in Canada reported a variety of positive dietary practices including an improvement in food preparation. Future health promotion strategies should encourage cultural sensitivity in efforts to reduce the consumption of sugar-sweetened beverage, convenience foods and to encourage eating at home rather than dining out.	[Lesser, Iris A.; Gasevic, Danijela; Lear, Scott A.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Vancouver, BC, Canada; [Lear, Scott A.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Lear, Scott A.] Providence Hlth Care, Div Cardiol, Vancouver, BC, Canada	Simon Fraser University; Simon Fraser University	Lear, SA (corresponding author), Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Vancouver, BC, Canada.	slear@providencehealth.bc.ca		Gasevic, Danijela/0000-0001-5976-4011	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Koning L, 2012, CIRCULATION, V125, P1735, DOI 10.1161/CIRCULATIONAHA.111.067017; El Hassan DA, 2012, CAN J DIET PRACT RES, V73, P143, DOI 10.3148/73.3.2012.143; Goel MS, 2004, JAMA-J AM MED ASSOC, V292, P2860, DOI 10.1001/jama.292.23.2860; Holmboe-Ottesen G, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.18891; Jasti S, 2011, AM J HEALTH BEHAV, V35, P734; Kandula NR, 2008, DIABETES CARE, V31, P1621, DOI 10.2337/dc07-2182; Ko GTC, 2007, ASIA PAC J CLIN NUTR, V16, P757; Koya DL, 2007, J GEN INTERN MED, V22, P841, DOI 10.1007/s11606-007-0163-y; Lassetter JH, 2009, J TRANSCULT NURS, V20, P93, DOI 10.1177/1043659608325841; Lauderdale DS, 2000, INT J OBESITY, V24, P1188, DOI 10.1038/sj.ijo.0801365; Lear SA, 2006, ETHNIC DIS, V16, P96; LEE MM, 1994, INT J EPIDEMIOL, V23, P984, DOI 10.1093/ije/23.5.984; MARMOT MG, 1975, AM J EPIDEMIOL, V102, P514, DOI 10.1093/oxfordjournals.aje.a112189; McDonald JT, 2004, SOC SCI MED, V59, P1613, DOI 10.1016/j.socscimed.2004.02.004; Mellin-Olsen T, 2005, ETHNIC HEALTH, V10, P311, DOI 10.1080/13557850500145238; National Asian Pacific American Community Development Data Center, 2005, S AS DEM AN; Pais P, 1996, LANCET, V348, P358, DOI 10.1016/S0140-6736(96)02507-X; Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287; Raj S, 1999, J AM DIET ASSOC, V99, P1106, DOI 10.1016/S0002-8223(99)00266-7; Regev-Tobias H, 2012, NUTRITION, V28, P30, DOI 10.1016/j.nut.2011.02.010; Rosenmoller DL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-42; Roville-Sausse FN, 2005, PUBLIC HEALTH, V119, P726, DOI 10.1016/j.puhe.2004.10.021; Statistics Canada, 2010, STUD PROJ DIV CAN PO; Tami SH, 2012, ETHNIC DIS, V22, P192; Tremblay Mark S, 2005, Health Rep, V16, P23; U.S. Census Bureau, 2012, ACSBR1106 US CENS BU; Varghese S, 2002, CAN J DIET PRACT RES, V63, P72, DOI 10.3148/63.2.2002.72; Wandel M, 2008, APPETITE, V50, P376, DOI 10.1016/j.appet.2007.09.003	28	97	98	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88495	10.1371/journal.pone.0088495	http://dx.doi.org/10.1371/journal.pone.0088495			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3RA	24558396	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700042
J	Zheng, J; Li, J; Xu, LN; Xie, GY; Wen, QY; Luo, JD; Li, D; Huang, DH; Fan, SQ				Zheng, Jun; Li, Jiao; Xu, Lina; Xie, Guiyuan; Wen, Qiuyuan; Luo, Jiadi; Li, Duo; Huang, Donghai; Fan, Songqing			Phosphorylated Mnk1 and eIF4E Are Associated with Lymph Node Metastasis and Poor Prognosis of Nasopharyngeal Carcinoma	PLOS ONE			English	Article							CAP-BINDING PROTEIN; TRANSLATIONAL CONTROL; CELL-PROLIFERATION; SIGNALING PATHWAY; UP-REGULATION; CANCER; EXPRESSION; EIF-4E; TUMORIGENESIS; PROGRESSION	Nasopharyngeal carcinoma (NPC) is a head and neck malignant tumor rare throughout most of the world but common in Southeast Asia, especially in Southern China. The phosphorylation of eukaryotic translation initiation factor 4E (eIF4E) by MAP kinase-interacting kinases (Mnk) on Ser-209 promotes cellular proliferation, survival, malignant transformation and metastasis. However, whether the alterations of the expression of p-eIF4E and p-Mnk1 protein are associated with clinicopathologic/prognostic implication for NPC has not been reported. The purposes of the present study are to examine the expression of p-eIF4E and p-Mnk1 protein in NPC and non-cancerous nasopharyngeal epithelial tissues by immunohistochemistry and evaluate the association between the expression of p-eIF4E and p-Mnk1 protein and clinicopathological characteristics of NPC. The results showed that the positive percentage of p-Mnk1 and p-eIF4E proteins expression in NPC (83.5% and 75.4%, respectively) was significantly higher than that in non-cancerous nasopharyngeal epithelium (40.0% and 32.9%, respectively). The positive expression of p-eIF4E and p-Mnk1 in the NPC with cervical lymph node metastasis was significantly higher than those without lymph node metastasis. Additionally, p-eIF4E expression was more pronouncedly increased in metastatic NPC than the matched primary NPC. Increase of p-eIF4E and p-Mnk1 expression was significantly correlated inversely with overall survival. Spearman's rank correlation test further showed that expression of p-Mnk1 was strongly positive correlated with expression of p-eIF4E in NPC. The expression of p-Mnk1 and p-eIF4E in NPC was proved to be the independent prognostic factors regardless of lymph node metastasis, clinical stages and combination of radiotherapy and chemotherapy, histological type, age and gender by multivariate analysis. Taken together, high expression of p-Mnk1 and p-eIF4E might be novel valuable biomarkers to predict poor prognosis of NPC and therapeutic targets for developing the valid treatment strategies.	[Zheng, Jun; Li, Jiao; Xu, Lina; Wen, Qiuyuan; Luo, Jiadi; Li, Duo; Fan, Songqing] Cent South Univ, Xiangya Hosp 2, Dept Pathol, Changsha, Hunan, Peoples R China; [Xie, Guiyuan] Cent South Univ, Xiangya Hosp 2, Dept Oncol, Changsha, Hunan, Peoples R China; [Huang, Donghai] Cent South Univ, Xiangya Hosp, Dept Otorhinolaryngol, Changsha, Hunan, Peoples R China; [Zheng, Jun] Changzhi Med Coll, Dept Biochem, Changzhi, Shanxi, Peoples R China	Central South University; Central South University; Central South University; Changzhi Medical College	Fan, SQ (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Pathol, Changsha, Hunan, Peoples R China.	fansongqing2003@hotmail.com	xu, li/GNH-3667-2022		National Natural Sciences Foundations of China [81071820, 81272566]	National Natural Sciences Foundations of China(National Natural Science Foundation of China (NSFC))	The work was supported by grants from the National Natural Sciences Foundations of China (NO: 81071820; 81272566) http://isisn.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astanehe A, 2012, ONCOGENE, V31, P4434, DOI 10.1038/onc.2011.617; Bianchini A, 2008, CARCINOGENESIS, V29, P2279, DOI 10.1093/carcin/bgn221; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-1; Chou J, 2008, HEAD NECK-J SCI SPEC, V30, P946, DOI 10.1002/hed.20833; Clemens MJ, 1999, INT J BIOCHEM CELL B, V31, P1, DOI 10.1016/S1357-2725(98)00127-7; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Fan SQ, 2009, CANCER BIOL THER, V8, P1463, DOI 10.4161/cbt.8.15.8960; Farias TP, 2003, ARCH OTOLARYNGOL, V129, P794, DOI 10.1001/archotol.129.7.794; Ferrandiz-Pulido C, 2013, J UROLOGY, V190, P2288, DOI 10.1016/j.juro.2013.06.015; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Graff JR, 2009, CANCER RES, V69, P3866, DOI 10.1158/0008-5472.CAN-08-3472; Hou JQ, 2012, ONCOTARGET, V3, P118; Khoury T, 2009, CLIN LUNG CANCER, V10, P58, DOI 10.3816/CLC.2009.n.009; Konicek BW, 2011, CANCER RES, V71, P1849, DOI 10.1158/0008-5472.CAN-10-3298; Lee CC, 2008, CLIN OTOLARYNGOL, V33, P442, DOI 10.1111/j.1749-4486.2008.01770.x; Liang S, 2013, ONCOL REP, V29, P2422, DOI 10.3892/or.2013.2397; Mahalingam M, 2001, PROG MOLEC, V27, P131; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; Muta D, 2011, J NEURO-ONCOL, V101, P33, DOI 10.1007/s11060-010-0233-6; Nathan CAO, 1999, LARYNGOSCOPE, V109, P1253, DOI 10.1097/00005537-199908000-00013; Pan CC, 2012, EXP THER MED, V4, P334, DOI 10.3892/etm.2012.584; Pons B, 2011, INT J ONCOL, V39, P1337, DOI 10.3892/ijo.2011.1118; Pyronnet S, 2000, BIOCHEM PHARMACOL, V60, P1237, DOI 10.1016/S0006-2952(00)00429-9; Razak ARA, 2010, EUR J CANCER, V46, P1967, DOI 10.1016/j.ejca.2010.04.004; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Rosenwald IB, 1999, ONCOGENE, V18, P2507, DOI 10.1038/sj.onc.1202563; Rosenwald IB, 2001, THROMB HAEMOSTASIS, V85, P142; Segrelles C, 2004, CARCINOGENESIS, V25, P1137, DOI 10.1093/carcin/bgh132; SHAM JST, 1990, INT J RADIAT ONCOL, V19, P929, DOI 10.1016/0360-3016(90)90014-B; Tao Qian, 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000312; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Wang ST, 1999, AM J PATHOL, V155, P247, DOI 10.1016/S0002-9440(10)65118-8; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Wei WI, 2010, CLIN EXP OTORHINOLAR, V3, P1, DOI 10.3342/ceo.2010.3.1.1; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Wheater MJ, 2010, CANCER BIOL THER, V10, P728, DOI 10.4161/cbt.10.7.12965; Wu MY, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0400-z; Yoshizawa A, 2010, CLIN CANCER RES, V16, P240, DOI 10.1158/1078-0432.CCR-09-0986; Zimmer SG, 2000, ANTICANCER RES, V20, P1343	39	35	38	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89220	10.1371/journal.pone.0089220	http://dx.doi.org/10.1371/journal.pone.0089220			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551240	gold, Green Published, Green Submitted			2022-12-27	WOS:000331271500105
J	Boltz, KA; Jasti, M; Townley, JM; Shippen, DE				Boltz, Kara A.; Jasti, Madhu; Townley, Jennifer M.; Shippen, Dorothy E.			Analysis of Poly(ADP-Ribose) Polymerases in Arabidopsis Telomere Biology	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; CHROMOSOME END PROTECTION; MAMMALIAN TELOMERES; IONIZING-RADIATION; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL INTERACTION; EMBRYONIC-DEVELOPMENT; CHROMATIN-STRUCTURE; CELL-SURVIVAL; DAMAGE	Maintaining the length of the telomere tract at chromosome ends is a complex process vital to normal cell division. Telomere length is controlled through the action of telomerase as well as a cadre of telomere-associated proteins that facilitate replication of the chromosome end and protect it from eliciting a DNA damage response. In vertebrates, multiple poly(ADP-ribose) polymerases (PARPs) have been implicated in the regulation of telomere length, telomerase activity and chromosome end protection. Here we investigate the role of PARPs in plant telomere biology. We analyzed Arabidopsis thaliana mutants null for PARP1 and PARP2 as well as plants treated with the PARP competitive inhibitor 3-AB. Plants deficient in PARP were hypersensitive to genotoxic stress, and expression of PARP1 and PARP2 mRNA was elevated in response to MMS or zeocin treatment or by the loss of telomerase. Additionally, PARP1 mRNA was induced in parp2 mutants, and conversely, PARP2 mRNA was induced in parp1 mutants. PARP3 mRNA, by contrast, was elevated in both parp1 and parp2 mutants, but not in seedlings treated with 3-AB or zeocin. PARP mutants and 3-AB treated plants displayed robust telomerase activity, no significant changes in telomere length, and no end-to-end chromosome fusions. Although there remains a possibility that PARPs play a role in Arabidopsis telomere biology, these findings argue that the contribution is a minor one.	[Boltz, Kara A.; Jasti, Madhu; Townley, Jennifer M.; Shippen, Dorothy E.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Shippen, DE (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	dshippen@tamu.edu			National Institutes of Health [GM065383]; NATIONAL CANCER INSTITUTE [T32CA009156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065383] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health (GM065383) to D. E. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Elmageed ZY, 2012, CELL SIGNAL, V24, P1, DOI 10.1016/j.cellsig.2011.07.019; Adams-Phillips L, 2008, MOL PLANT MICROBE IN, V21, P646, DOI 10.1094/MPMI-21-5-0646; Adams-Phillips L, 2010, PLANT PHYSIOL, V152, P267, DOI 10.1104/pp.109.148049; Amiard S, 2011, PLANT CELL, V23, P4254, DOI 10.1105/tpc.111.092387; Arneric M, 2007, EMBO REP, V8, P1080, DOI 10.1038/sj.embor.7401082; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Bai P, 2012, CELL METAB, V16, P290, DOI 10.1016/j.cmet.2012.06.016; Balestrazzi A, 2011, PLANT CELL REP, V30, P287, DOI 10.1007/s00299-010-0975-9; Beneke S, 2008, NUCLEIC ACIDS RES, V36, P6309, DOI 10.1093/nar/gkn615; Boehler C, 2011, P NATL ACAD SCI USA, V108, P2783, DOI 10.1073/pnas.1016574108; Boltz KA, 2012, MOL BIOL CELL, V23, P1558, DOI 10.1091/mbc.E11-12-1002; Brown EJ, 2000, GENE DEV, V14, P397; Canudas S, 2007, EMBO J, V26, P4867, DOI 10.1038/sj.emboj.7601903; Cao Y, 2002, ONCOGENE, V21, P3130, DOI 10.1038/sj.onc.1205419; Chan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000236; Chang P, 2004, NATURE, V432, P645, DOI 10.1038/nature03061; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Chiang YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002639; Chiang YJ, 2006, MOL CELL BIOL, V26, P2037, DOI 10.1128/MCB.26.6.2037-2043.2006; Cifuentes-Rojas C, 2012, GENE DEV, V26, P2512, DOI 10.1101/gad.202960.112; Citarelli M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-308; Cook BD, 2002, MOL CELL BIOL, V22, P332, DOI 10.1128/MCB.22.1.332-342.2002; Culligan K, 2004, PLANT CELL, V16, P1091, DOI 10.1105/tpc.018903; Culligan KM, 2006, PLANT J, V48, P947, DOI 10.1111/j.1365-313X.2006.02931.x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dantzer F, 2004, MOL CELL BIOL, V24, P1595, DOI 10.1128/MCB.24.4.1595-1607.2004; De Block M, 2005, PLANT J, V41, P95, DOI 10.1111/j.1365-313X.2004.02277.x; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; De Vos M, 2012, BIOCHEM PHARMACOL, V84, P137, DOI 10.1016/j.bcp.2012.03.018; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; di Fagagna FD, 1999, NAT GENET, V23, P76; Doucet-Chabeaud G, 2001, MOL GENET GENOMICS, V265, P954, DOI 10.1007/s004380100506; Dynek JN, 2004, SCIENCE, V304, P97, DOI 10.1126/science.1094754; Espejel S, 2004, J CELL BIOL, V167, P627, DOI 10.1083/jcb.200407178; Fitzgerald MS, 1999, P NATL ACAD SCI USA, V96, P14813, DOI 10.1073/pnas.96.26.14813; Fulcher N, 2009, P NATL ACAD SCI USA, V106, P20984, DOI 10.1073/pnas.0909218106; Furukawa T, 2010, DNA REPAIR, V9, P940, DOI 10.1016/j.dnarep.2010.06.006; Garcia V, 2003, PLANT CELL, V15, P119, DOI 10.1105/tpc.006577; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Ghosh U, 2005, FEBS J, V272, P4237, DOI 10.1111/j.1742-4658.2005.04837.x; Ghosh U, 2007, MUTAT RES-FUND MOL M, V615, P66, DOI 10.1016/j.mrfmmm.2006.10.002; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Gomes NMV, 2011, AGING CELL, V10, P761, DOI 10.1111/j.1474-9726.2011.00718.x; Gomez M, 2006, MOL BIOL CELL, V17, P1686, DOI 10.1091/mbc.E05-07-0672; Grandin N, 1997, GENE DEV, V11, P512, DOI 10.1101/gad.11.4.512; Gu PL, 2012, EMBO J, V31, P2309, DOI 10.1038/emboj.2012.96; Heacock M, 2004, EMBO J, V23, P2304, DOI 10.1038/sj.emboj.7600236; Heacock ML, 2007, NUCLEIC ACIDS RES, V35, P6490, DOI 10.1093/nar/gkm472; Hefner E, 2006, DNA REPAIR, V5, P102, DOI 10.1016/j.dnarep.2005.08.013; Hsiao SJ, 2006, MOL CELL BIOL, V26, P2044, DOI 10.1128/MCB.26.6.2044-2054.2006; Hunt L, 2007, PLANT J, V51, P341, DOI 10.1111/j.1365-313X.2007.03151.x; Hwang MG, 2007, NUCLEIC ACIDS RES, V35, P1333, DOI 10.1093/nar/gkm043; Ishikawa K, 2009, PLANT PHYSIOL, V151, P741, DOI 10.1104/pp.109.140442; Jaspers P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-170; Jia Q, 2013, PLANT MOL BIOL, V82, P339, DOI 10.1007/s11103-013-0065-9; Kaminker PG, 2001, J BIOL CHEM, V276, P35891, DOI 10.1074/jbc.M105968200; Kang HC, 2011, P NATL ACAD SCI USA, V108, P14103, DOI 10.1073/pnas.1108799108; Kannan K, 2008, MOL CELL BIOL, V28, P2332, DOI 10.1128/MCB.01490-07; Karamysheva ZN, 2004, J BIOL CHEM, V279, P47799, DOI 10.1074/jbc.M407938200; Kazda A, 2012, GENE DEV, V26, P1703, DOI 10.1101/gad.194944.112; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Lamb RS, 2012, CELL MOL LIFE SCI, V69, P175, DOI 10.1007/s00018-011-0793-4; Leehy KA, 2013, PLANT CELL, V25, P1343, DOI 10.1105/tpc.112.107425; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Martin V, 2007, P NATL ACAD SCI USA, V104, P14038, DOI 10.1073/pnas.0705497104; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; McNees CJ, 2010, J CELL BIOL, V188, P639, DOI 10.1083/jcb.200908136; Miyake Y, 2009, MOL CELL, V36, P193, DOI 10.1016/j.molcel.2009.08.009; Nakaoka H, 2012, J BIOL CHEM, V287, P619, DOI 10.1074/jbc.M111.263723; NOSSERI C, 1994, EXP CELL RES, V212, P367, DOI 10.1006/excr.1994.1156; Oka S, 2012, CIRC RES, V111, P611, DOI 10.1161/CIRCRESAHA.111.247932; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Peterson SE, 2001, NAT GENET, V27, P64, DOI 10.1038/83778; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Riha K, 2003, P NATL ACAD SCI USA, V100, P611, DOI 10.1073/pnas.0236128100; Riha K, 2001, SCIENCE, V291, P1797, DOI 10.1126/science.1057110; Sabourin M, 2007, MOL CELL, V27, P550, DOI 10.1016/j.molcel.2007.07.016; Samper E, 2001, J CELL BIOL, V154, P49, DOI 10.1083/jcb.200103049; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Schulz P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037287; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smith S, 2001, TRENDS BIOCHEM SCI, V26, P174, DOI 10.1016/S0968-0004(00)01780-1; Smith S, 1999, J CELL SCI, V112, P3649; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Song XY, 2008, P NATL ACAD SCI USA, V105, P19815, DOI 10.1073/pnas.0807867105; Stewart JA, 2012, EMBO J, V31, P3537, DOI 10.1038/emboj.2012.215; Stilmann M, 2009, MOL CELL, V36, P365, DOI 10.1016/j.molcel.2009.09.032; Surovtseva YV, 2009, MOL CELL, V36, P207, DOI 10.1016/j.molcel.2009.09.017; Ting NSY, 2005, NUCLEIC ACIDS RES, V33, P2090, DOI 10.1093/nar/gki342; Tong WM, 2001, MOL CELL BIOL, V21, P4046, DOI 10.1128/MCB.21.12.4046-4054.2001; Tseng SF, 2006, NUCLEIC ACIDS RES, V34, P6327, DOI 10.1093/nar/gkl786; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; Ullrich O, 1999, P NATL ACAD SCI USA, V96, P6223, DOI 10.1073/pnas.96.11.6223; Vanderauwera S, 2007, P NATL ACAD SCI USA, V104, P15150, DOI 10.1073/pnas.0706668104; Vespa L, 2005, GENE DEV, V19, P2111, DOI 10.1101/gad.1333805; Yamazaki H, 2012, GENE DEV, V26, P241, DOI 10.1101/gad.177873.111; Yoshiyama K, 2009, P NATL ACAD SCI USA, V106, P12843, DOI 10.1073/pnas.0810304106; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222	101	22	22	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88872	10.1371/journal.pone.0088872	http://dx.doi.org/10.1371/journal.pone.0088872			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551184	Green Published, gold, Green Submitted			2022-12-27	WOS:000331266000079
J	Kannurpatti, SS; Motes, MA; Biswal, BB; Rypma, B				Kannurpatti, Sridhar S.; Motes, Michael A.; Biswal, Bharat B.; Rypma, Bart			Assessment of Unconstrained Cerebrovascular Reactivity Marker for Large Age-Range fMRI Studies	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; BOLD FMRI; FUNCTIONAL CONNECTIVITY; HYPERCAPNIC NORMALIZATION; VARIABILITY; ACTIVATION; AMPLITUDE; SIGNAL; MRI; CO2	Breath hold (BH), a commonly used task to measure cerebrovascular reactivity (CVR) in fMRI studies varies in outcome among individuals due to subject-physiology and/or BH-inspiration/expiration differences (i.e., performance). In prior age-related fMRI studies, smaller task-related BOLD response variability is observed among younger than older individuals. Also, a linear CVR versus task relationship exists in younger individuals which maybe useful to test the accuracy of CVR responses in older groups. Hence we hypothesized that subject-related physiological and/or BH differences, if present, may compromise CVR versus task linearity in older individuals. To test the hypothesis, empirical BH versus task relationships from motor and cognitive areas were obtained in younger (mean age = 26 years) and older (mean age = 58 years) human subjects. BH versus task linearity was observed only in the younger group, confirming our hypothesis. Further analysis indicated BH responses and its variability to be similar in both younger and older groups, suggesting that BH may not accurately represent CVR in a large age range. Using the resting state fluctuation of amplitude (RSFA) as an unconstrained alternative to BH, subject-wise correspondence between BH and RSFA was tested. Correlation between BH versus RSFA was significant within the motor but was not significant in the cognitive areas in the younger and was completely disrupted in both areas in the older subjects indicating that BH responses are constrained by subject-related physiology and/or performance-related differences. Contrasting BH to task, RSFA-task relationships were independent of age accompanied by age-related increases in CVR variability as measured by RSFA, not observed with BH. Together the results obtained indicate that RSFA accurately represents CVR in any age range avoiding multiple and yet unknown physiologic and task-related pitfalls of BH.	[Kannurpatti, Sridhar S.; Biswal, Bharat B.] RUTGERS New Jersey Med Sch, Dept Radiol, Newark, NJ 07102 USA; [Motes, Michael A.; Rypma, Bart] Univ Texas Dallas, Sch Behav & Brain Sci, Dallas, TX 75230 USA; [Biswal, Bharat B.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Texas System; University of Texas Dallas; New Jersey Institute of Technology	Kannurpatti, SS (corresponding author), RUTGERS New Jersey Med Sch, Dept Radiol, Newark, NJ 07102 USA.	kannursr@njms.rutgers.edu; bart.rypma@utd.edu		Motes, Michael/0000-0001-6635-6948	National Institute of Health [AG029523-02, AG032088-02]; American Heart Association [0930132N]; NATIONAL INSTITUTE ON AGING [R01AG029523, R01AG032088] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institute of Health through the grants AG029523-02 (BR), AG032088-02 (BB) and American Heart Association grant 0930132N (SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandettini PA, 1997, NMR BIOMED, V10, P197, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<197::AID-NBM466>3.0.CO;2-S; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2007, MAGN RESON IMAGING, V25, P1358, DOI 10.1016/j.mri.2007.03.022; Cohen ER, 2004, NEUROIMAGE, V23, P613, DOI 10.1016/j.neuroimage.2004.06.021; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; D'Esposito M, 1999, NEUROIMAGE, V10, P6, DOI 10.1006/nimg.1999.0444; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; Di X., 2012, CEREB CORTEX; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Handwerker DA, 2007, HUM BRAIN MAPP, V28, P846, DOI 10.1002/hbm.20307; HONG SK, 1971, J APPL PHYSIOL, V30, P540, DOI 10.1152/jappl.1971.30.4.540; Huettel SA, 2001, NEUROIMAGE, V13, P161, DOI 10.1006/nimg.2000.0675; Kannurpatti SS, 2008, NEUROIMAGE, V40, P1567, DOI 10.1016/j.neuroimage.2007.09.040; Kannurpatti SS, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00007; Kannurpatti SS, 2011, HUM BRAIN MAPP, V32, P1125, DOI 10.1002/hbm.21097; Kannurpatti SS, 2011, MAGN RESON IMAGING, V29, P140, DOI 10.1016/j.mri.2010.07.006; Kannurpatti SS, 2010, MAGN RESON IMAGING, V28, P466, DOI 10.1016/j.mri.2009.12.007; Kannurpatti SS, 2002, MAGN RESON MED, V47, P864, DOI 10.1002/mrm.10131; Kastrup A, 1998, STROKE, V29, P2641, DOI 10.1161/01.STR.29.12.2641; Kastrup A, 2001, MAGN RESON IMAGING, V19, P13, DOI 10.1016/S0730-725X(01)00227-2; Leoni RF, 2012, RADIOL RES PRACT, V2012, DOI 10.1155/2012/268483; Liau J, 2009, NEUROIMAGE, V45, P420, DOI 10.1016/j.neuroimage.2008.11.032; Liu P, 2012, HUM BRAIN MAPP; Liu TT, 2013, NEUROIMAGE; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lythgoe DJ, 1999, MAGN RESON IMAGING, V17, P495, DOI 10.1016/S0730-725X(98)00211-2; Mandell DM, 2008, STROKE, V39, P2021, DOI 10.1161/STROKEAHA.107.506709; Mennes M., 2012, CEREB CORTEX; Motes MA, 2011, COGN NEUROSCI-UK, V2, P1, DOI 10.1080/17588928.2010.512974; Murphy K, 2011, NEUROIMAGE, V54, P369, DOI 10.1016/j.neuroimage.2010.07.059; Parkes MJ, 2006, EXP PHYSIOL, V91, P1, DOI 10.1113/expphysiol.2005.031625; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ratnatunga C, 1990, Eur J Vasc Surg, V4, P519, DOI 10.1016/S0950-821X(05)80795-9; Riecker A, 2006, NEUROIMAGE, V32, P1345, DOI 10.1016/j.neuroimage.2006.05.021; Roberts P, 2009, COMP BREATH HOLDING, P1532; ROSTRUP E, 1994, NMR BIOMED, V7, P29, DOI 10.1002/nbm.1940070106; Rypma B, 2000, NAT NEUROSCI, V3, P509, DOI 10.1038/74889; Rypma B, 2006, NEUROIMAGE, V33, P969, DOI 10.1016/j.neuroimage.2006.05.065; STEVENS CD, 1946, J CLIN INVEST, V25, P723, DOI 10.1172/JCI101755; Tancredi FB, 2013, J CEREBR BLOOD F MET, V33, P1066, DOI 10.1038/jcbfm.2013.48; Thomason ME, 2005, NEUROIMAGE, V25, P824, DOI 10.1016/j.neuroimage.2004.12.026; Thomason ME, 2008, NEUROIMAGE, V39, P206, DOI 10.1016/j.neuroimage.2007.08.014; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Wise RG, 2004, NEUROIMAGE, V21, P1652, DOI 10.1016/j.neuroimage.2003.11.025; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012	47	26	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88751	10.1371/journal.pone.0088751	http://dx.doi.org/10.1371/journal.pone.0088751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551151	Green Submitted, Green Published, gold			2022-12-27	WOS:000331266000061
J	Margry, B; Kersemakers, SCW; Hoek, A; Arkesteijn, GJA; Wieland, WH; van Eden, W; Broere, F				Margry, Bram; Kersemakers, Saskia C. W.; Hoek, Aad; Arkesteijn, Ger J. A.; Wieland, Willemien H.; van Eden, Willem; Broere, Femke			Activated Peritoneal Cavity B-1a Cells Possess Regulatory B Cell Properties	PLOS ONE			English	Article							B10 CELLS; INDUCTION; RESPONSES; MICE; AUTOIMMUNITY; INFLAMMATION; SUPPRESSION; EXPRESSION; DEPLETION; DISEASE	Previous studies have suggested that murine peritoneal cavity-derived B-1a cells possess similarities with described regulatory B cell subsets. The aim of the current study was to examine the potential immunoregulatory function of peritoneal cavity-derived B(-1a) cells. In vitro activation of peritoneal cavity-derived B-and B-1a cells shows that activation of these B cells with anti-CD40 and LPS induces these cells to secrete more IL-10, IL-6 and IgM as compared to splenic B cells. In a suppression assay, CD40/TLR4-activated peritoneal cavity B cells possess regulatory B cell functions as they inhibit the capacity of CD4(+) T cells to produce both tumor necrosis factor-a and interferon-c. Splenic B cells did not show this, whereas non-activated peritoneal cavity B cells augmented the capacity of CD4(+) T cells to produce tumor necrosis factor-alpha, while the ability to produce interferon-c was not altered. The current paper compares splenic B cells to peritoneal cavity B(-1a) cells in an in vitro activation-and an suppression-assay and concludes that peritoneal cavity B(-1a) cells possess properties that appear similar to splenic autoimmune-suppressive regulatory B cell subsets described in the literature.	[Margry, Bram; Kersemakers, Saskia C. W.; Hoek, Aad; Arkesteijn, Ger J. A.; Wieland, Willemien H.; van Eden, Willem; Broere, Femke] Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands	Utrecht University	Broere, F (corresponding author), Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands.	f.broere@uu.nl		Broere, Femke/0000-0001-9343-0111; Arkesteijn, Ger/0000-0001-7739-582X; van Eden, Willem/0000-0003-1272-704X	TI Pharma [T1-214-1]	TI Pharma	This work was supported by TI Pharma T1-214-1 (www.tipharma.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amu S, 2010, J ALLERGY CLIN IMMUN, V125, P1114, DOI 10.1016/j.jaci.2010.01.018; Barr TA, 2012, J EXP MED, V209, P1001, DOI 10.1084/jem.20111675; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Blair PA, 2009, J IMMUNOL, V182, P3492, DOI 10.4049/jimmunol.0803052; Carter NA, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3736; Carter NA, 2011, J IMMUNOL, V186, P5569, DOI 10.4049/jimmunol.1100284; DiLillo DJ, 2010, ANN NY ACAD SCI, V1183, P38, DOI 10.1111/j.1749-6632.2009.05137.x; DiLillo DJ, 2013, LEUKEMIA, V27, P170, DOI 10.1038/leu.2012.165; Evans JG, 2007, J IMMUNOL, V178, P7868, DOI 10.4049/jimmunol.178.12.7868; Fillatreau S, 2008, NAT REV IMMUNOL, V8, P391, DOI 10.1038/nri2315; Flores-Borja F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005407; Gray D, 2007, EUR J IMMUNOL, V37, P3304, DOI 10.1002/eji.200737728; Gray M, 2007, P NATL ACAD SCI USA, V104, P14080, DOI 10.1073/pnas.0700326104; Horikawa M, 2011, J CLIN INVEST, V121, P4268, DOI 10.1172/JCI59266; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Koni PA, 2013, J IMMUNOL, V190, P3189, DOI 10.4049/jimmunol.1203364; Kretschmer B, 2011, IMMUNOL LETT, V136, P221, DOI 10.1016/j.imlet.2011.01.013; Lampropoulou V, 2008, J IMMUNOL, V180, P4763, DOI 10.4049/jimmunol.180.7.4763; Margry B, 2013, EUR J IMMUNOL, V43, P2317, DOI 10.1002/eji.201343418; Maseda D, 2013, J IMMUNOL, V191, P2780, DOI 10.4049/jimmunol.1300649; Matsushita T, 2010, J IMMUNOL, V185, P2240, DOI 10.4049/jimmunol.1001307; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Miles K, 2012, P NATL ACAD SCI USA, V109, P887, DOI 10.1073/pnas.1109173109; Mohan C, 1998, ARTHRITIS RHEUM-US, V41, P1652, DOI 10.1002/1529-0131(199809)41:9<1652::AID-ART17>3.0.CO;2-W; Nakashima H, 2010, J IMMUNOL, V184, P4637, DOI 10.4049/jimmunol.0901719; O'Neill SK, 2007, J IMMUNOL, V179, P5109, DOI 10.4049/jimmunol.179.8.5109; Palos MC, 2012, INFLAMM RES, V61, P1187, DOI 10.1007/s00011-012-0514-y; Poe JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022464; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Shimomura Y, 2008, INT IMMUNOL, V20, P729, DOI 10.1093/intimm/dxn031; Silverman GJ, 2013, NAT REV RHEUMATOL, V9, P291, DOI 10.1038/nrrheum.2013.30; Sindhava VJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00372; Suzuki K, 2010, IMMUNOL REV, V237, P180, DOI 10.1111/j.1600-065X.2010.00941.x; van dV, 2012, PLOS ONE, V7; Velupillai P, 1997, J IMMUNOL, V158, P338; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Yanaba K, 2009, J IMMUNOL, V182, P7459, DOI 10.4049/jimmunol.0900270; Yang M, 2010, J IMMUNOL, V184, P3321, DOI 10.4049/jimmunol.0902551; Yang Y, 2007, P NATL ACAD SCI USA, V104, P4542, DOI 10.1073/pnas.0700001104; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501	42	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88869	10.1371/journal.pone.0088869	http://dx.doi.org/10.1371/journal.pone.0088869			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551182	gold, Green Published, Green Submitted			2022-12-27	WOS:000331266000078
J	Xiao, TT; Wang, YY; Zhang, Y; Bai, CH; Shen, XC				Xiao, Ting-Ting; Wang, Yuan-Yuan; Zhang, Yan; Bai, Cong-Hui; Shen, Xiang-Chun			Similar to Spironolactone, Oxymatrine Is Protective in Aldosterone-Induced Cardiomyocyte Injury via Inhibition of Calpain and Apoptosis-Inducing Factor Signaling	PLOS ONE			English	Article							CELL-DEATH; MYOCYTE APOPTOSIS; HEART-FAILURE; MECHANISMS; CALCIUM; ACTIVATION; PATHWAYS; SURVIVAL; DISEASE; SYSTEM	Accumulating evidence indicates that oxymatrine (OMT) possesses variously pharmacological properties, especially on the cardiovascular system. We previously demonstrated that activated calpain/apoptosis-inducing factor (AIF)-mediated pathway was the key molecular mechanism in aldosterone (ALD) induces cardiomyocytes apoptosis. In the present study, we extended the experimentation by investigating the effect of OMT on cardiomyocytes exposed to ALD, as compared to spironolactone (Spiro), a classical ALD receptor antagonist. Cardiomyocytes were pre-incubated with OMT, Spiro or vehicle for 1 h, and then, cardiomyocytes were exposed to ALD 24 h. The cell injury was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) assay and lactate dehydrogenase (LDH) leakage ratio. Apoptosis was determined by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay, annexin V/PI staining, and relative caspase-3 activity assay. Furthermore, expression of pro-apoptotic proteins including truncated Bid (tBid), calpain and AIF were evaluated by western blot analysis. ALD stimulation increased cardiomyocytes apoptosis, caspase-3 activity and protein expression of calpain, tBid and AIF in the cytosol (p<0.05). Pre-incubated with cardiomyocytes injury and increased caspase-3 activity were significantly attenuated (p<0.05). Furthermore, OMT suppressed ALD-induced high expression of calpain and AIF. And these effects of OMT could be comparable to Spiro. These findings indicated that OMT might be a potential cardioprotective-agent against excessive ALD-induced cardiotoxicity, at least in part, mediated through inhibition of calpain/AIF signaling.	[Xiao, Ting-Ting; Zhang, Yan; Bai, Cong-Hui; Shen, Xiang-Chun] Guiyang Med Univ, Res Div Pharmacol, Guiyang, Peoples R China; [Xiao, Ting-Ting] Hong Kong Baptist Univ, Sch Chinese Med, Kowloon, Hong Kong, Peoples R China; [Wang, Yuan-Yuan] Guiyang Med Univ, Res Div Pathophysiol, Guiyang, Peoples R China; [Shen, Xiang-Chun] Zhejiang Sci Tech Univ, Sch Life Sci, Hangzhou, Zhejiang, Peoples R China	Guizhou Medical University; Hong Kong Baptist University; Guizhou Medical University; Zhejiang Sci-Tech University	Shen, XC (corresponding author), Guiyang Med Univ, Res Div Pharmacol, Guiyang, Peoples R China.	shengxiangchun@126.com	Lv, Yuanjie/AER-0767-2022		National Natural Science Foundation of China [81173586]; Provincial Key Technologies R&D Program of Guizhou [SY-2011-3010]; Program for New Century Excellent Talents in University [NCET -13-0747]; Excellent Scientific and Technological & Educational Talents of Governor' Specal Funds in Guizhou Province [2011-28]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Key Technologies R&D Program of Guizhou; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Excellent Scientific and Technological & Educational Talents of Governor' Specal Funds in Guizhou Province	This study was supported by the National Natural Science Foundation of China (No.81173586), the Provincial Key Technologies R&D Program of Guizhou (No. SY-2011-3010), the Program for New Century Excellent Talents in University (NCET -13-0747), and the Excellent Scientific and Technological & Educational Talents of Governor' Specal Funds in Guizhou Province (No.2011-28). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajiro K, 2008, EXP CELL RES, V314, P1237, DOI 10.1016/j.yexcr.2007.12.028; Alves AJ, 2010, WORLD J CARDIOL, V2, P187, DOI 10.4330/wjc.v2.i7.187; Armstrong PW, 2011, NEW ENGL J MED, V364, P79, DOI 10.1056/NEJMe1012547; Burniston JG, 2005, J MOL CELL CARDIOL, V39, P395, DOI 10.1016/j.yjmcc.2005.04.001; Callera GE, 2011, CARDIOVASC RES, V91, P720, DOI 10.1093/cvr/cvr131; Dooley R, 2011, FRONT BIOSCI-LANDMRK, V16, P440, DOI 10.2741/3697; Ferron L, 2011, CARDIOVASC RES, V90, P105, DOI 10.1093/cvr/cvq379; Gan RT, 2011, PLANTA MED, V77, P226, DOI 10.1055/s-0030-1250256; Hayashi H, 2008, HYPERTENS RES, V31, P363, DOI 10.1291/hypres.31.363; Henry-Mowatt J, 2004, ONCOGENE, V23, P2850, DOI 10.1038/sj.onc.1207534; Hong-Li S, 2008, PHYTOTHER RES, V22, P985, DOI 10.1002/ptr.2452; Huang LL, 2012, NEPHRON EXP NEPHROL, V120, pE115, DOI 10.1159/000339500; Husi H, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-110; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Leal J., 2012, EUROPEAN CARDIOVASCU, P116; Lee WK, 2006, AM J PHYSIOL-RENAL, V291, pF823, DOI 10.1152/ajprenal.00276.2005; Mandic A, 2002, MOL CELL BIOL, V22, P3003, DOI 10.1128/MCB.22.9.3003-3013.2002; Mano A, 2004, CIRCULATION, V110, P317, DOI 10.1161/01.CIR.0000135599.33787.CA; Manrique C, 2009, MED CLIN N AM, V93, P569, DOI 10.1016/j.mcna.2009.02.014; Manrique Camila, 2007, V139, P163; McMurray JJV, 2004, NEW ENGL J MED, V351, P526, DOI 10.1056/NEJMp048144; Mihailidou AS, 2009, HYPERTENSION, V54, P1306, DOI 10.1161/HYPERTENSIONAHA.109.136242; Movsesyan VA, 2004, CELL DEATH DIFFER, V11, P1121, DOI 10.1038/sj.cdd.4401442; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Rizzuto R, 2003, ONCOGENE, V22, P8619, DOI 10.1038/sj.onc.1207105; Shahbaz AU, 2011, J CARDIOVASC PHARM, V57, P37, DOI 10.1097/FJC.0b013e3181fe1250; Shen XC, 2011, J ASIAN NAT PROD RES, V13, P215, DOI 10.1080/10286020.2010.550883; Soberman Judith, 2002, Curr Opin Investig Drugs, V3, P1024; Tirard M, 2004, J MOL ENDOCRINOL, V32, P825, DOI 10.1677/jme.0.0320825; Tokarska-Schlattner M, 2006, J MOL CELL CARDIOL, V41, P389, DOI 10.1016/j.yjmcc.2006.06.009; Rueda JOV, 2012, J APPL PHYSIOL, V112, P2110, DOI 10.1152/japplphysiol.01383.2011; Vijayaraghavan K, 2011, CARDIOL CLIN, V29, P137, DOI 10.1016/j.ccl.2010.11.003; Vindis C, 2005, ARTERIOSCL THROM VAS, V25, P639, DOI 10.1161/01.ATV.0000154359.60886.33; Weber KT, 2001, NEW ENGL J MED, V345, P1689, DOI 10.1056/NEJMra000050; Xiao TT, 2013, FOOD CHEM TOXICOL, V53, P364, DOI 10.1016/j.fct.2012.12.022; Yogi A, 2013, CELL SIGNAL, V25, P2163, DOI 10.1016/j.cellsig.2013.07.002; Yong-Gang C, 2010, PHYTOTHER RES, V24, P1844, DOI 10.1002/ptr.3206; Zhang YM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-49; Zhao J, 2010, BRIT J PHARMACOL, V159, P1584, DOI 10.1111/j.1476-5381.2009.00551.x; Zhao JP, 2008, SURG TODAY, V38, P931, DOI 10.1007/s00595-008-3785-8; Zhao YG, 2003, GASTROENTEROLOGY, V125, P854, DOI 10.1016/S0016-5085(03)01066-7; 杨钰萍, 2009, [中国医院药学杂志, Chinese Journal of Hospital Pharmacy], V29, P405	42	28	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88856	10.1371/journal.pone.0088856	http://dx.doi.org/10.1371/journal.pone.0088856			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551180	gold, Green Submitted, Green Published			2022-12-27	WOS:000331266000076
J	Sitaras, I; Kalthoff, D; Beer, M; Peeters, B; de Jong, MCM				Sitaras, Ioannis; Kalthoff, Donata; Beer, Martin; Peeters, Ben; de Jong, Mart C. M.			Immune Escape Mutants of Highly Pathogenic Avian Influenza H5N1 Selected Using Polyclonal Sera: Identification of Key Amino Acids in the HA Protein	PLOS ONE			English	Article							A VIRUSES; HEMAGGLUTININ MOLECULE; ANTIGENIC SITES; EVOLUTION; POULTRY; NEUTRALIZATION; TRANSMISSION; VACCINATION; OUTBREAKS; VACCINES	Evolution of Avian Influenza (AI) viruses - sespecially of the Highly Pathogenic Avian Influenza (HPAI) H5N1 subtype - is a major issue for the poultry industry. HPAI H5N1 epidemics are associated with huge economic losses and are sometimes connected to human morbidity and mortality. Vaccination (either as a preventive measure or as a means to control outbreaks) is an approach that splits the scientific community, due to the risk of it being a potential driving force in HPAI evolution through the selection of mutants able to escape vaccination-induced immunity. It is therefore essential to study how mutations are selected due to immune pressure. To this effect, we performed an in vitro selection of mutants from HPAI A/turkey/Turkey/1/05 (H5N1), using immune pressure from homologous polyclonal sera. After 42 rounds of selection, we identified 5 amino acid substitutions in the Haemagglutinin (HA) protein, most of which were located in areas of antigenic importance and suspected to be prone to selection pressure. We report that most of the mutations took place early in the selection process. Finally, our antigenic cartography studies showed that the antigenic distance between the selected isolates and their parent strain increased with passage number.	[Sitaras, Ioannis; de Jong, Mart C. M.] Wageningen Univ, Dept Anim Sci, NL-6700 AP Wageningen, Netherlands; [Sitaras, Ioannis; Peeters, Ben] Univ Wageningen & Res Ctr, Cent Vet Inst, Dept Virol, Lelystad, Netherlands; [Kalthoff, Donata; Beer, Martin] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Riems, Germany	Wageningen University & Research; Wageningen University & Research; Friedrich Loeffler Institute	de Jong, MCM (corresponding author), Wageningen Univ, Dept Anim Sci, NL-6700 AP Wageningen, Netherlands.	mart.dejong@wur.nl	de Jong, Mart C.M./GQQ-0825-2022	de Jong, Mart C.M./0000-0002-5339-1995; Sitaras, Ioannis/0000-0003-0161-8024; Hoffmann, Donata/0000-0003-4552-031X	Impulse Veterinary Avian Influenza Research in the Netherlands program of the Economic Structure Enhancement Fund	Impulse Veterinary Avian Influenza Research in the Netherlands program of the Economic Structure Enhancement Fund	This research was funded by the Impulse Veterinary Avian Influenza Research in the Netherlands program of the Economic Structure Enhancement Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwhab EM, 2012, VIRUS GENES, V45, P14, DOI 10.1007/s11262-012-0758-1; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Arafa A, 2012, ARCH VIROL, V157, P1931, DOI 10.1007/s00705-012-1385-9; ARCHETTI I, 1950, J EXP MED, V92, P441, DOI 10.1084/jem.92.5.441; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Cattoli G, 2011, J VIROL, V85, P8718, DOI 10.1128/JVI.02403-10; Chakrabarti AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007846; Cinatl J, 2007, MED MICROBIOL IMMUN, V196, P181, DOI 10.1007/s00430-007-0042-5; Dapat IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036455; Domingo E, 1997, BIOL TRACE ELEM RES, V56, P23, DOI 10.1007/BF02778981; DONALD HB, 1954, J GEN MICROBIOL, V10, P457, DOI 10.1099/00221287-10-3-457; Drake JW, 1999, ANN NY ACAD SCI, V870, P100, DOI 10.1111/j.1749-6632.1999.tb08870.x; DUARTE EA, 1994, INFECT AGENT DIS, V3, P201; Duvvuri Venkata R. S. K., 2009, Genomics Proteomics & Bioinformatics, V7, P47, DOI 10.1016/S1672-0229(08)60032-7; ECDC, 2011, SURV REP INFL VIR CH; EIGEN M, 1993, SCI AM, V269, P42, DOI 10.1038/scientificamerican0793-42; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Fouchier RAM, 2010, AVIAN DIS, V54, P220, DOI 10.1637/8740-032509-ResNote.1; GERHARD W, 1978, J EXP MED, V148, P383, DOI 10.1084/jem.148.2.383; Ginting TE, 2012, J VIROL, V86, P121, DOI 10.1128/JVI.06085-11; GITELMAN AK, 1986, J GEN VIROL, V67, P2247, DOI 10.1099/0022-1317-67-10-2247; Graham M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016087; Grund C, 2011, VACCINE, V29, P5567, DOI 10.1016/j.vaccine.2011.01.006; Hafez MH, 2010, POULTRY SCI, V89, P1609, DOI 10.3382/ps.2010-00708; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hoper D, 2012, J VIROL, V86, P1394, DOI 10.1128/JVI.00797-11; Igarashi M, 2008, VIROLOGY, V376, P323, DOI 10.1016/j.virol.2008.03.036; Ilyushina NA, 2012, J VIROL, V86, P4724, DOI 10.1128/JVI.06774-11; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jiang WM, 2010, J GEN VIROL, V91, P2491, DOI 10.1099/vir.0.023168-0; Kao CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031162; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; Kaverin NV, 2004, J VIROL, V78, P240, DOI 10.1128/JVI.78.1.240-249.2004; Kaverin NV, 2002, J GEN VIROL, V83, P2497, DOI 10.1099/0022-1317-83-10-2497; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; LAMBKIN R, 1994, J GEN VIROL, V75, P3493, DOI 10.1099/0022-1317-75-12-3493; Lee CW, 2004, J VIROL, V78, P8372, DOI [10.1128/JVI.78.15.8372-8381.2004, 10.1128/jvi.78.15.8372-8381.2004]; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Nishiura H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055358; Park KJ, 2011, J GEN VIROL, V92, P36, DOI 10.1099/vir.0.024992-0; Pavade G, 2011, REV SCI TECH OIE, V30, P661; PHILPOTT M, 1989, J VIROL, V63, P3453, DOI 10.1128/JVI.63.8.3453-3458.1989; Piralla A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028332; Portuguese Laboratory Network for the Diagnosis of Influenza I, 2012, EURO SURVEILL, V17; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; Siddique N, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-300; Smith Derek J, 2004, Discov Med, V4, P371; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Smith DJ, 2004, PLOS COMPUT BIOL, V4, P371; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Sun SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022844; Swayne DE, 2011, REV SCI TECH OIE, V30, P839; Swayne DE, 2012, AVIAN DIS, V56, P818, DOI 10.1637/10183-041012-Review.1; Swayne DE, 2012, EXPERT REV VACCINES, V11, P877, DOI 10.1586/ERV.12.60; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tsuchiya E, 2002, J GEN VIROL, V83, P1137, DOI 10.1099/0022-1317-83-5-1137; Ubol S, 2011, J GEN VIROL, V92, P307, DOI 10.1099/vir.0.025973-0; UN FAO, 2012, H5N1 HPAI GLOB OV JA; UN OIE, 2012, MAN DIAGN TESTS VACC; Van Borm S, 2010, AVIAN DIS, V54, P558, DOI 10.1637/8756-033109-ResNote.1; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Watanabe Y, 2012, J GEN VIROL, V93, P2215, DOI 10.1099/vir.0.044032-0; Webster RG, 2006, EMERG INFECT DIS, V12, P3, DOI 10.3201/eid1201.051024; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WEBSTER RG, 1982, NATURE, V296, P115, DOI 10.1038/296115a0; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; World Health Organization (WHO), 2011, AV INFL FACT SHEET; Wu WL, 2008, J VIROL, V82, P1798, DOI 10.1128/JVI.02256-07; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; YEWDELL JW, 1986, J VIROL, V57, P623, DOI 10.1128/JVI.57.2.623-628.1986	77	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e84628	10.1371/journal.pone.0084628	http://dx.doi.org/10.1371/journal.pone.0084628			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586231	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900001
J	Dreno, B; Urosevic-Maiwald, M; Kim, Y; Guitart, J; Duvic, M; Dereure, O; Khammari, A; Knol, AC; Derbij, A; Lusky, M; Didillon, I; Santoni, AM; Acres, B; Bataille, V; Chenard, MP; Bleuzen, P; Limacher, JM; Dummer, R				Dreno, Brigitte; Urosevic-Maiwald, Mirjana; Kim, Youn; Guitart, Joan; Duvic, Madeleine; Dereure, Olivier; Khammari, Amir; Knol, Anne-Chantal; Derbij, Anna; Lusky, Monika; Didillon, Isabelle; Santoni, Anne-Marie; Acres, Bruce; Bataille, Vincent; Chenard, Marie-Pierre; Bleuzen, Pascal; Limacher, Jean-Marc; Dummer, Reinhard			TG1042 (Adenovirus-interferon-gamma) in Primary Cutaneous B-cell Lymphomas: A Phase II Clinical Trial	PLOS ONE			English	Article							WHO-EORTC CLASSIFICATION; GENE-TRANSFER; INTERLEUKIN-2; MELANOMA; CANCER; EXPERIENCE; DELIVERY; THERAPY	Rational: While a variety of registered therapies exist for Cutaneous T Cell Lymphoma, no such therapy is available for Cutaneous B Cell Therapy. In this context we performed a phase II, open label, multicenter, non-comparative study to evaluate the efficacy and safety of repeated intra-lesional administrations of TG1042 (adenovirus-interferon-c) in patients with relapsing primary cutaneous B-cell lymphomas (CBCL). Method: Thirteen patients have been enrolled and received intralesional injections of TG1042 containing 5610 10 viral particles into up to six lesions simultaneously. Injections were performed on days 1, 8 and 15 of each of four consecutive 28 day cycles. Results: Eleven (85%) out of 13 enrolled patients showed an objective response after injections of TG1042. Seven patients (54%) exhibited complete and four (31%) displayed partial response. The median time to disease progression in the study population was 23.5 months (range 6.25 to 26+). Most commonly observed adverse events were minor to moderate flu-like symptoms, fatigue and injection site reactions. Conclusions: Our study showed that treatment with TG1042 was associated with a clinical benefit in the majority of the patients with relapsing CBCL, including tumor regression, a clinically meaningful duration of response and a good treatment tolerance.	[Dreno, Brigitte; Khammari, Amir; Knol, Anne-Chantal] Univ Hosp, Dept Skin Canc, Nantes, France; [Urosevic-Maiwald, Mirjana; Dummer, Reinhard] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland; [Kim, Youn] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Guitart, Joan] Northwestern Univ, Sch Med, Chicago, IL USA; [Duvic, Madeleine] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Dereure, Olivier] St Eloi Hosp, Dept Dermatol, Montpellier, France; [Derbij, Anna; Lusky, Monika; Didillon, Isabelle; Santoni, Anne-Marie; Acres, Bruce; Bataille, Vincent; Bleuzen, Pascal; Limacher, Jean-Marc] Transgene SA, Strasbourg, France; [Chenard, Marie-Pierre] Univ Hosp, Dept Pathol, Strasbourg, France	Nantes Universite; CHU de Nantes; University of Zurich; University Zurich Hospital; Stanford University; Northwestern University; University of Texas System; UTMD Anderson Cancer Center; Universite de Montpellier; CHU de Montpellier; Transgene SA; CHU Strasbourg	Dreno, B (corresponding author), Univ Hosp, Dept Skin Canc, Nantes, France.	brigitte.dreno@wanadoo.fr	KNOL, Anne Chantal C/K-7974-2015; Chenard, Marie-Pierre/O-2373-2016	KNOL, Anne Chantal C/0000-0003-4011-5008; 	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000371] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Bradford PT, 2009, BLOOD, V113, P5064, DOI 10.1182/blood-2008-10-184168; Dummer R, 2004, BLOOD, V104, P1631, DOI 10.1182/blood-2004-01-0360; Dummer R, 2000, SEMIN CUTAN MED SURG, V19, P78, DOI 10.1016/S1085-5629(00)80003-6; Dummer R, 2008, MOL THER, V16, P985, DOI 10.1038/mt.2008.32; Dummer R, 2010, MOL THER, V18, P1244, DOI 10.1038/mt.2010.52; Galanis E, 1999, J CLIN ONCOL, V17, P3313, DOI 10.1200/JCO.1999.17.10.3313; Kim EJ, 2005, J CLIN INVEST, V115, P798, DOI 10.1172/JCI200524826; Lewis V, 2004, J INVEST DERM SYMP P, V9, P169, DOI 10.1111/j.1087-0024.2004.09113.x; Newton R, 1997, INT J CANCER, V72, P923, DOI 10.1002/(SICI)1097-0215(19970917)72:6<923::AID-IJC1>3.0.CO;2-R; Olsen Elise A, 2003, Dermatol Ther, V16, P311, DOI 10.1111/j.1396-0296.2003.01643.x; Pileri A, 2011, SEMIN DIAGN PATHOL, V28, P214, DOI 10.1053/j.semdp.2011.04.002; Quereux G, 2011, ACTA DERM-VENEREOL, V91, P562, DOI 10.2340/00015555-1113; Radny P, 2003, BRIT J CANCER, V89, P1620, DOI 10.1038/sj.bjc.6601320; Senff NJ, 2008, BLOOD, V112, P1600, DOI 10.1182/blood-2008-04-152850; Senff NJ, 2007, ARCH DERMATOL, V143, P1520, DOI 10.1001/archderm.143.12.1520; Stewart AK, 1999, GENE THER, V6, P350, DOI 10.1038/sj.gt.3300833; Trudel S, 2003, CANCER GENE THER, V10, P755, DOI 10.1038/sj.cgt.7700626; Urosevic M, 2007, J CLIN INVEST, V117, P2834, DOI 10.1172/JCI32077; Willemze R, 2005, BLOOD, V105, P3768, DOI 10.1182/blood-2004-09-3502; Zinzani PL, 2006, J CLIN ONCOL, V24, P1376, DOI 10.1200/JCO.2005.03.6285	20	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e83670	10.1371/journal.pone.0083670	http://dx.doi.org/10.1371/journal.pone.0083670			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586226	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000331880700002
J	Skefos, J; Cummings, C; Enzer, K; Holiday, J; Weed, K; Levy, E; Yuce, T; Kemper, T; Bauman, M				Skefos, Jerry; Cummings, Christopher; Enzer, Katelyn; Holiday, Jarrod; Weed, Katrina; Levy, Ezra; Yuce, Tarik; Kemper, Thomas; Bauman, Margaret			Regional Alterations in Purkinje Cell Density in Patients with Autism	PLOS ONE			English	Article							CEREBELLAR CONTRIBUTIONS; ALZHEIMERS-DISEASE; VESTIBULAR NUCLEI; NEURONAL DENSITY; LOBULE-VII; PROJECTIONS; BRAIN; INDIVIDUALS; VERMIS; CONNECTIVITY	Neuropathological studies, using a variety of techniques, have reported a decrease in Purkinje cell (PC) density in the cerebellum in autism. We have used a systematic sampling technique that significantly reduces experimenter bias and variance to estimate PC densities in the postmortem brains of eight clinically well-documented individuals with autism, and eight age-and gender-matched controls. Four cerebellar regions were analyzed: a sensorimotor area comprised of hemispheric lobules IV-VI, crus I & II of the posterior lobe, and lobule X of the flocculonodular lobe. Overall PC density was thus estimated using data from all three cerebellar lobes and was found to be lower in the cases with autism as compared to controls, an effect that was most prominent in crus I and II (p < 0.05). Lobule X demonstrated a trend towards lower PC density in only the males with autism (p = 0.05). Brain weight, a correlate of tissue volume, was found to significantly contribute to the lower lobule X PC density observed in males with autism, but not to the finding of lower PC density in crus I & II. Therefore, lower crus I & II PC density in autism is more likely due to a lower number of PCs. The PC density in lobule X was found to correlate with the ADI-R measure of the patient's use of social eye contact (R 2 = 20.75, p = 0.012). These findings support the hypothesis that abnormal PC density may contribute to selected clinical features of the autism phenotype.	[Skefos, Jerry; Cummings, Christopher; Enzer, Katelyn; Holiday, Jarrod; Weed, Katrina; Levy, Ezra; Yuce, Tarik; Kemper, Thomas; Bauman, Margaret] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA	Boston University	Skefos, J (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA.	skefos@gmail.com			Autism Research Foundation	Autism Research Foundation	This work was supported by The Autism Research Foundation (http://www.theautismresearchfoundation.org) and Autism Speaks File Number 1391 (http://www.autismspeaks.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agashiwala RM, 2008, BRAIN RES, V1236, P73, DOI 10.1016/j.brainres.2008.07.119; ALTMAN J, 1996, DEV CEREBELLAR SYSTE; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andersen BB, 2003, J COMP NEUROL, V466, P356, DOI 10.1002/cne.10884; Angevine J, 1961, HUMAN CEREBELLUM ATL; Junior EA, 2007, J MATERN-FETAL NEO M, V20, P581, DOI 10.1080/14767050701482928; Bailey A, 1998, BRAIN, V121, P889, DOI 10.1093/brain/121.5.889; Balaban CD, 2004, BRAIN RES, V996, P126, DOI 10.1016/j.brainres.2003.10.026; Balsters JH, 2010, NEUROIMAGE, V49, P2045, DOI 10.1016/j.neuroimage.2009.10.045; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; BRAUTH SE, 1977, EXP BRAIN RES, V28, P73; Christ SE, 2011, NEUROPSYCHOLOGY, V25, P690, DOI 10.1037/a0024256; Cohen B, 1999, J VESTIBUL RES-EQUIL, V9, P163; Cullen DK, 2010, BRAIN RES, V1359, P44, DOI 10.1016/j.brainres.2010.08.058; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; Danielsson S, 2005, EPILEPSIA, V46, P918, DOI 10.1111/j.1528-1167.2005.57504.x; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; Fatemi SH, 2002, CELL MOL NEUROBIOL, V22, P171, DOI 10.1023/A:1019861721160; Fehlow P, 1993, Padiatr Grenzgeb, V31, P259; Fukutani Y, 1996, NEUROSCI LETT, V214, P33; Guerin P, 1996, DEV MED CHILD NEUROL, V38, P203; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; Hayter AL, 2007, NEUROIMAGE, V36, P943, DOI 10.1016/j.neuroimage.2007.03.011; Heinsen H, 2000, J CHEM NEUROANAT, V20, P49, DOI 10.1016/S0891-0618(00)00067-3; Herculano-Houzel S, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00012; Holdnack J, 2011, ASSESSMENT, V18, P192, DOI 10.1177/1073191110394771; Ito M., 2012, CEREBELLUM BRAIN IMP; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Ivenshitz M, 2010, J NEUROPHYSIOL, V104, P1052, DOI 10.1152/jn.00914.2009; KARHUNEN PJ, 1994, BRIT MED J, V308, P1663, DOI 10.1136/bmj.308.6945.1663; KEMPER TL, 1993, NEUROL CLIN, V11, P175, DOI 10.1016/S0733-8619(18)30176-2; KUME A, 1991, J NEUROL SCI, V101, P178, DOI 10.1016/0022-510X(91)90043-7; Larsell O, 1941, J COMP NEUROL, V75, P315, DOI 10.1002/cne.900750208; LARSELL O, 1958, ANAT REC, V130, P329; Lee M, 2002, BRAIN, V125, P1483, DOI 10.1093/brain/awf160; Limperopoulos C, 2005, PEDIATRICS, V115, P688, DOI 10.1542/peds.2004-1169; LOHR JB, 1986, BIOL PSYCHIAT, V21, P865, DOI 10.1016/0006-3223(86)90259-3; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Matsumoto R, 1998, ACTA NEUROPATHOL, V95, P149, DOI 10.1007/s004010050779; Mouton P.R., 2001, PRINCIPLES PRACTICES; O'Reilly JX, 2010, CEREB CORTEX, V20, P953, DOI 10.1093/cercor/bhp157; ORNITZ EM, 1968, ARCH GEN PSYCHIAT, V19, P22; Ozol K, 1999, J COMP NEUROL, V412, P95; Pakan JMP, 2008, J COMP NEUROL, V508, P402, DOI 10.1002/cne.21623; Pakan JMP, 2010, J COMP NEUROL, V518, P175, DOI 10.1002/cne.22192; PHILLIPS SC, 1987, BRAIN, V110, P301, DOI 10.1093/brain/110.2.301; Poirier M, 2011, J ABNORM PSYCHOL, V120, P247, DOI 10.1037/a0022298; Ptak R., 2011, NEUROSCIENTIST REV J; Rice Catherine, 2009, Morbidity and Mortality Weekly Report, V58, P1; RITVO ER, 1986, AM J PSYCHIAT, V143, P862; Rogers JH, 1999, MECH DEVELOP, V87, P119, DOI 10.1016/S0925-4773(99)00154-9; Rubia K, 2007, HUM BRAIN MAPP, V28, P1163, DOI 10.1002/hbm.20347; Saksena S, 2008, INT J DEV NEUROSCI, V26, P705, DOI 10.1016/j.ijdevneu.2008.07.007; Schmahmann J.D., 2000, MRI ATLAS HUMAN CERE; Schmahmann JD, 1997, INT REV NEUROBIOL, V41, P31, DOI 10.1016/S0074-7742(08)60346-3; Schmahmann JD, 1996, HUM BRAIN MAPP, V4, P174, DOI 10.1002/(SICI)1097-0193(1996)4:3<174::AID-HBM3>3.0.CO;2-0; Schmahmann JD, 2010, NEUROPSYCHOL REV, V20, P236, DOI 10.1007/s11065-010-9142-x; Shi LM, 2009, BRAIN BEHAV IMMUN, V23, P116, DOI 10.1016/j.bbi.2008.07.012; Sjobeck M, 2001, DEMENT GERIATR COGN, V12, P211, DOI 10.1159/000051260; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Straka H, 2006, J NEUROPHYSIOL, V96, P1963, DOI 10.1152/jn.00334.2006; Taylor MJ, 2012, NEUROPHYSIOL CLIN, V42, P19, DOI 10.1016/j.neucli.2011.08.002; Tedesco AM, 2011, BRAIN, V134, P3669, DOI 10.1093/brain/awr266; TORVIK A, 1986, J NEUROL SCI, V76, P283, DOI 10.1016/0022-510X(86)90176-0; Van Kooij BJM, 2011, DEV MED CHILD NEUROL; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Vastagh C, 2005, ANAT EMBRYOL, V209, P471, DOI 10.1007/s00429-005-0458-x; Wall DP, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.10; Wegiel J, 1999, BRAIN RES, V818, P41, DOI 10.1016/S0006-8993(98)01279-7; Wegiel J, 2013, BRAIN RES, V1512, P106, DOI 10.1016/j.brainres.2013.03.037; Wegiel J, 2010, ACTA NEUROPATHOL, V119, P755, DOI 10.1007/s00401-010-0655-4; Whitney ER, 2008, CEREBELLUM, V7, P406, DOI 10.1007/s12311-008-0043-y; Whitney ER, 2009, J NEUROSCI RES, V87, P2245, DOI 10.1002/jnr.22056; WILLIAMS RS, 1980, ARCH NEUROL-CHICAGO, V37, P749, DOI 10.1001/archneur.1980.00500610029003; Witelson SF, 2006, BRAIN, V129, P386, DOI 10.1093/brain/awh696; Xiong GX, 2002, NEUROSCI LETT, V322, P173, DOI 10.1016/S0304-3940(02)00108-8; Yerys BE, 2011, CHILD NEUROPSYCHOL, V17, P391, DOI 10.1080/09297049.2010.547462	80	98	99	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e81255	10.1371/journal.pone.0081255	http://dx.doi.org/10.1371/journal.pone.0081255			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586223	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700001
J	Ling, L; Cheng, Y; Ding, LC; Yang, XJ				Ling, Lin; Cheng, Yan; Ding, Liucheng; Yang, Xiangjun			Association of Serum Periostin with Cardiac Function and Short-Term Prognosis in Acute Myocardial Infarction Patients	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; MATRICELLULAR PROTEINS; HEART-FAILURE; EXPRESSION; AMI	Background: Periostin was proved to play an important role in extra-cellular matrix remodeling after acute myocardial infarction (AMI). Myocardial periostin was markedly up-regulated after AMI and participated in the maladaptive process of cardiac remodeling. However, few researches focused on the circulating periostin and its significance. This study aims to investigate the association of serum periostin level with cardiac function and short-term prognosis in AMI patients. Methodology/Principal Findings: We totally recruited 50 patients diagnosed as ST-elevation myocardial infarction. Blood samples were taken within 12 hours after the onset of AMI before emergency coronary revascularization procedures. Serum periostin was measured using enzyme-linked immunosorbent assay. All patients received echocardiography examination within one week after hospitalization. Correlations of serum periostin with echocardiography parameters, Killip class and myocardium injury biomarkers (CK-MB/troponin T) were investigated. AMI patients were divided into two groups by serum periostin level (higher/lower periostin group) and followed up for six months. Primary endpoints included cardiovascular mortality, nonfatal stroke/transient ischemic attack, chest pain occurrence and re-hospitalization. Secondary endpoint referred to composite cardiovascular events including all the primary endpoints. Result: Serum periostin was in negative association with left ventricular ejection fraction (LVEF) (r = 20.472, * p<0.01) and left atrium diameter (LAD) (r = 20.328, * p<0.05). Positive correlation was found between serum periostin level and Killip class (r = 0.395, * p<0.01). There was no association between serum periostin and CK-MB or troponin T (p>0.05). After six months follow up, patients in higher periostin group showed increased composite cardiovascular events (* p>0.05). Patients showed no significant difference in primary endpoints between the two groups. Conclusions/Significance: Serum periostin was in negative correlation with LVEF and LAD, in positive association with Killip class and higher serum periostin level may be predictive for worse short-term disease prognosis indicated as more composite cardiovascular events six months post AMI.	[Ling, Lin; Yang, Xiangjun] Soochow Univ, Affiliated Hosp 1, Dept Cardiol, Suzhou, Peoples R China; [Cheng, Yan] Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Dept Cardiol, Wuxi, Peoples R China; [Ding, Liucheng] Nanjing Med Univ, Affiliated Hosp 2, Nanjing, Jiangsu, Peoples R China	Soochow University - China; Nanjing Medical University; Nanjing Medical University	Yang, XJ (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Cardiol, Suzhou, Peoples R China.	xiangjun_yang@126.com			Youth Science and Technology of Suzhou Science and Education Project [KJXW2013004]	Youth Science and Technology of Suzhou Science and Education Project	This work was supported by the Youth Science and Technology of Suzhou Science and Education Project, Grant No. KJXW2013004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chatila Khaled, 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P21; Cheng CW, 2012, J INVEST MED, V60, P523, DOI 10.2310/JIM.0b013e3182408549; Cho YH, 2012, BIOMATERIALS, V33, P1376, DOI 10.1016/j.biomaterials.2011.10.078; Dobaczewski M, 2010, J MOL CELL CARDIOL, V48, P504, DOI 10.1016/j.yjmcc.2009.07.015; Dorn GW, 2007, NEW ENGL J MED, V357, P1552, DOI 10.1056/NEJMcibr074816; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; Iekushi K, 2007, HYPERTENSION, V49, P1409, DOI 10.1161/HYPERTENSIONAHA.106.080994; Jin J, 2010, CLIN INVEST MED, V33, pE304; Jugdutt BI, 2009, MOL CELL BIOCHEM, V322, P25, DOI 10.1007/s11010-008-9936-9; Katsuragi N, 2004, CIRCULATION, V110, P1806, DOI 10.1161/01.CIR.0000142607.33398.54; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Ladage D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059656; Litvin J, 2005, ANAT REC PART A, V287A, P1205, DOI 10.1002/ar.a.20237; Lorts A, 2009, CIRC RES, V104, pE1, DOI 10.1161/CIRCRESAHA.108.188649; O'Gara PT, 2013, J AM COLL CARDIOL, V61, P485, DOI [10.1161/CIR.0b013e3182742c84, 10.1016/j.jacc.2012.11.018]; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Okamoto H, 2012, CARDIOVASC THER, V30, pe198, DOI 10.1111/j.1755-5922.2011.00276.x; Roy R, 2013, J SURG RES, V185, P70, DOI 10.1016/j.jss.2013.05.084; Schellings MWM, 2004, CARDIOVASC RES, V64, P24, DOI 10.1016/j.cardiores.2004.06.006; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Snider P, 2008, CIRC RES, V102, P752, DOI 10.1161/CIRCRESAHA.107.159517; Stansfield WE, 2009, ANN THORAC SURG, V88, P1916, DOI 10.1016/j.athoracsur.2009.07.038; Taniguchi N, 2010, CIRC J, V74, P2365, DOI 10.1253/circj.CJ-10-0267; Wang DJ, 2003, HYPERTENSION, V42, P88, DOI 10.1161/01.HYP.0000074905.22908.A6; Wang FF, 2011, J CARDIOVASC MED, V12, P469, DOI 10.2459/JCM.0b013e328347e48c	26	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e88755	10.1371/journal.pone.0088755	http://dx.doi.org/10.1371/journal.pone.0088755			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586384	Green Submitted, gold, Green Published			2022-12-27	WOS:000331717900026
J	Ascolani, G; Lio, P				Ascolani, Gianluca; Lio, Pietro			Modeling TGF-beta in Early Stages of Cancer Tissue Dynamics	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MATHEMATICAL-MODEL; BONE; PROTEIN; CELLS; DIFFERENTIATION; CONSEQUENCES; HALLMARKS; MIGRATION; INSIGHTS	Recent works have highlighted a double role for the Transforming Growth Factor beta (TGF-beta): it inhibits cancer in healthy cells and potentiates tumor progression during late stage of tumorigenicity, respectively; therefore it has been termed the "Jekyll and Hyde" of cancer or, alternatively, an "excellent servant but a bad master". It remains unclear how this molecule could have the two opposite behaviours. In this work, we propose a TGF-beta multi scale mathematical model at molecular, cellular and tissue scales. The multi scalar behaviours of the TGF-beta are described by three coupled models built up together which can approximatively be related to distinct microscopic, mesoscopic, and macroscopic scales, respectively. We first model the dynamics of TGF-beta at the single-cell level by taking into account the intracellular and extracellular balance and the autocrine and paracrine behaviour of TGF-beta. Then we use the average estimates of the TGF-beta from the first model to understand its dynamics in a model of duct breast tissue. Although the cellular model and the tissue model describe phenomena at different time scales, their cumulative dynamics explain the changes in the role of TGF-beta in the progression from healthy to pre-tumoral to cancer. We estimate various parameters by using available gene expression datasets. Despite the fact that our model does not describe an explicit tissue geometry, it provides quantitative inference on the stage and progression of breast cancer tissue invasion that could be compared with epidemiological data in literature. Finally in the last model, we investigated the invasion of breast cancer cells in the bone niches and the subsequent disregulation of bone remodeling processes. The bone model provides an effective description of the bone dynamics in healthy and early stages cancer conditions and offers an evolutionary ecological perspective of the dynamics of the competition between cancer and healthy cells.	[Ascolani, Gianluca; Lio, Pietro] Univ Cambridge, Comp Lab, Cambridge CB2 3QG, England	University of Cambridge	Ascolani, G (corresponding author), Univ Cambridge, Comp Lab, Pembroke St, Cambridge CB2 3QG, England.	gianluca.ascolani@cl.cam.ac.uk	P. Lió, Pietro Lio/AAV-3358-2021	P. Lió, Pietro Lio/0000-0002-0540-5053	EU [305280]	EU(European Commission)	We received funding from the EU FP7-Health-F5-2012 under grant no. 305280 (MIMOmics). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboagye EO, 1999, CANCER RES, V59, P80; Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Al-Dujaili SA, 2011, J CELL BIOCHEM, V112, P2412, DOI 10.1002/jcb.23164; Armitage P, 2004, INT J EPIDEMIOL, V33, P1174, DOI 10.1093/ije/dyh216; Ayati BP, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-28; Bartocci Ezio, 2012, Transactions on Computational Systems Biology XIV. Special Issue on Computational Models for Cell Processes, P53, DOI 10.1007/978-3-642-35524-0_3; Bast R, 2000, ACS ATLAS CLIN ONCOL; Bhowmick NA, 2012, CANCER CELL, V22, P563, DOI 10.1016/j.ccr.2012.10.011; Bilezikian J.P., 2008, PRINCIPLES BONE BIOL; Buenzli PR, 2014, BIOMECH MODEL MECHAN, V13, P185, DOI 10.1007/s10237-013-0495-y; Buijs JT, 2011, CANCER MICROENVIRON, V4, P261, DOI 10.1007/s12307-011-0075-6; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Crank J., 1979, MATH DIFFUSION; Drake JM, 2009, MOL BIOL CELL, V20, P2207, DOI 10.1091/mbc.E08-10-1076; Drasin DJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3037; Dunn LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006896; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Fox SW, 2005, MOL CELL ENDOCRINOL, V243, P19, DOI 10.1016/j.mce.2005.09.008; Ganapathy V, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-122; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Hodge JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021462; Hoshino Y, 2011, J BIOCHEM, V149, P55, DOI 10.1093/jb/mvq114; Itoh S, 2012, J BIOCHEM, V151, P559, DOI 10.1093/jb/mvs042; Jabbar S, 2011, J CLIN PATHOL, V64, P354, DOI 10.1136/jcp.2010.086595; Jackson RC, 2012, BIODISCOVERY, V1, DOI [10.7750/BioDiscovery.2012.1.1, DOI 10.7750/BI0DISC0VERY.2012.1.1]; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Kolambkar YM, 2011, BONE, V49, P485, DOI 10.1016/j.bone.2011.05.010; Komarova SV, 2003, BONE, V33, P206, DOI 10.1016/S8756-3282(03)00157-1; Kubiczkova L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-183; Laise P, 2012, AIP ADV, V2, DOI 10.1063/1.3697962; Lio P, 2011, ELECTRON NOTES THEOR, V277, P41, DOI 10.1016/j.entcs.2011.09.034; Lio P, 2011, ELECTRON PROC THEOR, P82, DOI 10.4204/EPTCS.67.8; Liu T, 2010, BIOCHEM J, V430, P191, DOI 10.1042/BJ20100427; Manolagas SC, 2010, TRENDS ENDOCRIN MET, V21, P369, DOI 10.1016/j.tem.2010.01.010; McElwain S, 2009, J ROYAL SOC INTERFAC; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Moustakas A, 2013, TGF BETA HUMAN DIS; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nishimura R, 2009, IBMS BONEKEY, V11, P434; Oshimori N, 2012, CELL STEM CELL, V10, P63, DOI 10.1016/j.stem.2011.11.005; Parfitt A, 2010, SKELETAL HETEROGENEI; PARFITT AM, 1994, J CELL BIOCHEM, V55, P273, DOI 10.1002/jcb.240550303; Parfitt M, 2011, J BONE MINER RES, V26, P475, DOI 10.1002/jbmr.239; Pivonka Peter, 2012, Bonekey Rep, V1, P221, DOI 10.1038/bonekey.2012.221; Pivonka P, 2010, BONE, V47, P181, DOI 10.1016/j.bone.2010.04.601; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Reiter JG, 2013, EVOL APPL, V6, P34, DOI 10.1111/eva.12020; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Ryser MD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002703; Ryser MD, 2012, PLOS COMPUT BIOL, DOI [10.1371/journal.pcbi.1002703, DOI 10.1371/J0URNAL.PCBI.1002703]; Saltelli A, 2002, COMPUT PHYS COMMUN, V145, P280, DOI 10.1016/S0010-4655(02)00280-1; Schmierer B, 2008, P NATL ACAD SCI USA, V105, P6608, DOI 10.1073/pnas.0710134105; Smith DW, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040268, DOI 10.1371/J0URNAL.P0NE.0040268]; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Taylor MA, 2010, J MAMMARY GLAND BIOL, V15, P169, DOI 10.1007/s10911-010-9181-1; Therneau TM, 2008, CANCER INFORM, V6, P423; TOVAR A, 2004, THESIS U NOTRE DAME; Wendt MK, 2011, MOL BIOL CELL, V22, P2423, DOI 10.1091/mbc.E11-04-0306; WIER ML, 1986, J CELL BIOL, V103, P215, DOI 10.1083/jcb.103.1.215; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; Worthington JJ, 2011, TRENDS BIOCHEM SCI, V36, P47, DOI 10.1016/j.tibs.2010.08.002; Xu J, 2010, THESIS U ILLINOIS	65	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88533	10.1371/journal.pone.0088533	http://dx.doi.org/10.1371/journal.pone.0088533			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586338	Green Published, gold, Green Submitted			2022-12-27	WOS:000331714700020
J	Kayashima, Y; Tomita, H; Zhilicheva, S; Kim, S; Kim, HS; Bennett, BJ; Maeda, N				Kayashima, Yukako; Tomita, Hirofumi; Zhilicheva, Svetlana; Kim, Shinja; Kim, Hyung-Suk; Bennett, Brian J.; Maeda, Nobuyo			Quantitative Trait Loci Affecting Atherosclerosis at the Aortic Root Identified in an Intercross between DBA2J and 129S6 Apolipoprotein E-Null Mice	PLOS ONE			English	Article							E-DEFICIENT MICE; CORONARY-ARTERY-DISEASE; GENOME-WIDE ASSOCIATION; GENETIC-LOCI; QTL GENE; MOUSE; SUSCEPTIBILITY; EXPRESSION; CHOLESTEROL; STRAINS	Apolipoprotein E-null mice on a DBA/2J genetic background (DBA-apoE) are highly susceptible to atherosclerosis in the aortic root area compared with those on a 129S6 background (129-apoE). To explore atherosclerosis-responsible genetic regions, we performed a quantitative trait locus (QTL) analysis using 172 male and 137 female F2 derived from an intercross between DBA-apoE and 129-apoE mice. A genome-wide scan identified two significant QTL for the size of lesions at the root: one is Ath44 on Chromosome (Chr) 1 at 158 Mb, and the other Ath45 on Chr 2 at 162 Mb. Ath44 co-localizes with but appears to be independent of a previously reported QTL, Ath1, while Ath45 is a novel QTL. DBA alleles of both Ath44 and Ath45 confer atherosclerosis-susceptibility. In addition, a QTL on Chr 14 at 73 Mb was found significant only in males, and 129 allele conferring susceptibility. Further analysis detected female-specific interactions between a second QTL on Chr 1 at 73 Mb and a QTL on Chr 3 at 21 Mb, and between Chr 7 at 84 Mb and Chr 12 at 77 Mb. These loci for the root atherosclerosis were independent of QTLs for plasma total cholesterol and QTLs for triglycerides, but a QTL for HDL (Chr 1 at 126 Mb) overlapped with the Ath44. Notably, haplotype analysis among 129S6, DBA/2J and C57BL/6 genomes and their gene expression data narrowed the candidate regions for Ath44 and Ath45 to less than 5 Mb intervals where multiple genome wide associations with cardiovascular phenotypes have also been reported in humans. SNPs in or near Fmo3, Sele and Selp for Ath44, and Lbp and Pkig for Ath45 were suggested for further investigation as potential candidates underlying the atherosclerosis susceptibility.	[Kayashima, Yukako; Tomita, Hirofumi; Zhilicheva, Svetlana; Kim, Shinja; Kim, Hyung-Suk; Maeda, Nobuyo] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27514 USA; [Bennett, Brian J.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Maeda, N (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27514 USA.	nobuyo@med.unc.edu		bennett, brian/0000-0002-0766-3195	NIH [HL042630]; American Heart Association Fellowship [09POST2250823]; Uehara Memorial Foundation Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042630, R37HL042630] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Fellowship(American Heart Association); Uehara Memorial Foundation Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by an NIH grant HL042630 to NM (http://www.nih.gov/), an American Heart Association Fellowship Award 09POST2250823 to HT (http://www.heart.org/HEARTORG/), and an Uehara Memorial Foundation Fellowship (http://www.ueharazaidan.or.jp/) to YK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Bennett BJ, 2013, CELL METAB, V17, P49, DOI 10.1016/j.cmet.2012.12.011; Bennett BJ, 2012, ARTERIOSCL THROM VAS, V32, P1790, DOI 10.1161/ATVBAHA.112.253864; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Burkhardt R, 2011, ARTERIOSCL THROM VAS, V31, P775, DOI 10.1161/ATVBAHA.110.213843; Chen YY, 2007, CELL METAB, V6, P164, DOI 10.1016/j.cmet.2007.07.001; Colinayo VV, 2003, MAMM GENOME, V14, P464, DOI 10.1007/s00335-002-2187-2; Dansky HM, 2002, GENETICS, V160, P1599; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Harrap SB, 2002, ARTERIOSCL THROM VAS, V22, P874, DOI 10.1161/01.ATV.0000016258.40568.F1; Hau J, 2011, 2011 HDB LAB ANIMAL, VI; Holdt LM, 2008, ARTERIOSCL THROM VAS, V28, P1097, DOI 10.1161/ATVBAHA.108.165654; Hsu J, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005421; Idel S, 2003, P NATL ACAD SCI USA, V100, P14235, DOI 10.1073/pnas.1835672100; Ishimori N, 2004, ARTERIOSCL THROM VAS, V24, P161, DOI 10.1161/01.ATV.0000104027.52895.D7; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; KATSUDA S, 1992, AM J PATHOL, V140, P907; Korstanje R, 2004, J LIPID RES, V45, P881, DOI 10.1194/jlr.M300460-JLR200; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lepper PM, 2007, J AM COLL CARDIOL, V50, P25, DOI 10.1016/j.jacc.2007.02.070; Lum H, 2002, AM J PHYSIOL-CELL PH, V282, pC59, DOI 10.1152/ajpcell.00256.2001; Maeda N, 2007, ATHEROSCLEROSIS, V195, P75, DOI 10.1016/j.atherosclerosis.2006.12.006; Manichaikul A, 2011, AM J PHYSIOL-HEART C, V301, pH1056, DOI 10.1152/ajpheart.00366.2011; O'Donnell CJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S4; PAIGEN B, 1987, P NATL ACAD SCI USA, V84, P3763, DOI 10.1073/pnas.84.11.3763; PAIGEN B, 1995, AM J CLIN NUTR, V62, p458S, DOI 10.1093/ajcn/62.2.458S; Peyot ML, 2000, CIRC RES, V86, P76, DOI 10.1161/01.RES.86.1.76; Prins BP, 2012, ATHEROSCLEROSIS, V225, P1, DOI 10.1016/j.atherosclerosis.2012.05.015; Rodriguez JM, 2013, CIRC RES, V113, P1054, DOI 10.1161/CIRCRESAHA.113.302052; Safranow K, 2007, CARDIOLOGY, V108, P275, DOI 10.1159/000099096; Seidelmann SB, 2005, ARTERIOSCL THROM VAS, V25, P204, DOI 10.1161/01.ATV.0000149146.32385.1b; Smith JD, 2006, ARTERIOSCL THROM VAS, V26, P597, DOI 10.1161/01.ATV.0000201044.33220.5c; Smith JD, 2003, ARTERIOSCL THROM VAS, V23, P117, DOI 10.1161/01.ATV.0000047461.18902.80; Srivastava U, 2012, ARTERIOSCL THROM VAS, V32, P2380, DOI 10.1161/ATVBAHA.112.255703; STEWARTPHILLIPS JL, 1989, CLIN INVEST MED, V12, P121; Stoll LL, 2004, ARTERIOSCL THROM VAS, V24, P2227, DOI 10.1161/01.ATV.0000147534.69062.dc; Su ZG, 2009, J LIPID RES, V50, P2083, DOI 10.1194/jlr.M900076-JLR200; Teupser D, 2006, P NATL ACAD SCI USA, V103, P123, DOI 10.1073/pnas.0509570102; Tomita H, 2010, CIRC RES, V106, P1052, DOI 10.1161/CIRCRESAHA.109.207175; Wang SS, 2007, ARTERIOSCL THROM VAS, V27, P2671, DOI 10.1161/ATVBAHA.107.148106; Wang SS, 2007, CIRC RES, V101, pE11, DOI 10.1161/CIRCRESAHA.107.152975; Wang XS, 2005, NAT GENET, V37, P365, DOI 10.1038/ng1524; Wang XS, 2004, GENOME RES, V14, P1767, DOI 10.1101/gr.2668204; WARNICK GR, 1985, CLIN CHEM, V31, P217; Wolfrum S, 2010, ARTERIOSCL THROM VAS, V30, P1583, DOI 10.1161/ATVBAHA.110.205757; Yuan ZB, 2009, CIRC-CARDIOVASC GENE, V2, P220, DOI 10.1161/CIRCGENETICS.108.792499; Zhang ZM, 2012, CIRC-CARDIOVASC GENE, V5, P190, DOI 10.1161/CIRCGENETICS.111.961649; Zheng LH, 2000, BIOCHEM J, V349, P403, DOI 10.1042/0264-6021:3490403	49	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88274	10.1371/journal.pone.0088274	http://dx.doi.org/10.1371/journal.pone.0088274			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586312	Green Published, gold, Green Submitted			2022-12-27	WOS:000331714700012
J	Zeng, LN; Zhang, LL; Hu, ZQ; Ehle, EA; Chen, Y; Liu, LL; Chen, M				Zeng, Linan; Zhang, Lingli; Hu, Zhiqiang; Ehle, Emily A.; Chen, Yuan; Liu, Lili; Chen, Min			Systematic Review of Evidence-Based Guidelines on Medication Therapy for Upper Respiratory Tract Infection in Children with AGREE Instrument	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; ACUTE OTITIS-MEDIA; GRADE; MANAGEMENT; DIAGNOSIS; QUALITY; RECOMMENDATIONS; INFLUENZA; STRENGTH; RHINOSINUSITIS	Objectives: To summarize recommendations of existing guidelines on the treatment of upper respiratory tract infections (URTIs) in children, and to assess the methodological quality of these guidelines. Methods: We searched seven databases and web sites of relevant academic agencies. Evidence-based guidelines on pediatric URTIs were included. AGREE II was used to assess the quality of these guidelines. Two researchers selected guidelines independently and extracted information on publication years, institutions, target populations, recommendations, quality of evidence, and strength of recommendations. We compared the similarities and differences of recommendations and their strength. We also analyzed the reasons for variation. Results: Thirteen guidelines meeting our inclusion criteria were included. Huge differences existed among these 13 guidelines concerning the categorization of evidence and recommendations. Nearly all of these guidelines lacked the sufficient involvement of stake holders. Further, the applicability of these guidelines still needs to be improved. In terms of recommendations, penicillin and amoxicillin were suggested for group A streptococcal pharyngitis. Amoxicillin and amoxicillin-clavulanate were recommended for acute bacterial rhinosinusitis (ABRS). An observation of 2-3 days prior to antibiotic therapy initiation for mild acute otitis media (AOM) was recommended with amoxicillin as the suggested first choice agent. Direct evidence to support strong recommendations on the therapy for influenza is still lacking. In addition, the antimicrobial durations for pharyngitis and ABRS were still controversial. No consensus was reached for the onset of antibiotics for ABRS in children. Conclusions: Future guidelines should use a consistent grading system for the quality of evidence and strength of recommendations. More effort needs to be paid to seek the preference of stake holders and to improve the applicability of guidelines. Further, there are still areas in pediatric URTIs that need more research.	[Zeng, Linan; Zhang, Lingli; Hu, Zhiqiang; Chen, Yuan; Liu, Lili; Chen, Min] Sichuan Univ, West China Univ Hosp 2, Dept Pharm, Chengdu, Sichuan, Peoples R China; [Zeng, Linan; Zhang, Lingli; Chen, Yuan] Sichuan Univ, Key Lab Birth Defects & Related Dis Women & Child, Minist Educ, Chengdu, Sichuan, Peoples R China; [Zeng, Linan; Zhang, Lingli; Chen, Yuan] Sichuan Univ, West China Univ Hosp 2, Evidence Based Pharm Ctr, Chengdu, Sichuan, Peoples R China; [Hu, Zhiqiang; Liu, Lili; Chen, Min] Sichuan Univ, West China Sch Pharm, Chengdu, Sichuan, Peoples R China; [Ehle, Emily A.] Nebraska Med Ctr, Dept Pharm, Omaha, NE USA	Sichuan University; Sichuan University; Sichuan University; Sichuan University; University of Nebraska System; University of Nebraska Medical Center	Zhang, LL (corresponding author), Sichuan Univ, West China Univ Hosp 2, Dept Pharm, Chengdu, Sichuan, Peoples R China.	zhlingli@sina.com			National Natural Science Foundation of China [81373381]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Project Number: 81373381). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Health Care Policy and Research Acute Pain Management Panel, 1992, AC PAIN MAN OP MED P; AGREE Next Steps Consortium, 2009, AGREE 2 INSTR; [Anonymous], 2010, WHO GUID PHARM MAN P; Atkins D, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-38; Blomgren K, 2005, SCAND J INFECT DIS, V37, P245, DOI 10.1080/00365540410020857; Burda BU, 2011, J CLIN EPIDEMIOL, V64, P968, DOI 10.1016/j.jclinepi.2010.12.005; Chow AW, 2012, CLIN INFECT DIS, V54, pE72, DOI [10.1093/cid/cis370, 10.1093/cid/cir1043]; Clucas DB, 2008, B WORLD HEALTH ORGAN, V86, P275, DOI 10.2471/BLT.07.043034; Cohen R, 2000, PEDIATR INFECT DIS J, V19, P458, DOI 10.1097/00006454-200005000-00013; Coker TR, 2010, JAMA-J AM MED ASSOC, V304, P2161, DOI 10.1001/jama.2010.1651; DePestel DD, 2008, J AM PHARM ASSOC, V48, P530, DOI 10.1331/JAPhA.2008.07006; Eccles M, 1996, BMJ-BRIT MED J, V312, P760; Esposito S, 2008, J CHEMOTHERAPY, V20, P147, DOI 10.1179/joc.2008.20.2.147; Ferket BS, 2010, ARCH INTERN MED, V170, P27, DOI 10.1001/archinternmed.2009.434; Fletcher B., 1979, CAN MED ASSOC J, V121, P1193; Griffin GH, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003423.pub2; Guyatt GH, 2008, BRIT MED J, V336, P1170, DOI 10.1136/bmj.39504.506319.80; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P1049, DOI 10.1136/bmj.39493.646875.AE; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Harbour R, 2001, BRIT MED J, V323, P334, DOI 10.1136/bmj.323.7308.334; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; Jamison DT, 2006, DIS CONTROL PRIORITI; Kozyrskyj A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001095.pub2; Liao PF, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-43; Lieberthal AS, 2013, PEDIATRICS, V131, pE964, DOI 10.1542/peds.2012-3488; Lim Wendy, 2008, Hematology Am Soc Hematol Educ Program, P26, DOI 10.1182/asheducation-2008.1.26; Lo Vecchio A, 2011, J PEDIATR GASTR NUTR, V52, P183, DOI 10.1097/MPG.0b013e3181e233ac; Marcy M, MANAGEMENT ACUTE OTI; MCCORMICK A, 1995, MORBIDITY STAT GEN P; Morciano C, 2009, ANN I SUPER SANITA, V45, P185; *NAT I HLTH CLIN E, 2008, CLIN GUID, V69; Pichichero ME, 2005, PEDIATRICS, V115, P1048, DOI 10.1542/peds.2004-1276; Pichichero ME, 2007, OTOLARYNG HEAD NECK, V136, P340, DOI 10.1016/j.otohns.2006.10.007; Prior M, 2008, J EVAL CLIN PRACT, V14, P888, DOI 10.1111/j.1365-2753.2008.01014.x; Schror Karsten, 2007, Paediatr Drugs, V9, P195, DOI 10.2165/00148581-200709030-00008; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; Schunemann HJ, 2007, LANCET INFECT DIS, V7, P21, DOI 10.1016/S1473-3099(06)70684-3; Scottish Intercollegiate Guidelines Network, 2003, DIAGN MAN CHILDH OT; Shulman ST, 2012, CLIN INFECT DIS, V55, pE86, DOI 10.1093/cid/cis629; Snellman L., 2013, DIAGNOSIS TREATMENT; Solberg L I, 2000, Jt Comm J Qual Improv, V26, P525; Subcommittee of Clinical Practice Guideline for Diagnosis and Management of Acute Otitis Media in Children (Japan Otological Society Japan Society for Pediatric Otorhinolaryngology Japan Society for Infectious Diseases in Otolaryngology), 2012, Auris Nasus Larynx, V39, P1, DOI 10.1016/j.anl.2011.09.008; Tristram S, 2007, CLIN MICROBIOL REV, V20, P368, DOI 10.1128/CMR.00040-06; Wald ER, 2013, PEDIATRICS, V132, pE262, DOI 10.1542/peds.2013-1071; Wald ER, 2001, PEDIATRICS, V108, P798	46	22	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e87711	10.1371/journal.pone.0087711	http://dx.doi.org/10.1371/journal.pone.0087711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586287	gold, Green Published, Green Submitted			2022-12-27	WOS:000331714700007
J	Hinton, DJ; McGee-Lawrence, ME; Lee, MR; Kwong, HK; Westendorf, JJ; Choi, DS				Hinton, David J.; McGee-Lawrence, Meghan E.; Lee, Moonnoh R.; Kwong, Hoi K.; Westendorf, Jennifer J.; Choi, Doo-Sup			Aberrant Bone Density in Aging Mice Lacking the Adenosine Transporter ENT1	PLOS ONE			English	Article							REGULATES ETHANOL INTOXICATION; EXTRACELLULAR ADENOSINE; ALCOHOL-CONSUMPTION; NUCLEOSIDE; EXPRESSION; DIFFERENTIATION; OSTEOPOROSIS; RECEPTORS; MODEL; OSTEOBLASTS	Adenosine is known to regulate bone production and resorption in humans and mice. Type 1 equilibrative nucleoside transporter (ENT1) is responsible for the majority of adenosine transport across the plasma membrane and is ubiquitously expressed in both humans and mice. However, the contribution of ENT1-mediated adenosine levels has not been studied in bone remodeling. With the recent identification of the importance of adenosine signaling in bone homeostasis, it is essential to understand the role of ENT1 to develop novel therapeutic compounds for bone disorders. Here we examined the effect of ENT1 deletion on bone density using X-ray, dual energy X-ray absorptiometry and micro-computerized tomography analysis. Our results show that bone density and bone mineral density is reduced in the lower thoracic and lumbar spine as well as the femur of old ENT1 null mice (>7 months) compared to wild-type littermates. Furthermore, we found increased mRNA expression of tartrate-resistant acid phosphatase (TRAP), an osteoclast marker, in isolated long bones from 10 month old ENT1 null mice compared to wild-type mice. In addition, aged ENT1 null mice displayed severe deficit in motor coordination and locomotor activity, which might be attributed to dysregulated bone density. Overall, our study suggests that ENT1-regulated adenosine signaling plays an essential role in lumbar spine and femur bone density.	[Hinton, David J.; Lee, Moonnoh R.; Choi, Doo-Sup] Mayo Clin, Coll Med, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Hinton, David J.; Choi, Doo-Sup] Mayo Clin, Coll Med, Neurobiol Dis Program, Rochester, MN USA; [Choi, Doo-Sup] Mayo Clin, Coll Med, Dept Psychiat & Psychol, Rochester, MN USA; [McGee-Lawrence, Meghan E.; Westendorf, Jennifer J.] Mayo Clin, Coll Med, Dept Orthoped Surg & Orthoped Res, Rochester, MN USA; [Kwong, Hoi K.] Mayo Clin, Coll Med, Adv Genom Technol Ctr, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Choi, DS (corresponding author), Mayo Clin, Coll Med, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA.	choids@mayo.edu	Choi, Doo-Sup/G-9474-2012	Choi, Doo-Sup/0000-0002-6796-9938; McGee-Lawrence, Meghan/0000-0002-2728-5849	Samuel Johnson Foundation for Genomics of Addiction Program at Mayo Clinic; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018779] Funding Source: NIH RePORTER	Samuel Johnson Foundation for Genomics of Addiction Program at Mayo Clinic; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This project was funded by the Samuel Johnson Foundation for Genomics of Addiction Program at Mayo Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Costa MA, 2011, J CELL PHYSIOL, V226, P1353, DOI 10.1002/jcp.22458; Allen-Gipson DS, 2009, ALCOHOL CLIN EXP RES, V33, P791, DOI 10.1111/j.1530-0277.2009.00897.x; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Bradford J, 2009, P NATL ACAD SCI USA, V106, P22480, DOI 10.1073/pnas.0911503106; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Carroll SH, 2012, J BIOL CHEM, V287, P15718, DOI 10.1074/jbc.M112.344994; Castillo CA, 2009, EXP GERONTOL, V44, P453, DOI 10.1016/j.exger.2009.04.006; Chen H, 2004, HISTOL HISTOPATHOL, V19, P677, DOI 10.14670/HH-19.677; Chen HY, 2009, EXP GERONTOL, V44, P792, DOI 10.1016/j.exger.2009.09.009; Chen JH, 2010, BEHAV BRAIN RES, V208, P636, DOI 10.1016/j.bbr.2010.01.011; Choi DS, 2004, NAT NEUROSCI, V7, P855, DOI 10.1038/nn1288; Crusio WE, 2009, GENES BRAIN BEHAV, V8, P1, DOI 10.1111/j.1601-183X.2008.00438.x; Cunha Rodrigo A, 2005, Purinergic Signal, V1, P111, DOI 10.1007/s11302-005-0649-1; Evans BAJ, 2006, J BONE MINER RES, V21, P228, DOI 10.1359/JBMR.051021; Gharibi B, 2012, INT J OBESITY, V36, P397, DOI 10.1038/ijo.2011.129; Gharibi B, 2011, J BONE MINER RES, V26, P2112, DOI 10.1002/jbmr.424; Grenz A, 2012, J CLIN INVEST, V122, P693, DOI 10.1172/JCI60214; He W, 2012, PURINERG SIGNAL, V8, P327, DOI 10.1007/s11302-012-9292-9; He Wenjie, 2011, Front Biosci (Elite Ed), V3, P888; Hogan HA, 1997, ALCOHOL CLIN EXP RES, V21, P809, DOI 10.1111/j.1530-0277.1997.tb03844.x; Jee W. S. S., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P193; Johnell O, 2004, OSTEOPOROSIS INT, V15, P38, DOI 10.1007/s00198-003-1490-4; Kara FM, 2010, FASEB J, V24, P2325, DOI 10.1096/fj.09-147447; Kara FM, 2010, ARTHRITIS RHEUM-US, V62, P534, DOI 10.1002/art.27219; Lee MR, 2011, NEUROSCI LETT, V490, P90, DOI 10.1016/j.neulet.2010.12.033; Lee MR, 2011, ALCOHOL CLIN EXP RES, V35, P99, DOI 10.1111/j.1530-0277.2010.01326.x; Lee MR, 2010, PHARMACOL BIOCHEM BE, V95, P235, DOI 10.1016/j.pbb.2010.01.012; Lelovas PP, 2008, COMPARATIVE MED, V58, P424; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maddalozzo GF, 2009, OSTEOPOROSIS INT, V20, P1529, DOI 10.1007/s00198-009-0836-y; Maurel DB, 2012, OSTEOPOROSIS INT, V23, P1, DOI 10.1007/s00198-011-1787-7; Maurel DB, 2012, ALCOHOL CLIN EXP RES; McGee-Lawrence ME, 2013, BONE, V52, P296, DOI 10.1016/j.bone.2012.10.015; Mediero A, 2012, AM J PATHOL, V180, P775, DOI 10.1016/j.ajpath.2011.10.017; Mishina M, 2012, SYNAPSE, V66, P832, DOI 10.1002/syn.21573; NAGY LE, 1990, J BIOL CHEM, V265, P1946; Nam HW, 2012, ALCOHOL CLIN EXP RES, V36, P1117, DOI 10.1111/j.1530-0277.2011.01722.x; Nam HW, 2011, BIOL PSYCHIAT, V69, P1043, DOI 10.1016/j.biopsych.2011.02.013; Priemel M., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P212; Qaseem A, 2008, ANN INTERN MED, V149, P404, DOI 10.7326/0003-4819-149-6-200809160-00007; Rose JB, 2011, LIFE SCI, V89, P621, DOI 10.1016/j.lfs.2011.08.007; Ruby Christina L, 2010, Curr Drug Abuse Rev, V3, P163; Sampson HW, 1996, ALCOHOL CLIN EXP RES, V20, P1375, DOI 10.1111/j.1530-0277.1996.tb01137.x; Sarzi-Puttini P, 2004, CURR OPIN RHEUMATOL, V16, P287, DOI 10.1097/00002281-200405000-00021; Silva MJ, 2004, BONE, V35, P425, DOI 10.1016/j.bone.2004.03.027; Takedachi M, 2012, J CELL PHYSIOL, V227, P2622, DOI 10.1002/jcp.23001; Turner A. Simon, 2001, European Cells & Materials, V1, P66; Warraich S, 2012, J BONE MINER RES; Watanabe Ken, 2005, Molecular Aspects of Medicine, V26, P221, DOI 10.1016/j.mam.2005.01.006; Wu JH, 2010, ALCOHOL CLIN EXP RES, V34, P1110, DOI 10.1111/j.1530-0277.2010.01187.x; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]	51	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88818	10.1371/journal.pone.0088818	http://dx.doi.org/10.1371/journal.pone.0088818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586402	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900050
J	Ross, BC				Ross, Brian C.			Mutual Information between Discrete and Continuous Data Sets	PLOS ONE			English	Article								Mutual information (MI) is a powerful method for detecting relationships between data sets. There are accurate methods for estimating MI that avoid problems with "binning'' when both data sets are discrete or when both data sets are continuous. We present an accurate, non-binning MI estimator for the case of one discrete data set and one continuous data set. This case applies when measuring, for example, the relationship between base sequence and gene expression level, or the effect of a cancer drug on patient survival time. We also show how our method can be adapted to calculate the Jensen-Shannon divergence of two or more data sets.	Univ Washington, Dept Phys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Ross, BC (corresponding author), Univ Washington, Dept Phys, Seattle, WA 98195 USA.	heltilda@uw.edu		Ross, Brian/0000-0003-2432-4678	National Institutes of Health/National Human Genome Research Institute [R01HG005115]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005115] Funding Source: NIH RePORTER	National Institutes of Health/National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funding for this work was provided by National Institutes of Health/National Human Genome Research Institute grant R01HG005115. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M., 1970, HDB MATH FUNCTIONS; Cover T. M., 1991, ELEMENTS INFORM THEO; Grosse I, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041905; Kozachenko L.F., 1987, PROBL PEREDACHI INF, V23, P9; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138	5	280	282	6	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e87357	10.1371/journal.pone.0087357	http://dx.doi.org/10.1371/journal.pone.0087357			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586270	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900011
J	Ayers, S; Switnicki, MP; Angajala, A; Lammel, J; Arumanayagam, AS; Webb, P				Ayers, Stephen; Switnicki, Michal Piotr; Angajala, Anusha; Lammel, Jan; Arumanayagam, Anithachristy S.; Webb, Paul			Genome-Wide Binding Patterns of Thyroid Hormone Receptor Beta	PLOS ONE			English	Article							DEPENDENT NEGATIVE REGULATION; TRANSCRIPTION FACTOR-BINDING; GENE-EXPRESSION; RETINOIC ACID; RESPONSE ELEMENTS; DNA-BINDING; CHIP-SEQ; MECHANISM; REVEALS; DEFINES	Thyroid hormone (TH) receptors (TRs) play central roles in metabolism and are major targets for pharmaceutical intervention. Presently, however, there is limited information about genome wide localizations of TR binding sites. Thus, complexities of TR genomic distribution and links between TR beta binding events and gene regulation are not fully appreciated. Here, we employ a BioChIP approach to capture TR genome-wide binding events in a liver cell line (HepG2). Like other NRs, TR beta appears widely distributed throughout the genome. Nevertheless, there is striking enrichment of TR beta binding sites immediately 5' and 3' of transcribed genes and TR beta can be detected near 50% of T3 induced genes. In contrast, no significant enrichment of TR beta is seen at negatively regulated genes or genes that respond to unliganded TRs in this system. Canonical TRE half-sites are present in more than 90% of TR beta peaks and classical TREs are also greatly enriched, but individual TRE organization appears highly variable with diverse half-site orientation and spacing. There is also significant enrichment of binding sites for TR associated transcription factors, including AP-1 and CTCF, near TR peaks. We conclude that T3-dependent gene induction commonly involves proximal TR beta binding events but that far-distant binding events are needed for T3 induction of some genes and that distinct, indirect, mechanisms are often at play in negative regulation and unliganded TR actions. Better understanding of genomic context of TR binding sites will help us determine why TR regulates genes in different ways and determine possibilities for selective modulation of TR action.	[Ayers, Stephen; Switnicki, Michal Piotr; Angajala, Anusha; Lammel, Jan; Arumanayagam, Anithachristy S.; Webb, Paul] Methodist Hosp, Res Inst, Genom Med Program, Houston, TX 77030 USA; [Lammel, Jan] Tecnol Monterrey Sch Med, Monterrey, NL, Mexico	The Methodist Hospital System; The Methodist Hospital - Houston; Tecnologico de Monterrey	Webb, P (corresponding author), Methodist Hosp, Res Inst, Genom Med Program, 6535 Fannin, Houston, TX 77030 USA.	pwebb@tmhs.org	Ayers, Stephen D/O-4535-2014; Arumanayagam, Anithachristy/S-5750-2018	Ayers, Stephen D/0000-0003-1390-8969; Lammel Lindemann, Jan Antonio/0000-0002-3555-9571; Switnicki, Michal/0000-0003-0619-9375	American Thyroid Association; National Institutes of Health [RC4 DK090849]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC4DK090849] Funding Source: NIH RePORTER	American Thyroid Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by a grant from the American Thyroid Association and the National Institutes of Health (RC4 DK090849). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016344; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bhat MK, 1997, J BIOL CHEM, V272, P28989, DOI 10.1074/jbc.272.46.28989; BRENT G A, 1989, New Biologist, V1, P329; BRENT GA, 1992, MOL ENDOCRINOL, V6, P502, DOI 10.1210/me.6.4.502; Brent GA, 2012, J CLIN INVEST, V122, P3035, DOI 10.1172/JCI60047; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; CARR FE, 1992, J BIOL CHEM, V267, P18689; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chan IH, 2009, MOL ENDOCRINOL, V23, P1758, DOI 10.1210/me.2009-0025; Chatonnet F, 2013, P NATL ACAD SCI USA, V110, pE766, DOI 10.1073/pnas.1210626110; Choi KC, 2008, BIOCHEM J, V411, P19, DOI 10.1042/BJ20071393; Chong HK, 2010, NUCLEIC ACIDS RES, V38, P6007, DOI 10.1093/nar/gkq397; Cui JY, 2010, NUCLEIC ACIDS RES, V38, P7943, DOI 10.1093/nar/gkq654; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; DESVERGNE B, 1994, MOL CELL ENDOCRINOL, V100, P125, DOI 10.1016/0303-7207(94)90291-7; Diekman MJM, 2000, J CLIN ENDOCR METAB, V85, P1857, DOI 10.1210/jc.85.5.1857; Dong HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004610; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; FORMAN BM, 1992, MOL ENDOCRINOL, V6, P429, DOI 10.1210/me.6.3.429; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Isumi Y, 1998, ENDOCRINOLOGY, V139, P838, DOI 10.1210/en.139.3.838; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; KATZ RW, 1994, J BIOL CHEM, V269, P18915; Khorasanizadeh S, 2001, TRENDS BIOCHEM SCI, V26, P384, DOI 10.1016/S0968-0004(01)01800-X; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; Kim SW, 2005, J BIOL CHEM, V280, P14545, DOI 10.1074/jbc.M411517200; Kim SW, 2004, MOL ENDOCRINOL, V18, P2924, DOI 10.1210/me.2004-0255; Kininis M, 2007, MOL CELL BIOL, V27, P5090, DOI 10.1128/MCB.00083-07; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laperriere D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-23; LAZAR MA, 1991, MOL CELL BIOL, V11, P5005, DOI 10.1128/MCB.11.10.5005; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; Lin JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052407; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; LOPEZ G, 1993, MOL CELL BIOL, V13, P3042, DOI 10.1128/MCB.13.5.3042; Lupien M, 2009, MOL CELL BIOL, V29, P3413, DOI 10.1128/MCB.00020-09; Lutz M, 2003, EMBO J, V22, P1579, DOI 10.1093/emboj/cdg147; Malo MS, 2004, MOL ENDOCRINOL, V18, P1941, DOI 10.1210/me.2003-0351; Matsukawa T, 1996, J BIOCHEM-TOKYO, V119, P934; McKenna NJ, 2002, ENDOCRINOLOGY, V143, P2461, DOI 10.1210/endo.143.7.8892; Mendez-Pertuz M, 2003, EMBO J, V22, P3102, DOI 10.1093/emboj/cdg295; Figueira ACM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012628; Murakami Y, 1998, LIFE SCI, V63, pPL337, DOI 10.1016/S0024-3205(98)00503-7; NAAR AM, 1991, CELL, V65, P1267, DOI 10.1016/0092-8674(91)90021-P; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; PERLMANN T, 1993, GENE DEV, V7, P1411, DOI 10.1101/gad.7.7b.1411; Qi JS, 1997, MOL CELL BIOL, V17, P7195, DOI 10.1128/MCB.17.12.7195; Ribeiro RCJ, 2001, J BIOL CHEM, V276, P14987, DOI 10.1074/jbc.M010195200; SAMUELS HH, 1989, ANNU REV PHYSIOL, V51, P623, DOI 10.1146/annurev.ph.51.030189.003203; Santos GM, 2006, MOL PHARMACOL, V70, P793, DOI 10.1124/mol.106.025627; SAP J, 1990, EMBO J, V9, P887, DOI 10.1002/j.1460-2075.1990.tb08186.x; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; SPINDLER BJ, 1975, J BIOL CHEM, V250, P4113; SUGAWARA A, 1993, ENDOCRINOLOGY, V133, P965, DOI 10.1210/en.133.3.965; Suh JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070097; Taniyama M, 1996, EUR J CLIN INVEST, V26, P454, DOI 10.1046/j.1365-2362.1996.155307.x; Taniyama M, 1997, CLIN ENDOCRINOL, V46, P271, DOI 10.1046/j.1365-2265.1997.1220934.x; Tsai CC, 2004, VITAM HORM, V68, P93; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Velasco LFR, 2007, J BIOL CHEM, V282, P12458, DOI 10.1074/jbc.M610700200; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Weth O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010119; WONDISFORD FE, 1993, J BIOL CHEM, V268, P2749; Wu YF, 2001, J BIOL CHEM, V276, P3929, DOI 10.1074/jbc.M006743200; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yen PM, 2003, EMBO REP, V4, P581, DOI 10.1038/sj.embor.embor862; Yuan C, 2012, ENDOCRINOLOGY, V153, P501, DOI 10.1210/en.2011-1325	69	42	42	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e81186	10.1371/journal.pone.0081186	http://dx.doi.org/10.1371/journal.pone.0081186			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558356	Green Submitted, gold, Green Published			2022-12-27	WOS:000331706700002
J	Diffendorfer, JE; Compton, RW				Diffendorfer, Jay E.; Compton, Roger W.			Land Cover and Topography Affect the Land Transformation Caused by Wind Facilities	PLOS ONE			English	Article							ENERGY	Land transformation (ha of surface disturbance/MW) associated with wind facilities shows wide variation in its reported values. In addition, no studies have attempted to explain the variation across facilities. We digitized land transformation at 39 wind facilities using high resolution aerial imagery. We then modeled the effects of turbine size, configuration, land cover, and topography on the levels of land transformation at three spatial scales. The scales included strings (turbines with intervening roads only), sites (strings with roads connecting them, buried cables and other infrastructure), and entire facilities (sites and the roads or transmission lines connecting them to existing infrastructure). An information theoretic modeling approach indicated land cover and topography were well-supported variables affecting land transformation, but not turbine size or configuration. Tilled landscapes, despite larger distances between turbines, had lower average land transformation, while facilities in forested landscapes generally had the highest land transformation. At site and string scales, flat topographies had the lowest land transformation, while facilities on mesas had the largest. The results indicate the landscape in which the facilities are placed affects the levels of land transformation associated with wind energy. This creates opportunities for optimizing wind energy production while minimizing land cover change. In addition, the results indicate forecasting the impacts of wind energy on land transformation should include the geographic variables affecting land transformation reported here.	[Diffendorfer, Jay E.; Compton, Roger W.] US Geol Survey, Geosci & Environm Change Sci Ctr, Denver Fed Ctr, Denver, CO 80225 USA	United States Department of the Interior; United States Geological Survey	Diffendorfer, JE (corresponding author), US Geol Survey, Geosci & Environm Change Sci Ctr, Denver Fed Ctr, Denver, CO 80225 USA.	jediffendorfer@usgs.gov		Diffendorfer, Jay/0000-0003-1093-6948	Land Change Science Program at the United States Geological Survey	Land Change Science Program at the United States Geological Survey	This research was funded by the Land Change Science Program at the United States Geological Survey. http://www.usgs.gov/climate_landuse/lcs/. Program managers had no role in the study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Anderson DR, 2001, J WILDLIFE MANAGE, V65, P373, DOI 10.2307/3803088; Bureau of Land Management, 2005, FES0511 BUR LAND MAN; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; BURNHAM KP, 1992, WILDLIFE 2001 : POPULATIONS, P16; Chamberlin T. C., 1890, SCIENCE, V15, P92, DOI DOI 10.1126/SCIENCE.NS-15.366.92; Denholm P., 2009, NATL RENEWABLE ENERG; *DOE, 2008, DOEGO1020082567; Elliot DL, 1991, PNL7789; Elliott LP, 2007, BIOSCIENCE, V57, P608, DOI 10.1641/B570708; Fargione J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041468; Fthenakis V, 2009, RENEW SUST ENERG REV, V13, P1465, DOI 10.1016/j.rser.2008.09.017; Greenblatt J., 2009, CLEAN ENERGY 2030 GO; Hand M., 2012, EXPLORATION HIGH PEN, V1; Kiesecker JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017566; Kiesecker JM, 2009, BIOSCIENCE, V59, P77, DOI 10.1525/bio.2009.59.1.11; Kuvlesky WP, 2007, J WILDLIFE MANAGE, V71, P2487, DOI 10.2193/2007-248; MacKay D., 2008, SUSTAINABLE ENERGY H; McCullagh P, 1989, GEN LINEAR MODELS; McDonald RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006802; OSMOSYS, 2009, CONTR OSMOSYS FOR; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103; Pimentel D, 2002, BIOSCIENCE, V52, P1111, DOI 10.1641/0006-3568(2002)052[1111:RECAPI]2.0.CO;2; *R DEV COR TEAM, 2013, R LANG ENV STAT COMP; Siler-Evans K, 2013, P NATL ACAD SCI; Snyder B, 2009, RENEW ENERG, V34, P1567, DOI 10.1016/j.renene.2008.11.015	26	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88914	10.1371/journal.pone.0088914	http://dx.doi.org/10.1371/journal.pone.0088914			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558449	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700095
J	Edlow, AG; Vora, NL; Hui, L; Wick, HC; Cowan, JM; Bianchi, DW				Edlow, Andrea G.; Vora, Neeta L.; Hui, Lisa; Wick, Heather C.; Cowan, Janet M.; Bianchi, Diana W.			Maternal Obesity Affects Fetal Neurodevelopmental and Metabolic Gene Expression: A Pilot Study	PLOS ONE			English	Article							BODY-MASS INDEX; APOLIPOPROTEIN-D EXPRESSION; FREE MESSENGER-RNA; CELL-FREE DNA; AMNIOTIC-FLUID; PREFRONTAL CORTEX; OXIDATIVE STRESS; NERVOUS-SYSTEM; PREGNANCY; DISEASE	Objective: One in three pregnant women in the United States is obese. Their offspring are at increased risk for neurodevelopmental and metabolic morbidity. Underlying molecular mechanisms are poorly understood. We performed a global gene expression analysis of mid-trimester amniotic fluid cell-free fetal RNA in obese versus lean pregnant women. Methods: This prospective pilot study included eight obese (BMI >= 30) and eight lean (BMI<25) women undergoing clinically indicated mid-trimester genetic amniocentesis. Subjects were matched for gestational age and fetal sex. Fetuses with abnormal karyotype or structural anomalies were excluded. Cell-free fetal RNA was extracted from amniotic fluid and hybridized to whole genome expression arrays. Genes significantly differentially regulated in 8/8 obese-lean pairs were identified using paired t-tests with the Benjamini-Hochberg correction (false discovery rate of <0.05). Biological interpretation was performed with Ingenuity Pathway Analysis and the BioGPS gene expression atlas. Results: In fetuses of obese pregnant women, 205 genes were significantly differentially regulated. Apolipoprotein D, a gene highly expressed in the central nervous system and integral to lipid regulation, was the most up-regulated gene (9-fold). Apoptotic cell death was significantly down-regulated, particularly within nervous system pathways involving the cerebral cortex. Activation of the transcriptional regulators estrogen receptor, FOS, and STAT3 was predicted in fetuses of obese women, suggesting a pro-estrogenic, pro-inflammatory milieu. Conclusion: Maternal obesity affects fetal neurodevelopmental and metabolic gene expression as early as the second trimester. These findings may have implications for postnatal neurodevelopmental and metabolic abnormalities described in the offspring of obese women.	[Edlow, Andrea G.; Vora, Neeta L.; Hui, Lisa; Bianchi, Diana W.] Tufts Med Ctr, Mother Infant Res Inst, Boston, MA 02111 USA; [Wick, Heather C.] Tufts Univ, Dept Comp Sci, Medford, MA 02155 USA; [Cowan, Janet M.] Tufts Med Ctr, Dept Pathol & Lab Med, Boston, MA USA	Tufts Medical Center; Tufts University; Tufts Medical Center	Edlow, AG (corresponding author), Tufts Med Ctr, Mother Infant Res Inst, Boston, MA 02111 USA.	aedlow@tuftsmedicalcenter.org	Hui, Lisa/H-7109-2019	Hui, Lisa/0000-0002-9720-3562; Vora, Neeta/0000-0002-2504-9455; Edlow, Andrea/0000-0003-2915-5949	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R01 HD42053-10, R01 HD058880]; EPSRC [EP/F009429/2, EP/J016934/1, EP/F009429/1, EP/J016934/2] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042053, R01HD058880] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) awards R01 HD42053-10 and R01 HD058880. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix, 2012, NA33 REL HG U133 PLU; Armitage JA, 2008, FRONT HORM RES, V36, P73, DOI 10.1159/000115355; BAKER WA, 1994, DIABETIC MED, V11, P947, DOI 10.1111/j.1464-5491.1994.tb00252.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bianchi DW, 2001, CLIN CHEM, V47, P1867; Blaschke AJ, 1998, J COMP NEUROL, V396, P39, DOI 10.1002/(SICI)1096-9861(19980622)396:1<39::AID-CNE4>3.0.CO;2-J; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Choi KH, 2009, J PSYCHIATR NEUROSCI, V34, P450; Clementi AH, 2009, BBA-MOL BASIS DIS, V1792, P1062, DOI 10.1016/j.bbadis.2009.08.007; Crespo PS, 2007, PUBLIC HEALTH NUTR, V10, P1121, DOI 10.1017/S1368980007000596; Dietz JA, 2011, PRENATAL DIAG, V31, P598, DOI 10.1002/pd.2732; Durchdewald M, 2009, HISTOL HISTOPATHOL, V24, P14451, DOI 10.14670/HH-24.1451; Edlow AG, 2012, BBA-MOL BASIS DIS, V1822, P1970, DOI 10.1016/j.bbadis.2012.04.005; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flori E, 2004, HUM REPROD, V19, P723, DOI 10.1093/humrep/deh117; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gentleman R, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1034; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Greenhill CJ, 2011, J IMMUNOL, V186, P1199, DOI 10.4049/jimmunol.1002971; Guibert J, 2003, HUM REPROD, V18, P1733, DOI 10.1093/humrep/deg320; Hastings NE, 2007, AM J PHYSIOL-CELL PH, V293, pC1824, DOI 10.1152/ajpcell.00385.2007; He X, 2009, NEUROSCI LETT, V455, P183, DOI 10.1016/j.neulet.2009.03.038; Heerwagen MJR, 2010, AM J PHYSIOL-REG I, V299, pR711, DOI 10.1152/ajpregu.00310.2010; Heikura U, 2008, AM J EPIDEMIOL, V167, P169, DOI 10.1093/aje/kwm291; HERBST AL, 1971, NEW ENGL J MED, V284, P878, DOI 10.1056/NEJM197104222841604; Hinkle SN, 2012, INT J OBESITY, V36, P1312, DOI 10.1038/ijo.2012.143; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Hui L, 2013, PRENAT DIAGN; Hui L, 2013, OBSTET GYNECOL, V121, P1248, DOI 10.1097/AOG.0b013e318293d70b; Hui LS, 2012, HUM GENET, V131, P1751, DOI 10.1007/s00439-012-1195-x; Hui L, 2012, OBSTET GYNECOL, V119, P111, DOI 10.1097/AOG.0b013e31823d4150; IPA website, 2013, CALC INT P VAL FUNCT; IPA website, 2013, ING UPSTR REG AN WHI; Jolliffee I.T., 2002, PRINCIPAL COMPONENT; Khan MM, 2003, J NEUROCHEM, V86, P1089, DOI 10.1046/j.1471-4159.2003.01866.x; Kim SY, 2007, OBESITY, V15, P986, DOI 10.1038/oby.2007.621; Kim WS, 2009, J NEUROCHEM, V109, P1053, DOI 10.1111/j.1471-4159.2009.06031.x; Kirk SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005870; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Koide K, 2011, HUM GENET, V129, P295, DOI 10.1007/s00439-010-0923-3; Kosacka J, 2009, NEUROSCIENCE, V162, P282, DOI 10.1016/j.neuroscience.2009.04.073; Krakowiak P, 2012, PEDIATRICS, V129, pE1121, DOI 10.1542/peds.2011-2583; Lapaire O, 2007, CLIN CHEM, V53, P405, DOI 10.1373/clinchem.2006.076083; Larrabee PB, 2005, JAMA-J AM MED ASSOC, V293, P836, DOI 10.1001/jama.293.7.836; Lawlor DA, 2007, AM J EPIDEMIOL, V165, P418, DOI 10.1093/aje/kwk030; Liu ZT, 2001, FASEB J, V15, P1329, DOI 10.1096/fj.00-0530fje; Lun FMF, 2007, CLIN CHEM, V53, P796, DOI 10.1373/clinchem.2006.084350; Mahadik SP, 2002, SCHIZOPHR RES, V58, P55, DOI 10.1016/S0920-9964(01)00378-4; Makrydimas G, 2008, ULTRASOUND OBST GYN, V32, P594, DOI 10.1002/uog.6117; Massingham LJ, 2011, J MOL DIAGN, V13, P565, DOI 10.1016/j.jmoldx.2011.05.008; Masuzaki H, 2004, J MED GENET, V41, P289, DOI 10.1136/jmg.2003.015784; Min W, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-8; Morton GJ, 2011, PHYSIOL REV, V91, P389, DOI 10.1152/physrev.00007.2010; Neggers YH, 2003, ACTA OBSTET GYN SCAN, V82, P235, DOI 10.1034/j.1600-0412.2003.00090.x; Newbold RR, 2011, AM J CLIN NUTR, V94, p1939S, DOI 10.3945/ajcn.110.001057; Niculescu MD, 2009, INT J DEV NEUROSCI, V27, P627, DOI 10.1016/j.ijdevneu.2009.08.005; Olson N Eric, 2006, NeuroRx, V3, P373; Ordonez C, 2006, HISTOL HISTOPATHOL, V21, P361, DOI 10.14670/HH-21.361; Patel MP, 2009, CURR OPIN ONCOL, V21, P516, DOI 10.1097/CCO.0b013e328331a7a4; Pavlidis P, 2003, BIOINFORMATICS, V19, P1620, DOI 10.1093/bioinformatics/btg227; Pennings JLA, 2011, PRENATAL DIAG, V31, P1153, DOI 10.1002/pd.2850; Perdomo G, 2010, J LIPID RES, V51, P1298, DOI 10.1194/jlr.M001206; Peter I, 2008, DIAGN MOL PATHOL, V17, P185, DOI 10.1097/PDM.0b013e31815bcdb6; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Rodriguez A, 2008, INT J OBESITY, V32, P550, DOI 10.1038/sj.ijo.0803741; Romero R, 2006, AM J OBSTET GYNECOL, V195, P360, DOI 10.1016/j.ajog.2006.06.077; Slonim DK, 2009, P NATL ACAD SCI USA, V106, P9425, DOI 10.1073/pnas.0903909106; Stachowiak EK, 2013, NUTR NEUROSCI, V16, P96, DOI 10.1179/1476830512Y.0000000035; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tanda R, 2013, MATERN CHILD HLTH J, V17, P222, DOI 10.1007/s10995-012-0964-4; Thomas EA, 2003, BIOL PSYCHIAT, V54, P136, DOI 10.1016/S0006-3223(02)01976-5; Thomas EA, 2001, P NATL ACAD SCI USA, V98, P4066, DOI 10.1073/pnas.071056198; VIJAYARAGHAVAN S, 1994, J CLIN ENDOCR METAB, V79, P568, DOI 10.1210/jc.79.2.568; White CL, 2009, NEUROBIOL DIS, V35, P3, DOI 10.1016/j.nbd.2009.04.002; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Hristoskova Sashka, 2006, Archives of Gynecology and Obstetrics, V274, P25, DOI 10.1007/s00404-005-0109-8	77	51	51	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88661	10.1371/journal.pone.0088661	http://dx.doi.org/10.1371/journal.pone.0088661			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558408	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700054
J	Candia, CNH; Gutierrez-Medina, B				Hernandez Candia, Carmen Noemi; Gutierrez-Medina, Braulio			Direct Imaging of Phase Objects Enables Conventional Deconvolution in Bright Field Light Microscopy	PLOS ONE			English	Article							MODEL	In transmitted optical microscopy, absorption structure and phase structure of the specimen determine the three-dimensional intensity distribution of the image. The elementary impulse responses of the bright field microscope therefore consist of separate absorptive and phase components, precluding general application of linear, conventional deconvolution processing methods to improve image contrast and resolution. However, conventional deconvolution can be applied in the case of pure phase (or pure absorptive) objects if the corresponding phase (or absorptive) impulse responses of the microscope are known. In this work, we present direct measurements of the phase point-and line-spread functions of a high-aperture microscope operating in transmitted bright field. Polystyrene nanoparticles and microtubules (biological polymer filaments) serve as the pure phase point and line objects, respectively, that are imaged with high contrast and low noise using standard microscopy plus digital image processing. Our experimental results agree with a proposed model for the response functions, and confirm previous theoretical predictions. Finally, we use the measured phase point-spread function to apply conventional deconvolution on the bright field images of living, unstained bacteria, resulting in improved definition of cell boundaries and sub-cellular features. These developments demonstrate practical application of standard restoration methods to improve imaging of phase objects such as cells in transmitted light microscopy.	[Hernandez Candia, Carmen Noemi] Inst Potosino Invest Cient & Tecnol, Program Mol Biol, San Luis Potosi, Mexico; [Gutierrez-Medina, Braulio] Inst Potosino Invest Cient & Tecnol, Adv Mat Div, San Luis Potosi, Mexico	Instituto Potosino Investigacion Cientifica y Tecnologica; Instituto Potosino Investigacion Cientifica y Tecnologica	Gutierrez-Medina, B (corresponding author), Inst Potosino Invest Cient & Tecnol, Adv Mat Div, San Luis Potosi, Mexico.	bgutierrez@ipicyt.edu.mx		Gutierrez-Medina, Braulio/0000-0003-2810-6774	Fondos Sectoriales-SEP from Consejo Nacional de Ciencia y Tecnologia (CONACYT) [CB-2009/133053]	Fondos Sectoriales-SEP from Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grant Fondos Sectoriales-SEP-2009 (CB-2009/133053) from Consejo Nacional de Ciencia y Tecnologia (CONACYT, http://www.conacyt.gob.mx) to BG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARD DA, 1984, ANNU REV BIOPHYS BIO, V13, P191; Agero U, 2004, MICROSC RES TECHNIQ, V65, P159, DOI 10.1002/jemt.20117; Aguet F, 2008, IEEE T IMAGE PROCESS, V17, P1144, DOI 10.1109/TIP.2008.924393; Barone-Nugent ED, 2002, J MICROSC-OXFORD, V206, P194, DOI 10.1046/j.1365-2818.2002.01027.x; BATCHELDER JS, 1989, APPL PHYS LETT, V55, P215, DOI 10.1063/1.102268; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Cole RW, 2011, NAT PROTOC, V6, P1929, DOI 10.1038/nprot.2011.407; Degerman J, 2007, PROC SPIE, V6498, DOI 10.1117/12.704096; Dougherty RP, 2005, 11 AIAA CEAS AER C A; ERHARDT A, 1985, APPL OPTICS, V24, P194, DOI 10.1364/AO.24.000194; Gaskill J.D., 1978, LINEAR SYSTEMS FOURI; Gonzalez R.C., 2008, DIGITAL IMAGE PROCES; Goodman J W, 1996, INTRO FOURIER OPTICS; Gross H, 2005, HANDBOOK OF OPTICAL SYSTEMS, VOL 2: PHYSICAL IMAGE FORMATION, P239; Hanser BM, 2004, J MICROSC-OXFORD, V216, P32, DOI 10.1111/j.0022-2720.2004.01393.x; Candia CNH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057383; Hoebe RA, 2007, NAT BIOTECHNOL, V25, P249, DOI 10.1038/nbt1278; Holmes TJ, 2000, J MICROSC-OXFORD, V200, P114, DOI 10.1046/j.1365-2818.2000.00751.x; Inoue S, 1995, HDB PHOTONICS, VII, P171; Inoue S, 1986, VIDEO MICROSCOPY; McNally JG, 1999, METHODS, V19, P373, DOI 10.1006/meth.1999.0873; Mir M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039816; Oberlaender M, 2009, J MICROSC-OXFORD, V233, P275, DOI 10.1111/j.1365-2818.2009.03118.x; Patire AD, 1997, THESIS MIT CAMBRIDGE; Reshes G, 2008, BIOPHYS J, V94, P251, DOI 10.1529/biophysj.107.104398; ROSSMANN K, 1969, RADIOLOGY, V93, P257, DOI 10.1148/93.2.257; Sibarita JB, 2005, ADV BIOCHEM ENG BIOT, V95, P201, DOI 10.1007/b102215; STREIBL N, 1985, J OPT SOC AM A, V2, P121, DOI 10.1364/JOSAA.2.000121; Swedlow JR, 2007, METHOD CELL BIOL, V81, P447, DOI 10.1016/S0091-679X(06)81021-6; Tadrous PJ, 2010, J MICROSC-OXFORD, V237, P192, DOI 10.1111/j.1365-2818.2009.03323.x; van de Hulst H.C., 1981, LIGHT SCATTERING SMA; Vissapragada SS, 2008, THESIS DREXEL U PHIL; Wallace W, 2001, BIOTECHNIQUES, V31, P1076, DOI 10.2144/01315bi01; ZERNIKE F, 1955, SCIENCE, V121, P345, DOI 10.1126/science.121.3141.345	34	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89106	10.1371/journal.pone.0089106	http://dx.doi.org/10.1371/journal.pone.0089106			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558478	gold, Green Published			2022-12-27	WOS:000331706700124
J	Muise, ES; Zhu, YH; Verras, A; Karanam, BV; Gorski, J; Weingarth, D; Lin, HV; Hwa, J; Thompson, JR; Hu, GH; Liu, J; He, SW; DeVita, RJ; Shen, DM; Pinto, S				Muise, Eric S.; Zhu, Yonghua; Verras, Andreas; Karanam, Bindhu V.; Gorski, Judith; Weingarth, Drew; Lin, Hua V.; Hwa, Joyce; Thompson, John R.; Hu, Guanghui; Liu, Jian; He, Shuwen; DeVita, Robert J.; Shen, Dong-Ming; Pinto, Shirly			Identification and Characterization of Sebaceous Gland Atrophy-Sparing DGAT1 Inhibitors	PLOS ONE			English	Article							COA-DIACYLGLYCEROL ACYLTRANSFERASE; SKIN; DEFICIENCY; MECHANISM; GENE	Inhibition of Diacylglycerol O-acyltransferase 1 (DGAT1) has been a mechanism of interest for metabolic disorders. DGAT1 inhibition has been shown to be a key regulator in an array of metabolic pathways; however, based on the DGAT1 KO mouse phenotype the anticipation is that pharmacological inhibition of DGAT1 could potentially lead to skin related adverse effects. One of the aims in developing small molecule DGAT1 inhibitors that target key metabolic tissues is to avoid activity on skin-localized DGAT1 enzyme. In this report we describe a modeling-based approach to identify molecules with physical properties leading to differential exposure distribution. In addition, we demonstrate histological and RNA based biomarker approaches that can detect sebaceous gland atrophy pre-clinically that could be used as potential biomarkers in a clinical setting.	[Muise, Eric S.; Zhu, Yonghua; Verras, Andreas; Karanam, Bindhu V.; Gorski, Judith; Weingarth, Drew; Lin, Hua V.; Hwa, Joyce; Thompson, John R.; Hu, Guanghui; Liu, Jian; He, Shuwen; DeVita, Robert J.; Shen, Dong-Ming; Pinto, Shirly] Merck Res Labs, Discovery & Preclin Sci, Whithouse Stn, NJ 08889 USA	Merck & Company	Pinto, S (corresponding author), Merck Res Labs, Discovery & Preclin Sci, Whithouse Stn, NJ 08889 USA.	shirly_pinto@merck.com		Lin, Hua/0000-0001-5001-5567; Muise, Eric/0000-0002-1238-5118	Merck	Merck(Merck & Company)	Merck provided all funds for this work. All authors are current or former employees of Merck and may own stock or hold stock options in Merck. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Birch AM, 2010, CURR OPIN DRUG DISC, V13, P489; Cao JS, 2011, J BIOL CHEM, V286, P41838, DOI 10.1074/jbc.M111.245456; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Chen HC, 2002, J CLIN INVEST, V109, P175, DOI 10.1172/JCI0213880; Chen HC, 2002, ENDOCRINOLOGY, V143, P2893, DOI 10.1210/en.143.8.2893; Denison H, 2013, DIABETES OBES METAB, V15, P136, DOI 10.1111/dom.12002; Denison H, 2013, DIABETES OBES METAB, DOI [10.1111/dom.12221, DOI 10.1111/D0M.12221]; DeVita RJ, 2013, J MED CHEM, V56, P9820, DOI 10.1021/jm4007033; Gombert M, 2005, J IMMUNOL, V174, P5082, DOI 10.4049/jimmunol.174.8.5082; Hinde E, 2013, EXP DERMATOL, V22, P631, DOI 10.1111/exd.12207; Liao CZ, 2009, J CHEM INF MODEL, V49, P2801, DOI 10.1021/ci900289x; Lin HV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054480; Liu JQ, 2013, OBESITY, V21, P1406, DOI 10.1002/oby.20193; STEWART ME, 1991, ADV LIPID RES, V24, P263; Terao M, 2009, MOL CELL BIOL, V29, P357, DOI 10.1128/MCB.01385-08; Thiboutot D, 1998, J INVEST DERMATOL, V111, P390, DOI 10.1046/j.1523-1747.1998.00322.x; Turkish A, 2007, AM J PHYSIOL-GASTR L, V292, pG953, DOI 10.1152/ajpgi.00509.2006; Zheng Y, 2001, GENOMICS, V71, P182, DOI 10.1006/geno.2000.6429	18	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88908	10.1371/journal.pone.0088908	http://dx.doi.org/10.1371/journal.pone.0088908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558447	Green Submitted, Green Published, gold			2022-12-27	WOS:000331706700093
J	Ong'ang'o, JR; Mwachari, C; Kipruto, H; Karanja, S				Ong'ang'o, Jane Rahedi; Mwachari, Christina; Kipruto, Hillary; Karanja, Simon			The Effects on Tuberculosis Treatment Adherence from Utilising Community Health Workers: A Comparison of Selected Rural and Urban Settings in Kenya	PLOS ONE			English	Article							DOT; DECENTRALIZATION; DISTRICT; PROGRAM; CARE	Introduction: Community Health Workers (CHWs) have been utilised for various primary health care activities in different settings especially in developing countries. Usually when utilised in well defined terms, they have a positive impact. To support Kenya's policy on engagement of CHWs for tuberculosis (TB) control, there is need to demonstrate effects of utilising them. Objectives: This study assessed TB treatment adherence among patients who utilised CHWs in management of their illness in comparison to those who did not in urban and rural settings. Methods: A retrospective cohort study was conducted in selected health facilities using standard clinical records for each TB patient registered for treatment between 2005 to 2011. Qualitative data was collected from CHWs and health care providers. Results: The study assessed 2778 tuberculosis patients and among them 1499 (54%) utilized CHWs for their TB treatment. The urban setting in comparison with the rural setting contributed 70% of patients utilising the CHWs (p<0.001). Overall treatment adherence of the cohort was 79%. Categorizing by use of CHWs, adherence among patients who had utilized CHWs was 83% versus 68% among those that had not (p<0.001). In comparison between the rural and urban settings adherence was 76% and 81.5% (p<0.001) respectively and when categorized by use of CHWs it was 73% and 90% (p<0.001) for the rural and urban set ups respectively. Utilisation of CHWs remained significant in enhancing treatment adherence in the cohort with unadjusted and adjusted ORs; OR 2.25, (95% 1.86-2.73) p<0.001 and OR 1.98 (95% 1.51-2.5) p<0.001 respectively. It was most effective in the urban set-up, OR 2.65 (95% 2.02-3.48, p<0.001) in comparison to the rural set up, OR 0.74 (95% 0.56-0.97) p = 0.032. Conclusion: Utilisation of CHWs enhanced TB treatment adherence and the best effects were in the urban set-up.	[Ong'ang'o, Jane Rahedi; Mwachari, Christina] Kenya Med Res Inst KEMRI, Ctr Resp Dis Res, Nairobi, Kenya; [Kipruto, Hillary] World Hlth Org WHO, Kenya Country Off, Nairobi, Kenya; [Karanja, Simon] Jomo Kenyatta Univ Agr & Technol JKUAT, Coll Hlth Sci, Nairobi, Kenya	Kenya Medical Research Institute; World Health Organization; Jomo Kenyatta University of Agriculture & Technology	Ong'ang'o, JR (corresponding author), Kenya Med Res Inst KEMRI, Ctr Resp Dis Res, Nairobi, Kenya.	jrnabongo@gmail.com	Kipruto, Hillary/ABB-7126-2021; Amboko, Rashidi/D-9046-2015		Pan African Thoracic Society	Pan African Thoracic Society	This work was supported by Pan African Thoracic Society (www.africanthoracic.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adatu F, 2003, INT J TUBERC LUNG D, V7, pS63; [Anonymous], 2003, ADHERENCE LONG TERM; Bagchi S, 2010, INT J PREVENTIVE MED, V1, P223; Brownstein JN, 2005, AM J PREV MED, V29, P128, DOI 10.1016/j.amepre.2005.07.024; Byakika-Tusiime J, 2005, INT J STD AIDS, V16, P38, DOI 10.1258/0956462052932548; Cavalcante SC, 2007, INT J TUBERC LUNG D, V11, P544; Clarke M, 2005, INT J TUBERC LUNG D, V9, P673; Daniel O, 2004, 15 INT AIDS C BANGK; Delacollette C, 1996, B WORLD HEALTH ORGAN, V74, P423; Dick J, 1996, TUBERCLE LUNG DIS, V77, P274, DOI 10.1016/S0962-8479(96)90013-1; Dick J, 1997, S AFR MED J, V87, P1042; Dick J, 2005, OPERATIONS RES RESUL; Egwaga S, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-80; Friedman I, 2002, SEED TRUST HLTH PROG, V9, P176; Hill RC, 2005, INT J TUBERC LUNG D, V9, P1349; Kahssay HM., 1998, COMMUNITY HLTH WORKE; Kalyango JN, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-282; Kangangi JK, 2003, INT J TUBERC LUNG D, V7, pS5; Kironde S, 2002, INT J TUBERC LUNG D, V6, P104; Kironde Samson, 2002, Afr Health Sci, V2, P73; Lariosa Theresita R., 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P30; Lehmann U, 2004, 41 HUM RES HLTH DEV; Love MB, 1992, EMERGING ROLE COMMUN; Macq JCM, 2003, INT J TUBERC LUNG D, V7, P103; Maher D, 1999, INT J TUBERC LUNG D, V3, P762; MENON A, 1991, J TROP MED HYG, V94, P268; MENZIES R, 1993, TUBERCLE LUNG DIS, V74, P32, DOI 10.1016/0962-8479(93)90066-7; Ministry of Public Health and Sanitation Kenya, 2011, DIV LEPR TUB LUNG DI; Mkopi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051828; Nackers F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032140; Newell JN, 2006, LANCET, V367, P903, DOI 10.1016/S0140-6736(06)68380-3; Nyirenda TE, 2003, INT J TUBERC LUNG D, V7, pS21; NYONATOR FK, 2003, GHANA COMMUNITY HLTH; Okanurak K, 1996, ACTA TROP, V61, P157, DOI 10.1016/0001-706X(95)00115-U; Shargie EB, 2007, PLOS MED, V4, P280, DOI 10.1371/journal.pmed.0040037; Snider, 1982, B INT UNION TUBERC, V57, P247; SUMARTOJO E, 1993, AM REV RESPIR DIS, V147, P1311, DOI 10.1164/ajrccm/147.5.1311; Winch PJ, 2005, HEALTH POLICY PLANN, V20, P199, DOI 10.1093/heapol/czi027; World Health Organization, 1989, WHO TECHN SER, V780; World Health Organization, 2002, WHOCDSTB2002297; World Health Organization, 1994, WHOTB94179; Zvavamwe Z, 2009, INT J NURS STUD, V46, P302, DOI 10.1016/j.ijnurstu.2008.09.013	42	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88937	10.1371/journal.pone.0088937	http://dx.doi.org/10.1371/journal.pone.0088937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558452	Green Submitted, Green Published, gold			2022-12-27	WOS:000331706700098
J	Siu, KL; Miao, XN; Cai, H				Siu, Kin Lung; Miao, Xiao Niu; Cai, Hua			Recoupling of eNOS with Folic Acid Prevents Abdominal Aortic Aneurysm Formation in Angiotensin II-Infused Apolipoprotein E Null Mice	PLOS ONE			English	Article							ACCELERATED ATHEROSCLEROSIS; OXIDATIVE STRESS; VITAMIN-E; INFILTRATION; PATHOGENESIS; INHIBITION	We have previously shown that eNOS uncoupling mediates abdominal aortic aneurysm (AAA) formation in hph-1 mice. In the present study we examined whether recoupling of eNOS prevents AAA formation in a well-established model of Angiotensin II-infused apolipoprotein E (apoE) null mice by targeting some common pathologies of AAA. Infusion of Ang II resulted in a 92% incidence rate of AAA in the apoE null animals. In a separate group, animals were treated orally with folic acid (FA), which is known to recouple eNOS through augmentation of dihydrofolate reductase (DHFR) function. This resulted in a reduction of AAA rate to 19.5%. Imaging with ultrasound showed that FA markedly inhibited expansion of abdominal aorta. FA also abolished elastin breakdown and macrophage infiltration in the AAA animals. The eNOS uncoupling activity, assessed by L-NAME-sensitive superoxide production, was minimal at baseline but greatly exaggerated with Ang II infusion, which was completely attenuated by FA. This was accompanied by markedly improved tetrahydrobiopterin and nitric oxide bioavailability. Furthermore, the expression and activity of DHFR was decreased in Ang II-infused apoE null mice specifically in the endothelial cells, while FA administration resulted in its recovery. Taken together, these data further establish a significant role of uncoupled eNOS in mediating AAA formation, and a universal efficacy of FA in preventing AAA formation via restoration of DHFR to restore eNOS function.	[Cai, Hua] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Div Mol Med,Dept Anesthesiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Div Mol Med,Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Div Cardiol,Dept Anesthesiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Div Cardiol,Dept Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cai, H (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Div Mol Med,Dept Anesthesiol, Los Angeles, CA 90095 USA.	hcai@mednet.ucla.edu			National Institute of Health National Heart, Lung and Blood Institute (NHLBI) [HL077440, HL088975, HL108701, HL009968]; American Heart Association (AHA) [12EIA8990025]; AHA [11POST7140041]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108701, R01HL119968, R01HL088975, R01HL077440] Funding Source: NIH RePORTER	National Institute of Health National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association (AHA)(American Heart Association); AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institute of Health National Heart, Lung and Blood Institute (NHLBI) Grants HL077440 (HC), HL088975 (HC), HL108701 (HC, DGH), HL009968 (HC), an American Heart Association (AHA) Established Investigator Award (EIA) 12EIA8990025 (HC), and an AHA Postdoctoral Fellowship Award 11POST7140041 (KLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cafueri G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035312; Centers for Disease Control and Prevention National Center for Health Statistics, 2013, DAT COMP COMPR MORT, V2P; Chalupsky K, 2005, P NATL ACAD SCI USA, V102, P9056, DOI 10.1073/pnas.0409594102; Chen JQ, 2001, CIRCULATION, V104, P2391, DOI 10.1161/hc4501.099729; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Dikalova AE, 2010, AM J PHYSIOL-HEART C, V299, pH673, DOI 10.1152/ajpheart.00242.2010; DUBICK MA, 1987, P SOC EXP BIOL MED, V184, P138; Dubick MA, 1999, P SOC EXP BIOL MED, V220, P39, DOI 10.1046/j.1525-1373.1999.d01-6.x; Fatini C, 2005, J VASC SURG, V42, P415, DOI 10.1016/j.jvs.2005.05.044; Gao L, 2012, HYPERTENSION, V59, P158, DOI 10.1161/HYPERTENSIONAHA.111.181644; Gao L, 2009, J MOL CELL CARDIOL, V47, P752, DOI 10.1016/j.yjmcc.2009.07.025; Gavrila D, 2005, ARTERIOSCL THROM VAS, V25, P1671, DOI 10.1161/01.ATV.0000172631.50972.0f; Grigoryants V, 2005, J VASC SURG, V41, P108, DOI 10.1016/j.jvs.2004.09.033; HEINONEN OP, 1994, NEW ENGL J MED, V330, P1029; Johanning JM, 2001, J VASC SURG, V33, P579, DOI 10.1067/mva.2001.111805; Kuhlencordt PJ, 2001, CIRCULATION, V104, P448, DOI 10.1161/hc2901.091399; Michel JB, 2011, CARDIOVASC RES, V90, P18, DOI 10.1093/cvr/cvq337; Miller FJ, 2002, ARTERIOSCL THROM VAS, V22, P560, DOI 10.1161/01.ATV.0000013778.72404.30; Oak JH, 2007, DIABETES, V56, P118, DOI 10.2337/db06-0288; Qadura M, 2013, J VASC SURG, V57, P1676, DOI 10.1016/j.jvs.2013.02.013; Satoh K, 2009, NAT MED, V15, P649, DOI 10.1038/nm.1958; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Tamarat R, 2002, HYPERTENSION, V39, P830, DOI 10.1161/hy0302.104671; Thomas M, 2006, CIRCULATION, V114, P404, DOI 10.1161/CIRCULATIONAHA.105.607168; Tornwall ME, 2001, ATHEROSCLEROSIS, V157, P167, DOI 10.1016/S0021-9150(00)00694-8; Tsuruda T, 2008, CIRC RES, V102, P1368, DOI 10.1161/CIRCRESAHA.108.173682; Turner GH, 2009, J MAGN RESON IMAGING, V30, P455, DOI 10.1002/jmri.21843; Xiong WF, 2009, ATHEROSCLEROSIS, V202, P128, DOI 10.1016/j.atherosclerosis.2008.03.029; Yayama K, 2006, HYPERTENSION, V48, P958, DOI 10.1161/01.HYP.0000244108.30909.27	29	44	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88899	10.1371/journal.pone.0088899	http://dx.doi.org/10.1371/journal.pone.0088899			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558445	gold, Green Published, Green Submitted			2022-12-27	WOS:000331706700091
J	Tseliou, E; de Couto, G; Terrovitis, J; Sun, BM; Liu, WX; Marban, L; Marban, E				Tseliou, Eleni; de Couto, Geoffrey; Terrovitis, John; Sun, Baiming; Liu Weixin; Marban, Linda; Marban, Eduardo			Angiogenesis, Cardiomyocyte Proliferation and Anti-Fibrotic Effects Underlie Structural Preservation Post-Infarction by Intramyocardially-Injected Cardiospheres	PLOS ONE			English	Article							CARDIAC STEM-CELLS; ACUTE MYOCARDIAL-INFARCTION; VENTRICULAR ENLARGEMENT; PROGENITOR CELLS; HEART; COLLAGEN; REGENERATION; THERAPY; REPAIR; DIFFERENTIATION	Objective: We sought to understand the cellular and tissue-level changes underlying the attenuation of adverse remodeling by cardiosphere transplantation in acute myocardial infarction (MI). Background: Cardiospheres (CSps) are heart-derived multicellular clusters rich in stemness and capable of multilineage differentiation. Post-MI CSp transplantation improves left ventricular (LV) function and attenuates remodeling in both small and large animal studies. However, the mechanisms of benefit have not yet been fully elucidated. Methods: Four groups were studied: 1) "Sham'' (Wistar Kyoto rats with thoracotomy and ligature without infarction); 2) "MI'' (proximal LAD ligation with peri-infarct injection of vehicle); 3) "MI+CSp'' (MI with cardiospheres injected in the peri-infarct area); 4) "Small MI'' (mid-LAD ligation only). Results: In vivo 1 week after CSp transplantation, LV functional improvement was associated with an increase in cardiomyocyte proliferation. By 3 weeks, microvessel formation was enhanced, while cardiomyocyte hypertrophy and regional fibrosis were attenuated. Collagen deposition was reduced, collagen degradation was enhanced, and MMPs were upregulated. The beneficial effects of CSp transplantation were not observed in the Small MI group, indicating that the effects are not solely due to CSp-induced cardioprotection. In vitro, CSp-conditioned media reduced collagen production in coculture with fibroblasts and triggered neoangiogenesis in an ex vivo aortic ring assay. Conclusion: Cardiospheres enhance cardiomyocyte proliferation and angiogenesis, and attenuate hypertrophy and fibrosis, in the ischemic myocardium. These synergistic effects underlie the attenuation of adverse remodeling by cardiospheres.	[Tseliou, Eleni; de Couto, Geoffrey; Sun, Baiming; Liu Weixin; Marban, Linda; Marban, Eduardo] Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA; [Terrovitis, John] Univ Athens, Dept Cardiol 3, Athens, Greece	Cedars Sinai Medical Center; National & Kapodistrian University of Athens	Marban, E (corresponding author), Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA.	Eduardo.Marban@csmc.edu	Marban, Eduardo/GWC-8514-2022	de Couto, Geoffrey/0000-0002-1158-0560	California Institute of Regenerative Medicine	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine)	This work was supported by the California Institute of Regenerative Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Barile L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/354605; Bartosh TJ, 2008, J CELL BIOCHEM, V105, P612, DOI 10.1002/jcb.21862; Bradshaw AD, 2010, AM J PHYSIOL-HEART C, V298, pH614, DOI 10.1152/ajpheart.00474.2009; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; Braunwald E, 2013, J CLIN INVEST, V123, P6, DOI 10.1172/JCI67541; Chande M, 2001, LANCET, V357, P1099, DOI 10.1016/S0140-6736(00)04314-2; Chen LJ, 2012, STEM CELLS DEV, V21, P2122, DOI 10.1089/scd.2011.0463; Cheng K, 2012, STEM CELLS, V30, P2835, DOI 10.1002/stem.1184; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Costa EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070072; Davis DR, 2010, J MOL CELL CARDIOL, V49, P312, DOI 10.1016/j.yjmcc.2010.02.019; Davis DR, 2010, STEM CELLS, V28, P903, DOI 10.1002/stem.413; Davis DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007195; Duan Y, 2011, J CARDIOVASC TRANSL, V4, P605, DOI 10.1007/s12265-011-9304-0; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; Eschenhagen T, 2011, CIRC RES, V109, P1, DOI 10.1161/CIRCRESAHA.111.248039; Fernandes S, 2010, J MOL CELL CARDIOL, V49, P941, DOI 10.1016/j.yjmcc.2010.09.008; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Gaetani R, 2010, J CELL MOL MED, V14, P1071, DOI 10.1111/j.1582-4934.2010.01078.x; Gersh BJ, 2009, MAYO CLIN PROC, V84, P876, DOI 10.1016/S0025-6196(11)60505-3; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; GROSSMAN W, 1975, J CLIN INVEST, V56, P56, DOI 10.1172/JCI108079; Heinrich EM, 2012, CIRC RES, V110, P1014, DOI 10.1161/CIRCRESAHA.111.243394; Hirt MN, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0307-z; Ibrahim AG, 2012, AHA SCI SESSIONS; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kanazawa H, 2011, CIRCULATION, V124; KLONER RA, 1980, CIRCULATION, V62, P945, DOI 10.1161/01.CIR.62.5.945; Kshitiz, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003002; Laflamme MA, 2002, CIRC RES, V90, P634, DOI 10.1161/01.RES.0000014822.62629.EB; Lauden L, 2013, CIRC RES, V112, P451, DOI 10.1161/CIRCRESAHA.112.276501; Lee ST, 2011, J AM COLL CARDIOL, V57, P455, DOI 10.1016/j.jacc.2010.07.049; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Li TS, 2012, J AM COLL CARDIOL, V59, P942, DOI 10.1016/j.jacc.2011.11.029; Li TS, 2010, STEM CELLS, V28, P2088, DOI 10.1002/stem.532; Lipinski MJ, 2007, J AM COLL CARDIOL, V50, P1761, DOI 10.1016/j.jacc.2007.07.041; Lopez B, 2005, J HYPERTENS, V23, P1445, DOI 10.1097/01.hjh.0000173780.67308.f1; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Malliaras K, 2011, CLIN PHARMACOL THER, V90, P532, DOI 10.1038/clpt.2011.175; Malliaras K, 2013, EMBO MOL MED, V5, P191, DOI 10.1002/emmm.201201737; Malliaras K, 2012, CIRCULATION, V125, P100, DOI 10.1161/CIRCULATIONAHA.111.042598; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Mukherjee R, 2010, FASEB J, V24, P3819, DOI 10.1096/fj.10-155531; Nelson TJ, 2009, CIRCULATION, V120, P408, DOI 10.1161/CIRCULATIONAHA.109.865154; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Schwartz RS, 2002, NEW ENGL J MED, V346, P2, DOI 10.1056/NEJM200201033460102; Simpson DL, 2012, CIRCULATION, V126, pS46, DOI 10.1161/CIRCULATIONAHA.111.084699; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Spinale FG, 2011, CIRCULATION, V124, P2052, DOI 10.1161/CIRCULATIONAHA.111.064071; Sutton MS, 1997, CIRCULATION, V96, P3294; Tseliou E, 2013, J AM COLL CARDIOL, V61, P1108, DOI 10.1016/j.jacc.2012.10.052; WHITTAKER P, 1994, BASIC RES CARDIOL, V89, P397, DOI 10.1007/BF00788278; Ye JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030329; Yee K, 2011, AHA SCI SESSIONS; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613	61	47	48	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88590	10.1371/journal.pone.0088590	http://dx.doi.org/10.1371/journal.pone.0088590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558402	gold, Green Published, Green Submitted			2022-12-27	WOS:000331706700048
J	Zhao, YL; Zhang, J; Yuan, TJ; Shen, T; Li, W; Yang, SH; Hou, Y; Wang, YZ; Jin, H				Zhao, Yanli; Zhang, Ji; Yuan, Tianjun; Shen, Tao; Li, Wei; Yang, Shihua; Hou, Ying; Wang, Yuanzhong; Jin, Hang			Discrimination of Wild Paris Based on Near Infrared Spectroscopy and High Performance Liquid Chromatography Combined with Multivariate Analysis	PLOS ONE			English	Article							L.; LEAF	Different geographical origins and species of Paris obtained from southwestern China were discriminated by near infrared (NIR) spectroscopy and high performance liquid chromatography (HPLC) combined with multivariate analysis. The NIR parameter settings were scanning (64 times), resolution (4 cm(-1)), scanning range (10000 cm(-1)similar to 4000 cm(-1)) and parallel collection (3 times). NIR spectrum was optimized by TQ 8.6 software, and the ranges 7455 similar to 6852 cm(-1) and 5973 similar to 4007 cm(-1) were selected according to the spectrum standard deviation. The contents of polyphyllin I, polyphyllin II, polyphyllin VI, and polyphyllin VII and total steroid saponins were detected by HPLC. The contents of chemical components data matrix and spectrum data matrix were integrated and analyzed by partial least squares discriminant analysis (PLS-DA). From the PLS-DA model of NIR spectrum, Paris samples were separated into three groups according to the different geographical origins. The (RX)-X-2 and Q(2)Y described accumulative contribution rates were 99.50% and 94.03% of the total variance, respectively. The PLS-DA model according to 12 species of Paris described 99.62% of the variation in X and predicted 95.23% in Y. The results of the contents of chemical components described differences among collections quantitatively. A multivariate statistical model of PLS-DA showed geographical origins of Paris had a much greater influence on Paris compared with species. NIR and HPLC combined with multivariate analysis could discriminate different geographical origins and different species. The quality of Paris showed regional dependence.	[Zhao, Yanli; Zhang, Ji; Wang, Yuanzhong; Jin, Hang] Yunnan Acad Agr Sci, Inst Med Plants, Kunming, Yunnan, Peoples R China; [Yuan, Tianjun; Li, Wei; Yang, Shihua; Hou, Ying] Yunnan Reascend Tobacco Technol Grp Co Ltd, Kunming, Yunnan, Peoples R China; [Shen, Tao] Yuxi Normal Univ, Coll Resources & Environm, Yuxi, Yunnan, Peoples R China	Yunnan Academy of Agricultural Sciences; China National Tobacco Corporation; Yuxi Normal University	Wang, YZ (corresponding author), Yunnan Acad Agr Sci, Inst Med Plants, Kunming, Yunnan, Peoples R China.	boletus@126.com; jinhang2009@126.com	Zhang, Ji/B-2830-2013; zhao, yan/GWC-9174-2022; Lv, Yuanjie/AER-0767-2022	Zhang, Ji/0000-0002-7737-0785; 	National Natural Science Foundation of China [81260608, 81260610]; Special Fund for Agro-Scientific Research in the Public Interest [201303117]; Yunnan Provincial Natural Science Foundation [2013FD066, 2013FZ150]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-Scientific Research in the Public Interest; Yunnan Provincial Natural Science Foundation(Natural Science Foundation of Yunnan Province)	This work was supported by grants from National Natural Science Foundation of China (81260608 and 81260610), the Special Fund for Agro-Scientific Research in the Public Interest (201303117), the Yunnan Provincial Natural Science Foundation (2013FD066, 2013FZ150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HJ, 2013, J PHARMACEUT BIOMED, V85, P295, DOI 10.1016/j.jpba.2013.07.005; Chan E, 2010, CURR OPIN DRUG DISC, V13, P50; Chen QS, 2009, FOOD CHEM, V113, P1272, DOI 10.1016/j.foodchem.2008.08.042; [程建刚 CHENG Jiangang], 2009, [地理科学进展, Progress in Geography], V28, P18; Drasar P, 2004, J CHROMATOGR B, V812, P3, DOI 10.1016/j.jchromb.2004.09.037; Huck CW, 2005, ANAL CHIM ACTA, V538, P195, DOI 10.1016/j.aca.2005.01.064; Jiang Y, 2007, J PHARMACEUT BIOMED, V43, P341, DOI 10.1016/j.jpba.2006.06.030; Lee MS, 2005, CANCER BIOL THER, V4, P1248, DOI 10.4161/cbt.4.11.2136; Li H., 1986, BULL BOT RES, V6, P109; [李蒙 Li Meng], 2010, [中国农业气象, Chinese Journal of Agrometeorology], V31, P442; Li XD, 2012, EVID-BASED COMPL ALT, V12, P1; Louw ED, 2010, POSTHARVEST BIOL TEC, V58, P176, DOI 10.1016/j.postharvbio.2010.07.001; Man SL, 2009, ANAL BIOANAL CHEM, V395, P495, DOI 10.1007/s00216-009-2987-2; Manukyan A., 2011, MED AROMATIC PLANT S, V5, P119; Ong RCY, 2008, CANCER LETT, V261, P158, DOI 10.1016/j.canlet.2007.11.005; Otsuka M, 2001, ANALYST, V126, P1578, DOI 10.1039/b103498g; Qi LW, 2006, J CHROMATOGR A, V1134, P162, DOI 10.1016/j.chroma.2006.08.085; Siu FM, 2008, PROTEOMICS, V8, P3105, DOI 10.1002/pmic.200700829; [苏文华 Su Wenhua], 2003, [云南大学学报. 自然科学版, Journal of Yunnan University (Natural Science)], V25, P545; Suberu J, 2013, J PHARMACEUT BIOMED, V84, P269, DOI 10.1016/j.jpba.2013.06.025; Wu D, 2012, FOOD CHEM, V135, P2147, DOI 10.1016/j.foodchem.2012.07.011; [谢彩香 Xie Caixiang], 2011, [生态学报, Acta Ecologica Sinica], V31, P7551; Xie LJ, 2007, J FOOD ENG, V82, P395, DOI 10.1016/j.jfoodeng.2007.02.062; Yip PY, 2007, CHIN MED, V2, P1; Yu HY, 2009, FOOD CHEM, V113, P291, DOI 10.1016/j.foodchem.2008.06.083; Zhang JY, 2011, J ASIAN NAT PROD RES, V13, P670, DOI 10.1080/10286020.2011.578247; Zhang JinYu, 2012, African Journal of Pharmacy and Pharmacology, V6, P2802; Zhang L, 2013, J AGR FOOD CHEM, V61, P2597, DOI 10.1021/jf400428t; Zhao JL, 2010, MOLECULES, V15, P7961, DOI 10.3390/molecules15117961	29	44	51	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89100	10.1371/journal.pone.0089100	http://dx.doi.org/10.1371/journal.pone.0089100			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558477	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700123
J	Tu, LH; Hu, HL; Chen, G; Peng, Y; Xiao, YL; Hu, TX; Zhang, J; Li, XW; Liu, L; Tang, Y				Tu, Li-hua; Hu, Hong-ling; Chen, Gang; Peng, Yong; Xiao, Yin-long; Hu, Ting-xing; Zhang, Jian; Li, Xian-wei; Liu, Li; Tang, Yi			Nitrogen Addition Significantly Affects Forest Litter Decomposition under High Levels of Ambient Nitrogen Deposition	PLOS ONE			English	Article							TERRESTRIAL ECOSYSTEMS; PHOSPHORUS DYNAMICS; FOLIAR LITTER; RAINY AREA; CARBON; PATTERNS; RATES; PLANTATION; RELEASE; STORAGE	Background: Forest litter decomposition is a major component of the global carbon (C) budget, and is greatly affected by the atmospheric nitrogen (N) deposition observed globally. However, the effects of N addition on forest litter decomposition, in ecosystems receiving increasingly higher levels of ambient N deposition, are poorly understood. Methodology/Principal Findings: We conducted a two-year field experiment in five forests along the western edge of the Sichuan Basin in China, where atmospheric N deposition was up to 82-114 kg N ha(-1) in the study sites. Four levels of N treatments were applied: (1) control (no N added), (2) low-N (50 kg N ha(-1) year(-1)), (3) medium-N (150 kg N ha(-1) year(-1)), and (4) high-N (300 kg N ha(-1) year(-1)), N additions ranging from 40% to 370% of ambient N deposition. The decomposition processes of ten types of forest litters were then studied. Nitrogen additions significantly decreased the decomposition rates of six types of forest litters. N additions decreased forest litter decomposition, and the mass of residual litter was closely correlated to residual lignin during the decomposition process over the study period. The inhibitory effect of N addition on litter decomposition can be primarily explained by the inhibition of lignin decomposition by exogenous inorganic N. The overall decomposition rate of ten investigated substrates exhibited a significant negative linear relationship with initial tissue C/N and lignin/N, and significant positive relationships with initial tissue K and N concentrations; these relationships exhibited linear and logarithmic curves, respectively. Conclusions/Significance: This study suggests that the expected progressive increases in N deposition may have a potential important impact on forest litter decomposition in the study area in the presence of high levels of ambient N deposition.	[Tu, Li-hua; Hu, Hong-ling; Chen, Gang; Peng, Yong; Xiao, Yin-long; Hu, Ting-xing; Zhang, Jian; Li, Xian-wei] Sichuan Agr Univ, Coll Forestry, Yaan, Sichuan, Peoples R China; [Liu, Li] Sichuan Agr Univ, Maize Res Inst, Chengdu, Sichuan, Peoples R China; [Liu, Li] Sichuan Agr Univ, Personnel Dept, Chengdu, Sichuan, Peoples R China; [Tang, Yi] Sichuan Agr Univ, Coll Hort, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University	Hu, TX (corresponding author), Sichuan Agr Univ, Coll Forestry, Yaan, Sichuan, Peoples R China.	hutx001@163.com			National Natural Science Foundation, China [31300522]; Specialized Research Fund for the Doctoral Program of Higher Education, China [20125103120018]; Scientific Research Fund of Sichuan Provincial Education Department, China [12ZA118]; National Key Technology R&D Program of China [2011BAC09B05]; Program for Creative Group Construction in "211 Project'' of Sichuan Agricultural University	National Natural Science Foundation, China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education, China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Scientific Research Fund of Sichuan Provincial Education Department, China; National Key Technology R&D Program of China(National Key Technology R&D Program); Program for Creative Group Construction in "211 Project'' of Sichuan Agricultural University	This study was funded by the National Natural Science Foundation, China (No. 31300522), Specialized Research Fund for the Doctoral Program of Higher Education, China (No. 20125103120018), Scientific Research Fund of Sichuan Provincial Education Department, China (No. 12ZA118), National Key Technology R&D Program of China (No. 2011BAC09B05), and Program for Creative Group Construction in "211 Project'' of Sichuan Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Agren GI, 2001, OECOLOGIA, V128, P94, DOI 10.1007/s004420100646; Allison SD, 2009, SOIL BIOL BIOCHEM, V41, P293, DOI 10.1016/j.soilbio.2008.10.032; Berg B, 1986, SCAND J FOREST RES, V1, P359, DOI 10.1080/02827588609382428; Berg Bjorn, 1997, Environmental Reviews, V5, P1, DOI 10.1139/er-5-1-1; Carreiro MM, 2000, ECOLOGY, V81, P2359, DOI 10.1890/0012-9658(2000)081[2359:MESELD]2.0.CO;2; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Dentener F, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002672; Didham RK, 1998, OECOLOGIA, V116, P397, DOI 10.1007/s004420050603; Fang YT, 2011, J FOREST RES-JPN, V16, P341, DOI 10.1007/s10310-011-0267-4; FOG K, 1988, BIOL REV, V63, P433, DOI 10.1111/j.1469-185X.1988.tb00725.x; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Grimshaw H.M., 1989, CHEM ANAL ECOLOGICAL, V2nd, P81; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Hobbie SE, 2008, ECOLOGY, V89, P2633, DOI 10.1890/07-1119.1; Hobbie SE, 2012, ECOL MONOGR, V82, P389, DOI 10.1890/11-1600.1; Hobbie SE, 2005, ECOSYSTEMS, V8, P644, DOI 10.1007/s10021-003-0110-7; Hobbie SE, 2000, ECOLOGY, V81, P1867, DOI 10.1890/0012-9658(2000)081[1867:NLODIH]2.0.CO;2; Hogberg P, 2007, NATURE, V447, P781, DOI 10.1038/447781a; Holland EA, 2005, ECOL APPL, V15, P38, DOI 10.1890/03-5162; Hu ZY, 2007, PEDOSPHERE, V17, P360, DOI 10.1016/S1002-0160(07)60043-5; Jackson M. L., 1958, Soil Chemical Analysis.; Jia GD, 2010, ATMOS ENVIRON, V44, P2309, DOI 10.1016/j.atmosenv.2010.03.041; Jones J. B., 1990, SOIL TESTING PLANT A, P390; KEYSER P, 1978, J BACTERIOL, V135, P790, DOI 10.1128/JB.135.3.790-797.1978; Knops JMH, 2007, GLOBAL CHANGE BIOL, V13, P1960, DOI 10.1111/j.1365-2486.2007.01405.x; Knorr M, 2005, ECOLOGY, V86, P3252, DOI 10.1890/05-0150; KRUG FJ, 1979, ANALYST, V104, P47, DOI 10.1039/an9790400047; Liu XJ, 2011, ENVIRON POLLUT, V159, P2251, DOI 10.1016/j.envpol.2010.08.002; Magill AH, 1998, PLANT SOIL, V203, P301, DOI 10.1023/A:1004367000041; Manzoni S, 2010, ECOL MONOGR, V80, P89, DOI 10.1890/09-0179.1; Moore TR, 2006, ECOSYSTEMS, V9, P46, DOI 10.1007/s10021-004-0026-x; Olsen S. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P403; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; Prescott CE, 2010, BIOGEOCHEMISTRY, V101, P133, DOI 10.1007/s10533-010-9439-0; ROWLAND AP, 1994, COMMUN SOIL SCI PLAN, V25, P269, DOI 10.1080/00103629409369035; Sinsabaugh RL, 2010, SOIL BIOL BIOCHEM, V42, P391, DOI 10.1016/j.soilbio.2009.10.014; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Swift M. J., 1979, Decomposition in terrestrial ecosystems.; Ti CP, 2012, BIOGEOCHEMISTRY, V108, P381, DOI 10.1007/s10533-011-9606-y; Tu LH, 2013, PEDOSPHERE IN PRESS; Tu LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075862; Tu LH, 2013, SOIL BIOL BIOCHEM, V58, P255, DOI 10.1016/j.soilbio.2012.12.005; Tu Li-hua, 2012, Yingyong Shengtai Xuebao, V23, P2129; Tu LH, 2011, PLANT SOIL, V340, P383, DOI 10.1007/s11104-010-0610-0; Vestgarden LS, 2001, SOIL BIOL BIOCHEM, V33, P465, DOI 10.1016/S0038-0717(00)00187-5; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Waldrop MP, 2004, ECOL APPL, V14, P1172, DOI 10.1890/03-5120; [肖银龙 Xiao Yinlong], 2013, [生态学报, Acta Ecologica Sinica], V33, P7355; Xu ZF, 2013, ENVIRON POLLUT, V177, P201, DOI 10.1016/j.envpol.2012.12.031; Zhang DQ, 2008, J PLANT ECOL, V1, P85, DOI 10.1093/jpe/rtn002; Zhao X, 2009, WATER AIR SOIL POLL, V203, P277, DOI 10.1007/s11270-009-0011-2; Zhuang Ping, 2002, Shengwu Duoyangxing, V10, P339	54	39	43	14	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88752	10.1371/journal.pone.0088752	http://dx.doi.org/10.1371/journal.pone.0088752			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551152	Green Published, Green Submitted, gold			2022-12-27	WOS:000331271500064
J	Zhao, J; Kelnar, K; Bader, AG				Zhao, Jane; Kelnar, Kevin; Bader, Andreas G.			In-Depth Analysis Shows Synergy between Erlotinib and miR-34a	PLOS ONE			English	Article							CELL LUNG-CANCER; FACTOR RECEPTOR INHIBITORS; DRUG-COMBINATION; HIGH EXPRESSION; PHASE-II; GROWTH; RESISTANCE; GEFITINIB; EGFR; SENSITIVITY	Tyrosine kinase inhibitors directed against epidermal growth factor receptor (EGFR-TKI), such as erlotinib, are effective in a limited fraction of non-small cell lung cancer (NSCLC). However, the majority of NSCLC and other cancer types remain resistant. Therapeutic miRNA mimics modeled after endogenous tumor suppressor miRNAs inhibit tumor growth by repressing multiple oncogenes at once and, therefore, may be used to augment drug sensitivity. Here, we investigated the relationship of miR-34a and erlotinib and determined the therapeutic activity of the combination in NSCLC cells with primary and acquired erlotinib resistance. The drug combination was also tested in a panel of hepatocellular carcinoma cells (HCC), a cancer type known to be refractory to erlotinib. Using multiple analytical approaches, drug-induced inhibition of cancer cell proliferation was determined to reveal additive, antagonistic or synergistic effects. Our data show a strong synergistic interaction between erlotinib and miR-34a mimics in all cancer cells tested. Synergy was observed across a range of different dose levels and drug ratios, reducing IC50 dose requirements for erlotinib and miR-34a by up to 46-fold and 13-fold, respectively. Maximal synergy was detected at dosages that provide a high level of cancer cell inhibition beyond the one that is induced by the single agents alone and, thus, is of clinical relevance. The data suggest that a majority of NSCLC and other cancers previously not suited for erlotinib may prove sensitive to the drug when used in combination with a miR-34a-based therapy.	[Zhao, Jane; Kelnar, Kevin; Bader, Andreas G.] Mirna Therapeut Inc, Austin, TX 78744 USA		Bader, AG (corresponding author), Mirna Therapeut Inc, Austin, TX 78744 USA.	abader@mirnarx.com			National Institutes of Health [1R43CA134071, 1R43CA137939]; Cancer Prevention and Research Institute of Texas (CPRIT); NATIONAL CANCER INSTITUTE [R43CA137939, R43CA134071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas (CPRIT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health (1R43CA134071, 1R43CA137939, A.G.B.) and a commercialization grant from the Cancer Prevention and Research Institute of Texas (CPRIT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2011, CANCER LETT, V300, P197, DOI 10.1016/j.canlet.2010.10.006; American Cancer Society, 2013, CANC FACTS FIG 2013; Bader Andreas G., 2012, Frontiers in Genetics, V3, P120, DOI 10.3389/fgene.2012.00120; Bader AG, 2010, CANCER RES, V70, P7027, DOI 10.1158/0008-5472.CAN-10-2010; Bell DW, 2005, J CLIN ONCOL, V23, P8081, DOI 10.1200/JCO.2005.02.7078; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Fujimoto N, 2005, CANCER RES, V65, P11478, DOI 10.1158/0008-5472.CAN-05-1977; Fujita Y, 2008, BIOCHEM BIOPH RES CO, V377, P114, DOI 10.1016/j.bbrc.2008.09.086; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Gazdar AF, 2004, TRENDS MOL MED, V10, P481, DOI 10.1016/j.molmed.2004.08.008; Giles KM, 2013, MOL CANC THER; Gong YX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007273; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Herbst RS, 2005, J CLIN ONCOL, V23, P5892, DOI 10.1200/JCO.2005.02.840; Janmaat ML, 2003, CLIN CANCER RES, V9, P2316; Ji Q, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-266; Kaller M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010462; Kawano O, 2006, LUNG CANCER, V54, P209, DOI 10.1016/j.lungcan.2006.07.006; Kojima K, 2010, PROSTATE, V70, P1501, DOI 10.1002/pros.21185; Lal A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002363; Ling H, 2013, NAT REV DRUG DISCOV, V12, P847, DOI 10.1038/nrd4140; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Mudduluru G, 2011, ONCOGENE, V30, P2888, DOI 10.1038/onc.2011.13; Ono M, 2004, MOL CANCER THER, V3, P465; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Philip PA, 2005, J CLIN ONCOL, V23, P6657, DOI 10.1200/JCO.2005.14.696; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; Tallarida RJ, 2001, J PHARMACOL EXP THER, V298, P865; Tallarida RJ, 2006, J PHARMACOL EXP THER, V319, P1, DOI 10.1124/jpet.106.104117; Thomas MB, 2007, CANCER-AM CANCER SOC, V110, P1059, DOI 10.1002/cncr.22886; Van Schaeybroeck S, 2006, MOL CANCER THER, V5, P1154, DOI 10.1158/1535-7163.MCT-05-0446; Vinall RL, 2012, INT J CANCER, V130, P2526, DOI 10.1002/ijc.26256; Weeraratne SD, 2011, NEURO-ONCOLOGY, V13, P165, DOI 10.1093/neuonc/noq179; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Zhao J, 2013, MOL THER, V21, P1678, DOI 10.1038/mt.2013.148; Zhao Liang, 2010, Front Biosci (Elite Ed), V2, P241, DOI 10.2741/e86; Zhu AX, 2012, 37 ANN EUR SOC MED O	44	45	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89105	10.1371/journal.pone.0089105	http://dx.doi.org/10.1371/journal.pone.0089105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551227	Green Published, Green Submitted, gold			2022-12-27	WOS:000331271500099
J	Aring;ogren, J; Finn, M; Bengtsson, B; Segerman, B				Aogren, Joakim; Finn, Maria; Bengtsson, Bjorn; Segerman, Bo			Microevolution during an Anthrax Outbreak Leading to Clonal Heterogeneity and Penicillin Resistance	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; MYCOBACTERIUM-TUBERCULOSIS; SEQUENCE; PATIENT	Anthrax is a bacterial disease primarily affecting grazing animals but it can also cause severe disease in humans. We have used genomic epidemiology to study microevolution of the bacterium in a confined outbreak in cattle which involved emergence of an antibiotic-resistant phenotype. At the time of death, the animals contained a heterogeneous population of Single Nucleotide Variants (SNVs), some being clonal but most being subclonal. We found that independent isolates from the same carcass had similar levels of SNV differences as isolates from different animals. Furthermore the relative levels of subclonal populations were different in different locations in the same carcass. The heterogeneity appeared to be derived in part from heterogeneity in the infectious dose. The resistance phenotype was linked to clonal mutations in an anti-sigma factor gene and in one case was preceded by an acquisition of a hypermutator phenotype. In another animal, small subclonal populations were observed with counteracting mutations that had turned off the resistance genes. In summary, this study shows the importance of accounting for both acquired and inherited heterogeneity when doing high-resolution infection tracing and when estimating the risks associated with penicillin treatment.	[Aogren, Joakim; Segerman, Bo] Natl Vet Inst SVA, Dept Bacteriol, Uppsala, Sweden; [Finn, Maria; Bengtsson, Bjorn] Natl Vet Inst SVA, Dept Anim Hlth & Antimicrobial Strategies, Uppsala, Sweden; [Aogren, Joakim] Swedish Univ Agr Sci SLU, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden	National Veterinary Institute SVA; National Veterinary Institute SVA; Swedish University of Agricultural Sciences	Segerman, B (corresponding author), Natl Vet Inst SVA, Dept Bacteriol, Uppsala, Sweden.	bo.segerman@sva.se			EU-project AniBioThreat [Home/2009/ISEC/AG/191]; Prevention of and Fight against Crime Programme of the European Union; European Commission-Directorate General Home Affairs; Swedish Civil Contingencies Agency (MSB)	EU-project AniBioThreat; Prevention of and Fight against Crime Programme of the European Union; European Commission-Directorate General Home Affairs; Swedish Civil Contingencies Agency (MSB)	This work was supported by/executed in the framework of the EU-project AniBioThreat (grant agreement: Home/2009/ISEC/AG/191) with the financial support from the Prevention of and Fight against Crime Programme of the European Union, European Commission-Directorate General Home Affairs. This publication reflects the views only of the author, and the European Commission cannot be held responsible for any use which may be made of the information contained therein. This work was also supported by the Swedish Civil Contingencies Agency (MSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athamna A, 2004, J ANTIMICROB CHEMOTH, V54, P424, DOI 10.1093/jac/dkh258; BARNES JM, 1947, J PATHOL BACTERIOL, V59, P113, DOI 10.1002/path.1700590113; Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110; Casali N, 2012, GENOME RES, V22, P735, DOI 10.1101/gr.128678.111; Cavallo JD, 2002, ANTIMICROB AGENTS CH, V46, P2307, DOI 10.1128/AAC.46.7.2307-2309.2002; Chun JH, 2012, J BACTERIOL, V194, P4116, DOI 10.1128/JB.00159-12; *CLSI, 2010, A45A2 CLSI; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Kato-Maeda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058235; Keim P, 2009, MOL ASPECTS MED, V30, P397, DOI 10.1016/j.mam.2009.08.005; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Kupferschmidt K, 2011, SCIENCE, V333, P1818, DOI 10.1126/science.333.6051.1818; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee H, 2012, P NATL ACAD SCI USA, V109, pE2774, DOI 10.1073/pnas.1210309109; Liu Y., 2007, ELECT DNA ARRAYS DET; Luna VA, 2009, J MICROBIOL METH, V79, P301, DOI 10.1016/j.mimet.2009.09.023; Mayer TA, 2001, JAMA-J AM MED ASSOC, V286, P2549, DOI 10.1001/jama.286.20.2549; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Patra G, 2002, RES MICROBIOL, V153, P139, DOI 10.1016/S0923-2508(02)01299-8; PEREZLAGO L, 2013, J INFECT DIS; Price EP, 2012, EMERG INFECT DIS, V18, P1307, DOI 10.3201/eid1808.111343; Ringertz SH, 2000, LANCET, V356, P1574, DOI 10.1016/S0140-6736(00)03133-0; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Ross CL, 2009, J BACTERIOL, V191, P6683, DOI 10.1128/JB.00691-09; Sanchez H, 2007, MOL MICROBIOL, V65, P920, DOI 10.1111/j.1365-2958.2007.05835.x; STERN EJ, 2008, EMERGING INFECT DIS, V14; STOBER MG, 1979, CLIN EXAMINATION CAT; Swartz MN, 2001, NEW ENGL J MED, V345, P1621, DOI 10.1056/NEJMra012892; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Turnbull PCB, 2004, J CLIN MICROBIOL, V42, P3626, DOI 10.1128/jcm.42.8.3626-3634.2004; Turnbull PCB, 2008, ANTHRAX HUMANS ANIMA; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; Vogler AJ, 2002, ANTIMICROB AGENTS CH, V46, P511, DOI 10.1128/AAC.46.2.511-513.2002; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3	37	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89112	10.1371/journal.pone.0089112	http://dx.doi.org/10.1371/journal.pone.0089112			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551231	gold, Green Published, Green Submitted			2022-12-27	WOS:000331266000105
J	Wadood, A; Riaz, M; Uddin, R; ul-Haq, Z				Wadood, Abdul; Riaz, Muhammad; Uddin, Reaz; ul-Haq, Zaheer			In Silico Identification and Evaluation of Leads for the Simultaneous Inhibition of Protease and Helicase Activities of HCV NS3/4A Protease Using Complex Based Pharmacophore Mapping and Virtual Screening	PLOS ONE			English	Article							HEPATITIS-C VIRUS; DRUG DISCOVERY; PLUS RIBAVIRIN; PROTEINASE; NS4A; DOCKING; DESIGN; DOMAIN; MODEL	Hepatitis C virus (HCV) infection is an alarming and growing threat to public health. The present treatment gives limited efficacy and is poorly tolerated, recommending the urgent medical demand for novel therapeutics. NS3/4A protease is a significant emerging target for the treatment of HCV infection. This work reports the complex-based pharmacophore modeling to find out the important pharmacophoric features essential for the inhibition of both protease and helicase activity of NS3/4A protein of HCV. A seven featured pharmacophore model of HCV NS3/4A protease was developed from the crystal structure of NS3/4A protease in complex with a macrocyclic inhibitor interacting with both protease and helicase sites residues via MOE pharmacophore constructing tool. It consists of four hydrogen bond acceptors (Acc), one hydrophobic (Hyd), one for lone pair or active hydrogen (Atom L) and a heavy atom feature (Atom Q). The generated pharmacophore model was validated by a test database of seventy known inhibitors containing 55 active and 15 inactive/least active compounds. The validated pharmacophore model was used to virtually screen the ChemBridge database. As a result of screening 1009 hits were retrieved and were subjected to filtering by Lipinski's rule of five on the basis of which 786 hits were selected for further assessment using molecular docking studies. Finally, 15 hits of different scaffolds having interactions with important active site residues were predicted as lead candidates. These candidates having unique scaffolds have a strong likelihood to act as further starting points in the development of novel and potent NS3/4A protease inhibitors.	[Wadood, Abdul; Riaz, Muhammad] Abdul Wali Khan Univ Mardan, Dept Biochem, Computat Med Chem Lab, Mardan, Khyber Pakhthun, Pakistan; [Uddin, Reaz; ul-Haq, Zaheer] Univ Karachi, Dr Panjwani Ctr Mol Med & Drug Res, Karach, Sindh, Pakistan		Wadood, A (corresponding author), Abdul Wali Khan Univ Mardan, Dept Biochem, Computat Med Chem Lab, Mardan, Khyber Pakhthun, Pakistan.	awadood2001@yahoo.com	Ul-Haq, Zaheer/E-3061-2010; Uddin, Reaz/I-5673-2017; Wadood, Abdul/ABG-2789-2021	Ul-Haq, Zaheer/0000-0002-8530-8711; Uddin, Reaz/0000-0002-9928-4482; 				Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09; BARTENSCHLAGER R, 1995, J VIROL, V69, P7519, DOI 10.1128/JVI.69.12.7519-7528.1995; BARTENSCHLAGER R, 1994, J VIROL, V68, P5045, DOI 10.1128/JVI.68.8.5045-5055.1994; Beran RKF, 2008, J BIOL CHEM, V283, P29929, DOI 10.1074/jbc.M804065200; Beran RKF, 2007, J BIOL CHEM, V282, P34913, DOI 10.1074/jbc.M707165200; Brass V, 2008, P NATL ACAD SCI USA, V105, P14545, DOI 10.1073/pnas.0807298105; Chen KX, 2009, CURR OPIN INVEST DR, V10, P821; Clarke MO, 2011, BIOORG MED CHEM; Colvin HM, 2010, HEPATITIS AND LIVER CANCER: A NATIONAL STRATEGY FOR PREVENTION AND CONTROL OF HEPATITIS B AND C, P1; Debnath AK, 2003, J MED CHEM, V46, P4501, DOI 10.1021/jm030265z; Flisiak R, 2010, EXPERT OPIN INV DRUG, V19, P63, DOI 10.1517/13543780903431034; Fried M, 2002, AM POETRY REV, V31, P36; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Glunz PW, 2003, BIOORG MED CHEM LETT, V13, P785, DOI 10.1016/S0960-894X(03)00022-2; Hamid S., 2004, JPMA Journal of the Pakistan Medical Association, V54, P146; Han W, 2003, BIOORG MED CHEM LETT, V13, P1111, DOI 10.1016/S0960-894X(03)00031-3; Huang M, 2006, PROTEASES IN GASTROINTESTINAL TISSUES, P153; Ismail NSM, 2011, BIOORGAN MED CHEM, V19, P374, DOI 10.1016/j.bmc.2010.11.017; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; Koch JO, 1996, VIROLOGY, V221, P54, DOI 10.1006/viro.1996.0352; Kurogi Y, 2001, CURR MED CHEM, V8, P1035, DOI 10.2174/0929867013372481; Kwong AD, 2008, CURR OPIN PHARMACOL, V8, P522, DOI 10.1016/j.coph.2008.09.007; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Li XF, 2011, BIOORG MED CHEM LETT, V21, P2048, DOI 10.1016/j.bmcl.2011.02.006; Lindenbach B.D., 2001, FIELDS VIROLOGY, V1, P991, DOI DOI 10.1016/J.JMB.2013.11.024; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Lyne PD, 2002, DRUG DISCOV TODAY, V7, P1047, DOI 10.1016/S1359-6446(02)02483-2; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Melnikova I, 2011, NAT REV DRUG DISCOV, V10, P93, DOI 10.1038/nrd3361; Nizi E, 2004, BIOORG MED CHEM LETT, V14, P2151, DOI 10.1016/j.bmcl.2004.02.032; Reiser M, 2009, EXPERT REV ANTI-INFE, V7, P537, DOI 10.1586/ERI.09.30; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; SATOH S, 1995, J VIROL, V69, P4255, DOI 10.1128/JVI.69.7.4255-4260.1995; Schiering N, 2011, P NATL ACAD SCI USA, V108, P21052, DOI 10.1073/pnas.1110534108; TANJI Y, 1994, J VIROL, V68, P8418, DOI 10.1128/JVI.68.12.8418-8422.1994; Taremi SS, 1998, PROTEIN SCI, V7, P2143, DOI 10.1002/pro.5560071011; Wadood A, 2013, BIOINFORMATION, V9, P309, DOI 10.6026/97320630009309; Wadood A, 2012, CHEM BIOL DRUG DES, V79, P431, DOI 10.1111/j.1747-0285.2011.01281.x; Wands JR, 2004, NEW ENGL J MED, V351, P1567, DOI 10.1056/NEJMe048237; Wei J, 2007, J CHEM INF MODEL, V47, P613, DOI 10.1021/ci600410m; Yang SY, 2010, DRUG DISCOV TODAY, V15, P444, DOI 10.1016/j.drudis.2010.03.013	44	23	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89109	10.1371/journal.pone.0089109	http://dx.doi.org/10.1371/journal.pone.0089109			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551230	Green Submitted, Green Published, gold			2022-12-27	WOS:000331266000104
J	Kannan, S; Zacharias, M				Kannan, Srinivasaraghavan; Zacharias, Martin			Role of Tryptophan Side Chain Dynamics on the Trp-Cage Mini-Protein Folding Studied by Molecular Dynamics Simulations	PLOS ONE			English	Article							REPLICA-EXCHANGE SIMULATIONS; FREE-ENERGY LANDSCAPE; EXPLICIT SOLVENT; UNFOLDED STATE; FORCE-FIELD; MINIPROTEIN; WATER; RESOLUTION; COOPERATIVITY; INTERMEDIATE	The 20 residue Trp-cage mini-protein is one of smallest proteins that adopt a stable folded structure containing also well-defined secondary structure elements. The hydrophobic core is arranged around a single central Trp residue. Despite several experimental and simulation studies the detailed folding mechanism of the Trp-cage protein is still not completely understood. Starting from fully extended as well as from partially folded Trp-cage structures a series of molecular dynamics simulations in explicit solvent and using four different force fields was performed. All simulations resulted in rapid collapse of the protein to on average relatively compact states. The simulations indicate a significant dependence of the speed of folding to near-native states on the side chain rotamer state of the central Trp residue. Whereas the majority of intermediate start structures with the central Trp side chain in a near-native rotameric state folded successfully within less than 100 ns only a fraction of start structures reached near-native folded states with an initially non-native Trp side chain rotamer state. Weak restraining of the Trp side chain dihedral angles to the state in the folded protein resulted in significant acceleration of the folding both starting from fully extended or intermediate conformations. The results indicate that the side chain conformation of the central Trp residue can create a significant barrier for controlling transitions to a near native folded structure. Similar mechanisms might be of importance for the folding of other protein structures.	[Kannan, Srinivasaraghavan] Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore; [Kannan, Srinivasaraghavan] Agcy Sci Technol & Res, Ctr Expt Therapeut, Singapore, Singapore; [Zacharias, Martin] Tech Univ Munich, Phys Dept T38, Garching, Germany	Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); Experimental Therapeutics Centre; Technical University of Munich	Kannan, S (corresponding author), Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore.	raghavk@bii.a-star.edu.sg; Martin.Zacharias@ph.tum.de			DFG (Center of Integrated Protein Science Munich: CIPSM); European Union (PRACE-0 project) [pr89tu]; Joint Council Office (JCO) [11/03/FG/07/05]; Agency for Science, Technology and Research (A*STAR), Singapore	DFG (Center of Integrated Protein Science Munich: CIPSM); European Union (PRACE-0 project); Joint Council Office (JCO); Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	We thank the DFG (Center of Integrated Protein Science Munich: CIPSM), European Union (PRACE-0 project pr89tu) and Joint Council Office (JCO) (11/03/FG/07/05), Agency for Science, Technology and Research (A*STAR), Singapore, for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2005, J AM CHEM SOC, V127, P10943, DOI 10.1021/ja050664e; Barua B, 2001, LETT PEPT SCI, V8, P221, DOI 10.1007/BF02446520; Barua B, 2008, PROTEIN ENG DES SEL, V21, P171, DOI 10.1093/protein/gzm082; Beck DAC, 2007, J STRUCT BIOL, V157, P514, DOI 10.1016/j.jsb.2006.10.002; Case D, 2010, AMBER, V11; Chowdhury S, 2004, J PHYS CHEM B, V108, P13855, DOI 10.1021/jp0478920; Chowdhury S, 2003, J MOL BIOL, V327, P711, DOI 10.1016/S0022-2836(03)00177-3; Culik RM, 2011, ANGEW CHEM INT EDIT, V50, P10884, DOI 10.1002/anie.201104085; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Day R, 2010, PROTEINS, V78, P1889, DOI 10.1002/prot.22702; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deng NJ, 2013, J PHYS CHEM B, V117, P12787, DOI 10.1021/jp401962k; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Halabis A, 2012, J PHYS CHEM B, V116, P6898, DOI 10.1021/jp212630y; Han W, 2013, J PHYS CHEM B, V117, P13367, DOI 10.1021/jp404331d; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hu ZH, 2008, ARCH BIOCHEM BIOPHYS, V475, P140, DOI 10.1016/j.abb.2008.04.024; Hudaky P, 2008, BIOCHEMISTRY-US, V47, P1007, DOI 10.1021/bi701371x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Juraszek J, 2006, P NATL ACAD SCI USA, V103, P15859, DOI 10.1073/pnas.0606692103; Kannan S, 2007, PROTEINS, V66, P697, DOI 10.1002/prot.21258; Kannan S, 2009, INT J MOL SCI, V10, P1121, DOI 10.3390/ijms10031121; Kannan S, 2009, PROTEINS, V76, P448, DOI 10.1002/prot.22359; Lai ZZ, 2013, J PHYS CHEM B, V117, P4661, DOI 10.1021/jp309122b; Li DW, 2010, ANGEW CHEM INT EDIT, V49, P6778, DOI 10.1002/anie.201001898; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Marinelli F, 2013, BIOPHYS J, V105, P1236, DOI 10.1016/j.bpj.2013.07.046; Marinelli F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000452; Meuzelaar H, 2013, J PHYS CHEM B, V117, P11490, DOI 10.1021/jp404714c; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mok KH, 2007, NATURE, V447, P106, DOI 10.1038/nature05728; Neidigh JW, 2002, NAT STRUCT BIOL, V9, P425, DOI 10.1038/nsb798; Neuweiler H, 2005, P NATL ACAD SCI USA, V102, P16650, DOI 10.1073/pnas.0507351102; Ota M, 2004, P NATL ACAD SCI USA, V101, P17658, DOI 10.1073/pnas.0407015102; Paschek D, 2007, J STRUCT BIOL, V157, P524, DOI 10.1016/j.jsb.2006.10.031; Paschek D, 2008, P NATL ACAD SCI USA, V105, P17754, DOI 10.1073/pnas.0804775105; Pitera JW, 2003, P NATL ACAD SCI USA, V100, P7587, DOI 10.1073/pnas.1330954100; Qiu LL, 2002, J AM CHEM SOC, V124, P12952, DOI 10.1021/ja0279141; Rovo P, 2011, J PEPT SCI, V17, P610, DOI 10.1002/psc.1377; Scian M, 2012, P NATL ACAD SCI USA, V109, P12521, DOI 10.1073/pnas.1121421109; Shao Q, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4754656; Simmerling C, 2002, J AM CHEM SOC, V124, P11258, DOI 10.1021/ja0273851; Snow CD, 2002, J AM CHEM SOC, V124, P14548, DOI 10.1021/ja028604l; Williams DV, 2011, BIOCHEMISTRY-US, V50, P1143, DOI 10.1021/bi101555y; Xu WX, 2008, BIOPHYS CHEM, V137, P116, DOI 10.1016/j.bpc.2008.08.002; Yao XQ, 2008, BIOCHEM BIOPH RES CO, V373, P64, DOI 10.1016/j.bbrc.2008.05.179; Zheng WH, 2011, J PHYS CHEM B, V115, P1512, DOI 10.1021/jp1089596; Zhou RH, 2003, P NATL ACAD SCI USA, V100, P13280, DOI 10.1073/pnas.2233312100	50	18	18	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88383	10.1371/journal.pone.0088383	http://dx.doi.org/10.1371/journal.pone.0088383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24563686	gold, Green Submitted, Green Published			2022-12-27	WOS:000330834400064
J	Shojaie, A; Jauhiainen, A; Kallitsis, M; Michailidis, G				Shojaie, Ali; Jauhiainen, Alexandra; Kallitsis, Michael; Michailidis, George			Inferring Regulatory Networks by Combining Perturbation Screens and Steady State Gene Expression Profiles	PLOS ONE			English	Article							MODELS; CAUSALITY; SYSTEMS; RECONSTRUCTION; DISCOVERY	Reconstructing transcriptional regulatory networks is an important task in functional genomics. Data obtained from experiments that perturb genes by knockouts or RNA interference contain useful information for addressing this reconstruction problem. However, such data can be limited in size and/or are expensive to acquire. On the other hand, observational data of the organism in steady state (e.g., wild-type) are more readily available, but their informational content is inadequate for the task at hand. We develop a computational approach to appropriately utilize both data sources for estimating a regulatory network. The proposed approach is based on a three-step algorithm to estimate the underlying directed but cyclic network, that uses as input both perturbation screens and steady state gene expression data. In the first step, the algorithm determines causal orderings of the genes that are consistent with the perturbation data, by combining an exhaustive search method with a fast heuristic that in turn couples a Monte Carlo technique with a fast search algorithm. In the second step, for each obtained causal ordering, a regulatory network is estimated using a penalized likelihood based method, while in the third step a consensus network is constructed from the highest scored ones. Extensive computational experiments show that the algorithm performs well in reconstructing the underlying network and clearly outperforms competing approaches that rely only on a single data source. Further, it is established that the algorithm produces a consistent estimate of the regulatory network.	[Shojaie, Ali] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Jauhiainen, Alexandra] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Kallitsis, Michael; Michailidis, George] Univ Michigan, Dept Stat, Ann Arbor, MI 48109 USA	University of Washington; University of Washington Seattle; Karolinska Institutet; University of Michigan System; University of Michigan	Michailidis, G (corresponding author), Univ Michigan, Dept Stat, Ann Arbor, MI 48109 USA.	gmichail@umich.edu		Kallitsis, Michael/0000-0001-8086-499X	National Institutes of Health [1RC1CA145444-01, 1R21GM101719-01A1]; NATIONAL CANCER INSTITUTE [RC1CA145444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM101719] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by National Institutes of Health grants 1RC1CA145444-01 to GM and 1R21GM101719-01A1 to GM and AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anchang B, 2009, P NATL ACAD SCI USA, V106, P6447, DOI 10.1073/pnas.0809822106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dasgupta S, 2008, ALGORITHMS; Friedman N, 2003, MACH LEARN, V50, P95, DOI 10.1023/A:1020249912095; Frohlich H, 2010, BIOINFORMATICS, P238, DOI [10.1093/bioinformatics/btq631, DOI 10.1093/BI0INF0RMATICS/BTQ631]; Fujita A, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-39; Greenfield A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013397; Guo JA, 2011, BIOMETRIKA, V98, P1, DOI 10.1093/biomet/asq060; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Kalisch M, 2012, J STAT SOFTW, V47, P1; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Klamt S, 2010, BIOINFORMATICS, V26, P2160, DOI 10.1093/bioinformatics/btq342; Knuth D. E., 1974, Information Processing Letters, V2, P153, DOI 10.1016/0020-0190(74)90001-5; Maathuis MH, 2010, NAT METHODS, V7, P247, DOI 10.1038/nmeth0410-247; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Markowetz F, 2005, BIOINFORMATICS, V21, P4026, DOI 10.1093/bioinformatics/bti662; Markowetz F, 2007, BIOINFORMATICS, V23, pI305, DOI 10.1093/bioinformatics/btm178; Michailidis G, 2013, MATH BIOSCI, V246, P326, DOI 10.1016/j.mbs.2013.10.003; Mukhopadhyay ND, 2007, BIOINFORMATICS, V23, P442, DOI 10.1093/bioinformatics/btl598; Ohya Y, 2005, P NATL ACAD SCI USA, V102, P19015, DOI 10.1073/pnas.0509436102; Ong Irene M, 2002, Bioinformatics, V18 Suppl 1, pS241; Opgen-Rhein R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S2-S3; Perrin BE, 2003, BIOINFORMATICS, V19, pII138, DOI 10.1093/bioinformatics/btg1071; Piano F, 2002, CURR BIOL, V12, P1959, DOI 10.1016/S0960-9822(02)01301-5; Pinna A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012912; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Reimand J, 2010, NUCLEIC ACIDS RES, V38, P4768, DOI 10.1093/nar/gkq232; Shojaie A, 2012, STAT BIOSCI, V4, P66, DOI 10.1007/s12561-011-9050-5; Shojaie A, 2010, BIOINFORMATICS, V26, pi517, DOI 10.1093/bioinformatics/btq377; Shojaie A, 2010, BIOMETRIKA, V97, P519, DOI 10.1093/biomet/asq038; Shojaie A, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1483; Shojaie A, 2009, J COMPUT BIOL, V16, P407, DOI 10.1089/cmb.2008.0081; Song L, 2009, BIOINFORMATICS, V25, pI128, DOI 10.1093/bioinformatics/btp192; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Tarjan R., 1972, SIAM Journal on Computing, V1, P146, DOI 10.1137/0201010; Tresch A, 2008, STAT APPL GENET MOL, V7; van Wageningen S, 2010, CELL, V143, P991, DOI 10.1016/j.cell.2010.11.021; Yamaguchi R, 2007, IEEE SIGNAL PROC MAG, V24, P37, DOI 10.1109/MSP.2007.273053	43	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e82393	10.1371/journal.pone.0082393	http://dx.doi.org/10.1371/journal.pone.0082393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586224	gold, Green Published, Green Submitted			2022-12-27	WOS:000332396200003
J	Reyier, EA; Franks, BR; Chapman, DD; Scheidt, DM; Stolen, ED; Gruber, SH				Reyier, Eric A.; Franks, Bryan R.; Chapman, Demian D.; Scheidt, Douglas M.; Stolen, Eric D.; Gruber, Samuel H.			Regional-Scale Migrations and Habitat Use of Juvenile Lemon Sharks (Negaprion brevirostris) in the US South Atlantic	PLOS ONE			English	Article							INDIAN RIVER LAGOON; ATOL DAS ROCAS; MOVEMENT PATTERNS; CARCHARHINUS-LIMBATUS; RELATIVE ABUNDANCE; NURSERY GROUNDS; SUMMER NURSERY; SANDBAR SHARKS; BULL SHARKS; ESTUARINE	Resolving the geographic extent and timing of coastal shark migrations, as well as their environmental cues, is essential for refining shark management strategies in anticipation of increasing anthropogenic stressors to coastal ecosystems. We employed a regional-scale passive acoustic telemetry array encompassing 300 km of the east Florida coast to assess what factors influence site fidelity of juvenile lemon sharks (Negaprion brevirostris) to an exposed coastal nursery at Cape Canaveral, and to document the timing and rate of their seasonal migrations. Movements of 54 juvenile lemon sharks were monitored for three years with individuals tracked for up to 751 days. While most sharks demonstrated site fidelity to the Cape Canaveral region December through February under typical winter water temperatures, historically extreme declines in ocean temperature were accompanied by rapid and often temporary, southward displacements of up to 190 km along the Florida east coast. From late February through April each year, most sharks initiated a northward migration at speeds of up to 64 km day(-1) with several individuals then detected in compatible estuarine telemetry arrays in Georgia and South Carolina up to 472 km from release locations. Nineteen sharks returned for a second or even third consecutive winter, thus demonstrating strong seasonal philopatry to the Cape Canaveral region. The long distance movements and habitat associations of immature lemon sharks along the US southeast coast contrast sharply with the natal site fidelity observed in this species at other sites in the western Atlantic Ocean. These findings validate the existing multi-state management strategies now in place. Results also affirm the value of collaborative passive arrays for resolving seasonal movements and habitat preferences of migratory coastal shark species not easily studied with other tagging techniques.	[Reyier, Eric A.; Scheidt, Douglas M.; Stolen, Eric D.] Kennedy Space Ctr, Kennedy Space Ctr Ecol Program, Kennedy Space Ctr, FL 32899 USA; [Reyier, Eric A.; Scheidt, Douglas M.; Stolen, Eric D.] Kennedy Space Ctr, InoMed Hlth Applicat, Kennedy Space Ctr, FL USA; [Franks, Bryan R.] Florida Southern Coll, Dept Biol, Lakeland, FL USA; [Chapman, Demian D.] SUNY Stony Brook, Inst Ocean Conservat Sci, Stony Brook, NY 11794 USA; [Gruber, Samuel H.] Bimini Biol Field Stn, Bimini, Bahamas	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Reyier, EA (corresponding author), Kennedy Space Ctr, Kennedy Space Ctr Ecol Program, Kennedy Space Ctr, FL 32899 USA.	eric.a.reyier@nasa.gov			Henry Foundation; Busch-Gardens & Sea World Conservation Fund; Swiss Shark Foundation; Bimini Biological Field Station; Kennedy Space Center Medical and Environmental Support Contract	Henry Foundation; Busch-Gardens & Sea World Conservation Fund; Swiss Shark Foundation; Bimini Biological Field Station; Kennedy Space Center Medical and Environmental Support Contract	Funding provided by the Henry Foundation, Busch-Gardens & Sea World Conservation Fund, Swiss Shark Foundation, Bimini Biological Field Station, and Kennedy Space Center Medical and Environmental Support Contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel Daniel C., 2007, V50, P109; ASMFC, 2008, 46 ASMFC; Bass A.J., 1978, P545; Bates D., 2011, PACKAGE LME4 LINEAR; Bond ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032983; BROWN CA, 1988, COPEIA, P747; Burnham KP, 2002, MODEL SELECTION MULT, VXXVI; Castro J. I, 2011, SHARKS N AM; Castro JI, 1996, B MAR SCI, V59, P508; CASTRO JI, 1993, ENVIRON BIOL FISH, V36, P219, DOI 10.1007/BF00001717; CASTRO JI, 1993, ENVIRON BIOL FISH, V38, P37, DOI 10.1007/BF00842902; Chapman DD, 2005, MAR TECHNOL SOC J, V39, P42, DOI 10.4031/002533205787521640; Chapman DD, 2009, MOL ECOL, V18, P3500, DOI 10.1111/j.1365-294X.2009.04289.x; Curtis TH, 2011, T AM FISH SOC, V140, P1213, DOI 10.1080/00028487.2011.618352; DeAngelis BM, 2008, MAR ECOL PROG SER, V358, P257, DOI 10.3354/meps07308; Dodrill JW., 1977, HOOK LINE SURVEY SHA; Donaldson MR, 2008, J FISH BIOL, V73, P1491, DOI 10.1111/j.1095-8649.2008.02061.x; Feldheim KA, 2002, P ROY SOC B-BIOL SCI, V269, P1655, DOI 10.1098/rspb.2002.2051; Field IC, 2011, CORAL REEFS, V30, P61, DOI 10.1007/s00338-010-0699-x; Franks B.R., 2007, SPATIAL ECOLOGY RESO; Freitas RHA, 2006, J FISH BIOL, V68, P1319, DOI 10.1111/j.0022-1112.2006.00999.x; Garla Ricardo Clapis, 2009, Marine Biodiversity Records, V2, pe109, DOI 10.1017/S1755267209000670; GILMORE RG, 1995, B MAR SCI, V57, P153; Grubbs R. Dean, 2007, V50, P87; Gruber SH, 2001, T AM FISH SOC, V130, P376, DOI 10.1577/1548-8659(2001)130<0376:SOJLSA>2.0.CO;2; Gurshin Christopher W. D., 2007, V50, P141; Guttridge TL, 2012, MAR ECOL PROG SER, V445, P279, DOI 10.3354/meps09423; Hamel S, 2012, METHODS ECOL EVOL, V3, P731, DOI 10.1111/j.2041-210X.2012.00195.x; Heupel MR, 2006, ENVIRON BIOL FISH, V76, P47, DOI 10.1007/s10641-006-9007-6; Heupel Michelle R., 2007, V50, P265; Heupel MR, 2007, MAR ECOL PROG SER, V337, P287, DOI 10.3354/meps337287; Heupel MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009650; Heupel MR, 2010, MAR FRESHWATER RES, V61, P1, DOI 10.1071/MF09019; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Heupel MR, 2002, CAN J FISH AQUAT SCI, V59, P624, DOI 10.1139/F02-036; Hoenig JM, 1990, ELASMOBRANCHS LIVING; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Kessel S.T., 2010, THESIS CARDIFF U, DOI DOI 10.1578/AM.41.3.2015.245; KOHLER N. E., 1998, MAR FISH REV, V60, P1, DOI DOI 10.7755/MFR.81.2.1; Matich P, 2012, MAR ECOL PROG SER, V447, P165, DOI 10.3354/meps09497; Merson RR, 2001, ENVIRON BIOL FISH, V61, P13, DOI 10.1023/A:1011017109776; MORRISSEY JF, 1993, COPEIA, P425; MORRISSEY JF, 1993, ENVIRON BIOL FISH, V38, P311, DOI 10.1007/BF00007524; Murchie KJ, 2010, ENVIRON BIOL FISH, V89, P95, DOI 10.1007/s10641-010-9693-y; Musick JA, 2000, FISHERIES, V25, P9, DOI 10.1577/1548-8446(2000)025<0009:MOSATR>2.0.CO;2; Papastamatiou YP, 2010, J EXP MAR BIOL ECOL, V386, P94, DOI 10.1016/j.jembe.2010.02.009; Perkins T.H., 1997, DISTRIBUTION HARD BO; Reyier Eric A., 2008, Florida Scientist, V71, P134; Sarkar D., 2019, NLME LINEAR NONLINEA; Schwartz F.J., 2003, SHARKS SKATES RAYS C; SNELSON FF, 1981, ESTUARIES, V4, P110, DOI 10.2307/1351673; Speed CW, 2011, MAR ECOL PROG SER, V429, P261, DOI 10.3354/meps09080; Speed CW, 2010, MAR ECOL PROG SER, V408, P275, DOI 10.3354/meps08581; Springer S, 1967, SHARKS SKATES RAYS, P149, DOI DOI 10.1111/J.1095-8649.2012.03244.X; Stehlik L. L., 2007, ESSENTIAL FISH HABIT; Team R. D. C., 2012, R LANG ENV STAT COMP; Thorpe T, 2004, B MAR SCI, V74, P3; Ulrich Glenn F., 2007, V50, P125; Wetherbee BM, 2007, MAR ECOL PROG SER, V343, P283, DOI 10.3354/meps06920; Wiley TR, 2007, B MAR SCI, V80, P171; Yeiser BG, 2008, MAR FRESHWATER RES, V59, P489, DOI 10.1071/MF07181; Zuur Alain F., 2009, P1	62	22	22	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e88470	10.1371/journal.pone.0088470	http://dx.doi.org/10.1371/journal.pone.0088470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586329	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000011
J	Costantini, G; Perugini, M				Costantini, Giulio; Perugini, Marco			Generalization of Clustering Coefficients to Signed Correlation Networks	PLOS ONE			English	Article							SELF-ESTEEM DEVELOPMENT; WEIGHTED NETWORKS; COMPLEX NETWORKS; PERSONALITY; DIMENSIONS; CENTRALITY; MODEL; AGE	The recent interest in network analysis applications in personality psychology and psychopathology has put forward new methodological challenges. Personality and psychopathology networks are typically based on correlation matrices and therefore include both positive and negative edge signs. However, some applications of network analysis disregard negative edges, such as computing clustering coefficients. In this contribution, we illustrate the importance of the distinction between positive and negative edges in networks based on correlation matrices. The clustering coefficient is generalized to signed correlation networks: three new indices are introduced that take edge signs into account, each derived from an existing and widely used formula. The performances of the new indices are illustrated and compared with the performances of the unsigned indices, both on a signed simulated network and on a signed network based on actual personality psychology data. The results show that the new indices are more resistant to sample variations in correlation networks and therefore have higher convergence compared with the unsigned indices both in simulated networks and with real data.	[Costantini, Giulio; Perugini, Marco] Univ Milano Bicocca, Dept Psychol, Milan, Italy	University of Milano-Bicocca	Perugini, M (corresponding author), Univ Milano Bicocca, Dept Psychol, Milan, Italy.	giulio.costantini@unimib.it	Perugini, Marco/AAD-5880-2019; Costantini, Giulio/F-3829-2018	Perugini, Marco/0000-0002-4864-6623; Costantini, Giulio/0000-0001-6610-5452	Fondazione Cariplo (Cariplo Foundation) [2010-1432]	Fondazione Cariplo (Cariplo Foundation)(Fondazione Cariplo)	This work was supported by Fondazione Cariplo (Cariplo Foundation, www.fondazionecariplo.it), research grant "Dottorato ad alta formazione in Psicologia Sperimentale e Neuroscienze Cognitive'' (Advanced education doctorate in experimental psychology and cognitive neurosciences), grant number 2010-1432. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Ashton MC, 2007, PERS SOC PSYCHOL REV, V11, P150, DOI 10.1177/1088868306294907; Ashton MC, 2009, J PERS ASSESS, V91, P340, DOI 10.1080/00223890902935878; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bates D., 2013, MATRIX SPARSE DENSE; Block J, 2010, PSYCHOL INQ, V21, P2, DOI 10.1080/10478401003596626; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Borgatti S.P., 1997, CONNECTIONS, V1, P35; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Bringmann LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060188; Burt R.S., 1992, STRUCTURAL HOLES SOC, DOI DOI 10.1016/J.JET.2007.01.006; Butts CT, 2008, ASIAN J SOC PSYCHOL, V11, P13, DOI 10.1111/j.1467-839X.2007.00241.x; CARTWRIGHT D, 1956, PSYCHOL REV, V63, P277, DOI 10.1037/h0046049; Costantini G, 2012, EUR J PERSONALITY, V26, P434, DOI 10.1002/per.1869; Cramer AOJ, 2012, EUR J PERSONALITY, V26, P414, DOI 10.1002/per.1866; Cramer AOJ, 2010, BEHAV BRAIN SCI, V33, P137, DOI 10.1017/S0140525X09991567; De Nooy W., 2011, EXPLORATORY SOCIAL N, V2; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Erol RY, 2011, J PERS SOC PSYCHOL, V101, P607, DOI 10.1037/a0024299; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Funder DC, 2000, J PERS, V68, P451, DOI 10.1111/1467-6494.00103; Goekoop R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051558; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; HOFSTEE WKB, 1992, J PERS SOC PSYCHOL, V63, P146, DOI 10.1037/0022-3514.63.1.146; Hu B, 2005, PHYSICA A, V353, P576, DOI 10.1016/j.physa.2005.01.052; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Kalna G, 2007, AI COMMUN, V20, P263; Keeley J., 2008, STAT ED RES J, V7, P4, DOI DOI 10.52041/SERJ.V7I1.477; Kolaczyk ED, 2009, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-88146-1_1; Kunegis J., 2009, P 18 INT C WORLD WID, P741, DOI DOI 10.1145/1526709.1526809; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2012, J STAT SOFTW, V46, P1; Latora V, 2013, J STAT PHYS, V151, P745, DOI 10.1007/s10955-013-0722-z; Leskovec J, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1361; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Opsahl T, 2009, SOC NETWORKS, V31, P155, DOI 10.1016/j.socnet.2009.02.002; Orth U, 2010, J PERS SOC PSYCHOL, V98, P645, DOI 10.1037/a0018769; RAPOPORT A, 1961, BEHAV SCI, V6, P279; Revelle W., 2013, PROCEDURES PERSONALI; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Saramaki J, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.027105; Schmittmann VD, 2013, NEW IDEAS PSYCHOL, V31, P43, DOI 10.1016/j.newideapsych.2011.02.007; Schonbrodt FD, 2013, J RES PERS, V47, P609, DOI 10.1016/j.jrp.2013.05.009; Sherman RA, 2010, J PERS SOC PSYCHOL, V99, P330, DOI 10.1037/a0019796; Sherman RA, 2009, J RES PERS, V43, P1053, DOI 10.1016/j.jrp.2009.05.010; Thurstone LL, 1947, MULTIPLE FACTOR ANAL; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	53	30	30	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e88669	10.1371/journal.pone.0088669	http://dx.doi.org/10.1371/journal.pone.0088669			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3VI	24586367	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900024
J	Stewart, IB; Stewart, KL; Worringham, CJ; Costello, JT				Stewart, Ian B.; Stewart, Kelly L.; Worringham, Charles J.; Costello, Joseph T.			Physiological Tolerance Times while Wearing Explosive Ordnance Disposal Protective Clothing in Simulated Environmental Extremes	PLOS ONE			English	Article							UNCOMPENSABLE HEAT-STRESS; FLUID REPLACEMENT; TEMPERATURE; PERFORMANCE; EXERCISE; STRAIN; SENSOR	Explosive ordnance disposal (EOD) technicians are required to wear protective clothing to protect themselves from the threat of overpressure, fragmentation, impact and heat. The engineering requirements to minimise these threats results in an extremely heavy and cumbersome clothing ensemble that increases the internal heat generation of the wearer, while the clothing's thermal properties reduce heat dissipation. This study aimed to evaluate the heat strain encountered wearing EOD protective clothing in simulated environmental extremes across a range of differing work intensities. Eight healthy males [age 25 +/- 6 years (mean +/- sd), height 180 +/- 7 cm, body mass 79 +/- 9 kg, V. O-2max 57 +/- 6 ml. kg(-1) min(-1)] undertook nine trials while wearing an EOD9 suit (weighing 33.4 kg). The trials involved walking on a treadmill at 2.5, 4 and 5.5 km center dot h(-1) at each of the following environmental conditions, 21, 30 and 37 degrees C wet bulb globe temperature (WBGT) in a randomised controlled crossover design. The trials were ceased if the participants' core temperature reached 39 degrees C, if heart rate exceeded 90% of maximum, if walking time reached 60 minutes or due to fatigue/nausea. Tolerance times ranged from 10-60 minutes and were significantly reduced in the higher walking speeds and environmental conditions. In a total of 15 trials (21%) participants completed 60 minutes of walking; however, this was predominantly at the slower walking speeds in the 21 degrees C WBGT environment. Of the remaining 57 trials, 50 were ceased, due to attainment of 90% maximal heart rate. These near maximal heart rates resulted in moderate-high levels of physiological strain in all trials, despite core temperature only reaching 39 degrees C in one of the 72 trials.	[Stewart, Ian B.] Queensland Univ Technol, Sch Exercise & Nutr Sci, Brisbane, Qld 4001, Australia; Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Stewart, IB (corresponding author), Queensland Univ Technol, Sch Exercise & Nutr Sci, Brisbane, Qld 4001, Australia.	i.stewart@qut.edu.au	Stewart, Ian B/I-9927-2012; Costello, Joseph/AAW-8764-2020; Costello, Joseph/J-1374-2012; Costello, Joseph/G-6294-2011	Costello, Joseph/0000-0001-9510-7932; Costello, Joseph/0000-0001-9510-7932; Costello, Joseph/0000-0001-9510-7932; Stewart, Kelly/0000-0002-3386-7001; Stewart, Ian/0000-0003-1741-718X	Australian Government; National Security Science & Technology Centre within the Defence Science & Technology Organisation; US Government through the Technical Support Working Group within the Combating Terrorism Technical Support Office	Australian Government(Australian GovernmentCGIAR); National Security Science & Technology Centre within the Defence Science & Technology Organisation; US Government through the Technical Support Working Group within the Combating Terrorism Technical Support Office	This project is financially supported by the Australian Government, managed by the National Security Science & Technology Centre within the Defence Science & Technology Organisation, and the US Government through the Technical Support Working Group within the Combating Terrorism Technical Support Office. This support does not represent an endorsement of the contents or conclusions of the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	10.1520/F2668-07, 2011, F266807 ASTM INT, DOI DOI 10.1520/F2668-07; Byrne C, 2007, BRIT J SPORT MED, V41, P126, DOI 10.1136/bjsm.2006.026344; Cheung S.S., 2010, ADV ENV EXERCISE PHY; Cheung SS, 1998, EUR J APPL PHYSIOL O, V77, P139; Cheung SS, 1998, J APPL PHYSIOL, V84, P1731, DOI 10.1152/jappl.1998.84.5.1731; DUBOIS D, 1989, NUTRITION, V5, P303; Goodman DA, 2009, MED SCI SPORT EXER, V41, P597, DOI 10.1249/MSS.0b013e31818a0eef; Hunt AP, 2012, EUR J APPL PHYSIOL, V112, P1963, DOI 10.1007/s00421-011-2143-5; ISO, 2004, ISO98862004; Kenefick RW, 2009, MED SCI SPORT EXER, V41, P1311, DOI 10.1249/MSS.0b013e3181988c14; Larsen B, 2011, MIL MED, V176, P1265, DOI 10.7205/MILMED-D-10-00470; MCLELLAN TM, 1993, AVIAT SPACE ENVIR MD, V64, P587; McLellan TM, 2013, COMPR PHYSIOL, V3, P1363, DOI 10.1002/cphy.c130002; MONTAIN SJ, 1994, J APPL PHYSIOL, V77, P216, DOI 10.1152/jappl.1994.77.1.216; Moran DS, 1998, AM J PHYSIOL-REG I, V275, pR129, DOI 10.1152/ajpregu.1998.275.1.R129; Morris A, 1992, EVALUATION PERSONAL, P1; PANDOLF KB, 1977, J APPL PHYSIOL, V43, P577, DOI 10.1152/jappl.1977.43.4.577; Roeder RA, 2010, J CRANIOFAC SURG, V21, P971, DOI 10.1097/SCS.0b013e3181e1e802; Sawka MN, 2007, MED SCI SPORT EXER, V39, P377, DOI 10.1249/mss.0b013e31802ca597; Sleivert GG, 2007, INTJ SPORT PHYSIOL, V2, P98, DOI 10.1123/ijspp.2.1.98; Stewart IB, 2011, MIL MED, V176, P959, DOI 10.7205/MILMED-D-11-00052; Stewart IB, 2013, J ERGONOM S, VS2; STOLWIJK JA, 1966, PFLUG ARCH GES PHYS, V291, P129, DOI 10.1007/BF00412787; Taylor NAS, 2012, EUR J APPL PHYSIOL, V112, P3227, DOI 10.1007/s00421-011-2299-z; Thake C, 2009, P 13 INT ENV ERG C B; Townshend AD, 2010, MED SCI SPORT EXER, V42, P160, DOI 10.1249/MSS.0b013e3181af21e2; WHITE MK, 1991, ERGONOMICS, V34, P445	27	30	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e83740	10.1371/journal.pone.0083740	http://dx.doi.org/10.1371/journal.pone.0083740			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586228	gold, Green Published, Green Submitted			2022-12-27	WOS:000331717900001
J	Balint, A; Farsang, A; Zadori, Z; Belak, S				Balint, Adam; Farsang, Attila; Zadori, Zoltan; Belak, Sandor			Comparative In Vivo Analysis of Recombinant Type II Feline Coronaviruses with Truncated and Completed ORF3 Region	PLOS ONE			English	Article							INFECTIOUS PERITONITIS; CATS; PATHOGENESIS; PERSISTENCE; GENETICS; STRAINS; TROPISM; SAMPLES	Our previous in vitro comparative study on a feline coronavirus (FCoV) pair, differing only in the intactness of their ORF3abc regions, showed that the truncated ORF3abc plays an important role in the efficient macrophage/monocyte tropism of type II feline infectious peritonitis virus (FIPV). In the present study, we describe a challenge experiment with the same recombinant FCoVs in order to gain data on the in vivo characteristics on these viruses. While parent virus FIPV DF-2 developed feline infectious peritonitis in all the infected cats, its recombinant virus PBFIPV-DF-2, differing only in seven nucleotides, proved to be surprisingly low virulent, although caused an acute febrile episode similarly to the original FIPV DF-2. PBFIPV-DF-2 infection induced significantly lower virus neutralization titers than its parent virus, and lacked the second phase of viremia and development of fatal course of the disease. The recombinant PBFIPV-DF-2-R3i with completed ORF3abc gained biological properties that differentiate between the feline enteric coronavirus (FECV) and FIPV biotypes such as intensive replication in the gut, absence of viremia and weak or no serological response. Using reverse genetic approaches our study is the first experimental proof that ORF3abc is indeed responsible for the restriction of FECV replication to the intestine in vivo.	[Balint, Adam] Vet Diagnost Directorate, Natl Food Chain Safety Off, Budapest, Hungary; [Farsang, Attila] Directorate Vet Med Prod, Natl Food Chain Safety Off, Budapest, Hungary; [Zadori, Zoltan] Hungarian Acad Sci, Vet Med Res Inst, Agr Res Ctr, H-1581 Budapest, Hungary; [Belak, Sandor] SVA, Natl Vet Inst, Dept Virol Immunobiol & Parasitol, Uppsala, Sweden	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute; National Veterinary Institute SVA	Balint, A (corresponding author), Vet Diagnost Directorate, Natl Food Chain Safety Off, Budapest, Hungary.	balintad@nebih.gov.hu	Farsang, Attila/AAY-5458-2021; Belak, Sandor/AAP-4759-2021		Award of Excellence from the Swedish University of Agricultural Sciences; Agria Animal Insurance Company Agria Djurforsakring; Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA); Nemzeti Kutatasi es Technologiai Hivatal (NKTH) [08-C OTKA 81187]; Janos Bolyai Fellowship from the Hungarian Academy of Sciences [BO/00414/10]	Award of Excellence from the Swedish University of Agricultural Sciences; Agria Animal Insurance Company Agria Djurforsakring; Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Nemzeti Kutatasi es Technologiai Hivatal (NKTH)(National Office for Research and Technology); Janos Bolyai Fellowship from the Hungarian Academy of Sciences	This study was supported by Award of Excellence from the Swedish University of Agricultural Sciences; Agria Animal Insurance Company Agria Djurforsakring; Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA), and Nemzeti Kutatasi es Technologiai Hivatal (NKTH) (Mobilitas 08-C OTKA 81187; and Janos Bolyai Fellowship from the Hungarian Academy of Sciences (BO/00414/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDIE DD, 1992, VET REC, V130, P133, DOI 10.1136/vr.130.7.133; Addie D, 2009, J FELINE MED SURG, V11, P594, DOI 10.1016/j.jfms.2009.05.008; Balint A, 2012, J VIROL, V86, P6258, DOI 10.1128/JVI.00189-12; Chang HW, 2012, EMERG INFECT DIS, V18, P1089, DOI 10.3201/eid1807.120143; Chang HW, 2011, EMERG INFECT DIS, V17, P744, DOI [10.3201/eid1704.102027, 10.3201/eid1706.102027]; Chang HW, 2010, J GEN VIROL, V91, P415, DOI 10.1099/vir.0.016485-0; Cornillez-Ty CT, 2009, J VIROL, V83, P10314, DOI 10.1128/JVI.00842-09; Cruz JLG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002090; De Groot-Mijnes JDF, 2005, J VIROL, V79, P1036, DOI 10.1128/JVI.79.2.1036-1044.2005; Decaro N, 2005, J VIROL METHODS, V130, P72, DOI 10.1016/j.jviromet.2005.06.005; Dedeurwaerder A, 2013, VET MICROBIOL, V162, P447, DOI 10.1016/j.vetmic.2012.10.032; Dewerchin HL, 2005, ARCH VIROL, V150, P2483, DOI 10.1007/s00705-005-0598-6; Gunn-Moore DA, 1998, VET MICROBIOL, V62, P193, DOI 10.1016/S0378-1135(98)00210-7; Haijema BJ, 2004, J VIROL, V78, P3863, DOI 10.1128/JVI.78.8.3863-3871.2004; Haijema BJ, 2007, MOL CELL BIOL, P183; Herrewegh AAPM, 1997, VIROLOGY, V234, P349, DOI 10.1006/viro.1997.8663; Herrewegh AAPM, 1998, J VIROL, V72, P4508, DOI 10.1128/JVI.72.5.4508-4514.1998; HERREWEGH AAPM, 1995, VIROLOGY, V212, P622, DOI 10.1006/viro.1995.1520; HORZINEK MC, 1979, AM J VET RES, V40, P1487; HOSKINS JD, 1994, FELINE PRACT, V22, P9; Huang C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002433; Kennedy M, 2001, VET MICROBIOL, V81, P227, DOI 10.1016/S0378-1135(01)00354-6; Kipar A, 2010, J GEN VIROL, V91, P1698, DOI 10.1099/vir.0.020214-0; Lin CN, 2009, J FELINE MED SURG, V11, P413, DOI 10.1016/j.jfms.2008.09.004; Meli M, 2004, J FELINE MED SURG, V6, P69, DOI 10.1016/j.jfms.2003.08.007; PEDERSEN NC, 1981, AM J VET RES, V42, P368; Pedersen NC, 2004, J FELINE MED SURG, V6, P83, DOI 10.1016/j.jfms.2003.08.008; Pedersen NC, 2012, VIRUS RES, V165, P17, DOI 10.1016/j.virusres.2011.12.020; Pedersen NC, 2009, VIRUSES-BASEL, V1, P166, DOI 10.3390/v1020166; Pedersen NC, 2009, J FELINE MED SURG, V11, P225, DOI 10.1016/j.jfms.2008.09.008; Pedersen NC, 2008, J FELINE MED SURG, V10, P529, DOI 10.1016/j.jfms.2008.02.006; Poland AM, 1996, J CLIN MICROBIOL, V34, P3180, DOI 10.1128/JCM.34.12.3180-3184.1996; Rottier PJM, 2005, J VIROL, V79, P14122, DOI 10.1128/JVI.79.22.14122-14130.2005; Scott VL, 2008, VET IMMUNOL IMMUNOP, V123, P90, DOI 10.1016/j.vetimm.2008.01.014; Shiba N, 2007, VET MICROBIOL, V124, P348, DOI 10.1016/j.vetmic.2007.04.031; Simons FA, 2005, J VIROL METHODS, V124, P111, DOI 10.1016/j.jviromet.2004.11.012; Tekes G, 2012, J VIROL, V86, P6994, DOI 10.1128/JVI.00023-12; Vennema H, 1998, VIROLOGY, V243, P150, DOI 10.1006/viro.1998.9045; Vogel L, 2010, VET RES, V41, DOI 10.1051/vetres/2010043; Ziebuhr J, 2000, J GEN VIROL, V81, P853, DOI 10.1099/0022-1317-81-4-853	40	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88758	10.1371/journal.pone.0088758	http://dx.doi.org/10.1371/journal.pone.0088758			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586385	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000331714700029
J	Amaya, M; Voss, K; Sampey, G; Senina, S; de la Fuente, C; Mueller, C; Calvert, V; Kehn-Hall, K; Carpenter, C; Kashanchi, F; Bailey, C; Mogelsvang, S; Petricoin, E; Narayanan, A				Amaya, Moushimi; Voss, Kelsey; Sampey, Gavin; Senina, Svetlana; de la Fuente, Cynthia; Mueller, Claudius; Calvert, Valerie; Kehn-Hall, Kylene; Carpenter, Calvin; Kashanchi, Fatah; Bailey, Charles; Mogelsvang, Soren; Petricoin, Emanuel; Narayanan, Aarthi			The Role of IKK beta in Venezuelan Equine Encephalitis Virus Infection	PLOS ONE			English	Article							NF-KAPPA-B; IMMUNE-RESPONSE; KINASE IKK; OLD-WORLD; INHIBITION; PATHWAY; PHOSPHORYLATION; REPLICATION; MODULATION; APOPTOSIS	Venezuelan equine encephalitis virus (VEEV) belongs to the genus Alphavirus, family Togaviridae. VEEV infection is characterized by extensive inflammation and studies from other laboratories implicated an involvement of the NF-kappa B cascade in the in vivo pathology. Initial studies indicated that at early time points of VEEV infection, the NF-kappa B complex was activated in cells infected with the TC-83 strain of VEEV. One upstream kinase that contributes to the phosphorylation of p65 is the IKK beta component of the IKK complex. Our previous studies with Rift valley fever virus, which exhibited early activation of the NF-kappa B cascade in infected cells, had indicated that the IKK beta component underwent macromolecular reorganization to form a novel low molecular weight form unique to infected cells. This prompted us to investigate if the IKK complex undergoes a comparable macromolecular reorganization in VEEV infection. Size-fractionated VEEV infected cell extracts indicated a macromolecular reorganization of IKK beta in VEEV infected cells that resulted in formation of lower molecular weight complexes. Well-documented inhibitors of IKK beta function, BAY-11-7082, BAY-11-7085 and IKK2 compound IV, were employed to determine whether IKK beta function was required for the production of infectious progeny virus. A decrease in infectious viral particles and viral RNA copies was observed with inhibitor treatment in the attenuated and virulent strains of VEEV infection. In order to further validate the requirement of IKK beta for VEEV replication, we overexpressed IKK beta in cells and observed an increase in viral titers. In contrast, studies carried out using IKK beta(-/-) cells demonstrated a decrease in VEEV replication. In vivo studies demonstrated that inhibitor treatment of TC-83 infected mice increased their survival. Finally, proteomics studies have revealed that IKK beta may interact with the viral protein nsP3. In conclusion, our studies have revealed that the host IKK beta protein may be critically involved in VEEV replication.	[Amaya, Moushimi; Voss, Kelsey; Sampey, Gavin; Senina, Svetlana; de la Fuente, Cynthia; Kehn-Hall, Kylene; Carpenter, Calvin; Kashanchi, Fatah; Bailey, Charles; Narayanan, Aarthi] George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA 20110 USA; [Mueller, Claudius; Calvert, Valerie; Petricoin, Emanuel] George Mason Univ, Ctr Appl Prote & Personalized Med, Manassas, VA USA; [Mogelsvang, Soren] Serpin Pharma LLC, Manassas, VA USA	George Mason University; George Mason University	Narayanan, A (corresponding author), George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA 20110 USA.	anaraya1@gmu.edu	Mueller, Claudius/A-4459-2012; Kehn-Hall, Kylene/I-5752-2013	Mueller, Claudius/0000-0003-4499-4724; Voss, Kelsey/0000-0003-1732-2682; Kehn-Hall, Kylene/0000-0001-8036-7213	George Mason University; US Department of Energy [DE-SC0001599]; George Mason University Libraries Open Access Publishing Fund; College of Science to the Center for Applied Proteomics and Molecular Medicine	George Mason University; US Department of Energy(United States Department of Energy (DOE)); George Mason University Libraries Open Access Publishing Fund; College of Science to the Center for Applied Proteomics and Molecular Medicine	This work was supported by George Mason University start-up funds to AN, the US Department of Energy grant (DE-SC0001599) to CB and FK, and the generous support of the College of Science to the Center for Applied Proteomics and Molecular Medicine. Publication of this article was funded in part by the George Mason University Libraries Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PV, 2004, EMERG INFECT DIS, V10, P880, DOI 10.3201/eid1005.030634; Charles PC, 2001, VIROLOGY, V284, P190, DOI 10.1006/viro.2001.0878; Foy NJ, 2013, J VIROL, V87, P1997, DOI 10.1128/JVI.02853-12; Gamble C, 2012, BRIT J PHARMACOL, V165, P802, DOI 10.1111/j.1476-5381.2011.01608.x; Garcia MG, 2005, LEUKEMIA RES, V29, P1425, DOI 10.1016/j.leukres.2005.05.004; Garmashova N, 2007, J VIROL, V81, P2472, DOI 10.1128/JVI.02073-06; Hai T, 2006, J VIROL, V80, P4227, DOI 10.1128/JVI.80.9.4227-4241.2006; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hiscott J, 2006, ONCOGENE, V25, P6844, DOI 10.1038/sj.onc.1209941; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Jeong SJ, 2005, J BIOL CHEM, V280, P10326, DOI 10.1074/jbc.M412643200; Jose J, 2009, FUTURE MICROBIOL, V4, P837, DOI [10.2217/fmb.09.59, 10.2217/FMB.09.59]; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; Kehn-Hall K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034761; Keller SA, 2000, BLOOD, V96, P2537; Kim DY, 2013, J VIROL; Lamb K, 2010, VIROLOGY, V406, P261, DOI 10.1016/j.virol.2010.07.009; Le Negrate G, 2012, CELL MICROBIOL, V14, P168, DOI 10.1111/j.1462-5822.2011.01720.x; Lee J, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/416036; Liu F, 2012, IMMUNOL REV, V246, P239, DOI 10.1111/j.1600-065X.2012.01107.x; Narayanan A, 2012, J BIOL CHEM, V287, P33198, DOI 10.1074/jbc.M112.356535; Narayanan A, 2012, VIROLOGY, V432, P219, DOI 10.1016/j.virol.2012.06.007; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Sharma A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-289; Sharma A, 2009, J GEN VIROL, V90, P1836, DOI 10.1099/vir.0.010280-0; Shifera AS, 2010, BIOCHEM BIOPH RES CO, V396, P585, DOI 10.1016/j.bbrc.2010.05.012; Solt LA, 2008, IMMUNOL RES, V42, P3, DOI 10.1007/s12026-008-8025-1; Steele KE, 2010, VET PATHOL, V47, P790, DOI 10.1177/0300985810372508; Tergaonkar V, 2003, MOL CELL BIOL, V23, P8070, DOI 10.1128/MCB.23.22.8070-8083.2003; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; Weaver SC, 2004, ANNU REV ENTOMOL, V49, P141, DOI 10.1146/annurev.ento.49.061802.123422; Weaver SC, 1996, LANCET, V348, P436, DOI 10.1016/S0140-6736(96)02275-1; Zacks MA, 2010, VET MICROBIOL, V140, P281, DOI 10.1016/j.vetmic.2009.08.023	34	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e86745	10.1371/journal.pone.0086745	http://dx.doi.org/10.1371/journal.pone.0086745			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586253	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900005
J	Blumle, A; Meerpohl, JJ; Schumacher, M; von Elm, E				Bluemle, Anette; Meerpohl, Joerg J.; Schumacher, Martin; von Elm, Erik			Fate of Clinical Research Studies after Ethical Approval - Follow-Up of Study Protocols until Publication	PLOS ONE			English	Article							TRIALS; BIAS; COHORT	Background: Many clinical studies are ultimately not fully published in peer-reviewed journals. Underreporting of clinical research is wasteful and can result in biased estimates of treatment effect or harm, leading to recommendations that are inappropriate or even dangerous. Methods: We assembled a cohort of clinical studies approved 2000-2002 by the Research Ethics Committee of the University of Freiburg, Germany. Published full articles were searched in electronic databases and investigators contacted. Data on study characteristics were extracted from protocols and corresponding publications. We characterized the cohort, quantified its publication outcome and compared protocols and publications for selected aspects. Results: Of 917 approved studies, 807 were started and 110 were not, either locally or as a whole. Of the started studies, 576 (71%) were completed according to protocol, 128 (16%) discontinued and 42 (5%) are still ongoing; for 61 (8%) there was no information about their course. We identified 782 full publications corresponding to 419 of the 807 initiated studies; the publication proportion was 52% (95% CI: 0.48-0.55). Study design was not significantly associated with subsequent publication. Multicentre status, international collaboration, large sample size and commercial or non-commercial funding were positively associated with subsequent publication. Commercial funding was mentioned in 203 (48%) protocols and in 205 (49%) of the publications. In most published studies (339; 81%) this information corresponded between protocol and publication. Most studies were published in English (367; 88%); some in German (25; 6%) or both languages (27; 6%). The local investigators were listed as (co(-)) authors in the publications corresponding to 259 (62%) studies. Conclusion: Half of the clinical research conducted at a large German university medical centre remains unpublished; future research is built on an incomplete database. Research resources are likely wasted as neither health care professionals nor patients nor policy makers can use the results when making decisions.	[Bluemle, Anette; Meerpohl, Joerg J.; Schumacher, Martin] Univ Med Ctr, Ctr Med Biometry & Med Informat, Inst Med Biometry & Stat, Freiburg, Germany; [von Elm, Erik] Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Cochrane Switzerland, Lausanne, Switzerland	University of Freiburg; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Blumle, A (corresponding author), Univ Med Ctr, Ctr Med Biometry & Med Informat, Inst Med Biometry & Stat, Freiburg, Germany.	bluemle@cochrane.de	Meerpohl, Joerg J/J-4224-2013	Meerpohl, Joerg J/0000-0002-1333-5403; Blumle, Anette/0000-0003-2877-1029; von Elm, Erik/0000-0002-7412-0406	German Research Foundation (DFG) [EL 544/1-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	The work was supported by the German Research Foundation (DFG), grant number: EL 544/1-1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D.G., 1991, PRACTICAL STATISTIC; Blumle A, 2008, J MED ETHICS, V34, DOI 10.1136/jme.2008.024521; Blumle A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1828; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Decullier E, 2005, BMJ-BRIT MED J, V331, P19, DOI 10.1136/bmj.38488.385995.8F; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; Dickersin K, 2010, JLL B COMMENTARIES H; Doshi P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2865; Dwan K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000031.pub2; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Hasse W, 2001, DTSCH ARZTEBL, V98, P3100; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Jena S, 2010, EUROLBIOTECHLNEWS, V9; Loder E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3601; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Rothman KJ, 2008, MODERN EPIDEMIOLOGY, P287; Scherer RW, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000005.pub3, 10.1002/14651858.MR000005.pub4]; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Strech D, 2012, J CLIN EPIDEMIOL, V65, P276, DOI 10.1016/j.jclinepi.2011.07.002; von Elm E, 2008, SWISS MED WKLY, V138, P197, DOI 2008/13/smw-12027; von Elm E, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001516; World Medical Association, DECL HELS ETH PRINC	25	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e87184	10.1371/journal.pone.0087184	http://dx.doi.org/10.1371/journal.pone.0087184			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586265	Green Submitted, Green Published, gold			2022-12-27	WOS:000331711900008
J	Donnay, GF; Rankin, SK; Lopez-Gonzalez, M; Jiradejvong, P; Limb, CJ				Donnay, Gabriel F.; Rankin, Summer K.; Lopez-Gonzalez, Monica; Jiradejvong, Patpong; Limb, Charles J.			Neural Substrates of Interactive Musical Improvisation: An fMRI Study of 'Trading Fours' in Jazz	PLOS ONE			English	Article							BROCAS AREA; LANGUAGE; GENERATION; SYNTAX; CORTEX; BRAIN; PITCH	Interactive generative musical performance provides a suitable model for communication because, like natural linguistic discourse, it involves an exchange of ideas that is unpredictable, collaborative, and emergent. Here we show that interactive improvisation between two musicians is characterized by activation of perisylvian language areas linked to processing of syntactic elements in music, including inferior frontal gyrus and posterior superior temporal gyrus, and deactivation of angular gyrus and supramarginal gyrus, brain structures directly implicated in semantic processing of language. These findings support the hypothesis that musical discourse engages language areas of the brain specialized for processing of syntax but in a manner that is not contingent upon semantic processing. Therefore, we argue that neural regions for syntactic processing are not domain-specific for language but instead may be domain-general for communication.	[Donnay, Gabriel F.; Rankin, Summer K.; Lopez-Gonzalez, Monica; Jiradejvong, Patpong; Limb, Charles J.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA	Johns Hopkins University	Limb, CJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	climb@jhmi.edu	Rankin, Summer/J-5753-2014	Rankin, Summer/0000-0002-6886-3983	Dana Foundation; Brain Science Institute of Johns Hopkins University School of Medicine; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005211, T32DC000023] Funding Source: NIH RePORTER	Dana Foundation; Brain Science Institute of Johns Hopkins University School of Medicine; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This project was funded by the Dana Foundation and the Brain Science Institute of Johns Hopkins University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengtsson SL, 2007, J COGNITIVE NEUROSCI, V19, P830, DOI 10.1162/jocn.2007.19.5.830; Berkowitz AL, 2008, NEUROIMAGE, V41, P535, DOI 10.1016/j.neuroimage.2008.02.028; Berkowitz AL, 2010, NEUROIMAGE, V49, P712, DOI 10.1016/j.neuroimage.2009.08.042; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Brown S, 2006, EUR J NEUROSCI, V23, P2791, DOI 10.1111/j.1460-9568.2006.04785.x; Caplan R, 2001, NEUROREPORT, V12, P3625, DOI 10.1097/00001756-200111160-00050; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; Copeland R, 1980, THESIS KAERCEA MUSIC; Cross I, 2009, MUSIC SCI, P179; Cross Ian, 2009, COMMUNICATIVE MUSICA, P61; Eerola T, 2001, MUSIC PERCEPT, V18, P275, DOI 10.1525/mp.2001.18.3.275; Eerola T., 2004, MIDI TOOLBOX MATLAB; Eerola T., 2000, P 6 INT C MUS PERC C; Eerola T., 2002, P 7 INT C MUS PERC C, P473; Fadiga L, 2009, ANN NY ACAD SCI, V1169, P448, DOI 10.1111/j.1749-6632.2009.04582.x; Gernsbacher MA, 2003, ANNU REV PSYCHOL, V54, P91, DOI 10.1146/annurev.psych.54.101601.145128; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Jackendoff Ray, 2002, FDN LANGUAGE; Kivy Peter, 1989, SOUND SENTIMENT; Koelsch S, 2004, NAT NEUROSCI, V7, P302, DOI 10.1038/nn1197; Koelsch S, 2002, NEUROIMAGE, V17, P956, DOI 10.1016/S1053-8119(02)91154-7; Koelsch S, 2006, CORTEX, V42, P518, DOI 10.1016/S0010-9452(08)70390-3; Krumhansl C.L., 1990, COGNITIVE FDN MUSICA, P77; Krumhansl CL, 2000, PSYCHOL BULL, V126, P159, DOI 10.1037/0033-2909.126.1.159; Lee YS, 2011, NEUROIMAGE, V57, P293, DOI 10.1016/j.neuroimage.2011.02.006; Lerdahl F., 1983, GENERATIVE THEORY TO; Limb CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001679; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Mars RB, 2007, J NEUROSCI, V27, P1801, DOI 10.1523/JNEUROSCI.5344-06.2007; Meyer L., 1956, EMOTION MEANING MUSI; Monson I., 1996, SAYING SOMETHING JAZ, P73; NARMOUR E, 1990, ANAL COGNITION BASIC; Palmer C, 1997, ANNU REV PSYCHOL, V48, P115, DOI 10.1146/annurev.psych.48.1.115; PARNCUTT R, 1994, MUSIC PERCEPT, V11, P409; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Patel AD, 1998, J COGNITIVE NEUROSCI, V10, P717, DOI 10.1162/089892998563121; Perlman Alan M., 1981, SIGN MUSIC LIT, P169; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Ramachandran VS, 2003, SCI AM, V288, P52, DOI 10.1038/scientificamerican0503-52; Sawyer R., 2005, MUSICAL COMMUNICATIO, P45; SCHAFFLER L, 1993, BRAIN, V116, P695, DOI 10.1093/brain/116.3.695; Sloboda J.A., 2001, SERIES AFFECTIVE SCI; Swain J., 1997, MUSICAL LANGUAGES; Wikioo, 2021, THINKING JAZZ INFINI; ZATORRE RJ, 1991, J CLIN EXP NEUROPSYC, V13, P67	45	66	67	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88665	10.1371/journal.pone.0088665	http://dx.doi.org/10.1371/journal.pone.0088665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AB3TA	24586366	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900038
J	Edwards, BJ; Rottman, BM; Shankar, M; Betzler, R; Chituc, V; Rodriguez, R; Silva, L; Wibecan, L; Widness, J; Santos, LR				Edwards, Brian J.; Rottman, Benjamin M.; Shankar, Maya; Betzler, Riana; Chituc, Vladimir; Rodriguez, Ricardo; Silva, Liara; Wibecan, Leah; Widness, Jane; Santos, Laurie R.			Do Capuchin Monkeys (Cebus apella) Diagnose Causal Relations in the Absence of a Direct Reward?	PLOS ONE			English	Article							MACACA-MULATTA; YOUNG-CHILDREN; FOOD; INFORMATION; CHIMPANZEES; MECHANISMS; LOCATION; INFERENCES	We adapted a method from developmental psychology [1] to explore whether capuchin monkeys (Cebus apella) would place objects on a "blicket detector'' machine to diagnose causal relations in the absence of a direct reward. Across five experiments, monkeys could place different objects on the machine and obtain evidence about the objects' causal properties based on whether each object "activated'' the machine. In Experiments 1-3, monkeys received both audiovisual cues and a food reward whenever the machine activated. In these experiments, monkeys spontaneously placed objects on the machine and succeeded at discriminating various patterns of statistical evidence. In Experiments 4 and 5, we modified the procedure so that in the learning trials, monkeys received the audiovisual cues when the machine activated, but did not receive a food reward. In these experiments, monkeys failed to test novel objects in the absence of an immediate food reward, even when doing so could provide critical information about how to obtain a reward in future test trials in which the food reward delivery device was reattached. The present studies suggest that the gap between human and animal causal cognition may be in part a gap of motivation. Specifically, we propose that monkey causal learning is motivated by the desire to obtain a direct reward, and that unlike humans, monkeys do not engage in learning for learning's sake.	[Edwards, Brian J.] Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA; [Rottman, Benjamin M.; Shankar, Maya; Betzler, Riana; Chituc, Vladimir; Rodriguez, Ricardo; Silva, Liara; Wibecan, Leah; Widness, Jane; Santos, Laurie R.] Yale Univ, New Haven, CT USA	Northwestern University; Yale University	Edwards, BJ (corresponding author), Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA.	brian.edwards@u.northwestern.edu		Betzler, Riana/0000-0002-3971-6482; Rottman, Benjamin/0000-0002-4718-3970; Widness, Jane/0000-0002-9284-2066	NSF; NIH [F32HL108711]; McDonnell Scholar Grant; Yale University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL108711] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McDonnell Scholar Grant; Yale University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NSF(Graduate Research Fellowships to BJE and BMR), NIH (Grant F32HL108711 to BMR), McDonnell Scholar Grant (LRS), Yale University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basile BM, 2009, ANIM COGN, V12, P169, DOI 10.1007/s10071-008-0180-1; Beran MJ, 2011, COGNITION, V120, P90, DOI 10.1016/j.cognition.2011.02.016; Beran MJ, 2009, J EXP PSYCHOL-ANIM B, V35, P371, DOI 10.1037/a0014626; Blaisdell AP, 2006, SCIENCE, V311, P1020, DOI 10.1126/science.1121872; Brauer J, 2006, J COMP PSYCHOL, V120, P38, DOI 10.1037/0735-7036.120.1.38; Call J, 2004, J COMP PSYCHOL, V118, P232, DOI 10.1037/0735-7036.118.2.232; Call J., 2001, ANIM COGN, V3, P207, DOI [10.1007/s100710100078, DOI 10.1007/S100710100078]; Clark FE, 2013, AM J PRIMATOL, V75, P807, DOI 10.1002/ajp.22141; Cook C, 2011, COGNITION, V120, P341, DOI 10.1016/j.cognition.2011.03.003; Dickinson A, 2001, Q J EXP PSYCHOL-B, V54, P3, DOI 10.1080/02724990042000010; Fragaszy D. M., 2004, COMPLETE CAPUCHIN; Fujita K, 2009, ANIM COGN, V12, P575, DOI 10.1007/s10071-009-0217-0; Gopnik A, 2000, CHILD DEV, V71, P1205, DOI 10.1111/1467-8624.00224; Gopnik A, 2004, PSYCHOL REV, V111, P3, DOI 10.1037/0033-295X.111.1.3; Gopnik A, 2004, TRENDS COGN SCI, V8, P371, DOI 10.1016/j.tics.2004.06.005; Gopnik A, 2001, DEV PSYCHOL, V37, P620, DOI 10.1037//0012-1649.37.5.620; Gopnik A., 2000, EXPLANATION COGNITIO, P299; GWEON H, 2008, P 30 ANN C COGN SCI; Hampton RR, 2004, ANIM COGN, V7, P239, DOI 10.1007/s10071-004-0215-1; Hanus D, 2008, CURR BIOL, V18, pR370, DOI 10.1016/j.cub.2008.02.039; HARLOW HF, 1950, J COMP PHYSIOL PSYCH, V43, P289, DOI 10.1037/h0058114; Hayashi M, 2007, ANIM COGN, V10, P89, DOI 10.1007/s10071-006-0040-9; Hayashi M, 2009, ANIM COGN, V12, pS49, DOI 10.1007/s10071-009-0273-5; Kinzler KD, 2007, PROG BRAIN RES, V164, P257, DOI 10.1016/S0079-6123(07)64014-X; Kutlu MG, 2012, J EXP PSYCHOL ANIM B, V38, P84, DOI 10.1037/a0026221; Legare CH, 2012, CHILD DEV, V83, P173, DOI 10.1111/j.1467-8624.2011.01691.x; Lombrozo T, 2012, OXFORD HDB THINKING, P270; Lombrozo T, 2006, TRENDS COGN SCI, V10, P464, DOI 10.1016/j.tics.2006.08.004; Paukner A, 2006, ANIM COGN, V9, P110, DOI 10.1007/s10071-005-0007-2; Pearce JM, 2001, ANNU REV PSYCHOL, V52, P111, DOI 10.1146/annurev.psych.52.1.111; Penn DC, 2008, BEHAV BRAIN SCI, V31, P109, DOI 10.1017/S0140525X08003543; Penn DC, 2007, ANNU REV PSYCHOL, V58, P97, DOI 10.1146/annurev.psych.58.110405.085555; Povinelli DJ, 2001, CAN J EXP PSYCHOL, V55, P185, DOI 10.1037/h0087365; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Schulz LE, 2007, DEV PSYCHOL, V43, P1045, DOI 10.1037/0012-1649.43.4.1045; Shanks D.R, 1995, PSYCHOL ASS LEARNING; Skinner B. F., 1957, VERBAL BEHAV; Smith JD, 2003, BEHAV BRAIN SCI, V26, P317; Sobel DM, 2007, DEVELOPMENTAL SCI, V10, P298, DOI 10.1111/j.1467-7687.2007.00589.x; Tenenbaum JB, 2006, TRENDS COGN SCI, V10, P309, DOI 10.1016/j.tics.2006.05.009; Wasserman EA, 1997, ANNU REV PSYCHOL, V48, P573, DOI 10.1146/annurev.psych.48.1.573	42	6	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88595	10.1371/journal.pone.0088595	http://dx.doi.org/10.1371/journal.pone.0088595			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586347	gold, Green Published, Green Submitted			2022-12-27	WOS:000331711900031
J	Koduvayur, SP; Gussin, HA; Parthasarathy, R; Hao, ZG; Kay, BK; Pepperberg, DR				Koduvayur, Sujatha P.; Gussin, Helene A.; Parthasarathy, Rajni; Hao, Zengping; Kay, Brian K.; Pepperberg, David R.			Generation of Recombinant Antibodies to Rat GABA(A) Receptor Subunits by Affinity Selection on Synthetic Peptides	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC ACIDA; PHAGE-DISPLAY; ALLOSTERIC MODULATION; DIRECTED EVOLUTION; GLUTAMATE-RECEPTOR; GLYCINE RECEPTORS; MEMBRANE-PROTEIN; HIGH AVIDITY; A-RECEPTORS; FRAGMENTS	The abundance and physiological importance of GABA(A) receptors in the central nervous system make this neurotransmitter receptor an attractive target for localizing diagnostic and therapeutic biomolecules. GABA(A) receptors are expressed within the retina and mediate synaptic signaling at multiple stages of the visual process. To generate monoclonal affinity reagents that can specifically recognize GABA(A) receptor subunits, we screened two bacteriophage M13 libraries, which displayed human scFvs, by affinity selection with synthetic peptides predicted to correspond to extracellular regions of the rat alpha 1 and beta 2 GABA(A) subunits. We isolated three anti-beta 2 and one anti-alpha 1 subunit specific scFvs. Fluorescence polarization measurements revealed all four scFvs to have low micromolar affinities with their cognate peptide targets. The scFvs were capable of detecting fully folded GABA(A) receptors heterologously expressed by Xenopus laevis oocytes, while preserving ligand-gated channel activity. Moreover, A10, the anti-alpha 1 subunit-specific scFv, was capable of detecting native GABA(A) receptors in the mouse retina, as observed by immunofluorescence staining. In order to improve their apparent affinity via avidity, we dimerized the A10 scFv by fusing it to the Fc portion of the IgG. The resulting scFv-Fc construct had a K-d of similar to 26 nM, which corresponds to an approximately 135-fold improvement in binding, and a lower detection limit in dot blots, compared to the monomeric scFv. These results strongly support the use of peptides as targets for generating affinity reagents to membrane proteins and encourage investigation of molecular conjugates that use scFvs as anchoring components to localize reagents of interest at GABA(A) receptors of retina and other neural tissues, for studies of receptor activation and subunit structure.	[Koduvayur, Sujatha P.; Hao, Zengping; Kay, Brian K.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Gussin, Helene A.; Parthasarathy, Rajni; Pepperberg, David R.] Univ Illinois, Dept Ophthalmol & Visual Sci, Illinois Eye & Ear Infirm, Lions Illinois Eye Res Inst, Chicago, IL USA; [Parthasarathy, Rajni; Pepperberg, David R.] Univ Illinois, Dept Bioengn, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Koduvayur, SP (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	skoduvay@uic.edu	Parthasarathy, Rajni/AAF-8425-2020		NIH [EY016094, EY001792]; National Institute of General Medical Sciences (NIGMS) [1R01GM079096]; Daniel F. Rice Foundation and Ada L. Rice Foundation; BrightFocus Foundation; University of Illinois at Chicago Center for Clinical and Translational Sciences (CCTS) [UL1RR029879]; National Eye Institute; Zebrafish Protein Antibody Core [1R01GM079096]; NATIONAL EYE INSTITUTE [P30EY001792, R01EY016094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079096] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Daniel F. Rice Foundation and Ada L. Rice Foundation; BrightFocus Foundation(BrightFocus Foundation); University of Illinois at Chicago Center for Clinical and Translational Sciences (CCTS); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Zebrafish Protein Antibody Core; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH (http://grants.nih.gov/grants/oer.htm) grants EY016094 and EY001792 from the National Eye Institute (http://www.nei.nih.gov/funding/); National Institute of General Medical Sciences (NIGMS, http://www. nigms. nih. gov/Research/), Zebrafish Protein & Antibody Core (http://www.bio.anl.gov/molecular_and_systems_biology/zebrafish1. html) grant 1R01GM079096; the Daniel F. and Ada L. Rice Foundation (Skokie, IL); Hope for Vision (http:// hopeforvision.org/, Washington, D.C.), the BrightFocus Foundation (http://www. brightfocus. org/, formerly, the American Health Assistance Foundation) (Clarksburg, MD); Research to Prevent Blindness (http://www. rpbusa. org/rpb/, New York, NY); and University of Illinois at Chicago Center for Clinical and Translational Sciences (CCTS, http://www.uic.edu/depts/mcam/CCTS/) award UL1RR029879. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi L, 2010, CURR MED CHEM, V17, P1730, DOI 10.2174/092986710791111215; Adams GP, 1999, J IMMUNOL METHODS, V231, P249, DOI 10.1016/S0022-1759(99)00161-1; Albrecht H, 2007, Q J NUCL MED MOL IM, V51, P304; Arap W, 2002, NAT MED, V8, P121, DOI 10.1038/nm0202-121; Bali M, 2004, MOL PHARMACOL, V65, P68, DOI 10.1124/mol.65.1.68; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; BARBAS CF, 1991, P NATL ACAD SCI USA, V88, P7978, DOI 10.1073/pnas.88.18.7978; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Blazek D, 2003, FOLIA MICROBIOL, V48, P687, DOI 10.1007/BF02993480; Cunningham BT, 2004, J BIOMOL SCREEN, V9, P481, DOI 10.1177/1087057104267604; Duan Z, 2010, COMB CHEM HIGH T SCR, V13, P818, DOI 10.2174/138620710792927376; Eggers ED, 2006, J PHYSIOL-LONDON, V572, P215, DOI 10.1113/jphysiol.2005.103648; Eisenhardt SU, 2007, NAT PROTOC, V2, P3063, DOI 10.1038/nprot.2007.455; Falk R, 2012, METHODS, V58, P69, DOI 10.1016/j.ymeth.2012.07.008; Feigenspan A, 2004, J NEUROPHYSIOL, V92, P2789, DOI 10.1152/jn.00284.2004; Feigenspan A, 1998, PROG RETIN EYE RES, V17, P99, DOI 10.1016/S1350-9462(97)00008-6; Fletcher EL, 1998, J COMP NEUROL, V396, P351, DOI 10.1002/(SICI)1096-9861(19980706)396:3<351::AID-CNE6>3.0.CO;2-1; GREFERATH U, 1993, VISUAL NEUROSCI, V10, P551, DOI 10.1017/S0952523800004764; GREFERATH U, 1995, J COMP NEUROL, V353, P553, DOI 10.1002/cne.903530407; Grisshammer R, 2006, CURR OPIN BIOTECH, V17, P337, DOI 10.1016/j.copbio.2006.06.001; GRUNERT U, 1993, J COMP NEUROL, V335, P523, DOI 10.1002/cne.903350405; Gussin HA, 2006, J AM CHEM SOC, V128, P15701, DOI 10.1021/ja064324k; Gussin HA, 2013, ACS CHEM NEUROSCI, V4, P435, DOI 10.1021/cn300144v; Haidaris CG, 2001, J IMMUNOL METHODS, V257, P185, DOI 10.1016/S0022-1759(01)00463-X; Hawlisch H, 2001, ANAL BIOCHEM, V293, P142, DOI 10.1006/abio.2001.5120; Heeres JT, 2009, J AM CHEM SOC, V131, P18202, DOI 10.1021/ja907066r; Hotzel I, 2011, PROTEIN ENG DES SEL, V24, P679, DOI 10.1093/protein/gzr039; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; HOLLIGER P, 1993, P NATL ACAD SCI USA, V90, P6444, DOI 10.1073/pnas.90.14.6444; Hust M, 2002, J VIROL METHODS, V106, P225, DOI 10.1016/S0166-0934(02)00166-0; Janovjak H, 2010, NAT NEUROSCI, V13, P1027, DOI 10.1038/nn.2589; Juarez-Gonzalez VR, 2005, J MOL BIOL, V346, P1287, DOI 10.1016/j.jmb.2004.12.060; Junge F, 2008, CELL MOL LIFE SCI, V65, P1729, DOI 10.1007/s00018-008-8067-5; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; Kasturirangan S, 2010, CURR ALZHEIMER RES, V7, P214, DOI 10.2174/156720510791050876; Kortt AA, 2001, BIOMOL ENG, V18, P95, DOI 10.1016/S1389-0344(01)00090-9; Koulen P, 1996, J NEUROSCI, V16, P2127; Li YH, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-23; Luginbuhl B, 2006, J MOL BIOL, V363, P75, DOI 10.1016/j.jmb.2006.07.027; Lukasiewicz PD, 1998, SEMIN CELL DEV BIOL, V9, P293, DOI 10.1006/scdb.1998.0238; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Mao YJ, 2011, ANAL BIOCHEM, V415, P21, DOI 10.1016/j.ab.2011.04.004; Maynard J, 2000, ANNU REV BIOMED ENG, V2, P339, DOI 10.1146/annurev.bioeng.2.1.339; Milovnik P, 2009, PROTEIN ENG DES SEL, V22, P357, DOI 10.1093/protein/gzp011; Moghaddam A, 2003, J IMMUNOL METHODS, V280, P139, DOI 10.1016/S0022-1759(03)00109-1; MOHLER H, 1990, NEUROCHEM RES, V15, P199, DOI 10.1007/BF00972210; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; PACK P, 1992, BIOCHEMISTRY-US, V31, P1579, DOI 10.1021/bi00121a001; Papanastasiou D, 1999, J NEUROIMMUNOL, V94, P182, DOI 10.1016/S0165-5728(98)00249-5; Pershad K, 2011, ANAL BIOCHEM, V412, P210, DOI 10.1016/j.ab.2011.02.006; Peter JC, 2003, J BIOL CHEM, V278, P36740, DOI 10.1074/jbc.M306877200; Pini A, 2000, CURR PROTEIN PEPT SC, V1, P155, DOI 10.2174/1389203003381397; Qtaishat NM, 2013, ANAL BIOCHEM, V432, P49, DOI 10.1016/j.ab.2012.08.031; Schofield DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r254; SEEBURG PH, 1990, COLD SH Q B, V55, P29; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; SIGEL E, 1988, J NEUROSCI, V8, P289; Smith SM, 2011, METHODS MOL BIOL, V681, P485, DOI 10.1007/978-1-60761-913-0_29; Souriau C, 2004, GROWTH FACTORS, V22, P185, DOI 10.1080/08977190412331279872; Stein M, 2012, ANGEW CHEM INT EDIT, V51, P10500, DOI 10.1002/anie.201205475; Steinmeyer DE, 2008, DRUG DISCOV TODAY, V13, P613, DOI 10.1016/j.drudis.2008.04.005; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Ta HT, 2011, CIRC RES, V109, P365, DOI 10.1161/CIRCRESAHA.111.249375; Thie Holger, 2009, V525, P309, DOI 10.1007/978-1-59745-554-1_16; Tipps ME, 2010, J BIOL CHEM, V285, P22838, DOI 10.1074/jbc.M110.130815; Vaughan TJ, 1996, NAT BIOTECHNOL, V14, P309, DOI 10.1038/nbt0396-309; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Vu TQ, 2005, BIOMATERIALS, V26, P1895, DOI 10.1016/j.biomaterials.2004.06.007; WAFFORD KA, 1993, MOL PHARMACOL, V43, P240; Wagner S, 2006, TRENDS BIOTECHNOL, V24, P364, DOI 10.1016/j.tibtech.2006.06.008; Wassle H, 1998, VISION RES, V38, P1411, DOI 10.1016/s0042-6989(97)00300-3; Wisden W, 1992, Curr Opin Neurobiol, V2, P263, DOI 10.1016/0959-4388(92)90113-Y; WOODWARD RM, 1993, MOL PHARMACOL, V43, P609; Yang XL, 2004, PROG NEUROBIOL, V73, P127, DOI 10.1016/j.pneurobio.2004.04.002; Yip GM, 2013, NAT CHEM BIOL; Yue L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2094; Zucker CL, 1998, J COMP NEUROL, V393, P309, DOI 10.1002/(SICI)1096-9861(19980413)393:3<309::AID-CNE4>3.0.CO;2-5	77	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e87964	10.1371/journal.pone.0087964	http://dx.doi.org/10.1371/journal.pone.0087964			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586298	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900020
J	Alberti, CF; Horowitz, T; Bronstad, PM; Bowers, AR				Alberti, Concetta F.; Horowitz, Todd; Bronstad, P. Matthew; Bowers, Alex R.			Visual Attention Measures Predict Pedestrian Detection in Central Field Loss: A Pilot Study	PLOS ONE			English	Article							OF-VIEW TEST; MOBILITY PERFORMANCE; VISION; HEMIANOPIA; OCCLUSION; MULTIPLE; TRACKING; DRIVERS; RISK	Purpose: The ability of visually impaired people to deploy attention effectively to maximize use of their residual vision in dynamic situations is fundamental to safe mobility. We conducted a pilot study to evaluate whether tests of dynamic attention (multiple object tracking; MOT) and static attention (Useful Field of View; UFOV) were predictive of the ability of people with central field loss (CFL) to detect pedestrian hazards in simulated driving. Methods: 11 people with bilateral CFL (visual acuity 20/30-20/200) and 11 age-similar normally-sighted drivers participated. Dynamic and static attention were evaluated with brief, computer-based MOT and UFOV tasks, respectively. Dependent variables were the log speed threshold for 60% correct identification of targets (MOT) and the increase in the presentation duration for 75% correct identification of a central target when a concurrent peripheral task was added (UFOV divided and selective attention subtests). Participants drove in a simulator and pressed the horn whenever they detected pedestrians that walked or ran toward the road. The dependent variable was the proportion of timely reactions (could have stopped in time to avoid a collision). Results: UFOV and MOT performance of CFL participants was poorer than that of controls, and the proportion of timely reactions was also lower (worse) (84% and 97%, respectively; p = 0.001). For CFL participants, higher proportions of timely reactions correlated significantly with higher (better) MOT speed thresholds (r = 0.73, p = 0.01), with better performance on the UFOV divided and selective attention subtests (r = -0.66 and -0.62, respectively, p < 0.04), with better contrast sensitivity scores (r = 0.54, p = 0.08) and smaller scotomas (r = -0.60, p = 0.05). Conclusions: Our results suggest that brief laboratory-based tests of visual attention may provide useful measures of functional visual ability of individuals with CFL relevant to more complex mobility tasks.	[Alberti, Concetta F.; Bronstad, P. Matthew; Bowers, Alex R.] Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst,Massachusetts Eye & Ear, Boston, MA 02114 USA; [Horowitz, Todd] NCI, Basic Biobehav & Psychol Sci Branch, Behav Res Program, Div Canc Control & Populat Sci, Rockville, MD USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bowers, AR (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst,Massachusetts Eye & Ear, Boston, MA 02114 USA.	alex_bowers@meei.harvard.edu		Horowitz, Todd/0000-0001-5571-6266; Bowers, Alex/0000-0002-6038-0178	National Institutes of Health [EY018680, EY12890, 2P30EY003790]; Harvard Catalyst, The Harvard Clinical and Translational Science Center (NIH) [1 UL1 RR 025758-02]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY003790, R01EY012890, R00EY018680, R24EY012890, K99EY018680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Catalyst, The Harvard Clinical and Translational Science Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by National Institutes of Health grants EY018680, EY12890 and 2P30EY003790 (www.nei.nih.gov). Development of the brief MOT test was supported by a pilot grant from Harvard Catalyst, The Harvard Clinical and Translational Science Center (NIH Grant #1 UL1 RR 025758-02) www.nih.gov; catalyst.harvard.edu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Association of State Highway and Transportation Officials, 2004, POL GEOM DES HIGHW S; Ball KK, 2006, J AM GERIATR SOC, V54, P77, DOI 10.1111/j.1532-5415.2005.00568.x; Bowers A, 2005, OPTOMETRY VISION SCI, V82, P657, DOI 10.1097/01.opx.0000175558.33268.b5; Bowers A., 2011, PROC 6 INT DRIV S HU, P307; Bowers AR, 2010, INVEST OPHTH VIS SCI, V51, P6605, DOI 10.1167/iovs.10-5310; Bowers AR, 2009, INVEST OPHTH VIS SCI, V50, P5137, DOI 10.1167/iovs.09-3799; Bronstad PM, 2013, JAMA OPHTHALMOL, V131, P303, DOI 10.1001/jamaophthalmol.2013.1443; Bronstad PM, 2009, P 5 INT DRIV S HUM F, P320; Clay OJ, 2005, OPTOMETRY VISION SCI, V82, P724, DOI 10.1097/01.opx.0000175009.08626.65; Coeckelbergh TRM, 2004, HUM FACTORS, V46, P748, DOI 10.1518/hfes.46.4.748.56818; DeCarlo DK, 2003, OPTOMETRY VISION SCI, V80, P207, DOI 10.1097/00006324-200303000-00010; Dickinson, 1998, LOW VISION PRINCIPLE; Edwards JD, 2005, J CLIN EXP NEUROPSYC, V27, P529, DOI 10.1080/13803390490515432; Edwards JD, 2006, ARCH CLIN NEUROPSYCH, V21, P275, DOI 10.1016/j.acn.2006.03.001; Evans L., 2004, TRAFFIC SAFETY; Flombaum JI, 2008, COGNITION, V107, P904, DOI 10.1016/j.cognition.2007.12.015; Goldberg JL, 2013, JAMA OPHTHALMOL, V131, P1563, DOI 10.1001/jamaophthalmol.2013.5747; Hassan SE, 2002, OPTOMETRY VISION SCI, V79, P697, DOI 10.1097/00006324-200211000-00007; Hassell JB, 2006, BRIT J OPHTHALMOL, V90, P593, DOI 10.1136/bjo.2005.086595; Haymes SA, 2007, INVEST OPHTH VIS SCI, V48, P1149, DOI 10.1167/iovs.06-0886; Hogg RE, 2006, PROG RETIN EYE RES, V25, P249, DOI 10.1016/j.preteyeres.2005.11.002; Iordanescu L, 2009, J VISION, V9, DOI 10.1167/9.4.1; Kuyk T, 1999, J REHABIL RES DEV, V36, P303; Leat SJ, 2008, OPTOMETRY VISION SCI, V85, P1049, DOI 10.1097/OPX.0b013e31818b949d; Matthew Bronstad P, 2011, J Clin Exp Ophthalmol, V2011, P1; Owsley C, 2004, J AM GERIATR SOC, V52, P1901, DOI 10.1111/j.1532-5415.2004.52516.x; Owsley C, 2010, VISION RES, V50, P2348, DOI 10.1016/j.visres.2010.05.021; Patel RD, 2011, SEMIN OPHTHALMOL, V26, P372, DOI 10.3109/08820538.2011.570845; Peli E, 2005, TRANSPORT RES REC, P128; Peli E., 2002, DRIVING CONFIDENCE P; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Scholl BJ, 1999, COGNITIVE PSYCHOL, V38, P259, DOI 10.1006/cogp.1998.0698; TIMBERLAKE GT, 1987, INVEST OPHTH VIS SCI, V28, P1268; To L, 2013, VISION RES, V90, P15, DOI 10.1016/j.visres.2013.04.011; Verezen CA, 2011, OPTOMETRY VISION SCI, V88, P1164, DOI 10.1097/OPX.0b013e31822891e0; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Winer B.J., 1991, STAT PRINCIPLES EXPT; Woods RL, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3292015	39	10	10	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89381	10.1371/journal.pone.0089381	http://dx.doi.org/10.1371/journal.pone.0089381			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3RA	24558495	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700141
J	Rivero, DG; O'Brien, MJ				Garcia Rivero, Daniel; O'Brien, Michael J.			Phylogenetic Analysis Shows That Neolithic Slate Plaques from the Southwestern Iberian Peninsula Are Not Genealogical Recording Systems	PLOS ONE			English	Article							CONSTRUCTION; CLADISTICS; PREHISTORY; TRADITIONS; PARSIMONY; EVOLUTION; LANGUAGE; BEHAVIOR; TREES	Prehistoric material culture proposed to be symbolic in nature has been the object of considerable archaeological work from diverse theoretical perspectives, yet rarely are methodological tools used to test the interpretations. The lack of testing is often justified by invoking the opinion that the slippery nature of past human symbolism cannot easily be tackled by the scientific method. One such case, from the southwestern Iberian Peninsula, involves engraved stone plaques from megalithic funerary monuments dating ca. 3,500-2,750 (B.C.) (calibrated age). One widely accepted proposal is that the plaques are ancient mnemonic devices that record genealogies. The analysis reported here demonstrates that this is not the case, even when the most supportive data and techniques are used. Rather, we suspect there was a common ideological background to the use of plaques that overlay the southwestern Iberian Peninsula, with little or no geographic patterning. This would entail a cultural system in which plaque design was based on a fundamental core idea, with a number of mutable and variable elements surrounding it.	[Garcia Rivero, Daniel] Univ Seville, Dept Prehist & Archaeol, Seville, Spain; [O'Brien, Michael J.] Univ Missouri, Dept Anthropol, Columbia, MO 65211 USA	University of Sevilla; University of Missouri System; University of Missouri Columbia	O'Brien, MJ (corresponding author), Univ Missouri, Dept Anthropol, 200 Swallow Hall, Columbia, MO 65211 USA.	obrienm@missouri.edu	García-Rivero, Daniel/K-1845-2014	García-Rivero, Daniel/0000-0002-6112-3181				Aberg N., 1921, CIVILISATION ENEOLIT; Almagro Gorbea MJ, 1973, IDOLOS BRONCE 1 HISP; Ameghino F, 1879, REV ANTHR, V2, P210; Archibald JK, 2003, TAXON, V52, P187, DOI 10.2307/3647388; Blanco Gomez A, 2011, ZEPHYRUS, V67, P214; Buchanan B, 2008, J ARCHAEOL SCI, V35, P1683, DOI 10.1016/j.jas.2007.11.009; Buchanan B, 2007, J ANTHROPOL ARCHAEOL, V26, P366, DOI 10.1016/j.jaa.2007.02.005; Bueno Ramirez P, 2006, TRABAJOS PREHIST, V63, P191; Calado M, 2007, 1 CAMPESINOS LA RAYA, P27; Calado M, 2010, ROCK ART SCHIST PLAQ; Cap H, 2008, CLADISTICS, V24, P917, DOI 10.1111/j.1096-0031.2008.00223.x; Carpenter E, 1986, MAT STUDY SOCIAL SYM; Cartaiillac E, 1886, AGES PREHISTORIQUES; da Veiga SFE, 1887, ANTIGUIDADES MONUMEN, V2; Darwent J, 2006, MAPPING OUR ANCESTORS, P185; de Vasconcelos JL, 1897, RELIG LUSITANIA, V1; Dunnell R.C., 1971, SYSTEMATICS PREHISTO; Ferreira O da V, 1973, ESTUDIOS DEDICADOS P, V23, P233; Frankowski E., 1920, ESTELAS DISCOIDEAS P; Sanjuan LG, 2010, EUR J ARCHAEOL, V13, P255, DOI 10.1179/eja.2010.13.2.255; Goloboff Pablo A., 2005, P148; Goncalves VS, 1989, ALMANSOR, V7, P289; Goncalves VS., 2001, STAM 3 ANTA 3 HERDAD, V4, P115; Goncalves VS, 2006, REV PORT ARQUEOL, V9, P27; Hernandez-Pacheco E, 1916, PINTURAS PREHISTORIC; Holden C. J., 2005, EVOLUTION CULTURAL D, P53; Hurtado Perez V., 2009, OJOS QUE NUNCA SE CI, P137; Jordan P, 2003, J ANTHROPOL ARCHAEOL, V22, P42, DOI 10.1016/S0278-4165(03)00004-7; Jordan P, 2006, MAPPING OUR ANCESTORS, P149; Jordan P, 2010, PHILOS T R SOC B, V365, P3875, DOI 10.1098/rstb.2010.0092; Jordan P, 2009, J ANTHROPOL ARCHAEOL, V28, P342, DOI 10.1016/j.jaa.2009.05.004; Kopytoff I., 1987, AFRICAN FRONTIER REP; Laland KN, 2004, LEARN BEHAV, V32, P4; Leisner G., 1985, ANTAS CONCELHO REGUE; Leisner V, 1965, MEGALITHGRABER IBERI, V2; Lillios K., 2004, ESPRIT ENGRAVED STON; Lillios K, 2002, REV PORTUGUESA ARQUE, V5, P135; Lillios K., 2008, HERALDRY DEAD MEMORY; Lillios K., 2004, EUR J ARCHAEOL, V7, P125, DOI DOI 10.1177/1461957104053712; Lillios K.T, 2010, MAT MNEMONICS EVERYD, P40; Lillios Katina T., 2003, ARCHAEOLOGIES MEMORY, P129; Lillios KT, 2006, ANIMAIS PREHISTORIA, P27; Lisboa MIG, 1985, ARCHAEOLOGICAL REV C, V4, P181; Lycett SJ, 2007, P NATL ACAD SCI USA, V104, P17588, DOI 10.1073/pnas.0707930104; MADDISON WP, 1984, SYST ZOOL, V33, P83, DOI 10.2307/2413134; MARGUSH T, 1981, B MATH BIOL, V43, P239, DOI 10.1007/BF02459446; MENDES CORREA A. A., 1924, POVOS PRIMITIVOS LUS; Mesoudi A., 2011, CULTURAL EVOLUTION D; MORTILLET G., 1881, MUSEE PREHISTORIQUE; O'Brien MJ, 2013, ISR J ECOL EVOL, V59, P45, DOI 10.1080/15659801.2013.825431; O'Brien MJ, 2010, PHILOS T R SOC B, V365, P3797, DOI 10.1098/rstb.2010.0012; O'Brien Michael J., 2008, CULTURAL TRANSMISSIO, P77; O'Brien MJ, 2001, J ARCHAEOL SCI, V28, P1115, DOI 10.1006/jasc.2001.0681; O'Brien MJ, 2002, J THEOR BIOL, V215, P133, DOI 10.1006/jtbi.2002.2548; O'Brien MJ., 1999, SERIATION STRATIGRAP; O'Brien MJ, 2012, EVOLUTIONARY BIOL ME, P23; O'Leary MA, 2008, CLADISTICS, V24, P397, DOI 10.1111/j.1096-0031.2007.00187.x; OBrien M.J., 2003, CLADISTICS ARCHAEOLO; OBrien MJ, 2000, APPL EVOLUTIONARY AR; Oliveira J., 2006, PATRIMONIO ARQUEOLOG; Pol D, 2001, CLADISTICS, V17, P266, DOI 10.1111/j.1096-0031.2001.tb00123.x; RAMIREZ PB, 1992, ANTHROPOLOGIE, V96, P573; RAMIREZ PB, 2004, SINAIS PEDRA; Renfrew C., 1998, COGNITION MAT CULTUR; Renfrew Colin, 1998, COGNITION MAT CULTUR, P1; Riede F, 2011, PHILOS T R SOC B, V366, P793, DOI 10.1098/rstb.2010.0266; SANDERSON MJ, 1989, EVOLUTION, V43, P1781, DOI 10.1111/j.1558-5646.1989.tb02626.x; Shennan S. J, 2005, EVOLUTION CULTURAL D, P133; Simoes A. F., 1878, INTRO ARCHEOLOGIA PE; SLOWINSKI JB, 1993, SYST BIOL, V42, P155, DOI 10.2307/2992538; Smith HF, 2008, J HUM EVOL, V54, P684, DOI 10.1016/j.jhevol.2007.10.012; Sober E, 2004, SYST BIOL, V53, P644, DOI 10.1080/10635150490468657; Swadesh M., 1964, LANG CULT SOC, P624; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; SWOFFORD DL, 1992, SYSTEMATICS HIST ECO, P187; Tehrani J, 2002, J ANTHROPOL ARCHAEOL, V21, P443, DOI 10.1016/S0278-4165(02)00002-8; Tehrani JJ, 2009, ORIG HUM BEHAV, V2, P99; Tehrani JJ, 2010, PHILOS T R SOC B, V365, P3865, DOI 10.1098/rstb.2010.0020; Tehrani JJ, 2009, EVOL HUM BEHAV, V30, P286, DOI 10.1016/j.evolhumbehav.2009.03.002; Thomas JT, 2009, CAMB ARCHAEOL J, V19, P53, DOI 10.1017/S0959774309000031; Vansina J., 1990, PATHS RAINFORESTS HI; WHITTLE A, 1985, NEOLITHIC EUROPE SUR; Willey GR, 1945, AM ANTIQUITY, V11, P49, DOI 10.2307/275530	83	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88296	10.1371/journal.pone.0088296	http://dx.doi.org/10.1371/journal.pone.0088296			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558384	Green Published, gold			2022-12-27	WOS:000331706700030
J	Ju, CR; Chen, RC				Ju, Chunrong; Chen, Rongchang			Factors Associated with Impairment of Quadriceps Muscle Function in Chinese Patients with Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							VASTUS LATERALIS MUSCLE; FAT-FREE MASS; SKELETAL-MUSCLE; PHYSICAL-ACTIVITY; COPD; STRENGTH; EXERCISE; ENDURANCE; QUESTIONNAIRE; STIMULATION	Background: Quadriceps muscle dysfunction is well confirmed in chronic obstructive pulmonary disease (COPD) and reported to be related to a higher risk of mortality. Factors contributing to quadriceps dysfunction have been postulated, while not one alone could fully explain it and there are few reports on it in China. This study was aimed to investigate the severity of quadriceps dysfunction in patients with COPD, and to compare quadriceps muscle function in COPD and the healthy elderly. Methods: Quadriceps strength and endurance capabilities were investigated in 71 COPD patients and 60 age-matched controls; predicted values for quadriceps strength and endurance were calculated using regression equations (incorporating age, gender, anthropometric measurements and physical activities), based on the data from controls. Potential parameters related to quadriceps dysfunction in COPD were identified by stepwise regression analysis. Results: Mean values of quadriceps strength was 46% and endurance was 38% lower, in patients with COPD relative to controls. Gender, physical activities and anthropometric measurements were predictors to quadriceps function in the controls. While in COPD, forced expiratory volume in 1 second percentage of predicted value (FEV1% pred), nutritional depletion, gender and physical inactivity were identified as independent factors to quadriceps strength (R-2 = 0.72); FEV1%pred, thigh muscle mass, serum levels of tumor necrosis factor-alpha (TNF-alpha) and gender were correlated to quadriceps endurance variance, with each p<0.05. Conclusion: Quadriceps strength and endurance capabilities are both substantially impaired in Chinese COPD patients, with strength most affected. For the controls, physical activity is most important for quadriceps function. While for COPD patients, quadriceps dysfunction is related to multiple factors, with airflow limitation, malnutrition and muscle disuse being the main ones.	[Ju, Chunrong; Chen, Rongchang] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Chen, RC (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	chenrongchang2013@126.com			National Institute of Health [81100034]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was funded by the National Institute of Health [Grant 81100034]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Barreiro E, 2008, THORAX, V63, P100, DOI 10.1136/thx.2007.078030; Broekhuizen R, 2006, THORAX, V61, P17, DOI 10.1136/thx.2005.041996; Butcher Scott J, 2004, J Cardiopulm Rehabil, V24, P274, DOI 10.1097/00008483-200407000-00013; Caron MA, 2009, J APPL PHYSIOL, V107, P952, DOI 10.1152/japplphysiol.00194.2009; Coronell C, 2004, EUR RESPIR J, V24, P129, DOI 10.1183/09031936.04.00079603; Degens H, 2005, ACTA PHYSIOL SCAND, V184, P235, DOI 10.1111/j.1365-201X.2005.01447.x; Dempsey JA, 2006, RESP PHYSIOL NEUROBI, V151, P242, DOI 10.1016/j.resp.2005.12.015; Di Carlo A, 2004, J BIOL CHEM, V279, P16332, DOI 10.1074/jbc.M313931200; Donaldson AV, 2012, INT J CHRONIC OBSTR, V7, P523, DOI 10.2147/COPD.S28247; EDWARDS RHT, 1977, CLIN SCI MOL MED, V52, P283, DOI 10.1042/cs0520283; Engelen MPKJ, 2000, AM J CLIN NUTR, V71, P733, DOI 10.1093/ajcn/71.3.733; Gosker HR, 2007, EUR RESPIR J, V30, P73, DOI 10.1183/09031936.00146906; Gosker HR, 2007, THORAX, V62, P944, DOI 10.1136/thx.2007.078980; Gosker HR, 2003, EUR RESPIR J, V22, P280, DOI 10.1183/09031936.03.00012803; Gosker HR, 2003, CHEST, V123, P1416, DOI 10.1378/chest.123.5.1416; Hacievliyagil SS, 2013, NIGER J CLIN PRACT, V16, P76, DOI 10.4103/1119-3077.106771; Hernandes NA, 2009, J BRAS PNEUMOL, V35, P949, DOI 10.1590/S1806-37132009001000002; Hopkinson NS, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-25; Ju CR, 2012, RESP MED, V106, P102, DOI 10.1016/j.rmed.2011.07.016; Ju CR, 2011, CHINESE MED J-PEKING, V124, P2309, DOI 10.3760/cma.j.issn.0366-6999.2011.15.012; Kobayashi A, 2000, LUNG, V178, P119, DOI 10.1007/s004080000014; LAABAN JP, 1993, CHEST, V103, P1362, DOI 10.1378/chest.103.5.1362; Lee RC, 2000, AM J CLIN NUTR, V72, P796, DOI 10.1093/ajcn/72.3.796; Maltais F, 2000, THORAX, V55, P848, DOI 10.1136/thorax.55.10.848; MILLER AEJ, 1993, EUR J APPL PHYSIOL O, V66, P254, DOI 10.1007/BF00235103; O'Shea SD, 2009, CHEST, V136, P1269, DOI 10.1378/chest.09-0029; Rabinovich RA, 2010, CURR OPIN PULM MED, V16, P123, DOI 10.1097/MCP.0b013e328336438d; Reid MB, 2001, RESP RES, V2, P269, DOI 10.1186/rr67; Sandland C J, 2005, J Cardiopulm Rehabil, V25, P181, DOI 10.1097/00008483-200505000-00011; Schols AMWJ, 2005, AM J CLIN NUTR, V82, P53, DOI 10.1093/ajcn/82.1.53; Serres I, 1998, CHEST, V113, P900, DOI 10.1378/chest.113.4.900; Seymour JM, 2010, EUR RESPIR J, V36, P81, DOI 10.1183/09031936.00104909; Sugawara K, 2010, RESP MED, V104, P1883, DOI 10.1016/j.rmed.2010.05.008; Swallow EB, 2007, THORAX, V62, P115, DOI 10.1136/thx.2006.062026; Tan WC, 2005, RESPIROLOGY, V10, P9; van't Hul A, 2004, MUSCLE NERVE, V29, P267, DOI 10.1002/mus.10552; Vivodtzev I, 2006, CHEST, V129, P1540, DOI 10.1378/chest.129.6.1540; VOORRIPS LE, 1991, MED SCI SPORT EXER, V23, P974, DOI 10.1249/00005768-199108000-00015; Warwick G, 2013, RESPIROLOGY, V18, P874, DOI 10.1111/resp.12089; Whittom F, 1998, MED SCI SPORT EXER, V30, P1467, DOI 10.1097/00005768-199810000-00001; ZATTARAHARTMANN MC, 1995, MUSCLE NERVE, V18, P495, DOI 10.1002/mus.880180504	42	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e84167	10.1371/journal.pone.0084167	http://dx.doi.org/10.1371/journal.pone.0084167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558357	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700003
J	Kato, Y; Miyauchi, T; Abe, Y; Kojic, D; Tanaka, M; Chikazawa, N; Nakatake, Y; Ko, SBH; Kobayashi, D; Hazama, A; Fujiwara, S; Uchida, T; Yasui, M				Kato, Yasuhiro; Miyauchi, Takayuki; Abe, Youichiro; Kojic, Dusan; Tanaka, Manami; Chikazawa, Nana; Nakatake, Yuhki; Ko, Shigeru B. H.; Kobayashi, Daisuke; Hazama, Akihiro; Fujiwara, Shoko; Uchida, Tatsuya; Yasui, Masato			Unprecedented Cell-Selection Using Ultra-Quick Freezing Combined with Aquaporin Expression	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; WATER PERMEABILITY; CRYOPRESERVATION; TOLERANCE; MICROORGANISMS; SACCHAROMYCES; TEMPERATURE; INHIBITION; VIABILITY; NETWORKS	Freezing is usually used for preservation and storage of biological samples; however, this process may have some adverse effects such as cell membrane damage. Aquaporin (AQP), a water channel protein, has been suggested to play some roles for cryopreservation although its molecular mechanism remains unclear. Here we show that membrane damage caused by ultra-quick freezing is rescued by the expression of AQP4. We next examine if the expression of AQP combined with ultra-quick freezing can be used to select cells efficiently under freezing conditions where most cells are died. CHO cells stably expressing AQP4 were exclusively selected from mixed cell cultures. Having identified the increased expression of AQP4 during ES cell differentiation into neuro-ectoderm using bioinformatics, we confirmed the improved survival of differentiated ES cells with AQP4 expression. Finally we show that CHO cells transiently transfected with Endothelin receptor A and Aqp4 were also selected and concentrated by multiple cycles of freezing/thawing, which was confirmed with calcium imaging in response to endothelin. Furthermore, we found that the expression of AQP enables a reduction in the amount of cryoprotectants for freezing, thereby decreasing osmotic stress and cellular toxicity. Taken together, we propose that this simple but efficient and safe method may be applicable to the selection of mammalian cells for applications in regenerative medicine as well as cell-based functional assays or drug screening protocols.	[Kato, Yasuhiro; Miyauchi, Takayuki; Abe, Youichiro; Kojic, Dusan; Tanaka, Manami; Yasui, Masato] Keio Univ, Sch Med, Dept Pharmacol, Tokyo 160, Japan; [Chikazawa, Nana; Nakatake, Yuhki; Ko, Shigeru B. H.] Keio Univ, Sch Med, Dept Syst Med, Sakaguchi Lab, Tokyo, Japan; [Kobayashi, Daisuke; Hazama, Akihiro] Fukushima Med Univ, Sch Med, Dept Physiol, Fukushima, Japan; [Fujiwara, Shoko; Uchida, Tatsuya] Tokyo Univ Pharm & Life Sci, Dept Life Sci, Tokyo, Japan	Keio University; Keio University; Fukushima Medical University; Tokyo University of Pharmacy & Life Sciences	Yasui, M (corresponding author), Keio Univ, Sch Med, Dept Pharmacol, Tokyo 160, Japan.	myasui@a3.keio.jp	Nakatake, Yuhki/K-5405-2013; Abe, Yoichiro/J-5576-2013; Kojic, Dusan/AAO-9651-2021; Kobayashi, Daisuke/ABB-5208-2021; Abe, Yoichiro/AAN-8801-2020	Abe, Yoichiro/0000-0001-6163-8794; Kobayashi, Daisuke/0000-0003-2141-9444; Abe, Yoichiro/0000-0001-6163-8794; Kojic, Dusan/0000-0002-7199-0203	MEXT of Japan [22791938, 24792152]; Strategic International Research Cooperative Program; Japan Science and Technology Agency (JST); Keio Gijuku Academic Development Funds; Keio University	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic International Research Cooperative Program; Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Keio Gijuku Academic Development Funds; Keio University	This work was supported by Grant-in-Aid for Young Scientists (B) of MEXT of Japan (22791938 and 24792152), Strategic International Research Cooperative Program, Japan Science and Technology Agency (JST), Keio Gijuku Academic Development Funds and Keio University Special Grant-in-Aid for Innovative Collaborative Research Projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRE P, 1993, AM J PHYSIOL, V265, pF463; Aiba K, 2009, DNA RES, V16, P73, DOI 10.1093/dnares/dsn035; ANCHORDOGUY TJ, 1992, BIOCHIM BIOPHYS ACTA, V1104, P117, DOI 10.1016/0005-2736(92)90139-D; Bonhivers M, 1998, J BIOL CHEM, V273, P27565, DOI 10.1074/jbc.273.42.27565; Breunig M, 2007, P NATL ACAD SCI USA, V104, P14454, DOI 10.1073/pnas.0703882104; Claassen DA, 2009, MOL REPROD DEV, V76, P722, DOI 10.1002/mrd.21021; Cunningham JJ, 2012, NAT BIOTECHNOL, V30, P849, DOI 10.1038/nbt.2329; Dumont F, 2004, APPL ENVIRON MICROB, V70, P268, DOI 10.1128/AEM.70.1.268-272.2004; Edashige K, 2003, BIOL REPROD, V68, P87, DOI 10.1095/biolreprod.101.002394; Fujioka T, 2004, INT J DEV BIOL, V48, P1149, DOI 10.1387/ijdb.041852tf; Heng BC, 2006, J BIOMED SCI, V13, P433, DOI 10.1007/s11373-005-9051-9; Ibata K, 2011, BIOPHYS J, V101, P2277, DOI 10.1016/j.bpj.2011.08.045; Ikeshima-Kataoka H, 2013, MOL CELL NEUROSCI, V56, P65, DOI 10.1016/j.mcn.2013.02.002; Ismail M, 2009, BRIT J CANCER, V100, P1889, DOI 10.1038/sj.bjc.6605093; Katkov II, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/981606; La Porta CAM, 2006, BIOL CELL, V98, P89, DOI 10.1042/BC20040153; Malmersjo S, 2013, P NATL ACAD SCI USA, V110, pE1524, DOI 10.1073/pnas.1220179110; MAZUR P, 1968, CRYOBIOLOGY, V5, P1, DOI 10.1016/S0011-2240(68)80138-5; MAZUR P, 1970, SCIENCE, V168, P939, DOI 10.1126/science.168.3934.939; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Miyazaki K, 2013, J NEUROIMMUNOL, V260, P107, DOI 10.1016/j.jneuroim.2013.03.003; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Oshio K, 2004, NEUROSCIENCE, V127, P685, DOI 10.1016/j.neuroscience.2004.03.016; Reubinoff BE, 2001, HUM REPROD, V16, P2187, DOI 10.1093/humrep/16.10.2187; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; STEPONKUS PL, 1984, ANNU REV PLANT PHYS, V35, P543, DOI 10.1146/annurev.pp.35.060184.002551; TAKIGAWA M, 1995, EUR J BIOCHEM, V228, P102, DOI 10.1111/j.1432-1033.1995.0102o.x; Tanghe A, 2006, TRENDS MICROBIOL, V14, P78, DOI 10.1016/j.tim.2005.12.001; Tanghe A, 2005, APPL ENVIRON MICROB, V71, P6434, DOI 10.1128/AEM.71.10.6434-6437.2005; Tanghe A, 2004, APPL ENVIRON MICROB, V70, P3377, DOI 10.1128/AEM.70.6.3377-3382.2004; Tanghe A, 2003, ADV APPL MICROBIOL, V53, P129, DOI 10.1016/S0065-2164(03)53004-0; Xu X, 2010, BIOTECHNOL PROGR, V26, P827, DOI 10.1002/btpr.368	33	8	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e87644	10.1371/journal.pone.0087644	http://dx.doi.org/10.1371/journal.pone.0087644			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558371	Green Submitted, Green Published, gold			2022-12-27	WOS:000331706700017
J	Nachar, W; Busseuil, D; Shi, YF; Mihalache-Avram, T; Mecteau, M; Rheaume, E; Tardif, JC				Nachar, Walid; Busseuil, David; Shi, Yanfen; Mihalache-Avram, Teodora; Mecteau, Melanie; Rheaume, Eric; Tardif, Jean-Claude			Optimisation of Reference Genes for Gene-Expression Analysis in a Rabbit Model of Left Ventricular Diastolic Dysfunction	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; HEART-FAILURE; PCR DATA; NORMALIZATION; FIBROSIS; HYPERCHOLESTEROLEMIA; ECHOCARDIOGRAPHY; SELECTION; VELOCITY; PEPTIDE	Left ventricular diastolic dysfunction (LVDD) is characterized by the disturbance of ventricle's performance due to its abnormal relaxation or to its increased stiffness during the diastolic phase. The molecular mechanisms underlying LVDD remain unknown. We aimed to identify normalization genes for accurate gene-expression analysis of LVDD using quantitative real-time PCR (RT-PCR) in a new rabbit model of LVDD. Eighteen rabbits were fed with a normal diet (n = 7) or a 0.5% cholesterol-enriched diet supplemented with vitamin D2 (n = 11) for an average of 14.5 weeks. We validated the presence of LVDD in this model using echocardiography for diastolic function assessment. RT-PCR was performed using cDNA derived from left ventricle samples to measure the stability of 10 genes as candidate reference genes (Gapdh, Hprt1, Ppia, Sdha, Rpl5, Actb, Eef1e1, Ywhaz, Pgk1, and G6pd). Using geNorm analysis, we report that Sdha, Gapdh and Hprt1 genes had the highest stability (M<0.2). By contrast, Hprt1 and Rpl5 genes were found to represent the best combination for normalization when using the Normfinder algorithm (stability value of 0.042). Comparison of both normalization strategies highlighted an increase of natriuretic peptides (Bnp and Anp), monocytes chemotactic protein-1 (Mcp-1) and NADPH oxidase subunit (Nox-2) mRNA expressions in ventricle samples of the hypercholesterolemic rabbits compared to controls (P<0.05). This increase correlates with LVDD echocardiographic parameters and most importantly it molecularly validates the presence of the disease in our model. This is the first study emphasizing the selection of stable reference genes for RTPCR normalization in a rabbit model of LVDD.	[Nachar, Walid; Busseuil, David; Shi, Yanfen; Mihalache-Avram, Teodora; Mecteau, Melanie; Rheaume, Eric; Tardif, Jean-Claude] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Nachar, Walid; Busseuil, David; Shi, Yanfen; Mihalache-Avram, Teodora; Mecteau, Melanie; Rheaume, Eric; Tardif, Jean-Claude] Univ Montreal, Montreal, PQ, Canada; [Rheaume, Eric; Tardif, Jean-Claude] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Tardif, JC (corresponding author), Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada.	jean-claude.tardif@icm-mhi.org	Rheaume, Eric/ABA-4918-2021	Rheaume, Eric/0000-0002-0554-0984	Canada Research Chair in translational and personalized medicine [950-227725]	Canada Research Chair in translational and personalized medicine	Dr. Jean-Claude Tardif is the principal investigator of this article and he provided the funding from his Canada Research Chair in translational and personalized medicine #950-227725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Jacob, 2009, Heart Fail Clin, V5, P191, DOI 10.1016/j.hfc.2008.11.002; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bauersachs J, 2006, CARDIOVASC RES, V72, P438, DOI 10.1016/j.cardiores.2006.08.014; Borlaug BA, 2006, TRENDS CARDIOVAS MED, V16, P273, DOI 10.1016/j.tcm.2006.05.003; Busseuil D, 2008, BRIT J PHARMACOL, V154, P765, DOI 10.1038/bjp.2008.122; Busseuil D, 2010, CARDIOLOGY, V117, P234, DOI 10.1159/000322905; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caradec J, 2010, BRIT J CANCER, V103, P1475, DOI 10.1038/sj.bjc.6605851; Caradec J, 2010, BRIT J CANCER, V102, P1037, DOI 10.1038/sj.bjc.6605573; Dubi S, 2010, CARDIOVASC PATHOL, V19, P147, DOI 10.1016/j.carpath.2008.12.008; Fatima N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041533; Gan LM, 2004, ECHOCARDIOGR-J CARD, V21, P313, DOI 10.1111/j.0742-2822.2004.03111.x; Haugen E, 2007, INT J CARDIOL, V115, P24, DOI 10.1016/j.ijcard.2006.01.031; Huang Y, 2004, CIRCULATION, V109, P97, DOI 10.1161/01.CIR.0000109213.10461.F6; Irzmanski R, 2012, CLIN EXP HYPERTENS, V34, P530, DOI 10.3109/10641963.2012.702831; Kai H, 2005, HYPERTENS RES, V28, P483, DOI 10.1291/hypres.28.483; Khouri SJ, 2004, J AM SOC ECHOCARDIOG, V17, P290, DOI 10.1016/j.echo.2003.08.012; Lubien E, 2002, CIRCULATION, V105, P595, DOI 10.1161/hc0502.103010; Luchner A, 2001, CARDIOVASC RES, V51, P601, DOI 10.1016/S0008-6363(01)00316-9; Luo TY, 2004, J BIOMED SCI, V11, P829, DOI [10.1159/000081830, 10.1007/BF02254368]; Mamo S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-67; Martino A, 2011, J BIOTECHNOL, V153, P92, DOI 10.1016/j.jbiotec.2011.04.002; Mohamed BA, 2012, J MOL CELL CARDIOL, V53, P459, DOI 10.1016/j.yjmcc.2012.07.014; Murase T, 2012, HYPERTENS RES, V35, P186, DOI 10.1038/hr.2011.157; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Periasamy Muthu, 2008, Heart Fail Clin, V4, P13, DOI 10.1016/j.hfc.2007.10.007; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; ROSS R, 1976, SCIENCE, V193, P1094, DOI 10.1126/science.822515; Sciarretta S, 2009, CLIN SCI, V116, P467, DOI 10.1042/CS20080390; Shi YF, 2006, J THORAC CARDIOV SUR, V131, P1080, DOI 10.1016/j.jtcvs.2006.01.015; Song W, 2000, CARDIOVASC RES, V45, P595, DOI 10.1016/S0008-6363(99)00395-8; Sorescu Dan, 2002, Congest Heart Fail, V8, P132, DOI 10.1111/j.1527-5299.2002.00717.x; Talini E, 2008, ATHEROSCLEROSIS, V197, P346, DOI 10.1016/j.atherosclerosis.2007.05.024; Vandesompele, 2009, REAL TIME PCR CURREN; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Willems E, 2006, INT J DEV BIOL, V50, P627, DOI 10.1387/ijdb.052130ew; Xu Z, 2008, J CARDIOVASC PHARM, V51, P62, DOI 10.1097/FJC.0b013e31815bb629; Zhao YY, 2010, CANCER RES, V70, P9287, DOI 10.1158/0008-5472.CAN-10-2664	38	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89331	10.1371/journal.pone.0089331	http://dx.doi.org/10.1371/journal.pone.0089331			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558494	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700140
J	Sherwani, S; Farleigh, L; Agarwal, N; Loveless, S; Robertson, N; Hadaschik, E; Schnitzler, P; Bugert, JJ				Sherwani, Subuhi; Farleigh, Laura; Agarwal, Nidhi; Loveless, Samantha; Robertson, Neil; Hadaschik, Eva; Schnitzler, Paul; Bugert, Joachim Jakob			Seroprevalence of Molluscum contagiosum Virus in German and UK Populations	PLOS ONE			English	Article							ANTIBODIES; LESIONS; CELLS	Molluscum contagiosum virus (MCV) is a significant but underreported skin pathogen for children and adults. Seroprevalence studies can help establish burden of disease. Enzyme linked immunosorbent assay (ELISA) based studies have been published for Australian and Japanese populations and the results indicate seroprevalences between 6 and 22 percent in healthy individuals, respectively. To investigate seroprevalence in Europe, we have developed a recombinant ELISA using a truncated MCV virion surface protein MC084 (V123-R230) expressed in E. coli. The ELISA was found to be sensitive and specific, with low inter-and intra-assay variability. Sera from 289 German adults and children aged 0-40 years (median age 21 years) were analysed for antibodies against MC084 by direct binding ELISA. The overall seropositivity rate was found to be 14.8%. The seropositivity rate was low in children below the age of one (4.5%), peaked in children aged 210 years (25%), and fell again in older populations (11-40 years; 12.5%). Ten out of 33 healthy UK individuals (30.3%; median age 27 years) had detectable MC084 antibodies. MCV seroconversion was more common in dermatological and autoimmune disorders, than in immunocompromised patients or in patients with multiple sclerosis. Overall MCV seroprevalence is 2.1 fold higher in females than in males in a UK serum collection. German seroprevalences determined in the MC084 ELISA (14.8%) are at least three times higher than incidence of MC in a comparable Swiss population (4.9%). While results are not strictly comparable, this is lower than Australian seroprevalence in a virion based ELISA (n = 357; 23%; 1999), but higher than the seroprevalence reported in a Japanese study using an N-terminal truncation of MC133 (n = 108, 6%; 2000. We report the first large scale serological survey of MC in Europe (n = 393) and the first MCV ELISA based on viral antigen expressed in E. coli.	[Sherwani, Subuhi; Farleigh, Laura; Bugert, Joachim Jakob] Cardiff Univ, Sch Med, Inst Infect & Immun Med Microbiol, Cardiff CF10 3AX, S Glam, Wales; [Agarwal, Nidhi] Dr PN Behl Skin Inst & Sch Dermatol, New Delhi, India; [Loveless, Samantha; Robertson, Neil] Cardiff Univ, Sch Med, Inst Psychol Med & Clin Neurosci, Cardiff CF10 3AX, S Glam, Wales; [Hadaschik, Eva] Heidelberg Univ, Hautklin, Heidelberg, Germany; [Schnitzler, Paul] Heidelberg Univ, Dept Infect Dis, Heidelberg, Germany	Cardiff University; Cardiff University; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Bugert, JJ (corresponding author), Cardiff Univ, Sch Med, Inst Infect & Immun Med Microbiol, Cardiff CF10 3AX, S Glam, Wales.	bugertjj@cf.ac.uk	Bugert, Joachim/AAK-6459-2021; Sherwani, Subuhi/AAR-4495-2021; Bugert, Joachim Jakob/D-1705-2012	Sherwani, Subuhi/0000-0002-0631-708X; Bugert, Joachim Jakob/0000-0002-0556-3211	Wellcome Trust [WT 092488]; Medical Research Council [MR/L010305/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Subuhi Sherwani is self funded. Consumables expenses were partially supported by a Wellcome Trust grant to Bernhard Moser (grant Number WT 092488). Wellcome Trust had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birthistle K, 1997, J INFECTION, V34, P21, DOI 10.1016/S0163-4453(97)80005-9; BLASCO R, 1991, J VIROL, V65, P5910, DOI 10.1128/JVI.65.11.5910-5920.1991; BREMAN JG, 1980, NEW ENGL J MED, V303, P1263, DOI 10.1056/NEJM198011273032204; BROWN S T, 1974, Journal of the American Venereal Disease Association, V1, P35; Buckley R, 1999, ARCH DERMATOL, V135, P1167, DOI 10.1001/archderm.135.10.1167; Bugert J.J., 2008, ENCY VIROLOGY, P319; BULLER RML, 1995, VIROLOGY, V213, P655, DOI 10.1006/viro.1995.0037; BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991; BURNETT JW, 1966, J INVEST DERMATOL, V46, P76, DOI 10.1038/jid.1966.12; BURNETT JW, 1968, J INVEST DERMATOL, V50, P67, DOI 10.1038/jid.1968.10; Butala N, 2013, PEDIATRICS, V131, pE1650, DOI 10.1542/peds.2012-2933; Chen XY, 2013, LANCET INFECT DIS, V13, P877, DOI 10.1016/S1473-3099(13)70109-9; Delhon G, 2004, J VIROL, V78, P168, DOI 10.1128/JVI.78.1.168-177.2004; Esposito JJ, 1991, ARCH VIROL         S, V2, P91; Fife KH, 1996, VIROLOGY, V226, P95, DOI 10.1006/viro.1996.0631; GOTTLIEB SL, 1994, INT J DERMATOL, V33, P453, DOI 10.1111/j.1365-4362.1994.tb02853.x; Konya J, 1999, J INFECT DIS, V179, P701, DOI 10.1086/314620; KONYA J, 1992, J VIROL METHODS, V40, P183, DOI 10.1016/0166-0934(92)90067-N; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MITCHELL JC, 1953, BRIT J EXP PATHOL, V34, P44; POSTLETH.R, 1970, ARCH ENVIRON HEALTH, V21, P432, DOI 10.1080/00039896.1970.10667262; Reynolds MG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005255; Senkevich TG, 1996, SCIENCE, V273, P813, DOI 10.1126/science.273.5276.813; Sherwani Subuhi, 2012, Methods Mol Biol, V890, P135, DOI 10.1007/978-1-61779-876-4_8; SHIRODARIA PV, 1979, BRIT J DERMATOL, V101, P133, DOI 10.1111/j.1365-2133.1979.tb05597.x; Vermi W, 2011, J INVEST DERMATOL, V131, P426, DOI 10.1038/jid.2010.256; Watanabe T, 1998, J INFECT DIS, V177, P284, DOI 10.1086/514197; Watanabe T, 2000, ARCH DERMATOL, V136, P1518, DOI 10.1001/archderm.136.12.1518; Wenk C, 2003, PEDIATR DERMATOL, V20, P482, DOI 10.1111/j.1525-1470.2003.20605.x	30	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88734	10.1371/journal.pone.0088734	http://dx.doi.org/10.1371/journal.pone.0088734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558417	gold, Green Submitted, Green Published			2022-12-27	WOS:000331706700063
J	Singh, SA; Goldberg, TA; Henson, AL; Husain-Krautter, S; Nihrane, A; Blanc, L; Ellis, SR; Lipton, JM; Liu, JM				Singh, Sharon A.; Goldberg, Tracie A.; Henson, Adrianna L.; Husain-Krautter, Sehba; Nihrane, Abdallah; Blanc, Lionel; Ellis, Steven R.; Lipton, Jeffrey M.; Liu, Johnson M.			p53-Independent Cell Cycle and Erythroid Differentiation Defects in Murine Embryonic Stem Cells Haploinsufficient for Diamond Blackfan Anemia-Proteins: RPS19 versus RPL5	PLOS ONE			English	Article							P53 TUMOR-SUPPRESSOR; S19 DEFICIENCY; HEMATOPOIETIC DEFECTS; ZEBRAFISH MODEL; MUTATIONS; ERYTHROPOIESIS; ACTIVATION; FAILURE; LEADS; PROLIFERATION	Diamond Blackfan anemia (DBA) is a rare inherited bone marrow failure syndrome caused by ribosomal protein haploinsufficiency. DBA exhibits marked phenotypic variability, commonly presenting with erythroid hypoplasia, less consistently with non-erythroid features. The p53 pathway, activated by abortive ribosome assembly, is hypothesized to contribute to the erythroid failure of DBA. We studied murine embryonic stem (ES) cell lines harboring a gene trap mutation in a ribosomal protein gene, either Rps19 or Rpl5. Both mutants exhibited ribosomal protein haploinsufficiency and polysome defects. Rps19 mutant ES cells showed significant increase in p53 protein expression, however, there was no similar increase in the Rpl5 mutant cells. Embryoid body formation was diminished in both mutants but nonspecifically rescued by knockdown of p53. When embryoid bodies were further differentiated to primitive erythroid colonies, both mutants exhibited a marked reduction in colony formation, which was again nonspecifically rescued by p53 inhibition. Cell cycle analyses were normal in Rps19 mutant ES cells, but there was a significant delay in the G2/M phase in the Rpl5 mutant cells, which was unaffected by p53 knockdown. Concordantly, Rpl5 mutant ES cells had a more pronounced growth defect in liquid culture compared to the Rps19 mutant cells. We conclude that the defects in our RPS19 and RPL5 haploinsufficient mouse ES cells are not adequately explained by p53 stabilization, as p53 knockdown appears to increase the growth and differentiation potential of both parental and mutant cells. Our studies demonstrate that gene trap mouse ES cells are useful tools to study the pathogenesis of DBA.	[Singh, Sharon A.; Blanc, Lionel; Lipton, Jeffrey M.; Liu, Johnson M.] Hofstra North Shore LIJ Sch Med, Dept Mol Med, Hempstead, NY 11549 USA; [Singh, Sharon A.; Goldberg, Tracie A.; Husain-Krautter, Sehba; Nihrane, Abdallah; Blanc, Lionel; Lipton, Jeffrey M.; Liu, Johnson M.] Feinstein Inst Med Res, Manhasset, NY USA; [Singh, Sharon A.; Goldberg, Tracie A.; Blanc, Lionel; Lipton, Jeffrey M.; Liu, Johnson M.] Steven & Alexandra Cohen Childrens Med Ctr New Yo, Div Hematol Oncol, New Hyde Pk, NY USA; [Henson, Adrianna L.; Ellis, Steven R.] Univ Louisville, Dept Biochem, Louisville, KY 40292 USA; [Singh, Sharon A.; Blanc, Lionel; Lipton, Jeffrey M.; Liu, Johnson M.] Hofstra North Shore LIJ Sch Med, Dept Pediat, Hempstead, NY USA	Hofstra University; Northwell Health; Northwell Health; Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; University of Louisville; Hofstra University; Northwell Health	Singh, SA (corresponding author), Hofstra North Shore LIJ Sch Med, Dept Mol Med, Hempstead, NY 11549 USA.	ssingh1@nshs.edu		Blanc, Lionel/0000-0002-0185-6260; Husain-Krautter, Sehba/0000-0001-6002-8046	National Institutes of Health [R01HL079571]; Diamond-Blackfan Anemia Foundation; Daniela Maria Arturi Foundation; Pediatric Cancer Foundation; Saint Baldrick's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079571] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diamond-Blackfan Anemia Foundation; Daniela Maria Arturi Foundation; Pediatric Cancer Foundation; Saint Baldrick's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from the National Institutes of Health (R01HL079571 to J.M. Lipton), the Diamond-Blackfan Anemia Foundation, the Daniela Maria Arturi Foundation, the Pediatric Cancer Foundation, and the Saint Baldrick's Foundation (to S. A. Singh and J.M. Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badhai J, 2009, BBA-MOL BASIS DIS, V1792, P1036, DOI 10.1016/j.bbadis.2009.08.002; Chan Rebecca J., 2006, V330, P123; Chen WSV, 2003, METHOD ENZYMOL, V365, P367; Choi K, 1998, BIOCHEM CELL BIOL, V76, P947, DOI 10.1139/bcb-76-6-947; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; Devlin EE, 2010, BLOOD, V116, P2826, DOI 10.1182/blood-2010-03-275776; Dianzani I, 2008, HAEMATOL-HEMATOL J, V93, P1601, DOI 10.3324/haematol.2008.000513; Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238; Ellis SR, 2011, SEMIN HEMATOL, V48, P89, DOI 10.1053/j.seminhematol.2011.02.005; Farrar JE, 2011, BLOOD, V118, P6943, DOI 10.1182/blood-2011-08-375170; Forrai A, 2005, EXP HEMATOL, V33, P845, DOI 10.1016/j.exphem.2005.03.016; Fumagalli S, 2012, GENE DEV, V26, P1028, DOI 10.1101/gad.189951.112; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Ganguli G, 2002, EMBO REP, V3, P569, DOI 10.1093/embo-reports/kvf114; Garcon L, 2013, BLOOD, V122, P912, DOI 10.1182/blood-2013-01-478321; Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004; Gazda HT, 2004, BRIT J HAEMATOL, V127, P105, DOI 10.1111/j.1365-2141.2004.05152.x; HARVEY M, 1993, ONCOGENE, V8, P2457; Horn HF, 2008, ONCOGENE, V27, P5774, DOI 10.1038/onc.2008.189; Jaako P, 2011, BLOOD, V118, P6087, DOI 10.1182/blood-2011-08-371963; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kuramitsu M, 2008, BRIT J HAEMATOL, V140, P348, DOI 10.1111/j.1365-2141.2007.06930.x; Lipton JM, 2010, CURR OPIN PEDIATR, V22, P12, DOI 10.1097/MOP.0b013e328334573b; Lipton JM, 2009, HEMATOL ONCOL CLIN N, V23, P261, DOI 10.1016/j.hoc.2009.01.004; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; McGowan KA, 2011, SEMIN HEMATOL, V48, P106, DOI 10.1053/j.seminhematol.2011.02.001; Miyake K, 2008, STEM CELLS, V26, P323, DOI 10.1634/stemcells.2007-0569; Montel-Hagen A, 2008, BLOOD, V112, P4729, DOI 10.1182/blood-2008-05-159269; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Palis J, 2008, CURR OPIN HEMATOL, V15, P155, DOI 10.1097/MOH.0b013e3282f97ae1; PERDAHL EB, 1994, BLOOD, V83, P645; Quarello P, 2010, HAEMATOL-HEMATOL J, V95, P206, DOI 10.3324/haematol.2009.011783; Sankaran VG, 2012, J CLIN INVEST, V122, P2439, DOI 10.1172/JCI63597; Sengupta S, 2004, ANN NY ACAD SCI, V1024, P54, DOI 10.1196/annals.1321.005; Sieff CA, 2010, BRIT J HAEMATOL, V148, P611, DOI 10.1111/j.1365-2141.2009.07993.x; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Taylor AM, 2012, EXP HEMATOL, V40, P228, DOI [10.1016/j.exphem.2011.11.007, 10.1016/j.exphem.2011.11.007.]; Teng T, 2013, MOL CELL BIOL, V33, P4660, DOI 10.1128/MCB.01174-13; Torihara H, 2011, BRIT J HAEMATOL, V152, P648, DOI 10.1111/j.1365-2141.2010.08535.x; Uechi T, 2008, HUM MOL GENET, V17, P3204, DOI 10.1093/hmg/ddn216; Vlachos A, 2008, BRIT J HAEMATOL, V142, P859, DOI 10.1111/j.1365-2141.2008.07269.x; Vlachos A, 2012, BLOOD, V119, P3815, DOI 10.1182/blood-2011-08-375972; Weiss MJ, 2012, J CLIN INVEST, V122, P2346, DOI 10.1172/JCI63989; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131; WILES MV, 1991, DEVELOPMENT, V111, P259; Yadavilli S, 2009, DNA REPAIR, V8, P1215, DOI 10.1016/j.dnarep.2009.07.003; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	48	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89098	10.1371/journal.pone.0089098	http://dx.doi.org/10.1371/journal.pone.0089098			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558476	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700122
J	Yamazaki, F; Kim, HH; Lau, P; Hwang, CK; Iuvone, PM; Klein, D; Clokie, SJH				Yamazaki, Fumiyoshi; Kim, Hyun Hee; Lau, Pierre; Hwang, Christopher K.; Iuvone, P. Michael; Klein, David; Clokie, Samuel J. H.			pY RNA1-s2: A Highly Retina-Enriched Small RNA That Selectively Binds to Matrin 3 (Matr3)	PLOS ONE			English	Article							Y-RNAS; RECOGNITION MOTIF; LINEAGE ANALYSIS; PROTEIN; IDENTIFICATION; MICRORNAS; DEGRADATION; EVOLUTION; ABUNDANCE; SIRNAS	The purpose of this study was to expand our knowledge of small RNAs, which are known to function within protein complexes to modulate the transcriptional output of the cell. Here we describe two previously unrecognized, small RNAs, termed pY RNA1-s1 and pY RNA1-s2 (processed Y RNA1-stem -1 and -2), thereby expanding the list of known small RNAs. pY RNA1-s1 and pY RNA1-s2 were discovered by RNA sequencing and found to be 20-fold more abundant in the retina than in 14 other rat tissues. Retinal expression of pY RNAs is highly conserved, including expression in the human retina, and occurs in all retinal cell layers. Mass spectrometric analysis of pY RNA1-S2 binding proteins in retina indicates that pY RNA1-s2 selectively binds the nuclear matrix protein Matrin 3 (Matr3) and to a lesser degree to hnrpul1 (heterogeneous nuclear ribonucleoprotein U-like protein). In contrast, pY RNA1-s1 does not bind these proteins. Accordingly, the molecular mechanism of action of pY RNA1-s2 is likely be through an action involving Matr3; this 95 kDa protein has two RNA recognition motifs (RRMs) and is implicated in transcription and RNA-editing. The high affinity binding of pY RNA1-s2 to Matr3 is strongly dependent on the sequence of the RNA and both RRMs of Matr3. Related studies also indicate that elements outside of the RRM region contribute to binding specificity and that phosphorylation enhances pY RNA-s2/Matr3 binding. These observations are of significance because they reveal that a previously unrecognized small RNA, pY RNA1-s2, binds selectively to Matr3. Hypothetically, pY RNA1-S2 might act to modulate cellular function through this molecular mechanism. The retinal enrichment of pY RNA1-s2 provides reason to suspect that the pY RNA1-s2/Matr3 interaction could play a role in vision.	[Yamazaki, Fumiyoshi; Kim, Hyun Hee; Klein, David; Clokie, Samuel J. H.] Eunice Shriver Kennedy Natl Inst Child Hlth & Hum, Sect Neuroendocrinol, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA; [Lau, Pierre] NINDS, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Hwang, Christopher K.; Iuvone, P. Michael] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA; [Hwang, Christopher K.; Iuvone, P. Michael] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Emory University; Emory University	Klein, D (corresponding author), Eunice Shriver Kennedy Natl Inst Child Hlth & Hum, Sect Neuroendocrinol, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA.	kleind@mail.nih.gov		Klein, David/0000-0002-1792-5806; Clokie, Samuel/0000-0002-0025-3652	Intramural Research Program of the NICHD/NIH; NIH [R01 EY004864, P30 EY006360, T32 EY007092]; Research to Prevent Blindness, Inc. (RPB); RPB; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008836, ZIAHD008838, ZIAHD008837] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY007092, P30EY006360, R01EY004864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602] Funding Source: NIH RePORTER	Intramural Research Program of the NICHD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, Inc. (RPB)(Research to Prevent Blindness (RPB)); RPB; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported in part by the Intramural Research Program of the NICHD/NIH, by NIH grants R01 EY004864, P30 EY006360, T32 EY007092, and by an unrestricted departmental grant from Research to Prevent Blindness, Inc. (RPB). PMI is a recipient of a Senior Scientific Investigator Award from RPB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; BELGRADER P, 1991, J BIOL CHEM, V266, P9893; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Boria I, 2010, J MOL EVOL, V70, P346, DOI 10.1007/s00239-010-9332-4; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Chen XG, 2000, GENE DEV, V14, P777; Christov CP, 2006, MOL CELL BIOL, V26, P6993, DOI 10.1128/MCB.01060-06; Clokie SJ, 2012, J BIOL CHEM; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; FIELDSBERRY SC, 1992, P NATL ACAD SCI USA, V89, P693, DOI 10.1073/pnas.89.2.693; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Giordano G, 2005, J NEUROCHEM, V94, P808, DOI 10.1111/j.1471-4159.2005.03235.x; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hibino Y, 2006, BBA-GENE STRUCT EXPR, V1759, P195, DOI 10.1016/j.bbaexp.2006.04.010; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Inagaki H, 1996, J BIOL CHEM, V271, P12525, DOI 10.1074/jbc.271.21.12525; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khurana JS, 2010, J CELL BIOL, V191, P905, DOI 10.1083/jcb.201006034; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; LIVAK KJ, 1990, GENETICS, V124, P303; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Meiri E, 2010, NUCLEIC ACIDS RES, V38, P6234, DOI 10.1093/nar/gkq376; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Mosig A, 2007, THEOR BIOSCI, V126, P9, DOI 10.1007/s12064-007-0003-y; NAKAYASU H, 1991, P NATL ACAD SCI USA, V88, P10312, DOI 10.1073/pnas.88.22.10312; National Research Council (US) Committee, 2011, GUIDE CARE USE LAB A, V8th; Nicolas FE, 2012, FEBS LETT, V586, P1226, DOI 10.1016/j.febslet.2012.03.026; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Perreault J, 2007, MOL BIOL EVOL, V24, P1678, DOI 10.1093/molbev/msm084; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; PRUIJN GJM, 1993, BIOCHIM BIOPHYS ACTA, V1216, P395, DOI 10.1016/0167-4781(93)90006-Y; Przygodzka P, 2011, EXP CELL RES, V317, P802, DOI 10.1016/j.yexcr.2010.12.009; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; Rutjes SK, 1999, J BIOL CHEM, V274, P24799, DOI 10.1074/jbc.274.35.24799; Salton M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023882; Salton M, 2010, CELL CYCLE, V9, P1568, DOI 10.4161/cc.9.8.11298; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shinoda K, 2010, BIOINFORMATICS, V26, P576, DOI 10.1093/bioinformatics/btp700; Smalheiser NR, 2011, RNA, V17, P166, DOI 10.1261/rna.2123811; VANGELDER CWG, 1994, NUCLEIC ACIDS RES, V22, P2498, DOI 10.1093/nar/22.13.2498; VANHORN DJ, 1995, RNA, V1, P293	47	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88217	10.1371/journal.pone.0088217	http://dx.doi.org/10.1371/journal.pone.0088217			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558381	gold, Green Published, Green Submitted			2022-12-27	WOS:000331706700027
J	Clegg, CH; Roque, R; Perrone, LA; Rininger, JA; Bowen, R; Reed, SG				Clegg, Christopher H.; Roque, Richard; Perrone, Lucy A.; Rininger, Joseph A.; Bowen, Richard; Reed, Steven G.			GLA-AF, an Emulsion-Free Vaccine Adjuvant for Pandemic Influenza	PLOS ONE			English	Article							VIRUS; TRANSMISSION; NARCOLEPSY; ANTIBODIES; MEMORY; CELLS; MF59	The ongoing threat from Influenza necessitates the development of new vaccine and adjuvant technologies that can maximize vaccine immunogenicity, shorten production cycles, and increase global vaccine supply. Currently, the most successful adjuvants for Influenza vaccines are squalene-based oil-in-water emulsions. These adjuvants enhance seroprotective antibody titers to homologous and heterologous strains of virus, and augment a significant dose sparing activity that could improve vaccine manufacturing capacity. As an alternative to an emulsion, we tested a simple lipid-based aqueous formulation containing a synthetic TLR4 ligand (GLA-AF) for its ability to enhance protection against H5N1 infection. GLA-AF was very effective in adjuvanting recombinant H5 hemagglutinin antigen (rH5) in mice and was as potent as the stable emulsion, SE. Both adjuvants induced similar antibody titers using a sub-microgram dose of rH5, and both conferred complete protection against a highly pathogenic H5N1 challenge. However, GLA-AF was the superior adjuvant in ferrets. GLA-AF stimulated a broader antibody response than SE after both the prime and boost immunization with rH5, and ferrets were better protected against homologous and heterologous strains of H5N1 virus. Thus, GLA-AF is a potent emulsion-free adjuvant that warrants consideration for pandemic influenza vaccine development.	[Clegg, Christopher H.; Roque, Richard; Perrone, Lucy A.] TRIA Biosci Corp, Seattle, WA USA; [Rininger, Joseph A.] CaroGen Corp, Hamden, CT USA; [Bowen, Richard] Colorado State Univ, Ft Collins, CO 80523 USA; [Reed, Steven G.] Infect Dis Res Inst, Seattle, WA USA	Colorado State University	Clegg, CH (corresponding author), TRIA Biosci Corp, Seattle, WA USA.	cclegg@triabio.com		PERRONE. MSPH, PhD, LUCY A./0000-0003-2185-688X	National Institutes of Health [R44AI081383]; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI081383] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institute of Allergy and Infectious Diseases, National Institutes of Health grant R44AI081383. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002302; Anderson RC, 2010, COLLOID SURFACE B, V75, P123, DOI 10.1016/j.colsurfb.2009.08.022; Banzhoff A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004384; Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; Clegg CH, 2013, EXPERT REV VACCINES, V12, P767, DOI 10.1586/14760584.2013.811178; Clegg CH, 2012, P NATL ACAD SCI USA, V109, P17585, DOI 10.1073/pnas.1207308109; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Dormitzer PR, 2011, IMMUNOL REV, V239, P167, DOI 10.1111/j.1600-065X.2010.00974.x; Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x; Fox CB, 2013, VACCINE, V31, P1633, DOI 10.1016/j.vaccine.2012.10.048; Galli G, 2009, P NATL ACAD SCI USA, V106, P7962, DOI 10.1073/pnas.0903181106; Galli G, 2009, P NATL ACAD SCI USA, V106, P3877, DOI 10.1073/pnas.0813390106; Hagen SR, 1997, J CHROMATOGR A, V767, P53, DOI 10.1016/S0021-9673(97)00041-1; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; KENDAL AP, 1982, CONCEPTS PROCEDURES, pB17; Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336; Kothare SV, 2013, NEUROLOGY, V80, P1276, DOI 10.1212/WNL.0b013e31828ab382; Lam TTY, 2013, NATURE, V502, P241, DOI 10.1038/nature12515; Leroux-Roels I, 2010, VACCINE, V28, P849, DOI 10.1016/j.vaccine.2009.10.017; Lippi G, 2010, EUR J INTERN MED, V21, P70, DOI 10.1016/j.ejim.2009.12.001; McKeage K, 2011, DRUGS, V71, P465, DOI [10.2165/11206820-000000000-00000, 10.2165/11208090-000000000-00000]; McKinstry KK, 2011, J INTERN MED, V269, P507, DOI 10.1111/j.1365-2796.2011.02367.x; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; O'Hagan DT, 2012, VACCINE, V30, P4341, DOI 10.1016/j.vaccine.2011.09.061; Orr MT, 2013, J CONTROL RELEASE, V172, P190, DOI 10.1016/j.jconrel.2013.07.030; Pellegrini M, 2009, VACCINE, V27, P6959, DOI 10.1016/j.vaccine.2009.08.101; Qi X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4752; Rallabhandi P, 2008, J IMMUNOL, V180, P1139, DOI 10.4049/jimmunol.180.2.1139; Richard M, 2013, NATURE, V501, P560, DOI 10.1038/nature12476; Schwarz TF, 2009, VACCINE, V27, P6284, DOI 10.1016/j.vaccine.2009.01.040; Vesikari T, 2010, PEDIATRICS, V126, pE762, DOI 10.1542/peds.2009-2628; Wijnans L, 2013, VACCINE, V31, P1246, DOI 10.1016/j.vaccine.2012.12.015; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532	33	29	33	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88979	10.1371/journal.pone.0088979	http://dx.doi.org/10.1371/journal.pone.0088979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551202	Green Submitted, gold, Green Published			2022-12-27	WOS:000331271500088
J	Montero-Marin, J; Prado-Abril, J; Demarzo, MMP; Gascon, S; Garcia-Campayo, J				Montero-Marin, Jesus; Prado-Abril, Javier; Piva Demarzo, Marcelo Marcos; Gascon, Santiago; Garcia-Campayo, Javier			Coping with Stress and Types of Burnout: Explanatory Power of Different Coping Strategies	PLOS ONE			English	Article							EFFORT-REWARD-IMBALANCE; JOB STRESS; SOCIAL SUPPORT; QUESTIONNAIRE; NURSES; MINDFULNESS; ACCEPTANCE; DEFINITION; SETTINGS; TEACHERS	Background: Burnout occurs when professionals use ineffective coping strategies to try to protect themselves from work-related stress. The dimensions of 'overload', 'lack of development' and 'neglect', belonging to the 'frenetic', 'under-challenged' and 'worn-out' subtypes, respectively, comprise a brief typological definition of burnout. The aim of the present study was to estimate the explanatory power of the different coping strategies on the development of burnout subtypes. Methods: This was a cross-sectional survey with a random sample of university employees, stratified by occupation (n = 429). Multivariate linear regression models were constructed between the 'Burnout Clinical Subtypes Questionnaire', with its three dimensions - overload, lack of development and neglect-as dependent variables, and the 'Coping Orientation for Problem Experiences', with its fifteen dimensions, as independent variables. Adjusted multiple determination coefficients and beta coefficients were calculated to evaluate and compare the explanatory capacity of the different coping strategies. Results: The 'Coping Orientation for Problem Experiences' subscales together explained 15% of the 'overload' (p<0.001), 9% of the 'lack of development' (p<0.001), and 21% of the 'neglect' (p<0.001). 'Overload' was mainly explained by 'venting of emotions' (Beta = 0.34; p, 0.001); 'lack of development' by 'cognitive avoidance' (Beta = 0.21; p, 0.001); and 'neglect' by 'behavioural disengagement' (Beta = 0.40; p<0.001). Other interesting associations were observed. Conclusions: These findings further our understanding of the way in which the effectiveness of interventions for burnout may be improved, by influencing new treatments and preventive programmes using features of the strategies for handling stress in the workplace.	[Montero-Marin, Jesus] Univ Zaragoza, Fac Hlth Sci & Sports, Huesca, Spain; [Montero-Marin, Jesus; Garcia-Campayo, Javier] Univ Zaragoza, Dept Psychiat, Zaragoza, Spain; [Prado-Abril, Javier; Garcia-Campayo, Javier] Miguel Servet Univ Hosp, Psychiat Serv, Zaragoza, Spain; [Piva Demarzo, Marcelo Marcos] Univ Fed Sao Paulo, Dept Prevent Med, Sao Paulo, Brazil; [Gascon, Santiago] Univ Zaragoza, Dept Psychol, Teruel, Spain; [Montero-Marin, Jesus; Gascon, Santiago; Garcia-Campayo, Javier] REDIAPP Red Invest Actividades Prevent & Promoc S, Zaragoza, Spain	University of Zaragoza; University of Zaragoza; Miguel Servet University Hospital; Universidade Federal de Sao Paulo (UNIFESP); University of Zaragoza	Montero-Marin, J (corresponding author), Univ Zaragoza, Fac Hlth Sci & Sports, Huesca, Spain.	jmontero@unizar.es	Demarzo, Marcelo/A-7021-2010; Montero-Marin, Jesus/ABG-8919-2020; Prado-Abril, Javier/AAA-3600-2020	Demarzo, Marcelo/0000-0002-7447-1839; Montero-Marin, Jesus/0000-0001-5677-1662; Prado-Abril, Javier/0000-0002-7286-9034; Gascon, Santiago/0000-0002-3723-0673; Garcia-Campayo, Javier/0000-0002-3797-4218	Research Network on Preventative Activities and Health Promotion [RD06/0018/0017]; Health Sciences Institute of Aragon (IACS); CNPq - Brazilian National Council for Research and Technology Development	Research Network on Preventative Activities and Health Promotion; Health Sciences Institute of Aragon (IACS); CNPq - Brazilian National Council for Research and Technology Development	This study was possible as a result of the support received from the Research Network on Preventative Activities and Health Promotion (RD06/0018/0017) and the Health Sciences Institute of Aragon (IACS). MMPD is grateful to the CNPq - Brazilian National Council for Research and Technology Development for a postdoctoral fellowship (Science without Borders Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, SUEZ COMPL UN WAT RE; AUERBACH SM, 1976, J CONSULT CLIN PSYCH, V44, P809, DOI 10.1037/0022-006X.44.5.809; Bakker AB, 2001, J SOC CLIN PSYCHOL, V20, P82, DOI 10.1521/jscp.20.1.82.22251; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Beutler L.E., 1990, SYSTEMATIC TREATMENT; Brinkborg H, 2011, BEHAV RES THER, V49, P389, DOI 10.1016/j.brat.2011.03.009; Buunk BP., 1999, EUR REV SOC PSYCHOL, V10, P259, DOI [DOI 10.1080/14792779943000080, 10.1080/14792779943000080]; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Chapman LK, 2010, DEPRESS ANXIETY, V27, P316, DOI 10.1002/da.20510; Chen MJ, 2008, WORK STRESS, V22, P327, DOI 10.1080/02678370802573992; Crespo M., 1997, ANALISIS MODIFICACIO, V23, P797, DOI DOI 10.6018/ANALESPS.29.1.124531; Delaney-Black V, 2010, PEDIATRICS, V126, P887, DOI 10.1542/peds.2009-3059; Etxeberria J, 2007, MULTIPLE REGRESSION; Farber B.A, 1990, PSYCHOTHERAPY PRIVAT, V8, P35, DOI [DOI 10.1300/J294V08N01_07, 10.1300/J294v08n01_07]; Farber BA, 2000, J CLIN PSYCHOL, V56, P675, DOI 10.1002/(SICI)1097-4679(200005)56:5<675::AID-JCLP8>3.0.CO;2-D; Farber BA, 2000, J CLIN PSYCHOL, V56, P589, DOI 10.1002/(SICI)1097-4679(200005)56:5<589::AID-JCLP1>3.0.CO;2-S; Gerzina HA, 2012, TEACH LEARN MED, V24, P309, DOI 10.1080/10401334.2012.715255; Gibbons C, 2010, INT J NURS STUD, V47, P1299, DOI 10.1016/j.ijnurstu.2010.02.015; Gil-Monte P. R, 2007, SINDROME QUEMARSE TR; Gil-Monte P.R., 2005, SINDROME QUEMARSE TR; Griffith J, 1999, BRIT J EDUC PSYCHOL, V69, P517, DOI 10.1348/000709999157879; Guerrero E, 2003, ANAL PSICOL, V10, P145; Haberthur AK, 2009, J CLIN PSYCHOL, V65, P1039, DOI 10.1002/jclp.20606; Heiervang E, 2011, SOC PSYCH PSYCH EPID, V46, P69, DOI 10.1007/s00127-009-0171-9; Herbert JD, 2008, COGNITIVE BEHAV THER, P4; HOFER MA, 1972, PSYCHOSOM MED, V34, P481, DOI 10.1097/00006842-197211000-00001; Huberman A, 1999, UNDERSTANDING PREVEN, P159, DOI DOI 10.1017/CBO9780511527784.009; iD'Souza RM, 2003, J EPIDEMIOL COMMUNIT, V57, P849; Isaksson KE, 2013, BMC PUBLIC HEALTH, V10, P213; Kaplowitz MD, 2004, PUBLIC OPIN QUART, V68, P94, DOI 10.1093/poq/nfh006; King G, 2003, INT STUDIES PERSPECT, V4, P100, DOI DOI 10.1111/1528-3577.04105; Koenig HG, 2001, ANN PHARMACOTHER, V35, P352, DOI 10.1345/aph.10215; Lazarus R., 1984, STRESS APPRAISAL COP; LAZARUS RS, 1993, PSYCHOSOM MED, V55, P234, DOI 10.1097/00006842-199305000-00002; LAZARUS RS, 1993, ANNU REV PSYCHOL, V44, P1, DOI 10.1146/annurev.ps.44.020193.000245; Lloyd J, 2013, WORK STRESS, V27, P181, DOI 10.1080/02678373.2013.782157; Losa Iglesias ME, 2010, INT J NURS STUD, V47, P30, DOI 10.1016/j.ijnurstu.2009.06.014; Asuero AM, 2013, GAC SANIT, V27, P521, DOI 10.1016/j.gaceta.2013.04.007; Martinez-Gonzalez M, 2006, BIOESTADISTICA AMIGA, P851; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C., 1996, MASLACH BURNOUT INVE; McCracken LM, 2010, PAIN, V148, P141, DOI 10.1016/j.pain.2009.10.034; Montero-Marin J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1240; Montero-Marin J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-922; Montero-Marin Jesus, 2011, BMC Med Educ, V11, P103, DOI 10.1186/1472-6920-11-103; Montero-Marin J, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-74; Montero-Marin J, 2011, BMC MED EDUC, V11, DOI [10.1186/1472-6920-11-103, 10.1186/1471-244X-11-49]; Montero-Marin J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-302; Montero-Marin Jesus, 2009, J Occup Med Toxicol, V4, P31, DOI 10.1186/1745-6673-4-31; Ohue T, 2011, JPN J NURS SCI, V8, P76, DOI 10.1111/j.1742-7924.2010.00161.x; Paris M, 2010, J BEHAV HEALTH SER R, V37, P519, DOI 10.1007/s11414-009-9202-2; Paul HA, 2006, CHILD FAM BEHAV THER, V28, P73; Pejuskovic B, 2011, PSYCHIAT DANUB, V23, P389; Pisanti R, 2012, MED LAV, V103, P466; Demarzo MMP, 2012, INT J PREVENTIVE MED, V3, P670; Prati G, 2009, ANXIETY STRESS COPIN, V23, P1; Rodero B, 2012, J PSYCHOSOM RES, V73, P86, DOI 10.1016/j.jpsychores.2012.05.011; Russett B, 2003, INT STUDIES PERSPECT, V4, P88; Salanova M, 2005, PSICOTHEMA, V17, P390; Sasaki M, 2009, J NURS MANAGE, V17, P359, DOI 10.1111/j.1365-2834.2008.00960.x; Schulz M, 2009, J PSYCHIATR MENT HLT, V16, P225, DOI 10.1111/j.1365-2850.2008.01355.x; Sobczak LR, 2013, COGN BEHAV PRACT, V20, P13, DOI 10.1016/j.cbpra.2011.08.005; Tyrell Z, 2010, COG BEHAV THER, V3, P18; Unger JB, 1998, J ADOLESCENT RES, V13, P134, DOI 10.1177/0743554898132003; Unterbrink T, 2007, INT ARCH OCC ENV HEA, V80, P433, DOI 10.1007/s00420-007-0169-0; Vilardaga R, 2011, J SUBST ABUSE TREAT, V40, P323, DOI 10.1016/j.jsat.2010.11.015; Volker R, 2010, STRESS HEALTH, V26, P149, DOI 10.1002/smi.1276; Wallace SL, 2010, J EMPLOYMENT COUNS, V47, P111, DOI 10.1002/j.2161-1920.2010.tb00096.x; WEINBERGER DA, 1979, J ABNORM PSYCHOL, V88, P369, DOI 10.1037/0021-843X.88.4.369; Zeller JM, 2013, WORKPLACE HEALTH SAF, V61, P86, DOI 10.3928/21650799-20130116-67	70	47	48	4	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89090	10.1371/journal.pone.0089090	http://dx.doi.org/10.1371/journal.pone.0089090			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7GP	24551223	gold, Green Submitted, Green Published			2022-12-27	WOS:000331266000101
J	Snell, CE; Turley, H; McIntyre, A; Li, DM; Masiero, M; Schofield, CJ; Gatter, KC; Harris, AL; Pezzella, F				Snell, Cameron E.; Turley, Helen; McIntyre, Alan; Li, Demin; Masiero, Massimo; Schofield, Christopher J.; Gatter, Kevin C.; Harris, Adrian L.; Pezzella, Francesco			Proline-Hydroxylated Hypoxia-Inducible Factor 1 alpha (HIF-1 alpha) Upregulation in Human Tumours	PLOS ONE			English	Article							PROLYL HYDROXYLATION; FACTOR (HIF)-1-ALPHA; CANCER-CELLS; HIF-ALPHA; FACTOR-I; OXYGEN; EXPRESSION; HIF-2-ALPHA; PROTEIN; TARGET	The stabilisation of HIF-alpha is central to the transcriptional response of animals to hypoxia, regulating the expression of hundreds of genes including those involved in angiogenesis, metabolism and metastasis. HIF-alpha is degraded under normoxic conditions by proline hydroxylation, which allows for recognition and ubiquitination by the von-Hippel-Lindau (VHL) E3 ligase complex. The aim of our study was to investigate the posttranslational modification of HIF-1 alpha in tumours, to assess whether there are additional mechanisms besides reduced hydroxylation leading to stability. To this end we optimised antibodies against the proline-hydroxylated forms of HIF-1 alpha for use in formalin fixed paraffin embedded (FFPE) immunohistochemistry to assess effects in tumour cells in vivo. We found that HIF-1 alpha proline-hydroxylated at both VHL binding sites (Pro402 and Pro564), was present in hypoxic regions of a wide range of tumours, tumour xenografts and in moderately hypoxic cells in vitro. Staining for hydroxylated HIF-1 alpha can identify a subset of breast cancer patients with poorer prognosis and may be a better marker than total HIF-1 alpha levels. The expression of unhydroxylated HIF-1 alpha positively correlates with VHL in breast cancer suggesting that VHL may be rate-limiting for HIF degradation. Our conclusions are that the degradation of proline-hydroxylated HIF-1 alpha may be rate-limited in tumours and therefore provides new insights into mechanisms of HIF upregulation. Persistence of proline-hydroxylated HIF-1 alpha in perinecrotic areas suggests there is adequate oxygen to support prolyl hydroxylase domain (PHD) activity and proline-hydroxylated HIF-1 alpha may be the predominant form associated with the poorer prognosis that higher levels of HIF-1 alpha confer.	[Snell, Cameron E.; Turley, Helen; Gatter, Kevin C.; Pezzella, Francesco] Univ Oxford, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Tumour Pathol Grp, Oxford, England; [McIntyre, Alan; Harris, Adrian L.] Univ Oxford, Weatherall Inst Mol Med, Dept Med Oncol, Mol Oncol Labs, Oxford, England; [Li, Demin; Masiero, Massimo] Univ Oxford, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Haematooncol Grp, Oxford, England; [Schofield, Christopher J.] Univ Oxford, Chem Res Lab, Oxford, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford	Snell, CE (corresponding author), Univ Oxford, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Tumour Pathol Grp, Oxford, England.	Cameron.snell@gmail.com	Harris, Adrian L/ABA-3343-2020; Li, Demin/O-4065-2019; Snell, Cameron/M-7413-2015	Harris, Adrian L/0000-0003-1376-8409; Li, Demin/0000-0002-7118-3401; McIntyre, Alan/0000-0002-4791-7292; Schofield, Christopher/0000-0002-0290-6565; Snell, Cameron/0000-0001-7847-3041	Nuffield Medical Fellowship; British Heart Foundation [PG/12/33/29546] Funding Source: researchfish; Cancer Research UK [11359, 10702] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10163] Funding Source: researchfish	Nuffield Medical Fellowship; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	CS is supported by a Nuffield Medical Fellowship (http://www.admin.ox.ac.uk/councilsec/gov/linkedcharitiesoftheuniversityofoxford/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Beasley NJP, 2002, CANCER RES, V62, P2493; Beitner-Johnson D, 2001, CELL SIGNAL, V13, P23, DOI 10.1016/S0898-6568(00)00128-5; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bubendorf L, 2001, J PATHOL, V195, P72, DOI 10.1002/path.893; Cai QL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009720; Carroll VA, 2006, CANCER RES, V66, P6264, DOI 10.1158/0008-5472.CAN-05-2519; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Chan DA, 2002, J BIOL CHEM, V277, P40112, DOI 10.1074/jbc.M206922200; Couvelard A, 2005, HISTOPATHOLOGY, V46, P668, DOI 10.1111/j.1365-2559.2005.02160.x; Del Bufalo D, 2006, CANCER RES, V66, P5549, DOI 10.1158/0008-5472.CAN-05-2825; Doe MR, 2012, CANCER RES, V72, P949, DOI 10.1158/0008-5472.CAN-11-2371; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Evans SM, 2004, CANCER RES, V64, P1886, DOI 10.1158/0008-5472.CAN-03-2424; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Flashman E, 2010, FEBS J, V277, P4089, DOI 10.1111/j.1742-4658.2010.07804.x; Hewitson KS, 2007, J BIOL CHEM, V282, P3293, DOI 10.1074/jbc.M608337200; Huang LE, 2007, J MOL MED, V85, P139, DOI 10.1007/s00109-006-0133-6; Hutchison GJ, 2004, CLIN CANCER RES, V10, P8405, DOI 10.1158/1078-0432.CCR-03-0135; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Knowles HJ, 2003, CANCER RES, V63, P1764; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Makino Y, 2002, J BIOL CHEM, V277, P32405, DOI 10.1074/jbc.C200328200; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Masson N, 2012, EMBO REP, V13, P251, DOI 10.1038/embor.2012.9; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Miyake K, 2008, PANCREAS, V36, pE1, DOI 10.1097/MPA.0b013e31815f2c2a; Moeller BJ, 2007, CANCER METAST REV, V26, P241, DOI 10.1007/s10555-007-9056-0; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Soilleux EJ, 2005, HISTOPATHOLOGY, V47, P602, DOI 10.1111/j.1365-2559.2005.02280.x; Swietach P, 2007, CANCER METAST REV, V26, P299, DOI 10.1007/s10555-007-9064-0; Tian YM, 2011, J BIOL CHEM, V286, P13041, DOI 10.1074/jbc.M110.211110; Yu AY, 1998, AM J PHYSIOL-LUNG C, V275, pL818, DOI 10.1152/ajplung.1998.275.4.L818	38	32	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88955	10.1371/journal.pone.0088955	http://dx.doi.org/10.1371/journal.pone.0088955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24563687	Green Submitted, gold, Green Published			2022-12-27	WOS:000331262600121
J	Wei, BX; Xu, XM; Jin, ZY; Tian, YQ				Wei, Benxi; Xu, Xueming; Jin, Zhengyu; Tian, Yaoqi			Surface Chemical Compositions and Dispersity of Starch Nanocrystals Formed by Sulfuric and Hydrochloric Acid Hydrolysis	PLOS ONE			English	Article							FTIR; DEGRADATION; ADSORPTION; CELLULOSE; AMYLOSE; LIPIDS; PH	Surface chemical compositions of starch nanocrystals (SNC) prepared using sulfuric acid (H2SO4) and hydrochloric acid (HCl) hydrolysis were analyzed by X-ray photoelectron spectroscopy (XPS) and FT-IR. The results showed that carboxyl groups and sulfate esters were presented in SNC after hydrolysis with H2SO4, while no sulfate esters were detected in SNC during HCl-hydrolysis. TEM results showed that, compared to H2SO4-hydrolyzed sample, a wider size distribution of SNC prepared by HCl-hydrolysis were observed. Zeta-potentials were -23.1 and -5.02 mV for H2SO4- and HCl-hydrolyzed SNC suspensions at pH 6.5, respectively. Nevertheless, the zeta-potential values decreased to -32.3 and -10.2 mV as the dispersion pH was adjusted to 10.6. After placed 48 h at pH 10.6, zeta-potential increased to -24.1 mV for H2SO4-hydrolyzed SNC, while no change was detected for HCl-hydrolyzed one. The higher zeta-potential and relative small particle distribution of SNC caused more stable suspensions compared to HCl-hydrolyzed sample.	[Wei, Benxi; Xu, Xueming; Jin, Zhengyu; Tian, Yaoqi] Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi, Peoples R China; [Wei, Benxi; Xu, Xueming; Jin, Zhengyu; Tian, Yaoqi] Jiangnan Univ, Synerget Innovat Ctr Food Safety & Nutr, Wuxi, Peoples R China	Jiangnan University; Jiangnan University	Jin, ZY (corresponding author), Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi, Peoples R China.	jinlab2008@yahoo.com; yqtian@jiangnan.edu.cn	Tian, Yaoqi/E-7493-2010	Tian, Yaoqi/0000-0001-5693-8872	Natural Science Foundation of China [31201288]; Natural Science Foundation of Jiangsu Province [BK2012115]; Project of State Key Laboratory of Food Science and Technology, Jiangnan University [SKLF-ZZB-201206]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Project of State Key Laboratory of Food Science and Technology, Jiangnan University	This study was financially supported by Natural Science Foundation of China (No. 31201288), Natural Science Foundation of Jiangsu Province (No. BK2012115), and the Project of State Key Laboratory of Food Science and Technology, Jiangnan University (No. SKLF-ZZB-201206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angellier H, 2005, MACROMOL SYMP, V221, P95, DOI 10.1002/masy.200550310; Angellier H, 2005, LANGMUIR, V21, P2425, DOI 10.1021/la047530j; Angellier H, 2004, BIOMACROMOLECULES, V5, P1545, DOI 10.1021/bm049914u; Araki J, 1998, COLLOID SURFACE A, V142, P75, DOI 10.1016/S0927-7757(98)00404-X; Bratskaya S, 2007, BIOMACROMOLECULES, V8, P2960, DOI 10.1021/bm700620j; Chen GJ, 2008, POLYMER, V49, P1860, DOI 10.1016/j.polymer.2008.02.020; COLEMAN MM, 1988, MACROMOLECULES, V21, P59, DOI 10.1021/ma00179a014; Dorris G.M., 1978, CELLUL CHEM TECHNOL, V12, P9; Dufresne A, 2008, CAN J CHEM, V86, P484, DOI 10.1139/V07-152; Ibrahim M, 2005, INDIAN J PURE AP PHY, V43, P911; Kim HY, 2012, STARCH-STARKE, V64, P367, DOI 10.1002/star.201100105; Koshy KM, 1997, CARBOHYD RES, V297, P93, DOI 10.1016/S0008-6215(96)00254-6; Le Corre D, 2010, BIOMACROMOLECULES, V11, P1139, DOI 10.1021/bm901428y; Li C, 2012, STARCH-STARKE, V64, P497, DOI 10.1002/star.201100178; Lin N, 2012, NANOSCALE, V4, P3274, DOI 10.1039/c2nr30260h; Liu BJ, 2009, COLLOID SURFACE A, V339, P185, DOI 10.1016/j.colsurfa.2009.02.020; Liu DG, 2009, J COLLOID INTERF SCI, V339, P117, DOI 10.1016/j.jcis.2009.07.035; MARSH RA, 1982, STARKE, V34, P149, DOI 10.1002/star.19820340502; MEDNICK ML, 1962, J ORG CHEM, V27, P398, DOI 10.1021/jo01049a013; MILLAR GJ, 1995, J CATAL, V155, P52, DOI 10.1006/jcat.1995.1187; Mjorberg P. J., 1981, CELL CHEM TECHNOL, V15, P481; MORRISON WR, 1981, STARKE, V33, P408, DOI 10.1002/star.19810331203; MORRISON WR, 1988, J CEREAL SCI, V8, P1, DOI [10.1016/S0733-5210(88)80044-4, 10.1006/jcrs.1997.0181]; Mosier NS, 2002, BIOTECHNOL BIOENG, V79, P610, DOI 10.1002/bit.10316; Namazi H, 2010, CARBOHYD POLYM, V79, P731, DOI 10.1016/j.carbpol.2009.09.033; Putseys JA, 2010, J CEREAL SCI, V51, P238, DOI 10.1016/j.jcs.2010.01.011; Ren LL, 2012, CARBOHYD POLYM, V87, P1874, DOI 10.1016/j.carbpol.2011.08.070; Rindlav-Westling A, 2003, BIOMACROMOLECULES, V4, P166, DOI 10.1021/bm0256810; Rivero S, 2012, J AGR FOOD CHEM, V60, P492, DOI 10.1021/jf204077k; Roman M, 2004, BIOMACROMOLECULES, V5, P1671, DOI 10.1021/bm034519+; Singh V, 2008, INT J FOOD PROP, V11, P495, DOI 10.1080/10942910802083774; Singh V, 2000, CARBOHYD POLYM, V41, P191, DOI 10.1016/S0144-8617(99)00086-7; Sugama T, 1997, J MATER SCI, V32, P3995, DOI 10.1023/A:1018681203069; Yang F, 2007, J COLLOID INTERF SCI, V306, P285, DOI 10.1016/j.jcis.2006.10.062	34	41	42	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e86024	10.1371/journal.pone.0086024	http://dx.doi.org/10.1371/journal.pone.0086024			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586246	gold, Green Published, Green Submitted			2022-12-27	WOS:000332390800001
J	Mercadal, L; Metzger, M; Haymann, JP; Thervet, E; Boffa, JJ; Flamant, M; Vrtovsnik, FO; Gauci, C; Froissart, M; Stengel, B				Mercadal, Lucile; Metzger, Marie; Haymann, Jean Philippe; Thervet, Eric; Boffa, Jean-Jacques; Flamant, Martin; Vrtovsnik, Francois; Gauci, Cedric; Froissart, Marc; Stengel, Benedicte		NephroTest Study Grp	A 3-Marker Index Improves the Identification of Iron Disorders in CKD Anaemia	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; NATIONAL-HEALTH; HEPCIDIN EXPRESSION; TRANSFERRIN; DEFICIENCY; DIAGNOSIS	Background: Iron disorders are common and complex in chronic kidney disease (CKD). We sought to determine whether a 3-marker index would improve the classification of iron disorders in CKD anaemia. Methods: We studied the association between Hb level and iron indexes combining 2 or 3 of the following markers: serum ferritin (<40 ng/mL), transferrin saturation (TSAT<20%) and total iron binding capacity (TIBC<50 mu mol/L) in 1011 outpatients with non-dialysis CKD participating in the Nephrotest study. All had glomerular filtration rates measured (mGFR) by Cr-51-EDTA renal clearance; 199 also had hepcidin measures. Results: The TSAT-TIBC-ferritin index explained Hb variation better than indexes combining TSAT-TIBC or ferritin-TSAT. It showed hypotransferrinaemia and non-inflammatory functional iron deficiency (ID) to be more common than either absolute or inflammatory ID: 20%, 19%, 6%, and 2%, respectively. Hb was lower in all abnormal, compared with normal, iron profiles, and decreased more when mGFR was below 30 mL/min/1.73 m(2) (interaction p<0.0001). In patients with mGFR<30 mL/min/1.73 m(2), the Hb decreases associated with hypotransferrinaemia, non-inflammatory functional ID, and absolute ID were 0.83 +/- 0.16 g/dL, 0.51 +/- 0.18 and 0.89 +/- 0.29, respectively. Compared with normal iron profiles, hepcidin was severely depressed in absolute ID but higher in hypotransferrinaemia. Conclusions: The combined TSAT-TIBC-ferritin index identifies hypotransferrinaemia and non-inflammatory functional ID as the major mechanisms of iron disorders in CKD anaemia. Both disorders were associated with a greater decrease in Hb when mGFR was <30 mL/min/1.73 m(2). Taking these iron profiles into account may be useful in stratifying patients in clinical trials of CKD anaemia and might improve the management of iron therapy.	[Mercadal, Lucile; Metzger, Marie; Froissart, Marc; Stengel, Benedicte] INSERM, U1018, CESP Ctr Res Epidemiol & Populat Hlth, Epidemiol Diabet Obes & Kidney Dis Team, Villejuif, France; [Mercadal, Lucile] Hop La Pitie Salpetriere, AP HP, Dept Nephrol, Paris, France; [Metzger, Marie; Stengel, Benedicte] Univ Paris 11, UMRS 1018, Villejuif, France; [Haymann, Jean Philippe] Univ Paris 06, Hop Tenon, AP HP, Dept Physiol & Nephrol, Paris, France; [Haymann, Jean Philippe; Boffa, Jean-Jacques] INSERM, U702, Paris, France; [Thervet, Eric] Univ Paris 05, Hop Europeen G Pompidou, AP HP, Dept Nephrol, Paris, France; [Thervet, Eric] INSERM, UMR S775, Paris, France; [Boffa, Jean-Jacques] Univ Paris 06, Hop Tenon, AP HP, Dept Nephrol, Paris, France; [Flamant, Martin] Hop Bichat Claude Bernard, AP HP, Dept Physiol, F-75877 Paris, France; [Flamant, Martin; Vrtovsnik, Francois] Univ Paris Diderot, INSERM, U699, Paris, France; [Vrtovsnik, Francois] Hop Bichat Claude Bernard, AP HP, Dept Nephrol, F-75877 Paris, France; [Gauci, Cedric; Froissart, Marc] Univ Paris 05, Hop Europeen G Pompidou, AP HP, Dept Physiol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Mercadal, L (corresponding author), INSERM, U1018, CESP Ctr Res Epidemiol & Populat Hlth, Epidemiol Diabet Obes & Kidney Dis Team, Villejuif, France.	lucile.mercadal@psl.aphp.fr	Stengel, Benedicte/G-5730-2015; Froissart, Marc/L-7493-2014; Metzger, Marie/K-9772-2018	Stengel, Benedicte/0000-0001-9469-0804; Froissart, Marc/0000-0002-4010-3173; Vrtovsnik, Francois/0000-0003-1554-314X; Metzger, Marie/0000-0003-3597-5409; DAUGAS, Eric/0000-0001-7256-7979	INSERM GISIReSP [AO 8113LS TGIR]; French Ministry of Health [AOM 09114]; INSERM [AO 8022LS]; Agence de la Biomedecine [R0 8156LL]; AURA; Roche [2009-152-447G]; F. Hoffman-La Roche Ltd.; Amgen [20119011]	INSERM GISIReSP; French Ministry of Health; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence de la Biomedecine; AURA; Roche(Roche Holding); F. Hoffman-La Roche Ltd.; Amgen(Amgen)	The NephroTest CKD cohort study is supported by the following grants: INSERM GISIReSP AO 8113LS TGIR (BS), French Ministry of Health AOM 09114 (MF), INSERM AO 8022LS (BS), Agence de la Biomedecine R0 8156LL (BS), AURA (MF), and Roche 2009-152-447G (MF). The NephroTest initiative was also sponsored by unrestricted grants from F. Hoffman-La Roche Ltd (LM). BS benefits from an Investigator Sponsored Study from Amgen (20119011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby DR, 2009, KIDNEY INT, V75, P976, DOI 10.1038/ki.2009.21; Bartnikas TB, 2011, BLOOD, V117, P630, DOI 10.1182/blood-2010-05-287359; BEGUIN Y, 1993, BLOOD, V81, P1067; Bermejo F, 2009, WORLD J GASTROENTERO, V15, P4638, DOI 10.3748/wjg.15.4638; Bross R, 2009, AM J NEPHROL, V29, P571, DOI 10.1159/000191470; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Fernandez-Rodriguez AM, 1999, AM J KIDNEY DIS, V34, P508, DOI 10.1016/S0272-6386(99)70079-X; Fishbane S, 2009, CLIN J AM SOC NEPHRO, V4, P57, DOI 10.2215/CJN.01670408; Fraenkel PG, 2009, BLOOD, V113, P2843, DOI 10.1182/blood-2008-06-165340; GOYA N, 1972, BLOOD-J HEMATOL, V40, P239, DOI 10.1182/blood.V40.2.239.239; Herzog CA, 2004, J CARD FAIL, V10, P467, DOI 10.1016/j.cardfail.2004.03.003; Hsu CY, 2002, J AM SOC NEPHROL, V13, P504, DOI 10.1681/ASN.V132504; HUGGENVIK JI, 1989, BLOOD, V74, P482; Kalantar-Zadeh K, 1998, AM J KIDNEY DIS, V31, P263, DOI 10.1053/ajkd.1998.v31.pm9469497; Kopple JD, 2000, KIDNEY INT, V57, P1688, DOI 10.1046/j.1523-1755.2000.00014.x; Lipschitz D A, 1992, Nutrition, V8, P443; McFarlane SI, 2008, AM J KIDNEY DIS, V51, pS46, DOI 10.1053/j.ajkd.2007.12.019; Mercadal L, 2012, CLIN J AM SOC NEPHRO, V7, P35, DOI 10.2215/CJN.04690511; Moranne O, 2009, J AM SOC NEPHROL, V20, P164, DOI 10.1681/ASN.2008020159; Prinsen BHCMT, 2001, J AM SOC NEPHROL, V12, P1017, DOI 10.1681/ASN.V1251017; Rawat R, 2009, EUR J CLIN NUTR, V63, P787, DOI 10.1038/ejcn.2008.33; Sawhney MS, 2007, AM J GASTROENTEROL, V102, P82, DOI 10.1111/j.1572-0241.2006.00908.x; Stancu S, 2010, AM J KIDNEY DIS, V55, P639, DOI 10.1053/j.ajkd.2009.10.043; Trombini P, 2007, HAEMATOLOGICA, V92, P1407, DOI 10.3324/haematol.11377; WITTE DL, 1991, CLIN CHEM, V37, P484; Zhang AS, 2009, J BIOL CHEM, V284, P711, DOI 10.1074/jbc.R800017200	26	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e84144	10.1371/journal.pone.0084144	http://dx.doi.org/10.1371/journal.pone.0084144			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586229	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900002
J	Virtanen, M; Oksanen, T; Batty, GD; Ala-Mursula, L; Salo, P; Elovainio, M; Pentti, J; Lyback, K; Vahtera, J; Kivimaki, M				Virtanen, Marianna; Oksanen, Tuula; Batty, G. David; Ala-Mursula, Leena; Salo, Paula; Elovainio, Marko; Pentti, Jaana; Lyback, Katinka; Vahtera, Jussi; Kivimaki, Mika			Extending Employment beyond the Pensionable Age: A Cohort Study of the Influence of Chronic Diseases, Health Risk Factors, and Working Conditions	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; DISABILITY PENSION; EARLY RETIREMENT; SICKNESS ABSENCE; EUROPEAN-UNION; OLDER WORKERS; SHIFT WORK; JOB STRAIN; ILL HEALTH; PREDICTORS	Background: In response to the economic consequences of ageing of the population, governments are seeking ways with which people might work into older age. We examined the association of working conditions and health with extended employment (defined as >6 months beyond the pensionable age) in a cohort of older, non-disabled employees who have reached old-age retirement. Methods: A total of 4,677 Finnish employees who reached their old-age pensionable date between 2005 and 2011 (mean age 59.8 years in 2005, 73% women) had their survey responses before pensionable age linked to national health and pension registers, resulting in a prospective cohort study. Results: In all, 832 participants (17.8%) extended their employment by more than 6 months beyond the pensionable date. After multivariable adjustment, the following factors were associated with extended employment: absence of diagnosed mental disorder (OR 1.25, 95% confidence interval = 1.01-1.54) and psychological distress (OR 1.68; 1.35-2.08) and of the work characteristics, high work time control (OR 2.31; 1.88-2.84). The projected probability of extended employment was 21.3% (19.5-23.1) among those free of psychiatric morbidity and with high work time control, while the corresponding probability was only 9.2% (7.4-11.4) among those with both psychiatric morbidity and poor work time control. The contribution of chronic somatic diseases was modest. Conclusions: In the present study, good mental health in combination with the opportunity to control work time seem to be key factors in extended employment into older age. In addition, high work time control might promote work life participation irrespective of employees' somatic disease status.	[Virtanen, Marianna; Oksanen, Tuula; Salo, Paula; Pentti, Jaana; Vahtera, Jussi; Kivimaki, Mika] Finnish Inst Occupat Hlth, Ctr Expertise Dev Work & Org, Helsinki, Finland; [Virtanen, Marianna; Oksanen, Tuula; Salo, Paula; Pentti, Jaana; Vahtera, Jussi; Kivimaki, Mika] Finnish Inst Occupat Hlth, Ctr Expertise Dev Work & Org, Turku, Finland; [Batty, G. David; Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Batty, G. David] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Batty, G. David] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland; [Ala-Mursula, Leena] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Salo, Paula] Univ Turku, Dept Psychol, Turku, Finland; [Elovainio, Marko] Natl Inst Hlth & Welf, Serv Syst Dept, Helsinki, Finland; [Lyback, Katinka] Keva, Stat Serv Unit, Helsinki, Finland; [Vahtera, Jussi] Univ Turku, Dept Publ Hlth, Turku, Finland; [Vahtera, Jussi] Turku Univ Hosp, FIN-20520 Turku, Finland; [Kivimaki, Mika] Univ Helsinki, Inst Behav Sci, Helsinki, Finland	Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; University of London; University College London; University of Edinburgh; University of Edinburgh; University of Oulu; University of Turku; Finland National Institute for Health & Welfare; University of Turku; University of Turku; University of Helsinki	Virtanen, M (corresponding author), Finnish Inst Occupat Hlth, Ctr Expertise Dev Work & Org, Helsinki, Finland.	marianna.virtanen@ttl.fi	Salo, Paula/D-6649-2013; Oksanen, Tuula/AAK-5599-2021; Batty, GD/Y-4401-2018; Kivimaki, Mika/B-3607-2012	Salo, Paula/0000-0002-0812-277X; Batty, GD/0000-0003-1822-5753; Kivimaki, Mika/0000-0002-4699-5627; Elovainio, Marko/0000-0002-1401-1910; Vahtera, Jussi/0000-0002-6036-061X	Academy of Finland [258598, 265174, 264944, 128002]; Medical Research Council [K013351]; National Institutes of Health [HL36310, AG034454]; Finnish Work Environment Fund; ESRC [ES/J023299/1] Funding Source: UKRI; MRC [MR/K013351/1] Funding Source: UKRI; British Heart Foundation [PG/11/63/29011, RG/13/2/30098] Funding Source: researchfish; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; Medical Research Council [MR/K013351/1] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034454] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Finnish Work Environment Fund; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study is supported by the Academy of Finland http://www.aka.fi/en-GB/A/ (grants 258598, 265174, 264944, 128002) and participating organizations. MK is supported by the Medical Research Council www.mrc.ac.uk/ (K013351), the National Institutes of Health http://www.nia.nih.gov/ (HL36310, AG034454) and the Finnish Work Environment Fund http://www.tsr.fi/frontpage and is an ESRC professor http://www.esrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto M, 2010, ALKOHOLIRIIPPUVUUS; Ala-Mursula L, 2006, OCCUP ENVIRON MED, V63, P608, DOI 10.1136/oem.2005.023937; Ala-Mursula L, 2004, OCCUP ENVIRON MED, V61, P254, DOI 10.1136/oem.2002.005983; Albertsen K, 2007, SCAND J PUBLIC HEALT, V35, P78, DOI 10.1080/14034940600858474; Borsch-Supan A, 2009, J EUR SOC POLICY, V19, P341, DOI 10.1177/1350506809341515; Bohle P, 2010, INT J HEALTH SERV, V40, P23, DOI 10.2190/HS.40.1.b; Costa G, 2006, CHRONOBIOL INT, V23, P1125, DOI 10.1080/07420520601087491; Damman M, 2011, J GERONTOL B-PSYCHOL, V66, P617, DOI 10.1093/geronb/gbr092; Ekerdt DJ, 2010, J GERONTOL B-PSYCHOL, V65, P69, DOI 10.1093/geronb/gbp109; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Harkonmaki K, 2006, OCCUP ENVIRON MED, V63, P558, DOI 10.1136/oem.2005.022293; Heponiemi T, 2008, OCCUP MED-OXFORD, V58, P406, DOI 10.1093/occmed/kqn064; Holi MM, 2003, NORD J PSYCHIAT, V57, P233, DOI 10.1080/08039480310001418; Jagger C, 2008, LANCET, V372, P2124, DOI 10.1016/S0140-6736(08)61594-9; JENKINS CD, 1988, J CLIN EPIDEMIOL, V41, P313, DOI 10.1016/0895-4356(88)90138-2; Karasek R, 1990, HLTH WORK STRESS PRO; Keva, 2011, KUNT AL EL 2010; Kivimaki M, 2012, LANCET, V380, P1491, DOI 10.1016/S0140-6736(12)60994-5; Kivimaki M, 2003, AM J EPIDEMIOL, V158, P663, DOI 10.1093/aje/kwg185; Kosloski K, 2001, J GERONTOL B-PSYCHOL, V56, pP160, DOI 10.1093/geronb/56.3.P160; Kubicek B, 2010, RES AGING, V32, P467, DOI 10.1177/0164027510364120; Kujala UM, 2002, AM J EPIDEMIOL, V156, P985, DOI 10.1093/aje/kwf151; Mantyniemi A, 2012, OCCUP ENVIRON MED, V69, P574, DOI 10.1136/oemed-2011-100411; National Public Health Institute, 2002, TERV JA TOIM SUOM TE; Oliveira Martins J, 2005, IMPACTS AGEING DEMAN, P420; Oxley H., 2009, POLICIES HLTH AGEING; Raymo JM, 2011, J GERONTOL B-PSYCHOL, V66, P249, DOI 10.1093/geronb/gbq106; Rechel B, 2013, LANCET, V381, P1312, DOI 10.1016/S0140-6736(12)62087-X; Robroek SJW, 2013, SCAND J WORK ENV HEA, V39, P125, DOI 10.5271/sjweh.3319; Salo P, 2010, SLEEP, V33, P1323, DOI 10.1093/sleep/33.10.1323; Siegrist J, 1996, J Occup Health Psychol, V1, P27, DOI 10.1037/1076-8998.1.1.27; Stattin M, 2005, OCCUP ENVIRON MED, V62, P135, DOI 10.1136/oem.2004.015669; Thomas C, 2010, EUR J EPIDEMIOL, V25, P305, DOI 10.1007/s10654-010-9438-4; Tuchsen F, 2008, OCCUP ENVIRON MED, V65, P283, DOI 10.1136/oem.2007.036525; Vahtera J, 2004, BMJ-BRIT MED J, V328, P555, DOI 10.1136/bmj.37972.496262.0D; Vahtera J, 2010, OCCUP ENVIRON MED, V67, P479, DOI 10.1136/oem.2008.045096; van den Berg T, 2010, OCCUP ENVIRON MED, V67, P845, DOI 10.1136/oem.2009.051730; van den Berg TIJ, 2010, J OCCUP ENVIRON MED, V52, P576, DOI 10.1097/JOM.0b013e3181de8133; Vyas MV, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4800; Wang HX, 2002, AM J EPIDEMIOL, V155, P1081, DOI 10.1093/aje/155.12.1081; Wise DA, 2008, DEMOGRAPHY S, V47, pS131	41	62	63	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88695	10.1371/journal.pone.0088695	http://dx.doi.org/10.1371/journal.pone.0088695			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3TA	24586372	Green Published, gold			2022-12-27	WOS:000331711900039
J	Daly, B; Long, WC				Daly, Benjamin; Long, W. Christopher			Inter-Cohort Cannibalism of Early Benthic Phase Blue King Crabs (Paralithodes platypus): Alternate Foraging Strategies in Different Habitats Lead to Different Functional Responses	PLOS ONE			English	Article							DENSITY-DEPENDENT PREDATION; BODY-SIZE; CAMTSCHATICUS TILESIUS; CANCER-MAGISTER; CHESAPEAKE-BAY; DUNGENESS CRAB; RED; PREY; TEMPERATURE; SURVIVAL	Blue king crabs (Paralithodes platypus) are commercially and ecologically important in Alaska, USA, but population abundances have fluctuated over the past several decades likely resulting from a combination of environmental and biological factors, including recruitment variability. Cannibalism between cohorts may be a source of mortality limiting recruitment success in the wild, but the degree of inter-cohort cannibalism is unknown for early benthic phase blue king crabs. In laboratory experiments, we evaluated the effects of habitat type (sand and shell) on the predator functional response and foraging behavior of year-1 blue king crabs as predators of year-0 conspecifics and examined the effects of predator presence on crypsis of prey crabs. In sand, consumption rates increased with predator size and prey density until satiation, while predation rates in shell were low regardless of predator size or prey density. These differential predation rates yielded a type III functional response in sand but a type I functional response in shell habitat. Crypsis of prey crabs was generally high and did not change in the presence of predators. Predator foraging activity was reduced in shell and may be an adaptive behavior to balance foraging efficiency and susceptibility to larger predators. Our results demonstrate that early benthic phase blue king crabs are cannibalistic between cohorts in the laboratory and that shell material is extremely effective for reducing encounter rates with conspecific predators. The distribution and abundance of such habitat may be important for recruitment success in some populations. Future studies should compare benthic habitat and species assemblages in areas with variable abundances, such as the Pribilof Islands and Saint Matthew Island in the eastern Bering Sea, to better understand possible mechanisms for recruitment variability.	[Daly, Benjamin; Long, W. Christopher] NOAA, Kodiak Lab, Resource Assessment & Conservat Engn Div, Alaska Fisheries Sci Ctr,Natl Marine Fisheries Se, Kodiak, AK USA	National Oceanic Atmospheric Admin (NOAA) - USA	Daly, B (corresponding author), NOAA, Kodiak Lab, Resource Assessment & Conservat Engn Div, Alaska Fisheries Sci Ctr,Natl Marine Fisheries Se, Kodiak, AK USA.	ben.daly@noaa.gov	Long, William C/C-7074-2009	Long, William C/0000-0002-7095-1245	NOAA, National Marine Fisheries Service	NOAA, National Marine Fisheries Service(National Oceanic Atmospheric Admin (NOAA) - USA)	Funding was supplied by NOAA, National Marine Fisheries Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander ME, 2013, J EXP MAR BIOL ECOL, V439, P92, DOI 10.1016/j.jembe.2012.10.006; Alexander ME, 2012, MAR ECOL PROG SER, V468, P191, DOI 10.3354/meps09978; Andresen H, 2010, J EXP MAR BIOL ECOL, V390, P31, DOI 10.1016/j.jembe.2010.04.027; Armstrong D.A., 1985, EARLY LIFE HIST JUVE, P211; Armstrong D.A., 1987, DISTRIBUTION ABUNDAN; Bolker B, 2008, ECOLOGICAL MODELS DA; Borisov RR, 2007, RUSS J MAR BIOL +, V33, P227, DOI 10.1134/S1063074007040049; BOTSFORD LW, 1978, J FISH RES BOARD CAN, V35, P833, DOI 10.1139/f78-134; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chuchukalo VI, 2011, RUSS J MAR BIOL+, V37, P558, DOI 10.1134/S1063074011070029; Daly B, 2013, 2013 E BER IN PRESS; Daly B, 2014, J EXP MAR BIOL ECOL, V451, P98, DOI 10.1016/j.jembe.2013.11.011; Daly B, 2013, AQUACULTURE, V416, P196, DOI 10.1016/j.aquaculture.2013.09.024; Daly B, 2012, AQUACULTURE, V364, P206, DOI 10.1016/j.aquaculture.2012.08.034; Daly B, 2012, J EXP MAR BIOL ECOL, V429, P47, DOI 10.1016/j.jembe.2012.06.010; Daly B, 2009, AQUACULTURE, V293, P68, DOI 10.1016/j.aquaculture.2009.04.010; DEW CB, 1990, CAN J FISH AQUAT SCI, V47, P1944, DOI 10.1139/f90-219; Dittel AI, 1995, B MAR SCI, V57, P902; Downes S, 2001, ECOLOGY, V82, P2870, DOI 10.2307/2679967; FERNANDEZ M, 1993, CAN J FISH AQUAT SCI, V50, P2100, DOI 10.1139/f93-234; FOX LR, 1975, ANNU REV ECOL SYST, V6, P87, DOI 10.1146/annurev.es.06.110175.000511; HASSELL MP, 1977, J ANIM ECOL, V46, P249, DOI 10.2307/3959; Heck KL, 2001, MAR ECOL PROG SER, V222, P163, DOI 10.3354/meps222163; HINES AH, 1990, MAR ECOL PROG SER, V67, P105, DOI 10.3354/meps067105; Hines AH, 2009, MAR ECOL PROG SER, V385, P127, DOI 10.3354/meps08055; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; Januario SM, 2013, J EXP MAR BIOL ECOL, V446, P36, DOI 10.1016/j.jembe.2013.04.017; Kolts JM, 2013, MAR ECOL PROG SER, V483, P209, DOI 10.3354/meps10292; KURIHARA Y, 1987, MAR ECOL PROG SER, V41, P123, DOI 10.3354/meps041123; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LIPCIUS RN, 1986, ECOLOGY, V67, P1361, DOI 10.2307/1938692; Long WC, 2012, J EXP MAR BIOL ECOL, V422, P101, DOI 10.1016/j.jembe.2012.04.019; Long WC, 2012, MAR ECOL PROG SER, V456, P139, DOI 10.3354/meps09702; Long WC, 2013, J EXP MAR BIOL ECOL, V449, P142, DOI 10.1016/j.jembe.2013.09.004; Long WC, 2012, J EXP MAR BIOL ECOL, V413, P50, DOI 10.1016/j.jembe.2011.11.015; Lovrich GA, 1997, J EXP MAR BIOL ECOL, V211, P225, DOI 10.1016/S0022-0981(96)02715-3; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; MANSOUR RA, 1991, MAR ECOL PROG SER, V72, P239, DOI 10.3354/meps072239; Marshall S, 2005, APPL ANIM BEHAV SCI, V90, P65, DOI 10.1016/j.applanim.2004.07.007; Moksnes PO, 1997, J EXP MAR BIOL ECOL, V215, P157, DOI 10.1016/S0022-0981(97)00052-X; Morse DH, 2006, BEHAV ECOL, V17, P405, DOI 10.1093/beheco/arj053; NPFMC (North Pacific Fishery Management Council), 2011, STOCK ASS FISH EV RE; Palacios R, 1985, COMMUNITY ANAL APPL, P193; Pirtle JL, 2012, MAR ECOL PROG SER, V465, P169, DOI 10.3354/meps09883; Pirtle JL, 2010, J EXP MAR BIOL ECOL, V393, P130, DOI 10.1016/j.jembe.2010.07.012; POLIS GA, 1981, ANNU REV ECOL SYST, V12, P225, DOI 10.1146/annurev.es.12.110181.001301; Seitz RD, 2001, ECOLOGY, V82, P2435, DOI 10.1890/0012-9658(2001)082[2435:DDPHVA]2.0.CO;2; Shafir S, 1988, BEHAV ECOLOGY, V9, P74; SIH A, 1982, ECOLOGY, V63, P786, DOI 10.2307/1936799; Stevens BG, 2005, J EXP MAR BIOL ECOL, V321, P1, DOI 10.1016/j.jembe.2004.12.026; Stevens BG, 2008, AQUAC RES, V39, P390, DOI 10.1111/j.1365-2109.2007.01798.x; Stoner AW, 2013, J EXP MAR BIOL ECOL, V442, P10, DOI 10.1016/j.jembe.2013.02.002; Stoner AW, 2010, J SHELLFISH RES, V29, P1005, DOI 10.2983/035.029.0401; Sullivan ME, 2008, DEEP-SEA RES PT II, V55, P1729, DOI 10.1016/j.dsr2.2008.03.004; Swiney KM, 2013, AQUAC RES, V44, P1007, DOI 10.1111/j.1365-2109.2012.03105.x; Swingle JS, 2013, AQUACULTURE, V384, P13, DOI 10.1016/j.aquaculture.2012.12.015; Tapella F, 2009, J EXP MAR BIOL ECOL, V372, P31, DOI 10.1016/j.jembe.2009.02.003; Tschanz B, 2007, ECOLOGY, V88, P1300, DOI 10.1890/06-1512; WAHLE RA, 1992, OIKOS, V65, P52, DOI 10.2307/3544887	59	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88694	10.1371/journal.pone.0088694	http://dx.doi.org/10.1371/journal.pone.0088694			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558414	Green Submitted, Green Published, gold			2022-12-27	WOS:000331706700060
J	Feng, YL; Huang, W; Wani, M; Yu, XY; Ashraf, M				Feng, Yuliang; Huang, Wei; Wani, Mashhood; Yu, Xiyong; Ashraf, Muhammad			Ischemic Preconditioning Potentiates the Protective Effect of Stem Cells through Secretion of Exosomes by Targeting Mecp2 via miR-22	PLOS ONE			English	Article							INFARCTED HEART; SURVIVAL; TRANSPLANTATION; EXPRESSION; REPAIR	Mesenchymal stem cells (MSCs) have potential application for the treatment of ischemic heart diseases. Besides differentiation properties, MSCs protect ischemic cardiomyocytes by secretion of paracrine factors. In this study, we found exosomes enriched with miR-22 were secreted by MSCs following ischemic preconditioning (Exo(IPC)) and mobilized to cardiomyocytes where they reduced their apoptosis due to ischemia. Interestingly, by time-lapse imaging, we for the first time captured the dynamic shedding of miR-22 loaded exosomes from cytosol to extracellular space. Furthermore, the antiapoptotic effect of miR-22 was mediated by direct targeting of methyl CpG binding protein 2 (Mecp2). In vivo data showed that delivery of Exo(IPC) significantly reduced cardiac fibrosis. Our data identified a significant benefit of Exo(IPC) for the treatment of cardiac diseases by targeting Mecp2 via miR-22.	[Feng, Yuliang; Yu, Xiyong] Southern Med Univ, Guangdong Acad Med Sci, Guangdong Prov Cardiovasc Inst, Med Res Ctr,Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China; [Feng, Yuliang; Huang, Wei; Wani, Mashhood; Ashraf, Muhammad] Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH USA	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Southern Medical University - China; University System of Ohio; University of Cincinnati	Yu, XY (corresponding author), Southern Med Univ, Guangdong Acad Med Sci, Guangdong Prov Cardiovasc Inst, Med Res Ctr,Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China.	yuxycn@hotmail.com; ashrafm251@gmail.com	Ashraf, Muhammad/ABB-3463-2021; HUANG, WEI/A-4639-2013	Huang, Wei/0000-0003-3046-4220	National Institutes of Health [R37-HL-074272, HL-095375, HL-087246]; National Natural Science Foundation of China [81120108003]; National Key Basic Research Program of China [2012CB526602]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095375, R01HL087246, R37HL074272] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R37-HL-074272, HL-095375, HL-087246 (to M. Ashraf) and National Natural Science Foundation of China (No. 81120108003), National Key Basic Research Program of China (No. 2012CB526602) (to X.Y. Yu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Saavedra M, 2010, HUM MOL GENET, V19, P2177, DOI 10.1093/hmg/ddq096; Buccini S, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0301-5; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gnecchi M, 2012, VASC PHARMACOL, V57, P48, DOI 10.1016/j.vph.2012.04.002; Gurha P, 2012, CIRCULATION, V125, P2751, DOI 10.1161/CIRCULATIONAHA.111.044354; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Huang ZP, 2013, CIRC RES, V112, P1234, DOI 10.1161/CIRCRESAHA.112.300682; Katare R, 2011, CIRC RES, V109, P894, DOI 10.1161/CIRCRESAHA.111.251546; Kim HW, 2009, J BIOL CHEM, V284, P33161, DOI 10.1074/jbc.M109.020925; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Leroux L, 2010, MOL THER, V18, P1545, DOI 10.1038/mt.2010.108; Lu G, 2009, CIRCULATION, V119, P2587, DOI 10.1161/CIRCULATIONAHA.108.827691; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Pasha Z, 2008, CARDIOVASC RES, V77, P134, DOI 10.1093/cvr/cvm025; Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005; Roccaro AM, 2013, J CLIN INVEST, V123, P1542, DOI 10.1172/JCI66517; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596	19	299	332	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88685	10.1371/journal.pone.0088685	http://dx.doi.org/10.1371/journal.pone.0088685			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558412	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700058
J	Kuwabara, T; Mori, K; Kasahara, M; Yokoi, H; Imamaki, H; Ishii, A; Koga, K; Sugawara, A; Yasuno, S; Ueshima, K; Morikawa, T; Konishi, Y; Imanishi, M; Nishiyama, A; Nakao, K; Mukoyama, M				Kuwabara, Takashige; Mori, Kiyoshi; Kasahara, Masato; Yokoi, Hideki; Imamaki, Hirotaka; Ishii, Akira; Koga, Kenichi; Sugawara, Akira; Yasuno, Shinji; Ueshima, Kenji; Morikawa, Takashi; Konishi, Yoshio; Imanishi, Masahito; Nishiyama, Akira; Nakao, Kazuwa; Mukoyama, Masashi			Predictive Significance of Kidney Myeloid-Related Protein 8 Expression in Patients with Obesity- or Type 2 Diabetes-Associated Kidney Diseases	PLOS ONE			English	Article							IGA NEPHROPATHY; BLOOD-PRESSURE; MACROPHAGES; MICE; ANGIOTENSINOGEN; HYPERGLYCEMIA; CALPROTECTIN; PROGRESSION; PODOCYTES; CHILDREN	Background and Objective: We have reported that toll-like receptor 4 (TLR4) and one of its endogenous ligands, myeloid-related protein 8 (MRP8 or S100A8), play an important role in the progression of diabetic nephropathy in mice. The aim of this study was to evaluate significance of kidney MRP8 expression in patients with obesity- or type 2 diabetes-associated kidney diseases. Methods: In diabetic, obese or control subjects, MRP8 mRNA and protein expression levels in renal biopsy samples were determined by real-time RT-PCR and immunohistochemistry (n = 28 and 65, respectively), and their associations with baseline and prognostic parameters were analyzed. Effects of MRP8 upon pro-inflammatory gene expressions were examined using macrophages. Results: Kidney MRP8 gene and protein expression levels were elevated in obese or diabetic groups compared to control group. Among all subjects, by univariate linear regression analysis, glomerular MRP8-positive cell count and tubulointerstitial MRP8-positive area at baseline were both, respectively, correlated not only with various known risk factors for diabetic nephropathy (such as systolic blood pressure, proteinuria and serum creatinine) but also with extent of glomerulosclerosis and tubulointerstitial fibrosis. Independent factors predicting urinary protein levels a year later were examined by multivariate analysis, and they included glomerular MRP8-positive cell count (beta = 0.59, P < 0.001), proteinuria (beta = 0.37, P = 0.002) and systolic blood pressure (beta = 0.21, P = 0.04) at baseline, after adjustment for known risk factors. MRP8 protein expression was observed in CD68-positive macrophages and atrophic tubules. In cultured mouse macrophages, MRP8 protein induced proinflammatory cytokine expressions and also triggered auto-induction of MRP8 in a TLR4-dependent manner. Conclusions: Glomerular MRP8 expression appears to be associated with progression of proteinuria in obese or type 2 diabetic patients, possibly by inducing inflammatory changes in macrophages through TLR4 signaling.	[Kuwabara, Takashige; Mori, Kiyoshi; Kasahara, Masato; Yokoi, Hideki; Imamaki, Hirotaka; Ishii, Akira; Koga, Kenichi; Nakao, Kazuwa; Mukoyama, Masashi] Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Kyoto, Japan; [Mori, Kiyoshi; Nakao, Kazuwa] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Kyoto, Japan; [Kasahara, Masato; Yasuno, Shinji; Ueshima, Kenji] Kyoto Univ Hosp, Dept EBM Res, Inst Adv Clin & Translat Sci, Kyoto 606, Japan; [Sugawara, Akira] Osaka Red Cross Hosp, Dept Nephrol, Osaka, Japan; [Morikawa, Takashi; Konishi, Yoshio; Imanishi, Masahito] Osaka City Gen Hosp, Div Nephrol & Hypertens, Osaka, Japan; [Nishiyama, Akira] Kagawa Univ, Sch Med, Dept Pharmacol, Takamatsu, Kagawa 760, Japan	Kyoto University; Kyoto University; Kyoto University; Osaka Red Cross Hospital; Osaka City General Hospital; Kagawa University	Mori, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Kyoto, Japan.	keyem@kuhp.kyoto-u.ac.jp	Yokoi, Hideki/AAV-9038-2021; Yokoi, Hideki/R-1289-2016; Mori, Kiyoshi/N-1267-2014	Yokoi, Hideki/0000-0001-8343-9737; Yokoi, Hideki/0000-0001-8343-9737; Mori, Kiyoshi/0000-0002-7285-8351; Kuwabara, Takashige/0000-0003-3507-4328; Nishiyama, Akira/0000-0001-5971-820X	Ministry of Health, Labour and Welfare of Japan; Japanese Ministry of Education, Culture, Sports, Science and Technology; Japan Foundation for Applied Enzymology; Smoking Research Foundation	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Foundation for Applied Enzymology; Smoking Research Foundation	This work was supported in part by Grant-in-Aid for Diabetic Nephropathy and Nephrosclerosis Research from the Ministry of Health, Labour and Welfare of Japan (to KM), research grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology (to TK, KM, and MM), from the Japan Foundation for Applied Enzymology (to TK) and from the Smoking Research Foundation (to MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Croce K, 2009, CIRCULATION, V120, P427, DOI 10.1161/CIRCULATIONAHA.108.814582; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Fujiu K, 2011, J CLIN INVEST, V121, P3425, DOI 10.1172/JCI57582; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; Hoshino K, 1999, J IMMUNOL, V162, P3749; Jin Y, 2013, DIABETES CARE; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Kawasaki Y, 2005, AM J KIDNEY DIS, V45, P510, DOI 10.1053/j.ajkd.2004.11.019; Kawasaki Y, 2009, TOHOKU J EXP MED, V218, P49, DOI 10.1620/tjem.218.49; Kuwabara T, 2012, DIABETOLOGIA, V55, P2256, DOI 10.1007/s00125-012-2578-1; Kuwabara T, 2009, KIDNEY INT, V75, P285, DOI 10.1038/ki.2008.499; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Loser K, 2010, NAT MED, V16, P713, DOI 10.1038/nm.2150; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsusaka T, 2012, J AM SOC NEPHROL, V23, P1181, DOI 10.1681/ASN.2011121159; Mortensen OH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007419; Nagareddy PR, 2013, CELL METAB, V17, P695, DOI 10.1016/j.cmet.2013.04.001; Nishiyama A, 2011, NEPHROL DIAL TRANSPL, V26, P170, DOI 10.1093/ndt/gfq371; ODINK K, 1987, NATURE, V330, P80, DOI 10.1038/330080a0; Ogawa Y, 2012, J AM SOC NEPHROL, V23, P1198, DOI 10.1681/ASN.2011100985; Pepper RJ, 2013, KIDNEY INT, V83, P1150, DOI 10.1038/ki.2013.2; Praga M, 2006, CURR OPIN NEPHROL HY, V15, P481, DOI 10.1097/01.mnh.0000242172.06459.7c; Ravid M, 1998, ARCH INTERN MED, V158, P998, DOI 10.1001/archinte.158.9.998; Ruggenenti P, 1998, J AM SOC NEPHROL, V9, P2157; Sekimoto R, 2012, BIOCHEM BIOPH RES CO, V419, P782, DOI 10.1016/j.bbrc.2012.02.102; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; TAFT JL, 1994, DIABETES, V43, P1046, DOI 10.2337/diabetes.43.8.1046; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Yokoi H, 2008, KIDNEY INT, V73, P446, DOI 10.1038/sj.ki.5002722	30	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88942	10.1371/journal.pone.0088942	http://dx.doi.org/10.1371/journal.pone.0088942			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558454	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700100
J	Liu, BY; Campo, EM; Bossing, T				Liu, Boyin; Campo, Eva M.; Bossing, Torsten			Drosophila Embryos as Model to Assess Cellular and Developmental Toxicity of Multi-Walled Carbon Nanotubes (MWCNT) in Living Organisms	PLOS ONE			English	Article							NERVOUS-SYSTEM LINEAGES; GENE-EXPRESSION; NANOMATERIALS; CYTOTOXICITY; MELANOGASTER; MECHANISMS; FATE	Different toxicity tests for carbon nanotubes (CNT) have been developed to assess their impact on human health and on aquatic and terrestrial animal and plant life. We present a new model, the fruit fly Drosophila embryo offering the opportunity for rapid, inexpensive and detailed analysis of CNTs toxicity during embryonic development. We show that injected Dil labelled multi-walled carbon nanotubes (MWCNTs) become incorporated into cells in early Drosophila embryos, allowing the study of the consequences of cellular uptake of CNTs on cell communication, tissue and organ formation in living embryos. Fluorescently labelled subcellular structures showed that MWCNTs remained cytoplasmic and were excluded from the nucleus. Analysis of developing ectodermal and neural stem cells in MWCNTs injected embryos revealed normal division patterns and differentiation capacity. However, an increase in cell death of ectodermal but not of neural stem cells was observed, indicating stem cell-specific vulnerability to MWCNT exposure. The ease of CNT embryo injections, the possibility of detailed morphological and genomic analysis and the low costs make Drosophila embryos a system of choice to assess potential developmental and cellular effects of CNTs and test their use in future CNT based new therapies including drug delivery.	[Liu, Boyin; Bossing, Torsten] Univ Bangor, Sch Biol Sci, Bangor, Gwynedd, Wales; [Campo, Eva M.] Univ Bangor, Sch Elect Engn, Bangor, Gwynedd, Wales	Bangor University; Bangor University	Bossing, T (corresponding author), Univ Plymouth, Sch Biomed & Healthcare Related Sci, Plymouth PL4 8AA, Devon, England.	torsten.bossing@plymouth.ac.uk	Campo, Eva/GQP-2694-2022; Liu, Boyin/HHS-3981-2022	Bossing, Torsten/0000-0002-3277-9130	Royal Society	Royal Society(Royal Society of London)	Royal Society Research Grant awarded to Torsten Bossing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2013, ANNU REV GENET, V47, P1, DOI 10.1146/annurev-genet-111212-133232; Bashaw GJ, 2010, COLD SPRING HARB PRO; Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; BOSSING T, 1994, DEVELOPMENT, V120, P1895; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; CAMPOSORTEGA JA, 1995, MOL NEUROBIOL, V10, P75, DOI 10.1007/BF02740668; Chen PH, 2013, BIOMATERIALS, V34, P5661, DOI 10.1016/j.biomaterials.2013.03.093; Cheng JP, 2012, INT J NANOMED, V7, P3731, DOI 10.2147/IJN.S30459; Cheng JP, 2009, TOXICOL APPL PHARM, V235, P216, DOI 10.1016/j.taap.2008.12.006; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; da Rocha AM, 2013, COMP BIOCHEM PHYS A, V165, P460, DOI 10.1016/j.cbpa.2013.03.025; De Volder MFL, 2013, SCIENCE, V339, P535, DOI 10.1126/science.1222453; Dresselhaus MS, 2004, PHILOS T R SOC A, V362, P2065, DOI 10.1098/rsta.2004.1430; Frenz LM, 1996, J CELL SCI, V109, P2649; Furrer MP, 2004, NEUROSIGNALS, V13, P37, DOI 10.1159/000076157; Galloway T, 2010, ENVIRON POLLUT, V158, P1748, DOI 10.1016/j.envpol.2009.11.013; Gilbert S.F., 2010, DEV BIOL; Gottschalk F, 2013, ENVIRON POLLUT, V181, P287, DOI 10.1016/j.envpol.2013.06.003; Hacker U, 1997, DEVELOPMENT, V124, P3565; Handy RD, 2012, ENVIRON TOXICOL CHEM, V31, P15, DOI 10.1002/etc.706; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Iyama T, 2013, DNA REPAIR, V12, P620, DOI 10.1016/j.dnarep.2013.04.015; Jia G, 2005, ENVIRON SCI TECHNOL, V39, P1378, DOI 10.1021/es048729l; Juillerat-Jeanneret L, 2013, NANOTOXICOLOGY; Kasai Y, 2012, PER MED, V7, P621; Kounatidis I, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120075; Lanone S, 2013, ADV DRUG DELIV REV; Lewinski N, 2008, SMALL, V4, P26, DOI 10.1002/smll.200700595; Liu Y, 2012, ACC CHEM RES; Manning L, 2012, CELL REP, V2, P1002, DOI 10.1016/j.celrep.2012.09.009; Mazumdar A, 2002, BIOESSAYS, V24, P1012, DOI 10.1002/bies.10184; Mehrotra S, 2006, PLOS GENET, V2, P1883, DOI 10.1371/journal.pgen.0020200; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Nouara A, 2013, NANOSCALE, V5, P6088, DOI 10.1039/c3nr00847a; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Philbrook NA, 2011, REPROD TOXICOL, V32, P442, DOI 10.1016/j.reprotox.2011.09.002; Prakash R, 2003, APPL PHYS LETT, V83, P1219, DOI 10.1063/1.1599042; RYAN AJ, 1991, NUCLEIC ACIDS RES, V19, P3295, DOI 10.1093/nar/19.12.3295; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; Shaw BJ, 2011, ENVIRON INT, V37, P1083, DOI 10.1016/j.envint.2011.03.009; Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; TECHNAU GM, 1987, DEVELOPMENT, V100, P1; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thorley AJ, 2013, PHARM THER; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	49	22	22	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88681	10.1371/journal.pone.0088681	http://dx.doi.org/10.1371/journal.pone.0088681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558411	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700057
J	McGhee, DJM; Ritchie, CW; Thompson, PA; Wright, DE; Zajicek, JP; Counsell, CE				McGhee, David J. M.; Ritchie, Craig W.; Thompson, Paul A.; Wright, David E.; Zajicek, John P.; Counsell, Carl E.			A Systematic Review of Biomarkers for Disease Progression in Alzheimer's Disease	PLOS ONE			English	Review							CLINICAL-TRIALS; DEMENTIA; DIAGNOSIS	Background: Using surrogate biomarkers for disease progression as endpoints in neuroprotective clinical trials may help differentiate symptomatic effects of potential neuroprotective agents from true slowing of the neurodegenerative process. A systematic review was undertaken to determine what biomarkers for disease progression in Alzheimer's disease exist and how well they perform. Methods: MEDLINE and Embase (1950-2011) were searched using five search strategies. Abstracts were assessed to identify papers meriting review in full. Studies of participants with probable Alzheimer's disease diagnosed by formal criteria were included. We made no restriction on age, disease duration, or drug treatment. We only included studies with a longitudinal design, in which the putative biomarker and clinical measure were both measured at least twice, as this is the only appropriate study design to use when developing a disease progression biomarker. We included studies which attempted to draw associations between the changes over time in the biomarker used to investigate disease progression and a clinical measure of disease progression. Results: Fifty-nine studies were finally included. The commonest biomarker modality examined was brain MRI (17/59, 29% of included studies). Median follow-up in included studies was only 1.0 (IQR 0.8-1.7) year and most studies only measured the putative biomarker and clinical measure twice. Included studies were generally of poor quality with small numbers of participants (median 31 (IQR 17 to 64)), applied excessively restrictive study entry criteria, had flawed methodologies and conducted overly simplistic statistical analyses without adjusting for confounding factors. Conclusions: We found insufficient evidence to recommend the use of any biomarker as an outcome measure for disease progression in Alzheimer's disease trials. However, further investigation into the efficacy of using MRI measurements of ventricular volume and whole brain volume appeared to be merited. A provisional 'roadmap' to improve the quality of future disease progression biomarker studies is presented.	[McGhee, David J. M.; Counsell, Carl E.] Univ Aberdeen, Div Appl Hlth Sci, Aberdeen, Scotland; [Ritchie, Craig W.] Univ London Imperial Coll Sci Technol & Med, Ctr Mental Hlth, London, England; [Thompson, Paul A.; Wright, David E.] Univ Plymouth, Ctr Hlth & Environm Stat, Plymouth PL4 8AA, Devon, England; [Zajicek, John P.] Univ Plymouth, Clin Neurol Res Grp, Plymouth PL4 8AA, Devon, England	University of Aberdeen; Imperial College London; University of Plymouth; University of Plymouth	McGhee, DJM (corresponding author), Univ Aberdeen, Div Appl Hlth Sci, Aberdeen, Scotland.	david.mcghee@abdn.ac.uk		Thompson, Paul/0000-0001-9940-6913; Murray, Dianna/0000-0003-3481-825X; McGhee, David/0000-0003-2985-6913	National Institute for Health Research (NIHR) [RP-PG-0707-10124]	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	This article presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (Grant Reference Number RP-PG-0707-10124). The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection, data analysis, data interpretation, writing of the report or for the decision to submit for publication.	Alzheimers Assoc, 1998, NEUROBIOL AGING, V19, P109; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Ball M, 1997, NEUROBIOL AGING, V18, pS1, DOI 10.1016/s0197-4580(97)00057-2; Bewick V, 2003, CRIT CARE, V7, P451, DOI 10.1186/cc2401; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; Brooks DJ, 2003, EXP NEUROL, V184, pS68, DOI 10.1016/j.expneurol.2003.08.008; Brown H, 2006, APPL MIXED MODELS ME, P215; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Hobart JC, 2007, LANCET NEUROL, V6, P1094, DOI 10.1016/S1474-4422(07)70290-9; Jorm AF, 1998, NEUROLOGY, V51, P728, DOI 10.1212/WNL.51.3.728; Knapp M, 2007, REPORT ALZHEIMERS SO; Knopman David, 2006, Alzheimers Dement, V2, P147, DOI 10.1016/j.jalz.2006.03.010; Knopman DS, 2008, COGN BEHAV NEUROL, V21, P197, DOI 10.1097/WNN.0b013e318190cf75; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; McGhee DJM, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-35; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Mohs RC, 1997, ALZ DIS ASSOC DIS, V11, pS13; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Tucker GT, 1995, CLIN MEASUREMENT DRU; Wadsworth LP, 2012, DEMENT GERIATR COGN, V34, P96, DOI 10.1159/000342119; Wolfson C, 2000, DRUG TREATMENTS AL 2	26	37	37	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88854	10.1371/journal.pone.0088854	http://dx.doi.org/10.1371/journal.pone.0088854			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558437	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700083
J	Nisbet, M; Markowitz, EM				Nisbet, Matthew; Markowitz, Ezra M.			Understanding Public Opinion in Debates over Biomedical Research: Looking beyond Political Partisanship to Focus on Beliefs about Science and Society	PLOS ONE			English	Article							ATTITUDES; CONTROVERSY; KNOWLEDGE; PARTICIPATION; PERCEPTIONS; INFORMATION; WORLDVIEWS; ISSUE	As social scientists have investigated the political and social factors influencing public opinion in science-related policy debates, there has been growing interest in the implications of this research for public communication and outreach. Given the level of political polarization in the United States, much of the focus has been on partisan differences in public opinion, the strategies employed by political leaders and advocates that promote those differences, and the counter-strategies for overcoming them. Yet this focus on partisan differences tends to overlook the processes by which core beliefs about science and society impact public opinion and how these schema are often activated by specific frames of reference embedded in media coverage and popular discourse. In this study, analyzing cross-sectional, nationally representative survey data collected between 2002 and 2010, we investigate the relative influence of political partisanship and science-related schema on Americans' support for embryonic stem cell research. In comparison to the influence of partisan identity, our findings suggest that generalized beliefs about science and society were more chronically accessible, less volatile in relation to media attention and focusing events, and an overall stronger influence on public opinion. Classifying respondents into four unique audience groups based on their beliefs about science and society, we additionally find that individuals within each of these groups split relatively evenly by partisanship but differ on other important dimensions. The implications for public engagement and future research on controversies related to biomedical science are discussed.	[Nisbet, Matthew] Amer Univ, Sch Commun, Washington, DC 20016 USA; [Markowitz, Ezra M.] Columbia Univ, Earth Inst, New York, NY USA; [Markowitz, Ezra M.] Columbia Univ, Ctr Res Environm Decis, New York, NY USA; [Markowitz, Ezra M.] Princeton Univ, Princeton Inst Int & Reg Studies, Princeton, NJ 08544 USA	American University; Columbia University; Columbia University; Princeton University	Nisbet, M (corresponding author), Amer Univ, Sch Commun, Washington, DC 20016 USA.	nisbetmc@gmail.com	Nisbet, Matthew C./AAG-7562-2019; Nisbet, Matthew C./E-4245-2010	Nisbet, Matthew C./0000-0002-6765-1364; Markowitz, Ezra/0000-0002-8140-2970	Provost's Office at American University	Provost's Office at American University	Funding from the Provost's Office at American University supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz A, 2009, DISAPPEARING CTR ENG; Allum N, 2014, PUBLIC UNDE IN PRESS; Allum N, 2008, PUBLIC UNDERST SCI, V17, P35, DOI 10.1177/0963662506070159; Becker AB, 2010, INT J PUBLIC OPIN R, V22, P181, DOI 10.1093/ijpor/edp047; Bolsen T, 2013, APSA 2013 ANN M; Bolsen T., 2013, EFFECTS POLITICIZATI; Bowers J, 2005, POLIT ANAL, V13, P301, DOI 10.1093/pan/mpi031; Brossard D, 2007, INT J PUBLIC OPIN R, V19, P24, DOI 10.1093/ijpor/edl003; Brossard D, 2009, PUBLIC UNDERST SCI, V18, P546, DOI 10.1177/0963662507087304; Bubela T, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-133; Bubela T, 2009, NAT BIOTECHNOL, V27, P514, DOI 10.1038/nbt0609-514; Caulfield T, 2012, PUBLIC HEALTH GENOM, V15, P209, DOI 10.1159/000336533; Caulfield T, 2007, AM J BIOETHICS, V7, P51, DOI 10.1080/15265160601109655; Clifford S, 2014, J POLIT IN PRESS, V75, P659; Critchley CR, 2008, PUBLIC UNDERST SCI, V17, P309, DOI 10.1177/0963662506070162; ELLISON CG, 1995, REV RELIG RES, V36, P245, DOI 10.2307/3511533; Fischhoff B, 2013, P NATL ACAD SCI USA, V110, P14033, DOI 10.1073/pnas.1213273110; Fiske SusanT., 1991, SOCIAL COGNITION 2; Goidel K, 2006, POLIT BEHAV, V28, P175, DOI 10.1007/s11109-006-9007-4; Haidt J., 2012, RIGHTEOUS MIND WHY G; Hartings MR, 2011, NAT CHEM, V3, P674, DOI 10.1038/nchem.1094; Hillygus DS, 2008, PERSUADABLE VOTER: WEDGE ISSUES IN PRESIDENTIAL CAMPAIGNS, P1; Ho SS, 2008, INT J PUBLIC OPIN R, V20, P171, DOI 10.1093/ijpor/edn017; Illes J, 2010, NAT REV NEUROSCI, V11, P61, DOI 10.1038/nrn2773; Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547; Levendusky Matthew., 2009, PARTISAN SORT LIBERA; Maibach EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017571; Maibach EW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-299; Master Z, 2013, SCI ENG ETHICS, V19, P321, DOI 10.1007/s11948-011-9327-6; McKibben B., 2004, ENOUGH STAYING HUMAN; Miller J.D., 2001, BIOMEDICAL COMMUNICA; Miller J.D., 1997, PUBLIC PERCEPTIONS S; Myers TA, 2012, CLIMATIC CHANGE, V113, P1105, DOI 10.1007/s10584-012-0513-6; Nisbet MC, 2007, PUBLIC UNDERST SCI, V16, P421, DOI 10.1177/0963662506065558; Nisbet MC, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-10; Nisbet MC, 2009, AM J BOT, V96, P1767, DOI 10.3732/ajb.0900041; Nisbet MC, 2005, INT J PUBLIC OPIN R, V17, P90, DOI 10.1093/ijpor/edh058; Nisbet MC, 2003, HARV INT J PRESS-POL, V8, P36, DOI 10.1177/1081180X02251047; Nisbet MC, 2002, COMMUN RES, V29, P584, DOI 10.1177/009365002236196; Nisbet MC, 2014, PUBLIC OPIN IN PRESS; Nisbet MC, 2012, BREAKTHROUGH J, V3, P55; Pardo R, 2008, SCI COMMUN, V30, P8, DOI 10.1177/1075547008319432; Park A, 2012, STEM CELL HOPE STEM; Popkin S., 1991, REASONING VOTER; Price V, 2005, PUBLIC OPIN QUART, V69, P179, DOI 10.1093/poq/nfi014; Sarewitz D, 2009, ISSUES SCI TECHNOL, V4, P89; Scheufele BT, 2010, SPREADING ACTIVATION, P110; Scheufele DA, 2003, INT J PUBLIC OPIN R, V15, P300, DOI 10.1093/ijpor/15.3.300; Scheufele DA, 2007, J COMMUN, V57, P9, DOI 10.1111/j.0021-9916.2007.00326.x; Scheufele DA, 2009, NAT NANOTECHNOL, V4, P91, DOI 10.1038/NNANO.2008.361	50	41	42	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88473	10.1371/journal.pone.0088473	http://dx.doi.org/10.1371/journal.pone.0088473			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3RA	24558393	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700039
J	Proietti, MC; Reisser, J; Marins, LF; Rodriguez-Zarate, C; Marcovaldi, MA; Monteiro, DS; Pattiaratchi, C; Secchi, ER				Proietti, Maira C.; Reisser, Julia; Marins, Luis Fernando; Rodriguez-Zarate, Clara; Marcovaldi, Maria A.; Monteiro, Danielle S.; Pattiaratchi, Charitha; Secchi, Eduardo R.			Genetic Structure and Natal Origins of Immature Hawksbill Turtles (Eretmochelys imbricata) in Brazilian Waters	PLOS ONE			English	Article							SEA-TURTLES; MARINE TURTLES; POPULATION-STRUCTURE; CHELONIA-MYDAS; MIGRATORY BEHAVIOR; MIXED STOCKS; WEST-INDIES; ATLANTIC; DISPERSAL; INCREASE	Understanding the connections between sea turtle populations is fundamental for their effective conservation. Brazil hosts important hawksbill feeding areas, but few studies have focused on how they connect with nesting populations in the Atlantic. Here, we (1) characterized mitochondrial DNA control region haplotypes of immature hawksbills feeding along the coast of Brazil (five areas ranging from equatorial to temperate latitudes, 157 skin samples), (2) analyzed genetic structure among Atlantic hawksbill feeding populations, and (3) inferred natal origins of hawksbills in Brazilian waters using genetic, oceanographic, and population size information. We report ten haplotypes for the sampled Brazilian sites, most of which were previously observed at other Atlantic feeding grounds and rookeries. Genetic profiles of Brazilian feeding areas were significantly different from those in other regions (Caribbean and Africa), and a significant structure was observed between Brazilian feeding grounds grouped into areas influenced by the South Equatorial/North Brazil Current and those influenced by the Brazil Current. Our genetic analysis estimates that the studied Brazilian feeding aggregations are mostly composed of animals originating from the domestic rookeries Bahia and Pipa, but some contributions from African and Caribbean rookeries were also observed. Oceanographic data corroborated the local origins, but showed higher connection with West Africa and none with the Caribbean. High correlation was observed between origins estimated through genetics/rookery size and oceanographic/rookery size data, demonstrating that ocean currents and population sizes influence haplotype distribution of Brazil's hawksbill populations. The information presented here highlights the importance of national conservation strategies and international cooperation for the recovery of endangered hawksbill turtle populations.	[Proietti, Maira C.; Monteiro, Danielle S.; Secchi, Eduardo R.] Univ Fed Rio Grande, Inst Oceanog, Rio Grande, RS, Brazil; [Reisser, Julia; Pattiaratchi, Charitha] Univ Western Australia, Oceans Inst, Perth, WA 6009, Australia; [Reisser, Julia; Pattiaratchi, Charitha] Univ Western Australia, Sch Civil Environm & Min Engn, Perth, WA 6009, Australia; [Reisser, Julia] CSIRO, Wealth Oceans Flagship, Floreat, WA, Australia; [Marins, Luis Fernando] Univ Fed Rio Grande, Inst Ciencias Biol, Rio Grande, RS, Brazil; [Rodriguez-Zarate, Clara] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Marcovaldi, Maria A.] Fundacao Pro Tamar, Praia Do Forte, BA, Brazil; [Monteiro, Danielle S.] Nucleo Educ & Monitoramento Ambiental, Rio Grande, RS, Brazil	Universidade Federal do Rio Grande; University of Western Australia; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Universidade Federal do Rio Grande; Flinders University South Australia	Proietti, MC (corresponding author), Univ Fed Rio Grande, Inst Oceanog, Rio Grande, RS, Brazil.	mairaproietti@gmail.com	Marins, Luis Fernando/L-1333-2014; Pattiaratchi, Charitha/E-6916-2011; Secchi, Eduardo R./ABF-1191-2020; Secchi, Eduardo/D-5038-2013; Reisser, Julia/K-2065-2013	Pattiaratchi, Charitha/0000-0003-2229-6183; Secchi, Eduardo R./0000-0001-9087-9909; Secchi, Eduardo/0000-0001-9087-9909; Proietti, Maira/0000-0002-5504-5770; Reisser, Julia/0000-0002-1785-1042; Marins, Luis/0000-0002-7219-5295	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Rufford Foundation [8110-2]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Rufford Foundation	Scholorship and travel funds were provided to MCP by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, http://www.capes.gov.br/. Fieldwork and analyses were funded by The Rufford Foundation, http://www.rufford.org/, Grant #8110-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Grobois FA, 2006, P 26 ANN S SEA TURTL, P179; Allen CD, 2013, MAR ECOL PROG SER, V472, P275, DOI 10.3354/meps10023; Amorocho DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031486; Avise JC, 2007, CONSERV GENET, P295; Balazs G, 1999, MARINE TURTLE SPECIA, V4, P101; Bass AL, 1996, MOL ECOL, V5, P321; Bass AL, 2006, J HERED, V97, P346, DOI 10.1093/jhered/esl004; Beggs Jennifer A., 2007, Endangered Species Research, V3, P159, DOI 10.3354/esr003159; Bellini C., 1996, MAR TURT NEWSL, V74, P12; Bellini Claudio, 2000, Marine Turtle Newsletter, V87, P11; Bjorndal KA, 2010, MAR BIOL, V157, P135, DOI 10.1007/s00227-009-1304-0; Blumenthal JM, 2009, MOL ECOL, V18, P4841, DOI 10.1111/j.1365-294X.2009.04403.x; Blumenthal JM, 2009, CHELONIAN CONSERV BI, V8, P1, DOI 10.2744/CCB-0758.1; Bolker BM, 2007, MOL ECOL, V16, P685, DOI 10.1111/j.1365-294X.2006.03161.x; Bolten AB, 2003, CRC MAR BIOL SER, P243; Bolten Alan B., 1999, P110; BOULON RH, 1994, COPEIA, P811; Bowen BW, 2007, MOL ECOL, V16, P4886, DOI 10.1111/j.1365-294X.2007.03542.x; Bowen BW, 2007, MOL ECOL, V16, P3514, DOI 10.1111/j.1365-294X.2007.03431.x; Bowen BW, 2007, MOL ECOL, V16, P49, DOI 10.1111/j.1365-294X.2006.03096.x; Bowen BW, 1996, ECOL APPL, V6, P566, DOI 10.2307/2269392; Browne DC, 2010, CONSERV GENET, V11, P1541, DOI 10.1007/s10592-009-9883-3; Carreras C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066037; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Diaz-Fernandez Rogelio, 1999, Chelonian Conservation and Biology, V3, P296; Diez CE, 2011, MONA MONITO ISLAND; Ehrhart Llewellyn M., 1999, P61; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fossette S, 2012, MAR ECOL PROG SER, V457, P285, DOI 10.3354/meps09581; Gallo B, 2000, P 18 INT SEA TURTL S, P150; Garduno-Andrade M, 2000, DINAMICA POBLACION T; Gaspar P, 2012, MAR ECOL PROG SER, V457, P265, DOI 10.3354/meps09689; Godfrey MH, 2007, MOL ECOL, V16, P3511, DOI 10.1111/j.1365-294X.2007.03356.x; Godley BJ, 2010, J APPL ECOL, V47, P769, DOI 10.1111/j.1365-2664.2010.01817.x; Grossman A, 2007, MAR TURT NEWSL, V116, P2; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Hamann M, 2011, ECOL MODEL, V222, P1515, DOI 10.1016/j.ecolmodel.2011.02.003; Hays GC, 2010, J R SOC INTERFACE, V7, P1319, DOI 10.1098/rsif.2010.0009; Hillis David M., 1996, P321; IUCN, 2012, IUCN RED LIST THREAT; Kamel SJ, 2009, J HERPETOL, V43, P367, DOI 10.1670/07-231R2.1; Lara-Ruiz P, 2006, CONSERV GENET, V7, P773, DOI 10.1007/s10592-005-9102-9; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leon Yolanda M., 1999, Chelonian Conservation and Biology, V3, P230; Leroux RA, 2012, J HERED, V103, P806, DOI 10.1093/jhered/ess055; Lima Eduardo H. S. M., 2008, Marine Turtle Newsletter, P14; Lopez-Castro MC, 2013, MAR ECOL PROG SER, V490, P233, DOI 10.3354/meps10433; Lumpkin R, 2007, LAGRANGIAN ANALYSIS AND PREDICTION OF COASTAL AND OCEAN DYNAMICS, P39, DOI 10.1017/CBO9780511535901.003; Luschi P, 2003, OIKOS, V103, P293, DOI 10.1034/j.1600-0706.2003.12123.x; Marcovaldi MA, 1999, BIOL CONSERV, V91, P35, DOI 10.1016/S0006-3207(99)00043-9; Marcovaldi MA, 2007, CHELONIAN CONSERV BI, V6, P223, DOI 10.2744/1071-8443(2007)6[223:FYOHST]2.0.CO;2; Marcovaldi Maria Angela, 2006, Marine Turtle Newsletter, P4; Meylan PA, 2011, B AM MUSEUM NAT HIST, V357; Moncada FG, 2012, BIOL CONSERV, V148, P191, DOI 10.1016/j.biocon.2012.01.011; Monzon-Arguello C, 2011, J EXP MAR BIOL ECOL, V407, P345, DOI 10.1016/j.jembe.2011.07.017; Monzon-Arguello C, 2010, J BIOGEOGR, V37, P1752, DOI 10.1111/j.1365-2699.2010.02326.x; Monzon-Arguello C, 2010, J EXP MAR BIOL ECOL, V387, P9, DOI 10.1016/j.jembe.2010.03.004; Mortimer JA, 2008, HAWKSBILL TURTLE ERE, DOI [10.2307/1564433, DOI 10.2307/1564433]; Mortimer JA, 2007, MOL ECOL, V16, P17, DOI 10.1111/j.1365-294X.2006.03252.x; Musick JA, 1996, BIOL SEA TURTLES, V1, P137; Naro-Maciel E, 2007, J HERED, V98, P29, DOI 10.1093/jhered/esl050; Oksanen AJ, 2013, VEGAN COMMUNITY ECOL; Pella J, 2001, FISH B-NOAA, V99, P151; Proietti M, 2013, FIGSHARE; Proietti M, 2013, HAWKSBILL 10 LOGGERH; Proietti MC, 2012, MAR ECOL PROG SER, V447, P195, DOI 10.3354/meps09477; Proietti Maira Carneiro, 2012, Marine Turtle Newsletter, P4; Putman NF, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1468; R Core Team, 2021, R LANGUAGE ENV STAT; Revuelta O, 2012, ORYX, V46, P348, DOI 10.1017/S0030605311001529; Richardson JI, 2006, ANIM CONSERV, V9, P302, DOI 10.1111/j.1469-1795.2006.00036.x; Richardson PB, 2009, CHELONIAN CONSERV BI, V8, P192, DOI 10.2744/CCB-0871.1; Santos AJB, 2013, ENDANGER SPECIES RES, V21, P25, DOI 10.3354/esr00505; Schuyler Q, 2014, CONSERV BIOL, V28, P129, DOI 10.1111/cobi.12126; Scott R, 2012, MAR BIOL, V159, P481, DOI 10.1007/s00227-011-1825-1; Shamblin BM, 2012, MAR ECOL PROG SER, V469, P145, DOI 10.3354/meps09980; Troeng S, 2005, ECOGRAPHY, V28, P394, DOI 10.1111/j.0906-7590.2005.04110.x; van Dam RP, 1998, J EXP MAR BIOL ECOL, V220, P15, DOI 10.1016/S0022-0981(97)00080-4; Vaske Jr T, 2006, PESCA ARQUIPELAGO SA, P152; Velez-Zuazo X, 2008, MOL ECOL, V17, P839, DOI 10.1111/j.1365-294X.2007.03635.x; Vilaca ST, 2013, J EXP MAR BIOL ECOL, V446, P334, DOI 10.1016/j.jembe.2013.06.004; Wood LD, 2013, HERPETOL CONSERV BIO, V8, P258; Zbinden JA, 2011, MAR ECOL PROG SER, V421, P291, DOI 10.3354/meps08871	83	24	24	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88746	10.1371/journal.pone.0088746	http://dx.doi.org/10.1371/journal.pone.0088746			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558419	Green Submitted, Green Published, gold			2022-12-27	WOS:000331706700065
J	Sharif, S; Abbasi, BH; Khurshid, A; Alam, MM; Shaukat, S; Angez, M; Rana, MS; Zaidi, SSZ				Sharif, Salmaan; Abbasi, Bilal Haider; Khurshid, Adnan; Alam, Muhammad Masroor; Shaukat, Shahzad; Angez, Mehar; Rana, Muhammad Suleman; Zaidi, Syed Sohail Zahoor			Evolution and Circulation of Type-2 Vaccine-Derived Polioviruses in Nad Ali District of Southern Afghanistan during June 2009-February 2011	PLOS ONE			English	Article							MOLECULAR EVOLUTION; WILD POLIOVIRUS; OUTBREAK; ERADICATION; STRAINS	Oral polio vaccine has been used successfully as a powerful tool to control the spread of wild polioviruses throughout the world; however, during replication in under immunized children, some vaccine viruses revert and acquire the neurovirulent phenotypic properties. In this study, we describe the evolution and circulation of Vaccine-Derived Polioviruses (VDPVs) in Helmand province of Afghanistan. We investigated 2646 AFP cases of Afghan children from June 2009-February 2011 and isolated 103 (04%) vaccine viruses, 45(1.7%) wild type polioviruses and six (0.22%) type 2 circulating vaccine-derived polioviruses (cVDPVs). These cVDPVs showed 97.7%-98.2% nucleotide and 98%-98.7% amino acid homology in VP1 region on comparison with Sabin type 2 reference strain. All these cVDPVs had two signature mutations of neurovirulent phenotypes and 12 additional mutations in P1 capsid region that might also have contributed to increase neurovirulence and replication. Phylogenetic analysis revealed that all these viruses were closely related and originated from previously reported Sabin like 2 virus from Pakistan which did not conform to the standard definition of VDPVs at that time. It was also observed that initial OPV dose was administered approximately 9 months prior to the collection of first stool specimen of index case. Our findings support that suboptimal surveillance and low routine immunization coverage have contributed to the emergence and spread of these viruses in Afghanistan. We therefore recommend high quality immunization campaigns not only in affected district Nad Ali but also in the bordering areas between Pakistan and Afghanistan to prevent the spread of cVDPVs.	[Sharif, Salmaan; Khurshid, Adnan; Alam, Muhammad Masroor; Shaukat, Shahzad; Angez, Mehar; Rana, Muhammad Suleman; Zaidi, Syed Sohail Zahoor] Natl Inst Hlth, Dept Virol, Islamabad, Pakistan; [Sharif, Salmaan; Abbasi, Bilal Haider] Quaid i Azam Univ, Dept Biotechnol, Islamabad, Pakistan	Quaid I Azam University	Zaidi, SSZ (corresponding author), Natl Inst Hlth, Dept Virol, Islamabad, Pakistan.	zaidis@pak.emro.who.int	Angez, Mehar/J-3792-2015; Zaidi, Syed Sohail Zahoor/F-7432-2015; Shaukat, Shahzad/HHZ-1088-2022; Rana, Dr. Muhammad Suleman/HCH-1540-2022; Abbasi, Bilal Haider/J-1810-2019	Abbasi, Bilal Haider/0000-0002-6529-2134				Afghanistan W, 2011, REP VACC DER POL VIR; Agol VI, 2006, CURR TOP MICROBIOL, V299, P211; Alexander JP, 2009, J INFECT DIS, V199, P391, DOI 10.1086/596052; Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P996; Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P1093; [Anonymous], 2000, WKLY EPIDEMIOL REC, V77, P133; [Anonymous], MMWR MORB MORTAL WKL, V55, P1093; Avellon A, 2008, EMERG INFECT DIS, V14, P1807, DOI 10.3201/eid1411.080517; Bellmunt A, 1999, VIROLOGY, V265, P178, DOI 10.1006/viro.1999.0003; Burns CC, 2013, J VIROL, V87, P4907, DOI 10.1128/JVI.02954-12; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1002; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P846; DOMINGO E, 1985, GENE, V40, P1, DOI 10.1016/0378-1119(85)90017-4; Dowdle WR, 2003, REV MED VIROL, V13, P277, DOI 10.1002/rmv.401; Friedrich F, 2000, ACTA VIROL, V44, P109; Gavrilin GV, 2000, J VIROL, V74, P7381, DOI 10.1128/JVI.74.16.7381-7390.2000; Guillot S, 2000, J VIROL, V74, P8434, DOI 10.1128/JVI.74.18.8434-8443.2000; Jenkins HE, 2010, NEW ENGL J MED, V362, P2360, DOI 10.1056/NEJMoa0910074; Jorba J, 2008, J VIROL, V82, P4429, DOI 10.1128/JVI.02354-07; Karakasiliotis I, 2005, J GEN VIROL, V86, P3137, DOI 10.1099/vir.0.80823-0; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kew Olen M., 2012, Morbidity and Mortality Weekly Report, V61, P741; Kew OM, 2004, B WORLD HEALTH ORGAN, V82, P16; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; KEW OM, 1984, REV INFECT DIS, V6, pS499; Kilpatrick DR, 2005, J VIROL, V79, P12623; KINNUNEN L, 1990, J GEN VIROL, V71, P317, DOI 10.1099/0022-1317-71-2-317; Li WH, 1996, MOL PHYLOGENET EVOL, V5, P182, DOI 10.1006/mpev.1996.0012; Polio laboratory manual - World Health Organization, 2004, WHOIVB04104; Rakoto-Andrianarivelo M, 2008, J INFECT DIS, V197, P1427, DOI 10.1086/587694; Razafindratsimandresy R, 2013, EMERGING INFECT DIS, V19; Rousset D, 2003, EMERGING INFECT DIS, V9; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shulman LM, 2000, J CLIN MICROBIOL, V38, P3729, DOI 10.1128/JCM.38.10.3729-3734.2000; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003; Zurbriggen S, 2008, APPL ENVIRON MICROB, V74, P5608, DOI 10.1128/AEM.02764-07; 2008, WKLY EPIDEMIOL REC, V84, P77	37	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88442	10.1371/journal.pone.0088442	http://dx.doi.org/10.1371/journal.pone.0088442			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558390	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700036
J	Smith, RCG; Price, SR				Smith, Rosanna C. G.; Price, Stephen R.			Modelling of Human Low Frequency Sound Localization Acuity Demonstrates Dominance of Spatial Variation of Interaural Time Difference and Suggests Uniform Just-Noticeable Differences in Interaural Time Difference	PLOS ONE			English	Article							AUDITORY-NERVE DATA; OWL TYTO-ALBA; BARN OWL; BRAIN-STEM; LATERAL POSITION; ACOUSTICAL CUES; TONES; LOCATION; HEAD; DISCRIMINATION	Sound source localization is critical to animal survival and for identification of auditory objects. We investigated the acuity with which humans localize low frequency, pure tone sounds using timing differences between the ears. These small differences in time, known as interaural time differences or ITDs, are identified in a manner that allows localization acuity of around 1 degrees at the midline. Acuity, a relative measure of localization ability, displays a non-linear variation as sound sources are positioned more laterally. All species studied localize sounds best at the midline and progressively worse as the sound is located out towards the side. To understand why sound localization displays this variation with azimuthal angle, we took a first-principles, systemic, analytical approach to model localization acuity. We calculated how ITDs vary with sound frequency, head size and sound source location for humans. This allowed us to model ITD variation for previously published experimental acuity data and determine the distribution of just-noticeable differences in ITD. Our results suggest that the best-fit model is one whereby just-noticeable differences in ITDs are identified with uniform or close to uniform sensitivity across the physiological range. We discuss how our results have several implications for neural ITD processing in different species as well as development of the auditory system.	[Smith, Rosanna C. G.; Price, Stephen R.] UCL, Dept Cell & Dev Biol, London, England; [Smith, Rosanna C. G.] UCL, Ctr Math Phys & Engn Life Sci & Expt Biol CoMPLEX, London, England	University of London; University College London; University of London; University College London	Smith, RCG (corresponding author), UCL, Dept Cell & Dev Biol, London, England.	r.c.smith@ucl.ac.uk		Smith, Rosanna/0000-0002-4058-1263; Price, Stephen/0000-0001-7804-9849	EPSRC; BBSRC; MRC; Wellcome Trust [094399/B/10/Z]	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the EPSRC (www.epsrc.ac.uk), BBSRC (www.bbsrc.ac.uk) and MRC (www.mrc.ac.uk) (doctoral training funding to RCGS) and the Wellcome Trust, www.wellcome.ac.uk (Grant 094399/B/10/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bala ADS, 2003, NATURE, V424, P771, DOI 10.1038/nature01835; Bala ADS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000675; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Bernstein LR, 2001, J NEUROSCI RES, V66, P1035, DOI 10.1002/jnr.10103; Blauert J., 1997, SPATIAL HEARING PSYC; Brughera A, 2013, J ACOUST SOC AM, V133, P2839, DOI 10.1121/1.4795778; Brungart DS, 1999, J ACOUST SOC AM, V106, P1465, DOI 10.1121/1.427180; CARR CE, 1990, J NEUROSCI, V10, P3227; COLBURN HS, 1977, J ACOUST SOC AM, V61, P525, DOI 10.1121/1.381294; DAVENPORT CHARLES BENEDICT, 1940, PROC AMER PHIL SOC, V83, P1; DOMNITZ RH, 1977, J ACOUST SOC AM, V61, P1586, DOI 10.1121/1.381472; Duda RO, 1998, J ACOUST SOC AM, V104, P3048, DOI 10.1121/1.423886; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; HAFTER ER, 1975, J ACOUST SOC AM, V57, P181, DOI 10.1121/1.380412; Hancock KE, 2004, J NEUROSCI, V24, P7110, DOI 10.1523/JNEUROSCI.0762-04.2004; Harper NS, 2004, NATURE, V430, P682, DOI 10.1038/nature02768; Hartley RVL, 1921, PHYS REV, V18, P431, DOI 10.1103/PhysRev.18.431; Hausmann L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007721; HILLENBRAND J, 1995, J ACOUST SOC AM, V97, P3099, DOI 10.1121/1.411872; Hillenbrand JM, 2009, ATTEN PERCEPT PSYCHO, V71, P1150, DOI 10.3758/APP.71.5.1150; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Jones HG, 2011, JARO-J ASSOC RES OTO, V12, P127, DOI 10.1007/s10162-010-0242-3; JOSEPH AW, 1993, J NEUROPHYSIOL, V69, P1197, DOI 10.1152/jn.1993.69.4.1197; KNUDSEN EI, 1984, J NEUROSCI, V4, P1001; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P1, DOI 10.1007/BF00663105; Koka K, 2008, J ACOUST SOC AM, V123, P4297, DOI 10.1121/1.2916587; Koka K, 2011, HEARING RES, V272, P135, DOI 10.1016/j.heares.2010.10.007; KUHN GF, 1977, J ACOUST SOC AM, V62, P157, DOI 10.1121/1.381498; Kuhn GF, 1987, DIRECTIONAL HEARING; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; Macpherson EA, 2002, J ACOUST SOC AM, V111, P2219, DOI 10.1121/1.1471898; MAKOUS JC, 1990, J ACOUST SOC AM, V87, P2188, DOI 10.1121/1.399186; McAlpine D, 2005, J PHYSIOL-LONDON, V566, P21, DOI 10.1113/jphysiol.2005.083113; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; MILLS AW, 1958, J ACOUST SOC AM, V30, P237, DOI 10.1121/1.1909553; Moore JM, 2008, HEARING RES, V238, P94, DOI 10.1016/j.heares.2007.11.006; Mossop JE, 1998, J ACOUST SOC AM, V104, P1574, DOI 10.1121/1.424369; MUSICANT AD, 1984, J ACOUST SOC AM, V75, P1195, DOI 10.1121/1.390770; Overholt M, 1992, J NEUROSCI, V12, P1698; PARKS TN, 1975, J COMP NEUROL, V164, P435, DOI 10.1002/cne.901640404; Perrott D, 1984, J ACOUST SOC AM, P1201; Peterson GE, 1952, J ACOUST SOC AM, V24; Phillips DP, 2012, NEUROSCI BIOBEHAV R, V36, P889, DOI 10.1016/j.neubiorev.2011.11.003; RABINOWITZ WM, 1993, PRESENCE, V2, P125; Ramon y Cajal S, 1904, HISTOLOGY NERVOUS SY, VI; Rayleigh L, 1876, NATURE, V14, P32, DOI DOI 10.1038/014032A0; Recanzone GH, 1998, J ACOUST SOC AM, V103, P1085, DOI 10.1121/1.421222; Rschevkin S, 1963, COURSE LECT THEORY S; SANDEL TT, 1955, J ACOUST SOC AM, V27, P842, DOI 10.1121/1.1908052; SAYERS BM, 1964, J ACOUST SOC AM, V36, P923, DOI 10.1121/1.1919121; SCHMIDT PH, 1953, ACTA PHYSIOL PHARM N, V3, P2; Schnupp JWH, 2003, J ACOUST SOC AM, V113, P2021, DOI 10.1121/1.1547460; SIMON HJ, 1994, J ACOUST SOC AM, V95, P1534, DOI 10.1121/1.408541; Stem RM, 1996, J ACOUST SOC AM, V100, P2278, DOI 10.1121/1.417937; STERN RM, 1978, J ACOUST SOC AM, V64, P127, DOI 10.1121/1.381978; STERN RM, 1988, J ACOUST SOC AM, V84, P156, DOI 10.1121/1.396982; Stevens SS, 1936, AM J PSYCHOL, V48, P297, DOI 10.2307/1415748; Tollin DJ, 2009, J ACOUST SOC AM, V126, P3125, DOI 10.1121/1.3257234; TRAHIOTIS C, 1986, J ACOUST SOC AM, V79, P1950, DOI 10.1121/1.393202; WHO (World Health Organization), 2013, WHO CHILD GROWTH STA; WIGHTMAN FL, 1992, J ACOUST SOC AM, V91, P1648, DOI 10.1121/1.402445; YIN TCT, 1990, J NEUROPHYSIOL, V64, P465, DOI 10.1152/jn.1990.64.2.465; YOST WA, 1988, J ACOUST SOC AM, V83, P1846, DOI 10.1121/1.396520; ZWISLOCKI J, 1956, J ACOUST SOC AM, V28, P860, DOI 10.1121/1.1908495	65	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89033	10.1371/journal.pone.0089033	http://dx.doi.org/10.1371/journal.pone.0089033			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558468	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700114
J	Wentzell, JS; Cassar, M; Kretzschmar, D				Wentzell, Jill S.; Cassar, Marlene; Kretzschmar, Doris			Organophosphate-Induced Changes in the PKA Regulatory Function of Swiss Cheese/NTE Lead to Behavioral Deficits and Neurodegeneration	PLOS ONE			English	Article							NEUROPATHY TARGET ESTERASE; ORTHO-CRESYL PHOSPHATE; DELAYED NEUROTOXICITY; DROSOPHILA; PROTEIN; EXPRESSION; NEURONS; BRAIN; GENE; HOMEOSTASIS	Organophosphate-induced delayed neuropathy (OPIDN) is a Wallerian-type axonopathy that occurs weeks after exposure to certain organophosphates (OPs). OPs have been shown to bind to Neuropathy Target Esterase (NTE), thereby inhibiting its enzymatic activity. However, only OPs that also induce the so-called aging reaction cause OPIDN. This reaction results in the release and possible transfer of a side group from the bound OP to NTE and it has been suggested that this induces an unknown toxic function of NTE. To further investigate the mechanisms of aging OPs, we used Drosophila, which expresses a functionally conserved orthologue of NTE named Swiss Cheese (SWS). Treating flies with the organophosporous compound tri-ortho-cresyl phosphate (TOCP) resulted in behavioral deficits and neurodegeneration two weeks after exposure, symptoms similar to the delayed effects observed in other models. In addition, we found that primary neurons showed signs of axonal degeneration within an hour after treatment. Surprisingly, increasing the levels of SWS, and thereby its enzymatic activity after exposure, did not ameliorate these phenotypes. In contrast, reducing SWS levels protected from TOCP-induced degeneration and behavioral deficits but did not affect the axonopathy observed in cell culture. Besides its enzymatic activity as a phospholipase, SWS also acts as regulatory PKA subunit, binding and inhibiting the C3 catalytic subunit. Measuring PKA activity in TOCP treated flies revealed a significant decrease that was also confirmed in treated rat hippocampal neurons. Flies expressing additional PKA-C3 were protected from the behavioral and degenerative phenotypes caused by TOCP exposure whereas primary neurons were not. In addition, knocking-down PKA-C3 caused similar behavioral and degenerative phenotypes as TOCP treatment. We therefore propose a model in which OP-modified SWS cannot release PKA-C3 and that the resulting loss of PKA-C3 activity plays a crucial role in developing the delayed symptoms of OPIDN but not in the acute toxicity.	[Wentzell, Jill S.; Cassar, Marlene; Kretzschmar, Doris] Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA	Oregon Health & Science University	Kretzschmar, D (corresponding author), Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA.	kretzsch@ohsu.edu		Cassar, Marlene/0000-0003-1500-8868; kretzschmar, doris/0000-0002-0519-2377	National Institutes of Health [NS047663-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the National Institutes of Health, grant number NS047663-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUDONIA MB, 1981, ANNU REV PHARMACOL, V21, P511, DOI 10.1146/annurev.pa.21.040181.002455; Akassoglou K, 2004, P NATL ACAD SCI USA, V101, P5075, DOI 10.1073/pnas.0401030101; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; BRAND AH, 1993, DEVELOPMENT, V118, P401; CARRINGTON CD, 1983, TOXICOL LETT, V18, P251, DOI 10.1016/0378-4274(83)90102-9; CHAPIN RE, 1991, TOXICOL APPL PHARM, V108, P194, DOI 10.1016/0041-008X(91)90110-Z; da Cruz AB, 2008, J NEUROSCI, V28, P10885, DOI 10.1523/JNEUROSCI.3015-08.2008; FUNK KA, 1994, ARCH TOXICOL, V68, P308, DOI 10.1007/s002040050074; Hein ND, 2010, TOXICOL LETT, V199, P1, DOI 10.1016/j.toxlet.2010.06.020; INUI K, 1993, FUND APPL TOXICOL, V20, P111, DOI 10.1006/faat.1993.1013; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; JOHNSON MK, 1990, TOXICOL APPL PHARM, V102, P385, DOI 10.1016/0041-008X(90)90036-T; JOHNSON MK, 1980, TOXICOL LETT, V5, P95, DOI 10.1016/0378-4274(80)90154-X; JOHNSON MK, 1974, J NEUROCHEM, V23, P785, DOI 10.1111/j.1471-4159.1974.tb04404.x; Johnson MK, 1982, TARGET INITIATION DE; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kraft R, 1998, J NEUROSCI, V18, P8886; Kretzschmar D, 2005, GLIA, V49, P59, DOI 10.1002/glia.20098; Kretzschmar D, 1997, J NEUROSCI, V17, P7425; Krishnan N, 2012, NEUROBIOL DIS; Lahiri DK, 2002, ANN NY ACAD SCI, V965, P324; LOTTI M, 1992, CRIT REV TOXICOL, V21, P465, DOI 10.3109/10408449209089884; Lotti M, 2000, ORGANOPHOSPHORUS COM; Lush MJ, 1998, BIOCHEM J, V332, P1; Moser M, 2004, MOL CELL BIOL, V24, P1667, DOI 10.1128/MCB.24.4.1667-1679.2004; Moser M, 2000, MECH DEVELOP, V90, P279, DOI 10.1016/S0925-4773(99)00239-7; Muhlig-Versen M, 2005, J NEUROSCI, V25, P2865, DOI 10.1523/JNEUROSCI.5097-04.2005; Petroianu G, 2001, J APPL TOXICOL, V21, P263, DOI 10.1002/jat.752; Rainier S, 2008, AM J HUM GENET, V82, P780, DOI 10.1016/j.ajhg.2007.12.018; Read DJ, 2007, TOXICOL APPL PHARM, V219, P190, DOI 10.1016/j.taap.2006.08.002; Read DJ, 2009, J NEUROSCI, V29, P11594, DOI 10.1523/JNEUROSCI.3007-09.2009; Schuh RA, 2002, TOXICOL APPL PHARM, V182, P176, DOI 10.1006/taap.2002.9445; SMITH HV, 1959, LANCET, V2, P1019; Smith MI, 1930, PUBLIC HEALTH REP, V45, P2509, DOI 10.2307/4579816; SRIVASTAVA AK, 1990, FOOD CHEM TOXICOL, V28, P303, DOI 10.1016/0278-6915(90)90047-Q; Tschape JA, 2002, EMBO J, V21, P6367, DOI 10.1093/emboj/cdf636; Wang L, 2009, NEUROTOXICOLOGY, V30, P1084, DOI 10.1016/j.neuro.2009.06.006; Winrow CJ, 2003, NAT GENET, V33, P477, DOI 10.1038/ng1131; Zaccheo O, 2004, J BIOL CHEM; Zimmermann B, 1999, J BIOL CHEM, V274, P5370, DOI 10.1074/jbc.274.9.5370	40	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e87526	10.1371/journal.pone.0087526	http://dx.doi.org/10.1371/journal.pone.0087526			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558370	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700016
J	Lehmann, S; Relano-Gines, A; Resina, S; Brillaud, E; Casanova, D; Vincent, C; Hamela, C; Poupeau, S; Laffont, M; Gabelle, A; Delaby, C; Belondrade, M; Arnaud, JD; Alvarez, MT; Maurel, JC; Maurel, P; Crozet, C				Lehmann, Sylvain; Relano-Gines, Aroa; Resina, Sarah; Brillaud, Elsa; Casanova, Danielle; Vincent, Charles; Hamela, Claire; Poupeau, Sophie; Laffont, Mathieu; Gabelle, Audrey; Delaby, Constance; Belondrade, Maxime; Arnaud, Jacques-Damien; Alvarez, Maria-Teresa; Maurel, Jean-Claude; Maurel, Patrick; Crozet, Carole			Systemic Delivery of siRNA Down Regulates Brain Prion Protein and Ameliorates Neuropathology in Prion Disorder	PLOS ONE			English	Article							MOUSE MODEL; THERAPY; DISEASE; MICE; DYSFUNCTION; GENE; RNAI; PRP	One of the main challenges for neurodegenerative disorders that are principally incurable is the development of new therapeutic strategies, which raises important medical, scientific and societal issues. Creutzfeldt-Jakob diseases are rare neurodegenerative fatal disorders which today remain incurable. The objective of this study was to evaluate the efficacy of the down-regulation of the prion protein (PrP) expression using siRNA delivered by, a water-in-oil microemulsion, as a therapeutic candidate in a preclinical study. After 12 days rectal mucosa administration of Aonys/PrP-siRNA in mice, we observed a decrease of about 28% of the brain PrPC level. The effect of Aonys/PrP-siRNA was then evaluated on prion infected mice. Several mice presented a delay in the incubation and survival time compared to the control groups and a significant impact was observed on astrocyte reaction and neuronal survival in the PrP-siRNA treated groups. These results suggest that a new therapeutic scheme based an innovative delivery system of PrP-siRNA can be envisioned in prion disorders.	[Lehmann, Sylvain; Gabelle, Audrey; Delaby, Constance; Crozet, Carole] Univ Montpellier I, Ctr Hosp Univ Montpellier U1040, INSERM, IMRB, Montpellier, France; [Lehmann, Sylvain; Relano-Gines, Aroa; Casanova, Danielle; Hamela, Claire; Belondrade, Maxime; Crozet, Carole] CNRS, UPR1142, Inst Genet Humaine, Montpellier, France; [Resina, Sarah; Brillaud, Elsa; Vincent, Charles; Poupeau, Sophie; Laffont, Mathieu; Maurel, Jean-Claude; Maurel, Patrick] Medesis Pharma SA, Baillargues, France; [Arnaud, Jacques-Damien; Alvarez, Maria-Teresa] Univ Montpellier 2, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier	Lehmann, S (corresponding author), Univ Montpellier I, Ctr Hosp Univ Montpellier U1040, INSERM, IMRB, Montpellier, France.	s-lehmann@chu-montpellier.fr	GABELLE, Audrey/X-9172-2019; Lehmann, Sylvain/P-1301-2017; Alvarez, Maria/GZH-1345-2022; crozet, carole/ABB-5877-2021	GABELLE, Audrey/0000-0002-7648-9194; Lehmann, Sylvain/0000-0001-6117-562X; Crozet, Carole/0000-0002-7292-7046; DELABY, Constance/0000-0002-8606-6814; RELANO GINES, AROA/0000-0002-3906-6360	Medesis Pharma	Medesis Pharma	This work was supported by Medesis Pharma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown P, 2009, CNS NEUROL DISORD-DR, V8, P316, DOI 10.2174/187152709789541989; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Mallucci G, 2005, NAT REV NEUROSCI, V6, P23, DOI 10.1038/nrn1584; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; Parchi P, 2012, FOLIA NEUROPATHOL, V50, P20; Parini P, 2006, EUR J CLIN INVEST, V36, P98, DOI 10.1111/j.1365-2362.2006.01597.x; Pouladi MA, 2012, NEUROBIOL DIS, V48, P282, DOI 10.1016/j.nbd.2012.06.026; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Pulford B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011085; Relano-Gines A., 2009, Infectious Disorders - Drug Targets, V9, P58; Relano-Gines A, 2011, J INFECT DIS, V204, P1038, DOI 10.1093/infdis/jir484; SAILER A, 1994, CELL, V77, P967, DOI 10.1016/0092-8674(94)90436-7; Sikorska Beata, 2012, Subcell Biochem, V65, P457, DOI 10.1007/978-94-007-5416-4_17; Toupet K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002773; White MD, 2008, P NATL ACAD SCI USA, V105, P10238, DOI 10.1073/pnas.0802759105; White MD, 2009, CNS NEUROL DISORD-DR, V8, P342, DOI 10.2174/187152709789541934; White MD, 2009, PRION, V3, P121, DOI 10.4161/pri.3.3.9289; Wroblewska M, 2011, ACTA BIOCHIM POL, V58, P275; Zannis VI, 2006, J MOL MED, V84, P276, DOI 10.1007/s00109-005-0030-4	22	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88797	10.1371/journal.pone.0088797	http://dx.doi.org/10.1371/journal.pone.0088797			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551164	Green Published, Green Submitted, gold			2022-12-27	WOS:000331271500069
J	Zhao, Y; Quigg, A				Zhao, Yan; Quigg, Antonietta			Nutrient Limitation in Northern Gulf of Mexico (NGOM): Phytoplankton Communities and Photosynthesis Respond to Nutrient Pulse	PLOS ONE			English	Article							MISSISSIPPI RIVER PLUME; PHOSPHORUS LIMITATION; SEASONAL DYNAMICS; FUNCTIONAL TRAITS; COASTAL WATERS; NITROGEN; GROWTH; EUTROPHICATION; PRODUCTIVITY; HYPOXIA	Although the Mississippi-Atchafalaya River system exports large amounts of nutrients to the Northern Gulf of Mexico annually, nutrient limitation of primary productivity still occurs offshore, acting as one of the major factors controlling local phytoplankton biomass and community structure. Bioassays were conducted for 48 hrs at two stations adjacent to the river plumes in April and August 2012. High Performance of Liquid Chromatography (HPLC) combined with ChemTax and a Fluorescence Induction and Relaxation (FIRe) system were combined to observe changes in the phytoplankton community structure and photosynthetic activity. Major fluorescence parameters (F-o, F-v/F-m) performed well to reveal the stimulating effect of the treatments with nitrogen (N-nitrate) and with nitrogen plus phosphate (+NPi). HPLC/ChemTax results showed that phytoplankton community structure shifted with nitrate addition: we observed an increase in the proportion of diatoms and prasinophytes and a decrease in cyanobacteria and prymnesiophytes. These findings are consistent with predictions from trait-based analysis which predict that phytoplankton groups with high maximum growth rates (mu(max)) and high nutrient uptake rates (V-max) readily take advantage of the addition of limiting nutrients. Changes in phytoplankton community structure, if persistent, could trigger changes of particular organic matter fluxes and alter the micro-food web cycles and bottom oxygen consumption.	[Zhao, Yan; Quigg, Antonietta] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; [Quigg, Antonietta] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System	Zhao, Y (corresponding author), Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA.	claire.zhy@tamu.edu			National Oceanographic and Atmospheric Administration (NOAA) CSCOR [NOS-NCCOS-2009-2001466]	National Oceanographic and Atmospheric Administration (NOAA) CSCOR(National Oceanic Atmospheric Admin (NOAA) - USA)	This work was supported by National Oceanographic and Atmospheric Administration (NOAA) CSCOR Grant number NOS-NCCOS-2009-2001466. This is a contribution of the NOAA NGOMEX research program. http://www.noaa.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolf JE, 2006, ESTUAR COAST SHELF S, V67, P108, DOI 10.1016/j.ecss.2005.11.030; AKSNES DL, 1991, MAR ECOL PROG SER, V70, P65, DOI 10.3354/meps070065; Cermeno P, 2011, MAR ECOL PROG SER, V429, P19, DOI 10.3354/meps09088; Cullen J.J., 2003, LIMNOL OCEANOGR B, V12, P29, DOI [10.1002/lob.200413229, DOI 10.1002/LOB.200413229, DOI 10.1002/L0B.200312229]; Dagg MJ, 2007, ESTUAR COAST, V30, P735, DOI 10.1007/BF02841331; Dagg MJ, 2003, J MARINE SYST, V43, P133, DOI 10.1016/j.jmarsys.2003.09.002; Danger M, 2008, OIKOS, V117, P1741, DOI 10.1111/j.1600-0706.2008.16793.x; DORTCH Q, 1992, CONT SHELF RES, V12, P1293, DOI 10.1016/0278-4343(92)90065-R; Edwards KF, 2013, ECOL LETT, V16, P56, DOI 10.1111/ele.12012; Edwards KF, 2011, ECOLOGY, V92, P2085, DOI 10.1890/11-0395.1; Eldridge PM, 2010, ECOL MODEL, V221, P1028, DOI 10.1016/j.ecolmodel.2009.04.054; Fennel K., 2013, J GEOPHYS RES-OCEANS, P1; FISHER TR, 1992, MAR ECOL PROG SER, V82, P51, DOI 10.3354/meps082051; GROVER JP, 1991, AM NAT, V138, P811, DOI 10.1086/285254; Grover JP, 2006, J PLANKTON RES, V28, P1, DOI 10.1093/plankt/fbi095; GROVER JP, 1991, J PHYCOL, V27, P70, DOI 10.1111/j.0022-3646.1991.00070.x; Habib OA, 1997, HYDROBIOLOGIA, V350, P63, DOI 10.1023/A:1003037012226; Howarth RW, 2006, LIMNOL OCEANOGR, V51, P364, DOI 10.4319/lo.2006.51.1_part_2.0364; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Kromkamp JC, 2003, EUR J PHYCOL, V38, P103, DOI 10.1080/0967026031000094094; Kuipers BR, 1999, MAR ECOL PROG SER, V180, P93, DOI 10.3354/meps180093; Lambert CD, 1999, CONT SHELF RES, V19, P1, DOI 10.1016/S0278-4343(98)00075-2; Laurent A, 2012, BIOGEOSCIENCES, V9, P4707, DOI 10.5194/bg-9-4707-2012; Laza-Martinez A, 2007, J PLANKTON RES, V29, P913, DOI 10.1093/plankt/fbm069; Lewitus AJ, 2005, ESTUARIES, V28, P160, DOI 10.1007/BF02732761; Litchman E, 2007, ECOL LETT, V10, P1170, DOI 10.1111/j.1461-0248.2007.01117.x; Litchman E, 2010, HYDROBIOLOGIA, V653, P15, DOI 10.1007/s10750-010-0341-5; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Lohrenz SE, 1999, CONT SHELF RES, V19, P1113, DOI 10.1016/S0278-4343(99)00012-6; Lugus A., 2004, J PLANKTON RES, V26, P291; Mackey MD, 1996, MAR ECOL PROG SER, V144, P265, DOI 10.3354/meps144265; Mahaffey C, 2012, MAR ECOL PROG SER, V460, P13, DOI 10.3354/meps09699; Moore CM, 2008, LIMNOL OCEANOGR, V53, P291, DOI 10.4319/lo.2008.53.1.0291; Paerl HW, 2009, ESTUAR COAST, V32, P593, DOI 10.1007/s12237-009-9158-8; Parkhill JP, 2001, J PHYCOL, V37, P517, DOI 10.1046/j.1529-8817.2001.037004517.x; Pinckney JL, 1996, J PLANKTON RES, V18, P1867, DOI 10.1093/plankt/18.10.1867; Qian YR, 2003, CONT SHELF RES, V23, P1, DOI 10.1016/S0278-4343(02)00173-5; Quigg A, 2013, CONT SHELF RES, V60, P1, DOI 10.1016/j.csr.2013.04.015; Quigg A, 2011, AQUAT GEOCHEM, V17, P519, DOI 10.1007/s10498-011-9134-3; Raateoja M, 2004, LIMNOL OCEANOGR, V49, P1006, DOI 10.4319/lo.2004.49.4.1006; Rabalais NN, 2007, ESTUAR COAST, V30, P753, DOI 10.1007/BF02841332; Rabalais NN, 2002, HYDROBIOLOGIA, V475, P39, DOI 10.1023/A:1020388503274; Schaeffer BA, 2012, MAR POLLUT BULL, V64, P1705, DOI 10.1016/j.marpolbul.2012.03.017; Schluter L, 2000, MAR ECOL PROG SER, V192, P49, DOI 10.3354/meps192049; SMITH SM, 1994, ESTUARIES, V17, P740, DOI 10.2307/1352744; Sommer U, 1995, LIMNOL OCEANOGR, V40, P1271, DOI 10.4319/lo.1995.40.7.1271; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Strom SL, 1996, MAR ECOL PROG SER, V130, P229, DOI 10.3354/meps130229; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Suggett DJ, 2009, AQUAT MICROB ECOL, V56, P227, DOI 10.3354/ame01357; Sylvan JB, 2007, LIMNOL OCEANOGR, V52, P2679, DOI 10.4319/lo.2007.52.6.2679; Sylvan JB, 2006, ENVIRON SCI TECHNOL, V40, P7548, DOI 10.1021/es061417t; Sylvan JB, 2011, ESTUAR COAST, V34, P1220, DOI 10.1007/s12237-011-9415-5; TILMAN D, 1982, ANNU REV ECOL SYST, V13, P349, DOI 10.1146/annurev.es.13.110182.002025; Tomas CR, 1997, IDENTIFYING MARINE P; Turner RE, 2013, AQUAT MICROB ECOL, V68, P159, DOI 10.3354/ame01607; TURNER RE, 1991, BIOSCIENCE, V41, P140, DOI 10.2307/1311453; Turner RE, 2006, MAR POLLUT BULL, V52, P139, DOI 10.1016/j.marpolbul.2005.08.012; Walker ND, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023716; Wawrik B, 2003, MAR ECOL PROG SER, V251, P87, DOI 10.3354/meps251087	60	12	12	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88732	10.1371/journal.pone.0088732	http://dx.doi.org/10.1371/journal.pone.0088732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551144	Green Published, gold, Green Submitted			2022-12-27	WOS:000331271500059
J	Fang, HW; Chiang, PH; Huang, YC				Fang, Hsin-Wei; Chiang, Po-Hsing; Huang, Yhu-Chering			Livestock-Associated Methicillin-Resistant Staphylococcus aureus ST9 in Pigs and Related Personnel in Taiwan	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; RAPID IDENTIFICATION; ST398; PREVALENCE; ANIMALS; INFECTIONS; CHILDREN; CLONES; ORIGIN; SWINE	Background: A livestock-associated (LA) methicillin-resistant Staphylococcus aureus (MRSA) strain sequence type 398 (ST398) is found related to animals and humans in Europe and North America. To evaluate the nasal carriage of MRSA among pigs and related workers in Taiwan, we conducted this study. Methods: From June 25 to October 1 2012, a total of 641 and 100 nasal swabs were obtained from pigs and related workers, respectively, from 22 pig farms nationwide and 2 pig auction markets in Taiwan. All MRSA isolates were molecularly characterized. Results: Overall, the nasal carriage rate of MRSA was 14.4% for pigs and 13% for humans. The carriage rate for pigs younger than 3 months was significantly higher than those older than 3 months (25.4% vs. 5.8%, p < .001). Percentage of MRSA-positive pig farms was 59.1% (13/22). The carriage rate for pigs in large-scale herds (>= 10000 pigs) was significantly higher than that in small-scale (34.3% vs. 7.0%, p < .001) and that in auction markets (3.8%). The carriage rate was 19.2% (10/52) for pig farm workers, and the rate in large-scale farms was significantly higher than that in small-scale (36.8% vs. 9.1%, p = .014). Except for 3 isolates from humans, the other 99 isolates belonged to sequence type (ST) 9. 83 of 89 isolates from pigs shared a common pulsotype, which was also shared by 6 isolates from humans. Conclusion: More than 10% of pigs and related workers in Taiwan carried LA-MRSA ST9 in nares and cross-species transmission of LA-MRSA was documented by molecular methods.	[Fang, Hsin-Wei; Chiang, Po-Hsing; Huang, Yhu-Chering] Chang Gung Univ, Sch Med, Tao Yuan, Taiwan; [Huang, Yhu-Chering] Chang Gung Mem Hosp Linkou, Dept Pediat, Tao Yuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital	Huang, YC (corresponding author), Chang Gung Univ, Sch Med, Tao Yuan, Taiwan.	ychuang@adm.cgmh.org.tw		Chiang, Po-Hsing/0000-0001-6026-8410	Medical Foundation in Memory of Dr. Deh-Lin Cheng and Nation Science Council of Executive Yuan, Taiwan [NSC 102-2628-B-182A-010]; Chang g Gung Memorial Hospital [BMRP236]	Medical Foundation in Memory of Dr. Deh-Lin Cheng and Nation Science Council of Executive Yuan, Taiwan; Chang g Gung Memorial Hospital(Chang Gung Memorial Hospital)	This research was supported by Medical Foundation in Memory of Dr. Deh-Lin Cheng and Nation Science Council of Executive Yuan, Taiwan (NSC 102-2628-B-182A-010) and from Chang g Gung Memorial Hospital (BMRP236). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Baba K, 2010, INT J ANTIMICROB AG, V36, P352, DOI 10.1016/j.ijantimicag.2010.06.040; Battisti A, 2010, VET MICROBIOL, V142, P361, DOI 10.1016/j.vetmic.2009.10.008; Boyce JM, 2005, LANCET INFECT DIS, V5, P653, DOI 10.1016/S1473-3099(05)70243-7; CLSI, 2018, PERF STAND ANT SUSC, P1; Cui SH, 2009, J ANTIMICROB CHEMOTH, V64, P680, DOI 10.1093/jac/dkp275; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fitzgerald JR, 2012, TRENDS MICROBIOL, V20, P192, DOI 10.1016/j.tim.2012.01.006; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Graham PL, 2006, ANN INTERN MED, V144, P318, DOI 10.7326/0003-4819-144-5-200603070-00006; Graveland H, 2011, INT J MED MICROBIOL, V301, P630, DOI 10.1016/j.ijmm.2011.09.004; Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990; Guardabassi L, 2007, VET MICROBIOL, V122, P384, DOI 10.1016/j.vetmic.2007.03.021; Guardabassi L, 2009, EMERG INFECT DIS, V15, P1998, DOI 10.3201/eid1512.090378; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Ho PL, 2012, J CLIN MICROBIOL, V50, P3735, DOI 10.1128/JCM.02053-12; Huang YC, 2008, CLIN MICROBIOL INFEC, V14, P1167, DOI 10.1111/j.1469-0691.2008.02115.x; Huang YC, 2011, INT J ANTIMICROB AG, V38, P2, DOI 10.1016/j.ijantimicag.2011.01.011; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; Ip M, 2005, J CLIN MICROBIOL, V43, P5069, DOI 10.1128/JCM.43.10.5069-5073.2005; Kang YC, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-284; Kock R, 2009, EUR J CLIN MICROBIOL, V28, P1375, DOI 10.1007/s10096-009-0795-4; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Larsen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031245; Lim SK, 2012, VET MICROBIOL, V155, P88, DOI 10.1016/j.vetmic.2011.08.011; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lo YP, 2012, COMP IMMUNOL MICROB, V35, P513, DOI 10.1016/j.cimid.2012.05.001; Lu SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018620; Neela V, 2009, J CLIN MICROBIOL, V47, P4138, DOI 10.1128/JCM.01363-09; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Otter JA, 2012, J HOSP INFECT, V81, P143, DOI 10.1016/j.jhin.2012.04.009; Rasigade JP, 2010, EMERG INFECT DIS, V16, P1330, DOI 10.3201/eid1608.100317; Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Tsai HY, 2012, INT J ANTIMICROB AG, V39, P449, DOI 10.1016/j.ijantimicag.2012.02.001; van Cleef BAGL, 2011, J CLIN MICROBIOL, V49, P1030, DOI 10.1128/JCM.00493-10; van der Mee-Marquet N, 2011, CLIN INFECT DIS, V52, P152, DOI 10.1093/cid/ciq053; Wan MT, 2013, VET MICROBIOL, V162, P779, DOI 10.1016/j.vetmic.2012.10.003; Wang JT, 2009, J CLIN MICROBIOL, V47, P2957, DOI 10.1128/JCM.00853-09; Wassenberg MWM, 2011, CLIN MICROBIOL INFEC, V17, P316, DOI 10.1111/j.1469-0691.2010.03260.x; Witte W, 2007, EMERG INFECT DIS, V13, P255, DOI 10.3201/eid1302.060924; Wulf MW, 2008, EURO SURVEILLANCE, V13; Yu F, 2008, CLIN MICROBIOL INFEC, V14, P381, DOI 10.1111/j.1469-0691.2007.01927.x; Zhao CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038577	47	38	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88826	10.1371/journal.pone.0088826	http://dx.doi.org/10.1371/journal.pone.0088826			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551168	gold, Green Published, Green Submitted			2022-12-27	WOS:000331266000072
J	Liu, ME; Huang, CC; Yang, AC; Tu, PC; Yeh, HL; Hong, CJ; Liou, YJ; Chen, JF; Chou, KH; Lin, CP; Tsai, SJ				Liu, Mu-En; Huang, Chu-Chung; Yang, Albert C.; Tu, Pei-Chi; Yeh, Heng-Liang; Hong, Chen-Jee; Liou, Ying-Jay; Chen, Jin-Fan; Chou, Kun-Hsien; Lin, Ching-Po; Tsai, Shih-Jen			Catechol-O-Methyltransferase Val158Met Polymorphism on the Relationship between White Matter Hyperintensity and Cognition in Healthy People	PLOS ONE			English	Article							PREFRONTAL CORTEX; HUMAN BRAIN; NEUROBIOLOGICAL CHANGES; COMT GENOTYPE; DOPAMINE; IMPAIRMENT; AGE; LESIONS; MECHANISMS; EXPRESSION	Background: White matter lesions can be easily observed on T2-weighted MR images, and are termed white matter hyperintensities (WMH). Their presence may be correlated with cognitive impairment; however, the relationship between regional WMH volume and catechol-O-methyltransferase (COMT) Val158Met polymorphism in healthy populations remains unclear. Methods: We recruited 315 ethnic Chinese adults with a mean age of 54.9 +/- 21.8 years (range: 21-89 y) to examine the genetic effect of COMT on regional WMH and the manner in which they interact to affect cognitive function in a healthy adult population. Cognitive tests, structural MRI scans, and genotyping of COMT were conducted for each participant. Results: Negative correlations between the Digit Span Forward (DSF) score and frontal WMH volumes (r = -.123, P=.032, uncorrected) were noted. For the genetic effect of COMT, no significant difference in cognitive performance was observed among 3 genotypic groups. However, differences in WMH volumes over the subcortical region (P = .016, uncorrected), whole brain (P = .047, uncorrected), and a trend over the frontal region (P = .050, uncorrected) were observed among 3 COMT genotypic groups. Met homozygotes and Met/Val heterozygotes exhibited larger WMH volumes in these brain regions than the Val homozygotes. Furthermore, a correlation between the DSF and regional WMH volume was observed only in Met homozygotes. The effect size (cohen's f) revealed a small effect. Conclusions: The results indicate that COMT might modulate WMH volumes and the effects of WMH on cognition.	[Liu, Mu-En; Yang, Albert C.; Tu, Pei-Chi; Hong, Chen-Jee; Liou, Ying-Jay; Tsai, Shih-Jen] Taipei Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Liu, Mu-En; Lin, Ching-Po] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Huang, Chu-Chung; Lin, Ching-Po] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Yang, Albert C.; Hong, Chen-Jee; Liou, Ying-Jay; Tsai, Shih-Jen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Yang, Albert C.] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Chungli 32054, Taiwan; [Tu, Pei-Chi] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Yeh, Heng-Liang] Hlth Care Grp, Taipei, Taiwan; [Chen, Jin-Fan] Tao Yuan Vet Hosp, Dept Pathol, Tao Yuan, Taiwan; [Chou, Kun-Hsien; Lin, Ching-Po] Natl Yang Ming Univ, Inst Neurosci, Sch Life Sci, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Central University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Lin, CP (corresponding author), Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan.	chingpolin@gmail.com; tsai610913@gmail.com	Tsai, Shih-Jen/AAK-7944-2020	Tsai, Shih-Jen/0000-0002-9987-022X; Huang, Chu-Chung/0000-0002-9096-9610; Yang, Albert Chih-Chieh/0000-0003-2794-9649	Taipei Veterans General Hospital, Taiwan [V101C-006, VGHUST101-G1-1-1, VGHUST102- G1-2-1]; National Science Council Grant, Taiwan [NSC 102-2314-B-075B-001, NSC 101-2321-B-010 -026 -, NSC 101-2911-I-008-001, NSC 101-2314-B-075 -040]	Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital); National Science Council Grant, Taiwan	This work was supported by grants V101C-006, VGHUST101-G1-1-1, VGHUST102- G1-2-1 from Taipei Veterans General Hospital, Taiwan, grants NSC 102-2314-B-075B-001, NSC 101-2321-B-010 -026 -, NSC 101-2911-I-008-001, NSC 101-2314-B-075 -040, and NSC 101-2911-I-008-001 from National Science Council Grant, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2011, NEUROPSYCHOLOGIA, V49, P3931, DOI 10.1016/j.neuropsychologia.2011.10.010; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bava S, 2010, NEUROPSYCHOL REV, V20, P398, DOI 10.1007/s11065-010-9146-6; Berman S, 2008, ANN NY ACAD SCI, V1141, P195, DOI 10.1196/annals.1441.031; Bray NJ, 2003, AM J HUM GENET, V73, P152, DOI 10.1086/376578; BRUN A, 1986, ANN NEUROL, V19, P253, DOI 10.1002/ana.410190306; Bunce D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013567; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Duncan, 2000, Am J Ophthalmol, V130, P687, DOI 10.1016/S0002-9394(00)00752-2; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Fernando MS, 2006, STROKE, V37, P1391, DOI 10.1161/01.STR.0000221308.94473.14; Fernstrom JD, 2000, AM J CLIN NUTR, V71, p1669S, DOI 10.1093/ajcn/71.6.1669S; Gerton BK, 2004, NEUROPSYCHOLOGIA, V42, P1781, DOI 10.1016/j.neuropsychologia.2004.04.023; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Gregoire J, 1997, AGING NEUROPSYCHOL C, V4, P140, DOI 10.1080/13825589708256642; Gunning-Dixon FM, 2009, INT J GERIATR PSYCH, V24, P109, DOI 10.1002/gps.2087; Kaasinen V, 2000, NEUROBIOL AGING, V21, P683, DOI 10.1016/S0197-4580(00)00149-4; Kohama SG, 2012, AGE, V34, P1093, DOI 10.1007/s11357-011-9357-7; Krimer LS, 1998, NAT NEUROSCI, V1, P286, DOI 10.1038/1099; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; LARUE A, 1987, INT J AGING HUM DEV, V25, P79, DOI 10.2190/DV3R-PBJQ-E0FT-7W2B; Li J, 2009, AM J MED GENET B, V150B, P375, DOI 10.1002/ajmg.b.30825; Liu B, 2010, NEUROIMAGE, V50, P243, DOI 10.1016/j.neuroimage.2009.12.020; LUNDSTROM K, 1995, BBA-PROTEIN STRUCT M, V1251, P1, DOI 10.1016/0167-4838(95)00071-2; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P594, DOI 10.1038/nn1438; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Muangpaisan Weerasak, 2010, Journal of the Medical Association of Thailand, V93, P224; Nordahl CW, 2006, J COGNITIVE NEUROSCI, V18, P418, DOI 10.1162/089892906775990552; Ota M, 2009, INT J GERIATR PSYCH, V24, P1463, DOI 10.1002/gps.2289; Pantoni L, 1997, STROKE, V28, P652, DOI 10.1161/01.STR.28.3.652; Pugh KG, 2002, NEUROBIOL AGING, V23, P421, DOI 10.1016/S0197-4580(01)00319-0; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Schmithorst VJ, 2005, HUM BRAIN MAPP, V26, P139, DOI 10.1002/hbm.20149; Schulingkamp RJ, 2000, NEUROSCI BIOBEHAV R, V24, P855, DOI 10.1016/S0149-7634(00)00040-3; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seger D, 2010, CLIN TOXICOL, V48, P695, DOI 10.3109/15563650.2010.516263; Sesack SR, 1998, J NEUROSCI, V18, P2697; Shin J, 2012, J NEUROL NEUROSUR PS, V83, P315, DOI 10.1136/jnnp-2011-300872; Smith EE, 2008, ARCH NEUROL-CHICAGO, V65, P94, DOI 10.1001/archneurol.2007.23; Sonohara K, 2008, GERIATR GERONTOL INT, V8, P93, DOI 10.1111/j.1447-0594.2008.00454.x; Thomason ME, 2010, NEUROIMAGE, V53, P926, DOI 10.1016/j.neuroimage.2010.01.033; Tomimoto H, 2003, ACTA NEUROPATHOL, V106, P527, DOI 10.1007/s00401-003-0749-3; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; van Amelsvoort T, 2008, PSYCHOL MED, V38, P89, DOI 10.1017/S0033291707000700; Volkow ND, 1998, AM J PSYCHIAT, V155, P344; Wang YQ, 2001, AM J PHYSIOL-REG I, V280, pR248, DOI 10.1152/ajpregu.2001.280.1.R248; White FJ, 1998, DRUG ALCOHOL DEPEN, V51, P141, DOI 10.1016/S0376-8716(98)00072-6; Xu HY, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00008; Xu HY, 2009, BEHAV NEUROSCI, V123, P418, DOI 10.1037/a0014477; Zhu GS, 2004, PSYCHOPHARMACOLOGY, V177, P178, DOI 10.1007/s00213-004-1938-z; Zinkstok J, 2006, NEUROSCI LETT, V405, P34, DOI 10.1016/j.neulet.2006.06.034	57	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88749	10.1371/journal.pone.0088749	http://dx.doi.org/10.1371/journal.pone.0088749			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551149	Green Published, gold, Green Submitted			2022-12-27	WOS:000331266000060
J	Christiansen, MT; Kaas, RS; Chaudhuri, RR; Holmes, MA; Hasman, H; Aarestrup, FM				Christiansen, Mette T.; Kaas, Rolf S.; Chaudhuri, Roy R.; Holmes, Mark A.; Hasman, Henrik; Aarestrup, Frank M.			Genome-Wide High-Throughput Screening to Investigate Essential Genes Involved in Methicillin-Resistant Staphylococcus aureus Sequence Type 398 Survival	PLOS ONE			English	Article							STATIONARY-PHASE; VIRULENCE GENES; MUTAGENESIS; EXPRESSION; PEPTIDOGLYCAN; STRAINS; PROTEIN; IDENTIFICATION; GROWTH; ACID	Livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) Sequence Type 398 (ST398) is an opportunistic pathogen that is able to colonize and cause disease in several animal species including humans. To better understand the adaptation, evolution, transmission and pathogenic capacity, further investigations into the importance of the different genes harboured by LA-MRSA ST398 are required. In this study we generated a genome-wide transposon mutant library in an LA-MRSA ST398 isolate to evaluate genes important for bacterial survival in laboratory and host-specific environments. The transposon mutant library consisted of approximately 1 million mutants with around 140,000 unique insertion sites and an average number of unique inserts per gene of 44.8. We identified LA-MRSA ST398 essential genes comparable to other high-throughput S. aureus essential gene studies. As ST398 is the most common MRSA isolated from pigs, the transposon mutant library was screened in whole porcine blood. Twenty-four genes were specifically identified as important for bacterial survival in porcine blood. Mutations in 23 of these genes resulted in attenuated bacterial fitness. Seven of the 23 genes were of unknown function, whereas 16 genes were annotated with functions predominantly related to carbon metabolism, pH shock and a variety of regulations and only indirectly to virulence factors. Mutations in one gene of unknown function resulted in a hypercompetitive mutant. Further evaluation of these genes is required to determine their specific relevance in blood survival.	[Christiansen, Mette T.; Kaas, Rolf S.; Hasman, Henrik; Aarestrup, Frank M.] Tech Univ Denmark, Natl Food Inst, DK-2800 Lyngby, Denmark; [Chaudhuri, Roy R.; Holmes, Mark A.] Univ Cambridge, Dept Vet Med, Cambridge, England	Technical University of Denmark; University of Cambridge	Christiansen, MT (corresponding author), UCL, London, England.	m.christiansen@ucl.ac.uk; fmaa@food.dtu.dk	Chaudhuri, Roy/E-3774-2014	Chaudhuri, Roy/0000-0001-5037-2695; Aarestrup, Frank/0000-0002-7116-2723; Kaas, Rolf Sommer/0000-0002-5050-8668; Hasman, Henrik/0000-0001-6314-2709; Holmes, Mark/0000-0002-5454-1625	Danish Ministry of Food, Agriculture and Fisheries [3304-FVFP-09-F-002-1]; Technical University of Denmark; MRC [G1001787] Funding Source: UKRI; Medical Research Council [G1001787] Funding Source: researchfish	Danish Ministry of Food, Agriculture and Fisheries; Technical University of Denmark; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded in part by the Danish Ministry of Food, Agriculture and Fisheries (Grant no. 3304-FVFP-09-F-002-1) and The Technical University of Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S., 2012, DIFFERENTIAL EXPRESS, DOI DOI 1016/j.jtbi.2009.04.013PMID:19406131; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson KL, 2010, FEMS IMMUNOL MED MIC, V60, P208, DOI 10.1111/j.1574-695X.2010.00736.x; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Chaudhuri RR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003456; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Cuny C, 2010, INT J MED MICROBIOL, V300, P109, DOI 10.1016/j.ijmm.2009.11.002; den Reijer PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053391; DEVRIESE LA, 1972, ZENTRALB VET RIEHE B, V19, P598; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; Fluit AC, 2012, CLIN MICROBIOL INFEC, V18, P735, DOI 10.1111/j.1469-0691.2012.03846.x; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; Hasman H, 2010, VET MICROBIOL, V141, P326, DOI 10.1016/j.vetmic.2009.09.025; HENZE U, 1993, J BACTERIOL, V175, P1612, DOI 10.1128/JB.175.6.1612-1620.1993; Hughes JD, 2007, TRANSFUSION, V47, P2050, DOI 10.1111/j.1537-2995.2007.01429.x; Khatiwara A, 2012, APPL ENVIRON MICROB, V78, P3098, DOI 10.1128/AEM.06865-11; Koprivnjak T, 2011, J BACTERIOL, V193, P4134, DOI 10.1128/JB.00288-11; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; MAIDHOF H, 1991, J BACTERIOL, V173, P3507, DOI 10.1128/jb.173.11.3507-3513.1991; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mei JM, 1997, MOL MICROBIOL, V26, P399, DOI 10.1046/j.1365-2958.1997.5911966.x; Pane-Farre J, 2006, INT J MED MICROBIOL, V296, P237, DOI 10.1016/j.ijmm.2005.11.011; Pickard D, 2013, J BACTERIOL, V195, P1320, DOI 10.1128/JB.01632-12; Plata K, 2009, ACTA BIOCHIM POL, V56, P597; Prasad UV, 2013, APPL BIOCHEM BIOTECH, V169, P862, DOI 10.1007/s12010-012-0027-8; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Rigby KM, 2012, SEMIN IMMUNOPATHOL, V34, P237, DOI 10.1007/s00281-011-0295-3; Rohrer S, 1999, P NATL ACAD SCI USA, V96, P9351, DOI 10.1073/pnas.96.16.9351; Salama NR, 2004, J BACTERIOL, V186, P7926, DOI 10.1128/JB.186.23.7926-7935.2004; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Saunders Nicholas A., 2007, V391, P71; Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376; Schneiker S, 2007, NAT BIOTECHNOL, V25, P1281, DOI 10.1038/nbt1354; Siboo IR, 2005, INFECT IMMUN, V73, P2273, DOI 10.1128/IAI.73.4.2273-2280.2005; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Somerville GA, 2003, J BACTERIOL, V185, P6686, DOI 10.1128/JB.185.22.6686-6694.2003; Somerville GA, 2002, INFECT IMMUN, V70, P6373, DOI 10.1128/IAI.70.11.6373-6382.2002; Sun F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015703; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; van Duijkeren E, 2008, VET MICROBIOL, V126, P383, DOI 10.1016/j.vetmic.2007.07.021; Verkade E, 2013, INFECT GENETICS EVOL; Wakeman CA, 2012, MOL MICROBIOL, V86, P1376, DOI 10.1111/mmi.12063	50	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e89018	10.1371/journal.pone.0089018	http://dx.doi.org/10.1371/journal.pone.0089018			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24563689	Green Accepted, Green Published, gold			2022-12-27	WOS:000331262600127
J	Bitter, K; Glaser, C; Neumann, K; Blunck, U; Frankenberger, R				Bitter, Kerstin; Glaeser, Christin; Neumann, Konrad; Blunck, Uwe; Frankenberger, Roland			Analysis of Resin-Dentin Interface Morphology and Bond Strength Evaluation of Core Materials for One Stage Post-Endodontic Restorations	PLOS ONE			English	Article							ROOT-CANAL DENTIN; REINFORCED COMPOSITE POSTS; PULP CHAMBER DENTIN; PUSH-OUT TESTS; FIBER POSTS; SMEAR LAYER; LUTING AGENT; ADHESIVE; SYSTEMS; TAGS	Purpose: Restoration of endodontically treated teeth using fiber posts in a one-stage procedure gains more popularity and aims to create a secondary monoblock. Data of detailed analyses of so called "post-and-core-systems" with respect to morphological characteristics of the resin-dentin interface in combination with bond strength measurements of fiber posts luted with these materials are scarce. The present study aimed to analyze four different post-and-core-systems with two different adhesive approaches (self-etch and etch-and-rinse). Materials and Methods: Human anterior teeth (n = 80) were endodontically treated and post space preparations and post placement were performed using the following systems: Rebilda Post/Rebilda DC/Futurabond DC (Voco) (RB), Luxapost/Luxacore Z/Luxabond Prebond and Luxabond A+B (DMG) (LC), X Post/Core X Flow/XP Bond and Self Cure Activator (Dentsply DeTrey) (CX), FRC Postec/MultiCore Flow/AdheSE DC (Ivoclar Vivadent) (MC). Adhesive systems and core materials of 10 specimens per group were labeled using fluorescent dyes and resin-dentin interfaces were analyzed using Confocal Laser Scanning Microscopy (CLSM). Bond strengths were evaluated using a push-out test. Data were analyzed using repeated measurement ANOVA and following post-hoc test. Results: CLSM analyses revealed significant differences between groups with respect to the factors hybrid layer thickness (p<0.0005) and number of resin tags (p = 0.02; ANOVA). Bond strength was significantly affected by core material (p = 0.001), location inside the root canal (p<0.0005) and incorporation of fluorescent dyes (p = 0.036; ANOVA). CX [7.7 (4.4) MPa] demonstrated significantly lower bond strength compared to LC [14.2 (8.7) MPa] and RB [13.3 (3.7) MPa] (p<0.05; Tukey HSD) but did not differ significantly from MC [11.5 (3.5) MPa]. Conclusion: It can be concluded that bond strengths inside the root canal were not affected by the adhesive approach of the post-and-core-system. All systems demonstrated homogenous hybrid layer formation and penetration into the dentinal tubules in spite of the complicating conditions for adhesion inside the root canal.	[Bitter, Kerstin; Glaeser, Christin; Blunck, Uwe] Charite, ChariteCtr 3, Univ Sch Dent Med, Dept Operat & Prevent Dent, D-13353 Berlin, Germany; [Neumann, Konrad] Charite, ChariteCtr 3, Dept Med Informat Biometry & Epidemiol, D-13353 Berlin, Germany; [Frankenberger, Roland] Univ Marburg, Dept Operat Dent & Endodontol, Marburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Philipps University Marburg	Bitter, K (corresponding author), Charite, ChariteCtr 3, Univ Sch Dent Med, Dept Operat & Prevent Dent, D-13353 Berlin, Germany.	kerstin.bitter@charite.de	Frankenberger, Roland/J-8198-2012; Blunck, Uwe/AAG-3093-2020	Frankenberger, Roland/0000-0002-5112-4463; Blunck, Uwe/0000-0001-6428-4987	VOCO; Dentsply DeTrey; Ivoclar Vivadent; DMG	VOCO; Dentsply DeTrey; Ivoclar Vivadent; DMG	This study was supported by VOCO, Dentsply DeTrey, Ivoclar Vivadent, and DMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSTER D, 1992, J DENT RES, V71, P1619, DOI 10.1177/00220345920710091401; Arrais CAG, 2007, J PROSTHET DENT, V97, P99, DOI 10.1016/j.prosdent.2006.12.007; Arrais CAG, 2009, J ADHES DENT, V11, P15; Arrais CAG, 2009, J DENT, V37, P219, DOI 10.1016/j.jdent.2008.11.016; Bitter K, 2006, INT ENDOD J, V39, P809, DOI 10.1111/j.1365-2591.2006.01155.x; Bitter K, 2012, INT ENDOD J, V45, P1116, DOI 10.1111/j.1365-2591.2012.02081.x; Bitter K, 2012, OPER DENT, V37, P397, DOI 10.2341/11-066-L; Bitter K, 2004, INT ENDOD J, V37, P840, DOI 10.1111/j.1365-2591.2004.00888.x; Bitter K, 2008, J ENDODONT, V34, P306, DOI 10.1016/j.joen.2007.12.011; Bitter K, 2009, J ENDODONT, V35, P1477, DOI 10.1016/j.joen.2009.07.026; Bitter K, 2009, J ADHES DENT, V11, P7; Bitter K, 2009, EUR J ORAL SCI, V117, P326, DOI 10.1111/j.1600-0722.2009.00623.x; Cagidiaco MC, 2008, INT J PROSTHODONT, V21, P328; CZONSTKOWSKY M, 1990, DENT CLIN N AM, V34, P13; D'Alpino PHP, 2006, J DENT, V34, P623, DOI 10.1016/j.jdent.2005.12.004; D'Alpino PHP, 2006, J ADHES DENT, V8, P285; Fawzi EM, 2010, J ADHES DENT, V12, P63, DOI 10.3290/j.jad.a17594; Ferrari M, 2000, INT ENDOD J, V33, P397, DOI 10.1046/j.1365-2591.2000.00310.x; Ferrari M, 2009, J DENT RES, V88, P951, DOI 10.1177/0022034509342851; Ferrari M, 2000, AM J DENT, V13, P255; Goracci C, 2008, J DENT RES, V87, P1122, DOI 10.1177/154405910808701208; Goracci C, 2007, J DENT, V35, P827, DOI 10.1016/j.jdent.2007.07.009; Gu XH, 2009, EUR J ORAL SCI, V117, P597, DOI 10.1111/j.1600-0722.2009.00661.x; Kenshima S, 2006, J DENT, V34, P775, DOI 10.1016/j.jdent.2006.03.001; Kurtz JS, 2003, AM J DENT, V16, p31A; Lohbauer U, 2008, J ADHES DENT, V10, P97; Malyk Y, 2010, INT ENDOD J, V43, P47, DOI 10.1111/j.1365-2591.2009.01631.x; Mazzoni A, 2009, EUR J ORAL SCI, V117, P447, DOI 10.1111/j.1600-0722.2009.00656.x; Mjor IA, 2001, INT ENDOD J, V34, P346, DOI 10.1046/j.1365-2591.2001.00393.x; Naumann M, 2012, J ENDODONT, V38, P432, DOI 10.1016/j.joen.2012.01.003; Perdigao J, 2007, PRACT PROCED AESTHET, V19, P365; Perdigao Jorge, 2007, J Prosthodont, V16, P154, DOI 10.1111/j.1532-849X.2006.00166.x; Perdigao Jorge, 2007, Pract Proced Aesthet Dent, V19, P359; Pest LB, 2002, DENT MATER, V18, P596, DOI 10.1016/S0109-5641(02)00003-9; Radovic I, 2008, EUR J ORAL SCI, V116, P557, DOI 10.1111/j.1600-0722.2008.00577.x; Rodig T, 2010, J ADHES DENT, V12, P197, DOI 10.3290/j.jad.a18441; Santos JN, 2006, J ENDODONT, V32, P1088, DOI 10.1016/j.joen.2006.07.001; Sarkis-Onofre R, 2013, OPER DENT; Sattabanasuk V, 2007, J DENT, V35, P467, DOI 10.1016/j.jdent.2007.01.002; Schmage P, 2009, J PROSTHET DENT, V102, P368, DOI 10.1016/S0022-3913(09)60196-7; Soares CJ, 2008, DENT MATER, V24, P1405, DOI 10.1016/j.dental.2008.03.004; Sterzenbach G, 2012, J ENDODONT, V38, P1557, DOI 10.1016/j.joen.2012.08.015; Sterzenbach G, 2012, ACTA ODONTOL SCAND, V70, P368, DOI 10.3109/00016357.2011.603702; Tay FR, 2005, J ENDODONT, V31, P584, DOI 10.1097/01.don.0000168891.23486.de; Tay FR, 2007, J ENDODONT, V33, P391, DOI 10.1016/j.joen.2006.10.009; Van Landuyt KL, 2007, BIOMATERIALS, V28, P3757, DOI 10.1016/j.biomaterials.2007.04.044; Van Meerbeek B, 2011, DENT MATER, V27, P17, DOI 10.1016/j.dental.2010.10.023; Watson T F, 1997, Adv Dent Res, V11, P433; Watzke R, 2008, DENT MATER, V24, P1512, DOI 10.1016/j.dental.2008.03.022; Zhang L, 2008, EUR J ORAL SCI, V116, P280, DOI 10.1111/j.1600-0722.2008.00536.x; Zicari F, 2008, DENT MATER, V24, P967, DOI 10.1016/j.dental.2007.11.011	51	19	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e86294	10.1371/journal.pone.0086294	http://dx.doi.org/10.1371/journal.pone.0086294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586248	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200008
J	Baca, M; Laderach, P; Haggar, J; Schroth, G; Ovalle, O				Baca, Maria; Laederach, Peter; Haggar, Jeremy; Schroth, Gotz; Ovalle, Oriana			An Integrated Framework for Assessing Vulnerability to Climate Change and Developing Adaptation Strategies for Coffee Growing Families in Mesoamerica	PLOS ONE			English	Article								The Mesoamerican region is considered to be one of the areas in the world most vulnerable to climate change. We developed a framework for quantifying the vulnerability of the livelihoods of coffee growers in Mesoamerica at regional and local levels and identify adaptation strategies. Following the Intergovernmental Panel on Climate Change (IPCC) concepts, vulnerability was defined as the combination of exposure, sensitivity and adaptive capacity. To quantify exposure, changes in the climatic suitability for coffee and other crops were predicted through niche modelling based on historical climate data and locations of coffee growing areas from Mexico, Guatemala, El Salvador and Nicaragua. Future climate projections were generated from 19 Global Circulation Models. Focus groups were used to identify nine indicators of sensitivity and eleven indicators of adaptive capacity, which were evaluated through semi-structured interviews with 558 coffee producers. Exposure, sensitivity and adaptive capacity were then condensed into an index of vulnerability, and adaptation strategies were identified in participatory workshops. Models predict that all target countries will experience a decrease in climatic suitability for growing Arabica coffee, with highest suitability loss for El Salvador and lowest loss for Mexico. High vulnerability resulted from loss in climatic suitability for coffee production and high sensitivity through variability of yields and out-migration of the work force. This was combined with low adaptation capacity as evidenced by poor post harvest infrastructure and in some cases poor access to credit and low levels of social organization. Nevertheless, the specific contributors to vulnerability varied strongly among countries, municipalities and families making general trends difficult to identify. Flexible strategies for adaption are therefore needed. Families need the support of government and institutions specialized in impacts of climate change and strengthening of farmer organizations to enable the adjustment of adaptation strategies to local needs and conditions.	[Baca, Maria; Laederach, Peter] Int Ctr Trop Agr CIAT, Managua, Nicaragua; [Haggar, Jeremy] Univ Greenwich, NRI, Chatham, Kent, England; [Schroth, Gotz] Rainforest Alliance, Wageningen, Netherlands; [Ovalle, Oriana] Int Ctr Trop Agr CIAT, Cali, Colombia	Alliance; International Center for Tropical Agriculture - CIAT; University of Greenwich; Alliance; International Center for Tropical Agriculture - CIAT	Baca, M (corresponding author), Int Ctr Trop Agr CIAT, Managua, Nicaragua.	magubago@gmail.com		Laderach, Peter/0000-0001-8708-6318	Green Mountain Coffee Roasters (GMCR); Natural Environment Research Council [NE/K501402/1] Funding Source: researchfish; NERC [NE/K501402/1] Funding Source: UKRI	Green Mountain Coffee Roasters (GMCR); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was conducted under the CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS) in collaboration with Catholic Relief Services (CRS) and additional funding from Green Mountain Coffee Roasters (GMCR). Funds were used for employment and development of research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no further patents, products in development or marketed products to declare.	Adger W.N., 1999, MITIG ADAPT STRAT GL, P253, DOI DOI 10.1023/A:1009601904210; Adger WN, 2003, ECON GEOGR, V79, P387; Altieri M.A., 2009, LEISA REV AGROECOLOG, V14, P5; Baker P, 2007, GLOBAL WARMING IMPAC; Castro F, 2004, 23 WORLD BANK LAT AM; CEPAL (Comision Economica Para America Latina y el Caribe), 2002, CENTR IMP CAID PREC; Cutter SL, 1996, PROG HUM GEOG, V20, P529, DOI 10.1177/030913259602000407; Davis AS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047149, 10.1371/journal.pone.0047981]; DFID (Departament for Internacional Development UK), 1999, HOJ OR MED VID SOST; Di Rienzo JA., 2008, INFOSTAT VERSION 200; Diaz R, 2009, REV IBEROAMERICANA R, V10, P61; Eakin H, 2011, ENVIRON MANAGE, V47, P352, DOI 10.1007/s00267-010-9603-2; ESCAMILLA E, 2005, MANEJO INTEGRADO PLA, V76, P5; Fabio Suarez, 1999, FUNDAMENTOS ESTADIST; Gay C, 2006, CLIMATIC CHANGE, V79, P259, DOI 10.1007/s10584-006-9066-x; Geilfus Frans, 1997, 80 HERRAMIENTAS DESA; Haggar J, 2013, ENVIRON MANAGE, V51, P811, DOI 10.1007/s00267-013-0019-7; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; IPCC Grupo Gubernamental de Expertos sobre el Cambio climatico, 2008, CAMB CLIM AG; Ipcc (Intergovernmental Panel on Climate Change), 2001, CLIM CHANG 2001 WORK; Jaramillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024528; Laderach P, 2012, SPECIALTY COFFEE MAN, P39; Laderach P, 2011, CLIM CHANG MANAG, P703, DOI 10.1007/978-3-642-14776-0_42; Moguel P, 1999, CONSERV BIOL, V13, P11, DOI 10.1046/j.1523-1739.1999.97153.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Ramirez J., 2010, DISAGGREGATION GLOBA; Schroth G, 2013, AGRONOMY SU IN PRESS; Smit B, 1996, CLIMATIC CHANGE, V33, P7, DOI 10.1007/BF00140511; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tucker CM, 2010, GLOBAL ENVIRON CHANG, V20, P23, DOI 10.1016/j.gloenvcha.2009.07.006; Yohe G., 2006, SYNTHETIC ASSESSMENT	31	103	106	5	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e88463	10.1371/journal.pone.0088463	http://dx.doi.org/10.1371/journal.pone.0088463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586328	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000332389000010
J	Cote, J; Bonvalot, Y; Carrier, G; Lapointe, C; Fuhr, U; Tomalik-Scharte, D; Wachall, B; Bouchard, M				Cote, Jonathan; Bonvalot, Yvette; Carrier, Gaetan; Lapointe, Caroline; Fuhr, Uwe; Tomalik-Scharte, Dorota; Wachall, Bertil; Bouchard, Michele			A Novel Toxicokinetic Modeling of Cypermethrin and Permethrin and Their Metabolites in Humans for Dose Reconstruction from Biomarker Data	PLOS ONE			English	Article							HORTICULTURAL GREENHOUSE WORKERS; PYRETHROID PESTICIDES; IN-VITRO; CLINICAL-MANIFESTATIONS; ANTIANDROGENIC ACTIVITY; PHARMACOKINETIC MODEL; GAS-CHROMATOGRAPHY; TRANS-PERMETHRIN; DNA-DAMAGE; EXPOSURE	To assess exposure to pyrethroids in the general population, one of most widely used method nowadays consists of measuring urinary metabolites. Unfortunately, interpretation of data is limited by the unspecified relation between dose and levels in biological tissues and excreta. The objective of this study was to develop a common multi-compartment toxicokinetic model to predict the time courses of two mainly used pyrethroid pesticides, permethrin and cypermethrin, and their metabolites (cis-DCCA, trans-DCCA and 3-PBA) in the human body and in accessible biological matrices following different exposure scenarios. Toxicokinetics was described mathematically by systems of differential equations to yield the time courses of these pyrethroids and their metabolites in the different compartments. Unknown transfer rate values between compartments were determined from best fits to available human data on the urinary excretion time courses of metabolites following an oral and dermal exposure to cypermethrin in volunteers. Since values for these coefficients have not yet been determined, a mathematical routine was programmed in MathCad to establish the possible range of values on the basis of physiological and mathematical considerations. The best combination of parameter values was then selected using a statistic measure (reliability factor) along with a statistically acceptable range of values for each parameter. With this approach, simulations provided a close approximation to published time course data. This model allows to predict urinary time courses of trans-DCCA, cis-DCCA and 3-PBA, whatever the exposure route. It can also serve to reconstruct absorbed doses of permethrin or cypermethrin in the population using measured biomarker data.	[Cote, Jonathan; Carrier, Gaetan; Bouchard, Michele] Univ Montreal, Chaire Anal & Gest Risques Toxicol, Dept Sante Environm & Sante Travail, Montreal, PQ, Canada; [Cote, Jonathan; Carrier, Gaetan; Bouchard, Michele] Univ Montreal, IRSPUM, Montreal, PQ, Canada; [Bonvalot, Yvette; Lapointe, Caroline] Hlth Canada, Environm Hlth Program, Longueuil, PQ, Canada; [Fuhr, Uwe; Tomalik-Scharte, Dorota] Univ Cologne, Dept Pharmacol, Clin Pharmacol Unit, D-50931 Cologne, Germany; [Wachall, Bertil] Infectopharm Arzneimittel & Consilium GmbH, Heppenheim, Germany	Universite de Montreal; Universite de Montreal; Health Canada; University of Cologne	Bouchard, M (corresponding author), Univ Montreal, Chaire Anal & Gest Risques Toxicol, Dept Sante Environm & Sante Travail, Montreal, PQ, Canada.	michele.bouchard@umontreal.ca			Health Canada's Chemicals Management Plan Monitoring & Surveillance Fund; Chair of Toxicological Risk Assessment and Management of the University of Montreal	Health Canada's Chemicals Management Plan Monitoring & Surveillance Fund; Chair of Toxicological Risk Assessment and Management of the University of Montreal	This study was funded by Health Canada's Chemicals Management Plan Monitoring & Surveillance Fund 2008-2011. The study was also supported by the Chair of Toxicological Risk Assessment and Management of the University of Montreal. The funders had no role in study design, data collection and analysis, decision to publish.	ANADON A, 1991, TOXICOL APPL PHARM, V110, P1, DOI 10.1016/0041-008X(91)90284-L; Berthet A, 2012, IMPACT PESTICIDES; Bordet F, 2002, J AOAC INT, V85, P1398; Bouchard M, 2005, J OCCUP ENVIRON HYG, V2, P155, DOI 10.1080/15459620590922407; Bouchard M, 2003, TOXICOL SCI, V73, P182, DOI 10.1093/toxsci/kfg061; Bouchard M, 2008, INT ARCH OCC ENV HEA, V81, P355, DOI 10.1007/s00420-007-0220-1; Bouchard M, 2006, ANN OCCUP HYG, V50, P505, DOI [10.1093/annhyg/mel005, 10.1093/annhyg/me1005]; Casida J. E., 1976, Archives of Environmental Contamination and Toxicology, V3, P491, DOI 10.1007/BF02220819; Centers for Disease Control and Prevention, 2009, 4 CDCP; Centers for Disease Control and Prevention (CDC), 2005, 3 CDC DEP HLTH HUM S, P349; Choi J, 2002, PESTIC BIOCHEM PHYS, V74, P117, DOI 10.1016/S0048-3575(02)00154-2; Choi JS, 2006, TOXICOL APPL PHARM, V211, P233, DOI 10.1016/j.taap.2005.06.022; Clark J. Marshall, 2007, Invertebrate Neuroscience, V7, P3, DOI 10.1007/s10158-006-0038-7; Couture C, 2009, J OCCUP ENVIRON HYG, V6, P341, DOI 10.1080/15459620902850907; CRAWFORD MJ, 1981, J AGR FOOD CHEM, V29, P130, DOI 10.1021/jf00103a033; CRAWFORD MJ, 1981, PESTIC SCI, V12, P399, DOI 10.1002/ps.2780120406; Cui Y, 2006, MUTAT RES-GEN TOX EN, V604, P36, DOI 10.1016/j.mrgentox.2005.12.003; EADSFORTH CV, 1983, XENOBIOTICA, V13, P67, DOI 10.3109/00498258309052238; EADSFORTH CV, 1988, XENOBIOTICA, V18, P603, DOI 10.3109/00498258809041697; FAO, 1980, JOINT M FAO PAN EXP; FAO, 1982, JOINT M FAO PAN EXP; Fortin MC, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-55; Gotoh Y, 1998, J TOXICOL-CLIN TOXIC, V36, P57, DOI 10.3109/15563659809162587; HE FS, 1989, ARCH TOXICOL, V63, P54, DOI 10.1007/BF00334635; Heredia-Ortiz R, 2013, J APPL TOXICOL, V33, P607, DOI 10.1002/jat.1782; Heredia-Ortiz R, 2012, TOXICOL LETT, V213, P27, DOI 10.1016/j.toxlet.2011.09.023; Heudorf U, 2001, ENVIRON HEALTH PERSP, V109, P213, DOI 10.2307/3434687; HUTSON DH, 1979, PROGR DRUG METABOLIS, V3, P215; Julien R, 2008, J EXPO SCI ENV EPID, V18, P167, DOI 10.1038/sj.jes.7500576; Kaneko H., 2001, HDB PESTICIDE TOXICO, P1263; Kuhn KH, 1999, B ENVIRON CONTAM TOX, V62, P101, DOI 10.1007/s001289900847; Lentza-Rizos C, 2001, J CHROMATOGR A, V921, P297, DOI 10.1016/S0021-9673(01)00874-3; Mirfazaelian A, 2006, TOXICOL SCI, V93, P432, DOI 10.1093/toxsci/kfl056; Nishi K, 2006, ARCH BIOCHEM BIOPHYS, V445, P115, DOI 10.1016/j.abb.2005.11.005; *NRC, 1994, HLTH EFF PERM IMPR A; Ross MK, 2006, BIOCHEM PHARMACOL, V71, P657, DOI 10.1016/j.bcp.2005.11.020; Sassine A, 2004, J ANAL TOXICOL, V28, P238, DOI 10.1093/jat/28.4.238; Schettgen T, 2002, TOXICOL LETT, V134, P141, DOI 10.1016/S0378-4274(02)00183-2; Scollon EJ, 2009, DRUG METAB DISPOS, V37, P221, DOI 10.1124/dmd.108.022343; SIDON EW, 1988, J TOXICOL ENV HEALTH, V23, P207, DOI 10.1080/15287398809531107; Sun H, 2007, CHEMOSPHERE, V66, P474, DOI 10.1016/j.chemosphere.2006.05.059; Tisch M, 2002, EUR ARCH OTO-RHINO-L, V259, P150, DOI 10.1007/s004050100406; Tomalik-Scharte D, 2005, EUR J CLIN PHARMACOL, V61, P399, DOI 10.1007/s00228-005-0932-7; Tornero-Velez R, 2012, TOXICOL SCI, V130, P33, DOI 10.1093/toxsci/kfs236; Tornero-Velez R, 2010, TOXICOL APPL PHARM, V244, P208, DOI 10.1016/j.taap.2009.12.034; Undeger U, 2005, ARCH TOXICOL, V79, P169, DOI 10.1007/s00204-004-0616-6; VANDERRHEE HJ, 1989, ACTA DERM-VENEREOL, V69, P170; Villarini M, 1998, TOXICOLOGY, V130, P129, DOI 10.1016/S0300-483X(98)00097-3; WOOLLEN BH, 1992, XENOBIOTICA, V22, P983, DOI 10.3109/00498259209049904; Zhang J, 2008, REPROD TOXICOL, V25, P491, DOI 10.1016/j.reprotox.2008.05.054	50	18	19	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e88517	10.1371/journal.pone.0088517	http://dx.doi.org/10.1371/journal.pone.0088517			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586336	Green Submitted, gold, Green Published			2022-12-27	WOS:000332389000013
J	Wang, C; Huang, CC; Qian, J; Xiao, J; Li, H; Wen, YL; He, XH; Ran, W; Shen, QR; Yu, GH				Wang, Chang; Huang, Chichao; Qian, Jian; Xiao, Jian; Li, Huan; Wen, Yongli; He, Xinhua; Ran, Wei; Shen, Qirong; Yu, Guanghui			Rapid and Accurate Evaluation of the Quality of Commercial Organic Fertilizers Using Near Infrared Spectroscopy	PLOS ONE			English	Article							REFLECTANCE SPECTROSCOPY; PIG MANURE; COMPOST; MATTER; STABILITY; PREDICT	The composting industry has been growing rapidly in China because of a boom in the animal industry. Therefore, a rapid and accurate assessment of the quality of commercial organic fertilizers is of the utmost importance. In this study, a novel technique that combines near infrared (NIR) spectroscopy with partial least squares (PLS) analysis is developed for rapidly and accurately assessing commercial organic fertilizers quality. A total of 104 commercial organic fertilizers were collected from full-scale compost factories in Jiangsu Province, east China. In general, the NIR-PLS technique showed accurate predictions of the total organic matter, water soluble organic nitrogen, pH, and germination index; less accurate results of the moisture, total nitrogen, and electrical conductivity; and the least accurate results for water soluble organic carbon. Our results suggested the combined NIR-PLS technique could be applied as a valuable tool to rapidly and accurately assess the quality of commercial organic fertilizers.	[Wang, Chang; Huang, Chichao; Qian, Jian; Xiao, Jian; Li, Huan; Wen, Yongli; Ran, Wei; Shen, Qirong; Yu, Guanghui] Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Natl Engn Res Ctr Organ Based Fertilizers, Nanjing, Jiangsu, Peoples R China; [He, Xinhua] Univ Western Australia, Sch Plant Biol, Crawley, Australia	Nanjing Agricultural University; University of Western Australia	Yu, GH (corresponding author), Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Natl Engn Res Ctr Organ Based Fertilizers, Nanjing, Jiangsu, Peoples R China.	yuguanghui@njau.edu.cn	He, Xinhua/B-8047-2015; Wang, Chang/E-5303-2019; Shen, Qirong/AAB-6531-2020; Yu, Guanghui/H-4968-2013	He, Xinhua/0000-0002-5570-3454; Wang, Chang/0000-0003-2217-5445; Yu, Guanghui/0000-0002-5699-779X	National Natural Science Foundation of China [41371248, 41371299]; National Basic Research Program of China [2011CB100503]; Natural Science Foundation of Jiangsu Province of China [BK20131321]; 111 Project [B12009]; Qing Lan Project, Innovative Research Team Development Plan of the Ministry of Education of China [IRT1256]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); 111 Project(Ministry of Education, China - 111 Project); Qing Lan Project, Innovative Research Team Development Plan of the Ministry of Education of China; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was funded by the National Natural Science Foundation of China (41371248 and 41371299), the National Basic Research Program of China (2011CB100503), the Natural Science Foundation of Jiangsu Province of China (BK20131321), the 111 Project (B12009), Qing Lan Project, Innovative Research Team Development Plan of the Ministry of Education of China (IRT1256), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht R, 2009, ENVIRON SCI TECHNOL, V43, P804, DOI 10.1021/es802064u; Albrecht R, 2008, BIORESOURCE TECHNOL, V99, P448, DOI 10.1016/j.biortech.2006.12.019; Bernal MP, 2009, BIORESOURCE TECHNOL, V100, P5444, DOI 10.1016/j.biortech.2008.11.027; Chang CW, 2001, SOIL SCI SOC AM J, V65, P480, DOI 10.2136/sssaj2001.652480x; Cozzolino D, 2003, J AGR SCI-CAMBRIDGE, V140, P65, DOI 10.1017/S0021859602002836; Fidencio PH, 2002, COMMUN SOIL SCI PLAN, V33, P1607, DOI 10.1081/CSS-120004302; Fluckiger M, 2011, FOOD CHEM, V126, P1817, DOI 10.1016/j.foodchem.2010.12.078; Francou U, 2005, COMPOST SCI UTIL, V13, P72; Fujiwara T, 2007, SOIL SCI PLANT NUTR, V53, P102, DOI 10.1111/j.1747-0765.2007.00109.x; Gajalakshmi S, 2008, CRIT REV ENV SCI TEC, V38, P311, DOI 10.1080/10643380701413633; Hayes DJM, 2012, BIORESOURCE TECHNOL, V119, P393, DOI 10.1016/j.biortech.2012.05.137; Huang G, 2007, J NEAR INFRARED SPEC, V15, P387, DOI 10.1255/jnirs.745; Lu W. Z., 2000, MODERN NEAR INFRARED; Malley DF, 2005, COMMUN SOIL SCI PLAN, V36, P455, DOI 10.1081/CSS-200043187; Meissl K, 2008, APPL SPECTROSC, V62, P873, DOI 10.1366/000370208785284277; Moral R, 2009, BIORESOURCE TECHNOL, V100, P5454, DOI 10.1016/j.biortech.2008.12.007; Moral R, 2007, P INT C ENV MAN ENG, P1683; Peltre C, 2011, SOIL BIOL BIOCHEM, V43, P197, DOI 10.1016/j.soilbio.2010.09.036; Saeys W, 2005, BIOSYST ENG, V91, P393, DOI 10.1016/j.biosystemseng.2005.05.001; Saeys W, 2004, J NEAR INFRARED SPEC, V12, P299, DOI 10.1255/jnirs.438; Said-Pullicino D, 2007, BIORESOURCE TECHNOL, V98, P1822, DOI 10.1016/j.biortech.2006.06.018; Soriano-Disla JM, 2010, GEODERMA, V158, P93, DOI 10.1016/j.geoderma.2009.12.022; Tang Z, 2011, CHEMOSPHERE, V82, P1202, DOI 10.1016/j.chemosphere.2010.11.032; Vernoux A, 2009, SCI TOTAL ENVIRON, V407, P2390, DOI 10.1016/j.scitotenv.2008.12.033; Xing L, 2008, POULTRY SCI, V87, P1281, DOI 10.3382/ps.2007-00464; Yang ZL, 2006, J NEAR INFRARED SPEC, V14, P261, DOI 10.1255/jnirs.643; Yu GH, 2011, WASTE MANAGE, V31, P1729, DOI 10.1016/j.wasman.2010.10.031; Yu GH, 2010, BIORESOURCE TECHNOL, V101, P8244, DOI 10.1016/j.biortech.2010.06.007	28	15	16	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e88279	10.1371/journal.pone.0088279	http://dx.doi.org/10.1371/journal.pone.0088279			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586313	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900009
J	Xue, WW; Yang, Y; Wang, XT; Liu, HX; Yao, XJ				Xue, Weiwei; Yang, Ying; Wang, Xiaoting; Liu, Huanxiang; Yao, Xiaojun			Computational Study on the Inhibitor Binding Mode and Allosteric Regulation Mechanism in Hepatitis C Virus NS3/4A Protein	PLOS ONE			English	Article							FREE-ENERGY CALCULATION; MOLECULAR-DYNAMICS; RESP METHODOLOGY; MM-PBSA; HCV NS3; DERIVATIVES; NETWORKS; COMMUNICATION; SIMULATIONS; RESISTANCE	HCV NS3/4A protein is an attractive therapeutic target responsible for harboring serine protease and RNA helicase activities during the viral replication. Small molecules binding at the interface between the protease and helicase domains can stabilize the closed conformation of the protein and thus block the catalytic function of HCV NS3/4A protein via an allosteric regulation mechanism. But the detailed mechanism remains elusive. Here, we aimed to provide some insight into the inhibitor binding mode and allosteric regulation mechanism of HCV NS3/4A protein by using computational methods. Four simulation systems were investigated. They include: apo state of HCV NS3/4A protein, HCV NS3/4A protein in complex with an allosteric inhibitor and the truncated form of the above two systems. The molecular dynamics simulation results indicate HCV NS3/4A protein in complex with the allosteric inhibitor 4VA adopts a closed conformation (inactive state), while the truncated apo protein adopts an open conformation (active state). Further residue interaction network analysis suggests the communication of the domain-domain interface play an important role in the transition from closed to open conformation of HCV NS3/4A protein. However, the inhibitor stabilizes the closed conformation through interaction with several key residues from both the protease and helicase domains, including His57, Asp79, Asp81, Asp168, Met485, Cys525 and Asp527, which blocks the information communication between the functional domains interface. Finally, a dynamic model about the allosteric regulation and conformational changes of HCV NS3/4A protein was proposed and could provide fundamental insights into the allosteric mechanism of HCV NS3/4A protein function regulation and design of new potent inhibitors.	[Xue, Weiwei; Wang, Xiaoting; Yao, Xiaojun] Lanzhou Univ, Dept Chem, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China; [Yang, Ying] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Yang, Ying] Peking Union Med Coll, Beijing 100021, Peoples R China; [Liu, Huanxiang] Lanzhou Univ, Sch Pharm, Lanzhou 730000, Peoples R China; [Yao, Xiaojun] Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Taipa, Macau, Peoples R China	Lanzhou University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Lanzhou University; Macau University of Science & Technology	Yao, XJ (corresponding author), Lanzhou Univ, Dept Chem, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China.	xjyao@lzu.edu.cn	Xue, Weiwei/C-7461-2016	Xue, Weiwei/0000-0002-3285-0574; Liu, Huanxiang/0000-0002-9284-3667	National Natural Science Foundation of China [21175063]; program for Changjiang Scholars and Innovative Research Team in University [PCSIRT: IRT1137]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China (Grant No. 21175063) and the program for Changjiang Scholars and Innovative Research Team in University (PCSIRT: IRT1137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; [Anonymous], 2008, AMBER 10; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Chiappori F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002844; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Ding SC, 2011, J VIROL, V85, P4343, DOI 10.1128/JVI.02130-10; Dixit A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002179; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Doncheva NT, 2011, TRENDS BIOCHEM SCI, V36, P179, DOI 10.1016/j.tibs.2011.01.002; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Fox T, 1998, J PHYS CHEM B, V102, P8070, DOI 10.1021/jp9717655; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Graham B, 2011, HEP DART 2011 KAUAI; GRAKOUI A, 1993, J VIROL, V67, P2832, DOI 10.1128/JVI.67.5.2832-2843.1993; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Huo SH, 2002, J MED CHEM, V45, P1412, DOI 10.1021/jm010338j; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; Ivetac A, 2009, J MOL BIOL, V388, P644, DOI 10.1016/j.jmb.2009.03.037; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klibanov OM, 2012, PHARMACOTHERAPY, V32, P173, DOI 10.1002/PHAR.1046; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kuhn B, 2005, J MED CHEM, V48, P4040, DOI 10.1021/jm049081q; Lam AMI, 2006, J VIROL, V80, P404, DOI 10.1128/JVI.80.1.404-411.2006; Li LW, 2007, J AM CHEM SOC, V129, P15668, DOI 10.1021/ja076046a; Lian P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018587; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; Matthews SJ, 2012, CLIN THER, V34, P1857, DOI 10.1016/j.clinthera.2012.07.011; Melnikova I, 2011, NAT REV DRUG DISCOV, V10, P93, DOI 10.1038/nrd3361; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Piggot TJ, 2012, BIOCHEMISTRY-US, V51, P1707, DOI 10.1021/bi201237a; Raney KD, 2010, J BIOL CHEM, V285, P22725, DOI 10.1074/jbc.R110.125294; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saalau-Bethell SM, 2011, LIV M SAN FRANC CA U; Saalau-Bethell SM, 2012, NAT CHEM BIOL, V8, P920, DOI [10.1038/NCHEMBIO.1081, 10.1038/nchembio.1081]; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen MY, 2013, MOL BIOSYST, V9, P2435, DOI 10.1039/c3mb70168a; Shen MY, 2013, MOL BIOSYST, V9, P361, DOI 10.1039/c2mb25408e; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Tan S. L, 2006, HEPATITIS C VIRUSES, P163; Thompson AJ, 2011, CURR OPIN VIROL, V1, P599, DOI 10.1016/j.coviro.2011.10.001; vanAalten DMF, 1995, PROTEIN ENG, V8, P1129; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; Wang JM, 2001, J AM CHEM SOC, V123, P5221, DOI 10.1021/ja003834q; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035159; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400; Wright DW, 2012, J AM CHEM SOC, V134, P12885, DOI 10.1021/ja301565k; Xu L, 2013, MOL BIOSYST, V9, P2107, DOI 10.1039/c3mb70120d; Xue WW, 2012, MOL BIOSYST, V8, P2753, DOI 10.1039/c2mb25157d; Xue WW, 2012, J COMPUT CHEM, V33, P527, DOI 10.1002/jcc.22887; Yang Y, 2011, J CHEM INF MODEL, V51, P3235, DOI 10.1021/ci200159g; Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8	63	20	20	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e87077	10.1371/journal.pone.0087077	http://dx.doi.org/10.1371/journal.pone.0087077			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586263	Green Published, Green Submitted, gold			2022-12-27	WOS:000332385900006
J	Fushing, H; Chen, SC; Hwang, CR				Fushing, Hsieh; Chen, Shu-Chun; Hwang, Chii-Ruey			Single Stock Dynamics on High-Frequency Data: From a Compressed Coding Perspective	PLOS ONE			English	Article							VOLUME; VOLATILITY; PHASES	High-frequency return, trading volume and transaction number are digitally coded via a nonparametric computing algorithm, called hierarchical factor segmentation (HFS), and then are coupled together to reveal a single stock dynamics without global state-space structural assumptions. The base-8 digital coding sequence, which is capable of revealing contrasting aggregation against sparsity of extreme events, is further compressed into a shortened sequence of state transitions. This compressed digital code sequence vividly demonstrates that the aggregation of large absolute returns is the primary driving force for stimulating both the aggregations of large trading volumes and transaction numbers. The state of system-wise synchrony is manifested with very frequent recurrence in the stock dynamics. And this data-driven dynamic mechanism is seen to correspondingly vary as the global market transiting in and out of contraction-expansion cycles. These results not only elaborate the stock dynamics of interest to a fuller extent, but also contradict some classical theories in finance. Overall this version of stock dynamics is potentially more coherent and realistic, especially when the current financial market is increasingly powered by high-frequency trading via computer algorithms, rather than by individual investors.	[Fushing, Hsieh] Univ Calif Davis, Davis, CA 95616 USA; [Chen, Shu-Chun; Hwang, Chii-Ruey] Acad Sinica, Inst Math, Taipei, Taiwan	University of California System; University of California Davis; Academia Sinica - Taiwan	Fushing, H (corresponding author), Univ Calif Davis, Davis, CA 95616 USA.	fhsieh@ucdavis.edu	Chanelian, Serena/ABE-4873-2021	Chanelian, Serena/0000-0001-5727-6137	NSF [DMS 1007219]	NSF(National Science Foundation (NSF))	This research was supported by NSF under grant DMS 1007219. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ane T, 2000, J FINANC, V55, P2259, DOI 10.1111/0022-1082.00286; BLACK F, 1973, J POLIT ECON, V81, P637, DOI 10.1086/260062; Chang LB, 2013, BULL INST MATH ACAD, V8, P31; Chang LB, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022116; Clark Carol, 2010, CHICAGO FED LETT, V272; Fushing H, 2006, J THEOR BIOL, V238, P805, DOI 10.1016/j.jtbi.2005.06.031; Fushing H, 2010, PSYCHOMETRIKA, V75, P351; Fushing H, 2009, INT J BIOSTATISTICS, V5; Fushing H, 2010, STAT BIOSCI, V2, P18, DOI 10.1007/s12561-010-9019-9; Fushing H, 2012, QUANT FINANC, V12, P213, DOI 10.1080/14697681003743040; Fushing H, 2010, J COMPUT GRAPH STAT, V19, P221, DOI 10.1198/jcgs.2009.07141; Fushing H, 2009, COMPUTATION STAT, V24, P409, DOI 10.1007/s00180-008-0134-8; GALLANT AR, 1992, REV FINANC STUD, V5, P199, DOI 10.1093/rfs/5.2.199; JONES CM, 1994, REV FINANC STUD, V7, P631, DOI 10.1093/rfs/7.4.631; KARPOFF JM, 1987, J FINANC QUANT ANAL, V22, P109, DOI 10.2307/2330874; TAUCHEN GE, 1983, ECONOMETRICA, V51, P485, DOI 10.2307/1912002	16	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e85018	10.1371/journal.pone.0085018	http://dx.doi.org/10.1371/journal.pone.0085018			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3VI	24586235	gold, Green Published, Green Submitted			2022-12-27	WOS:000331717900002
J	Vaz, MA; Martinez, JC; Devesa, JM; Trill, JD; Abraira, V; Riquelme, A; Carrato, A				Vaz, Maria Angeles; Martinez, Juan Carlos; Devesa, Jose Manuel; Trill, Javier Die; Abraira, Victor; Riquelme, Alejandro; Carrato, Alfredo			Prognostic Value of Stem Cell Quantification in Stage II Colon Cancer	PLOS ONE			English	Article							CD133 EXPRESSION; HEMATOPOIETIC STEM; EPITHELIAL-CELLS; POOR-PROGNOSIS; MARKER; AC133	Background: Cancer stem cells (CSCs) are a subset of tumor cells with capacity to self-renew and generate the diverse cells that make up the tumor. The aim of this study is to evaluate the prognostic value of CSCs in a highly homogeneous population of stage II colon cancer. Methods: One hundred stage II colon cancer patients treated by the same surgical team between 1977 and 2005 were retrospectively analyzed. None of the patients received adjuvant chemotherapy. Inmunohistochemistry expression of CD133, NANOG and CK20 was scored, using four levels: <10%, 11-25%, 26-50% and >50% positivity. Kaplan-Meier analysis and log rank test were used to compare survival. Results: The average patient age was 68 years (patients were between 45-92 years of age) and median follow up was 5.8 years. There was recurrent disease in 17 (17%); CD133 expression (defined by >10% positivity) was shown in 60% of the tumors, in 95% for NANOG and 78% for CK20. No correlation was found among expression levels of CD133, NANOG or CK20 and relapse-free survival (RFS) or overall survival (OS). However, a statistical significant correlation was found between established pathological prognostic factors and RFS and OS. Conclusions: Stem Cell quantification defined by CD133 and NANOG expression has no correlation with RFS or OS in this cohort of Stage II colon cancer.	[Vaz, Maria Angeles; Riquelme, Alejandro; Carrato, Alfredo] Ramon & Cajal Univ Hosp, Dept Med Oncol, Madrid, Spain; [Martinez, Juan Carlos] Hosp Univ G Maranon, Inst Oftalm, Dept Pathol, Madrid, Spain; [Devesa, Jose Manuel; Trill, Javier Die] Ramon & Cajal Univ Hosp, Dept Surg, Madrid, Spain; [Abraira, Victor] Ramon & Cajal Univ Hosp, Dept Stat, Madrid, Spain	Hospital Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal	Vaz, MA (corresponding author), Ramon & Cajal Univ Hosp, Dept Med Oncol, Madrid, Spain.	mavaz4@gmail.com	Martinez, Juan/GXM-4393-2022	CARRATO, ALFREDO/0000-0001-7749-8140; die trill, javier/0000-0003-2116-9190; Abraira, Victor/0000-0002-4615-8503				Arena V, 2011, ANTICANCER RES, V31, P4273; Coco C, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-71; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; Hibi K, 2009, HEPATO-GASTROENTEROL, V56, P995; Horst D, 2008, BRIT J CANCER, V99, P1285, DOI 10.1038/sj.bjc.6604664; Ishiguro T, 2012, BIOCHEM BIOPH RES CO, V418, P199, DOI 10.1016/j.bbrc.2011.10.123; Keysar SB, 2010, MOL CANCER THER, V9, P2450, DOI 10.1158/1535-7163.MCT-10-0530; Kojima M, 2008, CANCER SCI, V99, P1578, DOI 10.1111/j.1349-7006.2008.00849.x; Li CY, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-56; Mak A, 2011, J BIOL CHEM, V31, P4273; Marzesco AM, 2005, J CELL SCI, V118, P2849, DOI 10.1242/jcs.02439; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sgambato A, 2011, INT J CANCER, V128, P2247, DOI 10.1002/ijc.25551; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Wang ML, 2013, ONCOTARGETS THER, V6, P1207, DOI 10.2147/OTT.S38114; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zhang NH, 2012, EXP THER MED, V3, P973, DOI 10.3892/etm.2012.527	19	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e88480	10.1371/journal.pone.0088480	http://dx.doi.org/10.1371/journal.pone.0088480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586330	Green Submitted, Green Published, gold			2022-12-27	WOS:000331717900017
J	Boschetti, M; Nutini, F; Manfron, G; Brivio, PA; Nelson, A				Boschetti, Mirco; Nutini, Francesco; Manfron, Giacinto; Brivio, Pietro Alessandro; Nelson, Andrew			Comparative Analysis of Normalised Difference Spectral Indices Derived from MODIS for Detecting Surface Water in Flooded Rice Cropping Systems	PLOS ONE			English	Article							LANDSAT-TM; VEGETATION; CLASSIFICATION; NDWI; AGRICULTURE; FOREST; EXTENT; DATES; LAKES	Identifying managed flooding in paddy fields is commonly used in remote sensing to detect rice. Such flooding, followed by rapid vegetation growth, is a reliable indicator to discriminate rice. Spectral indices (SIs) are often used to perform this task. However, little work has been done on determining which spectral combination in the form of Normalised Difference Spectral Indices (NDSIs) is most appropriate for surface water detection or which thresholds are most robust to separate water from other surfaces in operational contexts. To address this, we conducted analyses on satellite and field spectral data from an agronomic experiment as well as on real farming situations with different soil and plant conditions. Firstly, we review and select NDSIs proposed in the literature, including a new combination of visible and shortwave infrared bands. Secondly, we analyse spectroradiometric field data and satellite data to evaluate mixed pixel effects. Thirdly, we analyse MODIS data and Landsat data at four sites in Europe and Asia to assess NDSI performance in real-world conditions. Finally, we test the performance of the NDSIs on MODIS temporal profiles in the four sites. We also compared the NDSIs against a combined index previously used for agronomic flood detection. Analyses suggest that NDSIs using MODIS bands 4 and 7, 1 and 7, 4 and 6 or 1 and 6 perform best. A common threshold for each NDSI across all sites was more appropriate than locally adaptive thresholds. In general, NDSIs that use band 7 have a negligible increase in Commission Error over those that use band 6 but are more sensitive to water presence in mixed land cover conditions typical of moderate spatial resolution analyses. The best performing NDSI is comparable to the combined index but with less variability in performance across sites, suggesting a more succinct and robust flood detection method.	[Boschetti, Mirco; Nutini, Francesco; Manfron, Giacinto; Brivio, Pietro Alessandro] CNR, Inst Electromagnet Sensing Environm, Milan, Italy; [Nutini, Francesco; Manfron, Giacinto] Univ Milan, Dept Agr & Environm Sci, Milan, Italy; [Nelson, Andrew] Int Rice Res Inst, Social Sci Div, Los Banos, Philippines	Consiglio Nazionale delle Ricerche (CNR); Istituto Per Il Rilevamento Elettromagnetico Dell'Ambiente (IREA-CNR); University of Milan; CGIAR; International Rice Research Institute (IRRI)	Boschetti, M (corresponding author), CNR, Inst Electromagnet Sensing Environm, Milan, Italy.	Boschetti.m@irea.cnr.it	Brivio, Pietro Alessandro/B-3704-2010; Nelson, Andy/G-3649-2012; nutini, francesco/P-9048-2018; Boschetti, Mirco/C-9351-2017	Brivio, Pietro Alessandro/0000-0002-5477-3194; Nelson, Andy/0000-0002-7249-3778; nutini, francesco/0000-0001-5430-5991; Boschetti, Mirco/0000-0003-2156-4166	RIICE (Remote Sensing based Information and Insurance for crops in emerging Economies); Swiss Agency for Development and Cooperation; GRiSP (Global Rice Science Partnership); CGIAR	RIICE (Remote Sensing based Information and Insurance for crops in emerging Economies); Swiss Agency for Development and Cooperation; GRiSP (Global Rice Science Partnership); CGIAR(CGIAR)	Funding for this research came from RIICE (Remote Sensing based Information and Insurance for crops in emerging Economies) funded by the Swiss Agency for Development and Cooperation (http://www.sdc.admin.ch) and from GRiSP (Global Rice Science Partnership) the CGIAR funded Research Program	Baret F, 2006, VGT4AFRICA USER MANU; Bocchi S, 2003, P 3 TEMP RIC C PUNT, P12; Bordogna G, 2012, ENVIRON MODELL SOFTW, P1, DOI [10.1016/j.envsoft.2012.03.016, DOI 10.1016/J.ENVS0FT.2012.03.016]; Boschetti L, 2004, REMOTE SENS ENVIRON, V91, P280, DOI 10.1016/j.rse.2004.02.015; Boschetti M, 2009, INT J REMOTE SENS, V30, P4643, DOI 10.1080/01431160802632249; Boschetti M., 2006, ITAL J AGROMETEOROL, V3, P40; Bouvet A, 2011, REMOTE SENS ENVIRON, V115, P1090, DOI 10.1016/j.rse.2010.12.014; Chen J, 2004, REMOTE SENS ENVIRON, V91, P332, DOI 10.1016/j.rse.2004.03.014; Cheralu C, 2011, STATUS PAPER RICE AN, P1; Chipman JW, 2007, INT J REMOTE SENS, V28, P4365, DOI 10.1080/01431160701241787; Fensholt R, 2003, REMOTE SENS ENVIRON, V87, P111, DOI 10.1016/j.rse.2003.07.002; Fischer G, 2009, P TECHN M EXP ROM IT; G20, 2011, CANN SUMM FIN DECL B, P20; Gao BC, 1996, REMOTE SENS ENVIRON, V58, P257, DOI 10.1016/S0034-4257(96)00067-3; Gerard F, 2003, IEEE T GEOSCI REMOTE, V41, P2575, DOI 10.1109/TGRS.2003.819190; Gond V, 2004, INT J REMOTE SENS, V25, P987, DOI 10.1080/0143116031000139908; Govaerts YM, 1999, INT J REMOTE SENS, V20, P1853, DOI 10.1080/014311699212524; Gumma MK, 2011, J APPL REMOTE SENS, V5, DOI 10.1117/1.3619838; HARDISKY MA, 1983, PHOTOGRAMM ENG REM S, V49, P77; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Ji L, 2011, INT J REMOTE SENS, V32, P6901, DOI 10.1080/01431161.2010.510811; Ji L, 2009, PHOTOGRAMM ENG REM S, V75, P1307, DOI 10.14358/PERS.75.11.1307; Key C.H., 1999, P JOINT FIRE SCI C W, P284; Lacaux JP, 2007, REMOTE SENS ENVIRON, V106, P66, DOI 10.1016/j.rse.2006.07.012; Licker R, 2010, GLOBAL ECOL BIOGEOGR, V19, P769, DOI 10.1111/j.1466-8238.2010.00563.x; Lobell DB, 2009, ANNU REV ENV RESOUR, V34, P179, DOI 10.1146/annurev.environ.041008.093740; Maclean JL, 2002, RICE ALMANAC, DOI [10.1093/aob/mcg189, DOI 10.1093/A0B/MCG189]; McFeeters SK, 1996, INT J REMOTE SENS, V17, P1425, DOI 10.1080/01431169608948714; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Nesbitt, 1997, RICE PRODUCTION CAMB; Ouma YO, 2006, INT J REMOTE SENS, V27, P3153, DOI 10.1080/01431160500309934; PALMER KF, 1974, J OPT SOC AM, V64, P1107, DOI 10.1364/JOSA.64.001107; Peng DL, 2011, INT J APPL EARTH OBS, V13, P13, DOI 10.1016/j.jag.2010.06.001; Pittman K, 2010, REMOTE SENS-BASEL, V2, P1844, DOI 10.3390/rs2071844; Portmann FT, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2008GB003435; RAMANKUTTY N, 2008, GLOBAL BIOGEOCHEM CY, V0022; Rogers AS, 2004, INT J REMOTE SENS, V25, P2317, DOI 10.1080/01431160310001618103; ROSENFIELD GH, 1986, PHOTOGRAMM ENG REM S, V52, P223; Rouse J.W., 1974, NASA GSFC TYPE 3 FIN, P1; Sacks WJ, 2010, GLOBAL ECOL BIOGEOGR, V19, P607, DOI 10.1111/j.1466-8238.2010.00551.x; Sakamoto T, 2007, REMOTE SENS ENVIRON, V109, P295, DOI 10.1016/j.rse.2007.01.011; Song C, 2001, REMOTE SENS ENVIRON, V75, P230, DOI 10.1016/S0034-4257(00)00169-3; Stroppiana D, 2012, IEEE GEOSCI REMOTE S, V9, P363, DOI 10.1109/LGRS.2011.2167953; Stroppiana D, 2009, FIELD CROP RES, V111, P119, DOI 10.1016/j.fcr.2008.11.004; Uchida S, 2007, 28 AS C REM SENS KUA, P5; Vina A, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023647; Vina A, 2011, IEEE GEOSCI REMOTE S, V8, P464, DOI 10.1109/LGRS.2010.2086430; Wilson EH, 2002, REMOTE SENS ENVIRON, V80, P385, DOI 10.1016/S0034-4257(01)00318-2; Xiao X, 2002, INT J REMOTE SENS, V23, P3009, DOI 10.1080/01431160110107734; Xiao XM, 2006, REMOTE SENS ENVIRON, V100, P95, DOI 10.1016/j.rse.2005.10.004; Xiao XM, 2005, REMOTE SENS ENVIRON, V95, P480, DOI 10.1016/j.rse.2004.12.009; Xu HQ, 2006, INT J REMOTE SENS, V27, P3025, DOI 10.1080/01431160600589179; You LZ, 2006, AGR SYST, V90, P329, DOI 10.1016/j.agsy.2006.01.008	53	120	119	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88741	10.1371/journal.pone.0088741	http://dx.doi.org/10.1371/journal.pone.0088741			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586381	Green Submitted, Green Published, gold			2022-12-27	WOS:000331714700026
J	Peterson, JM; Seldin, MM; Tan, SY; Wong, GW				Peterson, Jonathan M.; Seldin, Marcus M.; Tan, Stefanie Y.; Wong, G. William			CTRP2 Overexpression Improves Insulin and Lipid Tolerance in Diet-Induced Obese Mice	PLOS ONE			English	Article							ADIPOSE-TISSUE; GLUCOSE; ADIPOKINE; FAMILY; MUSCLE; INJURY	CTRP2 is a secreted plasma protein of the C1q family that enhances glycogen deposition and fat oxidation in cultured myotubes. Its in vivo metabolic function, however, has not been established. We show here that acute and chronic metabolic perturbations induced by fasting or high-fat feeding up-regulated the mRNA expression of Ctrp2 in white adipose tissue without affecting its circulating plasma levels. We generated a transgenic mouse model with elevated circulating levels of CTRP2 to determine its metabolic function in vivo. When fed a low-fat diet, wild-type and CTRP2 transgenic mice exhibited no metabolic phenotypes. When challenged with a high-fat diet to induce obesity, wild-type and CTRP2 transgenic mice had similar weight gain, adiposity, food intake, metabolic rate, and energy expenditure. Fasting serum lipid and adipokine profiles were also similar between the two groups of mice. However, while glucose and insulin levels in the fasted state were comparable between wild-type and CTRP2 transgenic mice, insulin levels in the fed state were consistently lower in transgenic mice. Notably, CTRP2 transgenic mice had improved insulin tolerance and a greater capacity to handle acute lipid challenge relative to littermate controls. Our results highlight, for the first time, the in vivo role of CTRP2 in modulating whole-body metabolism.	[Peterson, Jonathan M.; Seldin, Marcus M.; Tan, Stefanie Y.; Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Peterson, Jonathan M.; Seldin, Marcus M.; Tan, Stefanie Y.; Wong, G. William] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Wong, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	gwwong@jhmi.edu	Peterson, Jonathan M./H-3122-2019	Peterson, Jonathan M./0000-0002-9873-3880; Wong, G. William/0000-0002-5286-6506	National Institutes of Health [DK084171]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637, R01DK084171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded, in part, by a grant from the National Institutes of Health (DK084171) to GWW. SYT is supported by a predoctoral fellowship from the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byerly MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062862; Byerly MS, 2013, J BIOL CHEM IN PRESS; Cherrington AD, 1999, DIABETES, V48, P1198, DOI 10.2337/diabetes.48.5.1198; Enomoto T, 2011, J BIOL CHEM, V286, P34552, DOI 10.1074/jbc.M111.277319; Kambara T, 2012, J BIOL CHEM, V287, P18965, DOI 10.1074/jbc.M112.357939; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Lusk G, 1928, ELEMENTS SCI NUTR; Peterson JM, 2013, AM J PHYSIOL-REG I, V305, pR522, DOI 10.1152/ajpregu.00110.2013; Peterson JM, 2013, AM J PHYSIOL-GASTR L, V305, pG214, DOI 10.1152/ajpgi.00102.2013; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Seldin MM, 2013, REV ENDOCR IN PRESS; Su H, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0315-z; Uemura Y, 2013, FASEB J, V27, P25, DOI 10.1096/fj.12-213744; Wei ZK, 2013, J BIOL CHEM, V288, P10214, DOI 10.1074/jbc.M113.458711; Wei ZK, 2012, J BIOL CHEM, V287, P10301, DOI 10.1074/jbc.M111.303651; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Zheng QJ, 2011, ARTERIOSCL THROM VAS, V31, P2616, DOI 10.1161/ATVBAHA.111.231050	22	30	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88535	10.1371/journal.pone.0088535	http://dx.doi.org/10.1371/journal.pone.0088535			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586339	Green Published, gold			2022-12-27	WOS:000331714700021
J	Qin, YT; Zhang, Y; Wu, F; Su, Y; Lu, GN; Wang, RS				Qin, Yu-Tao; Zhang, Yong; Wu, Fang; Su, Yan; Lu, Ge-Ning; Wang, Ren-Sheng			Association between MTHFR Polymorphisms and Acute Myeloid Leukemia Risk: A Meta-Analysis	PLOS ONE			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE GENE; CHRONIC MYELOGENOUS LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; METABOLIZING-ENZYMES; FOLATE-DEFICIENCY; CANCER RISK; GENOTYPES; CHILDREN; ADENOMA; DNA	Previous observational studies investigating the association between methylenetetrahydrofolate reductase (MTHFR) polymorphisms and acute myeloid leukemia risk (AML) have yielded inconsistent results. The aim of this study is to derive a more precise estimation of the association between MTHFR (C677T and A1298C) polymorphisms and acute myeloid leukemia risk. PubMed and Embase databases were systematically searched to identify relevant studies from their inception to August 2013. Odds ratios (ORs) with 95% confidence intervals (CIs) were the metric of choice. Thirteen studies were selected for C677T polymorphism (1838 cases and 5318 controls) and 9 studies (1335 patients and 4295 controls) for A1298C polymorphism. Overall, pooled results showed that C677T polymorphism was not significant associated with AML risk(OR, 0.98-1.04; 95% CI, 0.86-0.92 to 1.09-1.25). Similar results were observed for the A1298C polymorphism and in subgroup analysis. All comparisons revealed no substantial heterogeneity nor did we detect evidence of publication bias. In summary, this meta-analysis provides evidence that MTHFR polymorphisms were not associated with AML risk. Further investigations are needed to offer better insight into the role of these polymorphisms in AML carcinogenesis.	[Qin, Yu-Tao; Zhang, Yong; Wu, Fang; Su, Yan; Lu, Ge-Ning; Wang, Ren-Sheng] Guangxi Med Univ, Affiliated Hosp 1, Dept Radiotherapy, Nanning, Guangxi, Peoples R China	Guangxi Medical University	Wang, RS (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Radiotherapy, Nanning, Guangxi, Peoples R China.	13807806008@163.com						Amorim M, 2008, PEDIATR HEMAT ONCOL, V25, P744, DOI 10.1080/08880010802435104; Ann Bishop L, 2009, BLOOD, V422; Barbosa CG, 2008, GENET MOL BIOL, V31, P29, DOI 10.1590/S1415-47572008000100005; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; Bolufer P, 2007, BRIT J HAEMATOL, V136, P590, DOI 10.1111/j.1365-2141.2006.06469.x; Bolufer P, 2007, HAEMATOLOGICA, V92, P308, DOI 10.3324/haematol.10752; Chen Bao-An, 2006, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V14, P1069; Chen J, 1999, J NUTR, V129, p560S, DOI 10.1093/jn/129.2.560S; Ramos FJD, 2006, LEUKEMIA LYMPHOMA, V47, P2070, DOI 10.1080/10428190600800132; Deeks JJ., 2020, COCHRANE HDB SYSTEMA, V1; Deligezer Ugur, 2003, Mol Diagn, V7, P181, DOI 10.2165/00066982-200307030-00007; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ding XP, 2012, ASIAN PAC J CANCER P, V13, P3937, DOI 10.7314/APJCP.2012.13.8.3937; Duthie SJ, 2002, J NUTR, V132, p2444S, DOI 10.1093/jn/132.8.2444S; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Giovannucci E, 2002, J NUTR, V132, p2350S, DOI 10.1093/jn/132.8.2350S; Greaves MF, 1997, LANCET, V349, P344, DOI 10.1016/S0140-6736(96)09412-3; Guenther BD, 1999, NAT STRUCT BIOL, V6, P359, DOI 10.1038/7594; Guillem VM, 2007, LEUKEMIA, V21, P1413, DOI 10.1038/sj.leu.2404709; Halsted C.H., 1995, FOLATE HLTH DIS, P313; Henderson E.S., 1990, HEMATOLOGY EDITORS, V4 th ed, P237; Hur M, 2006, CLIN LAB HAEMATOL, V28, P154, DOI 10.1111/j.1365-2257.2006.00769.x; Hussain SR, 2012, CANCER EPIDEMIOL, V36, pE227, DOI 10.1016/j.canep.2012.02.008; Kim HN, 2009, LEUKEMIA RES, V33, P82, DOI 10.1016/j.leukres.2008.07.026; Levine AJ, 2000, CANCER EPIDEM BIOMAR, V9, P657; Lightfoot TJ, 2010, BLOOD, V115, P3923, DOI 10.1182/blood-2009-10-249722; Moon HW, 2007, LEUKEMIA RES, V31, P1213, DOI 10.1016/j.leukres.2006.10.016; Niu YM, 2012, ASIAN PAC J CANCER P, V13, P3943, DOI 10.7314/APJCP.2012.13.8.3943; Pui CH, 2000, CURR OPIN ONCOL, V12, P3, DOI 10.1097/00001622-200001000-00002; Pui CH, 2006, CHILDHOOD LEUKEMIAS, 2ND EDITION, P1, DOI 10.1017/CBO9780511471001; Robien K, 2003, AM J EPIDEMIOL, V157, P571, DOI 10.1093/aje/kwg024; ROSS JA, 1994, EPIDEMIOL REV, V16, P243, DOI 10.1093/oxfordjournals.epirev.a036153; Savitskaya T, 2009, EJC SUPPL, V7, P571, DOI 10.1016/S1359-6349(09)71930-5; Sazawal S, 2010, INDIAN J HEMATOL BLO, V26, P148; Skibola CF, 1999, P NATL ACAD SCI USA, V96, P12810, DOI 10.1073/pnas.96.22.12810; Slattery ML, 1999, CANCER EPIDEM BIOMAR, V8, P513; Smith MT, 1998, ENVIRON HEALTH PERSP, V106, P937, DOI 10.2307/3434135; Sutton AJAK, 2000, METHODS METAANALYSIS; Teng Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055332; Ulrich CM, 1999, CANCER EPIDEM BIOMAR, V8, P659; Vahid P, 2010, LABMEDICINE, V41, P490, DOI 10.1309/LMA6H9RW9CKNLNDV; Wu Y, 2013, DNA CELL BIOL, V32, P260, DOI 10.1089/dna.2012.1931; Yamada K, 2001, P NATL ACAD SCI USA, V98, P14853, DOI 10.1073/pnas.261469998	43	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88823	10.1371/journal.pone.0088823	http://dx.doi.org/10.1371/journal.pone.0088823			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586405	gold, Green Submitted, Green Published			2022-12-27	WOS:000331714700034
J	Byrd, DT; Knobel, K; Affeldt, K; Crittenden, SL; Kimble, J				Byrd, Dana T.; Knobel, Karla; Affeldt, Katharyn; Crittenden, Sarah L.; Kimble, Judith			A DTC Niche Plexus Surrounds the Germline Stem Cell Pool in Caenorhabditis elegans	PLOS ONE			English	Article							RNA-BINDING PROTEIN; C-ELEGANS; MITOTIC REGION; SIGNALING LIGAND; LINE; GLP-1; GLD-1; DIFFERENTIATION; DECISION; PROGRESSION	The mesenchymal distal tip cell (DTC) provides the niche for Caenorhabditis elegans germline stem cells (GSCs). The DTC has a complex cellular architecture: its cell body caps the distal gonadal end and contacts germ cells extensively, but it also includes multiple cellular processes that extend along the germline tube and intercalate between germ cells. Here we use the lag-2 DTC promoter to drive expression of myristoylated GFP, which highlights DTC membranes and permits a more detailed view of DTC architecture. We find that short processes intercalating between germ cells contact more germ cells than seen previously. We define this region of extensive niche contact with germ cells as the DTC plexus. The extent of the DTC plexus corresponds well with the previously determined extent of the GSC pool. Moreover, expression of a differentiation marker increases as germ cells move out of the plexus. Maintenance of this DTC plexus depends on the presence of undifferentiated germ cells, suggesting that germ cell state can influence niche architecture. The roles of this DTC architecture remain an open question. One idea is that the DTC plexus delivers Notch signaling to the cluster of germ cells comprising the GSC pool; another idea is that the plexus anchors GSCs at the distal end.	[Byrd, Dana T.; Crittenden, Sarah L.; Kimble, Judith] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Byrd, Dana T.; Knobel, Karla; Affeldt, Katharyn; Kimble, Judith] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Kimble, Judith] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; [Kimble, Judith] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kimble, J (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA.	jekimble@wisc.edu			National Institute of Health postdoctoral fellowship [F32 GM072126]; National Institutes of Health [R01 GM069454]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM072126, R01GM069454] Funding Source: NIH RePORTER	National Institute of Health postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	DTB was supported by National Institute of Health postdoctoral fellowship F32 GM072126. JK is supported by National Institutes of Health grant R01 GM069454 and is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2011, SCIENCE, V332, P312, DOI 10.1126/science.1205971; Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; Bachorik JL, 2005, P NATL ACAD SCI USA, V102, P10893, DOI 10.1073/pnas.0504593102; Blelloch R, 1999, NATURE, V399, P586, DOI 10.1038/21196; BRENNER S, 1974, GENETICS, V77, P71; Byrd DT, 2009, SEMIN CELL DEV BIOL, V20, P1107, DOI 10.1016/j.semcdb.2009.09.005; Chen SY, 2011, CURR OPIN GENET DEV, V21, P684, DOI 10.1016/j.gde.2011.07.008; Cinquin O, 2010, P NATL ACAD SCI USA, V107, P2048, DOI 10.1073/pnas.0912704107; Cohen M, 2010, DEV CELL, V19, P78, DOI 10.1016/j.devcel.2010.06.006; Crittenden SL, 2006, MOL BIOL CELL, V17, P3051, DOI 10.1091/mbc.E06-03-0170; Crittenden SL, 2002, NATURE, V417, P660, DOI 10.1038/nature754; CRITTENDEN SL, 1994, DEVELOPMENT, V120, P2901; Dalfo D, 2012, CURR BIOL, V22, P712, DOI 10.1016/j.cub.2012.02.064; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Eckmann CR, 2004, GENETICS, V168, P147, DOI 10.1534/genetics.104.029264; Eckmann CR, 2002, DEV CELL, V3, P697, DOI 10.1016/S1534-5807(02)00322-2; Finger FP, 2003, DEV BIOL, V261, P220, DOI 10.1016/S0012-1606(03)00296-3; Fitzgerald K, 1995, DEVELOPMENT, V121, P4275; Fox PM, 2011, DEVELOPMENT, V138, P2223, DOI 10.1242/dev.059535; FRANCIS R, 1995, GENETICS, V139, P579; Gradilla AC, 2013, CELL TISSUE RES, V352, P59, DOI 10.1007/s00441-013-1578-x; Hall DH, 1999, DEV BIOL, V212, P101, DOI 10.1006/dbio.1999.9356; Hansen D, 2004, DEVELOPMENT, V131, P93, DOI 10.1242/dev.00916; Henderson ST, 1997, MOL BIOL CELL, V8, P1751, DOI 10.1091/mbc.8.9.1751; HENDERSON ST, 1994, DEVELOPMENT, V120, P2913; HODGKIN J, 1979, GENETICS, V91, P67; Hubbard EJA, 2007, DEV DYNAM, V236, P3343, DOI 10.1002/dvdy.21335; Jones AR, 1996, DEV BIOL, V180, P165, DOI 10.1006/dbio.1996.0293; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Kershner A, 2013, ADV EXP MED BIOL, V786, P29, DOI 10.1007/978-94-007-6621-1_3; Kim HS, 2011, DEVELOPMENT, V138, P4013, DOI 10.1242/dev.059568; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Kirilly D, 2011, DEVELOPMENT, V138, P5087, DOI 10.1242/dev.067850; Kraemer B, 1999, CURR BIOL, V9, P1009, DOI 10.1016/S0960-9822(99)80449-7; Lamont LB, 2004, DEV CELL, V7, P697, DOI 10.1016/j.devcel.2004.09.013; Lander AD, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-19; Lehmann R, 2012, CELL STEM CELL, V10, P729, DOI 10.1016/j.stem.2012.05.016; Lints R., 2009, REPROD SYSTEM SOMATI; Morgan DE, 2010, DEV BIOL, V346, P204, DOI 10.1016/j.ydbio.2010.07.022; Morris LX, 2011, DEVELOPMENT, V138, P2207, DOI 10.1242/dev.065508; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nadarajan S, 2009, DEVELOPMENT, V136, P2223, DOI 10.1242/dev.034603; Oatley JM, 2012, PHYSIOL REV, V92, P577, DOI 10.1152/physrev.00025.2011; Peters EC, 2013, G3-GENES GENOM GENET, V3, P181, DOI 10.1534/g3.112.004416; Rasband W., 2006, IMAGEJ; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Rojas-Rios P, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001298; Schumacher B, 2005, CELL, V120, P357, DOI 10.1016/j.cell.2004.12.009; Tsien RY, 2005, FEBS LETT, V579, P927, DOI 10.1016/j.febslet.2004.11.025; Voronina E, 2012, DEVELOPMENT, V139, P3732, DOI 10.1242/dev.083980; Wong BG, 2013, INTEGR BIOL-UK, V5, P976, DOI 10.1039/c3ib20291g; Wong MC, 2012, WIRES DEV BIOL, V1, P519, DOI 10.1002/wdev.45; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297	54	43	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88372	10.1371/journal.pone.0088372	http://dx.doi.org/10.1371/journal.pone.0088372			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586318	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900026
J	Ellam, T; Hameed, A; ul Haque, R; Muthana, M; Wilkie, M; Francis, SE; Chico, TJA				Ellam, Timothy; Hameed, Abdul; ul Haque, Risat; Muthana, Munitta; Wilkie, Martin; Francis, Sheila E.; Chico, Timothy J. A.			Vitamin D Deficiency and Exogenous Vitamin D Excess Similarly Increase Diffuse Atherosclerotic Calcification in Apolipoprotein E Knockout Mice	PLOS ONE			English	Article							CORONARY-ARTERY CALCIFICATION; D-RECEPTOR ACTIVATORS; 25-HYDROXYVITAMIN D; VASCULAR-DISEASE; CARDIOVASCULAR MORTALITY; MYOCARDIAL-INFARCTION; CARDIAC-HYPERTROPHY; KIDNEY-DISEASE; UNITED-STATES; OLDER-ADULTS	Background: Observational data associate lower levels of serum vitamin D with coronary artery calcification, cardiovascular events and mortality. However, there is little interventional evidence demonstrating that moderate vitamin D deficiency plays a causative role in cardiovascular disease. This study examined the cardiovascular effects of dietary vitamin D deficiency and of vitamin D receptor agonist (paricalcitol) administration in apolipoprotein E knockout mice. Methods: Mice were fed atherogenic diets with normal vitamin D content (1.5IU/kg) or without vitamin D. Paricalcitol, or matched vehicle, was administered 36 weekly by intraperitoneal injection. Following 20 weeks of these interventions cardiovascular phenotype was characterized by histological assessment of aortic sinus atheroma, soluble markers, blood pressure and echocardiography. To place the cardiovascular assessments in the context of intervention effects on bone, structural changes at the tibia were assessed by microtomography. Results: Vitamin D deficient diet induced significant reductions in plasma vitamin D (p<0.001), trabecular bone volume (p<0.01) and bone mineral density (p<0.005). These changes were accompanied by an increase in calcification density (number of calcifications per mm(2)) of von Kossa- stained aortic sinus atheroma (461 versus 200, p<0.01). Paricalcitol administration suppressed parathyroid hormone (p<0.001), elevated plasma calcium phosphate product (p<0.005) and induced an increase in calcification density (472 versus 200, p<0.005) similar to that seen with vitamin D deficiency. Atheroma burden, blood pressure, metabolic profile and measures of left ventricular hypertrophy were unaffected by the interventions. Conclusion: Vitamin D deficiency, as well as excess, increases atherosclerotic calcification. This phenotype is induced before other measures of cardiovascular pathology associated clinically with vitamin D deficiency. Thus, maintenance of an optimal range of vitamin D signalling may be important for prevention of atherosclerotic calcification.	[Ellam, Timothy; Hameed, Abdul; Francis, Sheila E.; Chico, Timothy J. A.] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England; [Ellam, Timothy; Wilkie, Martin] No Gen Hosp, Sheffield Kidney Inst, Sheffield S5 7AU, S Yorkshire, England; [ul Haque, Risat; Muthana, Munitta] Univ Sheffield, Dept Infect & Immun, Sheffield, S Yorkshire, England	University of Sheffield; Northern General Hospital; University of Sheffield	Ellam, T (corresponding author), Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England.	T.Ellam@sheffield.ac.uk	Hameed, Abdul/O-1782-2019	Hameed, Abdul/0000-0002-2128-2081; Haque, Md Risat Ul/0000-0003-1513-459X; Francis, Sheila/0000-0001-6552-0339; Chico, Timothy/0000-0002-7458-5481	British Heart Foundation Clinical Research Training Fellowship [FS/11/74/29015]; British Heart Foundation [FS/11/74/29015] Funding Source: researchfish	British Heart Foundation Clinical Research Training Fellowship; British Heart Foundation(British Heart Foundation)	TE is supported by a British Heart Foundation (www.bhf.org.uk) Clinical Research Training Fellowship FS/11/74/29015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bas A, 2006, J BONE MINER RES, V21, P484, DOI 10.1359/JBMR.051211; Becker LE, 2011, AM J PHYSIOL-RENAL, V300, pF772, DOI 10.1152/ajprenal.00042.2010; Bischoff-Ferrari HA, 2004, AM J MED, V116, P634, DOI 10.1016/j.amjmed.2003.12.029; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Bouillon R, 2013, J CLIN ENDOCR METAB, V98, pE1283, DOI 10.1210/jc.2013-1195; Brondum-Jacobsen P, 2013, ANN NEUROL, V73, P38, DOI 10.1002/ana.23738; Chen SC, 2011, CIRCULATION, V124, P1838, DOI 10.1161/CIRCULATIONAHA.111.032680; Chen SC, 2010, J STEROID BIOCHEM, V122, P326, DOI 10.1016/j.jsbmb.2010.08.007; de Boer IH, 2009, J AM SOC NEPHROL, V20, P1805, DOI 10.1681/ASN.2008111157; Deb DK, 2010, KIDNEY INT, V77, P1000, DOI 10.1038/ki.2010.22; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Elamin MB, 2011, J CLIN ENDOCR METAB, V96, P1931, DOI 10.1210/jc.2011-0398; Ellam T, 2011, ARTERIOSCL THROM VAS, V31, P1988, DOI 10.1161/ATVBAHA.111.231001; Ellam TJ, 2012, ATHEROSCLEROSIS, V220, P310, DOI 10.1016/j.atherosclerosis.2011.09.002; Fiscella K, 2010, ANN FAM MED, V8, P11, DOI 10.1370/afm.1035; Giallauria F, 2012, J CLIN ENDOCRINOL ME; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Gross ML, 2007, CLIN J AM SOC NEPHRO, V2, P121, DOI 10.2215/CJN.01760506; Jablonski KL, 2011, HYPERTENSION, V57, P63, DOI 10.1161/HYPERTENSIONAHA.110.160929; Jorde R, 2012, CIRCULATION, V126, P252, DOI 10.1161/CIRCULATIONAHA.112.119693; Karakas M, 2013, J CLIN ENDOCR METAB, V98, P272, DOI 10.1210/jc.2012-2368; LaClair RE, 2005, AM J KIDNEY DIS, V45, P1026, DOI 10.1053/j.ajkd.2005.02.029; Lau WL, 2012, KIDNEY INT, V82, P1261, DOI 10.1038/ki.2012.322; Li XW, 2010, ARTERIOSCL THROM VAS, V30, P321, DOI 10.1161/ATVBAHA.109.196576; Martins D, 2007, ARCH INTERN MED, V167, P1159, DOI 10.1001/archinte.167.11.1159; Mathew S, 2008, J AM SOC NEPHROL, V19, P1509, DOI 10.1681/ASN.2007080902; Nelson CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015469; Omdahl JL, 2002, ANNU REV NUTR, V22, P139, DOI 10.1146/annurev.nutr.22.120501.150216; Pilz S, 2008, STROKE, V39, P2611, DOI 10.1161/STROKEAHA.107.513655; Pilz S, 2009, NAT REV CARDIOL, V6, P621, DOI 10.1038/nrcardio.2009.135; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; Scatena M, 2007, ARTERIOSCL THROM VAS, V27, P2302, DOI 10.1161/ATVBAHA.107.144824; Schmidt N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035316; Shen HQ, 2010, ARTERIOSCL THROM VAS, V30, P2648, DOI 10.1161/ATVBAHA.110.211805; Shroff R, 2008, J AM SOC NEPHROL, V19, P1239, DOI 10.1681/ASN.2007090993; Szeto FL, 2012, MOL ENDOCRINOL, V26, P1091, DOI 10.1210/me.2011-1329; Takeda M, 2010, ARTERIOSCL THROM VAS, V30, P2495, DOI 10.1161/ATVBAHA.110.215459; Talmor Y, 2008, AM J PHYSIOL-RENAL, V294, pF1059, DOI 10.1152/ajprenal.00051.2008; Verstuyf A, 2010, KIDNEY INT, V78, P140, DOI 10.1038/ki.2010.17; Watson KE, 1997, CIRCULATION, V96, P1755, DOI 10.1161/01.CIR.96.6.1755; Weng S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054625; Xiang W, 2005, AM J PHYSIOL-ENDOC M, V288, pE125, DOI 10.1152/ajpendo.00224.2004; Zhou SH, 2010, ENDOCRINOLOGY, V151, P14, DOI 10.1210/en.2009-0969	44	31	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88767	10.1371/journal.pone.0088767	http://dx.doi.org/10.1371/journal.pone.0088767			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586387	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900046
J	Shigemura, J; Tanigawa, T; Nishi, D; Matsuoka, Y; Nomura, S; Yoshino, A				Shigemura, Jun; Tanigawa, Takeshi; Nishi, Daisuke; Matsuoka, Yutaka; Nomura, Soichiro; Yoshino, Aihide			Associations between Disaster Exposures, Peritraumatic Distress, and Posttraumatic Stress Responses in Fukushima Nuclear Plant Workers following the 2011 Nuclear Accident: The Fukushima NEWS Project Study	PLOS ONE			English	Article							MENTAL-HEALTH; INVENTORY; DISORDER; PTSD; PREDICTORS	Background: The 2011 Fukushima Daiichi Nuclear Power Plant accident was the worst nuclear disaster since Chernobyl. The nearby Daini plant also experienced substantial damage but remained intact. Workers for the both plants experienced multiple stressors as disaster victims and workers, as well as the criticism from the public due to their company's post-disaster management. Little is known about the psychological pathway mechanism from nuclear disaster exposures, distress during and immediately after the event (peritraumatic distress; PD), to posttraumatic stress responses (PTSR). Methods: A self-report questionnaire was administered to 1,411 plant employees (Daiichi, n = 831; Daini, n = 580) 2-3 months post-disaster (total response rate: 80.2%). The socio-demographic characteristics and disaster-related experiences were assessed as independent variables. PD and PTSR were measured by the Japanese versions of Peritraumatic Distress Inventory and the Impact of Event Scale-Revised, respectively. The analysis was conducted separately for the two groups. Bivariate regression analyses were performed to assess the relationships between independent variables, PD, and PTSR. Significant variables were subsequently entered in the multiple regression analyses to explore the pathway mechanism for development of PTSR. Results: For both groups, PTSR highly associated with PD (Daiichi: adjusted beta, 0.66; p<0.001; vs. Daini: adjusted beta, 0.67; p<0.001). PTSR also associated with discrimination/slurs experience (Daiichi: 0.11; p<0.001; vs. Daini, 0.09; p = 0.005) and presence of preexisting illness(es) (Daiichi: 0.07; p = 0.005; vs. Daini: 0.15; p<.0001). Other disaster-related variables were likely to be associated with PD than PTSR. Conclusion: Among the Fukushima nuclear plant workers, disaster exposures associated with PD. PTSR was highly affected by PD along with discrimination/slurs experience.	[Shigemura, Jun; Nomura, Soichiro; Yoshino, Aihide] Natl Def Med Coll, Dept Psychiat, Tokorozawa, Saitama 359, Japan; [Tanigawa, Takeshi] Ehime Univ, Grad Sch Med, Dept Publ Hlth, Toon, Ehime, Japan; [Nishi, Daisuke] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Mental Hlth Policy & Evaluat, Kodaira, Tokyo, Japan; [Matsuoka, Yutaka] Natl Ctr Neurol & Psychiat, Translat Med Ctr, Dept Clin Epidemiol, Kodaira, Tokyo, Japan; [Matsuoka, Yutaka] Natl Disaster Med Ctr, Dept Psychiat, Tachikawa, Tokyo, Japan	National Defense Medical College - Japan; Ehime University; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan	Shigemura, J (corresponding author), Natl Def Med Coll, Dept Psychiat, Tokorozawa, Saitama 359, Japan.	shige@ndmc.ac.jp	Matsuoka, Yutaka/N-1588-2019; Shigemura, Jun/ACX-4803-2022; Nishi, Daisuke/AAH-7211-2019	Matsuoka, Yutaka/0000-0002-8690-8129; Shigemura, Jun/0000-0002-7907-5034; Nishi, Daisuke/0000-0001-9349-3294	Health and Labour Sciences Research Grants (Research on Occupational Safety and Health) [H24-001, 25-H24-001]; Ministry of Health Labour and Welfare of Japan; Core Research for Evolutional Science and Technology (CREST); Japan Science and Technology Agency	Health and Labour Sciences Research Grants (Research on Occupational Safety and Health); Ministry of Health Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was partly supported by Health and Labour Sciences Research Grants (Research on Occupational Safety and Health H24-001 and 25-H24-001) from the Ministry of Health Labour and Welfare of Japan and by Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th, DOI [DOI 10.1176/APPI.BOOKS.9780890425596, DOI 10.1016/B978-0-12-809324-5.05530-9]; Association A.P., 2000, DIAGN STAT MAN MENT, VFourth; Bromet EJ, 2011, CLIN ONCOL-UK, V23, P297, DOI 10.1016/j.clon.2011.01.501; Bromet EJ, 2007, HEALTH PHYS, V93, P516, DOI 10.1097/01.HP.0000279635.14108.02; Brunet A, 2001, AM J PSYCHIAT, V158, P1480, DOI 10.1176/appi.ajp.158.9.1480; Gill DA, 2012, AM BEHAV SCI, V56, P3, DOI 10.1177/0002764211408585; Karam EG, 2010, BIOL PSYCHIAT, V68, P465, DOI 10.1016/j.biopsych.2010.04.032; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Lawyer SR, 2006, PSYCHIATRY, V69, P130, DOI 10.1521/psyc.2006.69.2.130; Loganovsky K, 2008, PSYCHOL MED, V38, P481, DOI 10.1017/S0033291707002371; Muralidharan S, 2011, PUBLIC RELAT REV, V37, P226, DOI 10.1016/j.pubrev.2011.04.006; Nishi D, 2010, PSYCHIAT CLIN NEUROS, V64, P149, DOI 10.1111/j.1440-1819.2010.02065.x; Nishi D, 2009, GEN HOSP PSYCHIAT, V31, P75, DOI 10.1016/j.genhosppsych.2008.09.002; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Peleg T, 2006, CNS SPECTRUMS, V11, P589, DOI 10.1017/S109285290001364X; Perko Tanja, 2011, Integrated Environmental Assessment and Management, V7, P388, DOI 10.1002/ieam.230; Shigemura J, 2012, JAMA-J AM MED ASSOC, V308, P667, DOI 10.1001/jama.2012.9699; Shigemura J, 2012, AM J PSYCHIAT, V169, P784, DOI 10.1176/appi.ajp.2012.12030387; Tanimoto T, 2012, LANCET, V379, pE34, DOI 10.1016/S0140-6736(12)60394-8; Weiss Daniel S., 1997, P399	21	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e87516	10.1371/journal.pone.0087516	http://dx.doi.org/10.1371/journal.pone.0087516			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3TA	24586278	Green Submitted, gold, Green Published			2022-12-27	WOS:000331711900013
J	Kim, YY; Moon, JS; Kwon, MC; Shin, J; Im, SK; Kim, HA; Han, JK; Kong, YY				Kim, Yoon-Young; Moon, Jin-Sook; Kwon, Min-chul; Shin, Juhee; Im, Sun-Kyoung; Kim, Hyun-A; Han, Jin-Kwan; Kong, Young-Yun			Meteorin Regulates Mesendoderm Development by Enhancing Nodal Expression	PLOS ONE			English	Article							RIGHT ASYMMETRIC EXPRESSION; ANTERIOR VISCERAL ENDODERM; EMBRYONIC STEM-CELLS; MESODERM FORMATION; PROMOTES DIFFERENTIATION; MOUSE; ANTAGONISTS; INDUCTION; EPIBLAST; ACTIVIN	During gastrulation, distinct lineage specification into three germ layers, the mesoderm, endoderm and ectoderm, occurs through an elaborate harmony between signaling molecules along the embryonic proximo-distal and anterior-posterior axes, and Nodal signaling plays a key role in the early embryonic development governing embryonic axis formation, mesoderm and endoderm specification, and left-right asymmetry determination. However, the mechanism by which Nodal expression is regulated is largely unknown. Here, we show that Meteorin regulates Nodal expression and is required for mesendoderm development. It is highly expressed in the inner cell mass of blastocysts and further in the epiblast and extra-embryonic ectoderm during gastrulation. Genetic ablation of the Meteorin gene resulted in early embryonic lethality, presumably due to impaired lineage allocation and subsequent cell accumulation. Embryoid body culture using Meteorin-null embryonic stem (ES) cells showed reduced Nodal expression and concomitant impairment of mesendoderm specification. Meteorin-null embryos displayed reduced levels of Nodal transcripts before the gastrulation stage, and impaired expression of Goosecoid, a definitive endoderm marker, during gastrulation, while the proximo-distal and anterior-posterior axes and primitive streak formation were preserved. Our results show that Meteorin is a novel regulator of Nodal transcription and is required to maintain sufficient Nodal levels for endoderm formation, thereby providing new insights in the regulation of mesendoderm allocation.	[Kim, Yoon-Young; Shin, Juhee; Im, Sun-Kyoung; Kim, Hyun-A; Kong, Young-Yun] Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Seoul 151742, South Korea; [Kim, Yoon-Young; Moon, Jin-Sook; Kwon, Min-chul; Shin, Juhee; Im, Sun-Kyoung; Han, Jin-Kwan] POSTECH, Dept Life Sci, Div Mol & Life Sci, Pohang, South Korea	Seoul National University (SNU); Pohang University of Science & Technology (POSTECH)	Kong, YY (corresponding author), Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Seoul 151742, South Korea.	ykong@snu.ac.kr		Moon, Jin-Sook/0000-0002-7231-328X	National Research Foundation of Korea (RND) [2013003731]; National R&D Program for Cancer Control, Ministry of Health & Welfare, the Republic of Korea (RND) [0920310]; Bio & Medical Technology Development Program of the National Research Foundation (NRF); Korean government (MEST) (RND) [2013037841]; Global Frontier Project grant (RND) of the National Research Foundation [2013045940]; Ministry of Education, Science and Technology of Korea	National Research Foundation of Korea (RND)(National Research Foundation of Korea); National R&D Program for Cancer Control, Ministry of Health & Welfare, the Republic of Korea (RND); Bio & Medical Technology Development Program of the National Research Foundation (NRF)(National Research Foundation of Korea); Korean government (MEST) (RND)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Global Frontier Project grant (RND) of the National Research Foundation(National Research Foundation of Korea); Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (RND no. 2013003731); National R&D Program for Cancer Control, Ministry of Health & Welfare, the Republic of Korea (RND no. 0920310); Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MEST) (RND no. 2013037841); and a Global Frontier Project grant (RND no. 2013045940) of the National Research Foundation funded by the Ministry of Education, Science and Technology of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 1999, GENE DEV, V13, P1589, DOI 10.1101/gad.13.12.1589; Agius E, 2000, DEVELOPMENT, V127, P1173; Ben-Haim N, 2006, DEV CELL, V11, P313, DOI 10.1016/j.devcel.2006.07.005; Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; Camus A, 2006, DEV BIOL, V295, P743, DOI 10.1016/j.ydbio.2006.03.047; Chen Y, 2001, NATURE, V411, P607, DOI 10.1038/35079121; CONLON FL, 1994, DEVELOPMENT, V120, P1919; Dunn NR, 2004, DEVELOPMENT, V131, P1717, DOI 10.1242/dev.01072; Hescheler J, 1997, CARDIOVASC RES, V36, P149, DOI 10.1016/S0008-6363(97)00193-4; Hudson C, 1997, CELL, V91, P397, DOI 10.1016/S0092-8674(00)80423-7; Jeong HW, 2009, J CLIN INVEST, V119, P3290, DOI 10.1172/JCI38416; Jorgensen JR, 2012, EXP NEUROL, V237, P260, DOI 10.1016/j.expneurol.2012.06.027; Jorgensen JR, 2011, NEUROBIOL DIS, V41, P160, DOI 10.1016/j.nbd.2010.09.003; Jorgensen JR, 2009, J MOL NEUROSCI, V39, P104, DOI 10.1007/s12031-009-9189-4; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Lawson KA, 1999, INT J DEV BIOL, V43, P773; Lee HS, 2010, J CELL SCI, V123, P1959, DOI 10.1242/jcs.063784; Lowe LA, 2001, DEVELOPMENT, V128, P1831; Lowe LA, 1996, NATURE, V381, P158, DOI 10.1038/381158a0; Mansergh FC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-5; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Mesnard D, 2006, DEVELOPMENT, V133, P2497, DOI 10.1242/dev.02413; Nagi A, 2003, MANIPULATING MOUSE E; Nishino J, 2004, EMBO J, V23, P1998, DOI 10.1038/sj.emboj.7600202; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Perea-Gomez A, 2002, DEV CELL, V3, P745, DOI 10.1016/S1534-5807(02)00321-0; Pfendler KC, 2005, STEM CELLS DEV, V14, P162, DOI 10.1089/scd.2005.14.162; Rodriguez TA, 2005, DEVELOPMENT, V132, P2513, DOI 10.1242/dev.01847; Saijoh Y, 2000, MOL CELL, V5, P35, DOI 10.1016/S1097-2765(00)80401-3; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Takenaga M, 2007, J CELL SCI, V120, P2078, DOI 10.1242/jcs.004127; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Thisse B, 2000, NATURE, V403, P425, DOI 10.1038/35000200; Varlet I, 1997, DEVELOPMENT, V124, P1033; Vincent SD, 2003, GENE DEV, V17, P1646, DOI 10.1101/gad.1100503; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Yamamoto M, 2004, NATURE, V428, P387, DOI 10.1038/nature02418; Yamamoto M, 2001, GENE DEV, V15, P1242, DOI 10.1101/gad.883901; Yasuo H, 1999, CURR BIOL, V9, P869, DOI 10.1016/S0960-9822(99)80391-1; ZHOU XL, 1993, NATURE, V361, P543, DOI 10.1038/361543a0	42	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88811	10.1371/journal.pone.0088811	http://dx.doi.org/10.1371/journal.pone.0088811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558432	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700078
J	Rodehacke, S; Mennigen, E; Muller, KU; Ripke, S; Jacob, MJ; Hubner, T; Schmidt, DHK; Goschke, T; Smolka, MN				Rodehacke, Sarah; Mennigen, Eva; Mueller, Kathrin U.; Ripke, Stephan; Jacob, Mark J.; Huebner, Thomas; Schmidt, Dirk H. K.; Goschke, Thomas; Smolka, Michael N.			Interindividual Differences in Mid-Adolescents in Error Monitoring and Post-Error Adjustment	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL; PREFRONTAL CORTEX; RESPONSE-INHIBITION; DEVELOPMENTAL FMRI; CONFLICT; TASK; PERFORMANCE; CHILDHOOD; ADULTHOOD	A number of studies have concluded that cognitive control is not fully established until late adolescence. The precise differences in brain function between adults and adolescents with respect to cognitive control, however, remain unclear. To address this issue, we conducted a study in which 185 adolescents (mean age (SD) 14.6 (0.3) years) and 28 adults (mean age (SD) 25.2 (6.3) years) performed a single task that included both a stimulus-response (S-R) interference component and a task-switching component. Behavioural responses (i.e. reaction time, RT; error rate, ER) and brain activity during correct, error and post-error trials, detected by functional magnetic resonance imaging (fMRI), were measured. Behaviourally, RT and ER were significantly higher in incongruent than in congruent trials and in switch than in repeat trials. The two groups did not differ in RT during correct trials, but adolescents had a significantly higher ER than adults. In line with similar RTs, brain responses during correct trials did not differ between groups, indicating that adolescents and adults engage the same cognitive control network to successfully overcome S-R interference or task switches. Interestingly, adolescents with stronger brain activation in the bilateral insulae during error trials and in fronto-parietal regions of the cognitive control network during post-error trials did have lower ERs. This indicates that those mid-adolescents who commit fewer errors are better at monitoring their performance, and after detecting errors are more capable of flexibly allocating further cognitive control resources. Although we did not detect a convincing neural correlate of the observed behavioural differences between adolescents and adults, the revealed interindividual differences in adolescents might at least in part be due to brain development.	[Rodehacke, Sarah; Mennigen, Eva; Mueller, Kathrin U.; Ripke, Stephan; Jacob, Mark J.; Huebner, Thomas; Schmidt, Dirk H. K.; Smolka, Michael N.] Tech Univ Dresden, Neuroimaging Ctr, D-01062 Dresden, Germany; [Rodehacke, Sarah; Mennigen, Eva; Mueller, Kathrin U.; Ripke, Stephan; Jacob, Mark J.; Huebner, Thomas; Schmidt, Dirk H. K.; Smolka, Michael N.] Tech Univ Dresden, Dept Psychiat & Psychotherapy, D-01062 Dresden, Germany; [Goschke, Thomas] Tech Univ Dresden, Dept Psychol, Inst Gen Psychol Biopsychol & Methods Psychol, D-01062 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden	Smolka, MN (corresponding author), Tech Univ Dresden, Neuroimaging Ctr, D-01062 Dresden, Germany.	michael.smolka@tu-dresden.de	Ripke, Stephan/AAK-5486-2021; Goschke, Thomas/I-2479-2014; Smolka, Michael/B-4865-2011; Mennigen, Eva/ABE-2117-2021	Smolka, Michael/0000-0001-5398-5569; Mennigen, Eva/0000-0001-5099-0274; Jurk, Sarah/0000-0003-2501-8058	German Ministry of Education and Research [BMBF 01EV0711]; IMAGEN project of the European Commission [PL037286]	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); IMAGEN project of the European Commission	This research was supported by grant # BMBF 01EV0711 (German Ministry of Education and Research) and by the IMAGEN project (PL037286) of the European Commission's 6th Framework Program (FP6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2009, NEUROSCI LETT, V463, P167, DOI 10.1016/j.neulet.2009.07.077; Adleman NE, 2002, NEUROIMAGE, V16, P61, DOI 10.1006/nimg.2001.1046; ALLPORT A, 1994, ATTENTION PERFORM, V15, P421; Anokhin AP, 2010, NEUROSCI LETT, V472, P119, DOI 10.1016/j.neulet.2010.01.067; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braet W, 2009, NEUROPSYCHOLOGIA, V47, P3143, DOI 10.1016/j.neuropsychologia.2009.07.018; Brass M, 2005, J COGNITIVE NEUROSCI, V17, P1367, DOI 10.1162/0898929054985400; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Casey BJ, 2000, P NATL ACAD SCI USA, V97, P8728, DOI 10.1073/pnas.97.15.8728; Church JA, 2010, HUM BRAIN MAPP, V31, P852, DOI 10.1002/hbm.21036; Cole MW, 2007, NEUROIMAGE, V37, P343, DOI 10.1016/j.neuroimage.2007.03.071; Critchley HD, 2005, NEUROIMAGE, V27, P885, DOI 10.1016/j.neuroimage.2005.05.047; Crone EA, 2006, J NEUROSCI, V26, P11239, DOI 10.1523/JNEUROSCI.2165-06.2006; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Egner T, 2007, COGN AFFECT BEHAV NE, V7, P380, DOI 10.3758/CABN.7.4.380; Fischer R, 2008, J EXP PSYCHOL LEARN, V34, P712, DOI 10.1037/0278-7393.34.3.712; Fitzgerald KD, 2010, NEUROIMAGE, V49, P3463, DOI 10.1016/j.neuroimage.2009.11.004; Giedd JN, 2009, J AM ACAD CHILD PSY, V48, P465, DOI 10.1097/CHI.0b013e31819f2715; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909; Goschke T, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P331; Gruber O, 2004, ACTA PSYCHOL, V115, P105, DOI 10.1016/j.actpsy.2003.12.003; Gruber O, 2006, NEUROIMAGE, V31, P887, DOI 10.1016/j.neuroimage.2005.12.043; Hester R, 2004, CEREB CORTEX, V14, P986, DOI 10.1093/cercor/bhh059; Hyafil A, 2009, J NEUROSCI, V29, P5135, DOI 10.1523/JNEUROSCI.2828-08.2009; Jonkman LM, 2006, BRAIN RES, V1097, P181, DOI 10.1016/j.brainres.2006.04.064; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kiesel A, 2010, PSYCHOL BULL, V136, P849, DOI 10.1037/a0019842; King JA, 2010, J NEUROSCI, V30, P12759, DOI 10.1523/JNEUROSCI.3274-10.2010; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; LEVIN HS, 1991, DEV NEUROPSYCHOL, V7, P377, DOI 10.1080/87565649109540499; Liston C, 2006, NEURON, V50, P643, DOI 10.1016/j.neuron.2006.04.015; Mansouri FA, 2009, NAT REV NEUROSCI, V10, P141, DOI 10.1038/nrn2538; Marsh R, 2006, HUM BRAIN MAPP, V27, P848, DOI 10.1002/hbm.20225; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Pochon JB, 2008, J NEUROSCI, V28, P3468, DOI 10.1523/JNEUROSCI.4195-07.2008; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rubia K, 2007, HUM BRAIN MAPP, V28, P1163, DOI 10.1002/hbm.20347; Rubia K, 2006, HUM BRAIN MAPP, V27, P973, DOI 10.1002/hbm.20237; Rudolf M, 2004, MULTIVARIATE VERFAHR; Ruge H, 2013, HUM BRAIN MAPP, V34, P12, DOI 10.1002/hbm.21420; Schweizer TA, 2007, J COGNITIVE NEUROSCI, V19, P1974, DOI 10.1162/jocn.2007.19.12.1974; Simoes-Franklin C, 2010, HUM BRAIN MAPP, V31, P458, DOI 10.1002/hbm.20879; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Stevens MC, 2009, HUM BRAIN MAPP, V30, P24, DOI 10.1002/hbm.20478; Takezawa T, 2005, PSYCHOL REP, V97, P515, DOI 10.2466/pr0.97.2.515-526; Taylor SF, 2007, NEUROSCIENTIST, V13, P160, DOI 10.1177/1073858406298184; Ullsperger M, 2005, COGN AFFECT BEHAV NE, V5, P467, DOI 10.3758/CABN.5.4.467; Ullsperger M, 2004, CORTEX, V40, P593, DOI 10.1016/S0010-9452(08)70155-2; Ullsperger M, 2010, BRAIN STRUCT FUNCT, V214, P629, DOI 10.1007/s00429-010-0261-1; Velanova K, 2008, CEREB CORTEX, V18, P2505, DOI 10.1093/cercor/bhn012; Wittchen H-U, 1997, COMMUNICATION; Wittfoth M, 2009, NEUROIMAGE, V44, P1201, DOI 10.1016/j.neuroimage.2008.09.026; Yeung N, 2006, J NEUROSCI, V26, P1429, DOI 10.1523/JNEUROSCI.3109-05.2006	60	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88957	10.1371/journal.pone.0088957	http://dx.doi.org/10.1371/journal.pone.0088957			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3RA	24558455	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700101
J	Silberbush, A; Tsurim, I; Rosen, R; Margalith, Y; Ovadia, O				Silberbush, Alon; Tsurim, Ido; Rosen, Ran; Margalith, Yoel; Ovadia, Ofer			Species-Specific Non-Physical Interference Competition among Mosquito Larvae	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; INTRASPECIFIC COMPETITION; CULISETA-LONGIAREOLATA; DEVELOPMENT TIME; DENSITY; CULICIDAE; SIZE; VECTOR; GROWTH; DISPLACEMENT	Individuals of different sex, size or developmental stage can compete differently and hence contribute distinctively to population dynamics. In species with complex life cycles such as insects, competitive ability is often positively correlated with larval developmental stage. Yet, little is known on how the development and survival of early-instars is influenced by interference from late-instar larvae, especially at low densities when exploitative competition is expected to be negligible. Furthermore, the specificity and mechanisms by which interference competition operates are largely unknown. We performed two complementary experiments aiming to quantify the competitive effects of late instar Ochlerotatus caspius on early instar larvae at low densities and under high resource supply rate. The first experiment examined the net effect of interference by 4th on 1st instar O. caspius larvae, relative to the effect of 1st instars on themselves. The second experiment examined the effect of species-specific, non-physical interference competition (i.e., cage larvae) by 4th on 1st instar O. caspius larvae at low or high densities. Specifically, we compared the responses of O. caspius larvae raised in the presence of caged con-or hetero-specific, Culiseta longiareolata, with that of larvae in the empty-cage control group. As expected, interference from late instar larvae had a net negative effect on the development rate of first instars. In contrast, the presence of caged con-specifics (non-physical interference) accelerated the development rate of O. caspius, however, this pattern was only evident at the low density. Notably, no such pattern was detected in the presence of caged hetero-specifics. These results strongly suggest the existence of species-specific growth regulating semiochemicals.	[Silberbush, Alon; Tsurim, Ido; Margalith, Yoel; Ovadia, Ofer] Ben Gurion Univ Negev, Dept Life Sci, Ctr Biol Control, IL-84105 Beer Sheva, Israel; [Tsurim, Ido] Achva Acad Coll, Dept Life Sci, Arugot, Israel; [Rosen, Ran] Agr Res Org, Volcani Ctr, Dept Entomol, IL-50250 Bet Dagan, Israel	Ben Gurion University; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Silberbush, A (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, Ctr Biol Control, IL-84105 Beer Sheva, Israel.	alonsil@gmail.com	Silberbush, Alon/AAD-3650-2021; Silberbush, Alon/GPP-6599-2022	Silberbush, Alon/0000-0002-8762-6836; Ovadia, Ofer/0000-0002-4941-4947; Tsurim, Ido/0000-0002-8510-3089				Alto BW, 2009, J ANIM ECOL, V78, P928, DOI 10.1111/j.1365-2656.2009.01558.x; Amr ZS, 1997, J AM MOSQUITO CONTR, V13, P375; BARBOSA P, 1973, ENTOMOL EXP APPL, V16, P146, DOI 10.1007/BF00290687; Bedhomme S, 2003, J EVOLUTION BIOL, V16, P721, DOI 10.1046/j.1420-9101.2003.00576.x; BLAUSTEIN L, 1993, ECOL ENTOMOL, V18, P104, DOI 10.1111/j.1365-2311.1993.tb01190.x; BLAUSTEIN L, 1994, J ANIM ECOL, V63, P841, DOI 10.2307/5261; Boggs CL, 2009, FUNCT ECOL, V23, P27, DOI 10.1111/j.1365-2435.2009.01527.x; Bradshaw WE, 1997, ECOLOGY, V78, P969, DOI 10.1890/0012-9658(1997)078[0969:HODTAP]2.0.CO;2; BROADIE KS, 1991, ECOL ENTOMOL, V16, P145, DOI 10.1111/j.1365-2311.1991.tb00203.x; Carron A., 2007, European Mosquito Bulletin, P4; Claessen D, 2000, AM NAT, V155, P219, DOI 10.1086/303315; Costanzo KS, 2005, ECOLOGY, V86, P3289, DOI 10.1890/05-0583; Crossland MR, 2012, BIOL LETTERS, V8, P226, DOI 10.1098/rsbl.2011.0794; De Roos AM, 2003, ECOL LETT, V6, P473, DOI 10.1046/j.1461-0248.2003.00458.x; Dieng H, 2002, MED VET ENTOMOL, V16, P285, DOI 10.1046/j.1365-2915.2002.00377.x; EDGERLY JS, 1992, J ANIM ECOL, V61, P139, DOI 10.2307/5517; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Ginzburg L. R., 2004, ECOLOGICAL ORBITS PL; Gleiser RM, 2000, ENTOMOL EXP APPL, V95, P135, DOI 10.1023/A:1003994321769; Grether GF, 2009, BIOL REV, V84, P617, DOI 10.1111/j.1469-185X.2009.00089.x; Gross EM, 2012, CHEMICAL ECOLOGY IN AQUATIC SYSTEMS, P196; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Juliano SA, 2009, ANNU REV ENTOMOL, V54, P37, DOI 10.1146/annurev.ento.54.110807.090611; Keddy P., 2001, COMPETITION; Lack D.L., 1971, ECOLOGICAL ISOLATION; Legros M, 2009, J MED ENTOMOL, V46, P409, DOI 10.1603/033.046.0301; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lurling M, 2003, J PLANKTON RES, V25, P967, DOI 10.1093/plankt/25.8.967; Maciá Arnaldo, 2009, Rev. Soc. Entomol. Argent., V68, P107; Mahmood F, 1997, J VECTOR ECOL, V22, P90; MARGALIT J, 1973, ISRAEL J ZOOL, V22, P27; Miller TX, 2011, TRENDS ECOL EVOL, V26, P183; Moll JD, 2008, AM NAT, V171, P839, DOI 10.1086/587517; MOORE CG, 1969, ANN ENTOMOL SOC AM, V62, P1325, DOI 10.1093/aesa/62.6.1325; MORI A, 1979, Tropical Medicine, V21, P85; Morin P., 1999, COMMUNITY ECOL; Muriu SM, 2013, J ANIM ECOL, V82, P166, DOI 10.1111/1365-2656.12002; Muturi EJ, 2010, ACTA TROP, V116, P141, DOI 10.1016/j.actatropica.2010.07.003; Ng'habi KR, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-49; Persson L, 1998, THEOR POPUL BIOL, V54, P270, DOI 10.1006/tpbi.1998.1380; PETERS TM, 1969, MOSQ NEWS, V29, P667; RAJAGOPALAN PK, 1976, INDIAN J MED RES, V64, P688; Rasband WS, 2011, IMAGEJ; REISEN WK, 1975, MOSQ NEWS, V35, P473; Reitz SR, 2002, ANNU REV ENTOMOL, V47, P435, DOI 10.1146/annurev.ento.47.091201.145227; RENSHAW M, 1993, ECOL ENTOMOL, V18, P223, DOI 10.1111/j.1365-2311.1993.tb01094.x; Roberts D, 1998, J MED ENTOMOL, V35, P665, DOI 10.1093/jmedent/35.5.665; Roberts D, 2010, ENTOMOL EXP APPL, V135, P271, DOI 10.1111/j.1570-7458.2010.00993.x; Roiz D, 2007, J VECTOR ECOL, V32, P10, DOI 10.3376/1081-1710(2007)32[10:ASOMBI]2.0.CO;2; Royama T., 1992, ANAL POPULATION ECOL; Shaalan E. A., 2012, Journal of Entomology, V9, P183, DOI 10.3923/je.2012.183.186; Shalaby A.M., 1972, Bulletin Soc Ent Egypte, V56, P301; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; SIDDIQUI T F, 1976, Tropical Medicine, V18, P195; Sokal RR, 1995, BIOMETRY PRINCIPLES; Suleman Mohammad, 1993, Pakistan Journal of Zoology, V25, P321; Telang A, 2007, J EXP BIOL, V210, P854, DOI 10.1242/jeb.02715; Tseng M, 2004, P ROY SOC B-BIOL SCI, V271, pS186, DOI 10.1098/rsbl.2003.0139; Tsurim I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057875; Turchin Peter, 2003, Monographs in Population Biology, V35, pi	61	11	11	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88650	10.1371/journal.pone.0088650	http://dx.doi.org/10.1371/journal.pone.0088650			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558406	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700052
J	Wang, C; Yu, JT; Wang, HF; Jiang, T; Tan, CC; Meng, XF; Soares, HD; Tan, L				Wang, Chong; Yu, Jin-Tai; Wang, Hui-Fu; Jiang, Teng; Tan, Chen-Chen; Meng, Xiang-Fei; Soares, Holly D.; Tan, Lan			Meta-Analysis of Peripheral Blood Apolipoprotein E Levels in Alzheimer's Disease	PLOS ONE			English	Article							SERUM CONCENTRATION; APOE LEVELS; POLYMORPHISM; DIAGNOSIS; BIOMARKERS; GENOTYPE; RISK	Background: Peripheral blood Apolipoprotein E (ApoE) levels have been proposed as biomarkers of Alzheimer's disease (AD), but previous studies on levels of ApoE in blood remain inconsistent. This meta-analysis was designed to re-examine the potential role of peripheral ApoE in AD diagnosis and its potential value as a candidate biomarker. Methods: We conducted a systematic literature search of MEDLINE, EMBASE, the Cochrane library, and BIOSIS previews for case-control studies measuring ApoE levels in serum or plasma from AD subjects and healthy controls. The pooled weighted mean difference (WMD) and 95% confidence interval (CI) were used to estimate the association between ApoE levels and AD risk. Results: Eight studies with a total of 2250 controls and 1498 AD cases were identified and analyzed. The pooled WMD from a random-effect model of AD participants compared with the healthy controls was -5.59 mg/l (95% CI: [-8.12, -3.06]). The overall pattern in WMD was not varied by characteristics of study, including age, country, assay method, publication year, and sample type. Conclusions: Our meta-analysis supports a lowered level of blood ApoE in AD patients, and indicates its potential value as an important risk factor for AD. Further investigation employing standardized assay for ApoE measurement are still warranted to uncover the precise role of ApoE in the pathophysiology of AD.	[Wang, Chong; Yu, Jin-Tai; Tan, Chen-Chen; Meng, Xiang-Fei; Tan, Lan] Qingdao Univ, Sch Med, Qingdao Municipal Hosp, Dept Neurol, Qingdao 266071, Shandong, Peoples R China; [Yu, Jin-Tai; Wang, Hui-Fu; Jiang, Teng; Tan, Lan] Nanjing Med Univ, Qingdao Municipal Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Yu, Jin-Tai; Tan, Lan] Ocean Univ China, Coll Med & Pharmaceut, Qingdao, Shandong, Peoples R China; [Soares, Holly D.] Bristol Myers Squibb, Wallingford Ctr, CT USA	Qingdao Municipal Hospital; Qingdao University; Nanjing Medical University; Ocean University of China; Bristol-Myers Squibb	Yu, JT (corresponding author), Qingdao Univ, Sch Med, Qingdao Municipal Hosp, Dept Neurol, Qingdao 266071, Shandong, Peoples R China.	yu-jintai@163.com; dr.tanlan@163.com	Yu, Jin-Tai/HDL-7766-2022; Meng, Xiangfei/I-6715-2019	Yu, Jin-Tai/0000-0002-7686-0547	National Natural Science Foundation of China [81000544, 81171209, 81371406]; Shandong Provincial Natural Science Foundation, China [ZR2010HQ004, ZR2011HZ001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province)	This work was supported by grants from the National Natural Science Foundation of China (81000544, 81171209, 81371406) and Shandong Provincial Natural Science Foundation, China (ZR2010HQ004, ZR2011HZ001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Doecke JD, 2012, ARCH NEUROL-CHICAGO, V69, P1318, DOI 10.1001/archneurol.2012.1282; Drzezga A, 2008, NEUROIMAGE, V39, P619, DOI 10.1016/j.neuroimage.2007.09.020; Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533; Ewers M, 2010, EXP GERONTOL, V45, P75, DOI 10.1016/j.exger.2009.09.005; Fan P, 2001, Hua Xi Yi Ke Da Xue Xue Bao, V32, P389; Guo LH, 2013, ALZ DIS ASSOC DIS, V27, P337, DOI 10.1097/WAD.0b013e31827b60d2; Gupta VB, 2011, NEUROLOGY, V76, P1091, DOI 10.1212/WNL.0b013e318211c352; Hauser PS, 2011, PROG LIPID RES, V50, P62, DOI 10.1016/j.plipres.2010.09.001; Hu WT, 2012, NEUROLOGY, V79, P897, DOI 10.1212/WNL.0b013e318266fa70; Jiang T, 2013, CURR ALZHEIMER RES, V10, P852; Jiang T, 2012, J ALZHEIMERS DIS, V31, P475, DOI 10.3233/JAD-2012-120640; Johnstone D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034341; Kuo YM, 1998, BIOCHEM BIOPH RES CO, V252, P711, DOI 10.1006/bbrc.1998.9652; Neale MC, 2000, GENET EPIDEMIOL, V18, P331, DOI 10.1002/(SICI)1098-2272(200004)18:4<331::AID-GEPI6>3.0.CO;2-V; O'Bryant SE, 2010, ARCH NEUROL-CHICAGO, V67, P1077, DOI 10.1001/archneurol.2010.215; Panza F, 2003, NEUROREPORT, V14, P605, DOI 10.1097/00001756-200303240-00016; Perneczky R, 2011, NEUROLOGY, V77, P35, DOI 10.1212/WNL.0b013e318221ad47; PETERSEN RC, 1995, JAMA-J AM MED ASSOC, V273, P1274, DOI 10.1001/jama.273.16.1274; Pfrieger FW, 2003, BBA-BIOMEMBRANES, V1610, P271, DOI 10.1016/S0005-2736(03)00024-5; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Roks G, 2002, AM J MED GENET, V114, P570, DOI 10.1002/ajmg.10407; Salmon DP, 2001, CLIN GERIATR MED, V17, P229, DOI 10.1016/S0749-0690(05)70067-7; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Scacchi R, 1999, NEUROSCI LETT, V259, P33, DOI 10.1016/S0304-3940(98)00889-1; Schiele F, 2000, ATHEROSCLEROSIS, V152, P475, DOI 10.1016/S0021-9150(99)00501-8; Siest G, 2000, CLIN CHEM LAB MED, V38, P721, DOI 10.1515/CCLM.2000.102; Simon R, 2012, MOL CELL PROTEOMICS, V11, P1389, DOI 10.1074/mcp.M112.018861; Slooter AJC, 1998, NEUROSCI LETT, V248, P21, DOI 10.1016/S0304-3940(98)00339-5; Soares HD, 2012, ARCH NEUROL-CHICAGO, V69, P1310, DOI 10.1001/archneurol.2012.1070; Song F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034078; Song FJ, 2001, EVAL HEALTH PROF, V24, P126, DOI 10.1177/01632780122034849; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stratman NC, 2005, CHEM PHYS LIPIDS, V137, P52, DOI 10.1016/j.chemphyslip.2005.06.005; Taddei K, 1997, NEUROSCI LETT, V223, P29, DOI 10.1016/S0304-3940(97)13394-8; Tangirala RK, 2001, J BIOL CHEM, V276, P261, DOI 10.1074/jbc.M003324200; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208; van Vliet P, 2009, NEUROLOGY, V73, P681, DOI 10.1212/WNL.0b013e3181b59c2e; Vincent-Viry M, 1998, CLIN CHEM, V44, P957; Yasuno F, 2012, NEUROBIOL AGING, V33, P2633, DOI 10.1016/j.neurobiolaging.2011.12.028	40	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89041	10.1371/journal.pone.0089041	http://dx.doi.org/10.1371/journal.pone.0089041			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558469	gold, Green Published, Green Submitted			2022-12-27	WOS:000331706700115
J	Zhang, WD; Zhang, FB; Shi, HC; Tan, RB; Han, S; Ye, G; Pan, S; Sun, F; Liu, XC				Zhang, Weidong; Zhang, Fangbiao; Shi, Hongcan; Tan, Rongbang; Han, Shi; Ye, Gang; Pan, Shu; Sun, Fei; Liu, Xingchen			Comparisons of Rabbit Bone Marrow Mesenchymal Stem Cell Isolation and Culture Methods In Vitro	PLOS ONE			English	Article							STROMAL CELLS; SCALE EXPANSION; ANIMAL SERUM; DIFFERENTIATION; BLOOD; LYSIS; TRANSPLANTATION; REGENERATION; HEPATOCYTES; INDUCTION	Bone marrow mesenchymal stem cells (BMSCs) have great potential in tissue engineering and clinical therapy, and various methods for isolation and cultivation of BMSCs have been reported. However, the best techniques are still uncertain. Therefore, we sought the most suitable among the four most common methods for BMSC separation from rabbits. BMSCs were obtained from untreated whole bone marrow (BM) adherent cultures, 3 volumes of red blood cells (RBC) lysed with ammonium chloride, 6 volumes of RBC lysed with ammonium chloride, and Ficoll density gradient centrifugation. Then, isolated BMSCs were evaluated with respect to primary cell yield, number of CFU-F colonies, proliferative capacity, cell phenotype, and chondrogenic differentiation potential. Our data show that BMSCs were successfully isolated by all four methods, and each method was similar with regard to cell morphology, phenotype, and differentiation potential. However, BMSCs from untreated whole BM adherent cultures had greater primary cell yields, larger colonies, and the shortest primary culture time (P<0.05). Moreover, the 4th generation of cultured cells had the strongest proliferative activity, the fastest growth rate and the most numerous cells compared with other cell passage generations (P<0.05). In conclusion, untreated whole BM adherent cultures are best for rabbit BMSC isolation and the 4th generation of cells has the strongest proliferation capacity.	[Zhang, Weidong; Zhang, Fangbiao; Shi, Hongcan; Tan, Rongbang; Han, Shi; Ye, Gang; Pan, Shu; Sun, Fei; Liu, Xingchen] Yangzhou Univ, Coll Clin Med, Dept Cardiothorac Surg, Yangzhou, Jiangsu, Peoples R China; [Zhang, Weidong; Zhang, Fangbiao; Shi, Hongcan; Tan, Rongbang; Han, Shi; Ye, Gang; Pan, Shu; Sun, Fei; Liu, Xingchen] Yangzhou Univ, Res Ctr Translat Med, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University	Shi, HC (corresponding author), Yangzhou Univ, Coll Clin Med, Dept Cardiothorac Surg, Yangzhou, Jiangsu, Peoples R China.	shihongcan@hotmail.com		Shi, Hongcan/0000-0002-2029-7150	National Natural Science Foundation of China [81170014, 81370118]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by The National Natural Science Foundation of China (no. 81170014, 81370118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Battah F, 2011, TOXICOL IN VITRO, V25, P1224, DOI 10.1016/j.tiv.2011.05.024; Berndt-Weis ML, 2009, TOXICOL IN VITRO, V23, P816, DOI 10.1016/j.tiv.2009.04.008; Bobis S, 2006, FOLIA HISTOCHEM CYTO, V44, P215; Conget PA, 1999, J CELL PHYSIOL, V181, P67, DOI 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.0.CO;2-C; Crisan M, 2013, STEM CELL RES THER, V4, DOI [10.1186/1757-6512-4-95, 10.1186/scrt306]; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Feng ZH, 2011, HEPATO-GASTROENTEROL, V58, P2081, DOI 10.5754/hge11220; Foster LJ, 2005, STEM CELLS, V23, P1367, DOI 10.1634/stemcells.2004-0372; Fukumoto T, 2003, OSTEOARTHR CARTILAGE, V11, P55, DOI 10.1053/joca.2002.0869; Heino TJ, 2008, CURR STEM CELL RES T, V3, P131, DOI 10.2174/157488808784223032; Horn P, 2008, CYTOTHERAPY, V10, P676, DOI 10.1080/14653240802398845; Horn P, 2011, METHODS MOL BIOL, V698, P23, DOI 10.1007/978-1-60761-999-4_3; Huang Q, 2009, CHINESE MED J-PEKING, V122, P83, DOI 10.3760/cma.j.issn.0366-6999.2009.01.015; Jarocha D, 2008, FOLIA HISTOCHEM CYTO, V46, P307, DOI 10.2478/v10042-008-0046-z; Jones E, 2008, RHEUMATOLOGY, V47, P126, DOI 10.1093/rheumatology/kem206; Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7; Karagianni M, 2013, CYTOTHERAPY, V15, P76, DOI 10.1016/j.jcyt.2012.11.001; Lee JW, 2009, EXPERT OPIN BIOL TH, V9, P1259, DOI 10.1517/14712590903213651; Liu P, 2008, ARTIF ORGANS, V32, P925, DOI 10.1111/j.1525-1594.2008.00654.x; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Mohammad-Gharibani P, 2012, RESTOR NEUROL NEUROS, V30, P511, DOI 10.3233/RNN-2012-100155; Muller I, 2006, CYTOTHERAPY, V8, P437, DOI 10.1080/14653240600920782; Peterbauer-Scherb A, 2010, J TISSUE ENG REGEN M, V4, P485, DOI 10.1002/term.262; Pierini M, 2012, CYTOTHERAPY, V14, P686, DOI 10.3109/14653249.2012.677821; Posel C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050293; Pulavendran S, 2010, IET NANOBIOTECHNOL, V4, P51, DOI 10.1049/iet-nbt.2009.0014; Rastegar Farbod, 2010, World J Stem Cells, V2, P67, DOI 10.4252/wjsc.v2.i4.67; Reinders MEJ, 2013, STEM CELL TRANSL MED, V2, P107, DOI 10.5966/sctm.2012-0114; Ringe J, 2002, CELL TISSUE RES, V307, P321, DOI 10.1007/s00441-002-0525-z; Schallmoser K, 2008, TISSUE ENG PT C-METH, V14, P185, DOI 10.1089/ten.tec.2008.0060; Schallmoser K, 2007, TRANSFUSION, V47, P1436, DOI 10.1111/j.1537-2995.2007.01220.x; Smits AM, 2005, J CELL MOL MED, V9, P25, DOI 10.1111/j.1582-4934.2005.tb00334.x; Williams AR, 2013, CIRCULATION, V127, P213, DOI 10.1161/CIRCULATIONAHA.112.131110; Zhao JW, 2012, MOLECULES, V17, P14975, DOI 10.3390/molecules171214975; [赵李平 Zhao Liping], 2012, [中华实验外科杂志, Chinese Journal of Experimental Surgery], V29, P1083	35	40	50	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88794	10.1371/journal.pone.0088794	http://dx.doi.org/10.1371/journal.pone.0088794			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558428	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700074
J	Zhu, XM; Deng, XP; Huang, GY; Wang, J; Yang, JW; Chen, S; Ma, X; Wang, BB				Zhu, Xiaomei; Deng, Xiaopeng; Huang, Guangying; Wang, Jing; Yang, Jingwen; Chen, Si; Ma, Xu; Wang, Binbin			A Novel Mutation of Hyaluronan Synthase 2 Gene in Chinese Children with Ventricular Septal Defect	PLOS ONE			English	Article							CARDIAC-VALVE FORMATION; TO-MESENCHYMAL TRANSITION; MOUSE HYALURONAN SYNTHASE; CONGENITAL HEART-DEFECTS; GROWTH-FACTOR; EXTRACELLULAR-MATRIX; MOLECULAR-CLONING; MORPHOGENESIS; RECEPTOR; EXPRESSION	As a major product of extracellular matrix (ECM), Hyaluronic acid (HA) is involved in early cardiac development and mainly synthesized by Hyaluronan synthase 2 (HAS2) during embryogenesis. Targeted deletion of HAS2 gene in mice led to obvious cardiac and vascular defects. To clarify the potential association of the mutation in HAS2 with the development of congenital heart disease (CHD), in this study, we sequenced the coding region of HAS2 and identified a novel non-synonymous variant c. A1496T (p.Glu499Val) in one of 100 non-syndromic Ventricular Septal Defect (VSD) patients. The variant was not observed in 250 controls. In addition, to determine the contribution of HAS2 variant in VSD, we compared HA content in supernatant using HA quantitative analysis and found that the mutation obviously affected the HA synthetic activity of HAS2. To our knowledge, this is the first time that the mutation in HAS2 was found in Chinese VSD patients, which suggested that HAS2 may be involved in the etiology of non-syndromic VSD and have the vital function in the development of heart septum.	[Zhu, Xiaomei; Ma, Xu; Wang, Binbin] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Zhu, Xiaomei; Yang, Jingwen; Chen, Si; Ma, Xu; Wang, Binbin] Natl Res Inst Family Planning, Beijing, Peoples R China; [Deng, Xiaopeng] China Med Univ, Shengjing Hosp, Dept Obstet & Gynecol, Shenyang, Peoples R China; [Ma, Xu] World Hlth Org Collaborating Ctr Res Human Reprod, Beijing, Peoples R China; [Huang, Guangying] Fudan Univ, Childrens Hosp, Shanghai 200433, Peoples R China; [Wang, Jing] Capital Med Univ, Sch Basic Med Sci, Dept Med Genet, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Research Institute for Family Planning - China; China Medical University; World Health Organization; Fudan University; Capital Medical University	Ma, X (corresponding author), Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China.	NICGR@263.net; wbbahu@163.com		Wang, Binbin/0000-0002-1597-5930	National Basic Research Program of China [2010CB5295040]; National Natural Science Foundation of China [81300131]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2010CB5295040, http://www.973.gov.cn/English/Index.aspx) and the National Natural Science Foundation of China (81300131, http://www.nsfc.gov.cn/publish/portal0/default.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; BALDWIN HS, 1994, CIRC RES, V74, P244, DOI 10.1161/01.RES.74.2.244; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Bourguignon LYW, 2007, J BIOL CHEM, V282, P1265, DOI 10.1074/jbc.M604672200; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Bruneau BG, 2002, CIRC RES, V90, P509, DOI 10.1161/01.RES.0000013072.51957.B7; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; Campo GM, 2012, BIOFACTORS, V38, P69, DOI 10.1002/biof.202; Cataluccia D, 2008, ANN NY ACAD SCI, V1123, P20, DOI 10.1196/annals.1420.004; DEANGELIS PL, 1994, BIOCHEMISTRY-US, V33, P9033, DOI 10.1021/bi00197a001; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; Fishman MC, 1997, DEVELOPMENT, V124, P2099; Hanson KP, 2013, TISSUE ENG PT A, V19, P1132, DOI [10.1089/ten.tea.2012.0316, 10.1089/ten.TEA.2012.0316]; HARDWICK C, 1992, J CELL BIOL, V117, P1343, DOI 10.1083/jcb.117.6.1343; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Karousou E, 2010, J BIOL CHEM, V285, P23647, DOI 10.1074/jbc.M110.127050; KRUG EL, 1985, DEV BIOL, V112, P414, DOI 10.1016/0012-1606(85)90414-2; Lagendijk AK, 2013, TRENDS CARDIOVAS MED, V23, P135, DOI 10.1016/j.tcm.2012.10.002; Lagendijk AK, 2010, TRENDS CARDIOVAS MED, V20, P124, DOI 10.1016/j.tcm.2010.10.003; Lockhart M, 2011, BIRTH DEFECTS RES A, V91, P535, DOI 10.1002/bdra.20810; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; MOLLER JH, 1995, PEDIATR CARDIOL, V16, P216, DOI 10.1007/BF00795710; Pandey MS, 2013, J BIOL CHEM, V288, P14068, DOI 10.1074/jbc.M112.442889; Penny DJ, 2011, LANCET, V377, P1103, DOI 10.1016/S0140-6736(10)61339-6; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Rilla K, 2005, J BIOL CHEM, V280, P31890, DOI 10.1074/jbc.M504736200; Rodgers LS, 2006, CIRC RES, V99, P583, DOI 10.1161/01.RES.0000242561.95978.43; Saavalainen K, 2005, J BIOL CHEM, V280, P14636, DOI 10.1074/jbc.M500206200; Schroeder JA, 2003, J MOL MED-JMM, V81, P392, DOI 10.1007/s00109-003-0456-5; Shirai M, 2009, P NATL ACAD SCI USA, V106, P18604, DOI 10.1073/pnas.0900635106; Spicer AP, 1997, GENOMICS, V41, P493, DOI 10.1006/geno.1997.4696; Spicer AP, 1996, J BIOL CHEM, V271, P23400, DOI 10.1074/jbc.271.38.23400; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Stevens MV, 2008, CIRC RES, V103, P1430, DOI 10.1161/CIRCRESAHA.108.180752; Sullivan KE, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024349; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Vigetti D, 2011, J BIOL CHEM, V286, P7917, DOI 10.1074/jbc.M110.193656; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; Wang DZ, 2010, PEDIATR CARDIOL, V31, P357, DOI 10.1007/s00246-010-9641-9; Watanabe K, 1996, J BIOL CHEM, V271, P22945, DOI 10.1074/jbc.271.38.22945; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; Yoshida M, 2000, J BIOL CHEM, V275, P497, DOI 10.1074/jbc.275.1.497; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	46	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e87437	10.1371/journal.pone.0087437	http://dx.doi.org/10.1371/journal.pone.0087437			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558368	gold, Green Published, Green Submitted			2022-12-27	WOS:000331706700014
J	Ceccarelli, M; Galluzzi, L; Migliazzo, A; Magnani, M				Ceccarelli, Marcello; Galluzzi, Luca; Migliazzo, Antonella; Magnani, Mauro			Detection and Characterization of Leishmania (Leishmania) and Leishmania (Viannia) by SYBR Green-Based Real-Time PCR and High Resolution Melt Analysis Targeting Kinetoplast Minicircle DNA	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CANINE LEISHMANIASIS; VISCERAL LEISHMANIASIS; PERIPHERAL-BLOOD; ASSAY; DIAGNOSIS; DOGS; QUANTIFICATION; AMPLIFICATION; AGENTS	Leishmaniasis is a neglected disease with a broad clinical spectrum which includes asymptomatic infection. A thorough diagnosis, able to distinguish and quantify Leishmania parasites in a clinical sample, constitutes a key step in choosing an appropriate therapy, making an accurate prognosis and performing epidemiological studies. Several molecular techniques have been shown to be effective in the diagnosis of leishmaniasis. In particular, a number of PCR methods have been developed on various target DNA sequences including kinetoplast minicircle constant regions. The first aim of this study was to develop a SYBR green-based qPCR assay for Leishmania (Leishmania) infantum detection and quantification, using kinetoplast minicircle constant region as target. To this end, two assays were compared: the first used previously published primer pairs (qPCR1), whereas the second used a nested primer pairs generating a shorter PCR product (qPCR2). The second aim of this study was to evaluate the possibility to discriminate among subgenera Leishmania (Leishmania) and Leishmania (Viannia) using the qPCR2 assay followed by melting or High Resolution Melt (HRM) analysis. Both assays used in this study showed good sensitivity and specificity, and a good correlation with standard IFAT methods in 62 canine clinical samples. However, the qPCR2 assay allowed to discriminate between Leishmania (Leishmania) and Leishmania (Viannia) subgenera through melting or HRM analysis. In addition to developing assays, we investigated the number and genetic variability of kinetoplast minicircles in the Leishmania (L.) infantum WHO international reference strain (MHOM/TN/80/IPT1), highlighting the presence of minicircle subclasses and sequence heterogeneity. Specifically, the kinetoplast minicircle number per cell was estimated to be 26,566 +/- 1,192, while the subclass of minicircles amplifiable by qPCR2 was estimated to be 1,263 +/- 115. This heterogeneity, also observed in canine clinical samples, must be taken into account in quantitative PCR-based applications; however, it might also be used to differentiate between Leishmania subgenera.	[Ceccarelli, Marcello; Galluzzi, Luca; Magnani, Mauro] Univ Urbino Carlo Bo, Dept Biomol Sci, Fano, PU, Italy; [Migliazzo, Antonella] Ist Zooprofilatt Sperimentale Sicilia, Palermo, PA, Italy	University of Urbino; IZS Sicilia	Galluzzi, L (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Fano, PU, Italy.	luca.galluzzi@uniurb.it	Galluzzi, Luca/G-3969-2012; Magnani, Mauro/A-1919-2008; Migliazzo, Antonella/R-4756-2017	Galluzzi, Luca/0000-0002-1747-526X; Migliazzo, Antonella/0000-0002-8341-1125; Magnani, Mauro/0000-0001-6456-6626; Ceccarelli, Marcello/0000-0003-1647-6284				Alvar J, 2004, ADV PARASIT, V57, P1, DOI 10.1016/S0065-308X(04)57001-X; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Aoun O, 2009, VET PARASITOL, V166, P27, DOI 10.1016/j.vetpar.2009.08.006; Cabral M, 1998, VET PARASITOL, V76, P173, DOI 10.1016/S0304-4017(97)00208-2; Cruz I, 2013, EXP PARASITOL, V134, P281, DOI 10.1016/j.exppara.2013.03.026; DEGRAVE W, 1994, MEM I OSWALDO CRUZ, V89, P463, DOI 10.1590/S0074-02761994000300032; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Galluzzi L, 2010, J APPL PHYCOL, V22, P1, DOI 10.1007/s10811-009-9411-3; Goto H, 2010, EXPERT REV ANTI-INFE, V8, P419, DOI [10.1586/eri.10.19, 10.1586/ERI.10.19]; Gradoni L, 2004, 0412 ISTISAN I SUP S; Gradoni L, 2000, LEISHMANIASIS OIE MA, P802; Gramiccia M, 2010, VET PARASITOL, V171, P223, DOI 10.1016/j.vetpar.2010.03.025; Harris E, 1998, J CLIN MICROBIOL, V36, P1989, DOI 10.1128/JCM.36.7.1989-1995.1998; Iniesta L, 2002, CLIN DIAGN LAB IMMUN, V9, P1137, DOI 10.1128/CDLI.9.5.1137-1141.2002; Lachaud L, 2002, J CLIN MICROBIOL, V40, P210, DOI 10.1128/JCM.40.1.210-215.2002; Lachaud L, 2001, J CLIN MICROBIOL, V39, P613, DOI 10.1128/JCM.39.2.613-617.2001; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Manna L, 2008, VET J, V177, P279, DOI 10.1016/j.tvjl.2007.04.013; Martin-Ezquerra G, 2009, BRIT J DERMATOL, V161, P320, DOI 10.1111/j.1365-2133.2009.09282.x; MARTY P, 1992, T ROY SOC TROP MED H, V86, P249, DOI 10.1016/0035-9203(92)90295-N; Mary C, 2004, J CLIN MICROBIOL, V42, P5249, DOI 10.1128/JCM.42.11.5249-5255.2004; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Pita-Pereira D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-15; Pornprasert S, 2008, EUR J HAEMATOL, V80, P510, DOI 10.1111/j.1600-0609.2008.01055.x; Price EP, 2007, APPL ENVIRON MICROB, V73, P3431, DOI 10.1128/AEM.02702-06; Quaresma PF, 2009, ACTA TROP, V111, P289, DOI 10.1016/j.actatropica.2009.05.008; Reed GH, 2007, PHARMACOGENOMICS, V8, P597, DOI 10.2217/14622416.8.6.597; RODGERS MR, 1990, EXP PARASITOL, V71, P267, DOI 10.1016/0014-4894(90)90031-7; Schulz A, 2003, J CLIN MICROBIOL, V41, P1529, DOI 10.1128/JCM.41.4.1529-1535.2003; SEMIAOSANTOS SJ, 1995, PARASITOL RES, V81, P235; Shlomai J, 2004, CURR MOL MED, V4, P623, DOI 10.2174/1566524043360096; Sideris V, 1999, EUR J EPIDEMIOL, V15, P271, DOI 10.1023/A:1007526401175; SIMPSON L, 1986, INT REV CYTOL, V99, P119; Simpson L, 1997, MOL BIOCHEM PARASIT, V86, P133, DOI 10.1016/S0166-6851(97)00037-6; SIMPSON L, 1971, J MOL BIOL, V56, P443, DOI 10.1016/0022-2836(71)90394-9; Sudarshan M, 2011, J ANTIMICROB CHEMOTH, V66, P1751, DOI 10.1093/jac/dkr185; Tsukayama P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001956; Tupperwar N, 2008, DIAGN MICR INFEC DIS, V61, P23, DOI 10.1016/j.diagmicrobio.2007.12.013; Vergel C, 2005, AM J TROP MED HYG, V72, P423, DOI 10.4269/ajtmh.2005.72.423; White H, 2006, TECHNOLOGY ASSESSMEN	40	43	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88845	10.1371/journal.pone.0088845	http://dx.doi.org/10.1371/journal.pone.0088845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551178	gold, Green Submitted, Green Published			2022-12-27	WOS:000331266000075
J	Chung, KM; Hsu, SC; Chu, YR; Lin, MY; Jiaang, WT; Chen, RH; Chen, X				Chung, Kuei-Min; Hsu, Shu-Ching; Chu, Yue-Ru; Lin, Mei-Yao; Jiaang, Weir-Tong; Chen, Ruey-Hwa; Chen, Xin			Fibroblast Activation Protein (FAP) Is Essential for the Migration of Bone Marrow Mesenchymal Stem Cells through RhoA Activation	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; STROMAL CELLS; SERINE-PROTEASE; TUMOR-GROWTH; IN-VITRO; DIFFERENTIAL EXPRESSION; ACTIN CYTOSKELETON; CLEAVING ENZYME; BREAST-CANCER; SEPRASE	Background: The ability of human bone marrow mesenchymal stem cells (BM-MSCs) to migrate and localize specifically to injured tissues is central in developing therapeutic strategies for tissue repair and regeneration. Fibroblast activation protein (FAP) is a cell surface serine protease expressed at sites of tissue remodeling during embryonic development. It is also expressed in BM-MSCs, but not in normal tissues or cells. The function of FAP in BM-MSCs is not known. Principal Findings: We found that depletion of FAP proteins significantly inhibited the migration of BM-MSCs in a transwell chemotaxis assay. Such impaired migration ability of BM-MSCs could be rescued by re-expressing FAP in these cells. We then demonstrated that depletion of FAP activated intracellular RhoA GTPase. Consistently, inhibition of RhoA activity using a RhoA inhibitor rescued its migration ability. Inhibition of FAP activity with an FAP-specific inhibitor did not affect the activation of RhoA or the migration of BM-MSCs. Furthermore, the inflammatory cytokines interleukin-1beta (IL-1 beta) and transforming growth factor-beta (TGF-beta) upregulated FAP expression, which coincided with better BM-MSC migration. Conclusions: Our results indicate FAP plays an important role in the migration of BM-MSCs through modulation of RhoA GTPase activity. The peptidase activity of FAP is not essential for such migration. Cytokines IL-1 beta and TGF-beta upregulate the expression level of FAP and thus enhance BM-MSC migration.	[Chung, Kuei-Min; Chu, Yue-Ru; Jiaang, Weir-Tong; Chen, Xin] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Miaoli, Taiwan; [Hsu, Shu-Ching] Natl Hlth Res Inst, Vaccine Res & Dev Ctr, Miaoli, Taiwan; [Lin, Mei-Yao; Chen, Ruey-Hwa] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Chen, Xin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; Academia Sinica - Taiwan; China Medical University Taiwan	Chung, KM (corresponding author), Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Miaoli, Taiwan.	970304@nhri.org.tw; xchen@nhri.org.tw	Chen, Ruey-Hwa/G-6121-2019; Jiaang, Weir-Torn/D-2072-2010; Hsu, Shu-Ching/E-3869-2010	Chen, Ruey-Hwa/0000-0001-8124-5832; 	National Science Council, Taiwan [NSC 98-3112-B-400-013]; National Health Research Institutes, Taiwan;  [NRPGMNRPGM-98LC009]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); 	The work was supported by (NRPGMNRPGM-98LC009), National Science Council (NSC 98-3112-B-400-013), Taiwan and National Health Research Institutes, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aertgeerts K, 2005, J BIOL CHEM, V280, P19441, DOI 10.1074/jbc.C500092200; Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Artym VV, 2002, CARCINOGENESIS, V23, P1593, DOI 10.1093/carcin/23.10.1593; Bae S, 2008, BRIT J HAEMATOL, V142, P827, DOI 10.1111/j.1365-2141.2008.07241.x; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Birnbaum T, 2007, J NEURO-ONCOL, V83, P241, DOI 10.1007/s11060-007-9332-4; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chen H, 2009, EXP MOL PATHOL, V87, P189, DOI 10.1016/j.yexmp.2009.09.001; Chen HW, 2013, J IMMUNOL, V190, P5065, DOI 10.4049/jimmunol.1202775; Chen HY, 2004, MOL CELL BIOL, V24, P10558, DOI 10.1128/MCB.24.24.10558-10572.2004; Chen WT, 2003, ADV EXP MED BIOL, V524, P197; Chen WT, 2003, CANCER METAST REV, V22, P259, DOI 10.1023/A:1023055600919; Cheng JD, 2002, CANCER RES, V62, P4767; Christiansen VJ, 2007, ARCH BIOCHEM BIOPHYS, V457, P177, DOI 10.1016/j.abb.2006.11.006; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; Dolznig Helmut, 2005, Cancer Immun, V5, P10; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Efron PA, 2004, J BURN CARE REHABIL, V25, P149, DOI 10.1097/01.BCR.0000111766.97335.34; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fox JM, 2007, BRIT J HAEMATOL, V137, P491, DOI 10.1111/j.1365-2141.2007.06610.x; Fu XB, 2009, WOUND REPAIR REGEN, V17, P185, DOI 10.1111/j.1524-475X.2009.00454.x; Gout SP, 2001, MOL BIOL CELL, V12, P3268, DOI 10.1091/mbc.12.10.3268; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Huang Y, 2004, CANCER RES, V64, P2712, DOI 10.1158/0008-5472.CAN-03-3184; Huang Y, 2011, CLIN EXP METASTAS, V28, P567, DOI 10.1007/s10585-011-9392-x; Huber MA, 2003, J INVEST DERMATOL, V120, P182, DOI 10.1046/j.1523-1747.2003.12035.x; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Jaganathan BG, 2007, STEM CELLS, V25, P1966, DOI 10.1634/stemcells.2007-0167; Kelly T, 2005, DRUG RESIST UPDATE, V8, P51, DOI 10.1016/j.drup.2005.03.002; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Lee HO, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-245; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Lee KN, 2006, BLOOD, V107, P1397, DOI 10.1182/blood-2005-08-3452; Lee KN, 2004, BLOOD, V103, P3783, DOI 10.1182/blood-2003-12-4240; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; MONSKY WL, 1994, CANCER RES, V54, P5702; Mueller SC, 1999, J BIOL CHEM, V274, P24947, DOI 10.1074/jbc.274.35.24947; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Niggli V, 1999, FEBS LETT, V445, P69, DOI 10.1016/S0014-5793(99)00098-8; O'Connor KL, 2012, AM J PHYSIOL-CELL PH, V302, pC605, DOI 10.1152/ajpcell.00095.2011; Ohnuma K, 2007, J BIOL CHEM, V282, P10117, DOI 10.1074/jbc.M609157200; OVERALL CM, 1991, J BIOL CHEM, V266, P14064; Park JE, 1999, J BIOL CHEM, V274, P36505, DOI 10.1074/jbc.274.51.36505; Poplawski SE, 2013, J MED CHEM, V56, P3467, DOI 10.1021/jm400351a; Ramirez-Montagut T, 2004, ONCOGENE, V23, P5435, DOI 10.1038/sj.onc.1207730; Rattigan Y, 2010, EXP CELL RES, V316, P3417, DOI 10.1016/j.yexcr.2010.07.002; RETTIG WJ, 1988, P NATL ACAD SCI USA, V85, P3110, DOI 10.1073/pnas.85.9.3110; RIES C, 1994, BLOOD, V83, P3638; RIES C, 1995, BIOL CHEM H-S, V376, P345; Ries C, 2007, BLOOD, V109, P4055, DOI 10.1182/blood-2006-10-051060; Rosenblum JS, 2003, CURR OPIN CHEM BIOL, V7, P496, DOI 10.1016/S1367-5931(03)00084-X; Ruster B, 2005, STEM CELLS DEV, V14, P231, DOI 10.1089/scd.2005.14.231; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; SCANLAN MJ, 1994, P NATL ACAD SCI USA, V91, P5657, DOI 10.1073/pnas.91.12.5657; Tang HK, 2009, ARCH BIOCHEM BIOPHYS, V485, P120, DOI 10.1016/j.abb.2009.02.015; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Tran E, 2013, J EXP MED, V210, P1125, DOI 10.1084/jem.20130110; Tsai TY, 2010, J MED CHEM, V53, P6572, DOI 10.1021/jm1002556; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Wicki A, 2001, INT J CANCER, V91, P763, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1128>3.0.CO;2-B; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762; Zhang F, 2009, J BIOL CHEM, V284, P17564, DOI 10.1074/jbc.M109.013987	66	48	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88772	10.1371/journal.pone.0088772	http://dx.doi.org/10.1371/journal.pone.0088772			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551161	Green Submitted, gold, Green Published			2022-12-27	WOS:000331266000067
J	Lung, RI; Chira, C; Andreica, A				Lung, Rodica Ioana; Chira, Camelia; Andreica, Anca			Game Theory and Extremal Optimization for Community Detection in Complex Dynamic Networks	PLOS ONE			English	Article								The detection of evolving communities in dynamic complex networks is a challenging problem that recently received attention from the research community. Dynamics clearly add another complexity dimension to the difficult task of community detection. Methods should be able to detect changes in the network structure and produce a set of community structures corresponding to different timestamps and reflecting the evolution in time of network data. We propose a novel approach based on game theory elements and extremal optimization to address dynamic communities detection. Thus, the problem is formulated as a mathematical game in which nodes take the role of players that seek to choose a community that maximizes their profit viewed as a fitness function. Numerical results obtained for both synthetic and real-world networks illustrate the competitive performance of this game theoretical approach.	[Lung, Rodica Ioana] Univ Babes Bolyai, Dept Stat Forecasting & Math, R-3400 Cluj Napoca, Romania; [Chira, Camelia; Andreica, Anca] Univ Babes Bolyai, Dept Comp Sci, R-3400 Cluj Napoca, Romania	Babes Bolyai University from Cluj; Babes Bolyai University from Cluj	Lung, RI (corresponding author), Univ Babes Bolyai, Dept Stat Forecasting & Math, R-3400 Cluj Napoca, Romania.	rodica.lung@econ.ubbcluj.ro	lung, rodica ioana I/C-4716-2011; Chira, Camelia/B-5566-2015; Chira, Camelia/AAO-7860-2020; Andreica, Anca M./C-4082-2011	Chira, Camelia/0000-0002-1949-1298; Andreica, Anca/0000-0003-2363-5757; Lung, Rodica Ioana/0000-0002-5572-8141	CNCS Romania; OPEN-RES Academic Writing project [PN-II-PT-PCCA-2011-3.1-0682];  [PN II TE 320]	CNCS Romania(Consiliul National al Cercetarii Stiintifice (CNCS)); OPEN-RES Academic Writing project; 	This research is supported by Grant PN II TE 320, "Emergence, auto-organization and evolution: New computational models in the study of complex systems," funded by CNCS Romania (http://uefiscdi.gov.ro/articole/1966/Proiecte-de-cercetare-pentru-stimularea-constituirii-de-tinere-echipe-de-cercetareindependente-ti.html). The first author would like to acknowledge the support received within the PN-II-PT-PCCA-2011-3.1-0682 OPEN-RES Academic Writing project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, P 12 ACM SIGKDD INT, DOI DOI 10.1145/1150402.1150467; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], CSNE0209030 CORR; [Anonymous], [No title captured]; Asur S, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P913; Boettcher S, 2001, PHYS REV LETT, V86, P5211, DOI 10.1103/PhysRevLett.86.5211; Chi Y, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P153; Chira C, 2011, LECT NOTES ARTIF INT, V6678, P380, DOI 10.1007/978-3-642-21219-2_48; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Folino F, 2010, 2010 INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM 2010), P256, DOI 10.1109/ASONAM.2010.23; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gong MG, 2012, J COMPUT SCI TECH-CH, V27, P455, DOI 10.1007/s11390-012-1235-y; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Kim MS, 2009, PROC VLDB ENDOW, V2; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056117; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Lin Y.R., 2008, P 17 INT C WORLD WID, P685, DOI [10.1145/1367497.1367590, DOI 10.1145/1367497.1367590]; Lung RI, 2008, INT J COMPUT COMMUN, V3, P364; Lung RI, 2011, STUD COMPUT INTELL, V387, P195; McKelvey R.D., 1996, HDB COMPUTATIONAL EC, V1, P87, DOI DOI 10.1016/S1574-0021(96)01004-0; Mitchell M., 2009, COMPLEXITY GUIDED TO; NASH J, 1951, ANN MATH, V54, P286, DOI 10.2307/1969529; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; PAPPI FU, 1993, CONTEMP SOCIOL, V22, P128, DOI 10.2307/2075047; Pizzuti C, 2008, LECT NOTES COMPUT SC, V5199, P1081, DOI 10.1007/978-3-540-87700-4_107; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Rosvall M, 2007, P NATL ACAD SCI USA, V104, P7327, DOI 10.1073/pnas.0611034104; Sun JM, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P687; Tang L., 2008, P 14 ACM SIGKDD INT, P677, DOI [10.1145/1401890.1401972, DOI 10.1145/1401890.1401972]; Tasgin M., 2006, COMMUNITY DETECTION; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WATTS DJ, 2003, 6 DEGREES SCI CONNEC	38	15	15	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e86891	10.1371/journal.pone.0086891	http://dx.doi.org/10.1371/journal.pone.0086891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586257	Green Published, gold			2022-12-27	WOS:000332389000005
J	Hesse, B; Langer, M; Varga, P; Pacureanu, A; Dong, P; Schrof, S; Mannicke, N; Suhonen, H; Olivier, C; Maurer, P; Kazakia, GJ; Raum, K; Peyrin, F				Hesse, Bernhard; Langer, Max; Varga, Peter; Pacureanu, Alexandra; Dong, Pei; Schrof, Susanne; Maennicke, Nils; Suhonen, Heikki; Olivier, Cecile; Maurer, Peter; Kazakia, Galateia J.; Raum, Kay; Peyrin, Francoise			Alterations of Mass Density and 3D Osteocyte Lacunar Properties in Bisphosphonate- Related Osteonecrotic Human Jaw Bone, a Synchrotron mu CT Study	PLOS ONE			English	Article							MINERALIZATION DENSITY; HIGH-RESOLUTION; HUMAN FEMUR; PHASE; MORPHOLOGY; TOMOGRAPHY; WOMEN; IMAGE; MECHANOTRANSDUCTION; EXTRACTION	Osteonecrosis of the jaw, in association with bisphosphonates (BRONJ) used for treating osteoporosis or cancer, is a severe and most often irreversible side effect whose underlying pathophysiological mechanisms remain largely unknown. Osteocytes are involved in bone remodeling and mineralization where they orchestrate the delicate equilibrium between osteoclast and osteoblast activity and through the active process called osteocytic osteolysis. Here, we hypothesized that (i) changes of the mineralized tissue matrix play a substantial role in the pathogenesis of BRONJ, and (ii) the osteocyte lacunar morphology is altered in BRONJ. Synchrotron mu CT with phase contrast is an appropriate tool for assessing both the 3D morphology of the osteocyte lacunae and the bone matrix mass density. Here, we used this technique to investigate the mass density distribution and 3D osteocyte lacunar properties at the sub-micrometer scale in human bone samples from the jaw, femur and tibia. First, we compared healthy human jaw bone to human tibia and femur in order to assess the specific differences and address potential explanations of why the jaw bone is exclusively targeted by the necrosis as a side effect of BP treatment. Second, we investigated the differences between BRONJ and control jaw bone samples to detect potential differences which could aid an improved understanding of the course of BRONJ. We found that the apparent mass density of jaw bone was significantly smaller compared to that of tibia, consistent with a higher bone turnover in the jaw bone. The variance of the lacunar volume distribution was significantly different depending on the anatomical site. The comparison between BRONJ and control jaw specimens revealed no significant increase in mineralization after BP. We found a significant decrease in osteocyte-lacunar density in the BRONJ group compared to the control jaw. Interestingly, the osteocyte-lacunar volume distribution was not altered after BP treatment.	[Hesse, Bernhard; Langer, Max; Pacureanu, Alexandra; Dong, Pei; Suhonen, Heikki; Olivier, Cecile; Peyrin, Francoise] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Hesse, Bernhard; Varga, Peter; Schrof, Susanne; Maennicke, Nils; Raum, Kay] Charite, Berlin Brandenburg Sch Regenerat Therapies, D-13353 Berlin, Germany; [Hesse, Bernhard; Varga, Peter; Schrof, Susanne; Maennicke, Nils; Raum, Kay] Charite, Julius Wolff Inst, D-13353 Berlin, Germany; [Langer, Max; Pacureanu, Alexandra; Dong, Pei; Olivier, Cecile; Peyrin, Francoise] Univ Lyon, CREATIS, CNRS UMR5220, INSA Lyon, Lyon, France; [Pacureanu, Alexandra] Uppsala Univ, Ctr Image Anal & Sci Life Lab, Uppsala, Sweden; [Maurer, Peter] Klinikum Bremerhaven Reinkenheide, Klin Mund Kiefer & Gesichtschirurg, Kiel, Germany; [Kazakia, Galateia J.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA	European Synchrotron Radiation Facility (ESRF); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; Uppsala University; University of California System; University of California San Francisco	Peyrin, F (corresponding author), European Synchrotron Radiat Facil, BP 220, F-38043 Grenoble, France.	peyrin@esrf.fr	Peyrin, Francoise/G-2823-2013; Langer, Max/E-1408-2013; Kazakia, Galateia J/AAY-7827-2020; Varga, Peter/H-6181-2012; Raum, Kay/A-5576-2013	Peyrin, Francoise/0000-0002-1988-3435; Langer, Max/0000-0002-5821-9617; Varga, Peter/0000-0003-2738-6436; Raum, Kay/0000-0003-0573-1622; Pacureanu, Alexandra/0000-0003-2306-7040; Suhonen, Heikki/0000-0002-0337-6308	German Research Council (DFG) [Ra1380/7]; Berlin-Brandenburg School for Regenerative Therapies [GSC 203]	German Research Council (DFG)(German Research Foundation (DFG)); Berlin-Brandenburg School for Regenerative Therapies	This work was supported by the German Research Council (DFG Grant Ra1380/7). BH receives a DFG stipend through the Berlin-Brandenburg School for Regenerative Therapies GSC 203. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MR, 2008, J ORAL MAXIL SURG, V66, P987, DOI 10.1016/j.joms.2008.01.038; Allen MR, 2009, J ORAL MAXIL SURG, V67, P1373, DOI 10.1016/j.joms.2009.03.048; Bach-Gansmo FL, 2013, CALCIFIED TISSUE INT, V92, P330, DOI 10.1007/s00223-012-9682-6; Bertoldo F, 2007, NAT CLIN PRACT ONCOL, V4, P711, DOI 10.1038/ncponc1000; Blaber EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061372; Boivin G, 2002, CALCIFIED TISSUE INT, V70, P503, DOI 10.1007/s00223-001-2048-0; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Bonnet N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058726; Burger EH, 1999, FASEB J, V13, pS101, DOI 10.1096/fasebj.13.9001.s101; Busse B, 2010, AGING CELL, V9, P1065, DOI 10.1111/j.1474-9726.2010.00633.x; Carpentier VT, 2012, BONE, V50, P688, DOI 10.1016/j.bone.2011.11.021; Carter Y, 2013, J STRUCT BIOL, V183, P519, DOI 10.1016/j.jsb.2013.07.004; Carter Y, 2013, BONE, V52, P126, DOI 10.1016/j.bone.2012.09.010; Cloetens P, 1997, J APPL PHYS, V81, P5878, DOI 10.1063/1.364374; Currey JD, 2003, J BIOMECH, V36, P1487, DOI 10.1016/S0021-9290(03)00124-6; CURREY JD, 1984, PHILOS T ROY SOC B, V304, P509, DOI 10.1098/rstb.1984.0042; Currey JD, 1984, MECH ADAPTION BONE; Dall'Ara E, 2013, BONE, V52, P27, DOI 10.1016/j.bone.2012.09.006; del Rio MS, 2004, AIP CONF PROC, V705, P784, DOI 10.1063/1.1757913; Dhillon S, 2008, DRUGS, V68, P507, DOI 10.2165/00003495-200868040-00010; Diemoz PC, 2012, OPT EXPRESS, V20, P27670, DOI 10.1364/OE.20.027670; Dierolf M, 2010, NATURE, V467, P436, DOI 10.1038/nature09419; Dong P, 2014, BONE, V60, P172, DOI 10.1016/j.bone.2013.12.008; Dong P, 2013, I S BIOMED IMAGING, P1492; European Medicines Agency, 2009, CHMP ASS REP BISPH O; FROST HM, 1960, J BONE JOINT SURG AM, V42, P144, DOI 10.2106/00004623-196042010-00012; Huja SS, 2006, ANAT REC PART A, V288A, P1243, DOI 10.1002/ar.a.20396; JARQUE CM, 1987, INT STAT REV, V55, P163, DOI 10.2307/1403192; Kazakia GJ, 2008, MED PHYS, V35, P3170, DOI 10.1118/1.2924210; Kingsmill VJ, 1998, J ANAT, V192, P245, DOI 10.1046/j.1469-7580.1998.19220245.x; Klein-Nulend J, 2013, BONE, V54, P182, DOI 10.1016/j.bone.2012.10.013; Kuhl S, 2012, ORAL ONCOL, V48, P938, DOI 10.1016/j.oraloncology.2012.03.028; Lakshmanan S, 2007, IEEE T ULTRASON FERR, V54, P1560, DOI 10.1109/TUFFC.2007.426; Lane NE, 2006, J BONE MINER RES, V21, P466, DOI 10.1359/JBMR.051103; Langer M, 2014, PHIL T R A IN PRESS; Langer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035691; LANYON LE, 1993, CALCIFIED TISSUE INT, V53, pS102, DOI 10.1007/BF01673415; Lesclous P, 2009, BONE, V45, P843, DOI 10.1016/j.bone.2009.07.011; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; Marinescu M, 2013, MOL IMAGING BIOL; MAROTTI G, 1995, BONE, V16, P125, DOI 10.1016/S8756-3282(94)00019-0; Maurer P, 2011, INT J ORAL MAX SURG, V40, P285, DOI 10.1016/j.ijom.2010.11.006; McCreadie BR, 2004, J BIOMECH, V37, P563, DOI 10.1016/S0021-9290(03)00287-2; Meiller TF, 2012, OPEN DENT J, V6, P5, DOI 10.2174/1874210601206010005; Mercer E, 2013, CALCIF TISSUE INT; Mullender MG, 2005, CALCIFIED TISSUE INT, V77, P291, DOI 10.1007/s00223-005-0043-6; Mullins L. P., 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P159, DOI 10.1080/10255840601110802; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nuzzo S, 2002, J BONE MINER RES, V17, P1372, DOI 10.1359/jbmr.2002.17.8.1372; Otto S, 2010, J ORAL MAXIL SURG, V68, P1158, DOI 10.1016/j.joms.2009.07.079; Pacureanu A, 2012, MED PHYS, V39, P2229, DOI 10.1118/1.3697525; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; Qing H, 2012, J BONE MINER RES, V27, P1018, DOI 10.1002/jbmr.1567; Qiu SJ, 2006, BONE, V38, P130, DOI 10.1016/j.bone.2005.07.004; Raum K, 2006, PHYS MED BIOL, V51, P747, DOI 10.1088/0031-9155/51/3/018; Roelofs AJ, 2010, J BONE MINER RES, V25, P606, DOI 10.1359/jbmr.091009; Roschger P, 2008, BONE, V42, P456, DOI 10.1016/j.bone.2007.10.021; Ruggiero SL, 2009, J ORAL MAXIL SURG, V67, P2, DOI 10.1016/j.joms.2009.01.009; Russell RGG, 2008, OSTEOPOROSIS INT, V19, P733, DOI 10.1007/s00198-007-0540-8; Schneider P, 2010, BONE, V47, P848, DOI 10.1016/j.bone.2010.07.026; Tommasini SM, 2012, BONE, V50, P596, DOI 10.1016/j.bone.2011.12.012; van Hove RP, 2009, BONE, V45, P321, DOI 10.1016/j.bone.2009.04.238; Varga P, 2013, ACTA BIOMATER, V9, P8118, DOI 10.1016/j.actbio.2013.05.015; Vatsa A, 2008, BONE, V43, P452, DOI 10.1016/j.bone.2008.01.030; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Webster DJ, 2013, BONE; WEINBAUM S, 1994, J BIOMECH, V27, P339, DOI 10.1016/0021-9290(94)90010-8; Weitkamp T, 2011, J SYNCHROTRON RADIAT, V18, P617, DOI 10.1107/S0909049511002895; Westbroek I, 2002, J BONE MINER RES, V17, P845, DOI 10.1359/jbmr.2002.17.5.845; Yoo TS, 2002, STUD HEALTH TECHNOL, V85, P586; Yu YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031771; Zhou XZ, 2009, BONE, V45, P704, DOI 10.1016/j.bone.2009.06.026	73	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e88481	10.1371/journal.pone.0088481	http://dx.doi.org/10.1371/journal.pone.0088481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586331	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900018
J	McEwan, K; Gilbert, P; Dandeneau, S; Lipka, S; Maratos, F; Paterson, KB; Baldwin, M				McEwan, Kirsten; Gilbert, Paul; Dandeneau, Stephane; Lipka, Sigrid; Maratos, Frances; Paterson, Kevin B.; Baldwin, Mark			Facial Expressions Depicting Compassionate and Critical Emotions: The Development and Validation of a New Emotional Face Stimulus Set	PLOS ONE			English	Article							LOVING-KINDNESS MEDITATION; ATTENTIONAL BIAS; SELF-COMPASSION; SOCIAL ANXIETY; RECOGNITION; THREAT; DEPRESSION; JUDGMENTS; HAPPY; INDIVIDUALS	Attachment with altruistic others requires the ability to appropriately process affiliative and kind facial cues. Yet there is no stimulus set available to investigate such processes. Here, we developed a stimulus set depicting compassionate and critical facial expressions, and validated its effectiveness using well-established visual-probe methodology. In Study 1, 62 participants rated photographs of actors displaying compassionate/kind and critical faces on strength of emotion type. This produced a new stimulus set based on N = 31 actors, whose facial expressions were reliably distinguished as compassionate, critical and neutral. In Study 2, 70 participants completed a visual-probe task measuring attentional orientation to critical and compassionate/kind faces. This revealed that participants lower in self-criticism demonstrated enhanced attention to compassionate/kind faces whereas those higher in self-criticism showed no bias. To sum, the new stimulus set produced interpretable findings using visual-probe methodology and is the first to include higher order, complex positive affect displays.	[McEwan, Kirsten] Cardiff Univ, Sch Med, Cardiff CF10 3AX, S Glam, Wales; [Gilbert, Paul] Kingsway Hosp, Mental Hlth Res Unit, Derby, England; [Dandeneau, Stephane] Univ Quebec, Dept Psychol, Montreal, PQ H3C 3P8, Canada; [Lipka, Sigrid; Maratos, Frances] Univ Derby, Ctr Psychol Res, Derby DE22 1GB, England; [Paterson, Kevin B.] Univ Leicester, Coll Med Biol Sci & Psychol, Leicester, Leics, England; [Baldwin, Mark] McGill Univ, Dept Psychol, Montreal, PQ, Canada	Cardiff University; University of Quebec; University of Quebec Montreal; University of Derby; University of Leicester; McGill University	McEwan, K (corresponding author), Cardiff Univ, Sch Med, Cardiff CF10 3AX, S Glam, Wales.	mcewank@cf.ac.uk		Lipka, Sigrid/0000-0002-4685-1324; Maratos, Frances/0000-0001-5738-6491; Gilbert, paul/0000-0001-8431-9892; Paterson, Kevin/0000-0002-8150-8628; McEwan, Kirsten/0000-0002-0945-0521; Dandeneau, Stephane/0000-0003-3466-8079				Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Amir N, 2009, BEHAV RES THER, V47, P153, DOI 10.1016/j.brat.2008.10.020; BENSON PJ, 1993, PERCEPTION, V22, P257, DOI 10.1068/p220257; Bernstein MJ, 2010, J EXP SOC PSYCHOL, V46, P196, DOI 10.1016/j.jesp.2009.08.010; BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037/0003-066X.36.2.129; Boyatzis RE, 2006, ACAD MANAG LEARN EDU, V5, P8, DOI 10.5465/AMLE.2006.20388381; Bradley BP, 1999, BRIT J CLIN PSYCHOL, V38, P267, DOI 10.1348/014466599162845; Cacioppo JT., 2008, LONELINESS HUMAN NAT; Campbell DW, 2009, DEPRESS ANXIETY, V26, P419, DOI 10.1002/da.20474; Dandeneau SD, 2007, J PERS SOC PSYCHOL, V93, P651, DOI 10.1037/0022-3514.93.4.651; Del Giudice M, 2007, DEV PSYCHOL, V43, P796, DOI 10.1037/0012-1649.43.3.796; Dewitte M, 2008, J RES PERS, V42, P498, DOI 10.1016/j.jrp.2007.07.010; Duchenne de Bologne GB, 1860, MECH HUMAN FACIAL EX; Dunbar RIM, 2010, NEUROSCI BIOBEHAV R, V34, P260, DOI 10.1016/j.neubiorev.2008.07.001; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; EKMAN P, 1992, PSYCHOL SCI, V3, P34, DOI 10.1111/j.1467-9280.1992.tb00253.x; EKMAN P, 1990, J PERS SOC PSYCHOL, V58, P342, DOI 10.1037/0022-3514.58.2.342; Ekman P., 2009, TELLING LIES CLUES D; Ekman P., 2002, FACIAL ACTION CODING; Ekman P., 1976, PICTURES FACIAL AFFE; Fredrickson BL, 2008, J PERS SOC PSYCHOL, V95, P1045, DOI 10.1037/a0013262; Fredrickson BL, 1998, REV GEN PSYCHOL, V2, P300, DOI DOI 10.1037/1089-2680.2.3.300; Gilbert P, 2004, BRIT J CLIN PSYCHOL, V43, P31, DOI 10.1348/014466504772812959; Gilbert P., 2010, COMPASSIONATE MIND N; Gilbert P, 2011, PSYCHOL PSYCHOTHER-T, V84, P239, DOI [10.1348/147608310X526511, 10.1111/j.2044-8341.2011.02046.x]; Haidt J, 1999, COGNITION EMOTION, V13, P225, DOI 10.1080/026999399379267; Hess U, 2000, J NONVERBAL BEHAV, V24, P265, DOI 10.1023/A:1006623213355; Heuer K, 2007, BEHAV RES THER, V45, P2990, DOI 10.1016/j.brat.2007.08.010; Hofmann SG, 2011, CLIN PSYCHOL REV, V31, P1126, DOI 10.1016/j.cpr.2011.07.003; Hutcherson CA, 2008, EMOTION, V8, P720, DOI 10.1037/a0013237; Ioannou MC, 2004, PERS INDIV DIFFER, V36, P1879, DOI 10.1016/j.paid.2003.08.018; Keltner D, 1996, COGNITION EMOTION, V10, P155, DOI 10.1080/026999396380312; Kolassa IT, 2009, COGNITION EMOTION, V23, P69, DOI 10.1080/02699930801940461; Konijn E., 2000, ACTING EMOTIONS SHAP; Lang PJ, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P97; Leary MR, 2007, J PERS SOC PSYCHOL, V92, P887, DOI 10.1037/0022-3514.92.5.887; Lee E, 2008, PSYCHIAT RES, V157, P77, DOI 10.1016/j.psychres.2007.02.005; Leppanen JM, 2004, PSYCHIAT RES, V128, P123, DOI 10.1016/j.psychres.2004.05.020; Longe O, 2010, NEUROIMAGE, V49, P1849, DOI 10.1016/j.neuroimage.2009.09.019; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; Lundqvist D., 1998, KAROLINSKA DIRECTED; Lutz A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001897; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; Maner JK, 2007, J PERS SOC PSYCHOL, V92, P42, DOI 10.1037/0022-3514.92.1.42; Mansell W, 1999, COGNITION EMOTION, V13, P673, DOI 10.1080/026999399379032; Maratos FA, 2012, COGN NEUROSCI-UK, V3, P62, DOI 10.1080/17588928.2011.613989; Maratos FA, 2011, EMOTION, V11, P1242, DOI 10.1037/a0024279; Matsumoto D, 1988, JAPANESE CAUCASIAN F; Mehu M., 2007, J EVOLUT PSYCHOL, V5, P183, DOI [DOI 10.1556/JEP.2007.1011, 10.1556/JEP.2007.1011]; Mogg K, 1999, BEHAV RES THER, V37, P595, DOI 10.1016/S0005-7967(98)00158-2; MOGG K, 1995, BRIT J CLIN PSYCHOL, V34, P17, DOI 10.1111/j.2044-8260.1995.tb01434.x; Mogg K, 1998, BEHAV RES THER, V36, P809, DOI 10.1016/S0005-7967(98)00063-1; Mogg K, 2008, BEHAV RES THER, V46, P656, DOI 10.1016/j.brat.2008.02.011; Mortillaro M, 2011, SOC PSYCHOL PERS SCI, V2, P262, DOI 10.1177/1948550610389080; Neff K, 2003, SELF IDENTITY, V2, P85, DOI 10.1080/15298860390129863; Ohman A, 2001, J PERS SOC PSYCHOL, V80, P381, DOI 10.1037//0022-3514.80.3.381; Pauley G, 2010, PSYCHOL PSYCHOTHER-T, V83, P129, DOI 10.1348/147608309X471000; Phillips T, 2008, BRIT J PSYCHOL, V99, P555, DOI 10.1348/000712608X298467; Plutchik R, 1980, EMOTIONS PSYCHOEVOLU; Porges SW, 2007, BIOL PSYCHOL, V74, P116, DOI 10.1016/j.biopsycho.2006.06.009; Preacher KJ, 2005, PSYCHOL METHODS, V10, P178, DOI 10.1037/1082-989X.10.2.178; Rapee RM, 1997, BEHAV RES THER, V35, P741, DOI 10.1016/S0005-7967(97)00022-3; Rocklin H, 2008, CLIN NEUROPSYCHIATR, V5, P132; RUSSELL JA, 1994, PSYCHOL BULL, V115, P102, DOI 10.1037/0033-2909.115.1.102; Sauter DA, 2007, MOTIV EMOTION, V31, P192, DOI 10.1007/s11031-007-9065-x; Schultheiss OC, 2005, EMOTION, V5, P41, DOI 10.1037/1528-3542.5.1.41; Schultheiss OC, 2007, MOTIV EMOTION, V31, P13, DOI 10.1007/s11031-006-9042-9; Segerstrom SC, 2001, J BEHAV MED, V24, P441, DOI 10.1023/A:1012271410485; Silvia PJ, 2006, J SOC CLIN PSYCHOL, V25, P585, DOI 10.1521/jscp.2006.25.6.585; Surguladze SA, 2004, NEUROPSYCHOLOGY, V18, P212, DOI 10.1037/0894-4105.18.2.212; Suslow T, 2004, J AFFECT DISORDERS, V83, P59, DOI 10.1016/j.jad.2004.03.003; Taylor B., 2009, KINDNESS; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Vrticka P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002868; Yik M, 2013, COGNITION EMOTION, V27, P1062, DOI 10.1080/02699931.2013.763769; Yoon KL, 2008, J ABNORM PSYCHOL, V117, P680, DOI 10.1037/0021-843X.117.3.680	76	20	22	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88783	10.1371/journal.pone.0088783	http://dx.doi.org/10.1371/journal.pone.0088783			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3TA	24586392	Green Published, gold			2022-12-27	WOS:000331711900048
J	Anderson, EM; Jenkins, AC; Caudle, RM; Neubert, JK				Anderson, Ethan M.; Jenkins, Alan C.; Caudle, Robert M.; Neubert, John K.			The Effects of a Co-Application of Menthol and Capsaicin on Nociceptive Behaviors of the Rat on the Operant Orofacial Pain Assessment Device	PLOS ONE			English	Article							INTRADERMAL INJECTION; THERMAL PREFERENCE; TRPA1 CONTRIBUTES; INDUCED ANALGESIA; RECEPTOR; TRPM8; ASSAY; HYPERALGESIA; CHANNELS; SENSITIVITY	Background: Transient receptor potential (TRP) cation channels are involved in the perception of hot and cold pain and are targets for pain relief in humans. We hypothesized that agonists of TRPV1 and TRPM8/TRPA1, capsaicin and menthol, would alter nociceptive behaviors in the rat, but their opposite effects on temperature detection would attenuate one another if combined. Methods: Rats were tested on the Orofacial Pain Assessment Device (OPAD, Stoelting Co.) at three temperatures within a 17 min behavioral session (33 degrees C, 21 degrees C, 45 degrees C). Results: The lick/face ratio (L/F: reward licking events divided by the number of stimulus contacts. Each time there is a licking event a contact is being made.) is a measure of nociception on the OPAD and this was equally reduced at 45 degrees C and 21 degrees C suggesting they are both nociceptive and/or aversive to rats. However, rats consumed (licks) equal amounts at 33 degrees C and 21 degrees C but less at 45 degrees C suggesting that heat is more nociceptive than cold at these temperatures in the orofacial pain model. When menthol and capsaicin were applied alone they both induced nociceptive behaviors like lower L/F ratios and licks. When applied together though, the licks at 21 degrees C were equal to those at 33 degrees C and both were significantly higher than at 45 degrees C. Conclusions: This suggests that the cool temperature is less nociceptive when TRPM8/TRPA1 and TRPV1 are co-activated. These results suggest that co-activation of TRP channels can reduce certain nociceptive behaviors. These data demonstrate that the motivational aspects of nociception can be influenced selectively by TRP channel modulation and that certain aspects of pain can be dissociated and therefore targeted selectively in the clinic.	[Anderson, Ethan M.; Caudle, Robert M.] Univ Florida, Coll Dent, Dept Oral & Maxillofacial Surg, Gainesville, FL 32611 USA; [Anderson, Ethan M.; Caudle, Robert M.] Univ Florida, Coll Med, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA; [Jenkins, Alan C.; Neubert, John K.] Univ Florida, Dept Orthodont, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Anderson, EM (corresponding author), Univ Florida, Coll Dent, Dept Oral & Maxillofacial Surg, Gainesville, FL 32611 USA.	ethan241@gmail.com		Caudle, Robert/0000-0002-2394-4114	NIH [5R44DA026220-03]; NATIONAL INSTITUTE ON DRUG ABUSE [R44DA026220] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was funded by the NIH grant 5R44DA026220-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian AN, 2011, CURR PHARM BIOTECHNO, V12, P89; Albin KC, 2008, CHEM SENSES, V33, P3, DOI 10.1093/chemse/bjm056; Anderson EM, 2012, NEUROSCIENCE, V223, P45, DOI 10.1016/j.neuroscience.2012.07.037; Anderson EM, 2012, NEUROSCIENCE, V214, P14, DOI 10.1016/j.neuroscience.2012.04.032; Anderson EM, 2013, JOVE-J VIS EXP, DOI 10.3791/50336; Caspani O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007383; Caspani O, 2009, J GEN PHYSIOL, V133, P245, DOI 10.1085/jgp.200810136; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cliff MA, 1996, PHYSIOL BEHAV, V59, P487, DOI 10.1016/0031-9384(95)02089-6; Daniels RL, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-23; del Camino D, 2010, J NEUROSCI, V30, P15165, DOI 10.1523/JNEUROSCI.2580-10.2010; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Dunham JP, 2010, NEUROSCIENCE, V165, P1412, DOI 10.1016/j.neuroscience.2009.11.065; Facer P, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-11; Farco JA, 2013, MINI-REV MED CHEM, V13, P124; Fluhr K, 2009, CLIN J PAIN, V25, P128, DOI 10.1097/AJP.0b013e3181817aa2; Frederick J, 2007, BIOCHEM BIOPH RES CO, V358, P1058, DOI 10.1016/j.bbrc.2007.05.029; Gaudioso C, 2012, PAIN, V153, P473, DOI 10.1016/j.pain.2011.11.014; Gentry C, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-4; Green BG, 2005, CHEM SENSES, V30, pI201, DOI 10.1093/chemse/bjh184; Green BG, 2000, PHYSIOL BEHAV, V68, P631, DOI 10.1016/S0031-9384(99)00221-8; Guimaraes M.Z.P., 2007, TRPA1 SENSORY CHANNE; Knowlton WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025894; Knowlton WM, 2010, PAIN, V150, P340, DOI 10.1016/j.pain.2010.05.021; Kwan KY, 2009, J GEN PHYSIOL, V133, P251, DOI 10.1085/jgp.200810146; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; LAMOTTE RH, 1991, J NEUROPHYSIOL, V66, P190, DOI 10.1152/jn.1991.66.1.190; Liu BY, 2013, PAIN, V154, P2169, DOI 10.1016/j.pain.2013.06.043; McKemy D., 2007, TRPM8 COLD MENTHOL R; McKemy DD, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-16; McKemy DD, 2013, ACS CHEM NEUROSCI, V4, P238, DOI 10.1021/cn300193h; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Neubert JK, 2006, BEHAV BRAIN RES, V170, P308, DOI 10.1016/j.bbr.2006.03.008; Neubert JK, 2005, PAIN, V116, P386, DOI 10.1016/j.pain.2005.05.011; Neubert JK, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-49; Neubert JK, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-43; Nolan TA, 2012, PAIN; Nolan TA, 2011, BEHAV BRAIN RES, V217, P477, DOI 10.1016/j.bbr.2010.10.022; Nolan TA, 2011, BEHAV BRAIN RES, V216, P723, DOI 10.1016/j.bbr.2010.08.023; Pan R, 2012, J PHARMACOL EXP THER, V343, P661, DOI 10.1124/jpet.112.196717; Patil MJ, 2010, NEUROSCIENCE, V171, P1109, DOI 10.1016/j.neuroscience.2010.09.031; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Roberts K, 2011, J CLIN NEUROSCI, V18, P926, DOI 10.1016/j.jocn.2010.11.015; Rossi HL, 2012, NEUROSCIENCE, V224, P294, DOI 10.1016/j.neuroscience.2012.08.015; Rossi HL, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-37; Rossi HL, 2008, BEHAV BRAIN RES, V187, P478, DOI 10.1016/j.bbr.2007.09.021; Rossi HL, 2009, J PAIN, V10, P646, DOI 10.1016/j.jpain.2009.01.002; Rossi HL, 2009, BEHAV BRAIN RES, V203, P240, DOI 10.1016/j.bbr.2009.05.009; Sang CN, 1996, ANESTHESIOLOGY, V85, P491, DOI 10.1097/00000542-199609000-00007; SIDELL N, 1990, J CELL PHYSIOL, V142, P410, DOI 10.1002/jcp.1041420226; SIMONE DA, 1989, PAIN, V38, P99, DOI 10.1016/0304-3959(89)90079-1; Sluka KA, 1997, PAIN, V71, P157, DOI 10.1016/S0304-3959(97)03354-X; Staaf S, 2009, PAIN, V144, P187, DOI 10.1016/j.pain.2009.04.013; Staruschenko A, 2010, J BIOL CHEM, V285, P15167, DOI 10.1074/jbc.M110.106153; SWANDULLA D, 1987, PFLUG ARCH EUR J PHY, V409, P52, DOI 10.1007/BF00584749; SWANDULLA D, 1986, NEUROSCI LETT, V68, P23, DOI 10.1016/0304-3940(86)90223-5; Szallasi A, 2007, COMPLEX REGULATION T; Zhao M, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-55	58	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89137	10.1371/journal.pone.0089137	http://dx.doi.org/10.1371/journal.pone.0089137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558480	gold, Green Submitted, Green Published			2022-12-27	WOS:000331706700126
J	Cavalcanti, E; Vadrucci, E; Delvecchio, FR; Addabbo, F; Bettini, S; Liou, R; Monsurro, V; Huang, AYC; Pizarro, TT; Santino, A; Chieppa, M				Cavalcanti, Elisabetta; Vadrucci, Elisa; Delvecchio, Francesca Romana; Addabbo, Francesco; Bettini, Simona; Liou, Rachel; Monsurro, Vladia; Huang, Alex Yee-Chen; Pizarro, Theresa Torres; Santino, Angelo; Chieppa, Marcello			Administration of Reconstituted Polyphenol Oil Bodies Efficiently Suppresses Dendritic Cell Inflammatory Pathways and Acute Intestinal Inflammation	PLOS ONE			English	Article							EPITHELIAL-CELLS; QUERCETIN GLUCURONIDES; BOWEL DISEASES; COLITIS; DIFFERENTIATION; BIOAVAILABILITY; STABILIZATION; ACTIVATION; QUERCITRIN; MECHANISM	Polyphenols are natural compounds capable of interfering with the inflammatory pathways of several in vitro model systems. In this study, we developed a stable and effective strategy to administer polyphenols to treat in vivo models of acute intestinal inflammation. The in vitro suppressive properties of several polyphenols were first tested and compared for dendritic cells (DCs) production of inflammatory cytokines. A combination of the polyphenols, quercetin and piperine, were then encapsulated into reconstituted oil bodies (OBs) in order to increase their stability. Our results showed that administration of low dose reconstituted polyphenol OBs inhibited LPS-mediated inflammatory cytokine secretion, including IL-6, IL-23, and IL-12, while increasing IL-10 and IL-1R alpha production. Mice treated with the polyphenol-containing reconstituted OBs (ROBs) were partially protected from dextran sodium sulfate (DSS)-induced colitis and associated weight loss, while mortality and inflammatory scores revealed an overall anti-inflammatory effect that was likely mediated by impaired DC immune responses. Our study indicates that the administration of reconstituted quercetin and piperine-containing OBs may represent an effective and potent anti-inflammatory strategy to treat acute intestinal inflammation.	[Cavalcanti, Elisabetta; Vadrucci, Elisa; Addabbo, Francesco; Chieppa, Marcello] IRCCS de Bellis, Lab Expt Immunopathol, Castellana Grotte, BA, Italy; [Vadrucci, Elisa; Delvecchio, Francesca Romana; Chieppa, Marcello] Mario Negri South, Lab Mucosal Immunol, Santa Maria Imbaro, CH, Italy; [Delvecchio, Francesca Romana; Chieppa, Marcello] ARCHES, Lab Translat Med, Castellana Grotte, BA, Italy; [Bettini, Simona] Univ Salento, Dept Engn Innovat, Lecce, Italy; [Liou, Rachel; Huang, Alex Yee-Chen] Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; [Monsurro, Vladia] Univ Verona, Sch Med, Dept Pathol & Diagnost, I-37100 Verona, Italy; [Pizarro, Theresa Torres] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Santino, Angelo] CNR, Inst Sci Food Prod, Lecce, Italy	IRCCS Saverio de Bellis; University of Salento; Case Western Reserve University; University of Verona; Case Western Reserve University; Consiglio Nazionale delle Ricerche (CNR); Istituto Scienze delle Produzioni Alimentari (ISPA-CNR)	Chieppa, M (corresponding author), IRCCS de Bellis, Lab Expt Immunopathol, Castellana Grotte, BA, Italy.	transmed@irccsdebellis.it	Chieppa, Marcello/I-8447-2018; Santino, Angelo/AAD-5735-2020; Huang, Alex/R-4662-2017; Huang, Alex Y./ABG-8182-2021; Chieppa, Marcello/AAG-9835-2019	Chieppa, Marcello/0000-0001-9819-0823; Santino, Angelo/0000-0002-3348-0747; Huang, Alex/0000-0002-5701-4521; Huang, Alex Y./0000-0002-5701-4521; Chieppa, Marcello/0000-0001-9819-0823; Bettini, Simona/0000-0002-5506-5413; Delvecchio, Francesca Romana/0000-0002-3661-1212	"My First AIRC Grant Italian Cancer Association'' Milano Italy [MFAG 10684]; Italian Ministry of Health; Fondazione Cassa di Risparmio di Puglia [GR2009]; "Pro.Ali.Fun'' (ARCHES, Castellana Grotte, Bari) [PON02_00186_2937475]; NIH [R01 CA154656, P01 DK091222]; St. Baldrick's Foundation; NATIONAL CANCER INSTITUTE [R01CA154656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK091222] Funding Source: NIH RePORTER	"My First AIRC Grant Italian Cancer Association'' Milano Italy; Italian Ministry of Health(Ministry of Health, Italy); Fondazione Cassa di Risparmio di Puglia; "Pro.Ali.Fun'' (ARCHES, Castellana Grotte, Bari); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Baldrick's Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by "My First AIRC Grant (MFAG 10684) Italian Cancer Association" Via Corridoni, 7 20122 Milano Italy; the Italian Ministry of Health, "GR2009" the Fondazione Cassa di Risparmio di Puglia, PON02_00186_2937475 "Pro.Ali.Fun" and 5 per mille 2010 (ARCHES, Castellana Grotte, Bari); A.Y.H. is supported by NIH R01 CA154656 and the St. Baldrick's Foundation; T. T. P is supported by NIH P01 DK091222. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardo D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036262; Bettini S, 2013, RSC ADV, V3, P5422, DOI 10.1039/c3ra40552d; BURN PL, 1992, J CHEM SOC CHEM COMM, P32, DOI 10.1039/c39920000032; Cai X, 2013, CURR MED CHEM, V20, P2572, DOI 10.2174/09298673113209990120; Chen MCM, 2004, J AGR FOOD CHEM, V52, P3982, DOI 10.1021/jf035533g; Chen X, 2006, CELL MOL IMMUNOL, V3, P401; Chieppa M, 2003, J IMMUNOL, V171, P4552, DOI 10.4049/jimmunol.171.9.4552; Comalada M, 2005, EUR J IMMUNOL, V35, P584, DOI 10.1002/eji.200425778; COOPER HS, 1993, LAB INVEST, V69, P238; D'Introno A, 2009, PLANT BIOTECHNOL J, V7, P422, DOI 10.1111/j.1467-7652.2009.00409.x; Dall'Acqua S, 2012, MOLECULES, V17, P8898, DOI 10.3390/molecules17088898; de Baey A, 2003, J IMMUNOL, V170, P5089, DOI 10.4049/jimmunol.170.10.5089; de Medina FS, 2002, LIFE SCI, V70, P3097, DOI 10.1016/S0024-3205(02)01568-0; Hanabuchi S, 2010, J IMMUNOL, V184, P2999, DOI 10.4049/jimmunol.0804106; Hart AL, 2005, GASTROENTEROLOGY, V129, P50, DOI 10.1053/j.gastro.2005.05.013; Iliev ID, 2009, MUCOSAL IMMUNOL, V2, P340, DOI 10.1038/mi.2009.13; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Kasimsetty SG, 2009, J AGR FOOD CHEM, V57, P10636, DOI 10.1021/jf902716r; Kawai Y, 2008, J BIOL CHEM, V283, P9424, DOI 10.1074/jbc.M706571200; Kesarwani Kritika, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P253, DOI 10.1016/S2221-1691(13)60060-X; Kim JJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3678; Kraus TA, 2004, GASTROENTEROLOGY, V126, P1771, DOI 10.1053/j.gastro.2004.03.076; Macagno A, 2007, TRENDS IMMUNOL, V28, P227, DOI 10.1016/j.it.2007.03.008; Manjeet R, 1999, INT J IMMUNOPHARMACO, V21, P435, DOI 10.1016/S0192-0561(99)00024-7; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Middel P, 2006, GUT, V55, P220, DOI 10.1136/gut.2004.063008; Naito Y, 2004, INFLAMM RES, V53, P462, DOI 10.1007/s00011-004-1281-1; Nish S, 2011, IMMUNITY, V34, P629, DOI 10.1016/j.immuni.2011.05.009; Parlato S, 2001, BLOOD, V98, P3022, DOI 10.1182/blood.V98.10.3022; Peng CC, 2003, BIOTECHNOL PROGR, V19, P1623, DOI 10.1021/bp034129z; Perrier C, 2011, IMMUNOTHERAPY-UK, V3, P1341, DOI [10.2217/imt.11.122, 10.2217/IMT.11.122]; Rescigno M, 2005, NAT MED, V11, P254, DOI 10.1038/nm0305-254; Rimoldi M, 2005, BLOOD, V106, P2818, DOI 10.1182/blood-2004-11-4321; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Romier B, 2008, BRIT J NUTR, V100, P542, DOI 10.1017/S0007114508966666; Romier B, 2009, NUTR REV, V67, P363, DOI 10.1111/j.1753-4887.2009.00210.x; Ruiz PA, 2007, J NUTR, V137, P1208, DOI 10.1093/jn/137.5.1208; Shirai M, 2001, J AGR FOOD CHEM, V49, P5602, DOI 10.1021/jf010713g; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tzen JTC, 1998, J BIOCHEM-TOKYO, V123, P318, DOI 10.1093/oxfordjournals.jbchem.a021939; Yang JH, 2006, DRUG METAB DISPOS, V34, P296, DOI 10.1124/dmd.105.005280	43	36	37	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88898	10.1371/journal.pone.0088898	http://dx.doi.org/10.1371/journal.pone.0088898			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558444	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700090
J	Hill, DB; Vasquez, PA; Mellnik, J; McKinley, SA; Vose, A; Mu, F; Henderson, AG; Donaldson, SH; Alexis, NE; Boucher, RC; Forest, MG				Hill, David B.; Vasquez, Paula A.; Mellnik, John; McKinley, Scott A.; Vose, Aaron; Mu, Frank; Henderson, Ashley G.; Donaldson, Scott H.; Alexis, Neil E.; Boucher, Richard C.; Forest, M. Gregory			A Biophysical Basis for Mucus Solids Concentration as a Candidate Biomarker for Airways Disease	PLOS ONE			English	Article							CYSTIC-FIBROSIS; RHEOLOGICAL PROPERTIES; PULMONARY SECRETIONS; VISCOELASTIC MODULI; RESPIRATORY MUCUS; SPUTUM; MUCIN; BRONCHIECTASIS; PENETRATION; DIFFUSION	In human airways diseases, including cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD), host defense is compromised and airways inflammation and infection often result. Mucus clearance and trapping of inhaled pathogens constitute key elements of host defense. Clearance rates are governed by mucus viscous and elastic moduli at physiological driving frequencies, whereas transport of trapped pathogens in mucus layers is governed by diffusivity. There is a clear need for simple and effective clinical biomarkers of airways disease that correlate with these properties. We tested the hypothesis that mucus solids concentration, indexed as weight percent solids (wt%), is such a biomarker. Passive microbead rheology was employed to determine both diffusive and viscoelastic properties of mucus harvested from human bronchial epithelial (HBE) cultures. Guided by sputum from healthy (1.5-2.5 wt%) and diseased (COPD, CF; 5 wt%) subjects, mucus samples were generated in vitro to mimic in vivo physiology, including intermediate range wt% to represent disease progression. Analyses of microbead datasets showed mucus diffusive properties and viscoelastic moduli scale robustly with wt%. Importantly, prominent changes in both biophysical properties arose at similar to 4 wt%, consistent with a gel transition (from a more viscous-dominated solution to a more elastic-dominated gel). These findings have significant implications for: (1) penetration of cilia into the mucus layer and effectiveness of mucus transport; and (2) diffusion vs. immobilization of micro-scale particles relevant to mucus barrier properties. These data provide compelling evidence for mucus solids concentration as a baseline clinical biomarker of mucus barrier and clearance functions.	[Hill, David B.; Vose, Aaron; Mu, Frank; Henderson, Ashley G.; Donaldson, Scott H.; Boucher, Richard C.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27514 USA; [Hill, David B.] Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC USA; [Vasquez, Paula A.; Mellnik, John; Forest, M. Gregory] Univ N Carolina, Dept Math, Chapel Hill, NC USA; [Vasquez, Paula A.; Mellnik, John; Forest, M. Gregory] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC USA; [McKinley, Scott A.] Univ Florida, Dept Math, Gainesville, FL 32611 USA; [Henderson, Ashley G.] Univ N Carolina, Dept Med, Div Pulm & Crit Care, Chapel Hill, NC USA; [Alexis, Neil E.] Univ N Carolina, Dept Pediat, Ctr Environm Med Asthma & Lung Biol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; State University System of Florida; University of Florida; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Hill, DB (corresponding author), Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27514 USA.	dbhill@med.unc.edu	Donaldson, Scott H./ABG-5157-2021	Donaldson, Scott H./0000-0003-4802-0388	National Science Foundation [DMS-1100281, DMR-1122483]; National Institutes of Health [NIH/NHLBI 1 P01 HL 108808-01A1, NIH/NHLBI 5 R01 HL 077546-05]; Simons Foundation [245653]; Cystic Fibrosis Foundation [HILL08I0, BUTTON07XX0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077546, P01HL108808] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was funded by National Science Foundation grants DMS-1100281, DMR-1122483, National Institutes of Health grants NIH/NHLBI 1 P01 HL 108808-01A1, NIH/NHLBI 5 R01 HL 077546-05, a Simons Foundation Collaboration Grant Number 245653, and the Cystic Fibrosis Foundation (HILL08I0, BUTTON07XX0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANSIL R, 1995, ANNU REV PHYSIOL, V57, P635, DOI 10.1146/annurev.ph.57.030195.003223; Bhat PG, 1996, J PHARM SCI, V85, P624, DOI 10.1021/js950381s; Boucher RC, 2003, PFLUG ARCH EUR J PHY, V445, P495, DOI 10.1007/s00424-002-0955-1; Button B, 2012, SCIENCE, V337, P937, DOI 10.1126/science.1223012; Celli JP, 2007, BIOMACROMOLECULES, V8, P1580, DOI 10.1021/bm0609691; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008; Dawson M, 2003, J BIOL CHEM, V278, P50393, DOI 10.1074/jbc.M309026200; Deng WH, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.011112; Didier G, 2012, J TIME SER ANAL, V33, P724, DOI 10.1111/j.1467-9892.2012.00792.x; Ernst D, 2012, SOFT MATTER, V8, P4886, DOI 10.1039/c2sm25220a; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Georgiades P, 2013, BIOPOLYMERS; Hill DB, 2012, ESTABLISHMENT RESP A; Jeffery PK, 1998, THORAX, V53, P129, DOI 10.1136/thx.53.2.129; Kater A, 2007, ANN NY ACAD SCI, V1112, P140, DOI 10.1196/annals.1415.006; Kesimer M, 2009, AM J PHYSIOL-LUNG C, V296, pL92, DOI 10.1152/ajplung.90388.2008; Kirch J, 2012, P NATL ACAD SCI USA, V109, P18355, DOI 10.1073/pnas.1214066109; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Lai SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004294; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P86, DOI 10.1016/j.addr.2008.09.012; Larsen TH, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.146001; Livraghi-Butrico A, 2012, MUCOSAL IMMUNOL, V5, P397, DOI 10.1038/mi.2012.17; Loughlin CE, 2010, RESP MED, V104, P29, DOI 10.1016/j.rmed.2009.07.002; Macierzanka A, 2011, SOFT MATTER, V7, P8077, DOI 10.1039/c1sm05888f; MacKintosh FC, 1999, CURR OPIN COLLOID IN, V4, P300, DOI 10.1016/S1359-0294(99)90010-9; Magdziarz M, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011129; Mall MA, 2008, AM J RESP CRIT CARE, V177, P730, DOI 10.1164/rccm.200708-1233OC; Mason TG, 2000, RHEOL ACTA, V39, P371, DOI 10.1007/s003970000094; Mason TG, 1997, PHYS REV LETT, V79, P3282, DOI 10.1103/PhysRevLett.79.3282; MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250; Matsui H, 2005, J IMMUNOL, V175, P1090, DOI 10.4049/jimmunol.175.2.1090; Matsui H, 2006, P NATL ACAD SCI USA, V103, P18131, DOI 10.1073/pnas.0606428103; MATTHEWS LW, 1963, AM REV RESPIR DIS, V88, P199; O'Malley D, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/01/L01001; PIN I, 1992, THORAX, V47, P25, DOI 10.1136/thx.47.1.25; POTTER JL, 1967, AM REV RESPIR DIS, V96, P83; PUCHELLE E, 1984, BIORHEOLOGY, V21, P265; Quraishi MS, 1998, CLIN OTOLARYNGOL, V23, P403, DOI 10.1046/j.1365-2273.1998.00172.x; ROBERTS GP, 1976, ARCH BIOCHEM BIOPHYS, V173, P528, DOI 10.1016/0003-9861(76)90289-7; Rubin BK, 2007, PAEDIATR RESPIR REV, V8, P4, DOI 10.1016/j.prrv.2007.02.004; Sackner M A, 1987, Eur J Respir Dis Suppl, V153, P159; Saito DM, 2010, AM J RHINOL ALLERGY, V24, P1, DOI 10.2500/ajra.2010.24.3420; Savin T, 2005, BIOPHYS J, V88, P623, DOI [10.1529/biophysj.104.042457, 10.1529/biophysj.104.04245]; Schuster BS, 2013, BIOMATERIALS, V34, P3439, DOI 10.1016/j.biomaterials.2013.01.064; SILBERBERG A, 1982, ADV EXP MED BIOL, V144, P53; TAM PY, 1980, BIORHEOLOGY, V17, P465; TAM PY, 1981, NATURE, V292, P340, DOI 10.1038/292340a0; Thornton DJ, 1997, J BIOL CHEM, V272, P9561; Waigh TA, 2005, REP PROG PHYS, V68, P685, DOI 10.1088/0034-4885/68/3/R04; Weber SC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.238102; WINTER HH, 1987, POLYM ENG SCI, V27, P1698, DOI 10.1002/pen.760272209; Yakubov GE, 2007, BIOMACROMOLECULES, V8, P3467, DOI 10.1021/bm700607w	54	113	113	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e87681	10.1371/journal.pone.0087681	http://dx.doi.org/10.1371/journal.pone.0087681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558372	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700018
J	Ismail, SA; Ghazoul, J; Ravikanth, G; Kushalappa, CG; Shaanker, RU; Kettle, CJ				Ismail, Sascha A.; Ghazoul, Jaboury; Ravikanth, Gudasalamani; Kushalappa, Cheppudira G.; Shaanker, Ramanan Uma; Kettle, Chris J.			Forest Trees in Human Modified Landscapes: Ecological and Genetic Drivers of Recruitment Failure in Dysoxylum malabaricum (Meliaceae)	PLOS ONE			English	Article							WESTERN-GHATS; BIODIVERSITY CONSERVATION; INBREEDING DEPRESSION; HABITAT FRAGMENTATION; SEED DISPERSAL; SACRED GROVES; SYNERGISMS; POLLEN; METAANALYSIS; DISTURBANCE	Tropical agro-forest landscapes are global priority areas for biodiversity conservation. Little is known about the ability of these landscapes to sustain large late successional forest trees upon which much forest biodiversity depends. These landscapes are subject to fragmentation and additional habitat degradation which may limit tree recruitment and thus compromise numerous ecosystem services including carbon storage and timber production. Dysoxylum malabaricum is a large canopy tree species in the Meliaceae, a family including many important tropical timber trees. This species is found in highly fragmented forest patches within a complex agro-forest landscape of the Western Ghats biodiversity hot spot, South India. In this paper we combined a molecular assessment of inbreeding with ecological and demographic data to explore the multiple threats to recruitment of this tree species. An evaluation of inbreeding, using eleven microsatellite loci in 297 nursery-reared seedlings collected form low and high density forest patches embedded in an agro-forest matrix, shows that mating between related individuals in low density patches leads to reduced seedling performance. By quantifying habitat degradation and tree recruitment within these forest patches we show that increasing canopy openness and the increased abundance of pioneer tree species lead to a general decline in the suitability of forest patches for the recruitment of D. malabaricum. We conclude that elevated inbreeding due to reduced adult tree density coupled with increased degradation of forest patches, limit the recruitment of this rare late successional tree species. Management strategies which maintain canopy cover and enhance local densities of adult trees in agro-forest mosaics will be required to ensure D. malabaricum persists in these landscapes. Our study highlights the need for a holistic understanding of the incipient processes that threaten populations of many important and rare tropical tree species in human dominated agro-forest landscapes.	[Ismail, Sascha A.; Ghazoul, Jaboury; Kettle, Chris J.] Swiss Fed Inst Technol, Inst Terr Ecosyst, Zurich, Switzerland; [Ravikanth, Gudasalamani; Shaanker, Ramanan Uma] Ashoka Trust Res Ecol & Environm, Bangalore, Karnataka, India; [Kushalappa, Cheppudira G.] Univ Agr Sci Bangalore, Coll Forestry, Ponnampet, Karnataka, India; [Shaanker, Ramanan Uma] Univ Agr Sci, Dept Crop Physiol, Bangalore, Karnataka, India; [Shaanker, Ramanan Uma] Univ Agr Sci, Sch Ecol & Conservat, Bangalore, Karnataka, India	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Agricultural Sciences Bangalore; University of Agricultural Sciences Bangalore; University of Agricultural Sciences Bangalore	Ismail, SA (corresponding author), Swiss Fed Inst Technol, Inst Terr Ecosyst, Zurich, Switzerland.	sascha.ismail@env.ethz.ch	Ismail, Sascha A./AAU-6260-2020; G, Ravikanth/AAI-5668-2020; Ghazoul, Jaboury/B-2121-2018; Kushalappa, Cheppudira/AAY-8491-2020	G, Ravikanth/0000-0002-9399-8580; Ismail, Sascha Asif/0000-0003-2883-0666; Uma Shaanker, Ramanan/0000-0003-3100-7654	ETH Zurich [ETH-22 08-2]	ETH Zurich(ETH Zurich)	This research was funded by ETH Zurich under the grant number ETH-22 08-2 (http://www.vpf.ethz.ch/researchfunding/index_EN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves WD, 2011, NEOTROP ENTOMOL, V40, P39, DOI 10.1590/S1519-566X2011000100006; Angeloni F, 2011, BIOL CONSERV, V144, P35, DOI 10.1016/j.biocon.2010.08.016; [Anonymous], 1952, WEALTH INDIA RAW MAT; Benitez-Malvido J, 2003, BIOTROPICA, V35, P530, DOI 10.1111/j.1744-7429.2003.tb00609.x; Berec L, 2007, TRENDS ECOL EVOL, V22, P185, DOI 10.1016/j.tree.2006.12.002; Bhagwat SA, 2005, ECOL SOC, V10; Bhagwat SA, 2005, CONSERV BIOL, V19, P1853, DOI 10.1111/j.1523-1739.2005.00248.x; Breed MF, 2012, MOL ECOL, V21, P5955, DOI 10.1111/mec.12056; Breed MF, 2012, ECOL LETT, V15, P444, DOI 10.1111/j.1461-0248.2012.01752.x; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brooks TM, 2004, BIOSCIENCE, V54, P1081, DOI 10.1641/0006-3568(2004)054[1081:CPBTGP]2.0.CO;2; Cascante A, 2002, CONSERV BIOL, V16, P137, DOI 10.1046/j.1523-1739.2002.00317.x; Chandrakanth MG, 2004, NAT RESOUR FORUM, V28, P102, DOI 10.1111/j.1477-8947.2004.00077.x; Chandran MDS, 1997, CURR SCI INDIA, V73, P146; CHANDRASHEKARA UM, 1994, J TROP ECOL, V10, P337, DOI 10.1017/S0266467400008014; Dick C. W., 2008, Tropical Plant Biology, V1, P20, DOI 10.1007/s12042-007-9006-6; Didham RK, 1996, TRENDS ECOL EVOL, V11, P255, DOI 10.1016/0169-5347(96)20047-3; Eggleton P, 1996, PHILOS T R SOC B, V351, P51, DOI 10.1098/rstb.1996.0004; Fox CW, 2011, EVOLUTION, V65, P246, DOI 10.1111/j.1558-5646.2010.01108.x; Galetti M, 2013, SCIENCE, V340, P1086, DOI 10.1126/science.1233774; Ganesh T, 2001, CURR SCI INDIA, V80, P394; Garcia C., 2006, ECOLOGICAL NATL NATU, P199; Garcia CA, 2010, CONSERV BIOL, V24, P479, DOI 10.1111/j.1523-1739.2009.01386.x; Ghazoul J, 2005, BIOL REV, V80, P413, DOI 10.1017/S1464793105006731; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hobbs RJ, 2001, CONSERV BIOL, V15, P1522, DOI 10.1046/j.1523-1739.2001.01092.x; Ismail SA, 2012, MOL ECOL, V21, P5484, DOI 10.1111/mec.12054; Jones DT, 2003, J APPL ECOL, V40, P380, DOI 10.1046/j.1365-2664.2003.00794.x; Kettle CJ, 2007, MOL ECOL, V16, P3581, DOI 10.1111/j.1365-294X.2007.03419.x; Kramer AT, 2008, CONSERV BIOL, V22, P878, DOI 10.1111/j.1523-1739.2008.00944.x; Kumar R, 2000, 100 RED LISTED MED P; Kushalappa C. G., 2001, FOREST GENETIC RESOU, P21; Laurance William F, 2006, Ecology, V87, P469, DOI 10.1890/05-0064; Laurance WF, 2009, CONSERV BIOL, V23, P1427, DOI 10.1111/j.1523-1739.2009.01336.x; LEE K. E., 1971, Termites and Soils.; LEMMON PAUL E., 1956, FOREST SCI, V2, P314; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Markl JS, 2012, CONSERV BIOL, V26, P1072, DOI 10.1111/j.1523-1739.2012.01927.x; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Mouillot D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001569; Naidoo R, 2008, P NATL ACAD SCI USA, V105, P9495, DOI 10.1073/pnas.0707823105; R Core Team, 2021, R LANGUAGE ENV STAT; Raman TRS, 2003, BIRD CONSERV INT, V13, P199, DOI 10.1017/S0959270903003162; Ritland K, 1996, GENET RES, V67, P175, DOI 10.1017/S0016672300033620; Scariot A, 2000, BIOTROPICA, V32, P662, DOI 10.1646/0006-3606(2000)032[0662:SMBLIA]2.0.CO;2; Tabarelli M, 2004, BIODIVERS CONSERV, V13, P1419, DOI 10.1023/B:BIOC.0000019398.36045.1b; Tabarelli M, 2012, BIOL CONSERV, V155, P136, DOI 10.1016/j.biocon.2012.06.020; Uriarte M, 2010, ECOLOGY, V91, P1317, DOI 10.1890/09-0785.1; Wright SJ, 2006, BIOTROPICA, V38, P287, DOI 10.1111/j.1744-7429.2006.00154.x	49	21	21	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89437	10.1371/journal.pone.0089437	http://dx.doi.org/10.1371/journal.pone.0089437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558500	Green Submitted, Green Published, gold			2022-12-27	WOS:000331706700146
J	Kessler, R; Hegenscheid, K; Fleck, S; Khaw, A; Kirsch, M; Hosten, N; Langner, S				Kessler, Rebecca; Hegenscheid, Katrin; Fleck, Steffen; Khaw, Alexander; Kirsch, Michael; Hosten, Norbert; Langner, Soenke			Patient Body Weight-Tailored Contrast Medium Injection Protocol for the Craniocervical Vessels: A Prospective Computed Tomography Study	PLOS ONE			English	Article							MULTIDETECTOR CT; HEPATIC ENHANCEMENT; ARTERIAL PHASE; BOLUS-TRACKING; MASS INDEX; HELICAL CT; ANGIOGRAPHY; DURATION; LIVER; UNIFORMITY	Objectives: To evaluate body weight-tailored contrast medium (CM) administration for computed tomography angiography (CTA) of the craniocervical vessels. Methods: Institutional review board approval was obtained, and all patients gave written informed consent. Sixty patients were consecutively assigned to one of three dose groups (20 patients per group) with CM doses of Visipaque 270 (R) (iodixanol 270 mg/ml) tailored to body weight at doses of 1.5, 1.0, or 0.5 ml/kg. Region-of-interest (ROI) analysis of maximum enhancement (ME) was conducted, and signal-to-noise-ratios (SNR) and contrast-to-noise-ratios (CNR) were calculated. Retrospective comparison was performed with three matched control groups examined with a standard CM dose (80 ml of Visipaque 270 (R)). Image quality was rated by two neuroradiologists blinded to the CM dose used. Interrater reliability was calculated using kappa statistics. Results: Body weight/BMI and ME were inversely correlated in the three control groups receiving the standard dose (r = -0.544/-0.597/-0.542/r = -0.358/r = -0.424/r = -0.280). Compared to standard dose, 1.5 ml/kg produced higher ME, SNR, and CNR in the anterior circulation (p <= 0.038), 1.0 ml/kg had higher ME in cervical and medium-sized cerebral arteries (p <= 0.034), and 0.5 ml/kg had lower ME, SNR and CNR for medium-sized cerebral arteries (p <= 0.049). ME, SNR, and CNR were the same for 1.5 ml/kg and 1.0 ml/kg (p >= 0.24), and both had higher values compared to 0.5 ml/kg (p <= 0.043/p <= 0.028). In patients with BMI>25, 1.5 ml/kg and 1.0 ml/kg produced higher ME than standard dose (p<0.001/p = 0.008), but ME in patients with BMI>25 did not differ between group 1 and group 2 (p = 0.673). In patients with BMI <= 25, 1.5 ml/kg and 1.0 ml/kg produced ME comparable to standard dose (p = 0.132/p = 0.403). Regardless of patient weight, 0.5 ml/kg yielded lower ME than standard dose (p = 0.019/0.002). Conclusions: Craniocervical CTA with a body weight-tailored CM dose of 1.0 ml/kg (270 mg iodine/ml) reduces iodine load in patients weighing <80 kg while producing ME similar to standard dose and improves ME in patients with BMI>25.	[Kessler, Rebecca; Hegenscheid, Katrin; Kirsch, Michael; Hosten, Norbert; Langner, Soenke] Univ Med Greifswald, Inst Diagnost Radiol & Neuroradiol, Greifswald, Germany; [Fleck, Steffen] Univ Med Greifswald, Dept Neurosurg, Greifswald, Germany; [Khaw, Alexander] Univ Med Greifswald, Dept Neurol, Greifswald, Germany	Greifswald Medical School; Greifswald Medical School; Greifswald Medical School	Kessler, R (corresponding author), Univ Med Greifswald, Inst Diagnost Radiol & Neuroradiol, Greifswald, Germany.	rebecca.seipel@uni-greifswald.de	Langner, Soenke/ABB-6744-2021	Langner, Soenke/0000-0001-7241-1173				Angermaier A, 2011, CEREBROVASC DIS, V31, P177, DOI 10.1159/000321868; Arakawa H, 2007, AM J ROENTGENOL, V189, P156, DOI 10.2214/AJR.06.1240; Arana E, 2009, EUR J RADIOL, V70, P507, DOI 10.1016/j.ejrad.2008.01.048; Awai K, 2004, RADIOLOGY, V230, P142, DOI 10.1148/radiol.2301021008; Bae KT, 1998, RADIOLOGY, V207, P647, DOI 10.1148/radiology.207.3.9609886; Bae KT, 2008, AM J ROENTGENOL, V190, P777, DOI 10.2214/AJR.07.2765; Bae KT, 2007, RADIOLOGY, V242, P582, DOI 10.1148/radiol.2422052132; Byrt T, 1996, EPIDEMIOLOGY, V7, P561, DOI 10.1097/00001648-199609000-00030; Fleischmann D, 2000, RADIOLOGY, V214, P363, DOI 10.1148/radiology.214.2.r00fe18363; FOX AJ, 1993, RADIOLOGY, V186, P316, DOI 10.1148/radiology.186.2.8421726; Herman S, 2004, J COMPUT ASSIST TOMO, V28, pS7, DOI 10.1097/01.rct.0000120855.80935.2f; Ho LM, 2007, RADIOLOGY, V243, P431, DOI 10.1148/radiol.2432060390; Ichikawa T, 2006, EUR J RADIOL, V58, P165, DOI 10.1016/j.ejrad.2005.11.037; Kalra MK, 2003, KOREAN J RADIOL, V4, P234, DOI 10.3348/kjr.2003.4.4.234; Katzberg RW, 2007, RADIOLOGY, V243, P622, DOI 10.1148/radiol.2433061411; Kondo H, 2010, RADIOLOGY, V254, P163, DOI 10.1148/radiol.09090369; Kondo H, 2008, RADIOLOGY, V249, P872, DOI 10.1148/radiol.2492080033; KORMANO M, 1983, INVEST RADIOL, V18, P364, DOI 10.1097/00004424-198307000-00013; Morcos SK, 1999, EUR RADIOL, V9, P1602, DOI 10.1007/s003300050894; Nakaura T, 2008, INVEST RADIOL, V43, P512, DOI 10.1097/RLI.0b013e3181727505; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; Roggenland D, 2008, AM J ROENTGENOL, V190, pW351, DOI 10.2214/AJR.07.3402; Sandstede JJW, 2001, EUR RADIOL, V11, P1396, DOI 10.1007/s003300000816; Schoellnast H, 2006, AM J ROENTGENOL, V187, P1074, DOI 10.2214/AJR.05.0714; Seifarth H, 2009, EUR RADIOL, V19, P2373, DOI 10.1007/s00330-009-1421-7; Shimizu T, 2000, J COMPUT ASSIST TOMO, V24, P219, DOI 10.1097/00004728-200003000-00006; Tan IYL, 2009, AM J NEURORADIOL, V30, P525, DOI 10.3174/ajnr.A1408; Tatsugami F, 2010, ACAD RADIOL, V17, P207, DOI 10.1016/j.acra.2009.09.010; U.S. National Library of Medicine National Institutes of Health, 2009, VISIPAQUE IOD INJ SO; Yamashita Y, 2000, RADIOLOGY, V216, P718, DOI 10.1148/radiology.216.3.r00se26718; Yanaga Y, 2007, RADIOLOGY, V245, P475, DOI 10.1148/radiol.2452061749	31	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88867	10.1371/journal.pone.0088867	http://dx.doi.org/10.1371/journal.pone.0088867			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558438	gold, Green Submitted, Green Published			2022-12-27	WOS:000331706700084
J	Murray, AD; McNeil, CJ; Salarirad, S; Whalley, LJ; Staff, RT				Murray, Alison D.; McNeil, Christopher J.; Salarirad, Sima; Whalley, Lawrence J.; Staff, Roger T.			Early Life Socioeconomic Circumstance and Late Life Brain Hyperintensities - A Population Based Cohort Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; LIVING-CONDITIONS; ADULT MORTALITY; HEART-DISEASE; CHILDHOOD; RISK; BIRTH; ORIGINS; EXPOSURE; STROKE	Context: There have been many reports confirming the association between lower childhood socioeconomic circumstance and cardiovascular disease but evidence for links with cerebrovascular disease is contradictory. Hyperintensities on brain magnetic resonance imaging are associated with vascular risk factors, cognitive decline, dementia and death. However, the relationship between childhood socioeconomic circumstance and these lesions is unclear. Objective: To test the hypothesis that childhood socioeconomic circumstance is associated with late life hyperintensity burden and that neither adult socioeconomic circumstance nor change in socioeconomic circumstance during life influence this effect. Design: Cohort study Setting: Community Participants: 227 community dwelling members of the 1936 Aberdeen Birth Cohort aged 68 years, who were free from dementia. Main Outcome Measures: Relationship between early life socioeconomic circumstance (paternal occupation) and abundance of late life brain hyperintensities. Results: We find significant negative correlations between childhood socioeconomic circumstance and white matter hyperintensities (rho = -0.18, P<0.01), and periventricular hyperintensities (rho = -0.15, P<0.05), between educational attainment and white matter hyperintensities (rho = -0.15, P<0.05) and periventricular hyperintensities (rho = -0.17, P<0.05), and between childhood intelligence and periventricular hyperintensities (rho = -0.14, P<0.05). The relationship is strongest for childhood socioeconomic circumstance and regional white matter hyperintensities, where there is a step change in increased burden from paternal occupation grades equivalent to a shift from "white collar" to "blue collar" paternal occupation. Significant correlations were also found between hypertension and hyperintensity burden in all brain regions (rho = 0.15-0.24, P<0.05). In models that include hypertension, the magnitude of the effect of childhood socioeconomic circumstance is similar to and independent from that of hypertension. Conclusions: Childhood socioeconomic circumstance predicts the burden of brain white matter hyperintensities aged 68 years. The mechanism underlying this effect is unknown, but may act through fetal and/or early life programming of cerebrovascular disease. Future work to understand this vulnerability will inform strategies to reduce dementia and stroke.	[Murray, Alison D.; McNeil, Christopher J.; Salarirad, Sima; Whalley, Lawrence J.; Staff, Roger T.] Univ Aberdeen, Aberdeen Biomed Imaging Ctr, Aberdeen, Scotland; [Staff, Roger T.] NHS Grampian, Dept Nucl Med, Aberdeen, Scotland	University of Aberdeen; University of Aberdeen	Murray, AD (corresponding author), Univ Aberdeen, Aberdeen Biomed Imaging Ctr, Aberdeen, Scotland.	a.d.murray@abdn.ac.uk	Murray, Alison/H-6250-2017; Staff, Roger T/G-1826-2011; whalley, lawrence j/E-9019-2011	Murray, Alison/0000-0003-4915-4847; Staff, Roger T/0000-0003-0620-8673; McNeil, Chris/0000-0001-7846-1083	Alzheimer's Research UK	Alzheimer's Research UK(Alzheimer's Research UK (ARUK))	Image acquisition and image analysis for this study was funded by the Alzheimer's Research Trust (now Alzheimer's Research UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Allin MPG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024525; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Barker DJP, 2001, BMJ-BRIT MED J, V323, P1273, DOI 10.1136/bmj.323.7324.1273; Benisty S, 2009, J NEUROL NEUROSUR PS, V80, P478, DOI 10.1136/jnnp.2008.160440; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Black R, 1980, INEQUALITIES HLTH; de Lau LML, 2009, J NEUROL NEUROSUR PS, V80, P149, DOI 10.1136/jnnp.2008.149286; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; DELAMOTHE T, 1991, BRIT MED J, V303, P1046, DOI 10.1136/bmj.303.6809.1046; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; FORSDAHL A, 1978, J EPIDEMIOL COMMUN H, V32, P34, DOI 10.1136/jech.32.1.34; Galobardes B, 2006, ANN EPIDEMIOL, V16, P91, DOI 10.1016/j.annepidem.2005.06.053; Gianaros PJ, 2011, CEREB CORTEX, V21, P896, DOI 10.1093/cercor/bhq160; Gianaros PJ, 2012, CEREB CORTEX; GLIKSMAN MD, 1995, J EPIDEMIOL COMMUN H, V49, P10, DOI 10.1136/jech.49.1.10; Great Britain Office of Population Censuses and Surveys, 1990, STAND OCC CLASS COD; Grimaud O, 2011, AGE AGEING, V40, P116, DOI 10.1093/ageing/afq142; Hart CL, 2003, J EPIDEMIOL COMMUN H, V57, P385, DOI 10.1136/jech.57.5.385; Hoyle R.H., 1995, STRUCTURAL EQUATION, P158; Joreskog KG, 1984, LISREL 6 USERS GUID; Meier IB, 2012, J INT NEUROPSYCH SOC, V18, P414, DOI 10.1017/S1355617712000227; Murray AD, 2011, BRAIN, V134, P3684, DOI 10.1093/brain/awr259; Murray AD, 2012, AGE, V34, P451, DOI 10.1007/s11357-011-9233-5; Naess O, 2004, J EPIDEMIOL COMMUN H, V58, P597, DOI 10.1136/jech.2003.012229; Pickett R. Wilkinson, 2010, SPIRIT LEVEL WHY EQU; Power C, 2005, AM J PUBLIC HEALTH, V95, P1396, DOI 10.2105/AJPH.2004.047340; Salarirad S, 2011, AGE AGEING, V40, P562, DOI 10.1093/ageing/afr065; SCHELTENS P, 1993, J NEUROL SCI, V114, P7, DOI 10.1016/0022-510X(93)90041-V; Scottish Council for Research in Education, 1933, INT SCOTT SCH CHILDR; Seidler A, 2007, OCCUP ENVIRON MED, V64, P108, DOI 10.1136/oem.2005.024190; Shenkin SD, 2009, STROKE, V40, P1225, DOI 10.1161/STROKEAHA.108.527259; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Singhal A, 2006, NUTR REV, V64, pS44, DOI 10.1301/nr.2006.may.S44-S49; Smith GD, 1998, BMJ-BRIT MED J, V316, P1631, DOI 10.1136/bmj.316.7145.1631; Soderlund H, 2006, NEUROBIOL AGING, V27, P16, DOI 10.1016/j.neurobiolaging.2004.12.008; Sposato LA, 2011, J STROKE CEREBROVASC; Staff RT, 2012, ANN NEUROL, V71, P653, DOI 10.1002/ana.22631; Wamala SP, 2001, INT J EPIDEMIOL, V30, P275, DOI 10.1093/ije/30.2.275; Whalley LJ, 2011, MATURITAS, V69, P365, DOI 10.1016/j.maturitas.2011.05.010; Wright CB, 2005, STROKE, V36, P1207, DOI 10.1161/01.STR.0000165923.02318.22	42	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88969	10.1371/journal.pone.0088969	http://dx.doi.org/10.1371/journal.pone.0088969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3RA	24558456	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700102
J	Utsunomiya, YT; Carmo, AS; Neves, HHR; Carvalheiro, R; Matos, MC; Zavarez, LB; Ito, PKRK; O'Brien, AMP; Solkner, J; Porto-Neto, LR; Schenkel, FS; McEwan, J; Cole, JB; da Silva, MVGB; Van Tassell, CP; Sonstegard, TS; Garcia, JF				Utsunomiya, Yuri T.; Carmo, Adriana S.; Neves, Haroldo H. R.; Carvalheiro, Roberto; Matos, Marcia C.; Zavarez, Ludmilla B.; Ito, Pier K. R. K.; O'Brien, Ana M. Perez; Soelkner, Johann; Porto-Neto, Laercio R.; Schenkel, Flavio S.; McEwan, John; Cole, John B.; da Silva, Marcos V. G. B.; Van Tassell, Curtis P.; Sonstegard, Tad S.; Garcia, Jose Fernando			Genome-Wide Mapping of Loci Explaining Variance in Scrotal Circumference in Nellore Cattle	PLOS ONE			English	Article							ADDITIVE GENETIC-RELATIONSHIPS; REPRODUCTIVE TRAITS; BINDING-PROTEINS; HEIFER PREGNANCY; GROWTH; ASSOCIATION; SELECTION; CLONING; FAMILY; SP4	The reproductive performance of bulls has a high impact on the beef cattle industry. Scrotal circumference (SC) is the most recorded reproductive trait in beef herds, and is used as a major selection criterion to improve precocity and fertility. The characterization of genomic regions affecting SC can contribute to the identification of diagnostic markers for reproductive performance and uncover molecular mechanisms underlying complex aspects of bovine reproductive biology. In this paper, we report a genome-wide scan for chromosome segments explaining differences in SC, using data of 861 Nellore bulls (Bos indicus) genotyped for over 777,000 single nucleotide polymorphisms. Loci that excel from the genome background were identified on chromosomes 4, 6, 7, 10, 14, 18 and 21. The majority of these regions were previously found to be associated with reproductive and body size traits in cattle. The signal on chromosome 14 replicates the pleiotropic quantitative trait locus encompassing PLAG1 that affects male fertility in cattle and stature in several species. Based on intensive literature mining, SP4, MAGEL2, SH3RF2, PDE5A and SNAI2 are proposed as novel candidate genes for SC, as they affect growth and testicular size in other animal models. These findings contribute to linking reproductive phenotypes to gene functions, and may offer new insights on the molecular biology of male fertility.	[Utsunomiya, Yuri T.; Carmo, Adriana S.; Matos, Marcia C.; Zavarez, Ludmilla B.; Garcia, Jose Fernando] UNESP Univ Estadual Paulista, Fac Ciencias Agr & Vet, Dept Med Vet Prevent & Reprod Anim, Sao Paulo, Brazil; [Neves, Haroldo H. R.; Carvalheiro, Roberto] UNESP Univ Estadual Paulista, Dept Zootecnia, Sao Paulo, Brazil; [Carvalheiro, Roberto] GenSys Consultores Associados, Porto Alegre, RS, Brazil; [Ito, Pier K. R. K.; Garcia, Jose Fernando] UNESP Univ Estadual Paulista, Fac Med Vet Aracatuba, Dept Apoio Saude & Prod Anim, Sao Paulo, Brazil; [Soelkner, Johann] BOKU Univ Nat Resources & Life Sci, Div Livestock Sci, Dept Sustainable Agr Syst, Vienna, Austria; [Porto-Neto, Laercio R.] CSIRO Commonwealth Sci & Ind Res Org, Food Futures Flagship, Brisbane, Qld, Australia; [Schenkel, Flavio S.] Univ Guelph, Ctr Genet Improvement Livestock, Guelph, ON N1G 2W1, Canada; [McEwan, John] AgResearch, Ctr Reprod & Genom, Mosgiel, Otago, New Zealand; [Cole, John B.] ARS, Anim Improvement Programs Lab, USDA, Beltsville, MD USA; [da Silva, Marcos V. G. B.] Embrapa Dairy Cattle, Bioinformat & Anim Genom Lab, Juiz De Fora, MG, Brazil; [Sonstegard, Tad S.] ARS, Bovine Funct Genom Lab, USDA, Beltsville, MD USA	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; University of Natural Resources & Life Sciences, Vienna; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Guelph; AgResearch - New Zealand; United States Department of Agriculture (USDA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); United States Department of Agriculture (USDA)	Garcia, JF (corresponding author), UNESP Univ Estadual Paulista, Fac Ciencias Agr & Vet, Dept Med Vet Prevent & Reprod Anim, Sao Paulo, Brazil.	jfgarcia@fmva.unesp.br	de Rezende Neves, Haroldo Henrique/F-9521-2012; Utsunomiya, Yuri Tani T/K-5214-2013; Carmo, Andreia/D-8603-2012; Carvalheiro, Roberto/I-2239-2013; Carvalheiro, Roberto/AAG-2222-2020; Schenkel, Flavio/ABG-1842-2021; Cole, John B./J-8571-2014; Van Tassell, Curtis P./O-4247-2019; Silva, Marcos Vinicius Gualberto Barbosa/AAS-1837-2020; Carmo, Adriana S/E-4342-2016; McEwan, John/A-1143-2008; Porto-Neto, Laercio R/D-2594-2012	Utsunomiya, Yuri Tani T/0000-0002-6526-8337; Carvalheiro, Roberto/0000-0002-4506-0555; Carvalheiro, Roberto/0000-0002-4506-0555; Cole, John B./0000-0003-1242-4401; Van Tassell, Curtis P./0000-0002-8416-2087; Silva, Marcos Vinicius Gualberto Barbosa/0000-0001-5449-1413; Carmo, Adriana S/0000-0002-2712-4789; McEwan, John/0000-0003-4801-6207; Porto-Neto, Laercio R/0000-0002-3536-8265; Perez O'Brien, Ana Maria/0000-0002-2077-8421; Schenkel, Flavio/0000-0001-8700-0633; Solkner, Johann/0000-0002-1517-5829	National Counsel of Technological and Scientific Development (CNPq) [560922/2010-8, 483590/2010-0]; Sao Paulo Research Foundation (FAPESP) [2011/16643-2, 2010/52030-2]; ARS [ARS-0423740] Funding Source: Federal RePORTER	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported by: National Counsel of Technological and Scientific Development (CNPq - http://www.cnpq.br/) (process 560922/2010-8 and 483590/2010-0); and Sao Paulo Research Foundation (FAPESP - http://www.fapesp.br/) (process 2011/16643-2 and 2010/52030-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alianca, 2012, SUM TOUR 2012 AL NEL; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Ball L, 1983, J SOC THERIO; Bickhart DM, 2012, GENOME RES, V22, P778, DOI 10.1101/gr.133967.111; Bischof JM, 2007, HUM MOL GENET, V16, P2713, DOI 10.1093/hmg/ddm225; BOURDON RM, 1986, J ANIM SCI, V62, P958, DOI 10.2527/jas1986.624958x; Brown PR, 2003, BIOL REPROD, V68, P2241, DOI 10.1095/biolreprod.102.013466; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Dias LT, 2003, REV BRAS ZOOTECN, V32, P1878, DOI 10.1590/S1516-35982003000800011; Evans JL, 1999, J ANIM SCI, V77, P2621; Fortes MRS, 2013, ANIM GENET, V44, P636, DOI 10.1111/age.12075; Fortes MRS, 2012, ANIM PROD SCI, V52, P143, DOI 10.1071/AN11165; Fortes MRS, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101089; French CA, 2003, CANCER RES, V63, P304; Garrick DJ, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-55; Gollner H, 2001, GENES CELLS, V6, P689, DOI 10.1046/j.1365-2443.2001.00455.x; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; HUGGINS C, 1948, J EXP MED, V88, P169, DOI 10.1084/jem.88.2.169; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Kinsella RJ, 2011, ENSEMBL BIOMARTS HUB; Kozlov SV, 2007, NAT GENET, V39, P1266, DOI 10.1038/ng2114; Langer C, 2002, BIOCHEM BIOPH RES CO, V296, P1051, DOI 10.1016/S0006-291X(02)02038-7; MARTIN LC, 1992, J ANIM SCI, V70, P4006, DOI 10.2527/1992.70124006x; McClure MC, 2010, ANIM GENET, V41, P597, DOI 10.1111/j.1365-2052.2010.02063.x; Neto MH, 1996, ARQ BRAS MED VET ZOO, V48, P755; Perez-Losada J, 2002, BLOOD, V100, P1274, DOI 10.1182/blood.V100.4.1274.h81602001274_1274_1286; Pryce JE, 2011, GENETICS, V187, P981, DOI 10.1534/genetics.110.123943; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Core Team, 2018, R LANG ENV STAT COMP; Ricke RM, 2012, J CELL BIOL, V199, P931, DOI 10.1083/jcb.201205115; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Satoh T, 1998, ANNU REV PHARMACOL, V38, P257, DOI 10.1146/annurev.pharmtox.38.1.257; Stefan M, 2005, GENOMICS, V85, P630, DOI 10.1016/j.ygeno.2005.02.004; Supp DM, 1996, DEV BIOL, V176, P284, DOI 10.1006/dbio.1996.0134; TOELLE VD, 1985, J ANIM SCI, V60, P89, DOI 10.2527/jas1985.60189x; Utsunomiya YT, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-52; Van Melis MH, 2010, J ANIM SCI, V88, P3809, DOI 10.2527/jas.2009-2127; Vezzosi D, 2011, EUR J ENDOCRINOL, V165, P177, DOI 10.1530/EJE-10-1123; YAN BF, 1995, ARCH BIOCHEM BIOPHYS, V316, P899, DOI 10.1006/abbi.1995.1121; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	43	32	32	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88561	10.1371/journal.pone.0088561	http://dx.doi.org/10.1371/journal.pone.0088561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558400	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700046
J	Restivo, A; Degano, I; Ribechini, E; Colombini, MP				Restivo, Annalaura; Degano, Ilaria; Ribechini, Erika; Colombini, Maria Perla			Development and Optimisation of an HPLC-DAD-ESI-Q-ToF Method for the Determination of Phenolic Acids and Derivatives	PLOS ONE			English	Article							MASS-SPECTROMETRY; CHROMATOGRAPHY; ANTIOXIDANTS	A method for the HPLC-MS/MS analysis of phenols, including phenolic acids and naphtoquinones, using an amideembedded phase column was developed and compared to the literature methods based on classical C18 stationary phase columns. RP-Amide is a recently developed polar embedded stationary phase, whose wetting properties mean that up to 100% water can be used as an eluent. The increased retention and selectivity for polar compounds and the possibility of working in 100% water conditions make this column particularly interesting for the HPLC analysis of phenolic acids and derivatives. In this study, the chromatographic separation was optimised on an HPLC-DAD, and was used to separate 13 standard phenolic acids and derivatives. The method was validated on an HPLC-ESI-Q-ToF. The acquisition was performed in negative polarity and MS/MS target mode. Ionisation conditions and acquisition parameters for the Q-ToF detector were investigated by working on collision energies and fragmentor potentials. The performance of the method was fully evaluated on standards. Moreover, several raw materials containing phenols were analysed: walnut, gall, wine, malbec grape, French oak, red henna and propolis. Our method allowed us to characterize the phenolic composition in a wide range of matrices and to highlight possible matrix effects.	[Restivo, Annalaura; Degano, Ilaria; Ribechini, Erika; Colombini, Maria Perla] Univ Pisa, Dipartimento Chim & Chim Ind, Pisa, Italy	University of Pisa	Degano, I (corresponding author), Univ Pisa, Dipartimento Chim & Chim Ind, Pisa, Italy.	ilaria.degano@unipi.it	Degano, Ilaria/F-9184-2012; Ribechini, Erika/M-7210-2014; Ribechini, Erika/AAH-3769-2020	Degano, Ilaria/0000-0002-3585-8555; Ribechini, Erika/0000-0002-4978-2782; Ribechini, Erika/0000-0002-4978-2782; colombini, maria perla/0000-0002-1666-8596	PAR-FAS Regione Toscana; VAT project	PAR-FAS Regione Toscana(Regione Toscana); VAT project	The authors gratefully acknowledge the VAT project ("La vita breve del tannino'', founded by PAR-FAS 2007-2013 Regione Toscana) for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Reidah IM, 2013, FOOD RES INT, V51, P354, DOI 10.1016/j.foodres.2012.12.033; Benhaim D, 2010, J CHROMATOGR A, V1217, P65, DOI 10.1016/j.chroma.2009.11.013; Benmeddour Z, 2013, J FUNCT FOODS, V5, P346, DOI 10.1016/j.jff.2012.11.005; Cannon J, 1994, DYE PLANTS DYEING; Chen LL, 2009, J PHARMACEUT BIOMED, V50, P127, DOI 10.1016/j.jpba.2009.03.039; Chocholous P, 2013, TALANTA, V103, P221, DOI 10.1016/j.talanta.2012.10.036; Degano I, 2009, APPL SPECTROSC REV, V44, P363, DOI 10.1080/05704920902937876; Degano I, 2009, THESIS; Rodriguez-Hernandez MD, 2012, J FOOD SCI, V77, pC1058, DOI 10.1111/j.1750-3841.2012.02886.x; Dugo P, 2009, J CHROMATOGR A, V1216, P7213, DOI 10.1016/j.chroma.2009.08.030; Francisco MLD, 2009, FOOD CHEM, V117, P356, DOI 10.1016/j.foodchem.2009.03.110; Ghafoor A. O., 2012, Journal of Chemical and Pharmaceutical Research, V4, P3158; Ghasemzadeh A, 2011, J MED PLANTS RES, V5, P6697, DOI 10.5897/JMPR11.1404; Hawryl MA, 2012, JPC-J PLANAR CHROMAT, V25, P394, DOI 10.1556/JPC.25.2012.5.2; Hofenk De Graaff J.H., 2004, COLOURFUL; Inbaraj BS, 2010, J PHARMACEUT BIOMED, V51, P549, DOI 10.1016/j.jpba.2009.09.006; Iswaldi I, 2011, ANAL BIOANAL CHEM, V400, P3643, DOI 10.1007/s00216-011-4998-z; Kale A., 2010, INT J PHARM BIOSCIEN, V1, P1; Khoddami A, 2013, MOLECULES, V18, P2328, DOI 10.3390/molecules18022328; McGachy NT, 2009, J SEP SCI, V32, P4101, DOI 10.1002/jssc.200900551; Motilva MJ, 2013, J CHROMATOGR A, V1292, P66, DOI 10.1016/j.chroma.2013.01.012; Neveu V, 2010, DATABASE-OXFORD, DOI 10.1093/database/bap024; Saxena M., 2012, INT J PHARM SCI REV, V16, P130, DOI DOI 10.5897/JMPR11.1404; Taylor PJ, 2005, CLIN BIOCHEM, V38, P328, DOI 10.1016/j.clinbiochem.2004.11.007	24	17	17	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88762	10.1371/journal.pone.0088762	http://dx.doi.org/10.1371/journal.pone.0088762			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551158	Green Published, gold, Green Submitted			2022-12-27	WOS:000331271500066
J	Rienth, M; Torregrosa, L; Kelly, MT; Luchaire, N; Pellegrino, A; Grimplet, J; Romieu, C				Rienth, Markus; Torregrosa, Laurent; Kelly, Mary T.; Luchaire, Nathalie; Pellegrino, Anne; Grimplet, Jerome; Romieu, Charles			Is Transcriptomic Regulation of Berry Development More Important at Night than During the Day?	PLOS ONE			English	Article							GRAPE BERRY; GENE-EXPRESSION; ORGANIC-ACIDS; OXIDATIVE STRESS; 9-CIS-EPOXYCAROTENOID DIOXYGENASE; PHOSPHOENOLPYRUVATE CARBOXYLASE; FUNCTIONAL-CHARACTERIZATION; ANTHOCYANIN BIOSYNTHESIS; PROLINE ACCUMULATION; AROMATIC COMPOSITION	Diurnal changes in gene expression occur in all living organisms and have been studied on model plants such as Arabidopsis thaliana. To our knowledge the impact of the nycthemeral cycle on the genetic program of fleshly fruit development has been hitherto overlooked. In order to circumvent environmental changes throughout fruit development, young and ripening berries were sampled simultaneously on continuously flowering microvines acclimated to controlled circadian light and temperature changes. Gene expression profiles along fruit development were monitored during both day and night with whole genome microarrays (Nimblegen (R) vitis 12x), yielding a total number of 9273 developmentally modulated probesets. All day-detected transcripts were modulated at night, whereas 1843 genes were night-specific. Very similar developmental patterns of gene expression were observed using independent hierarchical clustering of day and night data, whereas functional categories of allocated transcripts varied according to time of day. Many transcripts within pathways, known to be up-regulated during ripening, in particular those linked to secondary metabolism exhibited a clearer developmental regulation at night than during the day. Functional enrichment analysis also indicated that diurnally modulated genes considerably varied during fruit development, with a shift from cellular organization and photosynthesis in green berries to secondary metabolism and stress-related genes in ripening berries. These results reveal critical changes in gene expression during night development that differ from daytime development, which have not been observed in other transcriptomic studies on fruit development thus far.	[Rienth, Markus] Fdn Jean Poupelain, Javrezac, France; [Rienth, Markus; Torregrosa, Laurent; Luchaire, Nathalie] INRA SupAgro, UMR AGAP, Montpellier, France; [Kelly, Mary T.] Fac Pharm Montpellier, Lab Oenol, UMR1083, F-34060 Montpellier, France; [Luchaire, Nathalie; Pellegrino, Anne] INRA, UMR LEPSE, F-34060 Montpellier, France; [Grimplet, Jerome] Univ La Rioja, CSIC, ICVV, Logrono, Spain; [Romieu, Charles] INRA, UMR AGAP, F-34060 Montpellier, France	INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; Universite de Montpellier; INRAE; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-CAR-UR - Instituto de Ciencias de la Vid y del Vino (ICVV); Universidad de La Rioja; INRAE; Universite de Montpellier	Romieu, C (corresponding author), INRA, UMR AGAP, F-34060 Montpellier, France.	romieu@supagro.inra.fr	Rienth, Markus/AAK-3241-2021; Grimplet, Jerome/A-3422-2011; Rienth, Markus/AAI-5448-2021; Grimplet, Jérôme/M-4589-2019; romieu, charles/C-2115-2015	Rienth, Markus/0000-0002-6302-6297; Grimplet, Jerome/0000-0002-3265-4012; Grimplet, Jérôme/0000-0002-3265-4012; Luchaire, Nathalie/0000-0001-5566-7644; romieu, charles/0000-0003-2607-8335	ANR (Agence national de la recherche) -Genopole project [ANR-2010-GENM-004-01]; Jean Poupelain foundation (30 Rue Gate Chien, 16100 Javrezac, France)	ANR (Agence national de la recherche) -Genopole project(French National Research Agency (ANR)); Jean Poupelain foundation (30 Rue Gate Chien, 16100 Javrezac, France)	This work is part of the DURAVITIS program which is financially supported by the ANR (Agence national de la recherche) -Genopole (project ANR-2010-GENM-004-01) and the Jean Poupelain foundation (30 Rue Gate Chien, 16100 Javrezac, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DO, 2006, AM J ENOL VITICULT, V57, P249; Aharoni A, 2002, PLANT PHYSIOL, V129, P1019, DOI 10.1104/pp.003558; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; AMOR Y, 1995, P NATL ACAD SCI USA, V92, P9353, DOI 10.1073/pnas.92.20.9353; Bai Y, 2012, MOL GENET GENOMICS, V287, P663, DOI 10.1007/s00438-012-0707-7; BELY M, 1990, J FERMENT BIOENG, V70, P246, DOI 10.1016/0922-338X(90)90057-4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertelli AAA, 2009, J CARDIOVASC PHARM, V54, P468, DOI 10.1097/FJC.0b013e3181bfaff3; Beruter J, 2004, J PLANT PHYSIOL, V161, P1011, DOI 10.1016/j.jplph.2003.12.008; Bogs J, 2005, PLANT PHYSIOL, V139, P652, DOI 10.1104/pp.105.064238; Boss P.K., 2009, GRAPEVINE MOL PHYSL, P263, DOI DOI 10.1007/978-90-481-2305-6_10; Boss PK, 1996, PLANT MOL BIOL, V32, P565, DOI 10.1007/BF00019111; Boss PK, 2002, NATURE, V416, P847, DOI 10.1038/416847a; Bouloumpasi E, 2002, VITIS, V41, P195; Bourquin V, 2002, PLANT CELL, V14, P3073, DOI 10.1105/tpc.007773; Brillouet JM, 2013, ANN BOT-LONDON, V112, P1003, DOI 10.1093/aob/mct168; Broderick R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035537; Broderick R, 2009, BIOCHEM SOC T, V37, P926, DOI 10.1042/BST0370926; Burkle L, 2003, PLANT J, V34, P13, DOI 10.1046/j.1365-313X.2003.01700.x; Castillon A, 2007, TRENDS PLANT SCI, V12, P514, DOI 10.1016/j.tplants.2007.10.001; Chaib J, 2010, PLANT J, V62, P1083, DOI 10.1111/j.1365-313X.2010.04219.x; Chen FX, 2009, FOOD CHEM, V114, P657, DOI 10.1016/j.foodchem.2008.10.003; Chen LS, 1997, PLANT PHYSIOL, V115, P1127, DOI 10.1104/pp.115.3.1127; Chervin C, 2004, PLANT SCI, V167, P1301, DOI 10.1016/j.plantsci.2004.06.026; Chow BY, 2013, SEMIN CELL DEV BIOL, V24, P383, DOI 10.1016/j.semcdb.2013.02.005; Conde C, 2007, FOOD, V22, DOI DOI 10.1186/S12864-016-2660-Z; Coombe B. G., 2000, Australian Journal of Grape and Wine Research, V6, P131, DOI 10.1111/j.1755-0238.2000.tb00171.x; COOMBE BG, 1992, AM J ENOL VITICULT, V43, P101; COOMBE BG, 1973, PLANT PHYSIOL, V51, P629, DOI 10.1104/pp.51.4.629; Covington MF, 2007, PLOS BIOL, V5, P1773, DOI 10.1371/journal.pbio.0050222; CREASY GL, 1993, AM J ENOL VITICULT, V44, P187; Cruz-Rus E, 2010, J PLANT PHYSIOL, V167, P739, DOI 10.1016/j.jplph.2009.12.017; Cunningham FX, 1998, ANNU REV PLANT PHYS, V49, P557, DOI 10.1146/annurev.arplant.49.1.557; Davies C, 1997, PLANT PHYSIOL, V115, P1155, DOI 10.1104/pp.115.3.1155; Davies C., 2009, GRAPEVINE MOL PHYSL, P229, DOI [10.1007/978-90-481-2305-6_9, DOI 10.1007/978-90-481-2305-6_9]; DeBolt S, 2006, P NATL ACAD SCI USA, V103, P5608, DOI 10.1073/pnas.0510864103; Deluc LG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-429; Deytieux-Belleau C, 2007, J INT SCI VIGNE VIN, V41, P141; Diakou P, 2000, AUST J PLANT PHYSIOL, V27, P221; DROUET AG, 1977, PHYTOCHEMISTRY, V16, P505, DOI 10.1016/0031-9422(77)80002-2; Du H, 2010, PLANT PHYSIOL, V154, P1304, DOI 10.1104/pp.110.163741; El-Kereamy A, 2003, PHYSIOL PLANTARUM, V119, P175, DOI 10.1034/j.1399-3054.2003.00165.x; Emmerlich V, 2003, P NATL ACAD SCI USA, V100, P11122, DOI 10.1073/pnas.1832002100; Endow SA, 1999, EUR J BIOCHEM, V262, P12, DOI 10.1046/j.1432-1327.1999.00339.x; Etienne A, 2013, J EXP BOT, V64, P1451, DOI 10.1093/jxb/ert035; Eyeghe-Bickong HA, 2012, J CHROMATOGR B, V885, P43, DOI 10.1016/j.jchromb.2011.12.011; Famiani F, 2000, J EXP BOT, V51, P675, DOI 10.1093/jexbot/51.345.675; Fasoli M, 2012, PLANT CELL, V24, P3489, DOI 10.1105/tpc.112.100230; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; FINDLAY N, 1987, J EXP BOT, V38, P668, DOI 10.1093/jxb/38.4.668; Ford C. M., 1998, Australian Journal of Grape and Wine Research, V4, P48, DOI 10.1111/j.1755-0238.1998.tb00134.x; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Fortes AM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-149; Franks T, 2002, THEOR APPL GENET, V104, P192, DOI 10.1007/s001220100683; Fremont L, 2000, LIFE SCI, V66, P663, DOI 10.1016/S0024-3205(99)00410-5; GEIGENBERGER P, 1993, PLANTA, V189, P329, DOI 10.1007/BF00194429; Giovannoni J, 2001, ANNU REV PLANT PHYS, V52, P725, DOI 10.1146/annurev.arplant.52.1.725; GREENSPAN MD, 1994, PLANT CELL ENVIRON, V17, P811, DOI 10.1111/j.1365-3040.1994.tb00175.x; Grimplet J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-187; Grimplet Jerome, 2012, BMC Res Notes, V5, P213, DOI 10.1186/1756-0500-5-213; Grimplet J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008365; Guillaumie S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-165; Guo WJ, 2008, PLANT PHYSIOL, V147, P1710, DOI 10.1104/pp.108.120238; HALE CR, 1962, NATURE, V195, P917, DOI 10.1038/195917a0; HAMILTON AJ, 1991, P NATL ACAD SCI USA, V88, P7434, DOI 10.1073/pnas.88.16.7434; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; He F, 2010, MOLECULES, V15, P9057, DOI 10.3390/molecules15129057; Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8; Hernandez-Orte P, 2005, FOOD CHEM, V89, P163, DOI 10.1016/j.foodchem.2004.02.021; Hernandez-Orte P, 2002, J AGR FOOD CHEM, V50, P2891, DOI 10.1021/jf011395o; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; Hirner A, 2006, PLANT CELL, V18, P1931, DOI 10.1105/tpc.106.041012; HU CAA, 1992, P NATL ACAD SCI USA, V89, P9354, DOI 10.1073/pnas.89.19.9354; Ichihashi Y, 2010, PLANT CELL PHYSIOL, V51, P252, DOI 10.1093/pcp/pcp184; International Organisation of Vine and Wine, 2012, STAT REP WORLD VIT; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jimenez A, 2002, PLANTA, V214, P751, DOI 10.1007/s004250100667; JOHNSON RW, 1992, PLANT CELL ENVIRON, V15, P947, DOI 10.1111/j.1365-3040.1992.tb01027.x; Kelly MT, 2010, J CHROMATOGR A, V1217, P7385, DOI 10.1016/j.chroma.2010.09.047; Kennedy JA, 2001, J AGR FOOD CHEM, V49, P5348, DOI 10.1021/jf010758h; Kennedy JA, 2006, AM J ENOL VITICULT, V57, P239; Kim Y, 2012, MOL PLANT, V5, P678, DOI 10.1093/mp/sss005; Kleczkowski LA, 2010, CRIT REV PLANT SCI, V29, P191, DOI 10.1080/07352689.2010.483578; Kovermann P, 2007, PLANT J, V52, P1169, DOI 10.1111/j.1365-313X.2007.03367.x; Lai AG, 2012, P NATL ACAD SCI USA, V109, P17129, DOI 10.1073/pnas.1209148109; LAKSO AN, 1975, PLANT PHYSIOL, V56, P370, DOI 10.1104/pp.56.3.370; Lei M, 2001, J CELL SCI, V114, P1447; Li J, 2012, PROTOPLASMA, V249, P95, DOI 10.1007/s00709-011-0357-3; Lijavetzky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039547; Lobit P, 2006, J EXP BOT, V57, P1471, DOI 10.1093/jxb/erj128; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; Lu S, 2002, PLANT PHYSIOL, V130, P477, DOI 10.1104/pp.006544; Luchaire N, 2013, GIESCO 2013, P788; Lucker J, 2004, PHYTOCHEMISTRY, V65, P2649, DOI 10.1016/j.phytochem.2004.08.017; Lund ST, 2006, SCIENCE, V311, P804, DOI 10.1126/science.1118962; Martinez-Andujar C, 2011, P NATL ACAD SCI USA, V108, P17225, DOI 10.1073/pnas.1112151108; Mateo JJ, 2000, J CHROMATOGR A, V881, P557, DOI 10.1016/S0021-9673(99)01342-4; Mathieu S, 2005, J EXP BOT, V56, P2721, DOI 10.1093/jxb/eri265; Mchedlishvili N, 2012, J CELL SCI, V125, P906, DOI 10.1242/jcs.091967; McWatters HG, 2011, FEBS LETT, V585, P1474, DOI 10.1016/j.febslet.2011.03.051; Melino VJ, 2011, J SCI FOOD AGR, V91, P1712, DOI 10.1002/jsfa.4376; Mendes-Pinto MM, 2009, ARCH BIOCHEM BIOPHYS, V483, P236, DOI 10.1016/j.abb.2009.01.008; Miyawaki K, 2004, PLANT J, V37, P128, DOI 10.1046/j.1365-313X.2003.01945.x; Moing A, 2000, PHYSIOL PLANTARUM, V108, P1, DOI 10.1034/j.1399-3054.2000.108001001.x; Monagas M, 2005, CRIT REV FOOD SCI, V45, P85, DOI 10.1080/10408690490911710; Munoz-Robredo PR, 2011, CHILEAN J AGR RES, V71; Narsai R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-93; Nishimura C, 2004, PLANT CELL, V16, P1365, DOI 10.1105/tpc.021477; Nunan KJ, 1998, PLANT PHYSIOL, V118, P783, DOI 10.1104/pp.118.3.783; Nunan KJ, 2001, PLANTA, V214, P257, DOI 10.1007/s004250100609; Ojeda H, 1999, VITIS, V38, P145; Okamoto M, 2006, PLANT PHYSIOL, V141, P97, DOI 10.1104/pp.106.079475; Ollat N, 2002, J INT SCI VIGNE VIN, V36, P109; PARK SK, 1993, ACS SYM SER, V536, P98; Pereira HS, 2005, THEOR APPL GENET, V111, P871, DOI 10.1007/s00122-005-0009-0; Pilati S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-428; Pillet J, 2012, PLANT CELL PHYSIOL, V53, P1776, DOI 10.1093/pcp/pcs121; Pires N, 2010, MOL BIOL EVOL, V27, P862, DOI 10.1093/molbev/msp288; Pokhilko A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.69; Possner D., 1983, ACTA HORT, V139, P117, DOI [10.17660/ActaHortic.1983.139.16, DOI 10.17660/ACTAHORTIC.1983.139.16]; POSSNER DRE, 1985, VITIS, V24, P229; Ramassamy S, 1998, J EXP BOT, V49, P1909, DOI 10.1093/jexbot/49.329.1909; RAZUNGLES A, 1993, SCI ALIMENT, V13, P59; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rienth M, 2012, VITIS, V51, P167; Rienth M, 2013, P 18 INT S GIESCO, P412; Roosens NHCJ, 1998, PLANT PHYSIOL, V117, P263, DOI 10.1104/pp.117.1.263; Rotter A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-104; RUFFNER HP, 1982, VITIS, V21, P247; RUFFNER HP, 1976, PHYTOCHEMISTRY, V15, P1877, DOI 10.1016/S0031-9422(00)88835-4; Ryona I, 2010, J AGR FOOD CHEM, V58, P9723, DOI 10.1021/jf102072w; Sanmartin M, 2007, PLANTA, V225, P873, DOI 10.1007/s00425-006-0399-5; Schaffer R, 2001, PLANT CELL, V13, P113, DOI 10.1105/tpc.13.1.113; SCHMALSTIG JG, 1987, PLANT PHYSIOL, V85, P407, DOI 10.1104/pp.85.2.407; Schmulling T, 2002, J PLANT GROWTH REGUL, V21, P40, DOI 10.1007/s003440010046; SCHNEIDER A, 1987, AM J ENOL VITICULT, V38, P151; Sheetz MP, 1999, EUR J BIOCHEM, V262, P19, DOI 10.1046/j.1432-1327.1999.00340.x; Shelp BJ, 2012, BOTANY, V90, P651, DOI [10.1139/B2012-030, 10.1139/b2012-030]; Shelp BJ, 1999, TRENDS PLANT SCI, V4, P446, DOI 10.1016/S1360-1385(99)01486-7; Shen QX, 2001, PLANT MOL BIOL, V45, P327, DOI 10.1023/A:1006460231978; Singsaas E, 2001, NEW PHTYOLOGIST, V145, P39; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soufleros E, 1998, AM J ENOL VITICULT, V49, P266; Steffan H., 1975, Vitis, V14, P181; Stines A. P., 2000, Australian Journal of Grape and Wine Research, V6, P150, DOI 10.1111/j.1755-0238.2000.tb00174.x; Stines AP, 1999, PLANT PHYSIOL, V120, P923, DOI 10.1104/pp.120.3.923; Suzuki N, 2008, J BIOL CHEM, V283, P9269, DOI 10.1074/jbc.M709187200; Suzuki N, 2011, PLANT J, V66, P844, DOI 10.1111/j.1365-313X.2011.04550.x; Sweetman C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-691; Sweetman C, 2009, PHYTOCHEMISTRY, V70, P1329, DOI 10.1016/j.phytochem.2009.08.006; Terrier N, 2005, PLANTA, V222, P832, DOI 10.1007/s00425-005-0017-y; Terrier N, 2001, MOLECULAR BIOLOGY & BIOTECHNOLOGY OF THE GRAPEVINE, P35; Terrier N, 2001, PLANTA, V213, P20, DOI 10.1007/s004250000472; TESNIERE CM, 1993, AM J ENOL VITICULT, V44, P445; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Ton J, 2009, TRENDS PLANT SCI, V14, P310, DOI 10.1016/j.tplants.2009.03.006; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Wang JF, 2010, BIOSCI BIOTECH BIOCH, V74, P1583, DOI 10.1271/bbb.100175; Waterhouse AL, 2002, ANN NY ACAD SCI, V957, P21, DOI 10.1111/j.1749-6632.2002.tb02903.x; Williams C. A., 1994, FLAVONOIDS ADV RES 1, P337; WILSON B, 1984, J AGR FOOD CHEM, V32, P919, DOI 10.1021/jf00124a054; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Yang Y, 2012, APPL ENVIRON MICROB, V78, P5845, DOI 10.1128/AEM.00218-12; Yao YX, 2009, SCI HORTIC-AMSTERDAM, V122, P404, DOI 10.1016/j.scienta.2009.05.033; Zeilinger MN, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100101; Zhang XY, 2006, PLANT PHYSIOL, V142, P220, DOI 10.1104/pp.106.081430; Zhang XR, 2003, J AM SOC HORTIC SCI, V128, P316, DOI 10.21273/JASHS.128.3.0316	172	34	34	6	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88844	10.1371/journal.pone.0088844	http://dx.doi.org/10.1371/journal.pone.0088844			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551177	Green Submitted, Green Published, gold			2022-12-27	WOS:000331266000074
J	Insetta, ER; Soriano, AJ; Totanes, FIG; Macatangay, BJC; Belizario, VY				Insetta, Emily R.; Soriano, Alex J.; Totanes, Francis Isidore G.; Macatangay, Bernard J. C.; Belizario, Vicente Y., Jr.			Fear of Birth Defects Is a Major Barrier to Soil-Transmitted Helminth Treatment (STH) for Pregnant Women in the Philippines	PLOS ONE			English	Article							MEBENDAZOLE; THERAPY	The World Health Organization recommends anthelminthic treatment for pregnant women after the first trimester in soil-transmitted helminth (STH) endemic regions to prevent adverse maternal-fetal consequences. Although studies have shown the high prevalence of infection in the Philippines, no research has evaluated deworming practices. We hypothesized that pregnant women are not receiving deworming treatment and we aimed to identify barriers to World Health Organization guideline implementation. We conducted key informant interviews with local Department of Health (DOH) administrators, focus group discussions with nurses, midwives, and health care workers, and knowledge, attitudes, and practices surveys with women of reproductive age to elicit perspectives about deworming during pregnancy. Key informant interviews revealed that healthcare workers were not deworming pregnant women due to inadequate drug supply, infrastructure and personnel as well as fear of teratogenicity. Focus group discussions showed that healthcare workers similarly had not implemented guidelines due to infrastructure challenges and concerns for fetal malformations. The majority of local women believed that STH treatment causes side effects (74.8%) as well as maternal harm (67.3%) and fetal harm (77.9%). Women who were willing to take anthelminthics while pregnant had significantly greater knowledge as demonstrated by higher Treatment Scores (mean rank 146.92 versus 103.1, z = -4.40, p<0.001) and higher Birth Defect Scores (mean rank 128.09 versus 108.65, z = -2.43, p = 0.015). This study concludes that World Health Organization guidelines are not being implemented in the Philippines. Infrastructure, specific protocols, and education for providers and patients regarding anthelminthic treatment are necessary for the successful prevention of STH morbidity and mortality among pregnant women.	[Insetta, Emily R.; Soriano, Alex J.] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA; [Totanes, Francis Isidore G.; Belizario, Vicente Y., Jr.] Univ Philippines, NIH, Manila, Philippines; [Totanes, Francis Isidore G.; Belizario, Vicente Y., Jr.] Univ Philippines, Coll Publ Hlth, Manila, Philippines; [Macatangay, Bernard J. C.] Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of the Philippines System; University of the Philippines Manila; University of the Philippines System; University of the Philippines Manila; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Soriano, AJ (corresponding author), Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA.	soriano.alex@medstudent.pitt.edu		Macatangay, Bernard/0000-0002-0405-0991	University of Pittsburgh School of Medicine Dean's Summer Research Program	University of Pittsburgh School of Medicine Dean's Summer Research Program	The source of funding for this paper was the University of Pittsburgh School of Medicine Dean's Summer Research Program which awards medical students with trainee funds to complete clinic research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarillo MLE, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-14; Belizario VY, 2009, ASIA-PAC J PUBLIC HE, V21, P26, DOI 10.1177/1010539508327245; Brooker S, 2004, ADV PARASIT, V58, P197, DOI 10.1016/S0065-308X(04)58004-1; Christian M.S., 1987, REV DEV TOXICI UNPUB; de Silva NR, 1999, LANCET, V353, P1145, DOI 10.1016/S0140-6736(98)06308-9; Diav-Citrin O, 2003, AM J OBSTET GYNECOL, V188, P282, DOI 10.1067/mob.2003.79; Duque FT, 2006, INTEGRATED HELMINTH; Hotez PJ, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P467; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Larocque R, 2006, TROP MED INT HEALTH, V11, P1485, DOI 10.1111/j.1365-3156.2006.01706.x; Monse B, 2010, INT DENT J, V60, P85, DOI 10.1922/IDJ_2420Monse09; Nandha B, 2012, HEALTH EDUC RES, V27, P585, DOI 10.1093/her/cyr045; Ndibazza J, 2010, CLIN INFECT DIS, V50, P531, DOI 10.1086/649924; Strauss A., 1998, BASICS QUALITATIVE R; Torlesse H, 2001, T ROY SOC TROP MED H, V95, P195, DOI 10.1016/S0035-9203(01)90164-6; Urbani C, 2001, TROP MED INT HEALTH, V6, P935, DOI 10.1046/j.1365-3156.2001.00820.x; WHO Expert Committee on the Control of Schistosomiasis, 2001, 912 WHO EXP COMM CON	17	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e85992	10.1371/journal.pone.0085992	http://dx.doi.org/10.1371/journal.pone.0085992			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586245	Green Published, gold			2022-12-27	WOS:000332389000003
J	Morita, T; Koike, H; Hagiwara, H; Ito, E; Machida, M; Sato, S; Habe, H; Kitamoto, D				Morita, Tomotake; Koike, Hideaki; Hagiwara, Hiroko; Ito, Emi; Machida, Masayuki; Sato, Shun; Habe, Hiroshi; Kitamoto, Dai			Genome and Transcriptome Analysis of the Basidiomycetous Yeast Pseudozyma antarctica Producing Extracellular Glycolipids, Mannosylerythritol Lipids	PLOS ONE			English	Article							CYTOSOLIC ACETYL-COENZYME; ATP-CITRATE LYASE; CANDIDA-ANTARCTICA; USTILAGINOMYCETOUS YEAST; SP NOV.; OPEN SOFTWARE; GENE-CLUSTER; BIOSURFACTANTS; BIOSYNTHESIS; IDENTIFICATION	Pseudozyma antarctica is a non-pathogenic phyllosphere yeast known as an excellent producer of mannosylerythritol lipids (MELs), multi-functional extracellular glycolipids, from vegetable oils. To clarify the genetic characteristics of P. antarctica, we analyzed the 18 Mb genome of P. antarctica T-34. On the basis of KOG analysis, the number of genes (219 genes) categorized into lipid transport and metabolism classification in P. antarctica was one and a half times larger than that of yeast Saccharomyces cerevisiae (140 genes). The gene encoding an ATP/citrate lyase (ACL) related to acetyl-CoA synthesis conserved in oleaginous strains was found in P. antarctica genome: the single ACL gene possesses the four domains identical to that of the human gene, whereas the other oleaginous ascomycetous species have the two genes covering the four domains. P. antarctica genome exhibited a remarkable degree of synteny to U. maydis genome, however, the comparison of the gene expression profiles under the culture on the two carbon sources, glucose and soybean oil, by the DNA microarray method revealed that transcriptomes between the two species were significantly different. In P. antarctica, expression of the gene sets relating fatty acid metabolism were markedly up-regulated under the oily conditions compared with glucose. Additionally, MEL biosynthesis cluster of P. antarctica was highly expressed regardless of the carbon source as compared to U. maydis. These results strongly indicate that P. antarctica has an oleaginous nature which is relevant to its non-pathogenic and MEL-overproducing characteristics. The analysis and dataset contribute to stimulate the development of improved strains with customized properties for high yield production of functional bio-based materials.	[Morita, Tomotake; Ito, Emi; Sato, Shun; Habe, Hiroshi; Kitamoto, Dai] Natl Inst Adv Ind Sci & Technol, Res Inst Innovat Sustainable Chem, Tsukuba, Ibaraki, Japan; [Koike, Hideaki; Hagiwara, Hiroko; Machida, Masayuki] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST)	Morita, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Inst Innovat Sustainable Chem, Tsukuba Cent 5-2,1-1-1 Higashi, Tsukuba, Ibaraki, Japan.	morita-tomotake@aist.go.jp	kitamoto, dai/R-4905-2018; Morita, Tomotake/L-7073-2018; Habe, Hiroshi/L-8939-2018; Sato, Shun/M-5355-2016	kitamoto, dai/0000-0002-6859-8892; Morita, Tomotake/0000-0001-6956-3096; Habe, Hiroshi/0000-0001-8721-2206; Sato, Shun/0000-0002-0117-9984				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Blank K, 2006, J BIOTECHNOL, V125, P474, DOI 10.1016/j.jbiotec.2006.04.004; BOEKHOUT T, 1995, J GEN APPL MICROBIOL, V41, P359, DOI 10.2323/jgam.41.359; Boekhout T., 1998, P790, DOI 10.1016/B978-044481312-1/50108-8; BOOTHROYD B, 1956, CAN J BIOCHEM PHYS, V34, P10; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Dean RA, 2007, NAT BIOTECHNOL, V25, P67, DOI 10.1038/nbt0107-67; Fatland BL, 2002, PLANT PHYSIOL, V130, P740, DOI 10.1104/pp.008110; FLUHARTY AL, 1969, BIOCHEMISTRY-US, V8, P2627, DOI 10.1021/bi00834a056; Fukuoka T, 2007, APPL MICROBIOL BIOT, V76, P801, DOI 10.1007/s00253-007-1051-4; Fukuoka T, 2007, BIOTECHNOL LETT, V29, P1111, DOI 10.1007/s10529-007-9363-0; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Golubev Wladyslav, 2007, Mycoscience, V48, P29, DOI 10.1007/s10267-006-0324-6; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Hewald S, 2005, APPL ENVIRON MICROB, V71, P3033, DOI 10.1128/AEM.71.6.3033-3040.2005; Hewald S, 2006, APPL ENVIRON MICROB, V72, P5469, DOI 10.1128/AEM.00506-06; Hynes MJ, 2010, EUKARYOT CELL, V9, P1039, DOI 10.1128/EC.00080-10; Imura T, 2007, LANGMUIR, V23, P1659, DOI 10.1021/la0620814; Ito S, 2007, COLLOID SURFACE B, V58, P165, DOI 10.1016/j.colsurfb.2007.03.003; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kitamoto D, 1998, BIOTECHNOL LETT, V20, P813, DOI 10.1023/A:1005347022247; Kitamoto D, 2002, J BIOSCI BIOENG, V94, P187, DOI 10.1263/jbb.94.187; KITAMOTO D, 1990, AGR BIOL CHEM TOKYO, V54, P37, DOI 10.1080/00021369.1990.10869919; Kitamoto D, 2001, BIOTECHNOL LETT, V23, P1709, DOI 10.1023/A:1012464717259; Kitamoto D, 2009, CURR OPIN COLLOID IN, V14, P315, DOI 10.1016/j.cocis.2009.05.009; Kitamoto HK, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-44; Koitabashi M, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-40; Konishi M, 2007, APPL MICROBIOL BIOT, V75, P521, DOI 10.1007/s00253-007-0853-8; Konishi M, 2011, J BIOSCI BIOENG, V111, P702, DOI 10.1016/j.jbiosc.2011.02.004; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Kose O, 2002, BIORESOURCE TECHNOL, V83, P125, DOI 10.1016/S0960-8524(01)00203-6; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Mendgen K, 2002, TRENDS PLANT SCI, V7, P352, DOI 10.1016/S1360-1385(02)02297-5; Morita T, 2007, FEMS YEAST RES, V7, P286, DOI 10.1111/j.1567-1364.2006.00154.x; Morita T, 2006, APPL MICROBIOL BIOT, V73, P305, DOI 10.1007/s00253-006-0466-7; Morita T, 2006, YEAST, V23, P661, DOI 10.1002/yea.1386; Morita T, 2013, APPL MICROBIOL BIOT, V97, P4691, DOI 10.1007/s00253-013-4858-1; Morita T, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00064-13; Morita T, 2011, J BIOSCI BIOENG, V112, P137, DOI 10.1016/j.jbiosc.2011.04.008; Morita T, 2010, YEAST, V27, P905, DOI 10.1002/yea.1794; Morita T, 2009, BIOTECHNOL APPL BIOC, V53, P39, DOI 10.1042/BA20090033; R Core Team, 2021, R LANGUAGE ENV STAT; Rau U, 2005, APPL MICROBIOL BIOT, V68, P607, DOI 10.1007/s00253-005-1906-5; Schirawski J, 2010, SCIENCE, V330, P1546, DOI 10.1126/science.1195330; Schmid Rolf D, 1998, Angew Chem Int Ed Engl, V37, P1608, DOI 10.1002/(SICI)1521-3773(19980703)37:12<1608::AID-ANIE1608>3.0.CO;2-V; Seo HS, 2007, FEMS YEAST RES, V7, P1035, DOI 10.1111/j.1567-1364.2007.00251.x; Spoeckner S, 1999, APPL MICROBIOL BIOT, V51, P33, DOI 10.1007/s002530051359; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamano K, 2008, FUNGAL GENET BIOL, V45, P139, DOI 10.1016/j.fgb.2007.09.005; Tamano K, 2013, APPL MICROBIOL BIOT, V97, P269, DOI 10.1007/s00253-012-4193-y; Teichmann B, 2007, MOL MICROBIOL, V66, P525, DOI 10.1111/j.1365-2958.2007.05941.x; Vorapreeda T, 2012, MICROBIOL-SGM, V158, P217, DOI 10.1099/mic.0.051946-0; Wang QM, 2006, INT J SYST EVOL MICR, V56, P289, DOI 10.1099/ijs.0.63827-0; Yang YH, 2005, STAT BIOL HEALTH, P49	59	28	29	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e86490	10.1371/journal.pone.0086490	http://dx.doi.org/10.1371/journal.pone.0086490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586250	Green Submitted, Green Published, gold			2022-12-27	WOS:000331880700004
J	Olthof, NC; Speel, EJM; Kolligs, J; Haesevoets, A; Henfling, M; Ramaekers, FCS; Preuss, SF; Drebber, U; Wieland, U; Silling, S; Lam, WL; Vucic, EA; Kremer, B; Klussmann, JP; Huebbers, CU				Olthof, Nadine C.; Speel, Ernst-Jan M.; Kolligs, Jutta; Haesevoets, Annick; Henfling, Mieke; Ramaekers, Frans C. S.; Preuss, Simon F.; Drebber, Uta; Wieland, Ulrike; Silling, Steffi; Lam, Wan L.; Vucic, Emily A.; Kremer, Bernd; Klussmann, Jens-P.; Huebbers, Christian U.			Comprehensive Analysis of HPV16 Integration in OSCC Reveals No Significant Impact of Physical Status on Viral Oncogene and Virally Disrupted Human Gene Expression	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; SQUAMOUS-CELL CARCINOMAS; HUMAN-PAPILLOMAVIRUS-16 DNA; CERVICAL-CANCER; IN-SITU; HEAD; E6; PREVALENCE; LESIONS; GENOME	Infection with high-risk human papillomavirus (HPV) type 16 is an independent risk factor for the development of oropharyngeal squamous cell carcinomas (OSCC). However, it is unclear whether viral integration is an essential hallmark in the carcinogenic process of OSCC and whether HPV integration correlates with the level of viral gene transcription and influences the expression of disrupted host genes. We analyzed 75 patients with OSCC. HPV16-positivity was proven by p16(INK4A) immunohistochemistry, PCR and FISH. Viral integration was examined using DIPS-as well as APOT-PCR. Viral E2, E6 and E7 gene expression levels were quantified by quantitative reverse transcriptase (RT-q) PCR. Expression levels of 7 human genes disrupted by the virus were extracted from mRNA expression profiling data of 32 OSCCs. Viral copy numbers were assessed by qPCR in 73 tumors. We identified 37 HPV16-human fusion products indicating viral integration in 29 (39%) OSCC. In the remaining tumors (61%) only episome-derived PCR products were detected. When comparing OSCC with or without an integration-derived fusion product, we did not find significant differences in the mean RNA expression of viral genes E2, E6 and E7 or the viral copy numbers per cell, nor did the RNA expression of the HPV-disrupted genes differ from either group of OSCC. In conclusion, our data do not support the hypothesis that integration affects the levels of viral and/or HPV-disrupted human gene transcripts. Thus constitutive, rather than a high level, of expression of oncogene transcripts appears to be required in HPV-related OSCC.	[Olthof, Nadine C.; Kremer, Bernd] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Otorhinolaryngol & Head & Neck Surg, Maastricht, Netherlands; [Olthof, Nadine C.; Speel, Ernst-Jan M.; Haesevoets, Annick; Henfling, Mieke; Ramaekers, Frans C. S.] Maastricht Univ, Med Ctr, Dept Mol Cell Biol, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands; [Speel, Ernst-Jan M.] Maastricht Univ, Med Ctr, Dept Pathol, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands; [Kolligs, Jutta; Huebbers, Christian U.] Univ Cologne, Jean Uhrmacher Inst Otorhinolaryngol Res, D-50931 Cologne, Germany; [Preuss, Simon F.] Univ Hosp Cologne, Dept Otorhinolaryngol Head & Neck Surg, Cologne, Germany; [Drebber, Uta] Univ Hosp Cologne, Inst Pathol, Cologne, Germany; [Wieland, Ulrike; Silling, Steffi] Univ Hosp Cologne, Inst Virol, Natl Reference Ctr Papilloma & Polyomaviruses, Cologne, Germany; [Lam, Wan L.; Vucic, Emily A.] British Columbia Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC V5Z 1L3, Canada; [Klussmann, Jens-P.] Univ Hosp Giessen, Dept Otorhinolaryngol Head & Neck Surg, Giessen, Germany	Maastricht University; Maastricht University; Maastricht University; University of Cologne; University of Cologne; University of Cologne; University of Cologne; British Columbia Cancer Agency; University Hospital of Giessen & Marburg	Huebbers, CU (corresponding author), Univ Cologne, Jean Uhrmacher Inst Otorhinolaryngol Res, D-50931 Cologne, Germany.	christian.huebbers@uni-koeln.de		Klussmann, Jens Peter/0000-0002-8223-7954; Vucic, Emily/0000-0002-2728-8708; Huebbers, Christian/0000-0002-2934-1218	Koeln Fortune Program, Faculty of Medicine, University of Cologne, Cologne, Germany [40/2010]; Jean Uhrmacher Foundation, Cologne, Germany	Koeln Fortune Program, Faculty of Medicine, University of Cologne, Cologne, Germany; Jean Uhrmacher Foundation, Cologne, Germany	This study was supported by the Koeln Fortune Program, Faculty of Medicine, University of Cologne, Cologne, Germany (Grant number 40/2010 to CUH) and the Jean Uhrmacher Foundation, Cologne, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Pulido H, 2006, J CLIN MICROBIOL, V44, P1755, DOI 10.1128/JCM.44.5.1755-1762.2006; Balderas-Loaeza A, 2007, INT J CANCER, V120, P2165, DOI 10.1002/ijc.22563; Begum S, 2005, CLIN CANCER RES, V11, P5694, DOI 10.1158/1078-0432.CCR-05-0587; Chaiwongkot A, 2013, INT J CANCER, V132, P2087, DOI 10.1002/ijc.27906; Chang CC, 2011, J ORAL PATHOL MED, V40, P567, DOI 10.1111/j.1600-0714.2011.01009.x; Chang HH, 2009, ORAL ONCOL, V45, P610, DOI 10.1016/j.oraloncology.2008.08.011; Chow LT, 1997, CLIN DERMATOL, V15, P217, DOI 10.1016/S0738-081X(97)00069-2; Gallego MI, 1997, MOL CARCINOGEN, V19, P114, DOI 10.1002/(SICI)1098-2744(199707)19:2<114::AID-MC6>3.0.CO;2-F; Gammoh N, 2006, J VIROL, V80, P1787, DOI 10.1128/JVI.80.4.1787-1797.2006; Ganguly N, 2009, J BIOSCIENCES, V34, P113, DOI 10.1007/s12038-009-0013-7; Ghosh A, 2012, ANN SURG ONCOL, V19, pS528, DOI 10.1245/s10434-011-1991-x; Hafkamp HC, 2008, INT J CANCER, V122, P2656, DOI 10.1002/ijc.23458; Hafkamp HC, 2003, INT J CANCER, V107, P394, DOI 10.1002/ijc.11389; Hafner N, 2008, ONCOGENE, V27, P1610, DOI 10.1038/sj.onc.1210791; Hopman AHN, 2005, INT J CANCER, V115, P419, DOI 10.1002/ijc.20862; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; JEON S, 1995, P NATL ACAD SCI USA, V92, P1654, DOI 10.1073/pnas.92.5.1654; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Klaes R, 1999, CANCER RES, V59, P6132; Klussmann JP, 2009, CLIN CANCER RES, V15, P1779, DOI 10.1158/1078-0432.CCR-08-1463; Klussmann JP, 2001, CANCER-AM CANCER SOC, V92, P2875, DOI 10.1002/1097-0142(20011201)92:11&lt;2875::AID-CNCR10130&gt;3.0.CO;2-7; Klussmann JP, 2003, AM J PATHOL, V162, P747, DOI 10.1016/S0002-9440(10)63871-0; Klussmann JP, 2001, NEW ENGL J MED, V345, P376; Koskinen WJ, 2003, INT J CANCER, V107, P401, DOI 10.1002/ijc.11381; Kraus I, 2008, CANCER RES, V68, P2514, DOI 10.1158/0008-5472.CAN-07-2776; Lace MJ, 2011, J VIROL, V85, P1645, DOI 10.1128/JVI.02093-10; Li H, 2013, J CLIN VIROL, V56, P342, DOI 10.1016/j.jcv.2012.12.014; Luft F, 2001, INT J CANCER, V92, P9, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1144>3.0.CO;2-L; Mellin H, 2002, INT J CANCER, V102, P152, DOI 10.1002/ijc.10669; Mooren JJ, 2013, INT J CANCER, V132, P1781, DOI 10.1002/ijc.27846; Narisawa-Saito M, 2007, CANCER SCI, V98, P1505, DOI 10.1111/j.1349-7006.2007.00546.x; Olthof NC, 2012, REV MED VIROL, V22, P88, DOI 10.1002/rmv.714; Park IS, 2011, CANCER PREV RES, V4, P207, DOI 10.1158/1940-6207.CAPR-10-0147; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peter M, 2010, J PATHOL, V221, P320, DOI 10.1002/path.2713; Rampias T, 2009, JNCI-J NATL CANCER I, V101, P412, DOI 10.1093/jnci/djp017; Schmitz M, 2012, INT J CANCER, V131, pE593, DOI 10.1002/ijc.27433; SEEDORF K, 1985, VIROLOGY, V145, P181, DOI 10.1016/0042-6822(85)90214-4; Vinokurova S, 2005, JNCI-J NATL CANCER I, V97, P1816, DOI 10.1093/jnci/dji428; Vinokurova S, 2008, CANCER RES, V68, P307, DOI 10.1158/0008-5472.CAN-07-2754; Weissenborn SJ, 2003, J CLIN MICROBIOL, V41, P2763, DOI 10.1128/JCM.41.6.2763-2767.2003; Weissenborn SJ, 2010, NAT PROTOC, V5, P1, DOI 10.1038/nprot.2009.153; Wiest T, 2002, ONCOGENE, V21, P1510, DOI 10.1038/sj.onc.1205214; Wreesmann VB, 2007, ORL-J OTO-RHIN-LARYN, V69, P218, DOI 10.1159/000101542; Xu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066693; Ziegert C, 2003, ONCOGENE, V22, P3977, DOI 10.1038/sj.onc.1206629	46	70	70	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e88718	10.1371/journal.pone.0088718	http://dx.doi.org/10.1371/journal.pone.0088718			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586376	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700008
J	Douda, J; Doudova, J; Drasnarova, A; Kunes, P; Hadincova, V; Krak, K; Zakravsky, P; Mandak, B				Douda, Jan; Doudova, Jana; Drasnarova, Alena; Kunes, Petr; Hadincova, Veroslava; Krak, Karol; Zakravsky, Petr; Mandak, Bohumil			Migration Patterns of Subgenus Alnus in Europe since the Last Glacial Maximum: A Systematic Review	PLOS ONE			English	Review							GLUTINOSA L GAERTN; CRYPTIC NORTHERN REFUGIUM; INCANA L MOENCH; EARLY HOLOCENE; LATEGLACIAL VEGETATION; POLLEN RECORD; COMPARATIVE PHYLOGEOGRAPHY; ENVIRONMENTAL HISTORY; FLOODPLAIN FORESTS; LATE-PLEISTOCENE	Background/Aims: Recently, new palaeoecological records supported by molecular analyses and palaeodistributional modelling have provided more comprehensive insights into plant behaviour during the last Quaternary cycle. We reviewed the migration history of species of subgenus Alnus during the last 50,000 years in Europe with a focus on (1) a general revision of Alnus history since the Last Glacial Maximum (LGM), (2) evidence of northern refugia of Alnus populations during the LGM and (3) the specific history of Alnus in particular European regions. Methodology: We determined changes in Alnus distribution on the basis of 811 and 68 radiocarbon-dated pollen and macrofossil sites, respectively. We compiled data from the European Pollen Database, the Czech Quaternary Palynological Database, the Eurasian Macrofossil Database and additional literature. Pollen percentage thresholds indicating expansions or retreats were used to describe patterns of past Alnus occurrence. Principal Findings: An expansion of Alnus during the Late Glacial and early Holocene periods supports the presence of alders during the LGM in southern peninsulas and northerly areas in western Europe, the foothills of the Alps, the Carpathians and northeastern Europe. After glaciers withdrew, the ice-free area of Europe was likely colonized from several regional refugia; the deglaciated area of Scandinavia was likely colonized from a single refugium in northeastern Europe. In the more northerly parts of Europe, we found a scale-dependent pattern of Alnus expansion characterised by a synchronous increase of Alnus within individual regions, though with regional differences in the times of the expansion. In southern peninsulas, the Alps and the Carpathians, by contrast, it seems that Alnus expanded differently at individual sites rather than synchronously in whole regions. Conclusions: Our synthesis supports the idea that northern LGM populations were important sources of postglacial Alnus expansion. The delayed Alnus expansion apparent in some regions was likely a result of environmental limitations.	[Douda, Jan; Drasnarova, Alena; Mandak, Bohumil] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic; [Doudova, Jana; Drasnarova, Alena; Hadincova, Veroslava; Krak, Karol; Zakravsky, Petr; Mandak, Bohumil] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic; [Kunes, Petr] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic	Czech University of Life Sciences Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Charles University Prague	Douda, J (corresponding author), Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic.	douda@fzp.czu.cz	Doudová, Jana/AAB-7682-2022; Mandak, Bohumil/A-3348-2009; Hadincova, Veroslava/D-4572-2013; Zákravský, Petr/H-1639-2014; Krak, Karol/H-1602-2014; Kuneš, Petr/C-7099-2008; Havrdová, Alena/ABH-7634-2020	Hadincova, Veroslava/0000-0002-3825-1919; Kuneš, Petr/0000-0001-9605-8204; Mandak, Bohumil/0000-0002-9545-7497; Havrdova, Alena/0000-0002-7577-4815; Krak, Karol/0000-0002-0340-2086; Douda, Jan/0000-0002-1205-364X; Doudova, Jana/0000-0002-3186-4528	Agency of the Czech Republic [P504/11/0402]; Czech University of Life Sciences Prague [20124201];  [RVO 67985939]	Agency of the Czech Republic(Grant Agency of the Czech Republic); Czech University of Life Sciences Prague; 	This study was supported by grant no. P504/11/0402 from the Grant Agency of the Czech Republic (http://www.gacr.cz/en/) and grant CIGA no. 20124201 from the Czech University of Life Sciences Prague (http://ga.czu.cz/) and as part of the long-term research development project no. RVO 67985939 (http://www.msmt.cz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESHINSKAYA ZV, 1976, PROBLEMY PALEOHIDROL; Amon L, 2012, J QUATERNARY SCI, V27, P169, DOI 10.1002/jqs.1530; Andersen ST, 1965, MEDDELELSER DANSK GE, V15, P496; Ben Tiba B., 1982, ECOL MEDITERR, V8, P75; BENNETT KD, 1990, J QUATERNARY SCI, V5, P123, DOI 10.1002/jqs.3390050204; BENNETT KD, 1991, J BIOGEOGR, V18, P103, DOI 10.2307/2845248; Binney HA, 2009, QUATERNARY SCI REV, V28, P2445, DOI 10.1016/j.quascirev.2009.04.016; BJORCK S, 1987, QUATERNARY RES, V28, P1, DOI 10.1016/0033-5894(87)90030-5; Bjorkman L, 2003, REV PALAEOBOT PALYNO, V124, P79, DOI 10.1016/S0034-6667(02)00249-X; Blaauw M, 2010, QUAT GEOCHRONOL, V5, P512, DOI 10.1016/j.quageo.2010.01.002; Bos JAA, 2005, PALAEOGEOGR PALAEOCL, V227, P259, DOI 10.1016/j.palaeo.2005.05.020; Bozilova ED, 2000, NEW PHYTOL, V148, P315, DOI 10.1046/j.1469-8137.2000.00754.x; Bozilova ED, 1986, ANN U SOFIA FAC BIOL, V80, P48; BROWN A G, 1988, New Phytologist, V110, P425, DOI 10.1111/j.1469-8137.1988.tb00280.x; BUSH MB, 1987, J BIOGEOGR, V14, P479, DOI 10.2307/2844977; Carcaillet C, 2012, QUATERNARY RES, V78, P540, DOI 10.1016/j.yqres.2012.08.001; CHAMBERS FM, 1985, NEW PHYTOL, V101, P333, DOI 10.1111/j.1469-8137.1985.tb02840.x; CHAMBERS FM, 1989, J BIOGEOGR, V16, P541, DOI 10.2307/2845209; Chen ZD, 1999, AM J BOT, V86, P1168, DOI 10.2307/2656981; Chen ZD, 2004, INT J PLANT SCI, V165, P325, DOI 10.1086/382795; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Csillery K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001; DEBEAULIEU JL, 1984, BOREAS, V13, P111; DEBEAULIEU JL, 1992, QUATERNARY SCI REV, V11, P431, DOI 10.1016/0277-3791(92)90025-4; Douda J, 2008, PRESLIA, V80, P199; Douda J, 2010, J VEG SCI, V21, P1110, DOI 10.1111/j.1654-1103.2010.01213.x; Douda J, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009065; Eisenhut G., 1961, UNTERSUCHUNGEN BER M; Farcas S, 1999, CR ACAD SCI III-VIE, V322, P799, DOI 10.1016/S0764-4469(00)80039-6; Finsinger W, 2006, QUATERNARY SCI REV, V25, P612, DOI 10.1016/j.quascirev.2005.05.006; Follieri M, 1998, QUATERN INT, V47-8, P3, DOI 10.1016/S1040-6182(97)00065-7; FURLOW JJ, 1979, RHODORA, V81, P1; Fyfe RM, 2009, VEG HIST ARCHAEOBOT, V18, P417, DOI 10.1007/s00334-009-0215-9; Gaigalas AI, 1981, TARTU, P28; Gaillard MJ, 2008, VEG HIST ARCHAEOBOT, V17, P415, DOI [10.1007/s00334-008-0170-x, 10.1007/s00334-008-0169-3]; Giesecke T, 2007, J BIOGEOGR, V34, P118, DOI 10.1111/j.1365-2699.2006.01580.x; Giesecke T, 2014, VEG HIST ARCHAEOBOT, V23, P75, DOI 10.1007/s00334-012-0390-y; Giesecke T, 2011, QUATERNARY SCI REV, V30, P2805, DOI 10.1016/j.quascirev.2011.06.014; Godwin H., 1975, HIST BRIT FLORA; Gonzalez-Samperiz P, 2005, QUATERN INT, V140, P4, DOI 10.1016/j.quaint.2005.05.006; Henne PD, 2011, J BIOGEOGR, V38, P933, DOI 10.1111/j.1365-2699.2010.02460.x; Huntley B., 1983, An atlas of past and present pollen maps of Europe: 0-13 000 years ago.; Jalas J, 1976, ATLAS FLORAE EUROPAE; Jankovska V, 2008, PRESLIA, V80, P307; Kelly A, 2010, J QUATERNARY SCI, V25, P296, DOI 10.1002/jqs.1309; KELLY MG, 1991, J QUATERNARY SCI, V6, P209, DOI 10.1002/jqs.3390060304; King RA, 1998, MOL ECOL, V7, P1151, DOI 10.1046/j.1365-294x.1998.00432.x; Kullman L, 1998, BOREAS, V27, P153, DOI 10.1111/j.1502-3885.1998.tb00875.x; KULLMAN L, 1992, NEW PHYTOL, V120, P445, DOI 10.1111/j.1469-8137.1992.tb01085.x; Kunes P, 2008, J BIOGEOGR, V35, P2223, DOI 10.1111/j.1365-2699.2008.01974.x; Kunes P, 2009, PRESLIA, V81, P209; Latalowa M, 2006, VEG HIST ARCHAEOBOT, V15, P321, DOI 10.1007/s00334-006-0062-x; Leopold EB, 2012, PALYNOLOGY, V36, P131, DOI 10.1080/01916122.2012.657876; Lepais O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075029; Lepais O, 2011, J HERED, V102, P627, DOI 10.1093/jhered/esr062; Lisitsyna OV, 2011, REV PALAEOBOT PALYNO, V166, P311, DOI 10.1016/j.revpalbo.2011.06.004; Litynska-Zajac M., 1995, COMPLEX UPPER PALAEO, V1, P74; Lopez-Merino L, 2012, GLOBAL PLANET CHANGE, V92-93, P58, DOI 10.1016/j.gloplacha.2012.04.003; LOWE JJ, 1993, QUATERNARY SCI REV, V12, P727, DOI 10.1016/0277-3791(93)90010-J; Lucchi MR, 2008, QUATERNARY SCI REV, V27, P2456, DOI 10.1016/j.quascirev.2008.09.009; Magny M, 2011, QUATERNARY SCI REV, V30, P2459, DOI 10.1016/j.quascirev.2011.05.018; Magri D, 2006, NEW PHYTOL, V171, P199, DOI 10.1111/j.1469-8137.2006.01740.x; Magyari EK, 2008, J BIOGEOGR, V35, P865, DOI 10.1111/j.1365-2699.2007.01849.x; Magyari EK, 2012, QUATERNARY SCI REV, V35, P116, DOI 10.1016/j.quascirev.2012.01.006; Maliouchenko O, 2007, J BIOGEOGR, V34, P1601, DOI 10.1111/j.1365-2699.2007.01729.x; May L, 2012, REV PALAEOBOT PALYNO, V180, P15, DOI 10.1016/j.revpalbo.2012.04.007; MCVEAN DN, 1953, J ECOL, V41, P447, DOI 10.2307/2257070; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Montanari Carlo, 1996, Allionia (Turin), V34, P309; Muller UC, 2000, VEG HIST ARCHAEOBOT, V9, P125, DOI 10.1007/BF01300062; Palme AE, 2003, HEREDITY, V91, P465, DOI 10.1038/sj.hdy.6800307; Parducci L, 2012, SCIENCE, V335, P1083, DOI 10.1126/science.1216043; Paus A, 2003, QUATERNARY SCI REV, V22, P2285, DOI 10.1016/S0277-3791(03)00136-7; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pini R, 2010, QUATERNARY SCI REV, V29, P3115, DOI 10.1016/j.quascirev.2010.06.040; Pini R, 2009, QUATERNARY SCI REV, V28, P1268, DOI 10.1016/j.quascirev.2008.12.017; Punt W, 2003, NW EUROPEAN POLLER F, V8; R Core Team, 2021, R LANGUAGE ENV STAT; Ralska-Jasiewiczowa M., 2004, LATE GLACIAL HOLOCEN; Reille M, 2000, J QUATERNARY SCI, V15, P665, DOI 10.1002/1099-1417(200010)15:7<665::AID-JQS560>3.0.CO;2-G; Reille M, 1997, NEW PHYTOL, V135, P547, DOI 10.1046/j.1469-8137.1997.00683.x; Rochet J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-40; Saarse L, 2009, EST J EARTH SCI, V58, P317, DOI 10.3176/earth.2009.4.10; Scourse J, 2010, J QUATERNARY SCI, V25, P826, DOI 10.1002/jqs.1414; Seppa H., 1996, Fennia, V174, P1; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Stambouli-Essassi S., 2007, Geo-Eco-Trop, V31, P171; Stancikaite M, 2008, QUATERNARY SCI REV, V27, P127, DOI 10.1016/j.quascirev.2007.01.014; SUGITA S, 1994, J ECOL, V82, P881, DOI 10.2307/2261452; Svenning JC, 2008, J ECOL, V96, P1117, DOI 10.1111/j.1365-2745.2008.01422.x; TALLANTIRE PA, 1992, NEW PHYTOL, V122, P717, DOI 10.1111/j.1469-8137.1992.tb00101.x; TALLANTIRE PA, 1974, NEW PHYTOL, V73, P529, DOI 10.1111/j.1469-8137.1974.tb02131.x; Tonkov S, 2002, HOLOCENE, V12, P201, DOI 10.1191/0959683602hl535rp; Tonkov S, 2006, VEG HIST ARCHAEOBOT, V16, P15, DOI 10.1007/s00334-006-0041-2; Tout a coup la colere d'un homme a claque, 1987, HIST CONSTRUCTION NA; TZEDAKIS PC, 1994, J QUATERNARY SCI, V9, P257, DOI 10.1002/jqs.3390090306; Valiranta M, 2011, J BIOGEOGR, V38, P922, DOI 10.1111/j.1365-2699.2010.02448.x; van der Knaap WO, 2012, HOLOCENE, V22, P1373, DOI 10.1177/0959683612449763; Voznyachuk LN, 1978, MORPHOLOGY STRUCTURE; WALLER MP, 1994, NEW PHYTOL, V126, P369, DOI 10.1111/j.1469-8137.1994.tb03956.x; Watts WA, 1996, QUATERNARY SCI REV, V15, P133, DOI 10.1016/0277-3791(95)00093-3; WEST RG, 1980, NEW PHYTOL, V85, P571, DOI 10.1111/j.1469-8137.1980.tb00772.x; Wick L, 1997, ARCTIC ALPINE RES, V29, P445, DOI 10.2307/1551992; WIJMSTRA TA, 1969, ACTA BOT NEERL, V18, P511, DOI 10.1111/j.1438-8677.1969.tb00591.x; Willis KJ, 2004, QUATERNARY SCI REV, V23, P2369, DOI 10.1016/j.quascirev.2004.06.002; Willis KJ, 2000, QUATERNARY RES, V53, P203, DOI 10.1006/qres.1999.2119; Wohlfarth B, 2006, J PALEOLIMNOL, V35, P543, DOI 10.1007/s10933-005-3240-4; Wohlfarth B, 2002, QUATERNARY RES, V58, P261, DOI 10.1006/qres.2002.2386; Yaltrik Y, 1982, FLORA TURKEY, V7, P688; Zare H., 2012, Iranian Journal of Botany, V18, P10; Zarrina YP, 1973, PLEISTOCENE CHRONOLO, P160	112	36	37	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e88709	10.1371/journal.pone.0088709	http://dx.doi.org/10.1371/journal.pone.0088709			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586374	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900025
J	van der Valk, F; Hassing, C; Visser, M; Thakkar, P; Mohanan, A; Pathak, K; Dutt, C; Chauthaiwale, V; Ackermans, M; Nederveen, A; Serlie, M; Nieuwdorp, M; Stroes, E				van der Valk, Fleur; Hassing, Carlijne; Visser, Maartje; Thakkar, Purav; Mohanan, Anookh; Pathak, Kaushal; Dutt, Chaitanya; Chauthaiwale, Vijay; Ackermans, Mariette; Nederveen, Aart; Serlie, Mireille; Nieuwdorp, Max; Stroes, Erik			The Effect of a Diiodothyronine Mimetic on Insulin Sensitivity in Male Cardiometabolic Patients: A Double-Blind Randomized Controlled Trial	PLOS ONE			English	Article							HIGH-FAT-DIET; THYROID-HORMONE; FUNCTIONAL ANALOG; SKELETAL-MUSCLE; ADIPOSE-TISSUE; WHOLE-BODY; RESISTANCE; 3,5-DIIODO-L-THYRONINE; METABOLISM; OBESITY	Background and aims: Obesity and its associated cardiometabolic co-morbidities are increasing worldwide. Since thyroid hormone mimetics are capable of uncoupling the beneficial metabolic effects of thyroid hormones from their deleterious effects on heart, bone and muscle, this class of drug is considered as adjacent therapeutics to weight-lowering strategies. This study investigated the safety and efficacy of TRC150094, a thyroid hormone mimetic. Materials and Methods: This 4-week, randomized, placebo-controlled, double-blind trial was conducted in India and The Netherlands. Forty subjects were randomized at a 1: 1 ratio to receive either TRC150094 dosed at 50 mg or placebo once daily for 4 weeks. Hyperinsulinemic euglycemic clamp and 1 H-Magnetic Resonance Spectroscopy (MRS) were performed before and after treatment. Results: At baseline, subjects were characterized by markedly impaired hepatic and peripheral insulin sensitivity. TRC150094 dosed 50 mg once daily was safe and well tolerated. Hepatic nor peripheral insulin sensitivity improved after TRC150094 treatment, expressed as the suppression of Endogenous Glucose Production from 59.5 to 62.1%; p = 0.477, and the rate of glucose disappearance from 28.8 to 26.4 mu mol kg(-1) min(-1), p = 0.185. TRC150094 administration did not result in differences in fasting plasma free fatty acids from 0.51 to 0.51 mmol/L, p = 0.887 or in insulin-mediated suppression of lipolysis from 57 to 54%, p = 0.102. Also, intrahepatic triglyceride content was unaltered. Conclusion: Collectively, these data show that, in contrast to the potent metabolic effects in experimental models, TRC150094 at a dose of 50 mg daily does not improve the metabolic homeostasis in subjects at an increased cardiometabolic risk. Further studies are needed to evaluate whether TRC150094 has beneficial effects in patients with more severe metabolic derangement, such as overt diabetes mellitus and hypertriglyceridemia.	[van der Valk, Fleur; Hassing, Carlijne; Visser, Maartje; Nieuwdorp, Max; Stroes, Erik] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Thakkar, Purav; Mohanan, Anookh; Pathak, Kaushal; Dutt, Chaitanya; Chauthaiwale, Vijay] Torrent Pharmaceut Ltd, Dept Clin Res, Village Bhat, India; [Ackermans, Mariette] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Lab Endocrinol, NL-1105 AZ Amsterdam, Netherlands; [Nederveen, Aart] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [Serlie, Mireille] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van der Valk, F (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	f.m.valkvander@amc.nl		Nederveen, Aart/0000-0002-5477-973X	Torrent Pharmaceuticals, Ahmedabad, India	Torrent Pharmaceuticals, Ahmedabad, India	This research was funded by a research grant from Torrent Pharmaceuticals, Ahmedabad, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Ball SG, 1997, J MOL ENDOCRINOL, V19, P137, DOI 10.1677/jme.0.0190137; Bengtsson Per, 2012, KARO BIO TERMINSATES; Brenta G, 2009, THYROID, V19, P665, DOI 10.1089/thy.2009.0108; Bryzgalova G, 2008, J STEROID BIOCHEM, V111, P262, DOI 10.1016/j.jsbmb.2008.06.010; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Cioffi F, 2010, FASEB J, V24, P3451, DOI 10.1096/fj.10-157115; de Lange P, 2011, DIABETES, V60, P2730, DOI 10.2337/db11-0207; Eckel RH, 2011, ARTERIOSCL THROM VAS, V31, P1946, DOI 10.1161/ATVBAHA.111.233049; Hickner RC, 1999, J CLIN ENDOCR METAB, V84, P3886, DOI 10.1210/jc.84.11.3886; HORST C, 1989, BIOCHEM J, V261, P945, DOI 10.1042/bj2610945; Klein I, 2001, NEW ENGL J MED, V344, P501, DOI 10.1056/NEJM200102153440707; Klieverik LP, 2009, ENDOCRINOLOGY, V150, P5639, DOI 10.1210/en.2009-0297; Ladenson PW, 2010, NEW ENGL J MED, V362, P906, DOI 10.1056/NEJMoa0905633; Moreno M, 2008, THYROID, V18, P239, DOI 10.1089/thy.2007.0248; Moreno M, 2011, FASEB J, V25, P3312, DOI 10.1096/fj.11-181982; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Pasarica M, 2010, J CLIN ENDOCR METAB, V95, P4052, DOI 10.1210/jc.2009-2377; Pinna G, 1998, J CLIN ENDOCR METAB, V83, P3071, DOI 10.1210/jc.83.9.3071; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rezzonico J, 2011, THYROID, V21, P945, DOI 10.1089/thy.2010.0402; Ribeiro MO, 2008, THYROID, V18, P197, DOI 10.1089/thy.2007.0288; Silvestri E, 2012, MOL BIOSYST, V8, P1987, DOI 10.1039/c2mb25055a; Skarulis MC, 2010, J CLIN ENDOCR METAB, V95, P256, DOI 10.1210/jc.2009-0543; Soeters MR, 2009, AM J CLIN NUTR, V90, P1244, DOI 10.3945/ajcn.2008.27327; van Raalte DH, 2011, DIABETOLOGIA, V54, P2103, DOI 10.1007/s00125-011-2174-9; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Zambad SP, 2011, DIABETES METAB SYNDR, V4, P5, DOI 10.2147/DMSOTT.S15323	28	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e86890	10.1371/journal.pone.0086890	http://dx.doi.org/10.1371/journal.pone.0086890			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586256	Green Submitted, Green Published, gold			2022-12-27	WOS:000331717900006
J	Ayyadurai, S; Charania, MA; Xiao, B; Viennois, E; Zhang, YC; Merlin, D				Ayyadurai, Saravanan; Charania, Moiz A.; Xiao, Bo; Viennois, Emilie; Zhang, Yuchen; Merlin, Didier			Colonic miRNA Expression/Secretion, Regulated by Intestinal Epithelial PepT1, Plays an Important Role in Cell-to-Cell Communication during Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTERCELLULAR COMMUNICATION; ULCERATIVE-COLITIS; MICRORNA TARGETS; MESSENGER-RNAS; C-ELEGANS; IN-VIVO; CANCER; GENE; MECHANISM	PepT1 is a member of the proton-oligopeptide cotransporter family SLC15, which mediates the transport of di/tripeptides from intestinal lumen into epithelial cells. MicroRNAs (miRNAs), a small noncoding RNAs (21-23 nucleotides), post-transcriptionally regulate gene expression by binding to the 3'-untranslated regions (UTRs) of their target mRNAs. Although the role of most miRNAs remains elusive, they have been implicated in vital cellular functions such as intestinal epithelial cells differentiation, proliferation, and apoptosis. In the present study, we investigated the effect of intestinal epithelial PepT1 expression on microRNA (miRNA) expression/secretion in the colons of control mice and in mice with experimentally induced colonic inflammation (colitis). The colonic miRNA expression was deregulated in both colitis and control mice but the deregulation of miRNA expression/secretion was specific to colonic tissue and did not affect other tissues such as spleen and liver. Intestinal epithelial PepT1-dependent deregulation of colonic miRNA expression not only affects epithelial cells but also other cell types, such as intestinal macrophages. Importantly, we found the miRNA 23b which was known to be involved in inflammatory bowel disease was secreted and transported between cells to impose a gene-silencing effect on recipient intestinal macrophages. Based on our data, we may conclude that the expression of a specific protein, PepT1, in the intestine affects local miRNA expression/secretion in the colon on a tissue specific manner and may play an important role during the induction and progression of colitis. Colonic miRNA expression/secretion, regulated by intestinal epithelial PepT1, could play a crucial role in cell-to-cell communication during colitis.	[Ayyadurai, Saravanan; Charania, Moiz A.; Xiao, Bo; Viennois, Emilie; Zhang, Yuchen; Merlin, Didier] Georgia State Univ, Ctr Diagnost & Therapeut, Dept Biol & Chem, Atlanta, GA 30303 USA; [Viennois, Emilie; Merlin, Didier] Vet Affairs Med Ctr, Decatur, GA 30033 USA	University System of Georgia; Georgia State University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Ayyadurai, S (corresponding author), Georgia State Univ, Ctr Diagnost & Therapeut, Dept Biol & Chem, Atlanta, GA 30303 USA.	sayyadurai@gsu.edu	Zhang, Yuchen/GYI-8858-2022; Xiao, Bo/G-8200-2012	Viennois, Emilie/0000-0002-3104-620X	department of veteran's affairs	department of veteran's affairs(US Department of Veterans Affairs)	This work was supported by the department of veteran's affairs (Didier Merlin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Ayyadurai S, 2013, LAB INVEST, V93, P888, DOI 10.1038/labinvest.2013.77; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Baj-Krzyworzeka M, 2006, CANCER IMMUNOL IMMUN, V55, P808, DOI 10.1007/s00262-005-0075-9; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartels CL, 2010, ANN BIOL CLIN-PARIS, V68, P263, DOI 10.1684/abc.2010.0429; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Bussey KJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r27; Buyse M, 2003, AM J PATHOL, V163, P1969, DOI 10.1016/S0002-9440(10)63555-9; Buyse M, 2002, AM J PHYSIOL-CELL PH, V283, pC1795, DOI 10.1152/ajpcell.00186.2002; Charania MA, 2013, INFECT IMMUN, V81, P923, DOI 10.1128/IAI.01388-12; Charania MA, 2012, AM J PHYSIOL-GASTR L, V302, pG1282, DOI 10.1152/ajpgi.00401.2011; Chatterjee S, 2011, DEV CELL, V20, P388, DOI 10.1016/j.devcel.2011.02.008; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Dalal Sushila R, 2010, Gastroenterol Hepatol (N Y), V6, P714; Dalmasso G, 2008, GASTROENTEROLOGY, V134, P166, DOI 10.1053/j.gastro.2007.10.026; Dalmasso G, 2011, GASTROENTEROLOGY, V141, P1334, DOI 10.1053/j.gastro.2011.06.080; Dalmasso G, 2010, DIFFERENTIATION, V80, P147, DOI 10.1016/j.diff.2010.06.005; Dalmasso G, 2010, AM J PHYSIOL-GASTR L, V299, pG687, DOI 10.1152/ajpgi.00527.2009; Dame MK, 2010, IN VITRO CELL DEV-AN, V46, P114, DOI 10.1007/s11626-009-9247-9; Davis BN, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-18; Ehnfors J, 2009, CELL DEATH DIFFER, V16, P749, DOI 10.1038/cdd.2009.7; Fang K, 2011, PHYSIOL GENOMICS, V43, P43, DOI 10.1152/physiolgenomics.00138.2010; Furuta K, 2012, CURR OPIN CELL BIOL, V24, P211, DOI 10.1016/j.ceb.2011.12.005; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hannafon BN, 2013, INT J MOL SCI, V14, P14240, DOI 10.3390/ijms140714240; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jin XF, 2013, CELL MOL NEUROBIOL, V33, P601, DOI 10.1007/s10571-013-9940-9; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Kosaka N, 2012, J BIOL CHEM, V287, P1397, DOI 10.1074/jbc.M111.288662; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Laroui H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032084; Laroui H, 2010, GASTROENTEROLOGY, V138, P843, DOI 10.1053/j.gastro.2009.11.003; Lasser Cecilia, 2013, Methods Mol Biol, V1024, P109, DOI 10.1007/978-1-62703-453-1_9; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LI JX, 1992, CELL, V70, P791, DOI 10.1016/0092-8674(92)90312-Z; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Luo XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062880; McKenna LB, 2010, GASTROENTEROLOGY, V139, P1654, DOI 10.1053/j.gastro.2010.07.040; Merlin D, 2001, GASTROENTEROLOGY, V120, P1666, DOI 10.1053/gast.2001.24845; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Moldovan Leni, 2013, Methods Mol Biol, V1024, P129, DOI 10.1007/978-1-62703-453-1_10; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Muralidharan-Chari V, 2010, J CELL SCI, V123, P1603, DOI 10.1242/jcs.064386; Nguyen HTT, 2009, GASTROENTEROLOGY, V137, P1435, DOI 10.1053/j.gastro.2009.06.043; Nguyen HTT, 2010, J BIOL CHEM, V285, P1479, DOI 10.1074/jbc.M109.057141; Pekow JR, 2012, INFLAMM BOWEL DIS, V18, P187, DOI 10.1002/ibd.21691; Saban Ricardo, 2007, BMC Physiology, V7, P3, DOI 10.1186/1472-6793-7-3; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Viennois Emilie, 2013, BMC Res Notes, V6, P360, DOI 10.1186/1756-0500-6-360; Wang J, 2007, CLIN EXP METASTAS, V24, P411, DOI 10.1007/s10585-007-9078-6; Wang P, 2013, J IMMUNOL, V191, P1413, DOI 10.4049/jimmunol.1202598; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wojtal KA, 2009, DRUG METAB DISPOS, V37, P1871, DOI 10.1124/dmd.109.027367; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Wu F, 2010, INFLAMM BOWEL DIS, V16, P1729, DOI 10.1002/ibd.21267; Wu WKK, 2011, CARCINOGENESIS, V32, P247, DOI 10.1093/carcin/bgq243; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006073; Ziegler TR, 2002, AM J CLIN NUTR, V75, P922, DOI 10.1093/ajcn/75.5.922; Zucchelli M, 2009, INFLAMM BOWEL DIS, V15, P1562, DOI 10.1002/ibd.20963	67	27	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e87614	10.1371/journal.pone.0087614	http://dx.doi.org/10.1371/journal.pone.0087614			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586284	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900014
J	Shovlin, CL; Chamali, B; Santhirapala, V; Livesey, JA; Angus, G; Manning, R; Laffan, MA; Meek, J; Tighe, HC; Jackson, JE				Shovlin, Claire L.; Chamali, Basel; Santhirapala, Vatshalan; Livesey, John A.; Angus, Gillian; Manning, Richard; Laffan, Michael A.; Meek, John; Tighe, Hannah C.; Jackson, James E.			Ischaemic Strokes in Patients with Pulmonary Arteriovenous Malformations and Hereditary Hemorrhagic Telangiectasia: Associations with Iron Deficiency and Platelets	PLOS ONE			English	Article							TO-LEFT SHUNT; CONTRAST ECHOCARDIOGRAPHY; NATURAL-HISTORY; FACTOR-VIII; FOLLOW-UP; EMBOLIZATION; PLASMA; QUANTIFICATION; SARPOGRELATE; PREVALENCE	Background: Pulmonary first pass filtration of particles marginally exceeding similar to 7 mu m (the size of a red blood cell) is used routinely in diagnostics, and allows cellular aggregates forming or entering the circulation in the preceding cardiac cycle to lodge safely in pulmonary capillaries/arterioles. Pulmonary arteriovenous malformations compromise capillary bed filtration, and are commonly associated with ischaemic stroke. Cohorts with CT-scan evident malformations associated with the highest contrast echocardiographic shunt grades are known to be at higher stroke risk. Our goal was to identify within this broad grouping, which patients were at higher risk of stroke. Methodology: 497 consecutive patients with CT-proven pulmonary arteriovenous malformations due to hereditary haemorrhagic telangiectasia were studied. Relationships with radiologically-confirmed clinical ischaemic stroke were examined using logistic regression, receiver operating characteristic analyses, and platelet studies. Principal Findings: Sixty-one individuals (12.3%) had acute, non-iatrogenic ischaemic clinical strokes at a median age of 52 (IQR 41-63) years. In crude and age-adjusted logistic regression, stroke risk was associated not with venous thromboemboli or conventional neurovascular risk factors, but with low serum iron (adjusted odds ratio 0.96 [95% confidence intervals 0.92, 1.00]), and more weakly with low oxygen saturations reflecting a larger right-to-left shunt (adjusted OR 0.96 [0.92, 1.01]). For the same pulmonary arteriovenous malformations, the stroke risk would approximately double with serum iron 6 mu mol/L compared to mid-normal range (7-27 mu mol/L). Platelet studies confirmed overlooked data that iron deficiency is associated with exuberant platelet aggregation to serotonin (5HT), correcting following iron treatment. By MANOVA, adjusting for participant and 5HT, iron or ferritin explained 14% of the variance in log-transformed aggregation-rate (p = 0.039/p = 0.021). Significance: These data suggest that patients with compromised pulmonary capillary filtration due to pulmonary arteriovenous malformations are at increased risk of ischaemic stroke if they are iron deficient, and that mechanisms are likely to include enhanced aggregation of circulating platelets.	[Shovlin, Claire L.; Chamali, Basel; Santhirapala, Vatshalan] Imperial Coll London, Natl Heart & Lung Inst NHLI Cardiovasc Sci, London, England; [Santhirapala, Vatshalan; Livesey, John A.; Angus, Gillian; Manning, Richard; Laffan, Michael A.; Meek, John; Tighe, Hannah C.] Imperial Coll Healthcare NHS Trust, London, England; [Chamali, Basel; Santhirapala, Vatshalan; Livesey, John A.] Imperial Coll London, Imperial Coll Sch Med, London, England; [Laffan, Michael A.] Imperial Coll London, Ctr Haematol, London, England; [Jackson, James E.] Imperial Coll Healthcare NHS Trust, Dept Imaging, London, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London	Shovlin, CL (corresponding author), Imperial Coll London, Natl Heart & Lung Inst NHLI Cardiovasc Sci, London, England.	c.shovlin@imperial.ac.uk		Laffan, Michael/0000-0002-8268-3268; Shovlin, Claire/0000-0001-9007-5775	National Institute for Health Research: London (NW) Comprehensive Local Research Network; Imperial College Biomedical Research Centre; HHT patient donations; Imperial BSc project funding	National Institute for Health Research: London (NW) Comprehensive Local Research Network; Imperial College Biomedical Research Centre; HHT patient donations; Imperial BSc project funding	Funding support was received from National Institute for Health Research: London (NW) Comprehensive Local Research Network (CLS), Imperial College Biomedical Research Centre (CLS, ML); HHT patient donations; and Imperial BSc project funding (to CLS for BC, VS and JAL). The funders played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	AASSAR OS, 1991, LARYNGOSCOPE, V101, P977; An appreciation of Martin Blomley, REPORTER; ANAND IS, 1995, J AM COLL CARDIOL, V25, P1402, DOI 10.1016/0735-1097(95)00007-Q; Bajc M, 2009, EUR J NUCL MED MOL I, V36, P1356, DOI 10.1007/s00259-009-1170-5; Bang SM, 2013, ANN HEMATOL, V92, P59, DOI 10.1007/s00277-012-1563-6; BARZILAI B, 1991, AM J CARDIOL, V68, P1507, DOI 10.1016/0002-9149(91)90287-U; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Billinger M, 2013, AM J CARDIOL, V111, P286, DOI 10.1016/j.amjcard.2012.09.030; Blomley M, 1999, RADIOLOGY, V213, P1145; Burtis CA, 2006, TIETZ TXB CLIN CHEM; Buscarini E, 2011, DIGEST DIS SCI, V56, P2166, DOI 10.1007/s10620-011-1585-2; BUTLER BD, 1979, J APPL PHYSIOL, V47, P537, DOI 10.1152/jappl.1979.47.3.537; CHILVERS ER, 1988, CLIN RADIOL, V39, P611, DOI 10.1016/S0009-9260(88)80065-5; Clark K, 2013, AM J CARDIOL, V112, P731, DOI 10.1016/j.amjcard.2013.04.052; Cottin V, 2007, MEDICINE, V86, P1, DOI 10.1097/MD.0b013e31802f8da1; Coupland C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4551; Devlin HL, 2013, NEW ENGL J MED, V368, P876, DOI 10.1056/NEJMc1213554; DUTTON JAE, 1995, AM J ROENTGENOL, V165, P1119, DOI 10.2214/ajr.165.5.7572487; Easey AJ, 2003, J NEUROL NEUROSUR PS, V74, P743, DOI 10.1136/jnnp.74.6.743; Elphick A, 2014, LARYNGOSCOPE, V124, P1521, DOI 10.1002/lary.24526; Faughnan ME, 2011, J MED GENET, V48, P73, DOI 10.1136/jmg.2009.069013; Feinstein JA, 2002, AM J CARDIOL, V89, P281, DOI 10.1016/S0002-9149(01)02228-7; Finnamore H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076516; Folz BJ, 2005, RHINOLOGY, V43, P40; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Gallione CJ, 2004, LANCET, V363, P852, DOI 10.1016/S0140-6736(04)15732-2; Gazzaniga P, 2009, EUR J ECHOCARDIOGR, V10, P513, DOI 10.1093/ejechocard/jen317; Gillum RF, 1996, AM J EPIDEMIOL, V144, P59, DOI 10.1093/oxfordjournals.aje.a008855; Gupta P, 2002, AM J ROENTGENOL, V179, P347, DOI 10.2214/ajr.179.2.1790347; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; Hao Z., 2012, COCHRANE DB SYST REV, V3; Hara K, 2004, J LAB CLIN MED, V144, P31, DOI 10.1016/j.lab.2004.03.014; Hart JL, 2010, EUR RADIOL, V20, P2663, DOI 10.1007/s00330-010-1851-2; Hebert PC, 2004, CRIT CARE CLIN, V20, P187, DOI 10.1016/j.ccc.2004.01.001; Jackson SP, 2007, BLOOD, V109, P5087, DOI 10.1182/blood-2006-12-027698; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Kjeldsen AD, 1999, CHEST, V116, P432, DOI 10.1378/chest.116.2.432; Kjeldsen AD, 2000, AM J GASTROENTEROL, V95, P415, DOI 10.1111/j.1572-0241.2000.01792.x; Krings T, 2005, NEURORADIOLOGY, V47, P711, DOI 10.1007/s00234-005-1390-8; Livesey JA, 2012, THORAX, V67, P328, DOI 10.1136/thoraxjnl-2011-201076; Mager JJ, 2002, CLIN SCI, V102, P127, DOI 10.1042/CS20010051; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Moussouttas M, 2000, NEUROLOGY, V55, P959, DOI 10.1212/WNL.55.7.959; Nakayama M, 2012, INTERNAL MED, V51, P1677, DOI 10.2169/internalmedicine.51.7305; Nanthakumar K, 2001, AM HEART J, V141, P243, DOI 10.1067/mhj.2001.112682; Nieswandt B, 2011, J THROMB HAEMOST, V9, P92, DOI 10.1111/j.1538-7836.2011.04361.x; Ono Kenichiro, 2012, Brain and Nerve (Tokyo), V64, P185; Parra JA, 2010, EUR RESPIR J, V35, P1279, DOI 10.1183/09031936.00104309; Pilcher J, 2001, P 4 HHT SCI C, P58; PORTER WB, 1953, CIRCULATION, V8, P111, DOI 10.1161/01.CIR.8.1.111; REMY J, 1992, RADIOLOGY, V182, P809, DOI 10.1148/radiology.182.3.1535899; Roked F, 2011, AM J RESP CRIT CARE, V183, P828, DOI 10.1164/ajrccm.183.6.828; SANTHIRAPALA V, 2013, THORAX S3, V68, pA24; Shinohara Y, 2008, STROKE, V39, P1827, DOI 10.1161/STROKEAHA.107.505131; Shovlin C, 2008, BRIT DENT J, V205, P531, DOI 10.1038/sj.bdj.2008.978; Shovlin CL, 2008, BJOG-INT J OBSTET GY, V115, P1108, DOI 10.1111/j.1471-0528.2008.01786.x; Shovlin CL, 2008, EUR RESPIR J, V32, P162, DOI 10.1183/09031936.00126207; Shovlin CL, 2008, THORAX, V63, P259, DOI 10.1136/thx.2007.087452; Shovlin CL, 2011, EUR RESPIR MONOGR, P218, DOI 10.1183/1025448x.10008410; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Shovlin CL, 1999, THORAX, V54, P714, DOI 10.1136/thx.54.8.714; Shovlin CL, 2004, PULMONARY CIRCULATIO, P584; Shovlin CL, 2010, MURRAY NADELS TXB RE, P1261; Shovlin CL, 2005, MURRAY NADELS TXB RE, P1480; Shovlin CL, 2007, THROMB HAEMOSTASIS, V98, P1031, DOI 10.1160/TH07-01-0064; Shovlin CL, 2010, BLOOD REV, V24, P203, DOI 10.1016/j.blre.2010.07.001; Shovlin Claire L, 2010, PLoS One, V5, pe9154, DOI 10.1371/journal.pone.0009154; Silva BM, 2013, LARYNGOSCOPE, V123, P1092, DOI 10.1002/lary.23893; Thompson RD, 1999, CHEST, V115, P109, DOI 10.1378/chest.115.1.109; Uchiyama S, 2007, CEREBROVASC DIS, V24, P264, DOI 10.1159/000105135; UEKI J, 1994, THORAX, V49, P327, DOI 10.1136/thx.49.4.327; VALBERG LS, 1980, CAN MED ASSOC J, V122, P1240; van Gent MWF, 2010, CHEST, V138, P833, DOI 10.1378/chest.09-1849; van Gent MWF, 2009, CHEST, V135, P1288, DOI 10.1378/chest.08-1266; VANDEPETTE JEW, 1986, BRIT J HAEMATOL, V63, P369; Velthuis S, 2013, CHEST, V144, P542, DOI 10.1378/chest.12-1599; Weibel ER, 2009, SWISS MED WKLY, V139, P375, DOI smw-12270; Weng LC, 2008, STROKE, V39, P3152, DOI 10.1161/STROKEAHA.108.524934; WHYTE MKB, 1992, THORAX, V47, P790, DOI 10.1136/thx.47.10.790; Woods HF, 1977, CIBA F S, P227; YEUNG M, 1995, STROKE, V26, P1941, DOI 10.1161/01.STR.26.10.1941; Zukotynski K, 2007, CHEST, V132, P18, DOI 10.1378/chest.06-2356	82	57	58	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88812	10.1371/journal.pone.0088812	http://dx.doi.org/10.1371/journal.pone.0088812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586400	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900049
J	Mohawk, KL; Poly, F; Sahl, JW; Rasko, DA; Guerry, P				Mohawk, Krystle L.; Poly, Frederic; Sahl, Jason W.; Rasko, David A.; Guerry, Patricia			High Frequency, Spontaneous motA Mutations in Campylobacter jejuni Strain 81-176	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; GENOME SEQUENCE; EPITHELIAL-CELLS; FLAGELLAR MOTOR; GENE-EXPRESSION; PHASE VARIATION; NCTC 11168; INFECTION; VIRULENCE; COLONIZATION	Campylobacter jejuni is an important cause of bacterial diarrhea worldwide. The pathogenesis of C. jejuni is poorly understood and complicated by phase variation of multiple surface structures including lipooligosaccharide, capsule, and flagellum. When C. jejuni strain 81-176 was plated on blood agar for single colonies, the presence of translucent, non-motile colonial variants was noted among the majority of opaque, motile colonies. High-throughput genomic sequencing of two flagellated translucent and two opaque variants as well as the parent strain revealed multiple genetic changes compared to the published genome. However, the only mutated open reading frame common between the two translucent variants and absent from the opaque variants and the parent was motA, encoding a flagellar motor protein. A total of 18 spontaneous motA mutations were found that mapped to four distinct sites in the gene, with only one class of mutation present in a phase variable region. This study exemplifies the mutative/adaptive properties of C. jejuni and demonstrates additional variability in C. jejuni beyond phase variation.	[Mohawk, Krystle L.; Poly, Frederic; Guerry, Patricia] Naval Med Res Ctr, Enter Dis Dept, Silver Spring, MD 20910 USA; [Sahl, Jason W.; Rasko, David A.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Inst Genome Sci, Baltimore, MD 21201 USA	Naval Medical Research Center (NMRC); University System of Maryland; University of Maryland Baltimore	Guerry, P (corresponding author), Naval Med Res Ctr, Enter Dis Dept, Silver Spring, MD 20910 USA.	patricia.guerry@med.navy.mil		, Jason/0000-0002-2497-0138; David, Rasko/0000-0002-7337-7154	Military Infectious Diseases Research Program [6000.RAD1.DA3.A0308]	Military Infectious Diseases Research Program	This work was supported by the Military Infectious Diseases Research Program, Work unit no. 6000.RAD1.DA3.A0308. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto L, 2006, GASTROENTEROLOGY, V130, P1588, DOI 10.1053/j.gastro.2006.02.004; Bacon DJ, 2001, MOL MICROBIOL, V40, P769, DOI 10.1046/j.1365-2958.2001.02431.x; Barrero-Tobon AM, 2012, MOL MICROBIOL, V84, P352, DOI 10.1111/j.1365-2958.2012.08027.x; Bayliss CD, 2012, NUCLEIC ACIDS RES, V40, P5876, DOI 10.1093/nar/gks246; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Bucci C, 1999, MOL CELL, V3, P435, DOI 10.1016/S1097-2765(00)80471-2; BUCK GE, 1981, J CLIN MICROBIOL, V14, P585, DOI 10.1128/JCM.14.5.585-586.1981; CALDWELL MB, 1985, INFECT IMMUN, V50, P941, DOI 10.1128/IAI.50.3.941-943.1985; Carrillo CD, 2004, J BIOL CHEM, V279, P20327, DOI 10.1074/jbc.M401134200; CBS, 2007, TMHMM SERV V 2 0; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Cooper KK, 2013, RES MICROBIOL, V164, P6, DOI 10.1016/j.resmic.2012.10.002; Ewing CP, 2009, J BACTERIOL, V191, P7086, DOI 10.1128/JB.00378-09; Gaasbeek EJ, 2009, J BACTERIOL, V191, P3785, DOI 10.1128/JB.01817-08; Galkin VE, 2008, SCIENCE, V320, P382, DOI 10.1126/science.1155307; Gaynor EC, 2004, J BACTERIOL, V186, P503, DOI 10.1128/JB.186.2.503-517.2004; Gilliss D, 2013, MMWR-MORBID MORTAL W, V62, P283; Hendrixson DR, 2008, MOL MICROBIOL, V70, P519, DOI 10.1111/j.1365-2958.2008.06428.x; Hendrixson DR, 2006, MOL MICROBIOL, V61, P1646, DOI 10.1111/j.1365-2958.2006.05336.x; Hofreuter D, 2006, INFECT IMMUN, V74, P4694, DOI 10.1128/IAI.00210-06; Hu L, 1999, INFECT IMMUN, V67, P4171, DOI 10.1128/IAI.67.8.4171-4182.1999; Jerome JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016399; Jones FR, 2006, INFECT IMMUN, V74, P790, DOI 10.1128/IAI.74.1.790-793.2006; Kalischuk LD, 2010, AM J PHYSIOL-GASTR L, V298, pG1, DOI 10.1152/ajpgi.00193.2009; Konkel ME, 2004, J BACTERIOL, V186, P3296, DOI 10.1128/JB.186.11.3296-3303.2004; KORLATH JA, 1985, J INFECT DIS, V152, P592, DOI 10.1093/infdis/152.3.592; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; LABIGNEROUSSEL A, 1988, J BACTERIOL, V170, P1704, DOI 10.1128/jb.170.4.1704-1708.1988; LeClerc JE, 1996, SCIENCE, V274, P1208, DOI 10.1126/science.274.5290.1208; Linton D, 2001, CURR OPIN MICROBIOL, V4, P35, DOI 10.1016/S1369-5274(00)00161-2; Marshall JK, 2009, KIDNEY INT, V75, pS42, DOI 10.1038/ki.2008.618; Nachamkin I, 2001, J INFECT DIS, V184, P221, DOI 10.1086/322008; Novik V, 2010, INFECT IMMUN, V78, P3540, DOI 10.1128/IAI.00109-10; Obara M, 2008, J BACTERIOL, V190, P3565, DOI 10.1128/JB.00849-07; OELSCHLAEGER TA, 1993, P NATL ACAD SCI USA, V90, P6884, DOI 10.1073/pnas.90.14.6884; Park SF, 2000, J BACTERIOL, V182, P207, DOI 10.1128/JB.182.1.207-210.2000; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; PETERSON MC, 1994, WESTERN J MED, V161, P148; Pimentel M, 2008, DIGEST DIS SCI, V53, P982, DOI 10.1007/s10620-007-9977-z; Poly F, 2007, INFECT IMMUN, V75, P3859, DOI 10.1128/IAI.00159-07; Prunier AL, 2005, J BACTERIOL, V187, P3455, DOI 10.1128/JB.187.10.3455-3464.2005; Revez J, 2013, INFECT GENET EVOL, V16, P305, DOI 10.1016/j.meegid.2013.03.009; Revez J, 2012, J BACTERIOL, V194, P6298, DOI 10.1128/JB.01385-12; Rozen S, 2000, Methods Mol Biol, V132, P365; RUSSELL RG, 1989, INFECT IMMUN, V57, P1438, DOI 10.1128/IAI.57.5.1438-1444.1989; Silva J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00200; SKIRROW MB, 1980, J HYG-CAMBRIDGE, V85, P427, DOI 10.1017/S0022172400063506; Song YC, 2004, MOL MICROBIOL, V53, P541, DOI 10.1111/j.1365-2958.2004.04175.x; Spiller RC, 2007, J GASTROENTEROL, V42, P41, DOI 10.1007/s00535-006-1925-8; SUERBAUM S, 1993, J BACTERIOL, V175, P3278, DOI 10.1128/jb.175.11.3278-3288.1993; Tribble DR, 2010, INFECT IMMUN, V78, P1750, DOI 10.1128/IAI.01021-09; Turrientes MC, 2009, 19 EUR SOC CLIN MICR; van den Broek D, 2005, MICROBIOL-SGM, V151, P1403, DOI 10.1099/mic.0.27777-0; Verdu EF, 2007, CAN J GASTROENTEROL, V21, P453, DOI 10.1155/2007/169591; Wosten MMSM, 2004, J BIOL CHEM, V279, P16214, DOI 10.1074/jbc.M400357200; YAO RJ, 1994, MOL MICROBIOL, V14, P883, DOI 10.1111/j.1365-2958.1994.tb01324.x; Zhou JD, 1997, J MOL BIOL, V273, P428, DOI 10.1006/jmbi.1997.1316	57	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88043	10.1371/journal.pone.0088043	http://dx.doi.org/10.1371/journal.pone.0088043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558375	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700021
J	Peitsch, WK; Doerflinger, Y; Fischer-Colbrie, R; Huck, V; Bauer, AT; Utikal, J; Goerdt, S; Schneider, SW				Peitsch, Wiebke K.; Doerflinger, Yvette; Fischer-Colbrie, Reiner; Huck, Volker; Bauer, Alexander T.; Utikal, Jochen; Goerdt, Sergij; Schneider, Stefan W.			Desmoglein 2 Depletion Leads to Increased Migration and Upregulation of the Chemoattractant Secretoneurin in Melanoma Cells	PLOS ONE			English	Article							OPENER JO-1 IMPROVES; E-CADHERIN; TRANSENDOTHELIAL MIGRATION; NEUROPEPTIDE SECRETONEURIN; HUMAN MONOCYTES; MUSCLE-CELLS; IN-VITRO; EXPRESSION; ADHESION; PROLIFERATION	During development and progression of malignant melanoma, an important role has been attributed to alterations of cell-cell adhesions, in particular, to a "cadherin switch" from E-to N-cadherin. We have previously shown that a subtype of melanoma cells express the desmosomal cadherin desmoglein 2 as non-junction-bound cell surface protein in addition to classical cadherins. To study the role of desmoglein 2 in melanoma cells, melanoma lines containing high endogenous amounts of desmoglein 2 were depleted of the protein by RNA interference. Transwell migration and scratch wounding assays showed markedly increased migration upon desmoglein 2 suppression whereas proliferation and viability remained unaltered. In gene expression profiles, desmoglein 2 depletion was associated with overexpression of migration-related genes. Strongest overexpression was found for secretogranin II which has not been reported in melanoma cells before. The bioactive peptide derived from secretogranin II, secretoneurin, is known to exert chemoattractive functions and was demonstrated here to stimulate melanoma cell migration. In summary, we show that desmoglein 2 expression attenuates migration of melanoma cells. The mechanism of desmoglein 2 impaired cell migration is mediated by downregulation of secretogranin II. Loss of desmoglein 2 increases expression of secretogranin II, followed by an enhanced migratory activity of melanoma cells. Our data add a new pathway of regulating melanoma cell migration related to a desmoglein 2 - secretogranin II axis.	[Peitsch, Wiebke K.; Doerflinger, Yvette; Huck, Volker; Bauer, Alexander T.; Utikal, Jochen; Goerdt, Sergij; Schneider, Stefan W.] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Dermatol, Mannheim, Germany; [Peitsch, Wiebke K.; Doerflinger, Yvette] German Canc Res Ctr, Helmholtz Grp Cell Biol, Heidelberg, Germany; [Fischer-Colbrie, Reiner] Med Univ Innsbruck, Dept Pharmacol, A-6020 Innsbruck, Austria; [Utikal, Jochen] German Canc Res Ctr, Skin Canc Unit, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Medical University of Innsbruck; Helmholtz Association; German Cancer Research Center (DKFZ)	Peitsch, WK (corresponding author), Heidelberg Univ, Univ Med Ctr Mannheim, Dept Dermatol, Mannheim, Germany.	w.peitsch@dkfz-heidelberg.de	Huck, Volker/B-5627-2011	Huck, Volker/0000-0001-8988-1091; Utikal, Jochen/0000-0001-5316-0241	Deutsche Krebshilfe [108626, 109312]; Deutsche Forschungsgemeinschaft (DFG) [SFB/TR23]	Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Krebshilfe to WK Peitsch (project no. 108626) and to JU (project no. 109312) and a grant from the Deutsche Forschungsgemeinschaft (DFG) to SWS (SFB/TR23, project A9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht-Schgoer K, 2012, CIRCULATION, V126, P2491, DOI 10.1161/CIRCULATIONAHA.111.076950; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Beyer I, 2012, CLIN CANCER RES, V18, P3340, DOI 10.1158/1078-0432.CCR-11-3213; Beyer I, 2011, CANCER RES, V71, P7080, DOI 10.1158/0008-5472.CAN-11-2009; Biedermann K, 2005, J PATHOL, V207, P199, DOI 10.1002/path.1821; Bosserhoff AK, 2013, MOL CARCINOG, DOI [10.1002/mc.22018, DOI 10.1002/MC.22018.[]; Brandner JM, 2013, PATHOLOGY, V45, P443, DOI 10.1097/PAT.0b013e328363b3bd; Brennan D, 2012, ONCOGENE, V31, P1636, DOI 10.1038/onc.2011.346; Brennan D, 2007, J CELL SCI, V120, P758, DOI 10.1242/jcs.03392; Brennan D, 2009, CELL ADHES MIGR, V3, P148, DOI 10.4161/cam.3.2.7539; Cirillo N, 2008, J CELL BIOCHEM, V103, P598, DOI 10.1002/jcb.21431; Dunzendorfer S, 1998, BLOOD, V91, P1527, DOI 10.1182/blood.V91.5.1527.1527_1527_1532; Dunzendorfer S, 2001, J IMMUNOL, V166, P2167, DOI 10.4049/jimmunol.166.4.2167; Dusek RL, 2007, J DERMATOL SCI, V45, P7, DOI 10.1016/j.jdermsci.2006.10.006; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; Egger M, 2007, FASEB J, V21, P2906, DOI 10.1096/fj.06-7440com; Eshkind L, 2002, EUR J CELL BIOL, V81, P592, DOI 10.1078/0171-9335-00278; Fischer-Colbrie R, 2005, CURR PROTEIN PEPT SC, V6, P373, DOI 10.2174/1389203054546334; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Hartlieb E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053739; Helle KB, 2010, REGUL PEPTIDES, V165, P45, DOI 10.1016/j.regpep.2009.09.009; Hsu MY, 2000, AM J PATHOL, V156, P1515, DOI 10.1016/S0002-9440(10)65023-7; Hsu MY, 1996, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 1, NO 2, APRIL 1996, P188; Kahler CM, 1996, EUR J PHARMACOL, V304, P135, DOI 10.1016/0014-2999(96)00135-5; Kahler CM, 1997, ARTERIOSCL THROM VAS, V17, P2029, DOI 10.1161/01.ATV.17.10.2029; Kahler CM, 1997, ARTERIOSCL THROM VAS, V17, P932, DOI 10.1161/01.ATV.17.5.932; Kahler CM, 2002, REGUL PEPTIDES, V105, P35, DOI 10.1016/S0167-0115(01)00379-2; Kirchmair R, 2004, CIRCULATION, V110, P1121, DOI 10.1161/01.CIR.0000139884.81390.56; Kirchmair R, 2004, CIRCULATION, V109, P777, DOI 10.1161/01.CIR.0000112574.07422.C1; KIRCHMAIR R, 1993, NEUROSCIENCE, V53, P359, DOI 10.1016/0306-4522(93)90200-Y; Kuphal S, 2006, ONCOGENE, V25, P248, DOI 10.1038/sj.onc.1209054; Kuphal S, 2004, ONCOGENE, V23, P8509, DOI 10.1038/sj.onc.1207831; Kuphal S, 2012, ARCH BIOCHEM BIOPHYS, V524, P43, DOI 10.1016/j.abb.2011.10.020; Kuphal S, 2009, PIGM CELL MELANOMA R, V22, P296, DOI 10.1111/j.1755-148X.2009.00568.x; Kurzen H, 2003, J CUTAN PATHOL, V30, P621, DOI 10.1034/j.1600-0560.2003.00122.x; Li G, 2004, EXP CELL RES, V297, P142, DOI 10.1016/j.yexcr.2004.03.012; Li G, 2001, CANCER RES, V61, P3819; Lorch JH, 2004, J BIOL CHEM, V279, P37191, DOI 10.1074/jbc.M405123200; Lorch JH, 2007, CANCER RES, V67, P727, DOI 10.1158/0008-5472.CAN-06-2162; Ludwig T, 2002, AM J PHYSIOL-RENAL, V283, pF319, DOI 10.1152/ajprenal.00327.2001; Maret D, 2010, NEOPLASIA, V12, P1066, DOI 10.1593/neo.10954; Nava P, 2007, MOL BIOL CELL, V18, P4565, DOI 10.1091/mbc.E07-05-0426; Nishimura EK, 1999, DEV BIOL, V215, P155, DOI 10.1006/dbio.1999.9478; Peitsch WK, 1999, EUR J CELL BIOL, V78, P767, DOI 10.1016/S0171-9335(99)80027-2; Pieperhoff S, 2007, EUR J CELL BIOL, V86, P377, DOI 10.1016/j.ejcb.2007.04.001; Pieperhoff S, 2010, DERMAT RES PRACT, V2010, DOI 10.1155/2010/139167; Qi JF, 2006, MOL BIOL CELL, V17, P1261, DOI 10.1091/mbc.E05-10-0927; Qi JF, 2005, MOL BIOL CELL, V16, P4386, DOI 10.1091/mbc.E05-03-0186; REINISCH N, 1993, FEBS LETT, V334, P41, DOI 10.1016/0014-5793(93)81676-Q; Rickelt S, 2008, CELL TISSUE RES, V334, P401, DOI 10.1007/s00441-008-0704-7; SCHAFER S, 1994, EXP CELL RES, V211, P391, DOI 10.1006/excr.1994.1103; Schgoer W, 2009, CIRC RES, V105, P994, DOI 10.1161/CIRCRESAHA.109.199513; Schlegel N, 2010, AM J PHYSIOL-GASTR L, V298, pG774, DOI 10.1152/ajpgi.00239.2009; Schmitt CJ, 2007, J INVEST DERMATOL, V127, P2191, DOI 10.1038/sj.jid.5700849; Schnaeker EM, 2004, CANCER RES, V64, P8924, DOI 10.1158/0008-5472.CAN-04-0324; Schneider SW, 2004, ACTA NEUROPATHOL, V107, P272, DOI 10.1007/s00401-003-0810-2; Schratzberger P, 1996, NEUROSCI LETT, V214, P208, DOI 10.1016/0304-3940(96)12947-5; Seftor REB, 2012, AM J PATHOL, V181, P1115, DOI 10.1016/j.ajpath.2012.07.013; Spangler B, 2011, PIGM CELL MELANOMA R, V24, P148, DOI 10.1111/j.1755-148X.2010.00787.x; TANG A, 1994, J CELL SCI, V107, P983; Trojan L, 2005, ANTICANCER RES, V25, P183; Van Marck V, 2005, CANCER RES, V65, P8774, DOI 10.1158/0008-5472.CAN-04-4414; Wang HJ, 2011, NAT MED, V17, P96, DOI 10.1038/nm.2270; Yan SY, 2006, SURGERY, V140, P243, DOI 10.1016/j.surg.2006.04.001; Yashiro M, 2006, EUR J CANCER, V42, P2397, DOI 10.1016/j.ejca.2006.03.024; Zak J, 2000, PFLUG ARCH EUR J PHY, V440, P179, DOI 10.1007/s004240000282; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	67	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89491	10.1371/journal.pone.0089491	http://dx.doi.org/10.1371/journal.pone.0089491			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558503	gold, Green Published, Green Submitted			2022-12-27	WOS:000331706700149
J	Roje, DM				Roje, Dawn M.			Evaluating the Effects of Non-Neutral Molecular Markers on Phylogeny Inference	PLOS ONE			English	Article							EVOLUTIONARY; TELEOSTEI; ALIGNMENT; GOBIES; CLADES; ORDER	Nucleotide substitution models used in molecular phylogenetics do not account for nucleotide sequences evolving under selection, yet selection is rarely tested for. If non-neutral markers violate these models (i.e. non-independence of sites), it is expected that their reconstructed topologies be incongruent with those inferred from neutral ones and conclusions made from those phylogenies should be reexamined. Using rhodopsin as a phylogenetic marker has recently been called into question for exactly this reason. Rhodopsin is assumed to have evolved under strong positive selection for organisms that inhabit similar aquatic environments, making it unsuitable for the phylogenetics of aquatic organisms, but it is unclear what the effects of non-neutrality on phylogeny estimation are. To evaluate potential incongruence of neutral versus non-neutral markers, and the notion that rhodopsin should not be used in the molecular phylogenetics of fishes, a molecular dataset of 78 acanthomorph taxa and sequences from four nuclear, protein coding loci (including rhodopsin), were examined. Only one marker was found to be neutral while the remaining tests, for all other loci, rejected the null hypothesis of neutrality. To evaluate the possible effect(s) of positively versus negatively selected sites, the three non-neutral markers were analyzed to determine the presence of positively and negatively selected codons. To determine congruence in topology among ML trees inferred by individual neutral and non-neutral markers, as well as the combined (concatenated) dataset, tree, comparisons of distances among trees and hypothesis (topology) testing were carried out. Results of the tree distance metrics and topology testing support the notion that neutrality alone does not determine congruence in topology, and those data that are inferred to have evolved under selection should not necessarily be excluded. In addition, the number of sites inferred to have evolved under positive selection does not predict congruence with other markers or the topology inferred with the concatenated dataset.	Amer Museum Nat Hist, Dept Ichthyol, New York, NY 10024 USA	American Museum of Natural History (AMNH)	Roje, DM (corresponding author), Amer Museum Nat Hist, Dept Ichthyol, New York, NY 10024 USA.	droje@amnh.org						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Castoe TA, 2009, P NATL ACAD SCI USA, V106, P8986, DOI 10.1073/pnas.0900233106; Chen WJ, 2003, MOL PHYLOGENET EVOL, V26, P262, DOI 10.1016/S1055-7903(02)00371-8; Dettai A, 2005, CR BIOL, V328, P674, DOI 10.1016/j.crvi.2005.04.002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Goloboff PA, 2004, CLADISTICS, V20, P84; Goloboff PA, 2008, CLADISTICS, V24, P591, DOI 10.1111/j.1096-0031.2007.00189.x; Hagstrom GI, 2004, ARTIF LIFE, V10, P157, DOI 10.1162/106454604773563586; Hang DH, 2003, LECT NOTES COMPUT SC, V2723, P13; Jobb G, 2008, TREEFINDER VERSION O; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Larmuseau MHD, 2010, MOL PHYLOGENET EVOL, V55, P689, DOI 10.1016/j.ympev.2009.10.007; Li B, 2009, MOL PHYLOGENET EVOL, V50, P345, DOI 10.1016/j.ympev.2008.11.013; Mayden RL, 2007, J EXP ZOOL PART B, V308B, P642, DOI 10.1002/jez.b.21175; Niemiller ML, 2013, EVOLUTION, V67, P732, DOI 10.1111/j.1558-5646.2012.01822.x; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor MS, 2005, EVOLUTION, V59, P374; Tornabene L, 2013, SYST BIODIVERS, V11, P345, DOI 10.1080/14772000.2013.818589	24	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e87428	10.1371/journal.pone.0087428	http://dx.doi.org/10.1371/journal.pone.0087428			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558367	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700013
J	Takebayashi, A; Kimura, F; Kishi, Y; Ishida, M; Takahashi, A; Yamanaka, A; Takahashi, K; Suginami, H; Murakami, T				Takebayashi, Akie; Kimura, Fuminori; Kishi, Yohei; Ishida, Mitsuaki; Takahashi, Akimasa; Yamanaka, Akiyoshi; Takahashi, Kentaro; Suginami, Hiroshi; Murakami, Takashi			The Association between Endometriosis and Chronic Endometritis	PLOS ONE			English	Article							PLASMA-CELLS; EXPRESSION; WOMEN; ACTIVATION	Objective: To evaluate the association between endometriosis and chronic endometritis. Methods: Endometrial specimens were obtained from 71 patients, 34 with endometriosis (endometriosis group) and 37 without endometriosis (non-endometriosis group), who underwent hysterectomy, and the specimens were immunostained for the plasmacyte marker CD138. The rate of chronic endometritis was compared between the endometriosis group and the non-endometriosis group. Furthermore, the 71 patients were also divided into two groups, 28 with chronic endometritis (chronic endometritis group) and 43 without chronic endometritis (non-chronic endometritis group). Logistic regression analysis was performed with variables including age, body mass index (BMI), gravidity and parity, and diagnoses of leiomyoma, adenomyosis, and endometriosis on pathology to examine the independent effect of each variable on chronic endometritis. Patients suffering from cervical invasive carcinoma, endometrial carcinoma, and endometrial polyps or treated with gonadotropin-releasing hormone agonists, progestins, or oral contraceptives before surgery were excluded. Results: Chronic endometritis was identified in 52.94% of the endometriosis group and 27.02% of the non-endometriosis group (p<0.05). Logistic regression analysis revealed that endometriosis was associated with chronic endometritis. Conclusions: This result suggests a strong association between endometriosis and chronic endometritis.	[Takebayashi, Akie; Kimura, Fuminori; Takahashi, Akimasa; Yamanaka, Akiyoshi; Murakami, Takashi] Shiga Univ Med Sci, Dept Obstet & Gynecol, Otsu, Shiga 52021, Japan; [Kishi, Yohei; Suginami, Hiroshi] Takanohara Cent Hosp, Dept Obstet & Gynecol, Nara, Japan; [Ishida, Mitsuaki] Shiga Univ Med Sci, Dept Clin Lab Med, Otsu, Shiga 52021, Japan; [Ishida, Mitsuaki] Shiga Univ Med Sci, Div Diagnost Pathol, Otsu, Shiga 52021, Japan; [Takahashi, Kentaro] Shiga Univ Med Sci, Dept Community Perinatal Med, Otsu, Shiga 52021, Japan	Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science	Takebayashi, A (corresponding author), Shiga Univ Med Sci, Dept Obstet & Gynecol, Seta Tsukinowa Cho, Otsu, Shiga 52021, Japan.	akiie21@belle.shiga-med.ac.jp	Kimura, Fuminori/AAZ-7380-2020; Takahashi, Akimasa/AAD-4753-2019	Takahashi, Akimasa/0000-0001-5698-553X; Takahashi, Akimasa/0000-0002-2585-9271	Japan Society for the Promotion of Science [24659729, 23592400]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grants-in-Aid for Scientific Research of Japan Society for the Promotion of Science, Grant Number 24659729 and 23592400. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer-Garner IB, 2001, MODERN PATHOL, V14, P877, DOI 10.1038/modpathol.3880405; Berbic M, 2009, HUM REPROD, V24, P325, DOI 10.1093/humrep/den393; Braun DP, 1998, CURR OPIN OBSTET GYN, V10, P365, DOI 10.1097/00001703-199810000-00003; Canis M, 1997, FERTIL STERIL, V67, P817; Cicinelli E, 2005, J MINIM INVAS GYN L, V12, P514, DOI 10.1016/j.jmig.2005.07.394; CRUM CP, 1983, AM J OBSTET GYNECOL, V147, P812, DOI 10.1016/0002-9378(83)90045-5; Cullinan EB, 1996, P NATL ACAD SCI USA, V93, P3115, DOI 10.1073/pnas.93.7.3115; Feghali J, 2003, Gynecol Obstet Fertil, V31, P127, DOI 10.1016/S1297-9589(03)00007-9; Garcia-Velasco JA, 2003, SEMIN REPROD MED, V21, P165; Gazvani R, 2002, FERTIL STERIL, V77, P62, DOI 10.1016/S0015-0282(01)02954-5; GREENWOOD SM, 1981, OBSTET GYNECOL, V58, P176; Greten FR, 2004, CANCER LETT, V206, P193, DOI 10.1016/j.canlet.2003.08.029; Hever A, 2007, P NATL ACAD SCI USA, V104, P12451, DOI 10.1073/pnas.0703451104; Johnston-MacAnanny EB, 2010, FERTIL STERIL, V93, P437, DOI 10.1016/j.fertnstert.2008.12.131; Jones RK, 1998, HUM REPROD UPDATE, V4, P702, DOI 10.1093/humupd/4.5.702; Kasius JC, 2012, HUM REPROD, V27, P153, DOI 10.1093/humrep/der341; Khan KN, 2004, FERTIL STERIL, V81, P652, DOI 10.1016/j.fertnstert.2003.07.037; Kitaya K, 2011, AM J REPROD IMMUNOL, V66, P410, DOI 10.1111/j.1600-0897.2011.01051.x; Kitaya K, 2011, FERTIL STERIL, V95, P1156, DOI 10.1016/j.fertnstert.2010.09.061; Kyama Cleophas M, 2003, Reprod Biol Endocrinol, V1, P123, DOI 10.1186/1477-7827-1-123; Lebovic DI, 2002, IMMUNOL ALLERGY CLIN, V22, P585, DOI 10.1016/S0889-8561(02)00007-3; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Matalliotakis IM, 2003, INT IMMUNOPHARMACOL, V3, P81, DOI 10.1016/S1567-5769(02)00216-3; Noyes R W, 1975, Am J Obstet Gynecol, V122, P262; OOSTERLYNCK DJ, 1993, ARCH GYNECOL OBSTET, V253, P197, DOI 10.1007/BF02766646; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Polisseni F, 2003, GYNECOL OBSTET INVES, V55, P205, DOI 10.1159/000072075; Porta C, 2011, CANCER LETT, V305, P250, DOI 10.1016/j.canlet.2010.10.012; Siristatidis C, 2006, J OBSTET GYNAECOL RE, V32, P162, DOI 10.1111/j.1447-0756.2006.00373.x; Taylor HS, 1999, HUM REPROD, V14, P1328, DOI 10.1093/humrep/14.5.1328; Taylor RN, 1997, ANN NY ACAD SCI, V828, P194, DOI 10.1111/j.1749-6632.1997.tb48540.x; Taylor RN, 2002, ANN NY ACAD SCI, V955, P89, DOI 10.1111/j.1749-6632.2002.tb02769.x; Uo M, 2012, GUT IN PRESS; Vinatier D, 1996, HUM REPROD UPDATE, V2, P371, DOI 10.1093/humupd/2.5.371; WOOD GM, 1986, GUT, V27, P1151, DOI 10.1136/gut.27.10.1151; Wu MY, 2003, AM J REPROD IMMUNOL, V49, P285, DOI 10.1034/j.1600-0897.2003.01207.x	36	56	74	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88354	10.1371/journal.pone.0088354	http://dx.doi.org/10.1371/journal.pone.0088354			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558386	gold, Green Submitted, Green Published			2022-12-27	WOS:000331706700032
J	Bruckbauer, A; Zemel, MB				Bruckbauer, Antje; Zemel, Michael B.			Synergistic Effects of Polyphenols and Methylxanthines with Leucine on AMPK/Sirtuin-Mediated Metabolism in Muscle Cells and Adipocytes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MITOCHONDRIAL BIOGENESIS; SKELETAL-MUSCLE; ADIPOSE-TISSUE; ENERGY-METABOLISM; SIRT1 ACTIVATION; NITRIC-OXIDE; IN-VIVO; RESVERATROL; AMPK	The AMPK-Sirt1 pathway is an important regulator of energy metabolism and therefore a potential target for prevention and therapy of metabolic diseases. We recently demonstrated leucine and its metabolite beta-hydroxy-beta-methylbutyrate (HMB) to synergize with low-dose resveratrol (200 nM) to activate sirtuin signaling and stimulate energy metabolism. Here we show that leucine exerts a direct effect on Sirt1 kinetics, reducing its Km for NAD(+) by.50% and enabling low doses of resveratrol to further activate the enzyme (p = 0.012). To test which structure elements of resveratrol are necessary for synergy, we assessed potential synergy of structurally similar and dissimilar polyphenols as well as other compounds converging on the same pathways with leucine using fatty acid oxidation (FAO) as screening tool. Dose-response curves for FAO were constructed and the highest non-effective dose (typically 1-10 nM) was used with either leucine (0.5 mM) or HMB (5 mM) to treat adipocytes and myotubes for 24 h. Significant synergy was detected for stilbenes with FAO increase in adipocytes by 60-70% (p<0.05) and in myotubes.2000% (p<0.01). Sirt1 and AMPK activities were stimulated by similar to 65% (p<0.001) and similar to 50% (p<0.03), respectively. Similarly, hydroxycinnamic acids and derivatives (chlorogenic, cinnamic, and ferulic acids) combined with leucine/HMB increased FAO (300-1300%, p<0.01), AMPK activity (50-150%, p<0.01), and Sirt1 activity (similar to 70%, p<0.001). In contrast, more complex polyphenol structures, such as ellagic acid and epigallocatechin gallate required higher concentrations (> 1 mM) and exhibited little or no synergy. Thus, the six-carbon ring structure bound to a carboxylic group seems to be a necessary element for leucine/HMB synergy with other stilbenes and hydroxycinnamic acids to stimulate AMPK/Sirt1 dependent FAO; these effects occur at concentrations that produce no independent effects and are readily achievable via oral administration.	[Bruckbauer, Antje; Zemel, Michael B.] NuSirt Sci Inc, Res & Dev, Knoxville, TN 37931 USA		Bruckbauer, A (corresponding author), NuSirt Sci Inc, Res & Dev, Knoxville, TN 37931 USA.	abruckbauer@nusirt.com		Zemel, Michael/0000-0003-4104-5750	NuSirt Sciences, Inc.	NuSirt Sciences, Inc.	This project was internally funded by NuSirt Sciences, Inc. No external sponsors or funders were involved. The funder NuSirt Sciences Inc. played no role in study design, data collection and analysis, and the preparation of the manuscript. The funder approved the publication of the manuscript.	ARNER P, 1993, J LIPID RES, V34, P1737; Ayala JE, 2007, DIABETES, V56, P1025, DOI 10.2337/db06-0883; Baraldi PG, 2008, CHEM REV, V108, P238, DOI 10.1021/cr0682195; Boocock DJ, 2007, CANCER EPIDEM BIOMAR, V16, P1246, DOI 10.1158/1055-9965.EPI-07-0022; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Boswell-Smith V, 2006, J ALLERGY CLIN IMMUN, V117, P1237, DOI 10.1016/j.jaci.2006.02.045; Brasnyo P, 2011, BRIT J NUTR, V106, P383, DOI 10.1017/S0007114511000316; Brenmoehl J, 2013, MITOCHONDRION, DOI 10.1016/j.mito.2013.04.002; Bruckbauer A, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-77; Bruckbauer A, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-91; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003; Cho SJ, 2012, BRIT J NUTR, V108, P2166, DOI 10.1017/S0007114512000347; D'Archivio M, 2010, INT J MOL SCI, V11, P1321, DOI 10.3390/ijms11041321; De Toni L, 2011, J ENDOCRINOL INVEST, V34, P738, DOI 10.1007/BF03346724; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Francis SH, 2011, PHYSIOL REV, V91, P651, DOI 10.1152/physrev.00030.2010; Gertz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049761; Huang B, 2011, J AGR FOOD CHEM, V59, P3666, DOI 10.1021/jf104814t; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kang W, 2012, METABOLISM, V61, P424, DOI 10.1016/j.metabol.2011.08.003; Lira VA, 2010, J PHYSIOL-LONDON, V588, P3551, DOI 10.1113/jphysiol.2010.194035; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mitschke MM, 2013, FASEB J, V27, P1621, DOI 10.1096/fj.12-221580; Nin V, 2012, J BIOL CHEM, V287, P23489, DOI 10.1074/jbc.M112.365874; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Nisoli E, 2004, P NATL ACAD SCI USA, V101, P16507, DOI 10.1073/pnas.0405432101; Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Robich MP, 2011, EUR J PHARMACOL, V664, P45, DOI 10.1016/j.ejphar.2011.04.059; Sabatini S, 2011, ACTA BIOCHIM POL, V58, P237; Timmers S, 2012, AGING-US, V4, P146, DOI 10.18632/aging.100445; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08; Zhang R, 2009, ENDOCRINOLOGY, V150, P3076, DOI 10.1210/en.2009-0108	40	61	69	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89166	10.1371/journal.pone.0089166	http://dx.doi.org/10.1371/journal.pone.0089166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551237	Green Published, gold, Green Submitted			2022-12-27	WOS:000331271500102
J	de Pinho, JR; Grilo, C; Boone, RB; Galvin, KA; Snodgrass, JG				de Pinho, Joana Roque; Grilo, Clara; Boone, Randall B.; Galvin, Kathleen A.; Snodgrass, Jeffrey G.			Influence of Aesthetic Appreciation of Wildlife Species on Attitudes towards Their Conservation in Kenyan Agropastoralist Communities	PLOS ONE			English	Article							AMBOSELI-NATIONAL-PARK; PROTECTED AREAS; LOCAL PEOPLE; FEAR; BENEFITS; RESERVE; MAASAI; PREFERENCES; MANAGEMENT; ORGANISMS	The influence of human aesthetic appreciation of animal species on public attitudes towards their conservation and related decision-making has been studied in industrialized countries but remains underexplored in developing countries. Working in three agropastoralist communities around Amboseli National Park, southern Kenya, we investigated the relative strength of human aesthetic appreciation on local attitudes towards the conservation of wildlife species. Using semi-structured interviewing and free listing (n = 191) as part of a mixed methods approach, we first characterized local aesthetic judgments of wildlife species. With a Generalized Linear Mixed Models (GLMM) approach, we then determined the influence of perceiving four species as beautiful on local support for their protection ("rescuing them"), and of perceiving four other species as ugly on support for their removal from the area, while controlling for informant personal and household socioeconomic attributes. Perceiving giraffe, gazelles and eland as beautiful is the strongest variable explaining support for rescuing them. Ugliness is the strongest variable influencing support for the removal of buffalo, hyena, and elephant (but not lion). Both our qualitative and quantitative results suggest that perceptions of ugly species could become more positive through direct exposure to those species. We propose that protected areas in developing countries facilitate visitation by local residents to increase their familiarity with species they rarely see or most frequently see in conflict with human interests. Since valuing a species for its beauty requires seeing it, protected areas in developing countries should connect the people who live around them with the animals they protect. Our results also show that aesthetic appreciation of biodiversity is not restricted to the industrialized world.	[de Pinho, Joana Roque; Boone, Randall B.; Galvin, Kathleen A.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [de Pinho, Joana Roque] Univ Lisbon, Ctr Adm & Polit Publ, Inst Super Ciencias Sociais & Polit, P-1699 Lisbon, Portugal; [Grilo, Clara] CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain; [Grilo, Clara] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Grilo, Clara] Univ Aveiro, Ctr Estudos Ambiente & Mar, P-3800 Aveiro, Portugal; [Boone, Randall B.] Colorado State Univ, Dept Ecosyst Sci & Sustainabil, Ft Collins, CO 80523 USA; [Galvin, Kathleen A.; Snodgrass, Jeffrey G.] Colorado State Univ, Dept Anthropol, Ft Collins, CO 80523 USA	Colorado State University; Universidade de Lisboa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidade de Aveiro; Universidade de Aveiro; Colorado State University; Colorado State University	de Pinho, JR (corresponding author), Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA.	roquedepinho.joana@gmail.com	Boone, Randall B/N-6566-2013; Grilo, Clara/H-2002-2012; De Pinho, Joana Roque/L-2441-2014	Boone, Randall B/0000-0003-3362-2976; Grilo, Clara/0000-0001-9870-3115; De Pinho, Joana Roque/0000-0002-4659-2684	Fundacao para a Ciencia e a Tecnologia (FCT) [PRAXIS XXI/BD/19669/99, SFRH/BPD/43242/2008]; Fulbright Program in Portugal; Calouste Gulbenkian Foundation; Fundacao Luso-Americana para o Desenvolvimento; Global Livestock-Collaborative Research Support Program (USAID); Fundacao para a Ciencia e a Tecnologia [SFRH/BPD/64205/2009]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Fulbright Program in Portugal; Calouste Gulbenkian Foundation; Fundacao Luso-Americana para o Desenvolvimento; Global Livestock-Collaborative Research Support Program (USAID)(United States Agency for International Development (USAID)); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was possible thanks to grants from the Fundacao para a Ciencia e a Tecnologia (FCT) (PRAXIS XXI/BD/19669/99; SFRH/BPD/43242/2008), the Fulbright Program in Portugal, the Calouste Gulbenkian Foundation, the Fundacao Luso-Americana para o Desenvolvimento and the Global Livestock-Collaborative Research Support Program (USAID) to JRP; and a Fundacao para a Ciencia e a Tecnologia (SFRH/BPD/64205/2009) grant to CG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballouard JM, 2012, J HERPETOL, V46, P423, DOI 10.1670/11-118; BARRETT CB, 1995, WORLD DEV, V23, P1073, DOI 10.1016/0305-750X(95)00031-7; Bates D, 2011, IME4 LINEAR MIXED EF; Bernard H.R., 2002, RES METHODS ANTHR QU, V3rd; Bhola N, 2012, BIODIVERS CONSERV, V21, P1509, DOI 10.1007/s10531-012-0261-y; Bjornstad O., 2009, NCF SPATIAL NONPARAM; Boone Randall B., 2004, African Journal of Range & Forage Science, V21, P147, DOI 10.2989/10220110409485847; Brostrom G., 2011, GLMMML GEN LINEAR MO; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; BurnSilver S., 2007, FRAGMENTATION SEMIAR, P225; Collett DP, 1987, CONSERVATION AFRICA, P149; Coote J., 1992, ANTHR ART AESTHETICS, P245; Czech B, 1998, CONSERV BIOL, V12, P1103, DOI 10.1046/j.1523-1739.1998.97253.x; de Pinho J. R., 2009, STAYING TOGETHER PEO; Dollar L, 2012, EXPLORERS J STO 0719; Drury R, 2011, ANIM CONSERV, V14, P18, DOI 10.1111/j.1469-1795.2010.00375.x; Estren M. J., 2012, Journal of Animal Ethics, V2, P6; FINCH VA, 1977, ECOLOGY, V58, P1384, DOI 10.2307/1935090; Frynta D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063110; Frynta D, 2011, HUM ECOL, V39, P829, DOI 10.1007/s10745-011-9447-2; Frynta D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012568; Gadd ME, 2005, ENVIRON CONSERV, V32, P50, DOI 10.1017/S0376892905001918; Gillingham S, 1999, ENVIRON CONSERV, V26, P218, DOI 10.1017/S0376892999000302; Goldman M, 2007, ENVIRON PLANN D, V25, P307, DOI 10.1068/d0505; Goldman MJ, 2013, ORYX, V47, P490, DOI 10.1017/S0030605312000907; Goldman Mara J., 2010, Human Dimensions of Wildlife, V15, P332, DOI 10.1080/10871209.2010.506671; Groom R, 2008, ENVIRON CONSERV, V35, P242, DOI 10.1017/S037689290800489X; Gunnthorsdottir A, 2001, ANTHROZOOS, V14, P204, DOI 10.2752/089279301786999355; Hazzah L, 2009, BIOL CONSERV, V142, P2428, DOI 10.1016/j.biocon.2009.06.006; Heberlein TA, 2012, CONSERV BIOL, V26, P583, DOI 10.1111/j.1523-1739.2012.01892.x; Hill CM, 1998, ENVIRON CONSERV, V25, P244, DOI 10.1017/S0376892998000307; Huddy L, 2000, POLIT PSYCHOL, V21, P745, DOI 10.1111/0162-895X.00215; Infield M, 2001, CONSERV BIOL, V15, P800, DOI 10.1046/j.1523-1739.2001.015003800.x; Infield M., 2003, NAMES ANKOLE COWS; IUCN, 2011, IUCN 2011 IUCN RED L; Jackman B, 2012, ELEPHANTS KILLED MAA; Jacobson SK, 2012, CONSERV BIOL, V26, P171, DOI 10.1111/j.1523-1739.2011.01750.x; KALLAND A, 1993, ARCTIC, V46, P124; Kaltenborn B., 2010, HUM DIMENS WILDL, V11, P397; Kaltenborn BP, 2006, BIODIVERS CONSERV, V15, P4633, DOI 10.1007/s10531-005-6196-9; Klumpp D, 1993, BEING MAASAI ETHNICI, P195; Knegtering E, 2002, ENVIRON BEHAV, V34, P378, DOI 10.1177/0013916502034003006; Knight AJ, 2008, J ENVIRON PSYCHOL, V28, P94, DOI 10.1016/j.jenvp.2007.10.001; Kuriyan R, 2002, SOC NATUR RESOUR, V15, P949, DOI 10.1080/08941920290107675; Landova E, 2012, J ENVIRON PSYCHOL, V32, P69, DOI 10.1016/j.jenvp.2011.10.005; Lawson H, 2013, DAILY MAIL; Liskova S, 2013, ANTHROZOOS, V26, P27, DOI 10.2752/175303713X13534238631399; Maclennan SD, 2009, BIOL CONSERV, V142, P2419, DOI 10.1016/j.biocon.2008.12.003; Madden Francine, 2004, Human Dimensions of Wildlife, V9, P247, DOI 10.1080/10871200490505675; Maresova J, 2008, ECOL ECON, V64, P554, DOI 10.1016/j.ecolecon.2007.03.012; Maresova J, 2009, THEOR BIOSCI, V128, P227, DOI 10.1007/s12064-009-0075-y; Metrick A, 1996, LAND ECON, V72, P1, DOI 10.2307/3147153; Mol F., 1996, MAASAI LANGUAGE CULT; Montgomery CA, 2002, J ENVIRON MANAGE, V65, P313, DOI 10.1006/jema.2002.0553; Moss CJ., 2011, AMBOSELI ELEPHANTS; Okello MM, 2008, TOURISM MANAGE, V29, P751, DOI 10.1016/j.tourman.2007.08.003; Okello Moses Makonjio, 2005, Human Dimensions of Wildlife, V10, P19, DOI 10.1080/10871200590904851; Ole Kesoi E, 2012, LIONESS KILLED INSID; Peterson MN, 2010, CONSERV LETT, V3, P74, DOI 10.1111/j.1755-263X.2010.00099.x; Prokop P, 2013, ANIM CONSERV, V16, P458, DOI 10.1111/acv.12014; Prokop P, 2010, ANN ZOOL FENN, V47, P417, DOI 10.5735/086.047.0606; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Randler C, 2012, SOC ANIM, V20, P61, DOI 10.1163/156853012X614369; Reid R, 2004, LUCID WORKING PAPER; Revkin A. C., 2012, NY TIMES; Robinson LW, 2012, HUM ECOL, V40, P571, DOI 10.1007/s10745-012-9502-7; Roskaft E, 2003, EVOL HUM BEHAV, V24, P184, DOI 10.1016/S1090-5138(03)00011-4; Sachedina H, 2010, ORYX, V44, P390, DOI 10.1017/S0030605310000499; Somjee S., 1993, MAT CULTURE KENYA; Stern MJ, 2008, SOC NATUR RESOUR, V21, P859, DOI 10.1080/08941920801973763; Stokes DL, 2007, HUM ECOL, V35, P361, DOI 10.1007/s10745-006-9056-7; Treves A, 1999, J HUM EVOL, V36, P275, DOI 10.1006/jhev.1998.0268; Trimble MJ, 2010, CONSERV BIOL, V24, P886, DOI 10.1111/j.1523-1739.2010.01453.x; TURTON D, 1980, MAN, V15, P320, DOI 10.2307/2801674; Wangui EE, 2008, AGR HUM VALUES, V25, P365, DOI 10.1007/s10460-007-9111-z; Ward PI, 1998, CONSERV BIOL, V12, P1408, DOI 10.1046/j.1523-1739.1998.97402.x; WELLER SC, 1988, SYSTEMATIC DATA COLL; WESTERN D, 1994, NATURAL CONNECTIONS, P15; WESTERN D, 1982, AMBIO, V11, P302; Western D., 1972, East African Wildlife Journal, V10, P43; WESTERN D, 1979, HUM ECOL, V7, P75, DOI 10.1007/BF00889353; Western D, 2009, BIOL CONSERV, V142, P2538, DOI 10.1016/j.biocon.2009.05.025; Wildlife Connection, 2013, WILDL CONN BRIDG GAP; Woods B., 2000, J TOURISM STUDIES, V11, P25; Zuur Alain F., 2009, P1	85	59	61	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88842	10.1371/journal.pone.0088842	http://dx.doi.org/10.1371/journal.pone.0088842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7IR	24551176	gold, Green Published, Green Submitted			2022-12-27	WOS:000331271500076
J	Fraser, MD; Moorby, JM; Vale, JE; Evans, DM				Fraser, Mariecia D.; Moorby, Jon M.; Vale, James E.; Evans, Darren M.			Mixed Grazing Systems Benefit both Upland Biodiversity and Livestock Production	PLOS ONE			English	Article							WATER-SOLUBLE CARBOHYDRATE; LOLIUM-PERENNE L.; NITROUS-OXIDE; PERFORMANCE; BRITAIN; DIET; GRASSLANDS; MANAGEMENT; EMISSIONS; PASTURE	Background: With world food demand expected to double by 2050, identifying farming systems that benefit both agricultural production and biodiversity is a fundamentally important challenge for the 21st century, but this has to be achieved in a sustainable way. Livestock grazing management directly influences both economic outputs and biodiversity on upland farms while contributing to potentially damaging greenhouse gas emissions, yet no study has attempted to address these impacts simultaneously. Methods: Using a replicated, landscape-scale field experiment consisting of five management 'systems' we tested the effects of progressively altering elements within an upland farming system, viz i) incorporating cattle grazing into an upland sheep system, ii) integrating grazing of semi-natural rough grazing into a mixed grazing system based on improved pasture, iii) altering the stocking ratio within a mixed grazing system, and iv) replacing modern crossbred cattle with a traditional breed. We quantified the impacts on livestock productivity and numbers of birds and butterflies over four years. Results, Conclusion and Significance: We found that management systems incorporating mixed grazing with cattle improve livestock productivity and reduce methane emissions relative to sheep only systems. Systems that also included semi-natural rough grazing consistently supported more species of birds and butterflies, and it was possible to incorporate bouts of summer grazing of these pastures by cattle to meet habitat management prescriptions without compromising cattle performance overall. We found no evidence that the system incorporating a cattle breed popular as a conservation grazer was any better for bird and butterfly species richness than those based on a mainstream breed, yet methane emissions from such a system were predicted to be higher. We have demonstrated that mixed upland grazing systems not only improve livestock production, but also benefit biodiversity, suggesting a 'win-win' solution for farmers and conservationists.	[Fraser, Mariecia D.; Moorby, Jon M.; Vale, James E.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Evans, Darren M.] Univ Hull, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); University of Hull	Fraser, MD (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales.	mariecia.fraser@aber.ac.uk	Fraser, Mariecia/W-7321-2019; Evans, Darren Mark/J-9782-2012; Moorby, Jon/L-4586-2018	Moorby, Jon/0000-0002-4449-8432; Evans, Darren/0000-0003-4061-6726; Fraser, Mariecia/0000-0003-3999-1270	UK Department for Environment, Food and Rural Affairs [LS3407]	UK Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA))	The work was funded by the the UK Department for Environment, Food and Rural Affairs (project no. LS3407): https://www.gov.uk/government/ organisations/department-for-environment-food-rural-affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acs S, 2010, LAND USE POLICY, V27, P550, DOI 10.1016/j.landusepol.2009.07.009; Alderman G., 1993, EN PROT REQ RUM ADV; [Anonymous], 1994, NATURE FARMING LOW I; Bussink DW, 1998, NUTR CYCL AGROECOSYS, V51, P19, DOI 10.1023/A:1009747109538; Carey PD, 2002, BIOL CONSERV, V108, P183, DOI 10.1016/S0006-3207(02)00105-2; Clothier L, 2010, 20 DEFR AGR CHANG EN; DAVIES DA, 1984, GRASS FORAGE SCI, V39, P229, DOI 10.1111/j.1365-2494.1984.tb01687.x; DEFRA, 2012, AGR STAT CLIM CHANG; Dennis P, 2008, J APPL ECOL, V45, P279, DOI 10.1111/j.1365-2664.2007.01378.x; Dong H., 2006, GUIDELINES NATL GREE, V4; Eckard RJ, 2010, LIVEST SCI, V130, P47, DOI 10.1016/j.livsci.2010.02.010; Evans DM, 2006, BIOL LETTERS, V2, P636, DOI 10.1098/rsbl.2006.0543; Evans DM, 2005, BIOL LETTERS, V1, P322, DOI 10.1098/rsbl.2005.0335; Fraser MD, 2013, AGR ECOSYST ENVIRON, V175, P8, DOI 10.1016/j.agee.2013.05.002; Fraser MD, 2009, LIVEST SCI, V123, P70, DOI 10.1016/j.livsci.2008.10.008; Fuller RJ, 1999, BIOL CONSERV, V91, P73, DOI 10.1016/S0006-3207(99)00039-7; Furness R. W., 1993, BIRDS MONITORS ENV C; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; GRANT SA, 1985, J ECOL, V73, P987, DOI 10.2307/2260163; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Li DJ, 2013, J ENVIRON MANAGE, V128, P893, DOI 10.1016/j.jenvman.2013.06.026; Marchant J., 1990, POPULATION TRENDS BR; McAllister TA, 1996, CAN J ANIM SCI, V76, P231, DOI 10.4141/cjas96-035; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Miller LA, 2001, GRASS FORAGE SCI, V56, P383, DOI 10.1046/j.1365-2494.2001.00288.x; *MLC, 2000, SHEEP MAN MATT, V8; Moorby JM, 2006, GRASS FORAGE SCI, V61, P52, DOI 10.1111/j.1365-2494.2006.00507.x; Nolan T., 1992, Natural resource development and utilization: future research and technology management in soil-plant-animal-human systems: Proceedings of the Commission of European Communities Coordination Workshop, Wageningen, Netherlands, June 29-July 2, 1992., P12; Oenema O, 1997, SOIL USE MANAGE, V13, P288, DOI 10.1111/j.1475-2743.1997.tb00600.x; Oostermeijer JGB, 1998, BIOL CONSERV, V86, P271, DOI 10.1016/S0006-3207(98)00040-8; R Development Core Team, 2011, R LANG ENV STAT COMP; Reynal SM, 2005, J DAIRY SCI, V88, P4045, DOI 10.3168/jds.S0022-0302(05)73090-3; Sydes C., 1988, Special Publication of the British Ecological Society, V7, P323; Taylor K, 2001, J ECOL, V89, P126, DOI 10.1046/j.1365-2745.2001.00534.x; THOMPSON DBA, 1995, BIOL CONSERV, V71, P163, DOI 10.1016/0006-3207(94)00043-P; TILLEY J. M. A., 1963, JOUR BRIT GRASSLAND SOC, V18, P104; Todd RW, 2006, J ENVIRON QUAL, V35, P404, DOI 10.2134/jeq2005.0045; Vickery JA, 2001, J APPL ECOL, V38, P647, DOI 10.1046/j.1365-2664.2001.00626.x; Whitehead A., 2002, METAANALYSIS CONTROL; Wright IA, 2006, ANIM SCI, V82, P271, DOI 10.1079/ASC200517	40	51	51	4	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89054	10.1371/journal.pone.0089054	http://dx.doi.org/10.1371/journal.pone.0089054			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551216	Green Published, gold, Green Submitted			2022-12-27	WOS:000331266000095
J	Kim, HJ; Baek, MJ; Kim, S				Kim, Hyun Jung; Baek, Min Jae; Kim, SangYun			Alternative Type of the Trail Making Test in Nonnative English-Speakers: The Trail Making Test-Black & White	PLOS ONE			English	Article							RATING-SCALE SUM; NORMATIVE DATA; PART-B; VALIDATION; EDUCATION; NORMS; AGE	Objective: The Trail Making Test (TMT) has its limitations when applied to Eastern cultures due to its reliance on the alphabet. We looked for an alternative tool that is reliable and distinguishable like the TMT and devised the Trail Making Test Black & White (TMT-B&W) as a new variant. This study identifies the applicability of the TMT-B&W as a useful neuropsychological tool and determines whether the TMT-B&W could play an equivalent role as the TMT. Methods: The TMT-B&W uses numbers encircled by black or white circles as stimuli, instead of using the alphabet. A total of 138 participants were including containing groups of 31 cognitively normal controls (NC), 55 mild cognitive impairment (MCI), and 52 people with Alzheimer's disease (AD). Along with the TMT-B&W, the TMT and other neuropsychological tests were administered to all subjects. Results: A considerably low dropout rate for TMT B&W demonstrates that all participants were more willingly engaged in the TMT B&W than the TMT. In particular, subjects with cognitive impairments or lower levels of education performed better on the TMT-B&W than the TMT. The difference in time-to-completion of the TMT-B&W was significant according to the level of cognitive impairment. The TMT-B&W revealed a high correlation with the TMT and frontal lobe function test. Conclusion: The TMT-B&W is as reliable and effective as the TMT. It is worth developing a new variant of the TMT.	[Kim, Hyun Jung; Baek, Min Jae; Kim, SangYun] Seoul Natl Univ, Bundang Hosp, Clin Neurosci Inst, Seoungnam Si, Kyeonggi Do, South Korea; [Kim, SangYun] Seol Natl Univ, Bundang Hosp, Dept Neurol, Seoungnam Si, Kyeonggi Do, South Korea	Seoul National University (SNU)	Kim, S (corresponding author), Seoul Natl Univ, Bundang Hosp, Clin Neurosci Inst, Seoungnam Si, Kyeonggi Do, South Korea.	neuroksy@snu.ac.kr			Ministry of Knowledge Economy; Korea Evaluation Institute of Industrial Technology [Assessment Technology of Cognitive Ability in the Elderly] [10035434]	Ministry of Knowledge Economy(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Korea Evaluation Institute of Industrial Technology [Assessment Technology of Cognitive Ability in the Elderly]	The study was supported by the Ministry of Knowledge Economy and the Korea Evaluation Institute of Industrial Technology [10035434, Assessment Technology of Cognitive Ability in the Elderly]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscripts.	Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Barncord S W, 2001, Appl Neuropsychol, V8, P99, DOI 10.1207/S15324826AN0802_4; Boucugnani LL, 1989, ARCH CLIN NEUROPSYCH, V4, P161, DOI DOI 10.1093/ARCLIN/4.2.161; Christensen K. J., 1991, PSYCHOL ASSESSMENT J, V3, P168; D'Elia L.F., 1996, COLOR TRAILS TEST; Fernandez AL, 2008, SCAND J PSYCHOL, V49, P239, DOI 10.1111/j.1467-9450.2008.00637.x; GAUDINO EA, 1995, J CLIN EXP NEUROPSYC, V17, P529, DOI 10.1080/01688639508405143; Hashimoto R, 2006, PSYCHIAT CLIN NEUROS, V60, P422, DOI 10.1111/j.1440-1819.2006.01526.x; Horton A. M. J, 1979, CLIN NEUROPSYCHOLOGY, V1, P20; Kang SJ., 2002, J KOREAN NEUROL ASS, V20, P8; Kang SJ, 1997, J KOREAN NEUROL ASS, V24, P300; Kim Hyun Jung, 2011, [Dementia and Neurocognitive Disorders, Dementia and Neurocognitive Disorders(대한치매학회지)], V10, P95; Kortte Kathleen Bechtold, 2002, Appl Neuropsychol, V9, P106, DOI 10.1207/S15324826AN0902_5; Leitan LA, 1994, NEUROPSYCHOL REV, V4, P161; Lezak MD, 1995, NEUROPSYCHOLOGICAL A, V3; Lu Lei, 2002, Appl Neuropsychol, V9, P219, DOI 10.1207/S15324826AN0904_4; Marshall GA, 2006, ALZ DIS ASSOC DIS, V20, P56, DOI 10.1097/01.wad.0000201852.60330.16; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Moll J, 2002, ARQ NEURO-PSIQUIAT, V60, P900, DOI 10.1590/S0004-282X2002000600002; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P1091, DOI 10.1001/archneur.65.8.1091; O'Bryant SE, 2010, ARCH NEUROL-CHICAGO, V67, P746, DOI 10.1001/archneurol.2010.115; Oosterman JM, 2010, CLIN NEUROPSYCHOL, V24, P203, DOI 10.1080/13854040903482848; Park Jaeseol, 2007, [Dementia and Neurocognitive Disorders, Dementia and Neurocognitive Disorders(대한치매학회지)], V6, P12; Pena-Casanova J, 2009, ARCH CLIN NEUROPSYCH, V24, P321, DOI 10.1093/arclin/acp038; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; SHUTE GE, 1990, DEV NEUROPSYCHOL, V6, P1, DOI 10.1080/87565649009540445; Spreen O, 1998, COMPENDIUM NEUROPSYC; WALDMANN BW, 1992, J CLIN PSYCHOL, V48, P360, DOI 10.1002/1097-4679(199205)48:3<360::AID-JCLP2270480314>3.0.CO;2-P; WIEDERHOLT WC, 1993, J AM GERIATR SOC, V41, P639, DOI 10.1111/j.1532-5415.1993.tb06738.x	30	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89078	10.1371/journal.pone.0089078	http://dx.doi.org/10.1371/journal.pone.0089078			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7GP	24551221	gold, Green Published, Green Submitted			2022-12-27	WOS:000331266000100
J	Popp, AW; Buffat, H; Eberli, U; Lippuner, K; Ernst, M; Richards, RG; Stadelmann, VA; Windolf, M				Popp, Albrecht W.; Buffat, Helene; Eberli, Ursula; Lippuner, Kurt; Ernst, Manuela; Richards, R. Geoff; Stadelmann, Vincent A.; Windolf, Markus			Microstructural Parameters of Bone Evaluated Using HR-pQCT Correlate with the DXA-Derived Cortical Index and the Trabecular Bone Score in a Cohort of Randomly Selected Premenopausal Women	PLOS ONE			English	Article							QUANTITATIVE COMPUTED-TOMOGRAPHY; X-RAY ABSORPTIOMETRY; IN-VIVO ASSESSMENT; DISTAL RADIUS; POSTMENOPAUSAL WOMEN; MINERAL DENSITY; PRIMARY HYPERPARATHYROIDISM; OSTEOPOROTIC FRACTURES; MICROARCHITECTURE; TIBIA	Background: Areal bone mineral density is predictive for fracture risk. Microstructural bone parameters evaluated at the appendicular skeleton by high-resolution peripheral quantitative computed tomography (HR-pQCT) display differences between healthy patients and fracture patients. With the simple geometry of the cortex at the distal tibial diaphysis, a cortical index of the tibia combining material and mechanical properties correlated highly with bone strength ex vivo. The trabecular bone score derived from the scan of the lumbar spine by dual-energy X-ray absorptiometry (DXA) correlated ex vivo with the micro architectural parameters. It is unknown if these microstructural correlations could be made in healthy premenopausal women. Methods: Randomly selected women between 20-40 years of age were examined by DXA and HR-pQCT at the standard regions of interest and at customized sub regions to focus on cortical and trabecular parameters of strength separately. For cortical strength, at the distal tibia the volumetric cortical index was calculated directly from HR-pQCT and the areal cortical index was derived from the DXA scan using a Canny threshold-based tool. For trabecular strength, the trabecular bone score was calculated based on the DXA scan of the lumbar spine and was compared with the corresponding parameters derived from the HR-pQCT measurements at radius and tibia. Results: Seventy-two healthy women were included (average age 33.8 years, average BMI 23.2 kg/m(2)). The areal cortical index correlated highly with the volumetric cortical index at the distal tibia (R = 0.798). The trabecular bone score correlated moderately with the microstructural parameters of the trabecular bone. Conclusion: This study in randomly selected premenopausal women demonstrated that microstructural parameters of the bone evaluated by HR-pQCT correlated with the DXA derived parameters of skeletal regions containing predominantly cortical or cancellous bone. Whether these indexes are suitable for better predictions of the fracture risk deserves further investigation.	[Popp, Albrecht W.; Buffat, Helene; Lippuner, Kurt] Univ Hosp Bern, Dept Osteoporosis, Inselspital, CH-3010 Bern, Switzerland; [Popp, Albrecht W.; Buffat, Helene; Lippuner, Kurt] Univ Bern, Bern, Switzerland; [Eberli, Ursula; Ernst, Manuela; Richards, R. Geoff; Stadelmann, Vincent A.; Windolf, Markus] AO Res Inst Davos, Davos, Switzerland	University of Bern; University Hospital of Bern; University of Bern	Popp, AW (corresponding author), Univ Hosp Bern, Dept Osteoporosis, Inselspital, CH-3010 Bern, Switzerland.	albrecht.popp@insel.ch	Stadelmann, Vincent A./X-1543-2018; Richards, Robert G/I-8235-2015	Richards, Robert G/0000-0002-7778-2480; Windolf, Markus/0000-0001-8077-6914; Stadelmann, Vincent/0000-0002-8741-2184; Lippuner, Kurt/0000-0002-7195-3779; Popp, Albrecht/0000-0002-5954-7495; Perrelet, Romain/0000-0003-2925-6117	AO Research program	AO Research program	This study was funded by the AO Research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, World Health Organ Tech Rep Ser, V843, P1; BLACK DM, 1992, J BONE MINER RES, V7, P633; Boutroy S, 2005, J CLIN ENDOCR METAB, V90, P6508, DOI 10.1210/jc.2005-1258; Boutroy S, 2012, OSTEOPOROS INT; Burghardt AJ, 2010, BONE, V47, P519, DOI 10.1016/j.bone.2010.05.034; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; CASEZ JP, 1994, J BONE MINER RES, V9, P1851; Cohen A, 2009, J CLIN ENDOCR METAB, V94, P4351, DOI 10.1210/jc.2009-0996; CORDEY J, 1992, J BONE MINER RES, V7, pS437, DOI 10.1002/jbmr.5650071414; Hans D, 2011, J BONE MINER RES, V26, P2762, DOI 10.1002/jbmr.499; Hans D, 2011, J CLIN DENSITOM, V14, P302, DOI 10.1016/j.jocd.2011.05.005; Hernandez CJ, 2006, J BONE MINER RES, V21, P1248, DOI 10.1359/JBMR.060514; Holzer G, 2009, J BONE MINER RES, V24, P468, DOI 10.1359/JBMR.081108; Khosla S, 2006, J BONE MINER RES, V21, P124, DOI 10.1359/JBMR.050916; Laib A, 1999, BONE, V24, P35, DOI 10.1016/S8756-3282(98)00159-8; Liu XS, 2010, J BONE MINER RES, V25, P746, DOI 10.1359/jbmr.090822; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Nishiyama KK, 2012, OSTEOPOROS INT; Nishiyama KK, 2010, J BONE MINER RES, V25, P882, DOI 10.1359/jbmr.091020; Popp AW, 2009, OSTEOPOROSIS INT, V20, P1393, DOI 10.1007/s00198-008-0808-7; Popp AW, 2013, J BONE MINER RES, V28, P449, DOI 10.1002/jbmr.1775; Popp AW, 2012, BONE, V50, P296, DOI 10.1016/j.bone.2011.10.033; Pothuaud L, 2008, BONE, V42, P775, DOI 10.1016/j.bone.2007.11.018; Seeman E, 2003, J APPL PHYSIOL, V95, P2142, DOI 10.1152/japplphysiol.00564.2003; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Silva BC, 2013, J CLIN DENSITOM, V16, P554, DOI 10.1016/j.jocd.2013.07.001; Silva BC, 2013, J CLIN ENDOCR METAB, V98, P1963, DOI 10.1210/jc.2012-4255; Sode M, 2011, BONE, V48, P1291, DOI 10.1016/j.bone.2011.03.755; Sode M, 2010, BONE, V46, P1652, DOI 10.1016/j.bone.2010.02.021; Sornay-Rendu E, 2007, J BONE MINER RES, V22, P425, DOI 10.1359/JBMR.061206; Stein EM, 2010, J BONE MINER RES, V25, P2296, DOI 10.1002/jbmr.152; Vico L, 2008, J BONE MINER RES, V23, P1741, DOI 10.1359/JBMR.080704; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0	34	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88946	10.1371/journal.pone.0088946	http://dx.doi.org/10.1371/journal.pone.0088946			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551194	Green Published, gold, Green Submitted			2022-12-27	WOS:000331266000084
J	Ferguson, E; Semper, H; Yates, J; Fitzgerald, JE; Skatova, A; James, D				Ferguson, Eamonn; Semper, Heather; Yates, Janet; Fitzgerald, J. Edward; Skatova, Anya; James, David			The 'Dark Side' and 'Bright Side' of Personality: When Too Much Conscientiousness and Too Little Anxiety Are Detrimental with Respect to the Acquisition of Medical Knowledge and Skill	PLOS ONE			English	Article							JOB-PERFORMANCE; COGNITIVE-ABILITY; SELECTION; VALIDITY; TRAITS; SCHOOL; MODEL; TRAJECTORIES; INTELLIGENCE; ACHIEVEMENT	Theory suggests that personality traits evolved to have costs and benefits, with the effectiveness of a trait dependent on how these costs and benefits relate to the present circumstances. This suggests that traits that are generally viewed as positive can have a 'dark side' and those generally viewed as negative can have a 'bright side' depending on changes in context. We test this in a sample of 220 UK medical students with respect to associations between the Big 5 personality traits and learning outcomes across the 5 years of a medical degree. The medical degree offers a changing learning context from pre-clinical years (where a more methodical approach to learning is needed) to the clinical years (where more flexible learning is needed, in a more stressful context). We argue that while trait conscientiousness should enhance pre-clinical learning, it has a 'dark side' reducing the acquisition of knowledge in the clinical years. We also suggest that anxiety has a 'bright side' enhancing the acquisition of skills in the clinical years. We also explore if intelligence enhances learning across the medical degree. Using confirmatory factor analysis and structural equation modelling we show that medical skills and knowledge assessed in the pre-clinical and clinical years are psychometrically distinguishable, forming a learning 'backbone', whereby subsequent learning outcomes are predicted by previous ones. Consistent with our predictions conscientiousness enhanced preclinical knowledge acquisition but reduced the acquisition of clinical knowledge and anxiety enhanced the acquisition of clinical skills. We also identified a curvilinear U shaped association between Surgency (extraversion) and pre-clinical knowledge acquisition. Intelligence predicted initial clinical knowledge, and had a positive total indirect effect on clinical knowledge and clinical skill acquisition. For medical selection, this suggests that selecting students high on conscientiousness may be problematic, as it may be excluding those with some degree of moderate anxiety.	[Ferguson, Eamonn] Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England; [Semper, Heather] Staffordshire Univ, Ctr Hlth Psychol, Stoke On Trent ST4 2DE, Staffs, England; [Yates, Janet; James, David] Univ Nottingham, Sch Med, Med Educ Ctr, Queens Med Ctr, Nottingham, England; [Fitzgerald, J. Edward] Barnet Hosp, Dept Gen Surg, Barnet, England; [Skatova, Anya] Univ Nottingham, Horizon Digital Econ Res, Nottingham NG7 2RD, England	University of Nottingham; Staffordshire University; University of Nottingham; University of Nottingham	Ferguson, E (corresponding author), Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England.	eamonn.ferguson@nottingham.ac.uk	Dr Heather Semper, BSc MSc MPhil DHealthPsy/O-9997-2019; Skatova, Anya/B-7076-2016; Fitzgerald, James/F-2565-2013	Dr Heather Semper, BSc MSc MPhil DHealthPsy/0000-0003-1813-5811; Skatova, Anya/0000-0003-0300-4990; Fitzgerald, James/0000-0002-4453-5117; Ferguson, Eamonn/0000-0002-7678-1451	Trent Workforce Development Confederation; SIFT (Service Increment for Teaching); EPSRC [EP/G065802/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G065802/1] Funding Source: researchfish	Trent Workforce Development Confederation; SIFT (Service Increment for Teaching); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This project was initially funded by 'Trent Workforce Development Confederation' as a PhD studentship to HS. JY by SIFT (Service Increment for Teaching). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman PL, 1995, J EXP PSYCHOL-APPL, V1, P270, DOI 10.1037/1076-898X.1.4.270; Ackerman PL, 1997, PSYCHOL BULL, V102, P3; Al Kadri HMF, 2011, ADV HEALTH SCI EDUC, V16, P553, DOI 10.1007/s10459-010-9271-2; ANDERSON JR, 1982, PSYCHOL REV, V89, P369, DOI 10.1037/0033-295X.89.4.369; Back MD, 2013, J PERS SOC PSYCHOL, V105, P1013, DOI 10.1037/a0034431; Bore M, 2009, MED TEACH, V31, P1066, DOI 10.3109/01421590903095510; Borghans L, 2008, J HUM RESOUR, V43, P972; Boyce CJ, 2010, J RES PERS, V44, P535, DOI 10.1016/j.jrp.2010.05.001; Busato VV, 1999, PERS INDIV DIFFER, V26, P129; Chamorro-Premuzic T, 2003, J RES PERS, V37, P319, DOI 10.1016/S0092-6566(02)00578-0; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 1983, APPL MULTIPLE REGRES, P545; CORBALLIS MC, 1965, PSYCHOL REV, V72, P399, DOI 10.1037/h0022234; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Doherty EM, 2011, MED EDUC, V45, P132, DOI 10.1111/j.1365-2923.2010.03760.x; Eysenck HJ, 1967, BIOL BASIS PERSONALI, P399; Ferguson E, 2003, BRIT MED J, V326, P429, DOI 10.1136/bmj.326.7386.429; Ferguson E, 2002, BMJ-BRIT MED J, V324, P952, DOI 10.1136/bmj.324.7343.952; Ferguson E, 2000, J OCCUP ORGAN PSYCH, V73, P321, DOI 10.1348/096317900167056; FERGUSON E, 1997, J MANAGERIAL PSYCHOL, V0012, P00204, DOI DOI 10.1108/02683949710174829; Ferguson E, 2013, HEALTH PSYCHOL REV, V7, pS32, DOI 10.1080/17437199.2010.547985; Ferguson E, 2009, PSYCHOSOM MED, V71, P981, DOI 10.1097/PSY.0b013e3181bd888b; GOFF M, 1992, J EDUC PSYCHOL, V84, P537, DOI 10.1037/0022-0663.84.4.537; Goldberg L. R., 1992, PSYCHOL ASSESSMENT, V4, P26, DOI [10.1037/1040-3590.4.1.26, DOI 10.1037/1040-3590.4.1.26]; GREEN DW, 1995, BRIT J PSYCHOL, V86, P321, DOI 10.1111/j.2044-8295.1995.tb02755.x; Haslam N, 2012, PSYCHOL MED, V42, P903, DOI 10.1017/S0033291711001966; Hosmer DWJ., 1989, APPL LOGISTIC REGRES, P307; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; KRAIGER K, 1993, J APPL PSYCHOL, V78, P311, DOI 10.1037/0021-9010.78.2.311; Lievens F, 2009, J APPL PSYCHOL, V94, P1514, DOI 10.1037/a0016137; McCrea RR, 2003, PERSONALITY ADULTHOO, P268; McManus IC, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-29; McManus IC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-242; McManus IC, 2005, BRIT MED J, V331, P555, DOI 10.1136/bmj.331.7516.555; McManus IC, 2003, BRIT MED J, V326, P432; McManus IC, 2003, BRIT MED J, V327, P139, DOI 10.1136/bmj.327.7407.139; Muthen LK, 1998, MPLUS USERS GUIDE, P750; Nettle D, 2008, EUR J PERSONALITY, V22, P323, DOI 10.1002/per.672; Nettle D, 2006, AM PSYCHOL, V61, P622, DOI 10.1037/0003-066X.61.6.622; Ozer DJ, 2006, ANNU REV PSYCHOL, V57, P401, DOI 10.1146/annurev.psych.57.102904.190127; Patrick J, 1992, TRAINING RES PRACTIC, P561; Patterson F, 2007, SELECTING MED ED TRA, P31; Patterson F, 2008, MED EDUC, V42, P1195, DOI 10.1111/j.1365-2923.2008.03174.x; Penke L, 2007, EUR J PERSONALITY, V21, P549, DOI 10.1002/per.629; Perkins AM, 2009, J NEUROSCI, V29, P12617, DOI 10.1523/JNEUROSCI.2696-09.2009; Powis D, 2007, MED EDUC, V41, P242, DOI 10.1111/j.1365-2929.2006.02683.x; Powis D, 2005, J ADULT CONTIN EDUC, V11, P3; Radcliffe C, 2003, MED EDUC, V37, P32, DOI 10.1046/j.1365-2923.2003.01405.x; Reid WA, 2012, MED EDUC ONLINE, V17, DOI 10.3402/meo.v17i0.17205; Roberts BW, 2007, PERSPECT PSYCHOL SCI, V2, P313, DOI 10.1111/j.1745-6916.2007.00047.x; Salgado JF, 1997, J APPL PSYCHOL, V82, P30, DOI 10.1037/0021-9010.82.1.30; Schmidt FL, 1998, PSYCHOL BULL, V124, P262, DOI 10.1037/0033-2909.124.2.262; Skatova AA, 2011, THESIS U NOTTINGHAM, P200; Thoresen CJ, 2004, J APPL PSYCHOL, V89, P835, DOI 10.1037/0021-9010.89.5.835; Volk S, 2011, PERS INDIV DIFFER, V50, P810, DOI 10.1016/j.paid.2011.01.001; Widiger TA, 2008, CLIN PSYCHOL, V5, P197; Woolf K, 2011, BMJ-BRIT MED J, V342, DOI [10.1136/bmj.d901, DOI 10.1136/BMJ.D901.]; Woolf K, 2013, BRIT J EDUC PSYCHOL, V83, P135, DOI 10.1111/j.2044-8279.2011.02060.x; Zyphur MJ, 2008, J APPL PSYCHOL, V93, P217, DOI 10.1037/0021-9010.93.1.217; Zyphur MJ, 2008, HUM PERFORM, V21, P1, DOI 10.1080/08959280701521967	60	47	47	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e88606	10.1371/journal.pone.0088606	http://dx.doi.org/10.1371/journal.pone.0088606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3BU	24586353	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800006
J	Prieto, ML; O'Sullivan, L; Tan, SP; McLoughlin, P; Hughes, H; O'Donovan, O; Rea, MC; Kent, RM; Cassidy, JP; Gardiner, GE; Lawlor, PG				Prieto, Maria Luz; O'Sullivan, Laurie; Tan, Shiau Pin; McLoughlin, Peter; Hughes, Helen; O'Donovan, Orla; Rea, Mary C.; Kent, Robert M.; Cassidy, Joseph P.; Gardiner, Gillian E.; Lawlor, Peadar G.			Evaluation of the Efficacy and Safety of a Marine-Derived Bacillus Strain for Use as an In-Feed Probiotic for Newly Weaned Pigs	PLOS ONE			English	Article							CEREUS-VAR. TOYOI; DIETARY ZINC-OXIDE; ESCHERICHIA-COLI; GUT HEALTH; DIARRHEA; BACTERIA; GROWTH; ACID; COMBINATION; PERFORMANCE	Forty eight individual pigs (8.7 +/- 0.26 kg) weaned at 28 +/- 1 d of age were used in a 22-d study to evaluate the effect of oral administration of a Bacillus pumilus spore suspension on growth performance and health indicators. Treatments (n = 16) were: (1) non-medicated diet; (2) medicated diet with apramycin (200 mg/kg) and pharmacological levels of zinc oxide (2,500 mg zinc/kg) and (3) B. pumilus diet (non-medicated diet + 10(10) spores/day B. pumilus). Final body weight and average daily gain tended to be lower (P = 0.07) and feed conversion ratio was worsened (P<0.05) for the medicated treatment compared to the B. pumilus treatment. Ileal E. coli counts were lower for the B. pumilus and medicated treatments compared to the non-medicated treatment (P<0.05), perhaps as a result of increased ileal propionic acid concentrations (P<0.001). However, the medicated treatment reduced fecal (P<0.001) and cecal (P<0.05) Lactobacillus counts and tended to reduce the total cecal short chain fatty acid (SCFA) concentration (P = 0.10). Liver weights were lighter and concentrations of liver enzymes higher (P<0.05) in pigs on the medicated treatment compared to those on the non-medicated or B. pumilus treatments. Pigs on the B. pumilus treatment had lower overall lymphocyte and higher granulocyte percentages (P<0.001) and higher numbers of jejunal goblet cells (P<0.01) than pigs on either of the other two treatments or the non-medicated treatment, respectively. However, histopathological examination of the small intestine, kidneys and liver revealed no abnormalities. Overall, the B. pumilus treatment decreased ileal E. coli counts in a manner similar to the medicated treatment but without the adverse effects on growth performance, Lactobacillus counts, cecal SCFA concentration and possible liver toxicity experienced with the medicated treatment.	[Prieto, Maria Luz; O'Sullivan, Laurie; Tan, Shiau Pin; McLoughlin, Peter; Hughes, Helen; O'Donovan, Orla; Kent, Robert M.; Gardiner, Gillian E.] Waterford Inst Technol, Dept Chem & Life Sci, Ecoinnovat Res Ctr, Waterford, Ireland; [Rea, Mary C.; Kent, Robert M.] Food Res Ctr, TEAGASC, Fermoy, Co Cork, Ireland; [Cassidy, Joseph P.] Univ Coll Dublin, Vet Sci Ctr, Dublin 2, Ireland; [Lawlor, Peadar G.] TEAGASC, Anim & Grassland Res & Innovat Ctr, Pig Dev Dept, Fermoy, Co Cork, Ireland; [Rea, Mary C.] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland	South East Technological University (SETU); Teagasc; University College Dublin; Teagasc; University College Cork	Gardiner, GE (corresponding author), Waterford Inst Technol, Dept Chem & Life Sci, Ecoinnovat Res Ctr, Waterford, Ireland.	ggardiner@wit.ie		Hughes, Helen/0000-0002-5939-2323; Tan, Shiau Pin/0000-0002-1459-9996; McLoughlin, Peter/0000-0002-1185-9860; Cassidy, Joseph/0000-0002-9229-1831; O' Donovan, Orla/0000-0003-3980-8835; Rea, Mary/0000-0003-3782-0232	Higher Education Authority/Institutes of Technology Ireland Technological Sector Research Strand III Programme	Higher Education Authority/Institutes of Technology Ireland Technological Sector Research Strand III Programme	The study was funded by the Higher Education Authority/Institutes of Technology Ireland Technological Sector Research Strand III Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afifi NA, 1997, RES VET SCI, V62, P249, DOI 10.1016/S0034-5288(97)90199-5; Applegate TJ, 1999, COMP BIOCHEM PHYS B, V124, P381, DOI 10.1016/S0305-0491(99)00140-6; Baugher JL, 2011, J DAIRY SCI, V94, P4753, DOI 10.3168/jds.2011-4384; Bhandari SK, 2008, J ANIM SCI, V86, P836, DOI 10.2527/jas.2006-822; Boone L, 2005, VET CLIN PATH, V34, P182, DOI 10.1111/j.1939-165X.2005.tb00041.x; Buzoianu SG, 2012, ANIMAL, V6, P1609, DOI 10.1017/S1751731112000249; Casey PG, 2007, APPL ENVIRON MICROB, V73, P1858, DOI 10.1128/AEM.01840-06; COLE DJA, 1968, VET REC, V83, P459, DOI 10.1136/vr.83.18.459; Cutting SM, 2011, FOOD MICROBIOL, V28, P214, DOI 10.1016/j.fm.2010.03.007; De Angelis M, 2006, RES MICROBIOL, V157, P792, DOI 10.1016/j.resmic.2006.05.003; Desriac F, 2010, MAR DRUGS, V8, P1153, DOI 10.3390/md8041153; Dobson A, 2012, APPL ENVIRON MICROB, V78, P1, DOI 10.1128/AEM.05576-11; Elanco, 1998, APR SOL POWD, P1; FAO WHO, 2001, REP JOINT FAO WHO EX, DOI DOI 10.1201/9781420009613.CH16; Gaggia F, 2010, INT J FOOD MICROBIOL, V141, pS15, DOI 10.1016/j.ijfoodmicro.2010.02.031; Ganessunker D, 1999, JPEN-PARENTER ENTER, V23, P337, DOI 10.1177/0148607199023006337; Gao CW, 2000, DIGEST DIS SCI, V45, P1500, DOI 10.1023/A:1005592306587; Gardiner GE, 2004, APPL ENVIRON MICROB, V70, P1895, DOI 10.1128/AEM.70.4.1895-1906.2004; Hojberg O, 2005, APPL ENVIRON MICROB, V71, P2267, DOI 10.1128/AEM.71.5.2267-2277.2005; Jadamus A, 2002, J ANIM PHYSIOL AN N, V86, P42, DOI 10.1046/j.1439-0396.2002.00336.x; Jensen-Waern M, 1998, RES VET SCI, V64, P225, DOI 10.1016/S0034-5288(98)90130-8; Kaneko JJ, 2008, CLINICAL BIOCHEMISTRY OF DOMESTIC ANIMALS, 6TH EDITION, P1; Kyriakis SC, 1999, RES VET SCI, V67, P223, DOI 10.1053/rvsc.1999.0308; Lalles JP, 2007, P NUTR SOC, V66, P260, DOI 10.1017/S0029665107005484; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080097; Lynch MB, 2008, ANIMAL, V2, P425, DOI 10.1017/S1751731107001267; Mores N, 1998, ARQ BRAS MED VET ZOO, V50, P513; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; NRC, 2012, NUTR REQ SWIN; ODINK J, 1990, J ANIM SCI, V68, P163; Papatsiros VG, 2011, POL J VET SCI, V14, P117, DOI 10.2478/v10181-011-0017-8; Pluske JR, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-1; Prieto ML, 2012, MAR DRUGS, V10, P2280, DOI 10.3390/md10102280; Prieto ML, 2013, MAR DRUGS UNPUB; Radostitis O.M., 2007, VET MED TXB DIS CATT, V9th; Sakata T, 2003, P NUTR SOC, V62, P73, DOI 10.1079/PNS2002211; SAS/STAT, 2010, US GUID; Scharek L, 2007, VET IMMUNOL IMMUNOP, V120, P136, DOI 10.1016/j.vetimm.2007.07.015; Schneider G, 2006, MRI LIVER IMAGING TE; Thompson KL, 2006, POULTRY SCI, V85, P1535, DOI 10.1093/ps/85.9.1535; Tsukahara T, 2013, ANIM SCI J, V84, P316, DOI 10.1111/asj.12003; Walsh MC, 2013, BRIT J NUTR, V109, P873, DOI 10.1017/S0007114512002607; Walsh MC, 2012, BRIT J NUTR, V107, P364, DOI 10.1017/S0007114511003011; Wang JP, 2011, LIVEST SCI, V140, P131, DOI 10.1016/j.livsci.2011.02.017; Watanabe K., 2001, J VET EPIDEMIOL, V5, P25, DOI [10.2743/jve.5.25, DOI 10.2743/JVE.5.25]; Weiss D. J, 2011, SCHALMS VET HEMATOLO; Zani JL, 1998, J APPL MICROBIOL, V84, P68; Zhao YC, 2012, FISH SHELLFISH IMMUN, V32, P750, DOI 10.1016/j.fsi.2012.01.027	48	29	32	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e88599	10.1371/journal.pone.0088599	http://dx.doi.org/10.1371/journal.pone.0088599			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586349	Green Published, gold, Green Submitted			2022-12-27	WOS:000332389000015
J	Martinez-Gutierrez, M; Correa-Londono, LA; Castellanos, JE; Gallego-Gomez, JC; Osorio, JE				Martinez-Gutierrez, Marlen; Correa-Londono, Luis A.; Castellanos, Jaime E.; Gallego-Gomez, Juan C.; Osorio, Jorge E.			Lovastatin Delays Infection and Increases Survival Rates in AG129 Mice Infected with Dengue Virus Serotype 2	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; ANTIBODY-RESPONSE; CONTROLLED-TRIAL; ANIMAL-MODELS; MOUSE MODEL; IN-VIVO; INHIBITOR; STATINS; PROTEIN; REPLICATION	Background: It has been reported that treatment of DENV-infected cultures with Lovastatin (LOV), can affect viral assembly. The objective of this study was to evaluate the effect of LOV on the survival rate and viremia levels of DENV-2-infected AG129 mice. Methodology/Principal Findings: Mice were inoculated with 1x10(6) plaque-forming units (PFU/ml) of DENV-2 and treated with LOV (200 mg/kg/day). Pre-treatment with one or three doses of LOV increased the survival rate compared to untreated mice (7.3 and 7.1 days, respectively, compared to 4.8 days). Viremia levels also decreased by 21.8% compared to untreated mice, but only in the group administered three doses prior to inoculation. When LOV was administered after viral inoculation, the survival rate increased (7.3 days in the group treated at 24 hpi, 6.8 days in the group treated at 48 hpi and 6.5 days in the group treated with two doses) compared to the untreated group (4.8 days). Interestingly, the serum viral titer increased by 24.6% in mice treated at 48 hpi with a single dose of LOV and by 21.7% in mice treated with two doses (at 24 and 48 hpi) of LOV compared to untreated mice. Finally histopathological changes in the liver and spleen in infected and untreated mice included massive extramedullary erythropoiesis foci and inflammatory filtration, and these characteristics were decreased or absent in LOV-treated mice. Conclusions/Significance: Our results suggest that the effect of LOV on viremia depends on the timing of treatment and on the number of doses administered. We observed a significant increase in the survival rate in both schemes due to a delay in the progression of the disease. However, the results obtained in the post-treatment scheme must be handled carefully because this treatment scheme increases viremia and we do not know how this increase could affect disease progression in humans.	[Martinez-Gutierrez, Marlen] Univ Antioquia, Programa Estudio & Cotrol Enfermdades Trop, Medellin, Colombia; [Correa-Londono, Luis A.] Univ Antioquia, Fac Med, Medellin, Colombia; [Correa-Londono, Luis A.] Congregac Mariana, Lab Patol, Medellin, Colombia; [Castellanos, Jaime E.] Univ El Bosque, Grp Virol, Bogota, Colombia; [Gallego-Gomez, Juan C.] Univ Antioquia, Mol & Translat Med Grp, Viral Vector Core & Gene Therapy Neurosci Grp Ant, Medellin, Colombia; [Gallego-Gomez, Juan C.] Univ Antioquia, Mol & Translat Med Grp, Medellin, Colombia; [Osorio, Jorge E.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA	Universidad de Antioquia; Universidad de Antioquia; Universidad El Bosque; Universidad de Antioquia; Universidad de Antioquia; University of Wisconsin System; University of Wisconsin Madison	Martinez-Gutierrez, M (corresponding author), Univ Antioquia, Programa Estudio & Cotrol Enfermdades Trop, Medellin, Colombia.	mmartinezg@udea.edu.co	Gallegomez, Juantxo/AAX-1633-2020; Castellanos, Jaime/W-2635-2019	Gallegomez, Juantxo/0000-0001-7453-2569; Castellanos, Jaime/0000-0003-1596-8383; Martinez-Gutierrez, Marlen/0000-0002-9429-0058	COLCIENCIAS (Departamento Administrativo de Ciencia, Tecnologia e Innovacion) [111549326092]; COLCIENCIAS [1308-489-25267]	COLCIENCIAS (Departamento Administrativo de Ciencia, Tecnologia e Innovacion)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work was supported by COLCIENCIAS (Departamento Administrativo de Ciencia, Tecnologia e Innovacion) grant No. 111549326092. M.M.G. received a Ph.D. Fellowship (1308-489-25267) from COLCIENCIAS (http://www.colciencias.gov.co/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416; Brewoo JN, 2012, VACCINE, V30, P1513, DOI 10.1016/j.vaccine.2011.11.072; Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P15, DOI 10.1128/AAC.01429-12; Cassetti MC, 2010, VACCINE, V28, P4229, DOI 10.1016/j.vaccine.2010.04.045; Chang JH, 2011, ANTIVIR RES, V92, P369, DOI 10.1016/j.antiviral.2011.08.003; DUSTIN ML, 1988, J CELL BIOL, V107, P321, DOI 10.1083/jcb.107.1.321; ENDO A, 1976, FEBS LETT, V72, P323, DOI 10.1016/0014-5793(76)80996-9; Farrar J, 2007, TROP MED INT HEALTH, V12, P695, DOI [10.1111/j.1365-3156.2007.01838, 10.1111/j.1365-3156.2007.01838.x]; Gower TL, 2001, ANTIMICROB AGENTS CH, V45, P1231, DOI 10.1128/AAC.45.4.1231-1237.2001; Guilarde AO, 2008, J INFECT DIS, V197, P817, DOI 10.1086/528805; Isusi E, 2000, ATHEROSCLEROSIS, V153, P283, DOI 10.1016/S0021-9150(00)00407-X; Jasinska M, 2007, PHARMACOL REP, V59, P483; Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999; Julander Justin G., 2011, Antiviral Chemistry & Chemotherapy, V21, P105, DOI 10.3851/IMP1690; Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06; Lee E, 2006, J GEN VIROL, V87, P2791, DOI 10.1099/vir.0.82164-0; Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813; Lin CY, 2013, J FORMOS MED ASSOC, V112, P61, DOI 10.1016/j.jfma.2012.06.005; Lin YL, 1998, J VIROL, V72, P9729, DOI 10.1128/JVI.72.12.9729-9737.1998; Lingwood D, 2009, BIOCHEM SOC T, V37, P955, DOI 10.1042/BST0370955; Martinez-Gutierrez M, 2011, INTERVIROLOGY, V54, P202, DOI 10.1159/000321892; Miller JL, 2012, ANTIMICROB AGENTS CH, V56, P6379, DOI 10.1128/AAC.01554-12; Mueck AO, 2001, EXP CLIN ENDOCR DIAB, V109, P181, DOI 10.1055/s-2001-14843; Nguyen NM, 2013, J INFECT DIS, V207, P1442, DOI 10.1093/infdis/jis470; Oishi Kazunori, 2007, Journal of Infection and Chemotherapy, V13, P125, DOI 10.1007/s10156-007-0516-9; Organization PAH, 2011, NUMB REP CAS DENG FI; Orozco S, 2012, J GEN VIROL, V93, P2152, DOI 10.1099/vir.0.045088-0; Palaniswamy C, 2010, AM J THER, V17, P75, DOI 10.1097/MJT.0b013e31819cdc86; Poh MK, 2012, ANTIVIR RES, V93, P191, DOI 10.1016/j.antiviral.2011.11.014; Prestwood TR, 2008, J VIROL, V82, P8411, DOI 10.1128/JVI.00611-08; Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025; Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004; Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310; Shaw SK, 2004, J EXP MED, V200, P1571, DOI 10.1084/jem.20040965; Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06; Stanislaus R, 2001, J NEUROSCI RES, V66, P155, DOI 10.1002/jnr.1207; Stein DA, 2008, J ANTIMICROB CHEMOTH, V62, P555, DOI 10.1093/jac/dkn221; Tan GK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000672; Tapia-Conyer R, 2012, PAEDIATR INT CHILD H, V32, P14, DOI 10.1179/2046904712Z.00000000046; Tricou Vianney, 2010, PLoS Negl Trop Dis, V4, pe785, DOI 10.1371/journal.pntd.0000785; Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005; VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Watanabe S, 2012, ANTIVIR RES, V96, P32, DOI 10.1016/j.antiviral.2012.07.008; Watanabe S, 2012, J VIROL, V86, P5508, DOI 10.1128/JVI.07081-11; Whitehorn J, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-203; Xu XF, 2008, INTERVIROLOGY, V51, P182, DOI 10.1159/000151531; Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062	49	62	63	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e87412	10.1371/journal.pone.0087412	http://dx.doi.org/10.1371/journal.pone.0087412			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586275	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900010
J	de Castro, JMB; Martinon-Torres, M; Sier, MJ; Martin-Frances, L				Bermudez de Castro, Jose Maria; Martinon-Torres, Maria; Jan Sier, Mark; Martin-Frances, Laura			On the Variability of the Dmanisi Mandibles	PLOS ONE			English	Article							TOOTH WEAR; MANDIBULAR GROWTH; DENTAL REMAINS; EVOLUTIONARY SIGNIFICANCE; CONTINUOUS ERUPTION; EARLY HOMO; ATAPUERCA; GEORGIA; HOMINID; SKULL	The description of a new skull (D4500) from the Dmanisi site (Republic of Georgia) has reopened the debate about the morphological variability within the genus Homo. The new skull fits with a mandible (D2600) often referred as 'big' or 'enigmatic' because of its differences with the other Dmanisi mandibles (D211 and D2735). In this report we present a comparative study of the variability of the Dmanisi mandibles under a different perspective, as we focus in morphological aspects related to growth and development. We have followed the notion of modularity and phenotypic integration in order to understand the architectural differences observed within the sample. Our study reveals remarkable shape differences between D2600 and the other two mandibles, that are established early in the ontogeny (during childhood or even before) and that do not depend on size or sexual dimorphism. In addition, D2600 exhibits a mosaic of primitive and derived features regarding the Homo clade, which is absent in D211 and D2735. This mosaic expression is related to the location of the features and can be explained under the concept of modularity. Our study would support the possibility of two different paleodemes represented at the Dmanisi site. This hypothesis has been previously rejected on the basis that all the individuals were constrained in the same stratigraphic and taphonomic settings. However, our revision of the complex Dmanisi stratigraphy suggests that the accumulation could cover an undetermined period of time. Even if "short" in geological terms, the hominin accumulation was not necessarily synchronic. In the same line we discard that the differences between D2600 and the small mandibles are consequence of wear-related dentoalveolar remodeling. In addition, dental wear pattern of D2600 could suggest an adaptation to a different ecological niche than the other Dmanisi individuals.	[Bermudez de Castro, Jose Maria; Martinon-Torres, Maria; Jan Sier, Mark; Martin-Frances, Laura] Natl Res Ctr Human Evolut CENIEH, Dent Anthropol Grp, Burgos, Spain; [Jan Sier, Mark] Univ Utrecht, Paleomagnet Lab Ft Hoofddijk, Dept Earth Sci, Fac Geosci, Utrecht, Netherlands; [Jan Sier, Mark] Leiden Univ, Fac Archaeol, Human Origins Grp, Leiden, Netherlands	Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); Utrecht University; Leiden University; Leiden University - Excl LUMC	de Castro, JMB (corresponding author), Natl Res Ctr Human Evolut CENIEH, Dent Anthropol Grp, Burgos, Spain.	josemaria.bermudezdecastro@cenieh.es	Sier, Mark/AAA-8778-2020	Sier, Mark/0000-0002-4145-0556; Bermudez de Castro, Jose Maria/0000-0003-1314-3273; Martin-Frances Martin de la Fuente, Laura/0000-0001-5853-5014; Martinon-Torres, Maria/0000-0002-2750-4554	Spanish "Ministerio de Ciencia e Innovacion" [CGL2012-38434-C03-02]; Consejeria de Cultura y Turismo of Junta de Castilla y Leon; Fundacion Atapuerca; Fundacion Duques de Soria; Spanish "Ministerio de Asuntos Exteriores" (Agencia Espanola de Cooperacion Internacional y Desarrollo-AECID) [10-CAP-0078]; Netherlands Organisation for Scientific Research [NWO-ALW 823.01.003]; Spanish "Ministerio de Cultura"	Spanish "Ministerio de Ciencia e Innovacion"(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consejeria de Cultura y Turismo of Junta de Castilla y Leon; Fundacion Atapuerca; Fundacion Duques de Soria; Spanish "Ministerio de Asuntos Exteriores" (Agencia Espanola de Cooperacion Internacional y Desarrollo-AECID); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Spanish "Ministerio de Cultura"	This research was supported with funding from the Spanish "Ministerio de Ciencia e Innovacion", project no CGL2012-38434-C03-02, Consejeria de Cultura y Turismo of Junta de Castilla y Leon, Fundacion Atapuerca, Fundacion Duques de Soria, Spanish "Ministerio de Cultura" and "Ministerio de Asuntos Exteriores" (Agencia Espanola de Cooperacion Internacional y Desarrollo-AECID, Proyect 10-CAP-0078), and the Netherlands Organisation for Scientific Research (grant NWO-ALW 823.01.003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUIRRE E, 1977, J HUM EVOL, V6, P681, DOI 10.1016/S0047-2484(77)80094-8; ATCHLEY WR, 1991, BIOL REV, V66, P101, DOI 10.1111/j.1469-185X.1991.tb01138.x; Baena J, 2010, QUATERN INT, V223, P45, DOI 10.1016/j.quaint.2010.01.019; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; Bastir M, 2005, AM J PHYS ANTHROPOL, V128, P26, DOI 10.1002/ajpa.20191; Bastir M, 2004, J HUM EVOL, V47, P359, DOI 10.1016/j.jhevol.2004.08.009; Bastir M, 2007, P ROY SOC B-BIOL SCI, V274, P1125, DOI 10.1098/rspb.2006.0448; Bermudez De Castro Jose Maria, 2007, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V19, P149; BJORK A, 1983, EUR J ORTHODONT, V5, P1; BJORK A, 1991, Proceedings of the Finnish Dental Society, V87, P51; BJORK A, 1969, AMER J ORTHODONTICS, V55, P585, DOI 10.1016/0002-9416(69)90036-0; BJORK ARNE, 1963, JOUR DENT RES, V42, P400, DOI 10.1177/00220345630420014701; BJORK ARNE, 1955, ACTA ODONTOL SCAND, V13, P9, DOI 10.3109/00016355509028170; Boughner J, 2008, EVOL BIOL, V35, P296, DOI 10.1007/s11692-008-9043-6; BOUVIER M, 1986, AM J PHYS ANTHROPOL, V69, P473, DOI 10.1002/ajpa.1330690406; Brauer G, 1996, J HUM EVOL, V30, P445, DOI 10.1006/jhev.1996.0037; Calvo-Rathert M, 2008, QUATERNARY RES, V69, P91, DOI 10.1016/j.yqres.2007.09.001; CLARKE NG, 1991, AM J PHYS ANTHROPOL, V85, P293, DOI 10.1002/ajpa.1330850307; COLE TM, 1992, J HUM EVOL, V23, P253, DOI 10.1016/S0047-2484(05)80003-X; DAEGLING DJ, 1992, INT J PRIMATOL, V13, P545, DOI 10.1007/BF02547832; Daegling DJ, 1996, J HUM EVOL, V30, P315, DOI 10.1006/jhev.1996.0026; de Castro JMB, 1999, J HUM EVOL, V37, P523, DOI 10.1006/jhev.1999.0323; de Lumley H, 2002, CR PALEVOL, V1, P181, DOI 10.1016/S1631-0683(02)00023-4; de Lumley MA, 2006, CR PALEVOL, V5, P273, DOI 10.1016/j.crpv.2005.11.013; DEAN MC, 1992, J HUM EVOL, V22, P23, DOI 10.1016/0047-2484(92)90027-7; deCastro JMB, 1997, J HUM EVOL, V33, P333, DOI 10.1006/jhev.1997.0110; DECASTRO JMB, 1993, J HUM EVOL, V24, P339, DOI 10.1006/jhev.1993.1027; DZAPARIDZE V, 1989, JB ROM GERM ZENTRALM, V36, P67; Enlow D. H., 1990, FACIAL GROWTH; ENLOW DH, 1971, ANGLE ORTHOD, V41, P271; ENLOW DH, 1964, AM J ORTHOD DENTOFAC, V50, P25, DOI 10.1016/S0002-9416(64)80016-6; Enlow DH, 1996, ESSENTIALS FACIAL GR; Ferring R, 2011, P NATL ACAD SCI USA, V108, P10432, DOI 10.1073/pnas.1106638108; Gabounia L, 2002, CR PALEVOL, V1, P243, DOI 10.1016/S1631-0683(02)00032-5; Gabunia L, 2000, SCIENCE, V288, P1019, DOI 10.1126/science.288.5468.1019; GABUNIA L, 1995, NATURE, V373, P509, DOI 10.1038/373509a0; Gabunia L, 2001, EVOL ANTHROPOL, V10, P158, DOI 10.1002/evan.1030; Gabunia L, 2002, ARCHAEOL ETHNOL ANTH, V4, P145; Goguitchaichvili AT, 2000, CR ACAD SCI EARTH PL, V3, P183; Gonzalez-Jose R, 2008, NATURE, V453, P775, DOI 10.1038/nature06891; Hillson S, 2008, DENT PAHTOLOGY, P301; Hylander W.L., 1977, OROFACIAL GROWTH DEV, P301; HYLANDER WL, 1979, J MORPHOL, V160, P223, DOI 10.1002/jmor.1051600208; JOHANSON DC, 1987, NATURE, V327, P205, DOI 10.1038/327205a0; Kaifu Y, 2003, YEARB PHYS ANTHROPOL, V46, P47, DOI 10.1002/ajpa.10329; Klingenberg CP, 2003, EVOL DEV, V5, P522, DOI 10.1046/j.1525-142X.2003.03057.x; LAVERGNE J, 1977, SCAND J DENT RES, V85, P193; Lavergne J, 1982, Br J Orthod, V9, P51; LEAKEY LSB, 1964, NATURE, V202, P7, DOI 10.1038/202007a0; LEAKEY MG, 1995, NATURE, V376, P565, DOI 10.1038/376565a0; LEVERS BGH, 1983, ARCH ORAL BIOL, V28, P401, DOI 10.1016/0003-9969(83)90135-8; Liu YP, 2010, ANGLE ORTHOD, V80, P97, DOI 10.2319/020309-67.1; Lordkipanidze D, 2005, NATURE, V434, P717, DOI 10.1038/434717b; Lordkipanidze D, 2007, NATURE, V449, P305, DOI 10.1038/nature06134; Lordkipanidze D, 2006, ANAT REC PART A, V288A, P1146, DOI 10.1002/ar.a.20379; Lordkipanidze D, 2013, SCIENCE, V342, P326, DOI 10.1126/science.1238484; Lumley M.A., 2006, ANTHROPOLOGIE, p[D2280, D2282, 02700]; Margvelashvili A, 2013, P NATL ACAD SCI USA, V110, P17278, DOI 10.1073/pnas.1316052110; Martin-Frances L, 2014, CR PALEVOL, V13, P189, DOI 10.1016/j.crpv.2013.10.007; Martinon-Torres M, 2008, J HUM EVOL, V55, P249, DOI 10.1016/j.jhevol.2007.12.008; Martinon-Torres M, 2011, J HUM EVOL, V61, P1, DOI 10.1016/j.jhevol.2011.01.004; Mina M, 2001, CRIT REV ORAL BIOL M, V12, P276, DOI 10.1177/10454411010120040101; Moskowitsch M., 1993, INT J ANTHR, V8, P53; MOSS ML, 1980, AM J ORTHOD DENTOFAC, V77, P591, DOI 10.1016/0002-9416(80)90151-7; Moss ML, 1997, AM J ORTHOD DENTOFAC, V112, P410, DOI 10.1016/S0889-5406(97)70049-0; Moss ML, 1971, ASHA REPORTS; Moss ML, 1973, CRANIOFACIAL BIOL PR, P191; Mounier A, 2009, J HUM EVOL, V56, P219, DOI 10.1016/j.jhevol.2008.12.006; Pinhasi R., ADV HUMAN PALAEOPATH, P283; Polanski J. M, 2011, INT J EVOL BIOL, V2011; Premkumar S., 2011, TXB CRANIOFACIAL GRO; RAVOSA MJ, 1992, J HUM EVOL, V23, P197, DOI 10.1016/0047-2484(92)90107-K; RAVOSA MJ, 1991, J HUM EVOL, V20, P3, DOI 10.1016/0047-2484(91)90042-T; Rightmire GP, 2008, J HUM EVOL, V54, P904, DOI 10.1016/j.jhevol.2008.02.003; Rightmire GP, 2006, J HUM EVOL, V50, P115, DOI 10.1016/j.jhevol.2005.07.009; Rosas A, 1998, AM J PHYS ANTHROPOL, V107, P145, DOI 10.1002/(SICI)1096-8644(199810)107:2<145::AID-AJPA2>3.3.CO;2-8; Rosas A, 2004, ANAT REC PART A, V278A, P551, DOI 10.1002/ar.a.20049; Rosas A, 2001, AM J PHYS ANTHROPOL, V114, P74, DOI 10.1002/1096-8644(200101)114:1<74::AID-AJPA1007>3.3.CO;2-L; Rosas A, 1998, GEOBIOS-LYON, V31, P687, DOI 10.1016/S0016-6995(98)80055-7; Rosas A, 1985, ESTUDIO MORFOLOGICO; Rosas A, 1993, MANDIBULA BANYOLES C, P189; ROSAS A, 1992, ONTOGENIA FILOGENIA; Schlichting C, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P3; Schlosser G, 2002, THEORY BIOSCI, V121; Schwartz JH, 2000, SCIENCE, V289, P55; Skinner MM, 2006, J HUM EVOL, V51, P36, DOI 10.1016/j.jhevol.2006.01.006; SPADY M, 1992, AM J HUM BIOL, V4, P683, DOI 10.1002/ajhb.1310040514; Suwa G, 1997, NATURE, V389, P489, DOI 10.1038/39037; TALLGREN A, 1991, EUR J ORTHODONT, V13, P149, DOI 10.1093/ejo/13.2.149; Tattersall, 2003, HUMAN FOSSIL RECORD, DOI 10.1002/0471722715; TENCATE AR, 1998, ORAL HISTOLOGY DEV S, P289; VANARSDALE AP, 2012, PALEOANTHROPOLOGY, P134, DOI DOI 10.4207/PA.2012.ART73; VANLIMBORGH J, 1970, ACTA MORPHOL NEER SC, V8, P143; Vekua A, 2002, SCIENCE, V297, P85, DOI 10.1126/science.1072953; Wang MN, 2007, THESIS SAINT LOUIS U; Ward CV, 2010, PHILOS T R SOC B, V365, P3333, DOI 10.1098/rstb.2010.0039; WHITE TD, 1993, NATURE, V366, P261, DOI 10.1038/366261a0; WHITE TD, 1981, S AFR J SCI, V77, P445; WHITTAKER DK, 1982, ARCH ORAL BIOL, V27, P405, DOI 10.1016/0003-9969(82)90150-9; Winther RG, 2001, J EXP ZOOL, V291, P116, DOI 10.1002/jez.1064; WOOD BA, 1988, J ANAT, V156, P107; WOOD BA, 1986, AM J PHYS ANTHROPOL, V69, P117, DOI 10.1002/ajpa.1330690113	102	17	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88212	10.1371/journal.pone.0088212	http://dx.doi.org/10.1371/journal.pone.0088212			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586309	Green Submitted, gold, Green Published			2022-12-27	WOS:000331714700009
J	Fischer, R; Xygalatas, D; Mitkidis, P; Reddish, P; Tok, P; Konvalinka, I; Bulbulia, J				Fischer, Ronald; Xygalatas, Dimitris; Mitkidis, Panagiotis; Reddish, Paul; Tok, Penny; Konvalinka, Ivana; Bulbulia, Joseph			The Fire-Walker's High: Affect and Physiological Responses in an Extreme Collective Ritual	PLOS ONE			English	Article							PAIN	How do people feel during extreme collective rituals? Despite longstanding speculation, few studies have attempted to quantify ritual experiences. Using a novel pre/post design, we quantified physiological fluctuations (heart rates) and self-reported affective states from a collective fire-walking ritual in a Mauritian Hindu community. Specifically, we compared changes in levels of happiness, fatigue, and heart rate reactivity among high-ordeal participants (fire-walkers), low-ordeal participants (non-fire-walking participants with familial bonds to fire-walkers) and spectators (unrelated/unknown to the fire-walkers). We observed that fire-walkers experienced the highest increase in heart rate and reported greater happiness post-ritual compared to low-ordeal participants and spectators. Low-ordeal participants reported increased fatigue after the ritual compared to both fire-walkers and spectators, suggesting empathetic identification effects. Thus, witnessing the ritualistic suffering of loved ones may be more exhausting than experiencing suffering oneself. The findings demonstrate that the level of ritual involvement is important for shaping affective responses to collective rituals. Enduring a ritual ordeal is associated with greater happiness, whereas observing a loved-one endure a ritual ordeal is associated with greater fatigue post-ritual.	[Fischer, Ronald] Victoria Univ Wellington, Ctr Appl Cross Cultural Res, Wellington, New Zealand; [Fischer, Ronald] Victoria Univ Wellington, Sch Psychol, Wellington, New Zealand; [Fischer, Ronald; Xygalatas, Dimitris; Reddish, Paul; Tok, Penny; Bulbulia, Joseph] Masaryk Univ, LEVYNA Lab Expt Res Relig, Brno, Czech Republic; [Xygalatas, Dimitris; Mitkidis, Panagiotis] Aarhus Univ, Interact Minds Ctr IMC, Dept Culture & Soc, Aarhus, Denmark; [Mitkidis, Panagiotis] Duke Univ, Social Sci Res Inst, Ctr Adv Hindsight, Durham, NC USA; [Mitkidis, Panagiotis] Aarhus Univ, Sch Business & Social Sci, Interdisciplinary Ctr Org Architecture, Aarhus, Denmark; [Konvalinka, Ivana] Tech Univ Denmark, Dept Appl Math & Comp Sci, DK-2800 Lyngby, Denmark; [Konvalinka, Ivana] Cent European Univ, Dept Cognit Sci, Budapest, Hungary; [Bulbulia, Joseph] Victoria Univ Wellington, Fac Humanities & Social Studies, Wellington, New Zealand	Victoria University Wellington; Victoria University Wellington; Masaryk University Brno; Aarhus University; Duke University; Aarhus University; Technical University of Denmark; Central European University; Victoria University Wellington	Fischer, R (corresponding author), Victoria Univ Wellington, Ctr Appl Cross Cultural Res, Wellington, New Zealand.	ronald.fischer@vuw.ac.nz	Xygalatas, Dimitris/P-3376-2019; Xygalatas, Dimitris/C-1956-2014; Fischer, Ronald/G-6447-2017; Konvalinka, Ivana/AAC-3418-2022	Xygalatas, Dimitris/0000-0003-1561-9327; Xygalatas, Dimitris/0000-0003-1561-9327; Fischer, Ronald/0000-0002-3055-3955; Konvalinka, Ivana/0000-0003-3405-6291; Bulbulia, Joseph/0000-0002-5861-2056	University Research Funding Grant from Victoria University of Wellington (URF Grant) [8-3046-108855]; "Technologies of the Mind" project; Velux Foundation; Interactive Minds Centre at Aarhus University, Denmark; Laboratory for the Experimental Research of Religion at Masaryk University, (LEVYNA) [CZ.1.07/2.3.00/20.0048]; European Social Fund; state budget of the Czech Republic; Canadian Social Sciences and Humanities Research Council (SSHRC); Economic and Social Research Council [ES/I005455/1] Funding Source: researchfish; ESRC [ES/I005455/1] Funding Source: UKRI	University Research Funding Grant from Victoria University of Wellington (URF Grant); "Technologies of the Mind" project; Velux Foundation(Velux Fonden); Interactive Minds Centre at Aarhus University, Denmark; Laboratory for the Experimental Research of Religion at Masaryk University, (LEVYNA); European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic; Canadian Social Sciences and Humanities Research Council (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The study was supported by a University Research Funding Grant from Victoria University of Wellington (URF Grant 8-3046-108855); the "Technologies of the Mind" project, financed by the Velux Foundation; the Interactive Minds Centre at Aarhus University, Denmark; the Laboratory for the Experimental Research of Religion at Masaryk University, (LEVYNA, CZ.1.07/2.3.00/20.0048), co-financed by the European Social Fund and the state budget of the Czech Republic; and the Canadian Social Sciences and Humanities Research Council (SSHRC) project "The Evolution of Religion and Morality." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorta CS, 2005, HUM NATURE-INT BIOS, V16, P323, DOI 10.1007/s12110-005-1014-3; Atkinson QD, 2011, EVOL HUM BEHAV, V32, P50, DOI 10.1016/j.evolhumbehav.2010.09.002; Barrett LF, 1999, CURR DIR PSYCHOL SCI, V8, P10, DOI 10.1111/1467-8721.00003; Barrett LF, 1998, J PERS SOC PSYCHOL, V74, P967, DOI 10.1037/0022-3514.74.4.967; Bastian B, 2011, PSYCHOL SCI, V22, P334, DOI 10.1177/0956797610397058; Boecker H, 2008, CEREB CORTEX, V18, P2523, DOI 10.1093/cercor/bhn013; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dietrich A, 2004, BRIT J SPORT MED, V38, P536, DOI 10.1136/bjsm.2004.011718; Durkheim Emile, 1912, FORMES ELEMENTAIRES; Fischer R, 2013, HUM NATURE-INT BIOS, V24, P115, DOI 10.1007/s12110-013-9167-y; Franklin JC, 2013, PSYCHOL SCI, V24, P521, DOI 10.1177/0956797612458805; Franklin JC, 2010, J ABNORM PSYCHOL, V119, P850, DOI 10.1037/a0020896; Gibson AS, 2003, SPORTS MED, V33, P167; Haidt J., 2012, RIGHTEOUS MIND WHY G; Haidt J, 2008, J LEGAL STUD, V37, pS133, DOI 10.1086/529447; Konvalinka I, 2011, P NATL ACAD SCI USA, V108, P8514, DOI 10.1073/pnas.1016955108; McNeill W. H., 1995, KEEPING TOGETHER TIM; Olivola CY, 2013, J BEHAV DECIS MAKING, V26, P91, DOI 10.1002/bdm.767; Reddish P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071182; Reddish P, 2014, RELIG BRAIN BEHAV, V4, P3, DOI 10.1080/2153599X.2013.764545; SOLOMON RL, 1980, AM PSYCHOL, V35, P691, DOI 10.1037/0003-066X.35.8.691; Steffen R, 2012, LANCET INFECT DIS, V12, P142, DOI 10.1016/S1473-3099(11)70293-6; Tanimoto H, 2004, NATURE, V430, P983, DOI 10.1038/430983a; Taves Ann, 1999, FITS TRANCES VISIONS; Tewari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047291; Turner Victor, 1969, RITUAL PROCESS STRUC; WARD C, 1984, ETHOS, V12, P307, DOI 10.1525/eth.1984.12.4.02a00020; Whitehouse H., 2000, ARGUMENTS ICONS DIVE; Whitehouse Harvey, 2004, MODES RELIGIOSITY CO; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x; Xygalatas D., 2012, BURNING SAINTS COGNI; Xygalatas D, 2013, PSYCHOL SCI, V24, P1602, DOI 10.1177/0956797612472910	32	45	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88355	10.1371/journal.pone.0088355	http://dx.doi.org/10.1371/journal.pone.0088355			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3UC	24586315	Green Published, gold, Green Submitted			2022-12-27	WOS:000331714700014
J	Potuckova, E; Jansova, H; Machacek, M; Vavrova, A; Haskova, P; Tichotova, L; Richardson, V; Kalinowski, DS; Richardson, DR; Simunek, T				Potuckova, Eliska; Jansova, Hana; Machacek, Miloslav; Vavrova, Anna; Haskova, Pavlina; Tichotova, Lucie; Richardson, Vera; Kalinowski, Danuta S.; Richardson, Des R.; Simunek, Tomas			Quantitative Analysis of the Anti-Proliferative Activity of Combinations of Selected Iron-Chelating Agents and Clinically Used Anti-Neoplastic Drugs	PLOS ONE			English	Article							CELL-CYCLE ARREST; SALICYLALDEHYDE ISONICOTINOYL HYDRAZONE; BREAST-CANCER; ANTITUMOR-ACTIVITY; RIBONUCLEOTIDE REDUCTASE; OXIDATIVE STRESS; IN-VIVO; ANTHRACYCLINE CARDIOTOXICITY; METASTASIS SUPPRESSOR; IONIZING-RADIATION	Recent studies have demonstrated that several chelators possess marked potential as potent anti-neoplastic drugs and as agents that can ameliorate some of the adverse effects associated with standard chemotherapy. Anti-cancer treatment employs combinations of several drugs that have different mechanisms of action. However, data regarding the potential interactions between iron chelators and established chemotherapeutics are lacking. Using estrogen receptor-positive MCF-7 breast cancer cells, we explored the combined anti-proliferative potential of four iron chelators, namely: desferrioxamine (DFO), salicylaldehyde isonicotinoyl hydrazone (SIH), (E)-N'-[1-(2-hydroxy-5-nitrophenyl) ethyliden] isonicotinoyl hydrazone (NHAPI), and di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT), plus six selected anti-neoplastic drugs. These six agents are used for breast cancer treatment and include: paclitaxel, 5-fluorouracil, doxorubicin, methotrexate, tamoxifen and 4-hydroperoxycyclophosphamide (an active metabolite of cyclophosphamide). Our quantitative chelator-drug analyses were designed according to the Chou-Talalay method for drug combination assessment. All combinations of these agents yielded concentration-dependent, anti-proliferative effects. The hydrophilic siderophore, DFO, imposed antagonism when used in combination with all six anti-tumor agents and this antagonistic effect increased with increasing dose. Conversely, synergistic interactions were observed with combinations of the lipophilic chelators, NHAPI or Dp44mT, with doxorubicin and also the combinations of SIH, NHAPI or Dp44mT with tamoxifen. The combination of Dp44mT with anti-neoplastic agents was further enhanced following formation of its redox-active iron and especially copper complexes. The most potent combinations of Dp44mT and NHAPI with tamoxifen were confirmed as synergistic using another estrogen receptor-expressing breast cancer cell line, T47D, but not estrogen receptor-negative MDA-MB-231 cells. Furthermore, the synergy of NHAPI and tamoxifen was confirmed using MCF-7 cells by electrical impedance data, a mitochondrial inner membrane potential assay and cell cycle analyses. This is the first systematic investigation to quantitatively assess interactions between Fe chelators and standard chemotherapies using breast cancer cells. These studies are vital for their future clinical development.	[Potuckova, Eliska; Jansova, Hana; Machacek, Miloslav; Vavrova, Anna; Haskova, Pavlina; Tichotova, Lucie; Simunek, Tomas] Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Biochem Sci, Prague, Czech Republic; [Richardson, Vera; Kalinowski, Danuta S.; Richardson, Des R.] Univ Sydney, Bosch Inst, Mol Pharmacol & Pathol Program, Sydney, NSW 2006, Australia; [Richardson, Vera; Kalinowski, Danuta S.; Richardson, Des R.] Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia	Charles University Prague; University of Sydney; University of Sydney	Richardson, DR (corresponding author), Univ Sydney, Bosch Inst, Mol Pharmacol & Pathol Program, Sydney, NSW 2006, Australia.	d.richardson@med.usyd.edu.au; Tomas.Simunek@faf.cuni.cz	Jirkovska, Anna/E-8419-2012; Hašková, Pavlína/ABC-6019-2021; Simunek, Tomas/A-3938-2008; Jansova, Hana/S-5847-2017; Machacek, Miloslav/T-3378-2017	Jirkovska, Anna/0000-0002-0131-6010; Simunek, Tomas/0000-0001-5464-4176; Jansova, Hana/0000-0002-5377-518X; Machacek, Miloslav/0000-0001-7221-5914; Haskova, Pavlina/0000-0002-1179-8885; Kalinowski, Danuta/0000-0002-9303-7405; Richardson, Des/0000-0002-5506-3274; Richardson, Des/0000-0003-0960-6415	Charles University [GAUK 299511, SW 267004]; European Social Fund; state budget of the Czech Republic (Operational Program) [CZ.1.07/2.3.00/30.0022]; National Health and Medical Research Council (NHMRC) [571123, 1048972];  [1021607];  [1021601]	Charles University; European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic (Operational Program); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); ; 	This study was supported by the Charles University (projects GAUK 299511, SW 267004) and the European Social Fund and the state budget of the Czech Republic (Operational Program CZ.1.07/2.3.00/30.0022). DRR thanks the National Health and Medical Research Council (NHMRC) for a Senior Principal Research Fellowship (571123) and Project Grants (1021607 and 1021601). DSK also thanks the NHMRC for a Project Grant (1048972). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abassi YA, 2009, CHEM BIOL, V16, P712, DOI 10.1016/j.chembiol.2009.05.011; BECTON DL, 1989, CANCER RES, V49, P4809; Bendova P, 2010, CHEM RES TOXICOL, V23, P1105, DOI 10.1021/tx100125t; Berndt C, 2010, BIOCHEM J, V432, P295, DOI 10.1042/BJ20100996; Buss JL, 2004, CURR TOP MED CHEM, V4, P1623, DOI 10.2174/1568026043387269; Buss JL, 2003, CURR MED CHEM, V10, P1021, DOI 10.2174/0929867033457638; CARMINE TC, 1995, CANCER LETT, V94, P219, DOI 10.1016/0304-3835(95)03852-N; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cooper CE, 1996, J BIOL CHEM, V271, P20291, DOI 10.1074/jbc.271.34.20291; Cui Y, 2007, CANCER EPIDEM BIOMAR, V16, P1682, DOI 10.1158/1055-9965.EPI-07-0187; DONFRANCESCO A, 1995, EUR J CANCER, V31A, P612, DOI 10.1016/0959-8049(95)00068-T; Doulias PT, 2003, FREE RADICAL BIO MED, V35, P719, DOI 10.1016/S0891-5849(03)00396-4; Durken M, 2000, FREE RADICAL BIO MED, V28, P887, DOI 10.1016/S0891-5849(00)00174-X; EDWARD JT, 1988, J CHEM ENG DATA, V33, P538, DOI 10.1021/je00054a044; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Fu D, 2007, BLOOD, V110, P752, DOI 10.1182/blood-2007-03-076737; Garner DL, 1999, MOL REPROD DEV, V53, P222, DOI 10.1002/(SICI)1098-2795(199906)53:2&lt;222::AID-MRD11&gt;3.0.CO;2-L; Gianni L, 2007, CARDIOVASC TOXICOL, V7, P67, DOI 10.1007/s12012-007-0013-5; Goldhirsch A, 2001, J CLIN ONCOL, V19, P3817, DOI 10.1200/JCO.2001.19.18.3817; Goodman L. S., 2008, GOODMAN GILMANS MANU; Haskova P, 2011, FREE RADICAL BIO MED, V50, P537, DOI 10.1016/j.freeradbiomed.2010.12.004; Hatcher HC, 2009, FUTURE MED CHEM, V1, P1643, DOI 10.4155/FMC.09.121; HERSHKO C, 1993, J LAB CLIN MED, V122, P245; Hosokawa Yuko, 2010, Gan To Kagaku Ryoho, V37, P1805; Hruskova K, 2011, CHEM RES TOXICOL, V24, P290, DOI 10.1021/tx100359t; Jansson PJ, 2010, J INORG BIOCHEM, V104, P1224, DOI 10.1016/j.jinorgbio.2010.07.012; Jiang XP, 2002, ANTICANCER RES, V22, P2685; Kabat GC, 2007, CANCER CAUSE CONTROL, V18, P1047, DOI 10.1007/s10552-007-9058-9; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Kovacevic Z, 2011, MOL PHARM; Kovacevic Z, 2008, BBA-MOL CELL RES, V1783, P1981, DOI 10.1016/j.bbamcr.2008.05.016; Kovacevic Z, 2011, MOL PHARMACOL, V80, P598, DOI 10.1124/mol.111.073627; Kovacevic Z, 2011, CURR TOP MED CHEM, V11, P483, DOI 10.2174/156802611794785190; Kwiatkowski JL, 2011, HEMATOL-AM SOC HEMAT, P451, DOI 10.1182/asheducation-2011.1.451; Lane DJR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057273; Lovejoy DB, 2012, J MED CHEM, V55, P7230, DOI 10.1021/jm300768u; Lovejoy DB, 2011, CANCER RES, V71, P5871, DOI 10.1158/0008-5472.CAN-11-1218; Mackova E, 2012, CHEM-BIOL INTERACT, V197, P69, DOI 10.1016/j.cbi.2012.03.010; Majewska U, 2007, PHYS MED BIOL, V52, P3895, DOI 10.1088/0031-9155/52/13/016; Merlot AM, 2013, ANTIOXID REDOX SIGN, V18, P973, DOI 10.1089/ars.2012.4540; MILLART H, 1993, ANTICANCER RES, V13, P779; Moller S, 2008, ACTA ONCOL, V47, P506, DOI 10.1080/02841860802059259; Napier I, 2005, BLOOD, V105, P1867, DOI 10.1182/blood-2004-10-3856; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Noulsri E, 2009, AM J HEMATOL, V84, P170, DOI 10.1002/ajh.21350; NYHOLM S, 1993, J BIOL CHEM, V268, P26200; Olivieri NF, 1997, BLOOD, V89, P739, DOI 10.1182/blood.V89.3.739; Pahl PMB, 2007, J EXP THER ONCOL, V6, P193; Pinnix ZK, 2010, SCI TRANSL MED, V2, DOI [10.1126/scitranslmed.3001127, 10.1126/scisignal.3001127]; PORTER K, 1973, J CELL BIOL, V57, P815, DOI 10.1083/jcb.57.3.815; Quach P, 2012, MOL PHARMACOL, V82, P105, DOI 10.1124/mol.112.078964; Rao VA, 2011, CANCER CHEMOTH PHARM, V68, P1125, DOI 10.1007/s00280-011-1587-y; REIZENSTEIN P, 1991, MED ONCOL TUMOR PHAR, V8, P229; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; RICHARDSON D, 1994, CANCER RES, V54, P685; Richardson DR, 2006, J MED CHEM, V49, P6510, DOI 10.1021/jm0606342; Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7; RICHARDSON DR, 1995, BLOOD, V86, P4295, DOI 10.1182/blood.V86.11.4295.bloodjournal86114295; Shpyleva SI, 2011, BREAST CANCER RES TR, V126, P63, DOI 10.1007/s10549-010-0849-4; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Simunek T, 2008, BRIT J PHARMACOL, V155, P138, DOI 10.1038/bjp.2008.236; Simunek T, 2009, PHARMACOL REP, V61, P154; Sterba M, 2013, ANTIOXID REDOX SIGN, V18, P899, DOI 10.1089/ars.2012.4795; Tanaka T, 1997, BBA-MOL CELL RES, V1357, P91, DOI 10.1016/S0167-4889(97)00016-5; Tantivejkul K, 2003, BREAST CANCER RES TR, V79, P301, DOI 10.1023/A:1024078415339; THELANDER L, 1983, J BIOL CHEM, V258, P4063; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Toyokuni S, 1996, FREE RADICAL BIO MED, V20, P553, DOI 10.1016/0891-5849(95)02111-6; Turner J, 2005, BLOOD, V106, P3191, DOI 10.1182/blood-2005-03-1263; VANDEWALLE B, 1989, BIOCHEM BIOPH RES CO, V163, P149, DOI 10.1016/0006-291X(89)92112-8; Vyhlidal C, 2002, J MOL ENDOCRINOL, V29, P305, DOI 10.1677/jme.0.0290305; Wang G, 2004, BIOMETALS, V17, P15, DOI 10.1023/A:1024417309370; Wesierska-Gadek J, 2006, J CELL BIOCHEM, V98, P1367, DOI 10.1002/jcb.20960; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; Yin JY, 2011, CLIN CANCER RES, V17, P4600, DOI 10.1158/1078-0432.CCR-10-2591; Yu Y, 2012, BRIT J PHARMACOL, V165, P148, DOI 10.1111/j.1476-5381.2011.01526.x; Yu Y, 2007, CELL CYCLE, V6, P1982, DOI 10.4161/cc.6.16.4603; Yu Y, 2011, J BIOL CHEM, V286, P15413, DOI 10.1074/jbc.M111.225946; Yu Y, 2009, J MED CHEM, V52, P5271, DOI 10.1021/jm900552r; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868	81	16	16	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88754	10.1371/journal.pone.0088754	http://dx.doi.org/10.1371/journal.pone.0088754			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586383	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700028
J	Rietdorf, K; Bootman, MD; Sanderson, MJ				Rietdorf, Katja; Bootman, Martin D.; Sanderson, Michael J.			Spontaneous, Pro-Arrhythmic Calcium Signals Disrupt Electrical Pacing in Mouse Pulmonary Vein Sleeve Cells	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; HEART; RECEPTORS; MYOCYTES	The pulmonary vein, which returns oxygenated blood to the left atrium, is ensheathed by a population of unique, myocyte-like cells called pulmonary vein sleeve cells (PVCs). These cells autonomously generate action potentials that propagate into the left atrial chamber and cause arrhythmias resulting in atrial fibrillation; the most common, often sustained, form of cardiac arrhythmia. In mice, PVCs extend along the pulmonary vein into the lungs, and are accessible in a lung slice preparation. We exploited this model to study how aberrant Ca2+ signaling alters the ability of PVC networks to follow electrical pacing. Cellular responses were investigated using real-time 2-photon imaging of lung slices loaded with a Ca2+ sensitive fluorescent indicator (Ca2+ measurements) and phase contrast microscopy (contraction measurements). PVCs displayed global Ca2+ signals and coordinated contraction in response to electrical field stimulation (EFS). The effects of EFS relied on both Ca2+ influx and Ca2+ release, and could be inhibited by nifedipine, ryanodine or caffeine. Moreover, PVCs had a high propensity to show spontaneous Ca2+ signals that arose via stochastic activation of ryanodine receptors (RyRs). The ability of electrical pacing to entrain Ca2+ signals and contractile responses was dramatically influenced by inherent spontaneous Ca2+ activity. In PVCs with relatively low spontaneous Ca2+ activity (<1 Hz), entrainment with electrical pacing was good. However, in PVCs with higher frequencies of spontaneous Ca2+ activity (>1.5 Hz), electrical pacing was less effective; PVCs became unpaced, only partially-paced or displayed alternans. Because spontaneous Ca2+ activity varied between cells, neighboring PVCs often had different responses to electrical pacing. Our data indicate that the ability of PVCs to respond to electrical stimulation depends on their intrinsic Ca2+ cycling properties. Heterogeneous spontaneous Ca2+ activity arising from stochastic RyR opening can disengage them from sinus rhythm and lead to autonomous, proarrhythmic activity.	[Rietdorf, Katja; Sanderson, Michael J.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01605 USA; [Rietdorf, Katja; Bootman, Martin D.] Open Univ, Dept Life Hlth & Chem Sci, Milton Keynes MK7 6AA, Bucks, England; [Bootman, Martin D.] Babraham Inst, Signalling Programme, Cambridge, England	University of Massachusetts System; University of Massachusetts Worcester; Open University - UK; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Rietdorf, K (corresponding author), Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01605 USA.	katja.rietdorf@open.ac.uk	Bootman, Martin/AAB-3330-2019	Bootman, Martin/0000-0002-6447-3451	Biotechnology and Biological Sciences Research Council (BBSRC)	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	MJS and KR were funded by overhead resources. MDB was funded by the Biotechnology and Biological Sciences Research Council (BBSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arentz T, 2007, J CARDIOVASC ELECTR, V18, P31, DOI 10.1111/j.1540-8167.2006.00682.x; Berridge MJ, 2003, BIOCHEM SOC T, V31, P930; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Bers DM, 2006, PHYSIOLOGY, V21, P380, DOI 10.1152/physiol.00019.2006; Bootman MD, 2011, BBA-MOL CELL RES, V1813, P922, DOI 10.1016/j.bbamcr.2011.01.030; Calkins H, 2013, CIRC-ARRHYTHMIA ELEC, V6, P241, DOI 10.1161/CIRCEP.113.000377; Chang SH, 2008, LIFE SCI, V83, P284, DOI 10.1016/j.lfs.2008.06.014; Chen YJ, 2008, BRIT J PHARMACOL, V153, P915, DOI 10.1038/sj.bjp.0707564; Coutu P, 2006, AM J PHYSIOL-HEART C, V291, pH2290, DOI 10.1152/ajpheart.00730.2005; Dobrzynski H, 2013, PHARMACOL THERAPEUT, V139, P260, DOI 10.1016/j.pharmthera.2013.04.010; Eisner DA, 2009, CIRC J, V73, P1561, DOI 10.1253/circj.CJ-09-0478; Gonzalez MD, 2005, AM J GERIATR CARDIOL, V14, P26, DOI 10.1111/j.1076-7460.2005.03340.x; Heijman J, 2012, WIEN MED WOCHENSCHR, V162, P287, DOI 10.1007/s10354-012-0109-9; Hirose M, 2007, AM J PHYSIOL-HEART C, V292, pH1861, DOI 10.1152/ajpheart.00826.2006; Huang H, 2006, J CARDIOVASC ELECTR, V17, P1193, DOI 10.1111/j.1540-8167.2006.00599.x; Johnson DM, 2013, CIRC RES, V112, P246, DOI 10.1161/CIRCRESAHA.112.275735; Kracklauer MP, 2013, FEBS J, V280, P880, DOI 10.1111/febs.12076; Logantha SJRJ, 2010, CELL CALCIUM, V48, P150, DOI 10.1016/j.ceca.2010.08.002; Mackenzie L, 2002, J PHYSIOL-LONDON, V541, P395, DOI 10.1113/jphysiol.2001.013411; McCarron JG, 2000, J PHYSIOL-LONDON, V525, P113, DOI 10.1111/j.1469-7793.2000.00113.x; Moreira W, 2008, TEX HEART I J, V35, P356; Namekata I, 2013, BIOL PHARM BULL, V36, P2, DOI 10.1248/bpb.b212020; Nattel Stanley, 2003, Journal of Cardiovascular Pharmacology and Therapeutics, V8, pS5, DOI 10.1177/107424840300800102; Niggli E, 2011, CARDIOVASC RES, V91, P563, DOI 10.1093/cvr/cvr198; Okamoto Y, 2012, J MOL CELL CARDIOL, V52, P988, DOI 10.1016/j.yjmcc.2012.01.007; Patterson E, 2007, J CARDIOVASC ELECTR, V18, P1067, DOI 10.1111/j.1540-8167.2007.00909.x; Roderick HL, 2007, BIOCHEM SOC T, V35, P957, DOI 10.1042/BST0350957; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Sanderson MJ, 2011, PULM PHARMACOL THER, V24, P452, DOI 10.1016/j.pupt.2011.05.001; Sanderson MJ, 2003, METHOD ENZYMOL, V360, P447; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sherif HM, 2013, EUR J CARDIOTHORAC S; Smyrnias I, 2010, CELL CALCIUM, V47, P210, DOI 10.1016/j.ceca.2009.10.001; Takahara A, 2011, J PHARMACOL SCI, V115, P176, DOI 10.1254/jphs.10232FP; Ter Keurs HEDJ, 2007, PHYSIOL REV, V87, P457, DOI 10.1152/physrev.00011.2006; Thul R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00279; Tsuneoka Y, 2012, J PHARMACOL SCI, V119, P287, DOI 10.1254/jphs.12062SC; Voigt N, 2012, ADV EXP MED BIOL, V740, P1175, DOI 10.1007/978-94-007-2888-2_53; Yeh YH, 2008, CIRC-ARRHYTHMIA ELEC, V1, P93, DOI 10.1161/CIRCEP.107.754788; Yoshida N, 2013, ECHOCARDIOGR-J CARD, V30, P744, DOI 10.1111/echo.12143	41	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88649	10.1371/journal.pone.0088649	http://dx.doi.org/10.1371/journal.pone.0088649			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586364	Green Published, Green Accepted, gold			2022-12-27	WOS:000331714700024
J	Elshout, G; van Ierland, Y; Bohnen, AM; de Wilde, M; Moll, HA; Oostenbrink, R; Berger, MY				Elshout, Gijs; van Ierland, Yvette; Bohnen, Arthur M.; de Wilde, Marcel; Moll, Henriette A.; Oostenbrink, Rianne; Berger, Marjolein Y.			Alarming Signs and Symptoms in Febrile Children in Primary Care: An Observational Cohort Study in The Netherlands	PLOS ONE			English	Article							SERIOUS INFECTIONS; PREDICTION RULES; REFERRALS	Context: Febrile children in primary care have a low risk for serious infection. Although several alarming signs and symptoms are proposed to have predictive value for serious infections, most are based on research in secondary care. The frequency of alarming signs/symptoms has not been established in primary care; however, in this setting differences in occurrence may influence their predictive value for serious infections. Objective: To determine the frequency of alarming signs/symptoms in febrile children in primary care. Design: Observational cohort study. Clinical information was registered in a semi-structured way and manually recoded. Setting: General practitioners' out-of-hours service. Subjects: Face-to-face patient contacts concerning children (aged <= 16 years) with fever were eligible for inclusion. Main outcome measures: Frequency of 18 alarming signs and symptoms as reported in the literature. Results: A total of 10,476 patient contacts were included. The frequency of alarming signs/symptoms ranged from n = 1 (ABC instability; <0.1%) to n = 2,207 (vomiting & diarrhea; 21.1%). Of all children, 59.7% had one or more alarming signs and/or symptoms. Several alarming signs/symptoms were poorly registered with the frequency of missing information ranging from 1,347 contacts (temperature >40 degrees C as reported by the parents; 12.9%) to 8,647 contacts (parental concern; 82.5%). Conclusion: Although the prevalence of specific alarming signs/symptoms is low in primary care >50% of children have one or more alarming signs/symptoms. There is a need to determine the predictive value of alarming signs/symptoms not only for serious infections in primary care, but as well for increased risk of a complicated course of the illness.	[Elshout, Gijs; Bohnen, Arthur M.] Erasmus MC, Dept Gen Practice, Rotterdam, Netherlands; [van Ierland, Yvette; Moll, Henriette A.; Oostenbrink, Rianne] Erasmus MC Sophia Childrens Hosp, Dept Gen Pediat, Rotterdam, Netherlands; [de Wilde, Marcel] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [Berger, Marjolein Y.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Groningen	Berger, MY (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands.	m.y.berger@med.umcg.nl	Bohnen, Arthur M/F-7814-2011		Europe Container Terminals B.V. Europe Container Terminals B.V. is a non-medical, commercial source (i.e. a company concerning harbour-containers)	Europe Container Terminals B.V. Europe Container Terminals B.V. is a non-medical, commercial source (i.e. a company concerning harbour-containers)	This study was supported by an unrestricted grant from Europe Container Terminals B.V. Europe Container Terminals B.V. is a non-medical, commercial source (i.e. a company concerning harbour-containers). The funder had no role in study design, the collection, analysis or interpretation of data, writing the report or the decision to submit the manuscript for publication. The authors' relation does not alter their adherence to all the PLOS ONE policies on sharing data and materials.	Berger MY BL, 2008, HUISARTS WET, V51, P287; Craig JC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1594; Elshout G, 2013, BRIT J GEN PRACT, V63, pE437, DOI 10.3399/bjgp13X669158; Forrest CB, 2003, BRIT MED J, V326, P692, DOI 10.1136/bmj.326.7391.692; Giesen P, 2011, ANN INTERN MED, V155, P108, DOI 10.7326/0003-4819-155-2-201107190-00006; HALLAM L, 1994, BRIT MED J, V308, P249, DOI 10.1136/bmj.308.6923.249; Hansen BL, 1998, BRIT J GEN PRACT, V48, P1497; Huibers L, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-105; Muris JWM, 1990, HUISARTS WET, V33, P258; Oostenbrink R, 2012, ARCH DIS CHILD; Pallant J, 2010, SPSS SURVIVAL MANUAL, P134; Patel S, 2002, AM J EMERG MED, V20, P144, DOI 10.1053/ajem.2002.32638; Richardson M, 2007, BRIT MED J, V334, P1163, DOI 10.1136/bmj.39218.495255.AE; Thompson M, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16150; Van den Bruel Ann, 2006, BMC Fam Pract, V7, P23, DOI 10.1186/1471-2296-7-23; Van den Bruel A, 2010, LANCET, V375, P834, DOI 10.1016/S0140-6736(09)62000-6; van Ierland Y, 2011, FAM PRACT, V28, P334, DOI 10.1093/fampra/cmq097; Verbakel JY, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-10; Zwakhals SLN, 2010, LOCATIONS GEN PRACTI	19	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88114	10.1371/journal.pone.0088114	http://dx.doi.org/10.1371/journal.pone.0088114			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586305	gold, Green Published, Green Submitted			2022-12-27	WOS:000331711900024
J	Lara, T; Madrid, JA; Correa, A				Lara, Tania; Antonio Madrid, Juan; Correa, Angel			The Vigilance Decrement in Executive Function Is Attenuated When Individual Chronotypes Perform at Their Optimal Time of Day	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; MORNINGNESS-EVENINGNESS; PSYCHOMETRIC PROPERTIES; INHIBITORY CONTROL; SLEEP LOSS; ATTENTION; PHASE; TASK; TEMPERATURE; SYNCHRONY	Time of day modulates our cognitive functions, especially those related to executive control, such as the ability to inhibit inappropriate responses. However, the impact of individual differences in time of day preferences (i.e. morning vs. evening chronotype) had not been considered by most studies. It was also unclear whether the vigilance decrement (impaired performance with time on task) depends on both time of day and chronotype. In this study, morning- type and evening- type participants performed a task measuring vigilance and response inhibition (the Sustained Attention to Response Task, SART) in morning and evening sessions. The results showed that the vigilance decrement in inhibitory performance was accentuated at non-optimal as compared to optimal times of day. In the morning-type group, inhibition performance decreased linearly with time on task only in the evening session, whereas in the morning session it remained more accurate and stable over time. In contrast, inhibition performance in the evening-type group showed a linear vigilance decrement in the morning session, whereas in the evening session the vigilance decrement was attenuated, following a quadratic trend. Our findings imply that the negative effects of time on task in executive control can be prevented by scheduling cognitive tasks at the optimal time of day according to specific circadian profiles of individuals. Therefore, time of day and chronotype influences should be considered in research and clinical studies as well as real-word situations demanding executive control for response inhibition.	[Lara, Tania; Correa, Angel] Univ Granada, Ctr Invest Mente Cerebro & Comportamiento, Granada, Spain; [Antonio Madrid, Juan] Univ Murcia, Dept Fisiol, Murcia, Spain; [Correa, Angel] Univ Granada, Dept Psicol Expt, Granada, Spain	University of Granada; University of Murcia; University of Granada	Correa, A (corresponding author), Univ Granada, Ctr Invest Mente Cerebro & Comportamiento, Granada, Spain.	act@ugr.es		Correa, Angel/0000-0001-5256-4949; Madrid, Juan Antonio/0000-0002-9286-1371	Spanish Ministerio de Ciencia e Innovacion (Ramon y Cajal programme) [RYC-2007-00296]; Spanish Ministerio de Ciencia e Innovacion (PLAN NACIONAL del+D+i) [PSI2010-15399]; Junta de Andalucia [SEJ-3054]	Spanish Ministerio de Ciencia e Innovacion (Ramon y Cajal programme); Spanish Ministerio de Ciencia e Innovacion (PLAN NACIONAL del+D+i)(Ministry of Science and Innovation, Spain (MICINN)); Junta de Andalucia(Junta de Andalucia)	This work was supported by the Spanish Ministerio de Ciencia e Innovacion (Ramon y Cajal programme: RYC-2007-00296 and PLAN NACIONAL del+D+i: PSI2010-15399) and Junta de Andalucia (SEJ-3054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAN A, 1991, PERS INDIV DIFFER, V12, P241, DOI 10.1016/0191-8869(91)90110-W; Adan A, 2008, PROGR CIRCADIAN RHYT, P141; Adan A, 2012, CHRONOBIOL INT, V29, P1153, DOI 10.3109/07420528.2012.719971; Baehr EK, 2000, J SLEEP RES, V9, P117, DOI 10.1046/j.1365-2869.2000.00196.x; Bennett CL, 2008, AM J PSYCHOL, V121, P349, DOI 10.2307/20445471; Blatter K, 2007, PHYSIOL BEHAV, V90, P196, DOI 10.1016/j.physbeh.2006.09.009; Bratzke D, 2007, PSYCHOL SCI, V18, P456, DOI 10.1111/j.1467-9280.2007.01921.x; Bratzke D, 2012, CHRONOBIOL INT, V29, P55, DOI 10.3109/07420528.2011.635235; Bratzke D, 2009, J SLEEP RES, V18, P167, DOI 10.1111/j.1365-2869.2008.00729.x; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Caci H, 2005, PSYCHIAT RES, V134, P259, DOI 10.1016/j.psychres.2004.02.019; Cheyne JA, 2006, CONSCIOUS COGN, V15, P578, DOI 10.1016/j.concog.2005.11.009; Cosi S, 2008, PSYCHOL REP, V103, P336, DOI 10.2466/PR0.103.2.336-346; Di Milia L, 2011, ACCIDENT ANAL PREV, V43, P516, DOI 10.1016/j.aap.2009.12.018; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Finomore V, 2009, ERGONOMICS, V52, P791, DOI 10.1080/00140130802641627; Fossati A, 2002, PERCEPT MOTOR SKILL, V95, P621, DOI 10.2466/PMS.95.6.621-635; Goldstein D, 2007, PERS INDIV DIFFER, V42, P431, DOI 10.1016/j.paid.2006.07.008; Grier RA, 2003, HUM FACTORS, V45, P349, DOI 10.1518/hfes.45.3.349.27253; Hahn C, 2012, DEVELOPMENTAL SCI, V15, P408, DOI 10.1111/j.1467-7687.2012.01137.x; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; HORNE JA, 1980, ERGONOMICS, V23, P29, DOI 10.1080/00140138008924715; Katzenberg D, 1998, SLEEP, V21, P569, DOI 10.1093/sleep/21.6.569; Keppel G, 1991, DESIGN ANAL RES HDB; Kerkhof GA, 1996, NEUROSCI LETT, V218, P153, DOI 10.1016/S0304-3940(96)13140-2; KERKHOF GA, 1985, BIOL PSYCHOL, V20, P83, DOI 10.1016/0301-0511(85)90019-5; Kolodyazhniy V, 2011, J BIOL RHYTHM, V26, P55, DOI 10.1177/0748730410391619; Krauchi K, 2007, SLEEP MED REV, V11, P439, DOI 10.1016/j.smrv.2007.07.001; Krauchi K, 2000, AM J PHYSIOL-REG I, V278, pR741, DOI 10.1152/ajpregu.2000.278.3.R741; Lehnkering H, 2007, CHRONOBIOL INT, V24, P875, DOI 10.1080/07420520701648259; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; Mackworth NH, 1948, Q J EXP PSYCHOL, V1, P6, DOI 10.1080/17470214808416738; Manly T, 2003, NEUROCASE, V9, P340, DOI 10.1076/neur.9.4.340.15553; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P1, DOI 10.1016/S0028-3932(01)00086-0; Marek T, 2010, CHRONOBIOL INT, V27, P945, DOI 10.3109/07420528.2010.489400; May CP, 2005, PSYCHOL SCI, V16, P96, DOI 10.1111/j.0956-7976.2005.00788.x; May CP, 1998, J EXP PSYCHOL HUMAN, V24, P363, DOI 10.1037/0096-1523.24.2.363; Molenberghs P, 2009, NEUROPSYCHOLOGIA, V47, P2866, DOI 10.1016/j.neuropsychologia.2009.06.012; Molina E, 2013, YOU SHOULD NOT DRIVE; MONK T H, 1986, Chronobiology International, V3, P171, DOI 10.3109/07420528609066364; MONK TH, 1989, PSYCHIAT RES, V27, P89, DOI 10.1016/0165-1781(89)90013-9; Natale V, 1996, PERS INDIV DIFFER, V20, P491, DOI 10.1016/0191-8869(95)00213-8; Norman D. A., 1986, CONSCIOUSNESS SELF R, V4, P1; Oginska H, 2010, CHRONOBIOL INT, V27, P959, DOI 10.3109/07420528.2010.489412; Parasuraman R, 1977, VIGILANCE THEORY OPE, P559; Robertson IH, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P631; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Robertson IH., 2010, ATTENTION TIME, V79, P88, DOI DOI 10.1093/ACPROF:OSO/9780199563456.003.0006; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Romeijn N, 2011, J BIOL RHYTHM, V26, P68, DOI 10.1177/0748730410391894; Sarabia JA, 2008, PHYSIOL BEHAV, V95, P570, DOI 10.1016/j.physbeh.2008.08.005; Schmidt C, 2007, COGN NEUROPSYCHOL, V24, P755, DOI 10.1080/02643290701754158; Schmidt C, 2012, CHRONOBIOL INT, V29, P482, DOI 10.3109/07420528.2012.658984; Schmidt C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029658; Schneider W., 2002, E PRIME USERS GUIDE; Shaw TH, 2013, BRAIN COGNITION, V82, P265, DOI 10.1016/j.bandc.2013.05.003; Soler J, 2012, ACTAS ESP PSIQUIATRI, V40, P19; Taillard J, 1999, J SLEEP RES, V8, P291, DOI 10.1046/j.1365-2869.1999.00176.x; Vandewalle G, 2009, J NEUROSCI, V29, P7948, DOI 10.1523/JNEUROSCI.0229-09.2009; Vanin S, 2012, NATURE, V484, P371, DOI 10.1038/nature10991; Warm JS, 2008, HUM FACTORS, V50, P433, DOI 10.1518/001872008X312152	61	56	56	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88820	10.1371/journal.pone.0088820	http://dx.doi.org/10.1371/journal.pone.0088820			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3TA	24586404	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900051
J	Lee, GH; Lee, MR; Lee, HY; Kim, SH; Kim, HK; Kim, HR; Chae, HJ				Lee, Geum-Hwa; Lee, Mi-Rin; Lee, Hwa-Young; Kim, Seung Hyun; Kim, Hye-Kyung; Kim, Hyung-Ryong; Chae, Han-Jung			Eucommia ulmoides Cortex, Geniposide and Aucubin Regulate Lipotoxicity through the Inhibition of Lysosomal BAX	PLOS ONE			English	Article							MEMBRANE PERMEABILIZATION; HEPATIC LIPOTOXICITY; ANTIOXIDANT ACTIVITY; HYPOLIPIDEMIC ACTION; OLIV. LEAVES; CELL-DEATH; APOPTOSIS; EXTRACT; INVOLVEMENT; EXPRESSION	In this study we examined the inhibition of hepatic dyslipidemia by Eucommia ulmoides extract (EUE). Using a screening assay for BAX inhibition we determined that EUE regulates BAX-induced cell death. Among various cell death stimuli tested EUE regulated palmitate-induced cell death, which involves lysosomal BAX translocation. EUE rescued palmitate-induced inhibition of lysosomal V-ATPase, alpha-galactosidase, alpha-mannosidase, and acid phosphatase, and this effect was reversed by bafilomycin, a lysosomal V-ATPase inhibitor. The active components of EUE, aucubin and geniposide, showed similar inhibition of palmitate-induced cell death to that of EUE through enhancement of lysosome activity. Consistent with these in vitro findings, EUE inhibited the dyslipidemic condition in a high-fat diet animal model by regulating the lysosomal localization of BAX. This study demonstrates that EUE regulates lipotoxicity through a novel mechanism of enhanced lysosomal activity leading to the regulation of lysosomal BAX activation and cell death. Our findings further indicate that geniposide and aucubin, active components of EUE, may be therapeutic candidates for non-alcoholic fatty liver disease.	[Lee, Geum-Hwa; Lee, Mi-Rin; Lee, Hwa-Young; Kim, Hye-Kyung; Chae, Han-Jung] Chonbuk Natl Univ, Sch Med, Dept Pharmacol, Jeonju, South Korea; [Lee, Geum-Hwa; Lee, Mi-Rin; Lee, Hwa-Young; Kim, Hye-Kyung; Chae, Han-Jung] Chonbuk Natl Univ, Sch Med, Cardiovasc Res Inst, Jeonju, South Korea; [Kim, Seung Hyun] Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, Inchon, South Korea; [Kim, Hyung-Ryong] Wonkwang Univ, Sch Dent, Dept Dent Pharmacol, Iksan, South Korea; [Kim, Hyung-Ryong] Wonkwang Univ, Sch Dent, Wonkwang Dent Res Inst, Iksan, South Korea	Jeonbuk National University; Jeonbuk National University; Yonsei University; Wonkwang University; Wonkwang University	Chae, HJ (corresponding author), Chonbuk Natl Univ, Sch Med, Dept Pharmacol, Jeonju, South Korea.	hjchae@chonbuk.ac.kr		Chae, Han-Jung/0000-0003-4190-9889	National Research Foundation [2012R1A2A1A03001907, 2008-0062279]	National Research Foundation	This study was supported by the National Research Foundation (2012R1A2A1A03001907 and 2008-0062279). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, J GASTROEN HEPATOL, V17, pS186, DOI 10.1046/j.1440-1746.17.s1.10.x; Boya P, 2003, ONCOGENE, V22, P3927, DOI 10.1038/sj.onc.1206622; Chae HJ, 2003, GENE, V323, P101, DOI 10.1016/j.gene.2003.09.011; Choi MS, 2008, AM J CHINESE MED, V36, P81, DOI 10.1142/S0192415X08005606; Cox BE, 2007, J LIPID RES, V48, P1012, DOI 10.1194/jlr.M600390-JLR200; Crider BP, 2003, J BIOL CHEM, V278, P44281, DOI 10.1074/jbc.M307372200; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Feldstein AE, 2006, AM J PHYSIOL-GASTR L, V290, pG1339, DOI 10.1152/ajpgi.00509.2005; Harish R, 2010, J PHARM BIOALLIED SC, V2, P341, DOI 10.4103/0975-7406.72137; Hung MY, 2006, FOOD CHEM TOXICOL, V44, P1424, DOI 10.1016/j.fct.2006.03.009; Kagedal K, 2005, INT J EXP PATHOL, V86, P309, DOI 10.1111/j.0959-9673.2005.00442.x; Kim BH, 2009, J MED FOOD, V12, P764, DOI 10.1089/jmf.2008.1239; Kim HY, 2004, J ETHNOPHARMACOL, V93, P227, DOI 10.1016/j.jep.2004.03.047; Lee GH, 2012, INT J BIOCHEM CELL B, V44, P600, DOI 10.1016/j.biocel.2011.12.017; Lee GH, 2011, J BIOL CHEM, V286, P24743, DOI 10.1074/jbc.M110.167734; Li AM, 2005, J BIOL CHEM, V280, P17430, DOI 10.1074/jbc.C500058200; Li H, 2004, PHYTOCHEM ANALYSIS, V15, P306, DOI 10.1002/pca.783; Li H, 2009, J AOAC INT, V92, P103; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Li ZZ, 2008, HEPATOLOGY, V47, P1495, DOI 10.1002/hep.22183; Luo JY, 2009, J ENZYM INHIB MED CH, V24, P1280, DOI 10.3109/14756360902829741; Oberle C, 2010, CELL DEATH DIFFER, V17, P1167, DOI 10.1038/cdd.2009.214; Park SA, 2006, J MED FOOD, V9, P474, DOI 10.1089/jmf.2006.9.474; Park SA, 2006, J ETHNOPHARMACOL, V107, P412, DOI 10.1016/j.jep.2006.03.034; Peng MJ, 2013, J CHROMATOGR B, V940, P86, DOI 10.1016/j.jchromb.2013.09.032; Sobhan PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059350; Sobota JA, 2009, J CELL SCI, V122, P3542, DOI 10.1242/jcs.034298; Trivedi NS, 2000, PHOTOCHEM PHOTOBIOL, V71, P634, DOI 10.1562/0031-8655(2000)071<0634:QAOPLI>2.0.CO;2; Vuppalanchi R, 2009, HEPATOLOGY, V49, P306, DOI 10.1002/hep.22603; Werneburg NW, 2007, J BIOL CHEM, V282, P28960, DOI 10.1074/jbc.M705671200; Yamasaki M, 2005, BBA-MOL CELL BIOL L, V1735, P176, DOI 10.1016/j.bbalip.2005.05.010; Zhou J, 2013, CELL RES, V23, P508, DOI 10.1038/cr.2013.11	32	17	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88017	10.1371/journal.pone.0088017	http://dx.doi.org/10.1371/journal.pone.0088017			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586300	gold, Green Published, Green Submitted			2022-12-27	WOS:000331711900022
J	Chan, JYL; Wang, KH; Fang, CL; Chen, WY				Chan, Jung-Yi Lisa; Wang, Kuo-Hsien; Fang, Chia-Lang; Chen, Wei-Yu			Fibrous Papule of the Face, Similar to Tuberous Sclerosis Complex-Associated Angiofibroma, Shows Activation of the Mammalian Target of Rapamycin Pathway: Evidence for a Novel Therapeutic Strategy?	PLOS ONE			English	Article							GIANT-CELL ASTROCYTOMAS; FACIAL ANGIOFIBROMA; MTOR PATHWAY; ANGIOMYOLIPOMA; GENE; TSC2; LYMPHANGIOLEIOMYOMATOSIS; HAMARTOMAS; SIROLIMUS; TUMOR	Fibrous papules of the face are hamartomas characterized by stellate-shaped stromal cells, multinucleated giant cells, and proliferative blood vessels in the dermis. The pathogenesis of fibrous papules remains unclear. There is a striking microscopic resemblance between fibrous papules and tuberous sclerosis complex (TSC)-associated angiofibromas. A germline mutation of the TSC1 or TSC2 gene, leading to activation of the mammalian target of rapamycin (mTOR) pathway, accounts for the pathogenesis of TSC-associated angiofibromas. Activated mTOR subsequently activates p70 ribosomal protein S6 kinase (p70S6K) and ribosomal protein S6 (S6) by phosphorylation. Rapamycin, a mTOR inhibitor, is effective in treating TSC-associated angiofibromas. The aim of this study was to understand whether the mTOR pathway is activated in fibrous papules. We studied immunoexpressions of phosphorylated (p-) mTOR effectors in fibrous papules, TSC-associated angiofibromas, and normal skin controls. P-mTOR, p-p70S6K and p-S6 were highly expressed in dermal stromal cells and epidermal keratinocytes in fibrous papules and TSC-associated angiofibromas but not in fibroblasts and epidermal keratinocytes of normal skin controls (p<0.001). The results suggest topical rapamycin may be a novel treatment option for fibrous papules.	[Chan, Jung-Yi Lisa] Cathay Gen Hosp, Dept Dermatol, Taipei, Taiwan; [Wang, Kuo-Hsien] Taipei Med Univ Hosp, Dept Dermatol, Taipei, Taiwan; [Wang, Kuo-Hsien] Taipei Med Univ, Coll Med, Sch Med, Dept Dermatol, Taipei, Taiwan; [Fang, Chia-Lang; Chen, Wei-Yu] Taipei Med Univ, Coll Med, Sch Med, Dept Pathol, Taipei, Taiwan; [Fang, Chia-Lang; Chen, Wei-Yu] Taipei Med Univ, Wan Fang Hosp, Dept Pathol, Taipei, Taiwan	Cathay General Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital	Chen, WY (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Pathol, Taipei, Taiwan.	1047@tmu.edu.tw			Cathay General Hospital, Taipei, Taiwan [98CGH-TMU-06]	Cathay General Hospital, Taipei, Taiwan	This study was supported by the grant from Cathay General Hospital (98CGH-TMU-06), Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal C, 2005, J CUTAN PATHOL, V32, P424, DOI 10.1111/j.0303-6987.2005.00362.x; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Bittencourt RCA, 2001, J AM ACAD DERMATOL, V45, P731, DOI 10.1067/mjd.2001.116223; Budde K, 2012, AM J KIDNEY DIS, V59, P276, DOI 10.1053/j.ajkd.2011.10.013; Calonje E, 2010, ROOKS TXB DERMATOLOG, DOI [10.1002/9781444317633.ch56, DOI 10.1002/9781444317633.CH56]; Dabora SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023379; Dabora SL, 2001, AM J HUM GENET, V68, P64, DOI 10.1086/316951; Davies DM, 2011, CLIN CANCER RES, V17, P4071, DOI 10.1158/1078-0432.CCR-11-0445; Del Bufalo D, 2006, CANCER RES, V66, P5549, DOI 10.1158/0008-5472.CAN-05-2825; El-Hashemite N, 2003, LANCET, V361, P1348, DOI 10.1016/S0140-6736(03)13044-9; Fackler I, 2003, J CUTAN PATHOL, V30, P174, DOI 10.1034/j.1600-0560.2003.2o066.x; Franz DN, 2013, LANCET, V381, P125, DOI 10.1016/S0140-6736(12)61134-9; GRAHAM JH, 1965, J INVEST DERMATOL, V45, P194, DOI 10.1038/jid.1965.118; Grieb S, 2008, HAUTARZT, V59, P774, DOI 10.1007/s00105-008-1633-9; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; GUITART J, 1991, J CUTAN PATHOL, V18, P284, DOI 10.1111/j.1600-0560.1991.tb01237.x; Haemel AK, 2010, ARCH DERMATOL, V146, P715, DOI 10.1001/archdermatol.2010.125; Hofbauer GFL, 2008, BRIT J DERMATOL, V159, P473, DOI 10.1111/j.1365-2133.2008.08677.x; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kenerson H, 2007, HUM PATHOL, V38, P1361, DOI 10.1016/j.humpath.2007.01.028; Kenerson HL, 2002, CANCER RES, V62, P5645; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Kucher C, 2007, J CUTAN PATHOL, V34, P571, DOI 10.1111/j.1600-0560.2006.00667.x; Li SW, 2008, P NATL ACAD SCI USA, V105, P3539, DOI 10.1073/pnas.0712397105; Li SW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1236; McNamara EK, 2012, J DERMATOL TREAT, V23, P46, DOI 10.3109/09546634.2010.489598; Meigel W N, 1979, Am J Dermatopathol, V1, P329; Mutizwa MM, 2011, BRIT J DERMATOL, V165, P922, DOI 10.1111/j.1365-2133.2011.10476.x; NELLIST M, 1993, CELL, V75, P1305; NEMETH AJ, 1988, J AM ACAD DERMATOL, V19, P1102, DOI 10.1016/S0190-9622(88)70279-0; NICKEL WR, 1962, ARCH DERMATOL, V85, P209, DOI 10.1001/archderm.1962.01590020049006; Pan CC, 2008, J PATHOL, V214, P387, DOI 10.1002/path.2289; Plank TL, 1998, CANCER RES, V58, P4766; Ragaz A, 1979, Am J Dermatopathol, V1, P353, DOI 10.1097/00000372-197900140-00012; Robb VA, 2006, MODERN PATHOL, V19, P839, DOI 10.1038/modpathol.3800610; Rose C, 2000, AM J DERMATOPATH, V22, P563, DOI 10.1097/00000372-200012000-00018; Salido R, 2012, J EUR ACAD DERMATOL, V26, P1315, DOI 10.1111/j.1468-3083.2011.04212.x; SAYLAN T, 1971, BRIT J DERMATOL, V85, P111; Sepp T, 1996, J MED GENET, V33, P962, DOI 10.1136/jmg.33.11.962; SPIEGEL J, 1983, J AM ACAD DERMATOL, V9, P360, DOI 10.1016/S0190-9622(83)70142-8; Tyburczy ME, 2013, HUM MOL GEN IN PRESS; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Wataya-Kaneda M, 2011, BRIT J DERMATOL, V165, P912, DOI 10.1111/j.1365-2133.2011.10471.x; Yeung RS, 2003, GENE CHROMOSOME CANC, V38, P368, DOI 10.1002/gcc.10256	45	6	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89467	10.1371/journal.pone.0089467	http://dx.doi.org/10.1371/journal.pone.0089467			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558502	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700148
J	Deng, H; Zhang, XT; Wang, ML; Zheng, HY; Liu, LJ; Wang, ZY				Deng, Hao; Zhang, Xin-Tian; Wang, Mo-Lin; Zheng, Hong-Yan; Liu, Li-Jiang; Wang, Zhao-Yi			ER-alpha 36-Mediated Rapid Estrogen Signaling Positively Regulates ER-Positive Breast Cancer Stem/Progenitor Cells	PLOS ONE			English	Article							MAMMARY STEM-CELLS; RECEPTOR-ALPHA; EXPRESSION; VARIANT; GLAND; GATA-3; POPULATION; RESISTANCE; DIFFERENTIATION; IDENTIFICATION	The breast cancer stem cells (BCSC) play important roles in breast cancer occurrence, recurrence and metastasis. However, the role of estrogen signaling, a signaling pathway important in development and progression of breast cancer, in regulation of BCSC has not been well established. Previously, we identified and cloned a variant of estrogen receptor alpha, ER-alpha 36, with a molecular weight of 36 kDa. ER-alpha 36 lacks both transactivation domains AF-1 and AF-2 of the 66 kDa full-length ER-alpha (ER-alpha 66) and mediates rapid estrogen signaling to promote proliferation of breast cancer cells. In this study, we aim to investigate the function and the underlying mechanism of ER-alpha 36-mediated rapid estrogen signaling in growth regulation of the ER-positive breast cancer stem/progenitor cells. ER-positive breast cancer cells MCF7 and T47D as well as the variants with different levels of ER-alpha 36 expression were used. The effects of estrogen on BCSC's abilities of growth, self-renewal, differentiation and tumor-seeding were examined using tumorsphere formation, flow cytometry, indirect immunofluorence staining and in vivo xenograft assays. The underlying mechanisms were also studied with Western-blot analysis. We found that 17-beta-estradiol (E2 beta) treatment increased the population of ER-positive breast cancer stem/progenitor cells while failed to do so in the cells with knocked-down levels of ER-alpha 36 expression. Cells with forced expression of recombinant ER-alpha 36, however, responded strongly to E2 beta treatment by increasing growth in vitro and tumor-seeding efficiency in vivo. The rapid estrogen signaling via the AKT/GSK3 beta pathway is involved in estrogen-stimulated growth of ER-positive breast cancer stem/progenitor cells. We concluded that ER-alpha 36-mediated rapid estrogen signaling plays an important role in regulation and maintenance of ER-positive breast cancer stem/progenitor cells.	[Deng, Hao; Zhang, Xin-Tian; Wang, Mo-Lin; Wang, Zhao-Yi] Creighton Univ, Sch Med, Dept Med Microbiol, Omaha, NE 68178 USA; [Deng, Hao; Zhang, Xin-Tian; Wang, Mo-Lin; Wang, Zhao-Yi] Creighton Univ, Sch Med, Dept Immunol, Omaha, NE 68178 USA; [Deng, Hao; Zheng, Hong-Yan; Liu, Li-Jiang] Jianghan Univ, Jiangda Pathol Ctr, Wuhan, Hubei, Peoples R China; [Wang, Mo-Lin] Shandong Univ, Sch Med, Inst Med Genet, Jinan 250100, Shandong, Peoples R China	Creighton University; Creighton University; Jianghan University; Shandong University	Wang, ZY (corresponding author), Creighton Univ, Sch Med, Dept Med Microbiol, Omaha, NE 68178 USA.	zywang@creighton.edu			Nebraska Tobacco Settlement Biomedical Research Program [LB-606 (Stem Cell 2011-03), LB595]; Department of Defense [DAMD 11-1-0497]	Nebraska Tobacco Settlement Biomedical Research Program; Department of Defense(United States Department of Defense)	This work was supported by the Nebraska Tobacco Settlement Biomedical Research Program Awards LB-606 (Stem Cell 2011-03) and LB595, and Department of Defense grant DAMD 11-1-0497. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ao A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018810; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Asselin-Labat ML, 2006, J NATL CANCER I, V98, P1011, DOI 10.1093/jnci/djj267; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Bocchinfuso WP, 1997, J MAMMARY GLAND BIOL, V2, P323, DOI 10.1023/A:1026339111278; Boman BM, 2007, CLIN PHARMACOL THER, V81, P893, DOI 10.1038/sj.clpt.6100202; Cariati M, 2008, INT J CANCER, V122, P298, DOI 10.1002/ijc.23103; Charafe-Jauffret E, 2008, PATHOBIOLOGY, V75, P75, DOI 10.1159/000123845; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Clarke RB, 2005, DEV BIOL, V277, P443, DOI 10.1016/j.ydbio.2004.07.044; Clarke RB, 2003, CELL PROLIFERAT, V36, P45, DOI 10.1046/j.1365-2184.36.s.1.5.x; Dingli D, 2007, PLOS COMPUT BIOL, V3, P482, DOI 10.1371/journal.pcbi.0030053; Dontu G, 2004, TRENDS ENDOCRIN MET, V15, P193, DOI 10.1016/j.tem.2004.05.011; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; Fillmore CM, 2010, P NATL ACAD SCI USA, V107, P21737, DOI 10.1073/pnas.1007863107; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Han JS, 2009, INT J ONCOL, V34, P1449, DOI 10.3892/ijo_00000273; Kang LG, 2011, J STEROID BIOCHEM, V127, P262, DOI 10.1016/j.jsbmb.2011.08.011; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Lacroix M, 2004, MOL CELL ENDOCRINOL, V219, P1, DOI 10.1016/j.mce.2004.02.021; Lee LMJ, 2008, ANTICANCER RES, V28, P479; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Lin SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009013; Mallepell S, 2006, P NATL ACAD SCI USA, V103, P2196, DOI 10.1073/pnas.0510974103; Morimoto K, 2009, CANCER SCI, V100, P1062, DOI 10.1111/j.1349-7006.2009.01151.x; Oliveira LR, 2010, HISTOL HISTOPATHOL, V25, P371, DOI 10.14670/HH-25.371; Pelekanou V, 2012, STEROIDS, V77, P928, DOI 10.1016/j.steroids.2011.12.016; Shi L, 2009, J CLIN ONCOL, V27, P3423, DOI 10.1200/JCO.2008.17.2254; Sleeman KE, 2007, J CELL BIOL, V176, P19, DOI 10.1083/jcb.200604065; Voduc D, 2008, CANCER EPIDEM BIOMAR, V17, P365, DOI 10.1158/1055-9965.EPI-06-1090; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Zhang XT, 2011, ONCOGENE, V30, P770, DOI 10.1038/onc.2010.458; Zhang XT, 2013, ENDOCRINOLOGY, V154, P1990, DOI 10.1210/en.2013-1116	41	52	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88034	10.1371/journal.pone.0088034	http://dx.doi.org/10.1371/journal.pone.0088034			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558373	gold, Green Submitted, Green Published			2022-12-27	WOS:000331706700019
J	Sun, YG; Myers, CJ; Dicker, AP; Lu, B				Sun, Yunguang; Myers, Carey Jeanne; Dicker, Adam Paul; Lu, Bo			A Novel Radiation-Induced p53 Mutation Is Not Implicated in Radiation Resistance via a Dominant-Negative Effect	PLOS ONE			English	Article							CELL LUNG-CANCER; WILD-TYPE P53; TUMOR-SUPPRESSOR GENE; NON-HODGKINS-LYMPHOMA; DNA-BINDING DOMAIN; NF-KAPPA-B; MUTANT P53; PROSTATE-CANCER; 2ND CANCERS; TRANSCRIPTIONAL ACTIVATION	Understanding the mutations that confer radiation resistance is crucial to developing mechanisms to subvert this resistance. Here we describe the creation of a radiation resistant cell line and characterization of a novel p53 mutation. Treatment with 20 Gy radiation was used to induce mutations in the H460 lung cancer cell line; radiation resistance was confirmed by clonogenic assay. Limited sequencing was performed on the resistant cells created and compared to the parent cell line, leading to the identification of a novel mutation (del) at the end of the DNA binding domain of p53. Levels of p53, phosphop-53, p21, total caspase 3 and cleaved caspase 3 in radiation resistant cells and the radiation susceptible (parent) line were compared, all of which were found to be similar. These patterns held true after analysis of p53 overexpression in H460 cells; however, H1299 cells transfected with mutant p53 did not express p21, whereas those given WT p53 produced a significant amount, as expected. A luciferase assay demonstrated the inability of mutant p53 to bind its consensus elements. An MTS assay using H460 and H1299 cells transfected with WT or mutant p53 showed that the novel mutation did not improve cell survival. In summary, functional characterization of a radiation-induced p53 mutation in the H460 lung cancer cell line does not implicate it in the development of radiation resistance.	[Sun, Yunguang; Dicker, Adam Paul; Lu, Bo] Thomas Jefferson Univ, Dept Radiat Oncol, Philadelphia, PA 19107 USA; [Myers, Carey Jeanne] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Lu, B (corresponding author), Thomas Jefferson Univ, Dept Radiat Oncol, Philadelphia, PA 19107 USA.	bo.lu@jeffersonhospital.org		Dicker, Adam/0000-0003-0733-3337; Sun, Yunguang/0000-0003-4004-9514	Pennsylvania CURE grant [4100054872]; Kimmel Cancer Center Core Grant [-5 P30 CA056036-14]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER	Pennsylvania CURE grant; Kimmel Cancer Center Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was funded by Pennsylvania CURE grant 4100054872 and Kimmel Cancer Center Core Grant -5 P30 CA056036-14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arizti P, 2000, MOL CELL BIOL, V20, P7450, DOI 10.1128/MCB.20.20.7450-7459.2000; Armstrong MB, 2006, NEOPLASIA, V8, P967, DOI 10.1593/neo.06574; Aylon Y, 2011, CURR OPIN GENET DEV, V21, P86, DOI 10.1016/j.gde.2010.10.002; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BALAGURUMOORTHY P, 1995, P NATL ACAD SCI USA, V92, P8591, DOI 10.1073/pnas.92.19.8591; BARGONETTI J, 1993, GENE DEV, V7, P2565, DOI 10.1101/gad.7.12b.2565; Benchimol S, 2001, CELL DEATH DIFFER; Berkson RG, 2005, INT J CANCER, V115, P701, DOI 10.1002/ijc.20968; Blagosklonny MV, 2000, FASEB J, V14, P1901, DOI 10.1096/fj.99-1078rev; Bostrom PJ, 2007, EUR UROL, V52, P973, DOI 10.1016/j.eururo.2007.07.002; BRACHMAN DG, 1991, CANCER RES, V51, P6393; Brachmann RK, 1996, P NATL ACAD SCI USA, V93, P4091, DOI 10.1073/pnas.93.9.4091; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; Brown LM, 2007, BREAST CANCER RES TR, V106, P439, DOI 10.1007/s10549-007-9509-8; Chaturvedi AK, 2007, JNCI-J NATL CANCER I, V99, P1634, DOI 10.1093/jnci/djm201; Chene P, 1998, J MOL BIOL, V281, P205, DOI 10.1006/jmbi.1998.1897; Chene P, 1999, J MOL BIOL, V286, P1269, DOI 10.1006/jmbi.1999.2563; Chene P, 2000, BIOTECHNIQUES, V28, P240; Chene P, 2001, ONCOGENE, V20, P2611, DOI 10.1038/sj.onc.1204373; Chene P, 1997, J MOL BIOL, V273, P873, DOI 10.1006/jmbi.1997.1360; CHIBA I, 1990, ONCOGENE, V5, P1603; De Luca P, 2013, PROSTATE CANCER P D, V16, P233, DOI 10.1038/pcan.2013.12; de Vries A, 2002, P NATL ACAD SCI USA, V99, P2948, DOI 10.1073/pnas.052713099; DeBenedetti VMG, 1996, CANCER EPIDEM BIOMAR, V5, P93; DELEO AB, 1979, P NATL ACAD SCI USA, V76, P2420, DOI 10.1073/pnas.76.5.2420; Elbendary AA, 1996, CLIN CANCER RES, V2, P1571; Ettinger DS, 2013, J NATL COMPR CANC NE, V11, P645, DOI 10.6004/jnccn.2013.0084; FEARON ER, 1987, SCIENCE, V238, P193, DOI 10.1126/science.2889267; Fogelfeld L, 1996, J CLIN ENDOCR METAB, V81, P3039, DOI 10.1210/jc.81.8.3039; Gao WM, 2003, LUNG CANCER-J IASLC, V40, P141, DOI 10.1016/S0169-5002(03)00035-7; Gasco M, 2002, BREAST CANCER RES, V4, P70, DOI 10.1186/bcr426; Giglia-Mari G, 2003, HUM MUTAT, V21, P217, DOI 10.1002/humu.10179; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Hainaut P, 2000, ADV CANCER RES, V77, P81; Hall EJ, 2003, INT J RADIAT ONCOL, V56, P83, DOI 10.1016/S0360-3016(03)00073-7; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Hemminki K, 2008, J CLIN ONCOL, V26, P1850, DOI 10.1200/JCO.2007.14.6068; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Huang C, 2012, PROTEIN PHOSPHORYLAT; Huang S, 2011, CANCER RES, V71, P7071, DOI 10.1158/0008-5472.CAN-11-0128; IGGO R, 1990, LANCET, V335, P675, DOI 10.1016/0140-6736(90)90801-B; Jung IL, 2010, INT J MOL MED, V25, P517, DOI 10.3892/ijmm_00000372; Ko JL, 2000, INT J CANCER, V89, P265, DOI 10.1002/1097-0215(20000520)89:3<265::AID-IJC9>3.0.CO;2-N; Kozaki K, 2000, CANCER RES, V60, P2535; Kubbutat MHG, 1998, MOL CELL BIOL, V18, P5690, DOI 10.1128/MCB.18.10.5690; Kumar P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003027; Lee YS, 2010, INT J RADIAT ONCOL, V77, P858, DOI 10.1016/j.ijrobp.2009.12.076; Lehmann BD, 2012, J CLIN ONCOL, V30, P3648, DOI 10.1200/JCO.2012.44.0412; Levine AJ, 1995, ANN NY ACAD SCI, V768, P111, DOI 10.1111/j.1749-6632.1995.tb12115.x; Levine AJ, 2008, BLOOD, V112, P2997, DOI 10.1182/blood-2008-07-167718; Lubin DJ, 2010, J MOL BIOL, V395, P705, DOI 10.1016/j.jmb.2009.11.013; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Maki CG, 1999, J BIOL CHEM, V274, P16531, DOI 10.1074/jbc.274.23.16531; McLure KG, 1998, EMBO J, V17, P3342, DOI 10.1093/emboj/17.12.3342; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; Mudie NY, 2006, J CLIN ONCOL, V24, P1568, DOI 10.1200/JCO.2005.04.2200; Murphy SH, 2011, P NATL ACAD SCI USA, V108, P17117, DOI 10.1073/pnas.1114420108; Nagai W, 2012, BIOCHEM BIOPH RES CO, V421, P15, DOI 10.1016/j.bbrc.2012.03.091; NAKAZAWA H, 1994, P NATL ACAD SCI USA, V91, P360, DOI 10.1073/pnas.91.1.360; Nieder AM, 2008, J UROLOGY, V180, P2005, DOI 10.1016/j.juro.2008.07.038; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; PAVLETICH NP, 1993, GENE DEV, V7, P2556, DOI 10.1101/gad.7.12b.2556; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pinto EM, 2011, PITUITARY, V14, P400, DOI 10.1007/s11102-009-0194-y; Richiardi L, 2007, INT J CANCER, V120, P623, DOI 10.1002/ijc.22345; Rivlin Noa, 2011, Genes Cancer, V2, P466, DOI 10.1177/1947601911408889; RODRIGUES NR, 1990, P NATL ACAD SCI USA, V87, P7555, DOI 10.1073/pnas.87.19.7555; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; SANG BC, 1994, ONCOGENE, V9, P853; Schuler M, 2001, BIOCHEM SOC T, V29, P684, DOI 10.1042/0300-5127:0290684; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; SHAULIAN E, 1993, EMBO J, V12, P2789, DOI 10.1002/j.1460-2075.1993.tb05940.x; Shen Y, 2001, ADV CANCER RES, V82, P55, DOI 10.1016/S0065-230X(01)82002-9; Shi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033358; Shieh SY, 2000, GENE DEV, V14, P289; Soussi T, 2000, HUM MUTAT, V15, P105, DOI 10.1002/(SICI)1098-1004(200001)15:1<105::AID-HUMU19>3.0.CO;2-G; STENGER JE, 1994, EMBO J, V13, P6011, DOI 10.1002/j.1460-2075.1994.tb06947.x; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; Travis LB, 2005, JNCI-J NATL CANCER I, V97, P1354, DOI 10.1093/jnci/dji278; Tward JD, 2006, CANCER-AM CANCER SOC, V107, P108, DOI 10.1002/cncr.21971; Valenzuela MT, 2002, ONCOGENE, V21, P1108, DOI 10.1038/sj.onc.1205169; van Baardwijk A, 2008, INT J RADIAT ONCOL, V71, P1103, DOI 10.1016/j.ijrobp.2007.11.028; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; WANG X, 1995, CANCER EPIDEM BIOMAR, V4, P543; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; Xu XL, 2001, NAT GENET, V28, P266, DOI 10.1038/90108; Zhang H, 1991, ONCOGENE, V16, P1713	88	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e87492	10.1371/journal.pone.0087492	http://dx.doi.org/10.1371/journal.pone.0087492			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558369	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700015
J	Wack, DS; Polak, P; Furuyama, J; Burkard, RF				Wack, David S.; Polak, Paul; Furuyama, Jon; Burkard, Robert F.			Masking Level Differences - A Diffusion Tensor Imaging and Functional MRI Study	PLOS ONE			English	Article							AUDITORY-CORTEX; INFERIOR COLLICULUS; NOISE; RESPONSES; THALAMUS; LANGUAGE; HUMANS; SYSTEM; PITCH; TONES	In our previous study we investigated Masking Level Differences (MLD) using functional Magnetic Resonance Imaging (fMRI), but were unable to confirm neural correlations for the MLD within the auditory cortex and inferior colliculus. Here we have duplicated conditions from our previous study, but have included more participants and changed the study site to a new location with a newer scanner and presentation system. Additionally, Diffusion Tensor Imaging (DTI) is included to allow investigation of fiber tracts that may be involved with MLDs. Twenty participants were included and underwent audiometric testing and MRI scanning. The current study revealed regions of increased and decreased activity within the auditory cortex when comparing the combined noise and signal of the dichotic MLD stimuli (N0S pi and N pi S0) with N0S0. Furthermore, we found evidence of inferior colliculus involvement. Our DTI findings show strong correlations between DTI measures within the brainstem and signal detection threshold levels. Patterns of correlation when the signal was presented only to the right ear showed an extensive network in the left hemisphere; however, the opposite was not true for the signal presented only to the left ear. Our current study was able to confirm what we had previously hypothesized using fMRI, while extending our investigation of MLDs to include the characteristics of connecting neural pathways.	[Wack, David S.] SUNY Buffalo, Dept Nucl Med, Buffalo, NY 14260 USA; [Polak, Paul] SUNY Buffalo, Buffalo Neuroimaging Anal Ctr, Dept Neurol, Buffalo, NY 14260 USA; [Furuyama, Jon] Toshiba Amer Med Syst Inc, Tustin, CA USA; [Burkard, Robert F.] SUNY Buffalo, Dept Rehabil Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Toshiba Corporation; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Wack, DS (corresponding author), SUNY Buffalo, Dept Nucl Med, Buffalo, NY 14260 USA.	dswack@buffalo.edu		Polak, Paul/0000-0002-7719-7572	Toshiba America Medical Systems	Toshiba America Medical Systems	This project received funding from Toshiba America Medical Systems. Dr. Furuyama is an employee of Toshiba America Medical Systems. The scanner used was a Toshiba scanner. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ashburner J., 1997, CLIN MRI DEV MR, V7, P26; Badgaiyan RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028075; Barker D, 2012, CEREB CORTEX, V22, P745, DOI 10.1093/cercor/bhr065; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Budd TW, 2003, NEUROIMAGE, V20, P1783, DOI 10.1016/j.neuroimage.2003.07.026; Buxton R. B., 2009, INTRO FUNCTIONAL MAG; Chait M, 2006, CEREB CORTEX, V16, P835, DOI 10.1093/cercor/bhj027; Crippa Alessandro, 2010, Open Neuroimag J, V4, P16, DOI 10.2174/1874440001004010016; Edmister WB, 1999, HUM BRAIN MAPP, V7, P89, DOI 10.1002/(SICI)1097-0193(1999)7:2<89::AID-HBM2>3.3.CO;2-E; Ernst SMA, 2008, NEUROIMAGE, V43, P321, DOI 10.1016/j.neuroimage.2008.07.046; Ernst SMA, 2010, NEUROIMAGE, V49, P835, DOI 10.1016/j.neuroimage.2009.07.014; Fabri M, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/251308; Fowler C G, 1995, J Am Acad Audiol, V6, P399; Fowler C G, 1996, J Am Acad Audiol, V7, P23; FOWLER CG, 1992, J SPEECH HEAR RES, V35, P216, DOI 10.1044/jshr.3501.216; Friston K., 2007, STAT PARAMETRIC MAPP, DOI [10.1016/B978-0-12-372560-8.X5000-1, DOI 10.1016/B978-0-12-372560-8.X5000-1]; Guo YQ, 2003, HEARING RES, V178, P12, DOI 10.1016/S0378-5955(03)00023-6; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Hall DA, 2007, NEUROREPORT, V18, P323, DOI 10.1097/WNR.0b013e32802b70ce; Hall DA, 2009, CEREB CORTEX, V19, P576, DOI 10.1093/cercor/bhn108; Haruno M, 2006, J NEUROPHYSIOL, V95, P948, DOI 10.1152/jn.00382.2005; HIRSH IJ, 1948, J ACOUST SOC AM, V20, P536, DOI 10.1121/1.1906407; Huettel S. A., 2004, FUNCTIONAL MAGNETIC; HUGDAHL K, 1990, BRAIN LANG, V39, P1, DOI 10.1016/0093-934X(90)90001-W; Husain FT, 2011, BRAIN RES, V1369, P74, DOI 10.1016/j.brainres.2010.10.095; Jiang D, 1997, J NEUROPHYSIOL, V77, P3085, DOI 10.1152/jn.1997.77.6.3085; Karbe H, 1998, J CEREBR BLOOD F MET, V18, P1157, DOI 10.1097/00004647-199810000-00012; Katsunuma A, 2002, MAGN RESON MATER PHY, V13, P139, DOI 10.1016/S1352-8661(01)00142-9; Khalfa S, 2001, NEUROSCIENCE, V104, P347, DOI 10.1016/S0306-4522(01)00072-0; Kim S, 2006, SPEECH COMMUN, V48, P855, DOI 10.1016/j.specom.2006.03.004; Kimura D., 1967, CORTEX, V3, P163, DOI DOI 10.1016/S0010-9452(67)80010-8; Knaus TA, 2010, BRAIN LANG, V112, P113, DOI 10.1016/j.bandl.2009.11.005; Leon A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036203; LICKLIDER JCR, 1948, J ACOUST SOC AM, V20, P150, DOI 10.1121/1.1906358; Lin Y, 2008, J MAGN RESON IMAGING, V28, P598, DOI 10.1002/jmri.21464; Lockwood AH, 1999, CEREB CORTEX, V9, P65, DOI 10.1093/cercor/9.1.65; Luo WL, 2003, NEUROIMAGE, V19, P1014, DOI 10.1016/S1053-8119(03)00149-6; Mai J.K., 1997, ATLAS HUMAN BRAIN; Musiek FE, 2011, BRAIN COGNITION, V76, P225, DOI 10.1016/j.bandc.2011.03.011; OJEMANN GA, 1975, BRAIN LANG, V2, P101, DOI 10.1016/S0093-934X(75)80057-5; Palmer AR, 2000, J NEUROPHYSIOL, V84, P844, DOI 10.1152/jn.2000.84.2.844; Rivier F, 1997, NEUROIMAGE, V6, P288, DOI 10.1006/nimg.1997.0304; Schmithorst VJ, 2013, NEUROIMAGE CLIN; Seok JH, 2007, PSYCHIAT RES-NEUROIM, V156, P93, DOI 10.1016/j.pscychresns.2007.02.002; SHANKWEILER D, 1967, Q J EXP PSYCHOL, V19, P59, DOI 10.1080/14640746708400069; Smalt CJ, 2012, FUNCTIONAL MAGNETIC; SOKOLOFF L, 1977, J NEUROCHEM, V29, P13, DOI 10.1111/j.1471-4159.1977.tb03919.x; Stracke H, 2009, CEREB CORTEX, V19, P1440, DOI 10.1093/cercor/bhn183; SUGISHITA M, 1995, BRAIN, V118, P417, DOI 10.1093/brain/118.2.417; Tettamanti M, 2002, J NEUROPHYSIOL, V88, P1051, DOI 10.1152/jn.2002.88.2.1051; Wack DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041263; Wack DS, 2010, LOCALIZATION BINAURA; Westerhausen R, 2009, CEREB CORTEX, V19, P1322, DOI 10.1093/cercor/bhn173; Wong WYS, 2004, EAR HEARING, V25, P57, DOI 10.1097/01.AUD.0000111257.11898.64	54	8	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88466	10.1371/journal.pone.0088466	http://dx.doi.org/10.1371/journal.pone.0088466			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558392	Green Published, gold			2022-12-27	WOS:000331706700038
J	Webb, LE; Jensen, MB; Engel, B; van Reenen, CG; Gerrits, WJJ; de Boer, IJM; Bokkers, EAM				Webb, Laura E.; Jensen, Margit Bak; Engel, Bas; van Reenen, Cornelis G.; Gerrits, Walter J. J.; de Boer, Imke J. M.; Bokkers, Eddie A. M.			Chopped or Long Roughage: What Do Calves Prefer? Using Cross Point Analysis of Double Demand Functions	PLOS ONE			English	Article							DIFFERENT ROOTING MATERIALS; AFFECTING DIET SELECTION; VEAL CALVES; RUMEN DEVELOPMENT; CHEWING ACTIVITY; PARTICLE LENGTH; FOOD PREFERENCE; ANIMAL-WELFARE; FEED; BEHAVIOR	The present study aimed to quantify calves'(Bos taurus) preference for long versus chopped hay and straw, and hay versus straw, using cross point analysis of double demand functions, in a context where energy intake was not a limiting factor. Nine calves, fed milk replacer and concentrate, were trained to work for roughage rewards from two simultaneously available panels. The cost (number of muzzle presses) required on the panels varied in each session (left panel/right panel): 7/35, 14/28, 21/21, 28/14, 35/7. Demand functions were estimated from the proportion of rewards achieved on one panel relative to the total number of rewards achieved in one session. Cross points (cp) were calculated as the cost at which an equal number of rewards was achieved from both panels. The deviation of the cp from the midpoint (here 21) indicates the strength of the preference. Calves showed a preference for long versus chopped hay (cp = 14.5; P = 0.004), and for hay versus straw (cp = 38.9; P = 0.004), both of which improve rumen function. Long hay may stimulate chewing more than chopped hay, and the preference for hay versus straw could be related to hedonic characteristics. No preference was found for chopped versus long straw (cp = 20.8; P = 0.910). These results could be used to improve the welfare of calves in production systems; for example, in systems where calves are fed hay along with high energy concentrate, providing long hay instead of chopped could promote roughage intake, rumen development, and rumination.	[Webb, Laura E.; de Boer, Imke J. M.; Bokkers, Eddie A. M.] Wageningen Univ, Anim Prod Syst Grp, NL-6700 AP Wageningen, Netherlands; [Jensen, Margit Bak] Aarhus Univ, Dept Anim Sci, Tjele, Denmark; [Engel, Bas] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [van Reenen, Cornelis G.] Univ Wageningen & Res Ctr, Lelystad, Netherlands; [Gerrits, Walter J. J.] Wageningen Univ, Anim Nutr Grp, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Aarhus University; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Webb, LE (corresponding author), Wageningen Univ, Anim Prod Syst Grp, NL-6700 AP Wageningen, Netherlands.	laura.webb@wur.nl	Bokkers, Eddie/A-9073-2015; de Boer, Imke/P-7107-2014	Bokkers, Eddie/0000-0002-2000-7600; de Boer, Imke/0000-0002-0675-7528; , Laura/0000-0002-4943-4294; Jensen, Margit Bak/0000-0001-7982-582X	Division for Earth and Life Sciences (ALW) of the Netherlands Organisation for Scientific Research (NWO); Product Board Animal Feed; UFAW	Division for Earth and Life Sciences (ALW) of the Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Product Board Animal Feed; UFAW	This work was supported by the Division for Earth and Life Sciences (ALW) of the Netherlands Organisation for Scientific Research (NWO), and the Product Board Animal Feed. Travelling between The Netherlands and Denmark was supported by UFAW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saiady MY, 2010, ASIAN AUSTRAL J ANIM, V23, P475, DOI 10.5713/ajas.2010.90364; Bach A, 2013, J DAIRY SCI, V96, P4634, DOI 10.3168/jds.2012-6196; Berends H, 2012, J DAIRY SCI, V95, P3190, DOI 10.3168/jds.2011-4643; Breukink HJ, 1991, EAAP PUBLICATION, V52, P118; Brscic M, 2011, J DAIRY SCI, V94, P853, DOI 10.3168/jds.2010-3480; COOPER SDB, 1995, BRIT J NUTR, V74, P39, DOI 10.1079/BJN19950105; Cooper SDB, 1996, J ANIM SCI, V74, P1240; DEBOEVER JL, 1990, ANIM FEED SCI TECH, V27, P281, DOI 10.1016/0377-8401(90)90143-V; FORKMAN B, 1991, BEHAVIOUR, V117, P243, DOI 10.1163/156853991X00553; Gonzalez LA, 2012, ANIM FEED SCI TECH, V172, P66, DOI 10.1016/j.anifeedsci.2011.12.009; Heinrichs J, 2005, ADV DAIRY TECHNOL, V17, P179; Holm L, 2007, APPL ANIM BEHAV SCI, V107, P133, DOI 10.1016/j.applanim.2006.09.021; HUGHES BO, 1988, ANIM BEHAV, V36, P1696, DOI 10.1016/S0003-3472(88)80110-6; HURSH SR, 1993, DRUG ALCOHOL DEPEN, V33, P165, DOI 10.1016/0376-8716(93)90058-X; Inglis IR, 1997, ANIM BEHAV, V53, P1171, DOI 10.1006/anbe.1996.0320; Inglis IR, 2000, BEHAVIOUR, V137, P1567, DOI 10.1163/156853900502727; Inglis IR, 2001, ANIM BEHAV, V62, P543, DOI 10.1006/anbe.2001.1780; Jensen MB, 2007, APPL ANIM BEHAV SCI, V108, P31, DOI 10.1016/j.applanim.2006.10.014; Kammes KL, 2012, J DAIRY SCI, V95, P807, DOI 10.3168/jds.2011-4588; KENNEY PA, 1984, AUST J AGR RES, V35, P831, DOI 10.1071/AR9840831; KENNEY PA, 1984, AUST J AGR RES, V35, P551, DOI 10.1071/AR9840551; Krause KM, 2002, J DAIRY SCI, V85, P1947, DOI 10.3168/jds.S0022-0302(02)74271-9; Kyriazakis I, 1998, BRIT J NUTR, V79, P55, DOI 10.1079/BJN19980009; Mason GJ, 2004, ANIM WELFARE, V13, pS57; MATTHEWS LR, 1979, J EXP ANAL BEHAV, V32, P245, DOI 10.1901/jeab.1979.32-245; Mattiello S, 2002, J ANIM SCI, V80, P367; MCADIE TM, 1993, APPL ANIM BEHAV SCI, V37, P223, DOI 10.1016/0168-1591(93)90113-4; McCullagh P, 1989, GEN LINEAR MODELS; Morisse JP, 1999, ANIM WELFARE, V8, P43; OSBORNE SR, 1977, ANIM LEARN BEHAV, V5, P221, DOI 10.3758/BF03209232; Pedersen LJ, 2005, APPL ANIM BEHAV SCI, V94, P31, DOI 10.1016/j.applanim.2004.11.023; PROVENZA FD, 1995, J RANGE MANAGE, V48, P2, DOI 10.2307/4002498; Provenza FD, 1996, J ANIM SCI, V74, P2355; Redbo I, 1997, APPL ANIM BEHAV SCI, V53, P193, DOI 10.1016/S0168-1591(96)01145-8; REDBO I, 1990, APPL ANIM BEHAV SCI, V26, P57, DOI 10.1016/0168-1591(90)90087-T; SAS Institute, 2014, STAT AN SYST 9 2; Sorensen DB, 2004, ANIM BEHAV, V68, P949, DOI 10.1016/j.anbehav.2003.12.017; Sorensen DB, 2001, APPL ANIM BEHAV SCI, V74, P281, DOI 10.1016/S0168-1591(01)00166-6; Suarez BJ, 2007, J DAIRY SCI, V90, P2390, DOI 10.3168/jds.2006-524; Suarez BJ, 2006, J DAIRY SCI, V89, P4376, DOI 10.3168/jds.S0022-0302(06)72484-5; Veissier I, 1998, APPL ANIM BEHAV SCI, V57, P35, DOI 10.1016/S0168-1591(97)00108-1; Vicari T, 2008, DOMEST ANIM ENDOCRIN, V34, P74, DOI 10.1016/j.domaniend.2006.11.002; VSN International, 2012, GENSTAT WIND; Webb LE, 2013, J DAIRY SCI, V96, P7765, DOI 10.3168/jds.2012-6135; Webb LE, 2012, APPL ANIM BEHAV SCI, V136, P108, DOI 10.1016/j.applanim.2011.12.004; WELCH JG, 1982, J ANIM SCI, V54, P885, DOI 10.2527/jas1982.544885x; Welfare Quality<(R)>, 2009, WELF QUAL ASS PROT C; Wilson JR, 1996, AUST J AGR RES, V47, P199, DOI 10.1071/AR9960199	48	18	18	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88778	10.1371/journal.pone.0088778	http://dx.doi.org/10.1371/journal.pone.0088778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558426	gold, Green Submitted, Green Published			2022-12-27	WOS:000331706700072
J	Andreoli, SB; dos Santos, MM; Quintana, MI; Ribeiro, WS; Blay, SL; Taborda, JGV; Mari, JD				Andreoli, Sergio Baxter; dos Santos, Maira Mendes; Quintana, Maria Ines; Ribeiro, Wagner Silva; Blay, Sergio Luiz; Vernet Taborda, Jose Geraldo; Mari, Jair de Jesus			Prevalence of Mental Disorders among Prisoners in the State of Sao Paulo, Brazil	PLOS ONE			English	Article							PSYCHIATRIC MORBIDITY; ILLNESS; DIAGNOSIS; VERSION	Objective: To determine the prevalence of psychiatric disorders in the prison population in the State of Sao Paulo, Brazil. Methods: Through stratified random sampling, 1.192 men and 617 women prisoners were evaluated for the presence of psychiatric disorders by the Composite International Diagnostic Interview, 2.1 version, according to definitions and criteria of International Classification of Diseases (ICD-10). The prevalence estimates of mental disorders and their respective 95% confidence intervals were calculated and adjusted for sample design through complex sample analysis. Results: Lifetime and 12-month prevalence rates differed between genders. Lifetime and 12-month prevalence of any mental disorder was, respectively, 68.9% and 39.2% among women, and 56.1% and 22.1% among men. Lifetime and 12-month prevalence of anxious-phobic disorders was, respectively, 50% and 27.7% among women and 35.3% and 13.6% among men, of affective disorders was 40% and 21% among women and 20.8% and 9.9% among men, and of drug-related disorders was 25.2% and 1.6% among women and 26.5% and 1.3% among men. For severe mental disorders (psychotic, bipolar disorders, and severe depression), the lifetime and 12-month prevalence rates were, respectively, 25.8% and 14.7% among women, and 12.3% and 6.3% among men. Conclusions: This is the first large-scale epidemiological study performed with the prison population in Brazil, revealed high rates of psychiatric disorders among men and women. Many similarities, as well as some differences, were found between our results and those of studies conducted in other countries. The differences observed are more likely due to the peculiarities of the prison systems in each country than to the diagnostic criteria adopted in the studies. This fact reinforces the importance of conducting such studies as part of planning and development of appropriate policies for the particular mental health needs of specific prison populations.	[Andreoli, Sergio Baxter; dos Santos, Maira Mendes; Quintana, Maria Ines; Ribeiro, Wagner Silva; Blay, Sergio Luiz; Mari, Jair de Jesus] Univ Fed Sao Paulo, Dept Psychiat, Sao Paulo, Brazil; [Andreoli, Sergio Baxter] Santos Catholic Univ, Santos, Brazil; [Vernet Taborda, Jose Geraldo] Porto Alegre Sci Hlth Fed Univ, Dept Internal Med, Porto Alegre, RS, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Catolica de Santos	Andreoli, SB (corresponding author), Univ Fed Sao Paulo, Dept Psychiat, Sao Paulo, Brazil.	andreoli@unifesp.br	de Jesus Mari, Jair/A-7309-2008; Andreoli, Sergio Baxter/D-9568-2012; Andreoli, Sergio Baxter/M-7112-2019; Ribeiro, Wagner Silva/O-2927-2018; Quintana, Maria Ines/F-6320-2012	de Jesus Mari, Jair/0000-0002-5403-0112; Andreoli, Sergio Baxter/0000-0002-1976-0881; Andreoli, Sergio Baxter/0000-0002-1976-0881; Ribeiro, Wagner Silva/0000-0001-6735-3861; Quintana, Maria Ines/0000-0002-3808-8189	Brazilian Ministries of Health and of Science and Technology, through CNPq [554553/200X-8]; Secretariat of Prison Administration	Brazilian Ministries of Health and of Science and Technology, through CNPq; Secretariat of Prison Administration	This study received funding from the Brazilian Ministries of Health and of Science and Technology, through CNPq research announcement 07/2005, process 554553/200X-8, as well as from the Secretariat of Prison Administration, which enabled the access to prison inmates and provided technical support in the design and conduct of research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida N, 1997, BRIT J PSYCHIAT, V171, P524, DOI 10.1192/bjp.171.6.524; Andersen HS, 2004, ACTA PSYCHIAT SCAND, V110, P4, DOI 10.1111/j.1600-0447.2004.00436_1.x; Andrade LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031879; Assadi SM, 2006, BRIT J PSYCHIAT, V188, P159, DOI 10.1192/bjp.188.2.159; Biondi, 2010, JUNTO MISTURADO ETNO; Birmingham L, 2003, ADV PSYCHIAT TREATME, V9, P191, DOI DOI 10.1192/APT.9.3.191; Blaauw E, 2000, INT J LAW PSYCHIAT, V23, P649, DOI 10.1016/S0160-2527(00)00050-9; Brink J, 2005, CURR OPIN PSYCHIATR, V18, P536, DOI 10.1097/01.yco.0000179493.15688.78; Brooke D, 1996, BRIT MED J, V313, P1524, DOI 10.1136/bmj.313.7071.1524; Butler T, 2006, AUST NZ J PSYCHIAT, V40, P272, DOI 10.1111/j.1440-1614.2006.01785.x; Constantine R, 2010, PSYCHIAT SERV, V61, P451, DOI 10.1176/appi.ps.61.5.451; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Diamond PM, 2001, ADM POLICY MENT HLTH, V29, P21, DOI 10.1023/A:1013164814732; Falissard B, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-33; Fazel S., 2012, British Journal of Psychiatry, V200, P364, DOI 10.1192/bjp.bp.111.096370; Garbayo J, 2008, J BRAS PSIQUIATR, V57; Lafortune D, 2010, INT J LAW PSYCHIAT, V33, P94, DOI 10.1016/j.ijlp.2009.12.004; Levy P, 1999, SAMPLING POPULATIONS; Lukasiewicz M, 2007, SUBST ABUSE TREAT PR, V2, DOI 10.1186/1747-597X-2-1; Moraes Paulo Augusto Costivelli de, 2006, J. bras. psiquiatr., V55, P50, DOI 10.1590/S0047-20852006000100007; Palmer EJ, 2010, INT J LAW PSYCHIAT, V33, P89, DOI 10.1016/j.ijlp.2009.12.007; Plugge E, 2009, ADDICTION, V104, P215, DOI 10.1111/j.1360-0443.2008.02419.x; Ponde MP, 2011, J FORENSIC SCI, V56, P679, DOI 10.1111/j.1556-4029.2010.01691.x; Quintana MI, 2007, REV BRAS PSIQUIATR, V29, P18, DOI 10.1590/S1516-44462007000100007; Quintana MI, 2012, CAD SAUDE PUBLICA, V28, P1312, DOI 10.1590/S0102-311X2012000700009; Quintana MI, 2004, BRAZ J MED BIOL RES, V37, P1739, DOI 10.1590/S0100-879X2004001100020; Ribeiro WS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063545; Tye CS, 2006, AUST NZ J PSYCHIAT, V40, P266, DOI 10.1111/j.1440-1614.2006.01784.x; Vicens E, 2011, CRIM BEHAV MENT HEAL, V21, P321, DOI 10.1002/cbm.815; Way BB, 2008, PSYCHIAT SERV, V59, P1335, DOI 10.1176/ps.2008.59.11.1335; Zoccali R, 2008, INT J LAW PSYCHIAT, V31, P447, DOI 10.1016/j.ijlp.2008.08.004	31	39	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88836	10.1371/journal.pone.0088836	http://dx.doi.org/10.1371/journal.pone.0088836			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7IR	24551174	Green Published, Green Submitted, gold			2022-12-27	WOS:000331271500074
J	Deshpande, G; Willis, E; Chatterjee, S; Fernandez, R; Dias, K; Schedl, P				Deshpande, Girish; Willis, Elinor; Chatterjee, Sandip; Fernandez, Robert; Dias, Kristen; Schedl, Paul			BMP Signaling and the Maintenance of Primordial Germ Cell Identity in Drosophila Embryos	PLOS ONE			English	Article							STEM-CELLS; GENE-EXPRESSION; SEX DETERMINATION; MOUSE EMBRYO; OVARY; MIGRATION; NICHE; SPECIFICATION; EMBRYOGENESIS; MELANOGASTER	The specification of primordial germ cells (PGCs) and subsequent maintenance of germ-line identity in Drosophila embryos has long been thought to occur solely under the control of cell-autonomous factors deposited in the posterior pole plasm during oogenesis. However, here we document a novel role for somatic BMP signaling in the maintenance of PGC fate during the period leading up to embryonic gonad coalescence. We find that PGCs fail to maintain their germline identity when BMP signaling is compromised. They initiate but are unable to properly assemble the germline stem cell-specific organelle, the spectrosome, and they lose expression of the germline-specific gene Vasa. BMP signaling must, however, be finely tuned as there are deleterious consequences to PGCs when the pathway is excessively active. We show that one mechanism used to calibrate the effects of BMP signals is dependent on the Ubc9 homolog Lesswright (Lwr).	[Deshpande, Girish; Willis, Elinor; Chatterjee, Sandip; Fernandez, Robert; Dias, Kristen; Schedl, Paul] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Schedl, Paul] RAS, Inst Gene Biol, Moscow 117901, Russia	Princeton University; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences	Schedl, P (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	pschedl@princeton.edu		Fernandez, Robert/0000-0002-7187-3138	NIH [GM043432]; Gene Biology Institute by the Russian Federation Ministry of Education and Science [14.B25.31.0022]; BSF (US-Israel Binational Science Foundation) [2009439]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gene Biology Institute by the Russian Federation Ministry of Education and Science; BSF (US-Israel Binational Science Foundation)	The authors would like to acknowledge the support provided by NIH (GM043432), by a grant to the Gene Biology Institute by the Russian Federation Ministry of Education and Science (14.B25.31.0022) and by a grant from the BSF (US-Israel Binational Science Foundation) 2009439. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOYLE M, 1995, DEVELOPMENT, V121, P1815; BRAND AH, 1993, DEVELOPMENT, V118, P401; Casper A, 2006, DEVELOPMENT, V133, P2783, DOI 10.1242/dev.02415; Casper AL, 2009, DEVELOPMENT, V22, P722; Childs AJ, 2010, STEM CELLS, V28, P1368, DOI 10.1002/stem.440; Chou TB, 1996, GENETICS, V144, P1673; DESHPANDE G, 1995, MOL CELL BIOL, V15, P4430; Dorfman R, 2001, DEVELOPMENT, V128, P965; Durcova-Hills G, 2008, CURR TOP DEV BIOL, V83, P185, DOI [10.1016/S0070-2153(08)00406-7, 10.1016/S0070-2153(09)00406-7]; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; FOE VE, 1983, J CELL SCI, V61, P31; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gilboa L, 2004, CURR BIOL, V145, P871; Hashiyama K, 2011, SCIENCE, V333, P885, DOI 10.1126/science.1208146; Hashiyama K, 2009, GENE EXPR PATTERNS, V9, P50, DOI 10.1016/j.gep.2008.08.001; ILLMENSEE K, 1974, P NATL ACAD SCI USA, V71, P1016, DOI 10.1073/pnas.71.4.1016; Janzer B, 2001, MECH DEVELOP, V100, P3, DOI 10.1016/S0925-4773(00)00529-3; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Lesch BJ, 2012, NAT REV GENET, V13, P781, DOI 10.1038/nrg3294; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Liang YY, 2003, J BIOL CHEM, V278, P26307, DOI 10.1074/jbc.C300028200; Lin H, 1995, DEV GENET, V1, P6; Lin H, 1994, DEVELOPMENT, V4, P947; Long XM, 2000, J BIOL CHEM, V275, P40765, DOI 10.1074/jbc.M003949200; Maezawa T, 2009, DEV GROWTH DIFFER, V51, P453, DOI 10.1111/j.1440-169X.2009.01108.x; Mahowald AP, 2001, INT REV CYTOL, V203, P187; Miles WO, 2008, GENE DEV, V22, P2578, DOI 10.1101/gad.494808; Molyneaux K, 2004, INT J DEV BIOL, V48, P537, DOI 10.1387/ijdb.041833km; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nakamura A, 2008, DEVELOPMENT, V135, P3817, DOI 10.1242/dev.022434; Podos SD, 2001, DEV CELL, V1, P567, DOI 10.1016/S1534-5807(01)00057-0; Santos AC, 2004, CURR BIOL, V14, pR578, DOI 10.1016/j.cub.2004.07.018; Sato T, 2010, ZOOL SCI, V27, P804, DOI 10.2108/zsj.27.804; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Tam PPL, 1996, DEV BIOL, V178, P124, DOI 10.1006/dbio.1996.0203; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Van Doren M, 1998, CURR BIOL, V8, P243; Waterbury JA, 2000, GENETICS, V155, P1741; Wawersik M, 2005, DEV DYNAM, V234, P22, DOI 10.1002/dvdy.20503; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5	41	10	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88847	10.1371/journal.pone.0088847	http://dx.doi.org/10.1371/journal.pone.0088847			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551179	Green Published, gold, Green Submitted			2022-12-27	WOS:000331271500077
J	Mitome-Mishima, Y; Yamamoto, M; Yatomi, K; Nonaka, S; Miyamoto, N; Urabe, T; Arai, H; Oishi, H				Mitome-Mishima, Yumiko; Yamamoto, Munetaka; Yatomi, Kenji; Nonaka, Senshu; Miyamoto, Nobukazu; Urabe, Takao; Arai, Hajime; Oishi, Hidenori			Endothelial Cell Proliferation in Swine Experimental Aneurysm after Coil Embolization	PLOS ONE			English	Article							GUGLIELMI DETACHABLE COIL; RUPTURED INTRACRANIAL ANEURYSMS; CAROTID-ARTERY ANEURYSMS; ENDOVASCULAR TREATMENT; CEREBRAL ANEURYSMS; SACCULAR ANEURYSMS; PLATINUM COILS; TRIAL ISAT; PART I; MODEL	After coil embolization, recanalization in cerebral aneurysms adversely influences long-term prognosis. Proliferation of endothelial cells on the coil surface may reduce the incidence of recanalization and further improve outcomes after coil embolization. We aimed to map the expression of proliferating tissue over the aneurysmal orifice and define the temporal profile of tissue growth in a swine experimental aneurysm model. We compared the outcomes after spontaneous thrombosis with those of coil embolization using histological and morphological techniques. In aneurysms that we not coiled, spontaneous thrombosis was observed, and weak, easily detachable proliferating tissue was evident in the aneurysmal neck. In contrast, in the coil embolization group, histological analysis showed endothelial-like cells lining the aneurysmal opening. Moreover, immunohistochemical and morphological analysis suggested that these cells were immature endothelial cells. Our results indicated the existence of endothelial cell proliferation 1 week after coil embolization and showed immature endothelial cells in septal tissue between the systemic circulation and the aneurysm. These findings suggest that endothelial cells are lead to and proliferate in the former aneurysmal orifice. This is the first examination to evaluate the temporal change of proliferating tissue in a swine experimental aneurysm model.	[Mitome-Mishima, Yumiko; Yamamoto, Munetaka; Yatomi, Kenji; Arai, Hajime; Oishi, Hidenori] Juntendo Univ, Sch Med, Dept Neurosurg, Tokyo 113, Japan; [Oishi, Hidenori] Juntendo Univ, Sch Med, Dept Neuroendovasc Therapy, Tokyo, Japan; [Nonaka, Senshu] Juntendo Univ, Urayasu Hosp, Dept Neurosurg, Chiba, Japan; [Miyamoto, Nobukazu; Urabe, Takao] Juntendo Univ, Urayasu Hosp, Dept Neurol, Chiba, Japan	Juntendo University; Juntendo University; Juntendo University; Juntendo University	Mitome-Mishima, Y (corresponding author), Juntendo Univ, Sch Med, Dept Neurosurg, Tokyo 113, Japan.	ymishima@juntendo.ac.jp		Mitome-Mishima, Yumiko/0000-0001-8545-616X				Bouzeghrane F, 2010, AM J NEURORADIOL, V31, P418, DOI 10.3174/ajnr.A1853; Byrne JV, 1997, AM J NEURORADIOL, V18, P29; DAWSON RC, 1995, NEUROSURGERY, V36, P133, DOI 10.1227/00006123-199501000-00017; Dawson RC, 1996, AM J NEURORADIOL, V17, P853; Gallas S, 2009, AM J NEURORADIOL, V30, P1986, DOI 10.3174/ajnr.A1744; GERMAN WJ, 1954, NEW ENGL J MED, V250, P104, DOI 10.1056/NEJM195401212500303; GRAVES VB, 1992, AM J NEURORADIOL, V13, P189; GRAVES VB, 1993, AM J NEURORADIOL, V14, P787; GRAVES VB, 1990, AM J NEURORADIOL, V11, P249; GUGLIELMI G, 1991, J NEUROSURG, V75, P1, DOI 10.3171/jns.1991.75.1.0001; Hayakawa M, 2000, J NEUROSURG, V93, P561, DOI 10.3171/jns.2000.93.4.0561; Ishihara S, 2002, AJNR AM J NEURORADIO, V23; Johnston SC, 2001, STROKE, V32, P597, DOI 10.1161/01.STR.32.3.597; Kadirvel R, 2007, AM J NEURORADIOL, V28, P849; Lee D, 2007, J NEUROSURG, V107, P94, DOI 10.3171/JNS-07/07/0094; MASSOUD TF, 1994, NEURORADIOLOGY, V36, P537, DOI 10.1007/BF00593517; MAWAD ME, 1995, AM J NEURORADIOL, V16, P7; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Molyneux AJ, 2009, LANCET NEUROL, V8, P427, DOI 10.1016/S1474-4422(09)70080-8; Murayama Y, 1999, AM J NEURORADIOL, V20, P1986; Murayama Y, 1999, AM J NEURORADIOL, V20, P1992; Murayama Y, 1997, NEUROSURGERY, V40, P1233, DOI 10.1097/00006123-199706000-00024; Raymond J, 2003, STROKE, V34, P1398, DOI 10.1161/01.STR.0000073841.88563.E9; Szikora I, 1997, AM J NEURORADIOL, V18, P667; Tajiri N, 2012, CURR PHARM DESIGN, V18, P3663, DOI 10.2174/138161212802002724; Taylor RA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/746068; Walberer Maureen, 2010, Exp Transl Stroke Med, V2, P22, DOI 10.1186/2040-7378-2-22; Xia WL, 2010, CLIN EXP PHARMACOL P, V37, P253, DOI 10.1111/j.1440-1681.2009.05279.x; Yatomi K, 2012, J NEUROL SURG PART A, V73, P397, DOI 10.1055/s-0032-1322592	30	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89047	10.1371/journal.pone.0089047	http://dx.doi.org/10.1371/journal.pone.0089047			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551215	Green Published, Green Submitted, gold			2022-12-27	WOS:000331271500094
J	Wu, XJ; Zhang, HL; Liu, HY; Xing, YQ; Liu, KD				Wu, Xiujuan; Zhang, Hongliang; Liu, Haiyu; Xing, Yingqi; Liu, Kangding			Microembolic Signals Detected with Transcranial Doppler Sonography Differ between Symptomatic and Asymptomatic Middle Cerebral Artery Stenoses in Northeast China	PLOS ONE			English	Article							ACUTE STROKE PATIENTS; ATHEROSCLEROTIC STENOSIS; OCCLUSIVE DISEASE; ANGIOGRAPHY; ULTRASOUND; EMBOLI	Although microembolus monitoring has been widely used for ischemic cerebrovascular disease, the clinical significance of microembolic signal (MES) in asymptomatic middle cerebral artery (MCA) stenosis remains unclear. We aim to investigate the frequency of MES and the value of MES in predicting ischemic stroke secondary to asymptomatic MCA stenosis. From June 2011 to December 2012, microembolus monitoring was performed in 83 asymptomatic and 126 symptomatic subjects. By comparing the demographics and risk factors between the symptomatic and asymptomatic subjects, we found that the ratio of male sexuality and smoking history differed (101/126 vs 43/83, and 88/126 vs 38/83, respectively, p<0.01). The frequency of MES was significantly higher in the symptomatic group than in the asymptomatic group (49/126 vs 2/108, p<0.01). Specifically, the frequency of MES in the symptomatic and asymptomatic groups with mild stenosis, moderate stenosis, severe stenosis and occlusion groups was 4/18 (22.22%) vs 0/30 (0), 13/31 (41.94%) vs 1/28 (3.57%), 30/62 (48.39%) vs 1/39 (2.56%), 2/15 (13.33%) vs 0/11 (0), respectively. Except for the occlusive group, the frequency of MES is correlated with stenosis degree and symptom. Two patients in the asymptomatic group were found positive for MES, and the MES number was 1 for both. During the one-year follow-up, neither of them developed ischemic stroke. In conclusion, MES detected with TCD differs between symptomatic and asymptomatic MCA stenoses. Due to the low frequency, the value of MES as a predictor of subsequent ischemic stroke in patients with asymptomatic MCA stenosis might be limited.	[Wu, Xiujuan; Zhang, Hongliang; Liu, Haiyu; Xing, Yingqi; Liu, Kangding] Jilin Univ, Hosp 1, Dept Neurol, Ctr Neurosci, Changchun 130023, Peoples R China	Jilin University	Xing, YQ (corresponding author), Jilin Univ, Hosp 1, Dept Neurol, Ctr Neurosci, Changchun 130023, Peoples R China.	xingyq@sina.com; kangdingliu@163.com	Zhang, Hongliang/AAN-3077-2020	Zhang, Hongliang/0000-0001-9205-5559; Xing, Yingqi/0000-0002-7403-5789				Gao S, 2004, STROKE, V35, P2832, DOI 10.1161/01.STR.0000147035.31297.b6; Hao Q, 2010, CEREBROVASC DIS, V29, P424, DOI 10.1159/000289345; Komotar RJ, 2010, WORLD J RADIOL, V2, P166, DOI 10.4329/wjr.v2.i5.166; Kremer C, 2004, J NEUROL NEUROSUR PS, V75, P1300, DOI 10.1136/jnnp.2003.017863; Li ML, 2009, ATHEROSCLEROSIS, V204, P447, DOI 10.1016/j.atherosclerosis.2008.10.019; Markus HS, 2010, LANCET NEUROL, V9, P663, DOI 10.1016/S1474-4422(10)70120-4; Mok VCT, 2009, CEREBROVASC DIS, V28, P18, DOI 10.1159/000215939; Ni J, 2011, J NEUROL SCI, V301, P63, DOI 10.1016/j.jns.2010.10.029; Ritter MA, 2008, J NEUROL, V255, P953, DOI 10.1007/s00415-008-0638-8; ROTHER J, 1994, CEREBROVASC DIS, V4, P273, DOI 10.1159/000108494; Shan G, 2003, J NEUROIMAGING, V13, P124, DOI 10.1177/1051228403251190; Smith WS, 2009, STROKE, V40, P3834, DOI 10.1161/STROKEAHA.109.561787; SPENCER MP, 1990, STROKE, V21, P415, DOI 10.1161/01.STR.21.3.415; Tan TY, 2008, J CLIN ULTRASOUND, V36, P422, DOI 10.1002/jcu.20515; Wong KSL, 2010, LANCET NEUROL, V9, P489, DOI 10.1016/S1474-4422(10)70060-0; Wong KS, 2002, ANN NEUROL, V52, P74, DOI 10.1002/ana.10250; Wong KS, 2001, J NEUROIMAGING, V11, P137, DOI 10.1111/j.1552-6569.2001.tb00023.x; Wong KS, 2000, STROKE, V31, P2641, DOI 10.1161/01.STR.31.11.2641; Wu XJ, 2013, CHINESE MED J-PEKING, V126, P1355, DOI 10.3760/cma.j.issn.0366-6999.20121659; [邢英琦 XING YingQi], 2008, [中国老年学杂志, Chinese Journal of Gerontology], V28, P1906; Xu WH, 2010, ATHEROSCLEROSIS, V212, P507, DOI 10.1016/j.atherosclerosis.2010.06.035; ZANETTE EM, 1989, STROKE, V20, P899, DOI 10.1161/01.STR.20.7.899	22	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88986	10.1371/journal.pone.0088986	http://dx.doi.org/10.1371/journal.pone.0088986			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551204	gold, Green Published, Green Submitted			2022-12-27	WOS:000331271500090
J	Reeksting, BJ; Coetzer, N; Mahomed, W; Engelbrecht, J; van den Berg, N				Reeksting, Bianca J.; Coetzer, Nanette; Mahomed, Waheed; Engelbrecht, Juanita; van den Berg, Noelani			De Novo Sequencing, Assembly, and Analysis of the Root Transcriptome of Persea americana (Mill.) in Response to Phytophthora cinnamomi and Flooding	PLOS ONE			English	Article							HYDROXYPROLINE-RICH GLYCOPROTEINS; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; ARABIDOPSIS-THALIANA; LOW-OXYGEN; SIGNALING PATHWAYS; DIFFERENTIAL EXPRESSION; DEFENSE RESPONSES; MOLECULAR-BIOLOGY; HEMOGLOBIN GENE	Avocado is a diploid angiosperm containing 24 chromosomes with a genome estimated to be around 920 Mb. It is an important fruit crop worldwide but is susceptible to a root rot caused by the ubiquitous oomycete Phytophthora cinnamomi. Phytophthora root rot (PRR) causes damage to the feeder roots of trees, causing necrosis. This leads to branch-dieback and eventual tree death, resulting in severe losses in production. Control strategies are limited and at present an integrated approach involving the use of phosphite, tolerant rootstocks, and proper nursery management has shown the best results. Disease progression of PRR is accelerated under high soil moisture or flooding conditions. In addition, avocado is highly susceptible to flooding, with even short periods of flooding causing significant losses. Despite the commercial importance of avocado, limited genomic resources are available. Next generation sequencing has provided the means to generate sequence data at a relatively low cost, making this an attractive option for non-model organisms such as avocado. The aims of this study were to generate sequence data for the avocado root transcriptome and identify stress-related genes. Tissue was isolated from avocado infected with P. cinnamomi, avocado exposed to flooding and avocado exposed to a combination of these two stresses. Three separate sequencing runs were performed on the Roche 454 platform and produced approximately 124 Mb of data. This was assembled into 7685 contigs, with 106 448 sequences remaining as singletons. Genes involved in defence pathways such as the salicylic acid and jasmonic acid pathways as well as genes associated with the response to low oxygen caused by flooding, were identified. This is the most comprehensive study of transcripts derived from root tissue of avocado to date and will provide a useful resource for future studies.	[Reeksting, Bianca J.; Mahomed, Waheed; van den Berg, Noelani] Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa; [Coetzer, Nanette] Univ Pretoria, Bioinformat & Computat Biol Unit, Dept Biochem, ZA-0002 Pretoria, South Africa; [Reeksting, Bianca J.; Coetzer, Nanette; Mahomed, Waheed; Engelbrecht, Juanita; van den Berg, Noelani] Univ Pretoria, Forestry & Agr Biotechnol Inst, ZA-0002 Pretoria, South Africa	University of Pretoria; University of Pretoria; University of Pretoria	Reeksting, BJ (corresponding author), Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa.	bjreeksting@gmail.com	van den Berg, Noelani/B-9598-2008; Engelbrecht, Juanita/ABE-2891-2021; Reeksting, Bianca/ABF-8312-2020	van den Berg, Noelani/0000-0001-9574-7331; Engelbrecht, Juanita/0000-0002-4439-1205; Reeksting, Bianca/0000-0003-1219-9574	Technology and Human Resources Programme (THRIP) [TP2011060300010]; National Research Foundation (NRF); Hans Merensky Foundation; Genomics research institute (GRI) at the University of Pretoria	Technology and Human Resources Programme (THRIP); National Research Foundation (NRF); Hans Merensky Foundation; Genomics research institute (GRI) at the University of Pretoria	This work was supported by the Technology and Human Resources Programme (THRIP, grant number TP2011060300010) as an initiative of the National Research Foundation (NRF), the Hans Merensky Foundation, and the Genomics research institute (GRI) at the University of Pretoria. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Acosta-Muniz CH, 2012, PHYSIOL PLANTARUM, V144, P59, DOI 10.1111/j.1399-3054.2011.01522.x; Agarwal S, 2006, CRIT REV PLANT SCI, V25, P1, DOI 10.1080/07352680500365232; Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; Asselbergh B, 2008, MOL PLANT MICROBE IN, V21, P709, DOI 10.1094/MPMI-21-6-0709; Ben-Ya'acov A., 1995, Horticultural Reviews, V17, P381, DOI 10.1002/9780470650585.ch11; BIALE JB, 1946, AM J BOT, V33, P363, DOI 10.2307/2437124; Bond DM, 2009, PLANT J, V59, P576, DOI 10.1111/j.1365-313X.2009.03891.x; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen WQJ, 2004, TRENDS PLANT SCI, V9, P591, DOI 10.1016/j.tplants.2004.10.007; Collinge M, 2001, PLANT MOL BIOL, V46, P521, DOI 10.1023/A:1010639225091; Curtis RHC, 2013, MOL PLANT MICROBE IN, V26, P36, DOI 10.1094/MPMI-05-12-0135-FI; Cushman JC, 2000, CURR OPIN PLANT BIOL, V3, P117, DOI 10.1016/S1369-5266(99)00052-7; DARVAS JM, 1984, PLANT DIS, V68, P691, DOI 10.1094/PD-69-691; de Carvalho JF, 2013, HEREDITY, V110, P181, DOI 10.1038/hdy.2012.76; Deepak S, 2010, J PHYTOPATHOL, V158, P585, DOI 10.1111/j.1439-0434.2010.01669.x; DEMPSEY DA, 1995, B I PASTEUR, V93, P167, DOI 10.1016/0020-2452(96)81488-6; Ding LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019008; Dobrowolski MP, 2008, PLANT PATHOL, V57, P928, DOI 10.1111/j.1365-3059.2008.01883.x; Duvenhage J. A., 1994, Yearbook - South African Avocado Growers' Association, V17, P35; Ender F, 2002, PLANT CELL, V14, P1147, DOI 10.1105/tpc.000711; Eulgem T, 2005, TRENDS PLANT SCI, V10, P71, DOI 10.1016/j.tplants.2004.12.006; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Garcia-Pineda E, 2010, PLANT SOIL, V331, P45, DOI 10.1007/s11104-009-0225-5; Hahn DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-234; Halim VA, 2006, PLANT BIOLOGY, V8, P307, DOI 10.1055/s-2006-924025; Hardham AR, 2005, MOL PLANT PATHOL, V6, P589, DOI 10.1111/J.1364-3703.2005.00308.X; Huitema E, 2003, MOL PLANT PATHOL, V4, P487, DOI [10.1046/j.1364-3703.2003.00195.x, 10.1046/J.1364-3703.2003.00195.X]; Hutcheson SW, 1998, ANNU REV PHYTOPATHOL, V36, P59, DOI 10.1146/annurev.phyto.36.1.59; Jacobs KA, 1997, 19 USDA FOR SERV; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; KANELLIS AK, 1989, PLANT PHYSIOL, V90, P259, DOI 10.1104/pp.90.1.259; KANELLIS AK, 1989, PLANT CELL PHYSIOL, V30, P817, DOI 10.1093/oxfordjournals.pcp.a077811; KANELLIS AK, 1991, PLANT PHYSIOL, V96, P269, DOI 10.1104/pp.96.1.269; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Komatsu S, 2009, J PROTEOME RES, V8, P4766, DOI 10.1021/pr900460x; Kong P, 2003, PLANT PATHOL, V52, P681, DOI 10.1111/j.1365-3059.2003.00935.x; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Levy A, 2007, PLANT SIGNAL BEHAV, V2, P404, DOI 10.4161/psb.2.5.4334; Licausi F, 2011, NEW PHYTOL, V190, P550, DOI 10.1111/j.1469-8137.2010.03562.x; Licausi F, 2011, NEW PHYTOL, V190, P442, DOI 10.1111/j.1469-8137.2010.03451.x; Loulakakis CA, 2006, POSTHARVEST BIOL TEC, V39, P29, DOI 10.1016/j.postharvbio.2005.09.005; Ludwig AA, 2004, J EXP BOT, V55, P181, DOI 10.1093/jxb/erh008; Mahomed W, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-167; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Mosblech A, 2009, PLANT PHYSIOL BIOCH, V47, P511, DOI 10.1016/j.plaphy.2008.12.011; Moy P, 2004, MOL PLANT MICROBE IN, V17, P1051, DOI 10.1094/MPMI.2004.17.10.1051; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Nie XZ, 1997, PLANT PHYSIOL, V114, P835, DOI 10.1104/pp.114.3.835; Niggeweg R, 2000, PLANT MOL BIOL, V42, P775, DOI 10.1023/A:1006319113205; O'Kennedy MM, 2011, S AFR J BOT, V77, P335, DOI 10.1016/j.sajb.2010.09.016; Peterson MP, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-305; Porter BW, 2009, MOL GENET GENOMICS, V281, P609, DOI 10.1007/s00438-009-0434-x; Prabhu SA, 2012, ACTA BIOCH BIOPH SIN, V44, P415, DOI 10.1093/abbs/gms015; Ricoult C, 2006, J EXP BOT, V57, P3079, DOI 10.1093/jxb/erl069; Robinson LH, 2003, AUSTRALAS PLANT PATH, V32, P53, DOI 10.1071/AP02064; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rookes JE, 2008, PHYSIOL MOL PLANT P, V72, P151, DOI 10.1016/j.pmpp.2008.08.005; Sachs MM, 1996, J EXP BOT, V47, P1, DOI 10.1093/jxb/47.1.1; SIMMONS CR, 1994, CRIT REV PLANT SCI, V13, P325, DOI 10.1080/07352680490484569; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Takatsuji H, 1998, CELL MOL LIFE SCI, V54, P582, DOI 10.1007/s000180050186; TAYLOR ER, 1994, PLANT MOL BIOL, V24, P853, DOI 10.1007/BF00014440; Thanseem I, 2005, TREE PHYSIOL, V25, P1361, DOI 10.1093/treephys/25.11.1361; Urao T, 1999, PLANT CELL, V11, P1743, DOI 10.1105/tpc.11.9.1743; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; VICK BA, 1984, PLANT PHYSIOL, V75, P458, DOI 10.1104/pp.75.2.458; Visser EJW, 2003, ANN BOT-LONDON, V91, P107, DOI 10.1093/aob/mcg014; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wang YX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034225, 10.1371/journal.pone.0039525, 10.1371/journal.pone.0037152]; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; WESTE G, 1983, PHYTOPATHOL Z, V106, P163; Xue TT, 2009, J EXP BOT, V60, P339, DOI 10.1093/jxb/ern291; Zentmyer G.A., 1980, PHYTOPHTHORA CINNAMO; ZENTMYER GA, 1984, TROP PEST MANAGE, V30, P388, DOI 10.1080/09670878409370915; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042082; Zhou JM, 2000, MOL PLANT MICROBE IN, V13, P191, DOI 10.1094/MPMI.2000.13.2.191; Zou XL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-189	79	29	32	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e86399	10.1371/journal.pone.0086399	http://dx.doi.org/10.1371/journal.pone.0086399			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24563685	Green Submitted, Green Published, gold			2022-12-27	WOS:000331254600010
J	Cressman, R; Krivan, V; Brown, JS; Garay, J				Cressman, Ross; Krivan, Vlastimil; Brown, Joel S.; Garay, Jozsef			Game-Theoretic Methods for Functional Response and Optimal Foraging Behavior	PLOS ONE			English	Article							OPTIMAL PREY SELECTION; DIET; CONSEQUENCE; CONSTRAINTS; STRATEGY	We develop a decision tree based game-theoretical approach for constructing functional responses in multi-prey/multi-patch environments and for finding the corresponding optimal foraging strategies. Decision trees provide a way to describe details of predator foraging behavior, based on the predator's sequence of choices at different decision points, that facilitates writing down the corresponding functional response. It is shown that the optimal foraging behavior that maximizes predator energy intake per unit time is a Nash equilibrium of the underlying optimal foraging game. We apply these game-theoretical methods to three scenarios: the classical diet choice model with two types of prey and sequential prey encounters, the diet choice model with simultaneous prey encounters, and a model in which the predator requires a positive recognition time to identify the type of prey encountered. For both diet choice models, it is shown that every Nash equilibrium yields optimal foraging behavior. Although suboptimal Nash equilibrium outcomes may exist when prey recognition time is included, only optimal foraging behavior is stable under evolutionary learning processes.	[Cressman, Ross] Wilfrid Laurier Univ, Dept Math, Waterloo, ON N2L 3C5, Canada; [Krivan, Vlastimil] Acad Sci Czech Republ, Inst Entomol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic; [Krivan, Vlastimil] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Brown, Joel S.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Garay, Jozsef] Eotvos Lorand Univ, MTA ELTE Theoret Biol & Evolutionary Ecol Res Grp, Budapest, Hungary; [Garay, Jozsef] Eotvos Lorand Univ, Dept Plant Systemat Ecol & Theoret Biol, Budapest, Hungary	Wilfrid Laurier University; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Eotvos Lorand Research Network; Office for Supported Research Groups (ELKH); Eotvos Lorand University; Eotvos Lorand University	Krivan, V (corresponding author), Acad Sci Czech Republ, Inst Entomol, Ctr Biol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.	vlastimil.krivan@gmail.com	Krivan, Vlastimil/J-7015-2019; Krivan, Vlastimil/F-1709-2010	Krivan, Vlastimil/0000-0003-0971-1231; Krivan, Vlastimil/0000-0003-0971-1231; Garay, Jozsef/0000-0003-0860-2252	NSERC of Canada; Biology Centre [RVO:60077344]; Hungarian National Scientific Research Fund [OTKA K62000, K67961]	NSERC of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Biology Centre; Hungarian National Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	Support was provided by NSERC of Canada, the Biology Centre (RVO:60077344), and the Hungarian National Scientific Research Fund (OTKA K62000,K67961). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1996, EVOL ECOL, V10, P167, DOI 10.1007/BF01241783; [Anonymous], 1995, EVOLUTIONARY GAME TH; Berec L, 2000, THEOR POPUL BIOL, V58, P279, DOI 10.1006/tpbi.2000.1491; Broom M, 2004, B MATH BIOL, V66, P1645, DOI 10.1016/j.bulm.2004.03.009; Broom M., 2013, GAME THEORETICAL MOD; BROWN JS, 1989, OIKOS, V54, P33, DOI 10.2307/3565894; CHARNOV EL, 1976, AM NAT, V110, P141, DOI 10.1086/283054; Charnov EL., 1973, OPTIMAL FORAGING SOM; Clark CW, 2000, OX ECOL EV; Cressman R, 2003, ECON LEARN SOC EVOL, P1; Cressman R, 2011, ECOLOGY, V92, P432, DOI 10.1890/10-0199.1; Dubois F, 2012, P ROY SOC B-BIOL SCI, V279, P1977, DOI 10.1098/rspb.2011.2342; ENGEN S, 1984, AM NAT, V124, P352, DOI 10.1086/284278; ERICHSEN JT, 1980, J ANIM ECOL, V49, P271, DOI 10.2307/4288; GALE J, 1995, GAME ECON BEHAV, V8, P56, DOI 10.1016/S0899-8256(05)80017-X; Garay J., 2010, COMMUNITY ECOL, V11, P160, DOI [10.1556/ComEc.11.2010.2.4, DOI 10.1556/COMEC.11.2010.2.4]; Garay J, 2012, J THEOR BIOL, V310, P31, DOI 10.1016/j.jtbi.2012.06.021; Hassell MP., 1978, DYNAMICS ARTHROPOD P; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Holling C. S., 1959, Canadian Entomologist, V91, P385; HOLLING C. S., 1966, Memoirs of the Entomology Society of Canada; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; HOLT RD, 1987, AM NAT, V130, P412, DOI 10.1086/284718; Houston AI, 1999, MODELS ADAPTIVE BEHA; Jeschke JM, 2002, ECOL MONOGR, V72, P95, DOI 10.1890/0012-9615(2002)072[0095:PFRDBH]2.0.CO;2; KOTLER BP, 1995, EVOL ECOL, V9, P18, DOI 10.1007/BF01237693; KREBS JR, 1977, ANIM BEHAV, V25, P30, DOI 10.1016/0003-3472(77)90064-1; Krivan V, 1996, THEOR POPUL BIOL, V49, P265, DOI 10.1006/tpbi.1996.0014; LUCAS JR, 1983, AM NAT, V122, P191, DOI 10.1086/284130; Mukherjee S, 2013, BIOL REV, V88, P550, DOI 10.1111/brv.12014; Murdoch W.W., 2003, CONSUMER RESOURCE DY; PULLIAM HR, 1975, AM NAT, V109, P765, DOI 10.1086/283041; PULLIAM HR, 1974, AM NAT, V108, P59, DOI 10.1086/282885; RECHTEN C, 1983, ANIM BEHAV, V31, P576, DOI 10.1016/S0003-3472(83)80081-5; Samuelson L., 1997, EVOLUTIONARY GAMES E; Sandholm WH., 2010, POPULATION GAMES EVO; SELTEN R, 1983, MATH SOC SCI, V5, P269, DOI 10.1016/0165-4896(83)90012-4; SELTEN R, 1978, THEOR DECIS, V9, P127, DOI 10.1007/BF00131770; Stephens D.W., 1986, pi; STEPHENS DW, 1986, AM NAT, V127, P533, DOI 10.1086/284501; Vincent T. L., 2005, EVOLUTIONARY GAME TH; Wald A, 1944, ANN MATH STAT, V15, P283, DOI 10.1214/aoms/1177731235; Whelan CJ, 2005, OIKOS, V110, P481, DOI 10.1111/j.0030-1299.2005.13387.x	43	17	17	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e88773	10.1371/journal.pone.0088773	http://dx.doi.org/10.1371/journal.pone.0088773			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586390	Green Published, gold			2022-12-27	WOS:000332396200028
J	Storch, A; Kassubek, J; Tumani, H; Vladimirtsev, VA; Hermann, A; Osakovsky, VL; Baranov, VA; Krivoshapkin, VG; Ludolph, AC				Storch, Alexander; Kassubek, Jan; Tumani, Hayrettin; Vladimirtsev, Vsevolod A.; Hermann, Andreas; Osakovsky, Vladimir L.; Baranov, Vladimir A.; Krivoshapkin, Vadim G.; Ludolph, Albert C.			Communicating Hydrocephalus Following Eosinophilic Meningitis Is Pathogenic for Chronic Viliuisk Encephalomyelitis in Northeastern Siberia	PLOS ONE			English	Article							TOXOCARA-CANIS	Background: Viliuisk encephalomyelitis (VE) is an endemic neurological disease in Northeast Siberia and generally considered to be a chronic encephalomyelitis of unknown origin actually spreading in the Sakha (Yakutian) Republic. Methodology and Principle Findings: In search for the pathophysiology and causative agent of VE, we performed a cross-sectional study on clinical, serological and neuroimaging data on chronic VE patients during two medical expeditions to three villages within the Viliuiski river basin in the Republic of Sakha in 2000 and to the capital Yakutsk in 2006. The severity of the core clinical picture with predominant sensory ataxia, gait apraxia, lower limb spasticity, cognitive impairment and bladder dysfunction correlated with the degree of MRI findings showing enlargement of inner ventricular spaces as in communicating hydrocephalus. Laboratory studies revealed transient eosinophilia during the preceding acute meningitis-like phase, but no ongoing inflammatory process in the CSF. We found immune reactions against Toxocara canis in the majority of chronic VE patients but rarely in controls (P = 0.025; Fisher's exact test). Histological analysis of subacute to subchronic VE brain samples showed eosinophilic infiltrations with no signs of persistent Toxocara canis infection. Conclusions and Significance: Our data showed that pressure by the communicating hydrocephalus as a mechanical factor is the major pathogenic mechanism in chronic VE, most likely triggered by eosinophilic meningitis. There are no signs for an ongoing inflammatory process in chronic VE. The past eosinophilic reaction in VE might be caused by Toxocara ssp. infection and might therefore represent the first hint for an initial cause leading to the development of chronic VE. Our data provide a framework for future studies and potential therapeutic interventions for this enigmatic epidemic neurological disease potentially spreading in Sakha Republic.	[Storch, Alexander; Hermann, Andreas] Tech Univ Dresden, Dept Neurol, Div Neurodegenerat Dis, Dresden, Germany; [Storch, Alexander] German Ctr Neurodegenerat Dis DZNE Dresden, Dresden, Germany; [Kassubek, Jan; Tumani, Hayrettin; Ludolph, Albert C.] Univ Ulm, Dept Neurol, D-89069 Ulm, Germany; [Vladimirtsev, Vsevolod A.; Osakovsky, Vladimir L.; Krivoshapkin, Vadim G.] NEFU, Sci Res Inst Hlth, Yakutsk, Russia; [Baranov, Vladimir A.] Natl Med Ctr Yakutia, Dept Radiol, Yakutsk, Russia	Technische Universitat Dresden; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technische Universitat Dresden; Ulm University	Storch, A (corresponding author), Tech Univ Dresden, Dept Neurol, Div Neurodegenerat Dis, Dresden, Germany.	alexander.storch@neuro.med.tu-dresden.de; albert.ludolph@uni-ulm.de	Hermann, Andreas/D-4213-2017; Vladimirtsev, Vsevolod/H-1470-2019; Kassubek, Jan/GPX-0910-2022; Kassubek, Jan/F-2774-2015; Kassubek, Jan/O-1740-2019; Osakovskij, Vladimir L./A-7843-2014; Krivoshapkin, Vadim/AAX-9511-2021	Hermann, Andreas/0000-0002-7364-7791; Vladimirtsev, Vsevolod/0000-0002-5480-3592; Kassubek, Jan/0000-0002-7106-9270; Kassubek, Jan/0000-0002-7106-9270; Kassubek, Jan/0000-0002-7106-9270; Osakovskij, Vladimir L./0000-0001-9529-2488; Krivoshapkin, Vadim/0000-0002-8960-3283	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) to AS and ACL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartschi E, 2004, INFECTION, V32, P116, DOI 10.1007/s15010-004-3028-x; Ceianu C, 2008, CLIN VACCINE IMMUNOL, V15, P1749, DOI 10.1128/CVI.00275-08; Fillaux J, 2013, VET PARASITOL, V193, P327, DOI 10.1016/j.vetpar.2012.12.028; Finsterer Josef, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P279, DOI 10.1590/S0036-46652007000500002; Fisher M, 2003, TRENDS PARASITOL, V19, P167, DOI 10.1016/S1471-4922(03)00027-8; Goffette S, 2000, EUR J NEUROL, V7, P703, DOI 10.1046/j.1468-1331.2000.00123.x; Goldfarb LG, 2009, FOLIA NEUROPATHOL, V47, P171; GOLDFARB LG, 1992, BRAIN, V115, P961, DOI 10.1093/brain/115.4.961; Green AJE, 2003, J NEUROL SCI, V212, P69, DOI 10.1016/S0022-510X(03)00107-2; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lee HS, 2010, EPIDEMIOLOGY, V21, P24, DOI 10.1097/EDE.0b013e3181c30fd2; Lemieux L, 1998, Med Image Anal, V2, P227, DOI 10.1016/S1361-8415(98)80021-2; Lo Re III V, 2003, AM J MED, V114, P217, DOI 10.1016/S0002-9343(02)01495-X; Maak RL, 1887, VILIUISK AREA IAKUTS; Magnaval JF, 2011, VECTOR-BORNE ZOONOT, V11, P157, DOI 10.1089/vbz.2009.0105; McLean CA, 1997, NEUROPATH APPL NEURO, V23, P212, DOI 10.1046/j.1365-2990.1997.9098090.x; Moreira-Silva Sandra F., 2004, Rev. Soc. Bras. Med. Trop., V37, P169, DOI 10.1590/S0037-86822004000200011; Ota S, 1994, Rinsho Shinkeigaku, V34, P1148; Pinelli E, 2013, VET PARASITOL, V193, P337, DOI 10.1016/j.vetpar.2012.12.029; REIBER H, 1987, CLIN CHIM ACTA, V163, P319, DOI 10.1016/0009-8981(87)90250-6; Smith RR, 2000, NEUROIMAGING, P585; Stone R, 2002, SCIENCE, V296, P642, DOI 10.1126/science.296.5568.642; Storch A, 2008, NEUROL SCI, V29, P11, DOI 10.1007/s10072-008-0852-2; Taslowa R, 1982, PSYCHOL DISORDERS TY; Vidal JE, 2003, AM J TROP MED HYG, V69, P341, DOI 10.4269/ajtmh.2003.69.341; Xinou E, 2003, AM J NEURORADIOL, V24, P714	26	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e84670	10.1371/journal.pone.0084670	http://dx.doi.org/10.1371/journal.pone.0084670			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586232	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200005
J	Bidder, OR; Campbell, HA; Gomez-Laich, A; Urge, P; Walker, J; Cai, YZ; Gao, LL; Quintana, F; Wilson, RP				Bidder, Owen R.; Campbell, Hamish A.; Gomez-Laich, Agustina; Urge, Patricia; Walker, James; Cai, Yuzhi; Gao, Lianli; Quintana, Flavio; Wilson, Rory P.			Love Thy Neighbour: Automatic Animal Behavioural Classification of Acceleration Data Using the K-Nearest Neighbour Algorithm	PLOS ONE			English	Article							BODY ACCELERATION; LOCOMOTION; ACCELEROMETER; ECOLOGY; SYSTEM; SPEED	Researchers hoping to elucidate the behaviour of species that aren't readily observed are able to do so using biotelemetry methods. Accelerometers in particular are proving particularly effective and have been used on terrestrial, aquatic and volant species with success. In the past, behavioural modes were detected in accelerometer data through manual inspection, but with developments in technology, modern accelerometers now record at frequencies that make this impractical. In light of this, some researchers have suggested the use of various machine learning approaches as a means to classify accelerometer data automatically. We feel uptake of this approach by the scientific community is inhibited for two reasons; 1) Most machine learning algorithms require selection of summary statistics which obscure the decision mechanisms by which classifications are arrived, and 2) they are difficult to implement without appreciable computational skill. We present a method which allows researchers to classify accelerometer data into behavioural classes automatically using a primitive machine learning algorithm, k-nearest neighbour (KNN). Raw acceleration data may be used in KNN without selection of summary statistics, and it is easily implemented using the freeware program R. The method is evaluated by detecting 5 behavioural modes in 8 species, with examples of quadrupedal, bipedal and volant species. Accuracy and Precision were found to be comparable with other, more complex methods. In order to assist in the application of this method, the script required to run KNN analysis in R is provided. We envisage that the KNN method may be coupled with methods for investigating animal position, such as GPS telemetry or dead-reckoning, in order to implement an integrated approach to movement ecology research.	[Bidder, Owen R.; Urge, Patricia; Wilson, Rory P.] Swansea Univ, Coll Sci, Swansea, W Glam, Wales; [Campbell, Hamish A.] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Gomez-Laich, Agustina; Quintana, Flavio] Consejo Nacl Invest Cient & Tecnias, Ctr Nacl Patagon, Puerto Madryn, Chubut, Argentina; [Walker, James] Swansea Univ, Coll Engn, Swansea, W Glam, Wales; [Cai, Yuzhi] Swansea Univ, Sch Management, Swansea, W Glam, Wales; [Gao, Lianli] Univ Queensland, Sch Informat Technol & Elect Engn, Brisbane, Qld 4072, Australia; [Quintana, Flavio] Wildlife Conservat Soc, Buenos Aires, DF, Argentina	Swansea University; University of Queensland; Centro Nacional Patagonico (CENPAT); Swansea University; Swansea University; University of Queensland	Bidder, OR (corresponding author), Swansea Univ, Coll Sci, Swansea, W Glam, Wales.	o.r.bidder@gmail.co.uk		Campbell, Hamish/0000-0003-1428-1686; Quintana, Flavio/0000-0003-0696-2545	European Social Fund (ESF) through the European Union's Convergence programme; Welsh Government; Royal Society for the Prevention of Cruelty to Animals	European Social Fund (ESF) through the European Union's Convergence programme; Welsh Government; Royal Society for the Prevention of Cruelty to Animals	Owen R. Bidder is funded by the European Social Fund (ESF) through the European Union's Convergence programme administered by the Welsh Government and by the Royal Society for the Prevention of Cruelty to Animals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, UCDCSI20074; Baldi P., 1998, PHYS TODAY, DOI DOI 10.1063/1.1537915; Bidder OR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050556; Bidder OR, 2012, ZOOLOGY, V115, P58, DOI 10.1016/j.zool.2011.09.003; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Campbell HA, 2013, J EXP BIOL, V216, P4501, DOI 10.1242/jeb.089805; Chen KY, 2005, MED SCI SPORT EXER, V37, pS490, DOI 10.1249/01.mss.0000185571.49104.82; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Duda R. O., 1973, PATTERN CLASSIFICATI; FIX E, 1989, INT STAT REV, V57, P238, DOI 10.2307/1403797; Gao LL, 2013, ECOL INFORM, V13, P47, DOI 10.1016/j.ecoinf.2012.09.003; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Gottelli Dada, 1992, Oryx, V26, P205; Halsey LG, 2009, COMP BIOCHEM PHYS A, V152, P197, DOI 10.1016/j.cbpa.2008.09.021; Halsey LG, 2008, ZOOLOGY, V111, P231, DOI 10.1016/j.zool.2007.07.011; Halsey LG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010170; Halsey LG, 2009, J FIELD ORNITHOL, V80, P171, DOI 10.1111/j.1557-9263.2009.00219.x; Holmstrom H, 2001, SCAND J FOREST RES, V16, P67, DOI 10.1080/028275801300004424; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; Kato A, 2006, MAR ECOL PROG SER, V308, P293, DOI 10.3354/meps308293; KELLER JM, 1985, IEEE T SYST MAN CYB, V15, P580, DOI 10.1109/TSMC.1985.6313426; Khanvilkar AV, 2009, VET WORLD, V2, P240; Lagarde F, 2008, ANIM BEHAV, V75, P319, DOI 10.1016/j.anbehav.2007.01.010; Lee BK, 2010, STAT MED, V29, P337, DOI 10.1002/sim.3782; Liao YH, 2002, COMPUT SECUR, V21, P439, DOI 10.1016/S0167-4048(02)00514-X; Liu SP, 2012, IEEE ENG MED BIO, P6200, DOI 10.1109/EMBC.2012.6347410; Martiskainen P, 2009, APPL ANIM BEHAV SCI, V119, P32, DOI 10.1016/j.applanim.2009.03.005; Mehrotra R, 2006, ADV WATER RESOUR, V29, P987, DOI 10.1016/j.advwatres.2005.08.007; Mitchell T.M, 2003, MACH LEARN; Moreau M, 2009, APPL ANIM BEHAV SCI, V119, P158, DOI 10.1016/j.applanim.2009.04.008; Nathan R, 2012, J EXP BIOL, V215, P986, DOI 10.1242/jeb.058602; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19050, DOI 10.1073/pnas.0808918105; Powers D. M, 2011, ARXIV201016061; Qasem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031187; Ropert-Coudert Y, 2005, FRONT ECOL ENVIRON, V3, P437, DOI 10.2307/3868660; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Shepard Emily L. C., 2010, Endangered Species Research, V10, P47, DOI 10.3354/esr00084; SHORT RD, 1981, IEEE T INFORM THEORY, V27, P622, DOI 10.1109/TIT.1981.1056403; Stehman SV, 1997, REMOTE SENS ENVIRON, V62, P77, DOI 10.1016/S0034-4257(97)00083-7; Wilson AM, 2013, NATURE, V498, P185, DOI 10.1038/nature12295; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; WILSON RP, 1991, J EXP BIOL, V157, P557; Wilson RP, 2008, ENDANGER SPECIES RES, V10, P29, DOI [10.3354/esr00091, DOI 10.3354/ESR00091]; Yoda K, 1999, J EXP BIOL, V202, P3121; Yoda K, 2001, J EXP BIOL, V204, P685	47	63	63	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e88609	10.1371/journal.pone.0088609	http://dx.doi.org/10.1371/journal.pone.0088609			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586354	gold, Green Published, Green Submitted			2022-12-27	WOS:000331717900022
J	Neuberger, A; Meltzer, E; Leshem, E; Dickstein, Y; Stienlauf, S; Schwartz, E				Neuberger, Ami; Meltzer, Eyal; Leshem, Eyal; Dickstein, Yaakov; Stienlauf, Shmuel; Schwartz, Eli			The Changing Epidemiology of Human African Trypanosomiasis among Patients from Nonendemic Countries-1902-2012	PLOS ONE			English	Article							SLEEPING SICKNESS; INFECTION; TRAVELERS	Background: Although human African trypanosomiasis (HAT) is uncommon among patients from non-endemic countries (NEC), there has been an increase in the number of cases reported in recent years. Methods: A systematic review of the literature was performed. The number of incoming tourists to HAT endemic countries was obtained from the United Nations World Tourism Organization. All HAT cases diagnosed in patients from NEC were included. Immigrants and refugees were excluded. We compared patients during and after the colonial period, and analyzed the relationship between the number of incoming travellers and the number of HAT cases. Results: Between 1902 and 2012, HAT was reported in 244 patients. Most HAT cases were reported before 1920, and after the year 2000. In the colonial era the average age of patients was lower (32.5 +/- 7.8 vs. 43.0 +/- 16.1 years, P<0.001), the proportion of females was lower (10.0% vs. 23.9%, P<0.01], most cases were diagnosed in expatriates, missionaries and soldiers (74.3%), and Gambian trypanosomiasis accounted for 86/110, (78%) of cases. In the post-colonial era most patients 91/125 (72.8%) were short-term tourists to game parks in Eastern and South-Eastern Africa (mainly in Tanzania); Rhodesian trypanosomiasis accounted for 94/123 (76.4%) of cases. Between 1995 and 2010 there has been a constant linear increase in the number of incoming tourists to Tanzania, and HAT cases occurred in small outbreaks rather than following a similar linear pattern. Conclusions: In recent decades HAT patients from NEC are older, and more likely to be tourists who acquired the disease while visiting game-parks in Eastern and South-Eastern Africa. While Rhodesian trypanosomiasis is relatively uncommon among Africans, it now accounts for most cases reported among patients from NEC. Returning febrile travellers without an alternative diagnosis should be evaluated for HAT. Cases among travellers may serve as sentinels for Rhodesian trypanosomiasis "hot spots'' in Africa.	[Neuberger, Ami] Technion Israel Inst Technol, Rambam Med Ctr, Unit Infect Dis & Internal Med B, Haifa, Israel; [Neuberger, Ami] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; [Meltzer, Eyal; Leshem, Eyal; Stienlauf, Shmuel; Schwartz, Eli] Tel Aviv Univ, Sheba Med Ctr, Ctr Geog Med & Internal Med A & C, IL-69978 Tel Aviv, Israel; [Meltzer, Eyal; Leshem, Eyal; Stienlauf, Shmuel; Schwartz, Eli] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Dickstein, Yaakov] Rambam Med Ctr, Haifa, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Chaim Sheba Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology	Neuberger, A (corresponding author), Technion Israel Inst Technol, Rambam Med Ctr, Unit Infect Dis & Internal Med B, Haifa, Israel.	a_neuberger@rambam.health.gov.il		Dickstein, Yaakov/0000-0002-1063-5478; Leshem, Eyal/0000-0003-1267-6131				Atkins J, 1734, NAVY SURG PRACTICAL; BASSON W, 1977, S AFR MED J, V51, P453; Berrang-Ford L, 2012, EMERG INFECT DIS, V18, P1686, DOI 10.3201/eid1810.111213; Blum JA, 2012, EUR J CLIN MICROBIOL, V31, P905, DOI 10.1007/s10096-011-1403-y; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Centers for Disease Control (CDC), 1983, MMWR Morb Mortal Wkly Rep, V32, P112; Chappuis F, 2010, EMERG INFECT DIS, V16, P354, DOI 10.3201/eid1602.090967; Clerinx J, 2012, EUROSURVEILLANCE, V17, P10; COCHRAN R, 1983, ARCH DERMATOL, V119, P670, DOI 10.1001/archderm.119.8.670; Coulaud J P, 1970, Bull Soc Pathol Exot Filiales, V63, P685; DUGGAN AJ, 1966, J TROP MED HYG, V69, P124; DUPONT B, 1979, NOUV PRESSE MED, V8, P1579; Egan J, 2012, TRYPANOSOMIASIS US E; Ekwanzala M, 1996, LANCET, V348, P1427, DOI 10.1016/S0140-6736(96)06088-6; Fevre EM, 2004, EMERG INFECT DIS, V10, P567, DOI 10.3201/eid1003.020626; Forde R, 1920, J TROP MED, V5, P261; Freedman DO, 2009, TROPICAL DIS TRAVELE, P27; Gann LH, 1962, WHITE SETTLERS TROPI, P159; GEAR JHS, 1986, AM J TROP MED HYG, V35, P1146, DOI 10.4269/ajtmh.1986.35.1146; GINSBERG R, 1986, ANN EMERG MED, V15, P86, DOI 10.1016/S0196-0644(86)80496-6; HARRIES AD, 1988, T ROY SOC TROP MED H, V82, P578, DOI 10.1016/0035-9203(88)90516-0; Hide G, 2009, PARASITOLOGY, V136, P1491, DOI 10.1017/S0031182009990333; Jelinek T, 2002, EMERG INFECT DIS, V8, P634, DOI 10.3201/eid0806.010432; JUNYENT JMG, 1987, T ROY SOC TROP MED H, V81, P931, DOI 10.1016/0035-9203(87)90356-7; LEBRAS M, 1979, NOUV PRESSE MED, V8, P1098; LOSCHER T, 1989, DEUT MED WOCHENSCHR, V114, P1203, DOI 10.1055/s-2008-1066741; Malvy D, 2011, CLIN MICROBIOL INFEC, V17, P986, DOI 10.1111/j.1469-0691.2011.03536.x; Meltzer E, 2012, AM J TROP MED HYG, V87, P264, DOI 10.4269/ajtmh.2012.11-0512; Migchelsen SJ, 2011, INT J INFECT DIS, V15, pE517, DOI 10.1016/j.ijid.2011.03.018; NIEMAN RE, 1989, J INFECT DIS, V159, P360, DOI 10.1093/infdis/159.2.360; PIALOUX G, 1988, B SOC PATHOL EXOT, V81, P555; QUINN TC, 1983, ARCH INTERN MED, V143, P1021, DOI 10.1001/archinte.143.5.1021; Richter J, 2012, BMJ-BRIT MED J, V344, P2092; SEAH SKK, 1972, CAN MED ASSOC J, V106, P902; SEAH SKK, 1972, T ROY SOC TROP MED H, V66, P807, DOI 10.1016/0035-9203(72)90108-3; Simarro PP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001007; Simarro PP, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-57; Simarro PP, 2012, J TRAVEL MED, V19, P44, DOI 10.1111/j.1708-8305.2011.00576.x; Simon F, 2012, EMERG INFECT DIS, V18, P165, DOI 10.3201/eid1801.111384; SPENCER HC, 1975, ANN INTERN MED, V82, P633, DOI 10.7326/0003-4819-82-5-633; Stephens JWW, 1910, P R SOC LOND B-CONTA, V83, P28, DOI 10.1098/rspb.1910.0064; STERNER G, 1977, SCAND J INFECT DIS, V9, P154, DOI 10.3109/inf.1977.9.issue-2.21; Steverding D, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-3; TAELMAN H, 1988, B SOC PATHOL EXOT, V81, P578; Tong Jacqueline, 2011, Confl Health, V5, P7, DOI 10.1186/1752-1505-5-7; Urech K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001358; WEINBERG JR, 1989, T ROY SOC TROP MED H, V83, P77, DOI 10.1016/0035-9203(89)90714-1; Wolf T, 2012, EUROSURVEILLANCE, V17, P10	48	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88647	10.1371/journal.pone.0088647	http://dx.doi.org/10.1371/journal.pone.0088647			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586363	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900037
J	Cheng, Y; Liu, Y; Wu, B; Zhang, JZ; Gu, J; Liao, YL; Wang, FK; Mao, XH; Yu, XJ				Cheng, Yan; Liu, Yan; Wu, Bin; Zhang, Jian-zhi; Gu, Jiang; Liao, Ya-ling; Wang, Fu-kun; Mao, Xu-hu; Yu, Xue-jie			Proteomic Analysis of the Ehrlichia chaffeensis Phagosome in Cultured DH82 Cells	PLOS ONE			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; MYCOBACTERIUM-TUBERCULOSIS; LEGIONELLA-PNEUMOPHILA; ENDOPLASMIC-RETICULUM; CROSS-PRESENTATION; MEMBRANE-PROTEINS; APOPTOTIC CELLS; VACUOLAR SYSTEM; MATURATION; MACROPHAGES	Ehrlichia chaffeensis is an obligately intracellular bacterium that resides and multiplies within cytoplasmic vacuoles of phagocytes. The Ehrlichia-containing vacuole (ECV) does not fuse with lysosomes, an essential condition for Ehrlichia to survive inside phagocytes, but the mechanism of inhibiting the fusion of the phagosome with lysosomes is not clear. Understanding the ECV molecular composition may decipher the mechanism by which Ehrlichia inhibits phagosomelysosome fusion. In this study, we obtained highly purified ECVs from E. chaffeensis-infected DH82 cells by sucrose density gradient centrifugation and analyzed their composition by mass spectrometry-based proteomics. The ECV composition was compared with that of phagolysosomes containing latex beads. Lysosomal proteins such as cathepsin D, cathepsin S, and lysosomal acid phosphatase were not detected in E. chaffeensis phagosome preparations. Some small GTPases, involved in membrane dynamics and phagocytic trafficking, were detected in ECVs. A notable finding was that Rab7, a late endosomal marker, was consistently detected in E. chaffeensis phagosomes by mass spectrometry. Confocal microscopy confirmed that E. chaffeensis phagosomes contained Rab7 and were acidified at approximately pH 5.2, suggesting that the E. chaffeensis vacuole was an acidified late endosomal compartment. Our results also demonstrated by mass spectrometry and immunofluorescence analysis that Ehrlichia morulae were not associated with the autophagic pathway. Ehrlichia chaffeensis did not inhibit phagosomes containing latex beads from fusing with lysosomes in infected cells. We concluded that the E. chaffeensis vacuole was a late endosome and E. chaffeensis might inhibit phagosome-lysosome fusion by modifying its vacuolar membrane composition, rather than by regulating the expression of host genes involved in trafficking.	[Cheng, Yan; Gu, Jiang; Liao, Ya-ling; Mao, Xu-hu] Third Mil Med Univ, Coll Med Lab, Dept Clin Microbiol & Immunol, Chongqing, Peoples R China; [Cheng, Yan; Liu, Yan; Wu, Bin; Yu, Xue-jie] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Cheng, Yan; Wang, Fu-kun] Bethune Int Peace Hosp, Shijiazhuang, Peoples R China; [Liu, Yan] Anhui Prov Ctr Dis Control & Prevent, Hefei, Peoples R China; [Wu, Bin] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Zhang, Jian-zhi] Univ Texas Med Branch, Sch Hlth Profess, Galveston, TX 77555 USA; [Yu, Xue-jie] Shandong Univ, Sch Publ Hlth, Jinan 250100, Peoples R China	Army Medical University; University of Texas System; University of Texas Medical Branch Galveston; Jiangsu Provincial Center for Disease Control & Prevention; University of Texas System; University of Texas Medical Branch Galveston; Shandong University	Mao, XH (corresponding author), Third Mil Med Univ, Coll Med Lab, Dept Clin Microbiol & Immunol, Chongqing, Peoples R China.	maoxh2012@hotmail.com; xuyu@UTMB.EDU	Gu, Jiang/AAT-2432-2021; Yu, Xuejie/AAP-9246-2021	Gu, Jiang/0000-0001-8035-4551; 	National Institute of Allergy and Infectious Disease [AI31431]; Natural Science Foundation of China [31200142]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI031431, R01AI031431] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from National Institute of Allergy and Infectious Disease (AI31431) and by a grant from Natural Science Foundation of China (31200142). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; Allen LAH, 1996, J EXP MED, V184, P627, DOI 10.1084/jem.184.2.627; Alvarez-Dominguez C, 1999, J BIOL CHEM, V274, P11459, DOI 10.1074/jbc.274.17.11459; AlvarezDominguez C, 1997, J CELL SCI, V110, P731; Barnewall RE, 1997, INFECT IMMUN, V65, P1455, DOI 10.1128/IAI.65.4.1455-1461.1997; Bottger G, 1996, J BIOL CHEM, V271, P29191, DOI 10.1074/jbc.271.46.29191; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cardoso CM, TRAFFIC, V11, P221; Chong A, 2009, INFECT IMMUN, V77, P4724, DOI 10.1128/IAI.00150-09; Clemens DL, 2000, INFECT IMMUN, V68, P2671, DOI 10.1128/IAI.68.5.2671-2684.2000; Clemens DL, 2000, INFECT IMMUN, V68, P5154, DOI 10.1128/IAI.68.9.5154-5166.2000; Defacque H, 2000, EMBO J, V19, P199, DOI 10.1093/emboj/19.2.199; Ernst JD, 2000, CELL MICROBIOL, V2, P379, DOI 10.1046/j.1462-5822.2000.00075.x; Erwig LP, 2006, P NATL ACAD SCI USA, V103, P12825, DOI 10.1073/pnas.0605331103; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Giodini A, 2009, P NATL ACAD SCI USA, V106, P3324, DOI 10.1073/pnas.0813305106; GREENBERG S, 1991, J CELL BIOL, V113, P757, DOI 10.1083/jcb.113.4.757; GREENBERG S, 1995, TRENDS CELL BIOL, V5, P93, DOI 10.1016/S0962-8924(00)88957-6; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Jahraus A, 1998, J BIOL CHEM, V273, P30379, DOI 10.1074/jbc.273.46.30379; Kinchen JM, 2008, NAT REV MOL CELL BIO, V9, P781, DOI 10.1038/nrm2515; Kinchen JM, 2008, NAT CELL BIOL, V10, P556, DOI 10.1038/ncb1718; Lee BY, MOL CELL PROTEOMICS, V9, P32; Liu Y, 2011, MICROBES INFECT, V13, P232, DOI 10.1016/j.micinf.2010.10.021; LUKACS GL, 1990, J BIOL CHEM, V265, P21099; Mangahas PM, 2008, J CELL BIOL, V180, P357, DOI 10.1083/jcb.200708130; MATSUMOTO A, 1991, J ELECTRON MICROSC, V40, P356; May RC, 2000, NAT CELL BIOL, V2, P246, DOI 10.1038/35008673; May RC, 2001, J CELL SCI, V114, P1061; Mott J, 1999, INFECT IMMUN, V67, P1368, DOI 10.1128/IAI.67.3.1368-1378.1999; Mrowiec T, 2006, BIOL CHEM, V387, P1227, DOI 10.1515/BC.2006.152; MULLER WA, 1980, J CELL BIOL, V86, P292, DOI 10.1083/jcb.86.1.292; MULLER WA, 1980, J CELL BIOL, V86, P304, DOI 10.1083/jcb.86.1.304; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Niu H, 2008, CELL MICROBIOL, V10, P593, DOI 10.1111/j.1462-5822.2007.01068.x; Paddock CD, 2003, CLIN MICROBIOL REV, V16, P37, DOI 10.1128/CMR.16.1.37-64.2003; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; PIZON V, 1994, J CELL SCI, V107, P1661; POPOV VL, 1995, J MED MICROBIOL, V43, P411, DOI 10.1099/00222615-43-6-411; Robinson MS, 1996, CELL, V84, P13, DOI 10.1016/S0092-8674(00)80988-5; Rupper Adam, 2008, V445, P339, DOI 10.1007/978-1-59745-157-4_22; Stuart LM, 2007, NATURE, V445, P95, DOI 10.1038/nature05380; SWANSON MS, 1995, INFECT IMMUN, V63, P3609, DOI 10.1128/IAI.63.9.3609-3620.1995; Thomas S, 2009, PARASITE IMMUNOL, V31, P296, DOI 10.1111/j.1365-3024.2009.01099.x; Tisdale EJ, 1999, MOL BIOL CELL, V10, P1837, DOI 10.1091/mbc.10.6.1837; Tisdale EJ, 1996, J BIOL CHEM, V271, P29372, DOI 10.1074/jbc.271.46.29372; Tjelle TE, 2000, BIOESSAYS, V22, P255, DOI 10.1002/(SICI)1521-1878(200003)22:3<255::AID-BIES7>3.0.CO;2-R; Urwyler S, 2009, TRAFFIC, V10, P76, DOI 10.1111/j.1600-0854.2008.00851.x; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Walker DH, 1997, LAB INVEST, V76, P129	55	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88461	10.1371/journal.pone.0088461	http://dx.doi.org/10.1371/journal.pone.0088461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558391	gold, Green Published, Green Submitted			2022-12-27	WOS:000331706700037
J	Dawsey, SP; Hollenbeck, A; Schatzkin, A; Abnet, CC				Dawsey, Sonja P.; Hollenbeck, Albert; Schatzkin, Arthur; Abnet, Christian C.			A Prospective Study of Vitamin and Mineral Supplement Use and the Risk of Upper Gastrointestinal Cancers	PLOS ONE			English	Article							NUTRITION INTERVENTION TRIAL; GASTRIC-CANCER; ESOPHAGEAL ADENOCARCINOMA; ANTIOXIDANT SUPPLEMENTS; NATIONAL INSTITUTES; BARRETTS-ESOPHAGUS; MULTIVITAMIN USE; FOLLOW-UP; MORTALITY; PREVENTION	We examined the association of use of multivitamins or single vitamin/mineral supplements with risk of four upper gastrointestinal cancers in the NIH-AARP Diet and Health Study cohort with 11 years of follow-up. After exclusions, 490,593 persons were included in our analytic cohort and 1780 upper gastrointestinal cancers were accrued. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using Cox models with adjustment for potential confounders. We observed no significant associations between multivitamin use and risk for the four cancer outcomes in crude or adjusted models. Among individual vitamin or mineral supplements, use of iron supplements was associated with significantly lower risk of esophageal adenocarcinoma (HR = 0.68, 95% CI = 0.49 to 0.94) and a significantly increased risk of gastric noncardia adenocarcinoma (HR = 1.59, 95% CI = 1.24 to 2.05). For gastric noncardia adenocarcinoma, we saw associations with zinc use (HR = 1.28, 95% CI = 1.01 to 1.62) and vitamin C use (HR = 0.79 95% CI = 0.65 to 0.96). Calcium use, some of which was reported as antacids and used to treat reflux disease, was associated with higher risk of esophageal adenocarcinoma (HR = 1.27, 95% CI = 1.06 to 1.52) and gastric cardia adenocarcinoma (HR = 1.27, 95% CI = 1.03 to 1.56) cancers. We saw no evidence that multivitamin use was associated with reduced risk of four highly fatal upper gastrointestinal cancers, but there were some differences in risk with reported use of individual supplements.	[Dawsey, Sonja P.; Schatzkin, Arthur; Abnet, Christian C.] NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA; [Hollenbeck, Albert] AARP, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American Association of Retired Persons (AARP)	Abnet, CC (corresponding author), NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA.	abnetc@mail.nih.gov	Hollenbeck, Albert/AAG-9461-2020; Abnet, Christian C/C-4111-2015	Abnet, Christian C/0000-0002-3008-7843; Dawsey, Sonja/0000-0003-1605-3994	NIH, National Cancer Institute	NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the intramural research program of the NIH, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WF, 2010, JAMA-J AM MED ASSOC, V303, P1723, DOI 10.1001/jama.2010.496; Bailey RL, 2010, J NUTR, V140, P817, DOI 10.3945/jn.109.118539; BARONE J, 1992, NUTR CANCER, V18, P31, DOI 10.1080/01635589209514202; Bjelakovic G, 2004, LANCET, V364, P1219, DOI 10.1016/S0140-6736(04)17138-9; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Chen XX, 1999, CARCINOGENESIS, V20, P1801, DOI 10.1093/carcin/20.9.1801; Corley DA, 2008, AM J GASTROENTEROL, V103, P2997, DOI 10.1111/j.1572-0241.2008.02156.x; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Dong LM, 2008, NUTR CANCER, V60, P39, DOI 10.1080/01635580701586762; Duan L, 2009, CANCER EPIDEM BIOMAR, V18, P526, DOI 10.1158/1055-9965.EPI-08-0764; Duffield-Lillico AJ, 2002, CANCER EPIDEM BIOMAR, V11, P630; Farrow DC, 2000, CANCER CAUSE CONTROL, V11, P231, DOI 10.1023/A:1008913828105; Freedman ND, 2007, AM J EPIDEMIOL, V165, P1424, DOI 10.1093/aje/kwm051; HANSSON LE, 1994, INT J CANCER, V57, P638, DOI 10.1002/ijc.2910570505; Jacobs EJ, 2002, CANCER EPIDEM BIOMAR, V11, P35; Kamangar F, 2009, GASTROENTEROL CLIN N, V38, P27, DOI 10.1016/j.gtc.2009.01.004; Lam TK, 2013, AM J CLIN NUTR, V98, P1289, DOI 10.3945/ajcn.113.061267; Larsson SC, 2007, AM J CLIN NUTR, V85, P497, DOI 10.1093/ajcn/85.2.497; Lawson KA, 2007, J NATL CANCER I, V99, P754, DOI 10.1093/jnci/djk177; LI JY, 1993, J NATL CANCER I, V85, P1492, DOI 10.1093/jnci/85.18.1492; Mark SD, 2000, J NATL CANCER I, V92, P1753, DOI 10.1093/jnci/92.21.1753; Michaud D, 2005, J REGISTRY MANAGE, V2, P70; Neuhouser ML, 2009, ARCH INTERN MED, V169, P294, DOI 10.1001/archinternmed.2008.540; O'Rorke MA, 2012, INT J CANCER, V131, P1882, DOI 10.1002/ijc.27434; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Qiao YL, 2009, JNCI-J NATL CANCER I, V101, P507, DOI 10.1093/jnci/djp037; Rock CL, 2007, AM J CLIN NUTR, V85, p277S, DOI 10.1093/ajcn/85.1.277S; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; Steevens J, 2010, GASTROENTEROLOGY, V138, P1704, DOI 10.1053/j.gastro.2009.12.004; Terry P, 2000, INT J CANCER, V87, P750, DOI 10.1002/1097-0215(20000901)87:5&lt;750::AID-IJC19&gt;3.0.CO;2-6; Wang JB, 2013, JAMA INTERN MED, V173, P1259, DOI 10.1001/jamainternmed.2013.6066; Whiteman DC, 2008, GUT, V57, P173, DOI 10.1136/gut.2007.131375	32	21	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88774	10.1371/journal.pone.0088774	http://dx.doi.org/10.1371/journal.pone.0088774			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558423	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700069
J	Proenca-Ferreira, R; Brugnerotto, AF; Garrido, VT; Dominical, VM; Vital, DM; Ribeiro, MDR; dos Santos, ME; Traina, F; Olalla-Saad, ST; Costa, FF; Conran, N				Proenca-Ferreira, Renata; Brugnerotto, Ana Flavia; Garrido, Vanessa Tonin; Dominical, Venina Marcela; Vital, Daiana Morelli; Reis Ribeiro, Marilene de Fatima; dos Santos, Melissa Ercolin; Traina, Fabiola; Olalla-Saad, Sara T.; Costa, Fernando Ferreira; Conran, Nicola			Endothelial Activation by Platelets from Sickle Cell Anemia Patients	PLOS ONE			English	Article							KAPPA-B; POTENTIAL ROLE; STEADY-STATE; DISEASE; MONOCYTES; PLASMA; PATHOPHYSIOLOGY; VASOOCCLUSION; EPTIFIBATIDE; COAGULATION	Sickle cell anemia (SCA) is associated with a hypercoagulable state. Increased platelet activation is reported in SCA and SCA platelets may present augmented adhesion to the vascular endothelium, potentially contributing to the vaso-occlusive process. We sought to observe the effects of platelets (PLTs) from healthy control (CON) individuals and SCA individuals on endothelial activation, in vitro. Human umbilical vein endothelial cells (HUVEC) were cultured, in the presence, or not, of washed PLTs from CON or steady-state SCA individuals. Supernatants were reserved for cytokine quantification, and endothelial adhesion molecules (EAM) were analyzed by flow cytometry; gene expressions of ICAM1 and genes of the NF-kappa B pathway were analyzed by qPCR. SCA PLTs were found to be more inflammatory, displaying increased adhesive properties, an increased production of IL-1 beta and a tendency towards elevated expressions of P-selectin and activated alpha(IIbb)beta(3). Following culture in the presence of SCA PLTs, HUVEC presented significant augmentations in the expressions of the EAM, ICAM-1 and E-selectin, as well as increased IL-8 production and increased ICAM1 and NFKB1 (encodes p50 subunit of NF-kappa B) gene expressions. Interestingly, transwell inserts abolished the effects of SCA PLTs on EAM expression. Furthermore, an inhibitor of the NF-kappa B pathway, BAY 11-7082, also prevented the induction of EAM expression on the HUVEC surface by SCA PLTs. In conclusion, we find further evidence to indicate that platelets circulate in an activated state in sickle cell disease and are capable of stimulating endothelial cell activation. This effect appears to be mediated by direct contact, or even adhesion, between the platelets and endothelial cells and via NF kappa B-dependent signaling. As such, activated platelets in SCD may contribute to endothelial activation and, therefore, to the vaso-occlusive process. Results provide further evidence to support the use of anti-platelet approaches in association with other therapies for SCD.	[Proenca-Ferreira, Renata; Brugnerotto, Ana Flavia; Garrido, Vanessa Tonin; Dominical, Venina Marcela; Vital, Daiana Morelli; Traina, Fabiola; Olalla-Saad, Sara T.; Costa, Fernando Ferreira; Conran, Nicola] Univ Campinas UNICAMP, Sch Med, INCT Sangue, Haematol & Haemotherapy Ctr, Campinas, SP, Brazil; [Reis Ribeiro, Marilene de Fatima; dos Santos, Melissa Ercolin] Childrens Ctr Hematol Invest, Campinas, SP, Brazil; [Traina, Fabiola] Univ Sao Paulo, Riberao Preto Med Sch, Dept Internal Med, BR-14049 Ribeirao Preto, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo	Conran, N (corresponding author), Univ Campinas UNICAMP, Sch Med, INCT Sangue, Haematol & Haemotherapy Ctr, Campinas, SP, Brazil.	conran@unicamp.br	Conran, Nicola/B-8961-2012; Costa, Fernando F/D-1566-2012; Traina, Fabiola/U-1451-2019; Traina, Fabiola/L-3809-2014; CTC USP, CEPID 13 18/J-8951-2014	Conran, Nicola/0000-0001-5726-7919; Costa, Fernando F/0000-0002-4632-572X; Traina, Fabiola/0000-0003-4258-289X; Traina, Fabiola/0000-0003-4258-289X; CTC USP, CEPID 13 18/0000-0002-7123-9524	FAPESP [2008/57441-0, 2009/54279-0]; CNPq; INCT do Sangue	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT do Sangue	This work was supported by FAPESP (grants 2008/57441-0 and 2009/54279-0), CNPq, and INCT do Sangue. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 2007, ARCH NEUROL-CHICAGO, V64, P1567, DOI 10.1001/archneur.64.11.1567; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Belcher JD, 2000, BLOOD, V96, P2451, DOI 10.1182/blood.V96.7.2451.h8002451_2451_2459; Browne PV, 1996, AM J HEMATOL, V51, P296, DOI 10.1002/(SICI)1096-8652(199604)51:4<296::AID-AJH8>3.0.CO;2-R; CHAPLIN H, 1980, THROMB HAEMOSTASIS, V43, P218; CHAPLIN H JR, 1989, East African Medical Journal, V66, P574; Charneski L, 2010, AM J HEALTH-SYST PH, V67, P895, DOI 10.2146/ajhp090229; Colella MP, 2012, J THROMB HAEMOST, V10, P1967, DOI 10.1111/j.1538-7836.2012.04861.x; Conran N, 2009, HEMOGLOBIN, V33, P1, DOI 10.1080/03630260802625709; Desai PC, 2013, THROMB RES, V132, P341, DOI 10.1016/j.thromres.2013.08.002; Epinat JC, 1999, ONCOGENE, V18, P6896, DOI 10.1038/sj.onc.1203218; FINCO TS, 1995, IMMUNITY, V3, P263, DOI 10.1016/1074-7613(95)90112-4; FRANCIS RB, 1989, HAEMOSTASIS, V19, P105; Garrido VT, 2012, BRIT J HAEMATOL, V158, P788, DOI 10.1111/j.1365-2141.2012.09218.x; Hidalgo A, 2009, NAT MED, V15, P384, DOI 10.1038/nm.1939; Jakubowski JA, 2013, BRIT J CLIN PHARMACO, V75, P1433, DOI 10.1111/bcp.12042; KENNY MW, 1980, J CLIN PATHOL, V33, P622, DOI 10.1136/jcp.33.7.622; Laffont B, 2013, BLOOD, V122, P253, DOI 10.1182/blood-2013-03-492801; Lee SP, 2007, BRIT J HAEMATOL, V139, P612, DOI 10.1111/j.1365-2141.2007.06787.x; Lee SP, 2006, ARTERIOSCL THROM VAS, V26, P1626, DOI 10.1161/01.ATV.0000220374.00602.a2; MEHTA P, 1980, J PEDIATR-US, V96, P209, DOI 10.1016/S0022-3476(80)80804-3; Noubouossie DC, 2013, EUR J HAEMATOL; Novelli EM, 2012, AM J HEMATOL, V87, P326, DOI 10.1002/ajh.22274; OSAMO NO, 1981, ACTA HAEMATOL-BASEL, V66, P102, DOI 10.1159/000207105; PETERS M, 1994, THROMB HAEMOSTASIS, V71, P169; Polanowska-Grabowska R, 2010, ARTERIOSCL THROM VAS, V30, P2392, DOI 10.1161/ATVBAHA.110.211615; Proenca-Ferreira R, 2010, BRIT J HAEMATOL, V149, P280, DOI 10.1111/j.1365-2141.2010.08087.x; Sakamoto TM, 2013, CLIN BIOCH; Setty BNY, 2012, BRIT J HAEMATOL, V157, P370, DOI 10.1111/j.1365-2141.2012.09065.x; Setty BNY, 2001, BLOOD, V98, P3228, DOI 10.1182/blood.V98.12.3228; Setty BNY, 2000, BLOOD, V96, P1119, DOI 10.1182/blood.V96.3.1119; Solovey A, 1998, J CLIN INVEST, V101, P1899, DOI 10.1172/JCI1932; Sparkenbaugh E, 2013, BR J HAEMATOL; Stuart MJ, 2004, LANCET, V364, P1343, DOI 10.1016/S0140-6736(04)17192-4; Stuart MJ, 2001, PEDIATR PATHOL MOL M, V20, P27, DOI 10.1080/15513810109168816; Tomer A, 2004, J BIOL REG HOMEOS AG, V18, P172; Tomer A, 2001, J LAB CLIN MED, V137, P398, DOI 10.1067/mlc.2001.115450; TRIADOU P, 1990, NOUV REV FR HEMATOL, V32, P137; Villagra J, 2007, BLOOD, V110, P2166, DOI 10.1182/blood-2006-12-061697; Wun T, 1997, J LAB CLIN MED, V129, P507, DOI 10.1016/S0022-2143(97)90005-6; Wun T, 1998, BRIT J HAEMATOL, V100, P741, DOI 10.1046/j.1365-2141.1998.00627.x; Wun T, 2002, CLIN LAB HAEMATOL, V24, P81; Wun T, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-17	43	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89012	10.1371/journal.pone.0089012	http://dx.doi.org/10.1371/journal.pone.0089012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551209	Green Published, gold, Green Submitted			2022-12-27	WOS:000331266000090
J	Wu, L; Fu, ZH; Zhou, SJ; Gong, JP; Liu, CA; Qiao, ZR; Li, SW				Wu, Lun; Fu, Zhihao; Zhou, Shiji; Gong, Jianping; Liu, Chang An; Qiao, Zhengrong; Li, Shengwei			HIF-1 alpha and HIF-2 alpha: Siblings in Promoting Angiogenesis of Residual Hepatocellular Carcinoma after High-Intensity Focused Ultrasound Ablation	PLOS ONE			English	Article							INDUCIBLE FACTOR 1-ALPHA; ENDOTHELIAL GROWTH-FACTOR; RADIOFREQUENCY ABLATION; VASCULOGENIC MIMICRY; EPHA2 OVEREXPRESSION; TUMOR ANGIOGENESIS; HYPOXIA; EXPRESSION; MECHANISMS; VEGF	Background: High-intensity focused ultrasound (HIFU) is a widely applied to treatment for unresectable hepatocellular carcinoma. However, insufficient HIFU can result in rapid progression of the residual tumor. The mechanism of such rapid growth of the residual tumor after HIFU ablation is poorly understood. Objective: The aim of this study was to investigate the dynamic angiogenesis of residual tumor, and the temporal effect and mechanism of the HIF-1, 2 alpha in the residual tumor angiogenesis. Methods: Xenograft tumors of HepG2 cells were created by subcutaneously inoculating nude mice (athymic BALB/c nu/nu mice) with hepatoma cells. About thirty days after inoculation, all mice (except control group) were treated by HIFU and assigned randomly to 7 groups according to various time intervals (1st, 3rd, 5th day (d) and 1st, 2nd, 3rd, 4th week (w)). The residual tumor tissues were obtained from the experimental groups at various time points. Protein levels of HIF-1 alpha, HIF-2 alpha, VEGF-A, and EphA2 were quantified by immunohistochemistry analysis and Western Blot assays, and mRNA levels measured by Q-PCR. Microvascular density was calculated with counting of CD31 positive vascular endothelial cells by immunohistochemical staining. Results: Compared with the control group, protein and mRNA levels of HIF-1 alpha reached their highest levels on the 3rd day (P<0.01), then decreased (P<0.05). HIF-2 alpha expression reached its highest level on the 2nd week compared with control group (P<0.01), then decreased (2w-4w) (P<0.05). The protein and mRNA levels of VEGF-A and EphA2 in the residual tumor tissues group that received HIFU were significantly decreased until 1 week compared with the control group (P<0.01). However, the levels increased compared to controls in 2-4 weeks (P<0.05). Similar results were obtained for MVD expression (P<0.05). Conclusion: Insufficient HIFU ablation promotes the angiogenesis in residual carcinoma tissue over time. The data indicate that the HIF-1, 2 alpha/VEGFA/EphA2 pathway is involved.	[Wu, Lun; Fu, Zhihao; Gong, Jianping; Liu, Chang An; Li, Shengwei] Chongqing Med Univ, Affiliated Hosp 2, Dept Hepatobiliary Surg, Chongqing Key Lab Hepatobiliary Surg, Chongqing, Peoples R China; [Zhou, Shiji] Chongqing Med Univ, Affiliated Hosp 2, Dept Gastrointestinal Surg, Chongqing, Peoples R China; [Qiao, Zhengrong] Peoples Five Hosp Chongqing, Dept Gen Surg, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Li, SW (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Hepatobiliary Surg, Chongqing Key Lab Hepatobiliary Surg, Chongqing, Peoples R China.	lishengwei11@163.com	周, 世骥/AIA-4309-2022		National Natural Scientific Foundation of China [81272570]; Municipal Health Burean Science Foundation of Chongqing [2012-1-040, 2010-1-68]; National Natural Science Fund for Young [81301975]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Municipal Health Burean Science Foundation of Chongqing; National Natural Science Fund for Young	This research was supported by National Natural Scientific Foundation of China (No. 81272570), Municipal Health Burean Science Foundation of Chongqing (2012-1-040, 2010-1-68), and National Natural Science Fund for Young (81301975). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altun M, 2012, J BIOL CHEM, V287, P1962, DOI 10.1074/jbc.M111.305615; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bertout JA, 2009, P NATL ACAD SCI USA, V106, P14391, DOI 10.1073/pnas.0907357106; Brantley DM, 2002, ONCOGENE, V21, P7011, DOI 10.1038/sj.onc.1205679; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chan ACY, 2013, ANN SURG, V257, P686, DOI 10.1097/SLA.0b013e3182822c02; Chen DL, 2003, J BIOL CHEM, V278, P13595, DOI 10.1074/jbc.C200694200; Cheng N, 2002, MOL CANCER RES, V1, P2; Cheng N, 2003, NEOPLASIA, V5, P445, DOI 10.1016/S1476-5586(03)80047-7; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Fan YZ, 2010, WORLD J GASTRO SURG, V2, P117, DOI 10.4240/wjgs.v2.i4.117; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; He CJ, 2012, CANCER SCI, V103, P528, DOI 10.1111/j.1349-7006.2011.02177.x; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Jin-Lu M, 2011, BIOCHEM BIOPH RES CO, V408, P686, DOI 10.1016/j.bbrc.2011.04.089; Kaseb AO, 2009, CANCER-AM CANCER SOC, V115, P4895, DOI 10.1002/cncr.24537; Ke S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-73; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kong J, 2012, PLOS ONE, V7; Lu C, 2008, CANCER BIOL THER, V7, P1098, DOI 10.4161/cbt.7.7.6168; Merritt WM, 2010, CANCER BIOL THER, V10, P1306, DOI 10.4161/cbt.10.12.13582; Moeller BJ, 2005, CANCER CELL, V8, P99, DOI 10.1016/j.ccr.2005.06.016; Nilsson H, 2005, EXP CELL RES, V303, P447, DOI 10.1016/j.yexcr.2004.10.003; Ogawa K, 2000, ONCOGENE, V19, P6043, DOI 10.1038/sj.onc.1204004; Pan Y, 2004, ONCOGENE, V23, P4975, DOI 10.1038/sj.onc.1207657; Skuli N, 2012, J CLIN INVEST, V122, P1427, DOI 10.1172/JCI57322; Sun BC, 2007, CANCER LETT, V249, P188, DOI 10.1016/j.canlet.2006.08.016; Takeda N, 2010, GENE DEV, V24, P491, DOI 10.1101/gad.1881410; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tian T, 2010, CARCINOGENESIS, V31, P1211, DOI 10.1093/carcin/bgq085; VECCHIETTI V, 1979, FARMACO-ED SCI, V34, P829; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; [王璐 Wang Lu], 2011, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V31, P314; Xiang ZL, 2011, CLIN CANCER RES, V17, P5463, DOI 10.1158/1078-0432.CCR-10-3096; Yang P, 2009, HEPATOL RES, V39, P1169, DOI 10.1111/j.1872-034X.2009.00563.x; Zagzag D, 2000, CANCER-AM CANCER SOC, V88, P2606, DOI 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W; Zhou HB, 2011, JPN J RADIOL, V29, P615, DOI 10.1007/s11604-011-0603-9; Zhou JW, 2010, J OBSTET GYNAECOL RE, V36, P232, DOI 10.1111/j.1447-0756.2010.01196.x; Zhu GQ, 2010, CLIN CANCER RES, V16, P4732, DOI 10.1158/1078-0432.CCR-10-1408; Zhu H, 2011, CANCER BIOL THER, V11, P981, DOI 10.4161/cbt.11.11.15707	46	20	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88913	10.1371/journal.pone.0088913	http://dx.doi.org/10.1371/journal.pone.0088913			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551189	gold, Green Published, Green Submitted			2022-12-27	WOS:000331266000082
J	Song, Y; Lan, ZJ; Kohn, MH				Song, Ying; Lan, Zhenjiang; Kohn, Michael H.			Mitochondrial DNA Phylogeography of the Norway Rat	PLOS ONE			English	Article							WARFARIN-RESISTANCE; SUBSPECIFIC ORIGIN; POPULATION-GROWTH; MICE; MUTATIONS; ANTICOAGULANTS; POLYMORPHISM; NEUTRALITY; INFERENCE; LOCUS	Central Eastern Asia, foremost the area bordering northern China and Mongolia, has been thought to be the geographic region where Norway rats (Rattus norvegicus) have originated. However recent fossil analyses pointed to their origin in southern China. Moreover, whereas analyses of fossils dated the species' origin as,1.2-1.6 million years ago (Mya), molecular analyses yielded,0.5-2.9 Mya. Here, to study the geographic origin of the Norway rat and its spread across the globe we analyzed new and all published mitochondrial DNA cytochrome-b (cyt-b; N = 156) and D-loop (N = 212) sequences representing wild rats from four continents and select inbred strains. Our results are consistent with an origin of the Norway rat in southern China similar to 1.3 Mya, subsequent prehistoric differentiation and spread in China and Asia from an initially weakly structured ancestral population, followed by further spread and differentiation across the globe during historic times. The recent spreading occurred mostly from derived European populations rather than from archaic Asian populations. We trace laboratory strains to wild lineages from Europe and North America and these represent a subset of the diversity of the rat; leaving Asian lineages largely untapped as a resource for biomedical models. By studying rats from Europe we made the observation that mtDNA diversity cannot be interpreted without consideration of pest control and, possibly, the evolution of rodenticide resistance. However, demographic models explored by forward-time simulations cannot fully explain the low mtDNA diversity of European rats and lack of haplotype sharing with their source from Asia. Comprehensive nuclear marker analyses of a larger sample of Norway rats representing the world are needed to better resolve the evolutionary history of wild rats and of laboratory rats, as well as to better understand the evolution of anticoagulant resistance.	[Song, Ying; Lan, Zhenjiang; Kohn, Michael H.] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77251 USA; [Song, Ying] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Song, Ying] Chinese Acad Agr Sci, Inst Plant Protect, Key Lab Weed & Rodent Biol & Management, Beijing 100193, Peoples R China	Rice University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Kohn, MH (corresponding author), Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77251 USA.	hmkohn@rice.edu	Song, Ying/ABE-1050-2021	Song, Ying/0000-0001-5371-315X	National Institute of Health, National Heart, Lung and Blood Institute [R01HL091007-01A1-2]; Reckitt Benckiser Group plc.; Rice Startup funds; Reckitt Benckiser Group; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091007] Funding Source: NIH RePORTER	National Institute of Health, National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Reckitt Benckiser Group plc.; Rice Startup funds; Reckitt Benckiser Group; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was partially funded by R01HL091007-01A1-2 from the National Institute of Health, National Heart, Lung and Blood Institute, and funds from the Reckitt Benckiser Group plc., and Rice Startup funds, all to MHK. There are no conflicts of interest to declare, albeit the study was partly funded by the Reckitt Benckiser Group, and no patents, products in development or marketed products emerge from the study. The authors adhere to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin K.P., 2003, RATS MICE PEOPLE ROD; Aplin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026357; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BOYLE CM, 1960, NATURE, V188, P517, DOI 10.1038/188517a0; Burland T G, 2000, Methods Mol Biol, V132, P71; Canzian F, 1997, GENOME RES, V7, P262, DOI 10.1101/gr.7.3.262; Jin C, 2008, SPECTROSC SPECT ANAL, V28, P28; Chepko-Sade BD, 1987, MAMMALIAN DISPERSAL; Diaz JC, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-43; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; ESRI, 2012, ARCMAP 10 1; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fu YX, 1997, GENETICS, V147, P915; Geraldes A, 2008, MOL ECOL, V17, P5349, DOI 10.1111/j.1365-294X.2008.04005.x; Grandemange A, 2010, PEST MANAG SCI, V66, P270, DOI 10.1002/ps.1869; GREAVES JH, 1977, GENET RES, V30, P257, DOI 10.1017/S0016672300017663; Hansen V, 2012, SILK ROAD; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hedrich HJ, 2000, HDB EXPT ANIMALS, P1871; JACKSON WB, 1972, SCIENCE, V176, P1343, DOI 10.1126/science.176.4041.1343; Jones EP, 2013, TRENDS GENET, V29, P298, DOI 10.1016/j.tig.2012.11.011; Kohn MH, 1999, MAMM GENOME, V10, P696, DOI 10.1007/s003359901073; Kohn MH, 2003, GENETICS, V164, P1055; Kohn MH, 2000, P NATL ACAD SCI USA, V97, P7911, DOI 10.1073/pnas.97.14.7911; Li T, 2004, NATURE, V427, P541, DOI 10.1038/nature02254; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin XD, 2012, J VIROL, V86, P972, DOI 10.1128/JVI.00725-11; Long JL, 2003, INTRO MAMMALS WORLD; Lydekker R, 1896, HDB BRIT MAMMALIA; Matisoo-Smith E, 1998, P NATL ACAD SCI USA, V95, P15145, DOI 10.1073/pnas.95.25.15145; Pelz HJ, 2012, PEST MANAG SCI, V68, P254, DOI 10.1002/ps.2254; Pelz HJ, 2005, GENETICS, V170, P1839, DOI 10.1534/genetics.104.040360; Peng B, 2005, BIOINFORMATICS, V21, P3686, DOI 10.1093/bioinformatics/bti584; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prager EM, 1998, GENETICS, V150, P835; Rajabi-Maham H, 2008, MOL ECOL, V17, P627, DOI 10.1111/j.1365-294X.2007.03601.x; Rambaut A., 2007, TRACER V1 5; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Robins JH, 2008, MOL PHYLOGENET EVOL, V49, P460, DOI 10.1016/j.ympev.2008.08.001; Robins JH, 2007, MOL ECOL NOTES, V7, P717, DOI 10.1111/j.1471-8286.2007.01752.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; Rost S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-4; Rozen S, 2000, Methods Mol Biol, V132, P365; Schneider S, 1999, GENETICS, V152, P1079; Searle JB, 2009, P ROY SOC B-BIOL SCI, V276, P201, DOI 10.1098/rspb.2008.0958; Suckow MA, 2005, LAB RAT; TAJIMA F, 1989, GENETICS, V123, P585; TELLE H, 1971, WHO B, V45, P331; Verneau O, 1998, P NATL ACAD SCI USA, V95, P11284, DOI 10.1073/pnas.95.19.11284; Wu X, 2012, RES CHINAS FRONTIER, V11, P344; Yang H, 2007, NAT GENET, V39, P1100, DOI 10.1038/ng2087; Yang HN, 2011, NAT GENET, V43, P648, DOI 10.1038/ng.847; Yu Y., 2013, RASP RECONSTRUCT ANC	55	32	36	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e88425	10.1371/journal.pone.0088425	http://dx.doi.org/10.1371/journal.pone.0088425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586325	gold, Green Published, Green Submitted			2022-12-27	WOS:000332396200018
J	Akesson, S; Weimerskirch, H				Akesson, Susanne; Weimerskirch, Henri			Evidence for Sex-Segregated Ocean Distributions of First-Winter Wandering Albatrosses at Crozet Islands	PLOS ONE			English	Article							PELAGIC SEABIRDS; WIND; ORIENTATION; MIGRATION; NAVIGATION; MIGRANTS; INITIATION; PATTERN; CUES	The highly mobile wandering albatrosses (Diomedea exulans) are adapted to navigate the extreme environment of the Southern Ocean and return to isolated islands to breed. Each year they cover several hundreds of thousands of kilometers during travels across the sea. Little is known about the dispersal flights and migration of young albatrosses. We tracked, by satellite telemetry, the departure dispersal of 13 juvenile wandering albatrosses from the Crozet Islands and compared them with tracks of 7 unrelated adults during the interbreeding season. We used the satellite tracks to identify different behavioural steps of the inherited migration program used by juvenile wandering albatrosses during their first solo-migration. Our results show that the juvenile wandering albatrosses from Crozet Islands moved to sex-specific foraging zones of the ocean using at departures selectively the wind. The results suggest that the inherited migration program used by the juvenile wandering albatrosses encode several distinct steps, based on inherited preferred departure routes, differences in migration distance between sexes, and selective use of winds. During long transportation flights the albatrosses were influenced by winds and both adult and juveniles followed approximate loxodrome (rhumbline) routes coinciding with the foraging zone and the specific latitudes of their destination areas. During the long segments of transportation flights across open seas the juveniles selected routes at more northerly latitudes than adults.	[Akesson, Susanne] Lund Univ, Dept Biol, Lund, Sweden; [Weimerskirch, Henri] CNRS, Ctr Etud Biol Chize, Villiers En Bois, France	Lund University; Centre National de la Recherche Scientifique (CNRS)	Akesson, S (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	susanne.akesson@biol.lu.se	Weimerskirch, Henri/F-5562-2013; Weimerskirch, Henri/K-7306-2019; Akesson, Susanne/F-3175-2015	Weimerskirch, Henri/0000-0002-0457-586X; Akesson, Susanne/0000-0001-9039-2180	Swedish Research Council [621-2004-1686, 621-2007-5930, 621-2010-5584]; Tryggers Foundation; Institut Polaire Paul Emile Victor (IPEV) [109]; Centre for Animal Movements Research (CAnMove); Linnaeus grant from the Swedish Research Council [349-2007-8690]; Lund University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Tryggers Foundation; Institut Polaire Paul Emile Victor (IPEV); Centre for Animal Movements Research (CAnMove); Linnaeus grant from the Swedish Research Council; Lund University	Financial support was received from the Swedish Research Council (No. 621-2004-1686, 621-2007-5930, 621-2010-5584) and Tryggers Foundation (to S. Akesson) and from Institut Polaire Paul Emile Victor (IPEV, program No109; to H. Weimerskirch). This is a report with support from the Centre for Animal Movements Research (CAnMove) financed by a Linnaeus grant (No. 349-2007-8690) from the Swedish Research Council and Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able K.P., 1980, P283; Akesson S, 2005, J NAVIGATION, V58, P365, DOI 10.1017/S0373463305003401; Akesson S, 2003, AVIAN MIGRATION, P471; Akesson S, 2000, BEHAV ECOL SOCIOBIOL, V47, P140, DOI 10.1007/s002650050004; Akesson S, 1996, TRENDS ECOL EVOL, V11, P398, DOI 10.1016/0169-5347(96)30040-2; Akesson S, 2002, J AVIAN BIOL, V33, P349, DOI 10.1034/j.1600-048X.2002.02951.x; Akesson S, 1998, J AVIAN BIOL, V29, P618, DOI 10.2307/3677182; Akesson S, 2001, ANIM BEHAV, V61, P181, DOI 10.1006/anbe.2000.1562; Akesson S, 2007, BIOSCIENCE, V57, P123, DOI 10.1641/B570207; ALERSTAM T, 1993, PHILOS T ROY SOC B, V340, P55, DOI 10.1098/rstb.1993.0048; Alerstam T, 1996, J EXP BIOL, V199, P9; Batschelet E, 1981, CIRCULAR STAT BIOL; Belkin IM, 1996, J GEOPHYS RES-OCEANS, V101, P3675, DOI 10.1029/95JC02750; Berthold P, 1996, CONTROL BIRD MIGRATI; Bonadonna F, 2003, AVIAN MIGRATION, P367; Emlen S. T., 1975, AVIAN BIOL, VV, P129; Fransson T, 2005, J AVIAN BIOL, V36, P6, DOI 10.1111/j.0908-8857.2005.03471.x; Fransson T, 2001, NATURE, V414, P35, DOI 10.1038/35102115; Green M, 2004, ARDEA, V92, P145; Gudmundsson GA, 1998, J AVIAN BIOL, V29, P597, DOI 10.2307/3677180; Gwinner E., 1986, CIRCANNUAL RHYTHMS E; Imboden C., 1972, Vogelwarte, V26, P336; JOUVENTIN P, 1990, NATURE, V343, P746, DOI 10.1038/343746a0; Ketterson E.D., 1983, Current Ornithology, V1, P357; KREITHEN ML, 1974, J COMP PHYSIOL, V89, P73, DOI 10.1007/BF00696164; Nichols J., 2001, DISPERSAL; Papi F, 1996, J EXP BIOL, V199, P65; RABOL J, 1978, OIKOS, V30, P216, DOI 10.2307/3543481; Schaub M, 2004, ANIM BEHAV, V67, P229, DOI 10.1016/j.anbehav.2003.03.011; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Shaffer SA, 2001, FUNCT ECOL, V15, P203, DOI 10.1046/j.1365-2435.2001.00514.x; Snyder JP, 1997, FLATTENING EARTH 200; Thorup K, 2001, J AVIAN BIOL, V32, P111, DOI 10.1034/j.1600-048X.2001.320203.x; WARHAM J, 1990, PETRELS THEIR ECOLOG; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; WEIMERSKIRCH H, 1994, P ROY SOC B-BIOL SCI, V255, P91, DOI 10.1098/rspb.1994.0013; Weimerskirch H, 2000, NATURE, V406, P955, DOI 10.1038/35023068; Weimerskirch H, 2006, J AVIAN BIOL, V37, P23, DOI 10.1111/j.2006.0908-8857.03675.x; Weimerskirch H, 2002, SCIENCE, V295, P1259, DOI 10.1126/science.1068034; WEIMERSKIRCH H, 1993, AUK, V110, P325; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270; Wiltschko R., 1995, TIEROSYCHOL; Wood AG, 2000, J AVIAN BIOL, V31, P278, DOI 10.1034/j.1600-048X.2000.310302.x; WORTON BJ, 1995, J WILDLIFE MANAGE, V59, P794, DOI 10.2307/3801959	44	28	28	5	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e86779	10.1371/journal.pone.0086779	http://dx.doi.org/10.1371/journal.pone.0086779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586254	gold, Green Submitted, Green Published			2022-12-27	WOS:000332390800002
J	Joe, Y; Uddin, MJ; Zheng, M; Kim, HJ; Chen, Y; Yoon, NA; Cho, GJ; Park, JW; Chung, HT				Joe, Yeonsoo; Uddin, Md. Jamal; Zheng, Min; Kim, Hyo Jeong; Chen, Yingqing; Yoon, Nal Ae; Cho, Gyeong Jae; Park, Jeong Woo; Chung, Hun Taeg			Tristetraprolin Mediates Anti-Inflammatory Effect of Carbon Monoxide against DSS-Induced Colitis	PLOS ONE			English	Article							DEXTRAN SULFATE SODIUM; INTESTINAL INFLAMMATION; ULCERATIVE-COLITIS; MICE; MACROPHAGES; DISEASE; ALPHA; LIPOPOLYSACCHARIDE; INHIBITION; MOLECULES	Endogenous carbon monoxide (CO) exerts anti-inflammatory effects. Tristetraprolin (TTP) is known to destabilize proinflammatory transcripts. Here we found that exogenous CO enhanced the decay of TNF-alpha mRNA and suppressed TNF-alpha expression in LPS-activated macrophages from wild-type (WT) mice. However, TTP deficiency abrogated the effects of exogenous CO. While CO treatment prior to DSS administration in WT mice significantly reduced inflammatory cytokine levels and colitis, it failed to reduce the pro-inflammatory cytokine levels and colitis in TTP knockout (KO) mice. Our results demonstrate that TTP is a key factor mediating the anti-inflammatory action of CO in DSS-induced colitis.	[Joe, Yeonsoo; Uddin, Md. Jamal; Zheng, Min; Kim, Hyo Jeong; Chen, Yingqing; Yoon, Nal Ae; Park, Jeong Woo; Chung, Hun Taeg] Univ Ulsan, Dept Biol Sci, Ulsan 680749, South Korea; [Zheng, Min] Yanbian Univ, Affiliated Hosp, Dept Thorac & Cardiovasc Surg, Yanji, Peoples R China; [Cho, Gyeong Jae] Gyeongsang Natl Univ, Dept Anat, Sch Med, Jinju, South Korea; [Cho, Gyeong Jae] Gyeongsang Natl Univ, Inst Hlth Sci, Jinju, South Korea	University of Ulsan; Yanbian University; Gyeongsang National University; Gyeongsang National University	Park, JW (corresponding author), Univ Ulsan, Dept Biol Sci, Ulsan 680749, South Korea.	jwpark@ulsan.ac.kr; chung@ulsan.ac.kr	Chen, Yingqing/AAH-1367-2020; Uddin, Md Jamal/W-3434-2017	Uddin, Md Jamal/0000-0003-2911-3255; Chen, Yingqing/0000-0003-2326-7587	Bio & Medical Technology Development Program of the National Research Foundation (NRF); Korean government (MEST) [2012M3A9C3048687]	Bio & Medical Technology Development Program of the National Research Foundation (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This study was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MEST) (2012M3A9C3048687). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autschbach F, 2002, VIRCHOWS ARCH, V441, P500, DOI 10.1007/s00428-002-0684-z; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Cepinskas G, 2008, AM J PHYSIOL-GASTR L, V294, pG184, DOI 10.1152/ajpgi.00348.2007; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Garside P, 1999, CLIN EXP IMMUNOL, V118, P337; Hegazi RAF, 2005, J EXP MED, V202, P1703, DOI 10.1084/jem.20051047; Joe Y, 2011, J BIOL CHEM, V286, P24735, DOI 10.1074/jbc.M110.204859; Kelsall B, 2008, MUCOSAL IMMUNOL, V1, P460, DOI 10.1038/mi.2008.61; Khabar KSA, 2005, J INTERF CYTOK RES, V25, P1, DOI 10.1089/jir.2005.25.1; Kratochvill F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.93; KUMAGAI K, 1979, J IMMUNOL METHODS, V29, P17, DOI 10.1016/0022-1759(79)90121-2; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Molle C, 2013, J EXP MED, V210, P1675, DOI 10.1084/jem.20120707; Morse D, 2005, AM J RESP CRIT CARE, V172, P660, DOI 10.1164/rccm.200404-465SO; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Naito Y, 2012, CURR MED CHEM, V19, P70, DOI 10.2174/092986712803413935; Naito Y, 2003, J GASTROEN HEPATOL, V18, P560, DOI 10.1046/j.1440-1746.2003.03034.x; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Sawle P, 2005, BRIT J PHARMACOL, V145, P800, DOI 10.1038/sj.bjp.0706241; Shintani N, 1997, SCAND J IMMUNOL, V46, P581, DOI 10.1046/j.1365-3083.1997.d01-169.x; Shyu AB, 2000, CELL, V102, P135, DOI 10.1016/S0092-8674(00)00018-0; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Takagi T, 2011, DIGEST DIS SCI, V56, P1663, DOI 10.1007/s10620-010-1484-y; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006073; Zhang XC, 2005, J BIOL CHEM, V280, P8714, DOI 10.1074/jbc.M408092200	28	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88776	10.1371/journal.pone.0088776	http://dx.doi.org/10.1371/journal.pone.0088776			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586391	gold, Green Submitted, Green Published			2022-12-27	WOS:000331711900047
J	Zhou, D; Xiao, YY; Zhang, YY; Xu, ZQ; Cai, D				Zhou, Douglas; Xiao, Yanyang; Zhang, Yaoyu; Xu, Zhiqin; Cai, David			Granger Causality Network Reconstruction of Conductance-Based Integrate-and-Fire Neuronal Systems	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; STRUCTURAL CONNECTIVITY; ORIENTATION SELECTIVITY; LINEAR-DEPENDENCE; BRAIN NETWORKS; VISUAL-CORTEX; SPIKE TRAINS; MODEL; INPUT; DYNAMICS	Reconstruction of anatomical connectivity from measured dynamical activities of coupled neurons is one of the fundamental issues in the understanding of structure-function relationship of neuronal circuitry. Many approaches have been developed to address this issue based on either electrical or metabolic data observed in experiment. The Granger causality (GC) analysis remains one of the major approaches to explore the dynamical causal connectivity among individual neurons or neuronal populations. However, it is yet to be clarified how such causal connectivity, i.e., the GC connectivity, can be mapped to the underlying anatomical connectivity in neuronal networks. We perform the GC analysis on the conductance-based integrate-and-fire (I&F) neuronal networks to obtain their causal connectivity. Through numerical experiments, we find that the underlying synaptic connectivity amongst individual neurons or subnetworks, can be successfully reconstructed by the GC connectivity constructed from voltage time series. Furthermore, this reconstruction is insensitive to dynamical regimes and can be achieved without perturbing systems and prior knowledge of neuronal model parameters. Surprisingly, the synaptic connectivity can even be reconstructed by merely knowing the raster of systems, i.e., spike timing of neurons. Using spike-triggered correlation techniques, we establish a direct mapping between the causal connectivity and the synaptic connectivity for the conductance-based I&F neuronal networks, and show the GC is quadratically related to the coupling strength. The theoretical approach we develop here may provide a framework for examining the validity of the GC analysis in other settings.	[Zhou, Douglas; Xiao, Yanyang; Zhang, Yaoyu; Xu, Zhiqin; Cai, David] Shanghai Jiao Tong Univ, MOE LSC, Dept Math, Shanghai 200030, Peoples R China; [Zhou, Douglas; Xiao, Yanyang; Zhang, Yaoyu; Xu, Zhiqin; Cai, David] Shanghai Jiao Tong Univ, Inst Nat Sci, Shanghai 200030, Peoples R China; [Cai, David] NYU, Courant Inst Math Sci, New York, NY USA; [Cai, David] NYU, Ctr Neural Sci, New York, NY USA; [Cai, David] New York Univ Abu Dhabi, NYUAD Inst, Abu Dhabi, U Arab Emirates	Shanghai Jiao Tong University; Shanghai Jiao Tong University; New York University; New York University	Zhou, D (corresponding author), Shanghai Jiao Tong Univ, MOE LSC, Dept Math, Shanghai 200030, Peoples R China.	zdz@sjtu.edu.cn; cai@cims.nyu.edu	Zhou, Douglas/E-5428-2019	Zhou, Douglas/0000-0001-6631-2961; Zhang, Yaoyu/0000-0001-9374-2502; Xu, Zhi-Qin/0000-0003-0627-3520; Xiao, Yanyang/0000-0002-8284-5183	Shanghai Pujiang Program [10PJ1406300]; National Science Foundation in China [11101275, 91230202]; Scientific Research Foundation for the Returned Overseas Chinese Scholars from State Education Ministry in China; NYU Abu Dhabi Research Institute [G1301]; Undergraduate Research Program in Zhiyuan College at Shanghai Jiao Tong University;  [NSF-DMS-1009575]	Shanghai Pujiang Program(Shanghai Pujiang Program); National Science Foundation in China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars from State Education Ministry in China(Scientific Research Foundation for the Returned Overseas Chinese Scholars); NYU Abu Dhabi Research Institute; Undergraduate Research Program in Zhiyuan College at Shanghai Jiao Tong University; 	D.Z. is supported by Shanghai Pujiang Program (Grant No. 10PJ1406300), National Science Foundation in China (Grant No. 11101275 and No. 91230202), and the Scientific Research Foundation for the Returned Overseas Chinese Scholars from State Education Ministry in China. D.C. is supported by NSF-DMS-1009575. All authors are also supported by a research grant G1301 from NYU Abu Dhabi Research Institute. Y.X., Y.Z., and Z.X. were partially supported by an Undergraduate Research Program in Zhiyuan College at Shanghai Jiao Tong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avramescu S, 2008, J NEUROSCI, V28, P6760, DOI 10.1523/JNEUROSCI.0643-08.2008; Badel L, 2008, BIOL CYBERN, V99, P361, DOI 10.1007/s00422-008-0259-4; Barnett L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238701; Battaglia D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002438; Bhalla US, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000098; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Brette R, 2005, J NEUROPHYSIOL, V94, P3637, DOI 10.1152/jn.00686.2005; Brette R, 2009, NEURAL COMPUT, V21, P188, DOI [10.1162/neco.2009.12-07-657, 10.1162/neco.2008.12-07-657]; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Buchel C, 1997, CEREB CORTEX, V7, P768, DOI 10.1093/cercor/7.8.768; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burkitt AN, 2006, BIOL CYBERN, V95, P97, DOI 10.1007/s00422-006-0082-8; Burkitt AN, 2006, BIOL CYBERN, V95, P1, DOI 10.1007/s00422-006-0068-6; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Cai D, 2005, P NATL ACAD SCI USA, V102, P5868, DOI 10.1073/pnas.0501913102; Carandini M, 1996, J NEUROPHYSIOL, V76, P3425, DOI 10.1152/jn.1996.76.5.3425; Daley D.J., 2003, INTRO THEORY POINT P, V2nd ed; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Dayan P, 2001, COMPUTATIONAL NEUROS; DEBOER E, 1968, IEEE T BIO-MED ENG, VBM15, P169, DOI 10.1109/TBME.1968.4502561; Dhamala M, 2008, NEUROIMAGE, V41, P354, DOI 10.1016/j.neuroimage.2008.02.020; Dhamala M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018701; Ding M., 2006, HDB TIME SERIES ANAL, P437, DOI DOI 10.1002/9783527609970.CH17; Fourcaud-Trocme N, 2003, J NEUROSCI, V23, P11628; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Ge T, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000570; Geisler C, 2005, J NEUROPHYSIOL, V94, P4344, DOI 10.1152/jn.00510.2004; Gerhard F, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003138; Gerstner W, 2002, SPIKING NEURON MODEL; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; GEWEKE JF, 1984, J AM STAT ASSOC, V79, P907, DOI 10.2307/2288723; Gourevitch B, 2007, J NEUROPHYSIOL, V97, P2533, DOI 10.1152/jn.01106.2006; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Guo SX, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000087; Gutig R, 2003, J NEUROSCI, V23, P3697; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Horwitz B, 2003, NEUROIMAGE, V19, P466, DOI 10.1016/S1053-8119(03)00112-5; Hu SQ, 2012, NEUROCOMPUTING, V76, P44, DOI 10.1016/j.neucom.2010.10.017; Jia XX, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001045; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Kim S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001110; Kim WS, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/20006; Kispersky Tilman, 2011, Neural Syst Circuits, V1, P9, DOI 10.1186/2042-1001-1-9; Koch MA, 2002, NEUROIMAGE, V16, P241, DOI 10.1006/nimg.2001.1052; KOMATSU Y, 1988, BRAIN RES, V442, P359, DOI 10.1016/0006-8993(88)91526-0; Lee L, 2006, NEUROIMAGE, V30, P1243, DOI 10.1016/j.neuroimage.2005.11.007; Lehnertz K, 2011, PHYSIOL MEAS, V32, P1715, DOI 10.1088/0967-3334/32/11/R01; Levnajic Z, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.034101; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Lungarella M, 2006, PLOS COMPUT BIOL, V2, P1301, DOI 10.1371/journal.pcbi.0020144; Marinazzo D, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.056215; Marinazzo D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.144103; Matsumura M, 1996, J NEUROSCI, V16, P7757; McIntosh A. R., 1994, Human Brain Mapping, V2, P2; McLaughlin D, 2000, P NATL ACAD SCI USA, V97, P8087, DOI 10.1073/pnas.110135097; McQuarrie A. D, 1998, REGRESSION TIME SERI; MIROLLO RE, 1990, SIAM J APPL MATH, V50, P1645, DOI 10.1137/0150098; Moreno R, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.288101; Napoletani D, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026103; Neapolitan RE, 2009, PROBABILISTIC METHODS FOR BIOINFORMATICS WITH AN INTRODUCTION TO BAYESIAN NETWORKS, P1; Nedungadi AG, 2009, J COMPUT NEUROSCI, V27, P55, DOI 10.1007/s10827-008-0126-2; Newhall KA, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041903; Newhall KA, 2010, COMMUN MATH SCI, V8, P541; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; Okatan M, 2005, NEURAL COMPUT, V17, P1927, DOI 10.1162/0899766054322973; Pandit SM, 1983, TIME SERIES SYSTEM A; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; PERKEL DH, 1967, BIOPHYS J, V7, P391, DOI 10.1016/S0006-3495(67)86596-2; Prignano L, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.036112; Rabinovich MI, 2006, REV MOD PHYS, V78, P1213, DOI 10.1103/RevModPhys.78.1213; Rangan AV, 2007, J COMPUT NEUROSCI, V22, P81, DOI 10.1007/s10827-006-8526-7; Rangan AV, 2005, P NATL ACAD SCI USA, V102, P18793, DOI 10.1073/pnas.0509481102; Rauch A, 2003, J NEUROPHYSIOL, V90, P1598, DOI 10.1152/jn.00293.2003; Ren J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.058701; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Sato JR, 2006, NEUROIMAGE, V31, P187, DOI 10.1016/j.neuroimage.2005.11.039; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Seth AK, 2005, NETWORK-COMP NEURAL, V16, P35, DOI 10.1080/09548980500238756; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Seth AK, 2008, COGN NEURODYNAMICS, V2, P49, DOI 10.1007/s11571-007-9031-z; Shandilya SG, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/1/013004; Smirnov DA, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.046204; Snyder Donald Lee, 1991, RANDOM POINT PROCESS, DOI DOI 10.1007/978-1-4612-3166-0; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Stetter O, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002653; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Sun Y, 2010, J COMPUT NEUROSCI, V28, P247, DOI 10.1007/s10827-009-0202-2; Sun Y, 2009, J COMPUT NEUROSCI, V27, P369, DOI 10.1007/s10827-009-0151-9; Tao L, 2004, P NATL ACAD SCI USA, V101, P366, DOI 10.1073/pnas.2036460100; Timme M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.224101; Troyer TW, 1998, J NEUROSCI, V18, P5908; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Tuckwell H.C., 1988, INTRO THEORETICAL NE, DOI [10.1017/CBO9780511623202, DOI 10.1017/CBO9780511623202]; Upadhyay J, 2008, J NEUROSCI, V28, P3341, DOI 10.1523/JNEUROSCI.4434-07.2008; Van Bussel F, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00003; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wang XJ, 1996, J NEUROSCI, V16, P6402; Wiener N., 1956, MODERN MATH ENG, P165; Yu DC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.188701; Zhang J, 2013, J COMPUTATI IN PRESS; Zhang JW, 2014, J COMPUT NEUROSCI, V36, P279, DOI 10.1007/s10827-013-0472-6; ZHANG L, 1995, J PHYSIOL-LONDON, V488, P661, DOI 10.1113/jphysiol.1995.sp020998; Zhou D, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.054102; Zhou D, 2013, P NATL ACAD SCI USA, V110, P9517, DOI 10.1073/pnas.1308167110; Zhou D, 2010, J COMPUT NEUROSCI, V28, P229, DOI 10.1007/s10827-009-0201-3; Zhou D, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.031918	116	22	23	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e87636	10.1371/journal.pone.0087636	http://dx.doi.org/10.1371/journal.pone.0087636			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586285	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900015
J	de Oliveira, LRC; Peresi, E; Golim, MD; Gatto, M; Araujo, JP; da Costa, EAPN; Ayres, JA; Fortes, MRP; Calvi, SA				Cardoso de Oliveira, Larissa Ragozo; Peresi, Eliana; Golim, Marjorie de Assis; Gatto, Mariana; Araujo Junior, Joao Pessoa; Pellison Nunes da Costa, Erika Alessandra; Ayres, Jairo Aparecido; Parise Fortes, Maria Rita; Calvi, Sueli Aparecida			Analysis of Toll-Like Receptors, iNOS and Cytokine Profiles in Patients with Pulmonary Tuberculosis during Anti-Tuberculosis Treatment	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MYCOBACTERIUM-TUBERCULOSIS; NITRIC-OXIDE; T-CELLS; MOLECULAR-MECHANISMS; ACTIVE TUBERCULOSIS; DISEASE-ACTIVITY; IMMUNE-RESPONSE; HOST-DEFENSE; GAMMA	Toll-like receptors (TLRs) play an important role in mycobacterial infection, although little is known about the roles of these receptors, cytokines and nitric oxide during anti-tuberculosis treatment. Our objective was to evaluate the mRNA and cell surface expression of TLR2 and TLR4; inducible nitric oxide synthase (iNOS) expression; and cytokine Th1, Th2 and Th17 profiles in pulmonary tuberculosis patients at different time points of anti-tuberculosis treatment. Peripheral blood mononuclear cells (PBMCs) were obtained from PPD+ healthy controls and from patients receiving anti-tuberculosis treatment. Gene expression quantification was performed by qPCR, cell surface expression was assessed using flow cytometry, and cytokine quantification was conducted using the CBA technique. The treated patients presented higher gene expression and higher numbers of receptors on the cell surface of lymphocytes and monocytes than did control individuals. IL-12 and IFN-gamma levels increased after the start of treatment, whereas TNF-alpha levels were reduced. TGF-beta presented the highest levels during treatment. IL-10 and IL-17 expression and production tended to increase during treatment. iNOS gene expression was reduced throughout treatment in patients. Our results suggest that anti-tuberculosis treatment modulates the immune response, inducing an increase in the expression of TLRs and pro-and anti-inflammatory cytokines to combat bacteria and reduce the inflammatory process.	[Cardoso de Oliveira, Larissa Ragozo; Peresi, Eliana; Gatto, Mariana; Pellison Nunes da Costa, Erika Alessandra; Calvi, Sueli Aparecida] Univ Estadual Paulista, Dept Trop Dis, Botucatu Sch Med, Sao Paulo, Brazil; [Golim, Marjorie de Assis] Univ Estadual Paulista, Flow Cytometry Lab, Botucatu Sch Med, Hemoctr, Sao Paulo, Brazil; [Araujo Junior, Joao Pessoa] Univ Estadual Paulista, Biosci Inst, Dept Microbiol & Immunol, Sao Paulo, Brazil; [Ayres, Jairo Aparecido] Univ Estadual Paulista, Dept Nursing, Botucatu Sch Med, Sao Paulo, Brazil; [Parise Fortes, Maria Rita] Univ Estadual Paulista, Dermatol & Radiotherapy Dept, Botucatu Sch Med, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista	de Oliveira, LRC (corresponding author), Univ Estadual Paulista, Dept Trop Dis, Botucatu Sch Med, Sao Paulo, Brazil.	larissaragozo@yahoo.com.br	Gatto, Mariana/M-4755-2018; Araujo, Joao Pessoa/C-2444-2012; Lordelo, Eliana Peresi/H-4241-2013; Oliveira, Larissa R C/E-6480-2019; Araujo Jr, Joao Pessoa/Q-3043-2019	Gatto, Mariana/0000-0002-3115-0795; Araujo, Joao Pessoa/0000-0002-9153-1485; Oliveira, Larissa R C/0000-0002-9407-1496; Araujo Jr, Joao Pessoa/0000-0002-9153-1485; de Assis Golim, Marjorie/0000-0002-4824-9441; Peresi-Lordelo, Eliana/0000-0002-5320-6825	FAPESP	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study has been supported by the FAPESP; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel B, 2002, J IMMUNOL, V169, P3155, DOI 10.4049/jimmunol.169.6.3155; Aung H, 1996, J CLIN INVEST, V98, P1261, DOI 10.1172/JCI118910; Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x; Beatty WL, 2001, EUR J CELL BIOL, V80, P31, DOI 10.1078/0171-9335-00131; BERMUDEZ LEM, 1988, J IMMUNOL, V140, P3006; BEUTLER B, 1987, NEW ENGL J MED, V316, P379; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P7; Branger J, 2004, INFECT IMMUN, V72, P788, DOI 10.1128/IAI.72.2.788-794.2004; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Bulut Y, 2005, J BIOL CHEM, V280, P20961, DOI 10.1074/jbc.M411379200; Chackerian AA, 2001, INFECT IMMUN, V69, P2666, DOI 10.1128/IAI.69.4.2666-2674.2001; CHAN J, 1991, INFECT IMMUN, V59, P1755, DOI 10.1128/IAI.59.5.1755-1761.1991; Chang JS, 2006, J IMMUNOL, V176, P3010, DOI 10.4049/jimmunol.176.5.3010; Chen XC, 2010, AM J RESP CRIT CARE, V181, P734, DOI 10.1164/rccm.200909-1463OC; DENIS M, 1990, INT J IMMUNOPHARMACO, V12, P721, DOI 10.1016/0192-0561(90)90034-K; Deveci F, 2005, MEDIAT INFLAMM, P256, DOI 10.1155/MI.2005.256; Doherty TM, 2004, J CLIN INVEST, V114, P1699, DOI 10.1172/JCI200423867; Drennan MB, 2004, AM J PATHOL, V164, P49, DOI 10.1016/S0002-9440(10)63095-7; EUNKYEONG J, 2003, CURR OPIN INFECT DIS, V16, P205; Fenton MJ, 1997, INFECT IMMUN, V65, P5149, DOI 10.1128/IAI.65.12.5149-5156.1997; FOCACCIA R, 2005, TRATADO INFECTOLOGIA; Gupta D, 2010, J IMMUNOL, V184, P5444, DOI 10.4049/jimmunol.0903283; Henderson RA, 1997, J IMMUNOL, V159, P635; HernandezPando R, 1996, IMMUNOLOGY, V89, P26; Higgins DM, 2009, TUBERCULOSIS, V89, P149, DOI 10.1016/j.tube.2009.01.001; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Izzo A, 2005, TUBERCULOSIS, V85, P25, DOI 10.1016/j.tube.2004.09.008; Jo EK, 2003, CURR OPIN INFECT DIS, V16, P205, DOI 10.1097/00001432-200306000-00004; Jones BW, 2001, J LEUKOCYTE BIOL, V69, P1036; Juffermans NP, 1998, AM J RESP CRIT CARE, V157, P1328, DOI 10.1164/ajrccm.157.4.9709126; Karnofsky DA, 1949, EVALUATION CHEMOTHER, P191; Kaufmann SHE, 2002, ANN RHEUM DIS, V61, P54; KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4; Kleinnijenhuis J, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/405310; Koch R., 1890, DEUT MED WOCHENSCHR, V16, P1029, DOI [10.1055/s-0029-1207546, DOI 10.1055/S-0029-1207546]; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Ladel CH, 1997, INFECT IMMUN, V65, P1936, DOI 10.1128/IAI.65.5.1936-1938.1997; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Lin YG, 1996, INFECT IMMUN, V64, P1351, DOI 10.1128/IAI.64.4.1351-1356.1996; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Mansson A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-36; Maruyama T, 2011, SEMIN IMMUNOL, V23, P418, DOI 10.1016/j.smim.2011.06.005; Matsuzaki G, 2007, MICROBIOL IMMUNOL, V51, P1139, DOI 10.1111/j.1348-0421.2007.tb04008.x; Means TK, 1999, J IMMUNOL, V163, P3920; Means TK, 1999, J IMMUNOL, V163, P6748; Miller BH, 2004, INFECT IMMUN, V72, P2872, DOI 10.1128/IAI.72.5.2872-2878.2004; MORENO C, 1989, CLIN EXP IMMUNOL, V76, P240; Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Olobo JO, 2001, SCAND J IMMUNOL, V53, P85, DOI 10.1046/j.1365-3083.2001.00844.x; Peng MY, 2008, CELL MOL IMMUNOL, V5, P203, DOI 10.1038/cmi.2008.25; Peresi Eliana, 2008, J. bras. pneumol., V34, P942, DOI 10.1590/S1806-37132008001100009; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Prabha C, 2008, IMMUNOL LETT, V117, P26, DOI 10.1016/j.imlet.2007.11.002; Raja A, 2004, INDIAN J MED RES, V120, P213; Reiling N, 2002, J IMMUNOL, V169, P3480, DOI 10.4049/jimmunol.169.7.3480; Sahiratmadja E, 2007, INFECT IMMUN, V75, P820, DOI 10.1128/IAI.00602-06; Schluger NW, 1998, AM J RESP CRIT CARE, V157, P679, DOI 10.1164/ajrccm.157.3.9708002; Selek S, 2012, ENVIRON TOXICOL, V27, P380, DOI 10.1002/tox.20674; Sugawara I, 2003, MICROBIOL IMMUNOL, V47, P327, DOI 10.1111/j.1348-0421.2003.tb03404.x; Suzuki K, 2006, ACTA HISTOCHEM CYTOC, V39, P107, DOI 10.1267/ahc.06010; Torrado E, 2010, CYTOKINE GROWTH F R, V21, P455, DOI 10.1016/j.cytogfr.2010.10.004; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; van de Veerdonk FLV, 2010, J LEUKOCYTE BIOL, V88, P227, DOI 10.1189/jlb.0809550; Verbon A, 1999, CLIN EXP IMMUNOL, V115, P110; Wang J, 1999, J CLIN INVEST, V103, P1023, DOI 10.1172/JCI6224; Youmans G P, 1979, Pathobiol Annu, V9, P137; Yuhas Y, 2009, ANTIMICROB AGENTS CH, V53, P1539, DOI 10.1128/AAC.00961-08; Zahrt TC, 2003, MICROBES INFECT, V5, P159, DOI 10.1016/S1286-4579(02)00083-7; ZHANG M, 1995, INFECT IMMUN, V63, P3231, DOI 10.1128/IAI.63.8.3231-3234.1995	73	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88572	10.1371/journal.pone.0088572	http://dx.doi.org/10.1371/journal.pone.0088572			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558401	Green Submitted, Green Published, gold			2022-12-27	WOS:000331706700047
J	Ferket, BS; van Kempen, BJH; Hunink, MGM; Agarwal, I; Kavousi, M; Franco, OH; Steyerberg, EW; Max, W; Fleischmann, KE				Ferket, Bart S.; van Kempen, Bob J. H.; Hunink, M. G. Myriam; Agarwal, Isha; Kavousi, Maryam; Franco, Oscar H.; Steyerberg, Ewout W.; Max, Wendy; Fleischmann, Kirsten E.			Predictive Value of Updating Framingham Risk Scores with Novel Risk Markers in the US General Population	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ANKLE-BRACHIAL INDEX; C-REACTIVE PROTEIN; INTIMA-MEDIA THICKNESS; SERVICES TASK-FORCE; CARDIOVASCULAR RISK; ATHEROSCLEROSIS; METAANALYSIS; INDIVIDUALS; GUIDELINES	Background: According to population-based cohort studies CT coronary calcium score (CTCS), carotid intima-media thickness (cIMT), high-sensitivity C-reactive protein (CRP), and ankle-brachial index (ABI) are promising novel risk markers for improving cardiovascular risk assessment. Their impact in the U. S. general population is however uncertain. Our aim was to estimate the predictive value of four novel cardiovascular risk markers for the U. S. general population. Methods and Findings: Risk profiles, CRP and ABI data of 3,736 asymptomatic subjects aged 40 or older from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 exam were used along with predicted CTCS and cIMT values. For each subject, we calculated 10-year cardiovascular risks with and without each risk marker. Event rates adjusted for competing risks were obtained by microsimulation. We assessed the impact of updated 10-year risk scores by reclassification and C-statistics. In the study population (mean age 56 +/- 11 years, 48% male), 70% (80%) were at low (<10%), 19% (14%) at intermediate (>= 10-<20%), and 11% (6%) at high (>= 20%) 10-year CVD (CHD) risk. Net reclassification improvement was highest after updating 10-year CVD risk with CTCS: 0.10 (95%CI 0.02-0.19). The C-statistic for 10-year CVD risk increased from 0.82 by 0.02 (95%CI 0.01-0.03) with CTCS. Reclassification occurred most often in those at intermediate risk: with CTCS, 36% (38%) moved to low and 22% (30%) to high CVD (CHD) risk. Improvements with other novel risk markers were limited. Conclusions: Only CTCS appeared to have significant incremental predictive value in the U. S. general population, especially in those at intermediate risk. In future research, cost-effectiveness analyses should be considered for evaluating novel cardiovascular risk assessment strategies.	[Ferket, Bart S.; van Kempen, Bob J. H.; Hunink, M. G. Myriam; Kavousi, Maryam; Franco, Oscar H.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Ferket, Bart S.; van Kempen, Bob J. H.; Hunink, M. G. Myriam] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Hunink, M. G. Myriam] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Agarwal, Isha] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Steyerberg, Ewout W.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Max, Wendy] Univ Calif San Francisco, Inst Hlth & Aging, San Francisco, CA USA; [Max, Wendy] Univ Calif San Francisco, Dept Social & Behav Sci, San Francisco, CA USA; [Fleischmann, Kirsten E.] Univ Calif San Francisco, Div Cardiol, San Francisco, CA 94143 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Erasmus University Rotterdam; Erasmus MC; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Fleischmann, KE (corresponding author), Univ Calif San Francisco, Div Cardiol, San Francisco, CA 94143 USA.	fleischm@medicine.ucsf.edu	Kavousi, Maryam/F-1174-2018; Franco, Óscar H/ABE-2305-2020	Kavousi, Maryam/0000-0001-5976-6519; Franco, Óscar H/0000-0002-4606-4929; Ferket, Bart/0000-0003-2754-545X	National Institutes of Health/National Heart, Lung, and Blood Institute [R21 HL112255]; AXA Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL112255] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AXA Research Fund(AXA Research Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by an National Institutes of Health/National Heart, Lung, and Blood Institute grant R21 HL112255. Maryam Kavousi is supported by the AXA Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calonge N, 2009, ANN INTERN MED, V151, P474, DOI 10.7326/0003-4819-151-7-200910060-00008; Criqui MH, 2010, J AM COLL CARDIOL, V56, P1506, DOI 10.1016/j.jacc.2010.04.060; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Den Ruijter HM, 2012, JAMA-J AM MED ASSOC, V308, P796, DOI 10.1001/jama.2012.9630; Elias-Smale SE, 2010, J AM COLL CARDIOL, V56, P1407, DOI 10.1016/j.jacc.2010.06.029; Ferket BS, 2010, ARCH INTERN MED, V170, P27, DOI 10.1001/archinternmed.2009.434; Folsom AR, 2008, ARCH INTERN MED, V168, P1333, DOI 10.1001/archinte.168.12.1333; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Glasziou PP, 2001, DECISION MAKING HLTH; Greenland P, 2001, CIRCULATION, V104, P1863, DOI 10.1161/hc4201.097189; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Helfand M, 2009, ANN INTERN MED, V151, P496, DOI 10.7326/0003-4819-151-7-200910060-00010; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kavousi M, 2012, ANN INTERN MED, V156, P438, DOI 10.7326/0003-4819-156-6-201203200-00006; Murphy TP, 2012, ATHEROSCLEROSIS, V220, P160, DOI 10.1016/j.atherosclerosis.2011.10.037; Paynter NP, 2012, MED DECIS MAKING; Pencina MJ, 2012, STAT MED, V31, P1543, DOI 10.1002/sim.4508; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Pencina MJ, 2009, CIRCULATION, V119, P3078, DOI 10.1161/CIRCULATIONAHA.108.816694; Peters SAE, 2012, HEART, V98, P177, DOI 10.1136/heartjnl-2011-300747; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Shah T, 2009, INT J EPIDEMIOL, V38, P217, DOI 10.1093/ije/dyn217; van Kempen BJH, 2011, J AM COLL CARDIOL, V58, P1690, DOI 10.1016/j.jacc.2011.05.056; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	32	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88312	10.1371/journal.pone.0088312	http://dx.doi.org/10.1371/journal.pone.0088312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558385	Green Submitted, gold, Green Published			2022-12-27	WOS:000331706700031
J	Li, DL; Ma, ZY; Fu, ZJ; Ling, MY; Yan, CZ; Zhang, Y				Li, Duo-ling; Ma, Zhi-yong; Fu, Zhi-jie; Ling, Ming-ying; Yan, Chuan-zhu; Zhang, Yun			Glibenclamide Decreases ATP-Induced Intracellular Calcium Transient Elevation via Inhibiting Reactive Oxygen Species and Mitochondrial Activity in Macrophages	PLOS ONE			English	Article							EXTRACELLULAR NUCLEOTIDES; CHANNELS; CA2+; CELLS; INFLAMMATION; ACTIVATION; RECEPTORS; RELEASE; DISEASE	Increasing evidence has revealed that glibenclamide has a wide range of anti-inflammatory effects. However, it is unclear whether glibenclamide can affect the resting and adenosine triphosphate (ATP)-induced intracellular calcium ([Ca2+](i)) handling in Raw 264.7 macrophages. In the present study, [Ca2+](i) transient, reactive oxygen species (ROS) and mitochondrial activity were measured by the high-speed TILLvisION digital imaging system using the indicators of Fura 2-am, DCFDA and rhodamine-123, respectively. We found that glibenclamide, pinacidil and other unselective K+ channel blockers had no effect on the resting [Ca2+](i) of Raw 264.7 cells. Extracellular ATP (100 mM) induced [Ca2+](i) transient elevation independent of extracellular Ca2+. The transient elevation was inhibited by an ROS scavenger (tiron) and mitochondria inhibitor (rotenone). Glibenclamide and 5-hydroxydecanoate (5-HD) also decreased ATP-induced [Ca2+](i) transient elevation, but pinacidil and other unselective K+ channel blockers had no effect. Glibenclamide also decreased the peak of [Ca2+](i) transient induced by extracellular thapsigargin (Tg, 1 mu M). Furthermore, glibenclamide decreased intracellular ROS and mitochondrial activity. When pretreated with tiron and rotenone, glibenclamide could not decrease ATP, and Tg induced maximal [Ca2+](i) transient further. We conclude that glibenclamide may inhibit ATP-induced [Ca2+](i) transient elevation by blocking mitochondria K-ATP channels, resulting in decreased ROS generation and mitochondrial activity in Raw 264.7 macrophages.	[Li, Duo-ling; Ma, Zhi-yong; Ling, Ming-ying; Zhang, Yun] Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan 250100, Peoples R China; [Li, Duo-ling; Ma, Zhi-yong; Ling, Ming-ying; Zhang, Yun] Shandong Univ, Qilu Hosp, Chinese Minist Publ Hlth, Jinan 250100, Peoples R China; [Li, Duo-ling; Yan, Chuan-zhu] Shandong Univ, Qilu Hosp, Dept Neurol, Jinan 250100, Peoples R China; [Fu, Zhi-jie] Shandong Univ, Shandong Prov Qianfoshan Hosp, Dept Otorhinolaryngol, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Ma, ZY (corresponding author), Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan 250100, Peoples R China.	zhiyongma@yeah.net; yanczqlYY@126.com	ling, mingying/GZB-1112-2022		National 973 Basic Research Program of China [2011CB503906, 2012CB518603]; National High-tech Research and Development Program of China [2012AA02A510]; Program of Introducing Talents of Discipline to Universities [B07035]; State Program of National Natural Science Foundation of China for Innovative Research Group [81021001]; National Natural Science Foundation of China [30800468, 81100207]; Science and Technology Research Program of Shandong Province [2009GG10002034]; Natural Science Foundation from the Department of Science and Technology of Shandong Province [Y2005C32]	National 973 Basic Research Program of China(National Basic Research Program of China); National High-tech Research and Development Program of China(National High Technology Research and Development Program of China); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); State Program of National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Research Program of Shandong Province; Natural Science Foundation from the Department of Science and Technology of Shandong Province	This work was supported by the National 973 Basic Research Program of China (No. 2011CB503906, No. 2012CB518603), the National High-tech Research and Development Program of China (No. 2012AA02A510), the Program of Introducing Talents of Discipline to Universities (No. B07035), the State Program of National Natural Science Foundation of China for Innovative Research Group (No. 81021001), and the grants of the National Natural Science Foundation of China (No. 30800468, 81100207), the Science and Technology Research Program of Shandong Province (2009GG10002034), and the Natural Science Foundation (Y2005C32) from the Department of Science and Technology of Shandong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballanyi K, 2004, J EXP BIOL, V207, P3201, DOI 10.1242/jeb.01106; Chen Z, 2009, BIOCHEM BIOPH RES CO, V382, P381, DOI 10.1016/j.bbrc.2009.03.030; Das M, 2003, J PHYSIOL-LONDON, V547, P893, DOI 10.1113/jphysiol.2002.035006; Ding Y, 2010, J PHARMACOL EXP THER, V335, P693, DOI 10.1124/jpet.110.171975; Feissner RF, 2009, FRONT BIOSCI-LANDMRK, V14, P1197, DOI 10.2741/3303; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Flagg TP, 2010, PHYSIOL REV, V90, P799, DOI 10.1152/physrev.00027.2009; Goel M, 2010, AM J PHYSIOL-RENAL, V299, pF225, DOI 10.1152/ajprenal.00670.2009; Grahnert A, 2009, PURINERG SIGNAL, V5, P309, DOI 10.1007/s11302-009-9144-4; GREENBERG S, 1988, J BIOL CHEM, V263, P10337; Hanninen SL, 2010, CARDIOVASC RES, V88, P75, DOI 10.1093/cvr/cvq180; Hill LM, 2010, J IMMUNOL, V185, P3028, DOI 10.4049/jimmunol.1001298; Ito M, 2008, J PHARMACOL SCI, V107, P443, DOI 10.1254/jphs.08087FP; Koh GCKW, 2011, CLIN INFECT DIS, V52, P717, DOI 10.1093/cid/ciq192; la Sala A, 2003, J LEUKOCYTE BIOL, V73, P339, DOI 10.1189/jlb.0802418; Lalevee N, 1999, BIOL REPROD, V61, P343, DOI 10.1095/biolreprod61.2.343; Ling MY, 2013, ATHEROSCLEROSIS, V226, P348, DOI 10.1016/j.atherosclerosis.2012.11.016; Ma ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061018; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; McTaggart JS, 2010, J PHYSIOL-LONDON, V588, P3201, DOI 10.1113/jphysiol.2010.191767; Mikulski Z, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-133; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; Pain T, 2000, CIRC RES, V87, P460; Pfeiffer ZA, 2007, FREE RADICAL BIO MED, V42, P1506, DOI 10.1016/j.freeradbiomed.2007.02.010; Quast U, 2004, DIABETES, V53, pS156, DOI 10.2337/diabetes.53.suppl_3.S156; Rathore R, 2008, FREE RADICAL BIO MED, V45, P1223, DOI 10.1016/j.freeradbiomed.2008.06.012; Ryu SY, 2010, CELL CALCIUM, V47, P65, DOI 10.1016/j.ceca.2009.11.006; Simard JM, 2009, J CEREBR BLOOD F MET, V29, P317, DOI 10.1038/jcbfm.2008.120; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Xi Q, 2005, CIRC RES, V97, P354, DOI 10.1161/01.RES.0000177669.29525.78; Yan Y, 2006, ACTA PHARMACOL SIN, V27, P821, DOI 10.1111/j.1745-7254.2006.00390.x	31	12	13	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89083	10.1371/journal.pone.0089083	http://dx.doi.org/10.1371/journal.pone.0089083			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558474	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700120
J	Mao, Y; Fang, LQ; Ai, L; Li, CY; Wang, ZB; Wu, JR; Bai, J; Li, FQ				Mao, Ying; Fang, Liaoqiong; Ai, Liang; Li, Chongyan; Wang, Zhibiao; Wu, Junru; Bai, Jin; Li, Faqi			An In Vivo Study of the Effects on Serum Glucose, Amylase and Histopathology of the Feline Pancreatic Tissue Treated by Focused Ultrasound	PLOS ONE			English	Article							CANCER STATISTICS; GEMCITABINE; PRINCIPLES; RADIATION; ABLATION; THERAPY	Pancreatic cancer is one of the most malignant neoplasms originating in the digestive system. Focused ultrasound (FUS) treatment instead of the surgery operation has been used to treat Pancreatic cancer noninvasively in clinical trials. The endocrine and exocrine glands in pancreas provide the two unique functions for a person to be healthy. It is critically important to find out if the FUS treatment can still keep the normal functions of the two glands. The goal of this study is to examine and analyze changes in histopathology and serum glucose and amylase levels of the targeted in-vivo felines after the FUS treatment. Various percentage volumes of pancreas of felines were insonified. The FUS treatment (7.5 MHz of central frequency; 5 W of acoustical power; transducer f-number = 0.33; 6 s insonification time per point) effectively generated coagulative necrosis at the insonified site while leaving tissue outside the insonified site intact. It was also observed that all felines endured well with the FUS treatment; changes introduced to pancreatic tissue after up to 50% of a pancreas by volume was insonified by the FUS procedure did not affect its normal endocrine and exocrine functions.	[Mao, Ying; Fang, Liaoqiong; Ai, Liang; Wang, Zhibiao; Bai, Jin; Li, Faqi] Chongqing Med Univ, Coll Biomed Engn, State Key Lab Ultrasound Engn Med, Chongqing & Minist Sci & Technol, Chongqing, Peoples R China; [Li, Chongyan] Natl Engn Res Ctr Ultrasound Med, Chongqing, Peoples R China; [Wu, Junru] Univ Vermont, Dept Phys, Burlington, VT 05405 USA	Chongqing Medical University; University of Vermont	Bai, J (corresponding author), Chongqing Med Univ, Coll Biomed Engn, State Key Lab Ultrasound Engn Med, Chongqing & Minist Sci & Technol, Chongqing, Peoples R China.	sajinbai@haifu.com.cn; lifaqi70@163.com			National Basic Research Program 973 of China [2012CB722402, 2011CB707900]; National Natural Science Foundation of China [81127901, 30830040, 11274404, 30970827]; HAS fund of the University of Vermont	National Basic Research Program 973 of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); HAS fund of the University of Vermont	This work is supported in part by the National Basic Research Program 973 of China (Grant No. 2012CB722402 and Grant No. 2011CB707900) and funded by National Natural Science Foundation of China (Grant No. 81127901, 30830040, 11274404 and 30970827). JW has been supported partially by HAS fund of the University of Vermont. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buchler M, 1987, ACUTE PANCREATITIS, P143; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; CLAVIEN PA, 1989, BRIT J SURG, V76, P1234, DOI 10.1002/bjs.1800761205; CRAMP DG, 1967, J CLIN PATHOL, V20, P910, DOI 10.1136/jcp.20.6.910; DIMAGNO EP, 1973, NEW ENGL J MED, V288, P813, DOI 10.1056/NEJM197304192881603; Hwang JH, 2009, ULTRASOUND MED BIOL, V35, P967, DOI 10.1016/j.ultrasmedbio.2008.12.006; Iovanne J, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00006; Johung K, 2012, INT J RADIAT ONCOL, V82, P508, DOI 10.1016/j.ijrobp.2011.08.008; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Nakakura E. K., 2007, SURG LIVER BILIARY T, P849; Orsi F, 2010, J CANCER RES THER, V6, P414, DOI 10.4103/0973-1482.77064; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PIERRE KJ, 1976, CLIN CHEM, V22, P1219; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; STEINBERG WM, 1985, ANN INTERN MED, V102, P576, DOI 10.7326/0003-4819-102-5-576; Sung HY, 2011, PANCREAS, V40, P1080, DOI 10.1097/MPA.0b013e31821fde24; Ter Haar G, 2007, INT J HYPERTHER, V23, P89, DOI 10.1080/02656730601186138; Wilkowski R, 2005, J PANCREAS, V6, P216; Wu F, 2005, RADIOLOGY, V236, P1034, DOI 10.1148/radiol.2362041105; Wu J, 2008, ADV DRUG DELIVER REV, V60, P1103, DOI 10.1016/j.addr.2008.03.009; Xie BA, 2011, INT J MED SCI, V8, P9, DOI 10.7150/ijms.8.9; Xiong LL, 2009, J PANCREAS, V10, P123; Yeo CJ, 2005, CANC PRINCIPLES PRAC; [张樯 Zhang Qiang], 2011, [中国超声医学杂志, Chinese Journal of Ultrasonic in Medical], V27, P571; Zhao H, 2010, ANTI-CANCER DRUG, V21, P447, DOI 10.1097/CAD.0b013e32833641a7	25	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88815	10.1371/journal.pone.0088815	http://dx.doi.org/10.1371/journal.pone.0088815			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558434	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700080
J	Ophir, R; Sherman, A; Rubinstein, M; Eshed, R; Schwager, MS; Harel-Beja, R; Bar-Ya'akov, I; Holland, D				Ophir, Ron; Sherman, Amir; Rubinstein, Mor; Eshed, Ravit; Schwager, Michal Sharabi; Harel-Beja, Rotem; Bar-Ya'akov, Irit; Holland, Doron			Single-Nucleotide Polymorphism Markers from De-Novo Assembly of the Pomegranate Transcriptome Reveal Germplasm Genetic Diversity	PLOS ONE			English	Article							PUNICA-GRANATUM L.; SNP DISCOVERY; SSR-MARKERS; MICROSATELLITE MARKERS; PRUNUS-PERSICA; RNA-SEQ; CULTIVARS; RAPD; ANNOTATION; GENOTYPES	Pomegranate is a valuable crop that is grown commercially in many parts of the world. Wild species have been reported from India, Turkmenistan and Socotra. Pomegranate fruit has a variety of health-beneficial qualities. However, despite this crop's importance, only moderate effort has been invested in studying its biochemical or physiological properties or in establishing genomic and genetic infrastructures. In this study, we reconstructed a transcriptome from two phenotypically different accessions using 454-GS-FLX Titanium technology. These data were used to explore the functional annotation of 45,187 fully annotated contigs. We further compiled a genetic-variation resource of 7,155 simple-sequence repeats (SSRs) and 6,500 single-nucleotide polymorphisms (SNPs). A subset of 480 SNPs was sampled to investigate the genetic structure of the broad pomegranate germplasm collection at the Agricultural Research Organization (ARO), which includes accessions from different geographical areas worldwide. This subset of SNPs was found to be polymorphic, with 10.7% loci with minor allele frequencies of (MAF<0.05). These SNPs were successfully used to classify the ARO pomegranate collection into two major groups of accessions: one from India, China and Iran, composed of mainly unknown country origin and which was more of an admixture than the other major group, composed of accessions mainly from the Mediterranean basin, Central Asia and California. This study establishes a high-throughput transcriptome and genetic-marker infrastructure. Moreover, it sheds new light on the genetic interrelations between pomegranate species worldwide and more accurately defines their genetic nature.	[Ophir, Ron; Sherman, Amir; Rubinstein, Mor; Eshed, Ravit; Schwager, Michal Sharabi] Agr Res Org, Volcani Ctr, Dept Fruit Tree Sci, IL-50250 Bet Dagan, Israel; [Harel-Beja, Rotem; Bar-Ya'akov, Irit; Holland, Doron] Agr Res Org, Dept Fruit Tree Sci, Newe Yaar Ctr, Ramat Yishai, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Ophir, R (corresponding author), Agr Res Org, Volcani Ctr, Dept Fruit Tree Sci, IL-50250 Bet Dagan, Israel.	ron@agri.gov.il; asherman@agri.gov.il		Ophir, Ron/0000-0002-7951-6661	Chief Scientist Office, Ministry of Agriculture & Rural Development [203-0753]	Chief Scientist Office, Ministry of Agriculture & Rural Development	The authors acknowledge funding from the Chief Scientist Office, Ministry of Agriculture & Rural Development, http://www.science.moag.gov.il/, Agricultural Biotechnology 203-0753. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-569; Asgary S, 2014, PHYTOTHER RES, V28, P193, DOI 10.1002/ptr.4977; Aviram M, 2001, ATHEROSCLEROSIS, V158, P195, DOI 10.1016/S0021-9150(01)00412-9; Bachlava E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029814; Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68; Balfour IB, 1888, BOT SOCOTRA, P93; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Ben-Simhon Z, 2011, PLANTA, V234, P865, DOI 10.1007/s00425-011-1438-4; Billot C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059714; Blanca J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-280; Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Brachi B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-232; CHAKRABORTY R, 1993, HUM BIOL, V65, P875; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; da Maia LC, 2009, GENET MOL BIOL, V32, P822, DOI 10.1590/S1415-47572009005000091; da Silva JAT, 2013, SCI HORTIC-AMSTERDAM, V160, P85, DOI 10.1016/j.scienta.2013.05.017; Dafny-Yalin M, 2010, J AGR FOOD CHEM, V58, P4342, DOI 10.1021/jf904337t; Der JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-99; Emanuelli F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-39; Ercisli S, 2011, GENET MOL RES, V10, P459, DOI 10.4238/vol10-1gmr1155; Ercisli S, 2007, BIOCHEM SYST ECOL, V35, P764, DOI 10.1016/j.bse.2007.05.014; Ercisli S, 2011, BIOL RES, V44, P345, DOI /S0716-97602011000400005; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Frascaroli E, 2013, THEOR APPL GENET, V126, P133, DOI 10.1007/s00122-012-1968-6; Gai SP, 2012, GENE, V497, P256, DOI 10.1016/j.gene.2011.12.013; GOJOBORI T, 1982, J MOL EVOL, V18, P360, DOI 10.1007/BF01733904; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; GOOR A., 1956, The pomegranate; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Guo SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-454; Hajiahmadi Z, 2013, MOL BIOTECHNOL, V55, P249, DOI 10.1007/s12033-013-9676-2; Hamblin MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001367; Hasnaoui N., 2010, Diversity, V2, P107; Hasnaoui N, 2012, GENE, V493, P105, DOI 10.1016/j.gene.2011.11.012; Holland D., 2009, Horticultural Reviews, V35, P127; Imelfort M, 2009, BRIEF BIOINFORM, V10, P609, DOI 10.1093/bib/bbp039; Iorizzo M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-389; Jalikop SH, 2007, EUPHYTICA, V158, P201, DOI 10.1007/s10681-007-9443-1; Jalikop SH, 2005, ACTA HORTICULTURAE, V696; Jbir R, 2008, SCI HORTIC-AMSTERDAM, V115, P231, DOI 10.1016/j.scienta.2007.09.002; Jhanwar S, 2012, PLANT BIOTECHNOL J, V10, P690, DOI 10.1111/j.1467-7652.2012.00712.x; Kaya HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073674; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; LEVIN G M, 1981, Izvestiya Akademii Nauk Turkmenskoi SSR Seriya Biologicheskikh Nauk, P60; Liu GQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-700; Meisel L, 2005, BIOL RES, V38, P83, DOI 10.4067/S0716-97602005000100010; Melgarejo P, 2009, SCI HORTIC-AMSTERDAM, V120, P500, DOI 10.1016/j.scienta.2008.12.013; Soriano JM, 2011, MOL BREEDING, V27, P119, DOI 10.1007/s11032-010-9511-4; Natarajan P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-191; Neurath AR, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-41; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Odong TL, 2011, THEOR APPL GENET, V123, P195, DOI 10.1007/s00122-011-1576-x; Ono NN, 2011, J INTEGR PLANT BIOL, V53, P800, DOI 10.1111/j.1744-7909.2011.01073.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pirseyedi SM, 2010, INT J MOL SCI, V11, P2010, DOI 10.3390/ijms11052010; Popescu AA, 2012, BIOINFORMATICS, V28, P1536, DOI 10.1093/bioinformatics/bts184; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Pritchard JK, 2000, GENETICS, V155, P945; Qiu LJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-278; Rajaram V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-159; Rana JC, 2007, BIODIVERS CONSERV, V16, P3963, DOI 10.1007/s10531-007-9201-7; Ranade S. A., 2009, Physiology and Molecular Biology of Plants, V15, P61, DOI 10.1007/s12298-009-0006-x; Rauscher G, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-11; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rocha A, 2012, BREAST CANCER RES TR, V136, P647, DOI 10.1007/s10549-012-2264-5; Rostoks N, 2005, MOL GENET GENOMICS, V274, P515, DOI 10.1007/s00438-005-0046-z; Sarkhosh A, 2006, SCI HORTIC-AMSTERDAM, V111, P24, DOI 10.1016/j.scienta.2006.07.033; Seeram NP, 2006, J NUTR, V136, P2481, DOI 10.1093/jn/136.10.2481; Sharma PC, 2007, TRENDS BIOTECHNOL, V25, P490, DOI 10.1016/j.tibtech.2007.07.013; Sonah H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021298; Su CL, 2011, PLANT CELL PHYSIOL, V52, P1501, DOI 10.1093/pcp/pcr097; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Wang L, 2012, TRANSL ONCOL, V5, P345, DOI 10.1593/tlo.12190; Wang L, 2013, PLANT MOL BIOL, V83, P365, DOI 10.1007/s11103-013-0093-5; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weir B.S., 1990, GENETIC DATA ANAL ME; Wessling R, 2012, FUNGAL GENET BIOL, V49, P470, DOI 10.1016/j.fgb.2012.04.001; WRIGHT S, 1950, NATURE, V166, P247, DOI 10.1038/166247a0; Xu Y, 2004, GENOME, V47, P1091, DOI [10.1139/g04-058, 10.1139/G04-058]; Yasodha R, 2008, J GENET, V87, P21, DOI 10.1007/s12041-008-0003-9; Yuan Zhaohe, 2007, Journal of Genetics and Genomics, V34, P1061, DOI 10.1016/S1673-8527(07)60121-0; Zamani Z, 2007, J HORTIC SCI BIOTECH, V82, P11, DOI 10.1080/14620316.2007.11512192; Zhang TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057220; Zhang YP, 2012, GENET MOL RES, V11, P3032, DOI 10.4238/2012.May.30.1; Zhou YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-266	90	51	56	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88998	10.1371/journal.pone.0088998	http://dx.doi.org/10.1371/journal.pone.0088998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558460	Green Submitted, Green Published, gold			2022-12-27	WOS:000331706700106
J	Paula, CS; Bordin, IAS; Mari, JJ; Velasque, L; Rohde, LA; Coutinho, ESF				Paula, Cristiane S.; Bordin, Isabel A. S.; Mari, Jair Jesus; Velasque, Luciane; Rohde, Luis A.; Coutinho, Evandro S. F.			The Mental Health Care Gap among Children and Adolescents: Data from an Epidemiological Survey from Four Brazilian Regions	PLOS ONE			English	Article							K-SADS-PL; SERVICE USE; HELP-SEEKING; DISORDERS; VALIDITY; PREVALENCE; RESOURCES; PATHWAYS; SYSTEM; INCOME	Introduction: Worldwide, a minority of disordered children/adolescents receives mental health assistance. In order to improve service access, it is important to investigate factors that influence the process leading to receiving care. Data on frequency and barriers for mental health service use (MHSU) among Brazilian children/adolescents are extremely scarce and are needed to guide public policy. Objectives: To establish the frequency of MHSU among 6-to-16-year-old with psychiatric disorders from four Brazilian regions; and to identify structural/psychosocial/demographic barriers associated with child/adolescent MHSU. Methods: Multicenter cross-sectional-study involving four towns from four out of five Brazilian regions. In each town, a representative sample of elementary public school students was randomly selected (sample: 1,721). Child/adolescent MHSU was defined as being seen by a psychologist/psychiatrist/neurologist in the previous 12 months. Standardized instruments measured: (1) children/adolescent characteristics [(1.1) Schedule for Affective Disorders and Schizophrenia for School-Age Children (K-SADS-PL)-psychiatric disorders; (1.2) Ten Questions Screen-neurodevelopment problems; (1.3) two subtests of WISC-III-estimated IQ; (1.4) Academic Performance Test-school performance)], (2) factors related to mothers/main caregivers (Self-Reporting Questionnaire-anxiety/depression), (3) family (Brazilian Research-Companies-Association's Questionnaire-SES). Results: Only 19.8% of children/adolescents with psychiatric disorder have used mental health services in the previous 12 months. Multiple logistic regression modeling identified five factors associated with lower rates of MHSU (female gender, adequate school performance, mother/main caregiver living with a partner, lower SES, residing in deprived Brazilian regions) regardless of the presence of any psychiatric disorders/neurodevelopmental problems. Conclusions: Only a small proportion of children/adolescents with psychiatric disorders had been seen by a mental health specialist in the previous 12 months. Structural/psychosocial/demographic factors were associated with uneven access to service for certain groups of children/adolescents. These results call attention to the urgent need to implement programs to help reduce this large unmet mental health need; inequalities must be considered by policy makers when planning strategies to address barriers for care.	[Paula, Cristiane S.] Univ Presbiteriana Mackenzie, Programa Posgrad Disturbios Desenvolvimento, Sao Paulo, Brazil; [Paula, Cristiane S.; Bordin, Isabel A. S.; Mari, Jair Jesus] Univ Fed Sao Paulo, Dept Psiquiatria, Sao Paulo, Brazil; [Velasque, Luciane] Univ Fed Estado Rio de Janeiro, Dept Matemat & Estat, Rio De Janeiro, Brazil; [Rohde, Luis A.] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Coutinho, Evandro S. F.] Escola Nacl Saude Publ FIOCRUZ, Dept Epidemiol & Metodos Quantitat Saude, Rio De Janeiro, Brazil	Universidade Presbiteriana Mackenzie; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Estado do Rio de Janeiro; Universidade Federal do Rio Grande do Sul; Fundacao Oswaldo Cruz	Paula, CS (corresponding author), Univ Presbiteriana Mackenzie, Programa Posgrad Disturbios Desenvolvimento, Sao Paulo, Brazil.	csilvestrep09@gmail.com	de Jesus Mari, Jair/A-7309-2008; Rohde, Luis Augusto P/A-6426-2008; Paula, Cristiane Silvestre/D-8968-2017; Bordin, Isabel A./O-7640-2015	de Jesus Mari, Jair/0000-0002-5403-0112; Rohde, Luis Augusto P/0000-0002-4552-4188; Paula, Cristiane Silvestre/0000-0003-0438-9407; Coutinho, Evandro/0000-0002-4649-7353; Bordin, Isabel A./0000-0002-3173-5419	FAPESP; CNPQ	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The data collection of the study was funded by two Brazilian Research Funding Agencies: FAPESP (http://www.fapesp.br/) and CNPQ (http://www.cnpq.br/). No author was paid to write this article by a pharmaceutical company or any other agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegria M, 2004, MED CARE, V42, P447, DOI 10.1097/01.mlr.0000124248.64190.56; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Angold A, 2002, ARCH GEN PSYCHIAT, V59, P893, DOI 10.1001/archpsyc.59.10.893; Associacao Brasileira de Pesquisa de Mercado A, 2007, CRIT CLASS EC BRAS; Bahia L, 2008, CIENC SAUDE COLETIVA, V13, P1385, DOI 10.1590/S1413-81232008000500002; Beusenberg M, 1994, USERS GUIDE SELF REP; Borges G, 2008, B WORLD HEALTH ORGAN, V86, P757, DOI 10.2471/BLT.07.047696; Borges G, 2006, AM J PSYCHIAT, V163, P1371, DOI 10.1176/appi.ajp.163.8.1371; Brasil HHA, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-83; Brazilian Child Psychiatry Association A, 2007, DEP ABP REUN SAO PAU; Briggs-Gowan MJ, 2000, J AM ACAD CHILD PSY, V39, P841, DOI 10.1097/00004583-200007000-00012; Cabiya JJ, 2006, J CHILD PSYCHOL PSYC, V47, P840, DOI 10.1111/j.1469-7610.2006.01623.x; Coordenacao Geral de Saude Mental Ministerio da Saude M, 2012, SAUD MENT DAD 10; Cruz M, 2005, AVAL PSICOL, V4, P199; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; DURKIN MS, 1995, J EPIDEMIOL COMMUN H, V49, P431, DOI 10.1136/jech.49.4.431; Eaton J, 2011, LANCET, V378, P1592, DOI 10.1016/S0140-6736(11)60891-X; Farmer EMZ, 2003, PSYCHIATR SERV, V54, P60, DOI 10.1176/appi.ps.54.1.60; Fatori D, 2012, LANCET, V379, pE16, DOI 10.1016/S0140-6736(12)60105-6; Fernandes, 2013, INT J PSYCHIAT; Figueiredo V, 2002, WISC 3 ESCALA INTELI; Furgueson C, 1999, ARCH CLIN NEUROPSYCH, V14, P6, DOI 10.1093/arclin/14.1.6; Gerschman S, 2008, CIENC SAUDE COLETIVA, V13, P1441, DOI 10.1590/S1413-81232008000500010; Green JG, 2013, J AM ACAD CHILD PSY, V52, P501, DOI 10.1016/j.jaac.2013.03.002; GREENLAND S, 1989, AM J EPIDEMIOL, V130, P1066, DOI 10.1093/oxfordjournals.aje.a115409; Hosmer D, 2003, WILEY SERIES PROBABI, P528; Instituto Brasileiro de Geografia e Estatistica. IBGE, 2013, COOR TRAB REND PESQ; Instituto Brasileiro de Geografia e Estatistica. IBGE, 2013, CID; Instituto Brasileiro de Geografia e Estatistica. IBGE, 2010, SER HIST EST; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kieling C, 2011, LANCET, V378, P1515, DOI 10.1016/S0140-6736(11)60827-1; Kilian R., 2010, INT J MENT HEALTH PR, V12, P45, DOI DOI 10.1080/14623730.2010.9721825; Kleinbaum DG, 1998, APPL REGRESSION ANAL; MARI JD, 1986, BRIT J PSYCHIAT, V148, P23, DOI 10.1192/bjp.148.1.23; Mateus Mario D, 2008, Int J Ment Health Syst, V2, P12, DOI 10.1186/1752-4458-2-12; Mello Claudia Berlim de, 2011, Psic.: Teor. e Pesq., V27, P149, DOI 10.1590/S0102-37722011000200002; Merikangas KR, 2010, PEDIATRICS, V125, P75, DOI 10.1542/peds.2008-2598; Ohan JL, 2009, J CLIN CHILD ADOLESC, V38, P650, DOI 10.1080/15374410903103627; Ortega AN, 2007, ADM POLICY MENT HLTH, V34, P353, DOI 10.1007/s10488-007-0114-2; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Patel V, 2013, ARCH DIS CHILD, V98, P323, DOI 10.1136/archdischild-2012-302079; Paula CS, 2012, REV BRAS PSIQUIATR, V34, P334, DOI 10.1016/j.rbp.2012.04.001; Posserud MB, 2013, SCI WORLD J, DOI 10.1155/2013/247283; Razzouk D, 2013, POLITICA SAUDE MENTA, P232; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; Saxena S, 2011, PSYCHIAT SERV, V62, P123, DOI 10.1176/ps.62.2.pss6202_0123; Sayal K, 2006, J CHILD PSYCHOL PSYC, V47, P649, DOI 10.1111/j.1469-7610.2005.01543.x; Sourander A, 2004, J AM ACAD CHILD PSY, V43, P1250, DOI 10.1097/01.chi.0000134493.88549.e2; Sourander A, 2001, SOC PSYCH PSYCH EPID, V36, P294, DOI 10.1007/s001270170047; Sourander A, 2008, J AM ACAD CHILD PSY, V47, P317, DOI 10.1097/CHI.0b013e318160b98f; Stein L. M., 1994, TDE TESTE DESEMPENHO; STEIN Z, 1986, ANN NY ACAD SCI, V477, P8, DOI 10.1111/j.1749-6632.1986.tb40316.x; The Psychological Corporation P, 1992, WESCHL IND ACH TEST; United Nation U, 2013, COUNTR PROF HUM DEV; Wooldridge J, 2000, INTRO ECONOMETRICS M, P178; Zechmeister I, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-20; Zwaanswijk M, 2003, EUR CHILD ADOLES PSY, V12, P153, DOI 10.1007/S00787-003-0322-6	57	47	51	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88241	10.1371/journal.pone.0088241	http://dx.doi.org/10.1371/journal.pone.0088241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3RA	24558382	gold, Green Published, Green Submitted			2022-12-27	WOS:000331706700028
J	Peterson, MJ; Mueter, F; Criddle, K; Haynie, AC				Peterson, Megan J.; Mueter, Franz; Criddle, Keith; Haynie, Alan C.			Killer Whale Depredation and Associated Costs to Alaskan Sablefish, Pacific Halibut and Greenland Turbot Longliners	PLOS ONE			English	Article							ORCINUS-ORCA; MARINE MAMMALS; SPERM-WHALES; FISHERIES; CROZET; MODEL; GEAR	Killer whale (Orcinus orca) depredation (whales stealing or damaging fish caught on fishing gear) adversely impacts demersal longline fisheries for sablefish (Anoplopoma fimbria), Pacific halibut (Hippoglossus stenolepis) and Greenland turbot (Reinhardtius hippoglossoides) in the Bering Sea, Aleutian Islands and Western Gulf of Alaska. These interactions increase direct costs and opportunity costs associated with catching fish and reduce the profitability of longline fishing in western Alaska. This study synthesizes National Marine Fisheries Service observer data, National Marine Fisheries Service sablefish longline survey and fishermen-collected depredation data to: 1) estimate the frequency of killer whale depredation on longline fisheries in Alaska; 2) estimate depredation-related catch per unit effort reductions; and 3) assess direct costs and opportunity costs incurred by longliners in western Alaska as a result of killer whale interactions. The percentage of commercial fishery sets affected by killer whales was highest in the Bering Sea fisheries for: sablefish (21.4%), Greenland turbot (9.9%), and Pacific halibut (6.9%). Average catch per unit effort reductions on depredated sets ranged from 35.1-69.3% for the observed longline fleet in all three management areas from 1998-2012 (p < 0.001). To compensate for depredation, fishermen set additional gear to catch the same amount of fish, and this increased fuel costs by an additional 82% per depredated set (average $433 additional fuel per depredated set). In a separate analysis with six longline vessels in 2011 and 2012, killer whale depredation avoidance measures resulted in an average additional cost of $494 per depredated vessel-day for fuel and crew food. Opportunity costs of time lost by fishermen averaged $522 per additional vessel-day on the grounds. This assessment of killer whale depredation costs represents the most extensive economic evaluation of this issue in Alaska to date and will help longline fishermen and managers consider the costs and benefits of depredation avoidance and alternative policy solutions.	[Peterson, Megan J.; Mueter, Franz; Criddle, Keith] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Juneau, AK 99801 USA; [Haynie, Alan C.] Alaska Fisheries Sci Ctr, Resource Ecol & Fisheries Management Div, Seattle, WA USA	University of Alaska System; University of Alaska Fairbanks; National Oceanic Atmospheric Admin (NOAA) - USA	Peterson, MJ (corresponding author), Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Juneau, AK 99801 USA.	mjpeterson6@alaska.edu	Criddle, Keith R./P-7080-2016	Criddle, Keith R./0000-0001-9347-2944	Rasmuson Fisheries Research Center; National Science Foundation Marine Ecosystem Sustainability in the Arctic and Subarctic (MESAS) IGERT [DGE-0801720]; National Science Foundation Arctic Social Sciences Program [1107401]; Office of Polar Programs (OPP) [1107401] Funding Source: National Science Foundation	Rasmuson Fisheries Research Center; National Science Foundation Marine Ecosystem Sustainability in the Arctic and Subarctic (MESAS) IGERT; National Science Foundation Arctic Social Sciences Program(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by the Rasmuson Fisheries Research Center, the National Science Foundation Marine Ecosystem Sustainability in the Arctic and Subarctic (MESAS) IGERT (Award Number DGE-0801720), and the National Science Foundation Arctic Social Sciences Program (Award Number 1107401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JK, 2011, J ENVIRON ECON MANAG, V62, P386, DOI 10.1016/j.jeem.2011.07.001; Ai CR, 2003, ECON LETT, V80, P123, DOI 10.1016/S0165-1765(03)00032-6; Amoako-Tuffour J, 2008, MUNICH PERSONAL REPE; Barbeaux S., 2012, ASSESSMENT GREENLAND; Becker B, 2013, BOATING MAGAZINE; BECKER GS, 1965, ECON J, V75, P493, DOI 10.2307/2228949; Bjordal A., 2002, FISHERY MANAGERS GUI, V424, P21; Carothers C, 2013, MAR POLICY, V38, P515, DOI 10.1016/j.marpol.2012.08.007; Clark JM, 2010, CCAMLR SCI, V17, P163; Dalheim M., 1988, 8814 NW AL FISH CTR; Dalla Rosa L, 2007, J MAR BIOL ASSOC UK, V87, P135, DOI 10.1017/S0025315407054306; Donoghue M, 2007, WORKSH DEPR TUN LONG, P1; Fearnbach H, 2012, THESIS U ABERDEEN SC; Fisheries Economic Data Program, 2013, EFIN MONTHL MAR FUEL; Garrison LP, 2007, FISH B-NOAA, V105, P408; Hamer DJ, 2012, MAR MAMMAL SCI, V28, pE345, DOI 10.1111/j.1748-7692.2011.00544.x; Hanselman D, 2007, ALASKA SABLEFISH ASS; Hanselman D, 2010, DEV LONGLINE SURVEY, P533; Hardin JW., 2007, GEN LINEAR MODELS EX, V2, DOI DOI 10.1016/j.marpol.2012.12.026; Haynie AC, 2010, J ENVIRON ECON MANAG, V59, P165, DOI 10.1016/j.jeem.2009.11.001; Heeringa SG, 2017, APPL SURVEY DATA ANA, VSecond, DOI DOI 10.1201/9781315153278; Henderson M.M., 1999, ALSK FISH RES B, V6, P63; Herrmann M., 2006, MARINE RESOURCE EC, V21, P129; Huppert D. D., 2004, STUDY SUPPLY EFFECTS; Johannes RE, 2000, FISH FISH, V1, P257, DOI 10.1046/j.1467-2979.2000.00019.x; Layman RC, 1996, LAND ECON, V72, P113, DOI 10.2307/3147161; Matkin C, 1986, KILLER WHALE INTERAC; Matkin C, 1986, 2262 40ABNFS NAT MAR; MCKEAN JR, 1995, LAND ECON, V71, P95; NMFS, 2012, OBS SAMPL MAN N PAC; NMFS RAM Division, 2012, PAC HAL SABL IFQ REP; NOAA Fisheries, 2013, SEAS DAT FISH IND FI; Peterson MJ, 2013, ICES J MAR SCI, V70, P1220, DOI 10.1093/icesjms/fst045; Peterson MJ, 2013, MAR POLICY, V42, P315, DOI 10.1016/j.marpol.2013.04.001; Roche C, 2007, CCAMLR SCI, V14, P67; Sigler MF, 2008, MAR MAMMAL SCI, V24, P16, DOI 10.1111/j.1748-7692.2007.00149.x; Sivasubramaniam K., 1964, Bulletin of the Fisheries Research Station Ceylon, V17, P221; TEC Inc, 2009, CET DEPR HAW LONGL F; Tixier P, 2010, CCAMLR SCI, V17, P179; Tyedmers, 2001, FISHERIES CTR RES RE, V9, P12; US Department of Commerce, 2013, US CENS; US Department of Labor: Bureau of Labor Statistics, 2013, EC RES; US Energy Information Administration, 2013, PETR OTH LIQ PRIC; Wood S., 2007, MGCV PACKAGE; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; YANO K, 1995, FISH B-NOAA, V93, P355; Zuur Alain F., 2009, P1	47	39	39	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88906	10.1371/journal.pone.0088906	http://dx.doi.org/10.1371/journal.pone.0088906			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3RA	24558446	Green Published, gold, Green Submitted			2022-12-27	WOS:000331706700092
J	Zeri, M; Sa, LDA; Manzi, AO; Araujo, AC; Aguiar, RG; von Randow, C; Sampaio, G; Cardoso, FL; Nobre, CA				Zeri, Marcelo; Sa, Leonardo D. A.; Manzi, Antonio O.; Araujo, Alessandro C.; Aguiar, Renata G.; von Randow, Celso; Sampaio, Gilvan; Cardoso, Fernando L.; Nobre, Carlos A.			Variability of Carbon and Water Fluxes Following Climate Extremes over a Tropical Forest in Southwestern Amazonia	PLOS ONE			English	Article							SURFACE-AIR EXCHANGE; RAIN-FOREST; EDDY-COVARIANCE; USE EFFICIENCY; MICROMETEOROLOGICAL OBSERVATIONS; SONIC ANEMOMETER; CO2 FLUXES; OPEN-PATH; ENERGY; DIOXIDE	The carbon and water cycles for a southwestern Amazonian forest site were investigated using the longest time series of fluxes of CO2 and water vapor ever reported for this site. The period from 2004 to 2010 included two severe droughts (2005 and 2010) and a flooding year (2009). The effects of such climate extremes were detected in annual sums of fluxes as well as in other components of the carbon and water cycles, such as gross primary production and water use efficiency. Gap-filling and flux-partitioning were applied in order to fill gaps due to missing data, and errors analysis made it possible to infer the uncertainty on the carbon balance. Overall, the site was found to have a net carbon uptake of approximate to 5 t C ha(-1) year(-1), but the effects of the drought of 2005 were still noticed in 2006, when the climate disturbance caused the site to become a net source of carbon to the atmosphere. Different regions of the Amazon forest might respond differently to climate extremes due to differences in dry season length, annual precipitation, species compositions, albedo and soil type. Longer time series of fluxes measured over several locations are required to better characterize the effects of climate anomalies on the carbon and water balances for the whole Amazon region. Such valuable datasets can also be used to calibrate biogeochemical models and infer on future scenarios of the Amazon forest carbon balance under the influence of climate change.	[Zeri, Marcelo; von Randow, Celso; Sampaio, Gilvan] Inst Nacl Pesquisas Espaciais, Ctr Ciencia Sistema Terrestre, Cachoeira Paulista, SP, Brazil; [Sa, Leonardo D. A.] Inst Nacl Pesquisas Espaciais, Ctr Reg Amazonia, Belem, Para, Brazil; [Manzi, Antonio O.] INPA, Manaus, Amazonas, Brazil; [Araujo, Alessandro C.] Embrapa Amazonia Oriental, Belem, Para, Brazil; [Aguiar, Renata G.] Univ Fed Rondonia, Porto Velho, Rondonia, Brazil; [Cardoso, Fernando L.] Univ Fed Rondonia, Ji Parana, Rondonia, Brazil; [Nobre, Carlos A.] Minist Ciencia Tecnol & Inovacao, Secretaria Polit, Brasilia, DF, Brazil; [Nobre, Carlos A.] Minist Ciencia Tecnol & Inovacao, Programa Pesquisa, Brasilia, DF, Brazil; [Nobre, Carlos A.] Minist Ciencia Tecnol & Inovacao, Programas Desenvolvimento, Brasilia, DF, Brazil	Instituto Nacional de Pesquisas Espaciais (INPE); Instituto Nacional de Pesquisas Espaciais (INPE); Institute Nacional de Pesquisas da Amazonia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Rondonia; Universidade Federal de Rondonia	Zeri, M (corresponding author), Inst Nacl Pesquisas Espaciais, Ctr Ciencia Sistema Terrestre, Cachoeira Paulista, SP, Brazil.	marcelo.zeri@inpe.br	Sá, Leonardo/B-9731-2013; Manzi, Antonio/U-3141-2019; von Randow, Celso/B-3335-2009; Von Randow, Celso/AAW-8272-2020; Zeri, Marcelo/B-7701-2008; Sampaio, Gilvan/F-7482-2012; Sá, Leonardo/M-7736-2019	Sá, Leonardo/0000-0002-0402-323X; Manzi, Antonio/0000-0002-4860-6031; von Randow, Celso/0000-0003-1045-4316; Von Randow, Celso/0000-0003-1045-4316; Zeri, Marcelo/0000-0003-1244-0858; Sampaio, Gilvan/0000-0001-6956-3950; Sá, Leonardo/0000-0002-0402-323X	Sao Paulo Research Foundation (FAPESP) [2011/04101-0]; CNPq - Conselho Nacional de Pesquisa e Desenvolvimento Tecnologico [303.728/2010-8]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq - Conselho Nacional de Pesquisa e Desenvolvimento Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	M. Zeri is grateful to Sao Paulo Research Foundation (FAPESP) - grant 2011/04101-0 - for the support during the preparation of this manuscript. Leonardo Sa is particularly grateful to CNPq - Conselho Nacional de Pesquisa e Desenvolvimento Tecnologico - for his research grant (process 303.728/2010-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar RG, 2005, THESIS U FEDERAL MAT; Bolzan MJA, 2006, BRAZ J PHYS, V36, P1217, DOI 10.1590/S0103-97332006000700018; Andreae MO, 2004, SCIENCE, V303, P1337, DOI 10.1126/science.1092779; Andreae MO, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000524; Anthoni PM, 2004, AGR FOREST METEOROL, V121, P55, DOI 10.1016/S0168-1923(03)00162-X; Aubinet M, 2003, BOUND-LAY METEOROL, V108, P397, DOI 10.1023/A:1024168428135; Bagley JE, 2014, J CLIMATE, V27, P345, DOI 10.1175/JCLI-D-12-00369.1; Bai YF, 2012, ECOL RES, V27, P615, DOI 10.1007/s11284-012-0930-z; Baker IT, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000644; BALDOCCHI DD, 1988, ECOLOGY, V69, P1331, DOI 10.2307/1941631; Betts AK, 2009, GEOPHYS MONOGR SER, V186, P163, DOI 10.1029/2008GM000725; Betts AK, 2004, B AM METEOROL SOC, V85, P1673, DOI 10.1175/BAMS-85-11-1673; Betts AK, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008191; Betts AK, 2010, J ADV MODEL EARTH SY, V2, DOI 10.3894/JAMES.2010.2.6; Bolzan MJA, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000378; Bruno RD, 2006, HYDROL PROCESS, V20, P2477, DOI 10.1002/hyp.6211; Burba GG, 2008, GLOBAL CHANGE BIOL, V14, P1854, DOI 10.1111/j.1365-2486.2008.01606.x; Butt N, 2010, AGR FOREST METEOROL, V150, P361, DOI 10.1016/j.agrformet.2009.12.004; Campanharo ASLO, 2008, PHILOS T R SOC A, V366, P579, DOI 10.1098/rsta.2007.2118; Costa MH, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001179; Costa MH, 1999, J GEOPHYS RES-ATMOS, V104, P14189, DOI 10.1029/1998JD200126; da Rocha HR, 2004, ECOL APPL, V14, pS22; da Rocha HR, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2007JG000640; de Araujo AC, 2010, AGR FOREST METEOROL, V150, P226, DOI 10.1016/j.agrformet.2009.11.005; Dias MAFS, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000335; Doughty CE, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003670; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; Feigenwinter C, 2004, BOUND-LAY METEOROL, V113, P201, DOI 10.1023/B:BOUN.0000039372.86053.ff; Feigenwinter C, 2008, AGR FOREST METEOROL, V148, P12, DOI 10.1016/j.agrformet.2007.08.013; Finnigan J, 1999, AGR FOREST METEOROL, V97, P55, DOI 10.1016/S0168-1923(99)00049-0; Fisch G, 2004, THEOR APPL CLIMATOL, V78, P47, DOI 10.1007/s00704-004-0043-x; Fisher JB, 2009, GLOBAL CHANGE BIOL, V15, P2694, DOI 10.1111/j.1365-2486.2008.01813.x; Foken T, 1996, AGR FOREST METEOROL, V78, P83, DOI 10.1016/0168-1923(95)02248-1; Foken T, 2004, ATMOS OCEAN SCI LIB, V29, P181; Frank JM, 2013, AGR FOREST METEOROL, V171, P72, DOI 10.1016/j.agrformet.2012.11.005; Goulden ML, 2004, ECOL APPL, V14, pS42, DOI 10.1890/02-6008; Goulden ML, 1996, GLOBAL CHANGE BIOL, V2, P169, DOI 10.1111/j.1365-2486.1996.tb00070.x; GRACE J, 1995, SCIENCE, V270, P778, DOI 10.1126/science.270.5237.778; Gu LH, 1999, J GEOPHYS RES-ATMOS, V104, P31421, DOI 10.1029/1999JD901068; Gu LH, 2012, AGR FOREST METEOROL, V152, P135, DOI 10.1016/j.agrformet.2011.09.014; Hutyra LR, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000365; Kaimal J. C., 1994, ATMOSPHERIC BOUNDARY, DOI 10.1093/oso/9780195062397.001.0001; Keenan TF, 2013, NATURE, V499, P324, DOI 10.1038/nature12291; Kochendorfer J, 2012, BOUND-LAY METEOROL, V145, P383, DOI 10.1007/s10546-012-9738-1; Kruijt B, 2000, BOUND-LAY METEOROL, V94, P297, DOI 10.1023/A:1002401829007; Kruijt B, 2004, ECOL APPL, V14, pS101; Lee XH, 1998, AGR FOREST METEOROL, V91, P39, DOI 10.1016/S0168-1923(98)00071-9; Lee XH, 2002, BOUND-LAY METEOROL, V103, P277, DOI 10.1023/A:1014508928693; LEUNING R, 1992, BOUND-LAY METEOROL, V59, P297, DOI 10.1007/BF00119818; Leuning R, 2007, BOUND-LAY METEOROL, V123, P263, DOI 10.1007/s10546-006-9138-5; Lewis SL, 2011, SCIENCE, V331, P554, DOI 10.1126/science.1200807; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Malhi Y, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000623; Marengo JA, 2008, PHILOS T R SOC B, V363, P1773, DOI 10.1098/rstb.2007.0015; Marengo JA, 2008, J CLIMATE, V21, P495, DOI 10.1175/2007JCLI1600.1; Marengo JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047436; Marengo JA, 2012, THEOR APPL CLIMATOL, V107, P73, DOI 10.1007/s00704-011-0465-1; MONTGOMERY RB, 1948, J METEOROL, V5, P265, DOI 10.1175/1520-0469(1948)005<0265:VEFOHI>2.0.CO;2; MOORE CJ, 1986, BOUND-LAY METEOROL, V37, P17, DOI 10.1007/BF00122754; NEPSTAD DC, 1994, NATURE, V372, P666, DOI 10.1038/372666a0; Philip JR, 1963, AUST J PHYS, P16; Potter C, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034024; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Richardson AD, 2006, AGR FOREST METEOROL, V136, P1, DOI 10.1016/j.agrformet.2006.01.007; Richardson AD, 2007, AGR FOREST METEOROL, V147, P199, DOI 10.1016/j.agrformet.2007.06.004; Saleska SR, 2007, SCIENCE, V318, P612, DOI 10.1126/science.1146663; Saleska SR, 2003, SCIENCE, V302, P1554, DOI 10.1126/science.1091165; Samanta A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042154; SCHOTANUS P, 1983, BOUND-LAY METEOROL, V26, P81, DOI 10.1007/BF00164332; Stull R.B, 1988, INTRO BOUNDARY LAYER; Suyker AE, 2009, AGR FOREST METEOROL, V149, P443, DOI 10.1016/j.agrformet.2008.09.010; SWINBANK WC, 1951, J METEOROL, V8, P135, DOI 10.1175/1520-0469(1951)008<0135:TMOVTO>2.0.CO;2; Tota J, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000597; VanLoocke A, 2012, AGR FOREST METEOROL, V164, P82, DOI 10.1016/j.agrformet.2012.05.016; Vickers D, 1997, J ATMOS OCEAN TECH, V14, P512, DOI 10.1175/1520-0426(1997)014<0512:QCAFSP>2.0.CO;2; von Randow C, 2004, THEOR APPL CLIMATOL, V78, P5, DOI 10.1007/s00704-004-0041-z; von Randow C, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000379; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Wilczak JM, 2001, BOUND-LAY METEOROL, V99, P127, DOI 10.1023/A:1018966204465; Wilks A. A., 1995, STAT METHODS ATMOSPH; Wright I.R., 1996, AMAZONIAN DEFORESTAT, P473; Xu LA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046824; Yamasoe MA, 2006, ATMOS CHEM PHYS, V6, P1645, DOI 10.5194/acp-6-1645-2006; Zeng N, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/1/014002; Zeri M, 2013, J GEOPHYS RES-BIOGEO, V118, P581, DOI 10.1002/jgrg.20052; Zeri M, 2011, AGR ECOSYST ENVIRON, V144, P319, DOI 10.1016/j.agee.2011.09.006; Zeri M, 2011, BOUND-LAY METEOROL, V138, P413, DOI 10.1007/s10546-010-9563-3; Zeri M, 2010, AGR FOREST METEOROL, V150, P1543, DOI 10.1016/j.agrformet.2010.08.004; Zhao MS, 2010, SCIENCE, V329, P940, DOI 10.1126/science.1189590	89	29	31	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88130	10.1371/journal.pone.0088130	http://dx.doi.org/10.1371/journal.pone.0088130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558378	gold, Green Submitted, Green Published			2022-12-27	WOS:000331706700024
J	Mokany, K; Westcott, DA; Prasad, S; Ford, AJ; Metcalfe, DJ				Mokany, Karel; Westcott, David A.; Prasad, Soumya; Ford, Andrew J.; Metcalfe, Daniel J.			Identifying Priority Areas for Conservation and Management in Diverse Tropical Forests	PLOS ONE			English	Article							CLIMATE-CHANGE; BETA-DIVERSITY; WET TROPICS; ALPHA-DIVERSITY; BIODIVERSITY; PATTERNS; QUEENSLAND; TREE; SENSITIVITY; MODELS	The high concentration of the world's species in tropical forests endows these systems with particular importance for retaining global biodiversity, yet it also presents significant challenges for ecology and conservation science. The vast number of rare and yet to be discovered species restricts the applicability of species-level modelling for tropical forests, while the capacity of community classification approaches to identify priorities for conservation and management is also limited. Here we assessed the degree to which macroecological modelling can overcome shortfalls in our knowledge of biodiversity in tropical forests and help identify priority areas for their conservation and management. We used 527 plant community survey plots in the Australian Wet Tropics to generate models and predictions of species richness, compositional dissimilarity, and community composition for all the 4,313 vascular plant species recorded across the region (>1.3 million communities (grid cells)). We then applied these predictions to identify areas of tropical forest likely to contain the greatest concentration of species, rare species, endemic species and primitive angiosperm families. Synthesising these alternative attributes of diversity into a single index of conservation value, we identified two areas within the Australian wet tropics that should be a high priority for future conservation actions: the Atherton Tablelands and Daintree rainforest. Our findings demonstrate the value of macroecological modelling in identifying priority areas for conservation and management actions within highly diverse systems, such as tropical forests.	[Mokany, Karel] CSIRO, Ecosyst Sci, Canberra, ACT, Australia; [Westcott, David A.; Ford, Andrew J.] CSIRO, Ecosyst Sci, Atherton, Qld, Australia; [Prasad, Soumya] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India; [Metcalfe, Daniel J.] CSIRO, Ecosyst Sci, Dutton Park, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Indian Institute of Science (IISC) - Bangalore; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Mokany, K (corresponding author), CSIRO, Ecosyst Sci, Canberra, ACT, Australia.	Karel.Mokany@csiro.au	Metcalfe, Daniel J/G-3305-2010; Ford, Andrew J/D-3761-2011; Mokany, Karel/C-1464-2009; Westcott, David A/G-5559-2010	Metcalfe, Daniel J/0000-0001-6853-7072; 	Australia-India Strategic Research Fund	Australia-India Strategic Research Fund(Australian GovernmentDepartment of Industry, Innovation and Science)	This research was supported by a grant from the Australia-India Strategic Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ESTIMATION SOIL PROP; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Bostock P.D., 2010, CENSUS QUEENSLAND FL; Bradshaw CJA, 2009, FRONT ECOL ENVIRON, V7, P79, DOI 10.1890/070193; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; CARSON WP, 2008, TROPICAL FOREST COMM; Currie DJ, 2001, ECOSYSTEMS, V4, P216, DOI 10.1007/s10021-001-0005-4; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Ferrier S, 2006, J APPL ECOL, V43, P393, DOI 10.1111/j.1365-2664.2006.01149.x; Graham CH, 2010, ECOGRAPHY, V33, P1062, DOI 10.1111/j.1600-0587.2010.06430.x; Hilbert DW, 2007, PALAEOGEOGR PALAEOCL, V251, P104, DOI 10.1016/j.palaeo.2007.02.020; Hilbert David W., 1999, Diversity and Distributions, V5, P263, DOI 10.1046/j.1472-4642.1999.00060.x; Hilbert DW, 2001, AUSTRAL ECOL, V26, P590, DOI 10.1046/j.1442-9993.2001.01137.x; Jones MM, 2013, J ECOL, V101, P506, DOI 10.1111/1365-2745.12053; Lehmann A, 2003, ECOL MODEL, V160, P165, DOI 10.1016/S0304-3800(02)00354-X; Lomolino MV, 2004, FRONTIERS OF BIOGEOGRAPHY: NEW DIRECTIONS IN THE GEOGRAPHY OF NATURE, P1; Malhi Y, 2009, P NATL ACAD SCI USA, V106, P20610, DOI 10.1073/pnas.0804619106; Mayfield MM, 2013, AM J BOT IN PRESS; Metcalfe D. J., 2009, Pacific Conservation Biology, V15, P80; Metcalfe DJ, 2009, LIVING DYNAMIC TROPI, P123; Moilanen A, 2007, BIOL CONSERV, V134, P571, DOI 10.1016/j.biocon.2006.09.008; Mokany K, 2013, J BIOGEOGR, V40, P2299, DOI 10.1111/jbi.12175; Mokany K, 2013, J APPL ECOL, V50, P519, DOI 10.1111/1365-2664.12038; Mokany K, 2012, GLOBAL CHANGE BIOL, V18, P3149, DOI 10.1111/j.1365-2486.2012.02760.x; Mokany K, 2011, ECOL LETT, V14, P1043, DOI 10.1111/j.1461-0248.2011.01675.x; Mokany K, 2011, DIVERS DISTRIB, V17, P374, DOI 10.1111/j.1472-4642.2010.00735.x; Moritz C, 2001, P ROY SOC B-BIOL SCI, V268, P1875, DOI 10.1098/rspb.2001.1713; Neldner V. J., 2012, METHODOLOGY SURVEY M; Nix H. A, 1991, RAINFOREST ANIMALS A; Ostendorf B, 2001, ECOL MODEL, V145, P211, DOI 10.1016/S0304-3800(01)00392-1; Overton JM, 2009, DIVERS DISTRIB, V15, P731, DOI 10.1111/j.1472-4642.2009.00589.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Raymond O., 2009, AUSGEO NEWS, V93, P3; Sattler P., 1999, CONSERVATION STATUS; Shoo LP, 2005, BIOL CONSERV, V125, P335, DOI 10.1016/j.biocon.2005.04.003; Stanton P, 2005, VEGETATION WET TROPI; Ter Steege H, 2003, BIODIVERS CONSERV, V12, P2255, DOI 10.1023/A:1024593414624; Tracey J. G., 1975, VEGETATION HUMID TRO; Tracey JG, 1982, VEGETATION HUMID TRO; VanDerWal J, 2009, J BIOGEOGR, V36, P291, DOI 10.1111/j.1365-2699.2008.01993.x; WEBB LJ, 1968, ECOLOGY, V49, P296, DOI 10.2307/1934459; WEBB LJ, 1959, J ECOL, V47, P551, DOI 10.2307/2257290; Western A., 2004, SOIL HYDROLOGICAL PR; Wilford J, 2012, GEODERMA, V183, P124, DOI 10.1016/j.geoderma.2010.12.022; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; WILLIAMS WT, 1984, AUST J BOT, V32, P109, DOI 10.1071/BT9840109; Xu T., 2010, ANUCLIM VERSION 6 1	50	18	18	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89084	10.1371/journal.pone.0089084	http://dx.doi.org/10.1371/journal.pone.0089084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551222	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000331271500095
J	Allen, DJ; Adams, NL; Aladin, F; Harris, JP; Brown, DWG				Allen, David J.; Adams, Natalie L.; Aladin, Farah; Harris, John P.; Brown, David W. G.			Emergence of the GII-4 Norovirus Sydney2012 Strain in England, Winter 2012-2013	PLOS ONE			English	Article							GASTROENTERITIS OUTBREAKS; VARIANT; SURVEILLANCE; EVOLUTION	Norovirus is the commonest cause of acute gastrointestinal disease and is the main aetiological agent of outbreaks of gastroenteritis, particularly in semi-closed environments. Norovirus infections in England typically peak between December and March each year. The most commonly detected norovirus strains belong to the genetically diverse genogroup-II genotype-4 (GII-4) genocluster and in the previous two norovirus winter seasons the majority of GII-4 strains in circulation worldwide have been genetically similar to the GII-4 strain New Orleans 1805/2009/USA. At the beginning of the 2012/13 season a genetically distinct GII-4 strain (Sydney 2012/NSW0514/2012/AU) was described which emerged worldwide during the winter of 2012/13. Here we describe the emergence of norovirus strains genetically related to Sydney2012 in England during the 2012/13 season to replace NewOrleans2009 strains as the most commonly detected variant of GII-4 norovirus in England. Furthermore, we demonstrate that whilst the emergence of Sydney2012 coincided with an early peak in the number of norovirus outbreaks, there was not an overall increase in norovirus activity compared to the previous season. Finally, we show that the Sydney2012 strain is associated with distinct genetic changes compared to the NewOrleans2009 strain, and these changes may have contributed to the emergence of the Sydney2012 strain.	[Allen, David J.; Aladin, Farah; Brown, David W. G.] Publ Hlth England, Microbiol Serv, Virus Reference Dept, London, England; [Adams, Natalie L.; Harris, John P.] Publ Hlth England, Heath Protect Serv, Gastrointestinal Emerging & Zoonot Infect Dept, London, England; [Harris, John P.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Harris, John P.] Univ Liverpool, Natl Consortium Zoonosis Res, Liverpool, Merseyside, England	Public Health England; Public Health England; University of Liverpool; University of Liverpool	Allen, DJ (corresponding author), Publ Hlth England, Microbiol Serv, Virus Reference Dept, London, England.	david.james.allen@phe.gov.uk		Allen, David/0000-0002-1194-0415; Harris, John/0000-0001-9606-9480				Allen DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001485; Allen DJ, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-150; Bok K, 2009, J VIROL, V83, P11890, DOI 10.1128/JVI.00864-09; Bull RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000831; Cao S, 2007, J VIROL, V81, P5949, DOI 10.1128/JVI.00219-07; Debbink K, 2013, J INFECT DIS; Debbink K, 2012, J VIROL, V86, P1214, DOI 10.1128/JVI.06189-11; Gallimore CI, 2005, INT J FOOD MICROBIOL, V103, P323, DOI 10.1016/j.ijfoodmicro.2005.02.003; Harris J. P., 2011, Journal of Infection Prevention, V12, P102, DOI 10.1177/1757177410392094; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lindesmith LC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002705; Lopman B, 2004, LANCET, V363, P682, DOI 10.1016/S0140-6736(04)15641-9; Lopman BA, 2003, EMERG INFECT DIS, V9, P71; Mounts AW, 2000, J INFECT DIS, V181, pS284, DOI 10.1086/315586; Phillips G, 2010, AM J EPIDEMIOL, V171, P1014, DOI 10.1093/aje/kwq021; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; Shanker S, 2011, J VIROL, V85, P8635, DOI 10.1128/JVI.00848-11; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van Beek J, 2013, EUROSURVEILLANCE, V18, P8; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Xerry J, 2008, J CLIN MICROBIOL, V46, P947, DOI 10.1128/JCM.02240-07; Zakikhany K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041625; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	28	28	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88978	10.1371/journal.pone.0088978	http://dx.doi.org/10.1371/journal.pone.0088978			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551201	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000331266000087
J	Ferreyra, GA; Elinoff, JM; Demirkale, CY; Starost, MF; Buckley, M; Munson, PJ; Krakauer, T; Danner, RL				Ferreyra, Gabriela A.; Elinoff, Jason M.; Demirkale, Cumhur Y.; Starost, Matthew F.; Buckley, Marilyn; Munson, Peter J.; Krakauer, Teresa; Danner, Robert L.			Late Multiple Organ Surge in Interferon-Regulated Target Genes Characterizes Staphylococcal Enterotoxin B Lethality	PLOS ONE			English	Article							TOXIC-SHOCK-SYNDROME; A STREPTOCOCCAL INFECTIONS; DENDRITIC CELLS; I INTERFERON; BACTERIAL SUPERANTIGENS; INTRANASAL EXPOSURE; ENDOTHELIAL-CELLS; DAI DLM-1/ZBP1; MICE; EXPRESSION	Background: Bacterial superantigens are virulence factors that cause toxic shock syndrome. Here, the genome-wide, temporal response of mice to lethal intranasal staphylococcal enterotoxin B (SEB) challenge was investigated in six tissues. Results: The earliest responses and largest number of affected genes occurred in peripheral blood mononuclear cells (PBMC), spleen, and lung tissues with the highest content of both T-cells and monocyte/macrophages, the direct cellular targets of SEB. In contrast, the response of liver, kidney, and heart was delayed and involved fewer genes, but revealed a dominant genetic program that was seen in all 6 tissues. Many of the 85 uniquely annotated transcripts participating in this shared genomic response have not been previously linked to SEB. Nine of the 85 genes were subsequently confirmed by RTPCR in every tissue/organ at 24 h. These 85 transcripts, up-regulated in all tissues, annotated to the interferon (IFN)/antiviralresponse and included genes belonging to the DNA/RNA sensing system, DNA damage repair, the immunoproteasome, and the ER/metabolic stress-response and apoptosis pathways. Overall, this shared program was identified as a type I and II interferon (IFN)-response and the promoters of these genes were highly enriched for IFN regulatory matrices. Several genes whose secreted products induce the IFN pathway were up-regulated at early time points in PBMCs, spleen, and/or lung. Furthermore, IFN regulatory factors including Irf1, Irf7 and Irf8, and Zbp1, a DNA sensor/transcription factor that can directly elicit an IFN innate immune response, participated in this host-wide SEB signature. Conclusion: Global gene-expression changes across multiple organs implicated a host-wide IFN-response in SEB-induced death. Therapies aimed at IFN-associated innate immunity may improve outcome in toxic shock syndromes.	[Ferreyra, Gabriela A.; Elinoff, Jason M.; Danner, Robert L.] NIH, Funct Genom & Prote Facil, Dept Crit Care Med, Clin Res Ctr, Bethesda, MD 20892 USA; [Demirkale, Cumhur Y.; Munson, Peter J.] NIH, Math & Stat Comp Lab, Ctr Informat Technol, Bethesda, MD 20892 USA; [Starost, Matthew F.] NIH, Div Vet Resources, Off Res Serv, Bethesda, MD 20892 USA; [Buckley, Marilyn; Krakauer, Teresa] US Army Med Res Inst Infect Dis, Integrated Toxicol Div, Ft Detrick, MD 21702 USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); National Institutes of Health (NIH) - USA; United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army	Krakauer, T (corresponding author), US Army Med Res Inst Infect Dis, Integrated Toxicol Div, Ft Detrick, MD 21702 USA.	teresa.krakauer@us.army.mil; rdanner@nih.gov			Defense Threat Reduction Agency [DTRA 3.10035]; Intramural Research Program of the Critical Care Medicine Department, NIH Clinical Center; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000266] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL000188, ZIACL008060, ZIACL001164] Funding Source: NIH RePORTER	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Intramural Research Program of the Critical Care Medicine Department, NIH Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); CLINICAL CENTER	This research was entirely funded by The Defense Threat Reduction Agency (#DTRA 3.10035) and the Intramural Research Program of the Critical Care Medicine Department, NIH Clinical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atasheva S, 2012, J VIROL, V86, P8147, DOI 10.1128/JVI.00733-12; Barb JJ, 2009, MATH STAT COMPUTING; BERGDOLL MS, 1982, ANN INTERN MED, V96, P969, DOI 10.7326/0003-4819-96-6-969; BHARDWAJ N, 1993, J EXP MED, V178, P633, DOI 10.1084/jem.178.2.633; Brogan PA, 2004, ARTHRITIS RHEUM-US, V50, P589, DOI 10.1002/art.20021; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; CARLSSON R, 1988, J IMMUNOL, V140, P2484; Castelli J, 1998, BIOMED PHARMACOTHER, V52, P386, DOI 10.1016/S0753-3322(99)80006-7; CHEN JYJ, 1994, INFECT IMMUN, V62, P4626, DOI 10.1128/IAI.62.10.4626-4631.1994; Cho SH, 2009, BLOOD, V113, P2416, DOI 10.1182/blood-2008-03-144121; CHOI YW, 1989, P NATL ACAD SCI USA, V86, P8941, DOI 10.1073/pnas.86.22.8941; Chowdhary VR, 2012, J IMMUNOL, V189, P2054, DOI 10.4049/jimmunol.1201097; DANNER RL, 1991, CHEST, V99, P169, DOI 10.1378/chest.99.1.169; Darenberg J, 2003, CLIN INFECT DIS, V37, P333, DOI 10.1086/376630; Descloux E, 2008, EUR J CLIN MICROBIOL, V27, P37, DOI 10.1007/s10096-007-0405-2; DeVries AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022997; Dinges MM, 2001, INFECT IMMUN, V69, P7169, DOI 10.1128/IAI.69.11.7169-7172.2001; Doody GM, 2010, NUCLEIC ACIDS RES, V38, P5336, DOI 10.1093/nar/gkq268; DRAKE CG, 1992, J CLIN IMMUNOL, V12, P149, DOI 10.1007/BF00918083; Ebstein F, 2009, INT J BIOCHEM CELL B, V41, P1205, DOI 10.1016/j.biocel.2008.10.023; Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1197, DOI 10.1164/rccm.200204-302OC; Eriksson BKG, 1999, J INFECT DIS, V180, P410, DOI 10.1086/314872; Fang TC, 2012, J EXP MED, V209, P661, DOI 10.1084/jem.20112343; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; FRASER JD, 1992, J EXP MED, V175, P1131, DOI 10.1084/jem.175.4.1131; Galiveti CR, 2010, RNA, V16, P450, DOI 10.1261/rna.1755810; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Goenka S, 2006, P NATL ACAD SCI USA, V103, P4210, DOI 10.1073/pnas.0506981103; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Hakme A, 2008, DEV DYNAM, V237, P209, DOI 10.1002/dvdy.21399; Huys L, 2009, J EXP MED, V206, P1873, DOI 10.1084/jem.20090213; Huzella LM, 2009, RES VET SCI, V86, P241, DOI 10.1016/j.rvsc.2008.07.020; Kaul R, 1999, CLIN INFECT DIS, V28, P800, DOI 10.1086/515199; Komisar JL, 2001, TOXICOL PATHOL, V29, P369, DOI 10.1080/019262301316905336; Krakauer T, 1999, IMMUNOL RES, V20, P163, DOI 10.1007/BF02786471; KRAKAUER T, 1994, J LEUKOCYTE BIOL, V56, P458, DOI 10.1002/jlb.56.4.458; Krakauer T, 2010, TOXINS, V2, P1963, DOI 10.3390/toxins2081963; Krakauer T, 2010, ANTIMICROB AGENTS CH, V54, P1125, DOI 10.1128/AAC.01015-09; Krakauer T, 2009, INT IMMUNOPHARMACOL, V9, P1168, DOI 10.1016/j.intimp.2009.06.004; Lappin E, 2009, LANCET INFECT DIS, V9, P281, DOI 10.1016/S1473-3099(09)70066-0; Leung AKL, 2012, RNA BIOL, V9, P542, DOI 10.4161/rna.19899; Li H, 2007, CELL MOL IMMUNOL, V4, P407; Madsen JM, 2001, CLIN LAB MED, V21, P593; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; Martin FJ, 2009, J CLIN INVEST, V119, P1931, DOI 10.1172/JCI35879; MATTIX ME, 1995, TOXICOL PATHOL, V23, P262, DOI 10.1177/019262339502300304; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; Mehrotra P, 2011, J BIOL CHEM, V286, P1767, DOI 10.1074/jbc.M110.157768; NAGAKI M, 1994, GASTROENTEROLOGY, V106, P450, DOI 10.1016/0016-5085(94)90604-1; NORRBYTEGLUND A, 1995, SCAND J INFECT DIS, V27, P125, DOI 10.3109/00365549509018991; O'Neill LAJ, 2009, CELL, V138, P428, DOI 10.1016/j.cell.2009.07.021; Oudshoorn D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029870; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Plaza R, 2007, INFECT IMMUN, V75, P306, DOI 10.1128/IAI.01220-06; Rajagopalan G, 2006, INFECT IMMUN, V74, P1284, DOI 10.1128/IAI.74.2.1284-1296.2006; Roy CJ, 2005, INFECT IMMUN, V73, P2452, DOI 10.1128/IAI.73.4.2452-2460.2005; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Saemann MD, 2009, AM J TRANSPLANT, V9, P2655, DOI 10.1111/j.1600-6143.2009.02832.x; SARAWAR SR, 1994, J INFECT DIS, V170, P1189, DOI 10.1093/infdis/170.5.1189; Savransky V, 2003, TOXICOL PATHOL, V31, P373, DOI 10.1080/01926230390201093; SCHLIEVERT PM, 1986, LANCET, V1, P1149; Schmitz F, 2008, EUR J IMMUNOL, V38, P2981, DOI 10.1002/eji.200838761; Seishima M, 2009, CLIN EXP DERMATOL, V34, pE632, DOI 10.1111/j.1365-2230.2009.03353.x; Severa M, 2006, J BIOL CHEM, V281, P26188, DOI 10.1074/jbc.M604516200; SHANDS KN, 1980, NEW ENGL J MED, V303, P1436, DOI 10.1056/NEJM198012183032502; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stevens DL, 1996, INFECT DIS CLIN N AM, V10, P727, DOI 10.1016/S0891-5520(05)70324-X; STEVENS DL, 1989, NEW ENGL J MED, V321, P1, DOI 10.1056/NEJM198907063210101; STILES BG, 1993, INFECT IMMUN, V61, P5333, DOI 10.1128/IAI.61.12.5333-5338.1993; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tanaka Hideharu, 1995, Journal of Burn Care and Rehabilitation, V16, P616, DOI 10.1097/00004630-199511000-00011; Taylor RT, 2011, CELL HOST MICROBE, V10, P185, DOI 10.1016/j.chom.2011.08.004; Temajo NO, 2012, AUTOIMMUN REV, V11, P653, DOI 10.1016/j.autrev.2011.11.008; Tilahun AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016764; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Vitour Damien, 2007, Sci STKE, V2007, ppe20, DOI 10.1126/stke.3842007pe20; Wang JS, 2006, CELL MOL IMMUNOL, V3, P255; Wang ZC, 2008, P NATL ACAD SCI USA, V105, P5477, DOI 10.1073/pnas.0801295105; Weichhart T, 2009, TRENDS IMMUNOL, V30, P218, DOI 10.1016/j.it.2009.02.002; Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101; Yang ZQ, 2009, ARTERIOSCL THROM VAS, V29, P1213, DOI 10.1161/ATVBAHA.109.189407; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhu MH, 1999, CELL, V96, P121, DOI 10.1016/S0092-8674(00)80965-4	84	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88756	10.1371/journal.pone.0088756	http://dx.doi.org/10.1371/journal.pone.0088756			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551153	Green Published, Green Submitted, gold			2022-12-27	WOS:000331266000062
J	Patel, P; Khan, N; Rani, M; Gupta, D; Jameel, S				Patel, Paresh; Khan, Nabab; Rani, Manjusha; Gupta, Deepti; Jameel, Shahid			The Expression of HIV-1 Vpu in Monocytes Causes Increased Secretion of TGF-beta that Activates Profibrogenic Genes in Hepatic Stellate Cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GROWTH-FACTOR-BETA; INDUCED LIVER FIBROSIS; KAPPA-B ACTIVITY; C VIRUS; COINFECTED PATIENTS; COLLAGEN-I; TYPE-1; PROGRESSION; INFECTION	There is faster progression to fibrosis in persons with liver injury who are also infected with HIV. Other reports have suggested that HIV can directly infect and activate stellate cells, and the viral Tat and gp160 proteins also induce profibrogenic factors from peripheral blood mononuclear cells (PBMCs). We tested the role of HIV-1 Vpu accessory protein in promoting profibrogenic activation of hepatic stellate cells. Human stellate LX2 cells were cocultured with human monocytic U937 cells stably expressing the Vpu protein or latently infected U1 cells knocked down for Vpu expression, LX2 cells were also cultured with the supernatants from these cells. The expression of profibrogenic markers was evaluated in LX2 cells usingquantitative reverse transcription polymerase chain reaction (qRT-PCR), western blotting, immunofluorescence, flow cytometry and ELISA were used to confirm and quantitate protein expression. Monocytic cells expressing Vpu increased the expression of profibrogenic markers in LX2 cells. The culture supernatants of these cells contained increased levels of transforming growth factor beta (TGF-beta), which correlated with increased activity of the AP-1 transcription factor. Antibodies against TGF-beta or a TGF-beta receptor inhibitor (SB431452) reversed Vpu-mediated profibrogenic activation of LX2 cells, suggesting that TGF-beta mediated these effects. The cytokine macrophage migration inhibitory factor (MIF) attenuated Vpu-mediated TGF-beta secretion and profibrogenic effects on LX2 cells. Besides its other roles in pathogenesis, Vpu is likely to contribute to hepatic fibrosis through this hitherto unknown mechanism.	[Patel, Paresh; Khan, Nabab; Rani, Manjusha; Gupta, Deepti; Jameel, Shahid] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Jameel, S (corresponding author), Wellcome Trust DBT India Alliance, Plot 19,8-2-684-3K-19,Banjara Hills, Hyderabad, Andhra Pradesh, India.	shahid@icgeb.res.in	khan, Nabab/Z-3970-2019; Gupta, Deepti/U-1777-2019	khan, Nabab/0000-0002-8563-5341; Gupta, Deepti/0000-0001-7931-0017	Department of Biotechnology (DBT); Indian Council of Medical Research (ICMR); Council for Scientific and Industrial Research (CSIR); ICMR	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); ICMR(Indian Council of Medical Research (ICMR))	This work was funded by grants from the Department of Biotechnology (DBT) and Indian Council of Medical Research (ICMR). Senior Research Fellowships were awarded by the Council for Scientific and Industrial Research (CSIR) to PP, and by the ICMR to NK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrovandi GM, 1996, J VIROL, V70, P1505, DOI 10.1128/JVI.70.3.1505-1511.1996; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; BIRCHENALLROBERTS MC, 1990, MOL CELL BIOL, V10, P4978, DOI 10.1128/MCB.10.9.4978; Brau N, 2006, J HEPATOL, V44, P47, DOI 10.1016/j.jhep.2005.07.006; Chang LJ, 2005, GENE THER, V12, P1133, DOI 10.1038/sj.gt.3302509; Corpechot C, 2002, HEPATOLOGY, V35, P1010, DOI 10.1053/jhep.2002.32524; de Gouville AC, 2005, BRIT J PHARMACOL, V145, P166, DOI 10.1038/sj.bjp.0706172; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; Garba ML, 2002, J IMMUNOL, V168, P2247, DOI 10.4049/jimmunol.168.5.2247; GIBELLINI D, 1994, BRIT J HAEMATOL, V88, P261, DOI 10.1111/j.1365-2141.1994.tb05016.x; Heinrichs D, 2011, P NATL ACAD SCI USA, V108, P17444, DOI 10.1073/pnas.1107023108; HOUSSET C, 1990, HUM PATHOL, V21, P404, DOI 10.1016/0046-8177(90)90202-G; Hu R, 1996, CLIN IMMUNOL IMMUNOP, V80, P283, DOI 10.1006/clin.1996.0125; Hussain A, 2008, J VIROL, V82, P893, DOI 10.1128/JVI.01373-07; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jiao JJ, 2009, CURR OPIN GASTROEN, V25, P223, DOI 10.1097/MOG.0b013e3283279668; Karlmark Karlin Raja, 2008, Expert Rev Gastroenterol Hepatol, V2, P233, DOI 10.1586/17474124.2.2.233; KEKOW J, 1991, J CLIN INVEST, V87, P1010, DOI 10.1172/JCI115059; KEKOW J, 1990, P NATL ACAD SCI USA, V87, P8321, DOI 10.1073/pnas.87.21.8321; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Li JM, 1998, MOL CELL BIOL, V18, P110, DOI 10.1128/MCB.18.1.110; Ling H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054499; Macias J, 2009, HEPATOLOGY, V50, P1056, DOI 10.1002/hep.23136; MALDARELLI F, 1993, J VIROL, V67, P5056, DOI 10.1128/JVI.67.8.5056-5061.1993; MCELRATH MJ, 1989, P NATL ACAD SCI USA, V86, P675, DOI 10.1073/pnas.86.2.675; McIntyre Glen J, 2011, Genet Vaccines Ther, V9, P9, DOI 10.1186/1479-0556-9-9; Moreira RK, 2007, ARCH PATHOL LAB MED, V131, P1728; Nakamura T, 2000, HEPATOLOGY, V32, P247, DOI 10.1053/jhep.2000.9109; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; NOUCHI T, 1991, LIVER, V11, P100; Poggi A, 2006, CLIN DEV IMMUNOL, V13, P369, DOI 10.1080/17402520600645712; Preaux AM, 1999, HEPATOLOGY, V30, P944, DOI 10.1002/hep.510300432; Shah AH, 2010, CELL HOST MICROBE, V8, P397, DOI 10.1016/j.chom.2010.10.008; Sherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042; Stabinski L, 2011, ANTIVIR THER, V16, P405, DOI 10.3851/IMP1783; Tokarev A, 2013, J VIROL, V87, P2046, DOI 10.1128/JVI.02272-12; Tuyama AC, 2010, HEPATOLOGY, V52, P612, DOI 10.1002/hep.23679; Vasanwala FH, 2002, J IMMUNOL, V169, P1922, DOI 10.4049/jimmunol.169.4.1922; Weigert C, 2002, DIABETOLOGIA, V45, P890, DOI 10.1007/s00125-002-0843-4; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127	41	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88934	10.1371/journal.pone.0088934	http://dx.doi.org/10.1371/journal.pone.0088934			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551192	Green Published, Green Submitted, gold			2022-12-27	WOS:000331266000083
J	Appelt, S; Armougom, F; Le Bailly, M; Robert, C; Drancourt, M				Appelt, Sandra; Armougom, Fabrice; Le Bailly, Matthieu; Robert, Catherine; Drancourt, Michel			Polyphasic Analysis of a Middle Ages Coprolite Microbiota, Belgium	PLOS ONE			English	Article							SEQUENCE-ANALYSIS; ANCIENT DNA; GUT MICROBIOME; BACTERIAL-DNA; IDENTIFICATION; ACANTHAMOEBAE; PHYLOGENIES; ASCARIS; IMPACT; COLON	Paleomicrobiological investigations of a 14th-century coprolite found inside a barrel in Namur, Belgium were done using microscopy, a culture-dependent approach and metagenomics. Results were confirmed by ad hoc PCR - sequencing. Investigations yielded evidence for flora from ancient environment preserved inside the coprolite, indicated by microscopic observation of amoebal cysts, plant fibers, seeds, pollens and mold remains. Seventeen different bacterial species were cultured from the coprolite, mixing organisms known to originate from the environment and organisms known to be gut inhabitants. Metagenomic analyses yielded 107,470 reads, of which known sequences (31.9%) comprised 98.98% bacterial, 0.52% eukaryotic, 0.44% archaeal and 0.06% viral assigned reads. Most abundant bacterial phyla were Proteobacteria, Gemmatimonadetes, Actinobacteria and Bacteroidetes. The 16 S rRNA gene dataset yielded 132,000 trimmed reads and 673 Operational Taxonomic Units. Most abundant bacterial phyla observed in the 16 S rRNA gene dataset belonged to Proteobacteria, Firmicutes, Actinobacteria and Chlamydia. The Namur coprolite yielded typical gut microbiota inhabitants, intestinal parasites Trichuris and Ascaris and systemic pathogens Bartonella and Bordetella. This study adds knowledge to gut microbiota in medieval times.	[Appelt, Sandra; Armougom, Fabrice; Robert, Catherine; Drancourt, Michel] Aix Marseille Univ, Ctr Natl Rech Sci 7278, Inst Natl Sante & Rech Med 1095,IRD 198, Unite Rech Malad Infect Trop Emergentes,UM63, Marseille, France; [Le Bailly, Matthieu] Univ Franche Comte, Ctr Natl Rech Sci, UMR Chronoenvironm 6249, F-25030 Besancon, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); Universite de Franche-Comte	Drancourt, M (corresponding author), Aix Marseille Univ, Ctr Natl Rech Sci 7278, Inst Natl Sante & Rech Med 1095,IRD 198, Unite Rech Malad Infect Trop Emergentes,UM63, Marseille, France.	Michel.Drancourt@medicine.univ-mrs.fr	Le Bailly, Matthieu/AAA-2977-2019	Le Bailly, Matthieu/0000-0001-6320-6741				Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Cano RJ, 2000, AM J PHYS ANTHROPOL, V112, P297; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Cleeland LM, 2013, J ARCHAEOL SCI, V40, P3060, DOI 10.1016/j.jas.2013.03.010; Cooper A, 2000, SCIENCE, V289, P1139; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; da Rocha GC, 2009, REV BRAS PARASITOL V, V18, P70, DOI 10.4322/rbpv.01803013; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Chaves SAD, 2006, PALAEOGEOGR PALAEOCL, V237, P110, DOI 10.1016/j.palaeo.2005.11.031; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dittmar K, 2009, J PARASITOL, V95, P365, DOI 10.1645/GE-1676.1; Drancourt M, 2000, J CLIN MICROBIOL, V38, P3623, DOI 10.1128/JCM.38.10.3623-3630.2000; Drancourt M, 2005, NAT REV MICROBIOL, V3, P23, DOI 10.1038/nrmicro1063; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El Khechine A, 2009, MICROBIOL-SGM, V155, P2384, DOI 10.1099/mic.0.026484-0; Flores GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028132; Giongo A, 2010, DIVERSITY-BASEL, V2, P1015, DOI DOI 10.3390/d2071015; Glass E. M., 2010, COLD SPRING HARB PRO, V2010; Greenberg DE, 2006, PLOS PATHOG, V2, P260, DOI [10.1371/journal.ppat.0020028, 10.1382/journal.ppat.0020028]; Greub G, 2009, CLIN MICROBIOL INFEC, V15, P18, DOI 10.1111/j.1469-0691.2008.02633.x; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Iniguez AM, 2006, INT J PARASITOL, V36, P1419, DOI 10.1016/j.ijpara.2006.07.005; Jirku M, 2012, EMERG INFECT DIS, V18, P634, DOI 10.3201/eid1804.110984; Keita AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054679; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Lagier JC, 2012, CLIN MICROBIOL INFEC, V18, P1185, DOI 10.1111/1469-0691.12023; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Loreille O, 2001, INT J PARASITOL, V31, P1101, DOI 10.1016/S0020-7519(01)00214-4; Luciani S, 2006, AM J PHYS ANTHROPOL, V129, P620, DOI 10.1002/ajpa.20314; Maggi RG., 2011, MANUAL CLIN MICROBIO, P786; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Oh CS, 2010, MEM I OSWALDO CRUZ, V105, P225, DOI 10.1590/S0074-02762010000200020; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Raoult D, 2000, P NATL ACAD SCI USA, V97, P12800, DOI 10.1073/pnas.220225197; Rollo Franco, 2006, Med Secoli, V18, P725; Santiago-Rodriguez TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065191; Schlaberg R, 2012, EMERG INFECT DIS, V18, P422, DOI 10.3201/eid1803.111481; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schroeder JM, 2001, J CLIN MICROBIOL, V39, P1903, DOI 10.1128/JCM.39.5.1903-1911.2001; Seng P, 2013, J CLIN MICROBIOL, V51, P2182, DOI 10.1128/JCM.00492-13; Sheorey H, 2011, MANUAL CLIN MICROBIO, P2200; Sun SL, 2011, NUCLEIC ACIDS RES, V39, pD546, DOI 10.1093/nar/gkq1102; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tito RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051146; Tito RY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003703; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Ubaldi M, 1998, AM J PHYS ANTHROPOL, V107, P285, DOI 10.1002/(SICI)1096-8644(199811)107:3<285::AID-AJPA5>3.0.CO;2-U; Visvesvara GS, 2007, FEMS IMMUNOL MED MIC, V50, P1, DOI 10.1111/j.1574-695X.2007.00232.x; Von Konig CHW, 2011, MANUAL CLIN MICROBIO, V1, P739; Watanabe K, 2008, CURR MICROBIOL, V56, P458, DOI 10.1007/s00284-008-9107-y; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813	58	33	34	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e88376	10.1371/journal.pone.0088376	http://dx.doi.org/10.1371/journal.pone.0088376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586319	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200016
J	Englund, UH; Gertow, J; Kagedal, K; Elinder, F				Englund, Ulrika H.; Gertow, Jens; Kagedal, Katarina; Elinder, Fredrik			A Voltage Dependent Non-Inactivating Na+ Channel Activated during Apoptosis in Xenopus Oocytes	PLOS ONE			English	Article							VOLUME DECREASE; CELL SHRINKAGE; NEURONAL APOPTOSIS; POTASSIUM CHANNELS; NA+/CA2+ EXCHANGER; CASPASE ACTIVATION; SODIUM-CHANNELS; ION; DEPOLARIZATION; DEATH	Ion channels in the plasma membrane are important for the apoptotic process. Different types of voltage-gated ion channels are up-regulated early in the apoptotic process and block of these channels prevents or delays apoptosis. In the present investigation we examined whether ion channels are up-regulated in oocytes from the frog Xenopus laevis during apoptosis. The two-electrode voltage-clamp technique was used to record endogenous ion currents in the oocytes. During staurosporine-induced apoptosis a voltage-dependent Na+ current increased three-fold. This current was activated at voltages more positive than 0 mV (midpoint of the open-probability curve was +55 mV) and showed almost no sign of inactivation during a 1-s pulse. The current was resistant to the Na+-channel blockers tetrodotoxin (1 mM) and amiloride (10 mM), while the Ca2+-channel blocker verapamil (50 mM) in the bath solution completely blocked the current. The intracellular Na+ concentration increased in staurosporine-treated oocytes, but could be prevented by replacing extracellular Na+ whith either K+ or Choline(+). Prevention of this influx of Na+ also prevented the STS-induced up-regulation of the caspase-3 activity, suggesting that the intracellular Na+ increase is required to induce apoptosis. Taken together, we have found that a voltage dependent Na+ channel is up-regulated during apoptosis and that influx of Na+ is a crucial step in the apoptotic process in Xenopus oocytes.	[Englund, Ulrika H.; Gertow, Jens; Kagedal, Katarina; Elinder, Fredrik] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	Linkoping University	Elinder, F (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	fredrik.elinder@liu.se		Elinder, Fredrik/0000-0001-9125-5583; Gertow, Jens/0000-0002-5663-7209	Swedish Research Council; Swedish Heart-Lung Foundation; Swedish Brain Foundation; County Council of Ostergotland; King Gustaf V and Queen Victoria's Freemasons Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Brain Foundation; County Council of Ostergotland; King Gustaf V and Queen Victoria's Freemasons Foundation	This work was supported by the Swedish Research Council (www.vr.se), the Swedish Heart-Lung Foundation (www.hjart-lungfonden.se), the Swedish Brain Foundation (www.hjarnfonden.se), the County Council of Ostergotland (www.lio.se), and the King Gustaf V and Queen Victoria's Freemasons Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JN, 1997, METHODS ENZYMOLOGY, V207; Akanda N, 2008, CELL CYCLE, V7, P3225, DOI 10.4161/cc.7.20.6831; Akanda N, 2006, BIOPHYS J, V90, P4405, DOI 10.1529/biophysj.105.080028; Ali S, 2010, IEEE T, P1, DOI [10.1109/TNANO.2010.2089696, DOI 10.1109/TNAN0.2010.2089696]; Armstrong CM, 2003, P NATL ACAD SCI USA, V100, P6257, DOI 10.1073/pnas.0931278100; Arrebola F, 2005, APOPTOSIS, V10, P1317, DOI 10.1007/s10495-005-2718-x; Arrebola F, 2005, J CELL PHYSIOL, V204, P500, DOI 10.1002/jcp.20306; Asif MH, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3176441; Asif MH, 2010, MATERIALS, V3, P4657, DOI 10.3390/ma3094657; Banasiak KJ, 2004, NEUROSCIENCE, V126, P31, DOI 10.1016/S0306-4522(03)00425-1; BAUD C, 1982, P NATL ACAD SCI-BIOL, V79, P3188, DOI 10.1073/pnas.79.10.3188; Borjesson SI, 2011, J BIOL CHEM, V286, P39823, DOI 10.1074/jbc.M111.262725; Bortner CD, 2003, J BIOL CHEM, V278, P39176, DOI 10.1074/jbc.M303516200; Bortner CD, 2002, CELL DEATH DIFFER, V9, P1307, DOI 10.1038/sj.cdd.4401126; Bortner CD, 2001, J BIOL CHEM, V276, P4304, DOI 10.1074/jbc.M005171200; Burckhardt BC, 1997, PFLUG ARCH EUR J PHY, V434, P306, DOI 10.1007/s004240050401; Charpentier C, 2002, GEN PHYSL BIOPHYS, V21, P355; DASCAL N, 1987, CRIT REV BIOCHEM MOL, V22, P317, DOI 10.3109/10409238709086960; Dib-Hajj S, 2002, TRENDS NEUROSCI, V25, P253, DOI 10.1016/S0166-2236(02)02150-1; Elinder F, 2005, CELL DEATH DIFFER, V12, P1134, DOI 10.1038/sj.cdd.4401646; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hirn C, 2008, J GEN PHYSIOL, V132, P199, DOI 10.1085/jgp.200810024; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P449, DOI 10.1113/jphysiol.1952.sp004717; Hughes FM, 1997, J BIOL CHEM, V272, P30567, DOI 10.1074/jbc.272.48.30567; Johnson CE, 2010, CELL DEATH DIFFER, V17, P170, DOI 10.1038/cdd.2009.120; Khananshvili D, 2014, PFLUG ARCH EUR J PHY, V466, P43, DOI 10.1007/s00424-013-1405-y; Krumschnabel G, 2007, APOPTOSIS, V12, P1755, DOI 10.1007/s10495-007-0103-7; KUPITZ Y, 1993, SCIENCE, V261, P484, DOI 10.1126/science.8392753; Liu W, 2013, TOXICOL LETT, V224, P1, DOI [10.1016/j.toxlet.2013.10.009, DOI 10.1016/J.T0XLET.2013.10.009]; Madeja M, 2000, NEUROPHARMACOLOGY, V39, P202, DOI 10.1016/S0028-3908(99)00110-0; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Poulsen KA, 2010, AM J PHYSIOL-CELL PH, V298, pC14, DOI 10.1152/ajpcell.00654.2008; Roger S, 2004, BRIT J PHARMACOL, V141, P610, DOI 10.1038/sj.bjp.0705649; Rolf S, 2000, N-S ARCH PHARMACOL, V362, P22, DOI 10.1007/s002100000257; Singleton KR, 2009, EXP EYE RES, V89, P140, DOI 10.1016/j.exer.2009.02.023; Solis-Garrido LM, 2004, J BIOL CHEM, V279, P52414, DOI 10.1074/jbc.M408872200; Thompson GJ, 2001, BIOCHEM J, V357, P137, DOI 10.1042/0264-6021:3570137; Ulukaya E, 2011, CELL BIOCHEM FUNCT, V29, P468, DOI 10.1002/cbf.1774; Vasilyev A, 2002, J MEMBRANE BIOL, V185, P237, DOI 10.1007/s00232-001-0126-x; WEBER WM, 1995, BBA-BIOMEMBRANES, V1239, P201, DOI 10.1016/0005-2736(95)00151-R; Wei L, 2004, PFLUG ARCH EUR J PHY, V448, P325, DOI 10.1007/s00424-004-1277-2; YAMAGISHI T, 1995, EUR J PHARMACOL, V281, P151, DOI 10.1016/0014-2999(95)00240-L; Yang DP, 2013, AM J NEPHROL, V37, P264, DOI 10.1159/000348526; Yu SP, 1997, SCIENCE, V278, P114, DOI 10.1126/science.278.5335.114	45	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e88381	10.1371/journal.pone.0088381	http://dx.doi.org/10.1371/journal.pone.0088381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586320	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200017
J	Gao, JJ; Yu, XX; Ma, FM; Li, J				Gao, Jinjun; Yu, Xinxin; Ma, Fengming; Li, Jing			RNA-Seq Analysis of Transcriptome and Glucosinolate Metabolism in Seeds and Sprouts of Broccoli (Brassica oleracea var. italic)	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; FUNCTIONAL ANNOTATION; GLUTATHIONE-DEFICIENT; WALL BIOSYNTHESIS; PHYTOCHROME; CANCER; CELLS; IDENTIFICATION	Background: Broccoli (Brassica oleracea var. italica), a member of Cruciferae, is an important vegetable containing high concentration of various nutritive and functional molecules especially the anticarcinogenic glucosinolates. The sprouts of broccoli contain 10-100 times higher level of glucoraphanin, the main contributor of the anticarcinogenesis, than the edible florets. Despite the broccoli sprouts' functional importance, currently available genetic and genomic tools for their studies are very limited, which greatly restricts the development of this functionally important vegetable. Results: A total of,85 million 251 bp reads were obtained. After de novo assembly and searching the assembled transcripts against the Arabidopsis thaliana and NCBI nr databases, 19,441 top-hit transcripts were clustered as unigenes with an average length of 2,133 bp. These unigenes were classified according to their putative functional categories. Cluster analysis of total unigenes with similar expression patterns and differentially expressed unigenes among different tissues, as well as transcription factor analysis were performed. We identified 25 putative glucosinolate metabolism genes sharing 62.04-89.72% nucleotide sequence identity with the Arabidopsis orthologs. This established a broccoli glucosinolate metabolic pathway with high colinearity to Arabidopsis. Many of the biosynthetic and degradation genes showed higher expression after germination than in seeds; especially the expression of the myrosinase TGG2 was 20-130 times higher. These results along with the previous reports about these genes' studies in Arabidopsis and the glucosinolate concentration in broccoli sprouts indicate the breakdown products of glucosinolates may play important roles in the stage of broccoli seed germination and sprout development. Conclusion: Our study provides the largest genetic resource of broccoli to date. These data will pave the way for further studies and genetic engineering of broccoli sprouts and will also provide new insight into the genomic research of this species and its relatives.	[Gao, Jinjun; Yu, Xinxin; Li, Jing] Northeast Agr Univ, Coll Life Sci, Harbin, Peoples R China; [Ma, Fengming] Northeast Agr Univ, Key Lab Breed Improvement & Physioecol Cold Reg C, Harbin, Peoples R China	Northeast Agricultural University - China; Northeast Agricultural University - China	Li, J (corresponding author), Northeast Agr Univ, Coll Life Sci, Harbin, Peoples R China.	lijing@neau.edu.cn	Gao, Jinjun/AGQ-9202-2022		national Natural Science Foundation of China [31370334]; Opening project of Key Laboratory of breed improvement and physiecology of cold region crops, College of Heilongjiang Province; Heilongjiang Provincial University Science and Technology Innovation Team Building Program [2011TD005]	national Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Opening project of Key Laboratory of breed improvement and physiecology of cold region crops, College of Heilongjiang Province; Heilongjiang Provincial University Science and Technology Innovation Team Building Program	The national Natural Science Foundation of China 31370334 http://www.nsfc.gov.cn/Portal0/default152.htm; Opening project of Key Laboratory of breed improvement and physiecology of cold region crops, College of Heilongjiang Province http://61.167.33.11/kjgz/Index.asp?page=2; Heilongjiang Provincial University Science and Technology Innovation Team Building Program 2011TD005; http://61.167.33.11/kjgz/Index.asp?page=2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2006, NATURE, V442, P742, DOI 10.1038/442742a; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barth C, 2006, PLANT J, V46, P549, DOI 10.1111/j.1365-313X.2006.02716.x; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Bourdon V, 2002, CANCER RES, V62, P6218; Burow M, 2007, PLANT MOL BIOL, V64, P173, DOI 10.1007/s11103-007-9143-1; Celenza JL, 2005, PLANT PHYSIOL, V137, P253, DOI 10.1104/pp.104.054395; Chen YZ, 2011, COMPUT BIOL CHEM, V35, P10, DOI 10.1016/j.compbiolchem.2010.12.002; Cheung F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-542; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Cobbett CS, 1998, PLANT J, V16, P73, DOI 10.1046/j.1365-313x.1998.00262.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Duek PD, 2005, TRENDS PLANT SCI, V10, P51, DOI 10.1016/j.tplants.2004.12.005; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fahey JW, 1997, P NATL ACAD SCI USA, V94, P10367, DOI 10.1073/pnas.94.19.10367; Fahey JW, 1999, FOOD CHEM TOXICOL, V37, P973, DOI 10.1016/S0278-6915(99)00082-4; Falk KL, 2007, PLANT BIOLOGY, V9, P573, DOI 10.1055/s-2007-965431; Fan HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059997; Fei ZJ, 2004, PLANT J, V40, P47, DOI 10.1111/j.1365-313X.2004.02188.x; Feng CP, 2004, PLANT SCI, V167, P1099, DOI 10.1016/j.plantsci.2004.06.014; Gigolashvili T, 2008, NEW PHYTOL, V177, P627, DOI 10.1111/j.1469-8137.2007.02295.x; Gigolashvili T, 2007, PLANT J, V51, P247, DOI 10.1111/j.1365-313X.2007.03133.x; Gigolashvili T, 2007, PLANT J, V50, P886, DOI 10.1111/j.1365-313X.2007.03099.x; Gotz S, 2011, BIOINFORMATICS, V27, P919, DOI 10.1093/bioinformatics/btr059; Gonzalo MJ, 2005, THEOR APPL GENET, V110, P802, DOI 10.1007/s00122-004-1814-6; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hansen BG, 2007, PLANT J, V50, P902, DOI 10.1111/j.1365-313X.2007.03101.x; Hirai MY, 2007, P NATL ACAD SCI USA, V104, P6478, DOI 10.1073/pnas.0611629104; Hong SH, 2008, PLANT J, V55, P361, DOI 10.1111/j.1365-313X.2008.03508.x; Howe EA, 2011, BIOINFORMATICS, V27, P3209, DOI 10.1093/bioinformatics/btr490; Husebye H, 2002, PLANT PHYSIOL, V128, P1180, DOI 10.1104/pp.010925; Ichihashi Y, 2010, PLANT CELL PHYSIOL, V51, P252, DOI 10.1093/pcp/pcp184; Islam MM, 2009, PLANT CELL PHYSIOL, V50, P1171, DOI 10.1093/pcp/pcp066; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; Jiao YL, 2003, PLANT PHYSIOL, V133, P1480, DOI 10.1104/pp.103.029439; Jofuku KD, 2005, P NATL ACAD SCI USA, V102, P3117, DOI 10.1073/pnas.0409893102; Kallifatidis G, 2009, GUT, V58, P949, DOI 10.1136/gut.2008.149039; Kallifatidis G, 2011, MOL THER, V19, P188, DOI 10.1038/mt.2010.216; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Khanna R, 2004, PLANT CELL, V16, P3033, DOI 10.1105/tpc.104.025643; Knill T, 2008, PLANT PHYSIOL, V146, P1028, DOI 10.1104/pp.107.111609; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li J, 2008, PLANT PHYSIOL, V148, P1721, DOI 10.1104/pp.108.125757; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Michaud DS, 1999, JNCI-J NATL CANCER I, V91, P605, DOI 10.1093/jnci/91.7.605; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ni M, 1999, NATURE, V400, P781, DOI 10.1038/23500; Nozawa A, 2005, BIOSCI BIOTECH BIOCH, V69, P806, DOI 10.1271/bbb.69.806; Ohto M, 2005, P NATL ACAD SCI USA, V102, P3123, DOI 10.1073/pnas.0409858102; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Perez-Balibrea S, 2008, J SCI FOOD AGR, V88, P904, DOI 10.1002/jsfa.3169; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Pfalz M, 2011, PLANT CELL, V23, P716, DOI 10.1105/tpc.110.081711; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Qing DJ, 2009, PLANT CELL PHYSIOL, V50, P889, DOI 10.1093/pcp/pcp038; Razin SV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P217, DOI 10.1134/S0006297912030017; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Riechmann JL, 1998, BIOL CHEM, V379, P633; Rose P, 2000, CARCINOGENESIS, V21, P1983, DOI 10.1093/carcin/21.11.1983; Ruyter-Spira CP, 1998, ANIM GENET, V29, P85, DOI 10.1046/j.1365-2052.1998.00304.x; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Saleh A., 2003, GENETIKA+, V35, P37, DOI DOI 10.2298/GENSR0301037S; Schlaeppi K, 2008, PLANT J, V55, P774, DOI 10.1111/j.1365-313X.2008.03545.x; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Shamimuzzaman M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-477; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Tantikanjana T, 2004, PLANT PHYSIOL, V135, P840, DOI 10.1104/pp.104.040113; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; van Poppel G, 1999, ADV EXP MED BIOL, V472, P159; Verhoeven DTH, 1997, CHEM-BIOL INTERACT, V103, P79, DOI 10.1016/S0009-2797(96)03745-3; Verhoeven DTH, 1996, CANCER EPIDEM BIOMAR, V5, P733; Wang XC, 2009, CELL RES, V19, P224, DOI 10.1038/cr.2008.276; Wittstock U, 2010, ARABIDOPSIS BOOK, V8, P134; Wu LY, 2004, P NATL ACAD SCI USA, V101, P7094, DOI 10.1073/pnas.0402004101; Yan XF, 2007, PLANTA, V226, P1343, DOI 10.1007/s00425-007-0627-7; Yang SW, 2009, PLANT CELL, V21, P1341, DOI 10.1105/tpc.109.067215; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042082; Zhang YF, 2009, J GENET GENOMICS, V36, P99, DOI 10.1016/S1673-8527(08)60096-X; Zhao HT, 2012, PLANT SIGNAL BEHAV, V7, P1556, DOI 10.4161/psb.22404; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402; Zhao ZX, 2008, PLANT CELL, V20, P3210, DOI 10.1105/tpc.108.063263; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325; Zhou JL, 2009, PLANT CELL, V21, P248, DOI 10.1105/tpc.108.063321	92	47	50	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e88804	10.1371/journal.pone.0088804	http://dx.doi.org/10.1371/journal.pone.0088804			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586398	Green Submitted, gold, Green Published			2022-12-27	WOS:000332390800007
J	Chong, Y; Kim, JH; Lee, HY; Ahn, YC; Lee, KS; Ahn, MJ; Kim, J; Shim, YM; Han, J; Choi, YL				Chong, Yousun; Kim, Jae-Hun; Lee, Ho Yun; Ahn, Yong Chan; Lee, Kyung Soo; Ahn, Myung-Ju; Kim, Jhingook; Shim, Young Mog; Han, Joungho; Choi, Yoon-La			Quantitative CT Variables Enabling Response Prediction in Neoadjuvant Therapy with EGFR-TKIs: Are They Different from Those in Neoadjuvant Concurrent Chemoradiotherapy?	PLOS ONE			English	Article							CELL LUNG-CANCER; COMPUTED-TOMOGRAPHY; TUMOR RESPONSE; HISTOPATHOLOGIC RESPONSE; PREVIOUS CHEMOTHERAPY; VOLUME MEASUREMENT; CERVICAL-CANCER; STAGE IIIA; PHASE-II; SURVIVAL	Background and Purpose: To correlate changes of various CT parameters after the neoadjuvant treatment in patients with lung adenocarcinoma with pathologic responses, focused on their relationship with different therapeutic options, particularly of EGFR-TKI and concurrent chemoradiation therapy (CCRT) settings. Materials and Methods: We reviewed pre-operative CT images of primary tumors and surgical specimens obtained after neoadjuvant therapy (TKI, n = 23; CCRT, n = 28) from 51 patients with lung adenocarcinoma. Serial changes in tumor volume, density, mass, skewness/kurtosis, and size-zone variability/intensity variability) were assessed from CT datasets. The changes in CT parameters were correlated with histopathologic responses, and the relationship between CT variables and histopathologic responses was compared between TKI and CCRT groups. Results: Tumor volume, mass, kurtosis, and skewness were significant predictors of pathologic response in CCRT group in univariate analysis. Using multivariate analysis, kurtosis was found to be independent predictor. In TKI group, intensity variability and size-zone variability were significantly decreased in pathologic responder group. Intensity variability was found to be an independent predictor for pathologic response on multivariate analysis. Conclusions: Quantitative CT variables including histogram or texture analysis have potential as a predictive tool for response evaluation, and it may better reflect treatment response than standard response criteria based on size changes.	[Chong, Yousun; Kim, Jae-Hun; Lee, Ho Yun; Lee, Kyung Soo] Sungkyunkwan Univ, Sch Med, Dept Radiol, Seoul, South Korea; [Chong, Yousun; Kim, Jae-Hun; Lee, Ho Yun; Lee, Kyung Soo] Sungkyunkwan Univ, Ctr Imaging Sci, Seoul, South Korea; [Ahn, Yong Chan] Sungkyunkwan Univ, Sch Med, Dept Radiat Oncol, Seoul, South Korea; [Ahn, Myung-Ju] Sungkyunkwan Univ, Sch Med, Dept Internal Med, Div Hematooncol, Seoul, South Korea; [Kim, Jhingook; Shim, Young Mog] Sungkyunkwan Univ, Sch Med, Dept Thorac Surg, Seoul, South Korea; [Han, Joungho; Choi, Yoon-La] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, HY (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Radiol, Seoul, South Korea.	hoyunlee96@gmail.com	Lee, Ho Yun/D-6086-2012	Kim, Jae-Hun/0000-0003-3064-6948				Ahn HK, 2013, LUNG CANCER, V79, P300, DOI 10.1016/j.lungcan.2012.11.010; Alic L, 2011, PHYS MED BIOL, V56, P1601, DOI 10.1088/0031-9155/56/6/006; Aukema TS, 2010, J NUCL MED, V51, P1344, DOI 10.2967/jnumed.110.076224; Baek HJ, 2012, RADIOLOGY, V264, P834, DOI 10.1148/radiol.12112120; Brunelli A, 2009, EUR RESPIR J, V34, P17, DOI 10.1183/09031936.00184308; Chandarana H, 2012, RADIOLOGY, V265, P790, DOI 10.1148/radiol.12111281; de Hoop B, 2010, RADIOLOGY, V255, P199, DOI 10.1148/radiol.09090571; Dingemans AMC, 2011, ANN ONCOL, V22, P559, DOI 10.1093/annonc/mdq391; Edge SB, 2010, AJCC CANC STAGING MA; Ganeshan B, 2013, RADIOLOGY, V266, P326, DOI 10.1148/radiol.12112428; Ganeshan B, 2012, EUR RADIOL, V22, P796, DOI 10.1007/s00330-011-2319-8; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Goh V, 2011, RADIOLOGY, V261, P165, DOI 10.1148/radiol.11110264; HONG JH, 1992, INT J RADIAT ONCOL, V22, P913, DOI 10.1016/0360-3016(92)90787-I; JOHNSON CR, 1995, INT J RADIAT ONCOL, V33, P281, DOI 10.1016/0360-3016(95)00119-J; Kadota K, 2012, ANN SURG ONCOL, V19, P3598, DOI 10.1245/s10434-012-2414-3; Kamal NS, 2010, CLIN CANCER RES, V16, P1206, DOI 10.1158/1078-0432.CCR-09-2204; Kang H, 2012, KOREAN J RADIOL, V13, P371, DOI 10.3348/kjr.2012.13.4.371; Katakami N, 2012, CANCER-AM CANCER SOC, V118, P6126, DOI 10.1002/cncr.26689; Kozak MM, 2011, J THORAC ONCOL, V6, P920, DOI 10.1097/JTO.0b013e31821517db; Lee HY, 2012, RADIOLOGY, V264, P884, DOI 10.1148/radiol.12111793; Lee HY, 2011, LUNG CANCER, V73, P63, DOI 10.1016/j.lungcan.2010.10.019; Lee HY, 2010, KOREAN J RADIOL, V11, P618, DOI 10.3348/kjr.2010.11.6.618; Lee HY, 2010, J THORAC ONCOL, V5, P497, DOI 10.1097/JTO.0b013e3181d2efe7; Lee HY, 2013, J MAGN RESON IMAGING; Mayr NA, 2002, INT J RADIAT ONCOL, V52, P14, DOI 10.1016/S0360-3016(01)01808-9; O'Brien MB, 2012, TLS-TIMES LIT SUPPL, P6; Park BB, 2006, LUNG CANCER, V53, P323, DOI 10.1016/j.lungcan.2006.05.024; Schaake EE, 2012, J CLIN ONCOL, V30, P2731, DOI 10.1200/JCO.2011.39.4882; Shim JH, 2012, RADIOLOGY, V262, P708, DOI 10.1148/radiol.11110282; Sunaga N, 2007, LUNG CANCER, V56, P383, DOI 10.1016/j.lungcan.2007.01.025; Thibault G., 2009, PROC PATTERN RECOGNI, P140; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Vaidya M, 2012, RADIOTHER ONCOL, V102, P239, DOI 10.1016/j.radonc.2011.10.014; Waller D, 2004, EUR J CARDIO-THORAC, V26, P173, DOI 10.1016/j.ejcts.2004.03.041; William WN, 2013, J THORAC ONCOL, V8, P222, DOI 10.1097/JTO.0b013e3182774108; Win T, 2013, CLIN CANC RES; Yoon HJ, 2012, RADIOLOGY, V265, P939, DOI 10.1148/radiol.12112613; Zhao BS, 2010, CLIN CANCER RES, V16, P4647, DOI 10.1158/1078-0432.CCR-10-0125	39	36	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e88598	10.1371/journal.pone.0088598	http://dx.doi.org/10.1371/journal.pone.0088598			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586348	gold, Green Published, Green Submitted			2022-12-27	WOS:000332389000014
J	Paterson, KB; McGowan, VA; White, SJ; Malik, S; Abedipour, L; Jordan, TR				Paterson, Kevin B.; McGowan, Victoria A.; White, Sarah J.; Malik, Sameen; Abedipour, Lily; Jordan, Timothy R.			Reading Direction and the Central Perceptual Span in Urdu and English	PLOS ONE			English	Article							HEMISPHERIC-SPECIALIZATION; EYE-MOVEMENTS; INFORMATION; FIXATION; WORDS; RECOGNITION; ASYMMETRY; ATTENTION; HEBREW	Background: Normal reading relies on the reader making a series of saccadic eye movements along lines of text, separated by brief fixational pauses during which visual information is acquired from a region of text. In English and other alphabetic languages read from left to right, the region from which useful information is acquired during each fixational pause is generally reported to extend further to the right of each fixation than to the left. However, the asymmetry of the perceptual span for alphabetic languages read in the opposite direction (i.e., from right to left) has received much less attention. Accordingly, in order to more fully investigate the asymmetry in the perceptual span for these languages, the present research assessed the influence of reading direction on the perceptual span for bilingual readers of Urdu and English. Methods and Findings: Text in Urdu and English was presented either entirely as normal or in a gaze-contingent moving-window paradigm in which a region of text was displayed as normal at the reader's point of fixation and text outside this region was obscured. The windows of normal text extended symmetrically 0.5 degrees of visual angle to the left and right of fixation, or asymmetrically by increasing the size of each window to 1.5 degrees or 2.5 degrees to either the left or right of fixation. When participants read English, performance for the window conditions was superior when windows extended to the right. However, when reading Urdu, performance was superior when windows extended to the left, and was essentially the reverse of that observed for English. Conclusion: These findings provide a novel indication that the perceptual span is modified by the language being read to produce an asymmetry in the direction of reading and show for the first time that such an asymmetry occurs for reading Urdu.	[Paterson, Kevin B.; McGowan, Victoria A.; White, Sarah J.; Malik, Sameen; Abedipour, Lily; Jordan, Timothy R.] Univ Leicester, Coll Med Biol Sci & Psychol, Leicester, Leics, England	University of Leicester	Paterson, KB (corresponding author), Univ Leicester, Coll Med Biol Sci & Psychol, Leicester, Leics, England.	kbp3@leicester.ac.uk	White, Sarah J/L-8411-2016	White, Sarah J/0000-0003-3943-7149; Paterson, Kevin/0000-0002-8150-8628; McGowan, Victoria/0000-0003-1956-1599				Adamson MM, 2006, NEUROPSYCHOLOGY, V20, P232, DOI 10.1037/0894-4105.20.2.232; Almabruk AAA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018131; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Apel JK, 2012, PSYCHON B REV, V19, P1108, DOI 10.3758/s13423-012-0291-1; BAILEY IL, 1980, AM J OPTOM PHYS OPT, V57, P378; BALOTA DA, 1985, COGNITIVE PSYCHOL, V17, P364, DOI 10.1016/0010-0285(85)90013-1; BRADSHAW JL, 1983, BEHAV BRAIN SCI, V6, P528, DOI 10.1017/S0140525X00073775; BRIIHL D, 1995, J EXP PSYCHOL LEARN, V21, P55, DOI 10.1037/0278-7393.21.1.55; CHIARELLO C, 1988, BRAIN COGNITION, V7, P394, DOI 10.1016/0278-2626(88)90014-0; Engbert R, 2005, PSYCHOL REV, V112, P777, DOI 10.1037/0033-295X.112.4.777; Eviatar Z, 2004, NEUROPSYCHOLOGY, V18, P174, DOI 10.1037/0894-4105.18.1.174; FAUST M, 1993, BRAIN LANG, V44, P254, DOI 10.1006/brln.1993.1017; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; Haikio T, 2009, J EXP CHILD PSYCHOL, V102, P167, DOI 10.1016/j.jecp.2008.04.002; Hellige J. B., 1993, HEMISPHERIC ASYMMETR; Ibrahim R, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-3; Ibrahim R, 2009, NEUROPSYCHOLOGY, V23, P240, DOI 10.1037/a0014193; IKEDA M, 1978, VISION RES, V18, P83, DOI 10.1016/0042-6989(78)90080-9; Inhoff AW, 1998, J EXP PSYCHOL HUMAN, V24, P20, DOI 10.1037/0096-1523.24.1.20; Jordan TR, 2013, PSYCHON B REV, V20, P551, DOI 10.3758/s13423-012-0372-1; Jordan TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023957; Jordan TR, 2011, CORTEX, V47, P992, DOI 10.1016/j.cortex.2011.02.012; Jordan TR, 2009, NEUROPSYCHOLOGIA, V47, P2341, DOI 10.1016/j.neuropsychologia.2008.07.020; Jordan TR, 2013, PSYCHON B IN PRESS; KORIAT A, 1985, BRIT J PSYCHOL, V76, P161, DOI 10.1111/j.2044-8295.1985.tb01939.x; LIMA SD, 1985, J EXP PSYCHOL HUMAN, V11, P272, DOI 10.1037/0096-1523.11.3.272; MCCONKIE GW, 1975, PERCEPT PSYCHOPHYS, V17, P578, DOI 10.3758/BF03203972; MCCONKIE GW, 1976, B PSYCHONOMIC SOC, V8, P365, DOI 10.3758/BF03335168; Miellet S, 2009, PSYCHOL SCI, V20, P721, DOI 10.1111/j.1467-9280.2009.02364.x; Mirdehghan M., 2010, WRITING SYSTEMS RES, V2, P9, DOI [https://doi.org/10.1093/wsr/wsq005, DOI 10.1093/WSR/WSQ005]; MORRISON RE, 1981, PERCEPT PSYCHOPHYS, V30, P395, DOI 10.3758/BF03206156; Patching GR, 2005, MEM COGNITION, V33, P961, DOI 10.3758/BF03193205; Patching GR, 2005, INVEST OPHTH VIS SCI, V46, P2219, DOI 10.1167/iovs.03-1247; POLLATSEK A, 1981, BRAIN LANG, V14, P174, DOI 10.1016/0093-934X(81)90073-0; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1975, COGNITIVE PSYCHOL, V7, P65, DOI 10.1016/0010-0285(75)90005-5; RAYNER K, 1980, PERCEPT PSYCHOPHYS, V27, P537, DOI 10.3758/BF03198682; RAYNER K, 1982, PERCEPT PSYCHOPHYS, V31, P537, DOI 10.3758/BF03204186; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Reichle ED, 2003, BEHAV BRAIN SCI, V26, P445, DOI 10.1017/S0140525X03000104; UNDERWOOD NR, 1985, READ RES QUART, V20, P153, DOI 10.2307/747752; White SJ, 2005, PSYCHON B REV, V12, P466, DOI 10.3758/BF03193789; Williams CC, 2006, J EXP PSYCHOL HUMAN, V32, P1072, DOI 10.1037/0096-1523.32.4.1072	43	30	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e88358	10.1371/journal.pone.0088358	http://dx.doi.org/10.1371/journal.pone.0088358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC2ZX	24586316	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900010
J	Gueguen, C; Palmier, B; Plotkine, M; Marchand-Leroux, C; Bessson, VC				Gueguen, Cindy; Palmier, Bruno; Plotkine, Michel; Marchand-Leroux, Catherine; Bessson, Valerie C.			Neurological and Histological Consequences Induced by In Vivo Cerebral Oxidative Stress: Evidence for Beneficial Effects of SRT1720, a Sirtuin 1 Activator, and Sirtuin 1-Mediated Neuroprotective Effects of Poly(ADP-ribose) Polymerase Inhibition	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; PREVENTS NAD(+) DEPLETION; SMALL-MOLECULE ACTIVATORS; PROMOTES CELL-SURVIVAL; DNA-DAMAGE; PARP-1 INHIBITION; ARTERY OCCLUSION; NEURONAL DEATH; RAT; RESVERATROL	Poly(ADP-ribose) polymerase and sirtuin 1 are both NAD+-dependent enzymes. In vitro oxidative stress activates poly(ADPribose) polymerase, decreases NAD(+) level, sirtuin 1 activity and finally leads to cell death. Poly(ADP-ribose) polymerase hyperactivation contributes to cell death. In addition, poly(ADP-ribose) polymerase inhibition restores NAD(+) level and sirtuin 1 activity in vitro. In vitro sirtuin 1 induction protects neurons from cell loss induced by oxidative stress. In this context, the role of sirtuin 1 and its involvement in beneficial effects of poly(ADP-ribose) polymerase inhibition were evaluated in vivo in a model of cerebral oxidative stress induced by intrastriatal infusion of malonate in rat. Malonate promoted a NAD(+) decrease that was not prevented by 3-aminobenzamide, a poly(ADP-ribose) polymerase inhibitor, at 4 and 24 hours. However, 3-aminobenzamide increased nuclear SIRT1 activity/expression ratio after oxidative stress. Malonate induced a neurological deficit associated with a striatal lesion. Both were reduced by 3-aminobenzamide and SRT1720, a sirtuin 1 activator, showing beneficial effects of poly(ADP-ribose) polymerase inhibition and sirtuin 1 activation on oxidative stress consequences. EX527, a sirtuin 1 inhibitor, given alone, modified neither the score nor the lesion, suggesting that endogenous sirtuin 1 was not activated during cerebral oxidative stress. However, its association with 3-aminobenzamide suppressed the neurological improvement and the lesion reduction induced by 3-aminobenzamide. The association of 3-aminobenzamide with SRT1720, the sirtuin 1 activator, did not lead to a better protection than 3-aminobenzamide alone. The present data represent the first demonstration that the sirtuin 1 activator SRT1720 is neuroprotective during in vivo cerebral oxidative stress. Furthermore sirtuin 1 activation is involved in the beneficial effects of poly(ADP-ribose) polymerase inhibition after in vivo cerebral oxidative stress.	[Gueguen, Cindy; Palmier, Bruno; Plotkine, Michel; Marchand-Leroux, Catherine; Bessson, Valerie C.] Univ Paris 05, Fac Sci Pharmaceut & Biol, Pharmacol Circulat Cerebrale EA4475, Paris, France	UDICE-French Research Universities; Universite Paris Cite	Bessson, VC (corresponding author), Univ Paris 05, Fac Sci Pharmaceut & Biol, Pharmacol Circulat Cerebrale EA4475, Paris, France.	valerie.besson@parisdescartes.fr	besson, valerie C/L-7388-2017; MARCHAND-LEROUX, Catherine/L-7453-2017; BESSON, VALERIE/AAZ-9989-2020	besson, valerie C/0000-0002-1491-2380; MARCHAND-LEROUX, Catherine/0000-0003-0113-5348; BESSON, VALERIE/0000-0002-1491-2380	Universite Paris Descartes; Fondation des Gueules Cassees	Universite Paris Descartes; Fondation des Gueules Cassees	This work was supported partly by Universite Paris Descartes and by a grant from the Fondation des Gueules Cassees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeti R, 2011, BRAIN, V134, P1658, DOI 10.1093/brain/awr104; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Ba XQ, 2011, AM J PATHOL, V178, P946, DOI 10.1016/j.ajpath.2010.12.004; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; BERNOFSKY C, 1973, ANAL BIOCHEM, V53, P452, DOI 10.1016/0003-2697(73)90094-8; Besson VC, 2009, BRIT J PHARMACOL, V157, P695, DOI 10.1111/j.1476-5381.2009.00229.x; Besson VC, 2003, FREE RADICAL RES, V37, P1201, DOI 10.1080/10715760310001612568; Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; Caito S, 2010, BIOCHEM BIOPH RES CO, V392, P264, DOI 10.1016/j.bbrc.2009.12.161; Chen XR, 2008, J PHARMACOL EXP THER, V326, P966, DOI 10.1124/jpet.108.140368; Clark RSB, 2007, J NEUROTRAUM, V24, P1399, DOI 10.1089/neu.2007.0305; Cosi C, 2000, AMINO ACIDS, V19, P229, DOI 10.1007/s007260070054; Della-Morte D, 2009, NEUROSCIENCE, V159, P993, DOI 10.1016/j.neuroscience.2009.01.017; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Furukawa A, 2007, CELL PHYSIOL BIOCHEM, V20, P45, DOI 10.1159/000104152; GOLANOV EV, 1995, J CEREBR BLOOD F MET, V15, P172, DOI 10.1038/jcbfm.1995.19; Gupta YK, 2001, METHOD FIND EXP CLIN, V23, P241, DOI 10.1358/mf.2001.23.5.662120; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hoffmann E, 2013, BRIT J CLIN PHARMACO, V75, P186, DOI 10.1111/j.1365-2125.2012.04340.x; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Ichikawa T, 2013, RESPIROLOGY, V18, P332, DOI 10.1111/j.1440-1843.2012.02284.x; Julien C, 2009, J NEUROPATH EXP NEUR, V68, P48, DOI 10.1097/NEN.0b013e3181922348; Kauppinen TM, 2013, BBA-MOL CELL RES, V1833, P1985, DOI 10.1016/j.bbamcr.2013.04.005; Kolthur-Seetharam U, 2006, CELL CYCLE, V5, P873, DOI 10.4161/cc.5.8.2690; Komjati K, 2005, CNS NEUROL DISORD-DR, V4, P179, DOI 10.2174/1568007053544138; Liu D, 2009, NEUROMOL MED, V11, P28, DOI 10.1007/s12017-009-8058-1; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Margaill I, 2005, FREE RADICAL BIO MED, V39, P429, DOI 10.1016/j.freeradbiomed.2005.05.003; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Minor RK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00070; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Paucard A, 2005, FUND CLIN PHARMACOL, V19, P57, DOI 10.1111/j.1472-8206.2004.00297.x; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Rajamohan SB, 2009, MOL CELL BIOL, V29, P4116, DOI 10.1128/MCB.00121-09; SCHRAUFSTATTER IU, 1986, P NATL ACAD SCI USA, V83, P4908, DOI 10.1073/pnas.83.13.4908; SCHULZ JB, 1995, J NEUROCHEM, V64, P2239; SHAH GM, 1995, ANAL BIOCHEM, V227, P1, DOI 10.1006/abio.1995.1245; Shinmura K, 2008, AM J PHYSIOL-HEART C, V295, pH2348, DOI 10.1152/ajpheart.00602.2008; Sinha K, 2002, LIFE SCI, V71, P655, DOI 10.1016/S0024-3205(02)01691-0; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Strosznajder RP, 2010, MOL NEUROBIOL, V41, P187, DOI 10.1007/s12035-010-8124-6; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Velasquez DA, 2011, DIABETES, V60, P1177, DOI 10.2337/db10-0802; Wang Q, 2002, BRAIN RES, V958, P439, DOI 10.1016/S0006-8993(02)03543-6; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Xie J, 2013, PHARMACOL RES, V67, P60, DOI 10.1016/j.phrs.2012.10.010; Yamazaki Y, 2009, AM J PHYSIOL-ENDOC M, V297, pE1179, DOI 10.1152/ajpendo.90997.2008; Yang HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046364; Yang J, 2002, NEUROSCI LETT, V333, P91, DOI 10.1016/S0304-3940(02)01005-4; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Ying WH, 2005, J NEUROSCI RES, V79, P216, DOI 10.1002/jnr.20289; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08; Zhang F, 2010, EUR J PHARMACOL, V636, P1, DOI 10.1016/j.ejphar.2010.03.043	60	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e87367	10.1371/journal.pone.0087367	http://dx.doi.org/10.1371/journal.pone.0087367			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586272	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900008
J	Krag, LA; Herrmann, B; Karlsen, JD				Krag, Ludvig Ahm; Herrmann, Bent; Karlsen, Junita Diana			Inferring Fish Escape Behaviour in Trawls Based on Catch Comparison Data: Model Development and Evaluation Based on Data from Skagerrak, Denmark	PLOS ONE			English	Article							NEPHROPS NEPHROPS-NORVEGICUS; SIZE-SELECTION; CODENDS; RECOVERY; CAPTURE; DEVICES	During the fishing process, fish react to a trawl with a series of behaviours that often are species and size specific. Thus, a thorough understanding of fish behaviour in relation to fishing gear and a scientific understanding of the ability of different gear designs to utilize or stimulate various behavioural patterns during the catching process are essential for developing more efficient, selective, and environmentally friendly trawls. Although many behavioural studies using optical and acoustic observation systems have been conducted, harsh observation conditions on the fishing grounds often hamper the ability to directly observe fish behaviour in relation to fishing gear. As an alternative to optical and acoustic methods, we developed and applied a new mathematical model to catch data to extract detailed and quantitative information about species-and size-dependent escape behaviour in towed fishing gear such as trawls. We used catch comparison data collected with a twin trawl setup; the only difference between the two trawls was that a 12 m long upper section was replaced with 800 mm diamond meshes in one of them. We investigated the length-based escape behaviour of cod (Gadus morhua), haddock (Melanogrammus aeglefinus), saithe (Pollachius virens), witch flounder (Glyptocephalus cynoglossus), and lemon sole (Microstomus kitt) and quantified the extent to which behavioural responses set limits for the large mesh panel's selective efficiency. Around 85% of saithe, 80% of haddock, 44% of witch flounder, 55% of lemon sole, and 55% of cod (below 68 cm) contacted the large mesh panel and escaped. We also demonstrated the need to account for potential selectivity in the trawl body, as it can bias the assessment of length-based escape behaviour. Our indirect assessment of fish behaviour was in agreement with the direct observations made for the same species in a similar section of the trawl body reported in the literature.	[Krag, Ludvig Ahm; Karlsen, Junita Diana] Natl Inst Aquat Resources, DTU Aqua, Hirtshals, Denmark; [Herrmann, Bent] SINTEF, Fisheries & Aquaculture, Fishing Gear Technol, Hirtshals, Denmark	Technical University of Denmark; SINTEF	Krag, LA (corresponding author), Natl Inst Aquat Resources, DTU Aqua, North Sea Sci Pk, Hirtshals, Denmark.	lak@aqua.dtu.dk	Karlsen, Junita/AIA-5409-2022	Karlsen, Junita Diana/0000-0002-0496-4638; Herrmann, Bent/0000-0003-1325-6198; Krag, Ludvig Ahm/0000-0002-1531-1499	Commission of the European Communities under the project "Research on effective cod stock recovery measures''; Danish Directorate for Food, Fisheries, and Agri Business	Commission of the European Communities under the project "Research on effective cod stock recovery measures''; Danish Directorate for Food, Fisheries, and Agri Business	This study was conducted with financial support from the Commission of the European Communities under the project "Research on effective cod stock recovery measures'' and the Danish Directorate for Food, Fisheries, and Agri Business. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albalat A, 2010, J EXP MAR BIOL ECOL, V395, P206, DOI 10.1016/j.jembe.2010.09.002; Briggs RP, 1993, 1993B20 ICES CM; Bublitz CG, 1996, FISH RES, V25, P293, DOI 10.1016/0165-7836(95)00431-9; Chosid D.M., 2008, J OCEAN TECHNOL, V3, P29; Eigaard OR, 2012, AQUAT LIVING RESOUR, V25, P15, DOI 10.1051/alr/2011152; Engas A, 1998, ICES J MAR SCI, V55, P835, DOI 10.1006/jmsc.1998.0352; Ferro RST, 2007, ICES J MAR SCI, V64, P1543, DOI 10.1093/icesjms/fsm099; Frandsen RP, 2011, FISH RES, V111, P116, DOI 10.1016/j.fishres.2011.07.003; Frandsen RP, 2010, FISH RES, V101, P156, DOI 10.1016/j.fishres.2009.09.017; Fryer RJ, 2003, CAN J FISH AQUAT SCI, V60, P448, DOI 10.1139/F03-029; Galbraith RD, 1989, 16 SCOTT FISH; GLASS CW, 1995, FISH RES, V23, P157, DOI 10.1016/0165-7836(94)00330-Y; Graham N, 2004, ICES J MAR SCI, V61, P1036, DOI 10.1016/j.icesjms.2004.06.006; He P., 2010, BEHAV MARINE FISHES; Herrmann Bent, 2012, Journal of Northwest Atlantic Fishery Science, V44, P1, DOI 10.2960/J.v44.m680; Herrmann B, 2009, FISH RES, V97, P59, DOI 10.1016/j.fishres.2009.01.002; Holst R, 2009, CAN J FISH AQUAT SCI, V66, P2052, DOI 10.1139/F09-145; Holst R, 2009, FISH RES, V95, P254, DOI 10.1016/j.fishres.2008.09.027; Ingolfsson OA, 2006, FISH RES, V79, P303, DOI 10.1016/j.fishres.2005.12.017; Katsanevakis S, 2006, FISH RES, V81, P229, DOI 10.1016/j.fishres.2006.07.002; Krag LA, 2011, FISH RES, V110, P225, DOI 10.1016/j.fishres.2011.03.009; Krag LA, 2010, FISH RES, V101, P20, DOI 10.1016/j.fishres.2009.09.001; Krag LA, 2009, FISH RES, V98, P62, DOI 10.1016/j.fishres.2009.03.012; Krag LA, 2008, FISH RES, V91, P175, DOI 10.1016/j.fishres.2007.11.022; Krag LA, 2009, ICES J MAR SCI, V66, P772, DOI 10.1093/icesjms/fsp034; Madsen N, 2010, ICES J MAR SCI, V67, P2042, DOI 10.1093/icesjms/fsq153; MAIN J, 1985, FISH RES, V3, P131, DOI 10.1016/0165-7836(85)90014-1; Main J., 1982, SCOT FISH RES REP, V26, P1; Main J, 1985, 34 SCOTT FISH; Press W. H., 1992, ART SCI COMPUTING; Sistiaga M, 2010, FISH RES, V105, P187, DOI 10.1016/j.fishres.2010.05.006; THOMSEN B, 1993, ICES MAR SC, V196, P161; Thorsteinsson G, 1986, CMB45 ICES, P45; Wardle C.S., 1993, Fish and Fisheries Series, V7, P609; Wardle C.S., 1986, Progress in Underwater Science, V11, P95; Wienbeck H, 2011, FISH RES, V109, P80, DOI 10.1016/j.fishres.2011.01.019; Wileman D.A., 1996, 1126 ICES COOP	39	50	50	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88819	10.1371/journal.pone.0088819	http://dx.doi.org/10.1371/journal.pone.0088819			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586403	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700033
J	Lu, W; Yu, JL; Ai, Q; Liu, D; Song, C; Li, LQ				Lu, Wei; Yu, Jialin; Ai, Qing; Liu, Dong; Song, Chao; Li, Luquan			Increased Constituent Ratios of Klebsiella sp., Acinetobacter sp., and Streptococcus sp. and a Decrease in Microflora Diversity May Be Indicators of Ventilator-Associated Pneumonia: A Prospective Study in the Respiratory Tracts of Neonates	PLOS ONE			English	Article							DENTAL PLAQUE; COMMUNITY; DIAGNOSIS; DISEASE; IDENTIFICATION; INFECTIONS	Ventilator-associated pneumonia (VAP) is a common complication and cause of death in neonates on mechanical ventilation. However, it is difficult to define the causes of VAP. To understand the causes of VAP, we undertook a prospective study based on the diversity of the microflora in VAP. The experimental group consisted of newborns who suffered from respiratory distress syndrome (RDS) and VAP, while the control group suffered from RDS without VAP. Sputa were collected within 1, 3, and 5 days of ventilation and were divided into six groups. DNA was extracted from the samples, and the 16S rDNA was PCR amplified, separated using denaturing gradient gel electrophoresis (DGGE), cloned and sequenced. The resulting sequences were compared using BLAST. The DGGE pictures were measured, and the richness, Shannon-Wiener index, and cluster maps were analyzed. No differences were found regarding the constituent ratio of any genus between the Non-VAP and VAP group within 1 day after intubation. After 1 to 3 days, the constituent ratios of Klebsiella sp., Acinetobacter sp., and Streptococcus sp. in the VAP group were higher than those in the Non-VAP group, and the ratios of Serratia sp. and Achromobacter sp. were lower. After 3 to 5 days, the ratios of Klebsiella sp., Acinetobacter sp., Serratia sp., and Achromobacter sp. were lower than those in the Non-VAP group. The richness and Shannon-Wiener index of the Non-VAP group were higher than those of the VAP group from 1 to 3 days after intubation, while no differences were found within 1 day and from 3 to 5 days. We conclude that during the first three days of intubation, the microflora diversity in the lower respiratory tract was reduced due to VAP, and the greater constituent ratios of Klebsiella sp., Acinetobacter sp., and Streptococcus sp. in the sputum may be indicators of VAP.	[Lu, Wei; Yu, Jialin; Liu, Dong; Song, Chao; Li, Luquan] Chongqing Med Univ, Childrens Hosp, Dept Neonatol, Chongqing, Peoples R China; [Lu, Wei; Yu, Jialin; Ai, Qing; Liu, Dong; Song, Chao; Li, Luquan] Chongqing Med Univ, Childrens Hosp, Pediat Res Inst, Chongqing, Peoples R China; [Lu, Wei; Yu, Jialin; Ai, Qing; Liu, Dong; Song, Chao; Li, Luquan] Chongqing Med Univ, Childrens Hosp, Minist Educ, Key Lab Child Dev & Disorder, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Yu, JL (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Neonatol, Chongqing, Peoples R China.	tongxunzuozhe@163.com			National Natural Science Foundation of China [8107513]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant No. 8107513 from National Natural Science Foundation of China (General Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed NA, 2009, ANTIMICROB AGENTS CH, V53, P4258, DOI 10.1128/AAC.00546-09; Bahrani-Mougeot FK, 2007, J CLIN MICROBIOL, V45, P1588, DOI 10.1128/JCM.01963-06; Balter M, 2012, SCIENCE, V336, P1246, DOI 10.1126/science.336.6086.1246; Cairns S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014759; Cao M, 2011, J MICROBIOL, V49, P1000, DOI 10.1007/s12275-011-1523-1; Celik IH, 2012, EUR J PEDIATR, V171, P311, DOI 10.1007/s00431-011-1537-z; Chalmers NI, 2008, J BACTERIOL, V190, P8145, DOI 10.1128/JB.00983-08; Craven DE, 2011, CLIN CHEST MED, V32, P547, DOI 10.1016/j.ccm.2011.06.001; Gapon M. N., 2011, Klinicheskaya Laboratornaya Diagnostika, P18; Grgurich PE, 2013, CURR OPIN INFECT DIS, V26, P140, DOI 10.1097/QCO.0b013e32835ebbd0; Hamet M, 2012, INTENS CARE MED, V38, P1272, DOI 10.1007/s00134-012-2584-2; Hancock KL, 2012, AUST FAM PHYSICIAN, V41, P63; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Kellen berger E, 2001, EMBO REP, V2, P5; Kuziemski Arkadiusz, 2012, Przegl Epidemiol, V66, P403; Nazik H, 2012, SE ASIAN J TROP MED, V43, P1178; Payne MS, 2010, PEDIATR RES, V67, P412, DOI 10.1203/PDR.0b013e3181d026c3; Peters BM, 2012, CLIN MICROBIOL REV, V25, P193, DOI 10.1128/CMR.00013-11; Pierce-Hendry S. A., 2010, COMPEND CONTIN ED VE, V32, pE6; Pierce-Hendry Stephanie A, 2010, Compend Contin Educ Vet, V32, pE1; RELMAN DA, 1992, NEW ENGL J MED, V327, P293, DOI 10.1056/NEJM199207303270501; RELMAN DA, 1990, NEW ENGL J MED, V323, P1573, DOI 10.1056/NEJM199012063232301; SCHMIDT TM, 1991, J BACTERIOL, V173, P4371, DOI 10.1128/JB.173.14.4371-4378.1991; Shaffer Robyn Kroop, 2013, Yale Journal of Biology and Medicine, V86, P261; Signoretto C, 2010, J CLIN MICROBIOL, V48, P347, DOI 10.1128/JCM.00932-09; Vorwerk C, 2011, EMERG MED J, V28, P948, DOI 10.1136/emj.2009.087783; Wang Fei, 2013, Zhonghua Jie He He Hu Xi Za Zhi, V36, P27; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Yalaz M, 2012, TURKISH J PEDIATR, V54, P128	30	22	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e87504	10.1371/journal.pone.0087504	http://dx.doi.org/10.1371/journal.pone.0087504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586277	Green Published, gold, Green Submitted			2022-12-27	WOS:000331714700005
J	Atmadibrata, B; Liu, PY; Sokolowski, N; Zhang, LH; Wong, M; Tee, AE; Marshall, GM; Liu, T				Atmadibrata, Bernard; Liu, Pei Y.; Sokolowski, Nicolas; Zhang, Lihong; Wong, Matthew; Tee, Andrew E.; Marshall, Glenn M.; Liu, Tao			The Novel Long Noncoding RNA linc00467 Promotes Cell Survival but Is Down-Regulated by N-Myc	PLOS ONE			English	Article							WNT ANTAGONIST; GENE; CHROMATIN; TRANSCRIPTION; APOPTOSIS; SEQUENCE; INSIGHTS; PROTEIN; RD3	The worst subtype of neuroblastoma is caused by MYCN oncogene amplification and N-Myc oncoprotein over-expression. Long noncoding RNAs (lncRNAs) are emerging as critical regulators of gene expression and tumourigenesis. While Myc oncoproteins are well-known to exert tumourigenic effects by regulating the expression of protein-coding genes and microRNAs, little is known about which lncRNAs are Myc targets and whether the Myc target lncRNAs play a role in Myc-induced oncogenesis. Here we performed differential gene expression studies using lncRNA microarray in neuroblastoma cells after transfection with control or N-Myc-specific small interfering RNA (siRNA), and identified N-Myc target lncRNAs including the novel lncRNA linc00467, the expression and function of which were completely unknown. RT-PCR, chromatin immunoprecipitation and luciferase assays showed that N-Myc suppressed linc00467 gene expression through direct binding to the linc00467 gene promoter and reducing linc00467 promoter activity. While N-Myc suppressed the expression of RD3, the protein-coding gene immediately down-stream of linc00467 gene, through direct binding to the RD3 gene promoter and reducing RD3 promoter activity, linc00467 reduced RD3 mRNA expression. Moreover, Affymetrix microarray analysis revealed that one of genes significantly up-regulated by linc00467 siRNA was the tumour suppressor gene DKK1. Importantly, knocking-down linc00467 expression with siRNA in neuroblastoma cells reduced the number of viable cells and increased the percentage of apoptotic cells, and co-transfection with DKK1 siRNA blocked the effects. These findings therefore demonstrate that N-Myc-mediated suppression of linc00467 gene transcription counterintuitively blocks N-Myc-mediated reduction in RD3 mRNA expression, and reduces neuroblastoma cell survival by inducing DKK1 expression.	[Atmadibrata, Bernard; Liu, Pei Y.; Sokolowski, Nicolas; Zhang, Lihong; Wong, Matthew; Tee, Andrew E.; Marshall, Glenn M.; Liu, Tao] Childrens Canc Inst Australia Med Res, Sydney, NSW, Australia; [Zhang, Lihong] Fudan Univ, Sch Basic Med Sci, Dept Anat Histol & Embryol, Shanghai 200433, Peoples R China; [Marshall, Glenn M.] Sydney Childrens Hosp, Kids Canc Ctr, Randwick, NSW, Australia; [Liu, Tao] Univ New S Wales, UNSW Med, Sch Womens & Childrens Hlth, Sydney, NSW, Australia	Children's Cancer Institute; Children's Medical Research Institute - Australia; Fudan University; University of New South Wales Sydney	Liu, T (corresponding author), Childrens Canc Inst Australia Med Res, Sydney, NSW, Australia.	tliu@unsw.edu.au	Liu, Tao/A-3922-2015	Wong, Matthew/0000-0003-2680-961X; Liu, Tao/0000-0001-6244-7316	National Health and Medical Research Council Australia; Cancer Council New South Wales; ARC Future Fellowship	National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council New South Wales(Cancer Council New South Wales); ARC Future Fellowship(Australian Research Council)	The authors were supported by National Health and Medical Research Council Australia and Cancer Council New South Wales project grants. TL was a recipient of an ARC Future Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Friedman JS, 2006, AM J HUM GENET, V79, P1059, DOI 10.1086/510021; Garding A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003373; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Gregory SG, 2006, NATURE, V441, P315, DOI 10.1038/nature04727; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Hirata H, 2011, INT J CANCER, V128, P1793, DOI 10.1002/ijc.25507; Hosgood HD, 2009, OCCUP ENVIRON MED, V66, P848, DOI 10.1136/oem.2008.044024; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Johnsson P, 2013, NAT STRUCT MOL BIOL, V20, P440, DOI 10.1038/nsmb.2516; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Liu PY, 2013, CELL DEATH DIFFER, V20, P503, DOI 10.1038/cdd.2012.147; Liu T, 2007, P NATL ACAD SCI USA, V104, P18682, DOI 10.1073/pnas.0705524104; Liu T, 2009, EUR J CANCER, V45, P1846, DOI 10.1016/j.ejca.2009.03.002; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Marshall GM, 2010, ONCOGENE, V29, P5957, DOI 10.1038/onc.2010.332; Marshall GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002135; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P9511, DOI 10.1021/bi201342b; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Shou J, 2002, ONCOGENE, V21, P878, DOI 10.1038/sj.onc.1205138; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Suzuki Y, 2004, GENOME RES, V14, P1711, DOI 10.1101/gr.2435604; Takayama KI, 2013, EMBO J; Tripathi V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003368; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819	33	55	61	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88112	10.1371/journal.pone.0088112	http://dx.doi.org/10.1371/journal.pone.0088112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586304	Green Submitted, Green Published, gold			2022-12-27	WOS:000331711900023
J	Tomonoh, Y; Deshimaru, M; Araki, K; Miyazaki, Y; Arasaki, T; Tanaka, Y; Kitamura, H; Mori, F; Wakabayashi, K; Yamashita, S; Saito, R; Itoh, M; Uchida, T; Yamada, J; Migita, K; Ueno, S; Kitaura, H; Kakita, A; Lossin, C; Takano, Y; Hirose, S				Tomonoh, Yuko; Deshimaru, Masanobu; Araki, Kimi; Miyazaki, Yasuhiro; Arasaki, Tomoko; Tanaka, Yasuyoshi; Kitamura, Haruna; Mori, Fumiaki; Wakabayashi, Koichi; Yamashita, Sayaka; Saito, Ryo; Itoh, Masayuki; Uchida, Taku; Yamada, Junko; Migita, Keisuke; Ueno, Shinya; Kitaura, Hiroki; Kakita, Akiyoshi; Lossin, Christoph; Takano, Yukio; Hirose, Shinichi			The Kick-In System: A Novel Rapid Knock-In Strategy	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; FAMILIAL NEONATAL CONVULSIONS; MUTANT LOX SITES; EPILEPTIC ENCEPHALOPATHY; KCNQ3 MUTATIONS; MOUSE MODELS; GENE; RECOMBINATION; SEIZURES; MICE	Knock-in mouse models have contributed tremendously to our understanding of human disorders. However, generation of knock-in animals requires a significant investment of time and effort. We addressed this problem by developing a novel knock-in system that circumvents several traditional challenges by establishing stem cells with acceptor elements enveloping a particular genomic target. Once established, these acceptor embryonic stem (ES) cells are efficient at directionally incorporating mutated target DNA using modified Cre/lox technology. This is advantageous, because knock-ins are not restricted to one a priori selected variation. Rather, it is possible to generate several mutant animal lines harboring desired alterations in the targeted area. Acceptor ES cell generation is the rate-limiting step, lasting approximately 2 months. Subsequent manipulations toward animal production require an additional 8 weeks, but this delimits the full period from conception of the genetic alteration to its animal incorporation. We call this system a "kick-in'' to emphasize its unique characteristics of speed and convenience. To demonstrate the functionality of the kick-in methodology, we generated two mouse lines with separate mutant versions of the voltage-dependent potassium channel Kv7.2 (Kcnq2): p. Tyr284Cys (Y284C) and p. Ala306Thr (A306T); both variations have been associated with benign familial neonatal epilepsy. Adult mice homozygous for Y284C, heretofore unexamined in animals, presented with spontaneous seizures, whereas A306T homozygotes died early. Heterozygous mice of both lines showed increased sensitivity to pentylenetetrazole, possibly due to a reduction in M-current in CA1 hippocampal pyramidal neurons. Our observations for the A306T animals match those obtained with traditional knock-in technology, demonstrating that the kick-in system can readily generate mice bearing various mutations, making it a suitable feeder technology toward streamlined phenotyping.	[Tomonoh, Yuko; Hirose, Shinichi] Fukuoka Univ, Sch Med, Dept Pediat, Fukuoka 81401, Japan; [Uchida, Taku; Hirose, Shinichi] Fukuoka Univ, Cent Res Inst Mol Pathomech Epilepsy, Fukuoka 81401, Japan; [Deshimaru, Masanobu; Miyazaki, Yasuhiro; Arasaki, Tomoko; Tanaka, Yasuyoshi; Kitamura, Haruna] Fukuoka Univ, Dept Chem, Fac Sci, Fukuoka 81401, Japan; [Araki, Kimi] Kumamoto Univ, Div Dev Genet, Inst Resource Dev & Anal, Kumamoto, Japan; [Mori, Fumiaki; Wakabayashi, Koichi] Hirosaki Univ, Dept Neuropathol, Grad Sch Med, Hirosaki, Aomori, Japan; [Yamashita, Sayaka; Saito, Ryo; Takano, Yukio] Fukuoka Univ, Fac Pharmaceut Sci, Dept Physiol & Pharmacol, Fukuoka 81401, Japan; [Itoh, Masayuki] Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Kodaira, Tokyo 187, Japan; [Yamada, Junko; Migita, Keisuke; Ueno, Shinya] Hirosaki Univ, Dept Neurophysiol, Grad Sch Med, Hirosaki, Aomori, Japan; [Kitaura, Hiroki; Kakita, Akiyoshi] Niigata Univ, Brain Res Inst, Niigata, Japan; [Lossin, Christoph] Univ Calif Davis, Sch Med, Dept Neurol, Sacramento, CA 95817 USA	Fukuoka University; Fukuoka University; Fukuoka University; Kumamoto University; Hirosaki University; Fukuoka University; National Center for Neurology & Psychiatry - Japan; Hirosaki University; Niigata University; University of California System; University of California Davis	Hirose, S (corresponding author), Fukuoka Univ, Sch Med, Dept Pediat, Fukuoka 81401, Japan.	hirose@fukuoka-u.ac.jp	MORI, Fumiaki/L-5789-2019; Migita, Keisuke/E-8274-2013; 北浦, 弘樹/V-8356-2019	HIROSE, Shinichi/0000-0001-6796-3790	Japan Society for the Promotion of Science (JSPS) [24249060, 25670481]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [221S0002, 25129708]; MEXT; Ministry of Health, Labour and Welfare [H23-Nanji-Ippan-78]; Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP [21B-5, 24-7]; Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University; Mitsubishi Foundation; Takeda Scientific Foundation; Japan Epilepsy Research Foundation; Fukuoka University [117016]; Grants-in-Aid for Scientific Research [24659505] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP(National Center for Neurology & Psychiatry - Japan); Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University; Mitsubishi Foundation; Takeda Scientific Foundation(Takeda Science Foundation (TSF)); Japan Epilepsy Research Foundation; Fukuoka University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants for Scientific Research (A) (24249060 to SH), for Challenging Exploratory Research (25670481 to SH), for Bilateral Joint Research Projects (SH) from the Japan Society for the Promotion of Science (JSPS); Grants for Scientific Research on Innovative Areas (221S0002 to SH and 25129708 to SH) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); the MEXT-supported Program for the Strategic Research Foundation at Private Universities 2013-2017 (SH); Grants-in-aid for Research on Measures for Intractable Diseases (No. H23-Nanji-Ippan-78 to SH) from the Ministry of Health, Labour and Welfare; Intramural Research Grant (21B-5 and 24-7) for Neurological and Psychiatric Disorders of NCNP (SH); the Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University (SH); Grants from the Mitsubishi Foundation (SH), Takeda Scientific Foundation (SH) and the Japan Epilepsy Research Foundation (to TU); Research grants for the Central Research Institute for the Molecular Pathomechanisms of Epilepsy of Fukuoka University (SH) and Recommended Projects of Fukuoka University (117016 to SH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABREMSKI K, 1983, CELL, V32, P1301, DOI 10.1016/0092-8674(83)90311-2; Araki K, 1997, NUCLEIC ACIDS RES, V25, P868, DOI 10.1093/nar/25.4.868; Araki K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf102; Araki K, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-29; BERGER SL, 1989, METHOD ENZYMOL, V180, P3; Blumkin L, 2012, EUR J PAEDIATR NEURO, V16, P356, DOI 10.1016/j.ejpn.2011.11.004; Borgatti R, 2004, NEUROLOGY, V63, P57, DOI 10.1212/01.WNL.0000132979.08394.6D; Dedek K, 2003, EPILEPSY RES, V54, P21, DOI 10.1016/S0920-1211(03)00037-8; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; Hirose S, 2005, EPILEPSIA, V46, P38, DOI 10.1111/j.0013-9580.2005.461011.x; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Kaneko S, 2002, NEUROSCI RES, V44, P11, DOI 10.1016/S0168-0102(02)00065-2; Luttjohann A, 2009, PHYSIOL BEHAV, V98, P579, DOI 10.1016/j.physbeh.2009.09.005; MCLEOD M, 1986, MOL CELL BIOL, V6, P3357, DOI 10.1128/MCB.6.10.3357; Otto JF, 2009, EPILEPSIA, V50, P1752, DOI 10.1111/j.1528-1167.2009.02100.x; Otto JF, 2006, J NEUROSCI, V26, P2053, DOI 10.1523/JNEUROSCI.1575-05.2006; RONEN GM, 1993, NEUROLOGY, V43, P1355, DOI 10.1212/WNL.43.7.1355; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Singh NA, 2008, J PHYSIOL-LONDON, V586, P3405, DOI 10.1113/jphysiol.2008.154971; VanElzakker M, 2008, LEARN MEMORY, V15, P899, DOI 10.1101/lm.1196508; Vigevano F, 2005, BRAIN DEV-JPN, V27, P172, DOI 10.1016/j.braindev.2003.12.012; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Watanabe H, 2000, J NEUROCHEM, V75, P28, DOI 10.1046/j.1471-4159.2000.0750028.x; Weckhuysen S, 2012, ANN NEUROL, V71, P15, DOI 10.1002/ana.22644; Wefers B, 2013, P NATL ACAD SCI USA, V110, P3782, DOI 10.1073/pnas.1218721110; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458	30	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88549	10.1371/journal.pone.0088549	http://dx.doi.org/10.1371/journal.pone.0088549			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586341	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900029
J	da Silva, AA; Ranieri, TMS; Torres, FD; Vianna, FSL; Paniz, GR; Sanseverino, PB; Picon, PD; de Azevedo, PB; Costa, MH; Schuler-Faccini, L; Sanseverino, MTV				da Silva, Andre Anjos; Schilling Ranieri, Tani Maria; Torres, Fernanda Duarte; Luiz Vianna, Fernanda Sales; Paniz, Graziella Rangel; Sanseverino, Paula Baptista; Picon, Paulo Dornelles; de Azevedo, Pietro Baptista; Costa, Marta Haas; Schuler-Faccini, Lavinia; Vieira Sanseverino, Maria Teresa			Impact on Pregnancies in South Brazil from the Influenza A (H1N1) Pandemic: Cohort Study	PLOS ONE			English	Article							VIRUS-INFECTION; ASIAN INFLUENZA; OUTCOMES; WOMEN; RISK; CALIFORNIA; DEATH	Introduction: The emergence of a new subtype of the influenza virus in 2009 generated interest in the international medical community, the media, and the general population. Pregnant women are considered to be a group at risk of serious complications related to the H1N1 influenza virus. The aim of this study was to evaluate the outcomes and teratogenic effects of pregnancies exposed to the H1N1 virus during the Influenza A epidemic that occurred in the state of Rio Grande do Sul in 2009. Methods: This is an uncontrolled prospective cohort study of pregnant women with suspected symptoms of Influenza A who were reported in the Information System for Notifiable Diseases - Influenza (SINAN-Influenza) during the epidemic of 2009 (database from the state of Rio Grande do Sul, Brazil). There were 589 cases of pregnant women with suspected infection. Among these, 243 were tested by PCR and included in the analysis. The main outcome measures were: maternal deaths, pregnancy outcome, stillbirths, premature births, low birth weight, congenital malformations, and odds ratios for H1N1+ and non-H1N1 pregnant women. Results: There were one hundred and sixty-three (67%) confirmed cases of H1N1, 34 cases (14%) of seasonal Influenza A and 46 (19%) who were negative for Influenza A. There was no difference between the three groups in clinical parameters of the disease. There were 24 maternal deaths - 18 of them had H1N1. There were 8 stillbirths - 5 were children of H1N1 infected mothers. There were no differences in perinatal outcomes. Conclusions: The present data do not indicate an increase in teratogenic risk from exposure to the influenza A (H1N1) virus. These results will help to strengthen the data and clarify the health issues that arose after the pandemic.	[da Silva, Andre Anjos; Torres, Fernanda Duarte; Luiz Vianna, Fernanda Sales; Paniz, Graziella Rangel; Sanseverino, Paula Baptista; de Azevedo, Pietro Baptista; Costa, Marta Haas; Schuler-Faccini, Lavinia; Vieira Sanseverino, Maria Teresa] Hosp Clin Porto Alegre, Med Genet Serv, Teratogen Informat Serv, Porto Alegre, RS, Brazil; [da Silva, Andre Anjos; Schuler-Faccini, Lavinia] Univ Fed Rio Grande do Sul, Postgrad Program Genet & Mol Biol, BR-90046900 Porto Alegre, RS, Brazil; [Picon, Paulo Dornelles] Hosp Clin Porto Alegre, Dept Internal Med, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Schuler-Faccini, L (corresponding author), Hosp Clin Porto Alegre, Med Genet Serv, Teratogen Informat Serv, Porto Alegre, RS, Brazil.	lavinia.faccini@ufrgs.br	Vianna, Fernanda Sales Luiz/O-4337-2019; SCHULER-FACCINI, LAVINIA/C-8309-2013; Azevedo, Pietro/AAA-4264-2022; SCHULER-FACCINI, LAVINIA/K-2927-2016; Picon, Paulo/J-2448-2015; SANSEVERINO, MARIA TERESA V/G-3884-2017	SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460; Azevedo, Pietro/0000-0003-4496-8614; SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460; SANSEVERINO, MARIA TERESA V/0000-0002-7404-2911	Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) [007/2009]	Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	Funding was provided by Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS), n. 007/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P536; Australian and New Zealand Intensive Care Influenza Investigators, 2010, BRIT MED J, V340, pc1279; Bercini M, 2011, B EPIDEMIOLOGICO, V13, P1; Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947; Dolan GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041638; Dubar G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013112; European Medicines Agency, 2011, CHMP ASS REP NOV INF; FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gerard C, 2010, CDC PROT REAL TIM RT, V68, P68; Gerardin P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010896; Governo do Estado do Rio Grande do Sul, 2012, ATL SOC RIO GRAND SU; GREENBERG M, 1958, AM J OBSTET GYNECOL, V76, P897, DOI 10.1016/0002-9378(58)90027-9; Greer LG, 2010, OBSTET GYNECOL, V115, P711, DOI 10.1097/AOG.0b013e3181d44752; Haberg SE, 2013, NEW ENGL J MED, V368, P333, DOI 10.1056/NEJMoa1207210; Harris, 1919, JAMA-J AM MED ASSOC, V72, P978; Hewagama S, 2010, CLIN INFECT DIS, V50, P686, DOI 10.1086/650460; Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Jimenez MF, 2010, INT J GYNECOL OBSTET, V111, P217, DOI 10.1016/j.ijgo.2010.06.024; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Mendez-Figueroa H, 2011, AM J OBSTET GYNECOL, V204, pS58, DOI 10.1016/j.ajog.2011.02.058; Pasternak B, 2012, JAMA-J AM MED ASSOC, V308, P165, DOI 10.1001/jama.2012.6131; Pierce M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3214; Siston AM, 2010, JAMA-J AM MED ASSOC, V115, P717; Tanaka T, 2009, CAN MED ASSOC J, V181, P55, DOI 10.1503/cmaj.090866; Yokota RTC, 2011, EMERG INFECT DIS, V17, P1467, DOI 10.3201/eid1708.101233; 2009, MMWR MORB MORTAL WKL, V58, P467	28	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88624	10.1371/journal.pone.0088624	http://dx.doi.org/10.1371/journal.pone.0088624			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558404	gold, Green Published, Green Submitted			2022-12-27	WOS:000331706700050
J	Liu, L; Zhao, GF; Fan, HY; Zhao, XY; Li, PF; Wang, ZQ; Hu, YL; Hou, YY				Liu, Liu; Zhao, Guangfeng; Fan, Hongye; Zhao, Xiaoyin; Li, Pengfei; Wang, Zhiqun; Hu, Yali; Hou, Yayi			Mesenchymal Stem Cells Ameliorate Th1-Induced Pre-Eclampsia-Like Symptoms in Mice via the Suppression of TNF-alpha Expression	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; AGONISTIC AUTOANTIBODIES; MOUSE MODEL; RAT MODEL; PREECLAMPSIA; HYPERTENSION; CYTOKINES; RECEPTOR; IMBALANCE; PROTECT	Pre-eclampsia (PE) is thought to be a pregnancy-induced autoimmune disease. Despite several strategies carried out for targeting specific factors relevant to its pathogenesis, PE remains potentially fatal to some patients. Here, we reported a way to isolate mesenchymal stem cells (MSCs) from decidua. The MSCs not only exhibited differentiation and self-renewal capacities, they also possessed immunomodulatory functions and secreted some soluble mediators including IL-6, TGF-beta, IDO, VEGF and COX-2. Most importantly, the MSCs were specifically provided with the ability to suppress T cells proliferation by IDO in response to inflammatory cytokine IFN-gamma. Moreover, we developed a Th1 cell-induced PE mouse model which displayed a high level of pathogenesis factor TNF-alpha. Strikingly, MSCs-based therapy significantly ameliorated both clinical and histopathological severity of PE symptoms including decreasing the blood pressure and proteinuria, suppressing glomerulonephritis, protecting the feto-placental development. The therapy also reversed abnormal TNF-alpha expression in uterine and splenic lymphocytes. These data suggest that MSCs may ameliorate Th1-induced PE-like symptoms in mice via the suppression of TNF-alpha and MSCs-based therapy may provide a potential novel method for PE.	[Liu, Liu; Zhao, Guangfeng; Fan, Hongye; Zhao, Xiaoyin; Li, Pengfei; Hou, Yayi] Nanjing Univ, Sch Med, Immunol Lab, Nanjing 210008, Jiangsu, Peoples R China; [Liu, Liu; Zhao, Guangfeng; Fan, Hongye; Zhao, Xiaoyin; Li, Pengfei; Hou, Yayi] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Zhiqun; Hu, Yali] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Hou, Yayi] Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University	Hu, YL (corresponding author), Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China.	yalihu2009@gmail.com; yayihou@nju.edu.cn	Li, Pengfei/AAQ-6289-2020; LIU, LIU/H-7876-2016	Li, Pengfei/0000-0002-5928-1578; 	National Natural Science Foundation [81072410, 81270713]; Jiangsu Province Department of Health [XK200709, JHB2011-1]; Jiangsu province health department of China [81070508]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Jiangsu Province Department of Health; Jiangsu province health department of China	This work supported by grants from the National Natural Science Foundation (project number: 81072410, 81270713), the Special Research Grant of Jiangsu Province Department of Health (project number: XK200709 and JHB2011-1) and Special grant for maternal-fetal medicine from Jiangsu province health department of China (project number: 81070508). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Aicher A, 2003, CIRCULATION, V107, P2134, DOI 10.1161/01.CIR.0000062649.63838.C9; Alfaro MP, 2010, J BIOL CHEM, V285, P35645, DOI 10.1074/jbc.M110.135335; Carter D, 2005, BLOOD, V106, p160B; Conrad KP, 1998, AM J REPROD IMMUNOL, V40, P102; Conrad KP, 1997, AM J REPROD IMMUNOL, V37, P240; Darmochwal-Kolarz D, 1999, EUR J OBSTET GYN R B, V86, P165, DOI 10.1016/S0301-2115(99)00065-2; Dong MY, 2005, ACTA OBSTET GYN SCAN, V84, P788, DOI 10.1111/j.0001-6349.2005.00714.x; Goldman-Wohl DS, 2007, J REPROD IMMUNOL, V76, P54, DOI 10.1016/j.jri.2007.03.012; Gonzalez MA, 2009, ARTHRITIS RHEUM-US, V60, P1006, DOI 10.1002/art.24405; Gonzalez MA, 2009, GASTROENTEROLOGY, V136, P978, DOI 10.1053/j.gastro.2008.11.041; Gonzalez-Rey E, 2009, GUT, V58, P929, DOI 10.1136/gut.2008.168534; Gulati R, 2005, JNMA J Nepal Med Assoc, V44, P36; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3; Hoffmann DS, 2008, HYPERTENSION, V51, P1058, DOI 10.1161/HYPERTENSIONAHA.107.107219; Hu Y, 2007, INT J MOL SCI, V8, P1, DOI 10.3390/i8010001; Irani RA, 2010, HYPERTENSION, V55, P1246, DOI 10.1161/HYPERTENSIONAHA.110.150540; Kanasaki K, 2009, KIDNEY INT, V76, P831, DOI 10.1038/ki.2009.284; LaMarca BD, 2007, CURR HYPERTENS REP, V9, P480, DOI 10.1007/s11906-007-0088-1; Li ZH, 2007, HYPERTENSION, V50, P686, DOI 10.1161/HYPERTENSIONAHA.107.092098; Liu L, 2012, EUR J IMMUNOL, V42, P2190, DOI 10.1002/eji.201142356; Liu L, 2012, STEM CELLS, V30, P1756, DOI 10.1002/stem.1156; Marzi M, 1996, CLIN EXP IMMUNOL, V106, P127, DOI 10.1046/j.1365-2249.1996.d01-809.x; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Parrish MR, 2010, AM J HYPERTENS, V23, P911, DOI 10.1038/ajh.2010.70; Peracoli MTS, 2011, AM J REPROD IMMUNOL, V66, P460, DOI 10.1111/j.1600-0897.2011.01016.x; Picinich SC, 2007, EXPERT OPIN BIOL TH, V7, P965, DOI 10.1517/14712598.7.7.965; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rafei M, 2009, J IMMUNOL, V182, P5994, DOI 10.4049/jimmunol.0803962; Ramesar SV, 2010, EUR J OBSTET GYN R B, V149, P22, DOI 10.1016/j.ejogrb.2009.11.005; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Saito S, 1999, CLIN EXP IMMUNOL, V117, P550; Saito S, 1999, AM J REPROD IMMUNOL, V41, P297; Shen Y, 2011, HYPERTENS PREGNANCY, V30, P465, DOI 10.3109/10641955.2010.507842; Shi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44; Suzuki H, 2009, HYPERTENSION, V54, P1129, DOI 10.1161/HYPERTENSIONAHA.109.134668; Tang JM, 2006, EUR J CARDIO-THORAC, V30, P353, DOI 10.1016/j.ejcts.2006.02.070; Todt JC, 1996, AM J REPROD IMMUNOL, V36, P65; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Zenclussen AC, 2004, EUR J IMMUNOL, V34, P377, DOI 10.1002/eji.200324469; Zhang J, 2005, EXP NEUROL, V195, P16, DOI 10.1016/j.expneurol.2005.03.018; Zhang QZ, 2009, J IMMUNOL, V183, P7787, DOI 10.4049/jimmunol.0902318; Zhao SM, 2010, STEM CELLS DEV, V19, P607, DOI 10.1089/scd.2009.0345; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856	45	46	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88036	10.1371/journal.pone.0088036	http://dx.doi.org/10.1371/journal.pone.0088036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558374	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700020
J	Decoin, V; Barbey, C; Bergeau, D; Latour, X; Feuilloley, MGJ; Orange, N; Merieau, A				Decoin, Victorien; Barbey, Corinne; Bergeau, Dorian; Latour, Xavier; Feuilloley, Marc G. J.; Orange, Nicole; Merieau, Annabelle			A Type VI Secretion System Is Involved in Pseudomonas fluorescens Bacterial Competition	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; PROTEIN SECRETION; VIBRIO-CHOLERAE; OUTER-MEMBRANE; AERUGINOSA; EFFECTOR; IDENTIFICATION; PATHOGENESIS; VIRULENCE; APPARATUS	Protein secretion systems are crucial mediators of bacterial interactions with other organisms. Among them, the type VI secretion system (T6SS) is widespread in Gram-negative bacteria and appears to inject toxins into competitor bacteria and/or eukaryotic cells. Major human pathogens, such as Vibrio cholerae, Burkholderia and Pseudomonas aeruginosa, express T6SSs. Bacteria prevent self-intoxication by their own T6SS toxins by producing immunity proteins, which interact with the cognate toxins. We describe here an environmental P. fluorescens strain, MFE01, displaying an uncommon oversecretion of Hcp (hemolysin-coregulated protein) and VgrG (valine-glycine repeat protein G) into the culture medium. These proteins are characteristic components of a functional T6SS. The aim of this study was to attribute a role to this energy-consuming overexpression of the T6SS. The genome of MFE01 contains at least two hcp genes (hcp1 and hcp2), suggesting that there may be two putative T6SS clusters. Phenotypic studies have shown that MFE01 is avirulent against various eukaryotic cell models (amebas, plant or animal cell models), but has antibacterial activity against a wide range of competitor bacteria, including rhizobacteria and clinical bacteria. Depending on the prey cell, mutagenesis of the hcp2 gene in MFE01 abolishes or reduces this antibacterial killing activity. Moreover, the introduction of T6SS immunity proteins from S. marcescens, which is not killed by MFE01, protects E. coli against MFE01 killing. These findings suggest that the protein encoded by hcp2 is involved in the killing activity of MFE01 mediated by effectors of the T6SS targeting the peptidoglycan of Gram-negative bacteria. Our results indicate that MFE01 can protect potato tubers against Pectobacterium atrosepticum, which causes tuber soft rot. Pseudomonas fluorescens is often described as a major PGPR (plant growth-promoting rhizobacterium), and our results suggest that there may be a connection between the T6SS and the PGPR properties of this bacterium.	[Decoin, Victorien; Barbey, Corinne; Bergeau, Dorian; Latour, Xavier; Feuilloley, Marc G. J.; Orange, Nicole; Merieau, Annabelle] Univ Rouen, Normandie Univ, LMSM, IUT Evreux, Evreux, France	Universite de Rouen Normandie	Merieau, A (corresponding author), Univ Rouen, Normandie Univ, LMSM, IUT Evreux, EA 4312, Evreux, France.	annabelle.merieau@univ-rouen.fr		FEUILLOLEY, Marc G.J./0000-0001-6467-4336	Region Haute normandie et Ministere delegue a l'enseignement superieur et a la recherche; GRR SSE et FEDER (Europeen Union)	Region Haute normandie et Ministere delegue a l'enseignement superieur et a la recherche(Region Normandie); GRR SSE et FEDER (Europeen Union)	This research was supported by grants from Region Haute normandie et Ministere delegue a l'enseignement superieur et a la recherche, GRR SSE et FEDER (Europeen Union). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbey C, 2012, J PROTEOME RES, V11, P206, DOI 10.1021/pr200936q; Barret M, 2013, ENV MICROBIOL REP, V5, P117, DOI 10.1111/j.1758-2229.2012.00394.x; Barret M, 2011, MICROBIOL-SGM, V157, P1726, DOI 10.1099/mic.0.048645-0; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Burtnick MN, 2011, INFECT IMMUN, V79, P1512, DOI 10.1128/IAI.01218-10; Carruthers MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059388; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Chapalain A, 2008, CAN J MICROBIOL, V54, P19, DOI [10.1139/W07-110, 10.1139/w07-110]; Chou S, 2012, CELL REP, V1, P656, DOI 10.1016/j.celrep.2012.05.016; COMPEAU G, 1988, APPL ENVIRON MICROB, V54, P2432, DOI 10.1128/AEM.54.10.2432-2438.1988; Crepin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035176; DAGLEY S, 1950, J BACTERIOL, V60, P369, DOI 10.1128/JB.60.4.369-379.1950; Davey ME, 2003, J BACTERIOL, V185, P1027, DOI 10.1128/JB.185.3.1027-1036.2003; Dong TG, 2013, P NATL ACAD SCI USA, V110, P2623, DOI 10.1073/pnas.1222783110; El-Sayed AK, 2001, MICROBIOL-SGM, V147, P2127, DOI 10.1099/00221287-147-8-2127; English G, 2012, MOL MICROBIOL, V86, P921, DOI 10.1111/mmi.12028; Fritsch MJ, 2013, MOL CELL PROTEOMICS, V12, P2735, DOI 10.1074/mcp.M113.030502; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Guyard-Nicodeme M, 2008, J PROTEOME RES, V7, P1218, DOI 10.1021/pr070539x; HANCOCK REW, 1979, J BACTERIOL, V140, P902, DOI 10.1128/JB.140.3.902-910.1979; Heeb S, 2002, J BACTERIOL, V184, P1046, DOI 10.1128/jb.184.4.1046-1056.2002; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Jani AJ, 2010, CELL HOST MICROBE, V8, P2, DOI 10.1016/j.chom.2010.06.012; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Lesic B, 2009, MICROBIOL-SGM, V155, P2845, DOI 10.1099/mic.0.029082-0; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Maurhofer M, 1998, PHYTOPATHOLOGY, V88, P678, DOI 10.1094/PHYTO.1998.88.7.678; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Murdoch SL, 2011, J BACTERIOL, V193, P6057, DOI 10.1128/JB.05671-11; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Picot L, 2003, MICROB PATHOGENESIS, V35, P95, DOI 10.1016/S0882-4010(03)00092-5; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2013, NATURE, V496, P508, DOI 10.1038/nature12074; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Shrivastava S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002955; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Smadja B, 2004, MOL PLANT MICROBE IN, V17, P1269, DOI 10.1094/MPMI.2004.17.11.1269; Sperandio D, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-223; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Unterweger D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048320; Weller DM, 2007, PHYTOPATHOLOGY, V97, P250, DOI 10.1094/PHYTO-97-2-0250; Zhang H, 2013, J BIOL CHEM, V288, P5928, DOI 10.1074/jbc.M112.434357; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x	52	44	45	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89411	10.1371/journal.pone.0089411	http://dx.doi.org/10.1371/journal.pone.0089411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551247	Green Submitted, gold, Green Published			2022-12-27	WOS:000331271500111
J	Faure, E; Poissy, J; Goffard, A; Fournier, C; Kipnis, E; Titecat, M; Bortolotti, P; Martinez, L; Dubucquoi, S; Dessein, R; Gosset, P; Mathieu, D; Guery, B				Faure, Emmanuel; Poissy, Julien; Goffard, Anne; Fournier, Clement; Kipnis, Eric; Titecat, Marie; Bortolotti, Perinne; Martinez, Laura; Dubucquoi, Sylvain; Dessein, Rodrigue; Gosset, Philippe; Mathieu, Daniel; Guery, Benoit			Distinct Immune Response in Two MERS-CoV-Infected Patients: Can We Go from Bench to Bedside?	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; INNATE; INTERFERON; REPLICATION	One year after the occurrence of the first case of infection by the Middle East Respiratory Syndrome coronavirus (MERS-CoV) there is no clear consensus on the best treatment to propose. The World Health Organization, as well as several other national agencies, are still working on different clinical approaches to implement the most relevant treatment in MERS-CoV infection. We compared innate and adaptive immune responses of two patients infected with MERS-CoV to understand the underlying mechanisms involved in the response and propose potential therapeutic approaches. Broncho-alveolar lavage (BAL) of the first week and sera of the first month from the two patients were used in this study. Quantitative polymerase chain reaction (qRTPCR) was performed after extraction of RNA from BAL cells of MERS-CoV infected patients and control patients. BAL supernatants and sera were used to assess cytokines and chemokines secretion by enzyme-linked immunosorbent assay. The first patient died rapidly after 3 weeks in the intensive care unit, the second patient still recovers from infection. The patient with a poor outcome (patient 1), compared to patient 2, did not promote type-1 Interferon (IFN), and particularly IFN alpha, in response to double stranded RNA (dsRNA) from MERS-CoV. The absence of IFN alpha, known to promote antigen presentation in response to viruses, impairs the development of a robust antiviral adaptive Th-1 immune response. This response is mediated by IL-12 and IFN gamma that decreases viral clearance; levels of both of these mediators were decreased in patient 1. Finally, we confirm previous in vitro findings that MERS-CoV can drive IL-17 production in humans. Host recognition of viral dsRNA determines outcome in the early stage of MERS-CoV infection. We highlight the critical role of IFN alpha in this initial stage to orchestrate a robust immune response and bring substantial arguments for the indication of early IFNa treatment during MERS-CoV infection.	[Faure, Emmanuel; Kipnis, Eric; Bortolotti, Perinne; Martinez, Laura; Dessein, Rodrigue; Guery, Benoit] Univ Lille 2, Host Pathogen Translat Res Grp, Lille, France; [Poissy, Julien; Mathieu, Daniel] Univ Lille 2, Ctr Hosp Reg, Hop Roger Salengro, Pole Reanimat, Lille, France; [Poissy, Julien; Goffard, Anne; Fournier, Clement; Titecat, Marie; Dubucquoi, Sylvain; Mathieu, Daniel] Univ Lille 2, Univ Lille, Lille, France; [Goffard, Anne] Univ Lille 2, Ctr Hosp Reg, Ctr Biol Pathol, Lab Virol, Lille, France; [Fournier, Clement] Univ Lille 2, Ctr Hosp Reg, Clin Malad Resp Endoscopie Bronch & Pleurale Endo, Lille, France; [Titecat, Marie; Dubucquoi, Sylvain] Univ Lille 2, Ctr Hosp Reg, Ctr Biol Pathol, Inst Microbiol, Lille, France; [Gosset, Philippe; Guery, Benoit] Ctr Natl Rech Sci, Unite Mixte Rech 8204, Lille, France; [Gosset, Philippe; Guery, Benoit] Inst Natl Sante & Rech Med, U1019, Lille, France	Universite de Lille - ISITE; Universite de Lille; Centre Hospitalier Annecy Genevois; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Centre Hospitalier Annecy Genevois; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Centre Hospitalier Annecy Genevois; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Centre Hospitalier Annecy Genevois; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille	Guery, B (corresponding author), Univ Lille 2, Host Pathogen Translat Res Grp, Lille, France.	bguery@gmail.com	TITECAT, Marie/I-3277-2018; Dessein, Rodrigue/R-6134-2018; Guery, Benoit/AAP-2046-2021; Dubucquoi, Sylvain/I-5756-2018; Kipnis, Eric/C-6286-2016; Gosset, Philippe/C-6174-2018; Guery, Benoit/D-8089-2017; Faure, Emmanuel/AAD-9412-2020; Goffard, Anne/G-5488-2016	TITECAT, Marie/0000-0002-5860-0936; Dubucquoi, Sylvain/0000-0002-8962-3719; Kipnis, Eric/0000-0001-8887-7330; Gosset, Philippe/0000-0002-4043-6429; Guery, Benoit/0000-0002-6526-0714; Faure, Emmanuel/0000-0003-2618-2706; Goffard, Anne/0000-0002-6521-9711; , julien/0000-0001-6017-5353	CHRU Lille; Lille 2 University	CHRU Lille; Lille 2 University	This study was funded by CHRU Lille, Lille 2 University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4; Blander JM, 2012, NAT REV IMMUNOL, V12, P215, DOI 10.1038/nri3167; Cameron MJ, 2007, J VIROL, V81, P8692, DOI 10.1128/JVI.00527-07; de Wilde AH, 2013, J GEN VIROL, V94, P1749, DOI 10.1099/vir.0.052910-0; Frieman M, 2008, VIRUS RES, V133, P101, DOI 10.1016/j.virusres.2007.03.015; Guery B, 2013, LANCET, V381, P2265, DOI 10.1016/S0140-6736(13)60982-4; Josset L, 2013, MBIO, V4, DOI 10.1128/mBio.00165-13; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kumar P, 2013, CURR OPIN IMMUNOL, V25, P373, DOI 10.1016/j.coi.2013.03.011; Momattin H, 2013, INT J INFECT DIS, V17, pE792, DOI 10.1016/j.ijid.2013.07.002; Moore TC, 2011, VIROLOGY, V418, P40, DOI 10.1016/j.virol.2011.06.028; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; Reghunathan R, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-2; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P315, DOI 10.1016/j.cytogfr.2010.11.001; See H, 2008, PAEDIATR RESPIR REV, V9, P243, DOI 10.1016/j.prrv.2008.04.001; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Wang QH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003410; Welsh RM, 2013, VIROLOGY, V435, P37, DOI 10.1016/j.virol.2012.10.005; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Ysebrant de Lendonck L, 2013, P NATL ACAD SCI USA; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhu MS, 2004, CELL MOL IMMUNOL, V1, P193	23	171	174	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88716	10.1371/journal.pone.0088716	http://dx.doi.org/10.1371/journal.pone.0088716			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551142	Green Published, gold, Green Submitted			2022-12-27	WOS:000331271500058
J	Bedran, TBL; Grignon, L; Spolidorio, DP; Grenier, D				Lombardo Bedran, Telma Blanca; Grignon, Louis; Spolidorio, Denise Palomari; Grenier, Daniel			Subinhibitory Concentrations of Triclosan Promote Streptococcus mutans Biofilm Formation and Adherence to Oral Epithelial Cells	PLOS ONE			English	Article							INHIBITORY CONCENTRATIONS; CARIES PROCESS; IN-VITRO; ANTIBIOTICS; BACTERIA; AGENTS; HYDROPHOBICITY; CIPROFLOXACIN; VIRULENCE; STRAINS	Triclosan is a general membrane-active agent with a broad-spectrum antimicrobial activity that is commonly used in oral care products. In this study, we investigated the effect of sub-minimum inhibitory concentrations (MICs) of triclosan on the capacity of the cariogenic bacterium Streptococcus mutans to form biofilm and adhere to oral epithelial cells. As quantified by crystal violet staining, biofilm formation by two reference strains of S. mutans was dose-dependently promoted, in the range of 2.2- to 6.2-fold, by 1/2 and 1/4 MIC of triclosan. Observations by scanning electron microscopy revealed the presence of a dense biofilm attached to the polystyrene surface. Growth of S. mutans in the presence of triclosan at subMICs also increased its capacity to adhere to a monolayer of gingival epithelial cells. The expression of several genes involved in adherence and biofilm formation in S. mutans was investigated by quantitative RT-PCR. It was found that subMICs of triclosan significantly increased the expression of comD, gtfC, and luxS, and to a lesser extent of gtfB and atlA genes. These findings stress the importance of maintaining effective bactericidal concentrations of therapeutic triclosan since subMICs may promote colonization of the oral cavity by S. mutans.	[Lombardo Bedran, Telma Blanca] State Univ Sao Paulo, Araraquara Dent Sch, Dept Oral Diag & Surg, Sao Paulo, Brazil; [Grignon, Louis; Grenier, Daniel] Univ Laval, Fac Dent, Oral Ecol Res Grp, Quebec City, PQ, Canada; [Spolidorio, Denise Palomari] State Univ Sao Paulo, Araraquara Dent Sch, Dept Physiol & Pathol, Sao Paulo, Brazil	Universidade Estadual Paulista; Laval University; Universidade Estadual Paulista	Grenier, D (corresponding author), Univ Laval, Fac Dent, Oral Ecol Res Grp, Quebec City, PQ, Canada.	Daniel.Grenier@greb.ulaval.ca	Grenier, Daniel/E-5557-2015; Spolidorio, Denise Madalena Palomari/P-3530-2016	Grenier, Daniel/0000-0003-0878-4674; Spolidorio, Denise Madalena Palomari/0000-0003-2376-1024	Canadian Institutes of Health Research [95335]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institutes of Health Research (# 95335). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown TA, 2005, INFECT IMMUN, V73, P3147, DOI 10.1128/IAI.73.5.3147-3151.2005; Davies RM, 2004, J CLIN PERIODONTOL, V31, P1029, DOI 10.1111/j.1600-051X.2004.00614.x; Dong LP, 2012, INT J ANTIMICROB AG, V39, P390, DOI 10.1016/j.ijantimicag.2012.01.009; DOYLE RJ, 1990, MICROBIAL CELL SURFA, P387; Erdeljan P, 2012, J ENDOUROL, V26, P32, DOI 10.1089/end.2011.0183; Haraszthy VI, 2006, LETT APPL MICROBIOL, V43, P256, DOI 10.1111/j.1472-765X.2006.01961.x; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Huang RJ, 2012, EUR J ORAL SCI, V120, P319, DOI 10.1111/j.1600-0722.2012.00971.x; Jung CJ, 2009, MOL MICROBIOL, V74, P888, DOI 10.1111/j.1365-2958.2009.06903.x; Koo H, 2009, INT J ORAL SCI, V1, P229, DOI 10.4248/IJOS.09086; Kusumoto Y, 2004, J PERIODONTOL, V75, P370, DOI 10.1902/jop.2004.75.3.370; Majtan J, 2008, J APPL MICROBIOL, V104, P1294, DOI 10.1111/j.1365-2672.2007.03653.x; Mann Jonathan, 2001, Journal of Clinical Dentistry, V12, P71; Marquis A, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-80; Modeer T, 1996, J CLIN PERIODONTOL, V23, P927, DOI 10.1111/j.1600-051X.1996.tb00513.x; Mustafa M, 1998, EUR J ORAL SCI, V106, P637, DOI 10.1046/j.0909-8836.1998.eos106205.x; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Phan TN, 2006, CAN J MICROBIOL, V52, P977, DOI 10.1139/W06-055; Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000; ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1111/j.1574-6968.1980.tb05599.x; Schweizer HP, 2001, FEMS MICROBIOL LETT, V202, P1, DOI 10.1111/j.1574-6968.2001.tb10772.x; Senadheera D, 2008, BACTERIAL SIGNAL TRA; Starner TD, 2008, ANTIMICROB AGENTS CH, V52, P137, DOI 10.1128/AAC.00607-07; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; Takahashi N, 2008, CARIES RES, V42, P409, DOI 10.1159/000159604; Villalain J, 2001, ARCH BIOCHEM BIOPHYS, V390, P128, DOI 10.1006/abbi.2001.2356; WADE WG, 1992, J PERIODONTOL, V63, P280, DOI 10.1902/jop.1992.63.4.280; Wojnicz D, 2007, INT J ANTIMICROB AG, V29, P700, DOI 10.1016/j.ijantimicag.2007.01.007; WU Q, 1995, J BACTERIOL, V177, P1399, DOI 10.1128/jb.177.5.1399-1401.1995	30	43	44	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89059	10.1371/journal.pone.0089059	http://dx.doi.org/10.1371/journal.pone.0089059			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551218	Green Published, Green Submitted, gold			2022-12-27	WOS:000331266000097
J	Patton, DT; Plumb, AW; Redpath, SA; Osborne, LC; Perona-Wright, G; Abraham, N				Patton, Daniel T.; Plumb, Adam W.; Redpath, Stephen A.; Osborne, Lisa C.; Perona-Wright, Georgia; Abraham, Ninan			The Development and Survival but Not Function of Follicular B Cells Is Dependent on IL-7R alpha Tyr449 Signaling	PLOS ONE			English	Article							MARGINAL ZONE; PROTECTIVE IMMUNITY; RECEPTOR-ALPHA; DEFICIENT MICE; LYMPHOPOIESIS; IL-7; DIFFERENTIATION; MEMORY; B-1	IL-7 is a critical cytokine for lymphocyte development. Recent work has highlighted critical roles for IL-7 signaling in mature T cell homeostasis and function, but its role in B cells is less well characterized. Using a knock-in mouse possessing a Tyr to Phe mutation at position 449 (IL-7R alpha(449F/449F) mice) within the cytoplasmic SH2-binding motif of IL-7R alpha, we evaluated the role of IL-7R alpha Y449 motif in spleen B cells. IL-7R alpha(449F/449F) mice had reduced numbers and increased death of follicular B cells compared to WT, but had significantly more follicular cells than IL-7R alpha(-/-). The death of IL-7R alpha(449F/449F) follicular cells was not due to a failure to respond to BAFF or lower levels of BAFF, a critical B cell survival factor. Marginal zone B cells were unaffected by the IL-7R alpha(449F/449F) mutation. Any role for TSLP was ruled out, as TSLPR-/- mice had an identical B cell phenotype to wild-type mice. Bone marrow chimeras and the absence of IL-7R alpha on B cells suggested that IL-7 did not directly regulate mature B cells, but that an IL-7-responsive cell was influencing B cells. IL-7 was also critical at the checkpoint between the T1 and T2 stages in the spleen. IL-7R alpha(-/-) mice fail to develop T2 cells, but IL-7R alpha(449F/449F) show a reduction compared to WT but not complete absence of T2 cells. We also tested the functional responses of IL-7R alpha(449F/449F) to antigens and infection and found no difference in antibody responses to T-dependent or T-independent antigens, or to Influenza/A. IL-7 was important for generation of antibody responses to the intestinal worm H. polygyrus and for naive levels of IgA. Taken together, this suggests that IL-7 regulates follicular B cell numbers and survival in a cell-extrinsic manner, via a bone-marrow derived cell, but is not critical for antibody production outside the gut.	[Patton, Daniel T.; Plumb, Adam W.; Redpath, Stephen A.; Osborne, Lisa C.; Perona-Wright, Georgia; Abraham, Ninan] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Abraham, Ninan] Univ British Columbia, Dept Zool, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Abraham, N (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada.	ninan@mail.ubc.ca	Abraham, Ninan/K-5572-2012; Osborne, Lisa/K-3027-2015	Abraham, Ninan/0000-0002-2747-1246; Osborne, Lisa/0000-0002-7170-3235	Canadian Institutes for Health Research (CIHR) [MOP-84532, MOP-126060]; MSFHR Career Investigator award; CIHR Transplant Training and Michael Smith Foundation Postdoctoral Fellowships	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); MSFHR Career Investigator award; CIHR Transplant Training and Michael Smith Foundation Postdoctoral Fellowships	This work is supported by the Canadian Institutes for Health Research (CIHR) (MOP-84532 and MOP-126060 to N. Abraham). N. A. holds a MSFHR Career Investigator award and D. T. P. holds CIHR Transplant Training and Michael Smith Foundation Postdoctoral Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 1998, INT IMMUNOL, V10, P1, DOI 10.1093/intimm/10.1.1; Astrakhan A, 2007, NAT IMMUNOL, V8, P522, DOI 10.1038/ni1452; Carvalho TL, 2001, J EXP MED, V194, P1141, DOI 10.1084/jem.194.8.1141; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; Ceredig R, 2003, EUR J IMMUNOL, V33, P2567, DOI 10.1002/eji.200324134; Corcoran AE, 1996, EMBO J, V15, P1924, DOI 10.1002/j.1460-2075.1996.tb00543.x; Erlandsson L, 2004, EUR J IMMUNOL, V34, P3595, DOI 10.1002/eji.200425217; Gazit R, 2004, DEVELOPMENT, V131, P903, DOI 10.1242/dev.00982; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; Hardy RR, 2006, CURR OPIN IMMUNOL, V18, P547, DOI 10.1016/j.coi.2006.07.010; Jensen CT, 2008, BLOOD, V112, P2297, DOI 10.1182/blood-2008-04-150508; Lycke NY, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00329; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1034/j.1600-065X.2000.017515.x; McCarthy DD, 2011, J CLIN INVEST, V121, P3991, DOI 10.1172/JCI45563; Osborne LC, 2010, ONCOGENE, V29, P3854, DOI 10.1038/onc.2010.133; Osborne LC, 2007, J EXP MED, V204, P619, DOI 10.1084/jem.20061871; Osborne LC, 2011, J IMMUNOL, V186, P1981, DOI 10.4049/jimmunol.1002224; Perona-Wright G, 2010, NAT IMMUNOL, V11, P520, DOI 10.1038/ni.1866; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Plumb AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050199; Rauch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005456; RICH BE, 1993, J EXP MED, V177, P305, DOI 10.1084/jem.177.2.305; Shriner AK, 2010, J IMMUNOL, V185, P525, DOI 10.4049/jimmunol.0902841; URBAN JF, 1991, P NATL ACAD SCI USA, V88, P5513, DOI 10.1073/pnas.88.13.5513; Vosshenrich CAJ, 2003, NAT IMMUNOL, V4, P773, DOI 10.1038/ni956; Willems L, 2011, J IMMUNOL, V187, P3587, DOI 10.4049/jimmunol.1004012	27	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88771	10.1371/journal.pone.0088771	http://dx.doi.org/10.1371/journal.pone.0088771			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551160	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000331266000066
J	Qu, T; Huang, BY; Zhang, LL; Li, L; Xu, F; Huang, W; Li, CY; Du, YS; Zhang, GF				Qu, Tao; Huang, Baoyu; Zhang, Linlin; Li, Li; Xu, Fei; Huang, Wen; Li, Chunyan; Du, Yishuai; Zhang, Guofan			Identification and Functional Characterization of Two Executioner Caspases in Crassostrea gigas	PLOS ONE			English	Article							CELL-DEATH; CHROMATIN CONDENSATION; PACIFIC OYSTER; APOPTOSIS; ACTIVATION; PROTEIN; EXPRESSION; FAILURE; EVENTS; CPP32	Caspase-3 and caspase-7 are two key effector caspases that play important roles in apoptotic pathways that maintain normal tissue and organ development and homeostasis. However, little is known about the sequence, structure, activity, and function of effector caspases upon apoptosis in mollusks, especially marine bivalves. In this study, we investigated the possible roles of two executioner caspases in the regulation of apoptosis in the Pacific oyster Crassostrea gigas. A full-length capase-3-like gene named Cgcaspase-3 was cloned from C. gigas cDNA, encoding a predicted protein containing caspase family p20 and p10 domain profiles and a conserved caspase active site motif. Phylogenetic analysis demonstrated that both Cgcaspase-3 and Cgcaspase-1 may function as effector caspases clustered in the invertebrate branch. Although the sequence identities between the two caspases was low, both enzymes possessed executioner caspase activity and were capable of inducing cell death. These results suggested that Cgcaspase-3 and Cgcaspase-1 were two effector caspases in C. gigas. We also observed that nucleus-localized Cgcaspase-3, may function as a caspase-3-like protein and cytoplasm-localized Cgcaspase-1 may function as a caspase-7-like protein. Both Cgcaspase-3 and Cgcaspase-1 mRNA expression increased after larvae settled on the substratum, suggesting that both caspases acted in several tissues or organs that degenerated after oyster larvae settlement. The highest caspase expression levels were observed in the gills indicating that both effector caspases were likely involved in immune or metabolic processes in C. gigas.	[Qu, Tao; Huang, Baoyu; Zhang, Linlin; Li, Li; Xu, Fei; Huang, Wen; Li, Chunyan; Du, Yishuai; Zhang, Guofan] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Huang, Baoyu; Huang, Wen; Li, Chunyan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, L (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.	lili@qdio.ac.cn; gfzhang@qdio.ac.cn	li, li/GPX-3938-2022; LI, LI/GVS-5344-2022; Zhang, Linlin/I-4970-2014; huang, wen/GXW-0661-2022; Xu, Fei/A-1736-2012; Li, Li/AEM-3636-2022; li, li/HII-4157-2022	Zhang, Linlin/0000-0003-0247-7710; Xu, Fei/0000-0002-0981-8429; 	National Basic Research Program of China (973 Program) [2010CB126401]; National Natural Science Foundation of China [31302219]; National High Technology Research and Development Program (863 program) [2012AA10A405]; Mollusc Research and Development Center, CARS [CARS-48]; Taishan Scholars Climbing Program of Shandong; Oversea Taishan Scholar Program of Shandon	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program (863 program)(National High Technology Research and Development Program of China); Mollusc Research and Development Center, CARS; Taishan Scholars Climbing Program of Shandong; Oversea Taishan Scholar Program of Shandon	This research was supported by National Basic Research Program of China (973 Program, No. 2010CB126401), the National Natural Science Foundation of China (no. 31302219), National High Technology Research and Development Program (863 program, 2012AA10A405), Mollusc Research and Development Center, CARS(CARS-48), Taishan Scholars Climbing Program of Shandong and Oversea Taishan Scholar Program of Shandon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsopp TE, 2000, CELL DEATH DIFFER, V7, P984, DOI 10.1038/sj.cdd.4400733; Benjamin IJ, 2005, J CLIN INVEST, V115, P495, DOI 10.1172/JCI200524477; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buckley CD, 1999, NATURE, V397, P534, DOI 10.1038/17409; Cowling V, 2002, CELL DEATH DIFFER, V9, P1046, DOI 10.1038/sj.cdd.4401065; Du YS, 2013, FISH SHELLFISH IMMUN, V34, P939, DOI 10.1016/j.fsi.2012.12.007; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Evans S, 2009, AQUACULTURE, V286, P211, DOI 10.1016/j.aquaculture.2008.09.022; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Hacker G, 2000, CELL TISSUE RES, V301, P5, DOI 10.1007/s004410000193; Houde C, 2004, J NEUROSCI, V24, P9977, DOI 10.1523/JNEUROSCI.3356-04.2004; Kamada S, 2005, J BIOL CHEM, V280, P857, DOI 10.1074/jbc.C400538200; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Lacoste A, 2002, J CELL SCI, V115, P761; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Leonard JR, 2002, J NEUROPATH EXP NEUR, V61, P673, DOI 10.1093/jnen/61.8.673; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Monnier PP, 2011, J NEUROSCI, V31, P10494, DOI 10.1523/JNEUROSCI.0148-11.2011; Nasirudeen AMA, 2001, PARASITOL RES, V87, P559, DOI 10.1007/s004360100427; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Sahara S, 1999, NATURE, V401, P168, DOI 10.1038/43678; Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x; Shi XD, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037054, 10.1371/journal.pone.0030828]; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang LL, 2011, DEV COMP IMMUNOL, V35, P603, DOI 10.1016/j.dci.2011.01.005; Zheng TS, 1998, P NATL ACAD SCI USA, V95, P13618, DOI 10.1073/pnas.95.23.13618	33	51	55	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89040	10.1371/journal.pone.0089040	http://dx.doi.org/10.1371/journal.pone.0089040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551213	Green Published, Green Submitted, gold			2022-12-27	WOS:000331266000093
J	Zhou, Y; Shu, FR; Liang, XY; Chang, H; Shi, LY; Peng, XL; Zhu, JD; Mi, MT				Zhou, Yong; Shu, Furong; Liang, Xinyu; Chang, Hui; Shi, Linying; Peng, Xiaoli; Zhu, Jundong; Mi, Mantian			Ampelopsin Induces Cell Growth Inhibition and Apoptosis in Breast Cancer Cells through ROS Generation and Endoplasmic Reticulum Stress Pathway	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; REACTIVE OXYGEN; OXIDATIVE STRESS; DIHYDROMYRICETIN; AUTOPHAGY; PACLITAXEL; RESISTANCE; DEATH	Ampelopsin (AMP), a major bioactive constituent of Ampelopsis grossedentata, exerts a number of biological effects. In this study, we investigated its anti-cancer activity in human breast cancer cell lines, and explored the underlying mechanism of this action. Our results showed that treatment with AMP dose-dependently inhibited cell viability and induced apoptosis in MCF-7 and MDA-MB-231 breast cancer cells without cytotoxicity in human normal breast epithelial cells MCF-10A. Meanwhile, AMP dose-dependently triggered reactive oxygen species (ROS) generation in both breast cancer cells. The ROS scavenger N-acetyl-L-cysteine (NAC) strongly attenuated AMP-induced ROS production, along with cell growth inhibition and apoptosis. Furthermore, AMP was observed to activate endoplasmic reticulum (ER) stress, as evidenced by the up-regulation of ER stress-related proteins, including GRP78, p-PERK, p-elF2 alpha, cleaved ATF6 alpha and CHOP, while knockdown of ATF6 alpha or PERK markedly down-regulated AMP-induced CHOP expression. Blocking ER stress using 4-phenylbutyric acid not only down-regulated AMP-induced GRP78 and CHOP expression, but also significantly decreased AMP-induced cell growth inhibition and apoptosis, whereas ER stress inducer thapsigargin played opposing effects. Additionally, NAC inhibited AMP-induced ER stress by down-regulating GRP78 and CHOP expression. Conversely, blocking ER stress using CHOP siRNA decreased AMP-induced ROS production and cell apoptosis. Taken together, these results demonstrate that AMP has anti-tumor effects against breast cancer cells through ROS generation and ER stress pathway, which therefore provide experimental evidences for developing AMP as a new therapeutic drug for breast cancer.	[Zhou, Yong; Shu, Furong; Liang, Xinyu; Chang, Hui; Shi, Linying; Peng, Xiaoli; Zhu, Jundong; Mi, Mantian] Third Mil Med Univ, Res Ctr Nutr & Food Safety, Chongqing Key Lab Nutr & Food Safety, Inst Mil Prevent Med,Res Ctr Med Nutr, Chongqing, Peoples R China	Army Medical University	Zhu, JD (corresponding author), Third Mil Med Univ, Res Ctr Nutr & Food Safety, Chongqing Key Lab Nutr & Food Safety, Inst Mil Prevent Med,Res Ctr Med Nutr, Chongqing, Peoples R China.	zhujundong2013@126.com; mantian_mi@163.com		Chang, Hui/0000-0001-6693-2570	special fund of Chongqing key laboratory (CSTC) for Nutrition and Food Safety	special fund of Chongqing key laboratory (CSTC) for Nutrition and Food Safety	This work was supported by the special fund of Chongqing key laboratory (CSTC) for Nutrition and Food Safety. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishayee A, 2011, FRONT BIOSCI-LANDMRK, V16, P980, DOI 10.2741/3730; Di X, 2009, BIOCHEM PHARMACOL, V77, P1139, DOI 10.1016/j.bcp.2008.12.016; Feldman DE, 2005, MOL CANCER RES, V3, P597, DOI 10.1158/1541-7786.MCR-05-0221; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Huang J, 2011, ANTIOXID REDOX SIGN, V14, P2215, DOI 10.1089/ars.2010.3554; Jang KY, 2012, CANCER LETT, V319, P197, DOI 10.1016/j.canlet.2012.01.008; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang DH, 2013, CANCER LETT, V335, P404, DOI 10.1016/j.canlet.2013.02.059; Khongkow M, 2013, CARCINOGENESIS, V34, P1476, DOI 10.1093/carcin/bgt098; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kitamura M, 2008, AM J PHYSIOL-RENAL, V295, pF323, DOI 10.1152/ajprenal.00050.2008; Lau ATY, 2008, J CELL BIOCHEM, V104, P657, DOI 10.1002/jcb.21655; Li H, 2008, J AOAC INT, V91, P1278; Li L, 2012, FREE RADICAL BIO MED, V53, P1399, DOI 10.1016/j.freeradbiomed.2012.07.011; Li YC, 2012, TOXICOL APPL PHARM, V263, P21, DOI 10.1016/j.taap.2012.05.018; Li ZY, 2011, BIOCHEM BIOPH RES CO, V414, P5, DOI 10.1016/j.bbrc.2011.09.046; Liu BG, 2009, EUR FOOD RES TECHNOL, V230, P325, DOI 10.1007/s00217-009-1175-0; Lo C, 2011, MELANOMA RES, V21, P267, DOI 10.1097/CMR.0b013e3283414444; Lu DY, 2012, PHYTOMEDICINE, V19, P1093, DOI 10.1016/j.phymed.2012.06.010; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Mandl J, 2013, MOL ENDOCRINOL, V27, P384, DOI 10.1210/me.2012-1317; Mates JM, 2000, INT J BIOCHEM CELL B, V32, P157, DOI 10.1016/S1357-2725(99)00088-6; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; NI F, 2012, PLOS ONE, V7; Pierre AS, 2013, BBA-MOL CELL BIOL L, V1831, P759, DOI 10.1016/j.bbalip.2013.01.005; Quick QA, 2012, EXP THER MED, V3, P487, DOI 10.3892/etm.2011.422; Rigoulet M, 2011, ANTIOXID REDOX SIGN, V14, P459, DOI 10.1089/ars.2010.3363; Shen Y, 2012, J NEUROSCI, V32, P390, DOI 10.1523/JNEUROSCI.4639-11.2012; Shi JM, 2013, BIOCHEM PHARMACOL, V85, P913, DOI 10.1016/j.bcp.2013.01.009; SHI Y, 2012, PLOS ONE, V7; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Wlodkowic D, 2009, LEUKEMIA RES, V33, P1440, DOI 10.1016/j.leukres.2009.05.025; Woo KJ, 2007, BIOCHEM PHARMACOL, V73, P68, DOI 10.1016/j.bcp.2006.09.015; Yang JG, 2011, J MED PLANTS RES, V5, P114; Yang LH, 2012, MOL MED REP, V6, P1126, DOI 10.3892/mmr.2012.1023; Younce C, 2012, CELL PHYSIOL BIOCHEM, V30, P307, DOI 10.1159/000339066; Zhang BL, 2012, ANTI-CANCER DRUG, V23, P590, DOI 10.1097/CAD.0b013e32835019f9; Zhang YS, 2007, MAGN RESON CHEM, V45, P909, DOI 10.1002/mrc.2051; Zhao L, 2009, AGRO FOOD IND HI TEC, V20, P14; Zhu GY, 2011, EUR J PHARMACOL, V668, P88, DOI 10.1016/j.ejphar.2011.06.008	42	79	103	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89021	10.1371/journal.pone.0089021	http://dx.doi.org/10.1371/journal.pone.0089021			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551210	Green Submitted, Green Published, gold			2022-12-27	WOS:000331266000091
J	Koundourakis, NE; Androulakis, NE; Malliaraki, N; Tsatsanis, C; Venihaki, M; Margioris, AN				Koundourakis, Nikolaos E.; Androulakis, Nikolaos E.; Malliaraki, Niki; Tsatsanis, Christos; Venihaki, Maria; Margioris, Andrew N.			Discrepancy between Exercise Performance, Body Composition, and Sex Steroid Response after a Six-Week Detraining Period in Professional Soccer Players	PLOS ONE			English	Article							SKELETAL-MUSCLE; ENDURANCE; ADAPTATIONS; STRENGTH; HORMONE; TESTOSTERONE; SPRINT; POWER; MEN; PROTEIN	Purpose: The aim of this study was to examine the effects of a six-week off-season detraining period on exercise performance, body composition, and on circulating sex steroid levels in soccer players. Methods: Fifty-five professional male soccer players, members of two Greek Superleague Teams (Team A, n = 23; Team B, n = 22), participated in the study. The first two weeks of the detraining period the players abstained from any physical activity. The following four weeks, players performed low-intensity (50%-60% of VO(2)max) aerobic running of 20 to 30 minutes duration three times per week. Exercise performance testing, anthropometry, and blood sampling were performed before and after the six-week experimental period. Results: Our data showed that in both teams A and B the six-week detraining period resulted in significant reductions in maximal oxygen consumption (60,31 +/- 2,52 vs 57,67 +/- 2,54; p<0.001, and 60,47 +/- 4,13 vs 58,30 +/- 3,88; p<0.001 respectively), squat-jump (39,70 +/- 3,32 vs 37,30 +/- 3,08; p<0.001, and 41,05 +/- 3,34 vs 38,18 +/- 3,03; p<0.001 respectively), and countermovement-jump (41,04 +/- 3,99 vs 39,13 +/- 3,26; p<0.001 and 42,82 +/- 3,60 vs 40,09 +/- 2,79; p<0.001 respectively), and significant increases in 10-meters sprint (1,74<0,063 vs 1,79 +/- 0,064; p<0.001, and 1,73 +/- 0,065 vs 1,78 +/- 0,072; p<0.001 respectively), 20-meters sprint (3,02 +/- 0,05 vs 3,06 +/- 0,06; p<0.001, and 3,01 +/- 0,066 vs 3,06 +/- 0,063; p<0.001 respectively), body fat percentage (Team A; p<0.001, Team B; p<0.001), and body weight (Team A; p<0.001, Team B; p<0.001). Neither team displayed any significant changes in the resting concentrations of total-testosterone, free-testosterone, dehydroepiandrosterone-sulfate, Delta 4-androstenedione, estradiol, luteinizing hormone, follicle-stimulating hormone, and prolactin. Furthermore, sex steroids levels did not correlate with exercise performance parameters. Conclusion: Our results suggest that the six-week detraining period resulted in a rapid loss of exercise performance adaptations and optimal body composition status, but did not affect sex steroid resting levels. The insignificant changes in sex steroid concentration indicate that these hormones were a non-contributing parameter for the observed negative effects of detraining on exercise performance and body composition.	[Koundourakis, Nikolaos E.; Malliaraki, Niki; Tsatsanis, Christos; Venihaki, Maria; Margioris, Andrew N.] Univ Crete, Sch Med, Dept Clin Chem Biochem, Iraklion, Greece; [Androulakis, Nikolaos E.] Univ Hosp, Dept Hematol Lab, Iraklion, Greece; [Malliaraki, Niki; Margioris, Andrew N.] Univ Hosp, Iraklion, Greece	University of Crete; University of Patras; University of Patras	Koundourakis, NE (corresponding author), Univ Crete, Sch Med, Dept Clin Chem Biochem, Iraklion, Greece.	nkoyndoy@hotmail.com	Tsatsanis, Christos/AAM-9362-2020; Tsatsanis, Christos/C-2516-2018; Koundourakis, Nikolaos E/AAA-7667-2021	Tsatsanis, Christos/0000-0003-1214-4151; Tsatsanis, Christos/0000-0003-1214-4151; Androulakis, Nikolaos/0000-0001-8842-2360; Koundourakis, Nikolaos/0000-0002-3385-4956				AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Alison B1 MD, 2004, PRINCIPLES GENDER SP, P759; Amigo N, 1998, J SPORT MED PHYS FIT, V38, P298; ANDERSON KE, 1987, LIFE SCI, V40, P1761, DOI 10.1016/0024-3205(87)90086-5; Benardot D, 2006, ADV SPORTS NUTR, P309; Borer T, 2003, EXERCISE ENDOCRINOLO; Caldwell BP, 2009, J STRENGTH COND RES, V23, P1370, DOI 10.1519/JSC.0b013e3181a4e82f; Cangemi R, 2010, AGING CELL, V9, P236, DOI 10.1111/j.1474-9726.2010.00553.x; COYLE EF, 1984, J APPL PHYSIOL, V57, P1857, DOI 10.1152/jappl.1984.57.6.1857; Day DS, 2005, J CLIN ENDOCR METAB, V90, P3312, DOI 10.1210/jc.2004-1344; Esbjornsson-Liljedahl M, 1999, J APPL PHYSIOL, V87, P1326, DOI 10.1152/jappl.1999.87.4.1326; Garcia-Pallares J, 2010, EUR J APPL PHYSIOL, V110, P99, DOI 10.1007/s00421-010-1484-9; GEORGIADIS EI, 1992, HORM METAB RES, V24, P488, DOI 10.1055/s-2007-1003369; Gibney J, 2005, AM J PHYSIOL-ENDOC M, V289, pE266, DOI 10.1152/ajpendo.00483.2004; Hackney A C, 1989, Br J Sports Med, V23, P194; HAKKINEN K, 1985, EUR J APPL PHYSIOL O, V53, P287, DOI 10.1007/BF00422840; HAKKINEN K, 1983, MED SCI SPORT EXER, V15, P455; Hall HL, 1999, CLIN J SPORT MED, V9, P203, DOI 10.1097/00042752-199910000-00004; Hardman AE, 1998, J APPL PHYSIOL, V84, P1895, DOI 10.1152/jappl.1998.84.6.1895; HICKSON RC, 1982, J APPL PHYSIOL, V53, P225, DOI 10.1152/jappl.1982.53.1.225; Horstman AM, 2012, J GERONTOL A-BIOL, V67, P1140, DOI 10.1093/gerona/gls068; HORTOBAGYI T, 1993, MED SCI SPORT EXER, V25, P929; Hoshikawa Y, 2004, J SPORTS SCI, V22, P531; HOUMARD JA, 1992, INT J SPORTS MED, V13, P572, DOI 10.1055/s-2007-1024567; Izquierdo M, 2007, J STRENGTH COND RES, V21, P768; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; Kalapotharakos VI, 2011, J STRENGTH COND RES, V25, P1502, DOI 10.1519/JSC.0b013e3181da85a9; Kraemer WJ, 2002, J STRENGTH COND RES, V16, P373; Labrie F, 1997, J CLIN ENDOCR METAB, V82, P2396, DOI 10.1210/jc.82.8.2396; LaForgia J, 1999, EUR J CLIN NUTR, V53, P126, DOI 10.1038/sj.ejcn.1600689; MADSEN K, 1993, J APPL PHYSIOL, V75, P1444, DOI 10.1152/jappl.1993.75.4.1444; Markovic G, 2004, J STRENGTH COND RES, V18, P551, DOI 10.1519/00124278-200408000-00028; MARTIN WH, 1986, J AM COLL CARDIOL, V7, P982, DOI 10.1016/S0735-1097(86)80215-7; Maughan RJ, 1997, J SPORT SCI, V15, P265; McArdle W, 2009, EXERCISE PHYSL ENERG, P192; MOORE RL, 1987, J APPL PHYSIOL, V63, P1719, DOI 10.1152/jappl.1987.63.5.1719; Mujika I, 2000, SPORTS MED, V30, P79, DOI 10.2165/00007256-200030020-00002; NELSON AG, 1990, PHYS THER, V70, P287, DOI 10.1093/ptj/70.5.287; NEUFER PD, 1989, SPORTS MED, V8, P302, DOI 10.2165/00007256-198908050-00004; Ormsbee MJ, 2012, J STRENGTH COND RES, V26, P2087, DOI 10.1519/JSC.0b013e31823b874c; Orwoll E, 2006, J CLIN ENDOCR METAB, V91, P1336, DOI 10.1210/jc.2005-1830; Ostojic SM., 2003, J EXERC PHYSL ONLINE, V6, P3; Perez-Gomez J, 2008, EUR J APPL PHYSIOL, V102, P685, DOI 10.1007/s00421-007-0648-8; Phillips GB, 1996, EUR J ENDOCRINOL, V134, P201, DOI 10.1530/eje.0.1340201; Ramirez ME, 1997, METABOLISM, V46, P179, DOI 10.1016/S0026-0495(97)90299-7; Reilly T., 2003, SCI SOCCER; Rodriguez NR, 2009, MED SCI SPORT EXER, V41, P709, DOI 10.1249/MSS.0b013e31890eb86; Ross A, 2001, SPORTS MED, V31, P1063, DOI 10.2165/00007256-200131150-00003; Stolen T, 2005, SPORTS MED, V35, P501; Stone MH, 2003, J STRENGTH COND RES, V17, P140; Thorstensson, 1976, Acta Physiol Scand Suppl, V443, P1; Tremblay MS, 2004, J APPL PHYSIOL, V96, P531, DOI 10.1152/japplphysiol.00656.2003; Wang PT, 2006, CHINESE J PHYSIOL, V49, P251	53	65	67	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e87803	10.1371/journal.pone.0087803	http://dx.doi.org/10.1371/journal.pone.0087803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586293	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900019
J	Raizada, N; Sachdeva, KS; Chauhan, DS; Malhotra, B; Reddy, K; Dave, PV; Mundade, Y; Patel, P; Ramachandran, R; Das, R; Solanki, R; Wares, DF; Sahu, S; O'Brien, R; Paramasivan, CN; Dewan, PK				Raizada, Neeraj; Sachdeva, K. S.; Chauhan, D. S.; Malhotra, Bharti; Reddy, Kishore; Dave, P. V.; Mundade, Yamuna; Patel, Pranav; Ramachandran, Ranjani; Das, Ram; Solanki, Rajesh; Wares, Douglas Fraser; Sahu, Suvanand; O'Brien, Rick; Paramasivan, C. N.; Dewan, Puneet K.			A Multi-Site Validation in India of the Line Probe Assay for the Rapid Diagnosis of Multi-Drug Resistant Tuberculosis Directly from Sputum Specimens	PLOS ONE			English	Article							GENOTYPE MTBDR ASSAY; MYCOBACTERIUM-TUBERCULOSIS; ISONIAZID RESISTANCE; TREATMENT OUTCOMES; SOUTH-AFRICA; METAANALYSIS; RIFAMPIN; STRAINS; PERFORMANCE; MUTATIONS	Rifampicin (R) and isoniazid (H) are key first-line anti-tuberculosis drugs. Failure to detect resistance to these two drugs early results in treatment failure and poor clinical outcomes. The study purpose was to validate the use of the GenoType MTBDRplus line probe assay (LPA) to detect resistance to R and H in Mycobacterium tuberculosis strains directly from smearpositive sputum samples in India. Method: Smear positive sputum specimens from 320 patients were subjected to LPA and results compared against those from conventional Lowenstein Jensen (LJ) culture and drug susceptibility testing (C& DST). All specimens with discordant R DST results were subjected to either sequencing of the rpoB gene and/or repeat DST on liquid culture (MGIT 960) at a National Reference Laboratory. Results: Significantly higher proportion of interpretable results were observed with LPA compared to LJ C& DST (94% vs. 80%, p-value,0.01). A total of 248 patients had both LJ and LPA DST results available; 232 (93.5%) had concordant R DST results. Among the 16 discordant R DST results, 13 (81%) were resolved in agreement with LPA results. Final LPA performance characteristics were sensitivity 96% (CI: 90%-98%), specificity 99% (CI: 95%-99%), positive predictive value 99% (CI: 95%-99%), and negative predictive value 95% (CI: 89%-98%). The median turnaround testing time, including specimen transportation time, on LPA was 11 days as compared with 89 days for LJ C&DST. Conclusions: LPA proved highly accurate in the rapid detection of R resistance. The reduction in time to diagnosis may potentially enable earlier commencement of the appropriate drug therapy, leading to some reduction of transmission of drug-resistant strains.	[Raizada, Neeraj; Reddy, Kishore; Paramasivan, C. N.] Fdn Innovat New Diagnost, New Delhi, India; [Sachdeva, K. S.] Govt India, Cent TB Div, Directorate Gen Hlth Serv, Minist Hlth & Family Welf, New Delhi, India; [Chauhan, D. S.; Das, Ram] Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Agra, Uttar Pradesh, India; [Malhotra, Bharti] Sawai Man Singh Med Coll, Jaipur, Rajasthan, India; [Dave, P. V.; Patel, Pranav; Solanki, Rajesh] Directorate Hlth Serv, Gandhinagar, Gujarat, India; [Mundade, Yamuna] UNITAID, Geneva, Switzerland; [Ramachandran, Ranjani; Dewan, Puneet K.] WHO, New Delhi, India; [Wares, Douglas Fraser] WHO, Global TB Programme, CH-1211 Geneva, Switzerland; [Sahu, Suvanand] Stop TB Partnership, Geneva, Switzerland; [O'Brien, Rick] Fdn Innovat New Diagnost FIND, Geneva, Switzerland	Foundation For Innovative New Diagnostics; Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra; SMS Medical College & Hospital; World Health Organization; World Health Organization; Foundation For Innovative New Diagnostics	Raizada, N (corresponding author), Fdn Innovat New Diagnost, New Delhi, India.	drneerajraizada@gmail.com	Solanki, Dr. Rajesh/ABE-8666-2021	Solanki, Dr. Rajesh/0000-0003-3915-6064; Gray, Christen/0000-0002-9723-3032; Raizada, Neeraj/0000-0003-2116-332X; Nair, Sreenivas/0000-0002-2586-6797; Chauhan, Devendra Singh/0000-0001-6519-3200	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Albert H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-41; [Anonymous], GEN MTBDRPLUS VERS 1; [Anonymous], 2012, GUID PROGR MAN DRUG, P19; Barnard M, 2008, AM J RESP CRIT CARE, V177, P787, DOI 10.1164/rccm.200709-1436OC; Brossier F, 2006, J CLIN MICROBIOL, V44, P3659, DOI 10.1128/JCM.01054-06; Bwanga F, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-67; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Cavusoglu C, 2006, J CLIN MICROBIOL, V44, P2338, DOI 10.1128/JCM.00425-06; Evans J, 2009, J ANTIMICROB CHEMOTH, V63, P11, DOI 10.1093/jac/dkn433; Hillemann D, 2005, INT J TUBERC LUNG D, V9, P1161; Hillemann D, 2005, J CLIN MICROBIOL, V43, P3699, DOI 10.1128/JCM.43.8.3699-3703.2005; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Kent PT, 1985, GUIDE LEVEL 3 LAB; Ling DI, 2008, EUR RESPIR J, V32, P1165, DOI 10.1183/09031936.00061808; Makinen J, 2006, J CLIN MICROBIOL, V44, P350, DOI 10.1128/JCM.44.2.350-352.2006; Malik AN, 2005, LANCET INFECT DIS, V5, P174, DOI 10.1016/S1473-3099(05)01310-1; Miotto P, 2006, J CLIN MICROBIOL, V44, P2485, DOI 10.1128/JCM.00083-06; Nicol MP, 2008, T ROY SOC TROP MED H, V102, P955, DOI 10.1016/j.trstmh.2008.03.025; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Revised National tuberculosis programme, RNTCP STAT REP 2009; Srisuwanvilai LO, 2008, DIAGN MICR INFEC DIS, V61, P402, DOI 10.1016/j.diagmicrobio.2008.02.015; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; VESTAL AL, 1977, US DHEW PUBLICATION, P15; World Health Organisation, WHOHTMTB2012411	24	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88626	10.1371/journal.pone.0088626	http://dx.doi.org/10.1371/journal.pone.0088626			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586360	Green Submitted, gold, Green Published			2022-12-27	WOS:000331711900035
J	Liu, LY; Yu, YH; Hou, YS; Chai, JK; Duan, HJ; Chu, WL; Zhang, HJ; Hu, Q; Du, JD				Liu, Lingying; Yu, Yonghui; Hou, Yusen; Chai, Jiake; Duan, Hongjie; Chu, Wanli; Zhang, Haijun; Hu, Quan; Du, Jundong			Human Umbilical Cord Mesenchymal Stem Cells Transplantation Promotes Cutaneous Wound Healing of Severe Burned Rats	PLOS ONE			English	Article							BONE-MARROW; IN-VITRO; STROMAL CELLS; DIFFERENTIATION; THERAPY; REPAIR; INJURY	Background: Severe burns are a common and highly lethal trauma. The key step for severe burn therapy is to promote the wound healing as early as possible, and reports indicate that mesenchymal stem cell (MSC) therapy contributes to facilitate wound healing. In this study, we investigated effect of human umbilical cord MSCs (hUC-MSCs) could on wound healing in a rat model of severe burn and its potential mechanism. Methods: Adult male Wistar rats were randomly divided into sham, burn, and burn transplanted hUC-MSCs. GFP labeled hUC-MSCs or PBS was intravenous injected into respective groups. The rate of wound closure was evaluated by Image Pro Plus. GFP-labeled hUC-MSCs were tracked by in vivo bioluminescence imaging (BLI), and human-specific DNA expression in wounds was detected by PCR. Inflammatory cells, neutrophils, macrophages, capillaries and collagen types I/III in wounds were evaluated by histochemical staining. Wound blood flow was evaluated by laser Doppler blood flow meter. The levels of proinflammatory and anti-inflammatory factors, VEGF, collagen types I/III in wounds were analyzed using an ELISA. Results: We found that wound healing was significantly accelerated in the hUC-MSC therapy group. The hUC-MSCs migrated into wound and remarkably decreased the quantity of infiltrated inflammatory cells and levels of IL-1, IL-6, TNF-alpha and increased levels of IL-10 and TSG-6 in wounds. Additionally, the neovascularization and levels of VEGF in wounds in the hUC-MSC therapy group were markedly higher than those in other control groups. The ratio of collagen types I and III in the hUC-MSC therapy group were markedly higher than that in the burn group at indicated time after transplantation. Conclusion: The study suggests that hUC-MSCs transplantation can effectively improve wound healing in severe burned rat model. Moreover, these data might provide the theoretical foundation for the further clinical application of hUC-MSC in burn areas.	[Liu, Lingying; Yu, Yonghui; Hou, Yusen; Chai, Jiake; Duan, Hongjie; Chu, Wanli; Zhang, Haijun; Hu, Quan; Du, Jundong] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Burn & Plast Surg, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Chai, JK (corresponding author), Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Burn & Plast Surg, Beijing, Peoples R China.	cjk304@126.com	Yu, Yonghui/AAZ-4093-2021; Duan, Hongjie/HCI-0703-2022		National Natural Science Foundation of China [81372052]; General Financial Grant from the China Postdoctoral Science Foundation [2013M532200]; First Affiliated Hospital [QN201207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); General Financial Grant from the China Postdoctoral Science Foundation; First Affiliated Hospital	This work was supported by the National Natural Science Foundation of China (81372052), General Financial Grant from the China Postdoctoral Science Foundation (2013M532200), and the First Affiliated Hospital to the PLA General Hospital Science Research Foundation of China (QN201207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai ZM, 2013, CHINESE MED J-PEKING, V126, P1890, DOI 10.3760/cma.j.issn.0366-6999.20130045; Baksh D, 2007, STEM CELLS, V25, P1384, DOI 10.1634/stemcells.2006-0709; Bernardo ME, 2012, BONE MARROW TRANSPL, V47, P164, DOI 10.1038/bmt.2011.81; Chen K, 2010, CLIN IMMUNOL, V135, P448, DOI 10.1016/j.clim.2010.01.015; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Chu Wan-li, 2012, Zhonghua Yi Xue Za Zhi, V92, P853; Fong CY, 2007, REPROD BIOMED ONLINE, V15, P708, DOI 10.1016/S1472-6483(10)60539-1; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Han YF, 2011, BIOCHEM BIOPH RES CO, V413, P561, DOI 10.1016/j.bbrc.2011.09.001; Hocking AM, 2010, EXP CELL RES, V316, P2213, DOI 10.1016/j.yexcr.2010.05.009; Johansson U, 2008, DIABETES, V57, P2393, DOI 10.2337/db07-0981; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Krasnodembskaya A, 2010, STEM CELLS, V28, P2229, DOI 10.1002/stem.544; Lau K, 2009, EXP DERMATOL, V18, P921, DOI 10.1111/j.1600-0625.2009.00942.x; Leclerc T, 2011, CELL PROLIFERAT, V44, P48, DOI 10.1111/j.1365-2184.2010.00727.x; Li J, 2012, J ASIA TEFL, V9, P1, DOI 10.1186/1476-9255-9-33; Li JX, 2008, CELL RES, V18, P360, DOI 10.1038/cr.2007.103; Maxson S, 2012, STEM CELL TRANSL MED, V1, P142, DOI 10.5966/sctm.2011-0018; Oh JY, 2008, STEM CELLS, V26, P1047, DOI 10.1634/stemcells.2007-0737; Pillai SI, 2010, PHARM BIOL, V48, P1198, DOI 10.3109/13880200903578754; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Shi YH, 2012, BURNS, V38, P95, DOI 10.1016/j.burns.2010.06.002; Suzdaltseva YG, 2008, B EXP BIOL MED+, V145, P228, DOI 10.1007/s10517-008-0057-y; Tondreau T, 2009, CYTOTHERAPY, V11, P559, DOI 10.1080/14653240903051541; Troyer DL, 2008, STEM CELLS, V26, P591, DOI 10.1634/stemcells.2007-0439; Wang MJ, 2006, AM J PHYSIOL-REG I, V291, pR880, DOI 10.1152/ajpregu.00280.2006; Wang Y, 2009, SURGERY, V146, P198, DOI 10.1016/j.surg.2009.04.013; Yan H, 2013, CHINESE MED J-PEKING, V126, P1700, DOI 10.3760/cma.j.issn.0366-6999.20122728; Zhou YL, 2010, CHINESE MED J-PEKING, V123, P3282, DOI 10.3760/cma.j.issn.0366-6999.2010.22.021	30	153	168	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88348	10.1371/journal.pone.0088348	http://dx.doi.org/10.1371/journal.pone.0088348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586314	Green Published, gold, Green Submitted			2022-12-27	WOS:000331714700013
J	Chen, ZF; Zhang, HM; Wang, H; Matsumura, K; Wong, YH; Ravasi, T; Qian, PY				Chen, Zhang-Fan; Zhang, Huoming; Wang, Hao; Matsumura, Kiyotaka; Wong, Yue Him; Ravasi, Timothy; Qian, Pei-Yuan			Quantitative Proteomics Study of Larval Settlement in the Barnacle Balanus amphitrite	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; STATISTICAL-MODEL; ARGININE KINASE; GENE-EXPRESSION; CYPRIS LARVAE; CYCLIC-AMP; METAMORPHOSIS; PROTEIN; MUSCLE; INVOLVEMENT	Barnacles are major sessile components of the intertidal areas worldwide, and also one of the most dominant fouling organisms in fouling communities. Larval settlement has a crucial ecological effect not only on the distribution of the barnacle population but also intertidal community structures. However, the molecular mechanisms involved in the transition process from the larval to the juvenile stage remain largely unclear. In this study, we carried out comparative proteomic profiles of stage II nauplii, stage VI nauplii, cyprids, and juveniles of the barnacle Balanus amphitrite using labelfree quantitative proteomics, followed by the measurement of the gene expression levels of candidate proteins. More than 700 proteins were identified at each stage; 80 were significantly up-regulated in cyprids and 95 in juveniles vs other stages. Specifically, proteins involved in energy and metabolism, the nervous system and signal transduction were significantly up-regulated in cyprids, whereas proteins involved in cytoskeletal remodeling, transcription and translation, cell proliferation and differentiation, and biomineralization were up-regulated in juveniles, consistent with changes associated with larval metamorphosis and tissue remodeling in juveniles. These findings provided molecular evidence for the morphological, physiological and biological changes that occur during the transition process from the larval to the juvenile stages in B. amphitrite.	[Chen, Zhang-Fan; Wang, Hao; Matsumura, Kiyotaka; Wong, Yue Him; Qian, Pei-Yuan] Hong Kong Univ Sci & Technol, Div Life Sci, KAUST Global Collaborat Res Program, Hong Kong, Hong Kong, Peoples R China; [Zhang, Huoming] King Abdullah Univ Sci & Technol, Biosci Core Lab, Thuwal, Saudi Arabia; [Ravasi, Timothy] King Abdullah Univ Sci & Technol, Integrat Syst Biol Lab, Thuwal, Saudi Arabia	Hong Kong University of Science & Technology; King Abdullah University of Science & Technology; King Abdullah University of Science & Technology	Qian, PY (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, KAUST Global Collaborat Res Program, Hong Kong, Hong Kong, Peoples R China.	boqianpy@ust.hk	Ravasi, Timothy/B-8777-2008	Zhang, Huoming/0000-0001-5416-0358; Qian, Pei-Yuan/0000-0003-4074-9078; Ravasi, Timothy/0000-0002-9950-465X	Research Grants Council of the Hong Kong Special Administrative Region [GRF662413, AoE/P-04/04-II]; King Abdullah University of Science and Technology [SA-C0040/UK-C0016]	Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council); King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	This study was supported by grants from the Research Grants Council of the Hong Kong Special Administrative Region (GRF662413 and AoE/P-04/04-II) and an award from the King Abdullah University of Science and Technology (SA-C0040/UK-C0016) to P.-Y. Qian. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anil AC, 2010, J EXP MAR BIOL ECOL, V392, P89, DOI 10.1016/j.jembe.2010.04.012; Arbeitman MN, 2000, CELL, V101, P67, DOI 10.1016/S0092-8674(00)80624-8; BAXTER GT, 1992, BIOL BULL, V183, P147, DOI 10.2307/1542416; Berg J.M., 2002, BIOCHEMISTRY-US, V5th ed.; BERNARD FJ, 1962, J MORPHOL, V110, P19, DOI 10.1002/jmor.1051100103; BIANCHI A, 1990, J BIOL CHEM, V265, P1502; Bishop CD, 2001, BIOL BULL, V201, P394, DOI 10.2307/1543617; Bishop CD, 2001, J EXP ZOOL, V289, P374, DOI 10.1002/jez.1019; Braisted JC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-529; Chamberlin ME, 1997, J EXP BIOL, V200, P2789; Chandramouli KH, 2013, J PROTEOME RES, V12, P1344, DOI 10.1021/pr3010088; Chandramouli KH, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-51; Chen WT, 2008, DEV NEUROBIOL, V68, P1029, DOI 10.1002/dneu.20644; Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; CHOU TC, 1952, J BIOL CHEM, V196, P89; Clare AS, 1996, BIOFOULING, V10, P141, DOI 10.1080/08927019609386276; CLARE AS, 1995, J EXP BIOL, V198, P655; COSTLOW JOHN D., 1959, PHYSIOL ZOOL, V32, P177; De Gregoris TB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-62; DREYFUSS G, 1988, TRENDS BIOCHEM SCI, V13, P86, DOI 10.1016/0968-0004(88)90046-1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faimali M, 2003, BIOFOULING, V19, P213, DOI 10.1080/0892701021000044228; Footitt S, 2007, J EXP BOT, V58, P2959, DOI 10.1093/jxb/erm146; Gallus L, 2010, BIOFOULING, V26, P155, DOI 10.1080/08927010903391193; GIRAUD MM, 1981, COMP BIOCHEM PHYS A, V69, P381, DOI 10.1016/0300-9629(81)92993-5; Godenschwege TA, 2006, CURR BIOL, V16, P12, DOI 10.1016/j.cub.2005.11.062; Goss DJ, 2013, WIRES RNA, V4, P167, DOI 10.1002/wrna.1151; Gunter HM, 2007, DEV GENES EVOL, V217, P603, DOI 10.1007/s00427-007-0171-2; Han Z, 2013, J PROTEOME RES, V12, P2090, DOI 10.1021/pr301083e; Harrison PJH, 1999, BIOL BULL, V197, P144, DOI 10.2307/1542611; He LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064130; Heikkila JJ, 1997, CELL MOL LIFE SCI, V53, P114, DOI 10.1007/PL00000573; Heyland A, 2006, INTEGR COMP BIOL, V46, P743, DOI 10.1093/icb/icl023; Kamino K, 2000, J BIOL CHEM, V275, P27360; Kaneko Y, 2006, ZOOL SCI, V23, P533, DOI 10.2108/zsj.23.533; Katti C, 2010, J EXP BIOL, V213, P2589, DOI 10.1242/jeb.043869; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Knight J, 2000, J MAR BIOL ASSOC UK, V80, P113; KOULISH S, 1973, J MORPHOL, V140, P1, DOI 10.1002/jmor.1051400102; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Lagersson NC, 2002, MAR BIOL, V141, P513, DOI 10.1007/s00227-002-0854-1; Lagersson NC, 2002, J MAR BIOL ASSOC UK, V82, P573, DOI 10.1017/S0025315402005891; LANE ME, 1993, GENE DEV, V7, P1229, DOI 10.1101/gad.7.7a.1229; LEE JK, 1993, J CELL BIOL, V123, P1797, DOI 10.1083/jcb.123.6.1797; Levine MZ, 2001, J NEUROBIOL, V49, P277, DOI 10.1002/neu.10010; Li HL, 2010, J EXP MAR BIOL ECOL, V389, P45, DOI 10.1016/j.jembe.2010.03.019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; LUCAS MI, 1979, MAR BIOL, V55, P221, DOI 10.1007/BF00396822; Mahroof R, 2005, COMP BIOCHEM PHYS A, V141, P247, DOI 10.1016/j.cbpb.2005.05.044; Maruzzo D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037408; Melotte V, 2010, FASEB J, V24, P4153, DOI 10.1096/fj.09-151464; Meng W, 2008, ANAL CHEM, V80, P9797, DOI 10.1021/ac801344z; Miller M.A., 2010, P GAT COMP ENV WORKS; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Okazaki Y, 2000, GENE, V250, P127, DOI 10.1016/S0378-1119(00)00184-0; Pechenik JA, 2007, BIOL BULL-US, V213, P160, DOI 10.2307/25066632; Qian PY, 1999, HYDROBIOLOGIA, V402, P239, DOI 10.1023/A:1003704928668; Ritossa F, 1996, CELL STRESS CHAPERON, V1, P97, DOI 10.1379/1466-1268(1996)001<0097:DOTHSR>2.3.CO;2; Rozen S, 2000, Methods Mol Biol, V132, P365; SCHLAEPFER DD, 1990, J CELL BIOL, V111, P229, DOI 10.1083/jcb.111.1.229; SCHNEIDER A, 1989, INSECT BIOCHEM, V19, P471, DOI 10.1016/0020-1790(89)90029-2; Shimizu K, 1996, J EXP ZOOL, V276, P87, DOI 10.1002/(SICI)1097-010X(19961001)276:2<87::AID-JEZ1>3.0.CO;2-9; SRERE PA, 1953, J AM CHEM SOC, V75, P4874, DOI 10.1021/ja01115a547; Strumpf D, 1998, J CELL BIOL, V143, P1259, DOI 10.1083/jcb.143.5.1259; Thiyagarajan V, 2008, PROTEOMICS, V8, P3164, DOI 10.1002/pmic.200700904; UNDERWOOD AJ, 1989, TRENDS ECOL EVOL, V4, P16, DOI 10.1016/0169-5347(89)90008-6; Wang H, 2010, PROTEOMICS, V10, P2972, DOI 10.1002/pmic.201000056; Wang H, 2013, RES VET SCI, V95, P1125, DOI 10.1016/j.rvsc.2013.07.022; WOOLLACOTT RM, 1971, J MORPHOL, V134, P351, DOI 10.1002/jmor.1051340307; WROBLEWSKA B, 1993, J NEUROCHEM, V61, P943, DOI 10.1111/j.1471-4159.1993.tb03606.x; YAMAMOTO H, 1995, ZOOL SCI, V12, P391, DOI 10.2108/zsj.12.391; Yamamoto H, 1996, J EXP ZOOL, V275, P339, DOI 10.1002/(SICI)1097-010X(19960801)275:5<339::AID-JEZ2>3.0.CO;2-Q; Yamamoto H, 1997, ZOOL SCI, V14, P887, DOI 10.2108/zsj.14.887; Zhang HM, 2007, PROTEOMICS, V7, P1654, DOI 10.1002/pmic.200600579; Zhang HM, 2011, J PROTEOME RES, V10, P349, DOI 10.1021/pr100817v; Zhang HM, 2010, PROTEOMICS, V10, P2780, DOI 10.1002/pmic.201000066; Zhang YF, 2012, ACS CHEM BIOL, V7, P1049, DOI 10.1021/cb200545s; Zhang YF, 2011, BIOFOULING, V27, P467, DOI 10.1080/08927014.2011.583985; Zhang Y, 2010, J PROTEOME RES, V9, P4851, DOI 10.1021/pr100645z; Zhang Y, 2010, J PROTEOME RES, V9, P3146, DOI 10.1021/pr1000384; Zhao J, 2001, EUR J NEUROSCI, V13, P340, DOI 10.1046/j.1460-9568.2001.01396.x	83	55	55	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88744	10.1371/journal.pone.0088744	http://dx.doi.org/10.1371/journal.pone.0088744			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24714416	gold, Green Published, Green Submitted			2022-12-27	WOS:000331266000059
J	Chen, LH; Li, CX; Sargolzaei, M; Schenkel, F				Chen, Liuhong; Li, Changxi; Sargolzaei, Mehdi; Schenkel, Flavio			Impact of Genotype Imputation on the Performance of GBLUP and Bayesian Methods for Genomic Prediction	PLOS ONE			English	Article							RELATIONSHIP MATRIX; ACCURACY; SELECTION; VALUES; RELIABILITY; NUCLEOTIDE; STRATEGIES; CATTLE; CHIPS	The aim of this study was to evaluate the impact of genotype imputation on the performance of the GBLUP and Bayesian methods for genomic prediction. A total of 10,309 Holstein bulls were genotyped on the BovineSNP50 BeadChip (50 k). Five low density single nucleotide polymorphism (SNP) panels, containing 6,177, 2,480, 1,536, 768 and 384 SNPs, were simulated from the 50 k panel. A fraction of 0%, 33% and 66% of the animals were randomly selected from the training sets to have low density genotypes which were then imputed into 50 k genotypes. A GBLUP and a Bayesian method were used to predict direct genomic values (DGV) for validation animals using imputed or their actual 50 k genotypes. Traits studied included milk yield, fat percentage, protein percentage and somatic cell score (SCS). Results showed that performance of both GBLUP and Bayesian methods was influenced by imputation errors. For traits affected by a few large QTL, the Bayesian method resulted in greater reductions of accuracy due to imputation errors than GBLUP. Including SNPs with largest effects in the low density panel substantially improved the accuracy of genomic prediction for the Bayesian method. Including genotypes imputed from the 6 k panel achieved almost the same accuracy of genomic prediction as that of using the 50 k panel even when 66% of the training population was genotyped on the 6 k panel. These results justified the application of the 6 k panel for genomic prediction. Imputations from lower density panels were more prone to errors and resulted in lower accuracy of genomic prediction. But for animals that have close relationship to the reference set, genotype imputation may still achieve a relatively high accuracy.	[Chen, Liuhong; Li, Changxi] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Li, Changxi] Agr & Agri Food Canada, Lacombe Res Ctr, Lacombe, AB, Canada; [Sargolzaei, Mehdi] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada; [Schenkel, Flavio] LAlliance Boviteq Inc, Quebec City, PQ, Canada	University of Alberta; Agriculture & Agri Food Canada; University of Guelph	Chen, LH (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	liuhong@ualberta.ca; schenkel@uoguelph.ca	Schenkel, Flavio/ABG-1842-2021	WU, KWAN-DUN/0000-0002-3339-1509; Schenkel, Flavio/0000-0001-8700-0633; CHEN, YUNG-MING/0000-0002-9241-1258	Natural Sciences and Engineering Research Council of Canada; L'Alliance Boviteq Inc., Quebec, Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); L'Alliance Boviteq Inc., Quebec, Canada	This work was supported by the Natural Sciences and Engineering Research Council of Canada, and L'Alliance Boviteq Inc., Quebec, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boichard D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034130; Calus M P L, 2008, Genetics, V178, P553, DOI 10.1534/genetics.107.080838; Calus MPL, 2010, ANIMAL, V4, P157, DOI 10.1017/S1751731109991352; Cleveland MA, 2013, J ANIM SCI, V91, P3583, DOI 10.2527/jas.2013-6270; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; Dassonneville R, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-40; Gianola D, 2009, GENETICS, V183, P347, DOI 10.1534/genetics.109.103952; Gilmour AR, 2009, ASREML USER GUIDE RE; Goddard ME, 2011, J ANIM BREED GENET, V128, P409, DOI 10.1111/j.1439-0388.2011.00964.x; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Habier D, 2009, GENETICS, V182, P343, DOI 10.1534/genetics.108.100289; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Huang YJ, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-25; Khatkar MS, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-538; Legarra A, 2009, J DAIRY SCI, V92, P4656, DOI 10.3168/jds.2009-2061; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen THE, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-35; Mulder HA, 2012, J DAIRY SCI, V95, P876, DOI 10.3168/jds.2011-4490; NejatiJavaremi A, 1997, J ANIM SCI, V75, P1738; Sargolzaei M, 2008, J DAIRY SCI, V91, P2106, DOI 10.3168/jds.2007-0553; Sargolzaei M, 2011, GEBV SOFTWARE; Stachowicz K, 2011, J DAIRY SCI, V94, P5160, DOI 10.3168/jds.2010-3308; Van Doormaal B, 2012, GENOTYPING LOW DENSI; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Verbyla KL, 2009, GENET RES, V91, P307, DOI 10.1017/S0016672309990243; Weigel KA, 2010, J DAIRY SCI, V93, P5423, DOI 10.3168/jds.2010-3149; Wiggans GR, 2013, J DAIRY SCI, V96, P1258, DOI 10.3168/jds.2012-6192; Wiggans GR, 2011, J DAIRY SCI, V94, P6188, DOI 10.3168/jds.2011-4481; Zhang Z, 2011, J DAIRY SCI, V94, P3642, DOI 10.3168/jds.2010-3917; Zhang Z, 2010, J DAIRY SCI, V93, P5487, DOI 10.3168/jds.2010-3501; Zhang Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012648	34	80	86	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101544	10.1371/journal.pone.0101544	http://dx.doi.org/10.1371/journal.pone.0101544			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	24551186	gold, Green Submitted, Green Published			2022-12-27	WOS:000339992400017
J	Chen, CY; Borsuk, ME; Bugge, DM; Hollweg, T; Balcom, PH; Ward, DM; Williams, J; Mason, RP				Chen, Celia Y.; Borsuk, Mark E.; Bugge, Deenie M.; Hollweg, Terill; Balcom, Prentiss H.; Ward, Darren M.; Williams, Jason; Mason, Robert P.			Benthic and Pelagic Pathways of Methylmercury Bioaccumulation in Estuarine Food Webs of the Northeast United States	PLOS ONE			English	Article							SUBMARINE GROUNDWATER DISCHARGE; DISSOLVED ORGANIC-CARBON; SAN-FRANCISCO-BAY; INORGANIC MERCURY; GAS-CHROMATOGRAPHY; CONTINENTAL-SHELF; METHYL MERCURY; CHESAPEAKE BAY; TRACE-METALS; SEDIMENTS	Methylmercury (MeHg) is a contaminant of global concern that bioaccumulates and bioamagnifies in marine food webs. Lower trophic level fauna are important conduits of MeHg from sediment and water to estuarine and coastal fish harvested for human consumption. However, the sources and pathways of MeHg to these coastal fisheries are poorly known particularly the potential for transfer of MeHg from the sediment to biotic compartments. Across a broad gradient of human land impacts, we analyzed MeHg concentrations in food webs at ten estuarine sites in the Northeast US (from the Hackensack Meadowlands, NJ to the Gulf of Maine). MeHg concentrations in water column particulate material, but not in sediments, were predictive of MeHg concentrations in fish (killifish and Atlantic silversides). Moreover, MeHg concentrations were higher in pelagic fauna than in benthic-feeding fauna suggesting that MeHg delivery to the water column from methylation sites from within or outside of the estuary may be an important driver of MeHg bioaccumulation in estuarine pelagic food webs. In contrast, bulk sediment MeHg concentrations were only predictive of concentrations of MeHg in the infaunal worms. Our results across a broad gradient of sites demonstrate that the pathways of MeHg to lower trophic level estuarine organisms are distinctly different between benthic deposit feeders and forage fish. Thus, even in systems with contaminated sediments, transfer of MeHg into estuarine food webs maybe driven more by the efficiency of processes that determine MeHg input and bioavailability in the water column.	[Chen, Celia Y.; Bugge, Deenie M.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Borsuk, Mark E.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Hollweg, Terill] Stratus Consulting, Boulder, CO USA; [Balcom, Prentiss H.; Mason, Robert P.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Ward, Darren M.] Humboldt State Univ, Dept Fisheries Biol, Arcata, CA 95521 USA; [Williams, Jason] Washington State Univ, Dept Civil & Environm Engn, Pullman, WA 99164 USA	Dartmouth College; Dartmouth College; University of Connecticut; California State University System; California State Polytechnic University, Humboldt; Washington State University	Chen, CY (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	Celia.Y.Chen@dartmouth.edu	Borsuk, Mark/AAV-1663-2020; Ward, Darren/F-1203-2010; Zhou, Hua/HGC-9504-2022; Lu, Po-Liang/D-4499-2009; Siu, Leung-Kei/C-1368-2010	Ward, Darren/0000-0002-0049-5299; Lu, Po-Liang/0000-0002-7423-6783; Mason, Robert/0000-0002-7443-4931; Hollweg, Terill/0000-0002-0165-5653; Borsuk, Mark/0000-0002-5121-1110; Zhou, hua/0000-0002-2718-4108; Chen, Ying-Tsong/0000-0003-1337-4127	NIH from the National Institute of Environmental Health Sciences [P42 ES007373]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021950, P42ES007373] Funding Source: NIH RePORTER	NIH from the National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The project described was supported by NIH Grant Number P42 ES007373 from the National Institute of Environmental Health Sciences. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcom PH, 2004, MAR CHEM, V90, P53, DOI 10.1016/j.marchem.2004.02.020; Balcom PH, 2008, MAR CHEM, V109, P1, DOI 10.1016/j.marchem.2007.09.005; Beck AJ, 2009, ESTUAR COAST, V32, P535, DOI 10.1007/s12237-009-9140-5; Benoit JM, 1998, BIOGEOCHEMISTRY, V40, P249, DOI 10.1023/A:1005905700864; Benoit JM, 2003, ACS SYM SER, V835, P262; BLOOM N, 1989, CAN J FISH AQUAT SCI, V46, P1131, DOI 10.1139/f89-147; BLOOM N, 1988, ANAL CHIM ACTA, V208, P151, DOI 10.1016/S0003-2670(00)80743-6; BLOOM NS, 1983, MAR CHEM, V14, P49, DOI 10.1016/0304-4203(83)90069-5; Bone SE, 2007, ENVIRON SCI TECHNOL, V41, P3090, DOI 10.1021/es0622453; Chasar LC, 2009, ENVIRON SCI TECHNOL, V43, P2733, DOI 10.1021/es8027567; Chen CY, 2009, ENVIRON SCI TECHNOL, V43, P1804, DOI 10.1021/es8017122; Chen CM, 2012, J ELECTRON MATER, V41, P1, DOI 10.1007/s11664-011-1777-8; Cleckner LB, 2003, J GREAT LAKES RES, V29, P134, DOI 10.1016/S0380-1330(03)70422-5; Coelho JP, 2008, MAR POLLUT BULL, V56, P1104, DOI 10.1016/j.marpolbul.2008.03.020; COMPEAU GC, 1985, APPL ENVIRON MICROB, V50, P498, DOI 10.1128/AEM.50.2.498-502.1985; Conaway CH, 2003, MAR CHEM, V80, P199, DOI 10.1016/S0304-4203(02)00135-4; Davis JA, 2012, ENVIRON RES, V119, P3, DOI 10.1016/j.envres.2012.10.002; Deegan LA, 1997, MAR ECOL PROG SER, V147, P31, DOI 10.3354/meps147031; DRISCOLL CT, 1995, WATER AIR SOIL POLL, V80, P499, DOI 10.1007/BF01189700; FITZGERALD WF, 1979, ANAL CHEM, V51, P1714, DOI 10.1021/ac50047a030; Fitzgerald WF, 2010, SYNTHESIS ASSESSMENT; Fitzgerald WF, 2007, CHEM REV, V107, P641, DOI 10.1021/cr050353m; FRY B, 1984, CONTRIB MAR SCI, V27, P13; Fry B, 2008, MAR ECOL PROG SER, V369, P193, DOI 10.3354/meps07644; Fry B, 2012, ECOL APPL, V22, P606, DOI 10.1890/11-0921.1; Gagnon C, 1997, ENVIRON SCI TECHNOL, V31, P993, DOI 10.1021/es960364k; Galvan K, 2011, J EXP MAR BIOL ECOL, V410, P1, DOI 10.1016/j.jembe.2011.08.007; Gehrke GE, 2011, ENVIRON SCI TECHNOL, V45, P1264, DOI 10.1021/es103053y; GILL GA, 1985, DEEP-SEA RES, V32, P287, DOI 10.1016/0198-0149(85)90080-9; Gorski PR, 2008, ENVIRON POLLUT, V154, P116, DOI 10.1016/j.envpol.2007.12.004; GRIEB TM, 1990, ENVIRON TOXICOL CHEM, V9, P919, DOI [10.1897/1552-8618(1990)9[919:FAMAIF]2.0.CO;2, 10.1002/etc.5620090710]; Guo LD, 2001, ENVIRON SCI TECHNOL, V35, P885, DOI 10.1021/es001758l; Haas HL, 2009, J EXP MAR BIOL ECOL, V369, P8, DOI 10.1016/j.jembe.2008.09.027; Hall BD, 1997, WATER AIR SOIL POLL, V100, P13; Hammerschmidt CR, 2008, MAR CHEM, V109, P165, DOI 10.1016/j.marchem.2008.01.007; Hammerschmidt CR, 2006, GEOCHIM COSMOCHIM AC, V70, P918, DOI 10.1016/j.gca.2005.10.020; Hammerschmidt CR, 2004, MAR CHEM, V90, P31, DOI 10.1016/j.marchem.2004.02.024; Hesterberg D, 2001, ENVIRON SCI TECHNOL, V35, P2741, DOI 10.1021/es001960o; Heyes A, 2006, MAR CHEM, V102, P134, DOI 10.1016/j.marchem.2005.09.018; Hollweg TA, 2010, LIMNOL OCEANOGR, V55, P2703, DOI 10.4319/lo.2010.55.6.2703; Hollweg TA, 2009, MAR CHEM, V114, P86, DOI 10.1016/j.marchem.2009.04.004; HORVAT M, 1993, ANAL CHIM ACTA, V282, P153, DOI 10.1016/0003-2670(93)80364-Q; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Karagas MR, 2012, ENVIRON HEALTH PERSP, V120, P799, DOI 10.1289/ehp.1104494; Kim EH, 2004, MAR CHEM, V86, P121, DOI 10.1016/j.marchem.2003.12.004; Kim EH, 2006, MAR CHEM, V102, P300, DOI 10.1016/j.marchem.2006.05.006; Kim E, 2008, ECOL MODEL, V218, P267, DOI 10.1016/j.ecolmodel.2008.07.008; King JK, 1999, ENVIRON TOXICOL CHEM, V18, P1362, DOI 10.1002/etc.5620180704; Kiviat E, 2002, HACKENSACK MEADOWLAN; Langer C. S., 2001, Wetlands Ecology and Management, V9, P295, DOI 10.1023/A:1011816819369; Lawrence AL, 2001, ENVIRON POLLUT, V111, P217, DOI 10.1016/S0269-7491(00)00072-5; Lawrence AL, 1999, ENVIRON SCI TECHNOL, V33, P1871, DOI 10.1021/es981328j; Levin LA, 2001, ECOSYSTEMS, V4, P430, DOI 10.1007/s10021-001-0021-4; Liu B, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000752; Mason RP, 2006, MAR CHEM, V102, P96, DOI 10.1016/j.marchem.2005.09.021; Mason RP, 2012, ENVIRON RES, V119, P101, DOI 10.1016/j.envres.2012.03.013; Mason RP, 1999, ENVIRON TOXICOL CHEM, V18, P2438, DOI 10.1002/etc.5620181109; Mason RP, 1999, MAR CHEM, V65, P77, DOI 10.1016/S0304-4203(99)00012-2; MASON RP, 1995, WATER AIR SOIL POLL, V80, P915, DOI 10.1007/BF01189744; Mason RP, 1996, ENVIRON SCI TECHNOL, V30, P1835, DOI 10.1021/es950373d; Mergler D, 2007, AMBIO, V36, P3, DOI 10.1579/0044-7447(2007)36[3:MEAHEI]2.0.CO;2; Mikac N, 1999, APPL ORGANOMET CHEM, V13, P715, DOI 10.1002/(SICI)1099-0739(199910)13:10<715::AID-AOC918>3.0.CO;2-4; Morel FMM, 1998, ANNU REV ECOL SYST, V29, P543, DOI 10.1146/annurev.ecolsys.29.1.543; Pan JF, 2004, MAR ECOL PROG SER, V276, P125, DOI 10.3354/meps276125; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pickhardt PC, 2007, ENVIRON SCI TECHNOL, V41, P125, DOI 10.1021/es060966w; Pickhardt PC, 2006, ENVIRON TOXICOL CHEM, V25, P2132, DOI 10.1897/05-595R.1; Point D, 2007, ANAL BIOANAL CHEM, V389, P787, DOI 10.1007/s00216-007-1516-4; Power M, 2002, J APPL ECOL, V39, P819, DOI 10.1046/j.1365-2664.2002.00758.x; Rolfhus KR, 2001, GEOCHIM COSMOCHIM AC, V65, P407, DOI 10.1016/S0016-7037(00)00519-6; Rolfhus KR, 2011, ECOTOXICOLOGY, V20, P1520, DOI 10.1007/s10646-011-0733-y; Rutkiewicz J, 2011, ECOTOXICOLOGY, V20, P1669, DOI 10.1007/s10646-011-0730-1; Schartup AT, 2013, ENVIRON SCI TECHNOL, V47, P695, DOI 10.1021/es302566w; Scheulhammer AM, 2007, AMBIO, V36, P12, DOI 10.1579/0044-7447(2007)36[12:EOEMOT]2.0.CO;2; Shanley J.B., 2002, EOS T AM GEOPHYS UN, V83, P45; Skyllberg U, 2006, ENVIRON SCI TECHNOL, V40, P4174, DOI 10.1021/es0600577; Skyllberg U, 2010, ENVIRON SCI TECHNOL, V44, P1254, DOI 10.1021/es902091w; Stewart AR, 2008, CAN J FISH AQUAT SCI, V65, P2351, DOI 10.1139/F08-140; Sunderland EM, 2007, ENVIRON HEALTH PERSP, V115, P235, DOI 10.1289/ehp.9377; Sunderland EM, 2012, ENVIRON RES, V119, P27, DOI 10.1016/j.envres.2012.03.011; Sunderland EM, 2010, ENVIRON SCI TECHNOL, V44, P1698, DOI 10.1021/es9032524; Taylor DL, 2012, MAR POLLUT BULL, V64, P807, DOI 10.1016/j.marpolbul.2012.01.013; Taylor VF, 2008, ANAL BIOANAL CHEM, V392, P1283, DOI 10.1007/s00216-008-2403-3; Tseng CM, 2004, ANAL CHEM, V76, P7131, DOI 10.1021/ac049118e; United States :Environmental Protection Agency, 1998, 7473SW846 EPA; [USEPA] United States Environmental Protection Agency, 2001, EPA821R01020; USEPA United States Environmental Protection Agency, 2002, EPA821R02019; Watras CJ, 1998, SCI TOTAL ENVIRON, V219, P183, DOI 10.1016/S0048-9697(98)00228-9; WATRAS CJ, 1995, WATER AIR SOIL POLL, V84, P253, DOI 10.1007/BF00475343; WEIS P, 1986, ENVIRON POLLUT A, V40, P303, DOI 10.1016/0143-1471(86)90064-4; Wiener JG, 2012, ENVIRON POLLUT, V161, P350, DOI 10.1016/j.envpol.2011.09.025; Williams JJ, 2010, ENVIRON TOXICOL CHEM, V29, P1755, DOI 10.1002/etc.207; Wyn B, 2009, CAN J FISH AQUAT SCI, V66, P1532, DOI 10.1139/F09-097; Yee D, 2011, ENVIRON TOXICOL CHEM, V30, P88, DOI 10.1002/etc.366	95	115	123	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89305	10.1371/journal.pone.0089305	http://dx.doi.org/10.1371/journal.pone.0089305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	25144712	gold, Green Published, Green Submitted			2022-12-27	WOS:000331706700137
J	Chen, CJ; Wu, TL; Lu, PL; Chen, YT; Fung, CP; Chuang, YC; Lin, JC; Siu, LK				Chen, Chao-Ju; Wu, Tsu-Lan; Lu, Po-Liang; Chen, Ying-Tsong; Fung, Chang-Phone; Chuang, Yin-Ching; Lin, Jung-Chung; Siu, L. Kristopher			Closely Related NDM-1-Encoding Plasmids from Escherichia coli and Klebsiella pneumoniae in Taiwan	PLOS ONE			English	Article							BETA-LACTAMASE; 1ST IDENTIFICATION; RESISTANCE; STRAINS; PATIENT; OXYTOCA; NDM-1; INCN	Objective: Two plasmids carrying bla(NDM-1) isolated from carbapenem-resistant Klebsiella pneumoniae (CR-KP) and carbapenem-resistant Escherichia coli (CR-EC) were sequenced. CR-KP and CR-EC were isolated from two Taiwanese patients without travel histories. Methods: Complete sequencing of the plasmids (pLK75 and pLK78) was conducted using a shotgun approach. Annotation of the contigs was performed using the RAST Server, followed by manual inspection and correction. Results: These similar plasmids were obtained from two patients with overlapping stays at the same hospital. The pLK75 and pLK78 plasmids were 56,489-bp and 56,072-bp in length, respectively. Plasmid annotation revealed a common backbone similar to the IncN plasmid pR46. The regions flanking the bla(NDM-1) genes in these plasmids were very similar to plasmid pNDM-HU01 in Japan, which contains a complex class 1 integron located next to an ISCR1 element. The ISCR1 element has been suggested to provide a powerful mechanism for mobilising antibiotic resistance genes. Conclusion: Two indigenous NDM-1-producing Enterobacteriaceae cases were identified for the first time in Taiwan, highlighting the alarming introduction of NDM-1-producing Enterobacteriaceae in this region.	[Chen, Chao-Ju; Lu, Po-Liang] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Chao-Ju; Lu, Po-Liang] Kaohsiung Med Univ, Coll Med, Kaohsiung, Taiwan; [Wu, Tsu-Lan] Linkou Chang Gung Mem Hosp, Dept Clin Pathol, Taoyuan, Taiwan; [Chen, Ying-Tsong] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Chen, Ying-Tsong] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan; [Chen, Ying-Tsong] Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli, Taiwan; [Fung, Chang-Phone] Taipei Vet Gen Hosp, Dept Med, Infect Dis Sect, Taipei, Taiwan; [Chuang, Yin-Ching] Chi Mei Med Ctr, Dept Internal Med & Med Res, Tainan, Taiwan; [Chuang, Yin-Ching] Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan; [Lin, Jung-Chung; Siu, L. Kristopher] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan; [Lin, Jung-Chung] Natl Def Med Ctr, Inst Microbiol & Immunol, Taipei, Taiwan; [Siu, L. Kristopher] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Siu, L. Kristopher] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Chang Gung Memorial Hospital; National Chung Hsing University; National Chung Hsing University; National Health Research Institutes - Taiwan; Taipei Veterans General Hospital; Chi Mei Hospital; Chi Mei Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; China Medical University Taiwan; National Health Research Institutes - Taiwan	Lin, JC (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan.	linjungchung1@yahoo.com.tw	Borsuk, Mark/AAV-1663-2020; Ward, Darren/F-1203-2010; Zhou, Hua/HGC-9504-2022; Lu, Po-Liang/D-4499-2009; Siu, Leung-Kei/C-1368-2010	Ward, Darren/0000-0002-0049-5299; Lu, Po-Liang/0000-0002-7423-6783; Mason, Robert/0000-0002-7443-4931; Hollweg, Terill/0000-0002-0165-5653; Borsuk, Mark/0000-0002-5121-1110; Zhou, hua/0000-0002-2718-4108; Chen, Ying-Tsong/0000-0003-1337-4127	Taiwan Centers for Diseases Control [DOH101-DC-1024, DOH102-DC-1508]; National Health Research Institutes; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021950, P42ES007373] Funding Source: NIH RePORTER	Taiwan Centers for Diseases Control; National Health Research Institutes(National Health Research Institutes, Japan); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the project grants, DOH101-DC-1024 and DOH102-DC-1508, from Taiwan Centers for Diseases Control and National Health Research Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Chen YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048737; Chen YT, 2009, ANTIMICROB AGENTS CH, V53, P1235, DOI 10.1128/AAC.00970-08; CLSI, 2013, PERFORMANCE STANDARD; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HALL RM, 1987, NUCLEIC ACIDS RES, V15, P7491, DOI 10.1093/nar/15.18.7491; Huang TW, 2013, ANTIMICROB AGENTS CH, V57, P4072, DOI 10.1128/AAC.02266-12; Huang TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062774; Humphrey B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-53; Kim MN, 2012, J CLIN MICROBIOL, V50, P1433, DOI 10.1128/JCM.06855-11; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Lai CC, 2011, DIAGN MICR INFEC DIS, V71, P474, DOI 10.1016/j.diagmicrobio.2011.09.004; Li J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089893; Ma L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-599; Nordmann P, 2011, TRENDS MICROBIOL, V19, P588, DOI 10.1016/j.tim.2011.09.005; Rolain JM, 2010, CLIN MICROBIOL INFEC, V16, P1699, DOI 10.1111/j.1469-0691.2010.03385.x; Siu LK, 1997, ANTIMICROB AGENTS CH, V41, P468, DOI 10.1128/AAC.41.2.468; Toleman MA, 2006, MICROBIOL MOL BIOL R, V70, P296, DOI 10.1128/MMBR.00048-05; Wang SJ, 2013, DIAGN MICR INFEC DIS, V76, P248, DOI 10.1016/j.diagmicrobio.2013.02.003; Wu HS, 2010, J CHIN MED ASSOC, V73, P596, DOI 10.1016/S1726-4901(10)70129-5; Yong Dongeun, 2009, Antimicrob Agents Chemother, V53, P5046, DOI 10.1128/AAC.00774-09	22	115	123	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104899	10.1371/journal.pone.0104899	http://dx.doi.org/10.1371/journal.pone.0104899			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144712	Green Published, Green Submitted, gold			2022-12-27	WOS:000341106100028
J	Chen, CB; Zhou, H; Zhang, XL; Ma, XL; Liu, ZJ; Liu, XG				Chen, Changbao; Zhou, Hua; Zhang, Xiaolin; Ma, Xinlong; Liu, Zhongjun; Liu, Xiaoguang			Elevated Levels of Dickkopf-1 Are Associated with beta-Catenin Accumulation and Poor Prognosis in Patients with Chondrosarcoma	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; CANCER BONE METASTASES; HEPATOCELLULAR CARCINOMAS; NUCLEAR ACCUMULATION; EXPRESSION; PROTEIN; GENE; DKK1; REGULATOR; OSTEOSARCOMA	Background: Dickkopf-1 (DKK1) is an antagonist of Wnt/beta-catenin signaling implicated in tumorigenesis. However, the biological role of DKK1 and beta-catenin involved in chondrosarcoma has not been sufficiently investigated. This study was designed to investigate the expression profiles of DKK1 and beta-catenin, and to clarify their clinical values in chondrosarcoma. Methods: The mRNA and protein levels of DKK1 and beta-catenin in fresh chondrosarcoma and the corresponding non-tumor tissues were analyzed by Real-time PCR and Western blot, respectively. The protein expression patterns of DKK1 and bcatenin were investigated by immunohistochemistry. The associations among DKK1 level, beta-catenin accumulation, clinicopathological factors and the overall survival were separately evaluated. Results: Both DKK1 and beta-catenin levels were remarkably elevated in chondrosarcoma compared with the corresponding non-tumor tissues. High DKK1 level and positive beta-catenin accumulation in chondrosarcoma specimens were 58.7% and 53.9%, respectively. Elevated DKK1 level significantly correlated with positive beta-catenin accumulation, and they were remarkably associated with histological grade and Musculoskeletal Tumor Society stage. Furthermore, DKK1 level and bcatenin accumulation had significant impacts on the prognosis of chondrosarcoma patients. Multivariate analysis revealed that DKK1 level was an independent prognostic factor for overall survival. Conclusions: Elevated DKK1 levels associated with beta-catenin accumulation play a crucial role in chondrosarcoma. DKK1 can serve as a novel predictor of poor prognosis in patients with chondrosarcoma.	[Chen, Changbao; Zhang, Xiaolin; Ma, Xinlong] Tianjin Hosp, Dept Spinal Surg, Tianjin, Peoples R China; [Zhou, Hua; Liu, Zhongjun; Liu, Xiaoguang] Peking Univ, Dept Orthopaed Surg, Hosp 3, Beijing 100871, Peoples R China	Peking University	Ma, XL (corresponding author), Tianjin Hosp, Dept Spinal Surg, Tianjin, Peoples R China.	richivaldchen@gmail.com	Borsuk, Mark/AAV-1663-2020; Ward, Darren/F-1203-2010; Zhou, Hua/HGC-9504-2022; Lu, Po-Liang/D-4499-2009; Siu, Leung-Kei/C-1368-2010	Ward, Darren/0000-0002-0049-5299; Lu, Po-Liang/0000-0002-7423-6783; Mason, Robert/0000-0002-7443-4931; Hollweg, Terill/0000-0002-0165-5653; Borsuk, Mark/0000-0002-5121-1110; Zhou, hua/0000-0002-2718-4108; Chen, Ying-Tsong/0000-0003-1337-4127	National Natural Sciences Foundation of China [81102037]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021950, P42ES007373] Funding Source: NIH RePORTER	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from the National Natural Sciences Foundation of China (81102037). http://www.nsfc.gov.cn. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Bertoni F., 2002, WHO CLASSIFICATION T, P247; Bovee JVMG, 2005, LANCET ONCOL, V6, P599, DOI 10.1016/S1470-2045(05)70282-5; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Chen C, 2001, ANN SURG ONCOL, V18, P2364; Chen CB, 2011, J ORTHOP RES, V29, P143, DOI 10.1002/jor.21193; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Ellwanger K, 2008, MOL CELL BIOL, V28, P4875, DOI 10.1128/MCB.00222-08; Forget MA, 2007, BRIT J CANCER, V96, P646, DOI 10.1038/sj.bjc.6603579; Gelderblom H, 2008, ONCOLOGIST, V13, P320, DOI 10.1634/theoncologist.2007-0237; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Hall CL, 2006, J CELL BIOCHEM, V97, P661, DOI 10.1002/jcb.20735; Hameetman L, 2006, J PATHOL, V209, P501, DOI 10.1002/path.2008; Haydon RC, 2002, INT J CANCER, V102, P338, DOI 10.1002/ijc.10719; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kuphal S, 2006, ONCOGENE, V25, P5027, DOI 10.1038/sj.onc.1209508; Lee N, 2007, BRIT J CANCER, V97, P1552, DOI 10.1038/sj.bjc.6604069; Li XQ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-114; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Menezes ME, 2012, INT J CANCER, V130, P1477, DOI 10.1002/ijc.26449; Mitani T, 2012, J BIOL CHEM, V287, P33594, DOI 10.1074/jbc.M112.388298; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; O'Shea PJ, 2012, J BIOL CHEM, V287, P17812, DOI 10.1074/jbc.M111.311464; Rozeman LB, 2006, INT ORTHOP, V30, P437, DOI 10.1007/s00264-006-0212-x; Saito T, 2000, J PATHOL, V192, P342, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH705>3.0.CO;2-R; Schrage YM, 2009, AM J PATHOL, V174, P979, DOI 10.2353/ajpath.2009.080623; Suzuki R, 2007, BRIT J HAEMATOL, V138, P624, DOI 10.1111/j.1365-2141.2007.06702.x; Terris B, 1999, ONCOGENE, V18, P6583, DOI 10.1038/sj.onc.1203051; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Voorzanger-Rousselot N, 2007, BRIT J CANCER, V97, P964, DOI 10.1038/sj.bjc.6603959; Wunder JS, 2007, LANCET ONCOL, V8, P513, DOI 10.1016/S1470-2045(07)70169-9; Xu WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037624; Yamabuki T, 2007, CANCER RES, V67, P2517, DOI 10.1158/0008-5472.CAN-06-3369; Yu B, 2009, J HEPATOL, V50, P948, DOI 10.1016/j.jhep.2008.11.020	37	115	123	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105414	10.1371/journal.pone.0105414	http://dx.doi.org/10.1371/journal.pone.0105414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144712	gold, Green Submitted, Green Published			2022-12-27	WOS:000341106100065
J	Chen, LX; Cai, Y; Zhou, GB; Shi, XJ; Su, JH; Chen, GW; Lin, K				Chen, Linxiang; Cai, Ying; Zhou, Guangbiao; Shi, Xiaojun; Su, Jianhui; Chen, Guanwu; Lin, Kun			Rapid Sanger Sequencing of the 16S rRNA Gene for Identification of Some Common Pathogens	PLOS ONE			English	Article							ESCHERICHIA-COLI STRAINS; BACTERIAL IDENTIFICATION; DNA; PCR; AMPLIFICATION; SHIGELLA; SYSTEM; MYCOBACTERIA; DATABASE; SAMPLES	Conventional Sanger sequencing remains time-consuming and laborious. In this study, we developed a rapid improved sequencing protocol of 16S rRNA for pathogens identification by using a new combination of SYBR Green I real-time PCR and Sanger sequencing with FTA (R) cards. To compare the sequencing quality of this method with conventional Sanger sequencing, 12 strains, including three kinds of strains (1 reference strain and 3 clinical strains, which were previously identified by biochemical tests), which have 4 Pseudomonas aeruginosa, 4 Staphyloccocus aureus and 4 Escherichia coli, were targeted. Additionally, to validate the sequencing results and bacteria identification, expanded specimens with 90 clinical strains, also comprised of the three kinds of strains which included 30 samples respectively, were performed as just described. The results showed that although statistical differences (P<0.05) were found in sequencing quality between the two methods, their identification results were all correct and consistent. The workload, the time consumption and the cost per batch were respectively light versus heavy, 8 h versus 11 h and $420 versus $400. In the 90 clinical strains, all of the Pseudomonas aeruginosa and Staphyloccocus aureus strains were correctly identified, but only 26.7% of the Escherichia coli strains were recognized as Escherichia coli, while 33.3% as Shigella sonnei and 40% as Shigella dysenteriae. The protocol described here is a rapid, reliable, stable and convenient method for 16S rRNA sequencing, and can be used for Pseudomonas aeruginosa and Staphyloccocus aureus identification, yet it is not completely suitable for discriminating Escherichia coli and Shigella strains.	[Chen, Linxiang; Shi, Xiaojun; Lin, Kun] Shantou Univ Med Coll, Dept Prevent Med, Shantou, Guangdong, Peoples R China; [Chen, Linxiang; Cai, Ying; Zhou, Guangbiao; Su, Jianhui; Chen, Guanwu] Shantou Entry Exit Inspect & Quarantine Bur, Mol Biol Lab, Shantou, Guangdong, Peoples R China		Lin, K (corresponding author), Shantou Univ Med Coll, Dept Prevent Med, Shantou, Guangdong, Peoples R China.	klin@stu.edu.cn	Schenkel, Flavio/ABG-1842-2021	WU, KWAN-DUN/0000-0002-3339-1509; Schenkel, Flavio/0000-0001-8700-0633; CHEN, YUNG-MING/0000-0002-9241-1258	Shantou Bureau of Science and Technology [[2009]387-126]; Guangdong Entry-Exit Inspection and Quarantine Bureau [2012 GDK45]; Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology	Shantou Bureau of Science and Technology; Guangdong Entry-Exit Inspection and Quarantine Bureau; Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology	Shantou Bureau of Science and Technology (grant No. [2009]387-126), Guangdong Entry-Exit Inspection and Quarantine Bureau (grant No. 2012 GDK45) Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aye KS, 2011, JPN J INFECT DIS, V64, P246; Becker K, 2004, J CLIN MICROBIOL, V42, P4988, DOI 10.1128/JCM.42.11.4988-4995.2004; Bhattacharya D, 2003, APPL ENVIRON MICROB, V69, P1435, DOI 10.1128/AEM.69.3.1435-1441.2003; Cloud JL, 2004, J CLIN MICROBIOL, V42, P578, DOI 10.1128/JCM.42.2.578-584.2004; Corless CE, 2000, J CLIN MICROBIOL, V38, P1747, DOI 10.1128/JCM.38.5.1747-1752.2000; Fukushima H, 2003, J CLIN MICROBIOL, V41, P5134, DOI 10.1128/JCM.41.11.5134-5146.2003; Fukushima M, 2002, J CLIN MICROBIOL, V40, P2779, DOI 10.1128/JCM.40.8.2779-2785.2002; Gustavsson I, 2009, J CLIN VIROL, V46, P112, DOI 10.1016/j.jcv.2009.06.021; Hall L, 2003, J CLIN MICROBIOL, V41, P1447, DOI 10.1128/JCM.41.4.1447-1453.2003; Han XY, 2002, AM J CLIN PATHOL, V118, P796, DOI 10.1309/HN44-XQYM-JMAQ-2EDL; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Lan R, 2001, TRENDS MICROBIOL, V9, P419, DOI 10.1016/S0966-842X(01)02133-3; Li YY, 2006, J CLIN MICROBIOL, V44, P4376, DOI 10.1128/JCM.01389-06; Menassa N, 2010, INVEST OPHTH VIS SCI, V51, P1905, DOI 10.1167/iovs.09-3737; Monnet C, 2006, APPL ENVIRON MICROB, V72, P6972, DOI 10.1128/AEM.01303-06; Mullen MP, 2009, IRISH J AGR FOOD RES, V48, P109; PEATTIE DA, 1979, P NATL ACAD SCI USA, V76, P1760, DOI 10.1073/pnas.76.4.1760; Petti CA, 2007, CLIN INFECT DIS, V44, P1108, DOI 10.1086/512818; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; Schuurman T, 2004, J CLIN MICROBIOL, V42, P734, DOI 10.1128/JCM.42.2.734-740.2004; Smith L. M., 2004, BMC Ecology, V4, P4, DOI 10.1186/1472-6785-4-4; Tewari D, 2011, J VET DIAGN INVEST, V23, P1104, DOI 10.1177/1040638711425583; Vliegen I, 2006, J MICROBIOL METH, V66, P156, DOI 10.1016/j.mimet.2005.11.005; Willi B, 2009, J CLIN MICROBIOL, V47, P4049, DOI 10.1128/JCM.01478-09; Woo PCY, 2001, DIAGN MICR INFEC DIS, V39, P85, DOI 10.1016/S0732-8893(01)00206-1; Woo PCY, 2003, J CLIN MICROBIOL, V41, P1996, DOI 10.1128/JCM.41.5.1996-2001.2003	27	80	86	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88886	10.1371/journal.pone.0088886	http://dx.doi.org/10.1371/journal.pone.0088886			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551186	gold, Green Published, Green Submitted			2022-12-27	WOS:000331271500079
J	Wang, LL; Sun, XY; Li, SY; Zhang, T; Zhang, W; Zhai, PH				Wang, Linlin; Sun, Xiangyang; Li, Suyan; Zhang, Tao; Zhang, Wei; Zhai, Penghui			Application of Organic Amendments to a Coastal Saline Soil in North China: Effects on Soil Physical and Chemical Properties and Tree Growth	PLOS ONE			English	Article							BIOLOGICAL-PROPERTIES; MICROBIAL COMMUNITIES; CATION-EXCHANGE; SEWAGE-SLUDGE; BEET VINASSE; SODIC SOILS; NITROGEN; RECLAMATION; PHOSPHORUS; POTASSIUM	The ability of the following four organic amendments to ameliorate saline soil in coastal northern China was investigated from April 2010 to October 2012 in a field experiment: green waste compost (GWC), sedge peat (SP), furfural residue (FR), and a mixture of GWC, SP and FR (1: 1: 1 by volume) (GSF). Compared to a non-amended control (CK), the amendments, which were applied at 4.5 kg organic matter m(-3), dramatically promoted plant growth; improved soil structure; increased the cation exchange capacity (CEC), organic carbon, and available nutrients; and reduced the salt content, electrical conductivity (EC), and exchangeable sodium percentage (ESP). At the end of the experiment in soil amended with GSF, bulk density, EC, and ESP had decreased by 11, 87, and 71%, respectively, and total porosity and organic carbon had increased by 25 and 96% respectively, relative to the CK. The GSF treatment resulted in a significantly lower Na++K+ content than the other treatments. CEC and the contents of available N, P, and K were significantly higher in the GSF-treated soil than in the CK and were the highest in all treatments. The FR treatment resulted in the lowest pH value and Ca2+ concentration, which decreased by 8% and 39%, respectively, relative to the CK. Overall, the results indicate that a combination of green waste compost, sedge peat and furfural residue (GSF treatment) has substantial potential for ameliorating saline soils in the coastal areas of northern China, and it works better than each amendment alone. Utilization of GWC and FR can be an alternative organic amendment to substitute the nonrenewable SP in saline soil amelioration.	[Wang, Linlin; Sun, Xiangyang; Li, Suyan; Zhang, Tao; Zhang, Wei; Zhai, Penghui] Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China; [Wang, Linlin] Forestry Res Inst Hulun Buir, Hulun Buir, Inner Mongolia, Peoples R China	Beijing Forestry University	Sun, XY (corresponding author), Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China.	sunxy1965@126.com; lisuyan@bjfu.edu.cn	; Williams, Robert W./H-8789-2016	Deng, Hong-Wen/0000-0002-0387-8818; Williams, Robert W./0000-0001-8924-4447; Farber, Charles/0000-0002-6748-4711; Wang, Cong-Yi/0000-0001-7914-168X; Habibovic, Pamela/0000-0001-8249-5155	Eleventh Five-Year Plan of the National Scientific and Technical Supporting Programs [2009BADB2B0504]; Fundamental Research Funds for the Central Universities; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051190, R01AR050496, R01AR064825, R01AR057049, P50AR055081, R01AR050066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564, P01AG018397, R03AG020321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016662] Funding Source: NIH RePORTER	Eleventh Five-Year Plan of the National Scientific and Technical Supporting Programs; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the Eleventh Five-Year Plan of the National Scientific and Technical Supporting Programs (No. 2009BADB2B0504), and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi MK, 2007, COMMUN SOIL SCI PLAN, V38, P1691, DOI 10.1080/00103620701435464; Amezketa E, 2005, AGRON J, V97, P983, DOI 10.2134/agronj2004.0236; Antil Rajinder Singh, 2007, Archives of Agronomy and Soil Science, V53, P519, DOI 10.1080/03650340701571033; BAO SD, 2005, ANAL SOIL AGROCHEMIS; BARKHAM JP, 1993, BIODIVERS CONSERV, V2, P556, DOI 10.1007/BF00056749; Barzegar AR, 1997, SOIL SCI SOC AM J, V61, P1131, DOI 10.2136/sssaj1997.03615995006100040020x; Bhattacharyya P, 2007, CHEMOSPHERE, V66, P1789, DOI 10.1016/j.chemosphere.2006.07.062; Brady AC, 2002, NATURE PROPERTIES SO; Clark GJ, 2007, SOIL BIOL BIOCHEM, V39, P2806, DOI 10.1016/j.soilbio.2007.06.003; Cooperband L., 2002, BUILDING SOIL ORGANI; David R, 2002, GEODERMA, V107, P271, DOI 10.1016/S0016-7061(01)00152-5; Feng YJ, 2006, PEDOSPHERE, V16, P668, DOI 10.1016/S1002-0160(06)60101-X; Hahn AS, 2013, PLANT SOIL, V363, P331, DOI 10.1007/s11104-012-1306-4; Hanay A, 2004, COMPOST SCI UTIL, V12, P175, DOI 10.1080/1065657x.2004.10702177; Hyvonen R, 2008, BIOGEOCHEMISTRY, V89, P121, DOI 10.1007/s10533-007-9121-3; Jackson M. L., 1958, Soil Chemical Analysis.; Kahlown MA, 2003, AGR WATER MANAGE, V62, P127, DOI 10.1016/S0378-3774(03)00096-9; Kaya C, 2001, J PLANT NUTR, V24, P357, DOI 10.1081/PLN-100001394; Larney FJ, 2012, CAN J SOIL SCI, V92, P19, DOI [10.4141/cjss2010-064, 10.4141/CJSS2010-064]; Liang B, 2006, SOIL SCI SOC AM J, V70, P1719, DOI 10.2136/sssaj2005.0383; Liang YC, 2003, GEODERMA, V115, P149, DOI 10.1016/S0016-7061(03)00084-3; Liu GQ, 2009, BIORESOURCE TECHNOL, V100, P5103, DOI 10.1016/j.biortech.2009.03.081; Mamedov AI, 2002, SOIL TILL RES, V68, P121, DOI 10.1016/S0167-1987(02)00115-0; Melero S, 2007, EUR J AGRON, V26, P327, DOI 10.1016/j.eja.2006.11.004; Oo AN, 2013, LAND DEGRAD DEV, DOI 101002/ldr2208; Page A.L., 1982, AGRONOMY SERIES, V9, DOI DOI 10.1002/JP1N.19851480319; Pocknee S, 1997, SOIL SCI SOC AM J, V61, P86, DOI 10.2136/sssaj1997.03615995006100010014x; Qadir M, 2007, ADV AGRON, V96, P197, DOI 10.1016/S0065-2113(07)96006-X; Qadir M, 2004, SCI TOTAL ENVIRON, V323, P1, DOI 10.1016/j.scitotenv.2003.10.012; Qadir M, 1998, SOIL TILL RES, V45, P119, DOI 10.1016/S0933-3630(96)00130-4; Qadir M, 2000, LAND DEGRAD DEV, V11, P501, DOI 10.1002/1099-145X(200011/12)11:6<501::AID-LDR405>3.0.CO;2-S; RICHARDS LA, 1954, AGR HDB, V60, P98; Rietz DN, 2003, SOIL BIOL BIOCHEM, V35, P845, DOI 10.1016/S0038-0717(03)00125-1; Roca-Perez L, 2009, CHEMOSPHERE, V75, P781, DOI 10.1016/j.chemosphere.2008.12.058; Ros M, 2003, SOIL BIOL BIOCHEM, V35, P463, DOI 10.1016/S0038-0717(02)00298-5; Sumner M.E., 2000, HDB SOIL SCI; Sun R, 2011, BIORESOURCES, V6, P317; Tejada M, 2008, BIORESOURCE TECHNOL, V99, P1758, DOI 10.1016/j.biortech.2007.03.052; Tejada M, 2006, SOIL BIOL BIOCHEM, V38, P1413, DOI 10.1016/j.soilbio.2005.10.017; Tejada M, 2006, SOIL SCI SOC AM J, V70, P900, DOI 10.2136/sssaj2005.0271; Tejada M, 2005, EUR J AGRON, V23, P336, DOI 10.1016/j.eja.2005.02.005; TUCKER BM, 1954, AUST J AGR RES, V5, P706, DOI 10.1071/AR9540706; Wang Z.Q., 1993, SALINE SOIL IN CHINA; Warman PR, 2005, BIORESOURCE TECHNOL, V96, P955, DOI 10.1016/j.biortech.2004.08.003; Wichern J, 2006, GEODERMA, V137, P100, DOI 10.1016/j.geoderma.2006.08.001; Withers PJA, 2003, SOIL USE MANAGE, V19, P28, DOI 10.1111/j.1475-2743.2003.tb00276.x; Wong VNL, 2009, APPL SOIL ECOL, V41, P29, DOI 10.1016/j.apsoil.2008.08.006; Xing Y, 2012, CELL CHEM TECHNOL, V46, P249; Yazdanpanah N, 2013, AGR WATER MANAGE, V120, P39, DOI 10.1016/j.agwat.2012.08.017; Zhang L, 2013, BIORESOURCE TECHNOL, V131, P68, DOI 10.1016/j.biortech.2012.10.059; Zhang XC, 2002, J HYDROL, V260, P194, DOI 10.1016/S0022-1694(01)00612-6	51	125	145	9	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89185	10.1371/journal.pone.0089185	http://dx.doi.org/10.1371/journal.pone.0089185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	25330365	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700132
J	Wang, LS; Lu, WL; Zhang, L; Huang, Y; Scheib, R; Liu, XY; Myers, L; Lu, L; Farber, CR; Liu, GF; Wang, CY; Deng, HW; Williams, RW; Wang, YJ; Gu, WK; Jiao, Y				Wang, Lishi; Lu, Wenli; Zhang, Lei; Huang, Yue; Scheib, Rachel; Liu, Xiaoyun; Myers, Linda; Lu, Lu; Farber, Charles R.; Liu, Gaifen; Wang, Cong-Yi; Deng, Hongwen; Williams, Robert W.; Wang, Yongjun; Gu, Weikuan; Jiao, Yan			Trps1 Differentially Modulates the Bone Mineral Density between Male and Female Mice and Its Polymorphism Associates with BMD Differently between Women and Men	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; TRICHORHINOPHALANGEAL-SYNDROME; MISSENSE MUTATION; GENE-EXPRESSION; POPULATION; IDENTIFICATION; METAANALYSIS; NETWORKS; LINKAGE; GROWTH	The objective of our study was to identify genetic factors that regulate bone mineral density (BMD) in mice using well defined recombinant inbred strains. For this purpose we chose the BXD recombinant inbred (RI) strains derived from progeny of the C57BL/6J (B6) and DBA/2J (D2) progenitor strains. We sampled both male and female mice (similar to 4 each) of 46 strains at 3 months-of-age, measured their BMD, and conducted QTL mapping. The data were analyzed to identify candidates genes contained within the most significant quantitative trait locus (QTL). Evaluation of candidate genes included functional assessment, single nucleotide polymorphism (SNP) genotyping and direct sequencing. We established that there was a QTL for BMD in males on chromosome 15 that has the impact larger than QTLs on all other chromosomes. The QTL on chromosome 15 was narrowed to a genomic region between 38 Mbp and 52 Mbp. By examining transcripts within this region, we found an important candidate gene: trichorhinophalangeal syndrome, type I (Trps1). SNP analysis identified a nonsynonymous SNP (rs32398060) in Trps1 that co-segregated with bone mineral density. Analysis of association between this SNP within TRPS1 and BMD in a human population confirmed its significance.	[Wang, Lishi; Lu, Wenli; Huang, Yue; Scheib, Rachel; Liu, Xiaoyun; Gu, Weikuan; Jiao, Yan] Univ Tennessee, Hlth Sci Ctr, Campbell Clin, Dept Orthoped Surg & BioMed Engn, Memphis, TN 38163 USA; [Wang, Lishi] Inner Mongolia Med Univ, Dept Basic Med, Hohhot, Inner Mongolia, Peoples R China; [Zhang, Lei; Deng, Hongwen] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Biostat & Bioinformat, New Orleans, LA USA; [Myers, Linda] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN USA; [Lu, Lu; Williams, Robert W.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN USA; [Farber, Charles R.] Univ Virginia, Dept Med, Div Cardiol, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Farber, Charles R.] Univ Virginia, Dept Biochem & Mol Genet, Div Cardiol, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Liu, Gaifen; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Wang, Cong-Yi] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Ctr Biomed Res, Wuhan 430074, Hubei, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; Inner Mongolia Medical University; Tulane University; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Virginia; University of Virginia; Capital Medical University; Huazhong University of Science & Technology	Gu, WK (corresponding author), Univ Tennessee, Hlth Sci Ctr, Campbell Clin, Dept Orthoped Surg & BioMed Engn, Memphis, TN 38163 USA.	wgu@uthsc.edu; yjiao2@utusc.edu	; Williams, Robert W./H-8789-2016	Deng, Hong-Wen/0000-0002-0387-8818; Williams, Robert W./0000-0001-8924-4447; Farber, Charles/0000-0002-6748-4711; Wang, Cong-Yi/0000-0001-7914-168X; Habibovic, Pamela/0000-0001-8249-5155	National Institute of Arthritis (NIA); Musculoskeletal and Skin Diseases, National Institutes of Health (NIH) [R01 AR51190]; Genediscovery Core at UTHSC; Veterans Administration Medical Center in Memphis, Tennessee; NIH [P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, R03TW008221, R01 AR/AG 41398, R01 AR050066, R03 AG20321]; Franklin D. Dickson/Missouri Endowment; Edward G. Schlieder Endowment; National Natural Science Foundation of China [31100902]; National Heart, Lung, and Blood Institute (NHLBI); Boston University [N01-HC-25195]; NHLBI [N02-HL-64278]; NIA Division of Geriatrics and Clinical Gerontology; Genetic Determinants of Bone Fragility [P01-AG018397]; NIH NIA; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051190, R01AR050496, R01AR064825, R01AR057049, P50AR055081, R01AR050066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564, P01AG018397, R03AG020321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016662] Funding Source: NIH RePORTER	National Institute of Arthritis (NIA); Musculoskeletal and Skin Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genediscovery Core at UTHSC; Veterans Administration Medical Center in Memphis, Tennessee; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Franklin D. Dickson/Missouri Endowment; Edward G. Schlieder Endowment; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston University; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA Division of Geriatrics and Clinical Gerontology; Genetic Determinants of Bone Fragility; NIH NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The study was partially supported by grants from the National Institute of Arthritis (NIA) and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH)(R01 AR51190 to W.G.), Genediscovery Core at UTHSC, and the Veterans Administration Medical Center in Memphis, Tennessee. H. W. D. was partially supported by grants from NIH (P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, and R03TW008221), the Franklin D. Dickson/Missouri Endowment and the Edward G. Schlieder Endowment. L.Z. was partially supported by National Natural Science Foundation of China (project 31100902). The Framingham Heart Study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University (Contract No. N01-HC-25195). This manuscript was not prepared in collaboration with investigators of the Framingham Heart Study and does not necessarily reflect the opinions or views of the Framingham Heart Study, Boston University, or NHLBI. Funding for SHARe genotyping was provided by NHLBI Contract N02-HL-64278. Funding support for the Framingham Bone Mineral Density datasets was provided by NIH grants R01 AR/AG 41398, R01 AR050066 and R03 AG20321. Funding support for the Genetic Determinants of Bone Fragility (the Indiana fragility study) was provided through the NIA Division of Geriatrics and Clinical Gerontology. Genetic Determinants of Bone Fragility is a genome-wide association studies funded as part of the NIA Division of Geriatrics and Clinical Gerontology. Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by the NIA Division of Geriatrics and Clinical Gerontology and the NIA Division of Aging Biology. Support for the collection of datasets and samples were provided by the parent grant, Genetic Determinants of Bone Fragility (P01-AG018397). Funding support for the genotyping which was performed at the Johns Hopkins University Center for Inherited Diseases Research was provided by the NIH NIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackert-Bicknell CL, 2012, BONE; Andreux PA, 2012, CELL, V150, P1287, DOI 10.1016/j.cell.2012.08.012; Beamer WG, 1999, MAMM GENOME, V10, P1043, DOI 10.1007/s003359901159; BONJOUR JP, 1994, OSTEOPOROSIS INT, V4, P7; Calabrese G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003150; CARRINGTON PR, 1994, J AM ACAD DERMATOL, V31, P331, DOI 10.1016/S0190-9622(94)70166-0; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Garnero P., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P50; Geisert EE, 2009, MOL VIS, V15, P1730; Grubb SC, 2004, BIOINFORMATICS, V20, P2857, DOI 10.1093/bioinformatics/bth299; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ishimori N, 2008, J BONE MINER RES, V23, P1529, DOI 10.1359/JBMR.080414; Jiao Y, 2008, GENOMICS, V91, P407, DOI 10.1016/j.ygeno.2007.12.010; Klein RF, 1998, J BONE MINER RES, V13, P1648, DOI 10.1359/jbmr.1998.13.11.1648; Kolta S, 2003, J CLIN DENSITOM, V6, P251, DOI 10.1385/JCD:6:3:251; Li GHY, 2011, HUM GENET, V130, P539, DOI 10.1007/s00439-011-0972-2; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu EY, 2013, GENET EPIDEMIOL, V37, P25, DOI 10.1002/gepi.21690; Lynch RM, 2010, PHYSIOL GENOMICS, V41, P244, DOI 10.1152/physiolgenomics.00020.2010; Milner LC, 2010, INT REV NEUROBIOL, V91, P173, DOI 10.1016/S0074-7742(10)91006-4; NOLTORP S, 1986, ANN RHEUM DIS, V45, P31, DOI 10.1136/ard.45.1.31; Orwoll ES, 2001, J BONE MINER RES, V16, P1962, DOI 10.1359/jbmr.2001.16.11.1962; Pei YF, 2013, HUM MOL GENET; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Rossi A, 2007, BRIT J DERMATOL, V157, P1021, DOI 10.1111/j.1365-2133.2007.08158.x; Sarafoglou K, 2010, CLIN GENET, V78, P591, DOI 10.1111/j.1399-0004.2010.01434.x; SCHNITZLER CM, 1993, CALCIFIED TISSUE INT, V53, pS27, DOI 10.1007/BF01673398; Soon G, 2006, CALCIFIED TISSUE INT, V78, P186, DOI 10.1007/s00223-005-0191-8; Suwanwela J, 2011, J BONE MINER RES, V26, P747, DOI 10.1002/jbmr.271; Tariq M, 2008, BRIT J DERMATOL, V159, P476, DOI 10.1111/j.1365-2133.2008.08658.x; Tremollieres F, 2010, MATURITAS, V65, P348, DOI 10.1016/j.maturitas.2009.12.023; Vaccaro M, 2009, PEDIATR DERMATOL, V26, P171, DOI 10.1111/j.1525-1470.2009.00905.x; Wang JT, 2003, NEUROINFORMATICS, V1, P299, DOI 10.1385/NI:1:4:299; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Xiong Q, 2008, BIOINFORMATICS, V24, P1011, DOI 10.1093/bioinformatics/btn002; Xiong Q, 2009, GENOMICS, V93, P401, DOI 10.1016/j.ygeno.2008.12.008; Yu H, 2007, CALCIFIED TISSUE INT, V80, P103, DOI 10.1007/s00223-006-0187-z; Zhang L, 2009, ANN HUM GENET, V73, P601, DOI 10.1111/j.1469-1809.2009.00539.x	42	125	145	9	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84485	10.1371/journal.pone.0084485	http://dx.doi.org/10.1371/journal.pone.0084485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	25330365	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500131
